Citrus Sinensis ID: 043902

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------
Protein Sequence
LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGNDKLCGGIQKLQLPECSRKNPRKRLSLKIVIPVTISVPIFILLLAALVIYHIVKTSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSKIRMREE
Secondary Structure (PSIPRED)
cccccccccccccHHHHccccccEEEcccccccccccHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccHHHHHHHHccccccccEEcccccEEEEEEEccccEEEEEEEEcccccccccHHHHHHHHHcccccccccEEEEccccccccccEEEEEEccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHcccccccEEccccccccccccccEEEEcccccccccccccccccccccccccccccccccccccccccccccccEEHHHHHHHHHHHccccccccccccccHHHHHHHHcccccccEEcccccHHcccccccccccccccccHHHHHHHHHHHHHHHHHHHHHccccccccccccHHHHHHHHHHHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
cccccccccccccHHHcccccccEEEcccccccccccHHHcccccccEEEEccccccccccHHcccccccHHEcccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccHHHccccEEcHHHHHHHHccccHccEEEEEccEEEEEEEcccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccEEEEEEccccccHHHHHccccccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEccccHHHEEccccccEEEEcccHHHHccccccccccccEEEEEEEcccccccHHHccccccccccHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHcccHHHccHHHHHHHHHHHHHHHccccHHEEcccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHHHcccccc
Coil and Loop (DISEMBL)
lylgnnsfkgtiPVSLKSLRGLAELDLscnnlsgkvPQFFSKLLSLRHLNLSYneldgeisregifANASAisivgndklcggiqklqlpecsrknprkrlslkivipvTISVPIFILLLAALVIYHIVKtsrrqsappsnewqsglsylkisnatdnfseenligsgsfgsvykgtladgETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSscssvdyegndFKALVFEFMRngnldqwlhpstdeychfkkLSLMQRLNIVIDVASALDYLhnqydtpiahcdlkssnvlldegmiahvgdfglakflfeesntpsknqtmsnglkgsvgyippeyinghvSILGDIYSYGILLLEIftgkrptddmfkddLSIHKFVLMALPSHVMDVLDLSMLLeeendhekheeedlfpdIESQVAQKKLEECLVSVMRIGVmcsaasprdrvgMKFVVNNLQAIRSKIRMREE
Flexible Loop (DISEMBL)
lylgnnsfkgtiPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGNDKLCGGIQKLqlpecsrknprkrlslkivipVTISVPIFILLLAALVIYHIVKtsrrqsappsnewqsgLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESntpsknqtmsngLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSaasprdrvgmkFVVNNlqairskirmree
Low Complexity Region (SEG)
LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGNDKLCGGIQKLQLPECSRKNPRKRLSLKIVIPVTISVPIFILLLAALVIYHIVKTSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLeeendhekheeedLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSKIRMREE
Disordered region (IsUnstruct)
*********GTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGNDKLCGGIQKLQLPECSRKNPRKRLSLKIVIPVTISVPIFILLLAALVIYHIVKT***************LSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFE***************KGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLL***********************QKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI*********
Disordered Region (DISOPRED)
LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGNDKLCGGIQ********************VIPVTISVPIFILLLAALVIYH********************SYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLF**************GLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLE*******************QVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI**KI*****
Disordered Region (DISEMBL)
LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGNDKLCGGIQKLQLPECSRKNPRKRLSLKIVIPVTISVPIFILLLAALVIYHIVKT*************SGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEE*********DLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSKIRMREE
Disordered Region (DISPRO)
*YLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGNDKLCGGIQKLQLPECSRK***KRLSLKIVIPVTISVPIFILLLAALVIYHIVKTSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI*SKI*****
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGNDKLCGGIQKLQLPECSRKNPRKRLSLKIVIPVTISVPIFILLLAALVIYHIVKTSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSKIRMREE
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	477	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.943	0.445	0.440	1e-110
Q9SD62	1025	Putative receptor-like pr	no	no	0.960	0.446	0.455	1e-101
C0LGT6	1031	LRR receptor-like serine/	no	no	0.926	0.428	0.400	3e-98
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.928	0.452	0.348	7e-65
Q9FL28	1173	LRR receptor-like serine/	no	no	0.909	0.369	0.311	2e-61
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.888	0.338	0.347	2e-56
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.888	0.339	0.330	2e-55
C0LGX3	993	LRR receptor-like serine/	no	no	0.930	0.447	0.321	3e-50
Q9FRS6	1029	Leucine-rich repeat recep	no	no	0.897	0.415	0.304	6e-50
Q9SGP2	996	Receptor-like protein kin	no	no	0.882	0.422	0.323	4e-49

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  398 bits (1022), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 215/488 (44%), Positives = 309/488 (63%), Gaps = 38/488 (7%)

Query: 1    LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
            L+L  N F G IP  LK L G+ E+DLS N+LSG +P++F+    L +LNLS+N L+G++
Sbjct: 534  LFLEGNLFYGDIP-DLKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKV 592

Query: 61   SREGIFANASAISIVGNDKLCGGIQKLQLPECSRKNPR------KRLSLKIVIPVTISVP 114
              +GIF NA+ +SIVGN+ LCGGI   QL  C  + P        RL  K+VI V++ + 
Sbjct: 593  PVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLK-KVVIGVSVGIT 651

Query: 115  IFILLLAALVIYHIVKTSRRQSAPPSNEWQSGL-------SYLKISNATDNFSEENLIGS 167
            + +LL  A V    ++  R+++   +N   S L       SY  + NAT+ FS  N++GS
Sbjct: 652  LLLLLFMASVTLIWLR-KRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGS 710

Query: 168  GSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVD 226
            GSFG+VYK  L  + +  A+KVL +Q++GA+KSF+ EC +L  IRHRN++K++++CSS+D
Sbjct: 711  GSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSID 770

Query: 227  YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCH--FKKLSLMQRLNIVIDVASALDYLHNQ 284
            ++GN+F+AL++EFM NG+LD WLHP   E  H   + L+L++RLNI IDVAS LDYLH  
Sbjct: 771  FQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVH 830

Query: 285  YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
               PIAHCDLK SNVLLD+ + AHV DFGLA+ L +       NQ  S G++G++GY  P
Sbjct: 831  CHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAP 890

Query: 345  EY-INGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLS 403
            EY + G  SI GD+YS+GILLLE+FTGKRPT+++F  + +++ +   ALP  ++D++D S
Sbjct: 891  EYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDES 950

Query: 404  MLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN 463
            +L      H        FP +          ECL  V  +G+ C   SP +R+    VV 
Sbjct: 951  IL------HIGLRVG--FPVV----------ECLTMVFEVGLRCCEESPMNRLATSIVVK 992

Query: 464  NLQAIRSK 471
             L +IR +
Sbjct: 993  ELISIRER 1000

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  370 bits (949), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 225/494 (45%), Positives = 296/494 (59%), Gaps = 36/494 (7%)

Query: 1    LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
            L L  NSF G IP  ++ L GL  LDLS NNLSG +P++ +    L++LNLS N  DG +
Sbjct: 550  LLLQGNSFVGPIP-DIRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAV 608

Query: 61   SREGIFANASAISIVGNDKLCGGIQKLQLPECSRKNPRKRLSLKIVIPVTISVPIFILLL 120
              EG+F N SA+S+ GN  LCGGI  LQL  CS + PR+  S++ +I + +S  +  LLL
Sbjct: 609  PTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLL 668

Query: 121  AALVI-----YHI-VKTSRR------QSAPPSNEWQSGLSYLKISNATDNFSEENLIGSG 168
              L +     Y + VK+ R       +S  P   +   +SY ++   T  FS  NLIGSG
Sbjct: 669  LCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSG 728

Query: 169  SFGSVYKGTLADGETA-AIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDY 227
            +FG+V+KG L     A AIKVL L ++GA KSFI EC AL  IRHRN++K+V+ CSS D+
Sbjct: 729  NFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDF 788

Query: 228  EGNDFKALVFEFMRNGNLDQWLHPSTDEYCH--FKKLSLMQRLNIVIDVASALDYLHNQY 285
            EGNDF+ALV+EFM NGNLD WLHP   E      + L L  RLNI IDVASAL YLH   
Sbjct: 789  EGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYC 848

Query: 286  DTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPE 345
              PIAHCD+K SN+LLD+ + AHV DFGLA+ L +        Q  S G++G++GY  PE
Sbjct: 849  HNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPE 908

Query: 346  Y-INGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPS-HVMDVLDLS 403
            Y + GH SI+GD+YS+GI+LLEIFTGKRPT+ +F D L++H F   AL     +D+ D +
Sbjct: 909  YGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDET 968

Query: 404  MLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN 463
            +L      H                    + ECL  V R+GV CS  SP +R+ M   ++
Sbjct: 969  ILRGAYAQH------------------FNMVECLTLVFRVGVSCSEESPVNRISMAEAIS 1010

Query: 464  NLQAIRSKIRMREE 477
             L +IR      EE
Sbjct: 1011 KLVSIRESFFRDEE 1024

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  359 bits (921), Expect = 3e-98,   Method: Compositional matrix adjust.
 Identities = 196/489 (40%), Positives = 290/489 (59%), Gaps = 47/489 (9%)

Query: 1    LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
            L++  NSF G IP  +  L  L  +D S NNLSG++P++ + L SLR+LNLS N+ +G +
Sbjct: 542  LFMQGNSFDGAIP-DISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRV 600

Query: 61   SREGIFANASAISIVGNDKLCGGIQKLQLPEC-SRKNPRKRLSL----KIVIPVTISVPI 115
               G+F NA+A+S+ GN  +CGG++++QL  C  + +PRKR  L    K+V  + I +  
Sbjct: 601  PTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIAS 660

Query: 116  FILLLAALVIYHIVKTSRRQSAP---PSNEWQSGL-----SYLKISNATDNFSEENLIGS 167
             +L++    +   +K  ++ +A    PS+    G+     SY ++ +AT  FS  NLIGS
Sbjct: 661  LLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGS 720

Query: 168  GSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVD 226
            G+FG+V+KG L  + +  A+KVL L + GA KSF+ EC     IRHRN++K+++ CSS+D
Sbjct: 721  GNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLD 780

Query: 227  YEGNDFKALVFEFMRNGNLDQWLHPSTDEYC--HFKKLSLMQRLNIVIDVASALDYLHNQ 284
             EGNDF+ALV+EFM  G+LD WL     E    H + L+  ++LNI IDVASAL+YLH  
Sbjct: 781  SEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVH 840

Query: 285  YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
               P+AHCD+K SN+LLD+ + AHV DFGLA+ L++       NQ  S G++G++GY  P
Sbjct: 841  CHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAP 900

Query: 345  EY-INGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLS 403
            EY + G  SI GD+YS+GILLLE+F+GK+PTD+ F  D ++H +                
Sbjct: 901  EYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYT--------------- 945

Query: 404  MLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN 463
                          + +     S      ++E L  V+++G+ CS   PRDR+     V 
Sbjct: 946  --------------KSILSGCTSSGGSNAIDEGLRLVLQVGIKCSEEYPRDRMRTDEAVR 991

Query: 464  NLQAIRSKI 472
             L +IRSK 
Sbjct: 992  ELISIRSKF 1000

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  248 bits (633), Expect = 7e-65,   Method: Compositional matrix adjust.
 Identities = 170/488 (34%), Positives = 261/488 (53%), Gaps = 45/488 (9%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L  N F  T+P SL  L  L ELD+S N L+G +P  F +  +L+HLN S+N L G +
Sbjct: 496 LNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNV 555

Query: 61  SREGIFANASAISIVGNDKLCGGIQKLQLPECSRKNPRKRLSLKIVIPVTISVPIFILLL 120
           S +G F+  +  S +G+  LCG I+ +Q   C +K+ +    L  V+   I+ P+  +  
Sbjct: 556 SDKGSFSKLTIESFLGDSLLCGSIKGMQ--ACKKKH-KYPSVLLPVLLSLIATPVLCVFG 612

Query: 121 AALV----------IYHIVKTSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSF 170
             LV          +Y   +    +    ++     +SY ++  AT  F+  +LIGSG F
Sbjct: 613 YPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRF 672

Query: 171 GSVYKGTLADGETAAIKVLKLQQQGALK---SFIDECNALTSIRHRNILKIVSSCSSVDY 227
           G VYKG L +    A+KV  L  + AL+   SF  EC  L   RHRN+++I+++CS    
Sbjct: 673 GHVYKGVLRNNTKVAVKV--LDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKP-- 728

Query: 228 EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDT 287
               F ALV   M NG+L++ L+P   EY   K L L+Q +NI  DVA  + YLH+    
Sbjct: 729 ---GFNALVLPLMPNGSLERHLYPG--EYSS-KNLDLIQLVNICSDVAEGIAYLHHYSPV 782

Query: 288 PIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG-----LKGSVGYI 342
            + HCDLK SN+LLD+ M A V DFG+++ +     T S + ++S G     L GSVGYI
Sbjct: 783 KVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYI 842

Query: 343 PPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLD 401
            PEY  G   S  GD+YS+G+LLLEI +G+RPTD +  +  S+H+F    + SH  D L+
Sbjct: 843 APEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEF----MKSHYPDSLE 898

Query: 402 LSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFV 461
              ++E+     K       P  + +  +K   E ++ ++ +G++C+  +P  R  M  V
Sbjct: 899 --GIIEQALSRWK-------PQGKPEKCEKLWREVILEMIELGLVCTQYNPSTRPDMLDV 949

Query: 462 VNNLQAIR 469
            + +  ++
Sbjct: 950 AHEMGRLK 957

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  237 bits (604), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 154/494 (31%), Positives = 257/494 (52%), Gaps = 60/494 (12%)

Query: 1    LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
            L L  NSF G IP S  ++  L  LDLS NNL+G++P+  + L +L+HL L+ N L G +
Sbjct: 703  LNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHV 762

Query: 61   SREGIFANASAISIVGNDKLCGGIQKLQLPECSRKNPRKRLSLKIVIPVTI--------- 111
               G+F N +A  ++GN  LCG   K  L  C+ K      S +  + + I         
Sbjct: 763  PESGVFKNINASDLMGNTDLCG--SKKPLKPCTIKQKSSHFSKRTRVILIILGSAAALLL 820

Query: 112  SVPIFILLLAALVIYHIVKTSRRQSAPPSNEWQSGLSYLK-----ISNATDNFSEENLIG 166
             + + ++L         ++ S   S P   +  S L   +     +  ATD+F+  N+IG
Sbjct: 821  VLLLVLILTCCKKKEKKIENSSESSLP---DLDSALKLKRFEPKELEQATDSFNSANIIG 877

Query: 167  SGSFGSVYKGTLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNILKIVSSCSS 224
            S S  +VYKG L DG   A+KVL L++  A   K F  E   L+ ++HRN++KI+     
Sbjct: 878  SSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKIL----G 933

Query: 225  VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ 284
              +E    KALV  FM NGNL+  +H S          SL++++++ + +AS +DYLH+ 
Sbjct: 934  FAWESGKTKALVLPFMENGNLEDTIHGSAAPIG-----SLLEKIDLCVHIASGIDYLHSG 988

Query: 285  YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFL-FEESNTPSKNQTMSNGLKGSVGYIP 343
            Y  PI HCDLK +N+LLD   +AHV DFG A+ L F E  + + +   ++  +G++GY+ 
Sbjct: 989  YGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTAS---TSAFEGTIGYLA 1045

Query: 344  PEYINGH-VSILGDIYSYGILLLEIFTGKRPT--DDMFKDDLSIHKFVLMALPS---HVM 397
            PE+     V+   D++S+GI+++E+ T +RPT  +D    D+++ + V  ++ +    ++
Sbjct: 1046 PEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMV 1105

Query: 398  DVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVG 457
             VLD+                    ++   +   K EE +   +++ + C+++ P DR  
Sbjct: 1106 RVLDM--------------------ELGDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPD 1145

Query: 458  MKFVVNNLQAIRSK 471
            M  ++ +L  +R K
Sbjct: 1146 MNEILTHLMKLRGK 1159

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  220 bits (560), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 167/480 (34%), Positives = 243/480 (50%), Gaps = 56/480 (11%)

Query: 1    LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
            L L  N+F G IP ++ +L  L  LDLS N L G+VP     + SL +LNLSYN L+G++
Sbjct: 774  LDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKL 833

Query: 61   SREGIFANASAISIVGNDKLCGGIQKLQLPECSRKNPRKRLSLK---IVIPVTISVPIFI 117
             ++  F+   A + VGN  LCG      L  C+R   + + SL    +VI   IS    I
Sbjct: 834  KKQ--FSRWQADAFVGNAGLCGS----PLSHCNRAGSKNQRSLSPKTVVIISAISSLAAI 887

Query: 118  LLLAALVI------YHIVKTSR-----------RQSAP--PSNEWQSGLSYLKISNATDN 158
             L+  ++I      + + K  R              AP   +   +S + +  I  AT  
Sbjct: 888  ALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHY 947

Query: 159  FSEENLIGSGSFGSVYKGTLADGETAAIK-VLKLQQQGALKSFIDECNALTSIRHRNILK 217
             +EE +IGSG  G VYK  L +GET A+K +L      + KSF  E   L +IRHR+++K
Sbjct: 948  LNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVK 1007

Query: 218  IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK-LSLMQRLNIVIDVAS 276
            ++  CSS   + +    L++E+M NG++  WLH   +E    K+ L    RL I + +A 
Sbjct: 1008 LMGYCSS---KADGLNLLIYEYMANGSVWDWLH--ANENTKKKEVLGWETRLKIALGLAQ 1062

Query: 277  ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
             ++YLH     PI H D+KSSNVLLD  + AH+GDFGLAK L    +T +++ TM     
Sbjct: 1063 GVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTM---FA 1119

Query: 337  GSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSH 395
            GS GYI PEY      +   D+YS GI+L+EI TGK PT+ MF ++  + ++        
Sbjct: 1120 GSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRW-------- 1171

Query: 396  VMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDR 455
            V  VLD     E        E + L P  E    Q         V+ I + C+ + P++R
Sbjct: 1172 VETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQ---------VLEIALQCTKSYPQER 1222

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  216 bits (551), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 160/484 (33%), Positives = 241/484 (49%), Gaps = 60/484 (12%)

Query: 1    LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
            L L  N+F G IP ++ +L  L  LDLS N L+G+VP     + SL +LN+S+N L G++
Sbjct: 773  LDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKL 832

Query: 61   SREGIFANASAISIVGNDKLCGGIQKLQLPECSR---KNPRKRLSLKIVIPVT-----IS 112
             ++  F+   A S +GN  LCG      L  C+R    N ++ LS + V+ ++      +
Sbjct: 833  KKQ--FSRWPADSFLGNTGLCGS----PLSRCNRVRSNNKQQGLSARSVVIISAISALTA 886

Query: 113  VPIFILLLAAL---------------VIYHIVKTSRRQSAPP---SNEWQSGLSYLKISN 154
            + + IL++A                   Y    +S + +  P   +   +S + +  I  
Sbjct: 887  IGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIME 946

Query: 155  ATDNFSEENLIGSGSFGSVYKGTLADGETAAIK-VLKLQQQGALKSFIDECNALTSIRHR 213
            AT N SEE +IGSG  G VYK  L +GET A+K +L      + KSF  E   L  IRHR
Sbjct: 947  ATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHR 1006

Query: 214  NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKL-SLMQRLNIVI 272
            +++K++  CSS   +      L++E+M+NG++  WLH         KKL     RL I +
Sbjct: 1007 HLVKLMGYCSS---KSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAV 1063

Query: 273  DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
             +A  ++YLH+    PI H D+KSSNVLLD  M AH+GDFGLAK L E  +T + + T  
Sbjct: 1064 GLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTW- 1122

Query: 333  NGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA 391
                 S GYI PEY      +   D+YS GI+L+EI TGK PTD +F  ++ + ++V   
Sbjct: 1123 --FACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWV--- 1177

Query: 392  LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAAS 451
                            E +        D   D + +      E+    V+ I + C+  S
Sbjct: 1178 ----------------ETHLEVAGSARDKLIDPKLKPLLPFEEDAACQVLEIALQCTKTS 1221

Query: 452  PRDR 455
            P++R
Sbjct: 1222 PQER 1225

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGX3|HSL2_ARATH LRR receptor-like serine/threonine-protein kinase HSL2 OS=Arabidopsis thaliana GN=HSL2 PE=2 SV=1

 Score =  199 bits (507), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 155/482 (32%), Positives = 244/482 (50%), Gaps = 38/482 (7%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L NN  +G IP  L  L  L  LDLS N L+G++P    +L  L   N+S N+L G+I
Sbjct: 536 LNLSNNRLRGGIPPELGDLPVLNYLDLSNNQLTGEIPAELLRL-KLNQFNVSDNKLYGKI 594

Query: 61  SREGIFANASAISIVGNDKLCGGIQKLQLPECSRKNP-RKRLSLKIVIPVTISVPIFILL 119
              G   +    S +GN  LC        P      P R +   + ++P++I   + I+ 
Sbjct: 595 P-SGFQQDIFRPSFLGNPNLCA-------PNLDPIRPCRSKRETRYILPISI---LCIVA 643

Query: 120 LAALVIYHIVKTSRRQSAPPSNEWQSGLSYLKISNATDN----FSEENLIGSGSFGSVYK 175
           L   +++  +KT       P    +  + + ++    ++     +E+N+IGSG  G VY+
Sbjct: 644 LTGALVWLFIKTKPLFKRKPKRTNKITI-FQRVGFTEEDIYPQLTEDNIIGSGGSGLVYR 702

Query: 176 GTLADGETAAIKVL---KLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF 232
             L  G+T A+K L     Q+  +   F  E   L  +RH NI+K++  C+     G +F
Sbjct: 703 VKLKSGQTLAVKKLWGETGQKTESESVFRSEVETLGRVRHGNIVKLLMCCN-----GEEF 757

Query: 233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHC 292
           + LV+EFM NG+L   LH S  E+     L    R +I +  A  L YLH+    PI H 
Sbjct: 758 RFLVYEFMENGSLGDVLH-SEKEHRAVSPLDWTTRFSIAVGAAQGLSYLHHDSVPPIVHR 816

Query: 293 DLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEY-INGHV 351
           D+KS+N+LLD  M   V DFGLAK L  E N    + +MS  + GS GYI PEY     V
Sbjct: 817 DVKSNNILLDHEMKPRVADFGLAKPLKREDNDGVSDVSMS-CVAGSYGYIAPEYGYTSKV 875

Query: 352 SILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA---LPSHVMDVLDLSMLLEE 408
           +   D+YS+G++LLE+ TGKRP D  F ++  I KF + A    PS   +  D +M    
Sbjct: 876 NEKSDVYSFGVVLLELITGKRPNDSSFGENKDIVKFAMEAALCYPSPSAE--DGAM---N 930

Query: 409 ENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI 468
           ++    + +     D + +++ ++ EE +  V+ + ++C+++ P +R  M+ VV  L+  
Sbjct: 931 QDSLGNYRDLSKLVDPKMKLSTREYEE-IEKVLDVALLCTSSFPINRPTMRKVVELLKEK 989

Query: 469 RS 470
           +S
Sbjct: 990 KS 991

Receptor-like serine/threonine-kinase acting on substrates that controls floral organ abscission. Regulated by the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) family of ligands.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FRS6|PXL1_ARATH Leucine-rich repeat receptor-like protein kinase PXL1 OS=Arabidopsis thaliana GN=PXL1 PE=2 SV=1

 Score =  198 bits (504), Expect = 6e-50,   Method: Compositional matrix adjust.
 Identities = 156/513 (30%), Positives = 244/513 (47%), Gaps = 85/513 (16%)

Query: 1    LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
            L L +N   G IP +L  +  LA LDLS N+L+G +P       +L  LN+S+N+LDG I
Sbjct: 537  LNLKSNQLVGEIPKALAGMHMLAVLDLSNNSLTGNIPADLGASPTLEMLNVSFNKLDGPI 596

Query: 61   SREGIFANASAISIVGNDKLCGGIQKLQLPECSR--------KNPRK----RLSLKIVIP 108
                +FA      +VGN+ LCGG+    LP CS+        +NP +          ++ 
Sbjct: 597  PSNMLFAAIDPKDLVGNNGLCGGV----LPPCSKSLALSAKGRNPGRIHVNHAVFGFIVG 652

Query: 109  VTISVPIFILLLAALVIY---HIVKTSRRQ---SAPPSNEWQSGLSYLK-----ISNATD 157
             ++ V + ++ LA   IY    +     R+      P  EW   L   +       +   
Sbjct: 653  TSVIVAMGMMFLAGRWIYTRWDLYSNFAREYIFCKKPREEWPWRLVAFQRLCFTAGDILS 712

Query: 158  NFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKS--------------FIDE 203
            +  E N+IG G+ G VYK  +       + V KL +  + ++               + E
Sbjct: 713  HIKESNIIGMGAIGIVYKAEVMRRPLLTVAVKKLWRSPSPQNDIEDHHQEEDEEDDILRE 772

Query: 204  CNALTSIRHRNILKIVSSCSSVDYEGNDFKA-LVFEFMRNGNLDQWLHPSTDEYCHFKKL 262
             N L  +RHRNI+KI+       Y  N+ +  +V+E+M NGNL   LH S DE   F   
Sbjct: 773  VNLLGGLRHRNIVKILG------YVHNEREVMMVYEYMPNGNLGTALH-SKDE--KFLLR 823

Query: 263  SLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES 322
              + R N+ + V   L+YLHN    PI H D+KS+N+LLD  + A + DFGLAK +    
Sbjct: 824  DWLSRYNVAVGVVQGLNYLHNDCYPPIIHRDIKSNNILLDSNLEARIADFGLAKMMLH-- 881

Query: 323  NTPSKNQTMSNGLKGSVGYIPPEY-INGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD 381
                KN+T+S  + GS GYI PEY     +    DIYS G++LLE+ TGK P D  F+D 
Sbjct: 882  ----KNETVSM-VAGSYGYIAPEYGYTLKIDEKSDIYSLGVVLLELVTGKMPIDPSFEDS 936

Query: 382  LSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVA---QKKLEECLV 438
            + + +++                        +  + E L   I++ +A   +  +EE L+
Sbjct: 937  IDVVEWI----------------------RRKVKKNESLEEVIDASIAGDCKHVIEEMLL 974

Query: 439  SVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSK 471
            + +RI ++C+A  P+DR  ++ V+  L   + +
Sbjct: 975  A-LRIALLCTAKLPKDRPSIRDVITMLAEAKPR 1006

Involved in the regulation of procambium maintenance and polarity during vascular-tissue development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1

 Score =  196 bits (498), Expect = 4e-49,   Method: Compositional matrix adjust.
 Identities = 158/489 (32%), Positives = 239/489 (48%), Gaps = 68/489 (13%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L +N F G IP  + SL  L  LDLS N  SGK+P     L  L  LNLSYN L G++
Sbjct: 521 LNLADNEFTGKIPDEIGSLSVLNYLDLSGNMFSGKIPVSLQSL-KLNQLNLSYNRLSGDL 579

Query: 61  SREGIFANASAISIVGNDKLCGGIQKLQLPECSRKNPRKRLSLKIVIPVTISVPIFILLL 120
               +  +    S +GN  LCG I+ L    C  +N  K+     ++     +   +LL 
Sbjct: 580 P-PSLAKDMYKNSFIGNPGLCGDIKGL----CGSENEAKKRGYVWLLRSIFVLAAMVLLA 634

Query: 121 AALVIYHIVKTSRRQSAPPSNEWQSGLSYLKISNAT----DNFSEENLIGSGSFGSVYKG 176
                Y   +T ++  A   ++W + +S+ K+  +     ++  E+N+IG+G+ G VYK 
Sbjct: 635 GVAWFYFKYRTFKKARAMERSKW-TLMSFHKLGFSEHEILESLDEDNVIGAGASGKVYKV 693

Query: 177 TLADGETAAIKVL---KLQQQGAL------------KSFIDECNALTSIRHRNILKIVSS 221
            L +GET A+K L    +++ G              ++F  E   L  IRH+NI+K+   
Sbjct: 694 VLTNGETVAVKRLWTGSVKETGDCDPEKGYKPGVQDEAFEAEVETLGKIRHKNIVKLWCC 753

Query: 222 CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYL 281
           CS+      D K LV+E+M NG+L   LH S         L    R  I++D A  L YL
Sbjct: 754 CST-----RDCKLLVYEYMPNGSLGDLLHSSKG-----GMLGWQTRFKIILDAAEGLSYL 803

Query: 282 HNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGY 341
           H+    PI H D+KS+N+L+D    A V DFG+AK +      P   ++MS  + GS GY
Sbjct: 804 HHDSVPPIVHRDIKSNNILIDGDYGARVADFGVAKAVDLTGKAP---KSMSV-IAGSCGY 859

Query: 342 IPPEYING-HVSILGDIYSYGILLLEIFTGKRPTD-DMFKDDLSIHKFVLMALPSHVMDV 399
           I PEY     V+   DIYS+G+++LEI T KRP D ++ + DL   K+V   L       
Sbjct: 860 IAPEYAYTLRVNEKSDIYSFGVVILEIVTRKRPVDPELGEKDLV--KWVCSTL------- 910

Query: 400 LDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMK 459
                        +K  E  + P ++S       +E +  ++ +G++C++  P +R  M+
Sbjct: 911 ------------DQKGIEHVIDPKLDSC-----FKEEISKILNVGLLCTSPLPINRPSMR 953

Query: 460 FVVNNLQAI 468
            VV  LQ I
Sbjct: 954 RVVKMLQEI 962

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	477
224139072	970	predicted protein [Populus trichocarpa]	0.983	0.483	0.610	1e-157
255574413	468	ATP binding protein, putative [Ricinus c	0.943	0.961	0.596	1e-150
449483694	1005	PREDICTED: probable LRR receptor-like se	0.981	0.465	0.539	1e-144
357505893	1003	Receptor kinase-like protein [Medicago t	0.976	0.464	0.542	1e-142
449483698	1099	PREDICTED: probable LRR receptor-like se	0.979	0.424	0.514	1e-138
356566660	1020	PREDICTED: probable LRR receptor-like se	0.974	0.455	0.531	1e-138
449440269	1041	PREDICTED: probable LRR receptor-like se	0.983	0.450	0.517	1e-137
449483700	1343	PREDICTED: LOW QUALITY PROTEIN: putative	0.981	0.348	0.526	1e-136
449440271	1343	PREDICTED: LOW QUALITY PROTEIN: putative	0.981	0.348	0.526	1e-136
356523290	1001	PREDICTED: probable LRR receptor-like se	0.991	0.472	0.524	1e-132

>gi|224139072|ref|XP_002322973.1| predicted protein [Populus trichocarpa] gi|222867603|gb|EEF04734.1| predicted protein [Populus trichocarpa]

 Score =  561 bits (1447), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 292/478 (61%), Positives = 356/478 (74%), Gaps = 9/478 (1%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L+L  N F+G IP SL++LRGL ELDLS NNL+G+VP+F      LRHLNLS+N L+GE+
Sbjct: 474 LHLEGNKFEGPIPESLETLRGLEELDLSENNLTGRVPEFLGGFSVLRHLNLSHNNLEGEV 533

Query: 61  SREGIFANASAISIVGNDKLCGGIQKLQLPECSRKNPRKRLSLKIVIPVTISVPIFILLL 120
           SR+GI ANASA S+VGNDKLCGGI +L LP CSRKNPR+ LS K+VIP TI+     +LL
Sbjct: 534 SRDGILANASAFSVVGNDKLCGGIPELHLPPCSRKNPREPLSFKVVIPATIAAVFISVLL 593

Query: 121 AALVIYHIV-KTSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLA 179
            +L I+ I  K  R  + P   E Q G+SY ++  +T+ F+ ENLIGSGSFGSVYKG L+
Sbjct: 594 CSLSIFCIRRKLPRNSNTPTPEEQQVGISYSELIKSTNGFAAENLIGSGSFGSVYKGILS 653

Query: 180 -DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFE 238
            +G   AIK++ L Q+GA KSFIDECNAL SIRHRN+LKI+++CS+VD++GNDFK LVFE
Sbjct: 654 GEGTIVAIKIMNLLQKGASKSFIDECNALRSIRHRNLLKIITACSTVDHQGNDFKGLVFE 713

Query: 239 FMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSN 298
           FM NGNLDQWLHP+T++    KKLS  QRLNI IDVASALDYLH+Q  T I HCDLK SN
Sbjct: 714 FMSNGNLDQWLHPTTEQQYRTKKLSFTQRLNIAIDVASALDYLHHQCKTTIVHCDLKPSN 773

Query: 299 VLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEY-INGHVSILGDI 357
           VLLD+ M AHVGDF LAKFL E S  PS NQ++S  LKGS+GYIPPEY +   VS+LGDI
Sbjct: 774 VLLDDDMTAHVGDFELAKFLSEASKNPSINQSISVALKGSIGYIPPEYGMRSEVSVLGDI 833

Query: 358 YSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKH-- 415
           YSYGILLLE+FTGKRPTDDMF+ DL+IHKF  MA P +VM ++D SML EEE +  +   
Sbjct: 834 YSYGILLLEMFTGKRPTDDMFEGDLNIHKFADMAFPGNVMAIIDPSMLAEEEINENEVNE 893

Query: 416 ---EEEDLFPDIESQVAQ-KKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIR 469
              EE  +  + + QV +   +EECLVS+M IG+ CS  SP  R+ M  VVN LQ IR
Sbjct: 894 HGIEERAIIHNNDFQVNRTSNIEECLVSLMEIGLSCSNKSPGKRMAMNIVVNKLQVIR 951

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255574413|ref|XP_002528120.1| ATP binding protein, putative [Ricinus communis] gi|223532509|gb|EEF34299.1| ATP binding protein, putative [Ricinus communis]

 Score =  538 bits (1387), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 279/468 (59%), Positives = 347/468 (74%), Gaps = 18/468 (3%)

Query: 24  ELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGNDKLCGG 83
           ELDLS NNLSGK+P+F S+LLSLRHLNLSYN  DGE+S +GIFANASAISIVGNDKLCGG
Sbjct: 2   ELDLSSNNLSGKIPEFLSELLSLRHLNLSYNNFDGEVSTKGIFANASAISIVGNDKLCGG 61

Query: 84  IQKLQLPECSRKNPRKRLSLKIVIPVTISVPIFILLLAALV-IYHIVKTSRRQSAPPSNE 142
              L LP CS K   K  + KIVIP  I+  +F+++ + +V I+ + + SR++ +    E
Sbjct: 62  TVDLLLPTCSNKKQGK--TFKIVIPAAIA-GVFVIVASCIVAIFCMARNSRKKHSAAPEE 118

Query: 143 WQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFI 201
           WQ G+SY +++ +TD FS ENLIG GSFGSVYKG L+ +GE  A+KVL LQQQGA KSFI
Sbjct: 119 WQVGISYTELAKSTDGFSAENLIGLGSFGSVYKGVLSGNGEIVAVKVLNLQQQGASKSFI 178

Query: 202 DECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK 261
           DECNAL SIRHRN+++I+++CSS+D++GNDFKALVFEFM N +LD WLHP  DE     +
Sbjct: 179 DECNALRSIRHRNLIRIITTCSSIDHQGNDFKALVFEFMANRSLDDWLHPKADEQDRTMR 238

Query: 262 LSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEE 321
           LS ++RLNI ID+ASALDYLH+  +TPI HCDLK SNVLLD+ M AHVGDFGLA+FL E 
Sbjct: 239 LSFIKRLNIAIDIASALDYLHHYCETPIVHCDLKPSNVLLDKNMTAHVGDFGLARFLLEA 298

Query: 322 SNTPSK-NQTMSNGLKGSVGYIPPEY-INGHVSILGDIYSYGILLLEIFTGKRPTDDMFK 379
           S TP K  + MS  LKGS+GYIPPEY + G VSI GD+YSYGILLLE+FTG RPTDDMF 
Sbjct: 299 SETPFKRTEAMSVSLKGSIGYIPPEYGLGGQVSIFGDVYSYGILLLEMFTGIRPTDDMFT 358

Query: 380 DDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKK------L 433
           DD+SIHKFV MALP HVM V+D +ML+EEE + E  + +    DIE +    +      +
Sbjct: 359 DDISIHKFVAMALPEHVMGVIDSTMLIEEEEEDEDDDNKTCRDDIEEKDNDARISNTIEI 418

Query: 434 EECLVSVMRIGVMCSAASPRDRVGMKFVVNNL-----QAIRSKIRMRE 476
           E+CLVS++ IG+ CS+ SP  R+ M  VVN L       +RSK + R 
Sbjct: 419 EKCLVSIISIGLSCSSRSPGKRMTMDLVVNKLLDNRDSFLRSKNKSRR 466

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449483694|ref|XP_004156662.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus]

 Score =  519 bits (1336), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 260/482 (53%), Positives = 351/482 (72%), Gaps = 14/482 (2%)

Query: 1    LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
            LYLG N F+GTIP SLK+L+GL EL+LS NNL G +PQF   L SL+ L+LSYN   G++
Sbjct: 520  LYLGGNQFEGTIPESLKALKGLEELNLSSNNLFGPIPQFLGNLFSLKFLDLSYNNFKGKV 579

Query: 61   SREGIFANASAISIVGNDKLCGGIQKLQLPECSRKNPR---KRLSLKIVIPVTISVPIFI 117
            ++EGIF+N++  SI+GN+ LC G+++L LP C+    R   K L+ K++IPV  ++   +
Sbjct: 580  AKEGIFSNSTMFSILGNNNLCDGLEELHLPSCTSNRTRLSNKLLTPKVLIPVVSTLTFLV 639

Query: 118  LLLAALVIYHIVKTSRRQ--SAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYK 175
            + L+ L ++ ++K SR+   ++  S +  S +SYL+++ +T+ FS ENLIGSGSFGSVYK
Sbjct: 640  ISLSILSVFFMMKKSRKNVLTSAGSLDLLSQISYLELNRSTNGFSVENLIGSGSFGSVYK 699

Query: 176  GTLADGE-TAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA 234
            G L + +   A+KV+ LQQ GA KSF+DEC+ LT+IRHRN+LKI++SCSS D EGN+FKA
Sbjct: 700  GILLNNKPVVAVKVINLQQHGASKSFVDECSTLTNIRHRNLLKIITSCSSTDEEGNEFKA 759

Query: 235  LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDL 294
            +VF+FM NGNLD WLHP+  E  + +KLS +QRL+I IDVA+ALDYLHN  +TPI HCDL
Sbjct: 760  IVFDFMSNGNLDSWLHPTHVEN-NKRKLSFIQRLDIAIDVANALDYLHNHCETPIVHCDL 818

Query: 295  KSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEY-INGHVSI 353
            K SNVLLD+ M+AHVGDFGLA+F+ E SN     QTMS  LKGS+GYIPPEY   G++SI
Sbjct: 819  KPSNVLLDDDMVAHVGDFGLARFILEGSNHSVSRQTMSIALKGSIGYIPPEYGTGGNISI 878

Query: 354  LGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHE 413
             GDI+SYGILLLE+FTGKRPTD +F D + IH F  M LP  V+D++D S+L EE    E
Sbjct: 879  EGDIFSYGILLLEMFTGKRPTDSLFSDGVDIHLFTAMTLPHGVLDIVDHSLLSEETCQQE 938

Query: 414  KHEEED------LFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQA 467
               E+       +  + +S V Q+++EE LVS+MRIG+ CS+ +PR+R+ M  VV  LQ 
Sbjct: 939  AENEKKIQTIAIMSEEDQSGVGQRRMEEYLVSIMRIGLSCSSTTPRERMPMNIVVKKLQT 998

Query: 468  IR 469
            I+
Sbjct: 999  IK 1000

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357505893|ref|XP_003623235.1| Receptor kinase-like protein [Medicago truncatula] gi|355498250|gb|AES79453.1| Receptor kinase-like protein [Medicago truncatula]

 Score =  510 bits (1313), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 261/481 (54%), Positives = 347/481 (72%), Gaps = 15/481 (3%)

Query: 1    LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
            L++  N F+G IP ++++LRG+  +DLSCNNLSGK+P+F  ++  L HLNLSYN LDGE+
Sbjct: 530  LHMQGNFFEGNIPSTIQNLRGIQHIDLSCNNLSGKIPEFLGEIKGLMHLNLSYNNLDGEL 589

Query: 61   SREGIFANASAISIVGNDKLCGGIQKLQLPECSRKNPRKRLSLKIVIPVTISVPIFILLL 120
               GIF NA++ SI GN KLCGG+ +L LP C+ K   K  SLK++IP+  S  IF+L L
Sbjct: 590  PMNGIFKNATSFSINGNIKLCGGVPELNLPACTIKK-EKFHSLKVIIPIA-SALIFLLFL 647

Query: 121  AALVIYHIVKTSRRQSAPPSN---EWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGT 177
            +  +I  ++K SR++++  +    + +  +SY +I   T  FS +NLIGSGSFGSVYKGT
Sbjct: 648  SGFLIIIVIKRSRKKTSRETTTIEDLELNISYSEIVKCTGGFSNDNLIGSGSFGSVYKGT 707

Query: 178  LA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALV 236
            L+ DG T AIKVL L+Q+GA KSFIDECNAL  IRHRN+LKI+++ SS+D++G DFKALV
Sbjct: 708  LSSDGTTIAIKVLNLEQRGASKSFIDECNALKVIRHRNLLKIITAISSIDHQGKDFKALV 767

Query: 237  FEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKS 296
            +EFM NG+L+ WLHP   +    K L+ +QRLNI IDVA AL+YLH+  +TPI HCD+K 
Sbjct: 768  YEFMSNGSLEDWLHPINQK----KTLTFVQRLNIAIDVACALEYLHHFCETPIVHCDIKP 823

Query: 297  SNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEY-INGHVSILG 355
            SNVLLD  M+A VGDFGLA FLFEES    K+ TMS  LKGSVGYIPPEY + GH S LG
Sbjct: 824  SNVLLDNDMVARVGDFGLATFLFEESCDSPKHSTMSASLKGSVGYIPPEYGMGGHPSALG 883

Query: 356  DIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEE---NDH 412
            D+YSYGILLLEIFTGKRPT++MF+  + I +F  +ALP+H +D++D S+L ++E    DH
Sbjct: 884  DVYSYGILLLEIFTGKRPTNEMFEGGMGIQQFTALALPNHAIDIIDPSLLYDQEFDGKDH 943

Query: 413  EKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSKI 472
            +  EE+ L  + E       +E CL+SV++IGV CS+ SP +R+ M  VVN L AI +  
Sbjct: 944  DYSEEKALRREKEPG-DFSTMENCLISVLQIGVSCSSTSPNERIPMTLVVNKLHAINNSF 1002

Query: 473  R 473
            +
Sbjct: 1003 K 1003

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449483698|ref|XP_004156663.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus]

 Score =  498 bits (1283), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 251/488 (51%), Positives = 344/488 (70%), Gaps = 21/488 (4%)

Query: 1    LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
            LYLG N F GTIP SL++L+ L +L+LS NNLSG +PQF SKLL L  ++LSYN  +G++
Sbjct: 591  LYLGGNKFGGTIPQSLEALKSLKKLNLSSNNLSGPIPQFLSKLLFLVSVDLSYNNFEGKV 650

Query: 61   SREGIFANASAISIVGNDKLCGGIQKLQLPECSRKNPR----KRLSLKIVIPVTISVPIF 116
              EG+F+N++  SI+GN+ LCGG+ +L LP C+    R    + L  +++IP+ I +   
Sbjct: 651  PIEGVFSNSTMFSIIGNNNLCGGLHELHLPLCTSNQTRLSNKQFLKSRVLIPMAIVITFV 710

Query: 117  ILLLAALVIYHIVKTSRRQSAPP----SNEWQSGLSYLKISNATDNFSEENLIGSGSFGS 172
             +L+  +++  +++ SR+ ++      + E+   +SYL++S +T  FS ENLIGSGSFGS
Sbjct: 711  GILVVFILVCFVLRKSRKDASTTNSLSAKEFIPQISYLELSKSTSGFSTENLIGSGSFGS 770

Query: 173  VYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND 231
            VYKG L+ DG   A+KVL LQQQGA KSF+DECNAL++IRHRN+LKI++SCSS+D +GN+
Sbjct: 771  VYKGVLSNDGSVVAVKVLNLQQQGASKSFVDECNALSNIRHRNLLKIITSCSSIDGQGNE 830

Query: 232  FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAH 291
            FKALVF FM NGNLD WLHP  ++  + ++LSL+QRLNI ID+A  LDYLH   +TPI H
Sbjct: 831  FKALVFNFMSNGNLDCWLHPK-NQGTNLRRLSLIQRLNIAIDIACGLDYLHTHCETPIIH 889

Query: 292  CDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP-SKNQTMSNGLKGSVGYIPPEYING- 349
            CD+K SN+LLD+ M+AHVGDFGLA+F+ EESN   S +QTMS  LKGS+GYIPPEY +G 
Sbjct: 890  CDIKPSNILLDDDMVAHVGDFGLARFMLEESNDQISFSQTMSLALKGSIGYIPPEYGSGS 949

Query: 350  HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEE 409
             +S  GD++SYGILLLE+  GKRP DD F + + IH F    LP   + ++D S++ EE 
Sbjct: 950  RISTEGDVFSYGILLLEMIIGKRPIDDTFDNGVDIHLFTATMLPHEALGIIDPSIVFEET 1009

Query: 410  NDHEKHEEEDLFPDIE-------SQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVV 462
              H++ E  D    I         ++  + +EECLVS+MRIG+ CS   PR+R+ M  VV
Sbjct: 1010 --HQEEETNDEMQKIAIVSEQDCKEIVPRWMEECLVSIMRIGLSCSLREPRERMAMDVVV 1067

Query: 463  NNLQAIRS 470
            N LQAI+S
Sbjct: 1068 NELQAIKS 1075

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356566660|ref|XP_003551548.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Glycine max]

 Score =  498 bits (1281), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 256/482 (53%), Positives = 341/482 (70%), Gaps = 17/482 (3%)

Query: 1    LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
            ++L  N F+G IP +++ LRGL ++DLSCNN SGK+P+F  +   L HLNLSYN+  G++
Sbjct: 535  IHLQGNFFEGNIPSTMRYLRGLQDIDLSCNNFSGKIPEFLGEFKVLEHLNLSYNDFSGKL 594

Query: 61   SREGIFANASAISIVGNDKLCGGIQKLQLPECSRKNP---RKRLSLKIVIPVTISVPIFI 117
               GIF NA++ S+ GN KLCGG  +L LP C+ K     RK    K+VI V +++ +F+
Sbjct: 595  PMNGIFKNATSYSVYGNSKLCGGAPELDLPACTIKKASSFRKFHDPKVVISVIVAL-VFV 653

Query: 118  LLLAALVIYHIVKTSRRQSA--PPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYK 175
            LLL   +   +VK +R++++    + +    +SY +I+  T  FS +NL+GSGSFGSVYK
Sbjct: 654  LLLFCFLAISMVKRARKKASRSTTTKDLDLQISYSEIAKCTGGFSPDNLVGSGSFGSVYK 713

Query: 176  GTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA 234
            GTL+ DG + A+KVL L+Q+GA KSFIDEC  L SIRHRN+LKI+++ SSVD++GNDFKA
Sbjct: 714  GTLSSDGSSVAVKVLNLEQRGASKSFIDECQVLRSIRHRNLLKIITAISSVDHQGNDFKA 773

Query: 235  LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDL 294
            LVFEFM NG+L+ WLHP  ++    K LS +QRLNI IDVA AL+YLH+   TPI HCD+
Sbjct: 774  LVFEFMPNGSLEDWLHPVDNQQKQTKTLSFIQRLNIAIDVACALEYLHHFCHTPIVHCDI 833

Query: 295  KSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEY-INGHVSI 353
            K SNVLLD  M+AHVGDFGLA FLFEES+   +  TMS  LKGS+GYIPPEY + GH S 
Sbjct: 834  KPSNVLLDNDMVAHVGDFGLATFLFEESSGSPQQSTMSGVLKGSIGYIPPEYGMGGHPSA 893

Query: 354  LGDIYSYGILLLEIFTGKRPTDDMFKD-DLSIHKFVLMALPSHVMDVLDLSML----LEE 408
            LGDIYSYGILLLEIFTGKRPT +MF+   + IH+   ++LP+H M+++D  +L     ++
Sbjct: 894  LGDIYSYGILLLEIFTGKRPTHEMFEGVSMGIHQLTALSLPNHAMEIIDPLLLPKREFDD 953

Query: 409  ENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI 468
             N+    EEE +  + E +V    +E CLVSV++IGV CS  SPR+RV M  VVN L AI
Sbjct: 954  RNEQVSTEEEAILRENEPEV----IEGCLVSVLQIGVSCSVTSPRERVPMTEVVNKLHAI 1009

Query: 469  RS 470
            +S
Sbjct: 1010 KS 1011

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449440269|ref|XP_004137907.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus]

 Score =  496 bits (1276), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 252/487 (51%), Positives = 353/487 (72%), Gaps = 18/487 (3%)

Query: 1    LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
            L LG N F+GTIP SL +L+G+ EL+LS NNLSGK+PQF  KL SL++LNLSYN  +G++
Sbjct: 544  LNLGGNQFEGTIPESLGALKGIEELNLSSNNLSGKIPQFLGKLGSLKYLNLSYNNFEGQV 603

Query: 61   SREGIFANASAISIVGNDKLCGGIQKLQLPECS--RKNPRKR-LSLKIVIPVTISVPIFI 117
             +EG+F+N++ IS++GN+ LCGG+ +L LP C   R   RK+ ++ +++IP+  +V   +
Sbjct: 604  PKEGVFSNSTMISVIGNNNLCGGLPELHLPPCKYDRTYSRKKFMAPRVLIPIASTVTFLV 663

Query: 118  LLLAALVIYHIVKTSRRQSAPPSN---EWQSGLSYLKISNATDNFSEENLIGSGSFGSVY 174
            +L++ + +  +++ S++ ++  S+   E+   +SYL++S +T+ FS+EN IGSGSFGSVY
Sbjct: 664  ILVSIIFVCFVLRKSKKDASTNSSSTKEFLPQISYLELSKSTNGFSKENFIGSGSFGSVY 723

Query: 175  KGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK 233
            KG L +DG   AIKVL LQ QGA KSF+DECNAL++IRHRN+LKI++SCSS+D +GN+FK
Sbjct: 724  KGILSSDGSIVAIKVLNLQHQGASKSFVDECNALSNIRHRNLLKIITSCSSIDVQGNEFK 783

Query: 234  ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCD 293
            AL+F FM NGNLD  LHP T++  + ++LSL+QRLNI ID+A  LDYLHN  + PIAHCD
Sbjct: 784  ALIFNFMSNGNLDCLLHP-TNKQNNQRRLSLIQRLNIAIDIAYGLDYLHNHCEPPIAHCD 842

Query: 294  LKSSNVLLDEGMIAHVGDFGLAKFLFEESN-TPSKNQTMSNGLKGSVGYIPPEY-INGHV 351
            LK SN+LLD+ M+AHVGDFGLA+F+ E SN   S +QTMS  LKGS+GYIPPEY   G +
Sbjct: 843  LKPSNILLDDDMVAHVGDFGLARFMLEGSNDQTSLSQTMSLALKGSIGYIPPEYGTGGRI 902

Query: 352  SILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLE---E 408
            S  GD++SYGILLLE+  GKRPTD+ F D + IH F  MAL   V++++D S+L E   E
Sbjct: 903  STEGDVFSYGILLLEMIIGKRPTDEKFGDSVDIHLFTEMALSQGVINIVDPSLLYEETGE 962

Query: 409  ENDHEKHEEEDLFPDIESQVAQKK-----LEECLVSVMRIGVMCSAASPRDRVGMKFVVN 463
             N   K E++     + S+   K      +EEC++S++RIG+ CS   PR+R  +  V+N
Sbjct: 963  TNQEGKSEDKTQEIAVMSEEDHKGFVLSWMEECIISILRIGLSCSLRMPRERKPINVVIN 1022

Query: 464  NLQAIRS 470
             LQ I+S
Sbjct: 1023 ELQTIKS 1029

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449483700|ref|XP_004156664.1| PREDICTED: LOW QUALITY PROTEIN: putative receptor-like protein kinase At3g47110-like [Cucumis sativus]

 Score =  493 bits (1269), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 250/475 (52%), Positives = 341/475 (71%), Gaps = 7/475 (1%)

Query: 1    LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
            LYLG N F+GTIP S K+L+ L +L+LS NNL G +P+F  +L SL +++LSYN   G++
Sbjct: 537  LYLGGNQFEGTIPQSFKTLKSLVKLNLSHNNLIGPIPEFLCELPSLMYVDLSYNNFVGKV 596

Query: 61   SREGIFANASAISIVGNDKLCGGIQKLQLPECSRKNPRKRLSLKIVIPVTISVPIFILLL 120
              EG F+N++  SI+GN+ LC G+Q+L LP C   N + R S K++IP+  +V   ++L+
Sbjct: 597  PEEGAFSNSTMFSIIGNNNLCDGLQELHLPTC-MPNDQTRSSSKVLIPIASAVTSVVILV 655

Query: 121  AALVIYHIVKTSRRQSAPPS--NEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTL 178
            +   +  ++K SR+  +  S  NE+   +SYL++S +TD FS +NLIGSGSFG+VYKG L
Sbjct: 656  SIFCLCFLLKKSRKDISTSSFANEFLPQISYLELSKSTDGFSMDNLIGSGSFGTVYKGLL 715

Query: 179  ADGET-AAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVF 237
            ++G +  AIKVL LQQ+GA KSF+DECNAL++IRHRN+LKI++SCSS+D  GN+FKALVF
Sbjct: 716  SNGGSIVAIKVLNLQQEGASKSFVDECNALSNIRHRNLLKIITSCSSIDVHGNEFKALVF 775

Query: 238  EFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSS 297
             FM NGNLD WLHP  ++  + ++LSL+QRLNI ID+A  LDYLHN  +TPI HCDLK S
Sbjct: 776  NFMSNGNLDGWLHPP-NQGQNQRRLSLIQRLNIAIDIACGLDYLHNHCETPIVHCDLKPS 834

Query: 298  NVLLDEGMIAHVGDFGLAKFLFEESNTP-SKNQTMSNGLKGSVGYIPPEYINGH-VSILG 355
            N+LLD+ M+AHVGDFGLA+F+ E S+     +QTMS  LKGS+GYIPPEY  G  +SI G
Sbjct: 835  NILLDDNMVAHVGDFGLARFMLERSSDQIFFSQTMSLVLKGSIGYIPPEYGTGSIISIEG 894

Query: 356  DIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKH 415
            DI+SYGILLLE+  GKRPTDD F +D+ IH F   ALP   + ++D S+L EE    E +
Sbjct: 895  DIFSYGILLLEMIIGKRPTDDTFGNDMDIHLFTRRALPRDALSIIDPSILFEETCQEENN 954

Query: 416  EEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRS 470
            +++    +   ++  +   ECLVS+MRIG+ CS  +P +R  M  VVN LQAI+S
Sbjct: 955  DDKVKSGEDHKEIVPRWKVECLVSIMRIGLTCSLRAPSERTSMSVVVNELQAIKS 1009

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449440271|ref|XP_004137908.1| PREDICTED: LOW QUALITY PROTEIN: putative receptor-like protein kinase At3g47110-like [Cucumis sativus]

 Score =  493 bits (1268), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 250/475 (52%), Positives = 341/475 (71%), Gaps = 7/475 (1%)

Query: 1    LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
            LYLG N F+GTIP S K+L+ L +L+LS NNL G +P+F  +L SL +++LSYN   G++
Sbjct: 537  LYLGGNQFEGTIPQSFKTLKSLVKLNLSHNNLIGPIPEFLCELPSLMYVDLSYNNFVGKV 596

Query: 61   SREGIFANASAISIVGNDKLCGGIQKLQLPECSRKNPRKRLSLKIVIPVTISVPIFILLL 120
              EG F+N++  SI+GN+ LC G+Q+L LP C   N + R S K++IP+  +V   ++L+
Sbjct: 597  PEEGAFSNSTMFSIIGNNNLCDGLQELHLPTC-MPNDQTRSSSKVLIPIASAVTSVVILV 655

Query: 121  AALVIYHIVKTSRRQSAPPS--NEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTL 178
            +   +  ++K SR+  +  S  NE+   +SYL++S +TD FS +NLIGSGSFG+VYKG L
Sbjct: 656  SIFCLCFLLKKSRKDISTSSFANEFLPQISYLELSKSTDGFSMDNLIGSGSFGTVYKGLL 715

Query: 179  ADGET-AAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVF 237
            ++G +  AIKVL LQQ+GA KSF+DECNAL++IRHRN+LKI++SCSS+D  GN+FKALVF
Sbjct: 716  SNGGSIVAIKVLNLQQEGASKSFVDECNALSNIRHRNLLKIITSCSSIDVHGNEFKALVF 775

Query: 238  EFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSS 297
             FM NGNLD WLHP  ++  + ++LSL+QRLNI ID+A  LDYLHN  +TPI HCDLK S
Sbjct: 776  NFMSNGNLDGWLHPP-NQGQNQRRLSLIQRLNIAIDIACGLDYLHNHCETPIVHCDLKPS 834

Query: 298  NVLLDEGMIAHVGDFGLAKFLFEESNTP-SKNQTMSNGLKGSVGYIPPEYINGH-VSILG 355
            N+LLD+ M+AHVGDFGLA+F+ E S+     +QTMS  LKGS+GYIPPEY  G  +SI G
Sbjct: 835  NILLDDNMVAHVGDFGLARFMLERSSDQIFFSQTMSLVLKGSIGYIPPEYGTGSIISIEG 894

Query: 356  DIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKH 415
            DI+SYGILLLE+  GKRPTDD F +D+ IH F   ALP   + ++D S+L EE    E +
Sbjct: 895  DIFSYGILLLEMIIGKRPTDDTFGNDMDIHLFTRRALPRDALSIIDPSILFEETCQEENN 954

Query: 416  EEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRS 470
            +++    +   ++  +   ECLVS+MRIG+ CS  +P +R  M  VVN LQAI+S
Sbjct: 955  DDKVKSGEDHKEIVPRWKVECLVSIMRIGLTCSLRAPSERTSMSVVVNELQAIKS 1009

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356523290|ref|XP_003530273.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Glycine max]

 Score =  478 bits (1230), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 256/488 (52%), Positives = 344/488 (70%), Gaps = 15/488 (3%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L+L  NSF+G IP ++K LRGL ++DLS NNLSGK+P+F      L+HLNLSYN  +GEI
Sbjct: 507 LHLQGNSFEGNIPQTIKDLRGLLDIDLSRNNLSGKIPEFLGGFTELKHLNLSYNNFEGEI 566

Query: 61  SREGIFANASAISIVGNDKLCGGIQKLQLPECS---RKNPRKR--LSLKIVIPVTISVPI 115
            + GIF NA++IS+ GN KLCGG+ +L  P C+   RK  R R  ++ K+ IP+ I++ +
Sbjct: 567 PKNGIFKNATSISLYGNIKLCGGVSELNFPPCTIRKRKASRLRKLVASKVAIPIAIALIL 626

Query: 116 FILLLAALVIYHIVKTSRRQS--APPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSV 173
            +LL   L ++ IVK ++R++  +   N     +SY +I+  T  FS++NLIGSGSFGSV
Sbjct: 627 LLLLSCFLTLFPIVKRAKRKTPTSTTGNALDLEISYSEITKCTGGFSQDNLIGSGSFGSV 686

Query: 174 YKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF 232
           YKGTL+ DG   A+KVL LQQ+GA +SFIDEC+ L SIRHRN+LKI+++ S VD++GNDF
Sbjct: 687 YKGTLSGDGSIVAVKVLNLQQRGASRSFIDECHVLRSIRHRNLLKIITAISGVDHQGNDF 746

Query: 233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHC 292
           KALVFE+M NG+L+ WLHP  +     KKL+ +QRLNI IDVA AL+YLH+  +TPI HC
Sbjct: 747 KALVFEYMPNGSLEDWLHPVNNVQTQTKKLTFIQRLNIAIDVACALEYLHHFCETPIVHC 806

Query: 293 DLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEY-INGHV 351
           D+K SNVLLD  ++AHVGDFGLA FLFEES+  S    +S  L+GS+GYIPPEY + G  
Sbjct: 807 DIKPSNVLLDNDLVAHVGDFGLATFLFEESSKFSTQSVISASLRGSIGYIPPEYGMGGKP 866

Query: 352 SILGDIYSYGILLLEIFTGKRPTD-DMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEEN 410
           S LGD+YSYGILLLEIFTGKRPTD + F+  + IH+FV MALP+ V D++D S++ E++ 
Sbjct: 867 STLGDVYSYGILLLEIFTGKRPTDEEAFEGGMGIHQFVAMALPNRVTDIVDPSLVSEQDF 926

Query: 411 DHEKHEEEDLFPDIESQV-----AQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNL 465
           D E  E ED    I         A+  +E+C VS+M IG  CSA  P +R+ +  V+N L
Sbjct: 927 DEENQEFEDEEKAIRKNYEIEASAKGLMEDCFVSLMEIGASCSANPPSERMPITVVINKL 986

Query: 466 QAIRSKIR 473
            AI++  +
Sbjct: 987 HAIKNSFK 994

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	477
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.945	0.446	0.445	4.2e-102
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.958	0.445	0.444	2.7e-100
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.962	0.447	0.452	9.1e-100
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.947	0.447	0.421	1.3e-98
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.846	0.399	0.438	6.8e-98
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.809	0.374	0.445	4.8e-95
TAIR|locus:2175703	502	AT5G39390 [Arabidopsis thalian	0.754	0.717	0.415	5.8e-82
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.928	0.452	0.338	1.7e-62
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.924	0.375	0.324	8e-62
UNIPROTKB|O24435	813	O24435 "Receptor kinase-like p	0.555	0.325	0.453	5.1e-58

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 1012 (361.3 bits), Expect = 4.2e-102, P = 4.2e-102
 Identities = 217/487 (44%), Positives = 309/487 (63%)

Query:     1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
             L+L  N F G IP  LK L G+ E+DLS N+LSG +P++F+    L +LNLS+N L+G++
Sbjct:   534 LFLEGNLFYGDIP-DLKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKV 592

Query:    61 SREGIFANASAISIVGNDKLCGGIQKLQLPECSRKNP---RKRLSL--KIVIPVTISVPI 115
               +GIF NA+ +SIVGN+ LCGGI   QL  C  + P   +K  S   K+VI V++ + +
Sbjct:   593 PVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITL 652

Query:   116 FILLLAALVIYHIVKTSRRQSAPPSNEWQSGLSYL--KIS-----NATDNFSEENLIGSG 168
              +LL  A V   I    R+++   +N   S L  L  KIS     NAT+ FS  N++GSG
Sbjct:   653 LLLLFMASVTL-IWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSG 711

Query:   169 SFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDY 227
             SFG+VYK  L  + +  A+KVL +Q++GA+KSF+ EC +L  IRHRN++K++++CSS+D+
Sbjct:   712 SFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDF 771

Query:   228 EGNDFKALVFEFMRNGNLDQWLHPSTDEYCH--FKKLSLMQRLNIVIDVASALDYLHNQY 285
             +GN+F+AL++EFM NG+LD WLHP   E  H   + L+L++RLNI IDVAS LDYLH   
Sbjct:   772 QGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHC 831

Query:   286 DTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPE 345
               PIAHCDLK SNVLLD+ + AHV DFGLA+ L +       NQ  S G++G++GY  PE
Sbjct:   832 HEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPE 891

Query:   346 Y-INGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSM 404
             Y + G  SI GD+YS+GILLLE+FTGKRPT+++F  + +++ +   ALP  ++D++D S+
Sbjct:   892 YGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESI 951

Query:   405 LLXXXXXXXXXXXXXLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN 464
             L               FP +E          CL  V  +G+ C   SP +R+    VV  
Sbjct:   952 LHIGLRVG--------FPVVE----------CLTMVFEVGLRCCEESPMNRLATSIVVKE 993

Query:   465 LQAIRSK 471
             L +IR +
Sbjct:   994 LISIRER 1000

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 995 (355.3 bits), Expect = 2.7e-100, P = 2.7e-100
 Identities = 212/477 (44%), Positives = 294/477 (61%)

Query:     1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
             LYL NN   G+IP +L  L+GL  LDLS NNLSG++P   + +  L  LNLS+N   GE+
Sbjct:   550 LYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEV 609

Query:    61 SREGIFANASAISIVGNDKLCGGIQKLQLPECSRK-NPRKRLSLKIVIPVTISVPIFILL 119
                G FA AS ISI GN KLCGGI  L LP C      RK      V+P+++S+   + +
Sbjct:   610 PTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLLENRKHFP---VLPISVSLAAALAI 666

Query:   120 LAALVIYHIVKTSRRQSAPPSNEWQSG---LSYLKISNATDNFSEENLIGSGSFGSVYKG 176
             L++L +  I    R +   PS     G   +SY ++  ATD F+  NL+GSGSFGSVYKG
Sbjct:   667 LSSLYLL-ITWHKRTKKGAPSRTSMKGHPLVSYSQLVKATDGFAPTNLLGSGSFGSVYKG 725

Query:   177 TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALV 236
              L   +  A+KVLKL+   ALKSF  EC AL ++RHRN++KIV+ CSS+D  GNDFKA+V
Sbjct:   726 KLNIQDHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIV 785

Query:   237 FEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKS 296
             ++FM NG+L+ W+HP T++    + L+L +R+ I++DVA ALDYLH     P+ HCD+KS
Sbjct:   786 YDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKS 845

Query:   297 SNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILG 355
             SNVLLD  M+AHVGDFGLA+ L + ++   ++ T S G  G++GY  PEY  G + S  G
Sbjct:   846 SNVLLDSDMVAHVGDFGLARILVDGTSLIQQS-TSSMGFIGTIGYAAPEYGVGLIASTHG 904

Query:   356 DIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLXXXXXXXXX 415
             DIYSYGIL+LEI TGKRPTD  F+ DL + ++V + L   V DV+D  ++L         
Sbjct:   905 DIYSYGILVLEIVTGKRPTDSTFRPDLGLRQYVELGLHGRVTDVVDTKLILDSENWLNST 964

Query:   416 XXXXLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSKI 472
                            +++ EC+V ++R+G+ CS   P  R     +++ L AI+  +
Sbjct:   965 NNSPC----------RRITECIVWLLRLGLSCSQELPSSRTPTGDIIDELNAIKQNL 1011

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 990 (353.6 bits), Expect = 9.1e-100, P = 9.1e-100
 Identities = 223/493 (45%), Positives = 295/493 (59%)

Query:     1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
             L L  NSF G IP  ++ L GL  LDLS NNLSG +P++ +    L++LNLS N  DG +
Sbjct:   550 LLLQGNSFVGPIP-DIRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAV 608

Query:    61 SREGIFANASAISIVGNDKLCGGIQKLQLPECSRKNPRKRLSLKIVIPVTISVPIFILLL 120
               EG+F N SA+S+ GN  LCGGI  LQL  CS + PR+  S++ +I + +S  +  LLL
Sbjct:   609 PTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLL 668

Query:   121 AALVIYHI------VKTSRR------QSAPPSNEWQSGLSYLKISNATDNFSEENLIGSG 168
               L + ++      VK+ R       +S  P   +   +SY ++   T  FS  NLIGSG
Sbjct:   669 LCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSG 728

Query:   169 SFGSVYKGTLADGETA-AIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDY 227
             +FG+V+KG L     A AIKVL L ++GA KSFI EC AL  IRHRN++K+V+ CSS D+
Sbjct:   729 NFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDF 788

Query:   228 EGNDFKALVFEFMRNGNLDQWLHPSTDEYCH--FKKLSLMQRLNIVIDVASALDYLHNQY 285
             EGNDF+ALV+EFM NGNLD WLHP   E      + L L  RLNI IDVASAL YLH   
Sbjct:   789 EGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYC 848

Query:   286 DTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPE 345
               PIAHCD+K SN+LLD+ + AHV DFGLA+ L +        Q  S G++G++GY  PE
Sbjct:   849 HNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPE 908

Query:   346 Y-INGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSM 404
             Y + GH SI+GD+YS+GI+LLEIFTGKRPT+ +F D L++H F   AL       LD++ 
Sbjct:   909 YGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKR--QALDIT- 965

Query:   405 LLXXXXXXXXXXXXXLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN 464
                            +     +Q     + ECL  V R+GV CS  SP +R+ M   ++ 
Sbjct:   966 ------------DETILRGAYAQ--HFNMVECLTLVFRVGVSCSEESPVNRISMAEAISK 1011

Query:   465 LQAIRSKIRMREE 477
             L +IR      EE
Sbjct:  1012 LVSIRESFFRDEE 1024

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 979 (349.7 bits), Expect = 1.3e-98, P = 1.3e-98
 Identities = 204/484 (42%), Positives = 305/484 (63%)

Query:     1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
             +YL  N F GTIP  +K L G+  +DLS NNLSG + ++F     L +LNLS N  +G +
Sbjct:   535 IYLQENHFDGTIP-DIKGLMGVKNVDLSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRV 593

Query:    61 SREGIFANASAISIVGNDKLCGGIQKLQLPECSRKNP---RKRLSL--KIVIPVTISVPI 115
               EGIF NA+ +S+ GN  LCG I++L+L  C  + P    +  SL  K+ I V++ + +
Sbjct:   594 PTEGIFQNATLVSVFGNKNLCGSIKELKLKPCIAQAPPVETRHPSLLKKVAIGVSVGIAL 653

Query:   116 FILL-LAALVIYHIVKTSRR--QSAPPSNE-WQSGLSYLKISNATDNFSEENLIGSGSFG 171
              +LL + +L  +   K +++   SAP + E +   LSY  + NATD FS  N++GSGSFG
Sbjct:   654 LLLLFIVSLSWFKKRKNNQKINNSAPFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFG 713

Query:   172 SVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN 230
             +V+K  L  + +  A+KVL +Q++GA+KSF+ EC +L  IRHRN++K++++C+S+D++GN
Sbjct:   714 TVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGN 773

Query:   231 DFKALVFEFMRNGNLDQWLHPSTDEYCH--FKKLSLMQRLNIVIDVASALDYLHNQYDTP 288
             +F+AL++EFM NG+LD+WLHP   E  H   + L+L++RLNI IDVAS LDYLH     P
Sbjct:   774 EFRALIYEFMPNGSLDKWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEP 833

Query:   289 IAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEY-I 347
             IAHCDLK SN+LLD+ + AHV DFGLA+ L +       NQ  S G++G++GY  PEY +
Sbjct:   834 IAHCDLKPSNILLDDDLTAHVSDFGLARLLLKFDQESFFNQLSSAGVRGTIGYAAPEYGM 893

Query:   348 NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLX 407
              G  SI GD+YS+G+L+LE+FTGKRPT+++F  + +++ +   ALP  V+D+ D S+L  
Sbjct:   894 GGQPSIHGDVYSFGVLVLEMFTGKRPTNELFGGNFTLNSYTKAALPERVLDIADKSILHS 953

Query:   408 XXXXXXXXXXXXLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQA 467
                          FP +E          CL  ++ +G+ C   SP +R+        L +
Sbjct:   954 GLRVG--------FPVLE----------CLKGILDVGLRCCEESPLNRLATSEAAKELIS 995

Query:   468 IRSK 471
             IR +
Sbjct:   996 IRER 999

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 931 (332.8 bits), Expect = 6.8e-98, Sum P(2) = 6.8e-98
 Identities = 184/420 (43%), Positives = 279/420 (66%)

Query:     1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
             L+L  NSF G IP +++ L G+  +DLS N+LSG +P++F+    L +LNLS N   G++
Sbjct:   535 LFLQGNSFDGAIP-NIRGLMGVRRVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKV 593

Query:    61 SREGIFANASAISIVGNDKLCGGIQKLQLPECSRKNP---RKRLS--LKIVIPVTISVPI 115
               +G F N++ + + GN  LCGGI+ L+L  C  + P    K  S   K+ I V+I + +
Sbjct:   594 PSKGNFQNSTIVFVFGNKNLCGGIKDLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIAL 653

Query:   116 FILL-LAALVIYHIVKTSRRQSA----PPSNE-WQSGLSYLKISNATDNFSEENLIGSGS 169
              +LL +A++V+    K  + Q      P   E +   +SY  + NAT+ FS  N++GSGS
Sbjct:   654 LLLLVIASMVLCWFRKRRKNQQTNNLVPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGS 713

Query:   170 FGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYE 228
             FG+V+K  L  + +  A+KVL +Q++GA+KSF+ EC +L   RHRN++K++++C+S D++
Sbjct:   714 FGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQ 773

Query:   229 GNDFKALVFEFMRNGNLDQWLHPSTDEYCHF--KKLSLMQRLNIVIDVASALDYLHNQYD 286
             GN+F+AL++E++ NG++D WLHP   E      + L+L++RLNIVIDVAS LDYLH    
Sbjct:   774 GNEFRALIYEYLPNGSVDMWLHPEEVEEIRRPPRTLTLLERLNIVIDVASVLDYLHVHCH 833

Query:   287 TPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEY 346
              PIAHCDLK SNVLL++ + AHV DFGLA+ L +       NQ  S G++G++GY  PEY
Sbjct:   834 EPIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLKFDKESFLNQLSSAGVRGTIGYAAPEY 893

Query:   347 -INGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSML 405
              + G  SI GD+YS+G+LLLE+FTGKRPTD++F  +L++H +  +ALP  V ++ D ++L
Sbjct:   894 GMGGQPSIHGDVYSFGVLLLEMFTGKRPTDELFGGNLTLHSYTKLALPEKVFEIADKAIL 953

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 892 (319.1 bits), Expect = 4.8e-95, Sum P(2) = 4.8e-95
 Identities = 180/404 (44%), Positives = 265/404 (65%)

Query:     1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
             L++  NSF G IP  +  L  L  +D S NNLSG++P++ + L SLR+LNLS N+ +G +
Sbjct:   542 LFMQGNSFDGAIP-DISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRV 600

Query:    61 SREGIFANASAISIVGNDKLCGGIQKLQLPECS-RKNPRKR--LSL--KIVIPVTISVPI 115
                G+F NA+A+S+ GN  +CGG++++QL  C  + +PRKR  LS+  K+V  + I +  
Sbjct:   601 PTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIAS 660

Query:   116 FILLLAALVIYHIVKTSRRQSAP---PSNEWQSGL-----SYLKISNATDNFSEENLIGS 167
              +L++    +   +K  ++ +A    PS+    G+     SY ++ +AT  FS  NLIGS
Sbjct:   661 LLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGS 720

Query:   168 GSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVD 226
             G+FG+V+KG L  + +  A+KVL L + GA KSF+ EC     IRHRN++K+++ CSS+D
Sbjct:   721 GNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLD 780

Query:   227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEYC--HFKKLSLMQRLNIVIDVASALDYLHNQ 284
              EGNDF+ALV+EFM  G+LD WL     E    H + L+  ++LNI IDVASAL+YLH  
Sbjct:   781 SEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVH 840

Query:   285 YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
                P+AHCD+K SN+LLD+ + AHV DFGLA+ L++       NQ  S G++G++GY  P
Sbjct:   841 CHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAP 900

Query:   345 EY-INGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKF 387
             EY + G  SI GD+YS+GILLLE+F+GK+PTD+ F  D ++H +
Sbjct:   901 EYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSY 944

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)]

 Score = 756 (271.2 bits), Expect = 5.8e-82, Sum P(2) = 5.8e-82
 Identities = 159/383 (41%), Positives = 231/383 (60%)

Query:    22 LAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYN--------ELDGEISREGIFANASAIS 73
             +  LDL    LSG +      L  LR LNL  N        E +G +  +G+F N + +S
Sbjct:    75 VTSLDLGGFKLSGSISPSIGNLSFLRSLNLGDNSFQSNIPQEFEGSVPTKGVFQNGTTVS 134

Query:    74 IVGNDKLCGGIQKLQLPECSRKNPRKRLSLKIVIPVTISVPIFILLLAALVIYHIVKTSR 133
             + GN+ LCGG+ ++QL  C  ++PR++    +   V + V + +L L   +I   +   +
Sbjct:   135 VFGNENLCGGVIEMQLKPCI-ESPRQKKPFSLGEKVAVGVGVALLFL--FIIVASLSWFK 191

Query:   134 RQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ 192
             +++          +SY ++ NAT  FS  NLIGSG+F  V+KG L  + +  A+KVL L 
Sbjct:   192 KKN--------DKISYEELYNATSGFSSSNLIGSGNFSDVFKGLLGLEEKLVAVKVLNLL 243

Query:   193 QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPS 252
             + GA KSFI EC +   IRHRN+ K+++ CSS+D +GNDF+ALV+EFM  G+LD WL P 
Sbjct:   244 KHGATKSFIAECESFKGIRHRNLAKLITVCSSLDSQGNDFRALVYEFMPKGSLDMWLQPE 303

Query:   253 TDEYC--HFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG 310
               E    H + L+  +++NI IDVASAL+YLH     P+AHCD+K SNVLLD+ + AHV 
Sbjct:   304 DLESANNHSRSLTFAEKVNIAIDVASALEYLHVYCHDPVAHCDIKPSNVLLDDDLTAHVS 363

Query:   311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEY-INGHVSILGDIYSYGILLLEIFT 369
             DFGLA+ L+        NQ  S G++G++GY  PEY +    SI GD+YS+G+LLLE+FT
Sbjct:   364 DFGLARLLYNFDEKTFLNQFSSAGVRGTIGYAAPEYGMGSKPSIQGDVYSFGVLLLEMFT 423

Query:   370 GKRPTDDMFKDDLSIHKFVLMAL 392
             GK+PTD+ F    ++H +    L
Sbjct:   424 GKKPTDNSFGGGYNLHGYTKSVL 446

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 643 (231.4 bits), Expect = 1.7e-62, P = 1.7e-62
 Identities = 165/488 (33%), Positives = 261/488 (53%)

Query:     1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
             L L  N F  T+P SL  L  L ELD+S N L+G +P  F +  +L+HLN S+N L G +
Sbjct:   496 LNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNV 555

Query:    61 SREGIFANASAISIVGNDKLCGGIQKLQLPECSRKNPRKRLSLKIVIPVTISVPIFILLL 120
             S +G F+  +  S +G+  LCG I+ +Q   C +K+    + L +++ + I+ P+  +  
Sbjct:   556 SDKGSFSKLTIESFLGDSLLCGSIKGMQA--CKKKHKYPSVLLPVLLSL-IATPVLCVFG 612

Query:   121 AALV----------IYHIVKTSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSF 170
               LV          +Y   +    +    ++     +SY ++  AT  F+  +LIGSG F
Sbjct:   613 YPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRF 672

Query:   171 GSVYKGTLADGETAAIKVLKLQQQGALK---SFIDECNALTSIRHRNILKIVSSCSSVDY 227
             G VYKG L +    A+KVL    + AL+   SF  EC  L   RHRN+++I+++CS    
Sbjct:   673 GHVYKGVLRNNTKVAVKVL--DPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSK--- 727

Query:   228 EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDT 287
              G  F ALV   M NG+L++ L+P   EY   K L L+Q +NI  DVA  + YLH+    
Sbjct:   728 PG--FNALVLPLMPNGSLERHLYPG--EYSS-KNLDLIQLVNICSDVAEGIAYLHHYSPV 782

Query:   288 PIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG-----LKGSVGYI 342
              + HCDLK SN+LLD+ M A V DFG+++ +     T S + ++S G     L GSVGYI
Sbjct:   783 KVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYI 842

Query:   343 PPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLD 401
              PEY  G   S  GD+YS+G+LLLEI +G+RPTD +  +  S+H+F+    P  +  +++
Sbjct:   843 APEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIE 902

Query:   402 LSMLLXXXXXXXXXXXXXLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFV 461
              ++                 P  + +  +K   E ++ ++ +G++C+  +P  R  M  V
Sbjct:   903 QAL-------------SRWKPQGKPEKCEKLWREVILEMIELGLVCTQYNPSTRPDMLDV 949

Query:   462 VNNLQAIR 469
              + +  ++
Sbjct:   950 AHEMGRLK 957

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 641 (230.7 bits), Expect = 8.0e-62, P = 8.0e-62
 Identities = 162/500 (32%), Positives = 266/500 (53%)

Query:     1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
             L L  NSF G IP S  ++  L  LDLS NNL+G++P+  + L +L+HL L+ N L G +
Sbjct:   703 LNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHV 762

Query:    61 SREGIFANASAISIVGNDKLCGGIQKLQLPECSRKNPRKRLSLKI-VIPVTISVPIFILL 119
                G+F N +A  ++GN  LCG   K  L  C+ K      S +  VI + +     +LL
Sbjct:   763 PESGVFKNINASDLMGNTDLCGS--KKPLKPCTIKQKSSHFSKRTRVILIILGSAAALLL 820

Query:   120 LAALVIYHIVKTSRRQSAPPSNEWQSGL----SYLKISN--------ATDNFSEENLIGS 167
             +  LV+  I+   +++     N  +S L    S LK+          ATD+F+  N+IGS
Sbjct:   821 VLLLVL--ILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGS 878

Query:   168 GSFGSVYKGTLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNILKIVSSCSSV 225
              S  +VYKG L DG   A+KVL L++  A   K F  E   L+ ++HRN++KI+      
Sbjct:   879 SSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFA--- 935

Query:   226 DYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQY 285
              +E    KALV  FM NGNL+  +H S          SL++++++ + +AS +DYLH+ Y
Sbjct:   936 -WESGKTKALVLPFMENGNLEDTIHGSAAPIG-----SLLEKIDLCVHIASGIDYLHSGY 989

Query:   286 DTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFL-FEESNTPSKNQTMSNGLKGSVGYIPP 344
               PI HCDLK +N+LLD   +AHV DFG A+ L F E  + + +   ++  +G++GY+ P
Sbjct:   990 GFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTAS---TSAFEGTIGYLAP 1046

Query:   345 EYINGH-VSILGDIYSYGILLLEIFTGKRPT--DDMFKDDLSIHKFVLMALPSH---VMD 398
             E+     V+   D++S+GI+++E+ T +RPT  +D    D+++ + V  ++ +    ++ 
Sbjct:  1047 EFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVR 1106

Query:   399 VLDLSMLLXXXXXXXXXXXXXLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGM 458
             VLD+                    ++   +   K EE +   +++ + C+++ P DR  M
Sbjct:  1107 VLDM--------------------ELGDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPDM 1146

Query:   459 KFVVNNLQAIRSKIR-MREE 477
               ++ +L  +R K    RE+
Sbjct:  1147 NEILTHLMKLRGKANSFRED 1166

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 596 (214.9 bits), Expect = 5.1e-58, P = 5.1e-58
 Identities = 127/280 (45%), Positives = 177/280 (63%)

Query:     1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
             L+L NN   G+IP++L  L+GL  LDLS NNLSG++P     +  L  LNLS+N   GE+
Sbjct:   524 LFLQNNFLNGSIPIALTQLKGLDTLDLSGNNLSGQIPMSLGDMPLLHSLNLSFNSFHGEV 583

Query:    61 SREGIFANASAISIVGNDKLCGGIQKLQLPECSRKNPRKR----LSLKIVIPVTISVPIF 116
                G+FANAS I I GN  +CGGI +L LP CS K+ +K+    L L +VI +  ++ +F
Sbjct:   584 PTNGVFANASEIYIQGNAHICGGIPELHLPTCSLKSRKKKKHQILLLVVVICLVSTLAVF 643

Query:   117 ILLLAALVIYHIVKTSRRQSAPPSNEWQSG--LSYLKISNATDNFSEENLIGSGSFGSVY 174
              LL   L  +      R++  P +   Q    ++Y ++  ATD FS  +L+GSGSFGSVY
Sbjct:   644 SLLYMLLTCHK----RRKKEVPATTSMQGHPMITYKQLVKATDGFSSSHLLGSGSFGSVY 699

Query:   175 KGTL--ADGETA---AIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEG 229
             KG     DGE     A++VLKL+   ALKSF  EC  L + RHRN++KIV+ CSS+D  G
Sbjct:   700 KGEFDSQDGEITSLVAVRVLKLETPKALKSFTAECETLRNTRHRNLVKIVTICSSIDNRG 759

Query:   230 NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN 269
             NDFKA+V++FM NG+L+ WLHP T++    + L+L QR++
Sbjct:   760 NDFKAIVYDFMPNGSLEDWLHPETNDQAEQRHLTLHQRVS 799

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0016567 "protein ubiquitination" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.00161088 hypothetical protein (970 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	477
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-40
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-40
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-39
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-38
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-37
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-36
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-35
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-30
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-28
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	9e-28
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-27
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-27
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-26
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	9e-26
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-25
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	9e-25
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-24
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-22
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-22
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-21
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-21
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-21
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-21
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-21
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-20
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-20
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-20
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-20
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	8e-20
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-19
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-19
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-19
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	8e-19
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-18
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-18
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-18
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-17
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-17
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-17
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-17
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-17
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-17
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-17
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	8e-17
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-16
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-16
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-16
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-16
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	7e-16
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-15
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-15
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-15
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-15
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-15
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-15
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-15
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	7e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	8e-15
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	9e-15
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-14
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-14
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-14
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-14
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-14
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-14
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-14
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-14
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	8e-14
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-13
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-13
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-13
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-13
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-13
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-13
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-13
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-13
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-13
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-13
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-13
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	7e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	8e-13
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	8e-13
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-12
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-12
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-12
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-12
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-12
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	7e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	9e-12
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-11
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-11
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-11
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-11
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-11
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-11
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-11
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	7e-11
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-10
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-10
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-10
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-10
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-10
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-10
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-10
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-10
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-10
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-10
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	7e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	8e-10
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-09
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-09
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-09
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-09
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-09
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-09
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-09
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-09
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-09
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-09
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	6e-09
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	6e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	7e-09
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-08
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-08
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-08
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-08
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-08
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-08
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-08
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-08
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-08
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-08
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-08
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-08
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	6e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	7e-08
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-08
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	8e-08
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	8e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	9e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-07
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-07
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-07
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-07
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-07
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-07
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-07
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-07
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-07
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-07
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	5e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-07
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	7e-07
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	7e-07
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	8e-07
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	8e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	9e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-06
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-06
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-06
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-06
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-06
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-06
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-06
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-06
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-06
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-06
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-06
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-06
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-06
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-06
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-06
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-06
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	8e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-05
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-05
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-05
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-05
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-05
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-05
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-05
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-05
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-05
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-05
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	6e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-04
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-04
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-04
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-04
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-04
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-04
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	2e-04
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-04
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-04
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-04
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-04
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-04
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-04
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	5e-04
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-04
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	6e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	7e-04
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	7e-04
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.001
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	0.001
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.001
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.002
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	0.002
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	0.002
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	0.002
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.003
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	0.003
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	0.003
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	0.003
pfam03109	117	pfam03109, ABC1, ABC1 family	0.003
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  144 bits (366), Expect = 1e-40
 Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 26/208 (12%)

Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSC 222
           +G G FG+VY       G+  AIK++K +     L+  + E   L  + H NI+K+    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
                   +   LV E+   G+L   L        +  KLS  + L I++ +   L+YLH
Sbjct: 61  ED-----ENHLYLVMEYCEGGSLKDLLK------ENEGKLSEDEILRILLQILEGLEYLH 109

Query: 283 NQYDTPIAHCDLKSSNVLLDEG-MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGY 341
           +     I H DLK  N+LLD       + DFGL+K L  + +           + G+  Y
Sbjct: 110 SN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL-------LKTIVGTPAY 159

Query: 342 IPPEYING--HVSILGDIYSYGILLLEI 367
           + PE + G  + S   DI+S G++L E+
Sbjct: 160 MAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  144 bits (366), Expect = 4e-40
 Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 27/214 (12%)

Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQ--GALKSFIDECNALTSIRHRNILKIVSS 221
           +GSGSFG+VYK      G+  A+K+LK + +     ++   E   L  + H NI++++ +
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 222 CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYL 281
                +E  D   LV E+   G+L  +L            LS  +   I + +   L+YL
Sbjct: 67  -----FEDKDHLYLVMEYCEGGDLFDYLSRG-------GPLSEDEAKKIALQILRGLEYL 114

Query: 282 HNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGY 341
           H+     I H DLK  N+LLDE  +  + DFGLAK L        K+ +      G+  Y
Sbjct: 115 HSN---GIIHRDLKPENILLDENGVVKIADFGLAKKL-------LKSSSSLTTFVGTPWY 164

Query: 342 IPPEYINGH--VSILGDIYSYGILLLEIFTGKRP 373
           + PE + G        D++S G++L E+ TGK P
Sbjct: 165 MAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  141 bits (357), Expect = 7e-39
 Identities = 70/248 (28%), Positives = 106/248 (42%), Gaps = 27/248 (10%)

Query: 159 FSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQ-GALKSFIDECNALTSIRHRNIL 216
           +     +G GSFG VY       G+  AIKV+K ++     +  + E   L  ++H NI+
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           ++        +E  D   LV E+   G+L   L           +LS  +    +  + S
Sbjct: 61  RLYDV-----FEDEDKLYLVMEYCEGGDLFDLLK-------KRGRLSEDEARFYLRQILS 108

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
           AL+YLH++    I H DLK  N+LLDE     + DFGLA+ L                  
Sbjct: 109 ALEYLHSKG---IVHRDLKPENILLDEDGHVKLADFGLARQL--------DPGEKLTTFV 157

Query: 337 GSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSH 395
           G+  Y+ PE + G       DI+S G++L E+ TGK P        L + K +    P  
Sbjct: 158 GTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGD-DQLLELFKKIGKPKPPF 216

Query: 396 VMDVLDLS 403
                D+S
Sbjct: 217 PPPEWDIS 224

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  138 bits (351), Expect = 5e-38
 Identities = 63/221 (28%), Positives = 113/221 (51%), Gaps = 27/221 (12%)

Query: 165 IGSGSFGSVYKGTL-----ADGETAAIKVLKLQ-QQGALKSFIDECNALTSIRHRNILKI 218
           +G G+FG VYKGTL           A+K LK    +   + F++E + +  + H NI+++
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
           +  C+    +G     +V E+M  G+L  +L        H +KL+L   L + + +A  +
Sbjct: 67  LGVCT----QGEPLY-IVTEYMPGGDLLDFLRK------HGEKLTLKDLLQMALQIAKGM 115

Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
           +YL ++      H DL + N L+ E ++  + DFGL++ ++E+            G K  
Sbjct: 116 EYLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY-----RKRGGGKLP 167

Query: 339 VGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
           + ++ PE +  G  +   D++S+G+LL EIFT G++P   M
Sbjct: 168 IKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM 208

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  137 bits (348), Expect = 2e-37
 Identities = 63/247 (25%), Positives = 117/247 (47%), Gaps = 28/247 (11%)

Query: 163 NLIGSGSFGSVYKGTLADGET----AAIKVLKLQ-QQGALKSFIDECNALTSIRHRNILK 217
             +G G+FG VYKG L   +      A+K LK    +   K F+ E   +  + H N+++
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 218 IVSSCSSVD--YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK--LSLMQRLNIVID 273
           ++  C+  +  Y       LV E+M  G+L  +L  S   +   +K  LSL   L+  I 
Sbjct: 61  LLGVCTEEEPLY-------LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113

Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +A  ++YL ++      H DL + N L+ E ++  + DFGL++ ++++     K      
Sbjct: 114 IAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKL- 169

Query: 334 GLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDDLS--IHKFVL 389
                + ++ PE +   + +   D++S+G+LL EIFT G  P   +  +++   + K   
Sbjct: 170 ----PIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR 225

Query: 390 MALPSHV 396
           +  P + 
Sbjct: 226 LPKPEYC 232

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  135 bits (342), Expect = 1e-36
 Identities = 60/221 (27%), Positives = 108/221 (48%), Gaps = 28/221 (12%)

Query: 165 IGSGSFGSVYKGTL-----ADGETAAIKVLKL-QQQGALKSFIDECNALTSIRHRNILKI 218
           +G G+FG VYKG L           A+K LK    +  ++ F+ E   +  + H N++K+
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
           +  C+  +        +V E+M  G+L  +L  +        KLSL   L+  + +A  +
Sbjct: 67  LGVCTEEEPL-----YIVMEYMEGGDLLSYLRKNRP------KLSLSDLLSFALQIARGM 115

Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
           +YL ++      H DL + N L+ E ++  + DFGL++ L+++            G K  
Sbjct: 116 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD------YYRKRGGKLP 166

Query: 339 VGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDM 377
           + ++ PE +     +   D++S+G+LL EIFT G++P   M
Sbjct: 167 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM 207

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  132 bits (334), Expect = 2e-35
 Identities = 62/223 (27%), Positives = 109/223 (48%), Gaps = 31/223 (13%)

Query: 165 IGSGSFGSVYKGTLADG-----ETAAIKVLKL-QQQGALKSFIDECNALTSIRHRNILKI 218
           +G G+FG VYKGTL           A+K LK    +  ++ F+ E   +  + H NI+K+
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 219 VSSCSSVD--YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           +  C+  +          +V E+M  G+L  +L  +       K+LSL   L+  + +A 
Sbjct: 67  LGVCTEEEPLM-------IVMEYMPGGDLLDYLRKNRP-----KELSLSDLLSFALQIAR 114

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            ++YL ++      H DL + N L+ E ++  + DFGL++ L+++            G K
Sbjct: 115 GMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD------YYKVKGGK 165

Query: 337 GSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDM 377
             + ++ PE +     +   D++S+G+LL EIFT G+ P   M
Sbjct: 166 LPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGM 208

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  118 bits (298), Expect = 2e-30
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 26/217 (11%)

Query: 163 NLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGA--LKSFIDECNALTSIRHRNILKIV 219
            L+G GSFGSVY     D GE  A+K ++L       L++   E   L+S++H NI++  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKL--SLMQRLNIVIDVASA 277
            S      E N    +  E++  G+L   L         F KL   ++++      +   
Sbjct: 66  GSERDE--EKNTLN-IFLEYVSGGSLSSLLK-------KFGKLPEPVIRKY--TRQILEG 113

Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           L YLH+     I H D+K +N+L+D   +  + DFG AK L +           +  ++G
Sbjct: 114 LAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE-----GTGSVRG 165

Query: 338 SVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
           +  ++ PE I G       DI+S G  ++E+ TGK P
Sbjct: 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  111 bits (280), Expect = 5e-28
 Identities = 69/224 (30%), Positives = 112/224 (50%), Gaps = 27/224 (12%)

Query: 164 LIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
            IG G FG V  G    G+  A+K LK     A ++F+ E + +T++RH N+++++    
Sbjct: 13  TIGKGEFGDVMLGDYR-GQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLG--- 67

Query: 224 SVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN 283
            V  +GN    +V E+M  G+L  +L   +        ++L Q+L   +DV   ++YL  
Sbjct: 68  -VVLQGNPL-YIVTEYMAKGSLVDYLR--SRGRAV---ITLAQQLGFALDVCEGMEYLEE 120

Query: 284 QYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIP 343
           +      H DL + NVL+ E ++A V DFGLAK           +Q   +G K  V +  
Sbjct: 121 K---NFVHRDLAARNVLVSEDLVAKVSDFGLAK---------EASQGQDSG-KLPVKWTA 167

Query: 344 PEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH 385
           PE +     S   D++S+GILL EI++ G+ P   +   D+  H
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH 211

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  110 bits (278), Expect = 9e-28
 Identities = 71/224 (31%), Positives = 101/224 (45%), Gaps = 38/224 (16%)

Query: 159 FSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILK 217
           F     IG G FG VYK      G+  AIKV+KL+ +   +  I+E   L   +H NI+K
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN------IV 271
              S     Y   D   +V EF   G+L   L             S  Q L       + 
Sbjct: 62  YYGS-----YLKKDELWIVMEFCSGGSLKDLLK------------STNQTLTESQIAYVC 104

Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLL-DEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
            ++   L+YLH+     I H D+K++N+LL  +G +  + DFGL+  L   S+T     T
Sbjct: 105 KELLKGLEYLHSNG---IIHRDIKAANILLTSDGEV-KLIDFGLSAQL---SDTK-ARNT 156

Query: 331 MSNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRP 373
           M     G+  ++ PE ING       DI+S GI  +E+  GK P
Sbjct: 157 MV----GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  116 bits (292), Expect = 1e-27
 Identities = 116/470 (24%), Positives = 192/470 (40%), Gaps = 74/470 (15%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L +N   G IP S   +  L++LDLS N LSG++P+    + SL  +N+S+N L G +
Sbjct: 528 LDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSL 587

Query: 61  SREGIFANASAISIVGNDKLCGGIQKLQLPECSR--KNPRKRLSLKIVIPVTISVPIFIL 118
              G F   +A ++ GN  LCGG     LP C R  K P           +T ++  F++
Sbjct: 588 PSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFY------ITCTLGAFLV 641

Query: 119 LLAALVIYHIVKTSRRQSAPPSNEWQSGLSYLKI--SNATDNFS---------EENLIGS 167
           L      +  ++  R        E + G   L+   S  + + +         EEN+I  
Sbjct: 642 LALVAFGFVFIRG-RNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISR 700

Query: 168 GSFGSVYKGTLADGETAAIKVLKLQQQGAL-KSFIDECNALTSIRHRNILKIVSSCSSVD 226
           G  G+ YKG         + V ++    ++  S I +   +  ++H NI+K++  C S  
Sbjct: 701 GKKGASYKGKSIKNGMQFV-VKEINDVNSIPSSEIAD---MGKLQHPNIVKLIGLCRS-- 754

Query: 227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYD 286
                   L+ E++   NL + L          + LS  +R  I I +A AL +LH +  
Sbjct: 755 ---EKGAYLIHEYIEGKNLSEVL----------RNLSWERRRKIAIGIAKALRFLHCRCS 801

Query: 287 TPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEY 346
             +   +L    +++D     H+    L   L                   S  Y+ PE 
Sbjct: 802 PAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLL-----------CTDTKCFISSAYVAPET 849

Query: 347 I-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSML 405
                ++   DIY +G++L+E+ TGK P D  F    SI ++         +D     M 
Sbjct: 850 RETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLD-----MW 904

Query: 406 LEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDR 455
           ++              P I   V+  + E  +V VM + + C+A  P  R
Sbjct: 905 ID--------------PSIRGDVSVNQNE--IVEVMNLALHCTATDPTAR 938

Length = 968

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  110 bits (277), Expect = 1e-27
 Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 26/223 (11%)

Query: 159 FSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKI 218
           F+ E  +GSG FG V++G   +    AIK+LK       + F  E  AL  +RH++++ +
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 219 VSSCSSVD--YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            + CS  +  Y       ++ E M  G+L  +L  S +     + L +   +++   VA 
Sbjct: 68  FAVCSVGEPVY-------IITELMEKGSLLAFLR-SPEG----QVLPVASLIDMACQVAE 115

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            + YL  Q      H DL + N+L+ E ++  V DFGLA+ + E+    S         K
Sbjct: 116 GMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDK-------K 165

Query: 337 GSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
               +  PE  + G  S   D++S+GILL E+FT G+ P   M
Sbjct: 166 IPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM 208

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  107 bits (271), Expect = 1e-26
 Identities = 64/226 (28%), Positives = 99/226 (43%), Gaps = 34/226 (15%)

Query: 158 NFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGA--LKSFIDECNALTSIRHRN 214
            +     IG GSFG VY     +DG+   +K + L        +  ++E   L  + H N
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
           I+K   S     +E      +V E+   G+L Q +     E   F +    Q L+  + +
Sbjct: 61  IIKYYES-----FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPE---EQILDWFVQL 112

Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
             AL YLH++    I H D+K  N+ L    +  +GDFG++K L   S+T    +T+   
Sbjct: 113 CLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVL---SSTVDLAKTV--- 163

Query: 335 LKGSVG---YIPPEYING----HVSILGDIYSYGILLLEIFTGKRP 373
               VG   Y+ PE        + S   DI+S G +L E+ T K P
Sbjct: 164 ----VGTPYYLSPELCQNKPYNYKS---DIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  105 bits (264), Expect = 9e-26
 Identities = 65/219 (29%), Positives = 110/219 (50%), Gaps = 30/219 (13%)

Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALK--SFIDECNALTSIRHRNILKIVSSC 222
           +G+G FG V+ GT       A+K LK    G +   +F+ E   +  +RH  ++++ + C
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLK---PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70

Query: 223 SSVD--YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDY 280
           S  +  Y       +V E+M  G+L  +L   + E    KKL L Q +++   +A  + Y
Sbjct: 71  SEEEPIY-------IVTEYMSKGSLLDFLK--SGEG---KKLRLPQLVDMAAQIAEGMAY 118

Query: 281 LHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG 340
           L ++      H DL + N+L+ E ++  + DFGLA+ + ++  T  +      G K  + 
Sbjct: 119 LESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE------GAKFPIK 169

Query: 341 YIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
           +  PE  N G  +I  D++S+GILL EI T G+ P   M
Sbjct: 170 WTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM 208

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  106 bits (264), Expect = 3e-25
 Identities = 70/228 (30%), Positives = 111/228 (48%), Gaps = 24/228 (10%)

Query: 158 NFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQ---QQGALKSFIDECNALTSIRH-R 213
           ++     +G GSFG VY     D +  A+KVL  +   +   ++ F+ E   L S+ H  
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
           NI+K+        ++      LV E++  G+L+  L     +      LS  + L I+  
Sbjct: 59  NIVKLYDF-----FQDEGSLYLVMEYVDGGSLEDLLKKIGRK----GPLSESEALFILAQ 109

Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDE-GMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           + SAL+YLH++    I H D+K  N+LLD  G +  + DFGLAK L  +  + S    + 
Sbjct: 110 ILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAK-LLPDPGSTSSIPALP 165

Query: 333 NGLKGSVGYIPPEYING----HVSILGDIYSYGILLLEIFTGKRPTDD 376
           +   G+ GY+ PE + G    + S   DI+S GI L E+ TG  P + 
Sbjct: 166 STSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG 213

Length = 384

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 9e-25
 Identities = 67/220 (30%), Positives = 106/220 (48%), Gaps = 26/220 (11%)

Query: 158 NFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRN 214
           N+   +LIG G+FG VYKG  L  G+  AIK + L+  ++ ALKS + E + L +++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
           I+K + S      E +D   ++ E+  NG+L Q +         F           V  V
Sbjct: 61  IVKYIGS-----IETSDSLYIILEYAENGSLRQIIKK-------FGPFPESLVAVYVYQV 108

Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
              L YLH Q    + H D+K++N+L  +  +  + DFG+A  L + S            
Sbjct: 109 LQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-------DAS 158

Query: 335 LKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
           + G+  ++ PE I     S   DI+S G  ++E+ TG  P
Sbjct: 159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  102 bits (255), Expect = 2e-24
 Identities = 71/227 (31%), Positives = 113/227 (49%), Gaps = 33/227 (14%)

Query: 165 IGSGSFGSVYKGTLA------DGETAAIKVLK-LQQQGALKSFIDECNALTSIRHRNILK 217
           +G G+FG V+ G         D E  A+K LK      A K F  E   LT+ +H NI+K
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---------PSTDEYCHFKKLSLMQRL 268
               C+    EG D   +VFE+M +G+L+++L           S D      +L+L Q L
Sbjct: 73  FYGVCT----EG-DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPM--GELTLSQLL 125

Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
            I + +AS + YL +Q+     H DL + N L+   ++  +GDFG+++ ++         
Sbjct: 126 QIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGG 182

Query: 329 QTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRP 373
            TM       + ++PPE I     +   D++S+G++L EIFT GK+P
Sbjct: 183 HTML-----PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 95.6 bits (238), Expect = 3e-22
 Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 26/217 (11%)

Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSS 224
           +G+G FG V++G   +    A+K LK       K F+ E   +  +RH  ++++ + C+ 
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCTL 72

Query: 225 VD--YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
            +  Y       +V E M+ G+L ++L          + L L Q +++   VAS + YL 
Sbjct: 73  EEPIY-------IVTELMKYGSLLEYLQGGAG-----RALKLPQLIDMAAQVASGMAYLE 120

Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
            Q      H DL + NVL+ E  I  V DFGLA+ + E+     +      G K  + + 
Sbjct: 121 AQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE------GAKFPIKWT 171

Query: 343 PPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
            PE       SI  D++S+GILL EI T G+ P   M
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM 208

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 95.0 bits (237), Expect = 7e-22
 Identities = 66/240 (27%), Positives = 101/240 (42%), Gaps = 34/240 (14%)

Query: 157 DNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVL---KLQQQGALKSFIDECNALTSI-R 211
           D+F    +IG GSF +V         +  AIK+L   +L ++  +K    E   LT +  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H  I+K+  +      E N +   V E+  NG L Q++         +  L         
Sbjct: 61  HPGIIKLYYTFQD---EENLY--FVLEYAPNGELLQYIR-------KYGSLDEKCTRFYA 108

Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFL----FEESNTPSK 327
            ++  AL+YLH++    I H DLK  N+LLD+ M   + DFG AK L      ESN    
Sbjct: 109 AEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDA 165

Query: 328 NQTMSNGLKGS------VG---YIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM 377
               S   K        VG   Y+ PE +         D+++ G ++ ++ TGK P    
Sbjct: 166 TNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 93.2 bits (232), Expect = 2e-21
 Identities = 67/222 (30%), Positives = 97/222 (43%), Gaps = 33/222 (14%)

Query: 163 NLIGSGSFGSVYKG-TLADGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIV 219
           N IG G+FG VY    L  GE  A+K +++Q      +K   DE   L  ++H N+    
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNL---- 61

Query: 220 SSCSSVDYEG---NDFKALVF-EFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
                V Y G   +  K  +F E+   G L++ L        H + L         + + 
Sbjct: 62  -----VKYYGVEVHREKVYIFMEYCSGGTLEELLE-------HGRILDEHVIRVYTLQLL 109

Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
             L YLH+     I H D+K +N+ LD   +  +GDFG A  L   + T          L
Sbjct: 110 EGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG---EEVQSL 163

Query: 336 KGSVGYIPPEYINGHVSI--LG--DIYSYGILLLEIFTGKRP 373
            G+  Y+ PE I G          DI+S G ++LE+ TGKRP
Sbjct: 164 AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 93.5 bits (232), Expect = 2e-21
 Identities = 66/227 (29%), Positives = 113/227 (49%), Gaps = 33/227 (14%)

Query: 165 IGSGSFGSVYKGTLA------DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKI 218
           +G G+FG V+           D    A+K LK   + A + F  E   LT ++H++I++ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHP----------STDEYCHFKKLSLMQRL 268
              C+    EG     +VFE+MR+G+L+++L              D      +L+L Q L
Sbjct: 73  YGVCT----EG-RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAP--GQLTLGQML 125

Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
            I   +AS + YL + +     H DL + N L+ +G++  +GDFG+++ ++         
Sbjct: 126 AIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 182

Query: 329 QTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRP 373
           +TM       + ++PPE I     +   DI+S+G++L EIFT GK+P
Sbjct: 183 RTML-----PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 92.8 bits (231), Expect = 3e-21
 Identities = 62/227 (27%), Positives = 108/227 (47%), Gaps = 34/227 (14%)

Query: 162 ENLIGSGSFGSVYKGTLA----DGETAAIKVLKLQQQGALKS-FIDECNALTSIRHRNIL 216
           E +IG G FG V +G L          AIK LK       +  F+ E + +    H NI+
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 217 K---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
           +   +V+    V         ++ E+M NG+LD++L        +  K ++ Q + ++  
Sbjct: 69  RLEGVVTKSRPV--------MIITEYMENGSLDKFLRE------NDGKFTVGQLVGMLRG 114

Query: 274 VASALDYLHNQ-YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           +AS + YL    Y     H DL + N+L++  ++  V DFGL++ L +   T +     +
Sbjct: 115 IASGMKYLSEMNY----VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT-----T 165

Query: 333 NGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
            G K  + +  PE I     +   D++S+GI++ E+ + G+RP  DM
Sbjct: 166 KGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 91.7 bits (228), Expect = 5e-21
 Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 29/216 (13%)

Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNILKIVSSC 222
           +GSG FG V+ G        AIK+++   +GA+    FI+E   +  + H N++++   C
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +           +V E+M NG L  +L           KL     L++  DV  A++YL 
Sbjct: 69  TK-----QRPIFIVTEYMANGCLLNYLRE------RKGKLGTEWLLDMCSDVCEAMEYLE 117

Query: 283 -NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGY 341
            N +     H DL + N L+ E  +  V DFGLA+++ ++  T S+      G K  V +
Sbjct: 118 SNGF----IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ------GTKFPVKW 167

Query: 342 IPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTD 375
            PPE  +    S   D++S+G+L+ E+F+ GK P +
Sbjct: 168 APPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 92.5 bits (230), Expect = 5e-21
 Identities = 64/251 (25%), Positives = 115/251 (45%), Gaps = 28/251 (11%)

Query: 165 IGSGSFGSVYKGT-LADGETA----AIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKI 218
           +GSG+FG+VYKG  + +GE      AIKVL+ +    A K  +DE   + S+ H +++++
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
           +  C S          L+ + M  G L  ++    D       +     LN  + +A  +
Sbjct: 75  LGICLSSQV------QLITQLMPLGCLLDYVRNHKDN------IGSQYLLNWCVQIAKGM 122

Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
            YL    +  + H DL + NVL+       + DFGLAK L        + +  + G K  
Sbjct: 123 SYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----DVDEKEYHAEGGKVP 174

Query: 339 VGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALPSHV 396
           + ++  E I +   +   D++SYG+ + E+ T G +P + +   ++         LP   
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPP 234

Query: 397 MDVLDLSMLLE 407
           +  +D+ M+L 
Sbjct: 235 ICTIDVYMVLV 245

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 91.5 bits (227), Expect = 1e-20
 Identities = 66/235 (28%), Positives = 119/235 (50%), Gaps = 37/235 (15%)

Query: 162 ENLIGSGSFGSVYKGTL-ADGE---TAAIKVLKL----QQQGALKSFIDECNALTSIRHR 213
           E +IG+G FG V +G L   G+     AIK LK     +Q+   + F+ E + +    H 
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR---RDFLSEASIMGQFDHP 65

Query: 214 NILK----IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN 269
           NI+     +  S   +         ++ EFM NG LD +L  +  ++      +++Q + 
Sbjct: 66  NIIHLEGVVTKSRPVM---------IITEFMENGALDSFLRQNDGQF------TVIQLVG 110

Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
           ++  +A+ + YL    +    H DL + N+L++  ++  V DFGL++FL ++++ P+   
Sbjct: 111 MLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT--Y 165

Query: 330 TMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL 382
           T S G K  + +  PE I     +   D++SYGI++ E+ + G+RP  DM   D+
Sbjct: 166 TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 220

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 90.7 bits (226), Expect = 2e-20
 Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 30/223 (13%)

Query: 156 TDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRN 214
            + +     IG G+ G VYK T  A G+  AIK ++L++Q   +  I+E   +   +H N
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPN 76

Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDE-YCHFKKLSLMQRLNIVID 273
           I+    S     Y   D   +V E+M  G+L       TD    +F +++  Q   +  +
Sbjct: 77  IVDYYDS-----YLVGDELWVVMEYMDGGSL-------TDIITQNFVRMNEPQIAYVCRE 124

Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV--GDFGLAKFLFEESNTPSKNQTM 331
           V   L+YLH+Q    + H D+KS N+LL       V   DFG A  L       +K ++ 
Sbjct: 125 VLQGLEYLHSQ---NVIHRDIKSDNILL--SKDGSVKLADFGFAAQL-------TKEKSK 172

Query: 332 SNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFTGKRP 373
            N + G+  ++ PE I         DI+S GI+ +E+  G+ P
Sbjct: 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 90.7 bits (226), Expect = 2e-20
 Identities = 66/224 (29%), Positives = 105/224 (46%), Gaps = 48/224 (21%)

Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILK---I 218
           IG G++G VYK      GE  A+K ++++   +G   + I E   L  +RH NI++   I
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 219 VSSCSSVDYEGNDFKALVFEFMR---NGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           V+S      +G+ +  +VFE+M     G LD      T+     K    M++L       
Sbjct: 67  VTSKG----KGSIY--MVFEYMDHDLTGLLDSPEVKFTES--QIK--CYMKQL------L 110

Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
             L YLH+     I H D+K SN+L++   +  + DFGLA+       T   +   +N +
Sbjct: 111 EGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPY-----TKRNSADYTNRV 162

Query: 336 KGSVGYIPPEYINGHVSILG--------DIYSYGILLLEIFTGK 371
             ++ Y PPE       +LG        D++S G +L E+F GK
Sbjct: 163 I-TLWYRPPEL------LLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 89.6 bits (222), Expect = 3e-20
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 27/216 (12%)

Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNILKIVSSC 222
           IGSG FG V+ G   +    AIK ++   +GA+  + FI+E   +  + H  ++++   C
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIR---EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68

Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +           LVFEFM +G L  +L           K S    L + +DV   + YL 
Sbjct: 69  TE-----RSPICLVFEFMEHGCLSDYLRAQRG------KFSQETLLGMCLDVCEGMAYLE 117

Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
               + + H DL + N L+ E  +  V DFG+ +F+ ++        T S G K  V + 
Sbjct: 118 ---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD------QYTSSTGTKFPVKWS 168

Query: 343 PPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDD 376
            PE  +    S   D++S+G+L+ E+F+ GK P ++
Sbjct: 169 SPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 89.1 bits (221), Expect = 5e-20
 Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 23/210 (10%)

Query: 164 LIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALK-SFIDECNALTSIRHRNILKIVSSC 222
            IG G+FG VYKG L      A+K  +      LK  F+ E   L    H NI+K++  C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
             V  +      +V E +  G+L  +L    +       L++ + L + +D A+ ++YL 
Sbjct: 62  --VQKQP---IYIVMELVPGGSLLTFLRKKKNR------LTVKKLLQMSLDAAAGMEYLE 110

Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG-SVGY 341
           ++      H DL + N L+ E  +  + DFG+++   EE        T+S+GLK   + +
Sbjct: 111 SK---NCIHRDLAARNCLVGENNVLKISDFGMSR---EEEGG---IYTVSDGLKQIPIKW 161

Query: 342 IPPEYIN-GHVSILGDIYSYGILLLEIFTG 370
             PE +N G  +   D++SYGILL E F+ 
Sbjct: 162 TAPEALNYGRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 89.4 bits (222), Expect = 6e-20
 Identities = 66/234 (28%), Positives = 116/234 (49%), Gaps = 35/234 (14%)

Query: 159 FSEENLIGSGSFGSVYKG---TLADGETA---AIKVLKLQQQGALKS-FIDECNALTSIR 211
           F EE  +G G+FG VYKG      +  +A   AIK LK   +  ++  F  E   ++ ++
Sbjct: 9   FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ 66

Query: 212 HRNILKIVSSCS-SVDYEGNDFKALVFEFMRNGNLDQWL---HPSTDEYCHF------KK 261
           H NI+ ++  C+            ++FE++ +G+L ++L    P +D             
Sbjct: 67  HPNIVCLLGVCTKEQPT------CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120

Query: 262 LSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEE 321
           L     L+I I +A+ ++YL + +     H DL + N L+ EG+   + DFGL++ ++  
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIY-- 175

Query: 322 SNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRP 373
             +    +  S  L   V ++PPE I  G  +   DI+S+G++L EIF+ G +P
Sbjct: 176 --SADYYRVQSKSLL-PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 89.0 bits (221), Expect = 8e-20
 Identities = 67/264 (25%), Positives = 109/264 (41%), Gaps = 37/264 (14%)

Query: 159 FSEENL-----IGSGSFGSVYKGTL-----ADGETAAIKVLKLQQQGALKS-FIDECNAL 207
           F + +L     +G G FG V            GE  A+K L    +   +S F  E   L
Sbjct: 1   FEKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEIL 60

Query: 208 TSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQR 267
            ++ H NI+K    C      G     L+ E++ +G+L  +L        H  +++L + 
Sbjct: 61  RTLDHENIVKYKGVCEK---PGGRSLRLIMEYLPSGSLRDYLQR------HRDQINLKRL 111

Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
           L     +   +DYL +Q      H DL + N+L++   +  + DFGLAK L        K
Sbjct: 112 LLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL-----PEDK 163

Query: 328 NQTMSNGLKGS-VGYIPPEYINGHV-SILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIH 385
           +         S + +  PE +     S   D++S+G+ L E+FT   P+           
Sbjct: 164 DYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS------PPA 217

Query: 386 KFVLMALPSH-VMDVLDLSMLLEE 408
           +F+ M   +   M V  L  LL+E
Sbjct: 218 EFLRMIGIAQGQMIVTRLLELLKE 241

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 88.9 bits (220), Expect = 1e-19
 Identities = 64/226 (28%), Positives = 108/226 (47%), Gaps = 30/226 (13%)

Query: 165 IGSGSFGSVYKGT------LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKI 218
           +G G+FG V+           D    A+K LK     A K F  E   LT+++H +I+K 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHF---------KKLSLMQRLN 269
              C        D   +VFE+M++G+L+++L     +              +L L Q L+
Sbjct: 73  YGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127

Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
           I   +AS + YL +Q+     H DL + N L+   ++  +GDFG+++ ++          
Sbjct: 128 IASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184

Query: 330 TMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRP 373
           TM       + ++PPE I     +   D++S+G++L EIFT GK+P
Sbjct: 185 TML-----PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 88.1 bits (218), Expect = 1e-19
 Identities = 61/215 (28%), Positives = 106/215 (49%), Gaps = 29/215 (13%)

Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSS 224
           IG G FG+V +G    G+  A+K +K       ++F++E   +T + H+N+++++     
Sbjct: 14  IGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGV--- 67

Query: 225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ 284
           + + G     +V E M  GNL  +L            +S++Q L   +DVA  ++YL ++
Sbjct: 68  ILHNG---LYIVMELMSKGNLVNFLRTRGRAL-----VSVIQLLQFSLDVAEGMEYLESK 119

Query: 285 YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
               + H DL + N+L+ E  +A V DFGLA+                +  K  V +  P
Sbjct: 120 ---KLVHRDLAARNILVSEDGVAKVSDFGLARV----------GSMGVDNSKLPVKWTAP 166

Query: 345 EYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
           E + +   S   D++SYG+LL E+F+ G+ P   M
Sbjct: 167 EALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 88.4 bits (219), Expect = 1e-19
 Identities = 66/229 (28%), Positives = 114/229 (49%), Gaps = 34/229 (14%)

Query: 163 NLIGSGSFGSVYKGT----LADGE---TAAIKVLKLQQQGAL----KSFIDECNALTSIR 211
           N +GSG+FG VY+GT    L  G      A+K L+   +GA     K F+ E + +++  
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR---KGATDQEKKEFLKEAHLMSNFN 57

Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H NI+K++  C       N+ + ++ E M  G+L  +L  +  E      L+L + L+I 
Sbjct: 58  HPNIVKLLGVCLL-----NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDIC 112

Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG-----MIAHVGDFGLAKFLFEESNTPS 326
           +DVA    YL         H DL + N L+ E       +  +GDFGLA+ +++      
Sbjct: 113 LDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRK 169

Query: 327 KNQTMSNGLKGSVGYIPPE-YINGHVSILGDIYSYGILLLEIFT-GKRP 373
           + + +       V ++ PE  ++G  +   D++S+G+L+ EI T G++P
Sbjct: 170 EGEGLLP-----VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 86.4 bits (214), Expect = 4e-19
 Identities = 77/246 (31%), Positives = 125/246 (50%), Gaps = 29/246 (11%)

Query: 164 LIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGA-----LKSFID----ECNALTSIRHR 213
           LIGSGSFGSVY G  A  GE  A+K ++L    A      +S +D    E   L  ++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
           NI++ + S    D+  N F     E++  G++   L    + Y  F++ +L++  N V  
Sbjct: 67  NIVQYLGSSLDADHL-NIF----LEYVPGGSVAALL----NNYGAFEE-TLVR--NFVRQ 114

Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +   L+YLHN+    I H D+K +N+L+D      + DFG++K L E ++  +K      
Sbjct: 115 ILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKL-EANSLSTKTNGARP 170

Query: 334 GLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFTGKRPTDDM--FKDDLSIHKFVLM 390
            L+GSV ++ PE +     +   DI+S G L++E+ TGK P  D    +    I +    
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASP 230

Query: 391 ALPSHV 396
            +PS++
Sbjct: 231 EIPSNI 236

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 85.9 bits (213), Expect = 7e-19
 Identities = 70/221 (31%), Positives = 108/221 (48%), Gaps = 37/221 (16%)

Query: 164 LIGSGSFGSVYKG-TLADGETAAIKVLKL-----QQQGALKSFIDECNALTSIRHRNILK 217
           L+GSGSFGSVY+G  L DG+  A+K + L       Q A+K    E   L+ ++H NI++
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 218 IVSSCSSVDYEGNDFKALVF-EFMRNGNLDQWLHPSTDEYCHFKK--LSLMQRLNIVIDV 274
            + +    D         +F E +  G+L + L     +Y  F +  + L  R      +
Sbjct: 67  YLGTEREED------NLYIFLELVPGGSLAKLLK----KYGSFPEPVIRLYTR-----QI 111

Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
              L+YLH++      H D+K +N+L+D   +  + DFG+AK + E S   S        
Sbjct: 112 LLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS-------- 160

Query: 335 LKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRP 373
            KGS  ++ PE I   G   +  DI+S G  +LE+ TGK P
Sbjct: 161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 85.9 bits (212), Expect = 8e-19
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 23/215 (10%)

Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSS 224
           +G G FG V+ GT       AIK LK       ++F+ E   +  +RH  ++++ +  S 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 72

Query: 225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ 284
                 +   +V E+M  G+L  +L     +Y     L L Q +++   +AS + Y+   
Sbjct: 73  ------EPIYIVTEYMSKGSLLDFLKGEMGKY-----LRLPQLVDMAAQIASGMAYVERM 121

Query: 285 YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
                 H DL+++N+L+ E ++  V DFGLA+ +  E N  +  Q    G K  + +  P
Sbjct: 122 ---NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQ----GAKFPIKWTAP 172

Query: 345 E-YINGHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
           E  + G  +I  D++S+GILL E+ T G+ P   M
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 207

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 85.0 bits (210), Expect = 1e-18
 Identities = 78/272 (28%), Positives = 124/272 (45%), Gaps = 30/272 (11%)

Query: 164 LIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALK-SFIDECNALTSIRHRNILKIVSSC 222
           L+G G+FG V+KGTL D    A+K  K      LK  F+ E   L    H NI+K++  C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +           +V E +  G+   +L    DE      L   Q +   +D A+ + YL 
Sbjct: 62  TQ-----RQPIYIVMELVPGGDFLSFLRKKKDE------LKTKQLVKFALDAAAGMAYLE 110

Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG-SVGY 341
           ++      H DL + N L+ E  +  + DFG+++   E+    S     S+GLK   + +
Sbjct: 111 SK---NCIHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYS-----SSGLKQIPIKW 160

Query: 342 IPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL--SIHKFVLMALPSHVM 397
             PE +N G  S   D++SYGILL E F+ G  P   M        + K   M+ P    
Sbjct: 161 TAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCP 220

Query: 398 DVLDLSMLLEEENDHEKHEEEDLFPDIESQVA 429
           D  D+  +++   D+ K E    F +++ ++A
Sbjct: 221 D--DVYKVMQRCWDY-KPENRPKFSELQKELA 249

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 85.5 bits (211), Expect = 1e-18
 Identities = 64/223 (28%), Positives = 110/223 (49%), Gaps = 27/223 (12%)

Query: 165 IGSGSFGSVYKGTL------ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKI 218
           +G G+FG V+           D    A+K LK     A K F  E   LT+++H +I+K 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHF------KKLSLMQRLNIVI 272
              C     EG+    +VFE+M++G+L+++L     +           +L+  Q L+I  
Sbjct: 73  YGVC----VEGDPL-IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            +A+ + YL +Q+     H DL + N L+ E ++  +GDFG+++ ++          TM 
Sbjct: 128 QIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184

Query: 333 NGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRP 373
                 + ++PPE I     +   D++S G++L EIFT GK+P
Sbjct: 185 -----PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 84.6 bits (209), Expect = 2e-18
 Identities = 63/227 (27%), Positives = 110/227 (48%), Gaps = 29/227 (12%)

Query: 160 SEENLIGSGSFGSVYKGTLA----DGETAAIKVLKL-QQQGALKSFIDECNALTSIRHRN 214
           +++ +IG+G FG V++G L          AIK LK    +   + F+ E + +    H N
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67

Query: 215 ILKIVSSCSSVDYEGNDFK--ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
           I+++    +        FK   ++ E+M NG LD++L     E+      S  Q + ++ 
Sbjct: 68  IIRLEGVVTK-------FKPAMIITEYMENGALDKYLRDHDGEF------SSYQLVGMLR 114

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            +A+ + YL    D    H DL + N+L++  +   V DFGL++ L    + P    T S
Sbjct: 115 GIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVL---EDDPEGTYTTS 168

Query: 333 NGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
            G K  + +  PE I     +   D++S+GI++ E+ + G+RP  DM
Sbjct: 169 GG-KIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 83.1 bits (206), Expect = 6e-18
 Identities = 62/224 (27%), Positives = 94/224 (41%), Gaps = 37/224 (16%)

Query: 165 IGSGSFGSVYKGT-LADGETAAIKVL-------KLQQQGALKSFIDECNALTSIRHRNIL 216
           IG GSFG+V K    +DG+    K +       K +QQ      + E N L  ++H NI+
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQ-----LVSEVNILRELKHPNIV 62

Query: 217 K----IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
           +    I+   +   Y       +V E+   G+L Q +     E    K +       I+ 
Sbjct: 63  RYYDRIIDRSNQTLY-------IVMEYCEGGDLAQLIQKCKKE---RKYIEEEFIWRILT 112

Query: 273 DVASALDYLHN-QYDTP-IAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
            +  AL   HN       + H DLK +N+ LD      +GDFGLAK L  +S       +
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS-------S 165

Query: 331 MSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFTGKRP 373
            +    G+  Y+ PE +N        DI+S G L+ E+     P
Sbjct: 166 FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 82.6 bits (205), Expect = 7e-18
 Identities = 66/223 (29%), Positives = 99/223 (44%), Gaps = 45/223 (20%)

Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLK---LQQQGALKSFIDECNALTSIRHRNILKIVS 220
           +G GSFG V        G+  A+KVLK   + ++  ++  + E N L+ I H  I+K+  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN------IVIDV 274
           +     ++  +   LV E+   G L             F  LS   R +         ++
Sbjct: 61  A-----FQTEEKLYLVLEYAPGGEL-------------FSHLSKEGRFSEERARFYAAEI 102

Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
             AL+YLH+     I + DLK  N+LLD      + DFGLAK   E S+  S+  T    
Sbjct: 103 VLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAK---ELSSEGSRTNTFC-- 154

Query: 335 LKGSVGYIPPEYIN----GHVSILGDIYSYGILLLEIFTGKRP 373
             G+  Y+ PE +     G      D +S G+LL E+ TGK P
Sbjct: 155 --GTPEYLAPEVLLGKGYGKAV---DWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 63/222 (28%), Positives = 115/222 (51%), Gaps = 26/222 (11%)

Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSS 224
           +G+G FG V+ G   +    A+K LK     ++++F++E N + +++H  ++++ +  + 
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 225 VD--YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
            +  Y       ++ E+M  G+L  +L   +DE     K+ L + ++    +A  + Y+ 
Sbjct: 73  EEPIY-------IITEYMAKGSLLDFL--KSDEG---GKVLLPKLIDFSAQIAEGMAYIE 120

Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
            +      H DL+++NVL+ E ++  + DFGLA+ +  E N      T   G K  + + 
Sbjct: 121 RK---NYIHRDLRAANVLVSESLMCKIADFGLARVI--EDN----EYTAREGAKFPIKWT 171

Query: 343 PPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL 382
            PE IN G  +I  D++S+GILL EI T GK P   M   D+
Sbjct: 172 APEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV 213

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 82.6 bits (204), Expect = 1e-17
 Identities = 62/217 (28%), Positives = 112/217 (51%), Gaps = 27/217 (12%)

Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNILKIVSSC 222
           +G+G FG V+ G        AIK LK   QG++  ++F+ E N +  ++H  ++++ +  
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70

Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +       +   ++ E+M NG+L  +L   T E     KL++ + +++   +A  + ++ 
Sbjct: 71  T------QEPIYIITEYMENGSLVDFL--KTPEG---IKLTINKLIDMAAQIAEGMAFIE 119

Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
            +      H DL+++N+L+ E +   + DFGLA+ +  E N      T   G K  + + 
Sbjct: 120 RK---NYIHRDLRAANILVSETLCCKIADFGLARLI--EDN----EYTAREGAKFPIKWT 170

Query: 343 PPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
            PE IN G  +I  D++S+GILL EI T G+ P   M
Sbjct: 171 APEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM 207

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 73/257 (28%), Positives = 117/257 (45%), Gaps = 41/257 (15%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLADG-------ETAAIKVLK----LQQQGALKSFIDECN 205
           +N S    +G+G+FG V + T A G          A+K+LK      ++ AL S   E  
Sbjct: 35  NNLSFGKTLGAGAFGKVVEAT-AYGLSKSDAVMKVAVKMLKPTAHSSEREALMS---ELK 90

Query: 206 ALTSI-RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSL 264
            ++ +  H NI+ ++ +C+     G     ++ E+   G+L  +L    + +   + L  
Sbjct: 91  IMSHLGNHENIVNLLGACT---IGGPIL--VITEYCCYGDLLNFLRRKRESFLTLEDL-- 143

Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNT 324
              L+    VA  + +L ++      H DL + NVLL  G I  + DFGLA+ +  +SN 
Sbjct: 144 ---LSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNY 197

Query: 325 PSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL 382
             K        +  V ++ PE I N   +   D++SYGILL EIF+ G  P   M  D  
Sbjct: 198 VVKGNA-----RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS- 251

Query: 383 SIHKFV----LMALPSH 395
             +K +     MA P H
Sbjct: 252 KFYKLIKEGYRMAQPEH 268

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 23/215 (10%)

Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSS 224
           +G+G FG V+ GT       A+K LK       +SF++E   +  +RH  ++++ +  S 
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQLYAVVSE 72

Query: 225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ 284
                     +V E+M  G+L  +L            L L   +++   VA+ + Y+   
Sbjct: 73  EPI------YIVTEYMSKGSLLDFLKDGEGRA-----LKLPNLVDMAAQVAAGMAYIERM 121

Query: 285 YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
                 H DL+S+N+L+ +G++  + DFGLA+ +  E N  +  Q    G K  + +  P
Sbjct: 122 ---NYIHRDLRSANILVGDGLVCKIADFGLARLI--EDNEYTARQ----GAKFPIKWTAP 172

Query: 345 E-YINGHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
           E  + G  +I  D++S+GILL E+ T G+ P   M
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 81.5 bits (201), Expect = 2e-17
 Identities = 59/216 (27%), Positives = 105/216 (48%), Gaps = 29/216 (13%)

Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKS--FIDECNALTSIRHRNILKIVSSC 222
           +G+G FG V  G        AIK++K   +G++    FI+E   +  + H  ++++   C
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +    +   +  +V E+M NG L  +L        H K+    Q L +  DV   + YL 
Sbjct: 69  TK---QRPIY--IVTEYMSNGCLLNYLRE------HGKRFQPSQLLEMCKDVCEGMAYLE 117

Query: 283 N-QYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGY 341
           + Q+     H DL + N L+D+     V DFGL++++ ++  T S       G K  V +
Sbjct: 118 SKQF----IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV------GSKFPVRW 167

Query: 342 IPPE-YINGHVSILGDIYSYGILLLEIFT-GKRPTD 375
            PPE  +    S   D++++G+L+ E+++ GK P +
Sbjct: 168 SPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 81.2 bits (201), Expect = 3e-17
 Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 28/221 (12%)

Query: 158 NFSEENLIGSGSFGSVYKGTLAD-GETAAIKVL---KLQQQGALKSFIDECNALTSIRHR 213
           +F    +IG G+FG V      D  +  A+K +   K  ++G++++ ++E   L  + H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
            ++ +  S     ++  +   LV + +  G+L    H S        K S  Q    + +
Sbjct: 61  FLVNLWYS-----FQDEENMYLVVDLLLGGDLR--YHLS-----QKVKFSEEQVKFWICE 108

Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +  AL+YLH++    I H D+K  N+LLDE    H+ DF +A  +           T++ 
Sbjct: 109 IVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKV--------TPDTLTT 157

Query: 334 GLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFTGKRP 373
              G+ GY+ PE +     S+  D +S G+   E   GKRP
Sbjct: 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 81.1 bits (200), Expect = 4e-17
 Identities = 55/210 (26%), Positives = 105/210 (50%), Gaps = 22/210 (10%)

Query: 162 ENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVS 220
           ++ +G G +G VY+G       T A+K LK +    ++ F+ E   +  I+H N+++++ 
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 69

Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDY 280
            C+    E   +  ++ EFM  GNL  +L    +     ++++ +  L +   ++SA++Y
Sbjct: 70  VCT---REPPFY--IITEFMTYGNLLDYLR-ECNR----QEVNAVVLLYMATQISSAMEY 119

Query: 281 LHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG 340
           L  +      H DL + N L+ E  +  V DFGL++ +  ++ T         G K  + 
Sbjct: 120 LEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA------GAKFPIK 170

Query: 341 YIPPEYIN-GHVSILGDIYSYGILLLEIFT 369
           +  PE +     SI  D++++G+LL EI T
Sbjct: 171 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 80.6 bits (199), Expect = 5e-17
 Identities = 66/231 (28%), Positives = 112/231 (48%), Gaps = 40/231 (17%)

Query: 164 LIGSGSFGSVYKGTLAD-GETAAIKVLKL----------QQQGALKSFIDECNALTSIRH 212
           LIG G++G VY       GE  A+K ++L          +Q+  +K+   E   L  + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 213 RNILKIVSSCSSVDYE-GNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
            NI++ +       +E   ++ ++  E++  G++   L      Y  F++  L++     
Sbjct: 68  LNIVQYLG------FETTEEYLSIFLEYVPGGSIGSCLR----TYGRFEE-QLVRFF--T 114

Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
             V   L YLH++    I H DLK+ N+L+D   I  + DFG++K   +  +    +Q M
Sbjct: 115 EQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK---KSDDIYDNDQNM 168

Query: 332 SNGLKGSVGYIPPEYINGHVSILG-----DIYSYGILLLEIFTGKRPTDDM 377
           S  ++GSV ++ PE I  H    G     DI+S G ++LE+F G+RP  D 
Sbjct: 169 S--MQGSVFWMAPEVI--HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 80.3 bits (198), Expect = 5e-17
 Identities = 66/231 (28%), Positives = 111/231 (48%), Gaps = 31/231 (13%)

Query: 162 ENLIGSGSFGSVYKGTLA-DGE---TAAIKVLKL-QQQGALKSFIDECNALTSIRHRNIL 216
           E +IG+G FG V  G L   G+     AIK LK    +   + F+ E + +    H NI+
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 217 K---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
               +V+    V         +V E+M NG+LD +L        H  + +++Q + ++  
Sbjct: 69  HLEGVVTKSKPV--------MIVTEYMENGSLDAFLRK------HDGQFTVIQLVGMLRG 114

Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +AS + YL    D    H DL + N+L++  ++  V DFGL++ L    + P    T   
Sbjct: 115 IASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL---EDDPEAAYTTRG 168

Query: 334 GLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL 382
           G K  + +  PE I     +   D++SYGI++ E+ + G+RP  +M   D+
Sbjct: 169 G-KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV 218

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 80.0 bits (198), Expect = 6e-17
 Identities = 66/233 (28%), Positives = 106/233 (45%), Gaps = 49/233 (21%)

Query: 159 FSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILK 217
           F     +G GS+GSVYK      G+  AIKV+ ++    L+  I E + L       I+K
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE--EDLQEIIKEISILKQCDSPYIVK 62

Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS-LMQRLN------- 269
                    Y G+        + +N +L  W+     EYC    +S +M+  N       
Sbjct: 63  ---------YYGS--------YFKNTDL--WI---VMEYCGAGSVSDIMKITNKTLTEEE 100

Query: 270 ---IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
              I+      L+YLH+       H D+K+ N+LL+E   A + DFG++  L   ++T +
Sbjct: 101 IAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQL---TDTMA 154

Query: 327 KNQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDM 377
           K  T+     G+  ++ PE I   G+ +   DI+S GI  +E+  GK P  D+
Sbjct: 155 KRNTVI----GTPFWMAPEVIQEIGYNN-KADIWSLGITAIEMAEGKPPYSDI 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 81.4 bits (201), Expect = 8e-17
 Identities = 78/299 (26%), Positives = 139/299 (46%), Gaps = 66/299 (22%)

Query: 94  RKNPRKRLSLKIVIP---VTISVPIFILLLAALVIYHIVKTSRRQSAPPSNEWQSGLSYL 150
           +  PR+R  L + +P    +++VP+ +   ++             S+  S+   SG +  
Sbjct: 21  KSRPRRRPDLTLPLPQRDPSLAVPLPLPPPSS------------SSSSSSSSSASGSA-- 66

Query: 151 KISNATDNFSE---ENLIGSGSFGSVYK----GTLADGETAAIKVLKLQQQGALKSFI-D 202
              +A  + SE    N IGSG+ G+VYK     T   G   A+KV+    +  ++  I  
Sbjct: 67  --PSAAKSLSELERVNRIGSGAGGTVYKVIHRPT---GRLYALKVIYGNHEDTVRRQICR 121

Query: 203 ECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKL 262
           E   L  + H N++K    C  + ++ N    ++ EFM  G+L+   H + +++     L
Sbjct: 122 EIEILRDVNHPNVVK----CHDM-FDHNGEIQVLLEFMDGGSLEG-THIADEQF-----L 170

Query: 263 SLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES 322
           + + R      + S + YLH ++   I H D+K SN+L++      + DFG+++ L    
Sbjct: 171 ADVAR-----QILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRIL---- 218

Query: 323 NTPSKNQTMS--NGLKGSVGYIPPEYINGHVS------ILGDIYSYGILLLEIFTGKRP 373
                 QTM   N   G++ Y+ PE IN  ++        GDI+S G+ +LE + G+ P
Sbjct: 219 -----AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 59/218 (27%), Positives = 110/218 (50%), Gaps = 23/218 (10%)

Query: 162 ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSS 221
           E  +G+G FG V+  T       A+K +K     ++++F+ E N + +++H  ++K+ + 
Sbjct: 11  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAV 69

Query: 222 CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYL 281
            +       +   ++ EFM  G+L  +L   +DE     K  L + ++    +A  + ++
Sbjct: 70  VT------KEPIYIITEFMAKGSLLDFL--KSDEG---SKQPLPKLIDFSAQIAEGMAFI 118

Query: 282 HNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGY 341
             +      H DL+++N+L+   ++  + DFGLA+ +  E N      T   G K  + +
Sbjct: 119 EQR---NYIHRDLRAANILVSASLVCKIADFGLARVI--EDN----EYTAREGAKFPIKW 169

Query: 342 IPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
             PE IN G  +I  D++S+GILL+EI T G+ P   M
Sbjct: 170 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 77.8 bits (191), Expect = 4e-16
 Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 27/217 (12%)

Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNILKIVSSC 222
           +G G FG V+ GT       AIK LK    G +  ++F+ E   +  +RH  ++ + +  
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLK---PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70

Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           S       +   +V EFM  G+L  +L     +Y     L L Q +++   +A  + Y+ 
Sbjct: 71  SE------EPIYIVTEFMGKGSLLDFLKEGDGKY-----LKLPQLVDMAAQIADGMAYIE 119

Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
                   H DL+++N+L+ + ++  + DFGLA+ +  E N  +  Q    G K  + + 
Sbjct: 120 RM---NYIHRDLRAANILVGDNLVCKIADFGLARLI--EDNEYTARQ----GAKFPIKWT 170

Query: 343 PPE-YINGHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
            PE  + G  +I  D++S+GILL E+ T G+ P   M
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 77.6 bits (191), Expect = 5e-16
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 31/215 (14%)

Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNILKIVSSC 222
           +GSG FG V+ G        AIK +    +GA+  + FI+E   +  + H  ++++   C
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 223 SSVD--YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDY 280
           +     Y       +V EFM NG L  +L           K  L   L++  DV   ++Y
Sbjct: 69  TQQKPLY-------IVTEFMENGCLLNYLR---QRQGKLSKDML---LSMCQDVCEGMEY 115

Query: 281 LHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG 340
           L         H DL + N L+    +  V DFG+ +++ ++  T       S+G K  V 
Sbjct: 116 LER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS------SSGAKFPVK 166

Query: 341 YIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRP 373
           + PPE  N    S   D++S+G+L+ E+FT GK P
Sbjct: 167 WSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 77.9 bits (193), Expect = 5e-16
 Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 29/219 (13%)

Query: 159 FSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQ--GALKSFIDECNALTSIRHRNI 215
           + +   +G G++G VYK      GE  A+K ++L  +  G   + + E + L  ++H NI
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           +K++    +          LVFE+    +L ++L            LS     +I+  + 
Sbjct: 61  VKLLDVIHT-----ERKLYLVFEYCDM-DLKKYLDK------RPGPLSPNLIKSIMYQLL 108

Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN-QTMSNG 334
             L Y H+     I H DLK  N+L++   +  + DFGLA+       T +    T+   
Sbjct: 109 RGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTL--- 162

Query: 335 LKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
                 Y  PE + G  H S   DI+S G +  E+ TGK
Sbjct: 163 -----WYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 77.1 bits (190), Expect = 7e-16
 Identities = 67/227 (29%), Positives = 100/227 (44%), Gaps = 38/227 (16%)

Query: 158 NFSEENLIGSGSFGSVYK-GTLADGETAAIKVLKL--QQQGALKSFIDECNALTSIRHRN 214
           +F     +G GS+GSVYK   L+D +  A+K + L    Q   +  ++E   L S+ H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL------ 268
           I  I    + +D  GN    +V E+   G+L + +           K    ++L      
Sbjct: 61  I--ISYKEAFLD--GNKL-CIVMEYAPFGDLSKAI----------SKRKKKRKLIPEQEI 105

Query: 269 -NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
             I I +   L  LH Q    I H DLKS+N+LL    +  +GD G++K L         
Sbjct: 106 WRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVL--------- 153

Query: 328 NQTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
            + M+    G+  Y+ PE   G   S   DI+S G LL E+ T   P
Sbjct: 154 KKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 77.2 bits (191), Expect = 7e-16
 Identities = 68/235 (28%), Positives = 95/235 (40%), Gaps = 40/235 (17%)

Query: 165 IGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           +G GS G VYK      G+  A+K + +      +  +              LK + SC 
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQL-----------LRELKTLRSCE 57

Query: 224 S---VDYEGNDFK----ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           S   V   G  +K    ++V E+M  G+L   L     +     +  L     I   +  
Sbjct: 58  SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLL----KKVGKIPEPVLAY---IARQILK 110

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            LDYLH      I H D+K SN+L++      + DFG++K L    NT        N   
Sbjct: 111 GLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVL---ENT----LDQCNTFV 161

Query: 337 GSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM 390
           G+V Y+ PE I G   S   DI+S G+ LLE   GK P    F        F LM
Sbjct: 162 GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP----FLPPGQPSFFELM 212

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 24/222 (10%)

Query: 158 NFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRN 214
           +F   N IG GSFG V+K    AD    A+K + L +      +  IDE   L  +    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
           I++   S     +       +V E+  NG+L + L          + L   Q     I +
Sbjct: 61  IIRYYES-----FLDKGKLNIVMEYAENGDLHKLLKMQRG-----RPLPEDQVWRFFIQI 110

Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
              L +LH++    I H D+KS N+ LD      +GD G+AK L       S N   +N 
Sbjct: 111 LLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-------SDNTNFANT 160

Query: 335 LKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRPTD 375
           + G+  Y+ PE       +   D+++ G++L E  TGK P D
Sbjct: 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 37/223 (16%)

Query: 165 IGSGSFGSVY----KGTLADGETAAIKVLK---LQQQGALKSFIDECNALTSIRHRNILK 217
           I  G++G V+    K T   G+  AIKV+K   + ++  +   + E + L+  +   ++K
Sbjct: 1   ISKGAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57

Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHP--STDEYCHFKKLSLMQRLNIVIDVA 275
           +  S        N +  LV E++  G+L   L    S DE         + R   + ++ 
Sbjct: 58  LYYSFQGKK---NLY--LVMEYLPGGDLASLLENVGSLDED--------VAR-IYIAEIV 103

Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKF-LFEESNTPSKNQTMSN 333
            AL+YLH+     I H DLK  N+L+D  G +    DFGL+K  L       + ++    
Sbjct: 104 LALEYLHSN---GIIHRDLKPDNILIDSNGHLKLT-DFGLSKVGLVRRQINLNDDEKEDK 159

Query: 334 GLKGSVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRP 373
            + G+  YI PE I G     ++  D +S G +L E   G  P
Sbjct: 160 RIVGTPDYIAPEVILGQGHSKTV--DWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 64/211 (30%), Positives = 97/211 (45%), Gaps = 27/211 (12%)

Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSS 224
           IG G FG V  G    G   A+K +K       ++F+ E + +T +RH N+++++     
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLG---- 66

Query: 225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ 284
           V  E      +V E+M  G+L  +L            L     L   +DV  A++YL   
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEYLEAN 121

Query: 285 YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
                 H DL + NVL+ E  +A V DFGL K   E S+T        +  K  V +  P
Sbjct: 122 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASST-------QDTGKLPVKWTAP 168

Query: 345 EYI-NGHVSILGDIYSYGILLLEIFT-GKRP 373
           E +     S   D++S+GILL EI++ G+ P
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 59/219 (26%), Positives = 104/219 (47%), Gaps = 18/219 (8%)

Query: 164 LIGSGSFGSVYKGTLADGETA----AIKVLKLQ--QQGALKSFIDECNALTSIRHRNILK 217
           ++G G FGSV +G L+  + +    A+K +KL       ++ F+ E   +    H N++K
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 218 IVSSC-SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           ++  C  +   +      ++  FM++G+L  +L  S       K L L   L  ++D+A 
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEK-LPLQTLLKFMVDIAL 124

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            ++YL N+      H DL + N +L E M   V DFGL+K ++         Q      K
Sbjct: 125 GMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD---YYRQGRIA--K 176

Query: 337 GSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRP 373
             V +I  E +   V +   D++++G+ + EI T G+ P
Sbjct: 177 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 52/223 (23%), Positives = 91/223 (40%), Gaps = 37/223 (16%)

Query: 164 LIGSGSFGSVYKGT----LADGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILK- 217
            +G GSFG V +G            A+K LK  +    +  F+ E   + S+ H N+++ 
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 218 --IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
             +V +   +         +V E    G+L   L              +    +  + +A
Sbjct: 62  YGVVLTHPLM---------MVTELAPLGSLLDRLRKD-----ALGHFLISTLCDYAVQIA 107

Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
           + + YL ++      H DL + N+LL       +GDFGL + L +  +    +  M   L
Sbjct: 108 NGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNED----HYVMEEHL 160

Query: 336 KGSVGYIPPEYIN----GHVSILGDIYSYGILLLEIFT-GKRP 373
           K    +  PE +      H S   D++ +G+ L E+FT G+ P
Sbjct: 161 KVPFAWCAPESLRTRTFSHAS---DVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 75.3 bits (186), Expect = 4e-15
 Identities = 70/235 (29%), Positives = 106/235 (45%), Gaps = 44/235 (18%)

Query: 157 DNFSEENLIGSGSFGSV----YKGTLADGETAAIKVLKLQQQGALKS---FIDECNALTS 209
           D+F     +G+GSFG V    +KG+   G+  A+K+L   +   LK     ++E   L S
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57

Query: 210 IRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN 269
           IRH  ++ +  S     ++ +    LV E++  G L   L  S        +        
Sbjct: 58  IRHPFLVNLYGS-----FQDDSNLYLVMEYVPGGELFSHLRKS-------GRFPEPVARF 105

Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKN 328
               V  AL+YLH+     I + DLK  N+LLD +G I  + DFG AK +        K 
Sbjct: 106 YAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIK-ITDFGFAKRV--------KG 153

Query: 329 QTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD 381
           +T +  L G+  Y+ PE I   G+     D ++ GIL+ E+  G  P    F DD
Sbjct: 154 RTYT--LCGTPEYLAPEIILSKGYGK-AVDWWALGILIYEMLAGYPP----FFDD 201

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 5e-15
 Identities = 66/233 (28%), Positives = 103/233 (44%), Gaps = 48/233 (20%)

Query: 159 FSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILK 217
           F+    IG GSFG VYK       +  AIKV+ L++        DE   +     + I +
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA------EDEIEDIQ----QEI-Q 51

Query: 218 IVSSCSS---VDYEG---NDFK-ALVFEFMRNGNLDQWLHPST-DEYCHFKKLSLMQRLN 269
            +S C S     Y G      K  ++ E+   G+    L P   DE      ++ + R  
Sbjct: 52  FLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDE----TYIAFILR-- 105

Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLL-DEGMIAHVGDFGLAKFLFEESNTPSKN 328
              +V   L+YLH +      H D+K++N+LL +EG +  + DFG++  L   ++T SK 
Sbjct: 106 ---EVLLGLEYLHEEGKI---HRDIKAANILLSEEGDV-KLADFGVSGQL---TSTMSKR 155

Query: 329 QTMSNGLKGSVG---YIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM 377
            T        VG   ++ PE I         DI+S GI  +E+  G+ P  D+
Sbjct: 156 NTF-------VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 74.7 bits (183), Expect = 6e-15
 Identities = 67/226 (29%), Positives = 104/226 (46%), Gaps = 33/226 (14%)

Query: 158 NFSEENLIGSGSFGSVYKGT-LADGETAAIK---VLKLQQQGALKSFIDECNALTSIRHR 213
           NF  E  IG G F  VY+ T L DG   A+K   +  L    A    I E + L  + H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV-- 271
           N++K  +S      E N+   +V E    G+L + +        HFKK   +     V  
Sbjct: 63  NVIKYYASF----IEDNELN-IVLELADAGDLSRMIK-------HFKKQKRLIPEKTVWK 110

Query: 272 --IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
             + + SAL+++H++    + H D+K +NV +    +  +GD GL +F        S   
Sbjct: 111 YFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF-------SSKT 160

Query: 330 TMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRP 373
           T ++ L G+  Y+ PE I  NG+ +   DI+S G LL E+   + P
Sbjct: 161 TAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 74.3 bits (183), Expect = 7e-15
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 26/226 (11%)

Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           +++     IGSG++G VYK   +A GE  AIKV+KL+     +    E + L   RH NI
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62

Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           +    S     Y   D   +V E+   G+L       T       +++ + R     +  
Sbjct: 63  VAYFGS-----YLRRDKLWIVMEYCGGGSLQDIYQ-VTRGPLSELQIAYVCR-----ETL 111

Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
             L YLH        H D+K +N+LL E     + DFG++  L   + T +K ++     
Sbjct: 112 KGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQL---TATIAKRKS----F 161

Query: 336 KGSVGYIPPEYI----NGHVSILGDIYSYGILLLEIFTGKRPTDDM 377
            G+  ++ PE       G      DI++ GI  +E+   + P  D+
Sbjct: 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 73.9 bits (182), Expect = 8e-15
 Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 27/220 (12%)

Query: 165 IGSGSFGSVYKGT--LADGE--TAAIKVLKLQQQGALKS-FIDECNALTSIRHRNILKIV 219
           +G G+FGSV KG   +  G+    A+K LK +   A K  F+ E + +  + H  I++++
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
             C     +G     LV E    G L ++L     +        L     +   VA  + 
Sbjct: 63  GVC-----KGEPL-MLVMELAPLGPLLKYLK----KRREIPVSDL---KELAHQVAMGMA 109

Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSV 339
           YL +++     H DL + NVLL     A + DFG+++ L       S     +   +  +
Sbjct: 110 YLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRAL----GAGSDYYRATTAGRWPL 162

Query: 340 GYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
            +  PE IN G  S   D++SYG+ L E F+ G +P  +M
Sbjct: 163 KWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 74.3 bits (182), Expect = 9e-15
 Identities = 71/241 (29%), Positives = 119/241 (49%), Gaps = 33/241 (13%)

Query: 151 KISNATDNFSEENLIGSGSFGSVYKGTL---ADGE---TAAIKVLKLQQQGALKS-FIDE 203
           +I+ +T  F EE  +G   FG VYKG L   A GE     AIK LK + +G L+  F  E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWL-----HP---STDE 255
               + ++H NI+ ++   +          +++F +  + +L ++L     H    STD+
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTK-----EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113

Query: 256 YCHFKK-LSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL 314
               K  L     ++IV  +A+ +++L + +   + H DL + NVL+ + +   + D GL
Sbjct: 114 DKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGL 170

Query: 315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKR 372
               F E       + M N L   + ++ PE I  G  SI  DI+SYG++L E+F+ G +
Sbjct: 171 ----FREVYAADYYKLMGNSLL-PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 225

Query: 373 P 373
           P
Sbjct: 226 P 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 73.8 bits (181), Expect = 1e-14
 Identities = 55/230 (23%), Positives = 104/230 (45%), Gaps = 38/230 (16%)

Query: 165 IGSGSFGSVYKGT------LADGETAAIKVLKL-QQQGALKSFIDECNALTSIRHRNILK 217
           +G G FG V K T       A   T A+K+LK       L+  + E N L  + H +++K
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHF-----------------K 260
           +  +CS      +    L+ E+ + G+L  +L  S      +                 +
Sbjct: 68  LYGACSQ-----DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122

Query: 261 KLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFE 320
            L++   ++    ++  + YL    +  + H DL + NVL+ EG    + DFGL++ ++E
Sbjct: 123 ALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179

Query: 321 ESNTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
           E +   +++      +  V ++  E +  H+ +   D++S+G+LL EI T
Sbjct: 180 EDSYVKRSKG-----RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 73/234 (31%), Positives = 110/234 (47%), Gaps = 41/234 (17%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKL--QQQGALKSFIDECNALTSIRHR 213
           D F     IG G++G VYK    D GE  A+K ++L  +++G   + I E   L  + HR
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66

Query: 214 NILKIVSSCSSVDYEGNDFKA------LVFEFMRN---GNLDQWL-HPSTDEYCHFKKLS 263
           NI+ +    +    +  DFK       LVFE+M +   G L+  L H S D        S
Sbjct: 67  NIVNLKEIVTD-KQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK-----S 120

Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
            M++L         L+Y H        H D+K SN+LL+      + DFGLA+    E +
Sbjct: 121 FMKQL------LEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171

Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGH----VSILGDIYSYGILLLEIFTGKRP 373
            P  N+ +      ++ Y PPE + G      +I  D++S G +L E+FT K+P
Sbjct: 172 RPYTNKVI------TLWYRPPELLLGEERYGPAI--DVWSCGCILGELFT-KKP 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 73.8 bits (181), Expect = 1e-14
 Identities = 74/250 (29%), Positives = 104/250 (41%), Gaps = 30/250 (12%)

Query: 165 IGSGSFGSV----YKGTLAD-GETAAIKVLKLQQQGALKS-FIDECNALTSIRHRNILKI 218
           +G G FG V    Y       GE  A+K LK +      S +  E N L ++ H NI+K 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
              CS    +G     L+ E++  G+L  +L P         KL+L Q L     +   +
Sbjct: 72  KGCCSE---QGGKGLQLIMEYVPLGSLRDYL-PK-------HKLNLAQLLLFAQQICEGM 120

Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
            YLH+Q+     H DL + NVLLD   +  +GDFGLAK + E        +   +G    
Sbjct: 121 AYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPV 174

Query: 339 VGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALP-SHVM 397
             Y          S   D++S+G+ L E+ T         K      KF  M  P    M
Sbjct: 175 FWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPK------KFEEMIGPKQGQM 228

Query: 398 DVLDLSMLLE 407
            V+ L  LLE
Sbjct: 229 TVVRLIELLE 238

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 73.0 bits (179), Expect = 2e-14
 Identities = 86/316 (27%), Positives = 137/316 (43%), Gaps = 56/316 (17%)

Query: 165 IGSGSFGSVY------KGTLADGETAAIKVLKLQQQGA-LKSFIDECNALTSIRHRNILK 217
           +G G FG V       +G    GE  A+K LK +  G  +     E   L ++ H NI+K
Sbjct: 12  LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
               C+  +  GN  K L+ EF+ +G+L ++L  + +      K++L Q+L   + +   
Sbjct: 71  YKGICT--EDGGNGIK-LIMEFLPSGSLKEYLPRNKN------KINLKQQLKYAVQICKG 121

Query: 278 LDYL-HNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
           +DYL   QY     H DL + NVL++      +GDFGL K +     T  +  T+ + L 
Sbjct: 122 MDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAI----ETDKEYYTVKDDLD 173

Query: 337 GSVGYIPPE-YINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLS--IHKFVLMALP 393
             V +  PE  I     I  D++S+G+ L E+ T        + D  S  +  F+ M  P
Sbjct: 174 SPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT--------YCDSESSPMTLFLKMIGP 225

Query: 394 SH-VMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASP 452
           +H  M V  L  +LEE     +       P+   +V Q         +MR    C    P
Sbjct: 226 THGQMTVTRLVRVLEEGKRLPRP------PNCPEEVYQ---------LMR---KCWEFQP 267

Query: 453 RDRVGMKFVVNNLQAI 468
             R   + ++   +AI
Sbjct: 268 SKRTTFQNLIEGFEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 62/235 (26%), Positives = 112/235 (47%), Gaps = 33/235 (14%)

Query: 163 NLIGSGSFGSVYKGTLADGET----AAIKVL-KLQQQGALKSFIDECNALTSIRHRNILK 217
            +IG G FG VY GTL D +      A+K L ++     ++ F+ E   +    H N+L 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWL-----HPSTDEYCHFKKLSLMQRLNIVI 272
           ++  C  +  EG+    +V  +M++G+L  ++     +P+  +   F            +
Sbjct: 61  LLGIC--LPSEGSPL--VVLPYMKHGDLRNFIRSETHNPTVKDLIGFG-----------L 105

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            VA  ++YL ++      H DL + N +LDE     V DFGLA+ ++++      N T  
Sbjct: 106 QVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT-- 160

Query: 333 NGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH 385
            G K  V ++  E +     +   D++S+G+LL E+ T G  P  D+   D++++
Sbjct: 161 -GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY 214

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 31/224 (13%)

Query: 164 LIGSGSFGSVYKGTLADGE------TAAIKVLKLQ-QQGALKSFIDECNALTSI-RHRNI 215
            +G G+FG V K      +      T A+K+LK    +  L   + E   +  I +H+NI
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYC-------HFKKLSLMQ 266
           + ++  C+    EG  +  +V E+  +GNL  +L       EY          + L+   
Sbjct: 79  INLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133

Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
            ++    VA  +++L ++      H DL + NVL+ E  +  + DFGLA+ +        
Sbjct: 134 LVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDI--HHIDYY 188

Query: 327 KNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
           +  T  NG +  V ++ PE +   V +   D++S+G+LL EIFT
Sbjct: 189 RKTT--NG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 64/229 (27%), Positives = 107/229 (46%), Gaps = 39/229 (17%)

Query: 158 NFSEENLIGSGSFGSVYKGT-LADGETAAIK---VLKLQQQGALKSFIDECNALTSIRHR 213
           NF  E  IG G F  VY+ T L D +  A+K   + ++    A +  + E + L  + H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL----- 268
           N++K + S      E N+   +V E    G+L Q +        +FKK    +RL     
Sbjct: 63  NVIKYLDSF----IEDNELN-IVLELADAGDLSQMIK-------YFKK---QKRLIPERT 107

Query: 269 --NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
                + + SA++++H++    + H D+K +NV +    +  +GD GL +F        S
Sbjct: 108 VWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF-------S 157

Query: 327 KNQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRP 373
              T ++ L G+  Y+ PE I  NG+ +   DI+S G LL E+   + P
Sbjct: 158 SKTTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 31/227 (13%)

Query: 156 TDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLK---LQQQGALKSFIDECNALTSIR 211
             NF  E  IG G F  VYK   L DG   A+K ++   +    A +  + E + L  + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK----LSLMQR 267
           H N++K ++S     +  N+   +V E    G+L + +        HFKK    +     
Sbjct: 61  HPNVIKYLAS-----FIENNELNIVLELADAGDLSRMIK-------HFKKQKRLIPERTI 108

Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
               + + SAL+++H++    I H D+K +NV +    +  +GD GL +F   ++     
Sbjct: 109 WKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT----- 160

Query: 328 NQTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
             T ++ L G+  Y+ PE I+ +  +   DI+S G LL E+   + P
Sbjct: 161 --TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 72.0 bits (176), Expect = 6e-14
 Identities = 66/223 (29%), Positives = 106/223 (47%), Gaps = 31/223 (13%)

Query: 162 ENLIGSGSFGSVYKGTLA-DGE--TAAIKVLK-LQQQGALKSFIDECNALTSI-RHRNIL 216
           E++IG G+FG V +  +  DG    AAIK+LK    +   + F  E   L  +  H NI+
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPS----TD-----EYCHFKKLSLMQR 267
            ++ +C     E   +  +  E+   GNL  +L  S    TD     E+     L+  Q 
Sbjct: 67  NLLGAC-----ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
           L    DVA+ + YL    +    H DL + NVL+ E + + + DFGL++   EE      
Sbjct: 122 LQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYV--- 173

Query: 328 NQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
            +TM    +  V ++  E +N  V +   D++S+G+LL EI +
Sbjct: 174 KKTMG---RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 71.6 bits (176), Expect = 7e-14
 Identities = 50/221 (22%), Positives = 100/221 (45%), Gaps = 34/221 (15%)

Query: 165 IGSGSFGSVYKGTLAD------GETAAIKVLKLQQQGALK---SFIDECNALTSIRHRNI 215
           +G GSFG VY+G              AIK +   +  +++    F++E + +      ++
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTV--NENASMRERIEFLNEASVMKEFNCHHV 71

Query: 216 LKIVSSCSSVDYEGNDFKALV-FEFMRNGNLDQWLH---PSTDEYCHFKKLSLMQRLNIV 271
           ++++   S+          LV  E M  G+L  +L    P  +        +L + + + 
Sbjct: 72  VRLLGVVSTGQ------PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125

Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
            ++A  + YL         H DL + N ++ E +   +GDFG+ + ++ E++   K    
Sbjct: 126 AEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY-ETDYYRK---- 177

Query: 332 SNGLKG--SVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT 369
             G KG   V ++ PE + +G  +   D++S+G++L E+ T
Sbjct: 178 --GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 71.3 bits (175), Expect = 8e-14
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 24/226 (10%)

Query: 155 ATDNFSEENLIGSGSFGSVYKGTLA--DGETA----AIKVLKLQQQGALKS-FIDECNAL 207
             D+ +    +G G+FG VY+G     DG+      A+K L        +S F+ E   +
Sbjct: 4   PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63

Query: 208 TSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQR 267
           +   H+NI++       V +E    + ++ E M  G+L  +L  +         L++   
Sbjct: 64  SKFNHQNIVR----LIGVSFERLP-RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL 118

Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLFEESNT 324
           L    DVA    YL   +     H D+ + N LL     G +A + DFG+A+ ++  S  
Sbjct: 119 LFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY 175

Query: 325 PSKNQTMSNGLKGSVGYIPPE-YINGHVSILGDIYSYGILLLEIFT 369
               + M       + ++PPE +++G  +   D++S+G+LL EIF+
Sbjct: 176 RKGGRAML-----PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 70.7 bits (174), Expect = 1e-13
 Identities = 66/236 (27%), Positives = 100/236 (42%), Gaps = 40/236 (16%)

Query: 165 IGSGSFGSVYKGTLA-DGETAAIKVLK---LQQQGALKSFIDECNALTSIRHRNILKIVS 220
           +G G FG V    +     T A+K +K   + + G  +    E   L    H  I+K+  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHP--STDEY-CHFKKLSLMQRLNIVIDVASA 277
           +     ++   +  ++ E+   G L   L      DEY   F           +  V  A
Sbjct: 61  T-----FKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARF----------YIACVVLA 105

Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
            +YLHN+    I + DLK  N+LLD      + DFG AK L       S  +T +    G
Sbjct: 106 FEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLK------SGQKTWT--FCG 154

Query: 338 SVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRP--TDDMFKDDLSIHKFVL 389
           +  Y+ PE I   G+     D +S GILL E+ TG+ P   DD  +D + I+  +L
Sbjct: 155 TPEYVAPEIILNKGY-DFSVDYWSLGILLYELLTGRPPFGEDD--EDPMEIYNDIL 207

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 70.6 bits (174), Expect = 1e-13
 Identities = 52/161 (32%), Positives = 72/161 (44%), Gaps = 29/161 (18%)

Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNAL---TSIR----HRNIL 216
           +G G+FGSVY       GE  AIK +K        S+ +EC  L    S+R    H NI+
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMK----KKFYSW-EECMNLREVKSLRKLNEHPNIV 61

Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           K+      V  E ND    VFE+M  GNL Q L          K  S     +I+  +  
Sbjct: 62  KLKE----VFRE-NDELYFVFEYM-EGNLYQ-LMKDRKG----KPFSESVIRSIIYQILQ 110

Query: 277 ALDYLHNQ-YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK 316
            L ++H   +     H DLK  N+L+    +  + DFGLA+
Sbjct: 111 GLAHIHKHGF----FHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 65/239 (27%), Positives = 110/239 (46%), Gaps = 39/239 (16%)

Query: 150 LKISNATDNFSEENLIGSGSFGSVYKGT-LADGET----AAIKVLK-LQQQGALKSFIDE 203
           L+I   T+ F +  ++GSG+FG+VYKG  + +GE      AIK L+      A K  +DE
Sbjct: 1   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 59

Query: 204 CNALTSIRHRNILKIVSSC--SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK 261
              + S+ + ++ +++  C  S+V         L+ + M  G L  ++    D       
Sbjct: 60  AYVMASVDNPHVCRLLGICLTSTVQ--------LITQLMPFGCLLDYVREHKDNIGS--- 108

Query: 262 LSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEE 321
                 LN  + +A  ++YL  +    + H DL + NVL+       + DFGLAK L   
Sbjct: 109 ---QYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL--- 159

Query: 322 SNTPSKNQTMSNGLKGSVGYIPPEYI----NGHVSILGDIYSYGILLLEIFT-GKRPTD 375
                + +  + G K  + ++  E I      H S   D++SYG+ + E+ T G +P D
Sbjct: 160 --GADEKEYHAEGGKVPIKWMALESILHRIYTHQS---DVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 63/245 (25%), Positives = 103/245 (42%), Gaps = 54/245 (22%)

Query: 157 DNFSEENLIGSGSFGSVYKGT---LADGE---TAAIKVLK----LQQQGALKSFIDECNA 206
           +N      IG G+FG V++     L   E     A+K+LK       Q     F  E   
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ---ADFQREAAL 61

Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQ--------WLHPSTDEYCH 258
           +    H NI+K++  C+     G     L+FE+M  G+L++             +     
Sbjct: 62  MAEFDHPNIVKLLGVCA----VGKPM-CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS 116

Query: 259 FKK-------LSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD 311
            +K       LS  ++L I   VA+ + YL    +    H DL + N L+ E M+  + D
Sbjct: 117 ARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIAD 173

Query: 312 FGLAKFLFEESNTPSKNQTMSNGLKGS------VGYIPPEYI-NGHVSILGDIYSYGILL 364
           FGL           S+N   ++  K S      + ++PPE I     +   D+++YG++L
Sbjct: 174 FGL-----------SRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 222

Query: 365 LEIFT 369
            EIF+
Sbjct: 223 WEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 55/233 (23%), Positives = 99/233 (42%), Gaps = 29/233 (12%)

Query: 158 NFSEENLIGSGSFGSVYKGTL-----ADGET-AAIKVL-KLQQQGALKSFIDECNALTSI 210
           N  E   +G G FG V+           GET   +K L K + +     F  E +    +
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 211 RHRNILKIVSSCSSVD--YEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQ 266
            H+N+++++  C   +  Y       ++ E+   G+L Q+L    S DE      LS  Q
Sbjct: 66  SHKNVVRLLGLCREAEPHY-------MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQ 118

Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
           ++ +   +A  +D+L N       H DL + N L+       V    L+K ++       
Sbjct: 119 KVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKL 175

Query: 327 KNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
           +N  +       + ++ PE +     S   D++S+G+L+ E+FT G+ P   +
Sbjct: 176 RNALIP------LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL 222

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 62/236 (26%), Positives = 113/236 (47%), Gaps = 39/236 (16%)

Query: 159 FSEENLIGSGSFGSVYKGTL-----ADGETAAIKVLK----LQQQGALKSFIDECNALTS 209
           F EE  +G  +FG +YKG L        +  AIK LK     QQ G    F  E + +  
Sbjct: 9   FMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWG---EFQQEASLMAE 63

Query: 210 IRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWL---HPSTDEYCHFKKLSLMQ 266
           + H NI+ ++   +           ++FE++  G+L ++L    P +D  C   +   ++
Sbjct: 64  LHHPNIVCLLGVVTQ-----EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118

Query: 267 R-------LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLF 319
                   L+I I +A+ ++YL + +     H DL + N+L+ E +   + D GL++ ++
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIY 175

Query: 320 EESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRP 373
                  + +++       + ++PPE I  G  S   DI+S+G++L EIF+ G +P
Sbjct: 176 SADYYRVQPKSLL-----PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 69.9 bits (172), Expect = 3e-13
 Identities = 45/174 (25%), Positives = 73/174 (41%), Gaps = 37/174 (21%)

Query: 158 NFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFID-----ECNALTSIR 211
            + +   +G G++  VYK      G   AIK +KL ++   K  I+     E   L  ++
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFM--------RNGNLDQWLHPSTDEYCHFKKLS 263
           H NI+ ++               LVFEFM        ++ ++   L P+       K   
Sbjct: 61  HPNIIGLLDVFGH-----KSNINLVFEFMETDLEKVIKDKSIV--LTPA-----DIKSYM 108

Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF 317
           LM            L+YLH+ +   I H DLK +N+L+    +  + DFGLA+ 
Sbjct: 109 LM--------TLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARS 151

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 66/273 (24%), Positives = 108/273 (39%), Gaps = 38/273 (13%)

Query: 164 LIGSGSFGSVYKGTLADGETAAIKVLKLQQQGA---LKSFIDECNALTSIRHRNILKI-- 218
           LI      S+YKG   + +   I+  K   +G    +    +E   L  I   NILKI  
Sbjct: 27  LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85

Query: 219 --VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
             +     +        +L+ E+   G L + L    D       LS   +L++ ID   
Sbjct: 86  FIIDIVDDLPR-----LSLILEYCTRGYLREVLDKEKD-------LSFKTKLDMAIDCCK 133

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L  L+   + P  +  L S + L+ E     +   GL K L   S+ P KN        
Sbjct: 134 GLYNLYKYTNKPYKN--LTSVSFLVTENYKLKIICHGLEKIL---SSPPFKNVNF----- 183

Query: 337 GSVGYIPPEYINGHVS---ILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALP 393
             + Y   + +N   S   I  DIYS G++L EIFTGK P +++      I+  ++    
Sbjct: 184 --MVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL--TTKEIYDLIINKNN 239

Query: 394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIES 426
           S  +  LD  + ++   +     +    P+I+ 
Sbjct: 240 SLKLP-LDCPLEIKCIVEACTSHDSIKRPNIKE 271

Length = 283

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 65/223 (29%), Positives = 110/223 (49%), Gaps = 34/223 (15%)

Query: 164 LIGSGSFGSVYKGT-LADGETA----AIKVL-KLQQQGALKSFIDECNALTSIRHRNILK 217
           ++GSG+FG+VYKG  + +GET     AIK+L +     A   F+DE   + S+ H ++++
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
           ++  C S   +      LV + M +G L  ++H   D       +     LN  + +A  
Sbjct: 74  LLGVCLSPTIQ------LVTQLMPHGCLLDYVHEHKD------NIGSQLLLNWCVQIAKG 121

Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YL  +    + H DL + NVL+       + DFGLA+ L  E +    N   ++G K 
Sbjct: 122 MMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL--EGDEKEYN---ADGGKM 173

Query: 338 SVGYIPPEYIN----GHVSILGDIYSYGILLLEIFT-GKRPTD 375
            + ++  E I+     H S   D++SYG+ + E+ T G +P D
Sbjct: 174 PIKWMALECIHYRKFTHQS---DVWSYGVTIWELMTFGGKPYD 213

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 69.6 bits (170), Expect = 3e-13
 Identities = 55/222 (24%), Positives = 99/222 (44%), Gaps = 28/222 (12%)

Query: 164 LIGSGSFGSVYKGT-LADGETAAIKVL--KLQQQGALKSF---IDECNALTSIRHRNILK 217
           L+GSG FG+V+KG  + +G++  I V    +Q +   ++F    D   A+ S+ H  I++
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
           ++  C     +      LV +    G+L   +    D       L   + LN  + +A  
Sbjct: 74  LLGICPGASLQ------LVTQLSPLGSLLDHVRQHRD------SLDPQRLLNWCVQIAKG 121

Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YL       + H +L + N+LL    I  + DFG+A  L+     P   +   +  K 
Sbjct: 122 MYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY-----PDDKKYFYSEHKT 173

Query: 338 SVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
            + ++  E I  G  +   D++SYG+ + E+ + G  P   M
Sbjct: 174 PIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 25/218 (11%)

Query: 165 IGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKS-FIDECNALTSIRHRNILKIVSSC 222
           IG G+FG V+ G L AD    A+K  +      LK+ F+ E   L    H NI++++  C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +           +V E ++ G+   +L     E    K   L+Q   +V + A+ ++YL 
Sbjct: 63  TQ-----KQPIYIVMELVQGGDFLTFLR---TEGPRLKVKELIQ---MVENAAAGMEYLE 111

Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG-SVGY 341
           +++     H DL + N L+ E  +  + DFG+++   EE    +     + G+K   V +
Sbjct: 112 SKH---CIHRDLAARNCLVTEKNVLKISDFGMSRE--EEDGVYAS----TGGMKQIPVKW 162

Query: 342 IPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
             PE +N G  S   D++S+GILL E F+ G  P  ++
Sbjct: 163 TAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL 200

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 68.9 bits (169), Expect = 5e-13
 Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 43/225 (19%)

Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSC 222
           IG G+   VY    L + E  AIK + L++ Q ++     E  A++   H N++K     
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK--YYT 66

Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN------------I 270
           S V   G++   LV  ++  G+L                L +M+               +
Sbjct: 67  SFV--VGDEL-WLVMPYLSGGSL----------------LDIMKSSYPRGGLDEAIIATV 107

Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
           + +V   L+YLH+       H D+K+ N+LL E     + DFG++  L +  +   K   
Sbjct: 108 LKEVLKGLEYLHSNGQI---HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK--- 161

Query: 331 MSNGLKGSVGYIPPEYINGHV--SILGDIYSYGILLLEIFTGKRP 373
           +     G+  ++ PE +          DI+S+GI  +E+ TG  P
Sbjct: 162 VRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 68.6 bits (168), Expect = 7e-13
 Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 34/219 (15%)

Query: 164 LIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFID-ECNALTSIRHRNILKIVSS 221
           LIG G++G+VY+G  +  G   A+K++ L       S I  E   L+ +R      I   
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK- 66

Query: 222 CSSVDYEGNDFKA----LVFEFMRNGNLDQWLHPS-TDEYCHFKKLSLMQRLNIVIDVAS 276
                Y G+  K     ++ E+   G++   +      E      +S++ R     +V  
Sbjct: 67  -----YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKY----ISVIIR-----EVLV 112

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
           AL Y+H      + H D+K++N+L+       + DFG+A  L + S   SK  T      
Sbjct: 113 ALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS---SKRSTFV---- 162

Query: 337 GSVGYIPPEYINGHVS--ILGDIYSYGILLLEIFTGKRP 373
           G+  ++ PE I          DI+S GI + E+ TG  P
Sbjct: 163 GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 69.1 bits (169), Expect = 8e-13
 Identities = 72/223 (32%), Positives = 115/223 (51%), Gaps = 41/223 (18%)

Query: 164 LIGSGSFGSVY---KGTLAD-GETAAIKVLK---LQQQGALKSFIDECNALTSIRHRNIL 216
           ++G GSFG V+   K T  D G+  A+KVLK   L+ +  +++ + E + L  + H  I+
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFIV 61

Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPS---TDEYCHFKKLSLMQRLNIVID 273
           K+  +  +   EG  +  L+ +F+R G+L   L      T+E   F           + +
Sbjct: 62  KLHYAFQT---EGKLY--LILDFLRGGDLFTRLSKEVMFTEEDVKF----------YLAE 106

Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDE-GMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           +A ALD+LH+     I + DLK  N+LLDE G I  + DFGL+K   E  +   K  +  
Sbjct: 107 LALALDHLHS---LGIIYRDLKPENILLDEEGHIK-LTDFGLSK---ESIDHEKKAYSFC 159

Query: 333 NGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRP 373
               G+V Y+ PE +N  GH +   D +S+G+L+ E+ TG  P
Sbjct: 160 ----GTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 68.1 bits (166), Expect = 8e-13
 Identities = 60/219 (27%), Positives = 109/219 (49%), Gaps = 21/219 (9%)

Query: 165 IGSGSFGSVYKGTLADGET---AAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIV 219
           +G G FGSV +G L   ++    A+K +K+    +  ++ F+ E   +    H N+++++
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 220 SSC-SSVDYEGNDFKALVFEFMRNGNLDQWLHPST--DEYCHFKKLSLMQRLNIVIDVAS 276
             C  +V+ EG     ++  FM++G+L  +L  S   D   +     L++    + D+AS
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK---FMTDIAS 123

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            ++YL ++      H DL + N +L+E M   V DFGL+K ++   N     Q      K
Sbjct: 124 GMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIY---NGDYYRQGRIA--K 175

Query: 337 GSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRP 373
             V +I  E +   V +   D++S+G+ + EI T G+ P
Sbjct: 176 MPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 21/220 (9%)

Query: 163 NLIGSGSFGSVYKGTLADG-----ETAAIKVLKLQ-QQGALKSFIDECNALTSIRHRNIL 216
           +L+  G+FG ++ G L D      E   +K +K    +  +   + E   L  + H+NIL
Sbjct: 12  DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71

Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH-PSTDEYCHFKKLSLMQRLNIVIDVA 275
            I+  C     E  +   +++ +M  GNL  +L      E  + + LS  Q +++ I +A
Sbjct: 72  PILHVCI----EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127

Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
             + YLH +    + H D+ + N ++DE +   + D  L++ LF     P     + +  
Sbjct: 128 CGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLF-----PMDYHCLGDNE 179

Query: 336 KGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRP 373
              V ++  E + N   S   D++S+G+LL E+ T G+ P
Sbjct: 180 NRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 18/155 (11%)

Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIRHRNILKIVSS 221
           IG G++G VYK      GE  AIK +KL  + +G  K+ + E   L  + H NI+K++  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD- 65

Query: 222 CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYL 281
              V     D   LVFEFM   +L + +             S + +L         L + 
Sbjct: 66  ---VFRHKGDL-YLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQL------LQGLAFC 114

Query: 282 HNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK 316
           H+     I H DLK  N+L++   +  + DFGLA+
Sbjct: 115 HSHG---ILHRDLKPENLLINTEGVLKLADFGLAR 146

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 67.6 bits (165), Expect = 1e-12
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 25/223 (11%)

Query: 163 NLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGAL------KSFIDECNALTSIRHRNIL 216
            ++G G++G+VY G    G+  A+K ++L     L      +   +E + L S++H NI+
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           + + +C       ++  ++  EF+  G++   L+        F  L           +  
Sbjct: 66  QYLGTCLD-----DNTISIFMEFVPGGSISSILN-------RFGPLPEPVFCKYTKQILD 113

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            + YLHN     + H D+K +NV+L    I  + DFG A+ L       + +  M   + 
Sbjct: 114 GVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSN-MLKSMH 169

Query: 337 GSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDM 377
           G+  ++ PE IN  G+     DI+S G  + E+ TGK P   M
Sbjct: 170 GTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPLASM 211

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 25/212 (11%)

Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGAL-KSFIDECNALTSIRHRNILKIVSSC 222
           +G+G+ G V K      G+  A+K ++L+   A+ K  + E + L       I+    + 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
               Y   D  ++  E+M  G+LD+ L           ++       I + V   L YLH
Sbjct: 69  ----YNNGDI-SICMEYMDGGSLDKILKEVQ------GRIPERILGKIAVAVLKGLTYLH 117

Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
            ++   I H D+K SN+L++      + DFG++  L           +++    G+  Y+
Sbjct: 118 EKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN---------SLAKTFVGTSSYM 166

Query: 343 PPEYING-HVSILGDIYSYGILLLEIFTGKRP 373
            PE I G   S+  DI+S G+ L+E+ TG+ P
Sbjct: 167 APERIQGNDYSVKSDIWSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 27/220 (12%)

Query: 165 IGSGSFGSVYKG---TLADGETAAIKVLKLQQQG-ALK-SFIDECNALTSIRHRNILKIV 219
           +GSG+FG+V KG        +T A+K+LK      ALK   + E N +  + +  I++++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
             C +  +       LV E    G L+++L  +     H  + ++ +   +V  V+  + 
Sbjct: 63  GICEAESW------MLVMELAELGPLNKFLQKNK----HVTEKNITE---LVHQVSMGMK 109

Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSV 339
           YL    +T   H DL + NVLL     A + DFGL+K L  + N     +  ++G K  V
Sbjct: 110 YLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY---YKAKTHG-KWPV 162

Query: 340 GYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDM 377
            +  PE +N +  S   D++S+G+L+ E F+ G++P   M
Sbjct: 163 KWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 68/228 (29%), Positives = 105/228 (46%), Gaps = 41/228 (17%)

Query: 162 ENLIGSGSFGSVYKGTL-ADG--ETAAIKVLK-LQQQGALKSFIDECNALTSI-RHRNIL 216
           +++IG G+FG V K  +  DG    AAIK +K    +   + F  E   L  +  H NI+
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPS----TD-----EYCHFKKLSLMQR 267
            ++ +C     E   +  L  E+  +GNL  +L  S    TD            LS  Q 
Sbjct: 72  NLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
           L+   DVA  +DYL  +      H DL + N+L+ E  +A + DFGL           S+
Sbjct: 127 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL-----------SR 172

Query: 328 NQTMSNGLKGSVGYIPP-----EYINGHV-SILGDIYSYGILLLEIFT 369
            Q +   +K ++G +P      E +N  V +   D++SYG+LL EI +
Sbjct: 173 GQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 63/228 (27%), Positives = 100/228 (43%), Gaps = 38/228 (16%)

Query: 159 FSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILK 217
           F++   IG GSFG VYKG      E  AIK++ L++        DE   +     +  + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE------DEIEDI-----QQEIT 54

Query: 218 IVSSCSS---VDYEGNDFKA----LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
           ++S C S     Y G+  K     ++ E++  G+    L P   E  +           I
Sbjct: 55  VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA--------TI 106

Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
           + ++   LDYLH++      H D+K++NVLL E     + DFG+A  L       +  Q 
Sbjct: 107 LREILKGLDYLHSERKI---HRDIKAANVLLSEQGDVKLADFGVAGQL-------TDTQI 156

Query: 331 MSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFTGKRPTDDM 377
             N   G+  ++ PE I         DI+S GI  +E+  G+ P  D+
Sbjct: 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 68.7 bits (168), Expect = 2e-12
 Identities = 46/138 (33%), Positives = 65/138 (47%), Gaps = 17/138 (12%)

Query: 3   LGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI-- 60
           L  NS +G IP SL S+  L  LDLS N+ +G +P+   +L SLR LNL+ N L G +  
Sbjct: 449 LSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPA 508

Query: 61  SREGIFANASAISIVGNDKLCG--GIQKLQLPECSRKNPRKRLSLKIVIPVTISVPIFIL 118
           +  G   + ++ +   N  LCG  G     L  C        LS+   I +   V +  L
Sbjct: 509 ALGGRLLHRASFNFTDNAGLCGIPG-----LRACG-----PHLSVGAKIGIAFGVSVAFL 558

Query: 119 LLAALVIYHIVKTSRRQS 136
               LVI  +    RRQ+
Sbjct: 559 F---LVICAMCWWKRRQN 573

Length = 623

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 66.0 bits (161), Expect = 4e-12
 Identities = 61/257 (23%), Positives = 106/257 (41%), Gaps = 51/257 (19%)

Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSIR-HRNILKIVSSC 222
           I  G+FGSVY     + G+  AIKVLK       KS +   N +T+++  R I+ I    
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLK-------KSDMIAKNQVTNVKAERAIMMIQGES 56

Query: 223 SSV-----DYEGNDFKALVFEFMRNGN---LDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
             V      ++  D+  LV E++  G+   L + L    +++              + +V
Sbjct: 57  PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK----------QYIAEV 106

Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
              ++ LH      I H D+K  N+L+D+     + DFGL           S+N   +  
Sbjct: 107 VLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGL-----------SRNGLENKK 152

Query: 335 LKGSVGYIPPEYINGHVSI-LGDIYSYGILLLEIFTGKRP-----TDDMFKD----DLSI 384
             G+  Y+ PE I G     + D +S G ++ E   G  P      D +F +     ++ 
Sbjct: 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW 212

Query: 385 HKFVLMALPSHVMDVLD 401
            + V        +D+++
Sbjct: 213 PEEVKEFCSPEAVDLIN 229

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 66.0 bits (161), Expect = 5e-12
 Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 28/220 (12%)

Query: 158 NFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQ-QQGALKSFIDECNALTSIRHRNI 215
           NF +   +G G++ +VYKG     GE  A+K + L  ++G   + I E + +  ++H NI
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           +++      V +  N    LVFE+M     D+ L    D +     L      +    + 
Sbjct: 61  VRL----HDVIHTENKL-MLVFEYM-----DKDLKKYMDTHGVRGALDPNTVKSFTYQLL 110

Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
             + + H   +  + H DLK  N+L+++     + DFGLA+      NT S N+ +    
Sbjct: 111 KGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS-NEVV---- 162

Query: 336 KGSVGYIPPEYING----HVSILGDIYSYGILLLEIFTGK 371
             ++ Y  P+ + G      SI  DI+S G ++ E+ TG+
Sbjct: 163 --TLWYRAPDVLLGSRTYSTSI--DIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 66.6 bits (162), Expect = 7e-12
 Identities = 47/142 (33%), Positives = 75/142 (52%), Gaps = 13/142 (9%)

Query: 262 LSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEE 321
           LS M  +     VA+ +++L ++      H DL + NVL+ EG +  + DFGLA+ +  +
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIMRD 292

Query: 322 SNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFK 379
           SN  SK  T        + ++ PE I N   + L D++S+GILL EIFT G  P  ++  
Sbjct: 293 SNYISKGSTFL-----PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347

Query: 380 DDL---SIHKFVLMALPSHVMD 398
           ++    +I +   MA P+H  D
Sbjct: 348 NEQFYNAIKRGYRMAKPAHASD 369

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 65.5 bits (160), Expect = 9e-12
 Identities = 66/232 (28%), Positives = 104/232 (44%), Gaps = 38/232 (16%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLADGET-AAIKVLKLQQQGALKS---FIDECNALTSIRH 212
           D+      +G+G+FG V+       E   A+KV+ + +   LK      +E   L  + H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             I+++    +  D     F  ++ E++  G L  +L  S        + S    L    
Sbjct: 61  PFIIRLF--WTEHD---QRFLYMLMEYVPGGELFSYLRNS-------GRFSNSTGLFYAS 108

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
           ++  AL+YLH++    I + DLK  N+LLD EG I  + DFG AK L + + T       
Sbjct: 109 EIVCALEYLHSK---EIVYRDLKPENILLDKEGHI-KLTDFGFAKKLRDRTWT------- 157

Query: 332 SNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD 381
              L G+  Y+ PE I   GH   + D ++ GIL+ E+  G  P    F DD
Sbjct: 158 ---LCGTPEYLAPEVIQSKGHNKAV-DWWALGILIYEMLVGYPP----FFDD 201

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 65/224 (29%), Positives = 101/224 (45%), Gaps = 31/224 (13%)

Query: 159 FSEENLI-----GSGSFGSVYK---GTLAD--GETAAIKVLKLQQQGA--LKSFIDECNA 206
           F E +L      G G+FGSV       L D  GE  A+K  KLQ   A  L+ F  E   
Sbjct: 1   FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVK--KLQHSTAEHLRDFEREIEI 58

Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           L S++H NI+K    C S    G     LV E++  G+L  +L     E    +KL L  
Sbjct: 59  LKSLQHDNIVKYKGVCYSA---GRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYA 114

Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
                  +   ++YL ++      H DL + N+L++      +GDFGL K L ++     
Sbjct: 115 S-----QICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY-- 164

Query: 327 KNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
               +    +  + +  PE +     S+  D++S+G++L E+FT
Sbjct: 165 --YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 50/152 (32%), Positives = 77/152 (50%), Gaps = 14/152 (9%)

Query: 259 FKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFL 318
            + L+ +  L+    VA  +++L ++      H DL + NVLL +G I  + DFGLA+ +
Sbjct: 231 SEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDI 287

Query: 319 FEESNTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDD 376
             +SN  SK  T        V ++ PE I  ++ + L D++SYGILL EIF+ G  P   
Sbjct: 288 MHDSNYVSKGSTFL-----PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342

Query: 377 MFKDDLSIHKF---VLMALPSHVM-DVLDLSM 404
           M  D    +K      MA P H   +V D+ +
Sbjct: 343 MIVDSTFYNKIKSGYRMAKPDHATQEVYDIMV 374

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 62/241 (25%), Positives = 112/241 (46%), Gaps = 39/241 (16%)

Query: 165 IGSGSFGSVY--------KGTLADGETAAIKVLKLQ-QQGALKSFIDECNALTSI-RHRN 214
           +G G FG V         K    +  T A+K+LK    +  L   + E   +  I +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCH------FKKLSLM 265
           I+ ++ +C+    +      +V E+   GNL ++L    P   EY +       ++++  
Sbjct: 83  IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137

Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
             ++    VA  ++YL +Q      H DL + NVL+ E  +  + DFGLA+    + N  
Sbjct: 138 DLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DVNNI 190

Query: 326 SKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT------GKRPTDDMF 378
              +  +NG +  V ++ PE +   V +   D++S+G+L+ EIFT         P +++F
Sbjct: 191 DYYKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249

Query: 379 K 379
           K
Sbjct: 250 K 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 63/231 (27%), Positives = 106/231 (45%), Gaps = 33/231 (14%)

Query: 162 ENLIGSGSFGSVYKGTL---ADGE-TAAIKVLKL----QQQGALKSFIDECNALTSIRHR 213
           E ++G+G FG + +G L   +  E   AI  L+     +Q+   + F+ E   L    H 
Sbjct: 10  ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR---RGFLAEALTLGQFDHS 66

Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
           NI+++      V   GN    +V E+M NG LD +L        H  +L   Q + ++  
Sbjct: 67  NIVRL----EGVITRGNTM-MIVTEYMSNGALDSFLRK------HEGQLVAGQLMGMLPG 115

Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +AS + YL    +    H  L +  VL++  ++  +  F       +E  + +   TMS 
Sbjct: 116 LASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFR----RLQEDKSEAIYTTMSG 168

Query: 334 GLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL 382
             K  V +  PE I   H S   D++S+GI++ E+ + G+RP  DM   D+
Sbjct: 169 --KSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV 217

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 66/228 (28%), Positives = 111/228 (48%), Gaps = 46/228 (20%)

Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQ-GALKSFIDECNALTSIRHRN 214
           D++ +   +G GS+ +VYKG +  +G+  A+KV++LQ++ G   + I E + L  ++H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 215 IL---KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQW-------LHPSTDEYCHFKKLSL 264
           I+    I+ +  ++         LVFE++   +L Q+       LHP         KL L
Sbjct: 65  IVLLHDIIHTKETL--------TLVFEYVHT-DLCQYMDKHPGGLHPEN------VKLFL 109

Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNT 324
            Q L         L Y+H +Y   I H DLK  N+L+ +     + DFGLA+      + 
Sbjct: 110 FQLLR-------GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR----AKSV 155

Query: 325 PSKNQTMSNGLKGSVGYIPPEYINGHV--SILGDIYSYGILLLEIFTG 370
           PS   T SN +  ++ Y PP+ + G    S   D++  G + +E+  G
Sbjct: 156 PS--HTYSNEVV-TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 63.8 bits (156), Expect = 3e-11
 Identities = 49/174 (28%), Positives = 79/174 (45%), Gaps = 16/174 (9%)

Query: 159 FSEENLIGSGSFGSVYKGT-LADGETAAIKVLK--LQQQGALKSFIDECNAL---TSIRH 212
           + E   IG G++G+VYK   L  G   A+K ++  L ++G   S + E   L    S  H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            NI++++  C     +      LVFE +     DQ L  +    C    L      +++ 
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHV-----DQDLA-TYLSKCPKPGLPPETIKDLMR 114

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK-FLFEESNTP 325
            +   +D+LH+     I H DLK  N+L+       + DFGLA+ + FE + T 
Sbjct: 115 QLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTS 165

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 63.4 bits (154), Expect = 3e-11
 Identities = 65/222 (29%), Positives = 99/222 (44%), Gaps = 31/222 (13%)

Query: 165 IGSGSFGSVYKGTLADGET---AAIKVLKLQQQGALKSFIDECNALTSIRHR----NILK 217
           +GSG+FG V KG     +     AIKVLK + +   KS  DE      I H+     I++
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE---KSVRDEMMREAEIMHQLDNPYIVR 59

Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
           ++  C +      +   LV E    G L+++L    DE      + LM +      V+  
Sbjct: 60  MIGVCEA------EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQ------VSMG 107

Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YL  +      H DL + NVLL     A + DFGL+K L  + +         +  K 
Sbjct: 108 MKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY----YKARSAGKW 160

Query: 338 SVGYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDM 377
            + +  PE IN    S   D++SYGI + E F+ G++P   M
Sbjct: 161 PLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM 202

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 66/228 (28%), Positives = 114/228 (50%), Gaps = 39/228 (17%)

Query: 154 NATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQ-QQGALKSFIDECNALTSIR 211
            AT   + E L G GS+ +VYKG +  +G+  A+KV+ ++ ++G   + I E + L  ++
Sbjct: 3   AATSYLNLEKL-GEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK 61

Query: 212 HRNIL---KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQ 266
           H NI+    I+ +  ++ +        VFE+M   +L Q++  HP      +  +L + Q
Sbjct: 62  HANIVLLHDIIHTKETLTF--------VFEYMHT-DLAQYMIQHPGGLHPYNV-RLFMFQ 111

Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF-LFEESNTP 325
            L         L Y+H Q+   I H DLK  N+L     I+++G+  LA F L    + P
Sbjct: 112 LLR-------GLAYIHGQH---ILHRDLKPQNLL-----ISYLGELKLADFGLARAKSIP 156

Query: 326 SKNQTMSNGLKGSVGYIPPEYINGHV--SILGDIYSYGILLLEIFTGK 371
           S  QT S+ +  ++ Y PP+ + G    S   DI+  G + +E+  G+
Sbjct: 157 S--QTYSSEVV-TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 67/244 (27%), Positives = 115/244 (47%), Gaps = 45/244 (18%)

Query: 165 IGSGSFGSVY--KGTLADGET------AAIKVLKLQ-QQGALKSFIDECNALTSI-RHRN 214
           +G G FG V   +    D E        A+K+LK    +  L   I E   +  I +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCH------FKKLSLM 265
           I+ ++ +C+    +G  +  ++ E+   GNL ++L    P   EYC+       ++LS  
Sbjct: 86  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
             ++    VA  ++YL ++      H DL + NVL+ E  +  + DFGLA+    + +  
Sbjct: 141 DLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHI 193

Query: 326 SKNQTMSNGLKGSVGYIPPE----YINGHVSILGDIYSYGILLLEIFT------GKRPTD 375
              +  +NG +  V ++ PE     I  H S   D++S+G+LL EIFT         P +
Sbjct: 194 DYYKKTTNG-RLPVKWMAPEALFDRIYTHQS---DVWSFGVLLWEIFTLGGSPYPGVPVE 249

Query: 376 DMFK 379
           ++FK
Sbjct: 250 ELFK 253

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 63.0 bits (153), Expect = 5e-11
 Identities = 60/224 (26%), Positives = 108/224 (48%), Gaps = 18/224 (8%)

Query: 159 FSEENLIGSGSFGSVYKGTL----ADGETAAIKVLK--LQQQGALKSFIDECNALTSIRH 212
           F+   ++G G FGSV +  L       +  A+K+LK  +     ++ F+ E   +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 213 RNILKIVS-SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
            N++K++  S  S          ++  FM++G+L  +L  S      F  L L   +  +
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFT-LPLQTLVRFM 119

Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
           ID+AS ++YL ++      H DL + N +L+E M   V DFGL+K ++  S    +    
Sbjct: 120 IDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIY--SGDYYRQGCA 174

Query: 332 SNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRP 373
           S   K  V ++  E +  +V +   D++++G+ + EI T G+ P
Sbjct: 175 S---KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 63.0 bits (153), Expect = 5e-11
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 32/240 (13%)

Query: 165 IGSGSFGSVYKGTLADGETAAIKVLK-LQQQGALK---SFIDECNALTSIRHRNILKIVS 220
           IG+G FG V  G    G + A  V+K L+          F+ E      + H N+L+ + 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 221 SC-SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
            C  S+ Y       LV EF   G+L  +L  +        +  ++QR+    +VAS L 
Sbjct: 63  QCIESIPY------LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLL 114

Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSV 339
           +LH        H DL   N  L   +   +GD+GLA   + E    +K+          +
Sbjct: 115 WLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDC-----HAVPL 166

Query: 340 GYIPPEYING-HVSIL-------GDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLM 390
            ++ PE +      +L        +I+S G+ + E+FT   +P  D+   D  + K V+ 
Sbjct: 167 RWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL--SDEQVLKQVVR 224

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 62.8 bits (152), Expect = 5e-11
 Identities = 65/231 (28%), Positives = 103/231 (44%), Gaps = 44/231 (19%)

Query: 159 FSEENLIGSGSFGSVYKGTLADGET---AAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           F++   IG GSFG V+KG   D  T    AIK++ L++        DE   +     +  
Sbjct: 6   FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAE------DEIEDI-----QQE 52

Query: 216 LKIVSSCSS---VDYEGNDFKA----LVFEFMRNGN-LDQWLHPSTDEYCHFKKLSLMQR 267
           + ++S C S     Y G+  K     ++ E++  G+ LD       DE+         Q 
Sbjct: 53  ITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEF---------QI 103

Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
             ++ ++   LDYLH++      H D+K++NVLL E     + DFG+A  L       + 
Sbjct: 104 ATMLKEILKGLDYLHSEKKI---HRDIKAANVLLSEQGDVKLADFGVAGQL-------TD 153

Query: 328 NQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFTGKRPTDDM 377
            Q   N   G+  ++ PE I         DI+S GI  +E+  G+ P  DM
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 62.8 bits (152), Expect = 6e-11
 Identities = 67/222 (30%), Positives = 104/222 (46%), Gaps = 31/222 (13%)

Query: 163 NLIGSGSFGSVYKGTLA-DG--ETAAIKVLK-LQQQGALKSFIDECNALTSI-RHRNILK 217
           ++IG G+FG V K  +  DG    AAIK +K    +   + F  E   L  +  H NI+ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPS----TD-----EYCHFKKLSLMQRL 268
           ++ +C     E   +  L  E+  +GNL  +L  S    TD            LS  Q L
Sbjct: 61  LLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115

Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
           +   DVA  +DYL  +      H DL + N+L+ E  +A + DFGL++   +E       
Sbjct: 116 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYV---K 167

Query: 329 QTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
           +TM    +  V ++  E +N  V +   D++SYG+LL EI +
Sbjct: 168 KTMG---RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 63.1 bits (153), Expect = 7e-11
 Identities = 67/241 (27%), Positives = 112/241 (46%), Gaps = 39/241 (16%)

Query: 165 IGSGSFGSVY--------KGTLADGETAAIKVLKLQQQGA-LKSFIDECNALTSI-RHRN 214
           +G G FG V         K       T A+K+LK       L   + E   +  I +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH----PSTD---EYCHF--KKLSLM 265
           I+ ++ +C+    +      LV E+   GNL ++L     P  D   + C    ++L+  
Sbjct: 80  IINLLGACT----QDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134

Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
             ++    VA  ++YL +Q      H DL + NVL+ E  +  + DFGLA+   +  N  
Sbjct: 135 DLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLAR---DVHNID 188

Query: 326 SKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKR-----PTDDMF 378
              +T +NG +  V ++ PE +   V +   D++S+G+LL EIFT G       P +++F
Sbjct: 189 YYKKT-TNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246

Query: 379 K 379
           K
Sbjct: 247 K 247

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 59/232 (25%), Positives = 98/232 (42%), Gaps = 51/232 (21%)

Query: 158 NFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQ--GALKSFIDECNALTSIRHRN 214
            F + N IG G++G VY+      GE  A+K +++  +  G   S + E   L ++RH N
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 215 I--LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN--- 269
           I  LK V     +D         +F  M              EYC     SL+  +    
Sbjct: 68  IVELKEVVVGKHLDS--------IFLVM--------------EYCEQDLASLLDNMPTPF 105

Query: 270 -------IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES 322
                  +++ +   L YLH  +   I H DLK SN+LL +     + DFGLA+  +   
Sbjct: 106 SESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR-TYGLP 161

Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYING---HVSILGDIYSYGILLLEIFTGK 371
             P   + +      ++ Y  PE + G   + + + D+++ G +L E+   K
Sbjct: 162 AKPMTPKVV------TLWYRAPELLLGCTTYTTAI-DMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 28/220 (12%)

Query: 164 LIGSGSFGSVYKGTLA-DGET----AAIKVLKLQQQ-GALKSFIDECNALTSIRHRNILK 217
           ++GSG+FG+VYKG    DGE      AIKVL+      A K  +DE   +  +    + +
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
           ++  C +   +      LV + M  G L  ++  + D      ++     LN  + +A  
Sbjct: 74  LLGICLTSTVQ------LVTQLMPYGCLLDYVRENKD------RIGSQDLLNWCVQIAKG 121

Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YL    +  + H DL + NVL+       + DFGLA+ L        + +  ++G K 
Sbjct: 122 MSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLL-----DIDETEYHADGGKV 173

Query: 338 SVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTD 375
            + ++  E I +   +   D++SYG+ + E+ T G +P D
Sbjct: 174 PIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 54/224 (24%), Positives = 98/224 (43%), Gaps = 36/224 (16%)

Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           +G G+FG VYK      G  AA K+++++ +  L+ F+ E + L+  +H NI+ +  +  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 224 SVDYEGNDFKALVFEFMRNGNLDQWL----HPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
              YE   +  ++ EF   G LD  +       T+    +          +   +  AL+
Sbjct: 73  ---YENKLW--ILIEFCDGGALDSIMLELERGLTEPQIRY----------VCRQMLEALN 117

Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSV 339
           +LH+     + H DLK+ N+LL       + DFG++       +T  K  T      G+ 
Sbjct: 118 FLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKN---KSTLQKRDT----FIGTP 167

Query: 340 GYIPPEYINGHVS------ILGDIYSYGILLLEIFTGKRPTDDM 377
            ++ PE +              DI+S GI L+E+   + P  ++
Sbjct: 168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 38/222 (17%)

Query: 164 LIGSGSFGSVYKGTLADGE----TAAIKVLKLQQQGALKS-FIDECNALTSIRHRNILKI 218
            IG G FG VY+G     E      A+K  K     +++  F+ E   +    H +I+K+
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
           +   +       +   +V E    G L  +L  +         L L   +     +++AL
Sbjct: 73  IGVIT------ENPVWIVMELAPLGELRSYLQVNKYS------LDLASLILYSYQLSTAL 120

Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
            YL +       H D+ + NVL+       +GDFGL+++L +ES             K S
Sbjct: 121 AYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY-----------YKAS 166

Query: 339 VGYIP-----PEYIN-GHVSILGDIYSYGILLLEIFT-GKRP 373
            G +P     PE IN    +   D++ +G+ + EI   G +P
Sbjct: 167 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 69/241 (28%), Positives = 102/241 (42%), Gaps = 58/241 (24%)

Query: 158 NFSEENLIGSGSFGSV----YKGTLADGETAAIKVLKLQQQGALKS---FIDECNALTSI 210
           +F     +G+GSFG V    +KGT   GE  AIK LK ++   +K       E + L  +
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75

Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
            H  I+ ++ S     ++  +    + EF+  G L          + H +K         
Sbjct: 76  SHPFIVNMMCS-----FQDENRVYFLLEFVVGGEL----------FTHLRKAGRFPN--- 117

Query: 271 VIDVAS--------ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES 322
             DVA         A +YLH++    I + DLK  N+LLD      V DFG AK + + +
Sbjct: 118 --DVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172

Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDMFKD 380
            T          L G+  Y+ PE I   GH   + D ++ G+LL E   G  P    F D
Sbjct: 173 FT----------LCGTPEYLAPEVIQSKGHGKAV-DWWTMGVLLYEFIAGYPP----FFD 217

Query: 381 D 381
           D
Sbjct: 218 D 218

Length = 329

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 38/236 (16%)

Query: 159 FSEENLI-----GSGSFGSVYKGTLADGE--------TAAIKVLKLQQQGA-LKSFIDEC 204
           F  + L+     G G FG V +      +        T A+K+LK       L   I E 
Sbjct: 9   FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM 68

Query: 205 NALTSI-RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYC--- 257
             +  I +H+NI+ ++  C+    EG  +  ++ E+   GNL ++L    P   +Y    
Sbjct: 69  ELMKLIGKHKNIINLLGVCTQ---EGPLY--VIVEYAAKGNLREFLRARRPPGPDYTFDI 123

Query: 258 ---HFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL 314
                ++LS    ++    VA  ++YL ++      H DL + NVL+ E  +  + DFGL
Sbjct: 124 TKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGL 180

Query: 315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
           A+ + +        +  SNG +  V ++ PE +   V +   D++S+GIL+ EIFT
Sbjct: 181 ARGVHD----IDYYKKTSNG-RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 60.9 bits (147), Expect = 2e-10
 Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 42/230 (18%)

Query: 159 FSEENLIGSGSFGSVYKGTLADGET---AAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           F++   IG GSFG V+KG   D  T    AIK++ L++        DE   +     +  
Sbjct: 6   FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAE------DEIEDI-----QQE 52

Query: 216 LKIVSSCSS---VDYEGNDFKA----LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
           + ++S C S     Y G+  K     ++ E++  G+    L P          L   Q  
Sbjct: 53  ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--------PLDETQIA 104

Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
            I+ ++   LDYLH++      H D+K++NVLL E     + DFG+A  L       +  
Sbjct: 105 TILREILKGLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQL-------TDT 154

Query: 329 QTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFTGKRPTDDM 377
           Q   N   G+  ++ PE I         DI+S GI  +E+  G+ P  ++
Sbjct: 155 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 70/266 (26%), Positives = 110/266 (41%), Gaps = 49/266 (18%)

Query: 154 NATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRH 212
           N  ++F     IGSG++G VYK   +  GE AAIKV+KL+          E   +   +H
Sbjct: 6   NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH 65

Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            NI+    S     Y   D   +  EF   G+L    H +         LS  Q   +  
Sbjct: 66  SNIVAYFGS-----YLRRDKLWICMEFCGGGSLQDIYHVT-------GPLSESQIAYVSR 113

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           +    L YLH++      H D+K +N+LL +     + DFG++    + + T +K ++  
Sbjct: 114 ETLQGLYYLHSKGKM---HRDIKGANILLTDNGHVKLADFGVSA---QITATIAKRKS-- 165

Query: 333 NGLKGSVGYIPPEYI----NGHVSILGDIYSYGILLLEIFTGKRPTDDM----------- 377
               G+  ++ PE       G  + L DI++ GI  +E+   + P  D+           
Sbjct: 166 --FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK 223

Query: 378 -------FKDDL----SIHKFVLMAL 392
                   KD +    S H FV MAL
Sbjct: 224 SNFQPPKLKDKMKWSNSFHHFVKMAL 249

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 33/216 (15%)

Query: 165 IGSGSFGSVYKGTL----ADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNILKI 218
           +G GS+G V   +L     DG+   IK L L+       K+   E   L+ ++H NI+  
Sbjct: 8   VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64

Query: 219 VSSCSSVDYEGND-FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
             S     +EG D    +V  F   G+L   L     +      L   Q +   + +A A
Sbjct: 65  RES-----WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL-----LPENQVVEWFVQIAMA 114

Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT-MSNGLK 336
           L YLH ++   I H DLK+ NV L    I  VGD G+A+ L        +NQ  M++ L 
Sbjct: 115 LQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVL--------ENQCDMASTLI 163

Query: 337 GSVGYIPPE-YINGHVSILGDIYSYGILLLEIFTGK 371
           G+  Y+ PE + N   +   D+++ G  + E+ T K
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 61.4 bits (150), Expect = 3e-10
 Identities = 59/230 (25%), Positives = 89/230 (38%), Gaps = 52/230 (22%)

Query: 163 NLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFID------ECNALTSIRHRNI 215
             IGSG++G V        G   AIK  K+         ID      E   L  +RH NI
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIK--KISN--VFDDLIDAKRILREIKLLRHLRHENI 61

Query: 216 LKIVSSCSSVDYEGNDFKAL--VFEFMRNGNLDQWLH---PSTDEYCHFKKLSLMQRLNI 270
           + ++        E  DF  +  V E M   +L + +    P TD++  +           
Sbjct: 62  IGLLDILRPPSPE--DFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY----------F 108

Query: 271 VIDVASALDYLH--NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
           +  +   L YLH  N     + H DLK SN+L++      + DFGLA+ +  + +     
Sbjct: 109 LYQILRGLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG-- 161

Query: 329 QTMSNGLKGSVG---YIPPEYI----NGHVSILGDIYSYGILLLEIFTGK 371
                 L   V    Y  PE +        +I  DI+S G +  E+ T K
Sbjct: 162 -----FLTEYVVTRWYRAPELLLSSSRYTKAI--DIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 32/227 (14%)

Query: 156 TDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRN 214
            D   E  ++G G++G VY    L+     AIK +  +    ++   +E    + ++HRN
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI-- 272
           I++ + S S    E   FK +  E +  G+L   L          K   L      +I  
Sbjct: 67  IVQYLGSDS----ENGFFK-IFMEQVPGGSLSALLRS--------KWGPLKDNEQTIIFY 113

Query: 273 --DVASALDYLHNQYDTPIAHCDLKSSNVLLDE-GMIAHVGDFGLAKFLFEESNTPSKNQ 329
              +   L YLH+     I H D+K  NVL++    +  + DFG +K L       +   
Sbjct: 114 TKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-------AGIN 163

Query: 330 TMSNGLKGSVGYIPPEYINGHVSILG---DIYSYGILLLEIFTGKRP 373
             +    G++ Y+ PE I+      G   DI+S G  ++E+ TGK P
Sbjct: 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 60.3 bits (146), Expect = 3e-10
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 32/224 (14%)

Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGA----LKSFIDECNALTSIRHRNILKIVS 220
           IG+G FG V  G +  G T A  V+K  +  A       F++E     S++H N+L+ + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 221 SCSSV-DYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
            C+ V  Y       LV EF   G+L  +L             + +QR+    ++A  L 
Sbjct: 63  QCTEVTPY------LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLL 114

Query: 280 YLH-NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
           +LH N +     H DL   N LL   +   +GD+GL+   ++E    + +Q     L   
Sbjct: 115 HLHKNNF----IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQ-----LWVP 165

Query: 339 VGYIPPEYING-HVSIL-------GDIYSYGILLLEIFT-GKRP 373
           + +I PE ++  H ++L        +++S G+ + E+F  G +P
Sbjct: 166 LRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 60.1 bits (146), Expect = 5e-10
 Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 37/219 (16%)

Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNIL---KIV 219
           +G GS+ +VYKG +   G+  A+K ++L+  +GA  + I E + L  ++H NI+    I+
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72

Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVASA 277
            +  ++         LVFE++   +L Q++          H  +L L Q L         
Sbjct: 73  HTKKTL--------TLVFEYLDT-DLKQYMDDCGGGLSM-HNVRLFLFQLLR-------G 115

Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           L Y H +    + H DLK  N+L+ E     + DFGLA+      + PSK  T SN +  
Sbjct: 116 LAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLAR----AKSVPSK--TYSNEVV- 165

Query: 338 SVGYIPPEYINGHV--SILGDIYSYGILLLEIFTGKRPT 374
           ++ Y PP+ + G    S   D++  G +  E+ TG RP 
Sbjct: 166 TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG-RPL 203

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 59.9 bits (145), Expect = 5e-10
 Identities = 51/219 (23%), Positives = 96/219 (43%), Gaps = 27/219 (12%)

Query: 164 LIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGA------LKSFIDECNALTSIRHRNIL 216
            +G+G+F S Y+   +  G   A+K +   +  +      +++   E   +  + H +I+
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           +          E + F   V E+M  G++   L     +Y  FK+  +   +N    +  
Sbjct: 67  R----MLGATCEDSHFNLFV-EWMAGGSVSHLLS----KYGAFKEAVI---INYTEQLLR 114

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDE-GMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
            L YLH   +  I H D+K +N+L+D  G    + DFG A  L   +   +        L
Sbjct: 115 GLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL---AAKGTGAGEFQGQL 168

Query: 336 KGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
            G++ ++ PE + G       D++S G +++E+ T K P
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 60.0 bits (146), Expect = 7e-10
 Identities = 55/238 (23%), Positives = 100/238 (42%), Gaps = 40/238 (16%)

Query: 155 ATDNFSEENLIGSGSFGSVYKG-TLADGETAAIK--VLKLQQQGALKSFIDECNALTSIR 211
              ++     +G G+FG VYK   +  G   A+K  ++  ++ G   + + E   L  ++
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65

Query: 212 HRNILKIVSSCSSVDYEGNDFKA-----LVFEFMRNGNLDQWLH-PSTDEYCHFKKLSLM 265
           H N++ ++    +V+      +      +V  +M + +L   L  PS        KL+  
Sbjct: 66  HPNVVPLIDM--AVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSV-------KLTES 115

Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
           Q    ++ +   ++YLH  +   I H D+K++N+L+D   I  + DFGLA+        P
Sbjct: 116 QIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172

Query: 326 SKNQTMS----NGLKGSVGYIPPEYINGHVSILG--------DIYSYGILLLEIFTGK 371
                        L  +  Y PPE       +LG        DI+  G +  E+FT +
Sbjct: 173 KGGGGGGTRKYTNLVVTRWYRPPEL------LLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 59.1 bits (143), Expect = 7e-10
 Identities = 56/223 (25%), Positives = 106/223 (47%), Gaps = 26/223 (11%)

Query: 158 NFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRN 214
            + +  ++G G+FG V+     AD +   IK + ++Q  +    +  +EC  L  + H N
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
           I++   +     +  +    +V E+   G L +++    +       +     L+  + +
Sbjct: 61  IIEYYEN-----FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTI-----LHFFVQI 110

Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDE-GMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
             AL ++H +    I H DLK+ N+LLD+  M+  +GDFG++K L    ++ SK  T+  
Sbjct: 111 LLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKIL----SSKSKAYTVV- 162

Query: 334 GLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRPTD 375
              G+  YI PE   G   +   DI++ G +L E+ + KR  +
Sbjct: 163 ---GTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 59.3 bits (143), Expect = 8e-10
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 25/228 (10%)

Query: 148 SYLKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNA 206
           S + + +    ++    IG G+ G+VY    +A G+  AIK + LQQQ   +  I+E   
Sbjct: 10  SIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILV 69

Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           +   ++ NI+  + S     Y   D   +V E++  G+L         E C    +   Q
Sbjct: 70  MRENKNPNIVNYLDS-----YLVGDELWVVMEYLAGGSLTD----VVTETC----MDEGQ 116

Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
              +  +   ALD+LH+     + H D+KS N+LL       + DFG    +  E    S
Sbjct: 117 IAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---S 170

Query: 327 KNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFTGKRP 373
           K  TM     G+  ++ PE +         DI+S GI+ +E+  G+ P
Sbjct: 171 KRSTMV----GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 70/265 (26%), Positives = 120/265 (45%), Gaps = 43/265 (16%)

Query: 158 NFSEENLIGSGSFGSVY--KGTLADGETAAIKVLKL-----QQQGALKSFIDECNALTSI 210
            +     IG GSFG +Y  K   +D E   IK + L     +++ A K    E   L  +
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASK---KEVILLAKM 56

Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
           +H NI+   +S     ++ N    +V E+   G+L + ++            S  Q L+ 
Sbjct: 57  KHPNIVTFFAS-----FQENGRLFIVMEYCDGGDLMKRINRQ-----RGVLFSEDQILSW 106

Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE-GMIAHVGDFGLAKFLFEESNTPSKNQ 329
            + ++  L ++H   D  I H D+KS N+ L + GM+A +GDFG+A+ L   +++     
Sbjct: 107 FVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL---NDSMELAY 160

Query: 330 TMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV 388
           T      G+  Y+ PE   N   +   DI+S G +L E+ T K P    F+ + ++H+ V
Sbjct: 161 TCV----GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP----FEGN-NLHQLV 211

Query: 389 LMALPSHVMDV-----LDLSMLLEE 408
           L     +   +      DL  L+ +
Sbjct: 212 LKICQGYFAPISPNFSRDLRSLISQ 236

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 32/223 (14%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D+F + + +G+G+ G V+K +    G   A K++ L+ + A+++ I        IR   +
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQI--------IRELQV 56

Query: 216 LKIVSSCSSVDYEGNDFK----ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           L   +S   V + G  +     ++  E M  G+LDQ L  +        ++       + 
Sbjct: 57  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-------GRIPEQILGKVS 109

Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
           I V   L YL  ++   I H D+K SN+L++      + DFG++  L +         +M
Sbjct: 110 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---------SM 158

Query: 332 SNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRP 373
           +N   G+  Y+ PE + G H S+  DI+S G+ L+E+  G+ P
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 24/167 (14%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKL--QQQGALKSFIDECNALTSIRHR 213
           D + + N I  G++G VY+      GE  A+K LK+  +++G   + + E N L  ++H 
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64

Query: 214 NILKI----VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN 269
           NI+ +    V S         D   +V E++ + +L   +      +   +   LM +L 
Sbjct: 65  NIVTVKEVVVGS-------NLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQL- 115

Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK 316
                 S + +LH+ +   I H DLK+SN+LL+   I  + DFGLA+
Sbjct: 116 -----LSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR 154

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 65/233 (27%), Positives = 105/233 (45%), Gaps = 35/233 (15%)

Query: 148 SYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNA 206
           + + + +    ++    IG G+ G+VY    +A G+  AIK + LQQQ   +  I+E   
Sbjct: 10  TIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILV 69

Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTD---EYCHFKKLS 263
           +   +H NI+  + S     Y   D   +V E++  G+L       TD   E C    + 
Sbjct: 70  MRENKHPNIVNYLDS-----YLVGDELWVVMEYLAGGSL-------TDVVTETC----MD 113

Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG--DFGLAKFLFEE 321
             Q   +  +   AL++LH+     + H D+KS N+LL  GM   V   DFG    +  E
Sbjct: 114 EGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILL--GMDGSVKLTDFGFCAQITPE 168

Query: 322 SNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFTGKRP 373
               SK  TM     G+  ++ PE +         DI+S GI+ +E+  G+ P
Sbjct: 169 Q---SKRSTMV----GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 35/111 (31%), Positives = 58/111 (52%), Gaps = 15/111 (13%)

Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
           I + +  AL+YLH++    + H D+K SNVL++      + DFG++ +L       S  +
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL-----VDSVAK 160

Query: 330 TMSNGLKGSVGYIPPEYING-----HVSILGDIYSYGILLLEIFTGKRPTD 375
           T+  G K    Y+ PE IN         +  D++S GI ++E+ TG+ P D
Sbjct: 161 TIDAGCKP---YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 59.0 bits (142), Expect = 1e-09
 Identities = 60/229 (26%), Positives = 103/229 (44%), Gaps = 27/229 (11%)

Query: 148 SYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNA 206
           + + I +    ++    IG G+ G+V+    +A G+  AIK + LQ+Q   +  I+E   
Sbjct: 10  TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILV 69

Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           +  +++ NI+  + S     +   D   +V E++  G+L         E C    +   Q
Sbjct: 70  MKELKNPNIVNFLDS-----FLVGDELFVVMEYLAGGSLTD----VVTETC----MDEAQ 116

Query: 267 RLNIVIDVASALDYLH-NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
              +  +   AL++LH NQ    + H D+KS NVLL       + DFG    +  E    
Sbjct: 117 IAAVCRECLQALEFLHANQ----VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--- 169

Query: 326 SKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFTGKRP 373
           SK  TM     G+  ++ PE +         DI+S GI+ +E+  G+ P
Sbjct: 170 SKRSTMV----GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 25/211 (11%)

Query: 165 IGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           IG GS G V   T    G+  A+K + L++Q   +   +E   +    H N++ + +S  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNS-- 87

Query: 224 SVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN 283
              Y   D   +V EF+  G L       TD   H  +++  Q   + + V  AL YLHN
Sbjct: 88  ---YLVGDELWVVMEFLEGGAL-------TDIVTH-TRMNEEQIATVCLSVLRALSYLHN 136

Query: 284 QYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIP 343
           Q    + H D+KS ++LL       + DFG    +       SK       L G+  ++ 
Sbjct: 137 Q---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQV-------SKEVPKRKSLVGTPYWMA 186

Query: 344 PEYING-HVSILGDIYSYGILLLEIFTGKRP 373
           PE I+        DI+S GI+++E+  G+ P
Sbjct: 187 PEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 49/192 (25%), Positives = 80/192 (41%), Gaps = 32/192 (16%)

Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSS 221
           IG G+ G V+K      GET A+K + L+  + G     + E  AL + +H  ++K++  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL-- 65

Query: 222 CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK----LSLMQRLNIVIDVASA 277
              V   G+ F  LV E+M            +D     +     L   Q  + +  +   
Sbjct: 66  --DVFPHGSGF-VLVMEYM-----------PSDLSEVLRDEERPLPEAQVKSYMRMLLKG 111

Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + Y+H      I H DLK +N+L+    +  + DFGLA+   EE      +Q        
Sbjct: 112 VAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV------A 162

Query: 338 SVGYIPPEYING 349
           +  Y  PE + G
Sbjct: 163 TRWYRAPELLYG 174

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 27/229 (11%)

Query: 154 NATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRH 212
           N   ++     +GSG++G VYK   L  GE AA+K++KL+          E   +   +H
Sbjct: 6   NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKH 65

Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            NI+    S     Y   +   +  E+   G+L    H +         LS +Q   +  
Sbjct: 66  CNIVAYFGS-----YLSREKLWICMEYCGGGSLQDIYHVT-------GPLSELQIAYVCR 113

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           +    L YLH++      H D+K +N+LL +     + DFG+A  +   + T +K ++  
Sbjct: 114 ETLQGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAKI---TATIAKRKS-- 165

Query: 333 NGLKGSVGYIPPEYI----NGHVSILGDIYSYGILLLEIFTGKRPTDDM 377
               G+  ++ PE      NG  + L DI++ GI  +E+   + P  D+
Sbjct: 166 --FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 68/293 (23%), Positives = 133/293 (45%), Gaps = 39/293 (13%)

Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSS 221
           IG G+FG V+K       +  A+K + ++   +G   + + E   L  ++H N++ ++  
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 222 CSSVDYEGNDFKA---LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
           C +     N +K    LVFEF  + +L   L     ++   +   +M+ L       + L
Sbjct: 80  CRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKML------LNGL 132

Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
            Y+H      I H D+K++N+L+ +  I  + DFGLA+  F  S     N+  +N +  +
Sbjct: 133 YYIHR---NKILHRDMKAANILITKDGILKLADFGLAR-AFSLSKNSKPNR-YTNRVV-T 186

Query: 339 VGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHV 396
           + Y PPE + G        D++  G ++ E++T + P   + + +   H+  L+   S +
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSP---IMQGNTEQHQLTLI---SQL 239

Query: 397 -----------MDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLV 438
                      +D L+L   +E     ++  +E L P ++   A   +++ LV
Sbjct: 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLV 292

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 58/235 (24%), Positives = 103/235 (43%), Gaps = 44/235 (18%)

Query: 163 NLIGSGSFGSVYKG-TLADGETAAIKVLKLQQ----QGALKSFIDEC----------NAL 207
             +G G++G V K      G+  AIK +K+ +        +  +  C            +
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 208 TSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQR 267
             I+H NI+ +V       Y   DF  LV + M   +L + +           +L+  Q 
Sbjct: 75  NEIKHENIMGLVDV-----YVEGDFINLVMDIM-ASDLKKVVDRKI-------RLTESQV 121

Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA-KFLFEE-SNTP 325
             I++ + + L+ LH  Y     H DL  +N+ ++   I  + DFGLA ++ +   S+T 
Sbjct: 122 KCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178

Query: 326 SKNQTMSNGLKG-----SVGYIPPEYING----HVSILGDIYSYGILLLEIFTGK 371
           SK++TM    +      ++ Y  PE + G    H ++  D++S G +  E+ TGK
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAV--DMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 62/237 (26%), Positives = 92/237 (38%), Gaps = 54/237 (22%)

Query: 159 FSEENLIGSGSFGSVYKGT-LADGETAAIKVLKL---QQQGALKSFIDECNALTSIRHRN 214
           F++   IG GSFG+VY    +   E  AIK +     Q     +  I E   L  +RH N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYC----------HFKKLSL 264
                     ++Y+G         ++R      WL     EYC          H K L  
Sbjct: 77  T---------IEYKGC--------YLREHT--AWL---VMEYCLGSASDILEVHKKPLQE 114

Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNT 324
           ++   I       L YLH+       H D+K+ N+LL E     + DFG A  +     +
Sbjct: 115 VEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLV-----S 166

Query: 325 PSKNQTMSNGLKGSVGYIPPEYI----NGHVSILGDIYSYGILLLEIFTGKRPTDDM 377
           P      +N   G+  ++ PE I     G      D++S GI  +E+   K P  +M
Sbjct: 167 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 69/243 (28%), Positives = 120/243 (49%), Gaps = 44/243 (18%)

Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQ-QQGALKSFIDECNALTSIRHRNILK---IV 219
           +G G++ +V+KG +       A+K ++L+ ++GA  + I E + L +++H NI+    I+
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYC-HFKKLSLMQRLNIVIDVASAL 278
            +   +         LVFE++ + +L Q+L    +    H  K+ + Q L         L
Sbjct: 73  HTERCL--------TLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLR-------GL 116

Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
            Y H +    I H DLK  N+L++E     + DFGLA+      + P+K  T SN +  +
Sbjct: 117 SYCHKR---KILHRDLKPQNLLINEKGELKLADFGLAR----AKSVPTK--TYSNEVV-T 166

Query: 339 VGYIPPEYINGHV--SILGDIYSYGILLLEIFTGKRPTDDMF-----KDDLSIHKFVLMA 391
           + Y PP+ + G    S   D++  G +L E+ TG RP   MF     K++L +  F L+ 
Sbjct: 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATG-RP---MFPGSTVKEELHL-IFRLLG 221

Query: 392 LPS 394
            P+
Sbjct: 222 TPT 224

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 64/216 (29%), Positives = 108/216 (50%), Gaps = 36/216 (16%)

Query: 165 IGSGSFGSVYKG--TLADGETAAIKVLKLQ-QQGALKSFIDECNALTSIRHRNILK---I 218
           +G G++ +VYKG   L D    A+K ++L+ ++GA  + I E + L  ++H NI+    I
Sbjct: 14  LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDE-YCHFKKLSLMQRLNIVIDVASA 277
           + +  S+         LVFE++ + +L Q+L    +    H  KL L Q L         
Sbjct: 73  IHTEKSL--------TLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLR-------G 116

Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           L+Y H +    + H DLK  N+L++E     + DFGLA+      + P+K  T SN +  
Sbjct: 117 LNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR----AKSIPTK--TYSNEVV- 166

Query: 338 SVGYIPPEYINGHV--SILGDIYSYGILLLEIFTGK 371
           ++ Y PP+ + G    S   D++  G +  E+ TG+
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 63/230 (27%), Positives = 105/230 (45%), Gaps = 37/230 (16%)

Query: 158 NFSEENLIGSGSFGSVY----KGTLADGETAAIKVLK----LQQQGALKSFIDECNALTS 209
           NF    ++G+G++G V+     G    G+  A+KVLK    +Q+    +    E   L +
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 210 IRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN 269
           +R    L  +      D + +    L+ +++  G L  + H    E  HF +      + 
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLH----LILDYVNGGEL--FTHLYQRE--HFTE----SEVR 108

Query: 270 IVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSK 327
           + I ++  ALD+LH      I + D+K  N+LLD EG +  + DFGL+K    E     +
Sbjct: 109 VYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVV-LTDFGLSK----EFLAEEE 160

Query: 328 NQTMSNGLKGSVGYIPPEYIN----GHVSILGDIYSYGILLLEIFTGKRP 373
            +  S    G++ Y+ PE I     GH   + D +S G+L  E+ TG  P
Sbjct: 161 ERAYS--FCGTIEYMAPEVIRGGSGGHDKAV-DWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 56/227 (24%), Positives = 93/227 (40%), Gaps = 34/227 (14%)

Query: 158 NFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGA-----LKSFIDECNALTSIR 211
           N+    L+G G+FG VY     D G   A+K +            + +   E   L +++
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 212 HRNILKIVSSCSSVDYEG---NDFKALVF-EFMRNGNLDQWLHPSTDEYCHFKKLSLMQR 267
           H  I         V Y G   +D    +F E+M  G++        D+   +  L+    
Sbjct: 63  HERI---------VQYYGCLRDDETLSIFMEYMPGGSVK-------DQLKAYGALTETVT 106

Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
                 +   ++YLH      I H D+K +N+L D      +GDFG +K L     T   
Sbjct: 107 RKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL----QTICS 159

Query: 328 NQTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
           + T    + G+  ++ PE I+G       D++S G  ++E+ T K P
Sbjct: 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 57.4 bits (138), Expect = 3e-09
 Identities = 60/252 (23%), Positives = 115/252 (45%), Gaps = 31/252 (12%)

Query: 165 IGSGSFGSVY----KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVS 220
           +G GSFG VY    KG + D     + +  + +  +++  I+  N  + ++  N   +V 
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCHFKKLSLMQRLNIVIDVASA 277
               V  +G     ++ E M  G+L  +L    P  +        SL + + +  ++A  
Sbjct: 74  LLGVVS-QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131

Query: 278 LDYLH-NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
           + YL+ N++     H DL + N ++ E     +GDFG+ + ++E             G K
Sbjct: 132 MAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-------TDYYRKGGK 180

Query: 337 G--SVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFV---- 388
           G   V ++ PE + +G  +   D++S+G++L EI T  ++P   M  +   + +FV    
Sbjct: 181 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVLRFVMEGG 238

Query: 389 LMALPSHVMDVL 400
           L+  P +  D+L
Sbjct: 239 LLDKPDNCPDML 250

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 57.9 bits (140), Expect = 5e-09
 Identities = 46/146 (31%), Positives = 70/146 (47%), Gaps = 14/146 (9%)

Query: 262 LSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEE 321
           L L   L     VA  +D+L ++      H D+ + NVLL +G +A + DFGLA+ +  +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265

Query: 322 SNTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFK 379
           SN   K        +  V ++ PE I   V ++  D++SYGILL EIF+ GK P   +  
Sbjct: 266 SNYVVKGNA-----RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV 320

Query: 380 DDLSIHKFVLMALPSHVMDVLDLSML 405
           +     KF  M    + M   D +  
Sbjct: 321 NS----KFYKMVKRGYQMSRPDFAPP 342

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 57.4 bits (138), Expect = 6e-09
 Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 32/223 (14%)

Query: 157 DNFSEENLIGSGSFGSVYK-GTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D+F   + +G+G+ G V K      G   A K++ L+ + A+++ I        IR   +
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQI--------IRELQV 56

Query: 216 LKIVSSCSSVDYEGNDFK----ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           L   +S   V + G  +     ++  E M  G+LDQ L  +       K++       + 
Sbjct: 57  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA-------KRIPEEILGKVS 109

Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
           I V   L YL  ++   I H D+K SN+L++      + DFG++  L +         +M
Sbjct: 110 IAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---------SM 158

Query: 332 SNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRP 373
           +N   G+  Y+ PE + G H S+  DI+S G+ L+E+  G+ P
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 56.4 bits (137), Expect = 6e-09
 Identities = 41/129 (31%), Positives = 59/129 (45%), Gaps = 20/129 (15%)

Query: 260 KKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI-AHVGDFGLAKFL 318
            KLS  +   I+  +  AL+ LH      I H D+K  NVL D      ++ D+GL K  
Sbjct: 104 GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI- 159

Query: 319 FEESNTPSKNQTMSNGLKGSVGYIPPEYINGH---VSILGDIYSYGILLLEIFTGKRPTD 375
                TPS          G++ Y  PE I GH   VS   D ++ G+L  E+ TGK P  
Sbjct: 160 ---IGTPSC-------YDGTLDYFSPEKIKGHNYDVSF--DWWAVGVLTYELLTGKHPFK 207

Query: 376 DMFKDDLSI 384
           +   ++L +
Sbjct: 208 EDEDEELDL 216

Length = 267

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 56.4 bits (136), Expect = 7e-09
 Identities = 68/241 (28%), Positives = 104/241 (43%), Gaps = 45/241 (18%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHR 213
           D + +   IG G++G VYK       ET A+K ++L+Q  +G   + I E + L  ++H 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 214 NILKI--VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH----PSTDEYCHFKKLSLMQR 267
           NI+++  V       Y       LVFE++   +LD   H    P   +     K  L Q 
Sbjct: 62  NIVRLQDVVHSEKRLY-------LVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQI 111

Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIA-HVGDFGLAKFLFEESNTPS 326
           L         + Y H+     + H DLK  N+L+D    A  + DFGLA+        P 
Sbjct: 112 L-------RGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAF----GIPV 157

Query: 327 KNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMF 378
           +  T       ++ Y  PE + G  H S   DI+S G +  E      +F G    D++F
Sbjct: 158 RTFTHE---VVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF 214

Query: 379 K 379
           K
Sbjct: 215 K 215

Length = 294

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 56.6 bits (136), Expect = 8e-09
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 28/210 (13%)

Query: 165 IGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           +G G+FG VYK    + G  AA KV+  + +  L+ ++ E + L S  H NI+K++ +  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA-- 70

Query: 224 SVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN 283
              YE N +  ++ EF   G +D  +          + L+  Q   +      AL+YLH 
Sbjct: 71  -FYYENNLW--ILIEFCAGGAVDAVMLELE------RPLTEPQIRVVCKQTLEALNYLH- 120

Query: 284 QYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIP 343
             +  I H DLK+ N+L         GD  LA F     NT +  +   +   G+  ++ 
Sbjct: 121 --ENKIIHRDLKAGNILFTLD-----GDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMA 171

Query: 344 PEYINGHVS------ILGDIYSYGILLLEI 367
           PE +    S         D++S GI L+E+
Sbjct: 172 PEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 32/213 (15%)

Query: 165 IGSGSFGSVY--KGTLADGETAAIKVLKLQQQGALK-----SFIDECNALTSIRHRNILK 217
           +G GSFG+VY  K   A  E   +KVLK    G L          E   L+ + H  I+K
Sbjct: 8   LGKGSFGTVYLVKDKKAVAE-ERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66

Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHF-KKLSLMQRLNIVIDVAS 276
             +S     +   D   ++ E+    +LD  L    +E  H  K LS  Q     I +  
Sbjct: 67  FHAS-----FLERDAFCIITEYCEGRDLDCKL----EELKHTGKTLSENQVCEWFIQLLL 117

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            + Y+H +    I H DLK+ N+ L   ++  +GDFG+++ L    +       ++    
Sbjct: 118 GVHYMHQRR---ILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCD-------LATTFT 166

Query: 337 GSVGYIPPEYIN--GHVSILGDIYSYGILLLEI 367
           G+  Y+ PE +   G+ S   DI+S G +L E+
Sbjct: 167 GTPYYMSPEALKHQGYDS-KSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 55.9 bits (134), Expect = 1e-08
 Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 25/228 (10%)

Query: 148 SYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNA 206
           S + + +    ++    IG G+ G+VY    +A G+  AI+ + LQQQ   +  I+E   
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70

Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           +   ++ NI+  + S     Y   D   +V E++  G+L         E C    +   Q
Sbjct: 71  MRENKNPNIVNYLDS-----YLVGDELWVVMEYLAGGSLTD----VVTETC----MDEGQ 117

Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
              +  +   AL++LH+     + H D+KS N+LL       + DFG     F    TP 
Sbjct: 118 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG-----FCAQITPE 169

Query: 327 KNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFTGKRP 373
             Q+  + + G+  ++ PE +         DI+S GI+ +E+  G+ P
Sbjct: 170 --QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 28/219 (12%)

Query: 157 DNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           DNF +   IG GS G V   T+ + G+  A+K + L++Q   +   +E   +   +H N+
Sbjct: 23  DNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79

Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           +++ +S     Y   D   +V EF+  G L       TD   H  +++  Q   + + V 
Sbjct: 80  VEMYNS-----YLVGDELWVVMEFLEGGAL-------TDIVTH-TRMNEEQIAAVCLAVL 126

Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
            AL  LH Q    + H D+KS ++LL       + DFG    +       SK       L
Sbjct: 127 KALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQV-------SKEVPRRKSL 176

Query: 336 KGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRP 373
            G+  ++ PE I+        DI+S GI+++E+  G+ P
Sbjct: 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 60/234 (25%), Positives = 104/234 (44%), Gaps = 34/234 (14%)

Query: 158 NFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIRHRN 214
           NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 215 ILKIVSSCSSVDYEGNDFKA-LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
           I+K++      D    + K  LVFEF+ + +L +++     +      + L    + +  
Sbjct: 61  IVKLL------DVIHTENKLYLVFEFL-HQDLKKFM-----DASPLSGIPLPLIKSYLFQ 108

Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +   L + H+     + H DLK  N+L++      + DFGLA+        P +  T   
Sbjct: 109 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF----GVPVRTYTHE- 160

Query: 334 GLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
               ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 161 --VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 212

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 57/222 (25%), Positives = 88/222 (39%), Gaps = 38/222 (17%)

Query: 164 LIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
            IGSG+ G VYK          ++  K     A+K      N   + R    L +V    
Sbjct: 22  EIGSGTCGQVYK----------MRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSH 71

Query: 224 SVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL-------NIVIDVAS 276
              Y    +   + +       D ++       C  K L  +Q          + + +  
Sbjct: 72  DCPYIVKCYGYFITDS------DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVK 125

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
           AL YL  ++   + H D+K SN+LLD      + DFG++  L +     SK +T S    
Sbjct: 126 ALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVD-----SKAKTRS---A 175

Query: 337 GSVGYIPPEYI-----NGHVSILGDIYSYGILLLEIFTGKRP 373
           G   Y+ PE I     N    I  D++S GI L+E+ TG+ P
Sbjct: 176 GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 32/221 (14%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           DNF +   IG GS G V   T  + G   A+K + L++Q   +   +E   +   +H NI
Sbjct: 22  DNFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78

Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           +++ SS     Y   D   +V EF+  G L       TD   H  +++  Q   + + V 
Sbjct: 79  VEMYSS-----YLVGDELWVVMEFLEGGAL-------TDIVTH-TRMNEEQIATVCLAVL 125

Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
            AL +LH Q    + H D+KS ++LL       + DFG    + +E   P +       L
Sbjct: 126 KALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRRKS-----L 175

Query: 336 KGSVGYIPPEYINGHVSILG---DIYSYGILLLEIFTGKRP 373
            G+  ++ PE I+      G   DI+S GI+++E+  G+ P
Sbjct: 176 VGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 60/216 (27%), Positives = 86/216 (39%), Gaps = 30/216 (13%)

Query: 165 IGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSS-- 221
           +G G FG V    +   G+  A K L  ++   LK    E  AL     + IL+ VSS  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKR---LKKRKGEQMALN---EKKILEKVSSRF 54

Query: 222 --CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI-VIDVASAL 278
               +  +E  D   LV   M  G+L   +      Y   +      R       +   L
Sbjct: 55  IVSLAYAFETKDDLCLVMTLMNGGDLKYHI------YNVGEPGFPEARAIFYAAQIICGL 108

Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
           ++LH +    I + DLK  NVLLD+     + D GLA  L        K      G  G+
Sbjct: 109 EHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVEL--------KGGKKIKGRAGT 157

Query: 339 VGYIPPEYINGHV-SILGDIYSYGILLLEIFTGKRP 373
            GY+ PE + G V     D ++ G  L E+  G+ P
Sbjct: 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 50.2 bits (121), Expect = 2e-08
 Identities = 26/56 (46%), Positives = 30/56 (53%)

Query: 1  LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
          L L NN        + K L  L  LDLS NNL+   P+ FS L SLR L+LS N L
Sbjct: 5  LDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 66/229 (28%), Positives = 111/229 (48%), Gaps = 36/229 (15%)

Query: 158 NFSEENLIGSGSFGSVY---KGTLAD-GETAAIKVLK----LQQQGALKSFIDECNALTS 209
           NF    ++G+G++G V+   K T  D G+  A+KVL+    +Q+   ++    E N L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 210 IRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN 269
           +R    L  +      + + +    L+ +++  G +   L+       +F +  +  R  
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLH----LILDYVSGGEMFTHLYQRD----NFSEDEV--RF- 109

Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAK-FLFEESNTPSK 327
              ++  AL++LH      I + D+K  N+LLD EG +  + DFGL+K FL EE     K
Sbjct: 110 YSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVV-LTDFGLSKEFLSEE-----K 160

Query: 328 NQTMSNGLKGSVGYIPPEYI---NGHVSILGDIYSYGILLLEIFTGKRP 373
            +T S    G++ Y+ PE I    GH   + D +S GIL+ E+ TG  P
Sbjct: 161 ERTYS--FCGTIEYMAPEIIRGKGGHGKAV-DWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 62/243 (25%), Positives = 101/243 (41%), Gaps = 39/243 (16%)

Query: 165 IGSGSFGSVYK-GTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           +G+G+ GSV K   +  G   A KV+ +  + +++  I     L  +       IVS   
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQI--LRELQIMHECRSPYIVSFYG 70

Query: 224 SVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCHFKKLSLMQRLNIVIDVASALDY 280
           +   E N    +  EFM  G+LD+      P   E              I + V   L Y
Sbjct: 71  AFLNENN--ICMCMEFMDCGSLDRIYKKGGPIPVEILG----------KIAVAVVEGLTY 118

Query: 281 LHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG 340
           L+N +   I H D+K SN+L++      + DFG++  L           ++++   G+  
Sbjct: 119 LYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELI---------NSIADTFVGTST 167

Query: 341 YIPPEYINGH-VSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDV 399
           Y+ PE I G   ++  D++S GI ++E+  GK P      DD               M +
Sbjct: 168 YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG---------QDDPMGI 218

Query: 400 LDL 402
           LDL
Sbjct: 219 LDL 221

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 61/233 (26%), Positives = 98/233 (42%), Gaps = 44/233 (18%)

Query: 164 LIGSGSFGSV----YKGTLADGETAAIKVLK---LQQQGALKSFIDECNALTSIRHRNIL 216
           ++G GSFG V     KGT    E  A+KVLK   + Q   ++  + E   L        L
Sbjct: 2   VLGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFL 58

Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
             + SC    ++  D    V E++  G+L   +  S        +    +      ++  
Sbjct: 59  TQLHSC----FQTKDRLFFVMEYVNGGDLMFHIQRS-------GRFDEPRARFYAAEIVL 107

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
            L +LH   +  I + DLK  NVLLD EG I  + DFG+ K            + +  G+
Sbjct: 108 GLQFLH---ERGIIYRDLKLDNVLLDSEGHI-KIADFGMCK------------EGILGGV 151

Query: 336 K-----GSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRPTDDMFKDDL 382
                 G+  YI PE ++        D ++ G+LL E+  G+ P +   +D+L
Sbjct: 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL 204

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 58/219 (26%), Positives = 104/219 (47%), Gaps = 18/219 (8%)

Query: 164 LIGSGSFGSV-YKGTLADGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVS 220
           ++GSG+ G+V     ++DGE  A+KV+ ++   +        E   L +    +I+K   
Sbjct: 39  VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98

Query: 221 SCSSVDY---EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
             +  D    E     ALV ++   G+L Q +         F++    +   + I V  A
Sbjct: 99  DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFRE---HEAGLLFIQVLLA 155

Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + ++H+++   + H D+KS+N+LL    +  +GDFG +K     + T S +  +     G
Sbjct: 156 VHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMY---AATVSDD--VGRTFCG 207

Query: 338 SVGYIPPE-YINGHVSILGDIYSYGILLLEIFTGKRPTD 375
           +  Y+ PE +     S   D++S G+LL E+ T KRP D
Sbjct: 208 TPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 54.7 bits (131), Expect = 3e-08
 Identities = 58/229 (25%), Positives = 99/229 (43%), Gaps = 27/229 (11%)

Query: 159 FSEENLIGSGSFGSVYKGT-LADGETAAIKVLKL--QQQGALKSFIDECNALTSIRHRNI 215
           F    L+G+G++G VYKG  +  G+ AAIKV+ +   ++  +K  I+     +   HRNI
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS--HHRNI 65

Query: 216 LKIVSSCSSVDYEGNDFKA-LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
                +    +  G D +  LV EF   G++   +  +       + ++ + R     ++
Sbjct: 66  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR-----EI 120

Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
              L +LH      + H D+K  NVLL E     + DFG++  L        +     N 
Sbjct: 121 LRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-------DRTVGRRNT 170

Query: 335 LKGSVGYIPPEYI------NGHVSILGDIYSYGILLLEIFTGKRPTDDM 377
             G+  ++ PE I      +       D++S GI  +E+  G  P  DM
Sbjct: 171 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 54.3 bits (130), Expect = 5e-08
 Identities = 61/231 (26%), Positives = 93/231 (40%), Gaps = 42/231 (18%)

Query: 159 FSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL---QQQGALKSFIDECNALTSIRHRN 214
           FS+   IG GSFG+VY    + + E  AIK +     Q     +  I E   L  +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 215 ILKIVSSCSSVDYEGNDFKA----LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
                    ++ Y G   +     LV E+   G+    L        H K L  ++   +
Sbjct: 77  ---------TIQYRGCYLREHTAWLVMEYCL-GSASDLLE------VHKKPLQEVEIAAV 120

Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
                  L YLH+     + H D+K+ N+LL E  +  +GDFG A  +            
Sbjct: 121 THGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----------A 166

Query: 331 MSNGLKGSVGYIPPEYI----NGHVSILGDIYSYGILLLEIFTGKRPTDDM 377
            +N   G+  ++ PE I     G      D++S GI  +E+   K P  +M
Sbjct: 167 PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 53.6 bits (129), Expect = 6e-08
 Identities = 56/226 (24%), Positives = 87/226 (38%), Gaps = 33/226 (14%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLADGETA-AIKVLKLQQQGAL-KSFIDECNALTSIRHRN 214
           +   E + +G G+ GSV K  L +     A+K +       L K  + E     S +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN----- 269
           I+K   +      E +    +  E+   G+LD             K      R+      
Sbjct: 61  IVKYYGAFLD---ESSSSIGIAMEYCEGGSLDSIYK---------KVKKRGGRIGEKVLG 108

Query: 270 -IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
            I   V   L YLH      I H D+K SN+LL       + DFG++  L          
Sbjct: 109 KIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN-------- 157

Query: 329 QTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
            +++    G+  Y+ PE I G   SI  D++S G+ LLE+   + P
Sbjct: 158 -SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 53.6 bits (129), Expect = 7e-08
 Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 32/218 (14%)

Query: 164 LIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSC 222
           ++G GSFG V    L    E  AIK LK  +   L+    EC  +     R +L +    
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALK--KDVVLEDDDVECTMV----ERRVLALAWEH 55

Query: 223 SSV-----DYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
             +      ++  +    V E++  G+L   +  S        +    +      ++   
Sbjct: 56  PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSS-------GRFDEARARFYAAEIICG 108

Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
           L +LH +    I + DLK  NVLLD +G I  + DFG+ K   E  N     +  ++   
Sbjct: 109 LQFLHKKG---IIYRDLKLDNVLLDKDGHI-KIADFGMCK---ENMN----GEGKASTFC 157

Query: 337 GSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
           G+  YI PE + G       D +S+G+LL E+  G+ P
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 53.6 bits (129), Expect = 7e-08
 Identities = 64/232 (27%), Positives = 107/232 (46%), Gaps = 50/232 (21%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D+F +   +G+G+ G V K      G   A K++ L+ + A+++ I        IR    
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQI--------IRE--- 49

Query: 216 LKIVSSCSS---VDYEGNDFK----ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
           LK++  C+S   V + G  +     ++  E M  G+LDQ L          KK     R+
Sbjct: 50  LKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----------KKAG---RI 96

Query: 269 ------NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES 322
                  I I V   L YL  ++   I H D+K SN+L++      + DFG++  L +  
Sbjct: 97  PENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 152

Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRP 373
                  +M+N   G+  Y+ PE + G H ++  DI+S G+ L+E+  G+ P
Sbjct: 153 -------SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 53.5 bits (129), Expect = 7e-08
 Identities = 46/157 (29%), Positives = 71/157 (45%), Gaps = 21/157 (13%)

Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSS 221
           IG G++G VYK      GE  A+K ++L+   +G   + I E + L  + H NI++++  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD- 65

Query: 222 CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL--NIVIDVASALD 279
              V +  N    LVFEF     LD  L    D         L   L  + +  +   + 
Sbjct: 66  ---VVHSENKL-YLVFEF-----LDLDLKKYMD---SSPLTGLDPPLIKSYLYQLLQGIA 113

Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK 316
           Y H+     + H DLK  N+L+D      + DFGLA+
Sbjct: 114 YCHSHR---VLHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 54.9 bits (132), Expect = 8e-08
 Identities = 51/199 (25%), Positives = 85/199 (42%), Gaps = 21/199 (10%)

Query: 181 GETAAIKVLK---LQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVF 237
           G   AIK+L+    +++     F  E      + H NI+ ++ S  +           VF
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA----PPGLLFAVF 58

Query: 238 EFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSS 297
           E++    L + L  + D       L   +   +++ V  AL   HNQ    I H DLK  
Sbjct: 59  EYVPGRTLREVL--AAD-----GALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQ 108

Query: 298 NVLL---DEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH-VSI 353
           N+++        A V DFG+   L    +      T +  + G+  Y  PE + G  V+ 
Sbjct: 109 NIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTP 168

Query: 354 LGDIYSYGILLLEIFTGKR 372
             D+Y++G++ LE  TG+R
Sbjct: 169 NSDLYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 53.4 bits (128), Expect = 8e-08
 Identities = 69/285 (24%), Positives = 120/285 (42%), Gaps = 40/285 (14%)

Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQ--QQGALKSFIDECNALTSIR---HRNILKI 218
           IG G++G+VYK      G   A+K +++Q  + G   S + E   L  +    H NI+++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKL-SLMQRLNIVIDVASA 277
           +  C++   +      LVFE + + +L  +L          + +  LM++          
Sbjct: 68  MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQF------LRG 120

Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK-FLFEESNTPSKNQTMSNGLK 336
           LD+LH      I H DLK  N+L+  G    + DFGLA+ +  + + TP         + 
Sbjct: 121 LDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTP---------VV 168

Query: 337 GSVGYIPPE-YINGHVSILGDIYSYGILLLE------IFTGKRPTDDMFKDDLSIHKFVL 389
            ++ Y  PE  +    +   D++S G +  E      +F G    D + K       F L
Sbjct: 169 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK------IFDL 222

Query: 390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLE 434
           + LP       D+++     +       + + P+IE   AQ  LE
Sbjct: 223 IGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLE 267

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 53.0 bits (127), Expect = 8e-08
 Identities = 47/217 (21%), Positives = 94/217 (43%), Gaps = 30/217 (13%)

Query: 165 IGSGSFGSVYKGTLADGETAAIKVLK-LQQQGALK---SFIDECNALTSIRHRNILKIVS 220
           IG+G FG V    +      A  V+K L+   + K    F+ + +    ++H NIL+ + 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 221 SC-SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
            C  ++ Y       LVFE+   G+L  +L   + E  H +   L+    +  ++A+ + 
Sbjct: 63  QCVEAIPY------LLVFEYCELGDLKSYL---SQEQWHRRNSQLLLLQRMACEIAAGVT 113

Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSV 339
           ++H        H DL   N  L   +   VGD+G+    ++E    +++          +
Sbjct: 114 HMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-----PL 165

Query: 340 GYIPPEYING-HVSIL-------GDIYSYGILLLEIF 368
            ++ PE +   H  ++        ++++ G+ L E+F
Sbjct: 166 RWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 32/223 (14%)

Query: 159 FSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILK 217
           F +  ++G G FG V    + A G+  A K L+ ++   +K    E  AL     + IL+
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR---IKKRKGESMALN---EKQILE 55

Query: 218 IVSSCSSVD----YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI--V 271
            V+S   V     YE  D   LV   M  G+L   ++       H  +    +   +   
Sbjct: 56  KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-------HMGEAGFEEGRAVFYA 108

Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
            ++   L+ LH +    I + DLK  N+LLD+     + D GLA  + E        QT+
Sbjct: 109 AEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE-------GQTI 158

Query: 332 SNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRP 373
             G  G+VGY+ PE + N   +   D ++ G LL E+  G+ P
Sbjct: 159 -KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 54.1 bits (130), Expect = 1e-07
 Identities = 26/60 (43%), Positives = 33/60 (55%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L +N   G IP  L  ++ L  + L  NNLSG++P     L SL HL+L YN L G I
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI 252

Length = 968

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 29/230 (12%)

Query: 159 FSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSI-RHRNIL 216
           F    ++G+G++G VYKG  +  G+ AAIKV+ + +    +    E N L     HRNI 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIA 76

Query: 217 KIVSSCSSVDYEGNDFKA-LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI--D 273
               +       G+D +  LV EF   G++       TD   + K  +L +     I  +
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSV-------TDLVKNTKGNALKEDWIAYICRE 129

Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +   L +LH      + H D+K  NVLL E     + DFG++  L        +     N
Sbjct: 130 ILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL-------DRTVGRRN 179

Query: 334 GLKGSVGYIPPEYI------NGHVSILGDIYSYGILLLEIFTGKRPTDDM 377
              G+  ++ PE I      +       DI+S GI  +E+  G  P  DM
Sbjct: 180 TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 62/224 (27%), Positives = 95/224 (42%), Gaps = 26/224 (11%)

Query: 164 LIGSGSFGSVYKGTL-ADGETAAIKVLK---LQQQGALKSFIDECNALTSIRHRNILKIV 219
           ++G GSFG V    L   G   A+KVLK   + Q   ++  + E   L+  R+   L  +
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
             C    ++  D    V EF+  G+L   +  S       ++    +      ++ SAL 
Sbjct: 62  YCC----FQTPDRLFFVMEFVNGGDLMFHIQKS-------RRFDEARARFYAAEITSALM 110

Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSV 339
           +LH   D  I + DLK  NVLLD      + DFG+ K       T S          G+ 
Sbjct: 111 FLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-------FCGTP 160

Query: 340 GYIPPEYINGHV-SILGDIYSYGILLLEIFTGKRPTDDMFKDDL 382
            YI PE +   +     D ++ G+LL E+  G  P +   +DDL
Sbjct: 161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 54.0 bits (129), Expect = 1e-07
 Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 43/237 (18%)

Query: 165 IGSGSFGSVY----KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVS 220
           IG+G FG V+    K T       AI    L+++   +  I E N +  ++H+NI++ + 
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI-EVNVMRELKHKNIVRYID 79

Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDY 280
              +   + N    ++ EF   G+L + +      Y  F K+     ++I   +  AL Y
Sbjct: 80  RFLN---KANQKLYILMEFCDAGDLSRNIQKC---YKMFGKIEEHAIVDITRQLLHALAY 133

Query: 281 LHNQYDTP----IAHCDLKSSNVLLDEGM-----------------IAHVGDFGLAKFLF 319
            HN  D P    + H DLK  N+ L  G+                 IA +GDFGL+K + 
Sbjct: 134 CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG 193

Query: 320 EESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSIL---GDIYSYGILLLEIFTGKRP 373
            ES        M++   G+  Y  PE +           D+++ G ++ E+ +GK P
Sbjct: 194 IES--------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242

Length = 1021

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 67/241 (27%), Positives = 106/241 (43%), Gaps = 48/241 (19%)

Query: 158 NFSEENLIGSGSFGSVY----KGTLADGETAAIKVLK---LQQQGALKSFIDECNALTSI 210
           +F+   ++G GSFG V     KGT    E  AIK+LK   + Q   ++  + E   L   
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGT---DELYAIKILKKDVIIQDDDVECTMVEKRVLALP 57

Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
                L  + SC    ++  D    V E++  G+L            H +++   +  + 
Sbjct: 58  GKPPFLTQLHSC----FQTMDRLYFVMEYVNGGDL----------MYHIQQVGKFKEPHA 103

Query: 271 VI---DVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPS 326
           V    ++A  L +LH++    I + DLK  NV+LD EG I  + DFG+ K   E      
Sbjct: 104 VFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHI-KIADFGMCK---ENIFGGK 156

Query: 327 KNQTMSNGLKGSVGYIPPEYI-----NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD 381
             +T      G+  YI PE I        V    D +++G+LL E+  G+ P D   +D+
Sbjct: 157 TTRTFC----GTPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQPPFDGEDEDE 208

Query: 382 L 382
           L
Sbjct: 209 L 209

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 52/206 (25%), Positives = 86/206 (41%), Gaps = 35/206 (16%)

Query: 180 DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEF 239
           D +T    V+K  Q+G       E + L +I H +I+++  +     +  N F  L+   
Sbjct: 113 DNKTCEHVVIKAGQRGGT---ATEAHILRAINHPSIIQLKGT-----FTYNKFTCLILPR 164

Query: 240 MRNGNLDQWLHPSTDEYCHF---KKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKS 296
            +           TD YC+    + +++   L I   V  A+ YLH      I H D+K+
Sbjct: 165 YK-----------TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKA 210

Query: 297 SNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILG 355
            N+ ++      +GDFG A F  +       N     G  G++    PE +         
Sbjct: 211 ENIFINHPGDVCLGDFGAACFPVD------INANKYYGWAGTIATNAPELLARDPYGPAV 264

Query: 356 DIYSYGILLLEIFTGKRPTDDMFKDD 381
           DI+S GI+L E+ T     D +F+ D
Sbjct: 265 DIWSAGIVLFEMATCH---DSLFEKD 287

Length = 391

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 49/215 (22%), Positives = 95/215 (44%), Gaps = 30/215 (13%)

Query: 165 IGSGSFGS--VYKGTLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVS 220
           +G G+FG   +Y+ T  D      K + L +  +   +  ++E   L+ ++H NI+   +
Sbjct: 8   LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI--VIDVASAL 278
                 +  ++   +  E+   G L   +          K     + + +  +  + SA+
Sbjct: 67  H-----FMDDNTLLIEMEYANGGTLYDKI-------VRQKGQLFEEEMVLWYLFQIVSAV 114

Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
            Y+H      I H D+K+ N+ L +  +  +GDFG++K L  E        +M+  + G+
Sbjct: 115 SYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY-------SMAETVVGT 164

Query: 339 VGYIPPEYING-HVSILGDIYSYGILLLEIFTGKR 372
             Y+ PE   G   +   DI++ G +L E+ T KR
Sbjct: 165 PYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 67/241 (27%), Positives = 102/241 (42%), Gaps = 46/241 (19%)

Query: 156 TDNFSEENLIGSGSFGSVY----KGTLADGETAAIKVLK---LQQQGALKSFIDECNALT 208
             NF    ++G GSFG V     KGT    E  AIK+LK   + Q   ++  + E   L 
Sbjct: 1   DFNFL--MVLGKGSFGKVMLAERKGT---DELYAIKILKKDVVIQDDDVECTMVEKRVLA 55

Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
                  L  + SC    ++  D    V E++  G+L   +           K    Q +
Sbjct: 56  LQDKPPFLTQLHSC----FQTVDRLYFVMEYVNGGDLMYHIQ-------QVGKFKEPQAV 104

Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSK 327
               +++  L +LH +    I + DLK  NV+LD EG I  + DFG+ K           
Sbjct: 105 FYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHI-KIADFGMCK----------- 149

Query: 328 NQTMSNGLK-----GSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRPTDDMFKDD 381
            + M +G+      G+  YI PE I         D ++YG+LL E+  G+ P D   +D+
Sbjct: 150 -EHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208

Query: 382 L 382
           L
Sbjct: 209 L 209

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 51/221 (23%), Positives = 100/221 (45%), Gaps = 32/221 (14%)

Query: 162 ENLIGSGSFGSVYKGT---LADGETA-----AIKVLKLQQQGALKSFIDECNALTSIRHR 213
           E+L G G+F  ++KG    + D          +KVL    +   +SF +  + ++ + H+
Sbjct: 1   ESL-GQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHK 59

Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
           +++     C        D   +V E+++ G+LD +L  + +       +++  +L +   
Sbjct: 60  HLVLNYGVCV-----CGDESIMVQEYVKFGSLDTYLKKNKN------LINISWKLEVAKQ 108

Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM-- 331
           +A AL +L    D  + H ++ + NVLL         D       F + + P  + T+  
Sbjct: 109 LAWALHFLE---DKGLTHGNVCAKNVLL-----IREEDRKTGNPPFIKLSDPGISITVLP 160

Query: 332 SNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTG 370
              L   + ++PPE I    ++S+  D +S+G  L EIF+G
Sbjct: 161 KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 28/210 (13%)

Query: 165 IGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           +G G+FG VYK    + G  AA KV++ + +  L+ ++ E   L +  H  I+K++ +  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA-- 77

Query: 224 SVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN 283
              ++G  +  ++ EF   G +D  +          + L+  Q   I   +  AL YLH+
Sbjct: 78  -FYWDGKLW--IMIEFCPGGAVDAIMLELD------RGLTEPQIQVICRQMLEALQYLHS 128

Query: 284 QYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIP 343
                I H DLK+ NVLL        GD  LA F     N   K     +   G+  ++ 
Sbjct: 129 M---KIIHRDLKAGNVLLTLD-----GDIKLADFGVSAKNV--KTLQRRDSFIGTPYWMA 178

Query: 344 PEYI------NGHVSILGDIYSYGILLLEI 367
           PE +      +       DI+S GI L+E+
Sbjct: 179 PEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 49/218 (22%), Positives = 99/218 (45%), Gaps = 28/218 (12%)

Query: 165 IGSGSFGSVYKGTLAD---GETAA-IKVLKLQQQGALKS---FIDECNALTSIRHRNILK 217
           +G GSFG VY+G   D   GE    + V  + +  +L+    F++E + +      ++++
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCHFKKLSLMQRLNIVIDV 274
           ++   S           +V E M +G+L  +L    P  +        +L + + +  ++
Sbjct: 74  LLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128

Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
           A  + YL+ +      H DL + N ++       +GDFG+ + ++E             G
Sbjct: 129 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE-------TDYYRKG 178

Query: 335 LKG--SVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT 369
            KG   V ++ PE + +G  +   D++S+G++L EI +
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 60/215 (27%), Positives = 106/215 (49%), Gaps = 34/215 (15%)

Query: 165 IGSGSFGSVYKGTLADGET-AAIKVLKLQ-QQGALKSFIDECNALTSIRHRNILK---IV 219
           +G G++ +V+KG     E   A+K ++L+ ++GA  + I E + L  ++H NI+    IV
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTD-EYCHFKKLSLMQRLNIVIDVASAL 278
            +  S+         LVFE++ + +L Q++    +    H  K+ L Q L         L
Sbjct: 74  HTDKSL--------TLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILR-------GL 117

Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
            Y H +    + H DLK  N+L++E     + DFGLA+      + P+K  T SN +  +
Sbjct: 118 AYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR----AKSVPTK--TYSNEVV-T 167

Query: 339 VGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
           + Y PP+ + G    S   D++  G +  E+ +G+
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 52.9 bits (127), Expect = 3e-07
 Identities = 30/63 (47%), Positives = 33/63 (52%), Gaps = 1/63 (1%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L  N F G +P S  S R L  LDLS N  SG VP+    L  L  L LS N+L GEI
Sbjct: 457 LSLARNKFFGGLPDSFGSKR-LENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEI 515

Query: 61  SRE 63
             E
Sbjct: 516 PDE 518

Length = 968

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 51.5 bits (124), Expect = 3e-07
 Identities = 60/251 (23%), Positives = 96/251 (38%), Gaps = 59/251 (23%)

Query: 154 NATDNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKL--QQQGALKSFIDECNALTSI 210
           + T  F    +IG G++G VYK      G+  AIK++ +   ++  +K   +     ++ 
Sbjct: 3   DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSN- 61

Query: 211 RHRNILKIVSSCSSVDYEGNDFKA----------LVFEFMRNG---NLDQWLHPSTDEYC 257
            H NI           + G   K           LV E    G   +L + L        
Sbjct: 62  -HPNI---------ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG---- 107

Query: 258 HFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG--DFGLA 315
             K+L       I+ +    L YLH      + H D+K  N+LL +   A V   DFG++
Sbjct: 108 --KRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKN--AEVKLVDFGVS 160

Query: 316 KFLFEESNTPSKNQTMSNGLKGSVG---YIPPEYI------NGHVSILGDIYSYGILLLE 366
             L    +T  +  T        +G   ++ PE I      +       D++S GI  +E
Sbjct: 161 AQL---DSTLGRRNT-------FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210

Query: 367 IFTGKRPTDDM 377
           +  GK P  DM
Sbjct: 211 LADGKPPLCDM 221

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 51.9 bits (125), Expect = 3e-07
 Identities = 70/266 (26%), Positives = 109/266 (40%), Gaps = 52/266 (19%)

Query: 159 FSEENLIGSGSFGSVYKG---TLADGETAAIKVLK---LQQQGALKSFIDECNALTSIRH 212
           +  E  IG G++G VYK       DG+  AIK  K    Q  G  +S   E   L  ++H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 213 RNILKIVSSCSS---------VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
            N++ +V               DY  +D   ++ +F R       + PS       K L 
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQII-KFHRQAKRVS-IPPSM-----VKSL- 113

Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL----DEGMIAHVGDFGLAKFLF 319
           L Q LN        + YLH+ +   + H DLK +N+L+     E  +  +GD GLA+   
Sbjct: 114 LWQILN-------GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLF- 162

Query: 320 EESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTG- 370
              N P K     + +  ++ Y  PE + G  H +   DI++ G +  E      IF G 
Sbjct: 163 ---NAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219

Query: 371 --KRPTDDMFKDDLSIHKFVLMALPS 394
             K    + F+ D     F ++  P+
Sbjct: 220 EAKIKKSNPFQRDQLERIFEVLGTPT 245

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 38/112 (33%), Positives = 56/112 (50%), Gaps = 10/112 (8%)

Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
           L+    VA  + +L ++      H DL + N+LL  G I  + DFGLA+ +  +SN   K
Sbjct: 217 LSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273

Query: 328 NQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
                   +  V ++ PE I N   +   D++SYGILL EIF+ G  P   M
Sbjct: 274 GNA-----RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 51.4 bits (123), Expect = 3e-07
 Identities = 61/230 (26%), Positives = 99/230 (43%), Gaps = 45/230 (19%)

Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGAL-KSFIDECNALTSIRHRNILKIVSSC 222
           +G G+ G+VYK   L      A+KV+ L     L K  + E            L+I+  C
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSE------------LEILYKC 56

Query: 223 SS---VDYEGNDFK----ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
            S   + + G  F     ++  EFM  G+LD            ++K+       I + V 
Sbjct: 57  DSPYIIGFYGAFFVENRISICTEFMDGGSLDV-----------YRKIPEHVLGRIAVAVV 105

Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
             L YL   +   I H D+K SN+L++      + DFG++  L    N+ +K    +N  
Sbjct: 106 KGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTYVGTNA- 158

Query: 336 KGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSI 384
                Y+ PE I+G    I  D++S GI  +E+  G+ P   + K+  S+
Sbjct: 159 -----YMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL 203

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 51.5 bits (123), Expect = 4e-07
 Identities = 43/198 (21%), Positives = 92/198 (46%), Gaps = 32/198 (16%)

Query: 185 AIKVLKLQ-QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNG 243
           A+K+L+    + A   F+ E   ++ +++ NI++++  C S     +D   ++ E+M NG
Sbjct: 48  AVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVS-----DDPLCMITEYMENG 102

Query: 244 NLDQWLHPSTDEYCHFKK------LSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSS 297
           +L+Q+L    +    F        +S+   L + + +AS + YL +       H DL + 
Sbjct: 103 DLNQFL-SQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATR 158

Query: 298 NVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILG-- 355
           N L+       + DFG+++ L+       + + +          +P  ++     +LG  
Sbjct: 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAV----------LPIRWMAWESILLGKF 208

Query: 356 ----DIYSYGILLLEIFT 369
               D++++G+ L E+FT
Sbjct: 209 TTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 51.2 bits (123), Expect = 5e-07
 Identities = 49/171 (28%), Positives = 75/171 (43%), Gaps = 31/171 (18%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGAL----KSFIDECNALTSIR 211
             +     IGSG++G V        G+  AIK  K+     +    K  + E   L   +
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIK--KIPHAFDVPTLAKRTLRELKILRHFK 62

Query: 212 HRNILKIVSSCSSVDYEGNDFKA--LVFEFMRNGNLDQWLH---PSTDEY-CHFKKLSLM 265
           H NI+ I          G DFK   +V + M + +L   +H   P T+E+  +F    L 
Sbjct: 63  HDNIIAIRDILRP---PGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYF----LY 114

Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK 316
           Q L         L Y+H+     + H DLK SN+L++E     +GDFG+A+
Sbjct: 115 QLLR-------GLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 50.5 bits (121), Expect = 5e-07
 Identities = 56/235 (23%), Positives = 104/235 (44%), Gaps = 57/235 (24%)

Query: 165 IGSGSFGSVYKGTL---ADGETAA--------IKVLKLQQQGALKSFIDECNALTSIRHR 213
           +G G+F ++YKG L   +D +           +KVL    + +L +F +  + ++ + H+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLSHK 61

Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
           +++K+   C   +        +V E+++ G LD +LH   +      KL + ++L     
Sbjct: 62  HLVKLYGVCVRDENI------MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQL----- 110

Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
            ASAL YL    D  + H ++   N+L+             A++   E   P     +S+
Sbjct: 111 -ASALHYLE---DKKLVHGNVCGKNILV-------------ARYGLNEGYVPFIK--LSD 151

Query: 334 -GLKGSVG----------YIPPEYING---HVSILGDIYSYGILLLEIFT-GKRP 373
            G+  +V           +I PE I      ++I  D +S+G  LLEI + G+ P
Sbjct: 152 PGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEP 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 50.6 bits (121), Expect = 6e-07
 Identities = 64/226 (28%), Positives = 97/226 (42%), Gaps = 38/226 (16%)

Query: 159 FSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILK 217
           F    ++G G FG V    + A G+  A K  KL+++  +K    E  AL     + IL+
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKK-RIKKRKGEAMALN---EKQILE 55

Query: 218 IVSSCSSVD----YEGNDFKALVFEFMRNGNLDQWLH----PSTDEYCHFKKLSLMQR-L 268
            V+S   V     YE  D   LV   M  G+L   ++    P  DE          +R +
Sbjct: 56  KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE----------ERAV 105

Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
               ++   L+ LH +    I + DLK  N+LLD+     + D GLA  + E        
Sbjct: 106 FYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPE-------G 155

Query: 329 QTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
           +T+  G  G+VGY+ PE +         D +  G L+ E+  GK P
Sbjct: 156 ETI-RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 50.8 bits (122), Expect = 6e-07
 Identities = 66/291 (22%), Positives = 106/291 (36%), Gaps = 91/291 (31%)

Query: 158 NFSEENLIGSGSFGSVY----------------KGTLADGET-AAIKVLKL-QQQGALKS 199
           NF E+  +G G FG V+                +   AD     A+KVL+      A + 
Sbjct: 8   NFVEK--LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65

Query: 200 FIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEY 256
           F+ E   L+ +   NI +++  C+      +    ++ E+M NG+L+Q+L      T   
Sbjct: 66  FLKEVKILSRLSDPNIARLLGVCTV-----DPPLCMIMEYMENGDLNQFLQKHVAETSGL 120

Query: 257 CHFKK-LSLMQRLNIVIDVASALDYL--HNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG 313
               K LS    L +   +AS + YL   N       H DL + N L+ +     + DFG
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLN-----FVHRDLATRNCLVGKNYTIKIADFG 175

Query: 314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHV----------SILG-------D 356
                            MS  L  S  Y     + G            S+L        D
Sbjct: 176 -----------------MSRNLYSSDYY----RVQGRAPLPIRWMAWESVLLGKFTTKSD 214

Query: 357 IYSYGILLLEIFT-GKRP-----TDD--------MFKDDLSIHKFVLMALP 393
           ++++G+ L EI T  +       TD          F+DD    + + +  P
Sbjct: 215 VWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDD---GRQIYLPRP 262

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 50.5 bits (121), Expect = 7e-07
 Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 33/215 (15%)

Query: 164 LIGSGSFGSVYKGTLAD-GETAAIKV-LKLQQQGALKSF-IDECNALTSIRHRNILKIVS 220
           L+G GS+G V K    + G+  AIK  L+ +    +K   + E   L  +RH N++ ++ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 221 SCSSVD--YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
                   Y       LVFEF+ +  LD       ++Y +    S +++   +  +   +
Sbjct: 68  VFRRKKRLY-------LVFEFVDHTVLDD-----LEKYPNGLDESRVRK--YLFQILRGI 113

Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
           ++ H+     I H D+K  N+L+ +  +  + DFG A+ L      P +  T       +
Sbjct: 114 EFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL----AAPGEVYT---DYVAT 163

Query: 339 VGYIPPEYINGHVSILG---DIYSYGILLLEIFTG 370
             Y  PE + G     G   DI++ G L+ E+ TG
Sbjct: 164 RWYRAPELLVGDTK-YGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 50.3 bits (120), Expect = 7e-07
 Identities = 63/243 (25%), Positives = 105/243 (43%), Gaps = 48/243 (19%)

Query: 164 LIGSGSFGSVYKGTLAD-GETAAIKVL-----KLQQQGALKSFIDECNALTSIRHRNILK 217
           +IG G FG VY    AD G+  A+K L     K++Q   L           ++  R +L 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL-----------ALNERIMLS 49

Query: 218 IVSS-------CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
           +VS+       C S  +   D  + + + M  G+L    H    ++  F +  +      
Sbjct: 50  LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEAEMRFYAAE 105

Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA-KFLFEESNTPSKNQ 329
           +I     L+++HN++   + + DLK +N+LLDE     + D GLA  F        SK +
Sbjct: 106 II---LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF--------SKKK 151

Query: 330 TMSNGLKGSVGYIPPEYINGHVSI--LGDIYSYGILLLEIFTGKRPTDDM-FKDDLSIHK 386
             ++   G+ GY+ PE +   V+     D +S G +L ++  G  P      KD   I +
Sbjct: 152 PHAS--VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 209

Query: 387 FVL 389
             L
Sbjct: 210 MTL 212

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 50.2 bits (120), Expect = 8e-07
 Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 34/225 (15%)

Query: 164 LIGSGSFGSVYK--------GTLADGE----TAAIKVLKLQQQGALKSFIDECNALT-SI 210
            +GSG+FG VYK          LA  E      A    K ++  ++   + E   +   +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL-N 269
           RH NI++   +     +  ND   +V + +    L +  +   ++   F +    +R+ N
Sbjct: 67  RHPNIVRYYKT-----FLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTE----ERIWN 117

Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
           I + +  AL YLH +    I H DL  +N++L E     + DFGLAK    ES   S   
Sbjct: 118 IFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSV-- 173

Query: 330 TMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
                  G++ Y  PE +         D++++G +L ++ T + P
Sbjct: 174 ------VGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 50.0 bits (120), Expect = 8e-07
 Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 28/170 (16%)

Query: 164 LIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNILKIVS 220
           ++G G++G V K    A GE  AIK  K  +      K+ + E   L  +RH NI+ +  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEY-----CHFKKLSLMQRLNIVIDVA 275
           +      +G  +  LVFE+     +++ L    +           +  + Q L       
Sbjct: 68  AFRR---KGRLY--LVFEY-----VERTLLELLEASPGGLPPDAVRSYIWQLLQ------ 111

Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
            A+ Y H+     I H D+K  N+L+ E  +  + DFG A+ L     +P
Sbjct: 112 -AIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 50.8 bits (121), Expect = 9e-07
 Identities = 46/173 (26%), Positives = 85/173 (49%), Gaps = 19/173 (10%)

Query: 203 ECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKL 262
           E + L +  H  I+K        D++ +D   L+ E+   G+L++ +     E+  F++ 
Sbjct: 115 ELHCLAACDHFGIVKHFD-----DFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEY 169

Query: 263 SL-MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEE 321
            + +    IV+    ALD +H++    + H DLKS+N+ L    I  +GDFG     F +
Sbjct: 170 EVGLLFYQIVL----ALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFG-----FSK 217

Query: 322 SNTPSKNQTMSNGLKGSVGYIPPE-YINGHVSILGDIYSYGILLLEIFTGKRP 373
             + S +  +++   G+  Y+ PE +     S   D++S G++L E+ T  RP
Sbjct: 218 QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 28/63 (44%), Positives = 34/63 (53%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L NN   G IP  + S   L  LDL  N L GK+P   + L SL  L L+ N+L G+I
Sbjct: 145 LDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQI 204

Query: 61  SRE 63
            RE
Sbjct: 205 PRE 207

Length = 968

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 56/229 (24%), Positives = 96/229 (41%), Gaps = 35/229 (15%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQG-ALKSFIDECNALTSIRHRN 214
           ++  +   IG G+FG+V K      G   A+K ++        K  + + + +  +R  +
Sbjct: 4   EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVV--MRSSD 61

Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN----- 269
              IV    ++  EG+ +  +  E M           S D++  +    L   +      
Sbjct: 62  CPYIVKFYGALFREGDCW--ICMELMDI---------SLDKFYKYVYEVLKSVIPEEILG 110

Query: 270 -IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
            I +    AL+YL    +  I H D+K SN+LLD      + DFG++  L +     S  
Sbjct: 111 KIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD-----SIA 163

Query: 329 QTMSNGLKGSVGYIPPEYINGHVS----ILGDIYSYGILLLEIFTGKRP 373
           +T   G +    Y+ PE I+        +  D++S GI L E+ TGK P
Sbjct: 164 KTRDAGCRP---YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 56/225 (24%), Positives = 98/225 (43%), Gaps = 45/225 (20%)

Query: 164 LIGSGSFGSVYKGTLAD-GETAAIKVL-----KLQQQGALKSFIDECNALTSIRHRNILK 217
           +IG G FG VY    AD G+  A+K L     K++Q   L           ++  R +L 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL-----------ALNERIMLS 49

Query: 218 IVSS-------CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
           +VS+       C +  +   D    + + M  G+L    H    ++  F +  +  R   
Sbjct: 50  LVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDL----HYHLSQHGVFSEKEM--RF-Y 102

Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
             ++   L+++HN++   + + DLK +N+LLDE     + D GLA          SK + 
Sbjct: 103 ATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF-------SKKKP 152

Query: 331 MSNGLKGSVGYIPPEYINGHVSI--LGDIYSYGILLLEIFTGKRP 373
            ++   G+ GY+ PE +    +     D +S G +L ++  G  P
Sbjct: 153 HAS--VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 61/216 (28%), Positives = 93/216 (43%), Gaps = 33/216 (15%)

Query: 164 LIGSGSFGSVYKGT-LADGETAAIKVLK--LQQQGALKSFIDECNALTSIRHRNI---LK 217
            +GSG++GSV        GE  AIK L    Q +   K    E   L  ++H N+   L 
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81

Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
           + +S  S D E  DF  LV  +M+        HP +++   +          +V  +   
Sbjct: 82  VFTSAVSGD-EFQDF-YLVMPYMQTDLQKIMGHPLSEDKVQY----------LVYQMLCG 129

Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           L Y+H+     I H DLK  N+ ++E     + DFGLA+           +  M+ G   
Sbjct: 130 LKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR---------HADAEMT-GYVV 176

Query: 338 SVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
           +  Y  PE I    H +   DI+S G ++ E+ TGK
Sbjct: 177 TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 60/275 (21%), Positives = 112/275 (40%), Gaps = 77/275 (28%)

Query: 164 LIGSGSFGSVYKGTL------ADGETAAIKVLKLQQQGAL----KSFIDECNALTSI-RH 212
           ++G G+FG V + +       +   T A+K+LK   +GA     K+ + E   L  I  H
Sbjct: 14  VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLK---EGATASEHKALMSELKILIHIGNH 70

Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            N++ ++ +C+    + N    ++ EF + GNL  +L    + +  +++ S  QR     
Sbjct: 71  LNVVNLLGACT----KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRA 126

Query: 273 DV----------ASALDYLHNQYD------------------TPIA-------------- 290
            V          A     L +++                   +P+               
Sbjct: 127 MVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARG 186

Query: 291 ----------HCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG 340
                     H DL + N+LL E  +  + DFGLA+ ++++ +   K        +  + 
Sbjct: 187 MEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA-----RLPLK 241

Query: 341 YIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRP 373
           ++ PE I   V +   D++S+G+LL EIF+ G  P
Sbjct: 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 40/155 (25%), Positives = 73/155 (47%), Gaps = 16/155 (10%)

Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSS 221
           IG G++G VYKG     G+  A+K ++L+  ++G   + I E + L  ++H NI+ +   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD- 66

Query: 222 CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYL 281
              V  + +    L+FEF     L   L    D     + +      + +  +   + + 
Sbjct: 67  ---VLMQESRL-YLIFEF-----LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117

Query: 282 HNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK 316
           H++    + H DLK  N+L+D   +  + DFGLA+
Sbjct: 118 HSRR---VLHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 62/234 (26%), Positives = 95/234 (40%), Gaps = 54/234 (23%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGAL--KSFIDECNALTSIRHR 213
           D +   + +GSG++G V        G   AIK L    Q A+  K    E   L  + H 
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74

Query: 214 NI---LKIVSSCSSVDYEGNDFKA--LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
           N+   L + +  SS+     DF+   LV   M        L+           +   Q+L
Sbjct: 75  NVIGLLDVFTPASSL----EDFQDVYLVTHLM-----GADLN----------NIVKCQKL 115

Query: 269 N------IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES 322
           +      +V  +   L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E 
Sbjct: 116 SDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE- 171

Query: 323 NTPSKNQTMSNGLKGSVG---YIPPEYI-N-GHVSILGDIYSYGILLLEIFTGK 371
                       + G V    Y  PE + N  H +   DI+S G ++ E+ TGK
Sbjct: 172 ------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 26/62 (41%), Positives = 37/62 (59%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L+L  N   G IP S+ SL+ L  LDLS N+LSG++P+   +L +L  L+L  N   G+I
Sbjct: 265 LFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKI 324

Query: 61  SR 62
             
Sbjct: 325 PV 326

Length = 968

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 23/60 (38%), Positives = 33/60 (55%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L N   +G IP  +  LR L  ++LS N++ G +P     + SL  L+LSYN  +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Length = 623

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 70/235 (29%), Positives = 105/235 (44%), Gaps = 46/235 (19%)

Query: 165 IGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           IG G+FG VY+    D     A+KVL      + K  + +     +I  RNIL      +
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERNILV----RT 50

Query: 224 SVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYC------HFKKLSLM--QRLNIVI-DV 274
            +D E      L F F      D  L+  TD         H +K       R    I ++
Sbjct: 51  LLD-ESPFIVGLKFSF----QTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAEL 105

Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
             AL++LH +YD  I + DLK  N+LLD  G IA + DFGL+K         + N+T +N
Sbjct: 106 VLALEHLH-KYD--IVYRDLKPENILLDATGHIA-LCDFGLSK------ANLTDNKT-TN 154

Query: 334 GLKGSVGYIPPEYI---NGHVSILGDIYSYGILLLEIFTGKRP-----TDDMFKD 380
              G+  Y+ PE +    G+   + D +S G+L+ E+  G  P     T  M+++
Sbjct: 155 TFCGTTEYLAPEVLLDEKGYTKHV-DFWSLGVLVFEMCCGWSPFYAEDTQQMYRN 208

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 46/222 (20%)

Query: 165 IGSGSFG-SVYKGTLADGETAAIK---VLKLQQQGALKSFIDECNALTSIRHRNILKIVS 220
           IG GSFG ++   +  DG+   IK   + K+  +   +S   E   L++++H NI++   
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESR-KEVAVLSNMKHPNIVQYQE 66

Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM--------QRLNIVI 272
           S     +E N    +V ++   G+L             +KK++          Q L+  +
Sbjct: 67  S-----FEENGNLYIVMDYCEGGDL-------------YKKINAQRGVLFPEDQILDWFV 108

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM- 331
            +  AL ++H   D  I H D+KS N+ L +     +GDFG+A+ L         N T+ 
Sbjct: 109 QICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL---------NSTVE 156

Query: 332 -SNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGK 371
            +    G+  Y+ PE   N   +   DI++ G +L E+ T K
Sbjct: 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 56/250 (22%), Positives = 104/250 (41%), Gaps = 40/250 (16%)

Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D + +   IG G++G VYK      G+  A+K  +L+         +E    T++R  ++
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-------EEGIPPTALREISL 53

Query: 216 LKIVSSC-------SSVDYEGNDFKA---LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM 265
           L+++S              E  + K    LVFE++ + +L +++  +            +
Sbjct: 54  LQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTI 112

Query: 266 QRL--NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEES 322
           +     ++  VA    + H      + H DLK  N+L+D +  +  + D GL +      
Sbjct: 113 KSFMYQLLKGVA----HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF---- 161

Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKR--PTDDMF 378
           + P K+ T       ++ Y  PE + G  H S   DI+S G +  E+   +   P D   
Sbjct: 162 SIPVKSYTHE---IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL 218

Query: 379 KDDLSIHKFV 388
           +  L I K +
Sbjct: 219 QQLLHIFKLL 228

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 58/259 (22%), Positives = 100/259 (38%), Gaps = 72/259 (27%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLA----DGETAAIKVLK---LQQQGALKSFIDECNALTS 209
           D+F    +IG G+FG V+   L      G+  A+KVL+   + ++  +     E + L  
Sbjct: 1   DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD 57

Query: 210 IRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN 269
                I+K+  S     ++  +   LV E+M  G+L                ++L+ R +
Sbjct: 58  ADSPWIVKLYYS-----FQDEEHLYLVMEYMPGGDL----------------MNLLIRKD 96

Query: 270 IVID---------VASALDYLHNQ-YDTPIAHCDLKSSNVLLDEGMIAHV--GDFGLAKF 317
           +  +         +  ALD +H   +     H D+K  N+L+D     H+   DFGL K 
Sbjct: 97  VFPEETARFYIAELVLALDSVHKLGF----IHRDIKPDNILIDAD--GHIKLADFGLCKK 150

Query: 318 LFEESNTPSKNQTMSNGLK----------------------GSVGYIPPEYINGH-VSIL 354
           + +  +         N L                       G+  YI PE + G    + 
Sbjct: 151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE 210

Query: 355 GDIYSYGILLLEIFTGKRP 373
            D +S G++L E+  G  P
Sbjct: 211 CDWWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 50/224 (22%)

Query: 165 IGSGSFGSVYKGTLAD-GETAAIKVLK---LQQQGALKSFIDECNALTSIRHRNILKIVS 220
           +G G +G V+     D GE  A+K +K   L +   ++  + E + LT+ +   ++K++ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 221 SCSSVDY--------EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
           +    +Y         G DF+ L+      G L        +++  F           + 
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLS-------EDHARF----------YMA 108

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV--GDFGLAKFLFEESNTPSKNQT 330
           ++  A+D LH   +    H DLK  N L+D     H+   DFGL+K +           T
Sbjct: 109 EMFEAVDALH---ELGYIHRDLKPENFLIDA--SGHIKLTDFGLSKGIV----------T 153

Query: 331 MSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
            +N + GS  Y+ PE + G       D +S G +L E   G  P
Sbjct: 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 61/225 (27%), Positives = 96/225 (42%), Gaps = 36/225 (16%)

Query: 159 FSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILK 217
           F +  ++G G FG V    + A G+  A K L+ ++   +K    E  AL     + IL+
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKR---IKKRKGESMALN---EKQILE 55

Query: 218 IVSSCSSVD----YEGNDFKALVFEFMRNGNLDQWLH----PSTDEYCHFKKLSLMQRLN 269
            V+S   V+    YE  D   LV   M  G+L   ++    P  +E          + L 
Sbjct: 56  KVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEE---------ERALF 106

Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
              ++   L+ LH +      + DLK  N+LLD+     + D GLA  + E  +      
Sbjct: 107 YAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI----- 158

Query: 330 TMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
               G  G+VGY+ PE +N     L  D +  G L+ E+  G+ P
Sbjct: 159 ---RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 56/268 (20%), Positives = 103/268 (38%), Gaps = 75/268 (27%)

Query: 165 IGSGSFGSVYKGTL------ADGETAAIKVLKLQQQGAL----KSFIDECNALTSI-RHR 213
           +G G+FG V + +       A   T A+K+LK   +GA     K+ + E   L  I  H 
Sbjct: 15  LGRGAFGKVIQASAFGIEKSASCRTVAVKMLK---EGATASEYKALMTELKILIHIGHHL 71

Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
           N++ ++ +C+     G     +V E+ + GNL  +L    + +  ++  S  +R     +
Sbjct: 72  NVVNLLGACTK---PGGPLMVIV-EYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKE 127

Query: 274 V---------------------------ASALDYLHNQYDTPIA---------------- 290
                                           +     Y  P+                 
Sbjct: 128 GKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGME 187

Query: 291 --------HCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
                   H DL + N+LL E  +  + DFGLA+ ++++ +   K        +  + ++
Sbjct: 188 FLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA-----RLPLKWM 242

Query: 343 PPEYINGHV-SILGDIYSYGILLLEIFT 369
            PE I   V +   D++S+G+LL EIF+
Sbjct: 243 APESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 24/223 (10%)

Query: 158 NFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQ---QQGALKSFIDEC--NALTSIR 211
           N+    L+G G+FG VY    AD G   A+K +      Q+ + +    EC    L ++R
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H  I++        D E       V E+M  G++        D+   +  L+        
Sbjct: 63  HDRIVQYYGCLR--DPEEKKLSIFV-EYMPGGSI-------KDQLKAYGALTENVTRRYT 112

Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
             +   + YLH+     I H D+K +N+L D      +GDFG +K +     T   + T 
Sbjct: 113 RQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI----QTICMSGTG 165

Query: 332 SNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
              + G+  ++ PE I+G       D++S    ++E+ T K P
Sbjct: 166 IKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 62/237 (26%), Positives = 91/237 (38%), Gaps = 54/237 (22%)

Query: 159 FSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKL---QQQGALKSFIDECNALTSIRHRN 214
           F++   IG GSFG+VY        E  AIK +     Q     +  I E   L  I+H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYC----------HFKKLSL 264
                    S++Y+G         ++R      WL     EYC          H K L  
Sbjct: 87  ---------SIEYKGC--------YLREHT--AWL---VMEYCLGSASDLLEVHKKPLQE 124

Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNT 324
           ++   I       L YLH+     + H D+K+ N+LL E     + DFG A         
Sbjct: 125 VEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIA------ 175

Query: 325 PSKNQTMSNGLKGSVGYIPPEYI----NGHVSILGDIYSYGILLLEIFTGKRPTDDM 377
                + +N   G+  ++ PE I     G      D++S GI  +E+   K P  +M
Sbjct: 176 -----SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 61/229 (26%), Positives = 105/229 (45%), Gaps = 35/229 (15%)

Query: 158 NFSEENLIGSGSFGSVY---KGTLAD-GETAAIKVLK----LQQQGALKSFIDECNALTS 209
           NF    ++G+G++G V+   K +  D G+  A+KVLK    +Q+    +    E   L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 210 IRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN 269
           IR    L  +      D + +    L+ +++  G L  + H S  E   FK+    Q + 
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLH----LILDYINGGEL--FTHLSQRE--RFKE----QEVQ 108

Query: 270 IVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
           I   ++  AL++LH      I + D+K  N+LLD      + DFGL+K   E+    + +
Sbjct: 109 IYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS 165

Query: 329 QTMSNGLKGSVGYIPPEYI----NGHVSILGDIYSYGILLLEIFTGKRP 373
                   G++ Y+ P+ +     GH   + D +S G+L+ E+ TG  P
Sbjct: 166 ------FCGTIEYMAPDIVRGGDGGHDKAV-DWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 52/223 (23%), Positives = 91/223 (40%), Gaps = 24/223 (10%)

Query: 158 NFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKL-----QQQGALKSFIDECNALTSIR 211
           N+    L+G G+FG VY     D G   A K ++      +    + +   E   L +++
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H    +IV     +         +  E+M  G++        D+   +  L+        
Sbjct: 63  HE---RIVQYYGCLRDRAEKTLTIFMEYMPGGSV-------KDQLKAYGALTESVTRKYT 112

Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
             +   + YLH+     I H D+K +N+L D      +GDFG +K L     T   + T 
Sbjct: 113 RQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL----QTICMSGTG 165

Query: 332 SNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
              + G+  ++ PE I+G       D++S G  ++E+ T K P
Sbjct: 166 IRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 66/226 (29%), Positives = 97/226 (42%), Gaps = 38/226 (16%)

Query: 159 FSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILK 217
           F    ++G G FG V    + A G+  A K  KL+++  +K    E  AL   R   IL+
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKK-RIKKRKGEAMALNEKR---ILE 55

Query: 218 IVSSCSSVD----YEGNDFKALVFEFMRNGNLDQWLH----PSTDEYCHFKKLSLMQR-L 268
            V+S   V     YE  D   LV   M  G+L   ++    P  DE          QR +
Sbjct: 56  KVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDE----------QRAI 105

Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
               ++   L+ L  +    I + DLK  N+LLD+     + D GLA  + E        
Sbjct: 106 FYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE-------G 155

Query: 329 QTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
           +T+  G  G+VGY+ PE IN        D +  G L+ E+  G+ P
Sbjct: 156 ETV-RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 53/242 (21%), Positives = 102/242 (42%), Gaps = 33/242 (13%)

Query: 165 IGSGSFGSVYKGT--LADGETAAIKVLKLQ--QQGALKSFIDEC---NALTSIRHRNILK 217
           IG G++G V+K       G   A+K +++Q  ++G   S I E      L +  H N+++
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
           +   C+    +      LVFE + + +L  +L    +     + +  M     +  +   
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDM-----MFQLLRG 122

Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           LD+LH+     + H DLK  N+L+       + DFGLA+            Q     +  
Sbjct: 123 LDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY--------SFQMALTSVVV 171

Query: 338 SVGYIPPE-YINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHK----FVLMAL 392
           ++ Y  PE  +    +   D++S G +  E+F  ++P   +F+    + +      ++ L
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP---LFRGSSDVDQLGKILDVIGL 227

Query: 393 PS 394
           P 
Sbjct: 228 PG 229

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 31/214 (14%)

Query: 165 IGSGSFGSVYKGTLA----DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVS 220
           IG GS G V    +A     G   A+K++ L++Q   +   +E   +   +H+N++++  
Sbjct: 29  IGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85

Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDY 280
           S     Y   +   ++ EF++ G L   +  +        +L+  Q   +   V  AL Y
Sbjct: 86  S-----YLVGEELWVLMEFLQGGALTDIVSQT--------RLNEEQIATVCESVLQALCY 132

Query: 281 LHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG 340
           LH+Q    + H D+KS ++LL       + DFG    +       SK+      L G+  
Sbjct: 133 LHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQI-------SKDVPKRKSLVGTPY 182

Query: 341 YIPPEYINGHV-SILGDIYSYGILLLEIFTGKRP 373
           ++ PE I+        DI+S GI+++E+  G+ P
Sbjct: 183 WMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 48.0 bits (114), Expect = 4e-06
 Identities = 59/231 (25%), Positives = 98/231 (42%), Gaps = 41/231 (17%)

Query: 164 LIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSS- 221
           ++G GSFG V    L   GE  A+K LK          ID+    T +  R +L +    
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDV-----VLIDDDVECTMVEKR-VLALAWEN 55

Query: 222 -------CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
                  C+   ++  +    V EF+  G+L   +    D+     +  L +      ++
Sbjct: 56  PFLTHLYCT---FQTKEHLFFVMEFLNGGDL---MFHIQDK----GRFDLYRATFYAAEI 105

Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
              L +LH++    I + DLK  NV+LD      + DFG+ K      N    N+  +  
Sbjct: 106 VCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCK-----ENVFGDNRAST-- 155

Query: 335 LKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRP-----TDDMFK 379
             G+  YI PE + G   +   D +S+G+LL E+  G+ P      D++F+
Sbjct: 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 48.0 bits (114), Expect = 5e-06
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 34/219 (15%)

Query: 164 LIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSC 222
           ++G GSFG V+   L    +  AIK LK  +   L     EC    ++  + +L +    
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALK--KDVVLMDDDVEC----TMVEKRVLSLAWEH 55

Query: 223 SSVDYEGNDFKA-----LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
             + +    F+       V E++  G+L    H  +   CH  K  L +      ++   
Sbjct: 56  PFLTHLYCTFQTKENLFFVMEYLNGGDL--MFHIQS---CH--KFDLPRATFYAAEIICG 108

Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           L +LH++    I + DLK  N+LLD      + DFG+ K      N     +T      G
Sbjct: 109 LQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCK-----ENMLGDAKT--CTFCG 158

Query: 338 SVGYIPPEYINGH---VSILGDIYSYGILLLEIFTGKRP 373
           +  YI PE + G     S+  D +S+G+LL E+  G+ P
Sbjct: 159 TPDYIAPEILLGQKYNTSV--DWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 67/253 (26%), Positives = 104/253 (41%), Gaps = 31/253 (12%)

Query: 158 NFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           N+    L+G G+FG VY    AD G   A+K ++   +    S   E NAL       +L
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETS--KEVNALEC--EIQLL 58

Query: 217 KIVSSCSSVDYEG------NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
           K +     V Y G          ++  E M  G++        D+   +  L+       
Sbjct: 59  KNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSI-------KDQLKSYGALTENVTRKY 111

Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
              +   + YLH+     I H D+K +N+L D      +GDFG +K L     T   + T
Sbjct: 112 TRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL----QTICLSGT 164

Query: 331 MSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL 389
               + G+  ++ PE I+G       DI+S G  ++E+ T K P  + F+   +I K   
Sbjct: 165 GMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE-FEAMAAIFKIAT 223

Query: 390 M----ALPSHVMD 398
                 LP HV D
Sbjct: 224 QPTNPVLPPHVSD 236

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 48.7 bits (116), Expect = 6e-06
 Identities = 28/60 (46%), Positives = 37/60 (61%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L+L +N+F G IPV+L SL  L  L L  N  SG++P+   K  +L  L+LS N L GEI
Sbjct: 313 LHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEI 372

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 48.3 bits (115), Expect = 7e-06
 Identities = 27/63 (42%), Positives = 36/63 (57%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L LG N   G IP SL +L  L  L L+ N L G++P+   ++ SL+ + L YN L GEI
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI 228

Query: 61  SRE 63
             E
Sbjct: 229 PYE 231

Length = 968

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 39/221 (17%)

Query: 164 LIGSGSFGS--VYKGTLADGETAAIKVLKL-QQQGALKSFIDECNALTSIRHRNILKIVS 220
           ++G GSFG   + +   +D +  A+K ++L +   A++    E   L  ++H NI+    
Sbjct: 7   VVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65

Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQ-------WLHPSTDEYCHFKKLSLMQRLNIVID 273
           S     +E +    +V E+   G+L Q        L P       F ++ L         
Sbjct: 66  S-----FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL--------- 111

Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
               + ++H   +  + H D+KS N+ L +     +GDFG A+ L       +     + 
Sbjct: 112 ---GVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL-------TSPGAYAC 158

Query: 334 GLKGSVGYIPPE-YINGHVSILGDIYSYGILLLEIFTGKRP 373
              G+  Y+PPE + N   +   DI+S G +L E+ T K P
Sbjct: 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 65/242 (26%), Positives = 98/242 (40%), Gaps = 59/242 (24%)

Query: 157 DNFSEENLIGSGSFGSVY----KGTLADGETAAIKVLKLQQQGALK--SFIDECNALTSI 210
            +F  ++L+G G FG V     K T   G+  A+KV+K     A +  SF +E       
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEE------- 50

Query: 211 RHRNILKIVSS--CSSVDY--EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
             R+IL I +S     + Y  +  D   LV E+   G+L                LSL+ 
Sbjct: 51  -ERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDL----------------LSLLN 93

Query: 267 RLNIVIDVASALDYL-------HNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLF 319
           R     D   A  YL       H+ +     H D+K  NVL+D      + DFG A  L 
Sbjct: 94  RYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL- 152

Query: 320 EESNTPSKNQTMSNGLK-GSVGYIPPE-------YINGHVSILGDIYSYGILLLEIFTGK 371
                 + N+ +++ L  G+  YI PE          G   +  D +S G++  E+  G+
Sbjct: 153 ------TANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Query: 372 RP 373
            P
Sbjct: 207 SP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 36/114 (31%), Positives = 61/114 (53%), Gaps = 18/114 (15%)

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
           AL+ LH +++  + + DLK  N+LLD +G IA + DFGL K   ++ +        +N  
Sbjct: 105 ALENLH-KFN--VIYRDLKPENILLDYQGHIA-LCDFGLCKLNMKDDDK-------TNTF 153

Query: 336 KGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP-----TDDMFKDDLS 383
            G+  Y+ PE + GH  +   D ++ G+LL E+ TG  P      ++M++  L 
Sbjct: 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ 207

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 47.4 bits (112), Expect = 1e-05
 Identities = 69/293 (23%), Positives = 112/293 (38%), Gaps = 61/293 (20%)

Query: 131 TSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGS---GSFGSVYKGTL--ADGETAA 185
                 APP       L+  K+ +  +  +   +I     G+FG ++   L  +  E  A
Sbjct: 119 HLDFDEAPPDAAGPVPLAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEA 178

Query: 186 IKVLKLQQQGALKS-----------------FIDECNALTSIRHRNILKIVSSCSSVDYE 228
            + +    QG  K                    +E  AL  + H NILKI     S    
Sbjct: 179 RRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANT 238

Query: 229 ---GNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQY 285
                 +   ++ FM +   D    P            L Q   I+  +  A++Y+H   
Sbjct: 239 YMITQKYDFDLYSFMYDEAFDWKDRPL-----------LKQTRAIMKQLLCAVEYIH--- 284

Query: 286 DTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
           D  + H D+K  N+ L+ +G I  +GDFG A   FE+            G  G+V    P
Sbjct: 285 DKKLIHRDIKLENIFLNCDGKIV-LGDFGTA-MPFEKEREA-----FDYGWVGTVATNSP 337

Query: 345 EYI--NGHVSILGDIYSYGILLLEIFT---------GKRPTDDMFK--DDLSI 384
           E +  +G+  I  DI+S G++LL++ +         G +P   + K  D LS+
Sbjct: 338 EILAGDGYCEIT-DIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSV 389

Length = 501

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 41/196 (20%), Positives = 90/196 (45%), Gaps = 29/196 (14%)

Query: 185 AIKVLKLQ-QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNG 243
           A+K+L+    + A   F+ E   ++ ++  NI+++++ C +     +D   ++ E+M NG
Sbjct: 50  AVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCIT-----SDPLCMITEYMENG 104

Query: 244 NLDQWLH----PSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNV 299
           +L+Q+L         E      +S    + +   +AS + YL +       H DL + N 
Sbjct: 105 DLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161

Query: 300 LLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILG---- 355
           L+ +     + DFG+++ L+       + + +          +P  +++    +LG    
Sbjct: 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAV----------LPIRWMSWESILLGKFTT 211

Query: 356 --DIYSYGILLLEIFT 369
             D++++G+ L EI T
Sbjct: 212 ASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 62/236 (26%), Positives = 100/236 (42%), Gaps = 40/236 (16%)

Query: 164 LIGSGSFGSVYKG-TLADGETAAIKVLK--LQQQGALKS-FIDECNALTSIRHRNILKIV 219
           LIG G  G VY           A+K ++  L +   LK  F+ E      + H  I+ + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 220 SSCS---SVDY-----EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           S CS    V Y     EG   K+L+    +  +L + L   T         S+   L+I 
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKT---------SVGAFLSIF 119

Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG--DFGLAKFL----------- 318
             + + ++Y+H++    + H DLK  N+LL  G+   V   D+G A F            
Sbjct: 120 HKICATIEYVHSK---GVLHRDLKPDNILL--GLFGEVVILDWGAAIFKKLEEEDLLDID 174

Query: 319 FEESNTPSKNQTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
            +E N    + T+   + G+  Y+ PE + G   S   DIY+ G++L ++ T   P
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 47.0 bits (111), Expect = 1e-05
 Identities = 56/232 (24%), Positives = 100/232 (43%), Gaps = 29/232 (12%)

Query: 164 LIGSGSFGSV-YKGTLADGETAAIKVLKLQ---QQGALKSFIDECNALTSIRHRNILKIV 219
           L+G G+FG V      A G+  A+K+LK +    +  +   + E   L + RH  +  + 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
            S     ++  D    V E++  G L  + H S +      +           ++ SALD
Sbjct: 62  YS-----FQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYG-----AEIVSALD 109

Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSV 339
           YLH+     I + DLK  N++LD+     + DFGL K    ++ T            G+ 
Sbjct: 110 YLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT-------MKTFCGTP 159

Query: 340 GYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM 390
            Y+ PE + +       D +  G+++ E+  G+ P  +  +D   + + +LM
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN--QDHEKLFELILM 209

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 61/229 (26%), Positives = 93/229 (40%), Gaps = 36/229 (15%)

Query: 164 LIGSGSFGSVY----KGTLADGETAAIKVLK---LQQQGALKSFIDECNALTSIRHRNIL 216
           ++G GSFG V     KGT    E  AIKVLK   + Q   +   + E   L        L
Sbjct: 2   VLGKGSFGKVMLAELKGT---DEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFL 58

Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
             +  C    ++  D    V E++  G+L   +  S       +K    +      +V  
Sbjct: 59  TALHCC----FQTKDRLFFVMEYVNGGDLMFQIQRS-------RKFDEPRSRFYAAEVTL 107

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
           AL +LH      + + DLK  N+LLD      + DFG+ K    E        T      
Sbjct: 108 ALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK----EGILNGVTTTT---FC 157

Query: 337 GSVGYIPPEYINGH---VSILGDIYSYGILLLEIFTGKRPTDDMFKDDL 382
           G+  YI PE +       S+  D ++ G+L+ E+  G+ P +   +DDL
Sbjct: 158 GTPDYIAPEILQELEYGPSV--DWWALGVLMYEMMAGQPPFEADNEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 46.5 bits (111), Expect = 1e-05
 Identities = 66/253 (26%), Positives = 97/253 (38%), Gaps = 72/253 (28%)

Query: 164 LIGSGSFGSVY----KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIR-HRNILK- 217
           L+G G  G V+    KGT   G+  A+KVL        K  + + N +  +   + IL  
Sbjct: 8   LLGKGDVGRVFLVRLKGT---GKLFALKVL-------DKKEMIKRNKVKRVLTEQEILAT 57

Query: 218 -----IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
                + +  +S   E   +  LV ++   G L               +    + L+  +
Sbjct: 58  LDHPFLPTLYASFQTE--TYLCLVMDYCPGGELF-----------RLLQRQPGKCLSEEV 104

Query: 273 ------DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV--GDFGLAKFLFEE--- 321
                 +V  AL+YLH      I + DLK  N+LL E    H+   DF L+K    E   
Sbjct: 105 ARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPP 159

Query: 322 --------SNTPSKNQ-----------TMSNGLKGSVGYIPPEYI--NGHVSILGDIYSY 360
                   S   S N              SN   G+  YI PE I  +GH S + D ++ 
Sbjct: 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV-DWWTL 218

Query: 361 GILLLEIFTGKRP 373
           GILL E+  G  P
Sbjct: 219 GILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 50/157 (31%), Positives = 75/157 (47%), Gaps = 21/157 (13%)

Query: 165 IGSGSFGSVYKGTLA-DGETAAIKVLK---LQQQGALKSFIDECNALTSIRHRNILKIVS 220
           I  G+FG VY G    + +  A+KV+K   +  +  +     E +AL   +   I+ +  
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDY 280
           S  S +        LV E++  G++   LH     Y +F +   M    I  +VA ALDY
Sbjct: 72  SLQSANN-----VYLVMEYLIGGDVKSLLHI----YGYFDEE--MAVKYIS-EVALALDY 119

Query: 281 LHNQYDTPIAHCDLKSSNVLL-DEGMIAHVGDFGLAK 316
           LH      I H DLK  N+L+ +EG I  + DFGL+K
Sbjct: 120 LHRH---GIIHRDLKPDNMLISNEGHI-KLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 47.2 bits (112), Expect = 2e-05
 Identities = 25/61 (40%), Positives = 37/61 (60%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L +NS +G IP SL + R L  + L  N+ SG++P  F+KL  +  L++S N L G I
Sbjct: 385 LILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRI 444

Query: 61  S 61
           +
Sbjct: 445 N 445

Length = 968

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 59/231 (25%), Positives = 88/231 (38%), Gaps = 54/231 (23%)

Query: 165 IGSGSFGSVYKGTLA-DGETAAIKVLKL---QQQGALKSFIDECNALTSIRHRNILKIVS 220
           IG GSFG+VY  T +   E  A+K +     Q     +  I E   L  ++H N      
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN------ 82

Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYC----------HFKKLSLMQRLNI 270
              +++Y+G   K              WL     EYC          H K L  ++   I
Sbjct: 83  ---TIEYKGCYLK----------EHTAWL---VMEYCLGSASDLLEVHKKPLQEVEIAAI 126

Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
                  L YLH+     + H D+K+ N+LL E     + DFG A              +
Sbjct: 127 THGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKS-----------S 172

Query: 331 MSNGLKGSVGYIPPEYI----NGHVSILGDIYSYGILLLEIFTGKRPTDDM 377
            +N   G+  ++ PE I     G      D++S GI  +E+   K P  +M
Sbjct: 173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 66/232 (28%), Positives = 96/232 (41%), Gaps = 50/232 (21%)

Query: 157 DNFSEENLIGSGSFGSV-YKGTLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHR 213
           D + +   +GSG++G+V        G   AIK L    Q  L  K    E   L  ++H 
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74

Query: 214 NI---LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN- 269
           N+   L + +   S+D   +DF  LV  FM            TD      KL   ++L+ 
Sbjct: 75  NVIGLLDVFTPDLSLD-RFHDF-YLVMPFM-----------GTD----LGKLMKHEKLSE 117

Query: 270 -----IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNT 324
                +V  +   L Y+H      I H DLK  N+ ++E     + DFGLA+        
Sbjct: 118 DRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-------- 166

Query: 325 PSKNQTMSNGLKGSV---GYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
               QT S  + G V    Y  PE I    H +   DI+S G ++ E+ TGK
Sbjct: 167 ----QTDSE-MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 64/238 (26%), Positives = 100/238 (42%), Gaps = 30/238 (12%)

Query: 152 ISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSI 210
           + + TD +     IG G++G VYK T   DG  AA+K+L        +    E N L S+
Sbjct: 17  LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEYNILQSL 75

Query: 211 -RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN 269
             H N++K        D        LV E    G++ + +            L   QRL+
Sbjct: 76  PNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVK---------GLLICGQRLD 126

Query: 270 ---IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTP 325
              I   +  AL  L + ++  I H D+K +N+LL  EG +  V DFG++  L       
Sbjct: 127 EAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLV-DFGVSAQL------- 178

Query: 326 SKNQTMSNGLKGSVGYIPPEYI------NGHVSILGDIYSYGILLLEIFTGKRPTDDM 377
           +  +   N   G+  ++ PE I      +       D++S GI  +E+  G  P  DM
Sbjct: 179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 35/125 (28%), Positives = 62/125 (49%), Gaps = 12/125 (9%)

Query: 251 PSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG 310
              D Y     L+L   +     VA  +++L ++      H DL + N+LL E  +  + 
Sbjct: 167 EQEDLYKKV--LTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKIC 221

Query: 311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
           DFGLA+ ++++ +   K        +  + ++ PE I   V +I  D++S+G+LL EIF+
Sbjct: 222 DFGLARDIYKDPDYVRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Query: 370 -GKRP 373
            G  P
Sbjct: 277 LGASP 281

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 54/210 (25%), Positives = 86/210 (40%), Gaps = 45/210 (21%)

Query: 167 SGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVD 226
            GS G V+  T   G+   + VLK+ Q+G     + E   L ++ H +++++  +  S  
Sbjct: 76  PGSEGRVFVAT-KPGQPDPV-VLKIGQKGTT---LIEAMLLQNVNHPSVIRMKDTLVS-- 128

Query: 227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK----LSLMQRLNIVIDVASALDYLH 282
                   +V             H S+D Y +  K    L + Q L I   +   L YLH
Sbjct: 129 ---GAITCMVLP-----------HYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH 174

Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
            Q    I H D+K+ N+ +++     +GD G A+F                GL G+V   
Sbjct: 175 AQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF--------PVVAPAFLGLAGTVETN 223

Query: 343 PPEYI-----NGHVSILGDIYSYGILLLEI 367
            PE +     N       DI+S GI+L E+
Sbjct: 224 APEVLARDKYNSKA----DIWSAGIVLFEM 249

Length = 357

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 61/250 (24%), Positives = 98/250 (39%), Gaps = 44/250 (17%)

Query: 137 APPSNEWQSGLSYLKISNATDNFSEE-NLIGS---GSFGSVYKGTLADGETAAIKVLKLQ 192
           +P ++  Q        S+       + N++ S   GS G V+  T    E     ++K  
Sbjct: 68  SPQTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAV 127

Query: 193 QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPS 252
             G  K+   E + L +I HR I+ ++ +          +K+ V   M            
Sbjct: 128 TGG--KTPGREIDILKTISHRAIINLIHAYR--------WKSTVCMVMP--------KYK 169

Query: 253 TDEYCHFKK---LSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV 309
            D + +  +   L L Q + I   +  AL YLH +    I H D+K+ N+ LDE   A +
Sbjct: 170 CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVL 226

Query: 310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILG------DIYSYGIL 363
           GDFG A  L    +TP        G  G++    PE     +  L       DI+S G++
Sbjct: 227 GDFGAACKLDAHPDTPQ-----CYGWSGTLETNSPE-----LLALDPYCAKTDIWSAGLV 276

Query: 364 LLEIFTGKRP 373
           L E+      
Sbjct: 277 LFEMSVKNVT 286

Length = 392

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 45.7 bits (108), Expect = 3e-05
 Identities = 34/148 (22%), Positives = 69/148 (46%), Gaps = 21/148 (14%)

Query: 185 AIKVLKLQ-QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNG 243
           A+K+L+    + A   F+ E   L+ ++  NI++++  C        D   ++ E+M NG
Sbjct: 50  AVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD-----EDPLCMITEYMENG 104

Query: 244 NLDQWL------------HPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAH 291
           +L+Q+L            + +         +S    L++ + +AS + YL +       H
Sbjct: 105 DLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161

Query: 292 CDLKSSNVLLDEGMIAHVGDFGLAKFLF 319
            DL + N L+ E +   + DFG+++ L+
Sbjct: 162 RDLATRNCLVGENLTIKIADFGMSRNLY 189

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 55/232 (23%), Positives = 101/232 (43%), Gaps = 28/232 (12%)

Query: 164 LIGSGSFGSV-YKGTLADGETAAIKVLKLQ---QQGALKSFIDECNALTSIRHRNILKIV 219
           L+G G+FG V      A G   A+K+LK +    +  +   + E   L + RH  +  + 
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
            S     ++ +D    V E+   G L  + H S +      +           ++ SALD
Sbjct: 62  YS-----FQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYG-----AEIVSALD 109

Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSV 339
           YLH++ +  + + DLK  N++LD+     + DFGL K   ++  T            G+ 
Sbjct: 110 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-------MKTFCGTP 160

Query: 340 GYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM 390
            Y+ PE + +       D +  G+++ E+  G+ P  +  +D   + + +LM
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN--QDHEKLFELILM 210

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 40/219 (18%)

Query: 165 IGSGSFGSVYKGTLADGETA---AIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---L 216
           +GSG++GSV      D +T    A+K L    Q  +  K    E   L  ++H N+   L
Sbjct: 25  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 82

Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDV 274
            + +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +
Sbjct: 83  DVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQI 129

Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
              L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G
Sbjct: 130 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTG 176

Query: 335 LKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
              +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 46.0 bits (109), Expect = 4e-05
 Identities = 27/60 (45%), Positives = 35/60 (58%), Gaps = 2/60 (3%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L NN+F G+IP    S+  L  LDLS N LSG++P       SL+ L+L  N L G+I
Sbjct: 123 LNLSNNNFTGSIPRG--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180

Length = 968

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 45.2 bits (107), Expect = 4e-05
 Identities = 68/228 (29%), Positives = 105/228 (46%), Gaps = 49/228 (21%)

Query: 164 LIGSGSFGSVY---KGTLAD-GETAAIKVLKLQQQGALKSFI--DECNALTSIRHRNILK 217
           ++G G +G V+   K T AD G+  A+KVLK       K+ I  ++ +   +   RNIL+
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLK-------KATIVRNQKDTAHTKAERNILE 55

Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSL-MQRLNIVI-DVA 275
            V     VD        L++ F   G L   L     EY    +L + ++R  I + D A
Sbjct: 56  AVKHPFIVD--------LIYAFQTGGKLYLIL-----EYLSGGELFMHLEREGIFMEDTA 102

Query: 276 S--------ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
                    AL++LH Q    I + DLK  N+LLD      + DFGL K    E      
Sbjct: 103 CFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----- 154

Query: 328 NQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRP 373
             T+++   G++ Y+ PE +  +GH   + D +S G L+ ++ TG  P
Sbjct: 155 --TVTHTFCGTIEYMAPEILMRSGHGKAV-DWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 45.2 bits (107), Expect = 4e-05
 Identities = 54/223 (24%), Positives = 96/223 (43%), Gaps = 43/223 (19%)

Query: 164 LIGSGSFGSVY----KGTLADGETAAIKVLK---LQQQGALKSFIDECNALTSIRHRNIL 216
           L+G G+FG V     K T   G+  A+K+LK   +  +  +   + E   L + RH  + 
Sbjct: 2   LLGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58

Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPS-----TDEYCHFKKLSLMQRLNIV 271
            +  S     ++ +D    V E+   G L  + H S     +++   F            
Sbjct: 59  ALKYS-----FQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYG---------- 101

Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
            ++ SAL YLH+     + + DLK  N++LD+     + DFGL K   E  +  +  +T 
Sbjct: 102 AEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTF 155

Query: 332 SNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
                G+  Y+ PE +  +      D +  G+++ E+  G+ P
Sbjct: 156 C----GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 45.1 bits (107), Expect = 5e-05
 Identities = 51/171 (29%), Positives = 70/171 (40%), Gaps = 47/171 (27%)

Query: 165 IGSGSFGSV----YKGTLADGETAAIKVLKLQQQGALKSFI---DECNALTSIRHRNILK 217
           +G G FG V    YK T   GE  AIK LK       K  I   DE  +L     + I +
Sbjct: 7   LGRGHFGKVLLAEYKKT---GELYAIKALK-------KGDIIARDEVESLMC--EKRIFE 54

Query: 218 IVS-----------SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
             +           +C    ++  D    V E+   G+L   +H  TD +      S  +
Sbjct: 55  TANSERHPFLVNLFAC----FQTEDHVCFVMEYAAGGDL--MMHIHTDVF------SEPR 102

Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAK 316
            +     V   L YLH   +  I + DLK  N+LLD EG +  + DFGL K
Sbjct: 103 AVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFV-KIADFGLCK 149

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 44.7 bits (105), Expect = 5e-05
 Identities = 35/105 (33%), Positives = 53/105 (50%), Gaps = 13/105 (12%)

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
           +++ AL+YLH +    I + DLK  NVLLD EG I  + D+G+ K      +T S     
Sbjct: 104 EISLALNYLHER---GIIYRDLKLDNVLLDSEGHI-KLTDYGMCKEGLRPGDTTS----- 154

Query: 332 SNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRPTD 375
                G+  YI PE + G       D ++ G+L+ E+  G+ P D
Sbjct: 155 --TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 44.6 bits (105), Expect = 6e-05
 Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 54/238 (22%)

Query: 164 LIGSGSFGSVY----KGTLADGETAAIKVLK---LQQQGALKSFIDECNALTSIRHRNIL 216
           ++G GSFG V     KGT    E  AIK+LK   + Q   ++  + E   L        L
Sbjct: 7   VLGKGSFGKVMLAERKGT---DELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFL 63

Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI---D 273
             + SC    ++  D    V E++  G+L              +++   +  + V    +
Sbjct: 64  TQLHSC----FQTMDRLYFVMEYVNGGDL----------MYQIQQVGRFKEPHAVFYAAE 109

Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           +A  L +LH++    I + DLK  NV+LD EG I  + DFG+ K            + M 
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHI-KIADFGMCK------------ENMW 153

Query: 333 NGLK-----GSVGYIPPEYINGH---VSILGDIYSYGILLLEIFTGKRPTDDMFKDDL 382
           +G+      G+  YI PE I       S+  D +++G+LL E+  G+ P +   +D+L
Sbjct: 154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSV--DWWAFGVLLYEMLAGQAPFEGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 44.8 bits (106), Expect = 1e-04
 Identities = 26/60 (43%), Positives = 34/60 (56%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L +N F G IP +L     L  LDLS NNL+G++P+      +L  L L  N L+GEI
Sbjct: 337 LQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEI 396

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 44.8 bits (106), Expect = 1e-04
 Identities = 24/65 (36%), Positives = 33/65 (50%), Gaps = 1/65 (1%)

Query: 3   LGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQ-FFSKLLSLRHLNLSYNELDGEIS 61
           L   +  G I  ++  L  +  ++LS N LSG +P   F+   SLR+LNLS N   G I 
Sbjct: 76  LSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIP 135

Query: 62  REGIF 66
           R  I 
Sbjct: 136 RGSIP 140

Length = 968

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 27/216 (12%)

Query: 165 IGSGSFGSVYKGTL-ADGETAAIKVL---KLQQQGALKSFIDECNALTSIRHRNILKIVS 220
           +G G FG V    + A G+  A K L   +L+++   +  + E   L  +  R I+ +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDY 280
           +     ++      LV   M  G+L   ++   +E   F +    +       + S L++
Sbjct: 61  A-----FQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPE---PRACFYTAQIISGLEH 112

Query: 281 LHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG 340
           LH +    I + DLK  NVLLD      + D GLA  L +        Q+ + G  G+ G
Sbjct: 113 LHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKD-------GQSKTKGYAGTPG 162

Query: 341 YIPPEYINGH---VSILGDIYSYGILLLEIFTGKRP 373
           ++ PE + G     S+  D ++ G+ L E+   + P
Sbjct: 163 FMAPELLQGEEYDFSV--DYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 57/252 (22%), Positives = 104/252 (41%), Gaps = 37/252 (14%)

Query: 165 IGSGSFGSVYKGTLADGETAAIKVLK-LQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           +G G++G VYK    DG+      LK ++  G   S   E   L  ++H N++ +     
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIAL----Q 64

Query: 224 SVDYEGNDFKA-LVFEFMRNGNLDQW----LHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
            V    +D K  L+F++  +   D W     H ++       +L      +++  +   +
Sbjct: 65  KVFLSHSDRKVWLLFDYAEH---DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121

Query: 279 DYLHNQYDTPIAHCDLKSSNVLL-----DEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
            YLH  +   + H DLK +N+L+     + G +  + D G A+      N+P K     +
Sbjct: 122 HYLHANW---VLHRDLKPANILVMGEGPERGRV-KIADMGFARLF----NSPLKPLADLD 173

Query: 334 GLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKR---------PTDDMFKDDL 382
            +  +  Y  PE + G  H +   DI++ G +  E+ T +           T + F  D 
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQ 233

Query: 383 SIHKFVLMALPS 394
               F +M  P+
Sbjct: 234 LDRIFSVMGFPA 245

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 55/233 (23%), Positives = 89/233 (38%), Gaps = 51/233 (21%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQ-----QGALKSFIDECNALTSIR 211
           ++F+    +G+GSFG V   T  + +   + + + ++     Q  +     E   L  I 
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPS----TDEYCHFKK-----L 262
           H   + +  S     ++   +  LV EF+  G    +L  +     D  C +        
Sbjct: 90  HPFCVNLYGS-----FKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIF 144

Query: 263 SLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES 322
             +Q LNIV                   + DLK  N+LLD+     + DFG AK +    
Sbjct: 145 EYLQSLNIV-------------------YRDLKPENLLLDKDGFIKMTDFGFAKVV---- 181

Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRP 373
                  T +  L G+  YI PE +   GH     D ++ GI + EI  G  P
Sbjct: 182 ------DTRTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 71/293 (24%), Positives = 122/293 (41%), Gaps = 50/293 (17%)

Query: 164 LIGSGSFGSVYKGTLA-DGETAAIKVLK---LQQQGALKSFIDECNAL-TSIRHRNILKI 218
           +IG GSFG V       DG+  A+KVL+   +  +   K  + E N L  +++H  ++ +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI---VIDVA 275
             S     ++  +    V +F+  G L          + H ++              ++A
Sbjct: 62  HYS-----FQTTEKLYFVLDFVNGGEL----------FFHLQRERSFPEPRARFYAAEIA 106

Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
           SAL YLH+     I + DLK  N+LLD      + DFGL K    +S+T       +   
Sbjct: 107 SALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT-------TTTF 156

Query: 336 KGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTG-----KRPTDDMFKDDLSIHKFVL 389
            G+  Y+ PE I         D +  G +L E+  G      R   +M+  D  +HK ++
Sbjct: 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY--DNILHKPLV 214

Query: 390 MALPSHVMDVLDLSMLLEEE--------NDHEKHEEEDLFPDIE-SQVAQKKL 433
           +   + +     L  LLE++         D  + +E   F  +  + + QKK+
Sbjct: 215 LRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKI 267

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 66/237 (27%), Positives = 97/237 (40%), Gaps = 46/237 (19%)

Query: 163 NLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI--LKIV 219
           N+IG+GSFG VY+    D  E  AIK  K+ Q    K+   E   + ++ H NI  LK  
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIK--KVLQDPQYKN--RELLIMKNLNHINIIFLKDY 127

Query: 220 SSCSSV-DYEGNDFKALVFEFMRNGNLDQWLHPSTDEYC-HFKKLSLMQRLNIVIDVASA 277
                    E N F  +V EF     + Q +H     Y  +   L L         +  A
Sbjct: 128 YYTECFKKNEKNIFLNVVMEF-----IPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRA 182

Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGM-IAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
           L Y+H+++   I H DLK  N+L+D       + DFG AK L                 +
Sbjct: 183 LAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL--------------AGQ 225

Query: 337 GSVGYIPPEYINGHVSILG--------DIYSYGILLLE------IFTGKRPTDDMFK 379
            SV YI   +      +LG        D++S G ++ E      IF+G+   D + +
Sbjct: 226 RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVR 282

Length = 440

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 31/104 (29%), Positives = 49/104 (47%), Gaps = 11/104 (10%)

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           ++  AL++LH +    I + DLK  NVLLD      + D+G+ K      +T S      
Sbjct: 104 EICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST----- 155

Query: 333 NGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRPTD 375
               G+  YI PE + G       D ++ G+L+ E+  G+ P D
Sbjct: 156 --FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 39/155 (25%), Positives = 71/155 (45%), Gaps = 18/155 (11%)

Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSS 221
           IG G++G+V+K       E  A+K ++L    +G   S + E   L  ++H+NI+++   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 222 CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYL 281
             S     +    LVFE+  + +L ++      +       S M +L         L + 
Sbjct: 68  LHS-----DKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQL------LKGLAFC 115

Query: 282 HNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK 316
           H+     + H DLK  N+L+++     + DFGLA+
Sbjct: 116 HSHN---VLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 52/224 (23%), Positives = 97/224 (43%), Gaps = 34/224 (15%)

Query: 162 ENLIGSGSFGSVYKGTLADGE----TAAIKVLKLQQQGALKSFIDECNALTSIRHRNILK 217
           + LIG G FG VY+   A        A  K+  L+ +    + + E     +I   + + 
Sbjct: 17  DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENE----TIVMETLVYNNIYDIDKIA 72

Query: 218 IVSSCSSVDYEG-------NDFK--ALVFEFMRNGNLDQWLHPSTDEY-----CHFKKLS 263
           +  +  ++D+ G         FK   + + F+    L + L  +T E      C  KKL 
Sbjct: 73  LWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFI----LLEKLVENTKEIFKRIKCKNKKLI 128

Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
                NI+ D+ + L+Y+H      I+H D+K  N+++D     ++ D+G+A        
Sbjct: 129 K----NIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGK 181

Query: 324 TPSKNQTMSNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLE 366
               ++   +  +G++ Y   +  NG  V+  GD+ S G  +L+
Sbjct: 182 HIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225

Length = 294

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 42.6 bits (101), Expect = 3e-04
 Identities = 62/233 (26%), Positives = 98/233 (42%), Gaps = 63/233 (27%)

Query: 165 IGSGSFGSVYKGTLAD---GETAAIKVLKL-----QQQGALKSFIDECNALTSIR-HRNI 215
           +G G++G V+K    D    E  A+K  K+         A ++F  E   L  +  H NI
Sbjct: 15  LGKGAYGIVWKAI--DRRTKEVVALK--KIFDAFRNATDAQRTF-REIMFLQELGDHPNI 69

Query: 216 LKIVSSCSSVDYEGNDFKA-------LVFEFMRNGNLDQWLHPSTDEYCHFKK--LSLMQ 266
           +K++          N  KA       LVFE+M            TD +   +   L  + 
Sbjct: 70  VKLL----------NVIKAENDKDIYLVFEYM-----------ETDLHAVIRANILEDVH 108

Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
           +  I+  +  AL Y+H+     + H DLK SN+LL+      + DFGLA+ L E    P 
Sbjct: 109 KRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPE 165

Query: 327 KNQTMSNGLKGSVGYI------PPEYING--HVSILGDIYSYGILLLEIFTGK 371
            N  +++       Y+       PE + G    +   D++S G +L E+  GK
Sbjct: 166 -NPVLTD-------YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 42.2 bits (99), Expect = 3e-04
 Identities = 55/229 (24%), Positives = 97/229 (42%), Gaps = 36/229 (15%)

Query: 165 IGSGSFGSVYKGTLAD---------GETAAIKV-LKLQQQGALK---SFIDECNALTSIR 211
           +G G+   +Y G L                IKV LK+          +F +  + +  + 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H++I+ +   C   D E      +V EF+  G LD ++H  +D       L+   +  + 
Sbjct: 63  HKHIVLLYGVCVR-DVE----NIMVEEFVEFGPLDLFMHRKSD------VLTTPWKFKVA 111

Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLL-DEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
             +ASAL YL    D  + H ++ + N+LL  EG+    G F        +   P    +
Sbjct: 112 KQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPF----IKLSDPGIPITVLS 164

Query: 331 MSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEI-FTGKRPTDD 376
               ++  + +I PE +  + ++SI  D +S+G  L EI + G+ P  D
Sbjct: 165 RQECVE-RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 42.7 bits (101), Expect = 3e-04
 Identities = 46/178 (25%), Positives = 70/178 (39%), Gaps = 40/178 (22%)

Query: 154 NATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQ----QQGALKSFIDECNALT 208
           +    +   + IG G++G V   T    G   AIK  K+     Q    ++ + E   L 
Sbjct: 2   DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIK--KISPFEHQTFCQRT-LREIKILR 58

Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKA--LVFEFM--------RNGNLDQWLHPSTDEYCH 258
             +H NI+ I+       +E   F    +V E M        +  +L      S D   +
Sbjct: 59  RFKHENIIGILDIIRPPSFE--SFNDVYIVQELMETDLYKLIKTQHL------SNDHIQY 110

Query: 259 FKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK 316
           F    L Q L         L Y+H+     + H DLK SN+LL+      + DFGLA+
Sbjct: 111 F----LYQILR-------GLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLAR 154

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 42.4 bits (99), Expect = 3e-04
 Identities = 52/220 (23%), Positives = 94/220 (42%), Gaps = 28/220 (12%)

Query: 165 IGSGSFGSVYKGTLADGETAAIKVLK-LQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           +G G++G VYK    DG+      LK ++  G   S   E   L  ++H N++    S  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVI----SLQ 64

Query: 224 SVDYEGNDFKA-LVFEFMRNGNLDQW----LHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
            V     D K  L+F++  +   D W     H ++       +L      +++  +   +
Sbjct: 65  KVFLSHADRKVWLLFDYAEH---DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121

Query: 279 DYLHNQYDTPIAHCDLKSSNVLL-----DEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
            YLH  +   + H DLK +N+L+     + G +  + D G A+      N+P K     +
Sbjct: 122 HYLHANW---VLHRDLKPANILVMGEGPERGRV-KIADMGFARLF----NSPLKPLADLD 173

Query: 334 GLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  +  Y  PE + G  H +   DI++ G +  E+ T +
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 42.4 bits (100), Expect = 3e-04
 Identities = 45/166 (27%), Positives = 68/166 (40%), Gaps = 36/166 (21%)

Query: 165 IGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFID------ECNALTSIRHRNILK 217
           IG G++G V     ++  E  AIK +      A  + ID      E   L  + H N++ 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKI----ANAFDNRIDAKRTLREIKLLRHLDHENVIA 68

Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH-------PSTDEYCHFKKLSLMQRLNI 270
           I         E  +   +V+E M     D  LH         +D++C +    L Q L  
Sbjct: 69  IKDIMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQY---FLYQLLR- 119

Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK 316
                  L Y+H+     + H DLK SN+LL+      + DFGLA+
Sbjct: 120 ------GLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 42.1 bits (99), Expect = 4e-04
 Identities = 35/107 (32%), Positives = 55/107 (51%), Gaps = 17/107 (15%)

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
           +++ AL++LH +    I + DLK  NVLLD EG I  + D+G+ K      +T S     
Sbjct: 104 EISLALNFLHER---GIIYRDLKLDNVLLDAEGHI-KLTDYGMCKEGIRPGDTTST---- 155

Query: 332 SNGLKGSVGYIPPEYINGH---VSILGDIYSYGILLLEIFTGKRPTD 375
                G+  YI PE + G     S+  D ++ G+L+ E+  G+ P D
Sbjct: 156 ---FCGTPNYIAPEILRGEDYGFSV--DWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 41.9 bits (98), Expect = 4e-04
 Identities = 61/241 (25%), Positives = 99/241 (41%), Gaps = 40/241 (16%)

Query: 154 NATDNFSEENLIGSGSFGSVYK-GTLADGETAAIKVLKLQQQGALKSFIDE-----CNAL 207
           + +D +     IG G++G V+K     +G  AA+K+L           IDE      N L
Sbjct: 15  DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD------IDEEIEAEYNIL 68

Query: 208 TSIR-HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHF-KKLSLM 265
            ++  H N++K        D +  D   LV E    G++       TD    F K+   M
Sbjct: 69  KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV-------TDLVKGFLKRGERM 121

Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
           +   I   +  AL  L + +     H D+K +N+LL       + DFG++  L   ++T 
Sbjct: 122 EEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL---TSTR 178

Query: 326 SKNQTMSNGLKGSVG---YIPPEYI------NGHVSILGDIYSYGILLLEIFTGKRPTDD 376
            +  T       SVG   ++ PE I      +       D++S GI  +E+  G  P  D
Sbjct: 179 LRRNT-------SVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD 231

Query: 377 M 377
           +
Sbjct: 232 L 232

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 61/231 (26%), Positives = 101/231 (43%), Gaps = 33/231 (14%)

Query: 164 LIGSGSFGSVYKGT-LADGETAAIKVLK---LQQQGALKSFIDECNAL-TSIRHRNILKI 218
           +IG GSFG V      A+ +  A+KVL+   + ++   K  + E N L  +++H  ++ +
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
             S     ++  D    V +++  G L   L     E C  +  +         ++ASAL
Sbjct: 62  HFS-----FQTADKLYFVLDYINGGELFYHLQ---RERCFLEPRARF----YAAEIASAL 109

Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
            YLH+     I + DLK  N+LLD      + DFGL K   E + T S          G+
Sbjct: 110 GYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-------FCGT 159

Query: 339 VGYIPPEYINGH-VSILGDIYSYGILLLEIFTG-----KRPTDDMFKDDLS 383
             Y+ PE ++        D +  G +L E+  G      R T +M+ + L+
Sbjct: 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 210

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 41.4 bits (97), Expect = 5e-04
 Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 35/221 (15%)

Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           +G G++GSVYK      G T A+K ++L+        +DE      I   +IL    S  
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLE--------LDESKFNQIIMELDILHKAVSPY 60

Query: 224 SVDYEGNDF-KALVF---EFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
            VD+ G  F +  V+   E+M  G+LD+            + +       I   V   L 
Sbjct: 61  IVDFYGAFFIEGAVYMCMEYMDAGSLDKL----YAGGVATEGIPEDVLRRITYAVVKGLK 116

Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSV 339
           +L  +++  I H D+K +NVL++      + DFG++  L           +++    G  
Sbjct: 117 FLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV---------ASLAKTNIGCQ 165

Query: 340 GYIPPEYI-------NGHVSILGDIYSYGILLLEIFTGKRP 373
            Y+ PE I       N   ++  D++S G+ +LE+  G+ P
Sbjct: 166 SYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 41.5 bits (97), Expect = 6e-04
 Identities = 53/220 (24%), Positives = 94/220 (42%), Gaps = 37/220 (16%)

Query: 164 LIGSGSFGSV-YKGTLADGETAAIKVLKLQ---QQGALKSFIDECNALTSIRHRNILKIV 219
           L+G G+FG V      A G   A+K+L+ +    +  +   + E   L + RH  +  + 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPS-----TDEYCHFKKLSLMQRLNIVIDV 274
            +     ++ +D    V E+   G L  + H S     T+E   F             ++
Sbjct: 62  YA-----FQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYG----------AEI 104

Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
            SAL+YLH++    + + D+K  N++LD+     + DFGL K         S   TM   
Sbjct: 105 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK------EGISDGATMKT- 154

Query: 335 LKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRP 373
             G+  Y+ PE + +       D +  G+++ E+  G+ P
Sbjct: 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 41.5 bits (97), Expect = 6e-04
 Identities = 54/189 (28%), Positives = 83/189 (43%), Gaps = 31/189 (16%)

Query: 164 LIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKS-----FIDECNAL-TSIRHRNIL 216
           +IG GSFG V      +DG   A+KVL  Q++  LK       + E N L  +++H  ++
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVL--QKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +  S     ++  +    V +++  G L  + H    E C  +  +         +VAS
Sbjct: 60  GLHYS-----FQTAEKLYFVLDYVNGGEL--FFHLQR-ERCFLEPRARF----YAAEVAS 107

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
           A+ YLH+     I + DLK  N+LLD      + DFGL K   E   T S          
Sbjct: 108 AIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-------FC 157

Query: 337 GSVGYIPPE 345
           G+  Y+ PE
Sbjct: 158 GTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 41.8 bits (98), Expect = 7e-04
 Identities = 24/63 (38%), Positives = 33/63 (52%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L +NS  G IP  +  L+ L  L L  NN +GK+P   + L  L+ L L  N+  GEI
Sbjct: 289 LDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEI 348

Query: 61  SRE 63
            + 
Sbjct: 349 PKN 351

Length = 968

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 41.6 bits (97), Expect = 7e-04
 Identities = 61/255 (23%), Positives = 99/255 (38%), Gaps = 58/255 (22%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIR-HRN 214
           D+F    +IG G+FG V      D G   A+K+L+       K+ + E   +  IR  R+
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-------KADMLEKEQVAHIRAERD 53

Query: 215 ILKIVSSCSSVD--YEGNDFKAL--VFEFMRNGNLDQWLHPS---TDEYCHFKKLSLMQR 267
           IL        V   Y   D + L  + EF+  G++   L      ++E   F     +  
Sbjct: 54  ILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQF----YIAE 109

Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL------------- 314
             + ID    L ++H          D+K  N+LLD      + DFGL             
Sbjct: 110 TVLAIDAIHQLGFIHR---------DIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160

Query: 315 --------AKFLFEESNTPSKNQTMSNGLK-------GSVGYIPPE-YINGHVSILGDIY 358
                   + F F+  N+  K +T     +       G+  YI PE ++    + L D +
Sbjct: 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWW 220

Query: 359 SYGILLLEIFTGKRP 373
           S G+++ E+  G  P
Sbjct: 221 SLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 41.3 bits (97), Expect = 7e-04
 Identities = 57/219 (26%), Positives = 91/219 (41%), Gaps = 36/219 (16%)

Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLK--LQQQGALKSFIDECNALTSIRHRNILKIVSS 221
           IG G+FG V+  T   DG+  A+K +    Q   + K    E   L   +H N+L  +  
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67

Query: 222 CSSVDYEGNDFKALVFEFMRNGNLDQWLH-------PSTDEYCHFKKLSLMQRLNIVIDV 274
                 +  +   +V E M++      LH       P + ++    K+ L Q L      
Sbjct: 68  LQPPHIDPFEEIYVVTELMQSD-----LHKIIVSPQPLSSDHV---KVFLYQILR----- 114

Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
              L YLH+     I H D+K  N+L++   +  + DFGLA+    E    SK+ T    
Sbjct: 115 --GLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV---EEPDESKHMTQEVV 166

Query: 335 LKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +    Y  PE + G  H +   DI+S G +  E+   +
Sbjct: 167 TQ---YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 41.2 bits (97), Expect = 8e-04
 Identities = 60/236 (25%), Positives = 97/236 (41%), Gaps = 39/236 (16%)

Query: 165 IGSGSFGSV----YKGTLADGETAAIKVLK--LQQQGALKSFIDECNALTSIR-HRNILK 217
           +G G++G V       T ++ ET AIK +     ++   K  + E   L   R H+NI  
Sbjct: 8   LGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66

Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCHFKKLSLMQRLNIVIDV 274
           +      V     +   L  E M   +L Q +    P TD   HF+   + Q L      
Sbjct: 67  LYDM-DIVFPGNFNELYLYEELM-EADLHQIIRSGQPLTD--AHFQSF-IYQIL------ 115

Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
              L Y+H+     + H DLK  N+L++      + DFGLA+     S  P +N      
Sbjct: 116 -CGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGF---SENPGENAGFMTE 168

Query: 335 LKGSVGYIPPE----YINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHK 386
              +  Y  PE    + +   +I  D++S G +L E   G++P   +FK    + +
Sbjct: 169 YVATRWYRAPEIMLSFQSYTKAI--DVWSVGCILAE-LLGRKP---VFKGKDYVDQ 218

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 41.4 bits (97), Expect = 0.001
 Identities = 23/63 (36%), Positives = 31/63 (49%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L  N+  G IP  L S   L +L L  N+L G++P+      SLR + L  N   GE+
Sbjct: 361 LDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGEL 420

Query: 61  SRE 63
             E
Sbjct: 421 PSE 423

Length = 968

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 40.9 bits (96), Expect = 0.001
 Identities = 71/287 (24%), Positives = 112/287 (39%), Gaps = 61/287 (21%)

Query: 162 ENL--IGSGSFGSV---YKGTLADGETAAIKVLK--LQQQGALKSFIDECNALTSIRHRN 214
           +NL  IGSG+ G V   Y      G+  AIK L    Q     K    E   +  + H+N
Sbjct: 19  QNLKPIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKN 76

Query: 215 ILKIVSSCSSVDYEGNDFKA--LVFEFMRNGNLDQWLHPSTDEYCHFKKLS--LMQRLNI 270
           I+ +++   +      +F+   LV E M + NL Q +    D     +++S  L Q L  
Sbjct: 77  IIGLLN-VFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDH----ERMSYLLYQML-- 128

Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
                  + +LH+     I H DLK SN+++       + DFGLA+       T   +  
Sbjct: 129 -----CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTSFM 173

Query: 331 MSNGLKGSVGYIPPEYINGHVSILG-------DIYSYGILLLEIFTGKRPTDDMFKDDLS 383
           M+        Y+   Y      ILG       DI+S G ++ E+  G      +F     
Sbjct: 174 MTP-------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTV----LFPGTDH 222

Query: 384 IHKF-----VLMALPSHVMDVLDLS--MLLEEENDHEKHEEEDLFPD 423
           I ++      L       M  L  +    +E    +  +  E+LFPD
Sbjct: 223 IDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPD 269

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 60/255 (23%), Positives = 99/255 (38%), Gaps = 58/255 (22%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIR-HRN 214
           ++F    +IG G+FG V      D G   A+K+L+       K+ + E   +  IR  R+
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR-------KADMLEKEQVGHIRAERD 53

Query: 215 ILKIVSSCSSV----DYEGNDFKALVFEFMRNGNLDQWLHPS---TDEYCHFKKLSLMQR 267
           IL    S   V     ++      L+ EF+  G++   L      T+E   F        
Sbjct: 54  ILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQF-------- 105

Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL------------- 314
              + +   A+D +H        H D+K  N+LLD      + DFGL             
Sbjct: 106 --YIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160

Query: 315 --------AKFLFEESNTPSKNQTMSNGLK-------GSVGYIPPE-YINGHVSILGDIY 358
                   + F F+  N+  K +T     +       G+  YI PE ++    + L D +
Sbjct: 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWW 220

Query: 359 SYGILLLEIFTGKRP 373
           S G+++ E+  G  P
Sbjct: 221 SLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 40.2 bits (94), Expect = 0.002
 Identities = 27/77 (35%), Positives = 41/77 (53%), Gaps = 4/77 (5%)

Query: 3   LGNNSFKGTIPVSLKSL-RGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEIS 61
           L NN   G IP  + +    L  L+LS NN +G +P+    + +L  L+LS N L GEI 
Sbjct: 100 LSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGS--IPNLETLDLSNNMLSGEIP 157

Query: 62  RE-GIFANASAISIVGN 77
            + G F++   + + GN
Sbjct: 158 NDIGSFSSLKVLDLGGN 174

Length = 968

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 40.1 bits (94), Expect = 0.002
 Identities = 59/218 (27%), Positives = 89/218 (40%), Gaps = 25/218 (11%)

Query: 162 ENLIGSGSFGSVYKGT-LADGETAAIKVLK--LQQQGALKSFIDECNALTSIRHRNILKI 218
           + +IG GS+G V        GE  AIK +    +        + E   L  +RH +I++I
Sbjct: 5   QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 64

Query: 219 VSSCSSVDYEGNDFKAL--VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
                       +FK +  VFE M + +L Q +  + D      +  L Q L        
Sbjct: 65  KHIMLPPSR--REFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLR------- 114

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
           AL Y+H      + H DLK  N+L +      + DFGLA+  F  ++TP+          
Sbjct: 115 ALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF--NDTPT--AIFWTDYV 167

Query: 337 GSVGYIPPEYINGHVSILG---DIYSYGILLLEIFTGK 371
            +  Y  PE      S      DI+S G +  E+ TGK
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 39.9 bits (94), Expect = 0.002
 Identities = 44/167 (26%), Positives = 74/167 (44%), Gaps = 41/167 (24%)

Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSF--IDECNALTSIR-------HRN 214
           IG G+F  V K  +   G+  AIK +K       K F  +++ N L  I+       H N
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMK-------KHFKSLEQVNNLREIQALRRLSPHPN 59

Query: 215 ILKIVSSCSSVDYEGNDFK-ALVFEFMRNGNLDQWLHPSTDEYCHFKK----LSLMQRLN 269
           IL+++     V ++    + ALVFE M + NL          Y   K     L   +  +
Sbjct: 60  ILRLI----EVLFDRKTGRLALVFELM-DMNL----------YELIKGRKRPLPEKRVKS 104

Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK 316
            +  +  +LD++H      I H D+K  N+L+ + ++  + DFG  +
Sbjct: 105 YMYQLLKSLDHMHRN---GIFHRDIKPENILIKDDIL-KLADFGSCR 147

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 50/227 (22%), Positives = 90/227 (39%), Gaps = 30/227 (13%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLADGETA-AIKVL---KLQQQGALKSFIDECNALTSIRH 212
           ++F    +IG G+FG V    L + +   A+K+L   ++ ++     F +E + L +  +
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
           + I  +  +     ++  +   LV ++   G+L   L    D          +  + I I
Sbjct: 61  QWITTLHYA-----FQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI 115

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           D    L Y+H          D+K  N+L+D      + DFG    L E+    S      
Sbjct: 116 DSVHQLHYVHR---------DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-- 164

Query: 333 NGLKGSVGYIPPEYIN------GHVSILGDIYSYGILLLEIFTGKRP 373
               G+  YI PE +       G      D +S G+ + E+  G+ P
Sbjct: 165 ----GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 35.6 bits (83), Expect = 0.003
 Identities = 15/37 (40%), Positives = 19/37 (51%)

Query: 21 GLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELD 57
           L  LDLS N L+      F  L +L+ L+LS N L 
Sbjct: 1  NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT 37

Length = 60

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 58/218 (26%), Positives = 89/218 (40%), Gaps = 40/218 (18%)

Query: 165 IGSGSFGSVYKG-TLADGETAAIKVL--KLQQQGALKSFIDECNALTSIRHRNILKIVSS 221
           IGSG+ G V        G   A+K L    Q Q   K    E   L  + H+NI+ +++ 
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88

Query: 222 CSSVDY--EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
            +      E  D   LV E M + NL Q +H   D     +++S +     +  +   + 
Sbjct: 89  FTPQKSLEEFQDV-YLVMELM-DANLCQVIHMELDH----ERMSYL-----LYQMLCGIK 137

Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSV 339
           +LH+     I H DLK SN+++       + DFGLA+       T   N  M+       
Sbjct: 138 HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-------TACTNFMMTP------ 181

Query: 340 GYIPPEYINGHVSILG-------DIYSYGILLLEIFTG 370
            Y+   Y      ILG       DI+S G ++ E+  G
Sbjct: 182 -YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 39.4 bits (92), Expect = 0.003
 Identities = 55/188 (29%), Positives = 84/188 (44%), Gaps = 27/188 (14%)

Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLK---LQQQGALKSFIDECNAL-TSIRHRNILKIV 219
           IG GSFG V      ADG+  A+KVL+   + ++   K  + E N L  +++H  ++ + 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
            S     ++  D    V +++  G L  + H   +    F       R     ++ASAL 
Sbjct: 63  YS-----FQTADKLYFVLDYVNGGEL--FFHLQRER--SF--PEPRARF-YAAEIASALG 110

Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSV 339
           YLH+     I + DLK  N+LLD      + DFGL K   E S T S          G+ 
Sbjct: 111 YLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-------FCGTP 160

Query: 340 GYIPPEYI 347
            Y+ PE +
Sbjct: 161 EYLAPEVL 168

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 39.3 bits (92), Expect = 0.003
 Identities = 58/275 (21%), Positives = 103/275 (37%), Gaps = 38/275 (13%)

Query: 166 GSGSFGSVYKGTLADGETAAIKVLKLQQQGA--LKSFIDECNALTSIRHRNILKIVSSCS 223
                  + K         A+K + L       LK    E      ++H NIL  V+S  
Sbjct: 11  EDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF- 68

Query: 224 SVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCH--FKKLSLMQRLNIVIDVASALDYL 281
                 ++   +V   M  G+ +  L      +      +L++     I+ DV +ALDY+
Sbjct: 69  ---IVDSEL-YVVSPLMAYGSCEDLL----KTHFPEGLPELAIAF---ILKDVLNALDYI 117

Query: 282 HNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGY 341
           H++      H  +K+S++LL       +     +  + +      + + + +  K SV  
Sbjct: 118 HSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK---RQRVVHDFPKSSVKN 171

Query: 342 IP---PEYINGHVSILG-----DIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALP 393
           +P   PE +    ++ G     DIYS GI   E+  G  P  DM    + + K V   +P
Sbjct: 172 LPWLSPEVLQQ--NLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK-VRGTVP 228

Query: 394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQV 428
                +LD S     E+   +    +  P+    V
Sbjct: 229 C----LLDKSTYPLYEDSMSQSRSSNEHPNNRDSV 259

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|111949 pfam03109, ABC1, ABC1 family

 Score = 37.2 bits (87), Expect = 0.003
 Identities = 11/29 (37%), Positives = 16/29 (55%)

Query: 161 EENLIGSGSFGSVYKGTLADGETAAIKVL 189
           +E  I + S   V++  L DGE  A+KV 
Sbjct: 15  DEEPIAAASIAQVHRAVLKDGEEVAVKVQ 43

This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 39.0 bits (91), Expect = 0.004
 Identities = 52/224 (23%), Positives = 96/224 (42%), Gaps = 37/224 (16%)

Query: 165 IGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           +G GS G V+    +D  +  A+K + L    ++K  + E   +  + H NI+K+     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 224 SVDYEGNDFKALVFEF-------------MRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
               +  +    + E              + N  L+Q   P ++E+    +L + Q L  
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLAN-VLEQ--GPLSEEHA---RLFMYQLLR- 125

Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQ 329
                  L Y+H+     + H DLK +NV ++ E ++  +GDFGLA+ +       S   
Sbjct: 126 ------GLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY---SHKG 173

Query: 330 TMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGK 371
            +S GL  +  Y  P  +    + +   D+++ G +  E+ TGK
Sbjct: 174 YLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	477
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.98
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.92
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.87
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.87
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.87
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.87
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.87
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.85
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.85
PRK12274	218	serine/threonine protein kinase; Provisional	99.83
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.82
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.81
PRK10345	210	hypothetical protein; Provisional	99.8
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.8
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.79
smart00090	237	RIO RIO-like kinase.	99.78
PRK14879	211	serine/threonine protein kinase; Provisional	99.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.75
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.74
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.73
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.71
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.66
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.64
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.64
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.64
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.64
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.58
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.54
PLN03150	623	hypothetical protein; Provisional	99.52
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.46
KOG1243	690	consensus Protein kinase [General function predict	99.41
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.37
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.35
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.29
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.25
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.21
PLN03150	623	hypothetical protein; Provisional	99.19
COG4248	637	Uncharacterized protein with protein kinase and he	99.15
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.11
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.11
KOG3087	229	consensus Serine/threonine protein kinase [General	99.09
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.09
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.07
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.03
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.96
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.89
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.88
KOG0617	264	consensus Ras suppressor protein (contains leucine	98.83
PRK09902	216	hypothetical protein; Provisional	98.8
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.75
KOG0617	264	consensus Ras suppressor protein (contains leucine	98.75
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.73
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.62
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.62
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.59
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.46
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.42
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.37
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	98.34
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.32
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.27
KOG0472	565	consensus Leucine-rich repeat protein [Function un	98.27
PF01636	239	APH: Phosphotransferase enzyme family This family	98.25
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.24
KOG0472	565	consensus Leucine-rich repeat protein [Function un	98.24
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.23
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.22
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	98.14
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.11
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.09
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.07
PRK10593	297	hypothetical protein; Provisional	98.06
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.05
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.05
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.04
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.02
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	97.98
PLN02876	822	acyl-CoA dehydrogenase	97.97
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.9
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	97.81
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	97.73
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.72
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	97.71
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	97.7
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.68
KOG4237	498	consensus Extracellular matrix protein slit, conta	97.65
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.58
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	97.57
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.56
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	97.56
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.55
PRK05231	319	homoserine kinase; Provisional	97.55

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.3e-57  Score=497.38  Aligned_cols=415  Identities=27%  Similarity=0.429  Sum_probs=286.5

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcCCcc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGNDKL   80 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~~l   80 (477)
                      |+|++|+++|.+|..++++++|+.|||++|+++|.+|..+.++++|+.|++++|+|+|.+|....+.++....+.+|+.+
T Consensus       528 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~l  607 (968)
T PLN00113        528 LDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDL  607 (968)
T ss_pred             EECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccc
Confidence            46777777777777777777788888888888777887777777888888888888888887766667777788999999


Q ss_pred             ccccccccCCcccCCCCcccccceeeeeeechhHHHHHHHHHHHHhhhhhccccCCC--CCCCcccCC------ccHHHH
Q 043902           81 CGGIQKLQLPECSRKNPRKRLSLKIVIPVTISVPIFILLLAALVIYHIVKTSRRQSA--PPSNEWQSG------LSYLKI  152 (477)
Q Consensus        81 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~------~~~~~~  152 (477)
                      ||+.+....|+|.....  .....++++++++++++++++++++++++++++.+.+.  .....+...      ......
T Consensus       608 c~~~~~~~~~~c~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  685 (968)
T PLN00113        608 CGGDTTSGLPPCKRVRK--TPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITI  685 (968)
T ss_pred             cCCccccCCCCCccccc--cceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhH
Confidence            99876656677754321  11222222222222222222222222222221111111  001111110      011223


Q ss_pred             HHhhcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          153 SNATDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       153 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      ......|...+.||+|+||.||+|+. .++..||||.++.....    ...|++.+++++||||++++++|.     ..+
T Consensus       686 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~-----~~~  756 (968)
T PLN00113        686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCR-----SEK  756 (968)
T ss_pred             HHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEE-----cCC
Confidence            33446788889999999999999986 47899999998744321    235688999999999999999973     445


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+++|+|.++++          .++|..+.+++.|+|+||+|||+.+.++|+||||||+||+++.++.+++. 
T Consensus       757 ~~~lv~Ey~~~g~L~~~l~----------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-  825 (968)
T PLN00113        757 GAYLIHEYIEGKNLSEVLR----------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-  825 (968)
T ss_pred             CCEEEEeCCCCCcHHHHHh----------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-
Confidence            6899999999999999985          27899999999999999999997666799999999999999999988875 


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      ||.+....           ......++..|+|||++ .+.++.++|||||||++|||+||+.||+...........|+..
T Consensus       826 ~~~~~~~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~  894 (968)
T PLN00113        826 LSLPGLLC-----------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARY  894 (968)
T ss_pred             eccccccc-----------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHH
Confidence            66554321           11123578999999999 5579999999999999999999999996543333333333322


Q ss_pred             cCCc-hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHH
Q 043902          391 ALPS-HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIR  469 (477)
Q Consensus       391 ~~~~-~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  469 (477)
                      .... ....++|+.+...                      .....++..++.+++.+|++.||++||||+||++.|+++.
T Consensus       895 ~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  952 (968)
T PLN00113        895 CYSDCHLDMWIDPSIRGD----------------------VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS  952 (968)
T ss_pred             hcCccchhheeCccccCC----------------------CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence            2211 2222233222110                      0001123456889999999999999999999999999886


Q ss_pred             H
Q 043902          470 S  470 (477)
Q Consensus       470 ~  470 (477)
                      +
T Consensus       953 ~  953 (968)
T PLN00113        953 R  953 (968)
T ss_pred             c
Confidence            5

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-56  Score=431.94  Aligned_cols=290  Identities=37%  Similarity=0.640  Sum_probs=239.9

Q ss_pred             ccCCccHHHHHHhhcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeec
Q 043902          143 WQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSC  222 (477)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~  222 (477)
                      ....|++.++..+|++|+..+.||+|+||.||+|.+.+|..||||++.........+|.+|++++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            45668999999999999999999999999999999999999999988765433135699999999999999999999999


Q ss_pred             ccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec
Q 043902          223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD  302 (477)
Q Consensus       223 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~  302 (477)
                      .    +.++..+||||||++|+|.++|+....     ..++|..|++||.++|+||+|||+.+.+.|+||||||+|||||
T Consensus       141 ~----e~~~~~~LVYEym~nGsL~d~L~~~~~-----~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD  211 (361)
T KOG1187|consen  141 L----EGGEHRLLVYEYMPNGSLEDHLHGKKG-----EPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD  211 (361)
T ss_pred             e----cCCceEEEEEEccCCCCHHHHhCCCCC-----CCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC
Confidence            4    222268999999999999999997652     1789999999999999999999999888999999999999999


Q ss_pred             CCCcEEEecccccccccccCCCCCCCccccCCC-cccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCccc-c
Q 043902          303 EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL-KGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMF-K  379 (477)
Q Consensus       303 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~-~  379 (477)
                      +++++||+|||+|+.....       ....... .||.+|+|||+. .|..+.|+|||||||+++||+||+.|.+... .
T Consensus       212 ~~~~aKlsDFGLa~~~~~~-------~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~  284 (361)
T KOG1187|consen  212 EDFNAKLSDFGLAKLGPEG-------DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR  284 (361)
T ss_pred             CCCCEEccCccCcccCCcc-------ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc
Confidence            9999999999999765210       1111111 799999999999 6899999999999999999999999887543 3


Q ss_pred             cccceeeeeeccCCc-hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCCh
Q 043902          380 DDLSIHKFVLMALPS-HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGM  458 (477)
Q Consensus       380 ~~~~~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  458 (477)
                      ....+..|+...+.. .+.+++|+++....                   +..   ++++.++.+++.+|++.+|.+||+|
T Consensus       285 ~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~-------------------~~~---~~~~~~~~~~a~~C~~~~~~~RP~m  342 (361)
T KOG1187|consen  285 GELSLVEWAKPLLEEGKLREIVDPRLKEGE-------------------YPD---EKEVKKLAELALRCLRPDPKERPTM  342 (361)
T ss_pred             ccccHHHHHHHHHHCcchhheeCCCccCCC-------------------CCh---HHHHHHHHHHHHHHcCcCCCcCcCH
Confidence            333466776555555 67788888765210                   000   0346679999999999999999999


Q ss_pred             HHHHHHHHHHHH
Q 043902          459 KFVVNNLQAIRS  470 (477)
Q Consensus       459 ~evl~~L~~i~~  470 (477)
                      .||+++|+.+..
T Consensus       343 ~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  343 SQVVKELEGILS  354 (361)
T ss_pred             HHHHHHHHhhcc
Confidence            999999976654

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-50  Score=384.36  Aligned_cols=260  Identities=31%  Similarity=0.517  Sum_probs=208.2

Q ss_pred             CCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchh--hHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEE
Q 043902          159 FSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGA--LKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALV  236 (477)
Q Consensus       159 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  236 (477)
                      +...+.||+|+||+||+|.+.....||||++.......  .+.|.+|+.+|.+++|||||+++|+|..    .....++|
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~----~~~~~~iV  118 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTS----PPGSLCIV  118 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC----CCCceEEE
Confidence            33455699999999999999654459999998654222  5699999999999999999999999852    22268999


Q ss_pred             EeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCC-eeecCCCCCCeEecCCC-cEEEecccc
Q 043902          237 FEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTP-IAHCDLKSSNVLLDEGM-IAHVGDFGL  314 (477)
Q Consensus       237 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~dlkp~NIll~~~~-~~kl~DfG~  314 (477)
                      ||||++|+|..+++...     ...+++..+++++.|||+||.|||++   + ||||||||+|||++.++ ++||+|||+
T Consensus       119 tEy~~~GsL~~~l~~~~-----~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGl  190 (362)
T KOG0192|consen  119 TEYMPGGSLSVLLHKKR-----KRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGL  190 (362)
T ss_pred             EEeCCCCcHHHHHhhcc-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCcc
Confidence            99999999999998741     26799999999999999999999999   7 99999999999999998 999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccccC---CCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      ++.....       ....+...||..|||||++.+   .++.|+||||||+++|||+||+.||.+......         
T Consensus       191 sr~~~~~-------~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~---------  254 (362)
T KOG0192|consen  191 SREKVIS-------KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV---------  254 (362)
T ss_pred             ceeeccc-------cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH---------
Confidence            9876321       133344689999999999964   499999999999999999999999987532110         


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHh
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSK  471 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  471 (477)
                          ...++....                        +...+.+|...+..++.+||+.||++||++.|++..|+.+...
T Consensus       255 ----~~~v~~~~~------------------------Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~  306 (362)
T KOG0192|consen  255 ----ASAVVVGGL------------------------RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH  306 (362)
T ss_pred             ----HHHHHhcCC------------------------CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence                001110000                        0011112466689999999999999999999999999999886


Q ss_pred             hhh
Q 043902          472 IRM  474 (477)
Q Consensus       472 ~~~  474 (477)
                      +..
T Consensus       307 ~~~  309 (362)
T KOG0192|consen  307 ISS  309 (362)
T ss_pred             hcc
Confidence            553

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-50  Score=385.08  Aligned_cols=255  Identities=28%  Similarity=0.493  Sum_probs=214.9

Q ss_pred             CCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEee
Q 043902          160 SEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEF  239 (477)
Q Consensus       160 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~  239 (477)
                      ...+.||+|.||.||.|.++....||+|.++..... .+.|.+|+++|.+|+|+|||+++|+|.     .++..+|||||
T Consensus       209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~-~~~f~~Ea~iMk~L~H~~lV~l~gV~~-----~~~piyIVtE~  282 (468)
T KOG0197|consen  209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS-PEAFLREAQIMKKLRHEKLVKLYGVCT-----KQEPIYIVTEY  282 (468)
T ss_pred             HHHHHhcCCccceEEEEEEcCCCcccceEEeccccC-hhHHHHHHHHHHhCcccCeEEEEEEEe-----cCCceEEEEEe
Confidence            345789999999999999987779999999976433 378999999999999999999999984     34479999999


Q ss_pred             cCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccccc
Q 043902          240 MRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLF  319 (477)
Q Consensus       240 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  319 (477)
                      |+.|+|.++|+...     ...+...+.+.++.|||+||+||+++   ++|||||.++||||+++..+||+|||+|+...
T Consensus       283 m~~GsLl~yLr~~~-----~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~  354 (468)
T KOG0197|consen  283 MPKGSLLDYLRTRE-----GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIG  354 (468)
T ss_pred             cccCcHHHHhhhcC-----CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccC
Confidence            99999999998733     26789999999999999999999999   99999999999999999999999999999542


Q ss_pred             ccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCCchhH
Q 043902          320 EESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALPSHVM  397 (477)
Q Consensus       320 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  397 (477)
                      +      .......+..-+..|.|||.+ .++++.|||||||||+||||+| |+.||..+...+              +.
T Consensus       355 d------~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e--------------v~  414 (468)
T KOG0197|consen  355 D------DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE--------------VL  414 (468)
T ss_pred             C------CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH--------------HH
Confidence            2      223344455568899999999 7899999999999999999999 999987754322              22


Q ss_pred             HHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHhh
Q 043902          398 DVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSKI  472 (477)
Q Consensus       398 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  472 (477)
                      +.+                        ...++...++.|+..+.+++..||+.+|++|||++.+...|+.+...-
T Consensus       415 ~~l------------------------e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  415 ELL------------------------ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             HHH------------------------hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence            222                        223444556678889999999999999999999999999999887643

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-49  Score=360.95  Aligned_cols=250  Identities=26%  Similarity=0.393  Sum_probs=203.4

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec-cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc-ee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ-QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND-FK  233 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~-~~  233 (477)
                      .+.+....||+|..|+||+++++ +++.+|+|++... +....+++.+|++++.+.+||+||.++|.|     ..+. ..
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF-----~~~~~~i  153 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAF-----YSNGEEI  153 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEE-----EeCCceE
Confidence            34556789999999999999976 7899999999644 344568899999999999999999999996     3344 69


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN-QYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||++|+|++++...       +.+++...-+|+.+|++||.|||+ +   +|+||||||+|||++..|++||+||
T Consensus       154 sI~mEYMDgGSLd~~~k~~-------g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDF  223 (364)
T KOG0581|consen  154 SICMEYMDGGSLDDILKRV-------GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDF  223 (364)
T ss_pred             EeehhhcCCCCHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccc
Confidence            9999999999999999754       568999999999999999999996 5   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccccC-CCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      |.+..+.         .......+||..|||||.+.+ .|+.++||||||++++|+.+|+.||.......          
T Consensus       224 GVS~~lv---------nS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~----------  284 (364)
T KOG0581|consen  224 GVSGILV---------NSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY----------  284 (364)
T ss_pred             cccHHhh---------hhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC----------
Confidence            9999873         235667899999999999954 79999999999999999999999997531110          


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHH-HHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLE-ECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                        ....++++.-.....             |        ..++ .|..++..++..||+.||.+|||++|+++
T Consensus       285 --~~~~~Ll~~Iv~~pp-------------P--------~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  285 --LDIFELLCAIVDEPP-------------P--------RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             --CCHHHHHHHHhcCCC-------------C--------CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              122222222221110             0        0111 24555899999999999999999999985

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1e-48  Score=391.11  Aligned_cols=264  Identities=27%  Similarity=0.506  Sum_probs=218.0

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC------CCCEEEEEEeeeccch-hhHHHHHHHHHHhcCCCCCcceeeeecccccCCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQQQG-ALKSFIDECNALTSIRHRNILKIVSSCSSVDYEG  229 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  229 (477)
                      .+....+.||+|.||.||+|+..      +...||||.++..... ..++|.+|++++..++|||||+++|+|     ..
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC-----~~  560 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC-----RE  560 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----cc
Confidence            44556678999999999999853      3467999999977655 778999999999999999999999999     45


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCccc-------ccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDEYC-------HFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD  302 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~  302 (477)
                      ++..++|+|||..|||.+||........       ...+++..+.+.||.|||.||.||-++   .+|||||..+|+||.
T Consensus       561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVg  637 (774)
T KOG1026|consen  561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVG  637 (774)
T ss_pred             CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceec
Confidence            7789999999999999999975432110       134589999999999999999999999   999999999999999


Q ss_pred             CCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCccccc
Q 043902          303 EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKD  380 (477)
Q Consensus       303 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~  380 (477)
                      ++..+||+|||+++..+..++..     ......-+++|||||.+ .+++|.+||||||||+|||++| |+.||.+...+
T Consensus       638 e~l~VKIsDfGLsRdiYssDYYk-----~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~  712 (774)
T KOG1026|consen  638 ENLVVKISDFGLSRDIYSSDYYK-----VRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ  712 (774)
T ss_pred             cceEEEecccccchhhhhhhhhc-----ccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH
Confidence            99999999999999876544332     22234568999999999 8999999999999999999999 99999875443


Q ss_pred             ccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHH
Q 043902          381 DLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKF  460 (477)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e  460 (477)
                      +              +.+.+..+..                        -+.++.|+.++.+|+..||+.+|.+||+++|
T Consensus       713 E--------------VIe~i~~g~l------------------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~e  754 (774)
T KOG1026|consen  713 E--------------VIECIRAGQL------------------------LSCPENCPTEVYSLMLECWNENPKRRPSFKE  754 (774)
T ss_pred             H--------------HHHHHHcCCc------------------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHH
Confidence            2              2222222211                        2245678889999999999999999999999


Q ss_pred             HHHHHHHHHHh
Q 043902          461 VVNNLQAIRSK  471 (477)
Q Consensus       461 vl~~L~~i~~~  471 (477)
                      |-..|+..-+.
T Consensus       755 I~~~L~~~~~~  765 (774)
T KOG1026|consen  755 IHSRLQAWAQA  765 (774)
T ss_pred             HHHHHHHHHhc
Confidence            99999886543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.7e-48  Score=353.34  Aligned_cols=252  Identities=24%  Similarity=0.342  Sum_probs=199.1

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeeccch-------hhHHHHHHHHHHhcCCCCCcceeeeeccccc
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQG-------ALKSFIDECNALTSIRHRNILKIVSSCSSVD  226 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  226 (477)
                      ..+.|...+.||+|+||.|-+|.. ++|+.||||+++.....       ......+|+++|++++|||||++.+++    
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f----  245 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF----  245 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee----
Confidence            346677889999999999999975 58999999999754211       122356999999999999999999994    


Q ss_pred             CCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC--
Q 043902          227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG--  304 (477)
Q Consensus       227 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~--  304 (477)
                       +..+..|+||||+.||+|.+.+-.+       +.+.+..-..++.|++.|+.|||++   ||+||||||+|||+..+  
T Consensus       246 -~~~ds~YmVlE~v~GGeLfd~vv~n-------k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e  314 (475)
T KOG0615|consen  246 -EVPDSSYMVLEYVEGGELFDKVVAN-------KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAE  314 (475)
T ss_pred             -ecCCceEEEEEEecCccHHHHHHhc-------cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCc
Confidence             6777889999999999999998765       4577778889999999999999999   99999999999999766  


Q ss_pred             -CcEEEecccccccccccCCCCCCCccccCCCcccccccCcccccC---C-CCcccceeehHHHHHHHhhCCCCCCcccc
Q 043902          305 -MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING---H-VSILGDIYSYGILLLEIFTGKRPTDDMFK  379 (477)
Q Consensus       305 -~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~-~~~~~Dv~S~Gvvl~elltg~~p~~~~~~  379 (477)
                       ..+||+|||+|+...        ........+||+.|.|||++.+   . +..++|+||+||+||-+++|.+||.+...
T Consensus       315 ~~llKItDFGlAK~~g--------~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~  386 (475)
T KOG0615|consen  315 DCLLKITDFGLAKVSG--------EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT  386 (475)
T ss_pred             ceEEEecccchhhccc--------cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC
Confidence             789999999999762        2445567889999999999932   2 44589999999999999999999976433


Q ss_pred             cccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChH
Q 043902          380 DDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMK  459 (477)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~  459 (477)
                      +....            .++..-+..                      +.+....+..++..+++.+||..||++|||+.
T Consensus       387 ~~sl~------------eQI~~G~y~----------------------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~  432 (475)
T KOG0615|consen  387 DPSLK------------EQILKGRYA----------------------FGPLQWDRISEEALDLINWMLVVDPENRPSAD  432 (475)
T ss_pred             CccHH------------HHHhcCccc----------------------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHH
Confidence            22100            011110000                      01112223345588999999999999999999


Q ss_pred             HHHH
Q 043902          460 FVVN  463 (477)
Q Consensus       460 evl~  463 (477)
                      |+++
T Consensus       433 eaL~  436 (475)
T KOG0615|consen  433 EALN  436 (475)
T ss_pred             HHhc
Confidence            9985

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-46  Score=363.05  Aligned_cols=246  Identities=25%  Similarity=0.404  Sum_probs=205.4

Q ss_pred             cCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeec---cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQ---QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ..|...++||+|||+.||.++. .+|..||+|++...   .....+...+|+++.++|+|||||+++++     |++.+.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~-----FEDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF-----FEDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE-----eecCCc
Confidence            5789999999999999999997 78999999999743   34456788999999999999999999999     588999


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .|+|.|+|+.++|..+++.+       +.+++.++..+..||+.||.|||++   +|+|||||..|++++++.++||+||
T Consensus        93 VYivLELC~~~sL~el~Krr-------k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDF  162 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKRR-------KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDF  162 (592)
T ss_pred             eEEEEEecCCccHHHHHHhc-------CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEeccc
Confidence            99999999999999999844       6799999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      |+|..+..       ........+||+.|+|||++ ....+..+||||+||++|-|++|++||+...             
T Consensus       163 GLAt~le~-------~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-------------  222 (592)
T KOG0575|consen  163 GLATQLEY-------DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-------------  222 (592)
T ss_pred             ceeeeecC-------cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-------------
Confidence            99988732       12233457899999999999 4568999999999999999999999997631             


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                          +.+.++.-...+.           .+|.           .......+|+..+|+.||.+|||+++|+.
T Consensus       223 ----vkety~~Ik~~~Y-----------~~P~-----------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  223 ----VKETYNKIKLNEY-----------SMPS-----------HLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ----HHHHHHHHHhcCc-----------cccc-----------ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                2222221111110           0111           11234779999999999999999999985

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-47  Score=347.88  Aligned_cols=200  Identities=33%  Similarity=0.569  Sum_probs=179.0

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec--cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      ...+|...+.||+|+||+||+|+++ ++..||||.+...  .....+....|+.+|+.++|||||++++++     ..++
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~   82 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDD   82 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCC
Confidence            3467888889999999999999975 6899999999765  455667789999999999999999999996     5677


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC------C
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG------M  305 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~------~  305 (477)
                      ..++|||||.||+|.+|++..       ..+++.....++.|+|.||++||++   +||||||||.|||++..      -
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~~-------~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~  152 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRRR-------GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSP  152 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCc
Confidence            899999999999999999866       4699999999999999999999999   99999999999999765      4


Q ss_pred             cEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          306 IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       306 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      .+||+|||+|+.+.        ........+|++.|||||++ .++|+.|+|+||.|+++|++++|+.||+..
T Consensus       153 ~LKIADFGfAR~L~--------~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~  217 (429)
T KOG0595|consen  153 VLKIADFGFARFLQ--------PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE  217 (429)
T ss_pred             eEEecccchhhhCC--------chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            68999999999873        23445567899999999999 889999999999999999999999999853

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-48  Score=338.50  Aligned_cols=208  Identities=27%  Similarity=0.453  Sum_probs=178.2

Q ss_pred             hcCCCCCCeeeeeccceEEEEE-eCCCCEEEEEEeeec--cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          156 TDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ..+|.+.+.||+|.||.||++. ..+|..+|.|.++..  +....+....|+.+|++|+|||||+++++-.   .++.+.
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f---~~~~ev   94 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF---IEDNEV   94 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh---hccchh
Confidence            3467888999999999999997 568999999998843  4555678999999999999999999998532   244555


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCC-CeeecCCCCCCeEecCCCcEEEec
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDT-PIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      .++||||+..|+|...++.-..   ..+.+++..+|+++.|++.||.++|+.... -|.||||||.||+++.+|.+||+|
T Consensus        95 lnivmE~c~~GDLsqmIk~~K~---qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGD  171 (375)
T KOG0591|consen   95 LNIVMELCDAGDLSQMIKHFKK---QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGD  171 (375)
T ss_pred             hHHHHHhhcccCHHHHHHHHHh---ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeecc
Confidence            8999999999999999975443   236799999999999999999999995322 399999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ||+++++..       ......+.+||+.||+||.+ ...|+.||||||+||++|||+.-++||..
T Consensus       172 fGL~r~l~s-------~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g  230 (375)
T KOG0591|consen  172 FGLGRFLSS-------KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG  230 (375)
T ss_pred             chhHhHhcc-------hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc
Confidence            999998732       34445678999999999999 66799999999999999999999999975

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-47  Score=370.57  Aligned_cols=256  Identities=26%  Similarity=0.479  Sum_probs=215.8

Q ss_pred             CCCCCeeeeeccceEEEEEeC----CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          159 FSEENLIGSGSFGSVYKGTLA----DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       159 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ..+.++||.|.||.||+|+++    ....||||.+|... .....+|+.|+.+|.++.||||++|.|+.     ......
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV-----Tks~Pv  705 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV-----TKSKPV  705 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE-----ecCcee
Confidence            346789999999999999975    24579999999654 44567899999999999999999999994     566778


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++|+|||++|+|+.||+.+.      ..+++.+...++.+||.||+||.+.   ++|||||..+||||+.+..+|++|||
T Consensus       706 MIiTEyMENGsLDsFLR~~D------GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFG  776 (996)
T KOG0196|consen  706 MIITEYMENGSLDSFLRQND------GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFG  776 (996)
T ss_pred             EEEhhhhhCCcHHHHHhhcC------CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEecccc
Confidence            99999999999999999876      4589999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeecc
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      +++.+.++.    .......+..-+.+|.|||.+ ..++|.++||||||+|+||.++ |.+||-++.+.+.         
T Consensus       777 LSRvledd~----~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV---------  843 (996)
T KOG0196|consen  777 LSRVLEDDP----EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---------  843 (996)
T ss_pred             ceeecccCC----CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH---------
Confidence            999774432    223333444557899999999 7899999999999999999998 9999977654431         


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRS  470 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  470 (477)
                              +                     ..++..++...+.+|+..|.+|++.||+.|-.+||.+.||+..|+++-.
T Consensus       844 --------I---------------------kaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr  893 (996)
T KOG0196|consen  844 --------I---------------------KAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR  893 (996)
T ss_pred             --------H---------------------HHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence                    1                     1122234444556789999999999999999999999999999998743

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-45  Score=348.89  Aligned_cols=262  Identities=27%  Similarity=0.459  Sum_probs=208.7

Q ss_pred             HHhhcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          153 SNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       153 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      ....+.+.....||+|.||+||+|++.  ..||||+++...  ....+.|.+|+..+++-+|.||+-+.|+|..     .
T Consensus       388 eIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~-----p  460 (678)
T KOG0193|consen  388 EIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN-----P  460 (678)
T ss_pred             ccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC-----C
Confidence            344456667889999999999999986  369999998653  4467899999999999999999999999842     3


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      . ..||+.+|+|.+|+.+++..+      ..+...+.+.|+.|||+||.|||.+   +|+|||||+.||++.+++.|||+
T Consensus       461 ~-~AIiTqwCeGsSLY~hlHv~e------tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIg  530 (678)
T KOG0193|consen  461 P-LAIITQWCEGSSLYTHLHVQE------TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIG  530 (678)
T ss_pred             c-eeeeehhccCchhhhhccchh------hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEe
Confidence            3 499999999999999999765      6789999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCccccc----CCCCcccceeehHHHHHHHhhCCCCCCcccccccceee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN----GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHK  386 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~  386 (477)
                      |||++..-.-     -..........|...|||||++.    ..|+..+||||||+|+|||+||..||.....+.+ +..
T Consensus       531 DFGLatvk~~-----w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI-ifm  604 (678)
T KOG0193|consen  531 DFGLATVKTR-----WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI-IFM  604 (678)
T ss_pred             cccceeeeee-----eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe-EEE
Confidence            9999964311     11222233445788999999982    3589999999999999999999999984333322 211


Q ss_pred             eeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHH
Q 043902          387 FVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQ  466 (477)
Q Consensus       387 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  466 (477)
                      .-+..+...+.                                 .....|++++.+|+..||..++++||.+.+|+..|+
T Consensus       605 VGrG~l~pd~s---------------------------------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~  651 (678)
T KOG0193|consen  605 VGRGYLMPDLS---------------------------------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLE  651 (678)
T ss_pred             ecccccCccch---------------------------------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHH
Confidence            11111111000                                 112235677999999999999999999999999888


Q ss_pred             HHHH
Q 043902          467 AIRS  470 (477)
Q Consensus       467 ~i~~  470 (477)
                      .+..
T Consensus       652 ~l~~  655 (678)
T KOG0193|consen  652 ELLP  655 (678)
T ss_pred             Hhhh
Confidence            8766

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-45  Score=331.67  Aligned_cols=200  Identities=32%  Similarity=0.473  Sum_probs=177.9

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      ..++|+..++||+|+||.||.++.+ +++.+|+|+++...   ........+|..+|.+++||.||++.-.     |++.
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQt~   97 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQTE   97 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----cccC
Confidence            3578999999999999999999865 68999999997542   3456788999999999999999999876     6889


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +.+|+|+||+.||.|..+|++.       ..+++..+.-++.+|+.||.|||+.   +|+||||||+|||+|.+|+++|+
T Consensus        98 ~kLylVld~~~GGeLf~hL~~e-------g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~Lt  167 (357)
T KOG0598|consen   98 EKLYLVLDYLNGGELFYHLQRE-------GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLT  167 (357)
T ss_pred             CeEEEEEeccCCccHHHHHHhc-------CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEe
Confidence            9999999999999999999865       5689999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |||+++....       ........+||+.|||||++ ...++..+|+||+|+++|||++|.+||..
T Consensus       168 DFgL~k~~~~-------~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~  227 (357)
T KOG0598|consen  168 DFGLCKEDLK-------DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA  227 (357)
T ss_pred             ccccchhccc-------CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC
Confidence            9999986422       22334457899999999999 66799999999999999999999999975

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.4e-45  Score=322.80  Aligned_cols=276  Identities=19%  Similarity=0.276  Sum_probs=202.7

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      +.|+...++|+|+||.||+++.+ +|+.||||++....  ....+-.++|+++|++++|+|+|.++.+|     ......
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl   76 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL   76 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence            46778889999999999999976 69999999997443  33345678999999999999999999995     667789


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++|+||++..-|.+ |....      ..++...+.+++.|++.|+.|+|++   +++||||||+|||++.++.+||||||
T Consensus        77 hLVFE~~dhTvL~e-Le~~p------~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFG  146 (396)
T KOG0593|consen   77 HLVFEYCDHTVLHE-LERYP------NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFG  146 (396)
T ss_pred             EEEeeecchHHHHH-HHhcc------CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccch
Confidence            99999997754444 44332      4588899999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCccccccc-ceeeeeec
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDL-SIHKFVLM  390 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~-~~~~~~~~  390 (477)
                      +|+.+..       .....+..+.|.+|+|||.+-  .+|+..+||||.||++.||+||.+.|.+..+-+. -.......
T Consensus       147 FAR~L~~-------pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG  219 (396)
T KOG0593|consen  147 FARTLSA-------PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLG  219 (396)
T ss_pred             hhHhhcC-------CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHc
Confidence            9998731       233455677899999999993  4799999999999999999999999976432211 11111112


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      .+..+...++...-...    .-+.++..-...+.     +.......-+++++..|++.||++|++-+|++.
T Consensus       220 ~L~prhq~iF~~N~~F~----Gv~lP~~~~~epLe-----~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  220 NLIPRHQSIFSSNPFFH----GVRLPEPEHPEPLE-----RKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ccCHHHHHHhccCCcee----eeecCCCCCccchh-----hhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            22222233332211100    00000000000111     111112334889999999999999999999984

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=344.41  Aligned_cols=275  Identities=22%  Similarity=0.282  Sum_probs=204.5

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchh-hHHHHHHHHHHhcCC-CCCcceeeeecccccCCCCc
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGA-LKSFIDECNALTSIR-HRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~  231 (477)
                      ..++|...+.||.|.||.||+|+.. +|..||||.++..-... .-.=++|++.|.+++ ||||+++..++.    +...
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~----d~~~   83 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIR----DNDR   83 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhh----ccCc
Confidence            4568888999999999999999854 78999999998553322 122368999999998 999999999863    3333


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      .+++|||||+. +|+++++.+.      ..+++..+..|+.||++||+|+|.+   |+.|||+||+|||+..+..+||+|
T Consensus        84 ~L~fVfE~Md~-NLYqLmK~R~------r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaD  153 (538)
T KOG0661|consen   84 ILYFVFEFMDC-NLYQLMKDRN------RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIAD  153 (538)
T ss_pred             eEeeeHHhhhh-hHHHHHhhcC------CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecc
Confidence            89999999955 9999998774      7899999999999999999999999   999999999999999899999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc--cCCCCcccceeehHHHHHHHhhCCCCCCcccccccce--eee
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSI--HKF  387 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~--~~~  387 (477)
                      ||+||...        .....+..+.|.+|+|||++  .+.|+.+.|+||+||+++|+.+-++.|.+..+-+..+  ...
T Consensus       154 FGLARev~--------SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~V  225 (538)
T KOG0661|consen  154 FGLAREVR--------SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEV  225 (538)
T ss_pred             cccccccc--------cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHH
Confidence            99999763        23345667889999999998  6789999999999999999999999997754322211  000


Q ss_pred             eeccCCchhH--HHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          388 VLMALPSHVM--DVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       388 ~~~~~~~~~~--~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                      +.....+.+.  .-+-..+...             +|.....--......+..+..+++.+|+++||.+|||++|.++.
T Consensus       226 LGtP~~~~~~eg~~La~~mnf~-------------~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  226 LGTPDKDSWPEGYNLASAMNFR-------------FPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             hCCCccccchhHHHHHHHhccC-------------CCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            0000000000  0000011000             01000000111112234558899999999999999999999863

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-44  Score=336.41  Aligned_cols=268  Identities=24%  Similarity=0.360  Sum_probs=205.2

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .+.|+.+++||+|.||.||+|+. .+|+.||+|.++...  .....-..+|+.+|++|+||||+++.+....   .....
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~---~~~~s  192 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTS---KLSGS  192 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEe---cCCce
Confidence            45677888999999999999985 589999999998665  4455667899999999999999999998542   23568


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .|||+|||+. +|..++....      -.+++.++..++.|++.||.|+|++   +|+|||||.+|||||.+|.+||+||
T Consensus       193 iYlVFeYMdh-DL~GLl~~p~------vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDF  262 (560)
T KOG0600|consen  193 IYLVFEYMDH-DLSGLLSSPG------VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADF  262 (560)
T ss_pred             EEEEEecccc-hhhhhhcCCC------cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccc
Confidence            9999999976 8988887543      5799999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCccccccc--------
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDL--------  382 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~--------  382 (477)
                      |+|+++...      .....+..+-|.+|+|||.+-  ..|+.++|+||.||||.||++|++.|....+-+.        
T Consensus       263 GLAr~y~~~------~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklc  336 (560)
T KOG0600|consen  263 GLARFYTPS------GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLC  336 (560)
T ss_pred             cceeeccCC------CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHh
Confidence            999987432      222356677899999999994  4699999999999999999999999876322110        


Q ss_pred             ---ceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChH
Q 043902          383 ---SIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMK  459 (477)
Q Consensus       383 ---~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~  459 (477)
                         .-..|....+|.       ...             ..........+ .+.........++|+..+|..||.+|.|+.
T Consensus       337 GSP~e~~W~~~kLP~-------~~~-------------~kp~~~y~r~l-~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~  395 (560)
T KOG0600|consen  337 GSPTEDYWPVSKLPH-------ATI-------------FKPQQPYKRRL-RETFKDFPASALDLLEKLLSLDPDKRGTAS  395 (560)
T ss_pred             CCCChhccccccCCc-------ccc-------------cCCCCcccchH-HHHhccCCHHHHHHHHHHhccCccccccHH
Confidence               000011001110       000             00000001111 112334456688999999999999999999


Q ss_pred             HHHH
Q 043902          460 FVVN  463 (477)
Q Consensus       460 evl~  463 (477)
                      ++++
T Consensus       396 ~aL~  399 (560)
T KOG0600|consen  396 SALQ  399 (560)
T ss_pred             HHhc
Confidence            9875

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-44  Score=334.73  Aligned_cols=258  Identities=29%  Similarity=0.446  Sum_probs=199.1

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      ..+|...+.||+|+||.||++... +|...|||.+...+....+.+.+|+.+|.+++|||||+++|....   ......+
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~---~~~~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSS---RENDEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccc---ccCeeeE
Confidence            456778899999999999999975 499999999987644446778999999999999999999997321   1113689


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC-CCcEEEeccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE-GMIAHVGDFG  313 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~DfG  313 (477)
                      +.|||+++|+|.+++....      ..+++..+..++.||++||+|||++   +|+|+||||+|||++. ++.+||+|||
T Consensus        93 i~mEy~~~GsL~~~~~~~g------~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG  163 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYG------GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFG  163 (313)
T ss_pred             eeeeccCCCcHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCc
Confidence            9999999999999998653      2599999999999999999999999   9999999999999999 7999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCccccc-CC-CCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GH-VSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~-~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      +++....    ............||+.|||||++. +. ...++|||||||++.||+||++||.......          
T Consensus       164 ~a~~~~~----~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~----------  229 (313)
T KOG0198|consen  164 LAKKLES----KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA----------  229 (313)
T ss_pred             ccccccc----ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH----------
Confidence            9987632    011122344578999999999995 43 3359999999999999999999997520000          


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNL  465 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  465 (477)
                        +.+..+....                ..|.+.        +.......+++..|+..||++||||.++++.-
T Consensus       230 --~~~~~ig~~~----------------~~P~ip--------~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  230 --EALLLIGRED----------------SLPEIP--------DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             --HHHHHHhccC----------------CCCCCC--------cccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence              0000000000                001111        11133478899999999999999999999754

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=374.80  Aligned_cols=265  Identities=28%  Similarity=0.498  Sum_probs=215.5

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC--CCC----EEEEEEeeec-cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA--DGE----TAAIKVLKLQ-QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEG  229 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  229 (477)
                      .+.+....||+|.||.||.|.+.  +|.    .||+|.++.. +.....+|++|..+|++++|||||+++|+|.    . 
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l----~-  766 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL----D-  766 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec----C-
Confidence            34455678999999999999865  343    4888888754 4556689999999999999999999999984    3 


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEE
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV  309 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl  309 (477)
                      ....++++|||++|+|..||++.+........++....+.++.|||+|+.||+++   ++|||||..+|+||+....+||
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKI  843 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKI  843 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEE
Confidence            6678999999999999999998755444457899999999999999999999999   9999999999999999999999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeee
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~  387 (477)
                      +|||+|+.+...+.....     ....-+..|||||.+ .+.+|.|+|||||||++||++| |..||.+....+      
T Consensus       844 aDFGlArDiy~~~yyr~~-----~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~------  912 (1025)
T KOG1095|consen  844 ADFGLARDIYDKDYYRKH-----GEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE------  912 (1025)
T ss_pred             cccchhHhhhhchheecc-----CccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH------
Confidence            999999966443322221     112456889999999 6899999999999999999999 999997643221      


Q ss_pred             eeccCCchhHH-HhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHH
Q 043902          388 VLMALPSHVMD-VLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQ  466 (477)
Q Consensus       388 ~~~~~~~~~~~-~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  466 (477)
                              +.. +..                         ..+.+.+..|+..+.+++.+||+.+|++||++..+++.+.
T Consensus       913 --------v~~~~~~-------------------------ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~  959 (1025)
T KOG1095|consen  913 --------VLLDVLE-------------------------GGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDP  959 (1025)
T ss_pred             --------HHHHHHh-------------------------CCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhh
Confidence                    111 110                         0122334567888999999999999999999999999999


Q ss_pred             HHHHhhh
Q 043902          467 AIRSKIR  473 (477)
Q Consensus       467 ~i~~~~~  473 (477)
                      .+.....
T Consensus       960 ~i~~~~~  966 (1025)
T KOG1095|consen  960 AISNAAL  966 (1025)
T ss_pred             hhhhhhc
Confidence            8876543

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-43  Score=345.75  Aligned_cols=267  Identities=24%  Similarity=0.450  Sum_probs=202.1

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe------CCCCEEEEEEeeecc-chhhHHHHHHHHHHhcC-CCCCcceeeeecccccC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL------ADGETAAIKVLKLQQ-QGALKSFIDECNALTSI-RHRNILKIVSSCSSVDY  227 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  227 (477)
                      .++|.+.+.||+|+||.||+|..      .+++.||+|+++... ......+.+|+.++.++ +||||++++++|.    
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~----   81 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT----   81 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec----
Confidence            46788999999999999999974      235689999997543 23346789999999999 8999999999873    


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCcc---------------------------------------------------
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDEY---------------------------------------------------  256 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~---------------------------------------------------  256 (477)
                      ......++||||+++|+|.+++.......                                                   
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            34456899999999999999987532100                                                   


Q ss_pred             ----cccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccccccCCCCCCCcccc
Q 043902          257 ----CHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS  332 (477)
Q Consensus       257 ----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~  332 (477)
                          .....+++..++.++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||+++......     .....
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~-----~~~~~  233 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-----DYVRK  233 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCc-----chhcc
Confidence                0013588899999999999999999998   99999999999999999999999999998653211     11112


Q ss_pred             CCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhcc
Q 043902          333 NGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEEN  410 (477)
Q Consensus       333 ~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  410 (477)
                      ....++..|+|||++ ...++.++|||||||++|||++ |..||.......             .....+.....     
T Consensus       234 ~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-------------~~~~~~~~~~~-----  295 (338)
T cd05102         234 GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-------------EFCQRLKDGTR-----  295 (338)
T ss_pred             cCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-------------HHHHHHhcCCC-----
Confidence            233456789999998 5678999999999999999997 999986532110             00010000000     


Q ss_pred             cccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHh
Q 043902          411 DHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSK  471 (477)
Q Consensus       411 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  471 (477)
                          .    ..+           ..+...+.+++.+||+.||++|||+.|+++.|+++..+
T Consensus       296 ----~----~~~-----------~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         296 ----M----RAP-----------ENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             ----C----CCC-----------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                0    000           01133478999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-44  Score=340.26  Aligned_cols=256  Identities=23%  Similarity=0.363  Sum_probs=205.9

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec---cchhhHHHHHHHHHHhcC-CCCCcceeeeecccccCC
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ---QQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYE  228 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  228 (477)
                      ....+|...+.||+|+|++|++|+.. +++.||||++...   .....+....|-..|.+| .||.|++|+..     |+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T-----FQ  144 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT-----FQ  144 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE-----ee
Confidence            34578999999999999999999854 7999999998643   233445677888899999 89999999977     57


Q ss_pred             CCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEE
Q 043902          229 GNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH  308 (477)
Q Consensus       229 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k  308 (477)
                      +...+|+|+||+++|+|.++|+..       ..+++.....++.+|+.||+|||++   |||||||||+|||+|.++++|
T Consensus       145 D~~sLYFvLe~A~nGdll~~i~K~-------Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhik  214 (604)
T KOG0592|consen  145 DEESLYFVLEYAPNGDLLDLIKKY-------GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIK  214 (604)
T ss_pred             cccceEEEEEecCCCcHHHHHHHh-------CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEE
Confidence            888999999999999999999865       6799999999999999999999999   999999999999999999999


Q ss_pred             EecccccccccccCCCC----CCCccc--cCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccc
Q 043902          309 VGDFGLAKFLFEESNTP----SKNQTM--SNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD  381 (477)
Q Consensus       309 l~DfG~a~~~~~~~~~~----~~~~~~--~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~  381 (477)
                      |+|||.|+.+.+.....    ......  ...++||..|.+||++ .+..+..+|+|+|||++|.|+.|++||....+.-
T Consensus       215 ITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl  294 (604)
T KOG0592|consen  215 ITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL  294 (604)
T ss_pred             EeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH
Confidence            99999999886543321    111122  2668999999999999 6778999999999999999999999997632110


Q ss_pred             cceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHH
Q 043902          382 LSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFV  461 (477)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev  461 (477)
                                   -+..+++...                          +.++.++..+.+|+.+.|..||.+|+|.+||
T Consensus       295 -------------iFqkI~~l~y--------------------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qI  335 (604)
T KOG0592|consen  295 -------------IFQKIQALDY--------------------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQI  335 (604)
T ss_pred             -------------HHHHHHHhcc--------------------------cCCCCCCHHHHHHHHHHHccCccccccHHHH
Confidence                         0112221111                          1111223347789999999999999999887


Q ss_pred             HH
Q 043902          462 VN  463 (477)
Q Consensus       462 l~  463 (477)
                      -+
T Consensus       336 k~  337 (604)
T KOG0592|consen  336 KA  337 (604)
T ss_pred             hh
Confidence            65

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-43  Score=326.69  Aligned_cols=264  Identities=24%  Similarity=0.351  Sum_probs=207.8

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ..+.|+..+.||.|..++||+|+. +.+..||||++..+. ......+.+|+..|+.++||||++++..+     ..+..
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sF-----vv~~~   98 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSF-----VVDSE   98 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEE-----Eecce
Confidence            356889999999999999999984 578999999998654 33368899999999999999999998774     56778


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      +|+||.||.+|++.++++..-.     ..+++..+..|++++++||.|||.+   |.+|||||+.||||+.+|.+||+||
T Consensus        99 LWvVmpfMa~GS~ldIik~~~~-----~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadF  170 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKTYYP-----DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADF  170 (516)
T ss_pred             eEEeehhhcCCcHHHHHHHHcc-----ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCc
Confidence            9999999999999999986532     4589999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCccccc---CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN---GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      |.+..+.+..   ..........+||+.|||||++.   ..|+.|+||||||++.+||.+|..||.....-.        
T Consensus       171 gvsa~l~~~G---~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk--------  239 (516)
T KOG0582|consen  171 GVSASLFDSG---DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK--------  239 (516)
T ss_pred             eeeeeecccC---ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH--------
Confidence            9998876533   11112226778999999999962   249999999999999999999999997643221        


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                               ++-..+...+.           .+. ......+........+.+++..||..||.+|||++++++
T Consensus       240 ---------vLl~tLqn~pp-----------~~~-t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  240 ---------VLLLTLQNDPP-----------TLL-TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             ---------HHHHHhcCCCC-----------Ccc-cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                     11111111100           000 001112222223446889999999999999999999985

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-44  Score=342.76  Aligned_cols=244  Identities=26%  Similarity=0.434  Sum_probs=201.9

Q ss_pred             CCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEee
Q 043902          160 SEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEF  239 (477)
Q Consensus       160 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~  239 (477)
                      +.++.||.|+.|.||+|+++ ++.||||.++.       .-..+++.|.+|+||||+.+.|+|.     .....||||||
T Consensus       127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCt-----qsPcyCIiMEf  193 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCT-----QSPCYCIIMEF  193 (904)
T ss_pred             hhhhhhccCcccceeeeecc-CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeec-----CCceeEEeeec
Confidence            35678999999999999995 68999998873       2245788999999999999999994     34568999999


Q ss_pred             cCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccccc
Q 043902          240 MRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLF  319 (477)
Q Consensus       240 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  319 (477)
                      |+.|.|...|+..       ..++......|..+||.||.|||.+   .|||||||+-||||+.+..+||+|||.++...
T Consensus       194 Ca~GqL~~VLka~-------~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~  263 (904)
T KOG4721|consen  194 CAQGQLYEVLKAG-------RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELS  263 (904)
T ss_pred             cccccHHHHHhcc-------CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhh
Confidence            9999999999876       5688899999999999999999999   99999999999999999999999999998763


Q ss_pred             ccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCchhHH
Q 043902          320 EESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMD  398 (477)
Q Consensus       320 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  398 (477)
                      +        ......+.||..|||||++ +...++|+||||||||||||+||..||.+.....+.+     .. ..+.  
T Consensus       264 ~--------~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw-----GV-GsNs--  327 (904)
T KOG4721|consen  264 D--------KSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW-----GV-GSNS--  327 (904)
T ss_pred             h--------hhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEE-----ec-cCCc--
Confidence            2        2334567899999999999 6678999999999999999999999998754332211     00 0000  


Q ss_pred             HhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHh
Q 043902          399 VLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSK  471 (477)
Q Consensus       399 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  471 (477)
                                                   .....+++|+..+.-|+++||+..|..|||+.+++..|+-...+
T Consensus       328 -----------------------------L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe  371 (904)
T KOG4721|consen  328 -----------------------------LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE  371 (904)
T ss_pred             -----------------------------ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence                                         01112345677789999999999999999999999998765544

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-44  Score=306.65  Aligned_cols=275  Identities=20%  Similarity=0.283  Sum_probs=218.5

Q ss_pred             hhcCCCCCCeeeeeccceEEEEE-eCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ..++|.+.+.||+|||+-||.++ ..++..+|+|++........+..++|++..++++|||++++++++.....+.....
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            45789999999999999999998 56899999999998887778899999999999999999999999865544566779


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      |++++|...|+|.+.+.....   ....+++.+++.|+.++++||.+||+. .++++||||||.|||+.+.+.++|.|||
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~---kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKI---KGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             EEEeehhccccHHHHHHHHhh---cCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence            999999999999999976542   225699999999999999999999997 4469999999999999999999999999


Q ss_pred             ccccccccCCCCCCC--ccccCCCcccccccCccccc----CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeee
Q 043902          314 LAKFLFEESNTPSKN--QTMSNGLKGSVGYIPPEYIN----GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~  387 (477)
                      .+....-.-......  .........|..|+|||.+.    ...++++|||||||+||+|+.|..||+.....+.++.-.
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA  254 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA  254 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe
Confidence            997653211111110  01112334789999999993    247999999999999999999999998876666554433


Q ss_pred             eeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHH
Q 043902          388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQA  467 (477)
Q Consensus       388 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  467 (477)
                      +...           .+...  +       +      .         .....+.+++.+|++.||.+||++.+++..++.
T Consensus       255 v~n~-----------q~s~P--~-------~------~---------~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~  299 (302)
T KOG2345|consen  255 VQNA-----------QISIP--N-------S------S---------RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD  299 (302)
T ss_pred             eecc-----------ccccC--C-------C------C---------CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence            3210           00000  0       0      0         013448899999999999999999999999887


Q ss_pred             H
Q 043902          468 I  468 (477)
Q Consensus       468 i  468 (477)
                      +
T Consensus       300 L  300 (302)
T KOG2345|consen  300 L  300 (302)
T ss_pred             h
Confidence            5

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.8e-43  Score=304.76  Aligned_cols=265  Identities=21%  Similarity=0.329  Sum_probs=201.8

Q ss_pred             cCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .+|...+.||+|.||.||+|+. .+|+.||||.++...  .+......+|++.|+.++|+||+.+++++     ...+..
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCce
Confidence            4678889999999999999985 589999999998653  23345778999999999999999999994     677789


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      .+|+|||+. +|+..++...      ..++..++..++.++++|++|||++   .|+||||||.|+|++++|.+||+|||
T Consensus        77 ~lVfEfm~t-dLe~vIkd~~------i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFG  146 (318)
T KOG0659|consen   77 SLVFEFMPT-DLEVVIKDKN------IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFG  146 (318)
T ss_pred             EEEEEeccc-cHHHHhcccc------cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeeccc
Confidence            999999965 9999998765      6799999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc--cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee--
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL--  389 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~--  389 (477)
                      +|+.+...       .......+-|.+|+|||.+  ..+|+...||||.||++.||+-|.+-|.+..+  .+....+.  
T Consensus       147 LAr~f~~p-------~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD--idQL~~If~~  217 (318)
T KOG0659|consen  147 LARFFGSP-------NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD--IDQLSKIFRA  217 (318)
T ss_pred             chhccCCC-------CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch--HHHHHHHHHH
Confidence            99987432       2223333679999999999  34699999999999999999999877765322  11111110  


Q ss_pred             ------ccCCc--hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHH
Q 043902          390 ------MALPS--HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFV  461 (477)
Q Consensus       390 ------~~~~~--~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev  461 (477)
                            ..+|+  .+.+..+-....   ..    ....+            ...+...+++|+..++..||.+|+|++|+
T Consensus       218 LGTP~~~~WP~~~~lpdY~~~~~~P---~~----~~~~l------------f~aas~d~ldLl~~m~~ynP~~Rita~qa  278 (318)
T KOG0659|consen  218 LGTPTPDQWPEMTSLPDYVKIQQFP---KP----PLNNL------------FPAASSDALDLLSKMLTYNPKKRITASQA  278 (318)
T ss_pred             cCCCCcccCccccccccHHHHhcCC---CC----ccccc------------cccccHHHHHHHHhhhccCchhcccHHHH
Confidence                  11111  111111111000   00    00001            11223447899999999999999999999


Q ss_pred             HHH
Q 043902          462 VNN  464 (477)
Q Consensus       462 l~~  464 (477)
                      ++.
T Consensus       279 L~~  281 (318)
T KOG0659|consen  279 LKH  281 (318)
T ss_pred             hcc
Confidence            863

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-43  Score=337.03  Aligned_cols=250  Identities=22%  Similarity=0.353  Sum_probs=204.7

Q ss_pred             hhcCCCCCCeeeeeccceEEEEE-eCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ....|.....||+|..|.||.|. ..+++.||||++........+-..+|+.+|...+|+|||+++..+     --.+..
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sy-----lv~deL  345 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSY-----LVGDEL  345 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHh-----ccccee
Confidence            34678888999999999999997 457899999999988777778899999999999999999999985     345789


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++|||||++|+|.+.+...        .+++.++..|+.++++||+|||.+   +|+|||||.+|||++.++.+||+|||
T Consensus       346 WVVMEym~ggsLTDvVt~~--------~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFG  414 (550)
T KOG0578|consen  346 WVVMEYMEGGSLTDVVTKT--------RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFG  414 (550)
T ss_pred             EEEEeecCCCchhhhhhcc--------cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeee
Confidence            9999999999999998754        489999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccC
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMAL  392 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  392 (477)
                      ++..+..       ........+||+.|||||+. ...|++|.||||||++++||+-|++||-..  ..  +..      
T Consensus       415 Fcaqi~~-------~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE--~P--lrA------  477 (550)
T KOG0578|consen  415 FCAQISE-------EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE--NP--LRA------  477 (550)
T ss_pred             eeecccc-------ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC--Ch--HHH------
Confidence            9987743       23355677899999999999 567999999999999999999999998531  10  000      


Q ss_pred             CchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          393 PSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       393 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                          ..++-...      .....                ..+.....+.+++.+||..||++||++.|+++
T Consensus       478 ----lyLIa~ng------~P~lk----------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  478 ----LYLIATNG------TPKLK----------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             ----HHHHhhcC------CCCcC----------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence                00000000      00000                11112344889999999999999999999986

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.4e-42  Score=329.40  Aligned_cols=251  Identities=25%  Similarity=0.358  Sum_probs=197.4

Q ss_pred             CCeeeeeccceEEEEEeCCCCEEEEEEeeeccchh---hHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEe
Q 043902          162 ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGA---LKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFE  238 (477)
Q Consensus       162 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  238 (477)
                      ...||+|++|.||+|.+ +|+.||||+++......   .+.+.+|+.++.+++||||+++++++... .......++|||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~~~~~~~~lv~E  102 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI-VDDLPRLSLILE  102 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec-ccCCCceEEEEE
Confidence            36899999999999998 68999999997553322   46788999999999999999999987431 123456899999


Q ss_pred             ecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccc
Q 043902          239 FMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFL  318 (477)
Q Consensus       239 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  318 (477)
                      |+++|+|.+++...       ..+++...+.++.+++.||.|||+..  +++||||||+||++++++.+||+|||+++..
T Consensus       103 y~~~g~L~~~l~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~  173 (283)
T PHA02988        103 YCTRGYLREVLDKE-------KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKIL  173 (283)
T ss_pred             eCCCCcHHHHHhhC-------CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence            99999999999754       45889999999999999999999731  7889999999999999999999999999865


Q ss_pred             cccCCCCCCCccccCCCcccccccCccccc---CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCch
Q 043902          319 FEESNTPSKNQTMSNGLKGSVGYIPPEYIN---GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSH  395 (477)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  395 (477)
                      ..          ......|+..|+|||++.   +.++.++|||||||++|||+||+.||......               
T Consensus       174 ~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---------------  228 (283)
T PHA02988        174 SS----------PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---------------  228 (283)
T ss_pred             cc----------ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---------------
Confidence            21          112345788999999994   46899999999999999999999999753211               


Q ss_pred             hHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHH
Q 043902          396 VMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRS  470 (477)
Q Consensus       396 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  470 (477)
                        ++.+......   .      ....+           ..++..+.+++.+||+.||++|||++|+++.|+.++.
T Consensus       229 --~~~~~i~~~~---~------~~~~~-----------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        229 --EIYDLIINKN---N------SLKLP-----------LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             --HHHHHHHhcC---C------CCCCC-----------CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence              1111100000   0      00000           0123458899999999999999999999999999875

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-43  Score=340.11  Aligned_cols=259  Identities=25%  Similarity=0.437  Sum_probs=206.0

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC--CC---CEEEEEEeeec---cchhhHHHHHHHHHHhcCCCCCcceeeeecccccC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA--DG---ETAAIKVLKLQ---QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDY  227 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~---~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  227 (477)
                      .++....++||+|+||.||+|++.  ++   ..||||..+..   ......+|++|+++|.+++|||||+++|++     
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa-----  230 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA-----  230 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----
Confidence            345555689999999999999865  22   23899999852   355678999999999999999999999997     


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcE
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIA  307 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~  307 (477)
                      ......++|||+|.||+|.++|+...      ..++..+++.++.+.|.||+|||++   +++||||..+|+|++.++.+
T Consensus       231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~------~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~v  301 (474)
T KOG0194|consen  231 VLEEPLMLVMELCNGGSLDDYLKKNK------KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVV  301 (474)
T ss_pred             cCCCccEEEEEecCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeE
Confidence            45667999999999999999998764      3599999999999999999999999   99999999999999999999


Q ss_pred             EEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCccccccccee
Q 043902          308 HVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH  385 (477)
Q Consensus       308 kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~  385 (477)
                      ||+|||+++....       .........-+..|+|||.+ .+.++.++|||||||++||+++ |..||.......    
T Consensus       302 KISDFGLs~~~~~-------~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~----  370 (474)
T KOG0194|consen  302 KISDFGLSRAGSQ-------YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE----  370 (474)
T ss_pred             EeCccccccCCcc-------eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH----
Confidence            9999999876410       01111122457899999999 7789999999999999999999 888997643221    


Q ss_pred             eeeeccCCchhHHHh-hhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          386 KFVLMALPSHVMDVL-DLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       386 ~~~~~~~~~~~~~~~-d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                                +...+ -..                        ++...+...+..+..++.+|+..+|++||||.++.+.
T Consensus       371 ----------v~~kI~~~~------------------------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~  416 (474)
T KOG0194|consen  371 ----------VKAKIVKNG------------------------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKK  416 (474)
T ss_pred             ----------HHHHHHhcC------------------------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHH
Confidence                      11111 000                        0000111224558888999999999999999999999


Q ss_pred             HHHHHHhhh
Q 043902          465 LQAIRSKIR  473 (477)
Q Consensus       465 L~~i~~~~~  473 (477)
                      |+.+.....
T Consensus       417 l~~~~~~~~  425 (474)
T KOG0194|consen  417 LEALEKKKE  425 (474)
T ss_pred             HHHHHhccc
Confidence            999887654

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=331.37  Aligned_cols=262  Identities=21%  Similarity=0.388  Sum_probs=209.9

Q ss_pred             CCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccc-hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEE
Q 043902          158 NFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQ-GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALV  236 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  236 (477)
                      ...+.++||+|.||.|.++....+..||||.++.... ....+|.+|+++|.+++||||++++|+|.     .++..++|
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~-----~DePicmI  613 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCV-----QDDPLCMI  613 (807)
T ss_pred             heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeee-----cCCchHHH
Confidence            3446678999999999999998789999999997654 44589999999999999999999999994     46678999


Q ss_pred             EeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccc
Q 043902          237 FEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK  316 (477)
Q Consensus       237 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  316 (477)
                      +|||++|+|.+|+.....     ..+......+|+.||+.||+||.+.   ++|||||.++|+|+|.++++||+|||+++
T Consensus       614 ~EYmEnGDLnqFl~ahea-----pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR  685 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHEL-----PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSR  685 (807)
T ss_pred             HHHHhcCcHHHHHHhccC-----cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccc
Confidence            999999999999987642     2245566778999999999999998   99999999999999999999999999999


Q ss_pred             cccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh--CCCCCCcccccccceeeeeeccCC
Q 043902          317 FLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT--GKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      .++..+.     .......+-+++|||||.+ .|++|.++|||+||+++||+++  ...||.+..+++..          
T Consensus       686 ~lysg~y-----y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv----------  750 (807)
T KOG1094|consen  686 NLYSGDY-----YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV----------  750 (807)
T ss_pred             ccccCCc-----eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH----------
Confidence            7754322     3333445678999999998 8999999999999999999987  88999876544310          


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                      ++...+++-.-.                     ......+.-|+.++.+++.+||..|-.+|||++++...|++.
T Consensus       751 en~~~~~~~~~~---------------------~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  751 ENAGEFFRDQGR---------------------QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             HhhhhhcCCCCc---------------------ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            011111110000                     001112234577799999999999999999999999988764

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-42  Score=315.01  Aligned_cols=281  Identities=22%  Similarity=0.280  Sum_probs=209.3

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEee--eccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLK--LQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      ....|...+.||+|+||.|+.+... +|+.||||.+.  .......++..+|+++|+.++|+||+.+.+.........-.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            4556677899999999999999865 78999999987  44555568889999999999999999999997654445566


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..|+|+|+| +.+|...++.+       +.++......+..|+++||+|+|+.   +|+||||||+|++++.+...||+|
T Consensus       100 DvYiV~elM-etDL~~iik~~-------~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~D  168 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKSQ-------QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICD  168 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHcC-------ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecc
Confidence            799999999 66999999865       4589999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc--cCCCCcccceeehHHHHHHHhhCCCCCCcccc-cccceeeee
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFK-DDLSIHKFV  388 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~-~~~~~~~~~  388 (477)
                      ||+|+.....     ......+..+.|.+|+|||.+  ...||.+.||||.||++.||++|++.|.+... +...+...+
T Consensus       169 FGLAR~~~~~-----~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~  243 (359)
T KOG0660|consen  169 FGLARYLDKF-----FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILEL  243 (359)
T ss_pred             ccceeecccc-----CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHh
Confidence            9999987332     223344667889999999998  45799999999999999999999999876321 111111111


Q ss_pred             eccCCchhHHHhh-hhhhhhhc--ccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          389 LMALPSHVMDVLD-LSMLLEEE--NDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       389 ~~~~~~~~~~~~d-~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      .+..++.....+. ......-.  .......-...+|..            .....+|+.+||..||.+|+|++|.++
T Consensus       244 lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a------------~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  244 LGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNA------------NPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             cCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCC------------CHHHHHHHHHHhccCccccCCHHHHhc
Confidence            1111111111111 11110000  000011111122221            233789999999999999999999986

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-43  Score=336.64  Aligned_cols=256  Identities=27%  Similarity=0.458  Sum_probs=215.4

Q ss_pred             CCCCCCeeeeeccceEEEEEeCC-CCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEE
Q 043902          158 NFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALV  236 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  236 (477)
                      +.....+||.|.||.||.|.|+. .-.||||.++... ...++|++|+.+|+.++|||+|+++|+|.     .+...|||
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT-----~EpPFYIi  341 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----HEPPFYII  341 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhc-----cCCCeEEE
Confidence            34456789999999999999863 5689999998554 44689999999999999999999999995     34568999


Q ss_pred             EeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccc
Q 043902          237 FEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK  316 (477)
Q Consensus       237 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  316 (477)
                      +|||..|+|.+||+...     +..++.-..+.++.||+.||.||..+   ++|||||..+|+|+.++..+|++|||+++
T Consensus       342 TEfM~yGNLLdYLRecn-----r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsR  413 (1157)
T KOG4278|consen  342 TEFMCYGNLLDYLRECN-----RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSR  413 (1157)
T ss_pred             EecccCccHHHHHHHhc-----hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhh
Confidence            99999999999998653     35677778899999999999999999   99999999999999999999999999999


Q ss_pred             cccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCCc
Q 043902          317 FLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALPS  394 (477)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  394 (477)
                      ++..+..      ....+..-++.|.|||-+ ...++.|+|||+|||+|||+.| |..||.....               
T Consensus       414 lMtgDTY------TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl---------------  472 (1157)
T KOG4278|consen  414 LMTGDTY------TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---------------  472 (1157)
T ss_pred             hhcCCce------ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH---------------
Confidence            9854332      223334457889999999 6789999999999999999999 9999976421               


Q ss_pred             hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHh
Q 043902          395 HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSK  471 (477)
Q Consensus       395 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  471 (477)
                        .++++                     .+...++++.++.|+.++.+|++.||+++|.+||++.|+-+.++.+-..
T Consensus       473 --SqVY~---------------------LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~  526 (1157)
T KOG4278|consen  473 --SQVYG---------------------LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS  526 (1157)
T ss_pred             --HHHHH---------------------HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence              12221                     1223467778889999999999999999999999999999999987654

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=8.9e-42  Score=327.73  Aligned_cols=267  Identities=20%  Similarity=0.390  Sum_probs=197.1

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCC-----------------CCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcce
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLAD-----------------GETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILK  217 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~  217 (477)
                      .++|...+.||+|+||.||+|.+.+                 +..||+|.++... ......|.+|++++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3578888999999999999997532                 3479999987543 334567999999999999999999


Q ss_pred             eeeecccccCCCCceeeEEEeecCCCChhhhcccCCCc------------ccccccCCHHHHHHHHHHHHHHHHHHHcCC
Q 043902          218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDE------------YCHFKKLSLMQRLNIVIDVASALDYLHNQY  285 (477)
Q Consensus       218 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~  285 (477)
                      +++++     ...+..++||||+++|+|.+++......            ......+++..++.++.|++.||.|||+. 
T Consensus        84 ~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-  157 (304)
T cd05096          84 LLGVC-----VDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL-  157 (304)
T ss_pred             EEEEE-----ecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-
Confidence            99996     3456689999999999999998643210            11124578899999999999999999999 


Q ss_pred             CCCeeecCCCCCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHH
Q 043902          286 DTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILL  364 (477)
Q Consensus       286 ~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl  364 (477)
                        +|+||||||+||+++.++.+||+|||+++......     .........++..|+|||++ .+.++.++|||||||++
T Consensus       158 --~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l  230 (304)
T cd05096         158 --NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGD-----YYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTL  230 (304)
T ss_pred             --CccccCcchhheEEcCCccEEECCCccceecccCc-----eeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHH
Confidence              99999999999999999999999999997652211     11122233457889999998 66799999999999999


Q ss_pred             HHHhh--CCCCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHH
Q 043902          365 LEIFT--GKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMR  442 (477)
Q Consensus       365 ~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  442 (477)
                      |||++  +..||........  .        ....+.........             .        ......++..+.+
T Consensus       231 ~el~~~~~~~p~~~~~~~~~--~--------~~~~~~~~~~~~~~-------------~--------~~~~~~~~~~~~~  279 (304)
T cd05096         231 WEILMLCKEQPYGELTDEQV--I--------ENAGEFFRDQGRQV-------------Y--------LFRPPPCPQGLYE  279 (304)
T ss_pred             HHHHHccCCCCCCcCCHHHH--H--------HHHHHHhhhccccc-------------c--------ccCCCCCCHHHHH
Confidence            99987  5567754321110  0        00000000000000             0        0000112445889


Q ss_pred             HhhhcCCCCCCCCCChHHHHHHHH
Q 043902          443 IGVMCSAASPRDRVGMKFVVNNLQ  466 (477)
Q Consensus       443 l~~~Cl~~dP~~RPs~~evl~~L~  466 (477)
                      ++.+||+.||++|||+.||.+.|+
T Consensus       280 li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         280 LMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             HHHHHccCCchhCcCHHHHHHHHh
Confidence            999999999999999999998876

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.6e-41  Score=334.68  Aligned_cols=263  Identities=27%  Similarity=0.418  Sum_probs=199.3

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe------CCCCEEEEEEeeecc-chhhHHHHHHHHHHhcC-CCCCcceeeeecccccC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL------ADGETAAIKVLKLQQ-QGALKSFIDECNALTSI-RHRNILKIVSSCSSVDY  227 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  227 (477)
                      .++|+..+.||+|+||.||+|+.      .++..||||+++... ....+.+.+|++++..+ +||||++++++|     
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~-----  108 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC-----  108 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee-----
Confidence            45788899999999999999973      245689999997443 33446788999999999 899999999996     


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCcc---------------------------------------------------
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDEY---------------------------------------------------  256 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~---------------------------------------------------  256 (477)
                      ...+..++||||+++|+|.+++.......                                                   
T Consensus       109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence            45667899999999999999986532100                                                   


Q ss_pred             -----------------cccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccccc
Q 043902          257 -----------------CHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLF  319 (477)
Q Consensus       257 -----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  319 (477)
                                       .....+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~  265 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIR  265 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceecc
Confidence                             0012578899999999999999999998   99999999999999999999999999998653


Q ss_pred             ccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCCchhH
Q 043902          320 EESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALPSHVM  397 (477)
Q Consensus       320 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  397 (477)
                      ...     .........++..|+|||.+ .+.++.++|||||||++|||++ |..||.......             ...
T Consensus       266 ~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-------------~~~  327 (375)
T cd05104         266 NDS-----NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-------------KFY  327 (375)
T ss_pred             Ccc-----cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-------------HHH
Confidence            211     11111223456789999999 5678999999999999999998 888886532111             111


Q ss_pred             HHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          398 DVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       398 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                      ..+.......             .+.           ..+..+.+++.+|++.||++|||+.||++.|++.
T Consensus       328 ~~~~~~~~~~-------------~~~-----------~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         328 KMIKEGYRML-------------SPE-----------CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             HHHHhCccCC-------------CCC-----------CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            1111110000             000           0123478999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=7.3e-42  Score=321.87  Aligned_cols=255  Identities=24%  Similarity=0.389  Sum_probs=198.4

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC----CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA----DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|.++... ......+.+|+..+.+++||||+++++++     ..+
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~   78 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVI-----TRG   78 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----ecC
Confidence            356888899999999999999753    35689999998653 23346789999999999999999999986     456


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +..++||||+++|+|.+++....      ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++++
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~  149 (266)
T cd05064          79 NTMMIVTEYMSNGALDSFLRKHE------GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKIS  149 (266)
T ss_pred             CCcEEEEEeCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEEC
Confidence            67899999999999999997542      4589999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~  388 (477)
                      |||.+......      .........++..|+|||.+ .+.++.++|||||||++||+++ |+.||.......       
T Consensus       150 dfg~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-------  216 (266)
T cd05064         150 GFRRLQEDKSE------AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-------  216 (266)
T ss_pred             CCccccccccc------chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------
Confidence            99987643110      11111223456789999998 6678999999999999999875 999996532110       


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                             ..+.+.....               .+         .+..++..+.+++..||+.+|++|||+.|+.+.|.++
T Consensus       217 -------~~~~~~~~~~---------------~~---------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         217 -------VIKAVEDGFR---------------LP---------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -------HHHHHHCCCC---------------CC---------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                   0111100000               00         0011244588999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-41  Score=327.33  Aligned_cols=249  Identities=23%  Similarity=0.350  Sum_probs=198.6

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec----cc-hhhHHHHHHHHHHhcCC-CCCcceeeeeccccc
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ----QQ-GALKSFIDECNALTSIR-HRNILKIVSSCSSVD  226 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  226 (477)
                      ...+.|...+.||+|+||+|+.|... +|+.||+|++...    .. ...+...+|+.++++++ ||||++++.++    
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~----   89 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF----   89 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE----
Confidence            34678999999999999999999754 7899999977653    11 23456668999999999 99999999995    


Q ss_pred             CCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC-C
Q 043902          227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG-M  305 (477)
Q Consensus       227 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-~  305 (477)
                       ......++||||+.+|+|.+++...       .++.+.....++.|++.|++|+|++   +|+||||||+|||++.+ +
T Consensus        90 -~t~~~~~ivmEy~~gGdL~~~i~~~-------g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~  158 (370)
T KOG0583|consen   90 -ATPTKIYIVMEYCSGGDLFDYIVNK-------GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEG  158 (370)
T ss_pred             -ecCCeEEEEEEecCCccHHHHHHHc-------CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCC
Confidence             5666799999999999999999873       5688999999999999999999999   99999999999999999 9


Q ss_pred             cEEEecccccccccccCCCCCCCccccCCCcccccccCcccccCC--C-CcccceeehHHHHHHHhhCCCCCCccccccc
Q 043902          306 IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH--V-SILGDIYSYGILLLEIFTGKRPTDDMFKDDL  382 (477)
Q Consensus       306 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~-~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~  382 (477)
                      ++||+|||++....       .........+||+.|+|||++.++  | +.++||||+||+||-|++|+.||++..... 
T Consensus       159 ~~Kl~DFG~s~~~~-------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~-  230 (370)
T KOG0583|consen  159 NLKLSDFGLSAISP-------GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN-  230 (370)
T ss_pred             CEEEeccccccccC-------CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-
Confidence            99999999998752       123345567899999999999543  4 689999999999999999999998621100 


Q ss_pred             ceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHH
Q 043902          383 SIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVV  462 (477)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl  462 (477)
                                   +...+...   .           -.+|....          ...+..|+.+|+..||.+|+|+.||+
T Consensus       231 -------------l~~ki~~~---~-----------~~~p~~~~----------S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  231 -------------LYRKIRKG---E-----------FKIPSYLL----------SPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             -------------HHHHHhcC---C-----------ccCCCCcC----------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence                         00000000   0           00011000          12378899999999999999999998

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.5e-41  Score=334.51  Aligned_cols=264  Identities=26%  Similarity=0.439  Sum_probs=200.0

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC------CCCEEEEEEeeecc-chhhHHHHHHHHHHhcC-CCCCcceeeeecccccC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQQ-QGALKSFIDECNALTSI-RHRNILKIVSSCSSVDY  227 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  227 (477)
                      .++|+..+.||+|+||.||+|...      ++..||+|+++... ......+.+|+++++.+ +|+||++++++|     
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~-----  111 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC-----  111 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe-----
Confidence            457889999999999999998742      34579999997543 33346788999999999 899999999986     


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCc----------------------------------------------------
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDE----------------------------------------------------  255 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------------------------------------------------  255 (477)
                      ......++||||+++|+|.+++......                                                    
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            4556789999999999999998542110                                                    


Q ss_pred             -----------ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccccccCCC
Q 043902          256 -----------YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNT  324 (477)
Q Consensus       256 -----------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  324 (477)
                                 ......+++..+++++.|++.||.|||++   +|+||||||+||++++++.+||+|||+++......  
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~--  266 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS--  266 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCc--
Confidence                       01123578899999999999999999998   99999999999999999999999999997652211  


Q ss_pred             CCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCCchhHHHhhh
Q 043902          325 PSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDL  402 (477)
Q Consensus       325 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  402 (477)
                         .........++..|+|||++ .+.++.++|||||||++|||++ |+.||.......             .....+..
T Consensus       267 ---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-------------~~~~~~~~  330 (374)
T cd05106         267 ---NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-------------KFYKMVKR  330 (374)
T ss_pred             ---ceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-------------HHHHHHHc
Confidence               11112223456789999998 6679999999999999999997 999986532111             01111111


Q ss_pred             hhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHH
Q 043902          403 SMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIR  469 (477)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  469 (477)
                      ....             ..+.           ..+..+.+++.+||+.||++|||+.+|++.|+++.
T Consensus       331 ~~~~-------------~~~~-----------~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         331 GYQM-------------SRPD-----------FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             ccCc-------------cCCC-----------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            0000             0000           01234789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-41  Score=315.80  Aligned_cols=279  Identities=27%  Similarity=0.368  Sum_probs=203.0

Q ss_pred             cCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHh--cCCCCCcceeeeecccccCCCCceee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALT--SIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      ......+++|+|+||.||+|.+. ++.||||++....   .+.|.+|-++.+  .++|+||++++++-...+ ......+
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~eyw  284 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRMEYW  284 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCC-cccccee
Confidence            44456678999999999999995 5999999998554   367888877766  458999999999843222 1244789


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcC------CCCCeeecCCCCCCeEecCCCcEE
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ------YDTPIAHCDLKSSNVLLDEGMIAH  308 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------~~~~ivH~dlkp~NIll~~~~~~k  308 (477)
                      ||++|.+.|+|.+||..+        .++|....+|+..+++||+|||+.      .+++|+|||||++||||.+|+++.
T Consensus       285 LVt~fh~kGsL~dyL~~n--------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc  356 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKAN--------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC  356 (534)
T ss_pred             EEeeeccCCcHHHHHHhc--------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence            999999999999999865        489999999999999999999974      367899999999999999999999


Q ss_pred             EecccccccccccCCCCCCCccccCCCcccccccCcccccCCCC-------cccceeehHHHHHHHhhCCCCCCc--ccc
Q 043902          309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVS-------ILGDIYSYGILLLEIFTGKRPTDD--MFK  379 (477)
Q Consensus       309 l~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-------~~~Dv~S~Gvvl~elltg~~p~~~--~~~  379 (477)
                      |+|||+|..+..     ........+.+||.+|||||++.|...       .+.||||+|.|||||+++-.-++.  ..+
T Consensus       357 IaDFGLAl~~~p-----~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~  431 (534)
T KOG3653|consen  357 IADFGLALRLEP-----GKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPE  431 (534)
T ss_pred             eeccceeEEecC-----CCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCc
Confidence            999999998843     233344455889999999999966422       357999999999999996544421  111


Q ss_pred             cccceeeeeeccCCc--hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCC
Q 043902          380 DDLSIHKFVLMALPS--HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVG  457 (477)
Q Consensus       380 ~~~~~~~~~~~~~~~--~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs  457 (477)
                      -...+...+. .-|.  .+.+++-.               ++..|.+.+....-   ..+..+.+.+..||+.||+.|-|
T Consensus       432 Yqlpfe~evG-~hPt~e~mq~~VV~---------------kK~RP~~p~~W~~h---~~~~~l~et~EeCWDhDaeARLT  492 (534)
T KOG3653|consen  432 YQLPFEAEVG-NHPTLEEMQELVVR---------------KKQRPKIPDAWRKH---AGMAVLCETIEECWDHDAEARLT  492 (534)
T ss_pred             ccCchhHHhc-CCCCHHHHHHHHHh---------------hccCCCChhhhhcC---ccHHHHHHHHHHHcCCchhhhhh
Confidence            1111110010 0011  22222111               11112222222111   22556889999999999999999


Q ss_pred             hHHHHHHHHHHHHhh
Q 043902          458 MKFVVNNLQAIRSKI  472 (477)
Q Consensus       458 ~~evl~~L~~i~~~~  472 (477)
                      +.=|.+++.++..-.
T Consensus       493 A~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  493 AGCVEERMAELMMLW  507 (534)
T ss_pred             hHHHHHHHHHHhccC
Confidence            999999998876543

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-41  Score=312.40  Aligned_cols=282  Identities=26%  Similarity=0.413  Sum_probs=210.5

Q ss_pred             CccHHHHHHhhcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhc--CCCCCcceeeeecc
Q 043902          146 GLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTS--IRHRNILKIVSSCS  223 (477)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~  223 (477)
                      +.++.-......+....+.||+|.||.||+|+++ |+.||||++....+   ..+.+|.++.+.  ++|+||+.+++.-.
T Consensus       200 GlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~  275 (513)
T KOG2052|consen  200 GLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADN  275 (513)
T ss_pred             CchhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccc
Confidence            4444444555677788899999999999999995 89999999986544   567888888876  49999999998732


Q ss_pred             cccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHc-----CCCCCeeecCCCCCC
Q 043902          224 SVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN-----QYDTPIAHCDLKSSN  298 (477)
Q Consensus       224 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-----~~~~~ivH~dlkp~N  298 (477)
                      ... ..-.+++||++|.+.|||.|||...        .++....++++..+|.||+|||.     +..|.|.|||||+.|
T Consensus       276 ~~~-gs~TQLwLvTdYHe~GSL~DyL~r~--------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKN  346 (513)
T KOG2052|consen  276 KDN-GSWTQLWLVTDYHEHGSLYDYLNRN--------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKN  346 (513)
T ss_pred             cCC-CceEEEEEeeecccCCcHHHHHhhc--------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccccc
Confidence            211 2334689999999999999999754        58999999999999999999995     347899999999999


Q ss_pred             eEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccccCCC-------CcccceeehHHHHHHHhhC-
Q 043902          299 VLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHV-------SILGDIYSYGILLLEIFTG-  370 (477)
Q Consensus       299 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~Dv~S~Gvvl~elltg-  370 (477)
                      |||..++.+.|+|+|+|.......   ..-....+..+||.+|||||++....       -..+||||||.|+||+.-+ 
T Consensus       347 ILVKkn~~C~IADLGLAv~h~~~t---~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc  423 (513)
T KOG2052|consen  347 ILVKKNGTCCIADLGLAVRHDSDT---DTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRC  423 (513)
T ss_pred             EEEccCCcEEEeeceeeEEecccC---CcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHh
Confidence            999999999999999998764322   22233456778999999999995432       3468999999999999752 


Q ss_pred             ---------CCCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHH
Q 043902          371 ---------KRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVM  441 (477)
Q Consensus       371 ---------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  441 (477)
                               +.||.+....+.++.+         +.+++.-+.               +.|.+...   ....+++..+.
T Consensus       424 ~~ggi~eey~~Pyyd~Vp~DPs~ee---------MrkVVCv~~---------------~RP~ipnr---W~s~~~l~~m~  476 (513)
T KOG2052|consen  424 ESGGIVEEYQLPYYDVVPSDPSFEE---------MRKVVCVQK---------------LRPNIPNR---WKSDPALRVMA  476 (513)
T ss_pred             hcCCEehhhcCCcccCCCCCCCHHH---------Hhcceeecc---------------cCCCCCcc---cccCHHHHHHH
Confidence                     3466554444433221         112111100               00111100   01123466799


Q ss_pred             HHhhhcCCCCCCCCCChHHHHHHHHHHHH
Q 043902          442 RIGVMCSAASPRDRVGMKFVVNNLQAIRS  470 (477)
Q Consensus       442 ~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  470 (477)
                      ++++.||..||.-|-|+--+-+.|.++.+
T Consensus       477 klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  477 KLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             HHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            99999999999999999999999988874

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=7.3e-41  Score=318.29  Aligned_cols=250  Identities=24%  Similarity=0.347  Sum_probs=193.8

Q ss_pred             CCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          158 NFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .|+..+.||+|+||.||+|.. .+|+.||+|.+....   ......+.+|++++.+++|+||+++++++     ...+..
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~   75 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeE
Confidence            367788999999999999986 479999999987432   22234678999999999999999999885     456689


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||+++|+|.+++....     ...+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|||
T Consensus        76 ~lv~e~~~~g~L~~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg  147 (285)
T cd05631          76 CLVLTIMNGGDLKFHIYNMG-----NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLG  147 (285)
T ss_pred             EEEEEecCCCcHHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCC
Confidence            99999999999998876432     13588999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccC
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMAL  392 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  392 (477)
                      ++.....        ........||..|+|||++ .+.++.++|||||||++|||++|+.||.......           
T Consensus       148 ~~~~~~~--------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----------  208 (285)
T cd05631         148 LAVQIPE--------GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-----------  208 (285)
T ss_pred             CcEEcCC--------CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-----------
Confidence            9976421        1112344689999999999 5678999999999999999999999997532110           


Q ss_pred             CchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCC-----hHHHHH
Q 043902          393 PSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVG-----MKFVVN  463 (477)
Q Consensus       393 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  463 (477)
                         ..+.++........                     .........+.+|+.+||+.||.+||+     ++|+++
T Consensus       209 ---~~~~~~~~~~~~~~---------------------~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         209 ---KREEVDRRVKEDQE---------------------EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ---hHHHHHHHhhcccc---------------------cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence               00111111100000                     000011234789999999999999997     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1e-41  Score=342.54  Aligned_cols=269  Identities=21%  Similarity=0.305  Sum_probs=208.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCC-CEEEEEEeeeccchhhHHHHHHHHHHhcCC-CCCcceeeeeccccc-CCC-Cc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADG-ETAAIKVLKLQQQGALKSFIDECNALTSIR-HRNILKIVSSCSSVD-YEG-ND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~-~~  231 (477)
                      ..++++.+.|.+|||+.||.|+...+ ..||+|++-..+....+...+|+++|++|+ |+|||.+++...... ... ..
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            45667889999999999999997655 999999998888888899999999999996 999999999422211 122 35


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      +.+|.||||.+|+|-+++..+..     ..+++.++++|+.|+++|+++||.. .++|||||||-+||||+.++..||||
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq-----~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD  189 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQ-----TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD  189 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHh-----ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence            68899999999999999986643     4499999999999999999999996 77899999999999999999999999


Q ss_pred             ccccccccccCCCCCCCc--cccCCCcccccccCcccc---cC-CCCcccceeehHHHHHHHhhCCCCCCccccccccee
Q 043902          312 FGLAKFLFEESNTPSKNQ--TMSNGLKGSVGYIPPEYI---NG-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIH  385 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~---~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~  385 (477)
                      ||.+..............  ...-....|+.|+|||++   .+ .+++|+|||+|||+||-|+....||+....-.+.-.
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng  269 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNG  269 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEec
Confidence            999964322111000000  001123368999999998   33 589999999999999999999999976321111000


Q ss_pred             eeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHH
Q 043902          386 KFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNL  465 (477)
Q Consensus       386 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  465 (477)
                      .+.   +|.                             .         ......+.+|++.||+.||++||++-||+..+
T Consensus       270 ~Y~---~P~-----------------------------~---------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~  308 (738)
T KOG1989|consen  270 NYS---FPP-----------------------------F---------PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI  308 (738)
T ss_pred             ccc---CCC-----------------------------C---------ccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence            000   010                             0         01144588999999999999999999999999


Q ss_pred             HHHHHh
Q 043902          466 QAIRSK  471 (477)
Q Consensus       466 ~~i~~~  471 (477)
                      .+|+.+
T Consensus       309 ~~l~~~  314 (738)
T KOG1989|consen  309 FELANK  314 (738)
T ss_pred             HHHhcC
Confidence            988765

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.2e-41  Score=318.12  Aligned_cols=269  Identities=26%  Similarity=0.380  Sum_probs=199.9

Q ss_pred             CCCCCeeeeeccceEEEEEe-----CCCCEEEEEEeeeccc-hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          159 FSEENLIGSGSFGSVYKGTL-----ADGETAAIKVLKLQQQ-GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       159 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      |...+.||+|+||.||++..     .++..||+|.++.... .....+.+|++++++++||||++++++|..   .....
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~   82 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGGKG   82 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCCce
Confidence            37889999999999988653     3678999999975432 334678899999999999999999998742   33456


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++++|.+++...        .+++.+++.++.|++.||.|||+.   +++||||||+||++++++.+||+||
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~--------~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~df  151 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH--------KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDF  151 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeec
Confidence            89999999999999998643        489999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      |+++.......    .........++..|+|||.+ .+.++.++||||||+++|||+||..|+.................
T Consensus       152 g~~~~~~~~~~----~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  227 (283)
T cd05080         152 GLAKAVPEGHE----YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQ  227 (283)
T ss_pred             ccccccCCcch----hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccc
Confidence            99986532110    01112223456679999998 56789999999999999999999999864322111111100000


Q ss_pred             CC-chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHH
Q 043902          392 LP-SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIR  469 (477)
Q Consensus       392 ~~-~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  469 (477)
                      .. ..+.+.++......                        ....++..+.+++.+|++.+|++|||+++|++.|+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         228 MTVVRLIELLERGMRLP------------------------CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             cchhhhhhhhhcCCCCC------------------------CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            00 01111111110000                        00112345889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-41  Score=316.07  Aligned_cols=258  Identities=23%  Similarity=0.332  Sum_probs=197.1

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--------------chhhHHHHHHHHHHhcCCCCCcceee
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--------------QGALKSFIDECNALTSIRHRNILKIV  219 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~niv~l~  219 (477)
                      ..++|+..+.||+|.||.|-+|+.. +++.||||++....              ....+...+|+.+|++++|||||+|+
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            4578999999999999999999854 79999999986321              11235788999999999999999999


Q ss_pred             eecccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCe
Q 043902          220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNV  299 (477)
Q Consensus       220 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NI  299 (477)
                      .+..   ....+..|||+|||..|.+...=...       ..++..+.++++.++..||.|||.+   +|+||||||+|+
T Consensus       175 EvLD---DP~s~~~YlVley~s~G~v~w~p~d~-------~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNL  241 (576)
T KOG0585|consen  175 EVLD---DPESDKLYLVLEYCSKGEVKWCPPDK-------PELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNL  241 (576)
T ss_pred             Eeec---CcccCceEEEEEeccCCccccCCCCc-------ccccHHHHHHHHHHHHHHHHHHHhc---Ceeccccchhhe
Confidence            9854   35567899999999988875432211       2289999999999999999999999   999999999999


Q ss_pred             EecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccccC-C----CCcccceeehHHHHHHHhhCCCCC
Q 043902          300 LLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-H----VSILGDIYSYGILLLEIFTGKRPT  374 (477)
Q Consensus       300 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~----~~~~~Dv~S~Gvvl~elltg~~p~  374 (477)
                      ||+++|++||+|||.+........  ...........||+.|+|||...+ .    .+.+.||||+||+||.|+.|+.||
T Consensus       242 Ll~~~g~VKIsDFGVs~~~~~~~~--~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF  319 (576)
T KOG0585|consen  242 LLSSDGTVKISDFGVSNEFPQGSD--EGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF  319 (576)
T ss_pred             EEcCCCcEEeeccceeeecccCCc--cccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence            999999999999999986633211  112222344789999999999833 2    477889999999999999999999


Q ss_pred             CcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCC
Q 043902          375 DDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRD  454 (477)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~  454 (477)
                      .+.+.-.             -...++...+..               |...         +....+.+|+.++|..||++
T Consensus       320 ~~~~~~~-------------l~~KIvn~pL~f---------------P~~p---------e~~e~~kDli~~lL~KdP~~  362 (576)
T KOG0585|consen  320 FDDFELE-------------LFDKIVNDPLEF---------------PENP---------EINEDLKDLIKRLLEKDPEQ  362 (576)
T ss_pred             ccchHHH-------------HHHHHhcCcccC---------------CCcc---------cccHHHHHHHHHHhhcChhh
Confidence            6532110             011122111111               1100         11234789999999999999


Q ss_pred             CCChHHHHHH
Q 043902          455 RVGMKFVVNN  464 (477)
Q Consensus       455 RPs~~evl~~  464 (477)
                      |.+..+|...
T Consensus       363 Ri~l~~ik~H  372 (576)
T KOG0585|consen  363 RITLPDIKLH  372 (576)
T ss_pred             eeehhhheec
Confidence            9999998654

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=8.4e-42  Score=324.55  Aligned_cols=245  Identities=28%  Similarity=0.417  Sum_probs=202.1

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ++|.+.+.||+|.||.||+|+.+ +.+.||+|.+.+..  ....+...+|++++.+++||||+.++++     |++..+.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~es-----fEt~~~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLES-----FETSAHL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHh-----hcccceE
Confidence            57888899999999999999865 68999999987543  4456789999999999999999999998     5888999


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++|+||+.| +|..+|...       ..+++..+..++.+++.||.|||+.   +|.|||+||.|||++.++.+|++|||
T Consensus        77 ~vVte~a~g-~L~~il~~d-------~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg  145 (808)
T KOG0597|consen   77 WVVTEYAVG-DLFTILEQD-------GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFG  145 (808)
T ss_pred             EEEehhhhh-hHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhh
Confidence            999999976 999999865       5799999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccC
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMAL  392 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  392 (477)
                      +|+.+..       .....+...||+.|||||.. .+.|+..+|.||+||++||+++|++||...               
T Consensus       146 ~Ar~m~~-------~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~---------------  203 (808)
T KOG0597|consen  146 LARAMST-------NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR---------------  203 (808)
T ss_pred             hhhhccc-------CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH---------------
Confidence            9997632       45566778899999999999 567999999999999999999999999542               


Q ss_pred             CchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          393 PSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       393 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                        .+.+++......+.           ..|.           .....+..++...+..||.+|.|..+++.
T Consensus       204 --si~~Lv~~I~~d~v-----------~~p~-----------~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  204 --SITQLVKSILKDPV-----------KPPS-----------TASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             --HHHHHHHHHhcCCC-----------CCcc-----------cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence              11222211111110           0000           11223677888889999999999998874

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-42  Score=319.87  Aligned_cols=248  Identities=24%  Similarity=0.368  Sum_probs=202.5

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ...|+..+.||+|.||.||+|... .++.||+|++.... ....+...+|+.+|.+++++||.+++|.+     -.+..+
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsy-----l~g~~L   86 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSY-----LKGTKL   86 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhe-----eecccH
Confidence            346777899999999999999854 78999999998664 44567889999999999999999999984     567778


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      +++|||+.+|++.+.|+..       ..+.+..+.-++.++..||.|||++   +.+|||||+.|||+..+|.+|++|||
T Consensus        87 wiiMey~~gGsv~~lL~~~-------~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~Dfg  156 (467)
T KOG0201|consen   87 WIIMEYCGGGSVLDLLKSG-------NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFG  156 (467)
T ss_pred             HHHHHHhcCcchhhhhccC-------CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecc
Confidence            9999999999999999865       3347778888999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccccC-CCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccC
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMAL  392 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  392 (477)
                      .+-.+..       .......++||+.|||||++.+ .|+.|+||||||++.+||.+|.+|+.....  +...-.+....
T Consensus       157 Va~ql~~-------~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP--mrvlflIpk~~  227 (467)
T KOG0201|consen  157 VAGQLTN-------TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP--MRVLFLIPKSA  227 (467)
T ss_pred             eeeeeec-------hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc--ceEEEeccCCC
Confidence            9987632       2333467889999999999965 699999999999999999999999977543  11111111111


Q ss_pred             CchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          393 PSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       393 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      |..+..                                    .+...+.+++..||+.||+.|||+.++++
T Consensus       228 PP~L~~------------------------------------~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  228 PPRLDG------------------------------------DFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             CCcccc------------------------------------ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            111110                                    11334889999999999999999999985

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.1e-41  Score=317.85  Aligned_cols=255  Identities=26%  Similarity=0.505  Sum_probs=200.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      .++|+..+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+||+++++++     ...+..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   78 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIYI   78 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCcEE
Confidence            457888999999999999999988888999999875432 347889999999999999999999885     45667899


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      +|||+++++|.+++....     ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++
T Consensus        79 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~  150 (261)
T cd05072          79 ITEYMAKGSLLDFLKSDE-----GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLA  150 (261)
T ss_pred             EEecCCCCcHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccc
Confidence            999999999999987542     14588899999999999999999998   9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCC
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      ......      .........++..|+|||++ .+.++.++|||||||++|||+| |+.||.......            
T Consensus       151 ~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~------------  212 (261)
T cd05072         151 RVIEDN------EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD------------  212 (261)
T ss_pred             eecCCC------ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH------------
Confidence            865221      11112233467789999998 5678999999999999999999 999986432111            


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                        ....+......               +.         ...++..+.+++.+|++.+|++||+++++.+.|+++
T Consensus       213 --~~~~~~~~~~~---------------~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         213 --VMSALQRGYRM---------------PR---------MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             --HHHHHHcCCCC---------------CC---------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence              00000000000               00         001133478999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.8e-41  Score=318.03  Aligned_cols=270  Identities=24%  Similarity=0.413  Sum_probs=201.8

Q ss_pred             cCCCCCCeeeeeccceEEEEEe-----CCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          157 DNFSEENLIGSGSFGSVYKGTL-----ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .+|+..+.||+|+||.||++..     .++..||+|.++.......+.+.+|++++.+++||||+++++++..   .+..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc---CCCC
Confidence            4678889999999999999974     2578999999987666666789999999999999999999998642   3445


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++|+||+++|+|.+++....      ..+++..++.++.|++.||.|||+.   +++||||||+||++++++.+||+|
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~d  151 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHR------ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGD  151 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcC------cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECC
Confidence            6899999999999999996542      4589999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      ||++........    .........++..|+|||++ .+.++.++|||||||++|||++|..|+......   +......
T Consensus       152 fg~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~  224 (284)
T cd05081         152 FGLTKVLPQDKE----YYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGN  224 (284)
T ss_pred             CcccccccCCCc----ceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhccc
Confidence            999987632111    01111222345569999998 556899999999999999999988776432111   0000000


Q ss_pred             cCC--c---hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHH
Q 043902          391 ALP--S---HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNL  465 (477)
Q Consensus       391 ~~~--~---~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  465 (477)
                      ...  .   .+.+.+.....               .+         ....++..+.+++.+||+.+|++|||+.||++.|
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~---------------~~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l  280 (284)
T cd05081         225 DKQGQMIVYHLIELLKNNGR---------------LP---------APPGCPAEIYAIMKECWNNDPSQRPSFSELALQV  280 (284)
T ss_pred             ccccccchHHHHHHHhcCCc---------------CC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence            000  0   01111110000               00         0011234588999999999999999999999999


Q ss_pred             HHHH
Q 043902          466 QAIR  469 (477)
Q Consensus       466 ~~i~  469 (477)
                      +.++
T Consensus       281 ~~~~  284 (284)
T cd05081         281 EAIR  284 (284)
T ss_pred             HhcC
Confidence            8763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.1e-40  Score=312.01  Aligned_cols=250  Identities=26%  Similarity=0.428  Sum_probs=196.3

Q ss_pred             cCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEE
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALV  236 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  236 (477)
                      ++|+..+.||+|+||.||++.++++..+|+|.++.... ....+.+|++++++++||||++++++|     ...+..++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVC-----TQQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEE-----ccCCCEEEE
Confidence            45778899999999999999988888999998874432 236788999999999999999999986     445678999


Q ss_pred             EeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccc
Q 043902          237 FEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK  316 (477)
Q Consensus       237 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  316 (477)
                      |||+++|+|.+++....      ..+++..++.++.|++.||.|||+.   +++|+||||+||++++++.+||+|||.++
T Consensus        78 ~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~  148 (256)
T cd05114          78 TEFMENGCLLNYLRQRQ------GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTR  148 (256)
T ss_pred             EEcCCCCcHHHHHHhCc------cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCcc
Confidence            99999999999987543      3588999999999999999999999   99999999999999999999999999987


Q ss_pred             cccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCCc
Q 043902          317 FLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALPS  394 (477)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  394 (477)
                      .....      .........++..|+|||.+ ...++.++||||||+++|||++ |+.||.......             
T Consensus       149 ~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~-------------  209 (256)
T cd05114         149 YVLDD------EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE-------------  209 (256)
T ss_pred             ccCCC------ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------------
Confidence            65221      11112233456789999999 4568999999999999999999 899986432110             


Q ss_pred             hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHH
Q 043902          395 HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNL  465 (477)
Q Consensus       395 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  465 (477)
                      .+..+.... .         .    ..+..           ....+.+++.+|++.+|++|||++|+++.|
T Consensus       210 ~~~~i~~~~-~---------~----~~~~~-----------~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         210 VVEMISRGF-R---------L----YRPKL-----------ASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             HHHHHHCCC-C---------C----CCCCC-----------CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            000000000 0         0    00000           023488999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.6e-40  Score=316.83  Aligned_cols=204  Identities=24%  Similarity=0.411  Sum_probs=167.3

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC--CCCEEEEEEeeecc--chhhHHHHHHHHHHhcC---CCCCcceeeeecccccCCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA--DGETAAIKVLKLQQ--QGALKSFIDECNALTSI---RHRNILKIVSSCSSVDYEG  229 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~  229 (477)
                      .+|+..+.||+|+||.||+|+..  +++.||+|+++...  ......+.+|+.+++++   +||||++++++|.......
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888999999999999999863  46889999987543  22234566777776665   6999999999985443445


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEE
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV  309 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl  309 (477)
                      ....++||||++ ++|.+++.....     ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl  151 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPE-----PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL  151 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEE
Confidence            667899999996 699998865421     4588999999999999999999999   9999999999999999999999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      +|||+++....        ........||..|+|||.+ ...++.++|||||||++|||++|+.||...
T Consensus       152 ~Dfg~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  212 (290)
T cd07862         152 ADFGLARIYSF--------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS  212 (290)
T ss_pred             ccccceEeccC--------CcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCC
Confidence            99999976521        1223345689999999998 567899999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=6.6e-42  Score=320.71  Aligned_cols=248  Identities=32%  Similarity=0.556  Sum_probs=187.8

Q ss_pred             CCeeeeeccceEEEEEeC-----CCCEEEEEEeeeccc-hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          162 ENLIGSGSFGSVYKGTLA-----DGETAAIKVLKLQQQ-GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       162 ~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      .+.||.|.||.||+|.+.     .+..|+||.++.... ...+.|.+|++.+.+++||||++++|+|.     ..+..++
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~-----~~~~~~l   78 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI-----ENEPLFL   78 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE-----SSSSEEE
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc-----ccccccc
Confidence            468999999999999976     356899999975433 34689999999999999999999999984     3445899


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      |+||+++|+|.++|.....     ..+++..++.|+.|+++||.|||+.   +++|+||+++||+++.++.+||+|||++
T Consensus        79 v~e~~~~g~L~~~L~~~~~-----~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~  150 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKNK-----EPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLS  150 (259)
T ss_dssp             EEE--TTEBHHHHHHHTCT-----TTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTG
T ss_pred             ccccccccccccccccccc-----ccccccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence            9999999999999987621     5689999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCC
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      ......     ..............|+|||.+ .+.++.++||||||+++|||+| |+.||.+.....            
T Consensus       151 ~~~~~~-----~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~------------  213 (259)
T PF07714_consen  151 RPISEK-----SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE------------  213 (259)
T ss_dssp             EETTTS-----SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH------------
T ss_pred             cccccc-----ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc------------
Confidence            865211     111223334577899999999 5668999999999999999999 788886542111            


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNL  465 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  465 (477)
                        +.+.+.......                        ....++..+.+++..||+.||++|||+.++++.|
T Consensus       214 --~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  214 --IIEKLKQGQRLP------------------------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             --HHHHHHTTEETT------------------------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             --ccccccccccce------------------------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence              111110000000                        0001234488999999999999999999999886

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-41  Score=319.98  Aligned_cols=195  Identities=28%  Similarity=0.415  Sum_probs=169.1

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ++|+..+.||+|+||.||+|... +|+.||+|+++...   ....+.+.+|++++++++||||+++++++     .+...
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~   75 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRF   75 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCe
Confidence            46888999999999999999875 68999999997532   22345688999999999999999999874     56678


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++|+|.+++...       ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Df  145 (291)
T cd05612          76 LYMLMEYVPGGELFSYLRNS-------GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDF  145 (291)
T ss_pred             EEEEEeCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEec
Confidence            99999999999999999754       4588999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |+++....          ......|++.|+|||++ ...++.++|||||||++|||+||+.||..
T Consensus       146 g~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  200 (291)
T cd05612         146 GFAKKLRD----------RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD  200 (291)
T ss_pred             CcchhccC----------CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99976521          11234689999999998 44589999999999999999999999965

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.1e-40  Score=322.55  Aligned_cols=240  Identities=23%  Similarity=0.342  Sum_probs=189.6

Q ss_pred             CeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEe
Q 043902          163 NLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFE  238 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  238 (477)
                      +.||+|+||.||+++.. +|+.||+|+++...   ......+.+|++++.+++||||+++++++     ...+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence            46999999999999864 78999999998542   23345778899999999999999999885     56678999999


Q ss_pred             ecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccc
Q 043902          239 FMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFL  318 (477)
Q Consensus       239 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  318 (477)
                      |+++|+|.+++...       ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 ~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~  145 (323)
T cd05571          76 YANGGELFFHLSRE-------RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             CCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence            99999999998754       4589999999999999999999999   9999999999999999999999999998753


Q ss_pred             cccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCchhH
Q 043902          319 FEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVM  397 (477)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  397 (477)
                      ..       .........||+.|+|||++ ...++.++|||||||++|||+||+.||.......              ..
T Consensus       146 ~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--------------~~  204 (323)
T cd05571         146 IS-------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--------------LF  204 (323)
T ss_pred             cc-------CCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH--------------HH
Confidence            11       11122345689999999999 5568999999999999999999999996421110              00


Q ss_pred             HHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC-----ChHHHHH
Q 043902          398 DVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRV-----GMKFVVN  463 (477)
Q Consensus       398 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  463 (477)
                      ..+.   ...           ..+|           ......+.+++.+||+.||++||     ++.++++
T Consensus       205 ~~~~---~~~-----------~~~p-----------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         205 ELIL---MEE-----------IRFP-----------RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             HHHH---cCC-----------CCCC-----------CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            0000   000           0000           00123478899999999999999     7888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.9e-42  Score=313.18  Aligned_cols=282  Identities=24%  Similarity=0.317  Sum_probs=198.6

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      -.|...+++|.|+||.||+|... +++.||||.......    .-.+|+++|+++.|||||++.-++......+.-...+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            35667889999999999999965 579999998865432    2246999999999999999998876533222335668


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC-CcEEEecccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG-MIAHVGDFGL  314 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~DfG~  314 (477)
                      |||||+. +|..+++....   ....++...+.-+..||.+||+|||+.   +|+||||||.|+|+|.+ |.+||||||.
T Consensus       100 VleymP~-tL~~~~r~~~~---~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGS  172 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTR---ANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGS  172 (364)
T ss_pred             HHHhchH-HHHHHHHHHhh---cCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCc
Confidence            9999977 99998874321   125678888889999999999999998   99999999999999966 8999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc-
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA-  391 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~-  391 (477)
                      |+.+..        .........|..|+|||.+-  ..|+.+.||||.|||+.||+-|++-|.+...-+ .+...+... 
T Consensus       173 AK~L~~--------~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d-QL~eIik~lG  243 (364)
T KOG0658|consen  173 AKVLVK--------GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD-QLVEIIKVLG  243 (364)
T ss_pred             ceeecc--------CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH-HHHHHHHHhC
Confidence            998743        22234456789999999993  469999999999999999999999997632211 111111100 


Q ss_pred             CCc-hhHHHhhhhhhhhhcccccccccccccchhhhHHHHH-HHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH--HHHH
Q 043902          392 LPS-HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQK-KLEECLVSVMRIGVMCSAASPRDRVGMKFVVN--NLQA  467 (477)
Q Consensus       392 ~~~-~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  467 (477)
                      .|. .-...+.+.-            .+..+|.+......+ .........++++.+++.++|.+|.++.|++.  ..++
T Consensus       244 ~Pt~e~I~~mn~~y------------~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFde  311 (364)
T KOG0658|consen  244 TPTREDIKSMNPNY------------TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDE  311 (364)
T ss_pred             CCCHHHHhhcCccc------------ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHH
Confidence            010 0000000000            011111111111101 11122345889999999999999999999984  4455


Q ss_pred             HHH
Q 043902          468 IRS  470 (477)
Q Consensus       468 i~~  470 (477)
                      ++.
T Consensus       312 lr~  314 (364)
T KOG0658|consen  312 LRD  314 (364)
T ss_pred             hhC
Confidence            443

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-41  Score=296.90  Aligned_cols=197  Identities=28%  Similarity=0.410  Sum_probs=176.1

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .++|+..+.||.|+||.|.+++.+ +|..+|+|+++...   ....+...+|-.+|+.+.||.++++.+.|     .+..
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~~  117 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDNS  117 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccCC
Confidence            467888999999999999999965 78999999998654   23346678899999999999999999885     6778


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||++||.|.++|+..       .++++..+.-++.||+.||+|||+.   +|++|||||+|||+|.+|.+||+|
T Consensus       118 ~lymvmeyv~GGElFS~Lrk~-------~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitD  187 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLRKS-------GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITD  187 (355)
T ss_pred             eEEEEEeccCCccHHHHHHhc-------CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEe
Confidence            899999999999999999866       5699999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      ||+|+..          .......+||+.|+|||.+ ...++.++|.|||||++|||+.|.+||.+.
T Consensus       188 FGFAK~v----------~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~  244 (355)
T KOG0616|consen  188 FGFAKRV----------SGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD  244 (355)
T ss_pred             ccceEEe----------cCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence            9999976          2224567899999999999 556899999999999999999999999753

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.8e-41  Score=318.75  Aligned_cols=260  Identities=27%  Similarity=0.503  Sum_probs=201.0

Q ss_pred             cCCCCCCeeeeeccceEEEEEeCC------CCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLAD------GETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEG  229 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  229 (477)
                      ++|+..+.||+|+||.||+|....      ...||+|.++... ......+.+|++.+.+++||||+++++++     ..
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~   79 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVC-----TK   79 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEE-----cC
Confidence            468889999999999999998642      2579999987543 23346789999999999999999999986     44


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCc---------ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeE
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDE---------YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVL  300 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIl  300 (477)
                      .+..+++|||+++|+|.+++......         ......+++..++.++.|++.||.|||+.   +++|+||||+||+
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil  156 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCL  156 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEE
Confidence            56789999999999999999654211         00114588999999999999999999999   9999999999999


Q ss_pred             ecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCccc
Q 043902          301 LDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMF  378 (477)
Q Consensus       301 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~  378 (477)
                      +++++.+||+|||+++......     .........++..|+|||.+ .+.++.++|||||||++|||++ |..||....
T Consensus       157 ~~~~~~~~L~dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~  231 (283)
T cd05048         157 VGEGLTVKISDFGLSRDIYSAD-----YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS  231 (283)
T ss_pred             EcCCCcEEECCCcceeeccccc-----cccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            9999999999999997653211     11122334567889999988 6678999999999999999998 999986532


Q ss_pred             ccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCCh
Q 043902          379 KDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGM  458 (477)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  458 (477)
                      ..              .+.+.+......                        .....++..+.+|+.+||+.||.+||++
T Consensus       232 ~~--------------~~~~~i~~~~~~------------------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~  273 (283)
T cd05048         232 NQ--------------EVIEMIRSRQLL------------------------PCPEDCPARVYALMIECWNEIPARRPRF  273 (283)
T ss_pred             HH--------------HHHHHHHcCCcC------------------------CCcccCCHHHHHHHHHHccCChhhCcCH
Confidence            11              111111111000                        0011234568999999999999999999


Q ss_pred             HHHHHHHHH
Q 043902          459 KFVVNNLQA  467 (477)
Q Consensus       459 ~evl~~L~~  467 (477)
                      +||++.|+.
T Consensus       274 ~~i~~~l~~  282 (283)
T cd05048         274 KDIHTRLRS  282 (283)
T ss_pred             HHHHHHHhc
Confidence            999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=6.1e-41  Score=315.10  Aligned_cols=254  Identities=26%  Similarity=0.484  Sum_probs=198.9

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      .+|+..+.||+|+||.||+|... .++.||+|.++... .....+.+|++++.+++|+||++++++|     ...+..++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   79 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFYI   79 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEE-----cCCCCcEE
Confidence            45778889999999999999865 58899999987543 3346789999999999999999999986     34567899


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      ||||+++++|.+++....     ...+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||++
T Consensus        80 v~e~~~~~~L~~~~~~~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~  151 (263)
T cd05052          80 ITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS  151 (263)
T ss_pred             EEEeCCCCcHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccc
Confidence            999999999999986542     14589999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCC
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      ......      .........++..|+|||.+ ...++.++|||||||++|||+| |..||.....+.            
T Consensus       152 ~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~------------  213 (263)
T cd05052         152 RLMTGD------TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------------  213 (263)
T ss_pred             cccccc------eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------------
Confidence            865321      11111223346689999998 5578999999999999999998 999986432110            


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                        ..+.+.......                        ..+.++..+.+++.+|++.||++|||+.|+++.|+.+
T Consensus       214 --~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         214 --VYELLEKGYRME------------------------RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             --HHHHHHCCCCCC------------------------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence              111111100000                        0011234588999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.5e-40  Score=316.53  Aligned_cols=200  Identities=25%  Similarity=0.413  Sum_probs=167.8

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .++|...+.||+|+||.||+|... +++.||+|+++... ......+.+|++++++++||||+++++++     ......
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~   78 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCL   78 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeE
Confidence            357889999999999999999865 68999999987543 22345678999999999999999999985     456678


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||+++ +|.+++....      ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        79 ~lv~e~~~~-~l~~~l~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG  148 (288)
T cd07871          79 TLVFEYLDS-DLKQYLDNCG------NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFG  148 (288)
T ss_pred             EEEEeCCCc-CHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCc
Confidence            999999974 9998886432      3578899999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      +++....       .........++..|+|||.+.  ..++.++||||+||++|||+||+.||...
T Consensus       149 ~~~~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~  207 (288)
T cd07871         149 LARAKSV-------PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS  207 (288)
T ss_pred             ceeeccC-------CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9975421       111223346789999999883  35899999999999999999999999653

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.1e-40  Score=321.89  Aligned_cols=258  Identities=26%  Similarity=0.457  Sum_probs=200.1

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCC----EEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGE----TAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      .+|+..+.||+|+||.||+|++. ++.    .||+|.++... ....+.+.+|+.+++.++||||++++|+|..      
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~------   80 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------   80 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC------
Confidence            56899999999999999999864 333    48999987543 3445788999999999999999999999742      


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ...++|+||+++|+|.+++....      ..+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        81 ~~~~~v~e~~~~g~l~~~l~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~  151 (316)
T cd05108          81 STVQLITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKIT  151 (316)
T ss_pred             CCceeeeecCCCCCHHHHHHhcc------ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEc
Confidence            24679999999999999997543      4588999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~  388 (477)
                      |||+++......     .........++..|+|||++ .+.++.++|||||||++|||+| |+.||.......       
T Consensus       152 DfG~a~~~~~~~-----~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-------  219 (316)
T cd05108         152 DFGLAKLLGADE-----KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------  219 (316)
T ss_pred             cccccccccCCC-----cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence            999998763211     11112223356789999998 5678999999999999999998 999986532111       


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                             +..++.......             .+           ..+...+.+++.+||+.+|++|||+.+++..|..+
T Consensus       220 -------~~~~~~~~~~~~-------------~~-----------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~  268 (316)
T cd05108         220 -------ISSILEKGERLP-------------QP-----------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  268 (316)
T ss_pred             -------HHHHHhCCCCCC-------------CC-----------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                   111111100000             00           01123478899999999999999999999999888


Q ss_pred             HHhh
Q 043902          469 RSKI  472 (477)
Q Consensus       469 ~~~~  472 (477)
                      ..+.
T Consensus       269 ~~~~  272 (316)
T cd05108         269 ARDP  272 (316)
T ss_pred             HcCC
Confidence            7653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.4e-41  Score=326.24  Aligned_cols=266  Identities=24%  Similarity=0.413  Sum_probs=201.6

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC------CCCEEEEEEeeecc-chhhHHHHHHHHHHhcC-CCCCcceeeeecccccC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQQ-QGALKSFIDECNALTSI-RHRNILKIVSSCSSVDY  227 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  227 (477)
                      .++|.+.+.||+|+||.||+|...      +++.||+|+++... ....+.+.+|+.++.++ +|+||++++++|.    
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~----   81 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT----   81 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe----
Confidence            357889999999999999999642      35789999987543 23346788899999999 8999999999874    


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCc----------------------------------------------------
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDE----------------------------------------------------  255 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------------------------------------------------  255 (477)
                      ..+...++++||+++++|.+++......                                                    
T Consensus        82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            4456788999999999999998643210                                                    


Q ss_pred             --ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccccccCCCCCCCccccC
Q 043902          256 --YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN  333 (477)
Q Consensus       256 --~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  333 (477)
                        ......+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||+++.+....     ......
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~-----~~~~~~  233 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-----DYVRKG  233 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCc-----chhhcc
Confidence              00113689999999999999999999999   99999999999999999999999999998753211     111122


Q ss_pred             CCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhccc
Q 043902          334 GLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEEND  411 (477)
Q Consensus       334 ~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  411 (477)
                      ...++..|+|||++ ...++.++|||||||++|||++ |..||......+             .....+.......    
T Consensus       234 ~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-------------~~~~~~~~~~~~~----  296 (337)
T cd05054         234 DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-------------EFCRRLKEGTRMR----  296 (337)
T ss_pred             CCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-------------HHHHHHhccCCCC----
Confidence            34557789999988 6679999999999999999998 999986421110             0111110000000    


Q ss_pred             ccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHH
Q 043902          412 HEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRS  470 (477)
Q Consensus       412 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  470 (477)
                               .           .+.....+.+++.+|++.+|++||++.|+++.|+++.+
T Consensus       297 ---------~-----------~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         297 ---------A-----------PEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             ---------C-----------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                     0           00112348899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.2e-41  Score=301.41  Aligned_cols=202  Identities=26%  Similarity=0.363  Sum_probs=174.3

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc--hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ--GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .++|+..+.|++|.||.||+|+.+ +++.||+|+++....  +.--..++|+.+|.+++|||||.+-.+...   .+-+.
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG---~~~d~  151 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVG---SNMDK  151 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec---cccce
Confidence            457888899999999999999965 789999999986542  223456899999999999999999877543   44556


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .|+|||||+. +|.+++....      +++...++.-+..|+++|++|||.+   .|+|||||++|+|++..|.+||+||
T Consensus       152 iy~VMe~~Eh-DLksl~d~m~------q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDF  221 (419)
T KOG0663|consen  152 IYIVMEYVEH-DLKSLMETMK------QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADF  221 (419)
T ss_pred             eeeeHHHHHh-hHHHHHHhcc------CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEeccc
Confidence            9999999966 9999998765      5789999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      |+|+.+..       .....+..+-|.+|+|||.+-  ..|+...|+||+||++.||+++++.|.+.
T Consensus       222 GLAR~ygs-------p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~  281 (419)
T KOG0663|consen  222 GLAREYGS-------PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK  281 (419)
T ss_pred             chhhhhcC-------CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC
Confidence            99998732       233456677899999999993  35999999999999999999999998764

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=7.1e-41  Score=325.12  Aligned_cols=198  Identities=28%  Similarity=0.425  Sum_probs=170.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .++|+..+.||+|+||.||+++.. +|..+|+|.++... ......+.+|++++.+++||||+++++++     ..++..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   78 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI   78 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECCEE
Confidence            468999999999999999999975 68899999998653 23446799999999999999999999986     456678


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||+++|+|.+++...       ..+++..+..++.|++.||.|||+.  .+|+||||||+||+++.++.+||+|||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg  149 (331)
T cd06649          79 SICMEHMDGGSLDQVLKEA-------KRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFG  149 (331)
T ss_pred             EEEeecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCc
Confidence            9999999999999999754       4588999999999999999999985  169999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ++.....         .......|+..|+|||++ ...++.++|||||||++|||+||+.||..
T Consensus       150 ~~~~~~~---------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         150 VSGQLID---------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             ccccccc---------cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            9876521         122334689999999999 45689999999999999999999999965

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-40  Score=323.01  Aligned_cols=196  Identities=29%  Similarity=0.398  Sum_probs=170.1

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .++|...+.||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|+.++.+++||||+++++++     ..++
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~   91 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDEN   91 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcCC
Confidence            367888999999999999999975 68999999997542   23346788999999999999999999985     5667


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+++|+|.+++...       ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~D  161 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRKA-------GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTD  161 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEee
Confidence            899999999999999998754       4578889999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ||+++....          ......||+.|+|||++ ...++.++|||||||++|||+||+.||..
T Consensus       162 fg~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  217 (329)
T PTZ00263        162 FGFAKKVPD----------RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD  217 (329)
T ss_pred             ccCceEcCC----------CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC
Confidence            999986521          11234689999999999 45689999999999999999999999964

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.3e-40  Score=317.00  Aligned_cols=278  Identities=19%  Similarity=0.249  Sum_probs=197.4

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++...  ....+.+.+|++++.+++||||+++++++     ...+..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL   75 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence            46889999999999999999975 68899999997542  23346788999999999999999999885     556789


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||++++++..+....       ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||
T Consensus        76 ~lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg  145 (287)
T cd07848          76 YLVFEYVEKNMLELLEEMP-------NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFG  145 (287)
T ss_pred             EEEEecCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeecc
Confidence            9999999988776554322       4588999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccce-eeeeecc
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSI-HKFVLMA  391 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~~~  391 (477)
                      ++......      .........|+..|+|||++ .+.++.++|||||||++|||++|+.||......+... .......
T Consensus       146 ~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  219 (287)
T cd07848         146 FARNLSEG------SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGP  219 (287)
T ss_pred             Cccccccc------ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCC
Confidence            99865221      11122234688999999998 5568999999999999999999999997532211100 0000011


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      ++..............      ......  ..................+.+++.+||+.||++|||++|+++
T Consensus       220 ~~~~~~~~~~~~~~~~------~~~~~~--~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         220 LPAEQMKLFYSNPRFH------GLRFPA--VNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             CCHHHHHhhhccchhc------ccccCc--ccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            1110000000000000      000000  000000011111123445899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-41  Score=325.19  Aligned_cols=252  Identities=21%  Similarity=0.306  Sum_probs=197.1

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++...   ......+.+|++++.+++||||+++++++     ...+.
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~   75 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEY   75 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCE
Confidence            36888999999999999999976 58999999998542   23446788999999999999999999885     56678


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++|+|.+++...       ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Df  145 (333)
T cd05600          76 LYLAMEYVPGGDFRTLLNNL-------GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDF  145 (333)
T ss_pred             EEEEEeCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeC
Confidence            99999999999999999654       4588999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      |++.....          ......||..|+|||++ ...++.++|||||||++|||++|+.||........         
T Consensus       146 g~a~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---------  206 (333)
T cd05600         146 GLSKGIVT----------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET---------  206 (333)
T ss_pred             cCCccccc----------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH---------
Confidence            99976421          23345689999999999 45789999999999999999999999965321110         


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                          ...+........  .           +....     ........+.+++.+|+..+|.+||+++|+++.
T Consensus       207 ----~~~i~~~~~~~~--~-----------~~~~~-----~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         207 ----WENLKYWKETLQ--R-----------PVYDD-----PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ----HHHHHhcccccc--C-----------CCCCc-----cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence                000000000000  0           00000     000112347889999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.7e-41  Score=313.67  Aligned_cols=255  Identities=29%  Similarity=0.459  Sum_probs=200.6

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      .++|+..+.||+|++|.||+|...+++.||+|.++.... ..+.+.+|++++++++||||+++++++     ...+..++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   78 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVC-----TLEEPIYI   78 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEE-----ecCCCeee
Confidence            456888999999999999999987788999999875432 246789999999999999999999985     45567899


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      ||||+++++|.+++....     ...+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+|||++
T Consensus        79 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~  150 (261)
T cd05068          79 VTELMKYGSLLEYLQGGA-----GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLA  150 (261)
T ss_pred             eeecccCCcHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceE
Confidence            999999999999997543     14689999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCC
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      +.....      ......+...+..|+|||++ ...++.++||||||+++|||+| |+.||......             
T Consensus       151 ~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------------  211 (261)
T cd05068         151 RVIKED------IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-------------  211 (261)
T ss_pred             EEccCC------cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-------------
Confidence            876321      11111222335689999998 5578999999999999999999 99998653211             


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                       .+...++......                        ....+...+.+++.+|++.+|++||++.++.+.|+.+
T Consensus       212 -~~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         212 -EVLQQVDQGYRMP------------------------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             -HHHHHHHcCCCCC------------------------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence             1111111100000                        0001134488999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8.7e-41  Score=325.86  Aligned_cols=204  Identities=25%  Similarity=0.374  Sum_probs=168.5

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec--cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      +|++.+.||+|+||.||+|+.. +|..||+|+++..  .......+.+|++++++++||||+++++++...........+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4778899999999999999865 7899999998743  223345788999999999999999999987543333345689


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +||||+. ++|.+++...       ..+++..+..++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        81 lv~e~~~-~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~  149 (338)
T cd07859          81 VVFELME-SDLHQVIKAN-------DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGL  149 (338)
T ss_pred             EEEecCC-CCHHHHHHhc-------ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcc
Confidence            9999995 6899888644       4589999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCccccc---CCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN---GHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ++.......    .........||..|+|||++.   ..++.++|||||||++|||+||+.||..
T Consensus       150 ~~~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~  210 (338)
T cd07859         150 ARVAFNDTP----TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG  210 (338)
T ss_pred             ccccccccC----ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence            976422111    111223456899999999983   4689999999999999999999999965

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.4e-41  Score=315.64  Aligned_cols=256  Identities=30%  Similarity=0.517  Sum_probs=205.2

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      ...+|+..+.||.|+||.||+|...++..+++|.++.........+.+|+.++++++|+||+++++++     ...+..+
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   78 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC-----SVGEPVY   78 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeE-----ecCCCeE
Confidence            34678889999999999999999888999999999876655567889999999999999999999986     4556789


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +||||+++++|.+++.....     ..+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||.
T Consensus        79 lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~  150 (261)
T cd05148          79 IITELMEKGSLLAFLRSPEG-----QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGL  150 (261)
T ss_pred             EEEeecccCCHHHHHhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccc
Confidence            99999999999999976432     4589999999999999999999998   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccC
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMAL  392 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  392 (477)
                      +......       ........++..|+|||.+ .+.++.++||||||+++|+|++ |+.||......            
T Consensus       151 ~~~~~~~-------~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~------------  211 (261)
T cd05148         151 ARLIKED-------VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH------------  211 (261)
T ss_pred             hhhcCCc-------cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH------------
Confidence            9765221       1112233467789999998 5678999999999999999998 89998653211            


Q ss_pred             CchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          393 PSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       393 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                        ...+.+.......                        ....++..+.+++.+|++.||++|||++++++.|+.+
T Consensus       212 --~~~~~~~~~~~~~------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         212 --EVYDQITAGYRMP------------------------CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             --HHHHHHHhCCcCC------------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence              0111111100000                        0011234588999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-41  Score=324.35  Aligned_cols=252  Identities=24%  Similarity=0.432  Sum_probs=209.5

Q ss_pred             CCCeeeeeccceEEEEEeCC---C--CEEEEEEeeec-cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          161 EENLIGSGSFGSVYKGTLAD---G--ETAAIKVLKLQ-QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       161 ~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      ..+.||.|-||.||+|.+.+   |  -.||||..+.. ..+..+.|+.|..+|++++||||++++|+|.      ....+
T Consensus       393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~------e~P~W  466 (974)
T KOG4257|consen  393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV------EQPMW  466 (974)
T ss_pred             HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee------cccee
Confidence            34679999999999998642   3  35889998863 4556789999999999999999999999984      35589


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +|||.++-|.|..+|+.+.      ..++......++.||+.||+|||+.   .+|||||..+|||+.....+||+|||+
T Consensus       467 ivmEL~~~GELr~yLq~nk------~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGL  537 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQNK------DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGL  537 (974)
T ss_pred             EEEecccchhHHHHHHhcc------ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccch
Confidence            9999999999999999776      5688999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccC
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMAL  392 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  392 (477)
                      ++.+.++.      ....+...-++.|||||.+ -.++|.++|||-|||.+||+++ |..||....+.+....-      
T Consensus       538 SR~~ed~~------yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i------  605 (974)
T KOG4257|consen  538 SRYLEDDA------YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI------  605 (974)
T ss_pred             hhhccccc------hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe------
Confidence            99874432      2233344567889999999 6789999999999999999998 99999876554432110      


Q ss_pred             CchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHh
Q 043902          393 PSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSK  471 (477)
Q Consensus       393 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  471 (477)
                                                      ..+.+...++.|+..+..|+.+||+++|.+||++.|+...|..+++.
T Consensus       606 --------------------------------EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe  652 (974)
T KOG4257|consen  606 --------------------------------ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE  652 (974)
T ss_pred             --------------------------------cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence                                            00111223345778899999999999999999999999999998873

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.7e-40  Score=328.44  Aligned_cols=265  Identities=27%  Similarity=0.456  Sum_probs=201.3

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC------CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCC-CCCcceeeeecccccC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQQ-QGALKSFIDECNALTSIR-HRNILKIVSSCSSVDY  227 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~  227 (477)
                      .++|.+.+.||+|+||.||+|+..      .+..||||+++... ....+.+.+|+++++++. ||||++++++|     
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~-----  110 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC-----  110 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE-----
Confidence            568889999999999999999853      23479999997543 333467899999999996 99999999996     


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCcc---------------------------------------------------
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDEY---------------------------------------------------  256 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~---------------------------------------------------  256 (477)
                      ......++||||+++|+|.+++.......                                                   
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            45567899999999999999886532100                                                   


Q ss_pred             --------------------------------------cccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCC
Q 043902          257 --------------------------------------CHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSN  298 (477)
Q Consensus       257 --------------------------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~N  298 (477)
                                                            .....+++..++.++.|++.||.|||+.   +|+||||||+|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~N  267 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARN  267 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHh
Confidence                                                  0113478889999999999999999998   99999999999


Q ss_pred             eEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCc
Q 043902          299 VLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDD  376 (477)
Q Consensus       299 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~  376 (477)
                      |+++.++.+||+|||+++......     .........++..|+|||.+ .+.++.++|||||||++|||++ |..||..
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~  342 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDS-----NYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG  342 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccc-----cccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence            999999999999999998653211     11122234567889999998 5678999999999999999997 9999865


Q ss_pred             ccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC
Q 043902          377 MFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRV  456 (477)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  456 (477)
                      ...+..             ....+.....         .               .....++..+.+++.+||+.||++||
T Consensus       343 ~~~~~~-------------~~~~~~~~~~---------~---------------~~~~~~~~~l~~li~~cl~~dP~~RP  385 (400)
T cd05105         343 MIVDST-------------FYNKIKSGYR---------M---------------AKPDHATQEVYDIMVKCWNSEPEKRP  385 (400)
T ss_pred             cchhHH-------------HHHHHhcCCC---------C---------------CCCccCCHHHHHHHHHHCccCHhHCc
Confidence            321110             0000000000         0               00011234588999999999999999


Q ss_pred             ChHHHHHHHHHHHH
Q 043902          457 GMKFVVNNLQAIRS  470 (477)
Q Consensus       457 s~~evl~~L~~i~~  470 (477)
                      |+.+|.+.|+++.+
T Consensus       386 t~~~l~~~l~~l~~  399 (400)
T cd05105         386 SFLHLSDIVESLLP  399 (400)
T ss_pred             CHHHHHHHHHHHcC
Confidence            99999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-40  Score=323.08  Aligned_cols=247  Identities=24%  Similarity=0.333  Sum_probs=202.5

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .+-|...+.||.|+.|.|-+|++. +|+.+|||++....   ......+.+|+-+|+-++||||++++++     |++..
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydV-----we~~~   85 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDV-----WENKQ   85 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeee-----eccCc
Confidence            456778899999999999999864 89999999997542   2234567899999999999999999999     68899


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ++|+|.||+++|-|.+++-..       +++++.+..+++.||+.|+.|+|..   +|+||||||+|+|+|..+.+||+|
T Consensus        86 ~lylvlEyv~gGELFdylv~k-------G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIAD  155 (786)
T KOG0588|consen   86 HLYLVLEYVPGGELFDYLVRK-------GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIAD  155 (786)
T ss_pred             eEEEEEEecCCchhHHHHHhh-------CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeec
Confidence            999999999999999999755       5799999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccccCC--CCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH--VSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      ||+|..-.        ........+|++.|.|||++.|.  .+.++||||.||+||.|+||+.||++.            
T Consensus       156 FGMAsLe~--------~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd------------  215 (786)
T KOG0588|consen  156 FGMASLEV--------PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD------------  215 (786)
T ss_pred             cceeeccc--------CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc------------
Confidence            99997532        23445566899999999999664  488999999999999999999999852            


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                           ++..++.+-..+..+..                      .....+..+|+.+|+..||++|.|++||++.
T Consensus       216 -----Nir~LLlKV~~G~f~MP----------------------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  216 -----NIRVLLLKVQRGVFEMP----------------------SNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             -----cHHHHHHHHHcCcccCC----------------------CcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence                 11111111111111110                      1113347899999999999999999999863

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-40  Score=312.77  Aligned_cols=256  Identities=26%  Similarity=0.470  Sum_probs=200.3

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC----CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA----DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      .++|+..+.||+|+||.||+|.+.    +...||+|.++... ......|.+|+..+.+++||||+++++++     ...
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   77 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV-----TKS   77 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE-----ecC
Confidence            357889999999999999999874    24579999987543 33446789999999999999999999985     456


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +..++||||+++++|.+++....      ..+++..++.++.|++.||.|||+.   +|+|+||||+||++++++.++|+
T Consensus        78 ~~~~iv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~  148 (266)
T cd05033          78 RPVMIITEYMENGSLDKFLREND------GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVS  148 (266)
T ss_pred             CceEEEEEcCCCCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEEC
Confidence            67899999999999999997543      3689999999999999999999998   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~  388 (477)
                      |||+++.....     ..........++..|+|||.+ .+.++.++||||||+++|||++ |..||.......       
T Consensus       149 dfg~~~~~~~~-----~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-------  216 (266)
T cd05033         149 DFGLSRRLEDS-----EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-------  216 (266)
T ss_pred             ccchhhccccc-----ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH-------
Confidence            99999876311     111112233456789999998 5578999999999999999998 999985432111       


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                             ..+.+.......                        ....++..+.+++.+|++.+|++||++.||++.|+++
T Consensus       217 -------~~~~~~~~~~~~------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         217 -------VIKAVEDGYRLP------------------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             -------HHHHHHcCCCCC------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                   111110000000                        0001134488999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4.1e-40  Score=312.18  Aligned_cols=257  Identities=25%  Similarity=0.446  Sum_probs=197.9

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCC----EEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGE----TAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      ++|+..+.||+|+||.||+|.+. ++.    .+++|.+.... ......+..|+..+++++||||+++++++.      .
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~------~   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP------G   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC------C
Confidence            57788899999999999999864 444    47777775332 233467788888999999999999999863      2


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ...++++||+++|+|.+++....      ..+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~  151 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHR------DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIA  151 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEc
Confidence            34679999999999999997543      4589999999999999999999998   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~  388 (477)
                      |||+++......     .........++..|+|||.+ .+.++.++|||||||++||++| |+.||......        
T Consensus       152 Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--------  218 (279)
T cd05111         152 DFGVADLLYPDD-----KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--------  218 (279)
T ss_pred             CCccceeccCCC-----cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence            999998653211     11122334567889999998 5679999999999999999998 99998653211        


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                            ...+++.......             .+.           .+...+.+++.+|+..||++|||+.|+++.|..+
T Consensus       219 ------~~~~~~~~~~~~~-------------~~~-----------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~  268 (279)
T cd05111         219 ------EVPDLLEKGERLA-------------QPQ-----------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM  268 (279)
T ss_pred             ------HHHHHHHCCCcCC-------------CCC-----------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence                  1112221110000             000           0123467899999999999999999999999887


Q ss_pred             HHh
Q 043902          469 RSK  471 (477)
Q Consensus       469 ~~~  471 (477)
                      ..+
T Consensus       269 ~~~  271 (279)
T cd05111         269 ARD  271 (279)
T ss_pred             HhC
Confidence            653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.1e-40  Score=317.96  Aligned_cols=200  Identities=26%  Similarity=0.433  Sum_probs=167.8

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc-hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ-GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .++|...+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|+.++++++||||+++++++     ......
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~   78 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-----HTKETL   78 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-----ecCCeE
Confidence            468999999999999999999975 789999999875432 2235678899999999999999999985     456789


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||++ ++|.+++....      ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        79 ~lv~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg  148 (303)
T cd07869          79 TLVFEYVH-TDLCQYMDKHP------GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFG  148 (303)
T ss_pred             EEEEECCC-cCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCC
Confidence            99999995 68888776442      4578899999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      ++.....       .........++..|+|||.+.  ..++.++|||||||++|||+||+.||...
T Consensus       149 ~~~~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  207 (303)
T cd07869         149 LARAKSV-------PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM  207 (303)
T ss_pred             cceeccC-------CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9875421       111223356789999999883  35789999999999999999999999753

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=7.3e-40  Score=311.96  Aligned_cols=265  Identities=28%  Similarity=0.486  Sum_probs=204.1

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC------CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      .+|.+.+.||+|+||.||++...      ++..+|+|.++.......+.+.+|++++.+++||||++++++|     ...
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   79 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC-----VEG   79 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence            46788899999999999999742      3456899998866555567899999999999999999999996     445


Q ss_pred             ceeeEEEeecCCCChhhhcccCCC------cccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTD------EYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG  304 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~  304 (477)
                      +..++||||+++++|.+++.....      .......+++..++.++.|++.||+|||+.   +++||||||+||+++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~  156 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN  156 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence            678999999999999999864321      011224589999999999999999999998   99999999999999999


Q ss_pred             CcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCccccccc
Q 043902          305 MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL  382 (477)
Q Consensus       305 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~  382 (477)
                      +.+||+|||+++......     .........++..|+|||.+ ...++.++|||||||++|||+| |..||....... 
T Consensus       157 ~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-  230 (288)
T cd05093         157 LLVKIGDFGMSRDVYSTD-----YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-  230 (288)
T ss_pred             CcEEeccCCccccccCCc-----eeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence            999999999997653211     11112233457789999998 4568999999999999999999 899986432111 


Q ss_pred             ceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHH
Q 043902          383 SIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVV  462 (477)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl  462 (477)
                                   ..+.+.......             .+           ..+...+.+++.+|++.||.+|||+.||.
T Consensus       231 -------------~~~~i~~~~~~~-------------~~-----------~~~~~~l~~li~~~l~~~p~~Rpt~~~v~  273 (288)
T cd05093         231 -------------VIECITQGRVLQ-------------RP-----------RTCPKEVYDLMLGCWQREPHMRLNIKEIH  273 (288)
T ss_pred             -------------HHHHHHcCCcCC-------------CC-----------CCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence                         000000000000             00           00123488999999999999999999999


Q ss_pred             HHHHHHHHhh
Q 043902          463 NNLQAIRSKI  472 (477)
Q Consensus       463 ~~L~~i~~~~  472 (477)
                      +.|+.+..+.
T Consensus       274 ~~l~~~~~~~  283 (288)
T cd05093         274 SLLQNLAKAS  283 (288)
T ss_pred             HHHHHHHHhc
Confidence            9999988653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-40  Score=317.17  Aligned_cols=190  Identities=26%  Similarity=0.391  Sum_probs=163.4

Q ss_pred             eeeeccceEEEEEeC-CCCEEEEEEeeec---cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEeec
Q 043902          165 IGSGSFGSVYKGTLA-DGETAAIKVLKLQ---QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFM  240 (477)
Q Consensus       165 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  240 (477)
                      ||+|+||.||+|+.. +++.||+|+++..   .......+.+|+.++.+++||||+++++++     ...+..++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence            699999999999875 6889999999743   233446788999999999999999999885     5567899999999


Q ss_pred             CCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccccc
Q 043902          241 RNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFE  320 (477)
Q Consensus       241 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  320 (477)
                      ++|+|.+++...       ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        76 ~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~  145 (312)
T cd05585          76 NGGELFHHLQRE-------GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMK  145 (312)
T ss_pred             CCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCcc
Confidence            999999998754       4589999999999999999999999   999999999999999999999999999875321


Q ss_pred             cCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          321 ESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       321 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                             .........||..|+|||++ ...++.++|||||||++|||+||+.||..
T Consensus       146 -------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~  195 (312)
T cd05585         146 -------DDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD  195 (312)
T ss_pred             -------CCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC
Confidence                   11122345689999999999 55689999999999999999999999964

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=7.7e-40  Score=317.20  Aligned_cols=240  Identities=23%  Similarity=0.361  Sum_probs=189.6

Q ss_pred             CeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEe
Q 043902          163 NLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFE  238 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  238 (477)
                      +.||+|+||.||+++.. +|+.||+|+++...   ......+.+|++++++++||||+++.+++     ...+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence            46999999999999864 68999999997542   33446788999999999999999999885     56778999999


Q ss_pred             ecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccc
Q 043902          239 FMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFL  318 (477)
Q Consensus       239 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  318 (477)
                      |+++|+|..++...       ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        76 y~~~g~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~  145 (328)
T cd05593          76 YVNGGELFFHLSRE-------RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (328)
T ss_pred             CCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccC
Confidence            99999999888654       4589999999999999999999999   9999999999999999999999999998753


Q ss_pred             cccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCchhH
Q 043902          319 FEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVM  397 (477)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  397 (477)
                      ..       .........||..|+|||++ ...++.++|||||||++|||++|+.||.......              ..
T Consensus       146 ~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~--------------~~  204 (328)
T cd05593         146 IT-------DAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--------------LF  204 (328)
T ss_pred             CC-------cccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH--------------HH
Confidence            21       11122335689999999999 5578999999999999999999999996432110              00


Q ss_pred             HHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC-----ChHHHHH
Q 043902          398 DVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRV-----GMKFVVN  463 (477)
Q Consensus       398 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  463 (477)
                      ..+   ....           ..+|.           .....+.+++.+||+.||++||     ++.|+++
T Consensus       205 ~~~---~~~~-----------~~~p~-----------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         205 ELI---LMED-----------IKFPR-----------TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             HHh---ccCC-----------ccCCC-----------CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            000   0000           00000           0123377899999999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.4e-40  Score=315.57  Aligned_cols=260  Identities=30%  Similarity=0.536  Sum_probs=200.5

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC------CCCEEEEEEeeeccch-hhHHHHHHHHHHhcCCCCCcceeeeecccccCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQQQG-ALKSFIDECNALTSIRHRNILKIVSSCSSVDYE  228 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  228 (477)
                      .++|.+.+.||+|+||.||+|...      ++..||+|.++..... ..+.+.+|++++.+++|+||+++++++     .
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~   78 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVC-----T   78 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEE-----e
Confidence            356788899999999999999863      3478999999865443 457899999999999999999999996     4


Q ss_pred             CCceeeEEEeecCCCChhhhcccCCCc-------ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEe
Q 043902          229 GNDFKALVFEFMRNGNLDQWLHPSTDE-------YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL  301 (477)
Q Consensus       229 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll  301 (477)
                      .....++||||+++++|.+++......       ......+++..+..++.|++.|+.|||+.   +++||||||+||++
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili  155 (280)
T cd05049          79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLV  155 (280)
T ss_pred             cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEE
Confidence            457799999999999999999754211       11224588999999999999999999999   99999999999999


Q ss_pred             cCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccc
Q 043902          302 DEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFK  379 (477)
Q Consensus       302 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~  379 (477)
                      +.++.+||+|||+++......     .........++..|+|||++ .+.++.++|||||||++|||++ |+.||.....
T Consensus       156 ~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~  230 (280)
T cd05049         156 GYDLVVKIGDFGMSRDVYTTD-----YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN  230 (280)
T ss_pred             cCCCeEEECCcccceecccCc-----ceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence            999999999999997642211     11112233457889999998 5678999999999999999999 9999864321


Q ss_pred             cccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChH
Q 043902          380 DDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMK  459 (477)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~  459 (477)
                      ..              ..+.+.......             .           ...+...+.+++.+||+.||++||++.
T Consensus       231 ~~--------------~~~~~~~~~~~~-------------~-----------~~~~~~~~~~li~~~l~~~p~~Rp~~~  272 (280)
T cd05049         231 EE--------------VIECITQGRLLQ-------------R-----------PRTCPSEVYDIMLGCWKRDPQQRINIK  272 (280)
T ss_pred             HH--------------HHHHHHcCCcCC-------------C-----------CCCCCHHHHHHHHHHcCCCcccCCCHH
Confidence            11              111110000000             0           001134488999999999999999999


Q ss_pred             HHHHHHH
Q 043902          460 FVVNNLQ  466 (477)
Q Consensus       460 evl~~L~  466 (477)
                      ||++.|+
T Consensus       273 eil~~l~  279 (280)
T cd05049         273 DIHERLQ  279 (280)
T ss_pred             HHHHHhh
Confidence            9999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=6e-40  Score=317.41  Aligned_cols=240  Identities=22%  Similarity=0.340  Sum_probs=188.9

Q ss_pred             CeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEe
Q 043902          163 NLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFE  238 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  238 (477)
                      +.||+|+||.||+++.. +|..||+|+++...   ......+.+|++++++++||||+++++++     ...+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence            46999999999999864 78999999998542   23345678899999999999999999885     55678999999


Q ss_pred             ecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccc
Q 043902          239 FMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFL  318 (477)
Q Consensus       239 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  318 (477)
                      |+++|+|..++...       ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        76 ~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  145 (323)
T cd05595          76 YANGGELFFHLSRE-------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             CCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence            99999999888654       4589999999999999999999999   9999999999999999999999999998753


Q ss_pred             cccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCchhH
Q 043902          319 FEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVM  397 (477)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  397 (477)
                      ..       .........||..|+|||++ .+.++.++|||||||++|||++|+.||........             ..
T Consensus       146 ~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-------------~~  205 (323)
T cd05595         146 IS-------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-------------FE  205 (323)
T ss_pred             cC-------CCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH-------------HH
Confidence            21       11122335689999999999 56789999999999999999999999964321100             00


Q ss_pred             HHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC-----ChHHHHH
Q 043902          398 DVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRV-----GMKFVVN  463 (477)
Q Consensus       398 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  463 (477)
                      .+......               +|           ......+.+++.+||+.||++||     ++.++++
T Consensus       206 ~~~~~~~~---------------~p-----------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         206 LILMEEIR---------------FP-----------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             HHhcCCCC---------------CC-----------CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            00000000               00           00123478899999999999998     7888775

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.9e-40  Score=310.24  Aligned_cols=254  Identities=28%  Similarity=0.505  Sum_probs=199.0

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      .++|++.+.||+|+||.||+|+..++..||+|.++.... ..+.+.+|++++.+++||||+++++++      .....++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~------~~~~~~l   77 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIYI   77 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEE------CCCCcEE
Confidence            356889999999999999999987777899999985433 236789999999999999999999874      2345789


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      ||||+++|+|.+++.....     ..+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||.+
T Consensus        78 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~  149 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMG-----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA  149 (262)
T ss_pred             EEEcCCCCcHHHHHhhccc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCce
Confidence            9999999999999975321     4578999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCC
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      +......      ........++..|+|||+. .+.++.++|||||||++|||+| |..||.......            
T Consensus       150 ~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~------------  211 (262)
T cd05071         150 RLIEDNE------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------------  211 (262)
T ss_pred             eeccccc------cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH------------
Confidence            7653211      1112234467789999998 5678999999999999999999 888886532111            


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                        ..+.+......               +         ...+++..+.+++.+|++.||++||++.++++.|+..
T Consensus       212 --~~~~~~~~~~~---------------~---------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         212 --VLDQVERGYRM---------------P---------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             --HHHHHhcCCCC---------------C---------CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence              11101000000               0         0011244588999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.4e-40  Score=311.41  Aligned_cols=251  Identities=25%  Similarity=0.453  Sum_probs=196.4

Q ss_pred             cCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEE
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALV  236 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  236 (477)
                      ++|+..+.||+|+||.||.|...++..+|+|.++.... ....+.+|+.++.+++||||++++++|     ......++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv   77 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVC-----TKQRPIYIV   77 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEE-----ccCCCcEEE
Confidence            45778889999999999999987777899999875432 236789999999999999999999996     345568999


Q ss_pred             EeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccc
Q 043902          237 FEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK  316 (477)
Q Consensus       237 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  316 (477)
                      |||+++|+|.+++....      ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||.++
T Consensus        78 ~e~~~~~~l~~~i~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~  148 (256)
T cd05113          78 TEYMSNGCLLNYLREHG------KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSR  148 (256)
T ss_pred             EEcCCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccce
Confidence            99999999999987542      3589999999999999999999999   99999999999999999999999999987


Q ss_pred             cccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCCc
Q 043902          317 FLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALPS  394 (477)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  394 (477)
                      .....      .........++..|+|||.+ .+.++.++|||||||++|||+| |..||.......             
T Consensus       149 ~~~~~------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------------  209 (256)
T cd05113         149 YVLDD------EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-------------  209 (256)
T ss_pred             ecCCC------ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------------
Confidence            65321      11112233466789999999 4678999999999999999999 999986422110             


Q ss_pred             hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHH
Q 043902          395 HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQ  466 (477)
Q Consensus       395 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  466 (477)
                       ..+.+.......             .+.           .....+.+++.+||+.+|.+||++.++++.|+
T Consensus       210 -~~~~~~~~~~~~-------------~~~-----------~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         210 -TVEKVSQGLRLY-------------RPH-----------LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -HHHHHhcCCCCC-------------CCC-----------CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence             001000000000             000           01234889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.4e-40  Score=314.33  Aligned_cols=208  Identities=23%  Similarity=0.370  Sum_probs=176.8

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      ..++|+.+.+||+|+||.||+|+.+ +|..+|+|+++...   .+..+....|-.+|....+|.||+++-.     |++.
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQD~  213 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQDK  213 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ecCC
Confidence            4689999999999999999999865 79999999998653   4455678889999999999999999977     5889


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +++||||||++||++..+|...       ..+++.....++.+++-|+..||..   |++||||||+|+|||..|++||+
T Consensus       214 ~~LYLiMEylPGGD~mTLL~~~-------~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLS  283 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLLMRK-------DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLS  283 (550)
T ss_pred             CeeEEEEEecCCccHHHHHHhc-------CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeec
Confidence            9999999999999999999865       5799999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCC------------------CCCCC----------------------ccccCCCcccccccCcccc-cC
Q 043902          311 DFGLAKFLFEESN------------------TPSKN----------------------QTMSNGLKGSVGYIPPEYI-NG  349 (477)
Q Consensus       311 DfG~a~~~~~~~~------------------~~~~~----------------------~~~~~~~~gt~~y~aPE~~-~~  349 (477)
                      |||++.-+.....                  .....                      .......+||+.|+|||++ ..
T Consensus       284 DFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k  363 (550)
T KOG0605|consen  284 DFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK  363 (550)
T ss_pred             cccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC
Confidence            9999954321000                  00000                      0112346799999999999 44


Q ss_pred             CCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          350 HVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       350 ~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      .|+..+|+||+|||+|||+.|.+||...
T Consensus       364 gY~~~cDwWSLG~ImyEmLvGyPPF~s~  391 (550)
T KOG0605|consen  364 GYGKECDWWSLGCIMYEMLVGYPPFCSE  391 (550)
T ss_pred             CCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence            5999999999999999999999999764

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.8e-40  Score=310.06  Aligned_cols=253  Identities=26%  Similarity=0.508  Sum_probs=198.4

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      .++|++.+.||+|+||.||+|...++..+|+|.++..... .+.+.+|+.++++++|+|++++++++.      ....++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~-~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~l   77 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS-PESFLEEAQIMKKLRHDKLVQLYAVVS------EEPIYI   77 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC-HHHHHHHHHHHHhcCCCceEEEEeEEC------CCCcEE
Confidence            3578889999999999999999888889999999754432 367899999999999999999998852      345789


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      +|||+++++|.+++....     ...+++..++.++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++
T Consensus        78 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~  149 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGE-----GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLA  149 (260)
T ss_pred             EEEecCCCcHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceee
Confidence            999999999999987542     14589999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCC
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      ......      .........++..|+|||.+ .+.++.++||||||+++|||++ |..||......             
T Consensus       150 ~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-------------  210 (260)
T cd05070         150 RLIEDN------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-------------  210 (260)
T ss_pred             eeccCc------ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-------------
Confidence            765221      11111223456789999998 5678999999999999999999 88998643111             


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQA  467 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  467 (477)
                       ...+.+.......                        ........+.+++.+|++.+|++|||+.++.+.|++
T Consensus       211 -~~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         211 -EVLEQVERGYRMP------------------------CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -HHHHHHHcCCCCC------------------------CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             0111111100000                        000113448899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.4e-40  Score=314.73  Aligned_cols=264  Identities=28%  Similarity=0.497  Sum_probs=203.8

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC------CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      .+|...+.||+|+||.||+|...      ++..+++|.++.......+.+.+|++.+++++|+||+++++++     ...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVC-----GDG   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEE-----ccC
Confidence            45777889999999999999742      3556899998866655557899999999999999999999996     455


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCc---------ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDE---------YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL  301 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll  301 (477)
                      +..++||||+++++|.+++......         ......+++..++.++.|++.||+|||++   +++||||||+||++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~  156 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLV  156 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEE
Confidence            6789999999999999999653210         01124589999999999999999999999   99999999999999


Q ss_pred             cCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccc
Q 043902          302 DEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFK  379 (477)
Q Consensus       302 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~  379 (477)
                      +.++.++|+|||++.......     .........++..|+|||.+ ...++.++|||||||++|||+| |+.||.....
T Consensus       157 ~~~~~~~l~dfg~a~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  231 (291)
T cd05094         157 GANLLVKIGDFGMSRDVYSTD-----YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN  231 (291)
T ss_pred             ccCCcEEECCCCcccccCCCc-----eeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999997653211     11122334567889999998 5568999999999999999999 9999854321


Q ss_pred             cccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChH
Q 043902          380 DDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMK  459 (477)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~  459 (477)
                      ..              ..+.+.......                        ....++..+.+++.+|++.+|++|||+.
T Consensus       232 ~~--------------~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~  273 (291)
T cd05094         232 TE--------------VIECITQGRVLE------------------------RPRVCPKEVYDIMLGCWQREPQQRLNIK  273 (291)
T ss_pred             HH--------------HHHHHhCCCCCC------------------------CCccCCHHHHHHHHHHcccChhhCcCHH
Confidence            10              111110000000                        0001134488999999999999999999


Q ss_pred             HHHHHHHHHHHh
Q 043902          460 FVVNNLQAIRSK  471 (477)
Q Consensus       460 evl~~L~~i~~~  471 (477)
                      +|++.|+++...
T Consensus       274 ~v~~~l~~~~~~  285 (291)
T cd05094         274 EIYKILHALGKA  285 (291)
T ss_pred             HHHHHHHHHHhh
Confidence            999999999764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-40  Score=310.43  Aligned_cols=250  Identities=29%  Similarity=0.488  Sum_probs=195.6

Q ss_pred             cCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEE
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALV  236 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  236 (477)
                      .+|+..+.||+|+||.||+|...++..+|+|.+..... ....+.+|++++++++||||+++++++     ...+..++|
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv   77 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFIV   77 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEEE
Confidence            35778899999999999999987778899999864332 235788999999999999999999985     455678999


Q ss_pred             EeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccc
Q 043902          237 FEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK  316 (477)
Q Consensus       237 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  316 (477)
                      |||+++++|.+++....      ..+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++
T Consensus        78 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~  148 (256)
T cd05059          78 TEYMANGCLLNYLRERK------GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLAR  148 (256)
T ss_pred             EecCCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccce
Confidence            99999999999987543      3589999999999999999999999   99999999999999999999999999997


Q ss_pred             cccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCCc
Q 043902          317 FLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALPS  394 (477)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  394 (477)
                      .....      .........++..|+|||.+ .+.++.++||||||+++|||+| |+.||.......             
T Consensus       149 ~~~~~------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------------  209 (256)
T cd05059         149 YVLDD------QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-------------  209 (256)
T ss_pred             ecccc------cccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-------------
Confidence            65221      11111222345689999998 5678999999999999999999 899986432111             


Q ss_pred             hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHH
Q 043902          395 HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNL  465 (477)
Q Consensus       395 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  465 (477)
                       ....+.......             .+           ..++..+.+++.+|+..+|++|||+.|+++.|
T Consensus       210 -~~~~~~~~~~~~-------------~~-----------~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         210 -VVESVSAGYRLY-------------RP-----------KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             -HHHHHHcCCcCC-------------CC-----------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence             000000000000             00           01134588999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-40  Score=321.72  Aligned_cols=242  Identities=26%  Similarity=0.383  Sum_probs=198.1

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec---cchhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ---QQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEG  229 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  229 (477)
                      ..++|...++||+|.||+|+++..+ +++.+|||++++.   ..++.+..+.|-+++... +||.+++++++     |++
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----fQT  440 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----FQT  440 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----ccc
Confidence            4578889999999999999999976 6889999999865   356678888898888777 59999999988     689


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEE
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV  309 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl  309 (477)
                      .+++++||||+.||++..+.+.        ..+++..+.-++..|+.||.|||++   +|++||||.+|||||.+|++||
T Consensus       441 ~~~l~fvmey~~Ggdm~~~~~~--------~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~ki  509 (694)
T KOG0694|consen  441 KEHLFFVMEYVAGGDLMHHIHT--------DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKI  509 (694)
T ss_pred             CCeEEEEEEecCCCcEEEEEec--------ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEe
Confidence            9999999999999995544432        4699999999999999999999999   9999999999999999999999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeee
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~  388 (477)
                      +|||+++...       .........+||+.|+|||++ .+.|+.++|+|||||+||||+.|+.||....++        
T Consensus       510 ADFGlcKe~m-------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe--------  574 (694)
T KOG0694|consen  510 ADFGLCKEGM-------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE--------  574 (694)
T ss_pred             cccccccccC-------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH--------
Confidence            9999998642       123345668899999999999 567999999999999999999999999864332        


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCCh
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGM  458 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  458 (477)
                               ++.|.-+..+           ..+|..           +..+...++.+.+..||++|--+
T Consensus       575 ---------e~FdsI~~d~-----------~~yP~~-----------ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  575 ---------EVFDSIVNDE-----------VRYPRF-----------LSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ---------HHHHHHhcCC-----------CCCCCc-----------ccHHHHHHHHHHhccCcccccCC
Confidence                     2223222211           111211           13447889999999999999866

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3e-40  Score=311.06  Aligned_cols=260  Identities=23%  Similarity=0.403  Sum_probs=201.5

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec---cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ---QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.++..   .......+.+|++++++++||||+++++++     ...+.
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSF-----IEDNE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeE-----EECCe
Confidence            57889999999999999999864 7899999988643   233345788999999999999999999985     44567


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++|+||+++|+|.+++.....   ....+++..++.++.|++.||.|||++   +++|+||||+||+++.++.++|+||
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~  150 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKK---QKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDL  150 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECcc
Confidence            8999999999999998864321   114578899999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      |++......       ........++..|+|||.+ ...++.++|+||||+++|||++|+.||.....+..         
T Consensus       151 g~~~~~~~~-------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---------  214 (267)
T cd08228         151 GLGRFFSSK-------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF---------  214 (267)
T ss_pred             ccceeccch-------hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH---------
Confidence            998865221       1112234578899999998 55688999999999999999999999854221100         


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIR  469 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  469 (477)
                         ...+.+...   .             .+..       ..+.....+.+++.+||+.+|++||++.+|++.|++++
T Consensus       215 ---~~~~~~~~~---~-------------~~~~-------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         215 ---SLCQKIEQC---D-------------YPPL-------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             ---HHHHHHhcC---C-------------CCCC-------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence               011111000   0             0000       00112344889999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.8e-40  Score=319.66  Aligned_cols=196  Identities=27%  Similarity=0.392  Sum_probs=169.3

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCC--CCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLAD--GETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      .++|...+.||+|+||.||+|...+  +..||+|++....   ....+.+.+|+.++..++||||+++++++     ...
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~  103 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KDE  103 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----EeC
Confidence            4578899999999999999998542  4689999987432   23346788999999999999999999995     556


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +..++||||+++|+|.+++...       ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~  173 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRRN-------KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMT  173 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEe
Confidence            7899999999999999999754       4588999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |||++.....          ......||+.|+|||++ ...++.++|||||||++|||+||+.||..
T Consensus       174 DFG~a~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~  230 (340)
T PTZ00426        174 DFGFAKVVDT----------RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA  230 (340)
T ss_pred             cCCCCeecCC----------CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC
Confidence            9999976521          11234689999999999 55689999999999999999999999965

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.2e-40  Score=314.35  Aligned_cols=264  Identities=26%  Similarity=0.408  Sum_probs=200.0

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCC--EEEEEEeeec-cchhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCCc
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGE--TAAIKVLKLQ-QQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~  231 (477)
                      ++|++.+.||+|+||.||+|... ++.  .+++|.++.. .....+.+.+|++++.++ +||||+++++++     ....
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENRG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccCC
Confidence            57888999999999999999875 333  4788888743 333446789999999999 799999999986     4456


Q ss_pred             eeeEEEeecCCCChhhhcccCCCc---------ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDE---------YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD  302 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~  302 (477)
                      ..++|+||+++++|.+++......         ......+++..++.++.|++.||+|||+.   +++||||||+||+++
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~  153 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVG  153 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEEC
Confidence            789999999999999999653210         01123588999999999999999999998   999999999999999


Q ss_pred             CCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCccccc
Q 043902          303 EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKD  380 (477)
Q Consensus       303 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~  380 (477)
                      +++.+||+|||++.....        .........+..|+|||++ .+.++.++|||||||++|||+| |..||......
T Consensus       154 ~~~~~kl~dfg~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~  225 (297)
T cd05089         154 ENLASKIADFGLSRGEEV--------YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA  225 (297)
T ss_pred             CCCeEEECCcCCCccccc--------eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            999999999999864311        0011112235679999998 5568999999999999999998 99998653211


Q ss_pred             ccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHH
Q 043902          381 DLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKF  460 (477)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e  460 (477)
                      .              +.+.+.......                        ....+...+.+++.+|++.+|.+|||+.+
T Consensus       226 ~--------------~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  267 (297)
T cd05089         226 E--------------LYEKLPQGYRME------------------------KPRNCDDEVYELMRQCWRDRPYERPPFAQ  267 (297)
T ss_pred             H--------------HHHHHhcCCCCC------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            1              111111100000                        00011334789999999999999999999


Q ss_pred             HHHHHHHHHHhhhh
Q 043902          461 VVNNLQAIRSKIRM  474 (477)
Q Consensus       461 vl~~L~~i~~~~~~  474 (477)
                      +++.|+.+..+.+.
T Consensus       268 i~~~l~~~~~~~~~  281 (297)
T cd05089         268 ISVQLSRMLEARKA  281 (297)
T ss_pred             HHHHHHHHHHhhcc
Confidence            99999999887643

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.5e-40  Score=309.30  Aligned_cols=263  Identities=27%  Similarity=0.462  Sum_probs=198.3

Q ss_pred             CCCCCeeeeeccceEEEEEeC-C---CCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccC-CCCc
Q 043902          159 FSEENLIGSGSFGSVYKGTLA-D---GETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDY-EGND  231 (477)
Q Consensus       159 ~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~  231 (477)
                      |...+.||+|+||.||+|... +   +..||+|+++...  ......+.+|++.+++++||||+++++++..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            567789999999999999864 2   3679999988543  3334678999999999999999999998754221 2234


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++++||+++|+|..++...... .....+++..++.++.|++.||.|||+.   +++||||||+||++++++.+||+|
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~d  156 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLG-GLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVAD  156 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhcc-CCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECC
Confidence            579999999999999998543211 1224689999999999999999999998   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeee
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~  389 (477)
                      ||+++.......     ........++..|+|||.+ ...++.++|||||||++|||++ |..||......         
T Consensus       157 fg~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---------  222 (273)
T cd05035         157 FGLSKKIYSGDY-----YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---------  222 (273)
T ss_pred             ccceeecccccc-----ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---------
Confidence            999987633211     1111122346789999998 5568999999999999999999 88888643211         


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                           .+.+.+.......                        ....+...+.+++.+|++.||++|||+.|+++.|+++
T Consensus       223 -----~~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         223 -----EIYDYLRHGNRLK------------------------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             -----HHHHHHHcCCCCC------------------------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                 0111110000000                        0011234588999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.4e-40  Score=308.72  Aligned_cols=249  Identities=27%  Similarity=0.437  Sum_probs=195.8

Q ss_pred             cCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEE
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALV  236 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  236 (477)
                      .+|...+.||+|+||.||++... |..+|+|.++...  ..+.+.+|+.++++++|+|++++++++.    ..++..++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~lv   78 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIV   78 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEE----cCCCceEEE
Confidence            47888899999999999999874 7889999987443  2367899999999999999999998752    445668999


Q ss_pred             EeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccc
Q 043902          237 FEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK  316 (477)
Q Consensus       237 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  316 (477)
                      +||+++++|.+++.....     ..+++..++.++.|++.||+|||++   +++||||||+||++++++.+||+|||+++
T Consensus        79 ~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~  150 (256)
T cd05082          79 TEYMAKGSLVDYLRSRGR-----SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK  150 (256)
T ss_pred             EECCCCCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccce
Confidence            999999999999875431     3588999999999999999999999   99999999999999999999999999987


Q ss_pred             cccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCCc
Q 043902          317 FLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALPS  394 (477)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  394 (477)
                      ....          ......++..|+|||++ ...++.++|||||||++|||++ |+.||.......             
T Consensus       151 ~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~-------------  207 (256)
T cd05082         151 EASS----------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------------  207 (256)
T ss_pred             eccc----------cCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-------------
Confidence            5421          11122345689999998 5568999999999999999998 999985421110             


Q ss_pred             hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          395 HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       395 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                       +...+.......                        ....++..+.+++.+|++.+|++|||+.++++.|+++
T Consensus       208 -~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         208 -VVPRVEKGYKMD------------------------APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             -HHHHHhcCCCCC------------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence             001010000000                        0011234588999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4.6e-40  Score=307.07  Aligned_cols=247  Identities=25%  Similarity=0.446  Sum_probs=191.1

Q ss_pred             CeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEeec
Q 043902          163 NLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFM  240 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  240 (477)
                      +.||+|+||.||+|+.. +++.+|+|.+.... ......+.+|++++++++||||++++++|     ......++||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCCCCeEEEEeec
Confidence            46899999999999875 78999999886443 33446789999999999999999999996     4456789999999


Q ss_pred             CCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccccc
Q 043902          241 RNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFE  320 (477)
Q Consensus       241 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  320 (477)
                      ++++|.+++....      ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        76 ~~~~L~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  146 (252)
T cd05084          76 QGGDFLTFLRTEG------PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEED  146 (252)
T ss_pred             cCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccc
Confidence            9999999986432      4588999999999999999999999   999999999999999999999999999875421


Q ss_pred             cCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCCchhHH
Q 043902          321 ESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALPSHVMD  398 (477)
Q Consensus       321 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  398 (477)
                      ..     ..........+..|+|||.+ .+.++.++|||||||++|||++ |..||......              ....
T Consensus       147 ~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--------------~~~~  207 (252)
T cd05084         147 GV-----YASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--------------QTRE  207 (252)
T ss_pred             cc-----ccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--------------HHHH
Confidence            10     00111112235679999998 5678999999999999999998 88888542211              1111


Q ss_pred             HhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHH
Q 043902          399 VLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQ  466 (477)
Q Consensus       399 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  466 (477)
                      .+.......             .           .+.++..+.+++.+|++.+|++|||+.||++.|+
T Consensus       208 ~~~~~~~~~-------------~-----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         208 AIEQGVRLP-------------C-----------PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             HHHcCCCCC-------------C-----------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            111100000             0           0112345889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.3e-40  Score=319.05  Aligned_cols=198  Identities=27%  Similarity=0.436  Sum_probs=170.2

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .++|+..+.||+|+||.||++... ++..+|+|.++... ......+.+|++++++++|+||++++++|     ..++..
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   78 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI   78 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEE-----EECCEE
Confidence            468999999999999999999875 68899999987543 33346789999999999999999999996     446689


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||+++|+|.+++...       ..+++..+..++.|++.||.|||+.  .+++|+||||+||+++.++.+||+|||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg  149 (333)
T cd06650          79 SICMEHMDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFG  149 (333)
T ss_pred             EEEEecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCC
Confidence            9999999999999999753       4578899999999999999999974  179999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ++.....         .......|+..|+|||++ ...++.++|||||||++|||++|+.||..
T Consensus       150 ~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         150 VSGQLID---------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             cchhhhh---------hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            9875521         112334688999999999 45689999999999999999999999965

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.8e-40  Score=313.59  Aligned_cols=262  Identities=24%  Similarity=0.432  Sum_probs=199.6

Q ss_pred             CCCCCCeeeeeccceEEEEEeC------CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      +|...+.||+|+||.||+|...      ....+++|.+.... ......+.+|+.++++++||||+++++.|     ...
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGAC-----SQD   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecC
Confidence            4678899999999999999853      23578888887543 23346789999999999999999999986     445


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcc-----------------cccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecC
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEY-----------------CHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCD  293 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~-----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~d  293 (477)
                      +..++++||+.+|+|.+++.......                 .....+++..++.++.|++.||.|||+.   +++|||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~d  152 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRD  152 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhh
Confidence            66899999999999999986432110                 1124588999999999999999999998   999999


Q ss_pred             CCCCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CC
Q 043902          294 LKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GK  371 (477)
Q Consensus       294 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~  371 (477)
                      |||+||++++++.+||+|||+++......     .........++..|+|||.+ ...++.++||||||+++|||+| |.
T Consensus       153 ikp~nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~  227 (290)
T cd05045         153 LAARNVLVAEGRKMKISDFGLSRDVYEED-----SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG  227 (290)
T ss_pred             hhhheEEEcCCCcEEeccccccccccCcc-----chhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCC
Confidence            99999999999999999999997653211     11112233456789999988 5568999999999999999999 99


Q ss_pred             CCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCC
Q 043902          372 RPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAAS  451 (477)
Q Consensus       372 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~d  451 (477)
                      .||.....              +.+.+.+.......                        ....+...+.+++.+|++.+
T Consensus       228 ~p~~~~~~--------------~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~i~~cl~~~  269 (290)
T cd05045         228 NPYPGIAP--------------ERLFNLLKTGYRME------------------------RPENCSEEMYNLMLTCWKQE  269 (290)
T ss_pred             CCCCCCCH--------------HHHHHHHhCCCCCC------------------------CCCCCCHHHHHHHHHHccCC
Confidence            99864211              11222221111000                        00011334889999999999


Q ss_pred             CCCCCChHHHHHHHHHHHH
Q 043902          452 PRDRVGMKFVVNNLQAIRS  470 (477)
Q Consensus       452 P~~RPs~~evl~~L~~i~~  470 (477)
                      |++||++.|+++.|+++-.
T Consensus       270 P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         270 PDKRPTFADISKELEKMMV  288 (290)
T ss_pred             cccCCCHHHHHHHHHHHHh
Confidence            9999999999999998764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6e-41  Score=287.58  Aligned_cols=248  Identities=23%  Similarity=0.348  Sum_probs=203.0

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .++|++.+.||+|.||.||.|+.+ ++-.||+|++...+   ....+++.+|+++-+.|+||||+++++++     .+..
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f-----hd~~   95 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF-----HDSK   95 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----eccc
Confidence            578999999999999999999965 67899999987543   33447889999999999999999999994     6788


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..|+++||.+.|++...|.....     ..+++.....+..|+|.||.|+|..   +|+||||||+|+|++.++..||+|
T Consensus        96 riyLilEya~~gel~k~L~~~~~-----~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAd  167 (281)
T KOG0580|consen   96 RIYLILEYAPRGELYKDLQEGRM-----KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIAD  167 (281)
T ss_pred             eeEEEEEecCCchHHHHHHhccc-----ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccC
Confidence            89999999999999999985532     5688889999999999999999998   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccccC-CCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      ||-+..-         +.......+||..|.|||+..+ ..+.++|+|++|++.||++.|.+||+....+. .+....  
T Consensus       168 fGwsV~~---------p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-tYkrI~--  235 (281)
T KOG0580|consen  168 FGWSVHA---------PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-TYKRIR--  235 (281)
T ss_pred             CCceeec---------CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-HHHHHH--
Confidence            9998643         2334556789999999999955 58999999999999999999999998754211 111100  


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                           -.++.++.                               .......+++.+|+..+|.+|.+..||++.
T Consensus       236 -----k~~~~~p~-------------------------------~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  236 -----KVDLKFPS-------------------------------TISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             -----HccccCCc-------------------------------ccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                 00111110                               112347899999999999999999999763

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.9e-40  Score=308.36  Aligned_cols=253  Identities=25%  Similarity=0.499  Sum_probs=199.6

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      .++|...+.||+|+||.||+|...+++.||+|.+..... ....+.+|+.++++++|+|++++++++      ..+..++
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~------~~~~~~~   77 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV------TQEPIYI   77 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE------ccCCcEE
Confidence            457888999999999999999988899999999875443 236789999999999999999999874      2345899


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      +|||+++++|.+++.....     ..+++.++..++.|++.||.|||+.   +++||||||+||++++++.++|+|||++
T Consensus        78 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~  149 (260)
T cd05067          78 ITEYMENGSLVDFLKTPEG-----IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLA  149 (260)
T ss_pred             EEEcCCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcce
Confidence            9999999999999865421     4689999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCC
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      ......      .........++..|+|||++ .+.++.++||||||+++||+++ |+.||.......            
T Consensus       150 ~~~~~~------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------------  211 (260)
T cd05067         150 RLIEDN------EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE------------  211 (260)
T ss_pred             eecCCC------CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH------------
Confidence            765211      11112233457789999998 5668999999999999999999 999996532110            


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQA  467 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  467 (477)
                        ..+.+.......                        .....+..+.+++.+|++.+|++|||++++.+.|+.
T Consensus       212 --~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         212 --VIQNLERGYRMP------------------------RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             --HHHHHHcCCCCC------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence              111111000000                        000113348899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.2e-40  Score=312.36  Aligned_cols=266  Identities=24%  Similarity=0.424  Sum_probs=205.4

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCC-----CCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLAD-----GETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEG  229 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  229 (477)
                      .++|...+.||+|+||.||+|...+     +..|++|+++... ......+.+|+.++++++|+||+++++++.    ..
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~----~~   80 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCI----ED   80 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe----cC
Confidence            5678889999999999999999765     6889999887442 334567889999999999999999999874    44


Q ss_pred             CceeeEEEeecCCCChhhhcccCCC-cccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEE
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTD-EYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH  308 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k  308 (477)
                      +...++++||+++|+|.+++..... .......+++..++.++.|++.||.|||+.   +++|+||||+||++++++.+|
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~k  157 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVK  157 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEE
Confidence            5678999999999999999865421 111224689999999999999999999998   999999999999999999999


Q ss_pred             EecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceee
Q 043902          309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHK  386 (477)
Q Consensus       309 l~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~  386 (477)
                      |+|||+++.+....     .........++..|+|||++ ...++.++|||||||++||+++ |+.||.......     
T Consensus       158 l~d~g~~~~~~~~~-----~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----  227 (280)
T cd05043         158 ITDNALSRDLFPMD-----YHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-----  227 (280)
T ss_pred             ECCCCCcccccCCc-----eEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-----
Confidence            99999998653221     11112233457789999998 5568999999999999999999 999986531110     


Q ss_pred             eeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHH
Q 043902          387 FVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQ  466 (477)
Q Consensus       387 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  466 (477)
                               +...+.......                        ....++..+.+++.+|+..||++|||+.|+++.|+
T Consensus       228 ---------~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  274 (280)
T cd05043         228 ---------MAAYLKDGYRLA------------------------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLT  274 (280)
T ss_pred             ---------HHHHHHcCCCCC------------------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence                     111110000000                        00011334889999999999999999999999999


Q ss_pred             HHHHh
Q 043902          467 AIRSK  471 (477)
Q Consensus       467 ~i~~~  471 (477)
                      .+.++
T Consensus       275 ~~~~~  279 (280)
T cd05043         275 DFHAQ  279 (280)
T ss_pred             HHHhc
Confidence            98765

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.1e-39  Score=307.27  Aligned_cols=254  Identities=22%  Similarity=0.334  Sum_probs=197.4

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      .++|++.+.||+|+||.||+|+. .+++.||+|+++.........+.+|+.++.+++||||+++++++     ...+..+
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~-----~~~~~~~   82 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY-----LSREKLW   82 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEE-----EeCCEEE
Confidence            45799999999999999999996 47889999999865544556788999999999999999999986     4556789


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +||||+++++|.+++...       ..+++..+..++.|++.||.|||+.   +|+||||+|+||+++.++.++|+|||+
T Consensus        83 iv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~  152 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVT-------GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGV  152 (267)
T ss_pred             EEEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCcc
Confidence            999999999999998643       4578999999999999999999998   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCccccc----CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN----GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      +......       ........++..|+|||.+.    +.++.++|||||||++|||++|+.||........ .......
T Consensus       153 ~~~~~~~-------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~~~~  224 (267)
T cd06646         153 AAKITAT-------IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMSKS  224 (267)
T ss_pred             ceeeccc-------ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heeeecC
Confidence            9865211       11123346788999999872    3478899999999999999999999854321111 0000000


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNL  465 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  465 (477)
                      .+..       +...                 .         .......+.+++.+||+.+|++|||++++++.|
T Consensus       225 ~~~~-------~~~~-----------------~---------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         225 NFQP-------PKLK-----------------D---------KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCC-------CCCc-----------------c---------ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            0000       0000                 0         000123478999999999999999999998743

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.3e-39  Score=319.04  Aligned_cols=248  Identities=24%  Similarity=0.370  Sum_probs=189.2

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++|+||+++++++     ...+..
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~  147 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGEI  147 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCeE
Confidence            345667789999999999999865 68999999997543 23346789999999999999999999985     566788


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||+++|+|.+..           ...+..+..++.||+.||.|||++   +|+||||||+|||+++++.+||+|||
T Consensus       148 ~lv~e~~~~~~L~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG  213 (353)
T PLN00034        148 QVLLEFMDGGSLEGTH-----------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFG  213 (353)
T ss_pred             EEEEecCCCCcccccc-----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccc
Confidence            9999999999986532           245677889999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccccC------CCCcccceeehHHHHHHHhhCCCCCCcccccccceeee
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING------HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~  387 (477)
                      +++.....       ........||..|+|||++..      ..+.++|||||||++|||++|+.||......+      
T Consensus       214 ~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~------  280 (353)
T PLN00034        214 VSRILAQT-------MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD------  280 (353)
T ss_pred             cceecccc-------cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc------
Confidence            99865221       111234568999999998732      24568999999999999999999996321110      


Q ss_pred             eeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       388 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                              .............             +.        ....+...+.+++.+||+.||++|||+.|+++.
T Consensus       281 --------~~~~~~~~~~~~~-------------~~--------~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        281 --------WASLMCAICMSQP-------------PE--------APATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             --------HHHHHHHHhccCC-------------CC--------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                    0000000000000             00        000113348899999999999999999999863

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=7.1e-40  Score=309.36  Aligned_cols=263  Identities=24%  Similarity=0.434  Sum_probs=195.6

Q ss_pred             CCCCCeeeeeccceEEEEEeCC-CC--EEEEEEeeec--cchhhHHHHHHHHHHhcCCCCCcceeeeecccccC-CCCce
Q 043902          159 FSEENLIGSGSFGSVYKGTLAD-GE--TAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDY-EGNDF  232 (477)
Q Consensus       159 ~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~~  232 (477)
                      |.+.+.||+|+||.||+|+..+ +.  .+|+|.++..  .....+.+.+|++++.+++|+||++++++|..... .....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567889999999999998754 33  6899988753  23445788999999999999999999998743211 12235


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++++||+++|+|.+++...... .....+++.....++.|++.||.|||+.   +|+||||||+||++++++.+||+||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df  156 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLG-DCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADF  156 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhccc-CCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCC
Confidence            78999999999999987432211 1224589999999999999999999998   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeec
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  390 (477)
                      |+++.......     ........++..|+|||.. ...++.++|||||||++|||++ |+.||.......         
T Consensus       157 g~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---------  222 (272)
T cd05075         157 GLSKKIYNGDY-----YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---------  222 (272)
T ss_pred             CcccccCcccc-----eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---------
Confidence            99986532110     1111223456789999999 5568999999999999999999 888886421110         


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                           ..+.+.....         ..    .           ...++..+.+++.+||+.||++|||+.++++.|+++
T Consensus       223 -----~~~~~~~~~~---------~~----~-----------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         223 -----IYDYLRQGNR---------LK----Q-----------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             -----HHHHHHcCCC---------CC----C-----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                 1111100000         00    0           001133478999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-39  Score=331.15  Aligned_cols=252  Identities=20%  Similarity=0.296  Sum_probs=196.6

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-C-CCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-D-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      .|...+.||+|++|.||+|... + +..||+|.+..........+..|+.+++.++||||++++++|     ...+..++
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-----~~~~~~~l  142 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDF-----KSDDKLLL  142 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----EECCEEEE
Confidence            4888899999999999999754 3 678899987665555556788899999999999999999996     45678999


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      ||||+++|+|.+++.....   ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       143 v~E~~~gg~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla  216 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLK---EHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFS  216 (478)
T ss_pred             EEECCCCCCHHHHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCc
Confidence            9999999999998864321   124688999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCc
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPS  394 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  394 (477)
                      +.....     ..........||+.|+|||++ ...++.++|||||||++|||+||+.||......              
T Consensus       217 ~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~--------------  277 (478)
T PTZ00267        217 KQYSDS-----VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR--------------  277 (478)
T ss_pred             eecCCc-----cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--------------
Confidence            865221     111123345689999999999 556899999999999999999999999642111              


Q ss_pred             hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          395 HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       395 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                         +++.........          ..+           ..+...+.+++.+||+.||++||++.+++.
T Consensus       278 ---~~~~~~~~~~~~----------~~~-----------~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        278 ---EIMQQVLYGKYD----------PFP-----------CPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ---HHHHHHHhCCCC----------CCC-----------ccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence               111111110000          000           001234789999999999999999999874

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.6e-39  Score=309.06  Aligned_cols=272  Identities=24%  Similarity=0.427  Sum_probs=199.5

Q ss_pred             cCCCCCCeeeeeccceEEEEEe-----CCCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTL-----ADGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      ..|.+.+.||+|+||.||++..     .++..||+|.++... ......+.+|++++++++|||++++.+++..   .+.
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~   80 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGG   80 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCC
Confidence            3467889999999999999974     357889999987543 3334678999999999999999999998742   224


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ...++||||+++++|.+++....      ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~  151 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNK------NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIG  151 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEEC
Confidence            56899999999999999986442      3589999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      |||+++.......    .........++..|+|||++ .+.++.++|||||||++|||+|+..|..........   ...
T Consensus       152 dfg~~~~~~~~~~----~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~---~~~  224 (284)
T cd05079         152 DFGLTKAIETDKE----YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLK---MIG  224 (284)
T ss_pred             CCccccccccCcc----ceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhh---hcc
Confidence            9999986532111    11122234567789999998 557899999999999999999988765332111000   000


Q ss_pred             ccCCc-hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          390 MALPS-HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       390 ~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                      ....+ .....+.. ....     ...      +         ....+...+.+++.+|++.||++|||++++++.|+++
T Consensus       225 ~~~~~~~~~~~~~~-~~~~-----~~~------~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         225 PTHGQMTVTRLVRV-LEEG-----KRL------P---------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             cccccccHHHHHHH-HHcC-----ccC------C---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            00000 00000000 0000     000      0         0011234589999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.6e-39  Score=313.06  Aligned_cols=240  Identities=23%  Similarity=0.329  Sum_probs=187.6

Q ss_pred             CeeeeeccceEEEEEe----CCCCEEEEEEeeecc----chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          163 NLIGSGSFGSVYKGTL----ADGETAAIKVLKLQQ----QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      +.||+|+||.||+++.    .+++.||+|+++...    ......+.+|++++++++||||+++++++     ..++..+
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~~   76 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKLY   76 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeEE
Confidence            6799999999999985    357899999997532    22335678899999999999999999885     4567899


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +||||+++|+|.+++...       ..+.+..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        77 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~  146 (323)
T cd05584          77 LILEYLSGGELFMHLERE-------GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGL  146 (323)
T ss_pred             EEEeCCCCchHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcC
Confidence            999999999999998654       4578888899999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCC
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      ++....       .........||..|+|||++ ...++.++|||||||++|||++|+.||.......            
T Consensus       147 ~~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------------  207 (323)
T cd05584         147 CKESIH-------EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------------  207 (323)
T ss_pred             Ceeccc-------CCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------------
Confidence            875321       11122335689999999999 4568899999999999999999999996532110            


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC-----ChHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRV-----GMKFVVN  463 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  463 (477)
                       ....+......               .|.           .....+.+++.+|++.||++||     ++.++++
T Consensus       208 -~~~~~~~~~~~---------------~~~-----------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         208 -TIDKILKGKLN---------------LPP-----------YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             -HHHHHHcCCCC---------------CCC-----------CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence             01111110000               000           0123478999999999999999     7887765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=6.1e-40  Score=313.32  Aligned_cols=264  Identities=25%  Similarity=0.434  Sum_probs=201.1

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC------CCCEEEEEEeeecc-chhhHHHHHHHHHHhcC-CCCCcceeeeeccccc
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQQ-QGALKSFIDECNALTSI-RHRNILKIVSSCSSVD  226 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  226 (477)
                      ..++|+..+.||+|+||.||++...      ....+|+|.++... ......+.+|++++.++ +|+||++++++|    
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~----   85 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC----   85 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence            3467888999999999999999864      23679999987542 33346788999999999 799999999986    


Q ss_pred             CCCCceeeEEEeecCCCChhhhcccCCC---------cccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCC
Q 043902          227 YEGNDFKALVFEFMRNGNLDQWLHPSTD---------EYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSS  297 (477)
Q Consensus       227 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~  297 (477)
                       ..++..+++|||+++|+|.+++.....         .......+++..++.++.|++.||.|||+.   +|+||||||+
T Consensus        86 -~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~  161 (293)
T cd05053          86 -TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAAR  161 (293)
T ss_pred             -cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ccccccccee
Confidence             445678999999999999999864321         001235689999999999999999999998   9999999999


Q ss_pred             CeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCC
Q 043902          298 NVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTD  375 (477)
Q Consensus       298 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~  375 (477)
                      ||+++.++.+||+|||+++.+....     .........++..|+|||.+ ...++.++|||||||++|||++ |..||.
T Consensus       162 Nil~~~~~~~kL~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~  236 (293)
T cd05053         162 NVLVTEDHVMKIADFGLARDIHHID-----YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP  236 (293)
T ss_pred             eEEEcCCCeEEeCcccccccccccc-----ceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCC
Confidence            9999999999999999998653211     01111223356789999988 5678999999999999999998 999986


Q ss_pred             cccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCC
Q 043902          376 DMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDR  455 (477)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R  455 (477)
                      .....              .+.+.+.......                        ....+...+.+++.+|++.||++|
T Consensus       237 ~~~~~--------------~~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~~p~~R  278 (293)
T cd05053         237 GIPVE--------------ELFKLLKEGYRME------------------------KPQNCTQELYHLMRDCWHEVPSQR  278 (293)
T ss_pred             CCCHH--------------HHHHHHHcCCcCC------------------------CCCCCCHHHHHHHHHHcccCcccC
Confidence            42111              1111111100000                        000113348899999999999999


Q ss_pred             CChHHHHHHHHHHH
Q 043902          456 VGMKFVVNNLQAIR  469 (477)
Q Consensus       456 Ps~~evl~~L~~i~  469 (477)
                      ||+.|+++.|+.+.
T Consensus       279 ps~~eil~~l~~~~  292 (293)
T cd05053         279 PTFKQLVEDLDRML  292 (293)
T ss_pred             cCHHHHHHHHHHhh
Confidence            99999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.6e-39  Score=307.83  Aligned_cols=261  Identities=21%  Similarity=0.416  Sum_probs=197.6

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC------CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDY  227 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  227 (477)
                      ..++|+..+.||+|+||.||+|...      ++..||+|.++... ......+.+|+.++++++||||+++++++     
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----   78 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----   78 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence            4678999999999999999999753      35679999886432 23345788999999999999999999986     


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCcc---cccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDEY---CHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG  304 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~  304 (477)
                      ..+...++||||+++|+|.+++.......   .....+++..++.++.|++.||.|||+.   +++|+||||+||+++++
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~  155 (277)
T cd05062          79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED  155 (277)
T ss_pred             cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCC
Confidence            45567899999999999999986532110   0123468889999999999999999998   99999999999999999


Q ss_pred             CcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCccccccc
Q 043902          305 MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL  382 (477)
Q Consensus       305 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~  382 (477)
                      +.++|+|||+++.......     ........++..|+|||++ .+.++.++|||||||++|||++ |..||......  
T Consensus       156 ~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--  228 (277)
T cd05062         156 FTVKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--  228 (277)
T ss_pred             CCEEECCCCCccccCCcce-----eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--
Confidence            9999999999876532111     1111223457789999998 5678999999999999999999 78888643211  


Q ss_pred             ceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHH
Q 043902          383 SIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVV  462 (477)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl  462 (477)
                                  ...+.+.......             .           ...++..+.+++.+|++.||++|||+.|++
T Consensus       229 ------------~~~~~~~~~~~~~-------------~-----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l  272 (277)
T cd05062         229 ------------QVLRFVMEGGLLD-------------K-----------PDNCPDMLFELMRMCWQYNPKMRPSFLEII  272 (277)
T ss_pred             ------------HHHHHHHcCCcCC-------------C-----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence                        1111100000000             0           001133488999999999999999999999


Q ss_pred             HHHH
Q 043902          463 NNLQ  466 (477)
Q Consensus       463 ~~L~  466 (477)
                      +.|+
T Consensus       273 ~~l~  276 (277)
T cd05062         273 SSIK  276 (277)
T ss_pred             HHhh
Confidence            9886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.4e-40  Score=315.14  Aligned_cols=252  Identities=24%  Similarity=0.348  Sum_probs=203.8

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .++|...+++|+|+||.++.++.+ ++..+++|.+....  ........+|+.++++++|||||.+.+.+    ..++..
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~----~~~~~~   78 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSF----EEDGQL   78 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccch----hcCCce
Confidence            467889999999999999999865 68899999998554  33345788999999999999999999985    234444


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .+|||+|++||++.+.+....+     ..+++..+..++.|++.|+.|||+.   .|+|||||+.||+++.+..+||+||
T Consensus        79 l~Ivm~Y~eGg~l~~~i~~~k~-----~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDf  150 (426)
T KOG0589|consen   79 LCIVMEYCEGGDLAQLIKEQKG-----VLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDF  150 (426)
T ss_pred             EEEEEeecCCCCHHHHHHHHhh-----ccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecch
Confidence            9999999999999999987652     5689999999999999999999988   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      |+|+.+...       ........||+.|++||.+ +-+|+.|+|||||||++|||++-+++|....-...         
T Consensus       151 GlaK~l~~~-------~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L---------  214 (426)
T KOG0589|consen  151 GLAKILNPE-------DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL---------  214 (426)
T ss_pred             hhhhhcCCc-------hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH---------
Confidence            999987432       2244567899999999999 55799999999999999999999999975322111         


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                          +..+......                 .+...        ....+..++..|++.+|..||++.+++.+
T Consensus       215 ----i~ki~~~~~~-----------------Plp~~--------ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  215 ----ILKINRGLYS-----------------PLPSM--------YSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ----HHHHhhccCC-----------------CCCcc--------ccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                1111111100                 00001        13348899999999999999999999986

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.3e-39  Score=330.77  Aligned_cols=264  Identities=23%  Similarity=0.332  Sum_probs=201.0

Q ss_pred             HHHhhcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccC-
Q 043902          152 ISNATDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDY-  227 (477)
Q Consensus       152 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-  227 (477)
                      .....++|.+.+.||+|+||.||+|+. .+|+.||||++....  ......+.+|+..+..++|+|++++...+...+. 
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            344567999999999999999999985 479999999997542  3345678899999999999999998876532211 


Q ss_pred             --CCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC
Q 043902          228 --EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM  305 (477)
Q Consensus       228 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~  305 (477)
                        ......++||||+++|+|.+++.....   ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~---~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~  180 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAK---TNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNG  180 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCC
Confidence              111246899999999999999875431   125688999999999999999999999   999999999999999999


Q ss_pred             cEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccce
Q 043902          306 IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSI  384 (477)
Q Consensus       306 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~  384 (477)
                      .+||+|||+++.+....     .........||..|+|||++ .+.++.++|||||||++|||++|+.||.....     
T Consensus       181 ~vkL~DFGls~~~~~~~-----~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-----  250 (496)
T PTZ00283        181 LVKLGDFGFSKMYAATV-----SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-----  250 (496)
T ss_pred             CEEEEecccCeeccccc-----cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-----
Confidence            99999999998653211     11122345689999999999 55689999999999999999999999964211     


Q ss_pred             eeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          385 HKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       385 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                                  .++++.......          ..++           ..+...+.+++..||+.||.+||++.++++.
T Consensus       251 ------------~~~~~~~~~~~~----------~~~~-----------~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        251 ------------EEVMHKTLAGRY----------DPLP-----------PSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             ------------HHHHHHHhcCCC----------CCCC-----------CCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                        111111111000          0000           0113348899999999999999999999863

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=7.2e-40  Score=307.27  Aligned_cols=252  Identities=26%  Similarity=0.500  Sum_probs=196.7

Q ss_pred             cCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEE
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALV  236 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  236 (477)
                      ++|.....||+|++|.||+|...++..+|+|.+..... ..+.+.+|++++++++|+|++++++++.      .+..++|
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~v   78 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIYIV   78 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcEEE
Confidence            46788899999999999999987777899998875432 2367889999999999999999998752      3457899


Q ss_pred             EeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccc
Q 043902          237 FEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK  316 (477)
Q Consensus       237 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  316 (477)
                      |||+++++|.+++.....     ..+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||.+.
T Consensus        79 ~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~  150 (260)
T cd05069          79 TEFMGKGSLLDFLKEGDG-----KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLAR  150 (260)
T ss_pred             EEcCCCCCHHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccce
Confidence            999999999999975421     4578999999999999999999998   99999999999999999999999999997


Q ss_pred             cccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCCc
Q 043902          317 FLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALPS  394 (477)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  394 (477)
                      .....      .........++..|+|||.. .+.++.++|||||||++|||+| |+.||.......             
T Consensus       151 ~~~~~------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------------  211 (260)
T cd05069         151 LIEDN------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-------------  211 (260)
T ss_pred             EccCC------cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------------
Confidence            65221      11112233467789999998 5678999999999999999999 899986532111             


Q ss_pred             hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHH
Q 043902          395 HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQA  467 (477)
Q Consensus       395 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  467 (477)
                       ..+.+......             ..           ....+..+.+++.+|++.||++||++++|.+.|++
T Consensus       212 -~~~~~~~~~~~-------------~~-----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         212 -VLEQVERGYRM-------------PC-----------PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -HHHHHHcCCCC-------------CC-----------CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             00000000000             00           00113448899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=5.5e-40  Score=315.74  Aligned_cols=270  Identities=25%  Similarity=0.417  Sum_probs=204.4

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC--------CCCEEEEEEeeecc-chhhHHHHHHHHHHhcC-CCCCcceeeeecccc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA--------DGETAAIKVLKLQQ-QGALKSFIDECNALTSI-RHRNILKIVSSCSSV  225 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  225 (477)
                      .++|.+.+.||+|+||.||++...        ++..+|+|.++... ......+..|++++.++ +||||++++++|   
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~---   93 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC---   93 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE---
Confidence            357889999999999999999752        23579999998542 33446788899999999 799999999996   


Q ss_pred             cCCCCceeeEEEeecCCCChhhhcccCCCcc---------cccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCC
Q 043902          226 DYEGNDFKALVFEFMRNGNLDQWLHPSTDEY---------CHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKS  296 (477)
Q Consensus       226 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp  296 (477)
                        ...+..++||||+++|+|.+++.......         .....+++..++.++.|++.||+|||+.   +++||||||
T Consensus        94 --~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp  168 (307)
T cd05098          94 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAA  168 (307)
T ss_pred             --ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccH
Confidence              44567899999999999999997542110         0123589999999999999999999998   999999999


Q ss_pred             CCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCC
Q 043902          297 SNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPT  374 (477)
Q Consensus       297 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~  374 (477)
                      +||+++.++.+||+|||.++.......     ........++..|+|||.+ .+.++.++|||||||++|||++ |..||
T Consensus       169 ~Nill~~~~~~kL~dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~  243 (307)
T cd05098         169 RNVLVTEDNVMKIADFGLARDIHHIDY-----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY  243 (307)
T ss_pred             HheEEcCCCcEEECCCcccccccccch-----hhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence            999999999999999999876522110     1111122345689999998 5568999999999999999998 88888


Q ss_pred             CcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCC
Q 043902          375 DDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRD  454 (477)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~  454 (477)
                      .....+              .+.+.+......+                        ....+...+.+++.+|++.+|++
T Consensus       244 ~~~~~~--------------~~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~~p~~  285 (307)
T cd05098         244 PGVPVE--------------ELFKLLKEGHRMD------------------------KPSNCTNELYMMMRDCWHAVPSQ  285 (307)
T ss_pred             CcCCHH--------------HHHHHHHcCCCCC------------------------CCCcCCHHHHHHHHHHcccChhh
Confidence            542111              1111111100000                        00112345889999999999999


Q ss_pred             CCChHHHHHHHHHHHHhhhhcc
Q 043902          455 RVGMKFVVNNLQAIRSKIRMRE  476 (477)
Q Consensus       455 RPs~~evl~~L~~i~~~~~~~~  476 (477)
                      |||+.||++.|+++.+..+.++
T Consensus       286 Rps~~evl~~l~~~~~~~~~~~  307 (307)
T cd05098         286 RPTFKQLVEDLDRILALTSNQE  307 (307)
T ss_pred             CcCHHHHHHHHHHHHHHhhcCC
Confidence            9999999999999998766553

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=7.2e-40  Score=308.66  Aligned_cols=257  Identities=26%  Similarity=0.485  Sum_probs=198.4

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CC---CEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DG---ETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      .++|+..+.||+|+||.||+|+.. ++   ..+|+|.++... ....+.+.+|++++.+++|+|++++.+++     ...
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   78 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV-----TKF   78 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----ccC
Confidence            357788899999999999999865 33   379999887542 33456789999999999999999999996     455


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +..++||||+++++|.+++....      ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.+||+
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~  149 (268)
T cd05063          79 KPAMIITEYMENGALDKYLRDHD------GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVS  149 (268)
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEEC
Confidence            67899999999999999986543      4589999999999999999999998   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~  388 (477)
                      |||++........    ..........+..|+|||++ .+.++.++|||||||++|||+| |+.||......        
T Consensus       150 dfg~~~~~~~~~~----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--------  217 (268)
T cd05063         150 DFGLSRVLEDDPE----GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--------  217 (268)
T ss_pred             CCccceecccccc----cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--------
Confidence            9999976532111    11111122335679999998 5678999999999999999998 99998542211        


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                            .....+.......                        ....++..+.+++.+|++.+|++||++.+|++.|+++
T Consensus       218 ------~~~~~i~~~~~~~------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         218 ------EVMKAINDGFRLP------------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ------HHHHHHhcCCCCC------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                  1111111000000                        0001234588999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.1e-39  Score=316.04  Aligned_cols=240  Identities=23%  Similarity=0.352  Sum_probs=188.3

Q ss_pred             CeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEe
Q 043902          163 NLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFE  238 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  238 (477)
                      +.||+|+||.||++... +|+.||+|+++...   ......+.+|++++..++||||+++.+++     ...+..++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence            46999999999999864 78999999998542   23345678899999999999999999885     56678999999


Q ss_pred             ecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          239 FMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN-QYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       239 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      |+++|+|..++...       ..+++..+..++.|++.||.|||+ .   +|+||||||+|||++.++.+||+|||+++.
T Consensus        76 ~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~  145 (325)
T cd05594          76 YANGGELFFHLSRE-------RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKE  145 (325)
T ss_pred             CCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCee
Confidence            99999999988644       458999999999999999999997 6   999999999999999999999999999875


Q ss_pred             ccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCchh
Q 043902          318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHV  396 (477)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  396 (477)
                      ....       ........||..|+|||++ .+.++.++|||||||++|||+||+.||.....+.              .
T Consensus       146 ~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--------------~  204 (325)
T cd05594         146 GIKD-------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--------------L  204 (325)
T ss_pred             cCCC-------CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH--------------H
Confidence            3211       1112234689999999999 5578999999999999999999999996432110              1


Q ss_pred             HHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC-----ChHHHHH
Q 043902          397 MDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRV-----GMKFVVN  463 (477)
Q Consensus       397 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  463 (477)
                      ...+...   .           ..+|.           .....+.+++.+||+.||++|+     ++.++++
T Consensus       205 ~~~i~~~---~-----------~~~p~-----------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         205 FELILME---E-----------IRFPR-----------TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             HHHHhcC---C-----------CCCCC-----------CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            1111000   0           00000           0123377899999999999996     8998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.3e-39  Score=304.87  Aligned_cols=247  Identities=27%  Similarity=0.454  Sum_probs=191.2

Q ss_pred             eeeeeccceEEEEEeC---CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEe
Q 043902          164 LIGSGSFGSVYKGTLA---DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFE  238 (477)
Q Consensus       164 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  238 (477)
                      .||+|+||.||+|.++   ++..+|+|+++...  ....+.+.+|+.+++++.||||+++++++.      .+..++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEe
Confidence            5899999999999753   57899999987443  234567899999999999999999999852      345689999


Q ss_pred             ecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccc
Q 043902          239 FMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFL  318 (477)
Q Consensus       239 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  318 (477)
                      |+++|+|.+++...       ..+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++..
T Consensus        76 ~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~  145 (257)
T cd05116          76 LAELGPLNKFLQKN-------KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL  145 (257)
T ss_pred             cCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCcccccc
Confidence            99999999999643       4588999999999999999999998   9999999999999999999999999999865


Q ss_pred             cccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCCchh
Q 043902          319 FEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALPSHV  396 (477)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  396 (477)
                      .....    .........++..|+|||.+ .+.++.++|||||||++|||+| |+.||......              .+
T Consensus       146 ~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------------~~  207 (257)
T cd05116         146 GADEN----YYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--------------EV  207 (257)
T ss_pred             CCCCC----eeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------------HH
Confidence            32111    01111223346789999998 5568899999999999999998 99999653211              11


Q ss_pred             HHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          397 MDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       397 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                      .+.+.......             .|           ..+...+.+++.+|++.||++||++.+|.+.|++.
T Consensus       208 ~~~i~~~~~~~-------------~~-----------~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         208 TQMIESGERME-------------CP-----------QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             HHHHHCCCCCC-------------CC-----------CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            11111110000             00           01234488999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=8.9e-40  Score=306.01  Aligned_cols=248  Identities=26%  Similarity=0.442  Sum_probs=191.0

Q ss_pred             eeeeeccceEEEEEeC---CCCEEEEEEeeeccc-hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEee
Q 043902          164 LIGSGSFGSVYKGTLA---DGETAAIKVLKLQQQ-GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEF  239 (477)
Q Consensus       164 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~  239 (477)
                      .||+|+||.||+|.+.   ++..||+|++..... ...+.+.+|+.++++++||||++++++|.      ....++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~------~~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE------AEALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc------CCCeEEEEEe
Confidence            3899999999999764   355799999875532 33467899999999999999999999862      3457999999


Q ss_pred             cCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccccc
Q 043902          240 MRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLF  319 (477)
Q Consensus       240 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  319 (477)
                      +++++|.+++....      ..+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++....
T Consensus        76 ~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  146 (257)
T cd05115          76 ASGGPLNKFLSGKK------DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALG  146 (257)
T ss_pred             CCCCCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCcccccc
Confidence            99999999987543      4689999999999999999999998   99999999999999999999999999997652


Q ss_pred             ccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCCchhH
Q 043902          320 EESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALPSHVM  397 (477)
Q Consensus       320 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  397 (477)
                      ....    .........++..|+|||.+ .+.++.++|||||||++||+++ |..||.......              +.
T Consensus       147 ~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------------~~  208 (257)
T cd05115         147 ADDS----YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--------------VM  208 (257)
T ss_pred             CCcc----ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--------------HH
Confidence            2111    01112223346789999998 5568999999999999999997 999986532111              11


Q ss_pred             HHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          398 DVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       398 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                      ..+.......             .+           ..+..++.+++.+||..+|++||++.+|.+.|+.+
T Consensus       209 ~~~~~~~~~~-------------~~-----------~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         209 SFIEQGKRLD-------------CP-----------AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             HHHHCCCCCC-------------CC-----------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            1111100000             00           01234588999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.7e-39  Score=314.39  Aligned_cols=198  Identities=25%  Similarity=0.380  Sum_probs=166.7

Q ss_pred             CCCCCCeeeeeccceEEEEEe----CCCCEEEEEEeeecc----chhhHHHHHHHHHHhcC-CCCCcceeeeecccccCC
Q 043902          158 NFSEENLIGSGSFGSVYKGTL----ADGETAAIKVLKLQQ----QGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYE  228 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  228 (477)
                      +|++.+.||+|+||.||+++.    .+++.||+|+++...    ....+.+..|+.++.++ +|+||+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence            477889999999999999975    368899999997432    22345678899999999 589999999874     5


Q ss_pred             CCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEE
Q 043902          229 GNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH  308 (477)
Q Consensus       229 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k  308 (477)
                      ..+..++||||+++|+|.+++...       ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~k  145 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLYQR-------DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVV  145 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEE
Confidence            667889999999999999998654       4588999999999999999999999   999999999999999999999


Q ss_pred             EecccccccccccCCCCCCCccccCCCcccccccCcccccC--CCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       309 l~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |+|||+++.....      .........||..|+|||++.+  .++.++|||||||++|||+||+.||..
T Consensus       146 l~DfG~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~  209 (332)
T cd05614         146 LTDFGLSKEFLSE------EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL  209 (332)
T ss_pred             EeeCcCCcccccc------CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence            9999999764221      1112224568999999999854  478899999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=7.7e-40  Score=310.37  Aligned_cols=260  Identities=26%  Similarity=0.449  Sum_probs=200.6

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCC----EEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGE----TAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEG  229 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  229 (477)
                      .++|+..+.||+|+||.||+|++. +|.    .||+|+++... ......+.+|+.++..+.|+||++++++|.      
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~------   79 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICL------   79 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEc------
Confidence            457888999999999999999853 444    48999987543 334567889999999999999999999873      


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEE
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV  309 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl  309 (477)
                      ....++++||+++|+|.+++....      ..+++..++.++.|++.||.|||+.   +++||||||+||++++++.+||
T Consensus        80 ~~~~~l~~~~~~~g~l~~~l~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL  150 (279)
T cd05109          80 TSTVQLVTQLMPYGCLLDYVRENK------DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKI  150 (279)
T ss_pred             CCCcEEEEEcCCCCCHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEE
Confidence            234679999999999999997543      4589999999999999999999999   9999999999999999999999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeee
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~  387 (477)
                      +|||+++......     .........++..|+|||.. .+.++.++|||||||++|||+| |..||......       
T Consensus       151 ~dfG~~~~~~~~~-----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------  218 (279)
T cd05109         151 TDFGLARLLDIDE-----TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-------  218 (279)
T ss_pred             CCCCceeeccccc-----ceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------
Confidence            9999998653211     11112223456789999998 5678999999999999999998 89998643211       


Q ss_pred             eeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHH
Q 043902          388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQA  467 (477)
Q Consensus       388 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  467 (477)
                             .+...+.......                        ....+...+.+++.+|++.||++||++.|+++.|++
T Consensus       219 -------~~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~  267 (279)
T cd05109         219 -------EIPDLLEKGERLP------------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSR  267 (279)
T ss_pred             -------HHHHHHHCCCcCC------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                   1111111100000                        000113347899999999999999999999999998


Q ss_pred             HHHhhh
Q 043902          468 IRSKIR  473 (477)
Q Consensus       468 i~~~~~  473 (477)
                      +..+.+
T Consensus       268 ~~~~~~  273 (279)
T cd05109         268 MARDPS  273 (279)
T ss_pred             hhcCCc
Confidence            876654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.8e-40  Score=299.12  Aligned_cols=210  Identities=25%  Similarity=0.380  Sum_probs=172.7

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc--hhhHHHHHHHHHHhcCCCCC-cceeeeeccccc-CCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ--GALKSFIDECNALTSIRHRN-ILKIVSSCSSVD-YEGN  230 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~-~~~~  230 (477)
                      ...|...+.||+|.||+||+|+.. +|+.||+|.++....  +......+|+.++++++|+| |+++.+++.... +...
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            345666778999999999999854 789999999986643  34567789999999999999 999999974322 1223


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ...++|+||+. -+|..++.......   ..++...+..++.||++||+|||++   +|+||||||.|||++++|.+||+
T Consensus        90 ~~l~lvfe~~d-~DL~~ymd~~~~~~---~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKla  162 (323)
T KOG0594|consen   90 GKLYLVFEFLD-RDLKKYMDSLPKKP---QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLA  162 (323)
T ss_pred             ceEEEEEEeec-ccHHHHHHhccccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeee
Confidence            47889999995 49999997654210   3467788999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccccC--CCCcccceeehHHHHHHHhhCCCCCCcccc
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDDMFK  379 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~  379 (477)
                      |||+|+....       .....+..++|..|+|||++-|  .|+...||||+||++.||++++..|....+
T Consensus       163 DFGlAra~~i-------p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se  226 (323)
T KOG0594|consen  163 DFGLARAFSI-------PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE  226 (323)
T ss_pred             ccchHHHhcC-------CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence            9999996521       2333556678999999999933  599999999999999999999998876543

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.8e-39  Score=308.44  Aligned_cols=270  Identities=24%  Similarity=0.411  Sum_probs=204.0

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-----CCCEEEEEEeeeccch-hhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-----DGETAAIKVLKLQQQG-ALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      +.|...+.||+|+||.||+|++.     ++..+|+|+++..... ..+.+.+|++.+++++|+||+++++++..   ...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence            45677889999999999999853     3689999999865543 45789999999999999999999998642   335


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ...++||||+++++|.+++....      ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~  151 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHR------DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKIS  151 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCc------cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEc
Confidence            67899999999999999997543      3589999999999999999999998   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      |||.+........    .........++..|+|||.. ...++.++||||||+++|||+||..|+..........   ..
T Consensus       152 dfg~~~~~~~~~~----~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~---~~  224 (284)
T cd05038         152 DFGLAKVLPEDKD----YYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRM---IG  224 (284)
T ss_pred             ccccccccccCCc----ceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccc---cc
Confidence            9999987632111    11112223456679999998 5678999999999999999999999986532221111   00


Q ss_pred             ccCCc----hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHH
Q 043902          390 MALPS----HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNL  465 (477)
Q Consensus       390 ~~~~~----~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  465 (477)
                      .....    .+.+.+.....         .               .....++.++.+++.+|++.+|++||||.||+++|
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~---------~---------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l  280 (284)
T cd05038         225 IAQGQMIVTRLLELLKEGER---------L---------------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV  280 (284)
T ss_pred             cccccccHHHHHHHHHcCCc---------C---------------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence            00000    11111111000         0               00112234588999999999999999999999999


Q ss_pred             HHHH
Q 043902          466 QAIR  469 (477)
Q Consensus       466 ~~i~  469 (477)
                      ++++
T Consensus       281 ~~i~  284 (284)
T cd05038         281 DRLR  284 (284)
T ss_pred             hhcC
Confidence            9874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=320.01  Aligned_cols=205  Identities=23%  Similarity=0.362  Sum_probs=171.3

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ++|+..+.||+|+||.||+|+.. +|+.||||+++...   ......+.+|++++..++||||+++++++     ..++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~   75 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENY   75 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCe
Confidence            47889999999999999999875 68999999997542   23345678899999999999999999985     56778


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++|+|.+++...       ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        76 ~~lv~E~~~~g~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df  145 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMKK-------DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDF  145 (364)
T ss_pred             EEEEECCCCCcHHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeec
Confidence            99999999999999998754       4589999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCC-------------------------------ccccCCCcccccccCcccc-cCCCCcccceeeh
Q 043902          313 GLAKFLFEESNTPSKN-------------------------------QTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSY  360 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~-------------------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~  360 (477)
                      |++..+..........                               ........||+.|+|||++ ...++.++|||||
T Consensus       146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  225 (364)
T cd05599         146 GLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL  225 (364)
T ss_pred             ccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecc
Confidence            9987643211000000                               0011134689999999998 5568999999999


Q ss_pred             HHHHHHHhhCCCCCCc
Q 043902          361 GILLLEIFTGKRPTDD  376 (477)
Q Consensus       361 Gvvl~elltg~~p~~~  376 (477)
                      ||++|||++|..||..
T Consensus       226 G~il~el~~G~~Pf~~  241 (364)
T cd05599         226 GVIMYEMLVGYPPFCS  241 (364)
T ss_pred             hhHHHHhhcCCCCCCC
Confidence            9999999999999965

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5.8e-40  Score=310.88  Aligned_cols=261  Identities=25%  Similarity=0.406  Sum_probs=198.0

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeCC------CCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLAD------GETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDY  227 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  227 (477)
                      .+++|...+.||+|++|.||+|...+      +..|++|.+.... ......|.+|+.++++++|+||+++++++     
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----   78 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVS-----   78 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----
Confidence            35678899999999999999998753      5678999887443 33346789999999999999999999986     


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC--
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM--  305 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~--  305 (477)
                      ...+..++||||+++++|.+++............+++..++.++.||+.||.|||+.   +++||||||+||+++.++  
T Consensus        79 ~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~  155 (277)
T cd05036          79 FERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPG  155 (277)
T ss_pred             ccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCC
Confidence            345567999999999999999976532222234689999999999999999999999   999999999999998654  


Q ss_pred             -cEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCccccccc
Q 043902          306 -IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL  382 (477)
Q Consensus       306 -~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~  382 (477)
                       .+||+|||+++.......     .........+..|+|||++ .+.++.++|||||||++|||++ |..||......  
T Consensus       156 ~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--  228 (277)
T cd05036         156 RVAKIADFGMARDIYRASY-----YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--  228 (277)
T ss_pred             cceEeccCccccccCCccc-----eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--
Confidence             699999999986522110     1111122335689999998 5679999999999999999997 99998653211  


Q ss_pred             ceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHH
Q 043902          383 SIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVV  462 (477)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl  462 (477)
                                  ...+.+.......             .           ...++..+.+++.+|++.+|++|||+.+|+
T Consensus       229 ------------~~~~~~~~~~~~~-------------~-----------~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl  272 (277)
T cd05036         229 ------------EVMEFVTGGGRLD-------------P-----------PKGCPGPVYRIMTDCWQHTPEDRPNFATIL  272 (277)
T ss_pred             ------------HHHHHHHcCCcCC-------------C-----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence                        1111111100000             0           001134588999999999999999999999


Q ss_pred             HHHH
Q 043902          463 NNLQ  466 (477)
Q Consensus       463 ~~L~  466 (477)
                      +.|+
T Consensus       273 ~~l~  276 (277)
T cd05036         273 ERIQ  276 (277)
T ss_pred             HHhh
Confidence            9885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.9e-39  Score=308.33  Aligned_cols=260  Identities=25%  Similarity=0.433  Sum_probs=197.7

Q ss_pred             cCCCCCCeeeeeccceEEEEEe-----CCCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTL-----ADGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      ++|+..+.||+|+||.||+|..     .++..+++|.++... ......+.+|++++++++||||+++++++     ...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVV-----TQE   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE-----ecC
Confidence            4677889999999999999984     246789999997433 33346788999999999999999999985     455


Q ss_pred             ceeeEEEeecCCCChhhhcccCCC----------cccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeE
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTD----------EYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVL  300 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~----------~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIl  300 (477)
                      ...++||||+++++|.+++.....          .......+++...+.++.|++.||.|||++   +++||||||+||+
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil  156 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL  156 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence            678999999999999999853211          000123578999999999999999999999   9999999999999


Q ss_pred             ecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCccc
Q 043902          301 LDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMF  378 (477)
Q Consensus       301 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~  378 (477)
                      +++++.+||+|||+++......     .........++..|+|||++ .+.++.++|||||||++|||++ |..||....
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~  231 (283)
T cd05090         157 IGEQLHVKISDLGLSREIYSAD-----YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS  231 (283)
T ss_pred             EcCCCcEEeccccccccccCCc-----ceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence            9999999999999997653211     11112333456789999998 5678999999999999999999 998985421


Q ss_pred             ccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCCh
Q 043902          379 KDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGM  458 (477)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  458 (477)
                      ..              .+.+.++......                        ..+.+...+.+++.+|++.||++||++
T Consensus       232 ~~--------------~~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~  273 (283)
T cd05090         232 NQ--------------EVIEMVRKRQLLP------------------------CSEDCPPRMYSLMTECWQEGPSRRPRF  273 (283)
T ss_pred             HH--------------HHHHHHHcCCcCC------------------------CCCCCCHHHHHHHHHHcccCcccCcCH
Confidence            10              1111111111000                        000123347889999999999999999


Q ss_pred             HHHHHHHHH
Q 043902          459 KFVVNNLQA  467 (477)
Q Consensus       459 ~evl~~L~~  467 (477)
                      .+|++.|..
T Consensus       274 ~~i~~~l~~  282 (283)
T cd05090         274 KDIHTRLRS  282 (283)
T ss_pred             HHHHHHhhc
Confidence            999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-39  Score=305.13  Aligned_cols=250  Identities=30%  Similarity=0.499  Sum_probs=199.7

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      .++|+..+.||.|+||.||+|... |+.||+|.++.... ..+.+.+|+.++.+++|+||+++++++     ......++
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~   77 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVV-----LQGNPLYI   77 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEE-----cCCCCeEE
Confidence            457888999999999999999874 78999999986644 457899999999999999999999986     34667899


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      ||||+++++|.+++.....     ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||.+
T Consensus        78 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~  149 (256)
T cd05039          78 VTEYMAKGSLVDYLRSRGR-----AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLA  149 (256)
T ss_pred             EEEecCCCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccc
Confidence            9999999999999975431     3689999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCC
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      +.....          ......+..|+|||++ .+.++.++||||||+++||+++ |..||.......            
T Consensus       150 ~~~~~~----------~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------------  207 (256)
T cd05039         150 KEASQG----------QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------------  207 (256)
T ss_pred             cccccc----------cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH------------
Confidence            865211          1122346789999998 5678999999999999999997 999985432111            


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                        +...+.......                        ....++..+.+++.+|+..+|++|||+.|+++.|+.+
T Consensus       208 --~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         208 --VVPHVEKGYRME------------------------APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             --HHHHHhcCCCCC------------------------CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence              111110000000                        0001134588999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.3e-40  Score=300.88  Aligned_cols=246  Identities=23%  Similarity=0.362  Sum_probs=201.8

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeec---cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQ---QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      ..+|++.+.||+|.||.|-+|.. ..|+.||||.++..   +..+.-.+.+|+++|+.|+||||+.++.+     |++.+
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENkd  126 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENKD  126 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCCc
Confidence            35677888999999999999985 68999999999754   34455678899999999999999999998     58899


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ...+||||..+|.|++|+...       ..+++.+...++.||..|+.|+|.+   +++|||||.+|||+|.++++||+|
T Consensus       127 KIvivMEYaS~GeLYDYiSer-------~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIAD  196 (668)
T KOG0611|consen  127 KIVIVMEYASGGELYDYISER-------GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIAD  196 (668)
T ss_pred             eEEEEEEecCCccHHHHHHHh-------ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeec
Confidence            999999999999999999866       5699999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccccCC--CCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH--VSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      ||++..+..        ......++|++-|.+||..+|.  -++.+|-||+||+||-|+.|..||++..-.         
T Consensus       197 FGLSNly~~--------~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---------  259 (668)
T KOG0611|consen  197 FGLSNLYAD--------KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---------  259 (668)
T ss_pred             cchhhhhcc--------ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---------
Confidence            999987632        3344567899999999999764  478999999999999999999999863211         


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                              .++..-....     .+...              .    +....-|+++||..||++|-|+.+|...
T Consensus       260 --------~lvrQIs~Ga-----YrEP~--------------~----PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  260 --------RLVRQISRGA-----YREPE--------------T----PSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             --------HHHHHhhccc-----ccCCC--------------C----CchHHHHHHHHHhcCcccchhHHHHhhh
Confidence                    0111000000     00000              0    1225678999999999999999999864

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-39  Score=319.31  Aligned_cols=193  Identities=25%  Similarity=0.355  Sum_probs=164.0

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      ..+|++.+.||+|+||.||++... +++.||+|....      ..+.+|++++++++||||+++++++     ......+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~  159 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTF-----TYNKFTC  159 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEE-----EECCeeE
Confidence            357999999999999999999864 789999997542      4567899999999999999999985     4566789


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +|+|++. ++|..++...       ..+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       160 lv~e~~~-~~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~  228 (391)
T PHA03212        160 LILPRYK-TDLYCYLAAK-------RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGA  228 (391)
T ss_pred             EEEecCC-CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCc
Confidence            9999995 6888888644       4578999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ++.....      .........||+.|+|||++ ...++.++|||||||++|||+||+.||..
T Consensus       229 a~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~  285 (391)
T PHA03212        229 ACFPVDI------NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE  285 (391)
T ss_pred             ccccccc------cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence            9753211      11122345789999999999 55789999999999999999999988643

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.2e-39  Score=317.97  Aligned_cols=267  Identities=25%  Similarity=0.440  Sum_probs=200.2

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe------CCCCEEEEEEeeecc-chhhHHHHHHHHHHhcC-CCCCcceeeeecccccC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL------ADGETAAIKVLKLQQ-QGALKSFIDECNALTSI-RHRNILKIVSSCSSVDY  227 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  227 (477)
                      .++|...+.||+|+||.||+|..      .+++.||||+++... ......+.+|+.++.++ +||||++++++|.    
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~----   81 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT----   81 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee----
Confidence            45789999999999999999973      357899999997543 23346788999999999 6899999999873    


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCcc---------------------------------------------------
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDEY---------------------------------------------------  256 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~---------------------------------------------------  256 (477)
                      ..+...++||||+++|+|.+++.......                                                   
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence            34456789999999999999986432100                                                   


Q ss_pred             ---------cccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccccccCCCCCC
Q 043902          257 ---------CHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK  327 (477)
Q Consensus       257 ---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  327 (477)
                               .....+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.......     
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-----  233 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-----  233 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCc-----
Confidence                     0013478889999999999999999999   99999999999999999999999999997652211     


Q ss_pred             CccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCCchhHHHhhhhhh
Q 043902          328 NQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSML  405 (477)
Q Consensus       328 ~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  405 (477)
                      .........++..|+|||.+ ...++.++||||||+++|||++ |..||.......             .....+.....
T Consensus       234 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------------~~~~~~~~~~~  300 (343)
T cd05103         234 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------------EFCRRLKEGTR  300 (343)
T ss_pred             chhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-------------HHHHHHhccCC
Confidence            11111223456789999998 5668999999999999999997 999986421110             01111100000


Q ss_pred             hhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHh
Q 043902          406 LEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSK  471 (477)
Q Consensus       406 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  471 (477)
                      ..             .+.           .....+.+++..||+.||++|||+.||++.|+.+.+.
T Consensus       301 ~~-------------~~~-----------~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         301 MR-------------APD-----------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CC-------------CCC-----------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            00             000           0122478999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=318.53  Aligned_cols=255  Identities=24%  Similarity=0.361  Sum_probs=197.7

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ++|.+.+.||+|+||.||+|+.. +|+.||+|+++...   ......+.+|++++..++||||+++++++     ..++.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEH   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCe
Confidence            46888999999999999999975 78999999998542   23446788999999999999999999884     56778


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++++|.+++...       ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+||
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Df  145 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLIRK-------DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADF  145 (350)
T ss_pred             EEEEEcCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecC
Confidence            99999999999999999754       4588999999999999999999998   9999999999999999999999999


Q ss_pred             cccccccccCCC----------------------CCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh
Q 043902          313 GLAKFLFEESNT----------------------PSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT  369 (477)
Q Consensus       313 G~a~~~~~~~~~----------------------~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt  369 (477)
                      |++.........                      ............||..|+|||++ ...++.++|||||||++|||++
T Consensus       146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~  225 (350)
T cd05573         146 GLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY  225 (350)
T ss_pred             CCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhcc
Confidence            999865332100                      00001123345689999999999 5568999999999999999999


Q ss_pred             CCCCCCcccccccceeeeeeccCCchhHHHhh--hhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhc
Q 043902          370 GKRPTDDMFKDDLSIHKFVLMALPSHVMDVLD--LSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMC  447 (477)
Q Consensus       370 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C  447 (477)
                      |+.||.......             ....+..  ....               .|...         .....+.+++.+|
T Consensus       226 g~~Pf~~~~~~~-------------~~~~i~~~~~~~~---------------~p~~~---------~~~~~~~~li~~l  268 (350)
T cd05573         226 GFPPFYSDTLQE-------------TYNKIINWKESLR---------------FPPDP---------PVSPEAIDLICRL  268 (350)
T ss_pred             CCCCCCCCCHHH-------------HHHHHhccCCccc---------------CCCCC---------CCCHHHHHHHHHH
Confidence            999997532110             0011111  0000               00000         0123477899999


Q ss_pred             CCCCCCCCCC-hHHHHHH
Q 043902          448 SAASPRDRVG-MKFVVNN  464 (477)
Q Consensus       448 l~~dP~~RPs-~~evl~~  464 (477)
                      +. ||.+||+ ++|+++.
T Consensus       269 l~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         269 LC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             cc-ChhhcCCCHHHHhcC
Confidence            97 9999999 9999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.5e-39  Score=302.92  Aligned_cols=260  Identities=23%  Similarity=0.404  Sum_probs=202.4

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec---cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ---QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ++|+..+.||+|+||.||+|... +|+.||+|.++..   .....+.+.+|++++++++|+|++++++++     ...+.
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~-----~~~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASF-----IENNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeee-----ecCCe
Confidence            57889999999999999999976 7999999988642   223356789999999999999999999985     44567


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++|+|.+++.....   ....+++..++.++.+++.||.|||+.   +++||||+|+||+++.++.++|+||
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~  150 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKK---QKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDL  150 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcc---cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEecc
Confidence            8999999999999999864321   124588999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      |++......       ........++..|+|||.+ ...++.++|||||||++|+|++|+.||......           
T Consensus       151 ~~~~~~~~~-------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----------  212 (267)
T cd08224         151 GLGRFFSSK-------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----------  212 (267)
T ss_pred             ceeeeccCC-------CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-----------
Confidence            998765221       1112234578889999998 556899999999999999999999998542111           


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIR  469 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  469 (477)
                          ..++.+......             .+...       .+.....+.+++.+|++.+|++|||+.+|++.|++++
T Consensus       213 ----~~~~~~~~~~~~-------------~~~~~-------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         213 ----LYSLCKKIEKCD-------------YPPLP-------ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             ----HHHHHhhhhcCC-------------CCCCC-------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                011111000000             00000       0011334789999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.6e-39  Score=311.52  Aligned_cols=195  Identities=27%  Similarity=0.414  Sum_probs=163.0

Q ss_pred             CCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHH---hcCCCCCcceeeeecccccCCCCc
Q 043902          159 FSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNAL---TSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       159 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      |++.+.||+|+||.||+|... +++.||||+++...   ....+.+..|.+++   ++++||||+++++++     ...+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence            567889999999999999865 68999999997442   22334566666554   567899999999985     5667


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+++|+|..++..        ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|
T Consensus        76 ~~~lv~E~~~~~~L~~~~~~--------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~D  144 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIHT--------DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIAD  144 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCc
Confidence            89999999999999988753        3589999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ||+++....       .........|+..|+|||.+ ...++.++|||||||++|||++|+.||..
T Consensus       145 fg~~~~~~~-------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~  203 (324)
T cd05589         145 FGLCKEGMG-------FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG  203 (324)
T ss_pred             ccCCccCCC-------CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC
Confidence            999875321       11122345689999999999 55689999999999999999999999965

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.8e-39  Score=312.35  Aligned_cols=192  Identities=29%  Similarity=0.422  Sum_probs=163.2

Q ss_pred             CeeeeeccceEEEEEeC-CCCEEEEEEeeec---cchhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCCceeeEEE
Q 043902          163 NLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ---QQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGNDFKALVF  237 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  237 (477)
                      +.||+|+||.||+|+.. +++.||+|+++..   .......+..|..++..+ +||||+++++++     ...+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence            46999999999999875 6889999999743   233446678888888876 699999999985     5667899999


Q ss_pred             eecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          238 EFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       238 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      ||+++|+|.+++...       ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        76 Ey~~~g~L~~~i~~~-------~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~  145 (320)
T cd05590          76 EFVNGGDLMFHIQKS-------RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE  145 (320)
T ss_pred             cCCCCchHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCee
Confidence            999999999988754       4588999999999999999999999   999999999999999999999999999875


Q ss_pred             ccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ...       .........||+.|+|||++ ...++.++|||||||++|||++|+.||..
T Consensus       146 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~  198 (320)
T cd05590         146 GIF-------NGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA  198 (320)
T ss_pred             cCc-------CCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence            311       11122345689999999999 45689999999999999999999999965

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.9e-39  Score=307.85  Aligned_cols=202  Identities=26%  Similarity=0.420  Sum_probs=165.3

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcC---CCCCcceeeeecccccCCCCc
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSI---RHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~~~  231 (477)
                      +|++.+.||+|+||.||+|+.. +++.||+|.++...  ......+.+|+++++++   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999865 68999999987542  22224556777776665   799999999987544334456


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||++ ++|.+++.....     ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~d  151 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPP-----PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLAD  151 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECc
Confidence            7899999997 489888865421     4589999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ||+++....        ........+|..|+|||++ .+.++.++|||||||++|||++|++||..
T Consensus       152 fg~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~  209 (288)
T cd07863         152 FGLARIYSC--------QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG  209 (288)
T ss_pred             cCccccccC--------cccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCC
Confidence            999976521        1112334678999999998 56789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.8e-39  Score=311.80  Aligned_cols=266  Identities=24%  Similarity=0.422  Sum_probs=202.4

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC--------CCCEEEEEEeeecc-chhhHHHHHHHHHHhcC-CCCCcceeeeecccc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA--------DGETAAIKVLKLQQ-QGALKSFIDECNALTSI-RHRNILKIVSSCSSV  225 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  225 (477)
                      .++|.+.+.||+|+||.||+|+..        ++..||+|.++... ......+.+|+.++..+ +||||+++++++   
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~---   90 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC---   90 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE---
Confidence            567888999999999999999741        34579999987442 33456789999999999 899999999986   


Q ss_pred             cCCCCceeeEEEeecCCCChhhhcccCCCcc---------cccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCC
Q 043902          226 DYEGNDFKALVFEFMRNGNLDQWLHPSTDEY---------CHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKS  296 (477)
Q Consensus       226 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp  296 (477)
                        ......++||||+++|+|.+++.......         .....+++..++.++.|++.||.|||+.   +++||||||
T Consensus        91 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp  165 (304)
T cd05101          91 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAA  165 (304)
T ss_pred             --ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence              44567899999999999999997542110         1124588999999999999999999999   999999999


Q ss_pred             CCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCC
Q 043902          297 SNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPT  374 (477)
Q Consensus       297 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~  374 (477)
                      +||+++.++.+||+|||+++.......     ........++..|+|||++ .+.++.++||||||+++|||++ |..||
T Consensus       166 ~Nili~~~~~~kl~D~g~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~  240 (304)
T cd05101         166 RNVLVTENNVMKIADFGLARDVNNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY  240 (304)
T ss_pred             ceEEEcCCCcEEECCCccceecccccc-----cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence            999999999999999999986532111     1112223456789999998 5568999999999999999998 78887


Q ss_pred             CcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCC
Q 043902          375 DDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRD  454 (477)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~  454 (477)
                      ......              .+.+.+.......                        ....+...+.+++.+||+.+|++
T Consensus       241 ~~~~~~--------------~~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~cl~~~p~~  282 (304)
T cd05101         241 PGIPVE--------------ELFKLLKEGHRMD------------------------KPANCTNELYMMMRDCWHAIPSH  282 (304)
T ss_pred             ccCCHH--------------HHHHHHHcCCcCC------------------------CCCCCCHHHHHHHHHHcccChhh
Confidence            542111              1111111000000                        00112345889999999999999


Q ss_pred             CCChHHHHHHHHHHHHhh
Q 043902          455 RVGMKFVVNNLQAIRSKI  472 (477)
Q Consensus       455 RPs~~evl~~L~~i~~~~  472 (477)
                      |||+.|+++.|+++..-.
T Consensus       283 Rps~~e~l~~l~~~~~~~  300 (304)
T cd05101         283 RPTFKQLVEDLDRILTLT  300 (304)
T ss_pred             CCCHHHHHHHHHHHHHhh
Confidence            999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.6e-39  Score=317.37  Aligned_cols=252  Identities=21%  Similarity=0.282  Sum_probs=194.5

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      ..++|+..+.||+|+||.||+++.. +++.||+|+++...   ......+.+|+.+++.++||||+++++++     .++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~  115 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD  115 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence            3568899999999999999999865 68899999997432   22335678899999999999999999884     567


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ...++||||+++|+|.+++...        .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~~--------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~  184 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMSNY--------DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLA  184 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEE
Confidence            7899999999999999998642        378888999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccccC-----CCCcccceeehHHHHHHHhhCCCCCCccccccccee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-----HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIH  385 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~  385 (477)
                      |||++......      .........||+.|+|||++.+     .++.++|||||||++|||++|+.||.......    
T Consensus       185 DfG~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----  254 (370)
T cd05596         185 DFGTCMKMDAN------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----  254 (370)
T ss_pred             eccceeeccCC------CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH----
Confidence            99999765211      1112234568999999999832     37899999999999999999999996532110    


Q ss_pred             eeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCC--CCChHHHHH
Q 043902          386 KFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRD--RVGMKFVVN  463 (477)
Q Consensus       386 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~  463 (477)
                               ....+.+.....             .+|..         ......+.+++.+|++.+|.+  |||+.|+++
T Consensus       255 ---------~~~~i~~~~~~~-------------~~~~~---------~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         255 ---------TYSKIMDHKNSL-------------TFPDD---------IEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             ---------HHHHHHcCCCcC-------------CCCCc---------CCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence                     011111100000             00000         001234778999999999988  999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.4e-39  Score=311.24  Aligned_cols=193  Identities=27%  Similarity=0.388  Sum_probs=163.3

Q ss_pred             CeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCCceeeEEE
Q 043902          163 NLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGNDFKALVF  237 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  237 (477)
                      +.||+|+||.||+|+.. +++.||+|+++...   ......+..|.+++..+ +||||+++++++     ...+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence            46999999999999875 58899999997542   33445677899988866 799999999985     5567899999


Q ss_pred             eecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          238 EFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       238 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      ||+++|+|..++...       ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        76 E~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~  145 (321)
T cd05591          76 EYVNGGDLMFQIQRS-------RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKE  145 (321)
T ss_pred             eCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeeccccee
Confidence            999999999988654       4588999999999999999999999   999999999999999999999999999875


Q ss_pred             ccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      ...       .........||..|+|||++ ...++.++|||||||++|||+||+.||...
T Consensus       146 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~  199 (321)
T cd05591         146 GIL-------NGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD  199 (321)
T ss_pred             ccc-------CCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC
Confidence            421       11122345689999999998 456899999999999999999999999653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.2e-39  Score=314.11  Aligned_cols=192  Identities=25%  Similarity=0.381  Sum_probs=162.6

Q ss_pred             CeeeeeccceEEEEEeC-CCCEEEEEEeeec---cchhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCCceeeEEE
Q 043902          163 NLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ---QQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGNDFKALVF  237 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  237 (477)
                      +.||+|+||.||+|+.. +++.||+|+++..   .......+..|..++.++ +||||+++++++     ...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence            46999999999999865 6889999999854   223345677888888876 799999999985     5567899999


Q ss_pred             eecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          238 EFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       238 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      ||+++|+|..++...       ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        76 E~~~~~~L~~~~~~~-------~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~  145 (329)
T cd05618          76 EYVNGGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  145 (329)
T ss_pred             eCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence            999999999888644       4589999999999999999999999   999999999999999999999999999875


Q ss_pred             ccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ...       .........||..|+|||++ ...++.++|||||||++|||+||+.||..
T Consensus       146 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~  198 (329)
T cd05618         146 GLR-------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             ccC-------CCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence            321       11122345689999999999 55689999999999999999999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-40  Score=320.36  Aligned_cols=243  Identities=25%  Similarity=0.420  Sum_probs=197.3

Q ss_pred             eeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEeecCC
Q 043902          164 LIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRN  242 (477)
Q Consensus       164 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~  242 (477)
                      +||+|.||+||.|+.. +...+|||.+........+-+..|+.+.++++|.|||+++|.|     ..+++.-+.||.++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence            7999999999999965 5667999999877777778889999999999999999999996     566788999999999


Q ss_pred             CChhhhcccCCCcccccccC--CHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec-CCCcEEEeccccccccc
Q 043902          243 GNLDQWLHPSTDEYCHFKKL--SLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLF  319 (477)
Q Consensus       243 g~L~~~l~~~~~~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~DfG~a~~~~  319 (477)
                      |+|.++|....      .++  .+..+-.+.+||++||.|||++   .|||||||-+|||++ -.|.+||+|||.++.+.
T Consensus       657 GSLSsLLrskW------GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA  727 (1226)
T KOG4279|consen  657 GSLSSLLRSKW------GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA  727 (1226)
T ss_pred             CcHHHHHHhcc------CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhc
Confidence            99999998654      555  7788888999999999999999   999999999999996 57899999999998762


Q ss_pred             ccCCCCCCCccccCCCcccccccCcccc-cC--CCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCchh
Q 043902          320 EESNTPSKNQTMSNGLKGSVGYIPPEYI-NG--HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHV  396 (477)
Q Consensus       320 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  396 (477)
                      .       -......+.||..|||||++ .|  .|+.++|||||||++.||.||++||-........             
T Consensus       728 g-------inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-------------  787 (1226)
T KOG4279|consen  728 G-------INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-------------  787 (1226)
T ss_pred             c-------CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-------------
Confidence            2       23445667899999999999 55  3899999999999999999999999654222110             


Q ss_pred             HHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          397 MDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       397 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                        ++.-.+-        +     .-|        +.+++...+...++.+|+.+||.+||+++++++
T Consensus       788 --MFkVGmy--------K-----vHP--------~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  788 --MFKVGMY--------K-----VHP--------PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             --hhhhcce--------e-----cCC--------CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence              0000000        0     001        122333455788999999999999999999985

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2e-39  Score=311.06  Aligned_cols=264  Identities=28%  Similarity=0.424  Sum_probs=198.1

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCC--EEEEEEeeec-cchhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGE--TAAIKVLKLQ-QQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~  230 (477)
                      .++|++.+.||+|+||.||+|... ++.  .+++|.++.. .......+.+|++++.++ +|+||+++++++     ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~   80 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHR   80 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCC
Confidence            457888899999999999999864 454  4577776643 233446788999999999 899999999996     456


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcc---------cccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEY---------CHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL  301 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll  301 (477)
                      +..++||||+++|+|.+++.......         .....+++..++.++.|++.||+|||+.   +++||||||+||++
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili  157 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILV  157 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEe
Confidence            67899999999999999997542100         1124688999999999999999999998   99999999999999


Q ss_pred             cCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccc
Q 043902          302 DEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFK  379 (477)
Q Consensus       302 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~  379 (477)
                      +.++.+||+|||++.....        ........++..|+|||++ ...++.++|||||||++|||+| |..||.....
T Consensus       158 ~~~~~~kl~dfg~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  229 (303)
T cd05088         158 GENYVAKIADFGLSRGQEV--------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC  229 (303)
T ss_pred             cCCCcEEeCccccCcccch--------hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh
Confidence            9999999999999863210        0111112346679999998 4568999999999999999998 9999864321


Q ss_pred             cccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChH
Q 043902          380 DDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMK  459 (477)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~  459 (477)
                      ..              ..+.+.......             .+           ..+...+.+++.+|++.+|++||++.
T Consensus       230 ~~--------------~~~~~~~~~~~~-------------~~-----------~~~~~~~~~li~~~l~~~p~~Rp~~~  271 (303)
T cd05088         230 AE--------------LYEKLPQGYRLE-------------KP-----------LNCDDEVYDLMRQCWREKPYERPSFA  271 (303)
T ss_pred             HH--------------HHHHHhcCCcCC-------------CC-----------CCCCHHHHHHHHHHcCCChhhCcCHH
Confidence            10              000000000000             00           00123478999999999999999999


Q ss_pred             HHHHHHHHHHHhhh
Q 043902          460 FVVNNLQAIRSKIR  473 (477)
Q Consensus       460 evl~~L~~i~~~~~  473 (477)
                      ++++.|+++.+...
T Consensus       272 ~il~~l~~~~~~~~  285 (303)
T cd05088         272 QILVSLNRMLEERK  285 (303)
T ss_pred             HHHHHHHHHHHhhh
Confidence            99999998776543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.2e-39  Score=309.13  Aligned_cols=259  Identities=28%  Similarity=0.489  Sum_probs=198.9

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC------CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      .+|+..+.||+|+||.||++...      ++..+++|.++.........+.+|++.+.+++|+||+++++++     ...
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVC-----TEG   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEE-----ecC
Confidence            46777899999999999999632      4568999998866666667899999999999999999999986     445


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCc--------ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDE--------YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD  302 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~--------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~  302 (477)
                      ...+++|||+++|+|.+++......        ......+++..++.++.|++.|++|||+.   +++||||||+||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~  156 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVG  156 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEc
Confidence            6789999999999999998754210        11123588999999999999999999998   999999999999999


Q ss_pred             CCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCccccc
Q 043902          303 EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKD  380 (477)
Q Consensus       303 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~  380 (477)
                      +++.+||+|||++.......     .........++..|+|||.+ ...++.++|||||||++|||++ |..||......
T Consensus       157 ~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  231 (280)
T cd05092         157 QGLVVKIGDFGMSRDIYSTD-----YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT  231 (280)
T ss_pred             CCCCEEECCCCceeEcCCCc-----eeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH
Confidence            99999999999997652211     11112233456789999998 5668999999999999999998 89998643211


Q ss_pred             ccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHH
Q 043902          381 DLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKF  460 (477)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e  460 (477)
                      .              ..+.+.......                        ....++..+.+++.+||+.||++||++.|
T Consensus       232 ~--------------~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~  273 (280)
T cd05092         232 E--------------AIECITQGRELE------------------------RPRTCPPEVYAIMQGCWQREPQQRMVIKD  273 (280)
T ss_pred             H--------------HHHHHHcCccCC------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence            1              000000000000                        00012344889999999999999999999


Q ss_pred             HHHHHH
Q 043902          461 VVNNLQ  466 (477)
Q Consensus       461 vl~~L~  466 (477)
                      |++.|+
T Consensus       274 l~~~l~  279 (280)
T cd05092         274 IHSRLQ  279 (280)
T ss_pred             HHHHHh
Confidence            999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2e-39  Score=302.30  Aligned_cols=246  Identities=26%  Similarity=0.441  Sum_probs=191.4

Q ss_pred             CeeeeeccceEEEEEeCCCCEEEEEEeeeccc-hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEeecC
Q 043902          163 NLIGSGSFGSVYKGTLADGETAAIKVLKLQQQ-GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMR  241 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~  241 (477)
                      ++||+|+||.||+|...+++.+|+|.++.... .....+.+|++++++++||||++++++|     ...+..++||||++
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~   75 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC-----TQRQPIYIVMELVP   75 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEE-----ecCCccEEEEECCC
Confidence            36899999999999988899999999875432 2335788999999999999999999996     34557899999999


Q ss_pred             CCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccccccc
Q 043902          242 NGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEE  321 (477)
Q Consensus       242 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  321 (477)
                      +++|.+++....      ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        76 ~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  146 (250)
T cd05085          76 GGDFLSFLRKKK------DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG  146 (250)
T ss_pred             CCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccc
Confidence            999999986543      3578999999999999999999998   9999999999999999999999999998754211


Q ss_pred             CCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCCchhHHH
Q 043902          322 SNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALPSHVMDV  399 (477)
Q Consensus       322 ~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (477)
                            .........++..|+|||++ .+.++.++||||||+++||+++ |..||.......              ....
T Consensus       147 ------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--------------~~~~  206 (250)
T cd05085         147 ------IYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--------------AREQ  206 (250)
T ss_pred             ------ccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--------------HHHH
Confidence                  01111122346779999998 5678999999999999999999 999986432111              0000


Q ss_pred             hhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHH
Q 043902          400 LDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQ  466 (477)
Q Consensus       400 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  466 (477)
                      +.......             .           ...++..+.+++.+|++.+|++||++.|+++.|.
T Consensus       207 ~~~~~~~~-------------~-----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         207 VEKGYRMS-------------C-----------PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHcCCCCC-------------C-----------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            10000000             0           0011344889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6.7e-39  Score=310.88  Aligned_cols=192  Identities=25%  Similarity=0.377  Sum_probs=163.5

Q ss_pred             CeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCCceeeEEE
Q 043902          163 NLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGNDFKALVF  237 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  237 (477)
                      +.||+|+||.||+|+.. +++.||+|+++...   ......+..|..++.++ +||||+++++++     ......++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence            46999999999999865 68999999998542   23345678899999988 799999999985     5567899999


Q ss_pred             eecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          238 EFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       238 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      ||+++|+|.+++...       ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++.
T Consensus        76 e~~~~g~L~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~  145 (329)
T cd05588          76 EFVSGGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE  145 (329)
T ss_pred             eCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccc
Confidence            999999999888644       4589999999999999999999999   999999999999999999999999999874


Q ss_pred             ccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ...       .........||..|+|||++ ...++.++|||||||++|||+||+.||+.
T Consensus       146 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  198 (329)
T cd05588         146 GIR-------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             ccc-------CCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence            311       11122345689999999999 45689999999999999999999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.3e-39  Score=305.35  Aligned_cols=258  Identities=28%  Similarity=0.509  Sum_probs=197.3

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CC---CEEEEEEeeec-cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DG---ETAAIKVLKLQ-QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .+|...+.||+|+||.||+|... ++   ..||+|.++.. .......|..|+..+++++||||+++++++     ..+.
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~   78 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSR   78 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCC
Confidence            34678899999999999999864 33   36999998754 334457899999999999999999999985     4566


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+++++|.+++....      ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~d  149 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQND------GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSD  149 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECC
Confidence            7899999999999999987543      4589999999999999999999998   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeee
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~  389 (477)
                      ||++..........  ..........+..|+|||++ .+.++.++|||||||++||+++ |..||.......        
T Consensus       150 fg~~~~~~~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~--------  219 (269)
T cd05065         150 FGLSRFLEDDTSDP--TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--------  219 (269)
T ss_pred             CccccccccCcccc--ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH--------
Confidence            99987653211110  01111111224579999999 5678999999999999999887 999986432110        


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                            ..+.+......                        ....+++..+.+++.+|++.+|++||++.+|+..|+++
T Consensus       220 ------~~~~i~~~~~~------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         220 ------VINAIEQDYRL------------------------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ------HHHHHHcCCcC------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                  11111000000                        00011234478999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-39  Score=306.10  Aligned_cols=250  Identities=23%  Similarity=0.325  Sum_probs=193.2

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      +|+..+.||+|+||.||++... +++.||+|++....   ......+.+|+.++.+++||||+++++++     ..++..
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence            4778899999999999999864 68999999987432   22234678899999999999999999885     456689


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||+++|+|.+++....     ...+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|||
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg  147 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNMG-----NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLG  147 (285)
T ss_pred             EEEEeccCCCcHHHHHHhcC-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCC
Confidence            99999999999998886432     14589999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccC
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMAL  392 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  392 (477)
                      ++.....        ........|+..|+|||++ ...++.++|||||||++|||++|+.||.......           
T Consensus       148 ~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-----------  208 (285)
T cd05605         148 LAVEIPE--------GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-----------  208 (285)
T ss_pred             CceecCC--------CCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-----------
Confidence            9976521        1112234688999999999 5668999999999999999999999996522110           


Q ss_pred             CchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC-----ChHHHHH
Q 043902          393 PSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRV-----GMKFVVN  463 (477)
Q Consensus       393 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  463 (477)
                        ...++ .......  .                   ..........+.+++.+|++.||++||     +++++++
T Consensus       209 --~~~~~-~~~~~~~--~-------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         209 --KREEV-ERRVKED--Q-------------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             --HHHHH-HHHhhhc--c-------------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence              00000 0000000  0                   000011133478999999999999999     7888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=5.9e-39  Score=309.47  Aligned_cols=192  Identities=26%  Similarity=0.425  Sum_probs=161.1

Q ss_pred             CeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCCceeeEEE
Q 043902          163 NLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGNDFKALVF  237 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  237 (477)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|..++... +||||+++++++     ...+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            46999999999999875 68899999998542   23335566677777654 899999999885     5567899999


Q ss_pred             eecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          238 EFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       238 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      ||+++|+|..++...       ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        76 e~~~gg~L~~~~~~~-------~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~  145 (316)
T cd05592          76 EYLNGGDLMFHIQSS-------GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKE  145 (316)
T ss_pred             cCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeE
Confidence            999999999988654       4588999999999999999999998   999999999999999999999999999975


Q ss_pred             ccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ...       .........||..|+|||++ ...++.++|||||||++|||++|+.||..
T Consensus       146 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~  198 (316)
T cd05592         146 NMN-------GEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG  198 (316)
T ss_pred             CCC-------CCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC
Confidence            421       11223345689999999999 45689999999999999999999999965

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.7e-39  Score=319.01  Aligned_cols=204  Identities=22%  Similarity=0.352  Sum_probs=169.1

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .|+..+.||+|+||.||+|+.. +++.||+|+++...   ......+.+|++++.+++||||+++++++     .+.+..
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCEE
Confidence            5788899999999999999864 68899999997532   33446788999999999999999999985     556789


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||+++|+|.+++...       ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        77 ~lv~E~~~gg~L~~~l~~~-------~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFG  146 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIRM-------EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFG  146 (381)
T ss_pred             EEEEecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCc
Confidence            9999999999999998754       4588899999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCC----------------------------------------CCCccccCCCcccccccCcccc-cCCCC
Q 043902          314 LAKFLFEESNTP----------------------------------------SKNQTMSNGLKGSVGYIPPEYI-NGHVS  352 (477)
Q Consensus       314 ~a~~~~~~~~~~----------------------------------------~~~~~~~~~~~gt~~y~aPE~~-~~~~~  352 (477)
                      +++.........                                        ...........||..|+|||++ ...++
T Consensus       147 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~  226 (381)
T cd05626         147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT  226 (381)
T ss_pred             CCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC
Confidence            986431100000                                        0000011235699999999999 55689


Q ss_pred             cccceeehHHHHHHHhhCCCCCCc
Q 043902          353 ILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       353 ~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      .++|||||||++|||+||+.||..
T Consensus       227 ~~~DiwSlG~il~elltG~~Pf~~  250 (381)
T cd05626         227 QLCDWWSVGVILFEMLVGQPPFLA  250 (381)
T ss_pred             CccceeehhhHHHHHHhCCCCCcC
Confidence            999999999999999999999965

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.2e-39  Score=319.17  Aligned_cols=264  Identities=25%  Similarity=0.428  Sum_probs=199.8

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC------CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCC-CCCcceeeeecccccC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQQ-QGALKSFIDECNALTSIR-HRNILKIVSSCSSVDY  227 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~  227 (477)
                      .++|...+.||+|+||.||+|++.      .+..||+|+++... ....+.+.+|++++.++. ||||++++++|     
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~-----  110 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC-----  110 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE-----
Confidence            456778899999999999999863      34689999998543 233457889999999997 99999999997     


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCcc---------------------------------------------------
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDEY---------------------------------------------------  256 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~---------------------------------------------------  256 (477)
                      ...+..++||||+++|+|.++++......                                                   
T Consensus       111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence            34567899999999999999996532100                                                   


Q ss_pred             ----------------------------------------cccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCC
Q 043902          257 ----------------------------------------CHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKS  296 (477)
Q Consensus       257 ----------------------------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp  296 (477)
                                                              .....+++..++.++.|++.||.|||+.   +++||||||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp  267 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAA  267 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCc
Confidence                                                    1113578888999999999999999998   999999999


Q ss_pred             CCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCC
Q 043902          297 SNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPT  374 (477)
Q Consensus       297 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~  374 (477)
                      +||++++++.+||+|||+++.......     ........++..|+|||.+ .+.++.++|||||||++|||++ |..||
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~  342 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSN-----YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY  342 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccc-----cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999986522111     1112233467889999998 5568999999999999999998 88898


Q ss_pred             CcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCC
Q 043902          375 DDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRD  454 (477)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~  454 (477)
                      .......             .....+.......             .|           ..+...+.+++.+||..+|.+
T Consensus       343 ~~~~~~~-------------~~~~~~~~~~~~~-------------~p-----------~~~~~~l~~li~~cl~~~P~~  385 (401)
T cd05107         343 PELPMNE-------------QFYNAIKRGYRMA-------------KP-----------AHASDEIYEIMQKCWEEKFEI  385 (401)
T ss_pred             CCCCchH-------------HHHHHHHcCCCCC-------------CC-----------CCCCHHHHHHHHHHcCCChhH
Confidence            5431111             0111111110000             00           011234889999999999999


Q ss_pred             CCChHHHHHHHHHHH
Q 043902          455 RVGMKFVVNNLQAIR  469 (477)
Q Consensus       455 RPs~~evl~~L~~i~  469 (477)
                      ||+++||++.|+++.
T Consensus       386 RPs~~ell~~L~~~~  400 (401)
T cd05107         386 RPDFSQLVHLVGDLL  400 (401)
T ss_pred             CcCHHHHHHHHHHHh
Confidence            999999999998864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2e-39  Score=305.43  Aligned_cols=256  Identities=25%  Similarity=0.473  Sum_probs=197.4

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-C---CCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-D---GETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .+|.+.+.||+|+||.||+|... +   +..+|+|.++... ....+.+.+|+.++.+++||||+++++++     ..++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   78 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSK   78 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCC
Confidence            56788899999999999999863 2   3379999887543 33456889999999999999999999986     4566


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+++++|.+++....      ..+++.+++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~d  149 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKHD------GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSD  149 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCC
Confidence            7899999999999999997543      4589999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeee
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~  389 (477)
                      ||++........    .........++..|+|||++ .+.++.++|||||||++||+++ |..||......+.       
T Consensus       150 fg~~~~~~~~~~----~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~-------  218 (267)
T cd05066         150 FGLSRVLEDDPE----AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV-------  218 (267)
T ss_pred             CCcccccccccc----eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH-------
Confidence            999987632111    11111222345689999999 4578999999999999999887 9999865321110       


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                            ...+.+. ..         .      +.         ...++..+.+++.+|++.+|.+||+|.++++.|+++
T Consensus       219 ------~~~~~~~-~~---------~------~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         219 ------IKAIEEG-YR---------L------PA---------PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ------HHHHhCC-Cc---------C------CC---------CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                  0000000 00         0      00         001133478999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.4e-39  Score=305.41  Aligned_cols=256  Identities=22%  Similarity=0.390  Sum_probs=199.1

Q ss_pred             cCCCCCCeeeeeccceEEEEEeCC----CCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLAD----GETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      ++|...+.||+|+||.||+|...+    ...|++|...... ....+.+.+|+.++++++||||++++++|.      ..
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~------~~   79 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT------EN   79 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc------CC
Confidence            457788999999999999998643    3468999887554 344568999999999999999999999863      24


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+++|+|.+++....      ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d  150 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNK------YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGD  150 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEcc
Confidence            4689999999999999997542      3589999999999999999999998   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeee
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~  389 (477)
                      ||+++.....      .........++..|+|||.+ ...++.++||||||+++||+++ |..||........       
T Consensus       151 ~g~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-------  217 (270)
T cd05056         151 FGLSRYLEDE------SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-------  217 (270)
T ss_pred             Cceeeecccc------cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-------
Confidence            9999765321      11111223345689999998 4568999999999999999996 9999865322110       


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIR  469 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  469 (477)
                            ... +.....         .               .....++..+.+++.+|+..+|++|||+.++++.|++++
T Consensus       218 ------~~~-~~~~~~---------~---------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         218 ------IGR-IENGER---------L---------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             ------HHH-HHcCCc---------C---------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                  000 000000         0               000112345889999999999999999999999999987


Q ss_pred             Hh
Q 043902          470 SK  471 (477)
Q Consensus       470 ~~  471 (477)
                      .+
T Consensus       267 ~~  268 (270)
T cd05056         267 QE  268 (270)
T ss_pred             hc
Confidence            64

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5e-39  Score=316.02  Aligned_cols=200  Identities=22%  Similarity=0.347  Sum_probs=170.0

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      ..++|+..+.||+|+||.||+++.. +++.+|+|+++...   ......+.+|+.+++.++||||+++++++     ..+
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~  115 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDD  115 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcC
Confidence            4578999999999999999999975 68899999987422   22335678899999999999999999985     567


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +..++||||+++|+|.+++...        .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~~--------~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~  184 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMSNY--------DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLA  184 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEE
Confidence            7899999999999999998642        378889999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccccC-----CCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-----HVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |||++......      .........||+.|+|||++.+     .++.++|||||||++|||++|+.||..
T Consensus       185 DFG~a~~~~~~------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~  249 (370)
T cd05621         185 DFGTCMKMDET------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA  249 (370)
T ss_pred             ecccceecccC------CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence            99999865211      1112234569999999999832     378999999999999999999999965

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.3e-39  Score=303.99  Aligned_cols=260  Identities=24%  Similarity=0.400  Sum_probs=201.0

Q ss_pred             cCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ++|+..+.||+|+||.||+|.. .+++.++||.+....   ......+.+|+++++.++|+||+++++++     ..++.
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF-----IEDNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhhee-----EeCCe
Confidence            4678889999999999999985 478999999886432   23346788999999999999999999985     45667


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .+++|||+++++|.+++.....   ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+||
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df  150 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKK---QKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDL  150 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcc
Confidence            8999999999999998864221   124689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      |++......       ........++..|+|||++ ...++.++||||||+++|||++|..||.....+......     
T Consensus       151 g~~~~~~~~-------~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-----  218 (267)
T cd08229         151 GLGRFFSSK-------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK-----  218 (267)
T ss_pred             hhhhccccC-------CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh-----
Confidence            998765221       1112234578899999998 556889999999999999999999998542211000000     


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIR  469 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  469 (477)
                         .+.....                    +..       ....+...+.+++.+|++.||++||||.+|++.++++.
T Consensus       219 ---~~~~~~~--------------------~~~-------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         219 ---KIEQCDY--------------------PPL-------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             ---hhhcCCC--------------------CCC-------CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence               0000000                    000       00012344889999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.1e-39  Score=302.05  Aligned_cols=249  Identities=27%  Similarity=0.381  Sum_probs=197.1

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec--cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      +|+..+.||+|++|.||+|... +++.|++|.+...  .......+.+|++++++++|||++++++++     ...+..+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF-----LDKGKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee-----ccCCEEE
Confidence            4777889999999999999875 6899999998743  334457889999999999999999999985     4567899


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +||||+++++|.+++....     ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+
T Consensus        76 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~  147 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQR-----GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGV  147 (256)
T ss_pred             EEEEeCCCCcHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEccccc
Confidence            9999999999999997542     15688999999999999999999998   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCC
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      ++.....       ........|+..|+|||+. .+.++.++|||||||++|||+||+.||.......            
T Consensus       148 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------------  208 (256)
T cd08529         148 AKLLSDN-------TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA------------  208 (256)
T ss_pred             ceeccCc-------cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------------
Confidence            8865321       1112234578899999998 5668999999999999999999999996532110            


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                           .........             .+.+.        ......+.+++.+|++.+|++||++.++++.
T Consensus       209 -----~~~~~~~~~-------------~~~~~--------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         209 -----LILKIIRGV-------------FPPVS--------QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             -----HHHHHHcCC-------------CCCCc--------cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                 000000000             00000        0113448899999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.2e-39  Score=314.81  Aligned_cols=200  Identities=26%  Similarity=0.367  Sum_probs=169.9

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ++|...+.||+|+||.||+++.. +|+.||+|+++...   ....+.+.+|+.++..++|+||+++++++     ...+.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~   75 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDN   75 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCe
Confidence            46888999999999999999865 78999999998542   23346688899999999999999999885     55678


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++|+|.+++....      ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+||
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Df  146 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNRYE------DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADF  146 (330)
T ss_pred             EEEEECCCCCCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccC
Confidence            999999999999999997542      4589999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCccccc-------CCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-------GHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |++......      .........||..|+|||++.       +.++.++|||||||++|||++|+.||..
T Consensus       147 g~a~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~  211 (330)
T cd05601         147 GSAARLTAN------KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE  211 (330)
T ss_pred             CCCeECCCC------CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC
Confidence            999865221      111223346899999999983       2478899999999999999999999965

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.1e-39  Score=315.21  Aligned_cols=192  Identities=29%  Similarity=0.418  Sum_probs=163.7

Q ss_pred             CeeeeeccceEEEEEe----CCCCEEEEEEeeeccc--hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEE
Q 043902          163 NLIGSGSFGSVYKGTL----ADGETAAIKVLKLQQQ--GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALV  236 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  236 (477)
                      +.||+|+||.||+++.    .+|+.||+|+++....  .....+..|++++.+++||||+++++++     ..++..++|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEEE
Confidence            5799999999999874    3688999999985432  2335677899999999999999999985     556789999


Q ss_pred             EeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccc
Q 043902          237 FEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK  316 (477)
Q Consensus       237 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  316 (477)
                      |||+++|+|.+++...       ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        77 ~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  146 (318)
T cd05582          77 LDFLRGGDLFTRLSKE-------VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK  146 (318)
T ss_pred             EcCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCc
Confidence            9999999999998643       4589999999999999999999999   99999999999999999999999999987


Q ss_pred             cccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          317 FLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      .....       ........|+..|+|||.+ ...++.++|||||||++|||+||+.||..
T Consensus       147 ~~~~~-------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  200 (318)
T cd05582         147 ESIDH-------EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG  200 (318)
T ss_pred             ccCCC-------CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC
Confidence            64221       1122345689999999999 45689999999999999999999999965

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.3e-39  Score=308.58  Aligned_cols=258  Identities=27%  Similarity=0.444  Sum_probs=198.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC------CCCEEEEEEeeecc-chhhHHHHHHHHHHhcC-CCCCcceeeeecccccC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQQ-QGALKSFIDECNALTSI-RHRNILKIVSSCSSVDY  227 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  227 (477)
                      .++|...+.||+|+||.||++...      ++..||+|.++... ....+.+.+|+++++++ +||||++++++|     
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-----  108 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC-----  108 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE-----
Confidence            457889999999999999999742      34579999987543 33346789999999999 799999999986     


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcE
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIA  307 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~  307 (477)
                      ...+..++||||+++|+|.+++.....     ..+++.++..++.|++.||.|||++   +++|+||||+||+++.++.+
T Consensus       109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~  180 (302)
T cd05055         109 TIGGPILVITEYCCYGDLLNFLRRKRE-----SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIV  180 (302)
T ss_pred             ecCCceEEEEEcCCCCcHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeE
Confidence            445678999999999999999975431     3389999999999999999999998   99999999999999999999


Q ss_pred             EEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCccccccccee
Q 043902          308 HVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH  385 (477)
Q Consensus       308 kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~  385 (477)
                      +|+|||+++......     .........++..|+|||.+ .+.++.++|||||||++|||+| |..||.......    
T Consensus       181 ~l~dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~----  251 (302)
T cd05055         181 KICDFGLARDIMNDS-----NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS----  251 (302)
T ss_pred             EECCCcccccccCCC-----ceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH----
Confidence            999999997653211     11112223457789999988 5678999999999999999998 999986532110    


Q ss_pred             eeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHH
Q 043902          386 KFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNL  465 (477)
Q Consensus       386 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  465 (477)
                               .....++......             .+.           .....+.+++.+|++.+|++|||+.|+++.|
T Consensus       252 ---------~~~~~~~~~~~~~-------------~~~-----------~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l  298 (302)
T cd05055         252 ---------KFYKLIKEGYRMA-------------QPE-----------HAPAEIYDIMKTCWDADPLKRPTFKQIVQLI  298 (302)
T ss_pred             ---------HHHHHHHcCCcCC-------------CCC-----------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence                     1111111110000             000           0023488999999999999999999999999


Q ss_pred             HHH
Q 043902          466 QAI  468 (477)
Q Consensus       466 ~~i  468 (477)
                      +++
T Consensus       299 ~~~  301 (302)
T cd05055         299 GKQ  301 (302)
T ss_pred             Hhh
Confidence            874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-39  Score=303.04  Aligned_cols=249  Identities=27%  Similarity=0.455  Sum_probs=192.5

Q ss_pred             CeeeeeccceEEEEEeC--C--CCEEEEEEeeeccc-hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEE
Q 043902          163 NLIGSGSFGSVYKGTLA--D--GETAAIKVLKLQQQ-GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVF  237 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  237 (477)
                      +.||+|+||.||+|.+.  +  +..+|+|.++.... ...+.+.+|+++++++.|+|++++++++.      .+..++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence            46999999999999753  2  36899999875543 34567899999999999999999999852      34579999


Q ss_pred             eecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          238 EFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       238 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      ||+++|+|.+++...       ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+++.
T Consensus        75 e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~  144 (257)
T cd05060          75 ELAPLGPLLKYLKKR-------REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRA  144 (257)
T ss_pred             EeCCCCcHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccce
Confidence            999999999999754       3589999999999999999999998   999999999999999999999999999986


Q ss_pred             ccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCCch
Q 043902          318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALPSH  395 (477)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  395 (477)
                      ......    .........++..|+|||.+ .+.++.++|||||||++|||++ |..||.......              
T Consensus       145 ~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~--------------  206 (257)
T cd05060         145 LGAGSD----YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE--------------  206 (257)
T ss_pred             eecCCc----ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH--------------
Confidence            532111    11111222345689999998 5678999999999999999998 999986532111              


Q ss_pred             hHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHH
Q 043902          396 VMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIR  469 (477)
Q Consensus       396 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  469 (477)
                      +...+.......                        ....+...+.+++.+|+..+|++||++.++++.|+++.
T Consensus       207 ~~~~~~~~~~~~------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         207 VIAMLESGERLP------------------------RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             HHHHHHcCCcCC------------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            111111000000                        00011345889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5e-39  Score=311.30  Aligned_cols=197  Identities=27%  Similarity=0.371  Sum_probs=165.3

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec---cchhhHHHHHHHHHHhcCCCC-CcceeeeecccccCCCCce
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ---QQGALKSFIDECNALTSIRHR-NILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~~~~  232 (477)
                      +|+..+.||+|+||.||+|+.. +++.||+|+++..   .....+.+..|.+++..++|+ +|+++.+++     ...+.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence            4788899999999999999865 5789999999753   233456788899999999765 577777774     55678


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++|+|.+++...       ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Df  145 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQV-------GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADF  145 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeec
Confidence            99999999999999988654       4578999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |++.....       .........||..|+|||++ ...++.++|||||||++|||+||+.||..
T Consensus       146 g~~~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~  203 (324)
T cd05587         146 GMCKENIF-------GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG  203 (324)
T ss_pred             CcceecCC-------CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence            99864311       11122335689999999999 45689999999999999999999999965

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.8e-39  Score=310.69  Aligned_cols=192  Identities=29%  Similarity=0.409  Sum_probs=160.3

Q ss_pred             CeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHH-HHhcCCCCCcceeeeecccccCCCCceeeEEE
Q 043902          163 NLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECN-ALTSIRHRNILKIVSSCSSVDYEGNDFKALVF  237 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  237 (477)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+..|.. +++.++||||+++++++     ...+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence            46999999999999975 78999999997532   222344555554 56789999999999885     5567899999


Q ss_pred             eecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          238 EFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       238 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      ||+++|+|..++...       ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        76 e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~  145 (323)
T cd05575          76 DYVNGGELFFHLQRE-------RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKE  145 (323)
T ss_pred             cCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcc
Confidence            999999999988754       4588999999999999999999999   999999999999999999999999999875


Q ss_pred             ccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ...       .........||..|+|||++ ...++.++|||||||++|||++|+.||..
T Consensus       146 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~  198 (323)
T cd05575         146 GIE-------HSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS  198 (323)
T ss_pred             ccc-------CCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC
Confidence            321       11122345689999999999 55689999999999999999999999965

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=7.9e-39  Score=302.98  Aligned_cols=245  Identities=22%  Similarity=0.304  Sum_probs=186.4

Q ss_pred             eeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEeec
Q 043902          165 IGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFM  240 (477)
Q Consensus       165 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  240 (477)
                      ||+|+||.||+++.. +|+.||+|.+....   ......+..|++++.+++||||+++.+++     ..+...++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence            699999999999865 68999999986432   12234556799999999999999999885     5667899999999


Q ss_pred             CCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccccc
Q 043902          241 RNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFE  320 (477)
Q Consensus       241 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  320 (477)
                      ++++|.+++....     ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.....
T Consensus        76 ~g~~L~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~  147 (277)
T cd05607          76 NGGDLKYHIYNVG-----ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD  147 (277)
T ss_pred             CCCCHHHHHHhcc-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence            9999998886432     14588999999999999999999998   999999999999999999999999999876521


Q ss_pred             cCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCchhHHH
Q 043902          321 ESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDV  399 (477)
Q Consensus       321 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (477)
                              ........|+..|+|||++ .+.++.++|||||||++|||++|+.||.......             ...++
T Consensus       148 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-------------~~~~~  206 (277)
T cd05607         148 --------GKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-------------AKEEL  206 (277)
T ss_pred             --------CceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-------------hHHHH
Confidence                    1112234688999999998 5568999999999999999999999986421110             00011


Q ss_pred             hhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          400 LDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       400 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                      .........           ..+          .......+.+++..||+.||++||++.|+++.
T Consensus       207 ~~~~~~~~~-----------~~~----------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         207 KRRTLEDEV-----------KFE----------HQNFTEESKDICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             HHHhhcccc-----------ccc----------cccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence            110000000           000          00012347899999999999999999776643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.7e-39  Score=324.67  Aligned_cols=282  Identities=22%  Similarity=0.295  Sum_probs=193.2

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccC---CCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDY---EGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---~~~~  231 (477)
                      ..+|...+.||+|+||.||+|... +++.||||++....    ....+|+.++++++||||+++++++....+   ....
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            467999999999999999999864 68899999886432    234579999999999999999887533211   2233


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC-cEEEe
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM-IAHVG  310 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~  310 (477)
                      ..++||||+++ +|.+++.....   ....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++ .+||+
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~---~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~  213 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYAR---NNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLC  213 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeee
Confidence            57799999975 77776643211   125689999999999999999999999   999999999999998664 79999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~  388 (477)
                      |||+++.+...        .......||+.|+|||++.  ..++.++|||||||++|||+||.+||......+. +...+
T Consensus       214 DFGla~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~-~~~i~  284 (440)
T PTZ00036        214 DFGSAKNLLAG--------QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ-LVRII  284 (440)
T ss_pred             ccccchhccCC--------CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHH
Confidence            99999865221        1122346789999999883  3589999999999999999999999975321110 00000


Q ss_pred             ecc-CCc-hhHHHhhhhhhhhhcccccccccccccchhh-hHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH--
Q 043902          389 LMA-LPS-HVMDVLDLSMLLEEENDHEKHEEEDLFPDIE-SQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN--  463 (477)
Q Consensus       389 ~~~-~~~-~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--  463 (477)
                      ... .+. .......+...            +..++... .......+......+.+|+.+||+.||.+|||+.|+++  
T Consensus       285 ~~~~~p~~~~~~~~~~~~~------------~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp  352 (440)
T PTZ00036        285 QVLGTPTEDQLKEMNPNYA------------DIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP  352 (440)
T ss_pred             HHhCCCCHHHHHHhchhhh------------cccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence            000 000 00000000000            00000000 00111111112345889999999999999999999984  


Q ss_pred             HHHHHH
Q 043902          464 NLQAIR  469 (477)
Q Consensus       464 ~L~~i~  469 (477)
                      .++.++
T Consensus       353 ~f~~~~  358 (440)
T PTZ00036        353 FFDDLR  358 (440)
T ss_pred             hHHhhh
Confidence            444443

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-39  Score=317.24  Aligned_cols=205  Identities=24%  Similarity=0.369  Sum_probs=169.5

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ++|++.+.||+|+||.||++... +++.||+|++....   ......+.+|++++.+++||||+++++++     .+...
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~   75 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQY   75 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCe
Confidence            46888999999999999999864 78999999986432   23346788899999999999999999985     56778


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++|+|.+++...       ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~Df  145 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLIKY-------DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDF  145 (377)
T ss_pred             eEEEEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeec
Confidence            99999999999999998754       4588899999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCC----------CCC------------------------------ccccCCCcccccccCcccc-cCCC
Q 043902          313 GLAKFLFEESNTP----------SKN------------------------------QTMSNGLKGSVGYIPPEYI-NGHV  351 (477)
Q Consensus       313 G~a~~~~~~~~~~----------~~~------------------------------~~~~~~~~gt~~y~aPE~~-~~~~  351 (477)
                      |+++.+.......          ...                              ........||+.|+|||++ ...+
T Consensus       146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  225 (377)
T cd05629         146 GLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY  225 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC
Confidence            9996432110000          000                              0001124689999999999 5568


Q ss_pred             CcccceeehHHHHHHHhhCCCCCCc
Q 043902          352 SILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       352 ~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      +.++|||||||++|||+||+.||..
T Consensus       226 ~~~~DiwSlGvil~elltG~~Pf~~  250 (377)
T cd05629         226 GQECDWWSLGAIMFECLIGWPPFCS  250 (377)
T ss_pred             CCceeeEecchhhhhhhcCCCCCCC
Confidence            9999999999999999999999964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-39  Score=308.38  Aligned_cols=266  Identities=21%  Similarity=0.389  Sum_probs=195.2

Q ss_pred             cCCCCCCeeeeeccceEEEEEeCC---------------CCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLAD---------------GETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVS  220 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~  220 (477)
                      ++|++.+.||+|+||.||+++..+               ...||+|.++... ......+.+|++++.+++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578889999999999999987532               2358999987542 333467899999999999999999999


Q ss_pred             ecccccCCCCceeeEEEeecCCCChhhhcccCCCc-----ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCC
Q 043902          221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDE-----YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLK  295 (477)
Q Consensus       221 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk  295 (477)
                      ++     ......++||||+++++|.+++......     ......+++..++.++.|++.||.|||+.   +++|+|||
T Consensus        85 ~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlk  156 (295)
T cd05097          85 VC-----VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLA  156 (295)
T ss_pred             EE-----cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccC
Confidence            96     4556789999999999999998643210     01113478899999999999999999999   99999999


Q ss_pred             CCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh--CCC
Q 043902          296 SSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT--GKR  372 (477)
Q Consensus       296 p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt--g~~  372 (477)
                      |+||++++++.+||+|||++.......     .........++..|+|||.+ .+.++.++|||||||++|||++  |..
T Consensus       157 p~Nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~  231 (295)
T cd05097         157 TRNCLVGNHYTIKIADFGMSRNLYSGD-----YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQ  231 (295)
T ss_pred             hhhEEEcCCCcEEecccccccccccCc-----ceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCC
Confidence            999999999999999999997653211     11112233457789999988 6679999999999999999998  566


Q ss_pred             CCCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCC
Q 043902          373 PTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASP  452 (477)
Q Consensus       373 p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP  452 (477)
                      ||........ .         ....+..+......      .....               ..++..+.+++.+|++.||
T Consensus       232 p~~~~~~~~~-~---------~~~~~~~~~~~~~~------~~~~~---------------~~~~~~l~~li~~~l~~~p  280 (295)
T cd05097         232 PYSLLSDEQV-I---------ENTGEFFRNQGRQI------YLSQT---------------PLCPSPVFKLMMRCWSRDI  280 (295)
T ss_pred             CCcccChHHH-H---------HHHHHhhhhccccc------cCCCC---------------CCCCHHHHHHHHHHcCCCc
Confidence            7654221110 0         00000000000000      00000               0013458999999999999


Q ss_pred             CCCCChHHHHHHHH
Q 043902          453 RDRVGMKFVVNNLQ  466 (477)
Q Consensus       453 ~~RPs~~evl~~L~  466 (477)
                      ++|||+.+|++.|+
T Consensus       281 ~~RPs~~~i~~~l~  294 (295)
T cd05097         281 KDRPTFNKIHHFLR  294 (295)
T ss_pred             hhCcCHHHHHHHHh
Confidence            99999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.4e-39  Score=305.20  Aligned_cols=259  Identities=24%  Similarity=0.412  Sum_probs=196.4

Q ss_pred             CCCCCCeeeeeccceEEEEEeC------CCCEEEEEEeeeccch-hhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQQQG-ALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      +|...+.||+|+||.||+|...      ++..||+|+++..... ....+.+|+.++.+++||||+++++++     ...
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~~~   80 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV-----TKE   80 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----cCC
Confidence            4667788999999999999863      2578999999855432 346688999999999999999999996     445


Q ss_pred             ceeeEEEeecCCCChhhhcccCCC---------cccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTD---------EYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL  301 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll  301 (477)
                      ...++++||+++++|.+++.....         .......+++..++.++.|++.||.|||+.   +++||||||+||++
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~  157 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLV  157 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEe
Confidence            668999999999999999853211         011124588899999999999999999998   99999999999999


Q ss_pred             cCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccc
Q 043902          302 DEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFK  379 (477)
Q Consensus       302 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~  379 (477)
                      ++++.+||+|||+++......     .........++..|+|||.+ .+.++.++|||||||++|||+| |..||.....
T Consensus       158 ~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  232 (283)
T cd05091         158 FDKLNVKISDLGLFREVYAAD-----YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN  232 (283)
T ss_pred             cCCCceEecccccccccccch-----heeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            999999999999988653211     11112233457789999998 6778999999999999999998 8888754211


Q ss_pred             cccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChH
Q 043902          380 DDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMK  459 (477)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~  459 (477)
                      .              ...+.+.......                        ....++..+.+++..|++.+|++||+++
T Consensus       233 ~--------------~~~~~i~~~~~~~------------------------~~~~~~~~~~~li~~cl~~~p~~RP~~~  274 (283)
T cd05091         233 Q--------------DVIEMIRNRQVLP------------------------CPDDCPAWVYTLMLECWNEFPSRRPRFK  274 (283)
T ss_pred             H--------------HHHHHHHcCCcCC------------------------CCCCCCHHHHHHHHHHhCCCcccCCCHH
Confidence            1              0111110000000                        0012244588999999999999999999


Q ss_pred             HHHHHHHH
Q 043902          460 FVVNNLQA  467 (477)
Q Consensus       460 evl~~L~~  467 (477)
                      +|++.|+.
T Consensus       275 ~i~~~l~~  282 (283)
T cd05091         275 DIHSRLRT  282 (283)
T ss_pred             HHHHHhhC
Confidence            99999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-39  Score=304.09  Aligned_cols=254  Identities=27%  Similarity=0.533  Sum_probs=199.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      .++|.+.+.||+|+||.||+|...++..+|+|.++.... ..+.+.+|+..+++++|+|++++++++     ......++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~   78 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEEPIYI   78 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCCceEE
Confidence            467889999999999999999988888999999875433 346789999999999999999999985     44567899


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      ||||+++++|.+++.....     ..+++..+..++.|++.|+.|||+.   +++|+||||+||++++++.+||+|||.+
T Consensus        79 v~e~~~~~~L~~~i~~~~~-----~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~  150 (261)
T cd05034          79 VTEYMSKGSLLDFLKSGEG-----KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLA  150 (261)
T ss_pred             EEeccCCCCHHHHHhcccc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccc
Confidence            9999999999999976431     4589999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCC
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      ......      .........++..|+|||.+ .+.++.++|||||||++||++| |+.||.......            
T Consensus       151 ~~~~~~------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------------  212 (261)
T cd05034         151 RLIEDD------EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE------------  212 (261)
T ss_pred             eeccch------hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH------------
Confidence            765221      11111223345689999998 4568999999999999999999 999985432110            


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQA  467 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  467 (477)
                        ..+.+.......             .+           ..++..+.+++.+|++.+|++||+++++.+.|+.
T Consensus       213 --~~~~~~~~~~~~-------------~~-----------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         213 --VLEQVERGYRMP-------------RP-----------PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             --HHHHHHcCCCCC-------------CC-----------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence              011110000000             00           0012348899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5.2e-39  Score=307.21  Aligned_cols=250  Identities=22%  Similarity=0.301  Sum_probs=196.9

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ...+|+..+.||+|+||.||+|.. .+++.|++|.+..........+.+|+.+++.++|+|++++++.+     ......
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~-----~~~~~~   92 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDEL   92 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEE-----EeCCEE
Confidence            346888999999999999999985 47899999999876555557889999999999999999999986     346689


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||+++++|.+++..        ..+++.++..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        93 ~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg  161 (296)
T cd06654          93 WVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG  161 (296)
T ss_pred             EEeecccCCCCHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccc
Confidence            999999999999999863        2478899999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccC
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMAL  392 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  392 (477)
                      ++......       ........++..|+|||.+ ...++.++|||||||++|+|++|+.||........ +...     
T Consensus       162 ~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~~~-----  228 (296)
T cd06654         162 FCAQITPE-------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLI-----  228 (296)
T ss_pred             cchhcccc-------ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HHHH-----
Confidence            98764221       1112234578899999998 55688999999999999999999999965321110 0000     


Q ss_pred             CchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          393 PSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       393 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                            .......               .+         ..+.....+.+++.+|+..+|++|||+.|+++
T Consensus       229 ------~~~~~~~---------------~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         229 ------ATNGTPE---------------LQ---------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             ------hcCCCCC---------------CC---------CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence                  0000000               00         00011234788999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=7.4e-39  Score=308.81  Aligned_cols=192  Identities=26%  Similarity=0.426  Sum_probs=161.9

Q ss_pred             CeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCCceeeEEE
Q 043902          163 NLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGNDFKALVF  237 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  237 (477)
                      +.||+|+||.||+|+.. +|+.||+|+++...   ......+..|..++... +||||+++++++     ...+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence            46999999999999975 68899999998542   23345667788888754 899999999985     5667899999


Q ss_pred             eecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          238 EFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       238 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      ||+++|+|..++...       ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        76 E~~~~g~L~~~i~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~  145 (316)
T cd05620          76 EFLNGGDLMFHIQDK-------GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKE  145 (316)
T ss_pred             CCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCee
Confidence            999999999988653       4588999999999999999999999   999999999999999999999999999874


Q ss_pred             ccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ...       .........||..|+|||++ ...++.++|||||||++|||++|+.||..
T Consensus       146 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~  198 (316)
T cd05620         146 NVF-------GDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG  198 (316)
T ss_pred             ccc-------CCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence            311       11122345689999999999 55689999999999999999999999964

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-39  Score=307.13  Aligned_cols=260  Identities=22%  Similarity=0.429  Sum_probs=199.2

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC------CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYE  228 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  228 (477)
                      .++|.+.+.||+|+||.||+|...      ++..||+|.+.... ......+.+|+.++.+++|+||+++++++     .
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~   79 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S   79 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----c
Confidence            457888899999999999999864      24689999987443 23346788999999999999999999996     4


Q ss_pred             CCceeeEEEeecCCCChhhhcccCCCcc---cccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC
Q 043902          229 GNDFKALVFEFMRNGNLDQWLHPSTDEY---CHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM  305 (477)
Q Consensus       229 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~  305 (477)
                      .....++||||+++|+|.+++.......   .....+++..++.++.|++.||.|||+.   +++||||||+||+++.++
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~  156 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDL  156 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCC
Confidence            4577899999999999999996543211   1224578999999999999999999998   999999999999999999


Q ss_pred             cEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccc
Q 043902          306 IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLS  383 (477)
Q Consensus       306 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~  383 (477)
                      .+||+|||+++......     .........++..|+|||.+ .+.++.++|||||||++||++| |+.||.......  
T Consensus       157 ~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--  229 (277)
T cd05032         157 TVKIGDFGMTRDIYETD-----YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--  229 (277)
T ss_pred             CEEECCcccchhhccCc-----ccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH--
Confidence            99999999997653211     11112233467889999998 5678999999999999999998 999986422111  


Q ss_pred             eeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          384 IHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       384 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                                  ..+.+.......             .|           ..++..+.+++.+|++.+|++|||+.|+++
T Consensus       230 ------------~~~~~~~~~~~~-------------~~-----------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         230 ------------VLKFVIDGGHLD-------------LP-----------ENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             ------------HHHHHhcCCCCC-------------CC-----------CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                        111111000000             00           011344889999999999999999999999


Q ss_pred             HHH
Q 043902          464 NLQ  466 (477)
Q Consensus       464 ~L~  466 (477)
                      .|+
T Consensus       274 ~l~  276 (277)
T cd05032         274 SLK  276 (277)
T ss_pred             Hhc
Confidence            886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=7.7e-39  Score=309.83  Aligned_cols=197  Identities=25%  Similarity=0.366  Sum_probs=165.7

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCCce
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      +|...+.||+|+||.||+|+.. +++.||+|+++...   ......+..|..++..+ +|++|+++++++     ...+.
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence            4778899999999999999865 67899999998542   22334567788888877 578899998885     55678


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++|+|.+++...       ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~Df  145 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQV-------GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADF  145 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccC
Confidence            99999999999999988654       4588999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |+++....       .........||+.|+|||++ .+.++.++|||||||++|||+||+.||..
T Consensus       146 G~~~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~  203 (323)
T cd05616         146 GMCKENMW-------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG  203 (323)
T ss_pred             CCceecCC-------CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC
Confidence            99875321       11122345689999999999 55689999999999999999999999965

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=5.1e-39  Score=315.79  Aligned_cols=202  Identities=26%  Similarity=0.290  Sum_probs=166.5

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec--cchhhHHHHHHHHHHhcCCCCCcceeeeeccccc-CCCC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSSCSSVD-YEGN  230 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~~  230 (477)
                      ..++|+..+.||+|+||.||++... +|..||+|+++..  .......+.+|+.++..++||||+++++++.... ....
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578999999999999999999864 6899999998743  2334467889999999999999999999864321 1223


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ...++||||+++ +|.+.+.         ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~---------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~  165 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL  165 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh---------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEe
Confidence            457999999965 6666654         2378888999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      |||+++....        ........||..|+|||.+ ...++.++|||||||++|||+||+.||...
T Consensus       166 Dfg~a~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~  225 (359)
T cd07876         166 DFGLARTACT--------NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT  225 (359)
T ss_pred             cCCCcccccc--------CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            9999975421        1122345689999999999 456899999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.6e-39  Score=310.26  Aligned_cols=266  Identities=25%  Similarity=0.427  Sum_probs=200.7

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC--------CCCEEEEEEeeecc-chhhHHHHHHHHHHhcC-CCCCcceeeeecccc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA--------DGETAAIKVLKLQQ-QGALKSFIDECNALTSI-RHRNILKIVSSCSSV  225 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  225 (477)
                      .++|.+.+.||+|+||.||+|+..        ....+|+|.++... ......+.+|++++.++ +||||++++++|   
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~---   87 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC---   87 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE---
Confidence            357888999999999999999742        24579999987543 33456788999999999 699999999986   


Q ss_pred             cCCCCceeeEEEeecCCCChhhhcccCCCc---------ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCC
Q 043902          226 DYEGNDFKALVFEFMRNGNLDQWLHPSTDE---------YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKS  296 (477)
Q Consensus       226 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp  296 (477)
                        ......++||||+++|+|.+++......         ......+++..+..++.|++.||.|||++   +++||||||
T Consensus        88 --~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp  162 (314)
T cd05099          88 --TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAA  162 (314)
T ss_pred             --ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence              3456789999999999999999754210         01124589999999999999999999998   999999999


Q ss_pred             CCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCC
Q 043902          297 SNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPT  374 (477)
Q Consensus       297 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~  374 (477)
                      +||+++.++.+||+|||+++.......     ........++..|+|||.+ .+.++.++|||||||++|||++ |..||
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~  237 (314)
T cd05099         163 RNVLVTEDNVMKIADFGLARGVHDIDY-----YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY  237 (314)
T ss_pred             eeEEEcCCCcEEEcccccccccccccc-----ccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCC
Confidence            999999999999999999986532110     1111122345679999998 5668999999999999999999 88888


Q ss_pred             CcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCC
Q 043902          375 DDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRD  454 (477)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~  454 (477)
                      ......              .+.+.+.......                        ....+...+.+++.+|++.+|++
T Consensus       238 ~~~~~~--------------~~~~~~~~~~~~~------------------------~~~~~~~~l~~li~~cl~~~p~~  279 (314)
T cd05099         238 PGIPVE--------------ELFKLLREGHRMD------------------------KPSNCTHELYMLMRECWHAVPTQ  279 (314)
T ss_pred             CCCCHH--------------HHHHHHHcCCCCC------------------------CCCCCCHHHHHHHHHHcCCCccc
Confidence            543211              1111111000000                        00011334789999999999999


Q ss_pred             CCChHHHHHHHHHHHHhh
Q 043902          455 RVGMKFVVNNLQAIRSKI  472 (477)
Q Consensus       455 RPs~~evl~~L~~i~~~~  472 (477)
                      |||+.|+++.|+++....
T Consensus       280 Rps~~~ll~~l~~~~~~~  297 (314)
T cd05099         280 RPTFKQLVEALDKVLAAV  297 (314)
T ss_pred             CcCHHHHHHHHHHHHHHh
Confidence            999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=7.9e-39  Score=300.49  Aligned_cols=254  Identities=26%  Similarity=0.460  Sum_probs=190.3

Q ss_pred             CeeeeeccceEEEEEeC----CCCEEEEEEeeec-cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEE
Q 043902          163 NLIGSGSFGSVYKGTLA----DGETAAIKVLKLQ-QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVF  237 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  237 (477)
                      +.||+|+||.||+|...    ++..+|+|.+... .....+.+.+|+.+++.++|||+++++++|.    ..+...++|+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICL----PSEGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEee----cCCCCcEEEE
Confidence            46899999999999853    2457999988643 2344578889999999999999999999863    3445678999


Q ss_pred             eecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          238 EFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       238 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      ||+.+|+|.+++....      ...++..++.++.|++.||.|||+.   +++||||||+||++++++.+||+|||+++.
T Consensus        77 e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~  147 (262)
T cd05058          77 PYMKHGDLRNFIRSET------HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARD  147 (262)
T ss_pred             ecCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCcccccc
Confidence            9999999999997543      3467788899999999999999998   999999999999999999999999999976


Q ss_pred             ccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhC-CCCCCcccccccceeeeeeccCCch
Q 043902          318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTG-KRPTDDMFKDDLSIHKFVLMALPSH  395 (477)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~  395 (477)
                      .......   .........++..|+|||.+ .+.++.++|||||||++|||++| .+||......              .
T Consensus       148 ~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~--------------~  210 (262)
T cd05058         148 IYDKEYY---SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF--------------D  210 (262)
T ss_pred             ccCCcce---eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH--------------H
Confidence            5321100   01111233457789999998 56789999999999999999995 5555432110              0


Q ss_pred             hHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHH
Q 043902          396 VMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRS  470 (477)
Q Consensus       396 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  470 (477)
                      ....+   ....      ..    ..+           +.++..+.+++..||+.+|++||++.||++.|+++..
T Consensus       211 ~~~~~---~~~~------~~----~~~-----------~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         211 ITVYL---LQGR------RL----LQP-----------EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             HHHHH---hcCC------CC----CCC-----------CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            00000   0000      00    000           0112348899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=8.7e-39  Score=308.21  Aligned_cols=192  Identities=26%  Similarity=0.430  Sum_probs=161.6

Q ss_pred             CeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCCceeeEEE
Q 043902          163 NLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGNDFKALVF  237 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  237 (477)
                      +.||+|+||.||+|+.. +++.||+|+++...   ......+..|..++... +||||+++++++     .+.+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence            46999999999999975 57899999998542   23345667788888764 899999999985     5567899999


Q ss_pred             eecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          238 EFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       238 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      ||+++|+|.+++...       ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        76 ey~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~  145 (316)
T cd05619          76 EYLNGGDLMFHIQSC-------HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKE  145 (316)
T ss_pred             eCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceE
Confidence            999999999998753       4588999999999999999999999   999999999999999999999999999875


Q ss_pred             ccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ...       .........||..|+|||++ ...++.++|||||||++|||++|+.||..
T Consensus       146 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~  198 (316)
T cd05619         146 NML-------GDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG  198 (316)
T ss_pred             CCC-------CCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence            311       11122345689999999999 45689999999999999999999999965

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.1e-38  Score=303.90  Aligned_cols=262  Identities=21%  Similarity=0.407  Sum_probs=198.0

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC------CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDY  227 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  227 (477)
                      ..++|++.+.||+|+||.||+|..+      .+..||+|.++... ......+.+|+..+++++||||+++++++     
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----   78 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV-----   78 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence            4578999999999999999999753      24589999886443 22335688999999999999999999985     


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCc---ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDE---YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG  304 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~  304 (477)
                      ......++||||+++|+|.+++......   .......++..+..++.|++.||.|||++   +++||||||+||+++++
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~  155 (288)
T cd05061          79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD  155 (288)
T ss_pred             cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCC
Confidence            4456789999999999999999753211   11124567788999999999999999998   99999999999999999


Q ss_pred             CcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCccccccc
Q 043902          305 MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL  382 (477)
Q Consensus       305 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~  382 (477)
                      +.++|+|||+++.......     ........++..|+|||.+ .+.++.++|||||||++|||++ |..||.....++ 
T Consensus       156 ~~~~L~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-  229 (288)
T cd05061         156 FTVKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-  229 (288)
T ss_pred             CcEEECcCCcccccccccc-----ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence            9999999999986532111     1111222356789999998 5678999999999999999999 788886422111 


Q ss_pred             ceeeeeeccCCchhHH-HhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHH
Q 043902          383 SIHKFVLMALPSHVMD-VLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFV  461 (477)
Q Consensus       383 ~~~~~~~~~~~~~~~~-~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev  461 (477)
                                   +.+ +.+.....                         ..+.+...+.+++.+|++.||++|||+.|+
T Consensus       230 -------------~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l  271 (288)
T cd05061         230 -------------VLKFVMDGGYLD-------------------------QPDNCPERVTDLMRMCWQFNPKMRPTFLEI  271 (288)
T ss_pred             -------------HHHHHHcCCCCC-------------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence                         111 11000000                         000113458899999999999999999999


Q ss_pred             HHHHHHH
Q 043902          462 VNNLQAI  468 (477)
Q Consensus       462 l~~L~~i  468 (477)
                      ++.|++.
T Consensus       272 l~~l~~~  278 (288)
T cd05061         272 VNLLKDD  278 (288)
T ss_pred             HHHHHhh
Confidence            9988764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5.9e-39  Score=316.76  Aligned_cols=203  Identities=24%  Similarity=0.333  Sum_probs=166.8

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec--cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      +|+..+.||+|+||.||++... +|+.||+|.+...  .....+.+.+|++++..++|+||+++++++...........+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788899999999999999864 7899999998643  223446788999999999999999999987532222223689


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +|+||+. ++|.+++...       ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+
T Consensus        81 lv~e~~~-~~l~~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~  149 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP-------QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGL  149 (372)
T ss_pred             EEeeccc-cCHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccc
Confidence            9999996 5888877543       4589999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccccC--CCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      ++.....      .........++..|+|||.+.+  .++.++|||||||++|||++|+.||...
T Consensus       150 a~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  208 (372)
T cd07853         150 ARVEEPD------ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ  208 (372)
T ss_pred             eeecccC------ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC
Confidence            9764221      1112233457889999999843  4789999999999999999999999753

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.2e-38  Score=304.62  Aligned_cols=196  Identities=28%  Similarity=0.420  Sum_probs=168.4

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      ++|++.+.||+|+||.||++... ++..+|+|.++... ......+.+|++++.+++||||++++++|     ..++..+
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   75 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF-----YSDGEIS   75 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCEEE
Confidence            46888999999999999999865 68889999987543 23346688999999999999999999986     4567899


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN-QYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      +||||+++++|.+++...       ..+++..+..++.|+++||.|||+ .   +++|+||||+||+++.++.+||+|||
T Consensus        76 lv~ey~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg  145 (308)
T cd06615          76 ICMEHMDGGSLDQVLKKA-------GRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFG  145 (308)
T ss_pred             EEeeccCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCC
Confidence            999999999999999754       457899999999999999999997 5   89999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ++.....         .......++..|+|||.+ ...++.++|||||||++|||+||+.||..
T Consensus       146 ~~~~~~~---------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~  200 (308)
T cd06615         146 VSGQLID---------SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP  200 (308)
T ss_pred             Ccccccc---------cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence            9875421         112335678999999998 44689999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=5e-39  Score=303.56  Aligned_cols=257  Identities=24%  Similarity=0.324  Sum_probs=196.6

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcC-CCCCcceeeeecccccCC-CC
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYE-GN  230 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~-~~  230 (477)
                      .+++.|+..+.||+|+||.||+|... +++.||+|++..... ....+..|+.++.++ +|+|++++++++...... ..
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            45678889999999999999999865 688999999875433 336788999999998 699999999997543211 13


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ...++||||+++++|.+++....     ...+++..+..++.|++.||+|||+.   +|+|+||||+||++++++.++|+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~  153 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTK-----GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV  153 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEc
Confidence            56899999999999999987542     14588999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCccccc------CCCCcccceeehHHHHHHHhhCCCCCCcccccccce
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN------GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSI  384 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~  384 (477)
                      |||++.....       .........|+..|+|||++.      ..++.++|||||||++|||++|+.||........  
T Consensus       154 Dfg~~~~~~~-------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~--  224 (272)
T cd06637         154 DFGVSAQLDR-------TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA--  224 (272)
T ss_pred             cCCCceeccc-------ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH--
Confidence            9999876421       111223456889999999983      2478899999999999999999999864321100  


Q ss_pred             eeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          385 HKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       385 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                                 ... . ....    ..      . ..+           ..+...+.+++.+||..||.+|||+.|+++
T Consensus       225 -----------~~~-~-~~~~----~~------~-~~~-----------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         225 -----------LFL-I-PRNP----AP------R-LKS-----------KKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             -----------HHH-H-hcCC----CC------C-CCC-----------CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence                       000 0 0000    00      0 000           001234789999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5.5e-39  Score=301.27  Aligned_cols=253  Identities=25%  Similarity=0.505  Sum_probs=198.1

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      .++|...+.||+|+||.||+|...++..+++|.++... ...+.+.+|++++++++|+|++++.+++.     . ...++
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~-~~~~~   77 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-----K-EPIYI   77 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEc-----C-CCeEE
Confidence            46788899999999999999998778889999887543 23467899999999999999999998853     2 56799


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      +|||+++++|.+++.....     ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||.+
T Consensus        78 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~  149 (260)
T cd05073          78 ITEFMAKGSLLDFLKSDEG-----SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLA  149 (260)
T ss_pred             EEEeCCCCcHHHHHHhCCc-----cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcce
Confidence            9999999999999975421     4578899999999999999999998   9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCC
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      ......      .........++..|+|||++ .+.++.++|+|||||++|+++| |+.||.......            
T Consensus       150 ~~~~~~------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~------------  211 (260)
T cd05073         150 RVIEDN------EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE------------  211 (260)
T ss_pred             eeccCC------CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH------------
Confidence            765221      11112233456789999999 5568999999999999999999 899986432111            


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQA  467 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  467 (477)
                        ....+.......                        .....+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus       212 --~~~~~~~~~~~~------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         212 --VIRALERGYRMP------------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             --HHHHHhCCCCCC------------------------CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence              011110000000                        000113348899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.2e-38  Score=300.44  Aligned_cols=254  Identities=24%  Similarity=0.392  Sum_probs=194.7

Q ss_pred             HHhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          153 SNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       153 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      ..+++++.....||+|+||.||+|... ++..|++|.+........+.+.+|+.++++++|+||+++++++     ..++
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~   78 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD-----SENG   78 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeee-----ccCC
Confidence            345666667789999999999999854 6788999998866555567899999999999999999999986     4557


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccC--CHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC-CCcEE
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKL--SLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE-GMIAH  308 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~k  308 (477)
                      ..++|+||+++++|.+++....      ..+  ++..+..++.|++.||.|||+.   +|+||||||+||+++. ++.++
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~  149 (268)
T cd06624          79 FFKIFMEQVPGGSLSALLRSKW------GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVK  149 (268)
T ss_pred             EEEEEEecCCCCCHHHHHHHhc------ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEE
Confidence            7899999999999999997542      234  7888899999999999999998   9999999999999976 67999


Q ss_pred             EecccccccccccCCCCCCCccccCCCcccccccCccccc-C--CCCcccceeehHHHHHHHhhCCCCCCccccccccee
Q 043902          309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-G--HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIH  385 (477)
Q Consensus       309 l~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~--~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~  385 (477)
                      |+|||.+......       ........++..|+|||++. +  .++.++||||||+++|+|++|+.||.......... 
T Consensus       150 l~dfg~~~~~~~~-------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~-  221 (268)
T cd06624         150 ISDFGTSKRLAGI-------NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM-  221 (268)
T ss_pred             EecchhheecccC-------CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH-
Confidence            9999998765211       11122335788999999983 3  37899999999999999999999986422111000 


Q ss_pred             eeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          386 KFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       386 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                                    ........             .+.+        ...+...+.+++.+|++.+|++|||+.|+++
T Consensus       222 --------------~~~~~~~~-------------~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         222 --------------FKVGMFKI-------------HPEI--------PESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             --------------hhhhhhcc-------------CCCC--------CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence                          00000000             0000        0011234788999999999999999999975

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.3e-38  Score=301.90  Aligned_cols=194  Identities=24%  Similarity=0.375  Sum_probs=162.9

Q ss_pred             eeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEeec
Q 043902          165 IGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFM  240 (477)
Q Consensus       165 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  240 (477)
                      ||+|+||.||++... +|+.||+|.+....   ....+.+..|++++++++|+||+++.+++     ......++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence            699999999999865 78999999987432   22335678899999999999999999885     5567799999999


Q ss_pred             CCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccccc
Q 043902          241 RNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFE  320 (477)
Q Consensus       241 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  320 (477)
                      ++|+|..++.....   ....+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        76 ~~g~L~~~~~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  149 (280)
T cd05608          76 NGGDLRYHIYNVDE---ENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKD  149 (280)
T ss_pred             CCCCHHHHHHhccc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence            99999988753221   124689999999999999999999999   999999999999999999999999999976522


Q ss_pred             cCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          321 ESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       321 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      .       ........||..|+|||.+ .+.++.++|||||||++|||++|+.||..
T Consensus       150 ~-------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  199 (280)
T cd05608         150 G-------QSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA  199 (280)
T ss_pred             C-------CccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence            1       1122345689999999999 56789999999999999999999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.2e-38  Score=313.43  Aligned_cols=205  Identities=24%  Similarity=0.362  Sum_probs=171.1

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ++|+..+.||+|+||.||+|... +++.||+|+++...   ......+.+|+.++.+++|+||+++++.+     .+...
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence            47889999999999999999865 68999999997532   23345678899999999999999999985     56678


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++|+|.+++...       ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DF  145 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMKK-------DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDF  145 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeec
Confidence            99999999999999999754       4589999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCC----------------------------CCccccCCCcccccccCcccc-cCCCCcccceeehHHH
Q 043902          313 GLAKFLFEESNTPS----------------------------KNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGIL  363 (477)
Q Consensus       313 G~a~~~~~~~~~~~----------------------------~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvv  363 (477)
                      |+++..........                            ..........||..|+|||++ ...++.++|||||||+
T Consensus       146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvi  225 (363)
T cd05628         146 GLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI  225 (363)
T ss_pred             cCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHH
Confidence            99975422110000                            000011245799999999999 5568999999999999


Q ss_pred             HHHHhhCCCCCCc
Q 043902          364 LLEIFTGKRPTDD  376 (477)
Q Consensus       364 l~elltg~~p~~~  376 (477)
                      +|||++|+.||..
T Consensus       226 l~ell~G~~Pf~~  238 (363)
T cd05628         226 MYEMLIGYPPFCS  238 (363)
T ss_pred             HHHHHhCCCCCCC
Confidence            9999999999965

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=6.7e-39  Score=306.61  Aligned_cols=267  Identities=22%  Similarity=0.410  Sum_probs=198.1

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCC-----------------CCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcce
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLAD-----------------GETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILK  217 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~  217 (477)
                      ..+|++.+.||+|+||.||+|...+                 +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4578899999999999999987542                 2458999987543 334578899999999999999999


Q ss_pred             eeeecccccCCCCceeeEEEeecCCCChhhhcccCCCc----ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecC
Q 043902          218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDE----YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCD  293 (477)
Q Consensus       218 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~d  293 (477)
                      ++++|     ..++..++|+||+++++|.+++......    ......+++..++.++.|++.||+|||+.   +++|+|
T Consensus        84 ~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~d  155 (296)
T cd05051          84 LLGVC-----TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRD  155 (296)
T ss_pred             EEEEE-----ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence            99986     3456789999999999999998754311    01123689999999999999999999998   999999


Q ss_pred             CCCCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh--C
Q 043902          294 LKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT--G  370 (477)
Q Consensus       294 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt--g  370 (477)
                      |||+||+++.++.++|+|||+++......     .........++..|+|||++ .+.++.++|||||||++|||++  |
T Consensus       156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~  230 (296)
T cd05051         156 LATRNCLVGKNYTIKIADFGMSRNLYSSD-----YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCR  230 (296)
T ss_pred             cchhceeecCCCceEEccccceeecccCc-----ceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCC
Confidence            99999999999999999999997653211     11122234467789999998 5579999999999999999998  6


Q ss_pred             CCCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCC
Q 043902          371 KRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAA  450 (477)
Q Consensus       371 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~  450 (477)
                      ..||.......              ............     ..   ....+         ....++..+.+++.+|++.
T Consensus       231 ~~p~~~~~~~~--------------~~~~~~~~~~~~-----~~---~~~~~---------~~~~~~~~l~~li~~cl~~  279 (296)
T cd05051         231 EQPYEHLTDQQ--------------VIENAGHFFRDD-----GR---QIYLP---------RPPNCPKDIYELMLECWRR  279 (296)
T ss_pred             CCCCCCcChHH--------------HHHHHHhccccc-----cc---cccCC---------CccCCCHHHHHHHHHHhcc
Confidence            77775422111              000000000000     00   00000         0001124589999999999


Q ss_pred             CCCCCCChHHHHHHHH
Q 043902          451 SPRDRVGMKFVVNNLQ  466 (477)
Q Consensus       451 dP~~RPs~~evl~~L~  466 (477)
                      ||++|||+.||++.|+
T Consensus       280 ~p~~Rpt~~el~~~L~  295 (296)
T cd05051         280 DEEDRPTFREIHLFLQ  295 (296)
T ss_pred             ChhcCCCHHHHHHHhc
Confidence            9999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=9.1e-39  Score=308.56  Aligned_cols=240  Identities=25%  Similarity=0.358  Sum_probs=187.7

Q ss_pred             CeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCCceeeEEE
Q 043902          163 NLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGNDFKALVF  237 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  237 (477)
                      +.||+|+||.||+|+.. +++.||+|+++...   ......+..|.+++..+ +||||+++++++     ...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            46999999999999875 58899999998542   33445677888998887 699999999985     5567899999


Q ss_pred             eecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          238 EFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       238 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      ||+++|+|..++...       ..+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|||+++.
T Consensus        76 e~~~~~~L~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  145 (318)
T cd05570          76 EYVNGGDLMFHIQRS-------GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKE  145 (318)
T ss_pred             cCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCee
Confidence            999999999988654       4589999999999999999999999   999999999999999999999999999864


Q ss_pred             ccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCchh
Q 043902          318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHV  396 (477)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  396 (477)
                      ...       .........|+..|+|||++ ...++.++|||||||++|||++|+.||........             .
T Consensus       146 ~~~-------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~-------------~  205 (318)
T cd05570         146 GIL-------GGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL-------------F  205 (318)
T ss_pred             cCc-------CCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH-------------H
Confidence            311       11112234689999999999 55789999999999999999999999964321100             0


Q ss_pred             HHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCCh-----HHHHH
Q 043902          397 MDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGM-----KFVVN  463 (477)
Q Consensus       397 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~  463 (477)
                      ..+.....               ..+.           .....+.+++.+||+.||.+|||+     .++++
T Consensus       206 ~~i~~~~~---------------~~~~-----------~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         206 QSILEDEV---------------RYPR-----------WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             HHHHcCCC---------------CCCC-----------cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            00000000               0000           012347899999999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=8.8e-39  Score=333.56  Aligned_cols=271  Identities=21%  Similarity=0.278  Sum_probs=201.6

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ++|++.+.||+|+||.||+|... +|+.||+|+++...   ....+.+.+|++++++++||||+++++++     ..++.
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~-----~d~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC-----SDGDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE-----eeCCE
Confidence            57889999999999999999865 68999999987432   22346789999999999999999999986     45677


Q ss_pred             eeEEEeecCCCChhhhcccCCCc----ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEE
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDE----YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH  308 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k  308 (477)
                      .++||||+++|+|.+++......    .......++..++.++.||++||.|||+.   +|+||||||+||+++.++.+|
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vK  153 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVV  153 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEE
Confidence            89999999999999998642110    01123467788899999999999999999   999999999999999999999


Q ss_pred             EecccccccccccCCCC-----------CCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          309 VGDFGLAKFLFEESNTP-----------SKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       309 l~DfG~a~~~~~~~~~~-----------~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |+|||+++.........           ...........||+.|+|||++ ...++.++|||||||++|||+||+.||..
T Consensus       154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            99999998652111000           0001112235699999999998 55689999999999999999999999965


Q ss_pred             ccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC
Q 043902          377 MFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRV  456 (477)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  456 (477)
                      .........           ....++...                         ....+.+..+.+++.+|++.||++||
T Consensus       234 ~~~~ki~~~-----------~~i~~P~~~-------------------------~p~~~iP~~L~~LI~rcL~~DP~kR~  277 (932)
T PRK13184        234 KKGRKISYR-----------DVILSPIEV-------------------------APYREIPPFLSQIAMKALAVDPAERY  277 (932)
T ss_pred             cchhhhhhh-----------hhccChhhc-------------------------cccccCCHHHHHHHHHHccCChhhCc
Confidence            221110000           000000000                         00011234478899999999999996


Q ss_pred             -ChHHHHHHHHHHHHh
Q 043902          457 -GMKFVVNNLQAIRSK  471 (477)
Q Consensus       457 -s~~evl~~L~~i~~~  471 (477)
                       +++++.+.|+...+.
T Consensus       278 ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        278 SSVQELKQDLEPHLQG  293 (932)
T ss_pred             CHHHHHHHHHHHHHhc
Confidence             677788888776543

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.1e-38  Score=303.89  Aligned_cols=261  Identities=26%  Similarity=0.462  Sum_probs=198.1

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC------CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYE  228 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  228 (477)
                      .++|+..+.||+|+||.||+|...      ++..||+|.++... ......+.+|+.++++++||||++++++|     .
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~-----~   78 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVC-----A   78 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEE-----c
Confidence            467889999999999999999853      46789999987543 23346788999999999999999999986     4


Q ss_pred             CCceeeEEEeecCCCChhhhcccCCCc---------------ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecC
Q 043902          229 GNDFKALVFEFMRNGNLDQWLHPSTDE---------------YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCD  293 (477)
Q Consensus       229 ~~~~~~lv~e~~~~g~L~~~l~~~~~~---------------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~d  293 (477)
                      .+...++|+||+++|+|.+++......               ......+++..++.++.|++.||.|||+.   +++|||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~d  155 (288)
T cd05050          79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRD  155 (288)
T ss_pred             CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence            456789999999999999999643210               01123578899999999999999999998   999999


Q ss_pred             CCCCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CC
Q 043902          294 LKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GK  371 (477)
Q Consensus       294 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~  371 (477)
                      |||+||+++.++.++|+|||++........     .........+..|+|||.+ .+.++.++|||||||++|||++ |.
T Consensus       156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~  230 (288)
T cd05050         156 LATRNCLVGENMVVKIADFGLSRNIYSADY-----YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGM  230 (288)
T ss_pred             ccHhheEecCCCceEECccccceecccCcc-----ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCC
Confidence            999999999999999999999876522110     1111222346679999998 5678999999999999999998 88


Q ss_pred             CCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCC
Q 043902          372 RPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAAS  451 (477)
Q Consensus       372 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~d  451 (477)
                      .||.......             ....+.+....                +         ..+.++..+.+++.+|++.+
T Consensus       231 ~p~~~~~~~~-------------~~~~~~~~~~~----------------~---------~~~~~~~~l~~li~~~l~~~  272 (288)
T cd05050         231 QPYYGMAHEE-------------VIYYVRDGNVL----------------S---------CPDNCPLELYNLMRLCWSKL  272 (288)
T ss_pred             CCCCCCCHHH-------------HHHHHhcCCCC----------------C---------CCCCCCHHHHHHHHHHcccC
Confidence            8885422111             00000000000                0         00011345889999999999


Q ss_pred             CCCCCChHHHHHHHHH
Q 043902          452 PRDRVGMKFVVNNLQA  467 (477)
Q Consensus       452 P~~RPs~~evl~~L~~  467 (477)
                      |++|||+.|+++.|++
T Consensus       273 p~~Rpt~~el~~~l~~  288 (288)
T cd05050         273 PSDRPSFASINRILQR  288 (288)
T ss_pred             cccCCCHHHHHHHhhC
Confidence            9999999999999873

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.5e-39  Score=303.04  Aligned_cols=252  Identities=25%  Similarity=0.336  Sum_probs=195.4

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      .++|...+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.++..++||||+++++++     ...+..+
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~-----~~~~~~~   82 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY-----LRRDKLW   82 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EeCCEEE
Confidence            357778889999999999999864 6899999999866555556788999999999999999999985     4567889


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +|+||+++++|.+++...       ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+
T Consensus        83 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~  152 (267)
T cd06645          83 ICMEFCGGGSLQDIYHVT-------GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGV  152 (267)
T ss_pred             EEEeccCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccee
Confidence            999999999999998644       4589999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc----cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI----NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      +.....       .........|+..|+|||++    .+.++.++|||||||++|||++|+.||........        
T Consensus       153 ~~~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--------  217 (267)
T cd06645         153 SAQITA-------TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--------  217 (267)
T ss_pred             eeEccC-------cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--------
Confidence            876521       11122344688999999987    23588999999999999999999999854221110        


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                           +...........            ....         .......+.+++.+|++.+|++|||++++++
T Consensus       218 -----~~~~~~~~~~~~------------~~~~---------~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         218 -----LFLMTKSNFQPP------------KLKD---------KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             -----HHhhhccCCCCC------------cccc---------cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence                 000000000000            0000         0001223778999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.4e-39  Score=316.20  Aligned_cols=202  Identities=25%  Similarity=0.261  Sum_probs=167.4

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec--cchhhHHHHHHHHHHhcCCCCCcceeeeeccccc-CCCC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSSCSSVD-YEGN  230 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~~  230 (477)
                      ..++|...+.||+|+||.||++... .++.||||++...  .......+.+|+.+++.++||||+++++++.... ....
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4578999999999999999999864 6889999998743  2333467889999999999999999998864321 1233


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ...++||||+++ +|.+++.         ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~---------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~  168 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL  168 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH---------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEE
Confidence            467999999965 7777764         2378889999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      |||+++....        ........+|..|+|||++ ...++.++|||||||++|||++|+.||...
T Consensus       169 DfG~a~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  228 (364)
T cd07875         169 DFGLARTAGT--------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT  228 (364)
T ss_pred             eCCCccccCC--------CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence            9999976421        1122345689999999999 556899999999999999999999999653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=9.4e-39  Score=304.04  Aligned_cols=266  Identities=20%  Similarity=0.263  Sum_probs=201.4

Q ss_pred             HHHHHHhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcC-CCCCcceeeeeccccc
Q 043902          149 YLKISNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSI-RHRNILKIVSSCSSVD  226 (477)
Q Consensus       149 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  226 (477)
                      +..+..+.++|++.+.||+|+||.||++... +++.+|+|+++.... ....+.+|+.++.++ +||||++++++|....
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            3455567889999999999999999999864 688999998865332 235678899999999 6999999999875444


Q ss_pred             CCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCc
Q 043902          227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI  306 (477)
Q Consensus       227 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~  306 (477)
                      ...++..++||||+++++|.+++.....   ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~  162 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLK---RGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGG  162 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhc---cCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCC
Confidence            4556779999999999999998753211   124588999999999999999999998   9999999999999999999


Q ss_pred             EEEecccccccccccCCCCCCCccccCCCcccccccCccccc------CCCCcccceeehHHHHHHHhhCCCCCCccccc
Q 043902          307 AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN------GHVSILGDIYSYGILLLEIFTGKRPTDDMFKD  380 (477)
Q Consensus       307 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~  380 (477)
                      +||+|||+++.....       ........|+..|+|||++.      ..++.++|||||||++|||++|+.||......
T Consensus       163 ~kl~dfg~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~  235 (286)
T cd06638         163 VKLVDFGVSAQLTST-------RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM  235 (286)
T ss_pred             EEEccCCceeecccC-------CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh
Confidence            999999998765221       11122345889999999873      23788999999999999999999998643211


Q ss_pred             ccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHH
Q 043902          381 DLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKF  460 (477)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e  460 (477)
                      ..             +.... ...  .         .....+.           .+...+.+++.+|++.||++|||+.|
T Consensus       236 ~~-------------~~~~~-~~~--~---------~~~~~~~-----------~~~~~~~~li~~~l~~~p~~Rps~~e  279 (286)
T cd06638         236 RA-------------LFKIP-RNP--P---------PTLHQPE-----------LWSNEFNDFIRKCLTKDYEKRPTVSD  279 (286)
T ss_pred             HH-------------Hhhcc-ccC--C---------CcccCCC-----------CcCHHHHHHHHHHccCCcccCCCHHH
Confidence            00             00000 000  0         0000000           01223788999999999999999999


Q ss_pred             HHHH
Q 043902          461 VVNN  464 (477)
Q Consensus       461 vl~~  464 (477)
                      +++.
T Consensus       280 ll~~  283 (286)
T cd06638         280 LLQH  283 (286)
T ss_pred             Hhhc
Confidence            9874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.8e-39  Score=317.99  Aligned_cols=204  Identities=21%  Similarity=0.341  Sum_probs=168.8

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .|+..+.||+|+||.||+|+.. +++.||+|++....   ......+.+|++++++++|+||+++++.+     .+++..
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCEE
Confidence            5788999999999999999864 68899999997542   23346788999999999999999999985     556789


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||+++|+|.+++...       ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        77 ~lv~E~~~gg~L~~~l~~~-------~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFG  146 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIRM-------GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG  146 (382)
T ss_pred             EEEEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECC
Confidence            9999999999999998654       3578889999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCC----------------------------------------CCCccccCCCcccccccCcccc-cCCCC
Q 043902          314 LAKFLFEESNTP----------------------------------------SKNQTMSNGLKGSVGYIPPEYI-NGHVS  352 (477)
Q Consensus       314 ~a~~~~~~~~~~----------------------------------------~~~~~~~~~~~gt~~y~aPE~~-~~~~~  352 (477)
                      ++..+.......                                        ...........||+.|+|||++ ...++
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~  226 (382)
T cd05625         147 LCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT  226 (382)
T ss_pred             CCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC
Confidence            975331100000                                        0000011235689999999999 55689


Q ss_pred             cccceeehHHHHHHHhhCCCCCCc
Q 043902          353 ILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       353 ~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      .++|||||||++|||++|+.||..
T Consensus       227 ~~~DiwSlGvil~elltG~~Pf~~  250 (382)
T cd05625         227 QLCDWWSVGVILYEMLVGQPPFLA  250 (382)
T ss_pred             CeeeEEechHHHHHHHhCCCCCCC
Confidence            999999999999999999999965

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=6.8e-39  Score=302.37  Aligned_cols=253  Identities=29%  Similarity=0.437  Sum_probs=190.6

Q ss_pred             CeeeeeccceEEEEEeC-CCC--EEEEEEeeecc-chhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCCceeeEEE
Q 043902          163 NLIGSGSFGSVYKGTLA-DGE--TAAIKVLKLQQ-QGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGNDFKALVF  237 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  237 (477)
                      +.||+|+||.||+|... ++.  .+++|.++... ....+.+.+|++++.++ +||||++++++|     ...+..++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-----~~~~~~~lv~   75 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAI   75 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEE-----ecCCCceEEE
Confidence            36899999999999875 344  46888887432 34456788999999999 799999999996     3455689999


Q ss_pred             eecCCCChhhhcccCCCc---------ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEE
Q 043902          238 EFMRNGNLDQWLHPSTDE---------YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH  308 (477)
Q Consensus       238 e~~~~g~L~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k  308 (477)
                      ||+++|+|.+++......         ......+++..+..++.|++.||+|||+.   +++||||||+||++++++.+|
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~k  152 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK  152 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEE
Confidence            999999999998754210         01123588999999999999999999998   999999999999999999999


Q ss_pred             EecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceee
Q 043902          309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHK  386 (477)
Q Consensus       309 l~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~  386 (477)
                      |+|||++.....        .........+..|+|||++ ...++.++|||||||++|||++ |..||.......     
T Consensus       153 l~dfgl~~~~~~--------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-----  219 (270)
T cd05047         153 IADFGLSRGQEV--------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----  219 (270)
T ss_pred             ECCCCCccccch--------hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-----
Confidence            999999863210        1111112335679999998 5568999999999999999997 999986432110     


Q ss_pred             eeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHH
Q 043902          387 FVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQ  466 (477)
Q Consensus       387 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  466 (477)
                               ....+......+                        ....+...+.+++.+|++.||.+|||+.|+++.|+
T Consensus       220 ---------~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  266 (270)
T cd05047         220 ---------LYEKLPQGYRLE------------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN  266 (270)
T ss_pred             ---------HHHHHhCCCCCC------------------------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence                     011111000000                        00011234789999999999999999999999999


Q ss_pred             HHH
Q 043902          467 AIR  469 (477)
Q Consensus       467 ~i~  469 (477)
                      ++.
T Consensus       267 ~~~  269 (270)
T cd05047         267 RML  269 (270)
T ss_pred             Hhh
Confidence            875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.5e-39  Score=309.67  Aligned_cols=199  Identities=23%  Similarity=0.412  Sum_probs=166.6

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      ++|...+.||+|+||.||+|+.. +++.||+|.++... ......+.+|++++++++||||+++++++     ..++..+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   80 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV-----HTDKSLT   80 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEE-----eeCCeEE
Confidence            57889999999999999999865 68899999987543 22335678899999999999999999986     4566789


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +||||+++ +|.+++....      ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        81 lv~e~~~~-~l~~~~~~~~------~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~  150 (309)
T cd07872          81 LVFEYLDK-DLKQYMDDCG------NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGL  150 (309)
T ss_pred             EEEeCCCC-CHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcccc
Confidence            99999975 8888876442      4578899999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      ++.....       ........++..|+|||.+.  ..++.++|||||||++|||+||+.||...
T Consensus       151 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~  208 (309)
T cd07872         151 ARAKSVP-------TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS  208 (309)
T ss_pred             ceecCCC-------ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            8754211       11122345788999999883  35899999999999999999999999653

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.4e-39  Score=301.16  Aligned_cols=250  Identities=28%  Similarity=0.521  Sum_probs=195.8

Q ss_pred             cCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEE
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALV  236 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  236 (477)
                      .+|+..+.||+|+||.||+|...++..+|+|.++..... ...+.+|++++.+++|||++++++++     ......++|
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v   77 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPICLV   77 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC-HHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceEEE
Confidence            467788999999999999999877889999988744322 36789999999999999999999985     455678999


Q ss_pred             EeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccc
Q 043902          237 FEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK  316 (477)
Q Consensus       237 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  316 (477)
                      +||+++++|.+++....      ..+++..++.++.|++.|++|||+.   +++|+||||+||+++.++.+||+|||.+.
T Consensus        78 ~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~  148 (256)
T cd05112          78 FEFMEHGCLSDYLRAQR------GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTR  148 (256)
T ss_pred             EEcCCCCcHHHHHHhCc------cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCccee
Confidence            99999999999987543      3578999999999999999999998   99999999999999999999999999987


Q ss_pred             cccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCCc
Q 043902          317 FLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALPS  394 (477)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  394 (477)
                      .....      .........++..|+|||.+ .+.++.++||||||+++|||++ |+.||.......             
T Consensus       149 ~~~~~------~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------------  209 (256)
T cd05112         149 FVLDD------QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-------------  209 (256)
T ss_pred             ecccC------cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-------------
Confidence            65221      11112233456789999998 5678999999999999999998 999986432111             


Q ss_pred             hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHH
Q 043902          395 HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNL  465 (477)
Q Consensus       395 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  465 (477)
                       +.+.+.....             ...+..           ....+.+++.+||+.+|++|||+.|+++.|
T Consensus       210 -~~~~~~~~~~-------------~~~~~~-----------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         210 -VVETINAGFR-------------LYKPRL-----------ASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             -HHHHHhCCCC-------------CCCCCC-----------CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence             0000000000             000000           123488999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.9e-39  Score=315.23  Aligned_cols=198  Identities=31%  Similarity=0.411  Sum_probs=169.5

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeeccchhhHHHHHHHHHHhcCC-C-----CCcceeeeecccccCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIR-H-----RNILKIVSSCSSVDYE  228 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~  228 (477)
                      ..+|.+.++||+|.||.|-+|.. .+++.||||+++.... ...+...|+.+|..++ |     -|+|+++++     +.
T Consensus       185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~-----F~  258 (586)
T KOG0667|consen  185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDY-----FY  258 (586)
T ss_pred             EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeec-----cc
Confidence            34888999999999999999985 4799999999996643 3356678999999996 4     389999999     46


Q ss_pred             CCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC--Cc
Q 043902          229 GNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG--MI  306 (477)
Q Consensus       229 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~--~~  306 (477)
                      ..++.|||+|.+ .-+|.++++.+.     +..++...+..++.||+.||.+||+.   +|||+||||+||||.+-  ..
T Consensus       259 fr~HlciVfELL-~~NLYellK~n~-----f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~  329 (586)
T KOG0667|consen  259 FRNHLCIVFELL-STNLYELLKNNK-----FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSR  329 (586)
T ss_pred             cccceeeeehhh-hhhHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCc
Confidence            788999999999 559999998763     47799999999999999999999998   99999999999999643  38


Q ss_pred             EEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCccc
Q 043902          307 AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMF  378 (477)
Q Consensus       307 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~  378 (477)
                      +||+|||.|+...         .... ...-+..|+|||++ ..+|+.+.||||||||+.||+||.+.|.+..
T Consensus       330 vKVIDFGSSc~~~---------q~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n  392 (586)
T KOG0667|consen  330 IKVIDFGSSCFES---------QRVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN  392 (586)
T ss_pred             eeEEecccccccC---------Ccce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence            9999999998751         2222 45668889999999 6789999999999999999999988887643

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.4e-38  Score=307.46  Aligned_cols=203  Identities=21%  Similarity=0.277  Sum_probs=160.6

Q ss_pred             CCeeeeeccceEEEEEeC---CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEe
Q 043902          162 ENLIGSGSFGSVYKGTLA---DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFE  238 (477)
Q Consensus       162 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  238 (477)
                      .+.||+|+||.||+|+..   +++.||+|.++....  ...+.+|++++++++||||+++++++..   ..+...++|||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEe
Confidence            468999999999999864   467899999875432  2467889999999999999999998642   34556899999


Q ss_pred             ecCCCChhhhcccCCC--cccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEe----cCCCcEEEecc
Q 043902          239 FMRNGNLDQWLHPSTD--EYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL----DEGMIAHVGDF  312 (477)
Q Consensus       239 ~~~~g~L~~~l~~~~~--~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~Df  312 (477)
                      |+. ++|.+++.....  .......+++..+..++.|++.||.|||++   +|+||||||+|||+    +.++.+||+||
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            985 588887753221  111224588999999999999999999999   99999999999999    45678999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      |+++......    ..........||..|+|||++.  ..++.++||||+||++|||++|+.||...
T Consensus       157 G~a~~~~~~~----~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         157 GFARLFNSPL----KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             CceeccCCCC----ccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            9998652211    1112233456899999999984  34899999999999999999999999653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.3e-38  Score=301.89  Aligned_cols=250  Identities=23%  Similarity=0.365  Sum_probs=191.4

Q ss_pred             cCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      ++|+..+.||+|+||.||+|.. .+++.||+|++.... ......+.+|++++.+++||||+++++++     ...+..+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   75 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF-----FVENRIS   75 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EECCEEE
Confidence            3677889999999999999985 478999999987542 33346788999999999999999999986     4456789


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +||||+++++|..+.           .+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||+
T Consensus        76 lv~e~~~~~~l~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~  141 (279)
T cd06619          76 ICTEFMDGGSLDVYR-----------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGV  141 (279)
T ss_pred             EEEecCCCCChHHhh-----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCc
Confidence            999999999996542           367888899999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCC
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      +.....         .......|+..|+|||++ ...++.++|||||||++|+|++|+.||..........       .+
T Consensus       142 ~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-------~~  205 (279)
T cd06619         142 STQLVN---------SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-------MP  205 (279)
T ss_pred             ceeccc---------ccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-------ch
Confidence            976521         122335688999999999 5568999999999999999999999996532211100       00


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                      ......+......             ..+.          ......+.+++.+|++.+|++||+++|+++.
T Consensus       206 ~~~~~~~~~~~~~-------------~~~~----------~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         206 LQLLQCIVDEDPP-------------VLPV----------GQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             HHHHHHHhccCCC-------------CCCC----------CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            0111110000000             0000          0002237889999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-38  Score=297.77  Aligned_cols=252  Identities=20%  Similarity=0.321  Sum_probs=195.2

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-----chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-----QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      ++|...+.||+|++|.||+|... +++.+|+|.+....     ......+.+|++++.+++||||+++++++     ...
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~   76 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDD   76 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccC
Confidence            57889999999999999999864 68999999987432     12235688899999999999999999995     456


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +..++|+||+++++|.+++...       ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+
T Consensus        77 ~~~~~v~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~  146 (263)
T cd06625          77 ETLSIFMEYMPGGSVKDQLKAY-------GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLG  146 (263)
T ss_pred             CeEEEEEEECCCCcHHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEe
Confidence            6899999999999999998754       4578899999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      |||+++......    ..........++..|+|||.+ ...++.++||||||+++|||++|+.||.......        
T Consensus       147 dfg~~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------  214 (263)
T cd06625         147 DFGASKRLQTIC----SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA--------  214 (263)
T ss_pred             ecccceeccccc----cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH--------
Confidence            999997652211    011111234578899999999 4568999999999999999999999986421110        


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                           ...........             ...+           ..+...+.+++.+||..+|++|||+.|+++.
T Consensus       215 -----~~~~~~~~~~~-------------~~~~-----------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         215 -----AIFKIATQPTN-------------PQLP-----------SHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -----HHHHHhccCCC-------------CCCC-----------ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                 00000000000             0000           0113347889999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=320.05  Aligned_cols=255  Identities=26%  Similarity=0.446  Sum_probs=206.8

Q ss_pred             CCCCCeeeeeccceEEEEEe-CCC----CEEEEEEeeec-cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          159 FSEENLIGSGSFGSVYKGTL-ADG----ETAAIKVLKLQ-QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       159 ~~~~~~lg~G~~g~Vy~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ....++||+|+||+||+|.+ ..|    .+||+|++... ......+++.|+-.|.+++|||+++++|+|...      .
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------~  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------T  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc------h
Confidence            44568999999999999985 344    47899998744 344568899999999999999999999998532      2


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      ..||++||+.|+|.++++..+      ..+.....+.|+.|||+||.|||.+   .+|||||..+||||..-..+||.||
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr------~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdf  842 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHR------DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDF  842 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhh------ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEec
Confidence            789999999999999998765      6788999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeec
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  390 (477)
                      |+++.+..     +.......+..-.+.|||-|.+ ...++.++|||||||++||++| |..|++....++         
T Consensus       843 gla~ll~~-----d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e---------  908 (1177)
T KOG1025|consen  843 GLAKLLAP-----DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE---------  908 (1177)
T ss_pred             chhhccCc-----ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH---------
Confidence            99998743     2233334444557889999998 7789999999999999999999 999997753322         


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRS  470 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  470 (477)
                           +.+++....                        +...++-|...+..++.+||..|+..||+++++...+.++..
T Consensus       909 -----I~dlle~ge------------------------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  909 -----IPDLLEKGE------------------------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             -----hhHHHhccc------------------------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence                 222221111                        111233456669999999999999999999999999887765


Q ss_pred             h
Q 043902          471 K  471 (477)
Q Consensus       471 ~  471 (477)
                      .
T Consensus       960 d  960 (1177)
T KOG1025|consen  960 D  960 (1177)
T ss_pred             C
Confidence            4

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=6.9e-39  Score=316.83  Aligned_cols=206  Identities=21%  Similarity=0.326  Sum_probs=169.4

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|++++.+++|+||+++++.+     ..++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~   75 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDN   75 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCE
Confidence            36889999999999999999865 68999999987432   22346688999999999999999999985     56778


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++|+|.+++...       ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        76 ~~lv~E~~~~g~L~~~i~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DF  145 (376)
T cd05598          76 LYFVMDYIPGGDMMSLLIRL-------GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDF  145 (376)
T ss_pred             EEEEEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeC
Confidence            99999999999999999754       4578888999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCC------------------------------------CCCccccCCCcccccccCcccc-cCCCCccc
Q 043902          313 GLAKFLFEESNTP------------------------------------SKNQTMSNGLKGSVGYIPPEYI-NGHVSILG  355 (477)
Q Consensus       313 G~a~~~~~~~~~~------------------------------------~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~  355 (477)
                      |++..+.......                                    ...........||..|+|||++ ...++.++
T Consensus       146 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  225 (376)
T cd05598         146 GLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC  225 (376)
T ss_pred             CCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcce
Confidence            9975321000000                                    0000011235799999999999 55689999


Q ss_pred             ceeehHHHHHHHhhCCCCCCcc
Q 043902          356 DIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       356 Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      |||||||++|||++|+.||...
T Consensus       226 DiwSlGvilyell~G~~Pf~~~  247 (376)
T cd05598         226 DWWSVGVILYEMLVGQPPFLAD  247 (376)
T ss_pred             eeeeccceeeehhhCCCCCCCC
Confidence            9999999999999999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.1e-38  Score=309.14  Aligned_cols=192  Identities=29%  Similarity=0.398  Sum_probs=160.4

Q ss_pred             CeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHH-HHhcCCCCCcceeeeecccccCCCCceeeEEE
Q 043902          163 NLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECN-ALTSIRHRNILKIVSSCSSVDYEGNDFKALVF  237 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  237 (477)
                      +.||+|+||.||+|+.. +|+.+|+|++....   ......+..|.. +++.++||||+++++++     ...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence            46999999999999864 78999999997542   223345556655 46778999999999885     5567899999


Q ss_pred             eecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          238 EFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       238 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      ||+++|+|..++...       ..+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        76 e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~  145 (325)
T cd05604          76 DFVNGGELFFHLQRE-------RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKE  145 (325)
T ss_pred             cCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCccc
Confidence            999999999888644       4589999999999999999999999   999999999999999999999999999875


Q ss_pred             ccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ...       .........||..|+|||++ .+.++.++|||||||++|||++|+.||..
T Consensus       146 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~  198 (325)
T cd05604         146 GIA-------QSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC  198 (325)
T ss_pred             CCC-------CCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC
Confidence            311       11122345689999999999 55689999999999999999999999964

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.1e-38  Score=305.19  Aligned_cols=266  Identities=20%  Similarity=0.392  Sum_probs=196.8

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-----------------CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCccee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-----------------DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKI  218 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l  218 (477)
                      ++|++.+.||+|+||.||++...                 ++..+|+|+++... ......+.+|++++.+++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            56889999999999999998532                 23468999987543 3345688999999999999999999


Q ss_pred             eeecccccCCCCceeeEEEeecCCCChhhhcccCCCc----ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCC
Q 043902          219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDE----YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDL  294 (477)
Q Consensus       219 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dl  294 (477)
                      ++++     ...+..++||||+++|+|.+++......    ......+++..++.++.|++.||+|||+.   +++|+||
T Consensus        85 ~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl  156 (296)
T cd05095          85 LAVC-----ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDL  156 (296)
T ss_pred             EEEE-----ecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccC
Confidence            9986     4456689999999999999998754311    11224578899999999999999999999   9999999


Q ss_pred             CCCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh--CC
Q 043902          295 KSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT--GK  371 (477)
Q Consensus       295 kp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt--g~  371 (477)
                      ||+||+++.++.++|+|||+++.+....     .........++..|+|||.. .+.++.++|||||||++|||+|  |.
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~  231 (296)
T cd05095         157 ATRNCLVGKNYTIKIADFGMSRNLYSGD-----YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKE  231 (296)
T ss_pred             ChheEEEcCCCCEEeccCcccccccCCc-----ceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCC
Confidence            9999999999999999999997653211     01111223346789999987 6679999999999999999998  67


Q ss_pred             CCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCC
Q 043902          372 RPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAAS  451 (477)
Q Consensus       372 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~d  451 (477)
                      .||........     +     ..............            ..+         ....++..+.+++.+||+.|
T Consensus       232 ~p~~~~~~~~~-----~-----~~~~~~~~~~~~~~------------~~~---------~~~~~~~~~~~li~~cl~~~  280 (296)
T cd05095         232 QPYSQLSDEQV-----I-----ENTGEFFRDQGRQV------------YLP---------KPALCPDSLYKLMLSCWRRN  280 (296)
T ss_pred             CCccccChHHH-----H-----HHHHHHHhhccccc------------cCC---------CCCCCCHHHHHHHHHHcCCC
Confidence            78754221110     0     00001000000000            000         00012345889999999999


Q ss_pred             CCCCCChHHHHHHHH
Q 043902          452 PRDRVGMKFVVNNLQ  466 (477)
Q Consensus       452 P~~RPs~~evl~~L~  466 (477)
                      |++|||+.||++.|+
T Consensus       281 p~~Rp~~~~i~~~l~  295 (296)
T cd05095         281 AKERPSFQEIHATLL  295 (296)
T ss_pred             cccCCCHHHHHHHHh
Confidence            999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.9e-38  Score=297.82  Aligned_cols=238  Identities=22%  Similarity=0.394  Sum_probs=183.8

Q ss_pred             CeeeeeccceEEEEEeCC-------------CCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCC
Q 043902          163 NLIGSGSFGSVYKGTLAD-------------GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEG  229 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  229 (477)
                      +.||+|+||.||+|.+.+             ...|++|.+..........+.+|+.++.+++||||++++++|     ..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~-----~~   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVC-----VR   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ec
Confidence            368999999999998532             235889988766555567888999999999999999999996     34


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCc---
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI---  306 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~---  306 (477)
                      ....++||||+++|+|..++....      ..+++..++.++.|+++||+|||+.   +|+||||||+||+++.++.   
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~  146 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHRKS------DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGE  146 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCC
Confidence            556789999999999999886543      4589999999999999999999999   9999999999999987654   


Q ss_pred             ----EEEecccccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHh-hCCCCCCcccc
Q 043902          307 ----AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIF-TGKRPTDDMFK  379 (477)
Q Consensus       307 ----~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~ell-tg~~p~~~~~~  379 (477)
                          ++++|||++.....           .....++..|+|||.+.  +.++.++|||||||++|||+ +|..|+.....
T Consensus       147 ~~~~~~l~d~g~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~  215 (262)
T cd05077         147 CGPFIKLSDPGIPITVLS-----------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL  215 (262)
T ss_pred             CCceeEeCCCCCCccccC-----------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch
Confidence                89999999865411           12235778899999883  45899999999999999998 58888754211


Q ss_pred             cccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChH
Q 043902          380 DDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMK  459 (477)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~  459 (477)
                      ..              ...........             ..+             ....+.+++.+||+.||.+||++.
T Consensus       216 ~~--------------~~~~~~~~~~~-------------~~~-------------~~~~~~~li~~cl~~dp~~Rp~~~  255 (262)
T cd05077         216 AE--------------KERFYEGQCML-------------VTP-------------SCKELADLMTHCMNYDPNQRPFFR  255 (262)
T ss_pred             hH--------------HHHHHhcCccC-------------CCC-------------ChHHHHHHHHHHcCCChhhCcCHH
Confidence            00              00000000000             000             023478899999999999999999


Q ss_pred             HHHHHH
Q 043902          460 FVVNNL  465 (477)
Q Consensus       460 evl~~L  465 (477)
                      ++++.+
T Consensus       256 ~il~~~  261 (262)
T cd05077         256 AIMRDI  261 (262)
T ss_pred             HHHHhc
Confidence            998875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-38  Score=298.67  Aligned_cols=253  Identities=28%  Similarity=0.527  Sum_probs=196.8

Q ss_pred             CeeeeeccceEEEEEeCC----CCEEEEEEeeeccch-hhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEE
Q 043902          163 NLIGSGSFGSVYKGTLAD----GETAAIKVLKLQQQG-ALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVF  237 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  237 (477)
                      +.||+|+||.||+|....    +..|++|.++..... ..+.+.+|++.+.+++|+|++++++++     ......++||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVC-----TEEEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeee-----cCCCceEEEE
Confidence            468999999999998753    789999999865433 367889999999999999999999986     4467799999


Q ss_pred             eecCCCChhhhcccCCCc--ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          238 EFMRNGNLDQWLHPSTDE--YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       238 e~~~~g~L~~~l~~~~~~--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      ||+++++|.+++......  ......+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||.+
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~  152 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLS  152 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccc
Confidence            999999999999764210  00125689999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCC
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      ........     ........++..|+|||.+ .+.++.++||||+||++|||++ |..||......             
T Consensus       153 ~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------------  214 (262)
T cd00192         153 RDVYDDDY-----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-------------  214 (262)
T ss_pred             cccccccc-----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH-------------
Confidence            87633211     1223345578899999998 4578999999999999999999 69998753111             


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQ  466 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  466 (477)
                       .+.+.+.....         .               .....+...+.+++.+|++.+|++|||+.|+++.|+
T Consensus       215 -~~~~~~~~~~~---------~---------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         215 -EVLEYLRKGYR---------L---------------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -HHHHHHHcCCC---------C---------------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence             01111100000         0               000111345889999999999999999999998873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-38  Score=301.19  Aligned_cols=237  Identities=20%  Similarity=0.373  Sum_probs=182.4

Q ss_pred             eeeeeccceEEEEEeCC-------------------------CCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCccee
Q 043902          164 LIGSGSFGSVYKGTLAD-------------------------GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKI  218 (477)
Q Consensus       164 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l  218 (477)
                      .||+|+||.||+|.+..                         ...|++|++..........+.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            68999999999997421                         13588998876554445678899999999999999999


Q ss_pred             eeecccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCC
Q 043902          219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSN  298 (477)
Q Consensus       219 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~N  298 (477)
                      +++|.     .....++||||+++|+|..++....      ..+++..+..++.|+++||+|||+.   +|+||||||+|
T Consensus        82 ~~~~~-----~~~~~~lv~ey~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~N  147 (274)
T cd05076          82 HGVCV-----RGSENIMVEEFVEHGPLDVCLRKEK------GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKN  147 (274)
T ss_pred             EEEEE-----eCCceEEEEecCCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCccc
Confidence            99973     4557899999999999999986532      4588999999999999999999998   99999999999


Q ss_pred             eEecCCC-------cEEEecccccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHh-
Q 043902          299 VLLDEGM-------IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIF-  368 (477)
Q Consensus       299 Ill~~~~-------~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~ell-  368 (477)
                      |+++..+       .+|++|||.+.....           .....++..|+|||.+.  ..++.++|||||||++|||+ 
T Consensus       148 ill~~~~~~~~~~~~~kl~d~g~~~~~~~-----------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~  216 (274)
T cd05076         148 ILLARLGLAEGTSPFIKLSDPGVSFTALS-----------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICF  216 (274)
T ss_pred             EEEeccCcccCccceeeecCCcccccccc-----------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence            9997643       489999998864311           11234677899999883  35899999999999999995 


Q ss_pred             hCCCCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcC
Q 043902          369 TGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCS  448 (477)
Q Consensus       369 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl  448 (477)
                      +|+.||.......              .....+....               .+.           .....+.+++.+||
T Consensus       217 ~g~~p~~~~~~~~--------------~~~~~~~~~~---------------~~~-----------~~~~~~~~li~~cl  256 (274)
T cd05076         217 DGEVPLKERTPSE--------------KERFYEKKHR---------------LPE-----------PSCKELATLISQCL  256 (274)
T ss_pred             CCCCCccccChHH--------------HHHHHHhccC---------------CCC-----------CCChHHHHHHHHHc
Confidence            6999986432111              1111111000               000           00123788999999


Q ss_pred             CCCCCCCCChHHHHHHH
Q 043902          449 AASPRDRVGMKFVVNNL  465 (477)
Q Consensus       449 ~~dP~~RPs~~evl~~L  465 (477)
                      +.+|++|||+.+|++.|
T Consensus       257 ~~~p~~Rps~~~il~~L  273 (274)
T cd05076         257 TYEPTQRPSFRTILRDL  273 (274)
T ss_pred             ccChhhCcCHHHHHHhh
Confidence            99999999999999877

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8e-40  Score=316.27  Aligned_cols=247  Identities=25%  Similarity=0.423  Sum_probs=199.9

Q ss_pred             CCCCeeeeeccceEEEEEeC-CCCEEEEEEee----eccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          160 SEENLIGSGSFGSVYKGTLA-DGETAAIKVLK----LQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       160 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~----~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      ....+||+|+|-+||+|... +|..||--.++    .......++|..|+.+|+.|+||||++++.++.+   ..+....
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d---~~n~~in  119 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVD---TDNKTIN  119 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheec---CCCceee
Confidence            34568999999999999864 57777743333    2234456899999999999999999999998654   3345678


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec-CCCcEEEeccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFG  313 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~DfG  313 (477)
                      +|+|.|..|+|..|++..       +.++...+.+|+.||++||.|||++ .|+|+|||||-+||+|+ ..|.+||+|+|
T Consensus       120 ~iTEL~TSGtLr~Y~kk~-------~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLG  191 (632)
T KOG0584|consen  120 FITELFTSGTLREYRKKH-------RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLG  191 (632)
T ss_pred             eeeecccCCcHHHHHHHh-------ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchh
Confidence            999999999999999865       5688899999999999999999998 78999999999999997 45799999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccccCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCC
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      +|..+         .........||+.|||||++...|++.+||||||+.++||+|+..||.........+.+......|
T Consensus       192 LAtl~---------r~s~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP  262 (632)
T KOG0584|consen  192 LATLL---------RKSHAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKP  262 (632)
T ss_pred             HHHHh---------hccccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCH
Confidence            99876         233344478999999999999999999999999999999999999998754443333333333333


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      ..+..+-|+                                    .+.+++.+|+.. .++|||+.|++.
T Consensus       263 ~sl~kV~dP------------------------------------evr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  263 AALSKVKDP------------------------------------EVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HHhhccCCH------------------------------------HHHHHHHHHhcC-chhccCHHHHhh
Confidence            333333332                                    277899999999 999999999985

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.5e-38  Score=308.41  Aligned_cols=204  Identities=20%  Similarity=0.258  Sum_probs=163.4

Q ss_pred             CCCeeeee--ccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          161 EENLIGSG--SFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       161 ~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      ..++||+|  +|++||++..+ +|+.||+|+++...  ......+.+|+++++.++||||++++++|     ..++..++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~-----~~~~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATF-----IADNELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----EECCEEEE
Confidence            35689999  67899999864 78999999997543  23345677899999999999999999996     45667899


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      ||||+++|+|.+++.....     ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.++++||+..
T Consensus        77 v~e~~~~~~l~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~  148 (327)
T cd08227          77 VTSFMAYGSAKDLICTHFM-----DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSN  148 (327)
T ss_pred             EEeccCCCcHHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchh
Confidence            9999999999999864321     3588999999999999999999998   9999999999999999999999999876


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCccccc---CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN---GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      .....................++..|+|||++.   ..++.++|||||||++|||++|+.||...
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  213 (327)
T cd08227         149 LSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  213 (327)
T ss_pred             hccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            543211111000011112235677899999984   24889999999999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.2e-38  Score=306.95  Aligned_cols=240  Identities=25%  Similarity=0.314  Sum_probs=182.6

Q ss_pred             CeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHH-HHhcCCCCCcceeeeecccccCCCCceeeEEE
Q 043902          163 NLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECN-ALTSIRHRNILKIVSSCSSVDYEGNDFKALVF  237 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  237 (477)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|.. +++.++||||+++++++     ...+..++||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence            46999999999999875 67889999997532   122234444444 56788999999999885     5567899999


Q ss_pred             eecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          238 EFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       238 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      ||+++|+|.+++...       ..+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        76 e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~  145 (325)
T cd05602          76 DYINGGELFYHLQRE-------RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE  145 (325)
T ss_pred             eCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcc
Confidence            999999999998754       4577888889999999999999999   999999999999999999999999999875


Q ss_pred             ccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCchh
Q 043902          318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHV  396 (477)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  396 (477)
                      ...       .........||..|+|||++ ...++.++|||||||++|||++|+.||.......             ..
T Consensus       146 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------------~~  205 (325)
T cd05602         146 NIE-------HNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-------------MY  205 (325)
T ss_pred             ccc-------CCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH-------------HH
Confidence            421       11122345689999999999 5568999999999999999999999996432110             00


Q ss_pred             HHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          397 MDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       397 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      ..+......              ..+            .....+.+++.+|++.||.+||++.+.+.
T Consensus       206 ~~i~~~~~~--------------~~~------------~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         206 DNILNKPLQ--------------LKP------------NITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             HHHHhCCcC--------------CCC------------CCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence            111100000              000            01234788999999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=316.55  Aligned_cols=253  Identities=24%  Similarity=0.407  Sum_probs=205.8

Q ss_pred             CCCCCCeeeeeccceEEEEEeC--CCC--EEEEEEeeeccch-hhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA--DGE--TAAIKVLKLQQQG-ALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .....++||+|.||.|++|.|.  +|+  .||||.++..... ...+|++|+.+|.+|+|+|+++++|+..      +..
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl------~qp  184 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVL------DQP  184 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeec------cch
Confidence            3345578999999999999975  344  6899999866544 6689999999999999999999999842      356


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      ..+|||.++.|+|.+.|+...     ...+-......++.|||.||.||.++   ++|||||..+|+|+-..-.+||+||
T Consensus       185 ~mMV~ELaplGSLldrLrka~-----~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DF  256 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRKAK-----KAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDF  256 (1039)
T ss_pred             hhHHhhhcccchHHHHHhhcc-----ccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecc
Confidence            789999999999999998732     25677888899999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeec
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  390 (477)
                      |+.+.+...    ...+.+.....-++.|+|||.+ .++++.++|||+|||++|||+| |+.||.+....          
T Consensus       257 GLmRaLg~n----ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~----------  322 (1039)
T KOG0199|consen  257 GLMRALGEN----EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI----------  322 (1039)
T ss_pred             cceeccCCC----CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH----------
Confidence            999987432    2223444455567899999999 7889999999999999999999 89999763211          


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQ  466 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  466 (477)
                          .+.+.+|..                        .+...++.|.+.+.++++.||..+|++|||+..+.+.+-
T Consensus       323 ----qIL~~iD~~------------------------erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~  370 (1039)
T KOG0199|consen  323 ----QILKNIDAG------------------------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV  370 (1039)
T ss_pred             ----HHHHhcccc------------------------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence                334444422                        122234567888999999999999999999999985543

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.5e-38  Score=302.59  Aligned_cols=251  Identities=24%  Similarity=0.312  Sum_probs=198.2

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      +...+|+..+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+|++++++++     ..++.
T Consensus        16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~   90 (297)
T cd06656          16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDE   90 (297)
T ss_pred             ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCE
Confidence            3457899999999999999999986 47999999999866555557788999999999999999999986     45678


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++++|.+++..        ..+++.++..++.|++.||.|||+.   +++||||||+||+++.++.++|+||
T Consensus        91 ~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Df  159 (297)
T cd06656          91 LWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDF  159 (297)
T ss_pred             EEEeecccCCCCHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcC
Confidence            9999999999999999864        3478899999999999999999998   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      |++......       ........++..|+|||.+ .+.++.++|||||||++|++++|+.||........... .....
T Consensus       160 g~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-~~~~~  231 (297)
T cd06656         160 GFCAQITPE-------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IATNG  231 (297)
T ss_pred             ccceEccCC-------ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-eccCC
Confidence            998764221       1112234578899999998 55689999999999999999999999965322111000 00000


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      .+.         ..                          ........+.+++.+||+.+|++||++.++++
T Consensus       232 ~~~---------~~--------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         232 TPE---------LQ--------------------------NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCC---------CC--------------------------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000         00                          00011233678999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.7e-38  Score=305.86  Aligned_cols=192  Identities=28%  Similarity=0.386  Sum_probs=159.8

Q ss_pred             CeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHH-HHhcCCCCCcceeeeecccccCCCCceeeEEE
Q 043902          163 NLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECN-ALTSIRHRNILKIVSSCSSVDYEGNDFKALVF  237 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  237 (477)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|.. +++.++||||+++++++     ...+..++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence            46999999999999975 68899999997432   222344555554 57889999999999885     5567899999


Q ss_pred             eecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          238 EFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       238 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      ||+++|+|..++...       ..+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        76 e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  145 (321)
T cd05603          76 DYVNGGELFFHLQRE-------RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKE  145 (321)
T ss_pred             cCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence            999999999888643       4578889999999999999999998   999999999999999999999999999875


Q ss_pred             ccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ...       .........||..|+|||.+ ...++.++|||||||++|||++|+.||..
T Consensus       146 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  198 (321)
T cd05603         146 GVE-------PEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS  198 (321)
T ss_pred             CCC-------CCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC
Confidence            311       11122345689999999999 55689999999999999999999999965

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=6.9e-39  Score=314.44  Aligned_cols=201  Identities=25%  Similarity=0.260  Sum_probs=166.6

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec--cchhhHHHHHHHHHHhcCCCCCcceeeeeccccc-CCCC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSSCSSVD-YEGN  230 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~~  230 (477)
                      ..++|...+.||+|+||.||++... .++.||+|.+...  .......+.+|+.+++.++||||+++++++.... ....
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4578999999999999999999864 6889999998743  2333467888999999999999999999864321 1233


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ...++||||+++ +|.+.+.         ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~---------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~  161 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL  161 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh---------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEe
Confidence            457999999965 6766664         2478889999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |||+++....        ........||..|+|||++ ...++.++|||||||++|||++|+.||..
T Consensus       162 Dfg~~~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  220 (355)
T cd07874         162 DFGLARTAGT--------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG  220 (355)
T ss_pred             eCcccccCCC--------ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999975421        1122345689999999999 44689999999999999999999999965

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.1e-38  Score=296.52  Aligned_cols=249  Identities=25%  Similarity=0.363  Sum_probs=197.1

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCC-CCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      .++|+..+.||+|+||.||+|...+ ++.+++|.++....  .+.+.+|++++++++|+||+++++++     ......+
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~   74 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSY-----FKNTDLW   74 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCcEE
Confidence            3678899999999999999999764 88999999976543  57899999999999999999999986     4557789


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +++||+++++|.+++....      ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+
T Consensus        75 l~~e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~  145 (256)
T cd06612          75 IVMEYCGAGSVSDIMKITN------KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGV  145 (256)
T ss_pred             EEEecCCCCcHHHHHHhCc------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEccccc
Confidence            9999999999999986533      5689999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCC
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      +......       ........++..|+|||++ ...++.++||||||+++|+|++|+.||..........         
T Consensus       146 ~~~~~~~-------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~---------  209 (256)
T cd06612         146 SGQLTDT-------MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF---------  209 (256)
T ss_pred             chhcccC-------ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh---------
Confidence            9865321       1112234478899999998 4568999999999999999999999986532211000         


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                           .+.......             ..         ........+.+++.+|++.||++|||+.||++
T Consensus       210 -----~~~~~~~~~-------------~~---------~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         210 -----MIPNKPPPT-------------LS---------DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             -----hhccCCCCC-------------CC---------chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence                 000000000             00         00011234788999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.1e-38  Score=310.66  Aligned_cols=203  Identities=22%  Similarity=0.338  Sum_probs=171.5

Q ss_pred             HHHhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccC
Q 043902          152 ISNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDY  227 (477)
Q Consensus       152 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  227 (477)
                      +....++|+..+.||+|+||.||+++.. +++.+|+|++....   ......+.+|+.++..++||||+++++++     
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----  112 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----  112 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----
Confidence            3445689999999999999999999875 68899999987432   22335678899999999999999999885     


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcE
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIA  307 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~  307 (477)
                      ..+...++||||+++|+|.+++...        .++...+..++.|++.||.|||++   +|+||||||+||+++.++.+
T Consensus       113 ~~~~~~~lv~Ey~~gg~L~~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~i  181 (371)
T cd05622         113 QDDRYLYMVMEYMPGGDLVNLMSNY--------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHL  181 (371)
T ss_pred             EcCCEEEEEEcCCCCCcHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCE
Confidence            5667899999999999999998642        378888999999999999999999   99999999999999999999


Q ss_pred             EEecccccccccccCCCCCCCccccCCCcccccccCcccccC-----CCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          308 HVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-----HVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       308 kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ||+|||+++.....      .........||+.|+|||++.+     .++.++|||||||++|||++|+.||..
T Consensus       182 kL~DfG~a~~~~~~------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~  249 (371)
T cd05622         182 KLADFGTCMKMNKE------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA  249 (371)
T ss_pred             EEEeCCceeEcCcC------CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence            99999999865221      1112234569999999999832     378999999999999999999999965

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-38  Score=299.24  Aligned_cols=257  Identities=27%  Similarity=0.473  Sum_probs=199.5

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCC----EEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGE----TAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      .+|...+.||+|+||.||+|... +|.    .+|+|..+... ......+.+|+..+++++|||+++++++|..      
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------   80 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------   80 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence            56788899999999999999864 333    58999887553 3344678899999999999999999999742      


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ...++|+||+++|+|.+++....      ..+++..++.++.|++.||+|||+.   +++|+||||+||++++++.+||+
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~  151 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHK------DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKIT  151 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEEC
Confidence            56899999999999999997543      3589999999999999999999998   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~  388 (477)
                      |||.++......     .........++..|+|||.+ .+.++.++|+||||+++||++| |+.||......        
T Consensus       152 dfg~~~~~~~~~-----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------  218 (279)
T cd05057         152 DFGLAKLLDVDE-----KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--------  218 (279)
T ss_pred             CCcccccccCcc-----cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--------
Confidence            999998653211     11111223346789999988 5678999999999999999999 99998653211        


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                            .+.+.+.......             .+.           .+...+.+++.+||..+|.+||++.++++.|.++
T Consensus       219 ------~~~~~~~~~~~~~-------------~~~-----------~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         219 ------EIPDLLEKGERLP-------------QPP-----------ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             ------HHHHHHhCCCCCC-------------CCC-----------CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                  1111111100000             000           0123478899999999999999999999999998


Q ss_pred             HHh
Q 043902          469 RSK  471 (477)
Q Consensus       469 ~~~  471 (477)
                      ..+
T Consensus       269 ~~~  271 (279)
T cd05057         269 ARD  271 (279)
T ss_pred             HhC
Confidence            654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=8.4e-39  Score=299.09  Aligned_cols=249  Identities=23%  Similarity=0.338  Sum_probs=195.1

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec-cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ-QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      +|+..+.||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.++++++|+|++++.+.+     ...+..++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence            4778899999999999999865 6899999998743 234456788999999999999999999985     56678999


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      ||||+++|+|.+++.....     ..+++...+.++.|++.||.|||++   +++|+||||+||++++++.++++|||.+
T Consensus        76 v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~  147 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQRG-----KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSA  147 (255)
T ss_pred             EEeeCCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcc
Confidence            9999999999998865321     4578899999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCc
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPS  394 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  394 (477)
                      ......       ........|+..|+|||++ ...++.++|+||||+++|+|++|+.||........            
T Consensus       148 ~~~~~~-------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------------  208 (255)
T cd08219         148 RLLTSP-------GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------------  208 (255)
T ss_pred             eeeccc-------ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH------------
Confidence            765221       1112234678899999999 45689999999999999999999999964211000            


Q ss_pred             hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          395 HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       395 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                       ...+.    ...      .    ...+           ......+.+++.+||+.||++|||+.|++..
T Consensus       209 -~~~~~----~~~------~----~~~~-----------~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         209 -ILKVC----QGS------Y----KPLP-----------SHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -HHHHh----cCC------C----CCCC-----------cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence             00000    000      0    0000           0012337789999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.3e-38  Score=308.49  Aligned_cols=192  Identities=24%  Similarity=0.374  Sum_probs=163.4

Q ss_pred             CeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCCceeeEEE
Q 043902          163 NLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGNDFKALVF  237 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  237 (477)
                      +.||+|+||.||+|... +++.||+|+++...   ....+.+.+|..++.++ +||||+++++++     ...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence            46999999999999865 67899999998542   23345688899999888 699999999985     5567899999


Q ss_pred             eecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          238 EFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       238 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      ||+++|+|..++...       ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        76 e~~~~~~L~~~~~~~-------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~  145 (327)
T cd05617          76 EYVNGGDLMFHMQRQ-------RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKE  145 (327)
T ss_pred             eCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEecccccee
Confidence            999999999888644       4589999999999999999999999   999999999999999999999999999875


Q ss_pred             ccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ...       .........||..|+|||++ ...++.++|||||||++|||+||+.||..
T Consensus       146 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~  198 (327)
T cd05617         146 GLG-------PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI  198 (327)
T ss_pred             ccC-------CCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence            311       11122345689999999999 55789999999999999999999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.1e-38  Score=302.75  Aligned_cols=284  Identities=19%  Similarity=0.302  Sum_probs=199.7

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .++|...+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++     ......
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~~~~~   79 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSL   79 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE-----ecCCeE
Confidence            357889999999999999999865 68899999987543 23335678899999999999999999995     456779


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||++ ++|.+++....      ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg  149 (301)
T cd07873          80 TLVFEYLD-KDLKQYLDDCG------NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFG  149 (301)
T ss_pred             EEEEeccc-cCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCc
Confidence            99999996 58988886543      4578999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCcccccccc--eeeeee
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLS--IHKFVL  389 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~--~~~~~~  389 (477)
                      ++......       ........++..|+|||.+.  ..++.++|||||||++|||+||+.||.........  ......
T Consensus       150 ~~~~~~~~-------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~  222 (301)
T cd07873         150 LARAKSIP-------TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILG  222 (301)
T ss_pred             chhccCCC-------CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence            99754211       11122345688999999983  34788999999999999999999999653221100  000000


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH--HHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN--NLQA  467 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  467 (477)
                      .........+++.....           ....+.................+.+++.+|++.||.+|||++|+++  .++.
T Consensus       223 ~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~  291 (301)
T cd07873         223 TPTEETWPGILSNEEFK-----------SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC  291 (301)
T ss_pred             CCChhhchhhhcccccc-----------ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            00000000000000000           0000000000000111112334789999999999999999999987  4554


Q ss_pred             HHHhh
Q 043902          468 IRSKI  472 (477)
Q Consensus       468 i~~~~  472 (477)
                      +.+++
T Consensus       292 ~~~~~  296 (301)
T cd07873         292 LGERI  296 (301)
T ss_pred             ccchh
Confidence            44443

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3e-38  Score=297.81  Aligned_cols=255  Identities=22%  Similarity=0.371  Sum_probs=185.1

Q ss_pred             CeeeeeccceEEEEEeCC---CCEEEEEEeeeccc-hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEe
Q 043902          163 NLIGSGSFGSVYKGTLAD---GETAAIKVLKLQQQ-GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFE  238 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  238 (477)
                      +.||+|+||.||+|...+   +..+|+|.++.... .....+.+|+.++++++||||+++++++     ......++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQC-----TEVTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCCCCcEEEEE
Confidence            358999999999998643   45789998875432 3335788999999999999999999986     34556899999


Q ss_pred             ecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccc
Q 043902          239 FMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFL  318 (477)
Q Consensus       239 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  318 (477)
                      |+++|+|.+++......  .....++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+++..
T Consensus        76 ~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~  150 (269)
T cd05087          76 FCPLGDLKGYLRSCRKA--ELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNK  150 (269)
T ss_pred             CCCCCcHHHHHHHhhhc--ccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccc
Confidence            99999999999753211  113467788889999999999999998   9999999999999999999999999998754


Q ss_pred             cccCCCCCCCccccCCCcccccccCcccccC--------CCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeee
Q 043902          319 FEESNTPSKNQTMSNGLKGSVGYIPPEYING--------HVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~  389 (477)
                      ....     .........++..|+|||++.+        .++.++||||||+++|||++ |+.||.........      
T Consensus       151 ~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~------  219 (269)
T cd05087         151 YKED-----YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL------  219 (269)
T ss_pred             cCcc-----eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH------
Confidence            2111     1112233456788999999842        25789999999999999996 99999653221100      


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQ  466 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  466 (477)
                             ...+.....        ....    +.+..        .....+.+++..|+ .+|++|||++||+..|+
T Consensus       220 -------~~~~~~~~~--------~~~~----~~~~~--------~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         220 -------TYTVREQQL--------KLPK----PRLKL--------PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             -------HHHhhcccC--------CCCC----CccCC--------CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence                   000000000        0000    00000        00223677888998 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.2e-38  Score=306.44  Aligned_cols=198  Identities=27%  Similarity=0.373  Sum_probs=165.4

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCC-CCCcceeeeecccccCCCCce
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIR-HRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~  232 (477)
                      +|+..+.||+|+||.||+|... +|+.||+|+++...   ....+.+..|..++..+. |++|+++.+++     ...+.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence            3677889999999999999865 68999999997532   233456788999998886 56777787774     55678


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++|+|.+++...       ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+||
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~~-------~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Df  145 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQV-------GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADF  145 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEecc
Confidence            99999999999999998654       4589999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      |+++....       .........||..|+|||++ .+.++.++|||||||++|||+||+.||...
T Consensus       146 g~~~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~  204 (323)
T cd05615         146 GMCKEHMV-------DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE  204 (323)
T ss_pred             ccccccCC-------CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC
Confidence            99875321       11122334689999999999 556899999999999999999999999653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-38  Score=309.45  Aligned_cols=201  Identities=25%  Similarity=0.334  Sum_probs=167.3

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeeccccc-CCC
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVD-YEG  229 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~  229 (477)
                      ...++|...+.||+|+||.||+|... +++.||+|.++...  ......+.+|++++++++||||+++++++.... ...
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            34578999999999999999999864 78899999987532  223356778999999999999999998864321 122


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEE
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV  309 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl  309 (477)
                      ....+++++++ +++|.+++..        ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl  159 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKC--------QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRI  159 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEE
Confidence            34578999988 7899888753        3489999999999999999999999   9999999999999999999999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      +|||+++....          ......||..|+|||++.  ..++.++|||||||++|||++|+.||..
T Consensus       160 ~Dfg~~~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  218 (343)
T cd07878         160 LDFGLARQADD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG  218 (343)
T ss_pred             cCCccceecCC----------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            99999986521          123346899999999984  3589999999999999999999999965

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-38  Score=296.48  Aligned_cols=253  Identities=25%  Similarity=0.339  Sum_probs=198.6

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      .++|+..+.||.|+||.||+|... +++.+++|.+........+.+.+|++++++++||||+++++++     ......+
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~   76 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDKLW   76 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCEEE
Confidence            357888999999999999999864 6789999999876655668899999999999999999999985     4567799


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      ++|||+++++|.+++....      ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||.
T Consensus        77 l~~e~~~~~~l~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~  147 (262)
T cd06613          77 IVMEYCGGGSLQDIYQVTR------GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGV  147 (262)
T ss_pred             EEEeCCCCCcHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECcccc
Confidence            9999999999999987542      4588999999999999999999998   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cC---CCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NG---HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~---~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      +......       ........++..|+|||.+ ..   .++.++|||||||++|||+||+.||........        
T Consensus       148 ~~~~~~~-------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--------  212 (262)
T cd06613         148 SAQLTAT-------IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--------  212 (262)
T ss_pred             chhhhhh-------hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--------
Confidence            8765221       1112334678889999998 34   688999999999999999999999865321110        


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                           ..........    .           +..      .........+.+++.+|+..+|.+|||+++|+.
T Consensus       213 -----~~~~~~~~~~----~-----------~~~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         213 -----LFLISKSNFP----P-----------PKL------KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             -----HHHHHhccCC----C-----------ccc------cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                 0000000000    0           000      000111344889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=7.9e-39  Score=299.12  Aligned_cols=246  Identities=28%  Similarity=0.516  Sum_probs=192.9

Q ss_pred             cCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEE
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALV  236 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  236 (477)
                      ++|++.+.||+|+||.||++.. +++.||+|.++...  ....+.+|+.++.+++|||++++++++.      .+..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~------~~~~~~v   76 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVIL------HNGLYIV   76 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEc------CCCcEEE
Confidence            4688899999999999999975 67889999987543  2367889999999999999999999863      2336899


Q ss_pred             EeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccc
Q 043902          237 FEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK  316 (477)
Q Consensus       237 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  316 (477)
                      |||+++++|.+++.....     ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus        77 ~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~  148 (254)
T cd05083          77 MELMSKGNLVNFLRTRGR-----ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLAR  148 (254)
T ss_pred             EECCCCCCHHHHHHhcCc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccce
Confidence            999999999999975421     4578999999999999999999998   99999999999999999999999999987


Q ss_pred             cccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCCc
Q 043902          317 FLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALPS  394 (477)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  394 (477)
                      ....          .......+..|+|||.+ .+.++.++|+|||||++|||++ |+.||.......             
T Consensus       149 ~~~~----------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------------  205 (254)
T cd05083         149 VGSM----------GVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------------  205 (254)
T ss_pred             eccc----------cCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-------------
Confidence            5421          01122345679999998 5678999999999999999998 999986432110             


Q ss_pred             hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHH
Q 043902          395 HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQA  467 (477)
Q Consensus       395 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  467 (477)
                       ..+.+.......                        ....++..+.+++.+|++.+|++||+++++++.|++
T Consensus       206 -~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         206 -VKECVEKGYRME------------------------PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -HHHHHhCCCCCC------------------------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence             111111100000                        000113447899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.7e-38  Score=309.03  Aligned_cols=263  Identities=24%  Similarity=0.423  Sum_probs=199.4

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC--------CCCEEEEEEeeecc-chhhHHHHHHHHHHhcC-CCCCcceeeeeccccc
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA--------DGETAAIKVLKLQQ-QGALKSFIDECNALTSI-RHRNILKIVSSCSSVD  226 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  226 (477)
                      .+|.+.+.||+|+||.||+|...        .+..||+|.++... ....+.+.+|++++.++ +||||++++++|    
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~----   87 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC----   87 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE----
Confidence            46888999999999999999742        12368999887543 33457889999999999 799999999996    


Q ss_pred             CCCCceeeEEEeecCCCChhhhcccCCCc---------ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCC
Q 043902          227 YEGNDFKALVFEFMRNGNLDQWLHPSTDE---------YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSS  297 (477)
Q Consensus       227 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~  297 (477)
                       ...+..++++||+++|+|.+++......         ......+++..++.++.|++.||.|||+.   +++||||||+
T Consensus        88 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~  163 (334)
T cd05100          88 -TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR  163 (334)
T ss_pred             -ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence             3456789999999999999998753210         01224588999999999999999999998   9999999999


Q ss_pred             CeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCC
Q 043902          298 NVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTD  375 (477)
Q Consensus       298 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~  375 (477)
                      ||+++.++.+||+|||+++......     .........++..|+|||.+ ...++.++|||||||++|||++ |..||.
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~  238 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNID-----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP  238 (334)
T ss_pred             eEEEcCCCcEEECCcccceeccccc-----ccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCC
Confidence            9999999999999999997652211     01112223345679999998 5568999999999999999998 888885


Q ss_pred             cccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCC
Q 043902          376 DMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDR  455 (477)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R  455 (477)
                      ....+.              ....+.......             .           ...+...+.+++.+|++.+|++|
T Consensus       239 ~~~~~~--------------~~~~~~~~~~~~-------------~-----------~~~~~~~l~~li~~cl~~~p~~R  280 (334)
T cd05100         239 GIPVEE--------------LFKLLKEGHRMD-------------K-----------PANCTHELYMIMRECWHAVPSQR  280 (334)
T ss_pred             CCCHHH--------------HHHHHHcCCCCC-------------C-----------CCCCCHHHHHHHHHHcccChhhC
Confidence            432111              111110000000             0           00113348899999999999999


Q ss_pred             CChHHHHHHHHHHHH
Q 043902          456 VGMKFVVNNLQAIRS  470 (477)
Q Consensus       456 Ps~~evl~~L~~i~~  470 (477)
                      ||+.|+++.|+++..
T Consensus       281 ps~~ell~~l~~~~~  295 (334)
T cd05100         281 PTFKQLVEDLDRVLT  295 (334)
T ss_pred             cCHHHHHHHHHHHhh
Confidence            999999999998874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.4e-38  Score=296.73  Aligned_cols=254  Identities=22%  Similarity=0.386  Sum_probs=195.1

Q ss_pred             CCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeecc------chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          158 NFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQ------QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      +|...+.||+|+||.||+|...+++.+|+|.++...      ......+.+|++.+++++|+||++++++|     ...+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~   75 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-----LDDN   75 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-----ecCC
Confidence            477889999999999999998889999999987432      12235688999999999999999999996     4457


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++|+||+++++|.+++...       ..+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d  145 (265)
T cd06631          76 TISIFMEFVPGGSISSILNRF-------GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLID  145 (265)
T ss_pred             eEEEEEecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEecc
Confidence            899999999999999999643       3578899999999999999999998   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      ||++.......... ..........++..|+|||++ ...++.++|||||||++|+|++|+.||........        
T Consensus       146 fg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--------  216 (265)
T cd06631         146 FGCARRLAWVGLHG-THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA--------  216 (265)
T ss_pred             chhhHhhhhccccc-cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH--------
Confidence            99987652211110 111122345688999999999 45688999999999999999999999964311100        


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                           ........               ...+.+..        .....+.+++.+|++.+|++||++.|+++
T Consensus       217 -----~~~~~~~~---------------~~~~~~~~--------~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         217 -----MFYIGAHR---------------GLMPRLPD--------SFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             -----HHHhhhcc---------------CCCCCCCC--------CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                 00000000               00000000        01234789999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.2e-39  Score=282.65  Aligned_cols=253  Identities=25%  Similarity=0.375  Sum_probs=201.6

Q ss_pred             HHhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--------chhhHHHHHHHHHHhcC-CCCCcceeeeec
Q 043902          153 SNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--------QGALKSFIDECNALTSI-RHRNILKIVSSC  222 (477)
Q Consensus       153 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  222 (477)
                      ......|...+.||.|..+.|-++..+ +|..+|+|++....        ....+.-..|+.+|.++ .||+|+++.++ 
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~-   91 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV-   91 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee-
Confidence            344567888899999999999988754 78899999986432        11235567899999998 69999999999 


Q ss_pred             ccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec
Q 043902          223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD  302 (477)
Q Consensus       223 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~  302 (477)
                          ++.+...++|+|.|+.|.|.++|...       -.+++....+|+.|+.+|+.|||..   +||||||||+|||+|
T Consensus        92 ----yes~sF~FlVFdl~prGELFDyLts~-------VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILld  157 (411)
T KOG0599|consen   92 ----YESDAFVFLVFDLMPRGELFDYLTSK-------VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLD  157 (411)
T ss_pred             ----ccCcchhhhhhhhcccchHHHHhhhh-------eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeec
Confidence                57888899999999999999999865       5699999999999999999999999   999999999999999


Q ss_pred             CCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccccC-------CCCcccceeehHHHHHHHhhCCCCCC
Q 043902          303 EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-------HVSILGDIYSYGILLLEIFTGKRPTD  375 (477)
Q Consensus       303 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~Dv~S~Gvvl~elltg~~p~~  375 (477)
                      ++.++||+|||+++.+.+        .......+||++|.|||.+..       .|+...|+||.||++|.|+.|.+||-
T Consensus       158 dn~~i~isDFGFa~~l~~--------GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw  229 (411)
T KOG0599|consen  158 DNMNIKISDFGFACQLEP--------GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW  229 (411)
T ss_pred             cccceEEeccceeeccCC--------chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence            999999999999998733        233455789999999999832       37889999999999999999999995


Q ss_pred             cccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCC
Q 043902          376 DMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDR  455 (477)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R  455 (477)
                      ..                   .+++-.++..+-..                ++..+++.+....+.+|+.+||+.||.+|
T Consensus       230 HR-------------------kQmlMLR~ImeGky----------------qF~speWadis~~~KdLIsrlLqVdp~~R  274 (411)
T KOG0599|consen  230 HR-------------------KQMLMLRMIMEGKY----------------QFRSPEWADISATVKDLISRLLQVDPTKR  274 (411)
T ss_pred             HH-------------------HHHHHHHHHHhccc----------------ccCCcchhhccccHHHHHHHHHeeCchhc
Confidence            31                   11222222111000                01111222334458899999999999999


Q ss_pred             CChHHHHH
Q 043902          456 VGMKFVVN  463 (477)
Q Consensus       456 Ps~~evl~  463 (477)
                      .|++|+++
T Consensus       275 itake~La  282 (411)
T KOG0599|consen  275 ITAKEALA  282 (411)
T ss_pred             ccHHHHhc
Confidence            99999985

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.5e-38  Score=296.24  Aligned_cols=249  Identities=24%  Similarity=0.421  Sum_probs=193.8

Q ss_pred             CeeeeeccceEEEEEeCC--C--CEEEEEEeeeccc-hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEE
Q 043902          163 NLIGSGSFGSVYKGTLAD--G--ETAAIKVLKLQQQ-GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVF  237 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  237 (477)
                      +.||+|++|.||+|.+.+  +  ..||+|.++.... ...+.+.+|+..+++++||||+++++++.     . ...++|+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-----T-HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEc-----C-CeEEEEE
Confidence            468999999999998643  3  3699999986655 55678999999999999999999999863     3 6789999


Q ss_pred             eecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          238 EFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       238 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      ||+++++|.+++.....     ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||+++.
T Consensus        75 e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~  146 (257)
T cd05040          75 ELAPLGSLLDRLRKDAL-----GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRA  146 (257)
T ss_pred             EecCCCcHHHHHHhccc-----ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccc
Confidence            99999999999976431     3589999999999999999999999   999999999999999999999999999987


Q ss_pred             ccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCCch
Q 043902          318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALPSH  395 (477)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  395 (477)
                      ......    .........++..|+|||++ ...++.++|||||||++|||+| |+.||.......              
T Consensus       147 ~~~~~~----~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------------  208 (257)
T cd05040         147 LPQNED----HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--------------  208 (257)
T ss_pred             cccccc----ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--------------
Confidence            632111    11122234567889999998 4578999999999999999999 999986432111              


Q ss_pred             hHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHH
Q 043902          396 VMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQ  466 (477)
Q Consensus       396 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  466 (477)
                      ....++...  .      ..    ..           .+..+..+.+++.+|++.+|++|||+.|+++.|.
T Consensus       209 ~~~~~~~~~--~------~~----~~-----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         209 ILKKIDKEG--E------RL----ER-----------PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             HHHHHHhcC--C------cC----CC-----------CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            011111000  0      00    00           0011345889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-38  Score=295.64  Aligned_cols=247  Identities=26%  Similarity=0.463  Sum_probs=192.7

Q ss_pred             CeeeeeccceEEEEEeCCCCEEEEEEeeeccch-hhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEeecC
Q 043902          163 NLIGSGSFGSVYKGTLADGETAAIKVLKLQQQG-ALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMR  241 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~  241 (477)
                      ++||+|+||.||++...+++.|++|.++..... ....+.+|++++++++|+||+++++++     ......++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~e~~~   75 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC-----VQKQPIYIVMELVP   75 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEE-----ecCCCeEEEEEcCC
Confidence            468999999999999877999999998765433 456889999999999999999999986     45567899999999


Q ss_pred             CCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccccccc
Q 043902          242 NGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEE  321 (477)
Q Consensus       242 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  321 (477)
                      +++|.+++....      ..+++..++.++.+++.||.|||++   +++||||+|+||+++.++.+||+|||.+......
T Consensus        76 ~~~l~~~l~~~~------~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  146 (251)
T cd05041          76 GGSLLTFLRKKK------NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGG  146 (251)
T ss_pred             CCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence            999999986542      3578999999999999999999999   9999999999999999999999999999754211


Q ss_pred             CCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCCchhHHH
Q 043902          322 SNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALPSHVMDV  399 (477)
Q Consensus       322 ~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (477)
                      .     ..........+..|+|||.+ .+.++.++|||||||++|||+| |..||......              ...+.
T Consensus       147 ~-----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--------------~~~~~  207 (251)
T cd05041         147 I-----YTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--------------QTRER  207 (251)
T ss_pred             c-----ceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--------------HHHHH
Confidence            0     01111122346679999998 5678999999999999999999 88888543211              11111


Q ss_pred             hhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHH
Q 043902          400 LDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQ  466 (477)
Q Consensus       400 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  466 (477)
                      +.......                        ..+.++..+.+++.+|+..+|++|||+.|+++.|+
T Consensus       208 ~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         208 IESGYRMP------------------------APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HhcCCCCC------------------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            11100000                        00111345889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.7e-38  Score=300.28  Aligned_cols=248  Identities=22%  Similarity=0.307  Sum_probs=193.1

Q ss_pred             CCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEE
Q 043902          159 FSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVF  237 (477)
Q Consensus       159 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  237 (477)
                      |++.+.||+|+||.||+|... ++..+++|.+........+.+.+|++++..++|||++++++++     ...+..++|+
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-----~~~~~~~~v~   81 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF-----YYENNLWILI   81 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEE-----eeCCEEEEEE
Confidence            567788999999999999975 5788899998766555667889999999999999999999986     3456789999


Q ss_pred             eecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          238 EFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       238 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      ||+++++|..++....      ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus        82 e~~~~~~l~~~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~  152 (282)
T cd06643          82 EFCAGGAVDAVMLELE------RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK  152 (282)
T ss_pred             EecCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccc
Confidence            9999999999876432      4589999999999999999999998   999999999999999999999999999875


Q ss_pred             ccccCCCCCCCccccCCCcccccccCccccc------CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYIN------GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      ...       .........++..|+|||++.      ..++.++|||||||++|||++|+.||........         
T Consensus       153 ~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---------  216 (282)
T cd06643         153 NTR-------TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV---------  216 (282)
T ss_pred             ccc-------cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH---------
Confidence            421       111223346888999999872      2367899999999999999999999864321100         


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                          ..........            ....+           ......+.+++.+||+.||++||++.++++
T Consensus       217 ----~~~~~~~~~~------------~~~~~-----------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         217 ----LLKIAKSEPP------------TLAQP-----------SRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             ----HHHHhhcCCC------------CCCCc-----------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                0000000000            00000           001234789999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.3e-38  Score=304.87  Aligned_cols=203  Identities=21%  Similarity=0.284  Sum_probs=160.3

Q ss_pred             CCeeeeeccceEEEEEeC---CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEe
Q 043902          162 ENLIGSGSFGSVYKGTLA---DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFE  238 (477)
Q Consensus       162 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  238 (477)
                      ...||+|+||.||+|+..   ++..||+|.++....  ...+.+|++++++++||||+++++++..   ..+...++|+|
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEe
Confidence            368999999999999865   457899998875432  2467889999999999999999998642   34567899999


Q ss_pred             ecCCCChhhhcccCCC--cccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEe----cCCCcEEEecc
Q 043902          239 FMRNGNLDQWLHPSTD--EYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL----DEGMIAHVGDF  312 (477)
Q Consensus       239 ~~~~g~L~~~l~~~~~--~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~Df  312 (477)
                      |+.+ +|.+++.....  .......+++..+..++.|++.||.|||+.   +|+||||||+||++    +.++.+||+||
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            9864 77777643211  011224588999999999999999999999   99999999999999    56679999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      |+++......    ..........+|..|+|||++.  ..++.++|||||||++|||+||+.||...
T Consensus       157 G~a~~~~~~~----~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         157 GFARLFNSPL----KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cceeccCCCc----ccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            9998653211    1112233456899999999983  34799999999999999999999999653

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.2e-38  Score=300.59  Aligned_cols=253  Identities=29%  Similarity=0.503  Sum_probs=191.4

Q ss_pred             CeeeeeccceEEEEEeCC-------CCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          163 NLIGSGSFGSVYKGTLAD-------GETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      +.||+|+||.||+|+..+       +..+|+|.+.... ......+.+|+.++++++||||++++++|     ...+..+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVC-----LLNEPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeee-----cCCCCeE
Confidence            368999999999998642       2579999886443 23456889999999999999999999986     3455689


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC-----cEEE
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM-----IAHV  309 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-----~~kl  309 (477)
                      +||||+++++|.+++............+++..++.++.|++.||.|||+.   +++|+||||+||+++.+.     .++|
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l  152 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKI  152 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEE
Confidence            99999999999999975422111224578999999999999999999998   999999999999999877     8999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeee
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~  387 (477)
                      +|||+++.......     ........++..|+|||++ .+.++.++|||||||++|||+| |+.||......       
T Consensus       153 ~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-------  220 (269)
T cd05044         153 GDFGLARDIYKSDY-----YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-------  220 (269)
T ss_pred             CCcccccccccccc-----cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-------
Confidence            99999976532111     1111223456789999998 6678999999999999999998 99998642111       


Q ss_pred             eeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHH
Q 043902          388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQ  466 (477)
Q Consensus       388 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  466 (477)
                             .....++......                        .....+..+.+++.+||..+|++||++.+|++.|+
T Consensus       221 -------~~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         221 -------EVLQHVTAGGRLQ------------------------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             -------HHHHHHhcCCccC------------------------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                   0111111000000                        00111345789999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.7e-38  Score=300.58  Aligned_cols=250  Identities=24%  Similarity=0.361  Sum_probs=192.8

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .|+..+.||+|+||.||++... +++.||+|.+....   ......+.+|+.++.+++|++++++++.+     ...+..
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~   75 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEE
Confidence            3677789999999999999865 68999999987432   22234577899999999999999999885     456689


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||+++++|.+++.....     ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||
T Consensus        76 ~lv~e~~~g~~L~~~l~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg  147 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYHMGE-----AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLG  147 (285)
T ss_pred             EEEEEecCCCcHHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeecc
Confidence            999999999999998864321     4588999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccC
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMAL  392 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  392 (477)
                      ++.....        ........|+..|+|||++ .+.++.++|||||||++|||++|+.||........          
T Consensus       148 ~~~~~~~--------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~----------  209 (285)
T cd05630         148 LAVHVPE--------GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK----------  209 (285)
T ss_pred             ceeecCC--------CccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch----------
Confidence            9875421        1111234689999999999 56789999999999999999999999965321100          


Q ss_pred             CchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCC-----hHHHHH
Q 043902          393 PSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVG-----MKFVVN  463 (477)
Q Consensus       393 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  463 (477)
                      .+......+.. .                        ......+...+.+++..||+.||++|||     ++|+++
T Consensus       210 ~~~~~~~~~~~-~------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         210 REEVERLVKEV-Q------------------------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             HHHHHhhhhhh-h------------------------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            00000000000 0                        0000111334789999999999999999     888886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.1e-38  Score=301.49  Aligned_cols=199  Identities=25%  Similarity=0.390  Sum_probs=166.1

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      +|+..+.||+|++|.||+|+.. ++..||+|.++...  ......+.+|+.++.+++|||++++++++     ..+...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVL-----MQESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEE-----eeCCeEE
Confidence            4778899999999999999875 68999999987543  22346788999999999999999999996     4567889


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +||||++ ++|.+++.....    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||+
T Consensus        76 ~v~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~  147 (285)
T cd07861          76 LIFEFLS-MDLKKYLDSLPK----GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGL  147 (285)
T ss_pred             EEEecCC-CCHHHHHhcCCC----CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccc
Confidence            9999997 689888864321    24689999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccccC--CCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      +.....       .........++..|+|||.+.+  .++.++|||||||++|||+||+.||..
T Consensus       148 ~~~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~  204 (285)
T cd07861         148 ARAFGI-------PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG  204 (285)
T ss_pred             eeecCC-------CcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            875421       1111223456889999998833  478999999999999999999999965

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3e-38  Score=301.38  Aligned_cols=266  Identities=24%  Similarity=0.273  Sum_probs=201.1

Q ss_pred             cHHHHHHhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcC-CCCCcceeeeecccc
Q 043902          148 SYLKISNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSI-RHRNILKIVSSCSSV  225 (477)
Q Consensus       148 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  225 (477)
                      ...++..++++|...+.||+|+||.||++... +++.+|+|++..... ....+.+|+.++.++ +|||++++++++...
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            33455667889999999999999999999864 688999999875432 235677899999998 799999999997643


Q ss_pred             cCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC
Q 043902          226 DYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM  305 (477)
Q Consensus       226 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~  305 (477)
                      +....+..++||||+++++|.++++....   ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~  165 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLI---CGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEG  165 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence            33344678999999999999998864221   124689999999999999999999998   999999999999999999


Q ss_pred             cEEEecccccccccccCCCCCCCccccCCCcccccccCccccc-C-----CCCcccceeehHHHHHHHhhCCCCCCcccc
Q 043902          306 IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-G-----HVSILGDIYSYGILLLEIFTGKRPTDDMFK  379 (477)
Q Consensus       306 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~-----~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~  379 (477)
                      .+||+|||++......       ........|+..|+|||.+. +     .++.++|||||||++|||++|+.||.....
T Consensus       166 ~~kl~dfg~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~  238 (291)
T cd06639         166 GVKLVDFGVSAQLTST-------RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP  238 (291)
T ss_pred             CEEEeecccchhcccc-------cccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence            9999999998765221       11122345788999999873 2     268999999999999999999999865321


Q ss_pred             cccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChH
Q 043902          380 DDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMK  459 (477)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~  459 (477)
                      ..             .+.++.....        ...      .         ..+.....+.+++.+|++.+|++||++.
T Consensus       239 ~~-------------~~~~~~~~~~--------~~~------~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~  282 (291)
T cd06639         239 VK-------------TLFKIPRNPP--------PTL------L---------HPEKWCRSFNHFISQCLIKDFEARPSVT  282 (291)
T ss_pred             HH-------------HHHHHhcCCC--------CCC------C---------cccccCHHHHHHHHHHhhcChhhCcCHH
Confidence            10             0000000000        000      0         0001123488999999999999999999


Q ss_pred             HHHH
Q 043902          460 FVVN  463 (477)
Q Consensus       460 evl~  463 (477)
                      |+++
T Consensus       283 ~il~  286 (291)
T cd06639         283 HLLE  286 (291)
T ss_pred             HHhc
Confidence            9985

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-38  Score=304.08  Aligned_cols=200  Identities=26%  Similarity=0.382  Sum_probs=169.2

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec---cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ---QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ++|++.+.||+|+||.||+++.. +++.||+|+++..   .....+.+.+|..++..++|+||+++++++     ..++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence            47889999999999999999965 6899999999742   223345688899999999999999999985     56678


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++|+|.+++....      ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Df  146 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSKFE------DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADF  146 (331)
T ss_pred             EEEEEecCCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEEC
Confidence            999999999999999996532      4588999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCccccc------CCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN------GHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |++......      .........||..|+|||++.      +.++.++|||||||++|||++|+.||..
T Consensus       147 g~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  210 (331)
T cd05597         147 GSCLRLLAD------GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             CceeecCCC------CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence            998765221      111122346899999999984      3478899999999999999999999964

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3e-38  Score=303.01  Aligned_cols=259  Identities=27%  Similarity=0.468  Sum_probs=197.7

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCC----EEEEEEeeeccc-hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGE----TAAIKVLKLQQQ-GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEG  229 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  229 (477)
                      .++|+..+.||+|+||.||+|... +|.    .+|+|.+..... .....+.+|+.++++++||||++++++|..     
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----   80 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-----   80 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-----
Confidence            356778899999999999999863 444    578888875432 233478899999999999999999998732     


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEE
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV  309 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl  309 (477)
                       ...++++||+++|+|.+++....      ..+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||
T Consensus        81 -~~~~~v~e~~~~g~l~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL  150 (303)
T cd05110          81 -PTIQLVTQLMPHGCLLDYVHEHK------DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKI  150 (303)
T ss_pred             -CCceeeehhcCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEE
Confidence             23579999999999999987542      3578999999999999999999999   9999999999999999999999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeee
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~  387 (477)
                      +|||+++......     .........++..|+|||.+ ...++.++|||||||++|||++ |+.||......       
T Consensus       151 ~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~-------  218 (303)
T cd05110         151 TDFGLARLLEGDE-----KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR-------  218 (303)
T ss_pred             ccccccccccCcc-----cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------
Confidence            9999998653211     11112233457789999998 4568999999999999999998 89998653211       


Q ss_pred             eeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHH
Q 043902          388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQA  467 (477)
Q Consensus       388 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  467 (477)
                             ...+++.......             .+           ..+...+.+++..|+..+|++||++.++++.|++
T Consensus       219 -------~~~~~~~~~~~~~-------------~~-----------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~  267 (303)
T cd05110         219 -------EIPDLLEKGERLP-------------QP-----------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR  267 (303)
T ss_pred             -------HHHHHHHCCCCCC-------------CC-----------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                   1111111100000             00           0012347889999999999999999999999998


Q ss_pred             HHHhh
Q 043902          468 IRSKI  472 (477)
Q Consensus       468 i~~~~  472 (477)
                      +....
T Consensus       268 ~~~~~  272 (303)
T cd05110         268 MARDP  272 (303)
T ss_pred             HHhch
Confidence            86553

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.3e-38  Score=301.09  Aligned_cols=261  Identities=23%  Similarity=0.327  Sum_probs=199.3

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .++|+..+.||+|+||.||++... +|+.||+|++.... ....+.+.+|++++..++||||+++++++     ......
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   78 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF-----LNENNI   78 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeE-----ecCCEE
Confidence            356788899999999999999865 68899999887543 33457889999999999999999999996     445788


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||+++++|.+++...       ..+++..+..++.+++.||.|||+.  .+++||||+|+||++++++.++|+|||
T Consensus        79 ~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~g  149 (284)
T cd06620          79 CMCMEFMDCGSLDRIYKKG-------GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFG  149 (284)
T ss_pred             EEEEecCCCCCHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCC
Confidence            9999999999999988653       4589999999999999999999973  189999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccC
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMAL  392 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  392 (477)
                      ++.....         .......|+..|+|||++ .+.++.++|||||||++|+++||+.||........      ....
T Consensus       150 l~~~~~~---------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~------~~~~  214 (284)
T cd06620         150 VSGELIN---------SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD------GQDD  214 (284)
T ss_pred             cccchhh---------hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhh------hhhh
Confidence            9865421         111234688999999998 56789999999999999999999999975432211      0000


Q ss_pred             CchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHH
Q 043902          393 PSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNL  465 (477)
Q Consensus       393 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  465 (477)
                      +..+.+.+.......          ....+          ..+++..+.+++.+|++.||++|||+.|+++..
T Consensus       215 ~~~~~~~~~~~~~~~----------~~~~~----------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         215 PMGILDLLQQIVQEP----------PPRLP----------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             hhHHHHHHHHHhhcc----------CCCCC----------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            111111111111000          00000          011234588999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=8.8e-38  Score=297.10  Aligned_cols=197  Identities=25%  Similarity=0.392  Sum_probs=167.0

Q ss_pred             CCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          159 FSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       159 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      |+..+.||+|+||.||+|... +++.+|+|.+....   ......+.+|++++.+++|+|++++.+++     ..++..+
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~   76 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDALC   76 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEEE
Confidence            667789999999999999864 78999999987542   22234578899999999999999998885     4567899


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +||||+++++|.+++....     ...+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|||+
T Consensus        77 lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~  148 (285)
T cd05632          77 LVLTIMNGGDLKFHIYNMG-----NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGL  148 (285)
T ss_pred             EEEEeccCccHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCc
Confidence            9999999999998886432     14589999999999999999999998   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      +.....        ........|+..|+|||++ .+.++.++|+|||||++|||++|..||..
T Consensus       149 ~~~~~~--------~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~  203 (285)
T cd05632         149 AVKIPE--------GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG  203 (285)
T ss_pred             ceecCC--------CCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence            875421        1112234689999999999 56789999999999999999999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-38  Score=301.47  Aligned_cols=253  Identities=23%  Similarity=0.364  Sum_probs=198.8

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ..++|++.+.||.|+||.||+|... ++..+|+|+++.......+.+..|++++++++|+||+++++.+     ..+...
T Consensus         3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   77 (280)
T cd06611           3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY-----FYENKL   77 (280)
T ss_pred             chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----ecCCeE
Confidence            3567889999999999999999875 6899999999877666667899999999999999999999985     456778


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||+++++|.+++....      ..+++..+..++.|++.||.|||+.   +|+|+||+|+||+++.++.++|+|||
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g  148 (280)
T cd06611          78 WILIEFCDGGALDSIMLELE------RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFG  148 (280)
T ss_pred             EEEeeccCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCc
Confidence            99999999999999987543      4589999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCccccc------CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeee
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN------GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~  387 (477)
                      ++.....       .........++..|+|||.+.      ..++.++||||||+++|||++|+.||.......      
T Consensus       149 ~~~~~~~-------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------  215 (280)
T cd06611         149 VSAKNKS-------TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------  215 (280)
T ss_pred             cchhhcc-------cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------
Confidence            9875421       111223345788999999872      236789999999999999999999986532110      


Q ss_pred             eeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       388 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                             ....+...    .   .          +.+.      ....+...+.+++..|++.+|++||++.++++.
T Consensus       216 -------~~~~~~~~----~---~----------~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         216 -------VLLKILKS----E---P----------PTLD------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             -------HHHHHhcC----C---C----------CCcC------CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                   00000000    0   0          0000      000112347889999999999999999999863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.8e-38  Score=322.16  Aligned_cols=199  Identities=22%  Similarity=0.320  Sum_probs=160.5

Q ss_pred             HHhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCC------CCcceeeeecccc
Q 043902          153 SNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRH------RNILKIVSSCSSV  225 (477)
Q Consensus       153 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~~~~  225 (477)
                      ...+++|.+.+.||+|+||.||+|... +++.||||+++.... ....+..|++++.+++|      .+++++++++.  
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~--  201 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ--  201 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE--
Confidence            345688999999999999999999864 688999999974322 22445567777766654      45888888763  


Q ss_pred             cCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeEecCC
Q 043902          226 DYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN-QYDTPIAHCDLKSSNVLLDEG  304 (477)
Q Consensus       226 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~  304 (477)
                        ......++|||++ +++|.+++...       ..+++..+..|+.||+.||.|||+ .   +|+||||||+|||++.+
T Consensus       202 --~~~~~~~iv~~~~-g~~l~~~l~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~  268 (467)
T PTZ00284        202 --NETGHMCIVMPKY-GPCLLDWIMKH-------GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETS  268 (467)
T ss_pred             --cCCceEEEEEecc-CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecC
Confidence              3445789999988 77898888643       458999999999999999999997 5   99999999999999876


Q ss_pred             C----------------cEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHH
Q 043902          305 M----------------IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEI  367 (477)
Q Consensus       305 ~----------------~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~el  367 (477)
                      +                .+||+|||.+...          ........||..|+|||++ ...++.++|||||||++|||
T Consensus       269 ~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~----------~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~el  338 (467)
T PTZ00284        269 DTVVDPVTNRALPPDPCRVRICDLGGCCDE----------RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYEL  338 (467)
T ss_pred             CcccccccccccCCCCceEEECCCCccccC----------ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHH
Confidence            5                4999999987542          1122345789999999999 55799999999999999999


Q ss_pred             hhCCCCCCcc
Q 043902          368 FTGKRPTDDM  377 (477)
Q Consensus       368 ltg~~p~~~~  377 (477)
                      +||+.||+..
T Consensus       339 ltG~~pf~~~  348 (467)
T PTZ00284        339 YTGKLLYDTH  348 (467)
T ss_pred             HhCCCCCCCC
Confidence            9999999753

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.5e-38  Score=300.26  Aligned_cols=251  Identities=22%  Similarity=0.300  Sum_probs=195.8

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      .+.|++.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|+.++++++|+|++++++++     ..+...+
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   85 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF-----YWDGKLW   85 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEE-----EeCCeEE
Confidence            367889999999999999999875 5899999999877666678899999999999999999999986     3456789


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +||||+++++|..++....      ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+
T Consensus        86 lv~e~~~~~~l~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~  156 (292)
T cd06644          86 IMIEFCPGGAVDAIMLELD------RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGV  156 (292)
T ss_pred             EEEecCCCCcHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCcc
Confidence            9999999999998875432      4589999999999999999999998   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCccccc------CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeee
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN------GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~  388 (477)
                      +.....       .........++..|+|||++.      ..++.++|||||||++|||++|+.||.......       
T Consensus       157 ~~~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------  222 (292)
T cd06644         157 SAKNVK-------TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-------  222 (292)
T ss_pred             ceeccc-------cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-------
Confidence            865321       111122345788999999873      236789999999999999999999986421110       


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                            ........... .      .     .           ........+.+++.+|++.||++||++.|+++
T Consensus       223 ------~~~~~~~~~~~-~------~-----~-----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         223 ------VLLKIAKSEPP-T------L-----S-----------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ------HHHHHhcCCCc-c------C-----C-----------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                  00000000000 0      0     0           00011234788999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=8.1e-38  Score=294.36  Aligned_cols=203  Identities=24%  Similarity=0.378  Sum_probs=168.2

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-----chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-----QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      .+|+..+.||+|+||.||+|... ++..|++|.++...     ......+.+|+.++++++||||+++++++..   ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~   78 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAE   78 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCC
Confidence            46889999999999999999864 68999999986432     2234568889999999999999999998532   234


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ...++++||+++++|.+++...       ..+++...+.++.|++.||+|||+.   +++||||+|+||+++.++.+||+
T Consensus        79 ~~~~l~~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~  148 (266)
T cd06651          79 KTLTIFMEYMPGGSVKDQLKAY-------GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLG  148 (266)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEc
Confidence            6788999999999999998754       3478999999999999999999998   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |||+++......    ..........++..|+|||.+ ...++.++|||||||++|||++|+.||..
T Consensus       149 dfg~~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~  211 (266)
T cd06651         149 DFGASKRLQTIC----MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE  211 (266)
T ss_pred             cCCCcccccccc----ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccc
Confidence            999987652110    011112234578899999999 45689999999999999999999999964

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.9e-38  Score=297.13  Aligned_cols=247  Identities=25%  Similarity=0.371  Sum_probs=196.1

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      ..|+..+.||.|+||.||+|... ++..||+|.++... ......+.+|++++++++|+||+++++++     ..+...+
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   78 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKGTKLW   78 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCEEE
Confidence            45777889999999999999865 68899999987543 34457889999999999999999999986     4567899


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +||||+++|+|.+++..        ..+++.++..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+
T Consensus        79 lv~e~~~~~~L~~~i~~--------~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~  147 (277)
T cd06640          79 IIMEYLGGGSALDLLRA--------GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGV  147 (277)
T ss_pred             EEEecCCCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEccccc
Confidence            99999999999999864        3478889999999999999999998   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCC
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      +......       ........++..|+|||++ .+.++.++|+|||||++|||+||+.||........           
T Consensus       148 ~~~~~~~-------~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----------  209 (277)
T cd06640         148 AGQLTDT-------QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-----------  209 (277)
T ss_pred             ceeccCC-------ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-----------
Confidence            9765221       1112234578889999998 55689999999999999999999999865321110           


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                         ...+....                .+.        ....++..+.+++.+||+.+|++||++.++++.
T Consensus       210 ---~~~~~~~~----------------~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         210 ---LFLIPKNN----------------PPT--------LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             ---hhhhhcCC----------------CCC--------CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence               00000000                000        011224458899999999999999999999865

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.5e-38  Score=301.44  Aligned_cols=249  Identities=23%  Similarity=0.317  Sum_probs=196.8

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      ..+|+..+.||.|++|.||+|.. .+++.|++|.+........+.+.+|+..++.++|||++++++++     ...+..+
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~   92 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF-----LVGDELF   92 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeE-----ecCceEE
Confidence            34688899999999999999985 47899999999866555567889999999999999999999986     4566899


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +|+||+++++|..++..        ..+++.++..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+
T Consensus        93 lv~e~~~~~~L~~~~~~--------~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~  161 (296)
T cd06655          93 VVMEYLAGGSLTDVVTE--------TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGF  161 (296)
T ss_pred             EEEEecCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCcc
Confidence            99999999999998863        3478999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCC
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      +......       ........++..|+|||.+ .+.++.++|||||||++|+|++|+.||........           
T Consensus       162 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-----------  223 (296)
T cd06655         162 CAQITPE-------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-----------  223 (296)
T ss_pred             chhcccc-------cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----------
Confidence            8765221       1112234578899999998 55689999999999999999999999965321100           


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                        ...+ .......             .         .....+...+.+++.+||..||++|||+.+++.
T Consensus       224 --~~~~-~~~~~~~-------------~---------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         224 --LYLI-ATNGTPE-------------L---------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             --HHHH-HhcCCcc-------------c---------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence              0000 0000000             0         000011234778999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.1e-38  Score=298.93  Aligned_cols=238  Identities=21%  Similarity=0.423  Sum_probs=183.3

Q ss_pred             CeeeeeccceEEEEEeCC--------CCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          163 NLIGSGSFGSVYKGTLAD--------GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      +.||+|+||.||+|....        ...+++|.+........+.+.+|+.++++++|||++++++++.     .+...+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCV-----CGDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEE-----eCCCcE
Confidence            468999999999998642        2348888887655555578899999999999999999999963     445689


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCc--------
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI--------  306 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~--------  306 (477)
                      +||||+++|+|.+++....      ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.        
T Consensus        76 lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~  146 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNK------NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPF  146 (258)
T ss_pred             EEEecCCCCcHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCce
Confidence            9999999999999997543      3588999999999999999999999   9999999999999987765        


Q ss_pred             EEEecccccccccccCCCCCCCccccCCCcccccccCcccccC--CCCcccceeehHHHHHHHhhCC-CCCCcccccccc
Q 043902          307 AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK-RPTDDMFKDDLS  383 (477)
Q Consensus       307 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~elltg~-~p~~~~~~~~~~  383 (477)
                      ++++|||.+.....           .....++..|+|||++.+  .++.++|||||||++|||++|. .|+......   
T Consensus       147 ~~l~d~g~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~---  212 (258)
T cd05078         147 IKLSDPGISITVLP-----------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ---  212 (258)
T ss_pred             EEecccccccccCC-----------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH---
Confidence            69999998865421           122457788999999943  4799999999999999999985 555331110   


Q ss_pred             eeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          384 IHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       384 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                                 ...........               .|.           .....+.+++.+||+.||++|||++++++
T Consensus       213 -----------~~~~~~~~~~~---------------~~~-----------~~~~~~~~li~~~l~~~p~~Rps~~~il~  255 (258)
T cd05078         213 -----------KKLQFYEDRHQ---------------LPA-----------PKWTELANLINQCMDYEPDFRPSFRAIIR  255 (258)
T ss_pred             -----------HHHHHHHcccc---------------CCC-----------CCcHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                       00001100000               000           00234789999999999999999999998


Q ss_pred             HH
Q 043902          464 NL  465 (477)
Q Consensus       464 ~L  465 (477)
                      .|
T Consensus       256 ~l  257 (258)
T cd05078         256 DL  257 (258)
T ss_pred             hc
Confidence            86

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.2e-38  Score=294.05  Aligned_cols=249  Identities=26%  Similarity=0.383  Sum_probs=194.1

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      +|+..+.||+|++|.||++... +++.+|+|.+....  ....+.+.+|++++++++|+|++++.+.+.    ......+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence            4788899999999999999865 67899999987543  234467889999999999999999988742    2345689


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +||||+++++|.+++....     ...+++.+++.++.+++.|+.|||+.   +++||||||+||+++.++.++|+|||+
T Consensus        77 lv~e~~~~~~l~~~l~~~~-----~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~  148 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQK-----GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGI  148 (257)
T ss_pred             EEecccCCCcHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccc
Confidence            9999999999999997542     14589999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCC
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      +......       ........++..|+|||++ .+.++.++||||||+++|+|++|+.||........           
T Consensus       149 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-----------  210 (257)
T cd08223         149 ARVLENQ-------CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL-----------  210 (257)
T ss_pred             eEEeccc-------CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-----------
Confidence            9765221       1122334578899999998 55688999999999999999999999864211100           


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                        ...+.....                 +..        .......+.+++.+|++.||++|||+.++++
T Consensus       211 --~~~~~~~~~-----------------~~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         211 --VYRIIEGKL-----------------PPM--------PKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             --HHHHHhcCC-----------------CCC--------ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence              000000000                 000        0011234889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.6e-38  Score=330.29  Aligned_cols=258  Identities=22%  Similarity=0.328  Sum_probs=195.3

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      ...++|.+.+.||+|+||.||+|... ++..+|+|++....  ......+..|+.++.+++||||+++++++..   ...
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d---e~~   86 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN---KAN   86 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe---cCC
Confidence            34578999999999999999999865 57889999987542  3345678999999999999999999998642   345


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCC----CCeeecCCCCCCeEecC---
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYD----TPIAHCDLKSSNVLLDE---  303 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~----~~ivH~dlkp~NIll~~---  303 (477)
                      ...++||||+++|+|.++|.....   ....+++..++.|+.||+.||.|||+...    .+|+||||||+||||+.   
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~---~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~  163 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYK---MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR  163 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence            678999999999999999875321   12468999999999999999999998521    25999999999999964   


Q ss_pred             --------------CCcEEEecccccccccccCCCCCCCccccCCCcccccccCccccc---CCCCcccceeehHHHHHH
Q 043902          304 --------------GMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN---GHVSILGDIYSYGILLLE  366 (477)
Q Consensus       304 --------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~Dv~S~Gvvl~e  366 (477)
                                    ...+||+|||++..+..        ........||+.|+|||++.   ..++.++|||||||++||
T Consensus       164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~--------~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYE  235 (1021)
T PTZ00266        164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGI--------ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE  235 (1021)
T ss_pred             ccccccccccccCCCCceEEccCCccccccc--------cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHH
Confidence                          23589999999976521        11223456899999999983   347899999999999999


Q ss_pred             HhhCCCCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhh
Q 043902          367 IFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVM  446 (477)
Q Consensus       367 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  446 (477)
                      |+||+.||.......             .+...+.....               .+.          ......+.+|+..
T Consensus       236 LLTGk~PF~~~~~~~-------------qli~~lk~~p~---------------lpi----------~~~S~eL~dLI~~  277 (1021)
T PTZ00266        236 LCSGKTPFHKANNFS-------------QLISELKRGPD---------------LPI----------KGKSKELNILIKN  277 (1021)
T ss_pred             HHHCCCCCCcCCcHH-------------HHHHHHhcCCC---------------CCc----------CCCCHHHHHHHHH
Confidence            999999996421100             01110100000               000          0012348899999


Q ss_pred             cCCCCCCCCCChHHHHH
Q 043902          447 CSAASPRDRVGMKFVVN  463 (477)
Q Consensus       447 Cl~~dP~~RPs~~evl~  463 (477)
                      ||+.+|.+||++.|++.
T Consensus       278 ~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        278 LLNLSAKERPSALQCLG  294 (1021)
T ss_pred             HhcCChhHCcCHHHHhc
Confidence            99999999999999984

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=310.11  Aligned_cols=245  Identities=25%  Similarity=0.348  Sum_probs=195.3

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeec---cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQ---QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      ..-|+..+.||.|+||.||-|+. .+.+.||||.+...   .....+++++|+.+|.+++|||++.+-|++     -.+.
T Consensus        25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCy-----Lre~   99 (948)
T KOG0577|consen   25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCY-----LREH   99 (948)
T ss_pred             HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCccccccee-----eccc
Confidence            34566778899999999999985 47889999999743   344567899999999999999999999985     4556


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||| -|+-.+++.-..      +++.+.++..|+.+.+.||+|||+.   +.||||||..|||+++.|.+||+|
T Consensus       100 TaWLVMEYC-lGSAsDlleVhk------KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaD  169 (948)
T KOG0577|consen  100 TAWLVMEYC-LGSASDLLEVHK------KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLAD  169 (948)
T ss_pred             hHHHHHHHH-hccHHHHHHHHh------ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeecc
Confidence            689999999 558888876543      7789999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc----cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeee
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI----NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~  387 (477)
                      ||.|...           ...+.++||+.|||||++    .|+|+-|+||||+|++..||.-.++|+..+..-. .+-  
T Consensus       170 FGSAsi~-----------~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-ALY--  235 (948)
T KOG0577|consen  170 FGSASIM-----------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALY--  235 (948)
T ss_pred             ccchhhc-----------CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-HHH--
Confidence            9999765           234567899999999998    5789999999999999999999999976531100 000  


Q ss_pred             eeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       388 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                             ++...-.|.+.                    +..       -...+..++..||+.-|.+|||.++++.
T Consensus       236 -------HIAQNesPtLq--------------------s~e-------WS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  236 -------HIAQNESPTLQ--------------------SNE-------WSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             -------HHHhcCCCCCC--------------------Cch-------hHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence                   00000001110                    000       1233778899999999999999999875

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.5e-37  Score=292.74  Aligned_cols=252  Identities=28%  Similarity=0.415  Sum_probs=193.6

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccch---------hhHHHHHHHHHHhcCCCCCcceeeeecccccC
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQG---------ALKSFIDECNALTSIRHRNILKIVSSCSSVDY  227 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  227 (477)
                      +|.....||+|++|.||+|... +++.+|+|.+......         ..+.+.+|+.++++++||||+++++++     
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----   75 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS-----   75 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----
Confidence            4677889999999999999864 6889999988643221         235688899999999999999999985     


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcE
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIA  307 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~  307 (477)
                      ...+..++|+||+++++|.+++...       ..+++..+..++.|++.||.|||+.   +++||||+|+||++++++.+
T Consensus        76 ~~~~~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~  145 (267)
T cd06628          76 LDADHLNIFLEYVPGGSVAALLNNY-------GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGI  145 (267)
T ss_pred             EeCCccEEEEEecCCCCHHHHHHhc-------cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCE
Confidence            4566789999999999999999654       4578899999999999999999998   99999999999999999999


Q ss_pred             EEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceee
Q 043902          308 HVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHK  386 (477)
Q Consensus       308 kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~  386 (477)
                      +|+|||.++......... ..........|+..|+|||.+ .+.++.++|||||||++|+|++|+.||.......     
T Consensus       146 ~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----  219 (267)
T cd06628         146 KISDFGISKKLEANSLST-KTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-----  219 (267)
T ss_pred             EecccCCCcccccccccC-CccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-----
Confidence            999999998763211110 111112234578899999998 5568899999999999999999999996531100     


Q ss_pred             eeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          387 FVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       387 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                              .+.......                 .+..        .......+.+++.+||+.||.+||++.||++
T Consensus       220 --------~~~~~~~~~-----------------~~~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         220 --------AIFKIGENA-----------------SPEI--------PSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             --------HHHHHhccC-----------------CCcC--------CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                    000000000                 0000        0011334788999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5.2e-38  Score=297.18  Aligned_cols=259  Identities=22%  Similarity=0.392  Sum_probs=198.2

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC------CCCEEEEEEeeeccch-hhHHHHHHHHHHhcCCCCCcceeeeecccccCCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQQQG-ALKSFIDECNALTSIRHRNILKIVSSCSSVDYEG  229 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  229 (477)
                      ++|+..+.||+|+||.||+|+..      +.+.+++|.+...... ..+.+.+|++++++++|+||+++++++     ..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence            57888999999999999999864      3467999988755433 457899999999999999999999986     44


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCc--ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcE
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDE--YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIA  307 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~  307 (477)
                      ....++||||+++|+|.+++......  ......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~  156 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREV  156 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcE
Confidence            56789999999999999999754311  01112689999999999999999999998   99999999999999999999


Q ss_pred             EEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCccccccccee
Q 043902          308 HVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH  385 (477)
Q Consensus       308 kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~  385 (477)
                      +++|||++......      .........++..|+|||.+ .+..+.++||||||+++|+|++ |..||.......    
T Consensus       157 ~l~~~~~~~~~~~~------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~----  226 (275)
T cd05046         157 KVSLLSLSKDVYNS------EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE----  226 (275)
T ss_pred             EEcccccccccCcc------cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH----
Confidence            99999998754211      11122334567889999998 5568899999999999999999 788885422111    


Q ss_pred             eeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHH
Q 043902          386 KFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNL  465 (477)
Q Consensus       386 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  465 (477)
                               .+...........             .           ...++..+.+++.+|++.+|++|||+.|+++.|
T Consensus       227 ---------~~~~~~~~~~~~~-------------~-----------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l  273 (275)
T cd05046         227 ---------VLNRLQAGKLELP-------------V-----------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL  273 (275)
T ss_pred             ---------HHHHHHcCCcCCC-------------C-----------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence                     0000000000000             0           001134588999999999999999999999987


Q ss_pred             H
Q 043902          466 Q  466 (477)
Q Consensus       466 ~  466 (477)
                      .
T Consensus       274 ~  274 (275)
T cd05046         274 G  274 (275)
T ss_pred             c
Confidence            5

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.2e-38  Score=314.24  Aligned_cols=194  Identities=24%  Similarity=0.328  Sum_probs=162.8

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      ..+|.+.+.||+|+||.||++... .++.||||....      ..+.+|++++++++|+||+++++++     ..++..+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~-----~~~~~~~  236 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVR-----VVGGLTC  236 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEE-----EECCEEE
Confidence            457899999999999999999975 578999996432      3467899999999999999999986     3456789


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +|||++ .++|.+++....      ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       237 lv~e~~-~~~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGl  306 (461)
T PHA03211        237 LVLPKY-RSDLYTYLGARL------RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGA  306 (461)
T ss_pred             EEEEcc-CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCC
Confidence            999999 478888886432      4689999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCC
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTD  375 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~  375 (477)
                      ++......     .........||..|+|||++ ...++.++|||||||++|||++|..|+.
T Consensus       307 a~~~~~~~-----~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf  363 (461)
T PHA03211        307 ACFARGSW-----STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF  363 (461)
T ss_pred             ceeccccc-----ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence            98652211     11122345689999999999 5568999999999999999999887653

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=5.2e-38  Score=296.16  Aligned_cols=199  Identities=25%  Similarity=0.394  Sum_probs=157.4

Q ss_pred             CeeeeeccceEEEEEeCC---CCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEe
Q 043902          163 NLIGSGSFGSVYKGTLAD---GETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFE  238 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  238 (477)
                      +.||+|+||.||+|...+   ...+++|.+.... ......+.+|+..++.++|+||+++++.|     ......++|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~-----~~~~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQC-----IESIPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEE-----CCCCceEEEEE
Confidence            358999999999997543   3568888776433 23345788999999999999999999986     44567899999


Q ss_pred             ecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccc
Q 043902          239 FMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFL  318 (477)
Q Consensus       239 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  318 (477)
                      |+++|+|.+++......  .....++.....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus        76 ~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  150 (269)
T cd05042          76 FCPLGDLKNYLRSNRGM--VAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQ  150 (269)
T ss_pred             eCCCCcHHHHHHhcccc--ccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEecccccccc
Confidence            99999999999764321  113356788899999999999999999   9999999999999999999999999998754


Q ss_pred             cccCCCCCCCccccCCCcccccccCccccc--------CCCCcccceeehHHHHHHHhh-CCCCCCc
Q 043902          319 FEESNTPSKNQTMSNGLKGSVGYIPPEYIN--------GHVSILGDIYSYGILLLEIFT-GKRPTDD  376 (477)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~  376 (477)
                      ....     .........++..|+|||++.        ..++.++|||||||++|||++ |..||..
T Consensus       151 ~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~  212 (269)
T cd05042         151 YPED-----YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD  212 (269)
T ss_pred             ccch-----heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCc
Confidence            2211     011123344577899999862        246889999999999999999 7888864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5.4e-38  Score=308.54  Aligned_cols=205  Identities=25%  Similarity=0.372  Sum_probs=170.8

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ++|+..+.||+|+||.||+++.. +++.||+|+++...   ......+.+|+.++.+++|+||+++++.+     ...+.
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~   75 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRN   75 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence            46888999999999999999865 68999999997432   23346778899999999999999999885     56778


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++|+|.+++...       ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~Df  145 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMKK-------DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDF  145 (360)
T ss_pred             EEEEEeCCCCccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeec
Confidence            99999999999999998754       4588999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCC----------------------------CCccccCCCcccccccCcccc-cCCCCcccceeehHHH
Q 043902          313 GLAKFLFEESNTPS----------------------------KNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGIL  363 (477)
Q Consensus       313 G~a~~~~~~~~~~~----------------------------~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvv  363 (477)
                      |++...........                            ..........||+.|+|||++ ...++.++|||||||+
T Consensus       146 G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvi  225 (360)
T cd05627         146 GLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI  225 (360)
T ss_pred             cCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccce
Confidence            99875422110000                            000011235699999999998 5568999999999999


Q ss_pred             HHHHhhCCCCCCc
Q 043902          364 LLEIFTGKRPTDD  376 (477)
Q Consensus       364 l~elltg~~p~~~  376 (477)
                      +|||+||+.||..
T Consensus       226 lyel~tG~~Pf~~  238 (360)
T cd05627         226 MYEMLIGYPPFCS  238 (360)
T ss_pred             eeecccCCCCCCC
Confidence            9999999999965

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.7e-38  Score=295.47  Aligned_cols=251  Identities=27%  Similarity=0.444  Sum_probs=194.4

Q ss_pred             CCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhh--HHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          159 FSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       159 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      |+..+.||+|+||+||+++.. +++.+|+|++........  .....|+.++.+++||||+++++++     ......++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVF-----QDDNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEE-----EESSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccc-----cccccccc
Confidence            456789999999999999976 567899999987654332  2345699999999999999999995     44778899


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      ||||+++++|.+++...       ..+++..++.++.|+++||.+||+.   +++|+||||+||++++++.++|+|||.+
T Consensus        76 v~~~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~  145 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQKN-------KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSS  145 (260)
T ss_dssp             EEEEETTEBHHHHHHHH-------SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTT
T ss_pred             ccccccccccccccccc-------ccccccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence            99999999999999722       5689999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCC
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      ....       ..........++..|+|||.+.  ...+.++||||+|+++|+|++|..||......             
T Consensus       146 ~~~~-------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~-------------  205 (260)
T PF00069_consen  146 VKLS-------ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD-------------  205 (260)
T ss_dssp             EEST-------STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH-------------
T ss_pred             cccc-------ccccccccccccccccccccccccccccccccccccccccccccccccccccccch-------------
Confidence            7531       1223344566889999999985  56899999999999999999999999764100             


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                       .....+...........                  ..........+.+++..||+.||++|||+.++++
T Consensus       206 -~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  206 -DQLEIIEKILKRPLPSS------------------SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             -HHHHHHHHHHHTHHHHH------------------TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             -hhhhhhhhccccccccc------------------ccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             00111111110000000                  0000000145899999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.2e-38  Score=300.07  Aligned_cols=245  Identities=27%  Similarity=0.397  Sum_probs=192.7

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      .|+..+.||+|+||.||+|... ++..||+|.++... ....+.+.+|++++++++||||+++++++     ..+...++
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   79 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-----LKGTKLWI   79 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-----ccCCceEE
Confidence            4556678999999999999864 67899999987443 33456789999999999999999999985     45667899


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      ||||+++++|.+++..        ..+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||++
T Consensus        80 v~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~  148 (277)
T cd06642          80 IMEYLGGGSALDLLKP--------GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVA  148 (277)
T ss_pred             EEEccCCCcHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEcccccc
Confidence            9999999999998863        3478999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCc
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPS  394 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  394 (477)
                      ......       ........++..|+|||++ ...++.++|||||||++|||+||+.|+........            
T Consensus       149 ~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------------  209 (277)
T cd06642         149 GQLTDT-------QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------------  209 (277)
T ss_pred             ccccCc-------chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------------
Confidence            765221       1112234578899999999 45689999999999999999999999864321110            


Q ss_pred             hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          395 HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       395 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                        ...+.....                +..        ...+...+.+++.+|++.+|++||++.||++
T Consensus       210 --~~~~~~~~~----------------~~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         210 --LFLIPKNSP----------------PTL--------EGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             --HhhhhcCCC----------------CCC--------CcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence              000000000                000        0011334789999999999999999999997

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-40  Score=280.71  Aligned_cols=250  Identities=22%  Similarity=0.349  Sum_probs=198.0

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeec--cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ++.|++.+.||+|.|+.||++.. .+|+.+|+|++...  .....+.+.+|+++.+.++||||+++...     +....+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~t-----i~~~~~   84 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQEESF   84 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhh-----hcccce
Confidence            56788889999999999999975 47999999988633  33456888999999999999999999987     467788


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec---CCCcEEE
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHV  309 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl  309 (477)
                      .|+|+|+|.|++|..-+-.+       ..+++..+-..+.||+++|.|+|.+   +|||||+||+|+++-   ..--+||
T Consensus        85 ~ylvFe~m~G~dl~~eIV~R-------~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL  154 (355)
T KOG0033|consen   85 HYLVFDLVTGGELFEDIVAR-------EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKL  154 (355)
T ss_pred             eEEEEecccchHHHHHHHHH-------HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceee
Confidence            99999999999997655433       4578888999999999999999999   999999999999994   3346999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeee
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~  388 (477)
                      +|||+|..+.        ......+..||++|||||++ +.+++..+|||+.||+||-|+.|..||.+...+.       
T Consensus       155 ~~FGvAi~l~--------~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-------  219 (355)
T KOG0033|consen  155 ADFGLAIEVN--------DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------  219 (355)
T ss_pred             cccceEEEeC--------CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-------
Confidence            9999998762        34456678899999999999 6789999999999999999999999997632221       


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                                +...-.......+.                  .++....++..+|+.+||..||.+|.|+.|.++
T Consensus       220 ----------lye~I~~g~yd~~~------------------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  220 ----------LYEQIKAGAYDYPS------------------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             ----------HHHHHhccccCCCC------------------cccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence                      11111111110100                  001111234778999999999999999999874

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.2e-37  Score=295.75  Aligned_cols=263  Identities=24%  Similarity=0.311  Sum_probs=200.4

Q ss_pred             cHHHHHHhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcC-CCCCcceeeeecccc
Q 043902          148 SYLKISNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSI-RHRNILKIVSSCSSV  225 (477)
Q Consensus       148 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  225 (477)
                      +..++..+.+.|+..+.||+|+||.||+|... +++.+|+|++..... ....+..|+.++.++ +|+|++++++++...
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            44556667789999999999999999999864 688999999875433 335688899999998 699999999987432


Q ss_pred             cC-CCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC
Q 043902          226 DY-EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG  304 (477)
Q Consensus       226 ~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~  304 (477)
                      .. ......+++|||+++|+|.+++.....     ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++++
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~  157 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-----NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTEN  157 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence            11 235678999999999999999875432     4578888999999999999999999   99999999999999999


Q ss_pred             CcEEEecccccccccccCCCCCCCccccCCCcccccccCccccc------CCCCcccceeehHHHHHHHhhCCCCCCccc
Q 043902          305 MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN------GHVSILGDIYSYGILLLEIFTGKRPTDDMF  378 (477)
Q Consensus       305 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~  378 (477)
                      +.++|+|||++......       ........|+..|+|||.+.      ..++.++|||||||++|||++|..||....
T Consensus       158 ~~~~l~dfg~~~~~~~~-------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~  230 (282)
T cd06636         158 AEVKLVDFGVSAQLDRT-------VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH  230 (282)
T ss_pred             CCEEEeeCcchhhhhcc-------ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence            99999999998754211       11123356888999999873      247889999999999999999999996432


Q ss_pred             ccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCCh
Q 043902          379 KDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGM  458 (477)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  458 (477)
                      ....             ..........                 ..       ....+...+.+++.+||+.||.+|||+
T Consensus       231 ~~~~-------------~~~~~~~~~~-----------------~~-------~~~~~~~~~~~li~~cl~~~p~~Rp~~  273 (282)
T cd06636         231 PMRA-------------LFLIPRNPPP-----------------KL-------KSKKWSKKFIDFIEGCLVKNYLSRPST  273 (282)
T ss_pred             HHhh-------------hhhHhhCCCC-----------------CC-------cccccCHHHHHHHHHHhCCChhhCcCH
Confidence            1100             0000000000                 00       000113348899999999999999999


Q ss_pred             HHHHH
Q 043902          459 KFVVN  463 (477)
Q Consensus       459 ~evl~  463 (477)
                      .|+++
T Consensus       274 ~ell~  278 (282)
T cd06636         274 EQLLK  278 (282)
T ss_pred             HHHhc
Confidence            99875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=8.7e-38  Score=303.36  Aligned_cols=200  Identities=24%  Similarity=0.353  Sum_probs=169.4

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec---cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ---QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ++|...+.||+|+||.||+++.. +++.||+|+++..   .......+.+|..++..++|+||+++++++     ...+.
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence            47888999999999999999865 6889999998742   223345678899999999999999999985     56778


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++|+|.+++....      ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+||
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~~~------~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~Df  146 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSKFE------DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADF  146 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEec
Confidence            999999999999999997532      4588999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCccccc------CCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN------GHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |++......      .........||..|+|||++.      +.++.++|||||||++|||++|+.||..
T Consensus       147 G~a~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~  210 (331)
T cd05624         147 GSCLKMNQD------GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             cceeeccCC------CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence            999765221      111122346899999999984      3578999999999999999999999964

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.7e-37  Score=289.04  Aligned_cols=248  Identities=23%  Similarity=0.322  Sum_probs=195.3

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      +|+..+.||+|+||.||++... +|+.||+|.+....  ....+.+.+|+.++++++||||+++++++     ...+..+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence            4788899999999999999864 68999999987532  33446789999999999999999999985     5667899


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +|+||+++++|.+++.....     ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.
T Consensus        76 lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~  147 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQRG-----VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGI  147 (256)
T ss_pred             EEEecCCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccc
Confidence            99999999999998875421     3578999999999999999999998   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCC
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      +......       ........|+..|+|||+. .+..+.++|+|||||++|+|+||+.||.....              
T Consensus       148 ~~~~~~~-------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------------  206 (256)
T cd08218         148 ARVLNST-------VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM--------------  206 (256)
T ss_pred             eeecCcc-------hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH--------------
Confidence            9765221       1112234578889999998 55688999999999999999999999854211              


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                         .+.++.......             +.        ....+...+.+++.+|++.+|++||++.||++
T Consensus       207 ---~~~~~~~~~~~~-------------~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         207 ---KNLVLKIIRGSY-------------PP--------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             ---HHHHHHHhcCCC-------------CC--------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence               111111111000             00        00111334889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.1e-37  Score=293.87  Aligned_cols=198  Identities=22%  Similarity=0.414  Sum_probs=155.5

Q ss_pred             CeeeeeccceEEEEEeCCC---CEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEe
Q 043902          163 NLIGSGSFGSVYKGTLADG---ETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFE  238 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  238 (477)
                      +.||+|+||.||+|...++   ..+++|.++... ....+.+.+|+..+..++||||+++++.|     ......++|||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~~~~~~~lv~e   75 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQC-----VEAIPYLLVFE   75 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEe-----cCCCccEEEEe
Confidence            3589999999999975443   345666665433 33457899999999999999999999996     34567899999


Q ss_pred             ecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccc
Q 043902          239 FMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFL  318 (477)
Q Consensus       239 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  318 (477)
                      |+++|+|.+++.....   .....++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++...
T Consensus        76 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~  149 (268)
T cd05086          76 YCELGDLKSYLSQEQW---HRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSR  149 (268)
T ss_pred             cCCCCcHHHHHHhhhc---ccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEeccccccccc
Confidence            9999999999975421   123467778889999999999999998   9999999999999999999999999998643


Q ss_pred             cccCCCCCCCccccCCCcccccccCcccccC--------CCCcccceeehHHHHHHHhh-CCCCCCc
Q 043902          319 FEESNTPSKNQTMSNGLKGSVGYIPPEYING--------HVSILGDIYSYGILLLEIFT-GKRPTDD  376 (477)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~Dv~S~Gvvl~ellt-g~~p~~~  376 (477)
                      ....     .........++..|+|||++..        .++.++|||||||++|||++ |..||..
T Consensus       150 ~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~  211 (268)
T cd05086         150 YKED-----YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH  211 (268)
T ss_pred             Ccch-----hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Confidence            1110     1111233457889999998731        35789999999999999997 5667754

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.8e-37  Score=301.32  Aligned_cols=200  Identities=24%  Similarity=0.357  Sum_probs=168.6

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ++|+..+.||+|+||.||+++.. +++.+|+|++....   ......+.+|+.++..++|++|+++++++     ...+.
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN   75 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence            46888999999999999999875 57889999986422   22334578899999999999999999885     56678


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++|+|.+++....      ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+||
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~------~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~Df  146 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSKFE------DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF  146 (332)
T ss_pred             EEEEEeccCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeec
Confidence            999999999999999997532      4588999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCccccc------CCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN------GHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |++......      .........||..|+|||++.      +.++.++|||||||++|||++|+.||..
T Consensus       147 G~a~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~  210 (332)
T cd05623         147 GSCLKLMED------GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA  210 (332)
T ss_pred             chheecccC------CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence            998754221      111223356899999999873      3478999999999999999999999964

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.6e-38  Score=292.85  Aligned_cols=237  Identities=24%  Similarity=0.460  Sum_probs=183.9

Q ss_pred             CeeeeeccceEEEEEeCCCC-----------EEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          163 NLIGSGSFGSVYKGTLADGE-----------TAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      +.||+|+||.||+|...+..           .+++|.++..... ...+.+|+.++++++||||++++++|.     . .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~-~   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCV-----R-D   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEe-----c-C
Confidence            46899999999999975432           5788877654433 578899999999999999999999873     2 4


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC------
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM------  305 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~------  305 (477)
                      ..++||||+++|+|.+++....      ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++      
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~  144 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHREK------NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYV  144 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCc
Confidence            5689999999999999997643      2588999999999999999999998   999999999999999887      


Q ss_pred             -cEEEecccccccccccCCCCCCCccccCCCcccccccCccccc-C--CCCcccceeehHHHHHHHhh-CCCCCCccccc
Q 043902          306 -IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-G--HVSILGDIYSYGILLLEIFT-GKRPTDDMFKD  380 (477)
Q Consensus       306 -~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~--~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~  380 (477)
                       .+||+|||++.....           .....++..|+|||++. .  .++.++|||||||++|||++ |..||......
T Consensus       145 ~~~kl~Dfg~a~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~  213 (259)
T cd05037         145 PFIKLSDPGIPITVLS-----------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS  213 (259)
T ss_pred             eeEEeCCCCccccccc-----------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch
Confidence             799999999976421           12234667899999983 3  58999999999999999999 57777543211


Q ss_pred             ccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHH
Q 043902          381 DLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKF  460 (477)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e  460 (477)
                      .             ......+...              ...+.             ...+.+++.+|+..+|++|||+.|
T Consensus       214 ~-------------~~~~~~~~~~--------------~~~~~-------------~~~~~~li~~~l~~~p~~Rpt~~~  253 (259)
T cd05037         214 E-------------KERFYQDQHR--------------LPMPD-------------CAELANLINQCWTYDPTKRPSFRA  253 (259)
T ss_pred             h-------------HHHHHhcCCC--------------CCCCC-------------chHHHHHHHHHhccChhhCCCHHH
Confidence            0             0000000000              00000             134789999999999999999999


Q ss_pred             HHHHHH
Q 043902          461 VVNNLQ  466 (477)
Q Consensus       461 vl~~L~  466 (477)
                      |++.|+
T Consensus       254 il~~l~  259 (259)
T cd05037         254 ILRDLN  259 (259)
T ss_pred             HHHhcC
Confidence            998873

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-38  Score=295.32  Aligned_cols=247  Identities=26%  Similarity=0.391  Sum_probs=195.4

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      ++|+..+.||.|++|.||+|+.. +++.||+|.+.... ......+.+|++++++++|+|++++++++     .++...+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF-----LKGSKLW   75 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEE-----EECCeEE
Confidence            36788899999999999999865 68899999987543 33446788999999999999999999985     4457899


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +|+||+++++|.+++...        .+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||+
T Consensus        76 ~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~  144 (274)
T cd06609          76 IIMEYCGGGSCLDLLKPG--------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGV  144 (274)
T ss_pred             EEEEeeCCCcHHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccccc
Confidence            999999999999998643        588999999999999999999998   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCC
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      ++.....       ........++..|+|||++ ...++.++|||||||++|||+||+.||.......            
T Consensus       145 ~~~~~~~-------~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------------  205 (274)
T cd06609         145 SGQLTST-------MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------------  205 (274)
T ss_pred             ceeeccc-------ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------------
Confidence            9876321       1122334578889999999 5568999999999999999999999996432110            


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                        ....+.....                +.+...       .+...+.+++.+|+..+|++|||++++++
T Consensus       206 --~~~~~~~~~~----------------~~~~~~-------~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         206 --VLFLIPKNNP----------------PSLEGN-------KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             --HHHHhhhcCC----------------CCCccc-------ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence              0000000000                000000       01234788999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-37  Score=296.08  Aligned_cols=252  Identities=21%  Similarity=0.327  Sum_probs=194.0

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec-cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ-QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      ++|+..+.||+|+||.||++... +|..||+|.++.. .......+.+|++++.+++|+||+++++.+     ...+..+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF-----FIEGAVY   75 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhe-----ecCCeEE
Confidence            36788899999999999999976 7899999998754 233446889999999999999999999985     4567899


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +||||+++++|..++.....    ...+++..+..++.|++.||.|||+.  .+++|+||||+||+++.++.+||+|||+
T Consensus        76 lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~  149 (286)
T cd06622          76 MCMEYMDAGSLDKLYAGGVA----TEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGV  149 (286)
T ss_pred             EEEeecCCCCHHHHHHhccc----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCC
Confidence            99999999999999875321    24689999999999999999999963  1899999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccccC-------CCCcccceeehHHHHHHHhhCCCCCCcccccccceeee
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-------HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~  387 (477)
                      +.....         .......++..|+|||.+.+       .++.++|||||||++|||++|+.||........     
T Consensus       150 ~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-----  215 (286)
T cd06622         150 SGNLVA---------SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI-----  215 (286)
T ss_pred             cccccC---------CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH-----
Confidence            875421         11223357888999999832       248899999999999999999999964211000     


Q ss_pred             eeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       388 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                           ...+..+.+...                 +.        ....+...+.+++.+|++.+|++||++.++++
T Consensus       216 -----~~~~~~~~~~~~-----------------~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         216 -----FAQLSAIVDGDP-----------------PT--------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             -----HHHHHHHhhcCC-----------------CC--------CCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence                 000000110000                 00        00112344788999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.7e-37  Score=293.24  Aligned_cols=263  Identities=25%  Similarity=0.448  Sum_probs=194.8

Q ss_pred             CCCCCeeeeeccceEEEEEeC----CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCC-CCc
Q 043902          159 FSEENLIGSGSFGSVYKGTLA----DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYE-GND  231 (477)
Q Consensus       159 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~~~  231 (477)
                      |.+.+.||+|+||.||+|...    +++.||+|+++...  ....+.+.+|++++++++||||+++++++...... ...
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999853    46889999987542  33456788999999999999999999986432111 112


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++++||+.+|+|.+++...... .....+++...+.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~d  156 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIG-EEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVAD  156 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECc
Confidence            357899999999999887533211 1113578899999999999999999998   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeee
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~  389 (477)
                      ||+++......     .........++..|++||.+ .+.++.++|||||||++|||++ |+.||.......        
T Consensus       157 fg~~~~~~~~~-----~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~--------  223 (273)
T cd05074         157 FGLSKKIYSGD-----YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE--------  223 (273)
T ss_pred             ccccccccCCc-----ceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH--------
Confidence            99998653211     11111223456789999998 5568899999999999999999 888886432110        


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                            ....+.......             .+           ..+...+.+++.+|++.+|++|||+.|+++.|+++
T Consensus       224 ------~~~~~~~~~~~~-------------~~-----------~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         224 ------IYNYLIKGNRLK-------------QP-----------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ------HHHHHHcCCcCC-------------CC-----------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                  000000000000             00           01134588999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.1e-37  Score=288.64  Aligned_cols=249  Identities=20%  Similarity=0.305  Sum_probs=196.5

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec--cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      +|+..+.||.|+||.||.++.. +++.+++|.+...  .......+.+|++++++++|+||+++++++     ...+..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHF-----MDDNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEE-----ecCCeEE
Confidence            4788899999999999999854 6889999998754  234456788999999999999999999996     4567899


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      ++|||+++++|.+++....     ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||.
T Consensus        76 ~~~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~  147 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQK-----GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGI  147 (256)
T ss_pred             EEEEecCCCcHHHHHHhcc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcc
Confidence            9999999999999997542     14589999999999999999999998   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCC
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      +.......       .......++..|+|||.+ ...++.++||||||+++|||++|+.||......             
T Consensus       148 ~~~~~~~~-------~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-------------  207 (256)
T cd08221         148 SKILGSEY-------SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-------------  207 (256)
T ss_pred             eEEccccc-------ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-------------
Confidence            97652211       122345678999999998 446889999999999999999999998642110             


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                      +....+........                         ...+...+.+++.+|+..+|++|||+.|+++.
T Consensus       208 ~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         208 NLVVKIVQGNYTPV-------------------------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             HHHHHHHcCCCCCC-------------------------ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            00111110000000                         01113347889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.6e-37  Score=290.84  Aligned_cols=246  Identities=28%  Similarity=0.423  Sum_probs=193.7

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-----chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-----QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      +|+..+.||+|++|.||+|... ++..|++|.+....     ....+.+.+|++++++++|+||+++++++     ....
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence            4777899999999999999976 78999999987543     22446789999999999999999999985     4566


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++++||+++++|.+++...       ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d  145 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKKY-------GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLAD  145 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcc
Confidence            789999999999999998643       4578999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCC-CCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGH-VSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~-~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      ||.+......        .......++..|+|||.+ ... ++.++|+|||||++|+|++|+.||.......        
T Consensus       146 ~~~~~~~~~~--------~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--------  209 (258)
T cd06632         146 FGMAKQVVEF--------SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--------  209 (258)
T ss_pred             Cccceecccc--------ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--------
Confidence            9998765221        112345578899999998 344 8999999999999999999999986532100        


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                           .........   .             .+.+        .......+.+++.+|++.+|++||++.++++
T Consensus       210 -----~~~~~~~~~---~-------------~~~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         210 -----AVFKIGRSK---E-------------LPPI--------PDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             -----HHHHHHhcc---c-------------CCCc--------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                 000000000   0             0000        0001234778999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.9e-38  Score=289.08  Aligned_cols=257  Identities=23%  Similarity=0.331  Sum_probs=202.3

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .+.|+..+.||.|.-|+||+++.. ++..+|+|++....   .....+...|-++|+.+.||.++.+++.     ++.+.
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~-----fet~~  150 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS-----FETDK  150 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe-----eeccc
Confidence            345667789999999999999986 46899999997553   4445677889999999999999999998     57888


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      +.|+|||||+||+|..+++.+..     +.+++..+.-++.+|+-||+|||-.   |||.|||||+||||.++|++.|+|
T Consensus       151 ~~cl~meyCpGGdL~~LrqkQp~-----~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsD  222 (459)
T KOG0610|consen  151 YSCLVMEYCPGGDLHSLRQKQPG-----KRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSD  222 (459)
T ss_pred             eeEEEEecCCCccHHHHHhhCCC-----CccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeee
Confidence            99999999999999999987753     6799999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCC-----------------------------CC--------------------CCCccccCCCccccccc
Q 043902          312 FGLAKFLFEESN-----------------------------TP--------------------SKNQTMSNGLKGSVGYI  342 (477)
Q Consensus       312 fG~a~~~~~~~~-----------------------------~~--------------------~~~~~~~~~~~gt~~y~  342 (477)
                      |.++........                             ..                    ..........+||-.|.
T Consensus       223 FDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYl  302 (459)
T KOG0610|consen  223 FDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYL  302 (459)
T ss_pred             ccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccc
Confidence            999865421000                             00                    00112245678999999


Q ss_pred             CcccccC-CCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhccccccccccccc
Q 043902          343 PPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLF  421 (477)
Q Consensus       343 aPE~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~  421 (477)
                      |||++.| ..+.++|+|+|||++|||+.|..||.+...+.             .+..++-..+...              
T Consensus       303 APEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-------------Tl~NIv~~~l~Fp--------------  355 (459)
T KOG0610|consen  303 APEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-------------TLRNIVGQPLKFP--------------  355 (459)
T ss_pred             cceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-------------hHHHHhcCCCcCC--------------
Confidence            9999965 47999999999999999999999998754332             1222222221111              


Q ss_pred             chhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCC----hHHHH
Q 043902          422 PDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVG----MKFVV  462 (477)
Q Consensus       422 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~evl  462 (477)
                       ...         +....+.+|+++.|..||.+|-.    +.||-
T Consensus       356 -~~~---------~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  356 -EEP---------EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             -CCC---------cchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence             000         11344789999999999999987    66664

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.1e-37  Score=291.36  Aligned_cols=203  Identities=25%  Similarity=0.360  Sum_probs=167.6

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-----chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-----QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      .+|+..+.||+|+||.||+|... +|..||+|.+....     ....+.+.+|+.++++++||||+++++++..   ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   78 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PME   78 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCC
Confidence            47888999999999999999865 68999999886432     2234578889999999999999999997532   224


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ...++||||+++++|.+++...       ..+++...+.++.|++.||.|||+.   +++|+||||+||+++.++.++|+
T Consensus        79 ~~~~~v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~  148 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQLKSY-------GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLG  148 (265)
T ss_pred             ceEEEEEEecCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEEC
Confidence            5678999999999999998643       3478889999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |||++.......    ..........++..|+|||.+ ...++.++|||||||++|||++|+.||..
T Consensus       149 Dfg~~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  211 (265)
T cd06652         149 DFGASKRLQTIC----LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE  211 (265)
T ss_pred             cCcccccccccc----ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence            999997652211    011112234588899999998 55689999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-37  Score=295.95  Aligned_cols=262  Identities=23%  Similarity=0.274  Sum_probs=196.0

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc-hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ-GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      ++|+..+.||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||++++++|..   ......+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEE
Confidence            36788899999999999999975 688999999875432 345678999999999999999999998742   3345689


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +||||+++++|.+++.....   ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+
T Consensus        78 lv~e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~  151 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKK---RGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGV  151 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccc
Confidence            99999999999988754221   124578899999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCC
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      +.....         .......++..|+|||.+ .+.++.++|||||||++|+|++|+.||........         .+
T Consensus       152 ~~~~~~---------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---------~~  213 (287)
T cd06621         152 SGELVN---------SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL---------GP  213 (287)
T ss_pred             cccccc---------cccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC---------Ch
Confidence            875421         111233567889999998 56789999999999999999999999975321000         00


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      ......+.......  .. ...       ..    .    ......+.+++.+|++.+|++|||+.|+++
T Consensus       214 ~~~~~~~~~~~~~~--~~-~~~-------~~----~----~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         214 IELLSYIVNMPNPE--LK-DEP-------GN----G----IKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             HHHHHHHhcCCchh--hc-cCC-------CC----C----CchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            01111110000000  00 000       00    0    001234789999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-38  Score=304.10  Aligned_cols=190  Identities=28%  Similarity=0.372  Sum_probs=158.0

Q ss_pred             eeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcC---CCCCcceeeeecccccCCCCceeeEEE
Q 043902          165 IGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSI---RHRNILKIVSSCSSVDYEGNDFKALVF  237 (477)
Q Consensus       165 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~~~~~~lv~  237 (477)
                      ||+|+||.||+|+.. +++.||+|++....   ......+..|..++.+.   +||||+++++++     ......++||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence            699999999999865 68999999997432   22234455677777655   699999999884     5667899999


Q ss_pred             eecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          238 EFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       238 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      ||+++|+|.+++...       ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        76 e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~  145 (330)
T cd05586          76 DYMSGGELFWHLQKE-------GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKA  145 (330)
T ss_pred             cCCCCChHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence            999999999988644       4589999999999999999999999   999999999999999999999999999875


Q ss_pred             ccccCCCCCCCccccCCCcccccccCcccccC--CCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ...       .........||..|+|||++.+  .++.++|||||||++|||+||+.||..
T Consensus       146 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~  199 (330)
T cd05586         146 NLT-------DNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA  199 (330)
T ss_pred             CCC-------CCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence            321       1112234568999999999843  479999999999999999999999965

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.5e-37  Score=293.16  Aligned_cols=199  Identities=21%  Similarity=0.328  Sum_probs=168.0

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ++|+..+.||+|++|.||+|+.. +|+.||+|++....  ....+.+.+|++++.+++|+|++++++++     ......
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~   75 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKL   75 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEE
Confidence            46888899999999999999976 68999999987443  22335678999999999999999999985     456778


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||+++++|..++...       ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||
T Consensus        76 ~~v~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  145 (286)
T cd07847          76 HLVFEYCDHTVLNELEKNP-------RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFG  145 (286)
T ss_pred             EEEEeccCccHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccc
Confidence            9999999999888876543       3589999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      ++.......       .......++..|+|||.+.  ..++.++|||||||++|||++|+.||...
T Consensus       146 ~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~  204 (286)
T cd07847         146 FARILTGPG-------DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK  204 (286)
T ss_pred             cceecCCCc-------ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            998653211       1122345778899999983  35789999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.2e-37  Score=294.52  Aligned_cols=198  Identities=25%  Similarity=0.384  Sum_probs=168.1

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      +|++.+.||+|+||.||+|... +|+.||+|++....  ......+.+|+.++++++|||++++++++     ......+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence            4778899999999999999864 78999999997554  33456889999999999999999999985     4567889


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +|+||+ +++|.+++....      ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||.
T Consensus        76 ~v~e~~-~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~  145 (286)
T cd07832          76 LVMEYM-PSDLSEVLRDEE------RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGL  145 (286)
T ss_pred             EEeccc-CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeee
Confidence            999999 999999987543      4589999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      +.......      ........++..|+|||.+.  ..++.++||||+||++|||+||.+||..
T Consensus       146 ~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~  203 (286)
T cd07832         146 ARLFSEEE------PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG  203 (286)
T ss_pred             cccccCCC------CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence            98653211      11223346888999999983  3468999999999999999999877754

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.9e-38  Score=310.84  Aligned_cols=196  Identities=26%  Similarity=0.326  Sum_probs=165.0

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC---CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA---DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ..+|.+.+.||+|+||.||++...   .+..||+|.+...     ....+|++++++++||||+++++++     .....
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~  160 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAY-----RWKST  160 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeE-----eeCCE
Confidence            457999999999999999999753   4578999988643     2456899999999999999999885     45677


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++|||++. ++|.+++...       ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus       161 ~~lv~e~~~-~~l~~~l~~~-------~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~Df  229 (392)
T PHA03207        161 VCMVMPKYK-CDLFTYVDRS-------GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDF  229 (392)
T ss_pred             EEEEehhcC-CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccC
Confidence            899999995 6888888432       4689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      |+++......     .........||..|+|||++ ...++.++|||||||++|||++|+.||...
T Consensus       230 G~a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~  290 (392)
T PHA03207        230 GAACKLDAHP-----DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK  290 (392)
T ss_pred             ccccccCccc-----ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            9997653211     11122345789999999999 456899999999999999999999998653

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=303.33  Aligned_cols=284  Identities=20%  Similarity=0.241  Sum_probs=199.8

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .+++|++.+.||+|+||.||+|... +|+.||+|.++... ......+.+|+.++++++|+||+++++++....+.....
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            3578999999999999999999854 78999999987432 333466888999999999999999999876554455567


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++|+||+. ++|.+++..        ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+||
T Consensus        83 ~~lv~e~~~-~~l~~~~~~--------~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~df  150 (336)
T cd07849          83 VYIVQELME-TDLYKLIKT--------QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDF  150 (336)
T ss_pred             EEEEehhcc-cCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcc
Confidence            899999996 488877753        3589999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-c-CCCCcccceeehHHHHHHHhhCCCCCCccccccc--ceeeee
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-N-GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDL--SIHKFV  388 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~--~~~~~~  388 (477)
                      |++........    .........|+..|+|||.+ . ..++.++|||||||++|+|++|+.||........  .+....
T Consensus       151 g~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~  226 (336)
T cd07849         151 GLARIADPEHD----HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVL  226 (336)
T ss_pred             cceeecccccc----ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence            99976532111    11122335678999999987 3 3589999999999999999999999965321100  000000


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                      ....++....+.+..........    ...   +..   ............+.+++.+||+.+|++|||+.|+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~----~~~---~~~---~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         227 GTPSQEDLNCIISLRARNYIKSL----PFK---PKV---PWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             CCCCHHHHHHhhchhhhhHHhhc----CcC---Ccc---cHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00001111111111100000000    000   000   0000011113458899999999999999999999874

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-37  Score=305.03  Aligned_cols=191  Identities=24%  Similarity=0.381  Sum_probs=160.3

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ...+|.+.+.||+|+||.||+|+.. ++..||+|+....      ....|+.++++++||||+++++++     ......
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~  132 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTL-----VSGAIT  132 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheE-----EeCCee
Confidence            3457999999999999999999875 5788999975432      335699999999999999999986     455678


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++|+||+ .++|.+++....      ..+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       133 ~lv~e~~-~~~l~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG  202 (357)
T PHA03209        133 CMVLPHY-SSDLYTYLTKRS------RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLG  202 (357)
T ss_pred             EEEEEcc-CCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCc
Confidence            9999999 468888886543      5689999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCC
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPT  374 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~  374 (477)
                      +++....        ........||..|+|||++ ...++.++|||||||++|||+++..|+
T Consensus       203 ~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        203 AAQFPVV--------APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ccccccc--------CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            9975311        1122345689999999999 557899999999999999999965554

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.5e-37  Score=295.74  Aligned_cols=198  Identities=24%  Similarity=0.381  Sum_probs=167.3

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ++|+..+.||+|+||.||+|... +++.||+|++....  ....+.+.+|++++++++||||+++++++     ..+...
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL   75 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence            46888899999999999999975 58999999886432  22346788999999999999999999985     567789


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++|+||+++++|..+....       ..+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||
T Consensus        76 ~lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg  145 (286)
T cd07846          76 YLVFEFVDHTVLDDLEKYP-------NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFG  145 (286)
T ss_pred             EEEEecCCccHHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeee
Confidence            9999999999998876543       3489999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ++......       ........++..|+|||++.  ..++.++||||||+++|||++|++||..
T Consensus       146 ~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~  203 (286)
T cd07846         146 FARTLAAP-------GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG  203 (286)
T ss_pred             eeeeccCC-------ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence            98765221       11223345788999999984  3478899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.3e-38  Score=299.56  Aligned_cols=248  Identities=23%  Similarity=0.317  Sum_probs=192.6

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEE
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALV  236 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  236 (477)
                      .|.....||+|+||.||++... ++..||+|.+........+.+.+|+..+.+++|+|++++++.+     ...+..++|
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-----~~~~~~~lv   97 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY-----LVGDELWVV   97 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhe-----ecCCeEEEE
Confidence            3444567999999999999864 6889999998766555567789999999999999999999985     456788999


Q ss_pred             EeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccc
Q 043902          237 FEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK  316 (477)
Q Consensus       237 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  316 (477)
                      |||+++++|.+++..        ..+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|||++.
T Consensus        98 ~e~~~~~~L~~~~~~--------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~  166 (292)
T cd06658          98 MEFLEGGALTDIVTH--------TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCA  166 (292)
T ss_pred             EeCCCCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchh
Confidence            999999999998853        3478999999999999999999999   99999999999999999999999999987


Q ss_pred             cccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCch
Q 043902          317 FLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSH  395 (477)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  395 (477)
                      .....       ........|+..|+|||.+ ...++.++|||||||++|||++|+.||.......              
T Consensus       167 ~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--------------  225 (292)
T cd06658         167 QVSKE-------VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--------------  225 (292)
T ss_pred             hcccc-------cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------------
Confidence            54211       1112234578899999998 5568999999999999999999999986421110              


Q ss_pred             hHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          396 VMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       396 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                      ....+.......             .+.         .......+.+++..|+..||++|||++|+++.
T Consensus       226 ~~~~~~~~~~~~-------------~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         226 AMRRIRDNLPPR-------------VKD---------SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             HHHHHHhcCCCc-------------ccc---------ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            000000000000             000         00012237788999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.8e-37  Score=293.71  Aligned_cols=201  Identities=26%  Similarity=0.420  Sum_probs=166.0

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ++++|...+.||+|+||.||+|... +|..||+|+++... ......+.+|++++.+++|+||+++.+++     ..++.
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~   77 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII-----HTKET   77 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEE-----ecCCe
Confidence            4678999999999999999999864 68999999987543 22234678899999999999999999985     45667


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++|+||+. +++.+++....      ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+||
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Df  147 (291)
T cd07870          78 LTFVFEYMH-TDLAQYMIQHP------GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADF  147 (291)
T ss_pred             EEEEEeccc-CCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecc
Confidence            899999995 67777765432      3477888899999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccccC--CCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      |+++.....       ........++..|+|||.+.+  .++.++|||||||++|||+||+.||...
T Consensus       148 g~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~  207 (291)
T cd07870         148 GLARAKSIP-------SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV  207 (291)
T ss_pred             ccccccCCC-------CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence            998754211       111223356889999999843  4788999999999999999999999753

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3e-37  Score=294.57  Aligned_cols=250  Identities=23%  Similarity=0.317  Sum_probs=196.7

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      .++|...+.||+|+||.||++... ++..|++|.+........+.+.+|+.++.+++|||+++++++|     ...+..+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY-----LVGDELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhhee-----eeCCcEE
Confidence            468889999999999999999854 6889999998765555557889999999999999999999986     4456789


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +|+||+++++|.+++...        .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+
T Consensus        93 lv~e~~~~~~L~~~~~~~--------~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~  161 (293)
T cd06647          93 VVMEYLAGGSLTDVVTET--------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF  161 (293)
T ss_pred             EEEecCCCCcHHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcc
Confidence            999999999999998642        478889999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCC
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      +......       ........++..|+|||.+ .+.++.++|||||||++|++++|+.||........ .........+
T Consensus       162 ~~~~~~~-------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~~~~~~~~  233 (293)
T cd06647         162 CAQITPE-------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIATNGTP  233 (293)
T ss_pred             eeccccc-------ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eeehhcCCCC
Confidence            8755221       1122334578899999998 55689999999999999999999999965322110 0000000000


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                                                .++         ..+.....+.+++.+||+.+|++||++.+++..
T Consensus       234 --------------------------~~~---------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         234 --------------------------ELQ---------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             --------------------------CCC---------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                                      000         000012347789999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=8.4e-38  Score=297.17  Aligned_cols=197  Identities=23%  Similarity=0.402  Sum_probs=163.7

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      +|+..+.||+|+||.||+|+.. +|+.+|+|.++...  ......+.+|++++++++||||+++++++     .+....+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence            4778899999999999999875 68999999987532  22235678899999999999999999984     5567899


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +|+||++ ++|.+++....      ..+++..++.++.||++||.|||+.   +++||||||+||+++.++.+||+|||+
T Consensus        76 lv~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~  145 (284)
T cd07839          76 LVFEYCD-QDLKKYFDSCN------GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGL  145 (284)
T ss_pred             EEEecCC-CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccch
Confidence            9999996 58888776432      4589999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccccC--CCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ++....       .........++..|+|||.+.+  .++.++|||||||++|||+||..|+..
T Consensus       146 ~~~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~  202 (284)
T cd07839         146 ARAFGI-------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  202 (284)
T ss_pred             hhccCC-------CCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence            975421       1111223456889999999843  478999999999999999999988643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-37  Score=292.98  Aligned_cols=260  Identities=23%  Similarity=0.329  Sum_probs=199.0

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcC-CCCCcceeeeecccccC-CCC
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDY-EGN  230 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~-~~~  230 (477)
                      .++++|+..+.||+|++|.||+|... +++.+++|++..... ..+.+.+|+.++.++ .|+||+++++++..... ...
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            35789999999999999999999975 678999999876543 336789999999999 69999999999754322 235


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ...++||||+++++|.+++.....   ....+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~  155 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRK---KGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLV  155 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEEC
Confidence            668999999999999998864321   125689999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccccC------CCCcccceeehHHHHHHHhhCCCCCCcccccccce
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING------HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSI  384 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~  384 (477)
                      |||++.....       .........++..|+|||.+.+      .++.++|||||||++|+|+||+.||.......   
T Consensus       156 d~~~~~~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---  225 (275)
T cd06608         156 DFGVSAQLDS-------TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR---  225 (275)
T ss_pred             CCccceeccc-------chhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH---
Confidence            9999876522       1112233458889999998732      36789999999999999999999996421110   


Q ss_pred             eeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          385 HKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       385 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                                ....+.... .                +...      ........+.+++.+|+..||++|||+.|+++
T Consensus       226 ----------~~~~~~~~~-~----------------~~~~------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         226 ----------ALFKIPRNP-P----------------PTLK------SPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             ----------HHHHhhccC-C----------------CCCC------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                      000100000 0                0000      00112334789999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.8e-37  Score=291.63  Aligned_cols=253  Identities=24%  Similarity=0.382  Sum_probs=191.7

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc----------hhhHHHHHHHHHHhcCCCCCcceeeeeccccc
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ----------GALKSFIDECNALTSIRHRNILKIVSSCSSVD  226 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  226 (477)
                      +|...+.||+|+||.||+|... +|+.+|+|.++....          ...+.+.+|+.++.+++|+|++++++++    
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----   77 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE----   77 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence            4677889999999999999854 689999998864211          1234678899999999999999999986    


Q ss_pred             CCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCc
Q 043902          227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI  306 (477)
Q Consensus       227 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~  306 (477)
                       ...+..++||||+++++|.+++...       ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.
T Consensus        78 -~~~~~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~  146 (272)
T cd06629          78 -TTEEYLSIFLEYVPGGSIGSCLRTY-------GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGI  146 (272)
T ss_pred             -ccCCceEEEEecCCCCcHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCe
Confidence             4566789999999999999998754       4588899999999999999999998   9999999999999999999


Q ss_pred             EEEecccccccccccCCCCCCCccccCCCcccccccCccccc-C--CCCcccceeehHHHHHHHhhCCCCCCcccccccc
Q 043902          307 AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-G--HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLS  383 (477)
Q Consensus       307 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~--~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~  383 (477)
                      ++|+|||+++.....     ..........++..|+|||.+. .  .++.++|+||||+++||+++|..||.......  
T Consensus       147 ~~l~d~~~~~~~~~~-----~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--  219 (272)
T cd06629         147 CKISDFGISKKSDDI-----YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA--  219 (272)
T ss_pred             EEEeecccccccccc-----ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH--
Confidence            999999999764211     0111123345788999999983 2  37899999999999999999999985421110  


Q ss_pred             eeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          384 IHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       384 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                                 ...+.........             .+       ......+...+.+++.+|+..+|++|||+.||++
T Consensus       220 -----------~~~~~~~~~~~~~-------------~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         220 -----------AMFKLGNKRSAPP-------------IP-------PDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             -----------HHHHhhccccCCc-------------CC-------ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence                       0000000000000             00       0000112345888999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.4e-37  Score=292.14  Aligned_cols=253  Identities=23%  Similarity=0.318  Sum_probs=196.2

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      +|+..+.||.|+||.||++... ++..+|+|.++...  ....+.+.+|++++++++|+|++++++++..   ......+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence            4778899999999999999854 78899999987432  3344678899999999999999999987542   3456689


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHH-----cCCCCCeeecCCCCCCeEecCCCcEEE
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH-----NQYDTPIAHCDLKSSNVLLDEGMIAHV  309 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-----~~~~~~ivH~dlkp~NIll~~~~~~kl  309 (477)
                      ++|||+++++|.+++.....   ....+++..++.++.|++.||.|||     +.   +++|+||+|+||+++.++.+||
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl  151 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKK---ERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKL  151 (265)
T ss_pred             EEehhccCCCHHHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEE
Confidence            99999999999999865321   1256899999999999999999999     66   9999999999999999999999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeee
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~  388 (477)
                      +|||++......       ........++..|+|||.+ ...++.++||||||+++|+|++|+.||......        
T Consensus       152 ~d~g~~~~~~~~-------~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------  216 (265)
T cd08217         152 GDFGLAKILGHD-------SSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL--------  216 (265)
T ss_pred             ecccccccccCC-------cccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH--------
Confidence            999999865221       1112234678899999999 556899999999999999999999999653211        


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                            .+.+.+.....                +.+.        ......+.+++.+|++.+|++||++.||++.
T Consensus       217 ------~~~~~~~~~~~----------------~~~~--------~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         217 ------QLASKIKEGKF----------------RRIP--------YRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ------HHHHHHhcCCC----------------CCCc--------cccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                  01111110000                0000        0113348899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=9.2e-38  Score=293.73  Aligned_cols=252  Identities=25%  Similarity=0.391  Sum_probs=196.5

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      ++|+..+.||+|++|.||++... +++.+++|.+.... ......+.+|++++++++||||+++++.+     ......+
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF-----YNNGDIS   75 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheee-----ecCCEEE
Confidence            35778889999999999999876 68999999987553 34456789999999999999999999986     4457899


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN-QYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      +++||+++++|.+++....      ..+++..+..++.|++.||.|||+ .   +++|+||||+||++++++.++|+|||
T Consensus        76 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g  146 (265)
T cd06605          76 ICMEYMDGGSLDKILKEVQ------GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFG  146 (265)
T ss_pred             EEEEecCCCcHHHHHHHcc------CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence            9999999999999997543      458889999999999999999999 7   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccC
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMAL  392 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  392 (477)
                      .+......         ......++..|+|||.+ ...++.++||||||+++|+|++|+.||......            
T Consensus       147 ~~~~~~~~---------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------------  205 (265)
T cd06605         147 VSGQLVNS---------LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP------------  205 (265)
T ss_pred             cchhhHHH---------HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc------------
Confidence            98765211         11115678899999998 456899999999999999999999998653211            


Q ss_pred             CchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          393 PSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       393 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      ++...+.+.......             .+.....       .....+.+++.+|+..||++|||+.|++.
T Consensus       206 ~~~~~~~~~~~~~~~-------------~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         206 PDGIFELLQYIVNEP-------------PPRLPSG-------KFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             cccHHHHHHHHhcCC-------------CCCCChh-------hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            011111111111000             0000000       02334889999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-37  Score=293.66  Aligned_cols=200  Identities=26%  Similarity=0.422  Sum_probs=166.6

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc-hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ-GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .++|+..+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++|+||+++++++     ...+..
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   78 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTL   78 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeE
Confidence            367889999999999999999875 689999999875432 2234577899999999999999999985     456789


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||+++ +|.+++....      ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||
T Consensus        79 ~lv~e~~~~-~L~~~~~~~~------~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg  148 (291)
T cd07844          79 TLVFEYLDT-DLKQYMDDCG------GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFG  148 (291)
T ss_pred             EEEEecCCC-CHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccc
Confidence            999999974 9999886543      3578999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      +++....       .........++..|+|||.+.  ..++.++||||||+++|||++|+.||...
T Consensus       149 ~~~~~~~-------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~  207 (291)
T cd07844         149 LARAKSV-------PSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS  207 (291)
T ss_pred             cccccCC-------CCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9875311       011112234678899999883  34789999999999999999999999653

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-38  Score=299.23  Aligned_cols=252  Identities=22%  Similarity=0.321  Sum_probs=197.7

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeee--ccchhhHHHHHHHHHHhcCC-CCCcceeeeecccccCCCCce
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKL--QQQGALKSFIDECNALTSIR-HRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ...|++.++||.||.+.||++...+.+.+|+|.+..  .+......|.+|+..|.+|+ |.+||++++|-     -.+++
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d~~  434 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTDGY  434 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccCce
Confidence            467899999999999999999988888999987763  34555688999999999994 99999999993     45788


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      +|+||||- .-+|..+|.....      .+....+..+..||+.|+.++|.+   ||||.||||.|+|+-. |.+||+||
T Consensus       435 lYmvmE~G-d~DL~kiL~k~~~------~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDF  503 (677)
T KOG0596|consen  435 LYMVMECG-DIDLNKILKKKKS------IDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDF  503 (677)
T ss_pred             EEEEeecc-cccHHHHHHhccC------CCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeee
Confidence            99999987 5599999987652      233237788999999999999999   9999999999999865 57999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCccccc-C-----------CCCcccceeehHHHHHHHhhCCCCCCccccc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-G-----------HVSILGDIYSYGILLLEIFTGKRPTDDMFKD  380 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~-----------~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~  380 (477)
                      |+|..+..     +...-.....+||+.||+||.+. .           +.+.++||||+||+||+|+.|+.||......
T Consensus       504 GIA~aI~~-----DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~  578 (677)
T KOG0596|consen  504 GIANAIQP-----DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ  578 (677)
T ss_pred             chhcccCc-----cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH
Confidence            99987743     22334456678999999999882 1           2678999999999999999999999753211


Q ss_pred             ccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHH
Q 043902          381 DLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKF  460 (477)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e  460 (477)
                                  -.++..+.|+...             ..+|.+..          ..++.++++.||++||.+|||+.|
T Consensus       579 ------------~aKl~aI~~P~~~-------------Iefp~~~~----------~~~li~~mK~CL~rdPkkR~si~e  623 (677)
T KOG0596|consen  579 ------------IAKLHAITDPNHE-------------IEFPDIPE----------NDELIDVMKCCLARDPKKRWSIPE  623 (677)
T ss_pred             ------------HHHHHhhcCCCcc-------------ccccCCCC----------chHHHHHHHHHHhcCcccCCCcHH
Confidence                        0123334443221             11222221          112889999999999999999999


Q ss_pred             HHH
Q 043902          461 VVN  463 (477)
Q Consensus       461 vl~  463 (477)
                      +++
T Consensus       624 LLq  626 (677)
T KOG0596|consen  624 LLQ  626 (677)
T ss_pred             Hhc
Confidence            985

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.4e-37  Score=297.10  Aligned_cols=259  Identities=22%  Similarity=0.309  Sum_probs=194.8

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ++|...+.||+|+||.||++... +++.|++|.+....   ......+.+|++++..++||||+++++.+     ..++.
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRH   75 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCE
Confidence            36888999999999999999875 67899999987543   23345788999999999999999999885     55678


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++++|.+++...       ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~df  145 (305)
T cd05609          76 LCMVMEYVEGGDCATLLKNI-------GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDF  145 (305)
T ss_pred             EEEEEecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeC
Confidence            89999999999999999654       4588999999999999999999998   9999999999999999999999999


Q ss_pred             cccccccccCCC--------CCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccc
Q 043902          313 GLAKFLFEESNT--------PSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLS  383 (477)
Q Consensus       313 G~a~~~~~~~~~--------~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~  383 (477)
                      |+++........        ............++..|+|||.+ .+.++.++|+|||||++|||++|..||......   
T Consensus       146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---  222 (305)
T cd05609         146 GLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---  222 (305)
T ss_pred             CCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---
Confidence            998742110000        00001111234578899999998 556899999999999999999999998642111   


Q ss_pred             eeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          384 IHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       384 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                                    ++.........           ..+...        ..++..+.+++.+|++.||++||++.++.+
T Consensus       223 --------------~~~~~~~~~~~-----------~~~~~~--------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~  269 (305)
T cd05609         223 --------------ELFGQVISDDI-----------EWPEGD--------EALPADAQDLISRLLRQNPLERLGTGGAFE  269 (305)
T ss_pred             --------------HHHHHHHhccc-----------CCCCcc--------ccCCHHHHHHHHHHhccChhhccCccCHHH
Confidence                          11110000000           000000        011334789999999999999999766665


Q ss_pred             HHH
Q 043902          464 NLQ  466 (477)
Q Consensus       464 ~L~  466 (477)
                      .|+
T Consensus       270 ll~  272 (305)
T cd05609         270 VKQ  272 (305)
T ss_pred             HHh
Confidence            554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.8e-37  Score=290.41  Aligned_cols=250  Identities=30%  Similarity=0.589  Sum_probs=194.3

Q ss_pred             CCCCCeeeeeccceEEEEEeCC-----CCEEEEEEeeeccch-hhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          159 FSEENLIGSGSFGSVYKGTLAD-----GETAAIKVLKLQQQG-ALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       159 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      +++.+.||.|+||.||++...+     +..||+|.++..... ..+.+..|++.+.+++|+||+++++++     ...+.
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVC-----TEEEP   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEE-----cCCCe
Confidence            3567899999999999998753     488999999755433 557899999999999999999999986     44567


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .+++|||+++++|.+++.....     ..+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+||
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~df  147 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNRP-----KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDF  147 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhhh-----ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEccc
Confidence            9999999999999999975431     2289999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeec
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  390 (477)
                      |++........      .......++..|+|||.+ .+.++.++||||+|+++|||++ |..||......          
T Consensus       148 g~~~~~~~~~~------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~----------  211 (258)
T smart00219      148 GLSRDLYDDDY------YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE----------  211 (258)
T ss_pred             CCceecccccc------cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH----------
Confidence            99987633211      111123367899999998 5678999999999999999999 78887642111          


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNL  465 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  465 (477)
                          .+.+.+.......             .+           ..+...+.+++.+|+..||++|||+.|+++.|
T Consensus       212 ----~~~~~~~~~~~~~-------------~~-----------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      212 ----EVLEYLKKGYRLP-------------KP-----------ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ----HHHHHHhcCCCCC-------------CC-----------CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                0111110000000             00           00134588999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.7e-37  Score=295.11  Aligned_cols=198  Identities=27%  Similarity=0.424  Sum_probs=165.3

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      +|+..+.||.|++|.||+|+.. +|+.||+|.++...  ......+.+|++++++++||||+++++++     .+.+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence            4788899999999999999865 68999999987443  22335788999999999999999999985     4567789


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +||||+. ++|.+++.....     ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||+
T Consensus        76 ~v~e~~~-~~l~~~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~  146 (284)
T cd07860          76 LVFEFLH-QDLKKFMDASPL-----SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL  146 (284)
T ss_pred             EEeeccc-cCHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence            9999995 689888865421     4689999999999999999999998   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccccC--CCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      +......       ........++..|+|||.+.+  .++.++|||||||++|||+||+.||..
T Consensus       147 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~  203 (284)
T cd07860         147 ARAFGVP-------VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG  203 (284)
T ss_pred             hhhcccC-------ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            8754211       111223346788999998833  368899999999999999999999965

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=8.2e-37  Score=285.70  Aligned_cols=247  Identities=22%  Similarity=0.370  Sum_probs=193.2

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      +|+..+.||+|+||.||++... +++.+|+|.+....  ......+.+|++++++++|||++++++.+     ..++..+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence            4778899999999999999864 68899999987542  33456789999999999999999999874     5567899


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC-CcEEEeccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG-MIAHVGDFG  313 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~DfG  313 (477)
                      +||||+++++|.+++....     ...+++..+..++.+++.||.|||++   +++|+||+|+||+++++ +.+||+|||
T Consensus        76 lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~  147 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRC-----NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFG  147 (256)
T ss_pred             EEEecCCCCCHHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCC
Confidence            9999999999999997542     14589999999999999999999999   99999999999999854 468999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccC
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMAL  392 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  392 (477)
                      .+......        .......++..|+|||.+ ....+.++||||||+++|+|++|+.||.......           
T Consensus       148 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-----------  208 (256)
T cd08220         148 ISKILSSK--------SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA-----------  208 (256)
T ss_pred             CceecCCC--------ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH-----------
Confidence            99865221        112234578899999999 4567899999999999999999999986431110           


Q ss_pred             CchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          393 PSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       393 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                        ...........              ..+           ..+...+.+++.+||+.+|++|||+.|+++
T Consensus       209 --~~~~~~~~~~~--------------~~~-----------~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         209 --LVLKIMSGTFA--------------PIS-----------DRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             --HHHHHHhcCCC--------------CCC-----------CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence              01111000000              000           011334789999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=7.1e-37  Score=292.91  Aligned_cols=197  Identities=24%  Similarity=0.365  Sum_probs=165.3

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccch-----hhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQG-----ALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      +|+..+.||+|++|.||+|... +|+.||+|.++.....     ....+..|++++.+++|+||+++++++     .+..
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF-----GHKS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee-----ecCC
Confidence            4777889999999999999865 6899999999754322     235677899999999999999999996     4467


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+ +|+|.+++....      ..+++..++.++.|+++||.|||+.   +++|+||+|+||+++.++.++|+|
T Consensus        76 ~~~lv~e~~-~~~L~~~i~~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~d  145 (298)
T cd07841          76 NINLVFEFM-ETDLEKVIKDKS------IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLAD  145 (298)
T ss_pred             EEEEEEccc-CCCHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEcc
Confidence            899999999 999999997542      3589999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ||+++.....       ........++..|+|||.+.  ..++.++|||||||++|||++|.+||..
T Consensus       146 fg~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~  205 (298)
T cd07841         146 FGLARSFGSP-------NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG  205 (298)
T ss_pred             ceeeeeccCC-------CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC
Confidence            9999865221       11122234678899999883  3578999999999999999999877754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.6e-37  Score=296.90  Aligned_cols=245  Identities=22%  Similarity=0.303  Sum_probs=191.3

Q ss_pred             CCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEee
Q 043902          161 EENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEF  239 (477)
Q Consensus       161 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~  239 (477)
                      ....||+|+||.||+|... +++.||+|.+........+.+.+|+..+..++|||++++++++     ..++..++|+||
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~iv~e~   99 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY-----LVGEELWVLMEF   99 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhe-----eeCCeEEEEEec
Confidence            3457999999999999864 7899999999765555557788999999999999999999985     456778999999


Q ss_pred             cCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccccc
Q 043902          240 MRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLF  319 (477)
Q Consensus       240 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  319 (477)
                      +++++|.+++..        ..+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||++....
T Consensus       100 ~~~~~L~~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~  168 (297)
T cd06659         100 LQGGALTDIVSQ--------TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS  168 (297)
T ss_pred             CCCCCHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcc
Confidence            999999998753        3478999999999999999999999   99999999999999999999999999987542


Q ss_pred             ccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCchhHH
Q 043902          320 EESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMD  398 (477)
Q Consensus       320 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  398 (477)
                      ..       ........++..|+|||++ ...++.++|||||||++|||++|+.||.......              ...
T Consensus       169 ~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--------------~~~  227 (297)
T cd06659         169 KD-------VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--------------AMK  227 (297)
T ss_pred             cc-------cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------------HHH
Confidence            21       1112335688999999998 5578999999999999999999999986421110              000


Q ss_pred             HhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          399 VLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       399 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                      .+.......       ..               ........+.+++.+|++.+|++||++.|+++.
T Consensus       228 ~~~~~~~~~-------~~---------------~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         228 RLRDSPPPK-------LK---------------NAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             HHhccCCCC-------cc---------------ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            000000000       00               000012337789999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.1e-37  Score=290.86  Aligned_cols=253  Identities=21%  Similarity=0.337  Sum_probs=194.0

Q ss_pred             CCCCCCeeeeeccceEEEEEeCC--CCEEEEEEeeec----------cchhhHHHHHHHHHHhc-CCCCCcceeeeeccc
Q 043902          158 NFSEENLIGSGSFGSVYKGTLAD--GETAAIKVLKLQ----------QQGALKSFIDECNALTS-IRHRNILKIVSSCSS  224 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~  224 (477)
                      +|++.+.||+|+||.||+|....  ++.+|+|.+...          .......+..|+.++.+ ++||||+++++++  
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~--   78 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF--   78 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--
Confidence            47788999999999999999764  688999988632          22234567788888875 7999999999986  


Q ss_pred             ccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeEecC
Q 043902          225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN-QYDTPIAHCDLKSSNVLLDE  303 (477)
Q Consensus       225 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~  303 (477)
                         ..++..++||||+++++|.+++.....   ....+++..++.++.|++.||.|||+ .   +++|+||+|+||+++.
T Consensus        79 ---~~~~~~~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~  149 (269)
T cd08528          79 ---LENDRLYIVMDLIEGAPLGEHFNSLKE---KKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGE  149 (269)
T ss_pred             ---ccCCeEEEEEecCCCCcHHHHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECC
Confidence               456789999999999999998854211   12468899999999999999999996 5   8999999999999999


Q ss_pred             CCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCccccccc
Q 043902          304 GMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDL  382 (477)
Q Consensus       304 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~  382 (477)
                      ++.+||+|||.+......        .......++..|+|||.+ .+.++.++||||||+++|||++|+.||....... 
T Consensus       150 ~~~~~l~dfg~~~~~~~~--------~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~-  220 (269)
T cd08528         150 DDKVTITDFGLAKQKQPE--------SKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS-  220 (269)
T ss_pred             CCcEEEecccceeecccc--------cccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH-
Confidence            999999999999765221        122345678899999999 5568999999999999999999999985421100 


Q ss_pred             ceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHH
Q 043902          383 SIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVV  462 (477)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl  462 (477)
                                  ....+.+......                 .       .......+.+++.+|++.||++||++.||.
T Consensus       221 ------------~~~~~~~~~~~~~-----------------~-------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~  264 (269)
T cd08528         221 ------------LATKIVEAVYEPL-----------------P-------EGMYSEDVTDVITSCLTPDAEARPDIIQVS  264 (269)
T ss_pred             ------------HHHHHhhccCCcC-----------------C-------cccCCHHHHHHHHHHCCCCCccCCCHHHHH
Confidence                        0001110000000                 0       000123478899999999999999999999


Q ss_pred             HHHH
Q 043902          463 NNLQ  466 (477)
Q Consensus       463 ~~L~  466 (477)
                      ++++
T Consensus       265 ~~~~  268 (269)
T cd08528         265 AMIS  268 (269)
T ss_pred             HHhc
Confidence            9875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=9.2e-37  Score=286.63  Aligned_cols=252  Identities=25%  Similarity=0.349  Sum_probs=198.9

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc-hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ-GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      ++|+..+.||+|++|.||+|+.. +++.|++|++..... .....+.+|++.+.+++|+|++++++++     ......+
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF-----YKEGEIS   75 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----ccCCeEE
Confidence            36788899999999999999976 599999999876543 4457899999999999999999999985     4557899


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN-QYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      +|+||+++++|.+++...       ..+++..++.++.|+++|+.|||+ .   +++|+||+|+||+++.++.++|+|||
T Consensus        76 lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~  145 (264)
T cd06623          76 IVLEYMDGGSLADLLKKV-------GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFG  145 (264)
T ss_pred             EEEEecCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCc
Confidence            999999999999999754       458999999999999999999999 8   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccC
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMAL  392 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  392 (477)
                      .+......       ........++..|+|||.+ .+.++.++|+||||+++|+|+||+.||.......          .
T Consensus       146 ~~~~~~~~-------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~----------~  208 (264)
T cd06623         146 ISKVLENT-------LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS----------F  208 (264)
T ss_pred             cceecccC-------CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC----------H
Confidence            99865221       1111234578899999998 5568999999999999999999999996543200          0


Q ss_pred             CchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          393 PSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       393 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                      .+....+......                 .....       .....+.+++.+|++.+|++|||+.|+++.
T Consensus       209 ~~~~~~~~~~~~~-----------------~~~~~-------~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         209 FELMQAICDGPPP-----------------SLPAE-------EFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             HHHHHHHhcCCCC-----------------CCCcc-------cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            0001111100000                 00000       013348899999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.7e-37  Score=289.40  Aligned_cols=254  Identities=20%  Similarity=0.368  Sum_probs=194.0

Q ss_pred             CCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeecc------chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          158 NFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQ------QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      +|+..+.||+|++|.||+|.. .+++.||+|+++...      ....+.+.+|++.+++++|+||+++++++     ...
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence            477889999999999999985 478999999987433      12346789999999999999999999995     556


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC-cEEE
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM-IAHV  309 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl  309 (477)
                      +..++|+||+++++|.+++...       ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++ .+||
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l  145 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSKY-------GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRI  145 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEE
Confidence            7789999999999999998743       4588999999999999999999999   999999999999998775 6999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeee
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~  388 (477)
                      +|||.+.........   .........++..|+|||.+ ...++.++||||+|+++|+|++|+.||.......       
T Consensus       146 ~dfg~~~~~~~~~~~---~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------  215 (268)
T cd06630         146 ADFGAAARLAAKGTG---AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN-------  215 (268)
T ss_pred             ccccccccccccccc---CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc-------
Confidence            999999776322100   11112234578899999998 4568899999999999999999999986421110       


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                            ....+........             .+.        ..+.....+.+++.+|+..+|++|||+.|+++
T Consensus       216 ------~~~~~~~~~~~~~-------------~~~--------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         216 ------HLALIFKIASATT-------------APS--------IPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ------hHHHHHHHhccCC-------------CCC--------CchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                  0000000000000             000        00111344788999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1e-36  Score=286.43  Aligned_cols=253  Identities=26%  Similarity=0.418  Sum_probs=195.2

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc--hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ--GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      +|...+.||+|+||.||+|... +++.|++|.++....  .....+.+|++++++++|+||+++++.+     ...+..+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence            4778899999999999999864 789999999986544  3567899999999999999999999985     4567899


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +|+||+++++|.+++...       ..+++..+..++.+++.||.|||+.   +++|+||+|+||++++++.+||+|||+
T Consensus        76 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~  145 (264)
T cd06626          76 IFMEYCSGGTLEELLEHG-------RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGC  145 (264)
T ss_pred             EEEecCCCCcHHHHHhhc-------CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccccc
Confidence            999999999999998754       3478899999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCccccc-CC---CCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GH---VSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~---~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      +..........   ........++..|+|||++. ..   .+.++||||||+++||+++|+.||........        
T Consensus       146 ~~~~~~~~~~~---~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--------  214 (264)
T cd06626         146 AVKLKNNTTTM---GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--------  214 (264)
T ss_pred             ccccCCCCCcc---cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--------
Confidence            98763321111   11022356788999999983 33   78999999999999999999999964321100        


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                           ....+..    .  .       ...+|..         ..+...+.+++.+|++.+|++|||+.|++.
T Consensus       215 -----~~~~~~~----~--~-------~~~~~~~---------~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         215 -----IMFHVGA----G--H-------KPPIPDS---------LQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             -----HHHHHhc----C--C-------CCCCCcc---------cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                 0000000    0  0       0000000         001234778999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8.9e-37  Score=287.22  Aligned_cols=259  Identities=23%  Similarity=0.345  Sum_probs=198.4

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      ++|++.+.||.|+||.||+|... ++..+++|++.... ......+.+|++.++.++|+|++++++.+     ...+..+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDELW   75 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEEE
Confidence            47889999999999999999864 68899999987443 33557889999999999999999999885     4567889


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +|+|++++++|.+++.....    ...+++..+..++.|++.||+|||+.   +++||||+|+||++++++.++|+|||+
T Consensus        76 iv~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~  148 (267)
T cd06610          76 LVMPYLSGGSLLDIMKSSYP----RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGV  148 (267)
T ss_pred             EEEeccCCCcHHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccch
Confidence            99999999999999975421    14589999999999999999999998   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cC-CCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccC
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NG-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMAL  392 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  392 (477)
                      +..+.......   ........|+..|+|||++ .+ .++.++|+|||||++|||++|+.||.......           
T Consensus       149 ~~~~~~~~~~~---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-----------  214 (267)
T cd06610         149 SASLADGGDRT---RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-----------  214 (267)
T ss_pred             HHHhccCcccc---ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-----------
Confidence            98764322111   0122334688899999998 44 58999999999999999999999996532111           


Q ss_pred             CchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          393 PSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       393 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                        ...+.......        .      .+...      ........+.+++.+|++.||++|||+.|+++
T Consensus       215 --~~~~~~~~~~~--------~------~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         215 --VLMLTLQNDPP--------S------LETGA------DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             --hHHHHhcCCCC--------C------cCCcc------ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence              00010000000        0      00000      00112344789999999999999999999975

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-37  Score=297.86  Aligned_cols=251  Identities=23%  Similarity=0.317  Sum_probs=203.1

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc---hhhHHHHHHHHHHhcCC-CCCcceeeeecccccCC
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ---GALKSFIDECNALTSIR-HRNILKIVSSCSSVDYE  228 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~  228 (477)
                      .....|+..+.||+|.||.||+++.+ +|+.+|+|++.....   .......+|+++|+++. |||||.+.+.+     +
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-----e  106 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-----E  106 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----E
Confidence            34567888899999999999999976 599999999975543   23468899999999998 99999999994     6


Q ss_pred             CCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC----
Q 043902          229 GNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG----  304 (477)
Q Consensus       229 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~----  304 (477)
                      .....++|||++.||.|.+.+...        .+++.....++.|++.|+.|||+.   +|+||||||+|+|+...    
T Consensus       107 ~~~~~~lvmEL~~GGeLfd~i~~~--------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~  175 (382)
T KOG0032|consen  107 DPDSVYLVMELCEGGELFDRIVKK--------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGS  175 (382)
T ss_pred             cCCeEEEEEEecCCchHHHHHHHc--------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCC
Confidence            777899999999999999998744        289999999999999999999998   99999999999999633    


Q ss_pred             CcEEEecccccccccccCCCCCCCccccCCCcccccccCccccc-CCCCcccceeehHHHHHHHhhCCCCCCcccccccc
Q 043902          305 MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLS  383 (477)
Q Consensus       305 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~  383 (477)
                      +.+|++|||++.....        .......+||+.|+|||++. ..++..+||||+||++|.|++|.+||.........
T Consensus       176 ~~ik~~DFGla~~~~~--------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~  247 (382)
T KOG0032|consen  176 GRIKLIDFGLAKFIKP--------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF  247 (382)
T ss_pred             CcEEEeeCCCceEccC--------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH
Confidence            4799999999987621        33456678999999999996 68999999999999999999999999764332211


Q ss_pred             eeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          384 IHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       384 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      .             .+......                      +..+..+.....+.+++..|+..||.+|+|+.++++
T Consensus       248 ~-------------~i~~~~~~----------------------f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  248 L-------------AILRGDFD----------------------FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             H-------------HHHcCCCC----------------------CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            1             11111110                      000111112344789999999999999999999997

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=6.4e-38  Score=321.90  Aligned_cols=264  Identities=25%  Similarity=0.366  Sum_probs=194.0

Q ss_pred             HHhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec-cchhhHHHHHHHHHHhcCCCCCcceeeeeccccc----
Q 043902          153 SNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ-QQGALKSFIDECNALTSIRHRNILKIVSSCSSVD----  226 (477)
Q Consensus       153 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  226 (477)
                      +....+|++.++||+||||.||+++.+ ||+.||||++... .........+|+..|++|+|||||+++..+....    
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            456678999999999999999999987 9999999999755 3344567889999999999999999876421100    


Q ss_pred             ---------------------------------------------------------CC---------------------
Q 043902          227 ---------------------------------------------------------YE---------------------  228 (477)
Q Consensus       227 ---------------------------------------------------------~~---------------------  228 (477)
                                                                               ++                     
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                     00                     


Q ss_pred             ------------------------CC--------ceeeEEEeecCCCChhhhcccCCCcccccccC-CHHHHHHHHHHHH
Q 043902          229 ------------------------GN--------DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKL-SLMQRLNIVIDVA  275 (477)
Q Consensus       229 ------------------------~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l-~~~~~~~i~~~ia  275 (477)
                                              .+        ...||-||||+..++.++++.+.       .. .....++++.+|+
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~-------~~~~~d~~wrLFreIl  707 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH-------FNSQRDEAWRLFREIL  707 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc-------cchhhHHHHHHHHHHH
Confidence                                    00        24678899998888888876542       11 3567899999999


Q ss_pred             HHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccccc------c-----cCCCCCCCccccCCCcccccccCc
Q 043902          276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLF------E-----ESNTPSKNQTMSNGLKGSVGYIPP  344 (477)
Q Consensus       276 ~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~------~-----~~~~~~~~~~~~~~~~gt~~y~aP  344 (477)
                      .||+|+|++   |||||||||.||++|++..+||+|||+|....      +     ............++.+||.-|+||
T Consensus       708 EGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP  784 (1351)
T KOG1035|consen  708 EGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP  784 (1351)
T ss_pred             HHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence            999999999   99999999999999999999999999998732      0     011112223345678899999999


Q ss_pred             cccc--C--CCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccc
Q 043902          345 EYIN--G--HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDL  420 (477)
Q Consensus       345 E~~~--~--~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~  420 (477)
                      |++.  .  +|+.|+|+||+|||++||+.   ||....+....+...-...+|.. .++.++.                 
T Consensus       785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~~~-----------------  843 (1351)
T KOG1035|consen  785 ELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFDPE-----------------  843 (1351)
T ss_pred             HHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-ccccccc-----------------
Confidence            9992  2  59999999999999999985   46543322222221112222221 1111111                 


Q ss_pred             cchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          421 FPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       421 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                                      ...-.+++.++++.||.+|||+.|++.
T Consensus       844 ----------------~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  844 ----------------HPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             ----------------chHHHHHHHHHhcCCCccCCCHHHHhh
Confidence                            112468999999999999999999985

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=6.2e-37  Score=290.99  Aligned_cols=252  Identities=21%  Similarity=0.320  Sum_probs=188.2

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHH-HhcCCCCCcceeeeecccccCCCCcee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNA-LTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|+++... ......+..|+.. ++..+|||++++++++     ..++..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~-----~~~~~~   75 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL-----FREGDV   75 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEE-----ecCCcE
Confidence            46888999999999999999875 69999999987543 2233456666665 5566899999999996     345678


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||++ |+|.+++.....   ....+++..++.++.|++.||.|||+++  +++||||||+||+++.++.+||+|||
T Consensus        76 ~lv~e~~~-~~l~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg  149 (283)
T cd06617          76 WICMEVMD-TSLDKFYKKVYD---KGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFG  149 (283)
T ss_pred             EEEhhhhc-ccHHHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecc
Confidence            99999996 688888764321   1156899999999999999999999852  89999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCccccc-----CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeee
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-----GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~  388 (477)
                      ++.....        ........++..|+|||.+.     ..++.++|+|||||++|||++|+.||.......       
T Consensus       150 ~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------  214 (283)
T cd06617         150 ISGYLVD--------SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-------  214 (283)
T ss_pred             ccccccc--------ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-------
Confidence            9976521        11122345788899999883     246889999999999999999999986421110       


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                           +.+......... .             .+          .+.+...+.+++.+|+..+|++||++.|+++
T Consensus       215 -----~~~~~~~~~~~~-~-------------~~----------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         215 -----QQLKQVVEEPSP-Q-------------LP----------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             -----HHHHHHHhcCCC-C-------------CC----------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 011111100000 0             00          0011334789999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-37  Score=295.75  Aligned_cols=257  Identities=27%  Similarity=0.350  Sum_probs=196.5

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc---hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ---GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ++|+..+.||+|++|.||+|... +++.||+|.+.....   ...+.+.+|++.+.+++|+||+++++.+     .....
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~   75 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETY   75 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCE
Confidence            36888899999999999999875 589999999975432   2446788999999999999999999985     55678


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+.+++|.+++....     ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+||
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~df  147 (316)
T cd05574          76 LCLVMDYCPGGELFRLLQRQP-----GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDF  147 (316)
T ss_pred             EEEEEEecCCCCHHHHHHhCC-----CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeec
Confidence            999999999999999987542     14689999999999999999999998   9999999999999999999999999


Q ss_pred             cccccccccCCCCCC----------------------CccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh
Q 043902          313 GLAKFLFEESNTPSK----------------------NQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT  369 (477)
Q Consensus       313 G~a~~~~~~~~~~~~----------------------~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt  369 (477)
                      |++............                      .........|+..|+|||++ ...++.++||||||+++|+|++
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~  227 (316)
T cd05574         148 DLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY  227 (316)
T ss_pred             chhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhh
Confidence            998765321110000                      00112234678899999999 5568999999999999999999


Q ss_pred             CCCCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCC
Q 043902          370 GKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSA  449 (477)
Q Consensus       370 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~  449 (477)
                      |+.||.......             ....+.+.....               +..         ......+.+++.+|++
T Consensus       228 g~~pf~~~~~~~-------------~~~~~~~~~~~~---------------~~~---------~~~~~~~~~li~~~l~  270 (316)
T cd05574         228 GTTPFKGSNRDE-------------TFSNILKKEVTF---------------PGS---------PPVSSSARDLIRKLLV  270 (316)
T ss_pred             CCCCCCCCchHH-------------HHHHHhcCCccC---------------CCc---------cccCHHHHHHHHHHcc
Confidence            999996532111             111111111000               000         0013448899999999


Q ss_pred             CCCCCCCC----hHHHHH
Q 043902          450 ASPRDRVG----MKFVVN  463 (477)
Q Consensus       450 ~dP~~RPs----~~evl~  463 (477)
                      .||++|||    ++|++.
T Consensus       271 ~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         271 KDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             CCHhHCCCchhhHHHHHc
Confidence            99999999    666654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=7.4e-37  Score=295.04  Aligned_cols=201  Identities=22%  Similarity=0.271  Sum_probs=160.3

Q ss_pred             CeeeeeccceEEEEEeCCCCEEEEEEeeec--cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEeec
Q 043902          163 NLIGSGSFGSVYKGTLADGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFM  240 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  240 (477)
                      +.+|.|+++.||++.. +++.||+|+++..  .......+.+|++.+++++|+||+++++++     ...+..+++|||+
T Consensus         8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~-----~~~~~~~~~~e~~   81 (314)
T cd08216           8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF-----IVDSELYVVSPLM   81 (314)
T ss_pred             HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhee-----ecCCeEEEEEecc
Confidence            3344555555555544 6899999999754  344557899999999999999999999985     5567789999999


Q ss_pred             CCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccccc
Q 043902          241 RNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFE  320 (477)
Q Consensus       241 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  320 (477)
                      ++|+|.+++.....     ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||.+.....
T Consensus        82 ~~~~l~~~l~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~  153 (314)
T cd08216          82 AYGSCEDLLKTHFP-----EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIK  153 (314)
T ss_pred             CCCCHHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecc
Confidence            99999999975421     3578899999999999999999999   999999999999999999999999999876543


Q ss_pred             cCCCCCCCccccCCCcccccccCcccccC---CCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          321 ESNTPSKNQTMSNGLKGSVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       321 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      ................++..|+|||++.+   .++.++|||||||++|||++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~  213 (314)
T cd08216         154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM  213 (314)
T ss_pred             ccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence            22211111122234457788999999843   4789999999999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1e-36  Score=289.38  Aligned_cols=270  Identities=23%  Similarity=0.274  Sum_probs=190.1

Q ss_pred             CCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCC-CCCcceeeeecccccCCCCceeeE
Q 043902          159 FSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIR-HRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       159 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      |+..+.||+|+||.||+|... +++.||+|.++... ........+|+..+.++. |+|++++++++..   ...+..++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~---~~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFD---RKTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEec---CCCCcEEE
Confidence            566789999999999999864 68999999987542 222234567899999885 9999999999742   22367899


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      |+||++ |+|.+++....      ..+++..++.++.|++.||.|||+.   +++||||+|+||+++. +.+||+|||++
T Consensus        78 v~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~  146 (282)
T cd07831          78 VFELMD-MNLYELIKGRK------RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSC  146 (282)
T ss_pred             EEecCC-ccHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccc
Confidence            999996 58888876532      4589999999999999999999999   9999999999999999 99999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-c-CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccC-
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-N-GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMAL-  392 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-  392 (477)
                      +.....        .......++..|+|||.+ . +.++.++|||||||++|||++|..||......+  ......... 
T Consensus       147 ~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~  216 (282)
T cd07831         147 RGIYSK--------PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLG  216 (282)
T ss_pred             cccccC--------CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcC
Confidence            765221        111224578899999976 3 457899999999999999999999996532211  000000000 


Q ss_pred             --CchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          393 --PSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       393 --~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                        ++.+..........           ...++.................+.+++.+||+.+|++|||++++++
T Consensus       217 ~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         217 TPDAEVLKKFRKSRHM-----------NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             CCCHHHHHhhcccccc-----------cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence              00110000000000           0000000000001111223566899999999999999999999975

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=5.5e-37  Score=292.84  Aligned_cols=267  Identities=18%  Similarity=0.219  Sum_probs=183.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCC----CCEEEEEEeeeccchhh-----------HHHHHHHHHHhcCCCCCcceeee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLAD----GETAAIKVLKLQQQGAL-----------KSFIDECNALTSIRHRNILKIVS  220 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~l~~  220 (477)
                      .++|.+.+.||+|+||.||+|...+    +..+|+|+.........           .....+...+..+.|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            4689999999999999999998654    45667776543321110           11233444566778999999998


Q ss_pred             ecccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeE
Q 043902          221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVL  300 (477)
Q Consensus       221 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIl  300 (477)
                      ++.... ......++++|++. .++.+.+...       ...++..+..++.|++.||.|||+.   +|+||||||+|||
T Consensus        91 ~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nil  158 (294)
T PHA02882         91 CGSFKR-CRMYYRFILLEKLV-ENTKEIFKRI-------KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIM  158 (294)
T ss_pred             eeeEec-CCceEEEEEEehhc-cCHHHHHHhh-------ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence            754211 12234577888774 3666665432       2356788899999999999999998   9999999999999


Q ss_pred             ecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccc
Q 043902          301 LDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFK  379 (477)
Q Consensus       301 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~  379 (477)
                      ++.++.++|+|||+++.+..................||..|+|||.. ...++.++|||||||++|||++|+.||.....
T Consensus       159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~  238 (294)
T PHA02882        159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH  238 (294)
T ss_pred             EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence            99999999999999987643221111111222334699999999998 45689999999999999999999999976422


Q ss_pred             cccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChH
Q 043902          380 DDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMK  459 (477)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~  459 (477)
                      ... ....       ...+.+..-....                       .....++..+.+++..|++.+|++||++.
T Consensus       239 ~~~-~~~~-------~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~  287 (294)
T PHA02882        239 NGN-LIHA-------AKCDFIKRLHEGK-----------------------IKIKNANKFIYDFIECVTKLSYEEKPDYD  287 (294)
T ss_pred             chH-HHHH-------hHHHHHHHhhhhh-----------------------hccCCCCHHHHHHHHHHHhCCCCCCCCHH
Confidence            110 0000       0001111000000                       00112245588999999999999999999


Q ss_pred             HHHHHH
Q 043902          460 FVVNNL  465 (477)
Q Consensus       460 evl~~L  465 (477)
                      ++.+.|
T Consensus       288 ~l~~~~  293 (294)
T PHA02882        288 ALIKIF  293 (294)
T ss_pred             HHHHhh
Confidence            999876

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.1e-36  Score=292.89  Aligned_cols=246  Identities=25%  Similarity=0.348  Sum_probs=191.3

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      ....|+..+.||+|+||.||+|... +++.||+|.+....   ....+.+.+|++++.+++|||++++.++|     ...
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~-----~~~   87 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCY-----LRE   87 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----EeC
Confidence            3456888999999999999999865 68999999986432   23345788999999999999999999996     345


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +..++|+||++ |++.+++....      ..+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++|+
T Consensus        88 ~~~~lv~e~~~-g~l~~~~~~~~------~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~  157 (307)
T cd06607          88 HTAWLVMEYCL-GSASDILEVHK------KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLA  157 (307)
T ss_pred             CeEEEEHHhhC-CCHHHHHHHcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEe
Confidence            67899999996 57777765332      4589999999999999999999998   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCccccc----CCCCcccceeehHHHHHHHhhCCCCCCcccccccceee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN----GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHK  386 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~  386 (477)
                      |||++.....           .....++..|+|||.+.    +.++.++||||||+++|||+||+.||........    
T Consensus       158 dfg~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~----  222 (307)
T cd06607         158 DFGSASLVSP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----  222 (307)
T ss_pred             ecCcceecCC-----------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH----
Confidence            9999875421           12235778899999872    4588999999999999999999999864321100    


Q ss_pred             eeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          387 FVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       387 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                               .......    .   .          +...       ...+...+.+++.+||+.+|++||++.+|+.
T Consensus       223 ---------~~~~~~~----~---~----------~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  266 (307)
T cd06607         223 ---------LYHIAQN----D---S----------PTLS-------SNDWSDYFRNFVDSCLQKIPQDRPSSEELLK  266 (307)
T ss_pred             ---------HHHHhcC----C---C----------CCCC-------chhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                     0000000    0   0          0000       0112345889999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=288.25  Aligned_cols=246  Identities=24%  Similarity=0.414  Sum_probs=192.2

Q ss_pred             CCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeecc-chhhHHHHHHHHHHhcCC---CCCcceeeeecccccCCCCce
Q 043902          158 NFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQ-QGALKSFIDECNALTSIR---HRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .|+..+.||+|+||.||+|.. .+++.||+|.++... ......+.+|+.++++++   |||+++++++|     ..+..
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~-----~~~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSY-----LKGPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeee-----eeCCE
Confidence            477788999999999999996 478999999987542 334567889999999986   99999999986     45667


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++++|.+++..        ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+||
T Consensus        77 ~~lv~e~~~~~~L~~~~~~--------~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~df  145 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKA--------GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDF  145 (277)
T ss_pred             EEEEEecCCCCcHHHHHHc--------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccC
Confidence            8999999999999998853        2588999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCccccc-C-CCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-G-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      |++.......       .......|+..|+|||.+. + .++.++|||||||++|+|++|+.||........  ......
T Consensus       146 g~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~  216 (277)
T cd06917         146 GVAALLNQNS-------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA--MMLIPK  216 (277)
T ss_pred             CceeecCCCc-------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh--hhcccc
Confidence            9998663211       1122345888999999983 3 468999999999999999999999965321110  000000


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      ..+                            +.+..       +.....+.+++.+|++.||++||++.|+++
T Consensus       217 ~~~----------------------------~~~~~-------~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         217 SKP----------------------------PRLED-------NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCC----------------------------CCCCc-------ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            000                            00000       001234788999999999999999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=7e-37  Score=289.78  Aligned_cols=246  Identities=26%  Similarity=0.398  Sum_probs=193.4

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      -|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|+..+.+++||||+++++++     ..+...++
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~l   79 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKLWI   79 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEE-----EeCCeEEE
Confidence            4677889999999999999864 68899999986433 33446788999999999999999999985     45677899


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      ||||+++++|.+++..        ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        80 v~e~~~~~~l~~~i~~--------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~  148 (277)
T cd06641          80 IMEYLGGGSALDLLEP--------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA  148 (277)
T ss_pred             EEEeCCCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccc
Confidence            9999999999999863        3478999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCc
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPS  394 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  394 (477)
                      ......       ........++..|+|||.+ ....+.++|+|||||++|+|++|..||......              
T Consensus       149 ~~~~~~-------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------------  207 (277)
T cd06641         149 GQLTDT-------QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--------------  207 (277)
T ss_pred             eecccc-------hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--------------
Confidence            765221       1112234578889999998 556889999999999999999999998642111              


Q ss_pred             hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          395 HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       395 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                      .....+.....                +.+.        ......+.+++.+|++.+|++||++.++++.
T Consensus       208 ~~~~~~~~~~~----------------~~~~--------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         208 KVLFLIPKNNP----------------PTLE--------GNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             HHHHHHhcCCC----------------CCCC--------cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            00000100000                0000        0113347889999999999999999999983

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=290.03  Aligned_cols=199  Identities=23%  Similarity=0.373  Sum_probs=167.4

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ++|+..+.||+|+||.||+|... +++.||+|.++...  ....+.+.+|++++++++|+||+++++++     ..++..
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   75 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAF-----RRKGRL   75 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheE-----EECCEE
Confidence            36888899999999999999875 68899999987432  33346789999999999999999999986     446679


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||++++.+..+....       ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||
T Consensus        76 ~iv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g  145 (288)
T cd07833          76 YLVFEYVERTLLELLEASP-------GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFG  145 (288)
T ss_pred             EEEEecCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeee
Confidence            9999999987777665432       4489999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc-cC-CCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NG-HVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ++.......      ........++..|+|||++ .. .++.++||||||+++|+|++|+.||..
T Consensus       146 ~~~~~~~~~------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~  204 (288)
T cd07833         146 FARALRARP------ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG  204 (288)
T ss_pred             cccccCCCc------cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            998763211      1122334578889999998 44 678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=8.6e-37  Score=291.87  Aligned_cols=207  Identities=21%  Similarity=0.324  Sum_probs=166.2

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCC-CCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIR-HRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ++|+..+.||+|+||.||+|... +++.||+|.++...  ......+.+|+.++.+++ ||||+++++++..........
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888999999999999999865 68999999987543  223467888999999995 699999999875433223345


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC-CCcEEEec
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE-GMIAHVGD  311 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~D  311 (477)
                      .++||||+++ +|.+++......  ....+++..++.++.||+.||.|||+.   +++||||+|+||+++. ++.+||+|
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~d  154 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRG--PGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIAD  154 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhccc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEee
Confidence            7999999975 888887644221  124689999999999999999999999   9999999999999998 88999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ||+++.....       ........++..|+|||++.  ..++.++||||||+++|||++|..||..
T Consensus       155 fg~~~~~~~~-------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~  214 (295)
T cd07837         155 LGLGRAFSIP-------VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG  214 (295)
T ss_pred             cccceecCCC-------ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Confidence            9998765211       11122234678899999883  3478999999999999999999999865

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.3e-36  Score=293.26  Aligned_cols=202  Identities=22%  Similarity=0.333  Sum_probs=160.4

Q ss_pred             Ceeeee--ccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEE
Q 043902          163 NLIGSG--SFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVF  237 (477)
Q Consensus       163 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  237 (477)
                      ..||+|  +||+||++... +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++     ..++..++|+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-----~~~~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-----TTGSWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-----ecCCceEEEE
Confidence            346666  89999999864 79999999987543  33446788999999999999999999996     4566789999


Q ss_pred             eecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          238 EFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       238 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      ||+.+++|.+++.....     ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||+.+..
T Consensus        79 e~~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~  150 (328)
T cd08226          79 PFMAYGSANSLLKTYFP-----EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYS  150 (328)
T ss_pred             ecccCCCHHHHHHhhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence            99999999999875421     3588999999999999999999998   999999999999999999999999986644


Q ss_pred             ccccCCCCCCCccccCCCcccccccCcccccC---CCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      ...................++..|+|||++.+   .++.++|||||||++|||++|+.||...
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  213 (328)
T cd08226         151 LVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM  213 (328)
T ss_pred             hhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            32111110000111112235667999999843   4789999999999999999999999764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-39  Score=282.69  Aligned_cols=248  Identities=25%  Similarity=0.354  Sum_probs=202.2

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      +-|++..+||+|+||.||+|.++ .|..+|+|.+....  ..+++.+|+.+++++..|++|+++|.+     .....+++
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSY-----FK~sDLWI  105 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSY-----FKHSDLWI  105 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhh-----ccCCceEe
Confidence            34567789999999999999865 79999999887654  458899999999999999999999985     45566899


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      |||||..|+..+.++.++      +++++.++..++..-++||.|||..   .-+|||||..|||++.+|.+||+|||.|
T Consensus       106 VMEYCGAGSiSDI~R~R~------K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVA  176 (502)
T KOG0574|consen  106 VMEYCGAGSISDIMRARR------KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVA  176 (502)
T ss_pred             ehhhcCCCcHHHHHHHhc------CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhcccc
Confidence            999999999999998665      7899999999999999999999998   8899999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCc
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPS  394 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  394 (477)
                      -.+.+       .....+...||+.|||||++ .-.|..++||||+|++..||..|++||.+...-...  -.+-...|.
T Consensus       177 GQLTD-------TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI--FMIPT~PPP  247 (502)
T KOG0574|consen  177 GQLTD-------TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI--FMIPTKPPP  247 (502)
T ss_pred             chhhh-------hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee--EeccCCCCC
Confidence            87632       33445667899999999999 446899999999999999999999999764321110  000000000


Q ss_pred             hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          395 HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       395 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      .                                  .+.+++-...+.++++.||-.+|++|-|+.++++
T Consensus       248 T----------------------------------F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  248 T----------------------------------FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             C----------------------------------CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            0                                  0011222344789999999999999999998876

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9e-39  Score=329.65  Aligned_cols=256  Identities=26%  Similarity=0.363  Sum_probs=199.9

Q ss_pred             HHhhcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCC
Q 043902          153 SNATDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEG  229 (477)
Q Consensus       153 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  229 (477)
                      ++.+-+|.....||.|.||.||.|.. .+|...|+|-++.+.  ....+...+|+.++..++|||+|+++|+     .-+
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGV-----EvH 1305 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGV-----EVH 1305 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCce-----eec
Confidence            34456778889999999999999985 579999999887543  3445678899999999999999999998     356


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEE
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV  309 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl  309 (477)
                      .+..+|.||||.+|+|.+.+...       ...++.....+..|++.|++|||++   |||||||||.||+++.+|.+|+
T Consensus      1306 Rekv~IFMEyC~~GsLa~ll~~g-------ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~ 1375 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLLEHG-------RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKY 1375 (1509)
T ss_pred             HHHHHHHHHHhccCcHHHHHHhc-------chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEe
Confidence            77899999999999999999865       3456666777889999999999999   9999999999999999999999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCcccccCC----CCcccceeehHHHHHHHhhCCCCCCccccccccee
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH----VSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIH  385 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~  385 (477)
                      +|||.|..+....   ...........||+.|||||++.|.    -..++||||+|||+.||+||++||.....+-..+-
T Consensus      1376 ~DFGsa~ki~~~~---~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy 1452 (1509)
T KOG4645|consen 1376 GDFGSAVKIKNNA---QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMY 1452 (1509)
T ss_pred             ecccceeEecCch---hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHh
Confidence            9999998874321   1112334567899999999999442    46789999999999999999999976543322111


Q ss_pred             eeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          386 KFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       386 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      +......|.                                     .++....+-.+++.+|+..||.+|.++.|+++
T Consensus      1453 ~V~~gh~Pq-------------------------------------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1453 HVAAGHKPQ-------------------------------------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             HHhccCCCC-------------------------------------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            111111111                                     11111233568899999999999998887765

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.1e-36  Score=288.50  Aligned_cols=195  Identities=30%  Similarity=0.423  Sum_probs=169.3

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ++|+..+.||+|+||.||++... +++.+|+|+++...   ......+.+|++++++++||||+++++++     .....
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   75 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSN   75 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCe
Confidence            46888899999999999999865 68999999987432   23346788999999999999999999985     55678


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++++|.+++...       ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+||
T Consensus        76 ~~~v~e~~~~~~L~~~~~~~-------~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~df  145 (290)
T cd05580          76 LYLVMEYVPGGELFSHLRKS-------GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDF  145 (290)
T ss_pred             EEEEEecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeC
Confidence            99999999999999998754       4588999999999999999999998   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |++......          .....++..|+|||.+ .+..+.++||||||+++|+|++|+.||..
T Consensus       146 g~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  200 (290)
T cd05580         146 GFAKRVKGR----------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD  200 (290)
T ss_pred             CCccccCCC----------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence            999765221          2234578899999998 55688999999999999999999999865

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.4e-36  Score=288.90  Aligned_cols=247  Identities=24%  Similarity=0.331  Sum_probs=192.7

Q ss_pred             CCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEE
Q 043902          158 NFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALV  236 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  236 (477)
                      .|...+.||+|++|.||++.. .+++.+++|.++.......+.+.+|+.++.+++|||++++++++     ...+..++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~-----~~~~~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY-----LVGDELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEE-----EcCCeEEEE
Confidence            455567999999999999985 47899999998765555556788999999999999999999985     456778999


Q ss_pred             EeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccc
Q 043902          237 FEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK  316 (477)
Q Consensus       237 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  316 (477)
                      +||+++++|.+++..        ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||.+.
T Consensus        95 ~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~  163 (285)
T cd06648          95 MEFLEGGALTDIVTH--------TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCA  163 (285)
T ss_pred             EeccCCCCHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccch
Confidence            999999999999864        2478899999999999999999999   99999999999999999999999999887


Q ss_pred             cccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCch
Q 043902          317 FLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSH  395 (477)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  395 (477)
                      .....       ........|+..|+|||.+ .+.++.++|||||||++|||++|+.||......              .
T Consensus       164 ~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--------------~  222 (285)
T cd06648         164 QVSKE-------VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--------------Q  222 (285)
T ss_pred             hhccC-------CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--------------H
Confidence            54211       1112234578899999998 456899999999999999999999998542110              0


Q ss_pred             hHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          396 VMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       396 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      ....+.....                +...      ........+.+++.+||+.+|++|||+.++++
T Consensus       223 ~~~~~~~~~~----------------~~~~------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         223 AMKRIRDNLP----------------PKLK------NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             HHHHHHhcCC----------------CCCc------ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            0000000000                0000      00001234889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-36  Score=288.13  Aligned_cols=197  Identities=26%  Similarity=0.407  Sum_probs=164.7

Q ss_pred             CCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          159 FSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       159 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      |+..+.||.|++|.||+|... +|..||+|++....  ......+.+|++.+++++|||++++++++     ...+..++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~-----~~~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV-----HSENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee-----ccCCeEEE
Confidence            567889999999999999865 79999999987543  22335788999999999999999999996     45678999


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      +|||++ ++|.+++.....     ..+++..++.++.|+++||.|||+.   +++||||+|+||+++.++.++|+|||++
T Consensus        76 v~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~  146 (283)
T cd07835          76 VFEFLD-LDLKKYMDSSPL-----TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLA  146 (283)
T ss_pred             EEeccC-cCHHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccc
Confidence            999995 689998875431     3589999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccccC--CCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ......       ........++..|+|||++.+  .++.++||||||+++|||++|+.||..
T Consensus       147 ~~~~~~-------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  202 (283)
T cd07835         147 RAFGVP-------VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPG  202 (283)
T ss_pred             cccCCC-------ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            754211       111122346788999998833  468999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.5e-36  Score=288.95  Aligned_cols=252  Identities=25%  Similarity=0.362  Sum_probs=198.6

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ..++.|+..+.||+|++|.||+|... ++..+++|+++.... ..+.+.+|++.+.+++|+|++++++++     .....
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~   89 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSY-----LVGDE   89 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEE-----EECCE
Confidence            45677888899999999999999976 689999999986544 457788999999999999999999986     34577


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++|+||+++++|.+++....      ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~  160 (286)
T cd06614          90 LWVVMEYMDGGSLTDIITQNF------VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADF  160 (286)
T ss_pred             EEEEEeccCCCcHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECcc
Confidence            999999999999999997642      3689999999999999999999998   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      |++......       ........++..|+|||.+ ...++.++|||||||++|+|++|+.||.......          
T Consensus       161 ~~~~~~~~~-------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~----------  223 (286)
T cd06614         161 GFAAQLTKE-------KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR----------  223 (286)
T ss_pred             chhhhhccc-------hhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH----------
Confidence            998654211       1112233577889999998 4568999999999999999999999986421110          


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                         ...........                 ..      .....+...+.+++.+|++.+|.+|||+.++++
T Consensus       224 ---~~~~~~~~~~~-----------------~~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         224 ---ALFLITTKGIP-----------------PL------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             ---HHHHHHhcCCC-----------------CC------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence               00000000000                 00      000112344889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.2e-36  Score=290.64  Aligned_cols=200  Identities=27%  Similarity=0.386  Sum_probs=166.9

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc--hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ--GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ++|+..+.||+|+||.||+|... +++.+++|.++....  .....+.+|+.++.+++||||+++++++..   .+....
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~---~~~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG---SNLDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe---cCCCcE
Confidence            57888999999999999999976 688999999975432  223467789999999999999999998642   223789


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||++ ++|.+++....      ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||
T Consensus        82 ~lv~e~~~-~~L~~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g  151 (293)
T cd07843          82 YMVMEYVE-HDLKSLMETMK------QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFG  151 (293)
T ss_pred             EEEehhcC-cCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecC
Confidence            99999997 59999886543      3589999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccccC--CCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ++......       ........++..|+|||.+.+  .++.++|+||||+++|||++|..||..
T Consensus       152 ~~~~~~~~-------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~  209 (293)
T cd07843         152 LAREYGSP-------LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG  209 (293)
T ss_pred             ceeeccCC-------ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99865321       112233456888999999843  468999999999999999999999865

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-37  Score=302.55  Aligned_cols=205  Identities=27%  Similarity=0.408  Sum_probs=172.1

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeeccccc-CCCCcee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVD-YEGNDFK  233 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~~~~~  233 (477)
                      ..|...+.||+|+||.||+|+.+ +|+.||||.++... ....+...+|+++|++++|+|||++++.=.... .......
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            34556678999999999999954 89999999998543 334577889999999999999999998732110 1113457


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec----CCCcEEE
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD----EGMIAHV  309 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~----~~~~~kl  309 (477)
                      .+|||||.+|||+..|....    +...+++.+.+.++.+++.||.|||++   +|+||||||.||++-    ....-||
T Consensus        93 vlvmEyC~gGsL~~~L~~PE----N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKL  165 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPE----NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKL  165 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcc----cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEee
Confidence            89999999999999998765    336799999999999999999999998   999999999999993    3336899


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      +|||.|+.+.+        .....+..||..|.+||++.  +.++.-+|.|||||++||+.||..||..
T Consensus       166 tDfG~Arel~d--------~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  166 TDFGAARELDD--------NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             ecccccccCCC--------CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence            99999997732        33677889999999999994  6799999999999999999999999965

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.7e-36  Score=289.55  Aligned_cols=209  Identities=23%  Similarity=0.393  Sum_probs=167.9

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccC---C
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDY---E  228 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---~  228 (477)
                      ..++|+..+.||+|+||.||+|... +++.||+|.+....  ......+.+|++++++++||||++++++|.....   .
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3457899999999999999999865 68999999987443  2223456789999999999999999998754321   1


Q ss_pred             CCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEE
Q 043902          229 GNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH  308 (477)
Q Consensus       229 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k  308 (477)
                      .....++||||+. ++|.+++....      ..+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+|
T Consensus        90 ~~~~~~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~k  159 (310)
T cd07865          90 YKGSFYLVFEFCE-HDLAGLLSNKN------VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILK  159 (310)
T ss_pred             CCceEEEEEcCCC-cCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEE
Confidence            2345799999996 58888876432      3589999999999999999999999   999999999999999999999


Q ss_pred             EecccccccccccCCCCCCCccccCCCcccccccCcccccC--CCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       309 l~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |+|||++..........   ........++..|+|||.+.+  .++.++||||||+++|||+||+.||..
T Consensus       160 l~dfg~~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~  226 (310)
T cd07865         160 LADFGLARAFSLSKNSK---PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG  226 (310)
T ss_pred             ECcCCCcccccCCcccC---CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            99999998663221110   112233457889999998843  378899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.7e-36  Score=288.22  Aligned_cols=273  Identities=22%  Similarity=0.311  Sum_probs=195.4

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      +|+..+.||.|++|.||+|+.. +|..||+|.++... ......+.+|+.++++++|+||+++++++     ...+..++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI-----HTENKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeE-----eeCCcEEE
Confidence            5788899999999999999975 68999999997553 23346778899999999999999999996     45567899


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      ||||+++ +|.+++.....    ...+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++|+|||++
T Consensus        76 v~e~~~~-~l~~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~  147 (284)
T cd07836          76 VFEYMDK-DLKKYMDTHGV----RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLA  147 (284)
T ss_pred             EEecCCc-cHHHHHHhcCC----CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchh
Confidence            9999975 88888765431    24589999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccccC--CCCcccceeehHHHHHHHhhCCCCCCcccccccceeeee---ec
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV---LM  390 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~---~~  390 (477)
                      ......       ........++..|+|||.+.+  .++.++|||||||++|||++|+.||........ .....   ..
T Consensus       148 ~~~~~~-------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~  219 (284)
T cd07836         148 RAFGIP-------VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ-LLKIFRIMGT  219 (284)
T ss_pred             hhhcCC-------ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCC
Confidence            754211       111223456888999998833  468899999999999999999999975322110 00000   00


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      ........+.+....            ....+...........+.....+.+++.+|++.||.+||++.|+++
T Consensus       220 ~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         220 PTESTWPGISQLPEY------------KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             CChhhHHHHhcCchh------------cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000000000000000            0000100001111111223455889999999999999999999975

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1e-36  Score=296.52  Aligned_cols=206  Identities=22%  Similarity=0.338  Sum_probs=169.8

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .++|+..+.||+|+||.||+|... +|+.||+|++....  ......+.+|+.++.+++||||+++.+++.... .....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence            478899999999999999999865 69999999987542  233467788999999999999999998764322 34457


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++|+||+. ++|.+++...       ..+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+||
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~df  151 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHSD-------QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDF  151 (334)
T ss_pred             EEEEEehhh-hhHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccc
Confidence            899999995 6899988644       4589999999999999999999998   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |++.........   .........++..|+|||.+.  ..++.++|||||||++|||++|+.||..
T Consensus       152 g~~~~~~~~~~~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~  214 (334)
T cd07855         152 GMARGLSSSPTE---HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPG  214 (334)
T ss_pred             ccceeecccCcC---CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCC
Confidence            999765321111   111223446888999999983  3589999999999999999999999965

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.5e-36  Score=297.55  Aligned_cols=201  Identities=25%  Similarity=0.273  Sum_probs=166.3

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec--cchhhHHHHHHHHHHhcCCCCCcceeeeeccccc-CCCC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSSCSSVD-YEGN  230 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~~  230 (477)
                      ..++|+..+.||+|+||.||+|... +|+.||+|.+...  .......+.+|+.++++++|+||+++++++.... +.+.
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999864 7899999998643  2333456788999999999999999999864321 1233


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ...++||||+. ++|.+.+..         .++...+..++.|++.||+|||+.   +++||||||+||+++.++.+||+
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~---------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~  160 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM---------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL  160 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh---------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEc
Confidence            46799999995 588887752         278889999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |||+++....        ........++..|+|||.+ ...++.++|||||||++|+|++|+.||..
T Consensus       161 Dfg~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~  219 (353)
T cd07850         161 DFGLARTAGT--------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG  219 (353)
T ss_pred             cCccceeCCC--------CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence            9999986521        1112234578899999998 55689999999999999999999999965

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2e-36  Score=283.27  Aligned_cols=248  Identities=25%  Similarity=0.372  Sum_probs=192.7

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      +|+..+.||+|+||.||+|... +|..+|+|.+....  ....+.+.+|++++++++|+|++++++.+     ......+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence            4778899999999999999875 68899999987542  22346788999999999999999999985     5567899


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC-cEEEeccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM-IAHVGDFG  313 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~DfG  313 (477)
                      +|+||+++++|.+++.....     ..+++..+..++.|+++||.|||+.   +++|+||+|+||++++++ .+||+|||
T Consensus        76 lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~  147 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQRG-----VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFG  147 (257)
T ss_pred             EEEecCCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccc
Confidence            99999999999999875421     3578999999999999999999998   999999999999999875 56999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccC
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMAL  392 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  392 (477)
                      .+......       ........|+..|+|||+. .+.++.++||||||+++|||++|..||.......           
T Consensus       148 ~~~~~~~~-------~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----------  209 (257)
T cd08225         148 IARQLNDS-------MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ-----------  209 (257)
T ss_pred             cchhccCC-------cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-----------
Confidence            98765221       1111224578899999998 5568999999999999999999999986421110           


Q ss_pred             CchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          393 PSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       393 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                        ............             ..+            .....+.+++.+|+..+|++|||+.|+++
T Consensus       210 --~~~~~~~~~~~~-------------~~~------------~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         210 --LVLKICQGYFAP-------------ISP------------NFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             --HHHHHhcccCCC-------------CCC------------CCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence              111111100000             000            01234789999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.6e-36  Score=287.43  Aligned_cols=241  Identities=21%  Similarity=0.290  Sum_probs=179.9

Q ss_pred             eeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHH---HhcCCCCCcceeeeecccccCCCCceeeEE
Q 043902          164 LIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNA---LTSIRHRNILKIVSSCSSVDYEGNDFKALV  236 (477)
Q Consensus       164 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~---l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  236 (477)
                      .||+|+||.||++... +++.+|+|.+....   ......+.+|..+   +...+|||++.+++++     ...+..++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAF-----HTPDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEE-----ecCCeEEEE
Confidence            4899999999999864 68999999986432   1112234444433   3344799999998885     455678999


Q ss_pred             EeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccc
Q 043902          237 FEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK  316 (477)
Q Consensus       237 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  316 (477)
                      |||+++|+|.+++...       ..+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++.
T Consensus        76 ~e~~~~~~L~~~i~~~-------~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~  145 (279)
T cd05633          76 LDLMNGGDLHYHLSQH-------GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC  145 (279)
T ss_pred             EecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcce
Confidence            9999999999988644       4589999999999999999999999   99999999999999999999999999987


Q ss_pred             cccccCCCCCCCccccCCCcccccccCccccc-C-CCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCc
Q 043902          317 FLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-G-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPS  394 (477)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  394 (477)
                      ....         .......|+..|+|||.+. + .++.++|||||||++|||++|..||........           .
T Consensus       146 ~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----------~  205 (279)
T cd05633         146 DFSK---------KKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----------H  205 (279)
T ss_pred             eccc---------cCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-----------H
Confidence            5421         1112345899999999983 3 478999999999999999999999965321110           0


Q ss_pred             hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC-----ChHHHHHH
Q 043902          395 HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRV-----GMKFVVNN  464 (477)
Q Consensus       395 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~  464 (477)
                      .+..... ...                        ....+.....+.+++.+|++.||++||     |++|+++.
T Consensus       206 ~~~~~~~-~~~------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         206 EIDRMTL-TVN------------------------VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             HHHHHhh-cCC------------------------cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            0000000 000                        000011133478899999999999999     59888763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.1e-36  Score=283.36  Aligned_cols=246  Identities=25%  Similarity=0.390  Sum_probs=193.9

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      +|+..+.||.|+||.||+|... ++..||+|.+....   ....+.+.+|++.+++++||||+++++++     .++...
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence            4778899999999999999975 68999999997542   23457889999999999999999999884     567789


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++|+||+.+++|.+++...       ..+++..+..++.|+++||.|||+.   +++|+||+|+||++++++.++|+|||
T Consensus        76 ~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~  145 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQK-------VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFN  145 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhc-------CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecc
Confidence            9999999999999998654       3588999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccC
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMAL  392 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  392 (477)
                      .+......        .......|+..|+|||.+ ...++.++|+||||+++|+|++|+.||.......           
T Consensus       146 ~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----------  206 (258)
T cd05578         146 IATKVTPD--------TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-----------  206 (258)
T ss_pred             cccccCCC--------ccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH-----------
Confidence            98765221        122334578899999998 4457999999999999999999999987532110           


Q ss_pred             CchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCCh--HHHH
Q 043902          393 PSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGM--KFVV  462 (477)
Q Consensus       393 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~--~evl  462 (477)
                      ...+......    .          ....+           +..+..+.+++.+|++.||.+||++  +|++
T Consensus       207 ~~~~~~~~~~----~----------~~~~~-----------~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         207 RDQIRAKQET----A----------DVLYP-----------ATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             HHHHHHHhcc----c----------cccCc-----------ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            0001110000    0          00000           0113448899999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.1e-36  Score=289.94  Aligned_cols=202  Identities=27%  Similarity=0.374  Sum_probs=166.5

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc--hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ--GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .++|+..+.||+|+||.||+|... +|+.||+|.++....  .....+.+|+.++.+++|+|++++++++..   ...+.
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~   82 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG---KHLDS   82 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec---CCCCe
Confidence            568999999999999999999975 689999999875432  222456789999999999999999998632   23356


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+. ++|.+++....      ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+||
T Consensus        83 ~~lv~e~~~-~~l~~~l~~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~df  152 (309)
T cd07845          83 IFLVMEYCE-QDLASLLDNMP------TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADF  152 (309)
T ss_pred             EEEEEecCC-CCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcc
Confidence            899999996 48888886532      4689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      |++.......       .......++..|+|||.+.  ..++.++|||||||++|||++|+.||...
T Consensus       153 g~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~  212 (309)
T cd07845         153 GLARTYGLPA-------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK  212 (309)
T ss_pred             ceeeecCCcc-------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9998653211       1122234577899999983  34789999999999999999999999653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-38  Score=302.54  Aligned_cols=251  Identities=24%  Similarity=0.327  Sum_probs=199.0

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCC-CCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      .+-|.++..||.|+||.||+|..++ +-..|-|++........+.|+-|+++|..+.||+||++++.+     ...+.++
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ay-----y~enkLw  105 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAY-----YFENKLW  105 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHH-----hccCceE
Confidence            4556677889999999999999764 555678999888888889999999999999999999999985     4566789


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +..|||.||-.+..+-.-.      ..+++.++.-++.|++.||.|||++   +|+|||||..|||++-+|.++|+|||.
T Consensus       106 iliEFC~GGAVDaimlEL~------r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGV  176 (1187)
T KOG0579|consen  106 ILIEFCGGGAVDAIMLELG------RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGV  176 (1187)
T ss_pred             EEEeecCCchHhHHHHHhc------cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccc
Confidence            9999999999998876554      6799999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCccccc------CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeee
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN------GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~  388 (477)
                      +....       ........+.||+.|||||+..      .+|+.++||||||++|.||..+.+|-.....-. .+.+..
T Consensus       177 SAKn~-------~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR-VllKia  248 (1187)
T KOG0579|consen  177 SAKNK-------STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIA  248 (1187)
T ss_pred             cccch-------hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH-HHHHHh
Confidence            86531       1233456788999999999872      369999999999999999999999965421100 000000


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      ...         .|.+...                          ..-...+.+++..||..||..||++.++++
T Consensus       249 KSe---------PPTLlqP--------------------------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  249 KSE---------PPTLLQP--------------------------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             hcC---------CCcccCc--------------------------chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            000         0000000                          000233778999999999999999999985

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-36  Score=285.98  Aligned_cols=199  Identities=29%  Similarity=0.458  Sum_probs=165.6

Q ss_pred             CCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          159 FSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       159 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      |++.+.||+|+||.||+|... +++.+|+|.+....  ......+.+|++++++++|+|++++++++..   ...+..++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTS---KGKGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEec---CCCCcEEE
Confidence            567789999999999999876 58899999998653  3344678899999999999999999999742   11368999


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      |+||+++ +|.+++....      ..+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||++
T Consensus        78 v~e~~~~-~l~~~~~~~~------~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~  147 (287)
T cd07840          78 VFEYMDH-DLTGLLDSPE------VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLA  147 (287)
T ss_pred             Eeccccc-cHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccce
Confidence            9999974 8988886542      4689999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      .......      ........++..|+|||.+.  ..++.++||||||+++|||+||+.||..
T Consensus       148 ~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~  204 (287)
T cd07840         148 RPYTKRN------SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQG  204 (287)
T ss_pred             eeccCCC------cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence            8663211      11122345678899999873  3578999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.1e-36  Score=296.44  Aligned_cols=286  Identities=19%  Similarity=0.201  Sum_probs=199.7

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec--cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .++|.+.+.||+|+||.||+|+.. +++.||+|.++..  .......+.+|+.++.+++|+||+++++++..........
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457889999999999999999864 7899999998743  2233456778999999999999999999865433233356


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++|+||+. ++|.+++...       ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+||
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Df  152 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS-------QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDF  152 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcC
Confidence            899999995 6898888643       4589999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCccccccc-c-eeeee
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDL-S-IHKFV  388 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~-~-~~~~~  388 (477)
                      |+++......       .......++..|+|||.+.  ..++.++|||||||++|+|++|+.||........ . .....
T Consensus       153 g~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  225 (337)
T cd07858         153 GLARTTSEKG-------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELL  225 (337)
T ss_pred             ccccccCCCc-------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHh
Confidence            9997652210       1122345788999999883  4689999999999999999999999964311000 0 00000


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH--HH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN--LQ  466 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~  466 (477)
                      ....++....+.+.......... ...    ..+.     .......+...+.+++.+|++.+|++|||++|+++.  +.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~-~~~----~~~~-----~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~  295 (337)
T cd07858         226 GSPSEEDLGFIRNEKARRYIRSL-PYT----PRQS-----FARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA  295 (337)
T ss_pred             CCCChHHhhhcCchhhhHHHHhc-Ccc----cccC-----HHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchh
Confidence            00000000000000000000000 000    0000     000111234558899999999999999999999975  55


Q ss_pred             HHH
Q 043902          467 AIR  469 (477)
Q Consensus       467 ~i~  469 (477)
                      .++
T Consensus       296 ~~~  298 (337)
T cd07858         296 SLH  298 (337)
T ss_pred             hhc
Confidence            443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-37  Score=287.06  Aligned_cols=246  Identities=24%  Similarity=0.343  Sum_probs=197.3

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .+.|+.-++||+||||.||-++.+ +|+.+|.|.+....   .....-.++|-.+|.+++.+.||.+--.     +++.+
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA-----feTkd  258 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA-----FETKD  258 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee-----ecCCC
Confidence            467888899999999999999865 79999999886432   2223456889999999999999987544     58899


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      .+|+|+..|.||+|.-+|.+...     ..+++..++-++.+|+.||.+||+.   +||.|||||+|||+|+.|+++|+|
T Consensus       259 ~LClVLtlMNGGDLkfHiyn~g~-----~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISD  330 (591)
T KOG0986|consen  259 ALCLVLTLMNGGDLKFHIYNHGN-----PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISD  330 (591)
T ss_pred             ceEEEEEeecCCceeEEeeccCC-----CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeec
Confidence            99999999999999999987643     5799999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      +|+|..+.+        .....+.+||.+|||||++ ++.|+...|.||+||++|||+.|+.||.......         
T Consensus       331 LGLAvei~~--------g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv---------  393 (591)
T KOG0986|consen  331 LGLAVEIPE--------GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV---------  393 (591)
T ss_pred             cceEEecCC--------CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh---------
Confidence            999987733        2233445899999999999 6679999999999999999999999996521110         


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCC
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVG  457 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs  457 (477)
                           -.+-+|.+...+..                     +..+.+.++..++....|+.||++|--
T Consensus       394 -----k~eEvdrr~~~~~~---------------------ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  394 -----KREEVDRRTLEDPE---------------------EYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             -----hHHHHHHHHhcchh---------------------hcccccCHHHHHHHHHHHccCHHHhcc
Confidence                 12234444433211                     112223444677888889999999864

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=6.4e-36  Score=286.81  Aligned_cols=207  Identities=28%  Similarity=0.406  Sum_probs=167.9

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeeccccc----
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVD----  226 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  226 (477)
                      ...++|++.+.||+|+||.||+|..+ +|+.||+|+++...  ......+.+|++++.+++|||++++++++....    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34678999999999999999999975 68999999997543  223356788999999999999999999874321    


Q ss_pred             -CCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC
Q 043902          227 -YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM  305 (477)
Q Consensus       227 -~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~  305 (477)
                       .......++|+||+++ ++.+++....      ..+++..+..++.|++.||+|||+.   +|+|+||||+||++++++
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~  153 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGL------VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKG  153 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCC
Confidence             1123478999999976 7777765432      4689999999999999999999999   999999999999999999


Q ss_pred             cEEEecccccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          306 IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       306 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      .+||+|||.+........      .......++..|+|||.+.  ...+.++|||||||++|||++|+.||..
T Consensus       154 ~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~  220 (302)
T cd07864         154 QIKLADFGLARLYNSEES------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA  220 (302)
T ss_pred             cEEeCcccccccccCCcc------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            999999999986532111      1122234577899999883  3478999999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-36  Score=289.20  Aligned_cols=208  Identities=24%  Similarity=0.366  Sum_probs=167.2

Q ss_pred             CCCCCCeeeeeccceEEEEEeC---CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA---DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      +|+..+.||+|+||.||+|...   +++.||+|.+....   ....+.+.+|+.++.+++||||+++++++..   ....
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE---HADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC---CCCc
Confidence            4778889999999999999964   47899999998633   3344677889999999999999999999742   2336


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC----CCcE
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE----GMIA  307 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~----~~~~  307 (477)
                      ..++||||+++ +|.+++......  ....+++..++.++.|++.||.|||+.   +++||||||+||+++.    ++.+
T Consensus        78 ~~~lv~e~~~~-~l~~~~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~  151 (316)
T cd07842          78 SVYLLFDYAEH-DLWQIIKFHRQA--KRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVV  151 (316)
T ss_pred             eEEEEEeCCCc-CHHHHHHhhccC--CCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceE
Confidence            79999999965 677766432211  113688999999999999999999999   9999999999999999    9999


Q ss_pred             EEecccccccccccCCCCCCCccccCCCcccccccCcccccC--CCCcccceeehHHHHHHHhhCCCCCCccc
Q 043902          308 HVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDDMF  378 (477)
Q Consensus       308 kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~~~  378 (477)
                      ||+|||++........    .........++..|+|||.+.+  .++.++|||||||++|||++|+.||....
T Consensus       152 kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  220 (316)
T cd07842         152 KIGDLGLARLFNAPLK----PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE  220 (316)
T ss_pred             EECCCccccccCCCcc----cccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence            9999999986532111    1112234567889999998833  47899999999999999999999997643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=6.7e-36  Score=279.64  Aligned_cols=252  Identities=26%  Similarity=0.385  Sum_probs=196.8

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc--hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ--GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      +|...+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|++.+++++|+||+++++.+..   ......+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERD---EEKNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEec---CCCCeEE
Confidence            4777899999999999999976 789999999876542  445788999999999999999999998632   1126789


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +|+||+++++|.+++...       ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.
T Consensus        78 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~  147 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKF-------GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGC  147 (260)
T ss_pred             EEEEecCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccccc
Confidence            999999999999998754       3689999999999999999999998   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCC
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      +........     ........++..|+|||.. ....+.++||||||+++|+|++|..||........           
T Consensus       148 ~~~~~~~~~-----~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----------  211 (260)
T cd06606         148 AKRLGDIET-----GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA-----------  211 (260)
T ss_pred             EEecccccc-----cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-----------
Confidence            987632111     0112345678899999999 45589999999999999999999999975321000           


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                       ..........                .+.+        .+.....+.+++.+|++.||++||++.|+++
T Consensus       212 -~~~~~~~~~~----------------~~~~--------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         212 -ALYKIGSSGE----------------PPEI--------PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             -HHHhccccCC----------------CcCC--------CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence             0000000000                0000        0011344889999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=313.61  Aligned_cols=263  Identities=25%  Similarity=0.441  Sum_probs=205.2

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC----C----CCEEEEEEeeecc-chhhHHHHHHHHHHhcC-CCCCcceeeeeccccc
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA----D----GETAAIKVLKLQQ-QGALKSFIDECNALTSI-RHRNILKIVSSCSSVD  226 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  226 (477)
                      ++....+.||+|.||.|++|...    .    ...||||.++... ....+.+..|+++|+.+ +|+||+.++|+|.   
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t---  372 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT---  372 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec---
Confidence            34455669999999999999743    1    4579999998543 34568899999999999 5999999999985   


Q ss_pred             CCCCceeeEEEeecCCCChhhhcccCC-Cccccc--------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCC
Q 043902          227 YEGNDFKALVFEFMRNGNLDQWLHPST-DEYCHF--------KKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSS  297 (477)
Q Consensus       227 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~--------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~  297 (477)
                        .++..++|+||+..|+|.++|+..+ ......        ..++....+.++.|||.||+||++.   +++||||..+
T Consensus       373 --~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR  447 (609)
T KOG0200|consen  373 --QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR  447 (609)
T ss_pred             --cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence              3678999999999999999998776 111111        2489999999999999999999999   9999999999


Q ss_pred             CeEecCCCcEEEecccccccccccCCCCCCCccccCCCc--ccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCC
Q 043902          298 NVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK--GSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRP  373 (477)
Q Consensus       298 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~--gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p  373 (477)
                      |||+.++..+||+|||+|+......      ........  -+..|||||.+ ...++.|+|||||||+||||+| |..|
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~------~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~P  521 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKD------YYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTP  521 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCC------ceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCC
Confidence            9999999999999999999653321      11111112  45679999999 5579999999999999999999 9999


Q ss_pred             CCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCC
Q 043902          374 TDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPR  453 (477)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~  453 (477)
                      |.+....             +.+.+.+.                        .+.+.+.++-|..++.++++.||+.+|+
T Consensus       522 Yp~~~~~-------------~~l~~~l~------------------------~G~r~~~P~~c~~eiY~iM~~CW~~~p~  564 (609)
T KOG0200|consen  522 YPGIPPT-------------EELLEFLK------------------------EGNRMEQPEHCSDEIYDLMKSCWNADPE  564 (609)
T ss_pred             CCCCCcH-------------HHHHHHHh------------------------cCCCCCCCCCCCHHHHHHHHHHhCCCcc
Confidence            9652100             01111111                        1223334445567799999999999999


Q ss_pred             CCCChHHHHHHHHHHHH
Q 043902          454 DRVGMKFVVNNLQAIRS  470 (477)
Q Consensus       454 ~RPs~~evl~~L~~i~~  470 (477)
                      +||++.|+.+.++....
T Consensus       565 ~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  565 DRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             cCCCHHHHHHHHHHHHH
Confidence            99999999999998543

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-35  Score=281.63  Aligned_cols=275  Identities=22%  Similarity=0.327  Sum_probs=191.4

Q ss_pred             CCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc--hhhHHHHHHHHHHhcC---CCCCcceeeeecccccCCCCce
Q 043902          159 FSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ--GALKSFIDECNALTSI---RHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       159 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      |++.+.||+|+||.||+|+.+ +++.||+|+++....  .....+.+|+.++.++   +|+|++++++++...+......
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567789999999999999976 589999999974322  2234566787776655   6999999999976443333345


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .+++|||+. ++|.+++.....     ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.+||+||
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~-----~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~df  151 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPK-----PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADF  151 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEecc
Confidence            899999996 489888865421     3589999999999999999999998   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      |.+......        .......++..|+|||.+ ...++.++|||||||++|||++|+.||.......          
T Consensus       152 g~~~~~~~~--------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~----------  213 (287)
T cd07838         152 GLARIYSFE--------MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD----------  213 (287)
T ss_pred             CcceeccCC--------cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH----------
Confidence            999765221        111223468889999999 5568999999999999999999999986532111          


Q ss_pred             CCchhHHHhhhhhhhh-hcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          392 LPSHVMDVLDLSMLLE-EENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                         ....+++...... .............++............+....+.+++.+||+.||++||++.|++.
T Consensus       214 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         214 ---QLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             ---HHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence               1111111100000 00000000000000000000001111222455789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1e-35  Score=277.18  Aligned_cols=248  Identities=27%  Similarity=0.405  Sum_probs=196.6

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEE
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALV  236 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  236 (477)
                      +|+..+.||+|++|.||++... +++.+++|++..........+.+|++.+++++|+|++++++++     ......+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY-----LKKDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEE-----ecCCeEEEE
Confidence            4777899999999999999975 7899999999876555567899999999999999999999985     445778999


Q ss_pred             EeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccc
Q 043902          237 FEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK  316 (477)
Q Consensus       237 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  316 (477)
                      +||+++++|.+++....      ..+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++|+|||.+.
T Consensus        76 ~e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~  146 (253)
T cd05122          76 MEFCSGGSLKDLLKSTN------QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSA  146 (253)
T ss_pred             EecCCCCcHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccc
Confidence            99999999999987542      4689999999999999999999998   99999999999999999999999999987


Q ss_pred             cccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCch
Q 043902          317 FLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSH  395 (477)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  395 (477)
                      ......      .  .....++..|+|||.+ .+..+.++||||||+++|+|++|+.||.......              
T Consensus       147 ~~~~~~------~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------------  204 (253)
T cd05122         147 QLSDTK------A--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK--------------  204 (253)
T ss_pred             cccccc------c--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH--------------
Confidence            653211      0  2345678899999998 4568999999999999999999999986531100              


Q ss_pred             hHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          396 VMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       396 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      ..........                +.....      ......+.+++.+|++.||++|||+.|+++
T Consensus       205 ~~~~~~~~~~----------------~~~~~~------~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         205 ALFKIATNGP----------------PGLRNP------EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             HHHHHHhcCC----------------CCcCcc------cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0000000000                000000      001234789999999999999999999975

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.3e-36  Score=286.29  Aligned_cols=200  Identities=27%  Similarity=0.381  Sum_probs=163.6

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ++|+..+.||+|++|.||+|... +|+.||+|.++...  ......+.+|++++++++||||+++++++     ......
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-----HSEKRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE-----ecCCeE
Confidence            56888999999999999999875 78999999986432  23345788999999999999999999996     456789


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC-CCcEEEecc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE-GMIAHVGDF  312 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Df  312 (477)
                      ++||||++ ++|.+++.....     ..+++..+..++.||+.||.|||++   +++|+||+|+||+++. ++.+||+||
T Consensus        77 ~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~df  147 (294)
T PLN00009         77 YLVFEYLD-LDLKKHMDSSPD-----FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADF  147 (294)
T ss_pred             EEEEeccc-ccHHHHHHhCCC-----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEccc
Confidence            99999995 588887754321     3467888899999999999999999   9999999999999985 567999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      |++......       ........++..|+|||++.  ..++.++|||||||++|+|+||+.||...
T Consensus       148 g~~~~~~~~-------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~  207 (294)
T PLN00009        148 GLARAFGIP-------VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD  207 (294)
T ss_pred             ccccccCCC-------ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999754211       11122345688999999883  34789999999999999999999999653

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=271.14  Aligned_cols=275  Identities=23%  Similarity=0.314  Sum_probs=204.5

Q ss_pred             HHHHHHhhcCCCCCCeeeeeccceEEEEE-eCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCC-CCCcceeeeeccccc
Q 043902          149 YLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIR-HRNILKIVSSCSSVD  226 (477)
Q Consensus       149 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  226 (477)
                      +.++-..|+     +.||+|+|+.|-.+. ..+|..+|||++.........+..+|++++.+++ |+||++++.+     
T Consensus        75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief-----  144 (463)
T KOG0607|consen   75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF-----  144 (463)
T ss_pred             HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH-----
Confidence            445544443     579999999999987 5789999999999887777889999999999994 9999999999     


Q ss_pred             CCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC-
Q 043902          227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM-  305 (477)
Q Consensus       227 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-  305 (477)
                      +++++..|+|||-|.||+|...++.+       ..+++.++.++..+|+.||.|||.+   ||.||||||+|||-.... 
T Consensus       145 FEdd~~FYLVfEKm~GGplLshI~~~-------~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~  214 (463)
T KOG0607|consen  145 FEDDTRFYLVFEKMRGGPLLSHIQKR-------KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNK  214 (463)
T ss_pred             hcccceEEEEEecccCchHHHHHHHh-------hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCC
Confidence            57888999999999999999999865       5689999999999999999999999   999999999999996544 


Q ss_pred             --cEEEecccccccccccCCCCCCCccccCCCcccccccCcccc---cC---CCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          306 --IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI---NG---HVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       306 --~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~---~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                        -+||+||.+..-+.................+|+..|||||+.   .+   .|+.+.|.||+||++|-|++|.+||.+.
T Consensus       215 vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~  294 (463)
T KOG0607|consen  215 VSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH  294 (463)
T ss_pred             cCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence              589999998865432222212222233456789999999987   23   4899999999999999999999999886


Q ss_pred             cccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCC
Q 043902          378 FKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVG  457 (477)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs  457 (477)
                      ...+-.+.   +...-..-.+.+=.+....    .        +     .+..+.+........+++...+..||.+|-+
T Consensus       295 Cg~dCGWd---rGe~Cr~CQ~~LFesIQEG----k--------Y-----eFPdkdWahIS~eakdlisnLlvrda~~rls  354 (463)
T KOG0607|consen  295 CGADCGWD---RGEVCRVCQNKLFESIQEG----K--------Y-----EFPDKDWAHISSEAKDLISNLLVRDAKQRLS  354 (463)
T ss_pred             cCCcCCcc---CCCccHHHHHHHHHHHhcc----C--------C-----cCChhhhHHhhHHHHHHHHHHHhccHHhhhh
Confidence            65543322   2111111111111111100    0        0     0111222222334667778888899999999


Q ss_pred             hHHHHH
Q 043902          458 MKFVVN  463 (477)
Q Consensus       458 ~~evl~  463 (477)
                      +.+++.
T Consensus       355 a~~vln  360 (463)
T KOG0607|consen  355 AAQVLN  360 (463)
T ss_pred             hhhccC
Confidence            998876

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-36  Score=280.46  Aligned_cols=203  Identities=24%  Similarity=0.364  Sum_probs=168.0

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec-----cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ-----QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      .+|...+.||+|+||.||+|... ++..||+|.+...     .......+.+|++++++++|+||+++++++..   ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~   78 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PEE   78 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCC
Confidence            47888999999999999999864 6899999987532     12334678899999999999999999998632   234


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ...++++||+++++|.+++...       ..+++.....++.|++.||.|||+.   +++|+||||+||+++.++.++|+
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~~~-------~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~  148 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLKAY-------GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLG  148 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEC
Confidence            5678999999999999998643       3478899999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |||+++......    ..........++..|+|||++ ...++.++|+|||||++|||++|+.||..
T Consensus       149 dfg~~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  211 (264)
T cd06653         149 DFGASKRIQTIC----MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE  211 (264)
T ss_pred             cccccccccccc----ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence            999998652110    011112234588999999999 44588999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=7.1e-36  Score=288.41  Aligned_cols=245  Identities=25%  Similarity=0.329  Sum_probs=189.7

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .|+..+.||+|+||.||+|+.. ++..+|+|.+....   ......+.+|++++++++|||+++++++|     ..+...
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~  100 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCY-----LREHTA  100 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeCCeE
Confidence            4677889999999999999864 68899999987432   23345788999999999999999999986     445678


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||++ |+|.+++....      ..+++.++..++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||
T Consensus       101 ~lv~e~~~-g~l~~~~~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg  170 (317)
T cd06635         101 WLVMEYCL-GSASDLLEVHK------KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFG  170 (317)
T ss_pred             EEEEeCCC-CCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCC
Confidence            99999996 57877775432      4589999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc----cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI----NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      ++.....           .....++..|+|||++    .+.++.++|||||||++|||++|+.||.......        
T Consensus       171 ~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--------  231 (317)
T cd06635         171 SASIASP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------  231 (317)
T ss_pred             CccccCC-----------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--------
Confidence            9865411           1234578889999987    2468999999999999999999999985421100        


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNL  465 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  465 (477)
                           ....+........                        ..+.....+.+++.+|++.+|.+||++.++++.+
T Consensus       232 -----~~~~~~~~~~~~~------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         232 -----ALYHIAQNESPTL------------------------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             -----HHHHHHhccCCCC------------------------CCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence                 0011110000000                        0001133478999999999999999999999753

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.9e-36  Score=288.50  Aligned_cols=256  Identities=22%  Similarity=0.290  Sum_probs=186.4

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCC-CCCcceeeeecccccCCCCceee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIR-HRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      +|...+.||+|+||.||++... +++.+|+|.+.... ......+.+|+..+.++. |+||+++++++     ..+...+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~-----~~~~~~~   79 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGAL-----FREGDCW   79 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEE-----ecCCcEE
Confidence            5566788999999999999865 68999999987543 234567889999999996 99999999985     3456788


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      ++|||+.. ++.++......  .....+++..+..++.|++.||+|||+.  .+++||||||+||+++.++.+||+|||+
T Consensus        80 ~~~e~~~~-~l~~l~~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~  154 (288)
T cd06616          80 ICMELMDI-SLDKFYKYVYE--VLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGI  154 (288)
T ss_pred             EEEecccC-CHHHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecch
Confidence            99999854 65554321000  0114689999999999999999999963  2899999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCccccc-C---CCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-G---HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~---~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      +.....        ........|+..|+|||.+. +   .++.++|||||||++|||++|+.||.......         
T Consensus       155 ~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---------  217 (288)
T cd06616         155 SGQLVD--------SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF---------  217 (288)
T ss_pred             hHHhcc--------CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH---------
Confidence            976522        11112335788999999983 3   58999999999999999999999986431000         


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                         +.+........                 +.+..    .....+...+.+++.+|++.+|++|||++||++.
T Consensus       218 ---~~~~~~~~~~~-----------------~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         218 ---DQLTQVVKGDP-----------------PILSN----SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             ---HHHhhhcCCCC-----------------CcCCC----cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               00000000000                 00000    0001123458899999999999999999999863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=6.5e-36  Score=291.28  Aligned_cols=205  Identities=26%  Similarity=0.378  Sum_probs=167.2

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec--cchhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ--QQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~  230 (477)
                      ..++|+..+.||+|+||.||+|... +|+.+|+|.+...  .......+.+|+.++.++ +||||++++++|..   .+.
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~   81 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END   81 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence            3567888999999999999999875 6889999988532  223345677899999999 99999999998642   334


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ...++||||++ ++|..++...        .+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~  149 (337)
T cd07852          82 KDIYLVFEYME-TDLHAVIRAN--------ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLA  149 (337)
T ss_pred             ceEEEEecccc-cCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEe
Confidence            56899999996 5998888642        478889999999999999999998   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc--cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |||++..........  .........|+..|+|||.+  ...++.++||||||+++|||+||+.||..
T Consensus       150 d~g~~~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~  215 (337)
T cd07852         150 DFGLARSLSELEENP--ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG  215 (337)
T ss_pred             eccchhccccccccc--cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence            999998663321110  01122334688999999987  34578999999999999999999999965

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-37  Score=278.53  Aligned_cols=271  Identities=21%  Similarity=0.342  Sum_probs=215.3

Q ss_pred             HHhhcCCCCCCeeeeeccceEEEEEeC------CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccc
Q 043902          153 SNATDNFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSV  225 (477)
Q Consensus       153 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  225 (477)
                      .....+++...++.+|.||.||+|.+.      +.+.|-+|.++... .-....++.|.-++..+.|||+.++.++|.  
T Consensus       280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i--  357 (563)
T KOG1024|consen  280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI--  357 (563)
T ss_pred             hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe--
Confidence            333456777788999999999999653      34567778776443 333467888988999999999999999985  


Q ss_pred             cCCCCceeeEEEeecCCCChhhhcccCC-CcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC
Q 043902          226 DYEGNDFKALVFEFMRNGNLDQWLHPST-DEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG  304 (477)
Q Consensus       226 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~  304 (477)
                        ++.+..++++.++.-|+|..||...+ .+....+.++..+...++.|++.|++|||++   +++|.||..+|+++|+.
T Consensus       358 --e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  358 --EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             --eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence              56677899999999999999997332 2223446788889999999999999999999   99999999999999999


Q ss_pred             CcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCccccccc
Q 043902          305 MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL  382 (477)
Q Consensus       305 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~  382 (477)
                      ..+||+|=.+++.+++.+.+-     .......+..||+||.+ +..++.++|||||||++|||+| |+.|+.+.+..  
T Consensus       433 LqVkltDsaLSRDLFP~DYhc-----LGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf--  505 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHC-----LGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF--  505 (563)
T ss_pred             eeEEeccchhccccCcccccc-----cCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH--
Confidence            999999999999886654332     22334467889999999 7789999999999999999999 99998764322  


Q ss_pred             ceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHH
Q 043902          383 SIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVV  462 (477)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl  462 (477)
                                  .+..++..                        +++...+-.|+.++..++.-||+..|++||+.+|++
T Consensus       506 ------------Em~~ylkd------------------------GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv  549 (563)
T KOG1024|consen  506 ------------EMEHYLKD------------------------GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLV  549 (563)
T ss_pred             ------------HHHHHHhc------------------------cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence                        12222211                        122223445788899999999999999999999999


Q ss_pred             HHHHHHHHhhh
Q 043902          463 NNLQAIRSKIR  473 (477)
Q Consensus       463 ~~L~~i~~~~~  473 (477)
                      ..|.++..++.
T Consensus       550 ~cLseF~~qlt  560 (563)
T KOG1024|consen  550 ICLSEFHTQLT  560 (563)
T ss_pred             HHHHHHHHHHh
Confidence            99999877654

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=8.4e-36  Score=280.68  Aligned_cols=248  Identities=21%  Similarity=0.282  Sum_probs=186.0

Q ss_pred             HHHHHhhcCCCCCCee--eeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcC-CCCCcceeeeecccc
Q 043902          150 LKISNATDNFSEENLI--GSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSI-RHRNILKIVSSCSSV  225 (477)
Q Consensus       150 ~~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  225 (477)
                      .+.....++|++.+.+  |+|+||.||++... ++..+|+|.+........     |......+ +|||++++++++   
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~---   78 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSV---   78 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEE---
Confidence            3445556777777776  99999999999864 688999999875432211     22222222 699999999986   


Q ss_pred             cCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC
Q 043902          226 DYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM  305 (477)
Q Consensus       226 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~  305 (477)
                        ...+..++||||+++++|.+++...       ..+++..+..++.|+++||.|||+.   +++||||||+||+++.++
T Consensus        79 --~~~~~~~iv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~  146 (267)
T PHA03390         79 --TTLKGHVLIMDYIKDGDLFDLLKKE-------GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAK  146 (267)
T ss_pred             --ecCCeeEEEEEcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCC
Confidence              4456899999999999999999754       3689999999999999999999999   999999999999999998


Q ss_pred             -cEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccc
Q 043902          306 -IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLS  383 (477)
Q Consensus       306 -~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~  383 (477)
                       .++|+|||++.....           .....++..|+|||++ .+.++.++|||||||++|||++|+.||.....+...
T Consensus       147 ~~~~l~dfg~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~  215 (267)
T PHA03390        147 DRIYLCDYGLCKIIGT-----------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD  215 (267)
T ss_pred             CeEEEecCccceecCC-----------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh
Confidence             999999999876421           1123578899999999 557899999999999999999999999753322211


Q ss_pred             eeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCC-hHHHH
Q 043902          384 IHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVG-MKFVV  462 (477)
Q Consensus       384 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl  462 (477)
                      ...         +.........                          ........+.+++.+||+.+|.+||+ ++|++
T Consensus       216 ~~~---------~~~~~~~~~~--------------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l  260 (267)
T PHA03390        216 LES---------LLKRQQKKLP--------------------------FIKNVSKNANDFVQSMLKYNINYRLTNYNEII  260 (267)
T ss_pred             HHH---------HHHhhcccCC--------------------------cccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence            100         0000000000                          00011344889999999999999996 68887


Q ss_pred             H
Q 043902          463 N  463 (477)
Q Consensus       463 ~  463 (477)
                      +
T Consensus       261 ~  261 (267)
T PHA03390        261 K  261 (267)
T ss_pred             c
Confidence            4

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=282.17  Aligned_cols=197  Identities=27%  Similarity=0.369  Sum_probs=164.2

Q ss_pred             CCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc-hhhHHHHHHHHHHhcCC-CCCcceeeeecccccCCCCceeeE
Q 043902          159 FSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ-GALKSFIDECNALTSIR-HRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       159 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      |.+.+.||+|++|.||+|... +++.|++|.+..... .......+|+..+.+++ |+|++++++++     ..++..++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-----~~~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVF-----RENDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHh-----hcCCcEEE
Confidence            567789999999999999975 578999999875432 22234567999999998 99999999986     44678999


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      ||||+ +|+|.+++....     ...+++..+..++.|++.||.|||++   +++|+||+|+||++++++.++|+|||.+
T Consensus        76 v~e~~-~~~l~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~  146 (283)
T cd07830          76 VFEYM-EGNLYQLMKDRK-----GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLA  146 (283)
T ss_pred             EEecC-CCCHHHHHHhcc-----cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccc
Confidence            99999 889999887543     14689999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc--cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      .....        ........++..|+|||.+  ...++.++|+||||+++|||++|+.||...
T Consensus       147 ~~~~~--------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~  202 (283)
T cd07830         147 REIRS--------RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS  202 (283)
T ss_pred             eeccC--------CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence            76522        1112234578899999988  335799999999999999999999998653

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.2e-36  Score=287.17  Aligned_cols=243  Identities=23%  Similarity=0.314  Sum_probs=189.9

Q ss_pred             CCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEeec
Q 043902          162 ENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFM  240 (477)
Q Consensus       162 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  240 (477)
                      ...||+|+||.||++... ++..||+|.+..........+.+|+.++.+++|+|++++++++     ...+..++||||+
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~   99 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWVVMEFL   99 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEE-----EeCCEEEEEEecC
Confidence            357999999999999874 7899999998755555557789999999999999999999985     4567899999999


Q ss_pred             CCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccccc
Q 043902          241 RNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFE  320 (477)
Q Consensus       241 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  320 (477)
                      ++++|.+++..        ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++.....
T Consensus       100 ~~~~L~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~  168 (292)
T cd06657         100 EGGALTDIVTH--------TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  168 (292)
T ss_pred             CCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence            99999998753        2478999999999999999999999   999999999999999999999999999875522


Q ss_pred             cCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCchhHHH
Q 043902          321 ESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDV  399 (477)
Q Consensus       321 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (477)
                      .       ........++..|+|||.+ ...++.++|+|||||++|||++|..||......              .....
T Consensus       169 ~-------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--------------~~~~~  227 (292)
T cd06657         169 E-------VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------------KAMKM  227 (292)
T ss_pred             c-------cccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------------HHHHH
Confidence            1       1112234578899999998 556899999999999999999999998642110              00011


Q ss_pred             hhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          400 LDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       400 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      +.......             ++.         .......+.+++.+|++.+|.+||++.++++
T Consensus       228 ~~~~~~~~-------------~~~---------~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         228 IRDNLPPK-------------LKN---------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHhhCCcc-------------cCC---------cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            11000000             000         0001233778899999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-36  Score=283.16  Aligned_cols=247  Identities=19%  Similarity=0.322  Sum_probs=199.1

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ..=|+..+.||+|.|+.|-+|++- +|..||||++....  .-....+.+|++-|+-++|||||++|.+     ......
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-----iDTQTK   91 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-----IDTQTK   91 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-----hcccce
Confidence            345777889999999999999854 89999999997553  3334678899999999999999999998     467788


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEe-cCCCcEEEec
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL-DEGMIAHVGD  311 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll-~~~~~~kl~D  311 (477)
                      +|+|+|.-.+|+|.+|+....      ..+.+....+++.||+.|+.|+|..   .+|||||||+||.+ ..-|-+||.|
T Consensus        92 lyLiLELGD~GDl~DyImKHe------~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTD  162 (864)
T KOG4717|consen   92 LYLILELGDGGDLFDYIMKHE------EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTD  162 (864)
T ss_pred             EEEEEEecCCchHHHHHHhhh------ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeee
Confidence            999999999999999997665      5689999999999999999999998   99999999999876 5668999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccccC-CC-CcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-HV-SILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      ||++-.+.+        ....+..+|+..|.|||++-| .| -+++||||+||+||.|++|+.||....+.+        
T Consensus       163 FGFSNkf~P--------G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE--------  226 (864)
T KOG4717|consen  163 FGFSNKFQP--------GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE--------  226 (864)
T ss_pred             ccccccCCC--------cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh--------
Confidence            999976632        333455689999999999944 34 578999999999999999999997643221        


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                           .+.-++|-....                          +.-...+..+|+..||..||.+|-|.+||+.
T Consensus       227 -----TLTmImDCKYtv--------------------------PshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  227 -----TLTMIMDCKYTV--------------------------PSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             -----hhhhhhcccccC--------------------------chhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence                 122222221110                          0111234678999999999999999999874

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=6.5e-36  Score=285.92  Aligned_cols=251  Identities=22%  Similarity=0.318  Sum_probs=188.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCC-CCEEEEEEeeecc-chhhHHHHHHHHHHhcCC-CCCcceeeeecccccCCCCce
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQ-QGALKSFIDECNALTSIR-HRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .++|+..+.||+|+||.||+|...+ ++.||||.++... ......+..|+..+.+.. |+||++++++|     .....
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~   88 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYF-----ITDSD   88 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheee-----ecCCe
Confidence            4678889999999999999999864 8999999997543 233456777887777774 99999999996     44667


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN-QYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      .++||||+. +++.+++....      ..+++..+..++.|++.||.|||+ .   +|+||||+|+||++++++.+||+|
T Consensus        89 ~~~v~e~~~-~~l~~l~~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~d  158 (296)
T cd06618          89 VFICMELMS-TCLDKLLKRIQ------GPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCD  158 (296)
T ss_pred             EEEEeeccC-cCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECc
Confidence            899999984 57777765432      468999999999999999999997 5   899999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccccC-----CCCcccceeehHHHHHHHhhCCCCCCcccccccceee
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-----HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHK  386 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~  386 (477)
                      ||++..+...        .......++..|+|||.+.+     .++.++||||||+++|||++|+.||........    
T Consensus       159 fg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----  226 (296)
T cd06618         159 FGISGRLVDS--------KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE----  226 (296)
T ss_pred             cccchhccCC--------CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH----
Confidence            9998765221        11122346788999999843     378999999999999999999999864211100    


Q ss_pred             eeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          387 FVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       387 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                              .+..+++.....              .+..         ..+...+.+++.+|++.||++||++.++++.
T Consensus       227 --------~~~~~~~~~~~~--------------~~~~---------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         227 --------VLTKILQEEPPS--------------LPPN---------EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             --------HHHHHhcCCCCC--------------CCCC---------CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                    011111110000              0000         0013347899999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=9.3e-36  Score=282.07  Aligned_cols=191  Identities=26%  Similarity=0.390  Sum_probs=161.7

Q ss_pred             eeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEeec
Q 043902          165 IGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFM  240 (477)
Q Consensus       165 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  240 (477)
                      ||+|+||+||++... +|+.+|+|.+....   ......+.+|++++++++||||+++++++     ...+..++||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence            689999999999854 68999999987432   22345678899999999999999999885     4567889999999


Q ss_pred             CCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccccc
Q 043902          241 RNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFE  320 (477)
Q Consensus       241 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  320 (477)
                      ++++|.+++.....     ..+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++|+|||.+.....
T Consensus        76 ~~~~L~~~l~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~  147 (277)
T cd05577          76 NGGDLKYHIYNVGE-----PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG  147 (277)
T ss_pred             CCCcHHHHHHHcCc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc
Confidence            99999999875431     3589999999999999999999999   999999999999999999999999999876521


Q ss_pred             cCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          321 ESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       321 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                              ........++..|+|||.+ .+.++.++|||||||++|+|++|+.||..
T Consensus       148 --------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  196 (277)
T cd05577         148 --------GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ  196 (277)
T ss_pred             --------CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence                    1112234577899999998 55689999999999999999999999965

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.8e-36  Score=280.45  Aligned_cols=248  Identities=26%  Similarity=0.352  Sum_probs=195.1

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      +|++.+.||+|+||.||++... +++.+++|.+....  ......+.+|++++++++|+||+++.+++     ......+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF-----LDGNKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhh-----ccCCEEE
Confidence            4778899999999999999754 78899999987542  33446788999999999999999999885     4557899


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +|+||+++++|.+++.....   ....+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||+
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~  149 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKK---KRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGI  149 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccc
Confidence            99999999999999865321   125689999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCC
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      +......         ......++..|+|||.+ ...++.++|+||||+++|||++|+.||.......            
T Consensus       150 ~~~~~~~---------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~------------  208 (256)
T cd08530         150 SKVLKKN---------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD------------  208 (256)
T ss_pred             hhhhccC---------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------------
Confidence            9876321         12234578899999999 5568899999999999999999999996532110            


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                        ....+...                ..+.+.        ......+.+++.+|++.+|++|||+.|+++
T Consensus       209 --~~~~~~~~----------------~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         209 --LRYKVQRG----------------KYPPIP--------PIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             --HHHHHhcC----------------CCCCCc--------hhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              00000000                000000        011344889999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.9e-37  Score=272.66  Aligned_cols=207  Identities=23%  Similarity=0.338  Sum_probs=172.3

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC---C--CCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA---D--GETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYE  228 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  228 (477)
                      ...|+....||+|.||.||+|.-.   +  ...+|+|.++.+.  .+......+|+.++..++|||++.+..++.    .
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl----~   98 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFL----S   98 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHh----c
Confidence            457888999999999999999643   2  2379999998553  334467889999999999999999998863    4


Q ss_pred             CCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC----
Q 043902          229 GNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG----  304 (477)
Q Consensus       229 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~----  304 (477)
                      .+...++++||.+. +|...++-.+..  ....++...+..|+.||+.|+.|||++   =|+||||||.||||..+    
T Consensus        99 ~d~~v~l~fdYAEh-DL~~II~fHr~~--~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgper  172 (438)
T KOG0666|consen   99 HDKKVWLLFDYAEH-DLWHIIKFHRAS--KAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPER  172 (438)
T ss_pred             cCceEEEEehhhhh-hHHHHHHHhccc--hhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCcc
Confidence            47789999999976 888888755432  225788999999999999999999999   79999999999999877    


Q ss_pred             CcEEEecccccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          305 MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       305 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |.+||+|||+++.+..    +-.........+-|++|+|||.+-  ..||.+.||||.||++.||+|-++.|..
T Consensus       173 G~VKIaDlGlaR~~~~----plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  173 GRVKIADLGLARLFNN----PLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             CeeEeecccHHHHhhc----cccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            8999999999998733    233333455677899999999993  4699999999999999999999988865

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.3e-35  Score=285.79  Aligned_cols=211  Identities=24%  Similarity=0.390  Sum_probs=167.4

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc--hhhHHHHHHHHHHhcCCCCCcceeeeecccccC---CC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ--GALKSFIDECNALTSIRHRNILKIVSSCSSVDY---EG  229 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---~~  229 (477)
                      .++|+..+.||+|+||.||+|... +++.+|+|++.....  .....+.+|++++.+++||||+++++++.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            578999999999999999999865 689999999865432  223467889999999999999999987643211   22


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEE
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV  309 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl  309 (477)
                      ....++|+||+.+ ++...+....      ..+++..+..++.|+++||.|||+.   +++|+||||+||++++++.++|
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~------~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l  156 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPS------VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKI  156 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence            3457999999965 6777665432      4689999999999999999999999   9999999999999999999999


Q ss_pred             ecccccccccccCCCCCC----CccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          310 GDFGLAKFLFEESNTPSK----NQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      +|||+++...........    .........++..|+|||.+.  ..++.++|||||||++|||++|+.||..
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~  229 (311)
T cd07866         157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG  229 (311)
T ss_pred             CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence            999999865332211110    111223345788899999873  3478999999999999999999999865

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.4e-36  Score=290.87  Aligned_cols=198  Identities=27%  Similarity=0.360  Sum_probs=163.0

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccC-CCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDY-EGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~  231 (477)
                      .++|...+.||+|+||.||+|... +|+.||+|+++...  ......+.+|++++.+++||||+++++++..... ....
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999864 78999999987432  2233568899999999999999999998643221 1224


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++|+||+.. +|..++.         ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|
T Consensus        94 ~~~lv~e~~~~-~l~~~~~---------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~d  160 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG---------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILD  160 (342)
T ss_pred             eEEEEeccccc-CHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEee
Confidence            56899999964 7776653         3478899999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ||+++....          ......++..|+|||.+.  ..++.++|||||||++|||++|+.||..
T Consensus       161 fg~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~  217 (342)
T cd07879         161 FGLARHADA----------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG  217 (342)
T ss_pred             CCCCcCCCC----------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            999875411          122345788899999983  3588999999999999999999999965

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.1e-35  Score=277.19  Aligned_cols=190  Identities=29%  Similarity=0.410  Sum_probs=162.8

Q ss_pred             eeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEeec
Q 043902          165 IGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFM  240 (477)
Q Consensus       165 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  240 (477)
                      ||.|++|.||+++.. +++.+|+|++....   ....+.+.+|++++++++||||+++++.+     ..+...++|+||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence            689999999999975 58999999987432   23346789999999999999999999985     4567789999999


Q ss_pred             CCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccccc
Q 043902          241 RNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFE  320 (477)
Q Consensus       241 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  320 (477)
                      ++++|.+++...       ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        76 ~~~~L~~~l~~~-------~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~  145 (262)
T cd05572          76 LGGELWTILRDR-------GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS  145 (262)
T ss_pred             CCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence            999999999754       3488999999999999999999998   999999999999999999999999999986532


Q ss_pred             cCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          321 ESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       321 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      ..        ......++..|+|||.+ ...++.++|+||||+++|+|++|..||...
T Consensus       146 ~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  195 (262)
T cd05572         146 GQ--------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGED  195 (262)
T ss_pred             cc--------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCC
Confidence            11        12234578889999998 556899999999999999999999999653

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.5e-35  Score=280.80  Aligned_cols=240  Identities=22%  Similarity=0.303  Sum_probs=180.0

Q ss_pred             eeeeeccceEEEEEeC-CCCEEEEEEeeeccc---hhhHHHHHHH---HHHhcCCCCCcceeeeecccccCCCCceeeEE
Q 043902          164 LIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ---GALKSFIDEC---NALTSIRHRNILKIVSSCSSVDYEGNDFKALV  236 (477)
Q Consensus       164 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  236 (477)
                      .||+|+||.||+|... +++.||+|.+.....   .....+..|.   +.+....||+|+++.+++     ...+..++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence            4899999999999864 689999999864321   1112234443   344456799999999884     556789999


Q ss_pred             EeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccc
Q 043902          237 FEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK  316 (477)
Q Consensus       237 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  316 (477)
                      |||+++|+|..++...       ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus        76 ~e~~~g~~L~~~l~~~-------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~  145 (278)
T cd05606          76 LDLMNGGDLHYHLSQH-------GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC  145 (278)
T ss_pred             EecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCcc
Confidence            9999999999988643       4589999999999999999999998   99999999999999999999999999987


Q ss_pred             cccccCCCCCCCccccCCCcccccccCccccc-C-CCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCc
Q 043902          317 FLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-G-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPS  394 (477)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  394 (477)
                      ....         .......|+..|+|||.+. + .++.++||||+||++|||++|+.||.........           
T Consensus       146 ~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~-----------  205 (278)
T cd05606         146 DFSK---------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----------  205 (278)
T ss_pred             ccCc---------cCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH-----------
Confidence            5421         1112346889999999984 4 5899999999999999999999999753211100           


Q ss_pred             hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC-----ChHHHHH
Q 043902          395 HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRV-----GMKFVVN  463 (477)
Q Consensus       395 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  463 (477)
                      .......   ...           ...+           ......+.+++.+|+..+|.+||     ++.++++
T Consensus       206 ~~~~~~~---~~~-----------~~~~-----------~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         206 EIDRMTL---TMA-----------VELP-----------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             HHHHHhh---ccC-----------CCCC-----------CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            0000000   000           0000           00123488999999999999999     9999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=281.31  Aligned_cols=272  Identities=23%  Similarity=0.292  Sum_probs=195.2

Q ss_pred             CCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc--hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          159 FSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ--GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       159 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      |+..+.||+|++|.||+|... +++.+++|.++....  .....+.+|++++++++|+||+++++++     ..+...++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-----RHKGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh-----ccCCCEEE
Confidence            567789999999999999865 789999999875432  2456788999999999999999999985     45578999


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      |+||+++ +|.+++....      ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+
T Consensus        76 v~e~~~~-~l~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~  145 (283)
T cd05118          76 VFEFMDT-DLYKLIKDRQ------RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLA  145 (283)
T ss_pred             EEeccCC-CHHHHHHhhc------ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeee
Confidence            9999975 8888876532      4689999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-cC-CCCcccceeehHHHHHHHhhCCCCCCcccccccc--eeeeeecc
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NG-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLS--IHKFVLMA  391 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~--~~~~~~~~  391 (477)
                      .......       .......++..|+|||.+ .. .++.++|+||||+++|+|+||+.||......+..  ........
T Consensus       146 ~~~~~~~-------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~  218 (283)
T cd05118         146 RSFGSPV-------RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTP  218 (283)
T ss_pred             EecCCCc-------ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            7663211       112234577889999998 33 5899999999999999999999998653221100  00000000


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      .+.......+......           ..++.................+.+++.+|++.||.+||++.+++.
T Consensus       219 ~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         219 DPEVWPKFTSLARNYK-----------FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             chHhcccchhhhhhhh-----------hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            0000000000000000           000000000011122334566899999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-35  Score=273.88  Aligned_cols=246  Identities=29%  Similarity=0.444  Sum_probs=194.7

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc--hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ--GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      +|+..+.||+|++|.||++... +++.|++|.+.....  .....+.+|++++.+++|+|++++++++     ......+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSI-----ETSDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEE-----EeCCEEE
Confidence            4778899999999999999865 678999999986543  4557899999999999999999999985     4457789


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +++||+++++|.+++...       ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||.
T Consensus        76 ~v~e~~~~~~L~~~~~~~-------~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~  145 (254)
T cd06627          76 IILEYAENGSLRQIIKKF-------GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGV  145 (254)
T ss_pred             EEEecCCCCcHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEecccc
Confidence            999999999999998754       4589999999999999999999998   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCC
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      +.......       .......++..|+|||.. ....+.++||||+|+++|+|++|+.||......             
T Consensus       146 ~~~~~~~~-------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-------------  205 (254)
T cd06627         146 ATKLNDVS-------KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-------------  205 (254)
T ss_pred             ceecCCCc-------ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-------------
Confidence            98763211       112334578899999998 445789999999999999999999998642110             


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                         ....+.... .         .. ..+           ......+.+++.+||..+|++|||+.|++.
T Consensus       206 ---~~~~~~~~~-~---------~~-~~~-----------~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         206 ---AALFRIVQD-D---------HP-PLP-----------EGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             ---HHHHHHhcc-C---------CC-CCC-----------CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence               000000000 0         00 000           001234789999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-35  Score=286.66  Aligned_cols=205  Identities=24%  Similarity=0.318  Sum_probs=169.7

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      +|.+.+.||+|++|.||+|+.. ++..+|+|.+....  ....+.+.+|+..+++++|+||+++.+++...........+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4788899999999999999975 58999999987543  34457889999999999999999999987543222334689


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +||||++ ++|.+++...       ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||+
T Consensus        81 lv~e~~~-~~l~~~l~~~-------~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~  149 (330)
T cd07834          81 IVTELME-TDLHKVIKSP-------QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGL  149 (330)
T ss_pred             EEecchh-hhHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCc
Confidence            9999997 5898888644       3689999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cC-CCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NG-HVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      +........    .........++..|+|||.+ .. .++.++|+||||+++|+|++|+.||...
T Consensus       150 ~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~  210 (330)
T cd07834         150 ARGVDPDED----EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR  210 (330)
T ss_pred             eEeeccccc----ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCC
Confidence            987632210    01122334578899999999 44 6899999999999999999999999654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=7.6e-36  Score=280.40  Aligned_cols=249  Identities=24%  Similarity=0.368  Sum_probs=189.0

Q ss_pred             eeeeccceEEEEEeC-CCCEEEEEEeeeccc---hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEeec
Q 043902          165 IGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ---GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFM  240 (477)
Q Consensus       165 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  240 (477)
                      ||.|+||.||+++.. +|+.+++|++.....   ...+.+.+|++++++++|||++++++.+     ......++++||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence            689999999999976 599999999875432   3456788999999999999999998874     5677899999999


Q ss_pred             CCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccccc
Q 043902          241 RNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFE  320 (477)
Q Consensus       241 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  320 (477)
                      ++++|.+++...       ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        76 ~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~  145 (265)
T cd05579          76 PGGDLASLLENV-------GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV  145 (265)
T ss_pred             CCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence            999999999753       3589999999999999999999998   999999999999999999999999999876432


Q ss_pred             cCCCC-CCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCchhHH
Q 043902          321 ESNTP-SKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMD  398 (477)
Q Consensus       321 ~~~~~-~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  398 (477)
                      ..... ...........++..|+|||.. ....+.++||||||+++||+++|+.||.......                 
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----------------  208 (265)
T cd05579         146 RRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-----------------  208 (265)
T ss_pred             CcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-----------------
Confidence            11100 0001122334578889999998 5568899999999999999999999996432110                 


Q ss_pred             HhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHH
Q 043902          399 VLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNL  465 (477)
Q Consensus       399 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  465 (477)
                      ..+........           .+..         ......+.+++.+|++.+|++|||+.++.+.|
T Consensus       209 ~~~~~~~~~~~-----------~~~~---------~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         209 IFQNILNGKIE-----------WPED---------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             HHHHHhcCCcC-----------CCcc---------ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence            00000000000           0000         00133478999999999999999995555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.6e-36  Score=305.08  Aligned_cols=202  Identities=23%  Similarity=0.320  Sum_probs=154.7

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC--CCCEEEEEEee-----------------eccchhhHHHHHHHHHHhcCCCCCc
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA--DGETAAIKVLK-----------------LQQQGALKSFIDECNALTSIRHRNI  215 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~-----------------~~~~~~~~~~~~e~~~l~~l~h~ni  215 (477)
                      ..++|++.+.||+|+||.||++..+  ++...+.|.+.                 .........+.+|+.++.+++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            3578999999999999999998753  22222222110                 0111233568899999999999999


Q ss_pred             ceeeeecccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCC
Q 043902          216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLK  295 (477)
Q Consensus       216 v~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk  295 (477)
                      +++++++     ...+..++|++++. ++|.+++......  ............++.|++.||.|||++   +|+|||||
T Consensus       226 v~l~~~~-----~~~~~~~lv~e~~~-~~l~~~l~~~~~~--~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLK  294 (501)
T PHA03210        226 LKIEEIL-----RSEANTYMITQKYD-FDLYSFMYDEAFD--WKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIK  294 (501)
T ss_pred             CcEeEEE-----EECCeeEEEEeccc-cCHHHHHhhcccc--ccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence            9999995     45667899999984 5777776543211  112334667788999999999999999   99999999


Q ss_pred             CCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCC
Q 043902          296 SSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRP  373 (477)
Q Consensus       296 p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p  373 (477)
                      |+|||++.++.+||+|||+++.+...      .........||..|+|||++ ...++.++|||||||++|||++|..+
T Consensus       295 P~NILl~~~~~vkL~DFGla~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~  367 (501)
T PHA03210        295 LENIFLNCDGKIVLGDFGTAMPFEKE------REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC  367 (501)
T ss_pred             HHHEEECCCCCEEEEeCCCceecCcc------cccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            99999999999999999999865221      11122345789999999999 55689999999999999999998754

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-35  Score=275.38  Aligned_cols=242  Identities=24%  Similarity=0.323  Sum_probs=181.8

Q ss_pred             CeeeeeccceEEEEEeC-CCCEEEEEEeeeccc---hhhHHHHHHHHHH-hcCCCCCcceeeeecccccCCCCceeeEEE
Q 043902          163 NLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ---GALKSFIDECNAL-TSIRHRNILKIVSSCSSVDYEGNDFKALVF  237 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  237 (477)
                      +.||+|+||.||+|... +|+.||+|+++....   .....+..|..++ ...+|+|++++++++     ..++..++|+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence            56899999999999864 689999999875431   2223344555444 455899999999985     4567899999


Q ss_pred             eecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          238 EFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       238 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      ||+++++|.+++...       ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||+++.
T Consensus        77 e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  146 (260)
T cd05611          77 EYLNGGDCASLIKTL-------GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRN  146 (260)
T ss_pred             eccCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeeccccee
Confidence            999999999999754       4588999999999999999999998   999999999999999999999999999875


Q ss_pred             ccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCchh
Q 043902          318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHV  396 (477)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  396 (477)
                      ...           .....++..|+|||.+ .+.++.++||||||+++|||+||..||.......              .
T Consensus       147 ~~~-----------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------------~  201 (260)
T cd05611         147 GLE-----------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA--------------V  201 (260)
T ss_pred             ccc-----------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH--------------H
Confidence            411           1234577889999998 4457999999999999999999999996432110              0


Q ss_pred             HHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHH
Q 043902          397 MDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNL  465 (477)
Q Consensus       397 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  465 (477)
                      ...+......        . ..            ...+.+...+.+++.+|++.+|++||++.++.+.|
T Consensus       202 ~~~~~~~~~~--------~-~~------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         202 FDNILSRRIN--------W-PE------------EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             HHHHHhcccC--------C-CC------------cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            0000000000        0 00            00011234588999999999999999886665443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=5.8e-35  Score=273.16  Aligned_cols=250  Identities=25%  Similarity=0.396  Sum_probs=196.9

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc--hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ--GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      +|+..+.||.|+||.||++... ++..+++|++.....  .....+.+|++.+++++|+|++++.+.+     ......+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~-----~~~~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESF-----EEKGKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEE-----ecCCEEE
Confidence            4778899999999999999975 689999999986533  4557788999999999999999999985     4457899


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +|+||+++++|.+++.....   ....+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||.
T Consensus        76 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~  149 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKK---EGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGI  149 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhc---cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccc
Confidence            99999999999999876421   125689999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCC
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      +......       ........|+..|+|||.. ...++.++|+||+|+++|+|++|+.||.......            
T Consensus       150 ~~~~~~~-------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------------  210 (258)
T cd08215         150 SKVLSST-------VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------------  210 (258)
T ss_pred             eeecccC-------cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------------
Confidence            9765221       1122334678899999998 5568999999999999999999999986432110            


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                       ........... .             .+.           .+...+.+++.+||..+|++|||+.|+++
T Consensus       211 -~~~~~~~~~~~-~-------------~~~-----------~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         211 -LALKILKGQYP-P-------------IPS-----------QYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             -HHHHHhcCCCC-C-------------CCC-----------CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             00000000000 0             000           11234789999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.8e-35  Score=288.59  Aligned_cols=206  Identities=22%  Similarity=0.342  Sum_probs=165.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeeccccc--------
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVD--------  226 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------  226 (477)
                      ..+|...+.||.|+||.||+|... +|..||+|.+........+.+.+|++++++++||||+++++++....        
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            468889999999999999999864 68999999998666555678899999999999999999998754211        


Q ss_pred             -CCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec-CC
Q 043902          227 -YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD-EG  304 (477)
Q Consensus       227 -~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~-~~  304 (477)
                       .......++|+||++ ++|.+++..        ..+++..+..++.|++.||.|||+.   +++||||||+||+++ ++
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~  151 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQ--------GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTED  151 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCC
Confidence             111245789999996 589888753        3478999999999999999999999   999999999999997 45


Q ss_pred             CcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-c-CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          305 MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-N-GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       305 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      +.+||+|||.++......    ..........++..|+|||.+ . ..++.++|||||||++|||++|+.||...
T Consensus       152 ~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~  222 (342)
T cd07854         152 LVLKIGDFGLARIVDPHY----SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA  222 (342)
T ss_pred             ceEEECCcccceecCCcc----ccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            678999999997652110    011111223578889999987 3 35788999999999999999999999653

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.6e-35  Score=284.83  Aligned_cols=246  Identities=25%  Similarity=0.367  Sum_probs=189.1

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec---cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ---QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .+.|+..+.||+|+||.||+|+.. ++..+|+|.+...   .......+.+|++++++++|+|++++.+++     ....
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   88 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-----LREH   88 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCC
Confidence            345777789999999999999965 6789999998642   223345788999999999999999999986     3456


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++|+||+. |++.+++....      ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|
T Consensus        89 ~~~lv~e~~~-~~l~~~~~~~~------~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~d  158 (308)
T cd06634          89 TAWLVMEYCL-GSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGD  158 (308)
T ss_pred             eeEEEEEccC-CCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECC
Confidence            7899999996 68877775432      4578999999999999999999998   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCccccc----CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeee
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN----GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~  387 (477)
                      ||++.....           .....++..|+|||.+.    +.++.++|||||||++|||++|..||.......      
T Consensus       159 fg~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------  221 (308)
T cd06634         159 FGSASIMAP-----------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------  221 (308)
T ss_pred             cccceeecC-----------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH------
Confidence            999876421           12235788999999872    457889999999999999999999985421110      


Q ss_pred             eeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       388 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                             ....+.....                 +..       ........+.+++.+||+.+|++||++.++++.
T Consensus       222 -------~~~~~~~~~~-----------------~~~-------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         222 -------ALYHIAQNES-----------------PAL-------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             -------HHHHHhhcCC-----------------CCc-------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence                   0000000000                 000       000113347899999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.8e-35  Score=282.74  Aligned_cols=242  Identities=25%  Similarity=0.329  Sum_probs=186.9

Q ss_pred             CCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          159 FSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       159 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      |...+.||+|+||.||+|+.. +|..|++|.+....   ......+.+|++++++++|||++++++++     .+....+
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   97 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCY-----LKEHTAW   97 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEE-----EeCCEEE
Confidence            566778999999999999864 68899999987432   23345688899999999999999999996     4566789


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +||||+. |++.+++....      ..+++.++..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||+
T Consensus        98 lv~e~~~-~~l~~~l~~~~------~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~  167 (313)
T cd06633          98 LVMEYCL-GSASDLLEVHK------KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGS  167 (313)
T ss_pred             EEEecCC-CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCC
Confidence            9999995 57877775432      4589999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCccccc----CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN----GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      +....           ......|+..|+|||++.    +.++.++|||||||++|||++|..||.......         
T Consensus       168 ~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~---------  227 (313)
T cd06633         168 ASKSS-----------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---------  227 (313)
T ss_pred             CcccC-----------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---------
Confidence            86421           112346788999999972    458899999999999999999999986531110         


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                          ...........                 ...       .......+.+++.+|++.+|.+||++.+++.
T Consensus       228 ----~~~~~~~~~~~-----------------~~~-------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         228 ----ALYHIAQNDSP-----------------TLQ-------SNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             ----HHHHHHhcCCC-----------------CCC-------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                00000000000                 000       0001223778999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3.4e-35  Score=279.82  Aligned_cols=254  Identities=22%  Similarity=0.323  Sum_probs=192.1

Q ss_pred             CCCCCCeeeeeccceEEEEEe----CCCCEEEEEEeeecc----chhhHHHHHHHHHHhcC-CCCCcceeeeecccccCC
Q 043902          158 NFSEENLIGSGSFGSVYKGTL----ADGETAAIKVLKLQQ----QGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYE  228 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  228 (477)
                      +|+..+.||+|++|.||+++.    .+++.||+|+++...    ....+.+.+|++++.++ +||||+++++.+     .
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~   75 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q   75 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence            467788999999999999974    257889999987432    22345688999999999 599999999874     5


Q ss_pred             CCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEE
Q 043902          229 GNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH  308 (477)
Q Consensus       229 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k  308 (477)
                      .+...++||||+++|+|.+++...       ..+++..+..++.|+++||.|||+.   +++||||+|+||+++.++.++
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~  145 (288)
T cd05583          76 TDTKLHLILDYVNGGELFTHLYQR-------EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVV  145 (288)
T ss_pred             cCCEEEEEEecCCCCcHHHHHhhc-------CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEE
Confidence            667789999999999999998643       3578999999999999999999998   999999999999999999999


Q ss_pred             EecccccccccccCCCCCCCccccCCCcccccccCcccccC-C--CCcccceeehHHHHHHHhhCCCCCCccccccccee
Q 043902          309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-H--VSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIH  385 (477)
Q Consensus       309 l~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~--~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~  385 (477)
                      |+|||+++......      ........|+..|+|||.+.+ .  .+.++||||||+++|||+||..||.......    
T Consensus       146 l~dfg~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----  215 (288)
T cd05583         146 LTDFGLSKEFLAEE------EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN----  215 (288)
T ss_pred             EEECcccccccccc------ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc----
Confidence            99999987653211      111223457889999999843 2  6889999999999999999999985321100    


Q ss_pred             eeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHH
Q 043902          386 KFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNL  465 (477)
Q Consensus       386 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  465 (477)
                               ...++. ......          ....+           ..+...+.+++.+|++.||++|||+.+|.+.|
T Consensus       216 ---------~~~~~~-~~~~~~----------~~~~~-----------~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l  264 (288)
T cd05583         216 ---------SQSEIS-RRILKS----------KPPFP-----------KTMSAEARDFIQKLLEKDPKKRLGANGADEIK  264 (288)
T ss_pred             ---------hHHHHH-HHHHcc----------CCCCC-----------cccCHHHHHHHHHHhcCCHhhccCcchHHHHh
Confidence                     000000 000000          00000           01123478899999999999999999887766


Q ss_pred             HH
Q 043902          466 QA  467 (477)
Q Consensus       466 ~~  467 (477)
                      +.
T Consensus       265 ~~  266 (288)
T cd05583         265 NH  266 (288)
T ss_pred             cC
Confidence            54

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-35  Score=286.50  Aligned_cols=248  Identities=27%  Similarity=0.360  Sum_probs=199.9

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      .....|.+...||+|.|+.|.+|+.. ++..||+|.+....  ....+.+.+|+++|..++|||||+++.+     .+..
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v-----~~t~  127 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSV-----IETE  127 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeee-----eeec
Confidence            44678899999999999999999865 79999999997553  3334568999999999999999999999     4678


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ..+|+||||+.+|.+++++...       ..+.+.....++.|+.+|++|||++   .|||||||++||||+.+.++||+
T Consensus       128 ~~lylV~eya~~ge~~~yl~~~-------gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIa  197 (596)
T KOG0586|consen  128 ATLYLVMEYASGGELFDYLVKH-------GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIA  197 (596)
T ss_pred             ceeEEEEEeccCchhHHHHHhc-------ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeee
Confidence            8899999999999999999865       3466688889999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccccC--CCCcccceeehHHHHHHHhhCCCCCCcccccccceeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~  388 (477)
                      |||++.++.        .........|++.|.|||++.|  ..++++|+||+|+++|-|+.|..||++..-....-+   
T Consensus       198 DfgfS~~~~--------~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r---  266 (596)
T KOG0586|consen  198 DFGFSTFFD--------YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR---  266 (596)
T ss_pred             ccccceeec--------ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccch---
Confidence            999998873        2334456789999999999955  368999999999999999999999986321111000   


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                                ++--...               .|...           .....+++++++-.+|.+|++++++.+
T Consensus       267 ----------vl~gk~r---------------Ip~~m-----------s~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  267 ----------VLRGKYR---------------IPFYM-----------SCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             ----------heeeeec---------------cccee-----------echhHHHHHHhhccCccccCCHHHhhh
Confidence                      0000000               00000           112567888899999999999999875

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=7.1e-35  Score=277.93  Aligned_cols=198  Identities=24%  Similarity=0.381  Sum_probs=164.9

Q ss_pred             CCCCCCeeeeeccceEEEEEe----CCCCEEEEEEeeecc----chhhHHHHHHHHHHhcC-CCCCcceeeeecccccCC
Q 043902          158 NFSEENLIGSGSFGSVYKGTL----ADGETAAIKVLKLQQ----QGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYE  228 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  228 (477)
                      +|+..+.||+|+||.||++..    .+|..||+|+++...    ....+.+.+|++++.++ +|+||+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence            477889999999999999985    368999999997532    22346678899999999 589999998874     5


Q ss_pred             CCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEE
Q 043902          229 GNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH  308 (477)
Q Consensus       229 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k  308 (477)
                      .+...++||||+++++|.+++...       ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.+|
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~k  145 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLSQR-------ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVV  145 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEE
Confidence            567789999999999999998754       4578899999999999999999998   999999999999999999999


Q ss_pred             EecccccccccccCCCCCCCccccCCCcccccccCcccccC---CCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       309 l~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |+|||++.......      ........|+..|+|||.+.+   .++.++||||||+++|+|+||+.||..
T Consensus       146 l~dfg~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~  210 (290)
T cd05613         146 LTDFGLSKEFHEDE------VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV  210 (290)
T ss_pred             EeeCccceeccccc------ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence            99999997652211      111223457889999999832   468899999999999999999999853

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-35  Score=287.51  Aligned_cols=202  Identities=27%  Similarity=0.330  Sum_probs=166.4

Q ss_pred             HHhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccC-C
Q 043902          153 SNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDY-E  228 (477)
Q Consensus       153 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~  228 (477)
                      ....++|+..+.||+|+||.||+|... +|..||+|+++...  ......+.+|++++++++||||+++++++..... .
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            345678999999999999999999854 78999999986432  2234568899999999999999999998643211 1


Q ss_pred             CCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEE
Q 043902          229 GNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH  308 (477)
Q Consensus       229 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k  308 (477)
                      .....++||||+ +++|.+++..        ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~--------~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~k  158 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKH--------EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELK  158 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEE
Confidence            123468999999 7799888753        3488999999999999999999999   999999999999999999999


Q ss_pred             EecccccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       309 l~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |+|||++.....          ......++..|+|||.+.  ..++.++|+|||||++|++++|+.||..
T Consensus       159 l~dfg~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~  218 (343)
T cd07880         159 ILDFGLARQTDS----------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG  218 (343)
T ss_pred             Eeeccccccccc----------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999875421          122345688999999984  3588999999999999999999999965

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=264.81  Aligned_cols=249  Identities=22%  Similarity=0.285  Sum_probs=189.4

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec-cchhhHHHHHHHHHHhcCC-CCCcceeeeecccccCCCCceee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ-QQGALKSFIDECNALTSIR-HRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      +...+..||.|..|.|++++.. +|..+|||.+... +....++++..++++.+.+ .|.||+.+||+     -.+...+
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyF-----i~n~dV~  167 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYF-----ITNTDVF  167 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEE-----eeCchHH
Confidence            3345567999999999999975 6899999999754 4455678888888877765 89999999996     3455578


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +.||.| ..-++.++....      .++++..+-++...+.+||.||.++.  +|+|||+||+|||+|+.|++|++|||+
T Consensus       168 IcMelM-s~C~ekLlkrik------~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGI  238 (391)
T KOG0983|consen  168 ICMELM-STCAEKLLKRIK------GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGI  238 (391)
T ss_pred             HHHHHH-HHHHHHHHHHhc------CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccc
Confidence            889988 446666666543      56888888899999999999999873  999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCccccc----CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN----GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      +-++.++        ...+...|-+.|||||.+.    .+|+.++||||||++++||.||+.||.....+-..       
T Consensus       239 sGrlvdS--------kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~-------  303 (391)
T KOG0983|consen  239 SGRLVDS--------KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV-------  303 (391)
T ss_pred             cceeecc--------cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH-------
Confidence            9887442        2233446888999999993    35899999999999999999999999763222111       


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                           +..+++.    +   ......+                +.+...+.+++..||..|+.+||...++++
T Consensus       304 -----ltkvln~----e---PP~L~~~----------------~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  304 -----LTKVLNE----E---PPLLPGH----------------MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             -----HHHHHhc----C---CCCCCcc----------------cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence                 1111110    0   0000000                002344789999999999999999998875

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3.5e-35  Score=284.61  Aligned_cols=198  Identities=25%  Similarity=0.351  Sum_probs=165.7

Q ss_pred             HHhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec--cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCC
Q 043902          153 SNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEG  229 (477)
Q Consensus       153 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  229 (477)
                      ...+++|+..+.||.|+||.||+|... ++..||+|++...  .....+.+.+|++++.+++|||++++.+++.    ..
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~----~~   81 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFI----SP   81 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEe----cC
Confidence            346788999999999999999999855 7899999987632  2233467889999999999999999999863    33


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEE
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV  309 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl  309 (477)
                      ....++|+||+ +++|.+++..        ..+++.....++.|++.||.|||+.   +++||||+|+||++++++.++|
T Consensus        82 ~~~~~lv~e~~-~~~L~~~~~~--------~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l  149 (328)
T cd07856          82 LEDIYFVTELL-GTDLHRLLTS--------RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKI  149 (328)
T ss_pred             CCcEEEEeehh-ccCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEe
Confidence            45688999998 5689888863        2467888889999999999999999   9999999999999999999999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCcccc-c-CCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-N-GHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      +|||.+.....          ......++..|+|||.+ . ..++.++|||||||++|||+||+.||..
T Consensus       150 ~dfg~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~  208 (328)
T cd07856         150 CDFGLARIQDP----------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG  208 (328)
T ss_pred             CccccccccCC----------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            99999875411          11234567889999987 3 3589999999999999999999999965

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4.7e-35  Score=284.99  Aligned_cols=206  Identities=24%  Similarity=0.382  Sum_probs=164.6

Q ss_pred             hcCCCC-CCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchh--------------hHHHHHHHHHHhcCCCCCcceee
Q 043902          156 TDNFSE-ENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGA--------------LKSFIDECNALTSIRHRNILKIV  219 (477)
Q Consensus       156 ~~~~~~-~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~  219 (477)
                      .++|.. .+.||+|+||.||+|... +++.||+|.++......              ...+.+|++++.+++|+||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            345654 477999999999999865 68999999987442211              12477899999999999999999


Q ss_pred             eecccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCe
Q 043902          220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNV  299 (477)
Q Consensus       220 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NI  299 (477)
                      +++     ...+..++||||+. |+|.+++...       ..+++.....++.|++.||.|||+.   +++|+||+|+||
T Consensus        87 ~~~-----~~~~~~~lv~e~~~-~~l~~~l~~~-------~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~ni  150 (335)
T PTZ00024         87 DVY-----VEGDFINLVMDIMA-SDLKKVVDRK-------IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANI  150 (335)
T ss_pred             EEE-----ecCCcEEEEEeccc-cCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHe
Confidence            985     45678999999996 6999988643       4588999999999999999999998   999999999999


Q ss_pred             EecCCCcEEEecccccccccccCCCCC-------CCccccCCCcccccccCcccccC--CCCcccceeehHHHHHHHhhC
Q 043902          300 LLDEGMIAHVGDFGLAKFLFEESNTPS-------KNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTG  370 (477)
Q Consensus       300 ll~~~~~~kl~DfG~a~~~~~~~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~elltg  370 (477)
                      +++.++.++|+|||++...........       ..........++..|+|||.+.+  .++.++|||||||++|||+||
T Consensus       151 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg  230 (335)
T PTZ00024        151 FINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG  230 (335)
T ss_pred             EECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhC
Confidence            999999999999999976531110000       00111223346788999999843  478999999999999999999


Q ss_pred             CCCCCcc
Q 043902          371 KRPTDDM  377 (477)
Q Consensus       371 ~~p~~~~  377 (477)
                      +.||...
T Consensus       231 ~~p~~~~  237 (335)
T PTZ00024        231 KPLFPGE  237 (335)
T ss_pred             CCCCCCC
Confidence            9999653

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.7e-35  Score=278.20  Aligned_cols=253  Identities=27%  Similarity=0.406  Sum_probs=196.3

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec---cchhhHHHHHHHHHHhcCC-CCCcceeeeecccccCCCCc
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ---QQGALKSFIDECNALTSIR-HRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~  231 (477)
                      ++|...+.||+|+||.||+|... +|+.||+|++...   .......+.+|.+++.+++ |+||+++++++     ...+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~   75 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEE   75 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCc
Confidence            46888899999999999999875 7899999998753   2233467889999999998 99999999985     5667


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+++++|.+++...       ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~d  145 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIRKY-------GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITD  145 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecC
Confidence            899999999999999999754       3689999999999999999999998   999999999999999999999999


Q ss_pred             ccccccccccCCCCC-------------CCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          312 FGLAKFLFEESNTPS-------------KNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       312 fG~a~~~~~~~~~~~-------------~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      ||++...........             ..........++..|+|||.. .+.++.++||||||++++++++|+.||...
T Consensus       146 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  225 (280)
T cd05581         146 FGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS  225 (280)
T ss_pred             CccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence            999986643221100             001223345678899999998 556899999999999999999999999753


Q ss_pred             cccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCC
Q 043902          378 FKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVG  457 (477)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs  457 (477)
                      ....             ......+....               .+           ......+.+++.+||+.+|++|||
T Consensus       226 ~~~~-------------~~~~~~~~~~~---------------~~-----------~~~~~~~~~li~~~l~~~p~~R~~  266 (280)
T cd05581         226 NEYL-------------TFQKILKLEYS---------------FP-----------PNFPPDAKDLIEKLLVLDPQDRLG  266 (280)
T ss_pred             cHHH-------------HHHHHHhcCCC---------------CC-----------CccCHHHHHHHHHHhcCCHhhCCC
Confidence            2100             00111100000               00           001234789999999999999999


Q ss_pred             h----HHHHH
Q 043902          458 M----KFVVN  463 (477)
Q Consensus       458 ~----~evl~  463 (477)
                      +    +|+++
T Consensus       267 ~~~~~~~ll~  276 (280)
T cd05581         267 VNEGYDELKA  276 (280)
T ss_pred             cccCHHHHhc
Confidence            9    66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-35  Score=278.17  Aligned_cols=196  Identities=28%  Similarity=0.433  Sum_probs=165.3

Q ss_pred             CCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          159 FSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       159 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      |+..+.||+|++|.||+|+.. +++.+|+|+++...  ....+.+..|+.++++++|+|++++++++     ...+..++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVI-----HTERKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhh-----hcCCceEE
Confidence            556788999999999999976 58999999998653  33346788999999999999999999985     44578999


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      |+||++ ++|.+++....      ..+++..+..++.|++.||.|||++   +++||||+|+||++++++.++|+|||.+
T Consensus        76 v~e~~~-~~l~~~i~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~  145 (282)
T cd07829          76 VFEYCD-MDLKKYLDKRP------GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLA  145 (282)
T ss_pred             EecCcC-cCHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcc
Confidence            999997 59999997542      3589999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-cC-CCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NG-HVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ......       ........++..|+|||.+ .. .++.++|||||||++|||++|+.||..
T Consensus       146 ~~~~~~-------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~  201 (282)
T cd07829         146 RAFGIP-------LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPG  201 (282)
T ss_pred             cccCCC-------ccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence            765221       1112233456789999998 33 689999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-34  Score=283.38  Aligned_cols=205  Identities=25%  Similarity=0.337  Sum_probs=169.0

Q ss_pred             HHHHHhhcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeeccccc
Q 043902          150 LKISNATDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVD  226 (477)
Q Consensus       150 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  226 (477)
                      .++...+++|...+.||+|+||.||+|.. .+++.||+|+++...  ....+.+.+|+.++.+++||||+++.+++....
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            45566789999999999999999999985 478999999987532  223456888999999999999999999864322


Q ss_pred             -CCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC
Q 043902          227 -YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM  305 (477)
Q Consensus       227 -~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~  305 (477)
                       +......+++++++ +++|.+++..        ..+++..+..++.|+++||.|||+.   +++||||||+||++++++
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~  157 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKC--------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC  157 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence             12234567888887 7899888753        3488999999999999999999999   999999999999999999


Q ss_pred             cEEEecccccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          306 IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       306 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      .+||+|||+++....          ......++..|+|||.+.  ..++.++|||||||++|||++|+.||..
T Consensus       158 ~~kl~dfg~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  220 (345)
T cd07877         158 ELKILDFGLARHTDD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG  220 (345)
T ss_pred             CEEEecccccccccc----------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999999875411          122345788999999883  3578999999999999999999999864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=7.8e-35  Score=283.02  Aligned_cols=204  Identities=23%  Similarity=0.289  Sum_probs=164.2

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-C--CCEEEEEEeeec--cchhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCCc
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-D--GETAAIKVLKLQ--QQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~  231 (477)
                      +|+..+.||+|+||.||+++.. +  +..||+|.+...  .....+.+.+|++++.++ .||||+++++.+... .....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF-PGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec-cccCC
Confidence            4777889999999999999965 3  789999998743  222346788999999999 599999999875321 12334


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++++||+. ++|.+++...       ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~D  148 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSG-------QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICD  148 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCc
Confidence            5788999885 6899988643       4589999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ||+++........   .........|+..|+|||.+.  ..++.++|||||||++|+|++|+.||..
T Consensus       149 fg~a~~~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~  212 (332)
T cd07857         149 FGLARGFSENPGE---NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG  212 (332)
T ss_pred             CCCceeccccccc---ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence            9999865321111   111123456889999999873  3579999999999999999999999865

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-36  Score=265.93  Aligned_cols=201  Identities=26%  Similarity=0.397  Sum_probs=175.0

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      ..++|+..++||+|.||.|-+++-+ +|+.+|+|+++...   .+....-+.|-++|+..+||.+..+--.     ++..
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-----FQt~  240 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-----FQTQ  240 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-----hccC
Confidence            3578999999999999999999865 79999999998653   3445566789999999999999877543     5888


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +.+|+||||..||.|.-+|...       ..+++....-+-..|+.||.|||++   +||.||||.+|.|+|.+|++||+
T Consensus       241 drlCFVMeyanGGeLf~HLsre-------r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKit  310 (516)
T KOG0690|consen  241 DRLCFVMEYANGGELFFHLSRE-------RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKIT  310 (516)
T ss_pred             ceEEEEEEEccCceEeeehhhh-------hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEee
Confidence            9999999999999999998765       4688888888999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      |||+++.-.       .........+||+.|.|||++ ...|+.++|.|.+||++|||++|+.||...
T Consensus       311 DFGLCKE~I-------~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~  371 (516)
T KOG0690|consen  311 DFGLCKEEI-------KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK  371 (516)
T ss_pred             ecccchhcc-------cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence            999997531       123345667899999999999 667999999999999999999999999753

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8e-35  Score=284.12  Aligned_cols=201  Identities=27%  Similarity=0.358  Sum_probs=166.1

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec--cchhhHHHHHHHHHHhcCCCCCcceeeeecccccC-CC
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDY-EG  229 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~  229 (477)
                      ...++|+....||+|++|.||+|+.. +++.||+|++...  .......+.+|+.++++++|+|++++.+++..... ..
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34678999999999999999999975 6889999998743  22234567789999999999999999987532211 12


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEE
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV  309 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl  309 (477)
                      ....++|+||+ +++|.+++..        ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~--------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL  159 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC--------QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKI  159 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEE
Confidence            23489999998 6799998864        3589999999999999999999998   9999999999999999999999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      +|||++.....          ......++..|+|||.+.  ..++.++|||||||++||++||+.||..
T Consensus       160 ~dfg~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~  218 (343)
T cd07851         160 LDFGLARHTDD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG  218 (343)
T ss_pred             ccccccccccc----------cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            99999976521          122345788899999983  3578999999999999999999999964

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=6.8e-35  Score=273.47  Aligned_cols=249  Identities=23%  Similarity=0.307  Sum_probs=186.6

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec-----cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ-----QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      +|.+.+.||+|+||.||++... .+..+++|+++..     .......+..|+.++.+++||||+++++++     ....
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF-----LERD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH-----hcCC
Confidence            4778899999999999999864 3455666666532     122334567899999999999999999985     4556


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++|+||+++++|.+++.....   ....+++..++.++.|++.||.|||+.   +++|+||+|+||++++ +.++|+|
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d  148 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKH---TGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGD  148 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhh---cccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecc
Confidence            78999999999999998864211   125689999999999999999999998   9999999999999986 4699999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      ||.+......       ........|+..|+|||.. ...++.++|+||||+++|+|++|..||.......         
T Consensus       149 ~g~~~~~~~~-------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---------  212 (260)
T cd08222         149 FGVSRLLMGS-------CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS---------  212 (260)
T ss_pred             cCceeecCCC-------cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---------
Confidence            9998765321       1122234578889999988 4457889999999999999999999985421100         


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                          ........    .             .+..        ...+...+.+++.+|++.+|++||++.|+++
T Consensus       213 ----~~~~~~~~----~-------------~~~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         213 ----VVLRIVEG----P-------------TPSL--------PETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             ----HHHHHHcC----C-------------CCCC--------cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                00000000    0             0000        0112345789999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-35  Score=261.14  Aligned_cols=256  Identities=20%  Similarity=0.257  Sum_probs=198.6

Q ss_pred             hhcCCCCC-CeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCCc
Q 043902          155 ATDNFSEE-NLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       155 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .+++|++. ++||-|-.|.|-.+..+ +|+.+|+|++...     ....+|+++.-.. .|||||++++++... +.+..
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs-~~~rk  132 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENS-YQGRK  132 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhh-ccCce
Confidence            45666653 68999999999999865 7999999998744     4456788876655 699999999997543 45667


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC---CCcEE
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE---GMIAH  308 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~~k  308 (477)
                      .+.+|||.|+||.|.+.++.+.+     ..+++.++-.|..||+.|+.|||+.   +|.||||||+|+|...   |-.+|
T Consensus       133 cLLiVmE~meGGeLfsriq~~g~-----~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lK  204 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDRGD-----QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLK  204 (400)
T ss_pred             eeEeeeecccchHHHHHHHHccc-----ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceE
Confidence            78899999999999999987754     6799999999999999999999999   9999999999999964   55799


Q ss_pred             EecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeee
Q 043902          309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       309 l~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~  387 (477)
                      |+|||+|+.-.        ........+-|+.|.|||++ ..+|+...|+||+||++|-|++|.+||.......      
T Consensus       205 LtDfGFAK~t~--------~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a------  270 (400)
T KOG0604|consen  205 LTDFGFAKETQ--------EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA------  270 (400)
T ss_pred             ecccccccccC--------CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc------
Confidence            99999998641        12233445679999999999 5679999999999999999999999997643211      


Q ss_pred             eeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       388 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                          ++..+..-+....        .             .+..+++.+..+...++++..|..+|.+|.|+.|+++
T Consensus       271 ----ispgMk~rI~~gq--------y-------------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  271 ----ISPGMKRRIRTGQ--------Y-------------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             ----CChhHHhHhhccC--------c-------------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence                1111111110000        0             0223344555666889999999999999999999975

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=274.34  Aligned_cols=209  Identities=28%  Similarity=0.464  Sum_probs=177.7

Q ss_pred             cCCCCCCeeeeeccceEEEEE-eCCCCEEEEEEeeecc-------chhhHHHHHHHHHHhcCCCCCcceeeeecccccCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQ-------QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYE  228 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  228 (477)
                      ++|-.+.+||+|||+.||+|. +...+.||||+-....       ....+...+|.++.+.|.||.||++++++.    -
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs----l  538 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS----L  538 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee----e
Confidence            355566789999999999997 4568899999875332       122345778999999999999999999975    3


Q ss_pred             CCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec---CCC
Q 043902          229 GNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD---EGM  305 (477)
Q Consensus       229 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~---~~~  305 (477)
                      +.+..|-|+|||+|.+|+-+|+..       +.+++.++..|+.||+.||.||.+. .++|+|-||||.|||+.   .-|
T Consensus       539 DtdsFCTVLEYceGNDLDFYLKQh-------klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacG  610 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYLKQH-------KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACG  610 (775)
T ss_pred             ccccceeeeeecCCCchhHHHHhh-------hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccc
Confidence            556789999999999999999866       5699999999999999999999986 77999999999999995   457


Q ss_pred             cEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cC----CCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          306 IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NG----HVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       306 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~----~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      .+||+|||+++.+.+++..............||.+|++||.+ -+    +++.|+||||.||++|.++.|+.||...
T Consensus       611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn  687 (775)
T KOG1151|consen  611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN  687 (775)
T ss_pred             eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence            899999999999977666655555566778899999999998 33    4799999999999999999999999753

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-37  Score=265.71  Aligned_cols=253  Identities=24%  Similarity=0.311  Sum_probs=186.7

Q ss_pred             CCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc-hhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCCceeeE
Q 043902          159 FSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ-GALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       159 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      .+.+..||.|.||+|++-.++ .|+..|||+++.... ...++++.|.+...+- +.||||+++|.+.     .++..++
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F-----~EGdcWi  140 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF-----SEGDCWI  140 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh-----cCCceee
Confidence            334567999999999999865 799999999986654 5667889998875554 7999999999973     4556899


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      .||.| ..||+.+-+.--.  .....+++...-.|+...+.||.||...  ..|+|||+||+|||++..|.+||+|||.+
T Consensus       141 CMELM-d~SlDklYk~vy~--vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIc  215 (361)
T KOG1006|consen  141 CMELM-DISLDKLYKRVYS--VQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGIC  215 (361)
T ss_pred             eHHHH-hhhHHHHHHHHHH--HHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccch
Confidence            99999 4477655421100  0114578888888999999999999976  48999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc--cCC-CCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccC
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI--NGH-VSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMAL  392 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~-~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  392 (477)
                      -.+.+        ....+...|-..|||||.+  .+. ++.+|||||+|++|||+.||+.||.....            +
T Consensus       216 GqLv~--------SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s------------v  275 (361)
T KOG1006|consen  216 GQLVD--------SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS------------V  275 (361)
T ss_pred             HhHHH--------HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH------------H
Confidence            77632        2233445678899999999  334 89999999999999999999999865321            0


Q ss_pred             CchhHHHhh--hhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          393 PSHVMDVLD--LSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       393 ~~~~~~~~d--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      -+++..++.  +......                     . ..-+....+.+++..|+..|-++||...++.+
T Consensus       276 feql~~Vv~gdpp~l~~~---------------------~-~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  276 FEQLCQVVIGDPPILLFD---------------------K-ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             HHHHHHHHcCCCCeecCc---------------------c-cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            111111111  1000000                     0 00011334889999999999999999998865

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-33  Score=263.66  Aligned_cols=190  Identities=33%  Similarity=0.439  Sum_probs=163.1

Q ss_pred             eeeeccceEEEEEeC-CCCEEEEEEeeeccc---hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEeec
Q 043902          165 IGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ---GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFM  240 (477)
Q Consensus       165 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  240 (477)
                      ||+|+||.||++... +++.+++|+++....   .....+..|++++++++|+|++++++.+     ..+...++||||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence            689999999999875 589999999875432   2346788999999999999999999884     5677899999999


Q ss_pred             CCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccccc
Q 043902          241 RNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFE  320 (477)
Q Consensus       241 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  320 (477)
                      ++++|.+++...       ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        76 ~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~  145 (250)
T cd05123          76 PGGELFSHLSKE-------GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSS  145 (250)
T ss_pred             CCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence            999999999754       3589999999999999999999998   999999999999999999999999999976522


Q ss_pred             cCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          321 ESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       321 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ..       .......++..|+|||.. ....+.++|+||||+++|++++|+.||..
T Consensus       146 ~~-------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~  195 (250)
T cd05123         146 EG-------SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA  195 (250)
T ss_pred             CC-------CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            11       123345678899999998 44578999999999999999999999965

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.3e-36  Score=257.86  Aligned_cols=209  Identities=24%  Similarity=0.414  Sum_probs=171.2

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeee--ccchhhHHHHHHHHHHhcCCCCCcceeeeecccccC---CCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKL--QQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDY---EGN  230 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---~~~  230 (477)
                      +.|....+||+|.||.||+|+.+ +|+.||+|++-.  +..+.-...++|+++|..++|+|++.++..|....-   ...
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            45566788999999999999865 678889887543  333444667899999999999999999999865332   223


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ...|+||++|+. +|..+|....      ..++..++.++..++..||.|+|+.   .|+|||+||.|+|++.++.+||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~------vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklA  166 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRK------VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLA  166 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCcc------ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEee
Confidence            458999999966 8999998654      5689999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc--cCCCCcccceeehHHHHHHHhhCCCCCCccc
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMF  378 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~  378 (477)
                      |||+++.+.......   ....+..+-|.+|++||.+  ...++++.|||+-||++.||+||.+-+....
T Consensus       167 DFGlar~fs~~~n~~---kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt  233 (376)
T KOG0669|consen  167 DFGLARAFSTSKNVV---KPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT  233 (376)
T ss_pred             ccccccceecccccC---CCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh
Confidence            999998764322211   1224456679999999999  4469999999999999999999998887643

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-35  Score=299.02  Aligned_cols=205  Identities=24%  Similarity=0.355  Sum_probs=179.3

Q ss_pred             HHHHhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeee---ccchhhHHHHHHHHHHhcCCCCCcceeeeeccccc
Q 043902          151 KISNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKL---QQQGALKSFIDECNALTSIRHRNILKIVSSCSSVD  226 (477)
Q Consensus       151 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  226 (477)
                      ++.-..++|.+.++||+|+||.|..++.+ +++.||+|+++.   -.......|..|-.+|..-+.+-|+++.-.     
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA-----  143 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA-----  143 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH-----
Confidence            34445689999999999999999999975 689999999975   234445789999999999999999988655     


Q ss_pred             CCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCc
Q 043902          227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI  306 (477)
Q Consensus       227 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~  306 (477)
                      |+++.++|+|||||+||+|-.+|...       ..+++..+..++..|+-||.-||+.   |+|||||||+|||+|..|+
T Consensus       144 FQD~~~LYlVMdY~pGGDlltLlSk~-------~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GH  213 (1317)
T KOG0612|consen  144 FQDERYLYLVMDYMPGGDLLTLLSKF-------DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGH  213 (1317)
T ss_pred             hcCccceEEEEecccCchHHHHHhhc-------CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCc
Confidence            58899999999999999999999754       4689999999999999999999999   9999999999999999999


Q ss_pred             EEEecccccccccccCCCCCCCccccCCCcccccccCcccc-----c-CCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          307 AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-----N-GHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       307 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      +||+|||.+..+..      .+...+...+|||.|++||++     . |.|++.+|+||+||++|||+.|..||..
T Consensus       214 ikLADFGsClkm~~------dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa  283 (1317)
T KOG0612|consen  214 IKLADFGSCLKMDA------DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA  283 (1317)
T ss_pred             EeeccchhHHhcCC------CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence            99999999987732      234556677899999999998     1 4699999999999999999999999964

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=6.3e-34  Score=298.87  Aligned_cols=147  Identities=29%  Similarity=0.428  Sum_probs=129.7

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .++|.+.+.||+|+||.||+|... +++.||+|+++...   ......+..|+.++..++||||+++++++     ....
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~   77 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSAN   77 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECC
Confidence            367889999999999999999976 68999999997532   23346788999999999999999999875     4566


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+.+++|.+++...       ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        78 ~~~lVmEy~~g~~L~~li~~~-------~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~D  147 (669)
T cd05610          78 NVYLVMEYLIGGDVKSLLHIY-------GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTD  147 (669)
T ss_pred             EEEEEEeCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEe
Confidence            899999999999999998643       4578899999999999999999998   999999999999999999999999


Q ss_pred             cccccc
Q 043902          312 FGLAKF  317 (477)
Q Consensus       312 fG~a~~  317 (477)
                      ||+++.
T Consensus       148 FGls~~  153 (669)
T cd05610         148 FGLSKV  153 (669)
T ss_pred             CCCCcc
Confidence            999863

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-35  Score=265.41  Aligned_cols=282  Identities=20%  Similarity=0.260  Sum_probs=202.4

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCC--C----Ccceeeeeccccc
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRH--R----NILKIVSSCSSVD  226 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~----niv~l~~~~~~~~  226 (477)
                      ..+.+|.+...+|+|.||.|-.+... .+..||||+++.-.. ..+..+-|+++|+++.+  |    -++.+.++     
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~w-----  159 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDW-----  159 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----
Confidence            34789999999999999999999754 578999999985543 23566789999999942  2    25666666     


Q ss_pred             CCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec----
Q 043902          227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD----  302 (477)
Q Consensus       227 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~----  302 (477)
                      ++-.++.|+|+|.+ |-|+.++|..+.     ..+++...+..|+.|++++++|||+.   +++|-||||+|||+.    
T Consensus       160 FdyrghiCivfell-G~S~~dFlk~N~-----y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~  230 (415)
T KOG0671|consen  160 FDYRGHICIVFELL-GLSTFDFLKENN-----YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEY  230 (415)
T ss_pred             hhccCceEEEEecc-ChhHHHHhccCC-----ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccce
Confidence            46678899999998 779999998763     47789999999999999999999999   999999999999993    


Q ss_pred             ----------------CCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHH
Q 043902          303 ----------------EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLL  365 (477)
Q Consensus       303 ----------------~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~  365 (477)
                                      .+..+|++|||.|.+-.          ......+.|..|+|||++ .-.++..+||||+||+|.
T Consensus       231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~----------e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~  300 (415)
T KOG0671|consen  231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDH----------EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILV  300 (415)
T ss_pred             EEEeccCCccceeccCCCcceEEEecCCcceec----------cCcceeeeccccCCchheeccCcCCccCceeeeeEEE
Confidence                            13468999999998642          122456789999999999 447999999999999999


Q ss_pred             HHhhCCCCCCcccc-cccceeeeeeccCCchhHHHhhhhh-----hhhhccc--cc--ccccccccchhhhHHHHHHHHH
Q 043902          366 EIFTGKRPTDDMFK-DDLSIHKFVLMALPSHVMDVLDLSM-----LLEEEND--HE--KHEEEDLFPDIESQVAQKKLEE  435 (477)
Q Consensus       366 elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~~-----~~~~~~~--~~--~~~~~~~~~~~~~~~~~~~~~~  435 (477)
                      |+.||...|..-.+ +...+.+.+...+|..+..-.+..-     ..+..+.  ..  +.-.+...|.-.   -....+.
T Consensus       301 ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~---~~~~~d~  377 (415)
T KOG0671|consen  301 ELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKK---YMLQDDL  377 (415)
T ss_pred             EeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHH---HhccCcH
Confidence            99999999876331 2223333344445554333221100     1110000  00  000000111000   0011122


Q ss_pred             HHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          436 CLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       436 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      ...++++|+..||..||.+|+|+.|++.
T Consensus       378 e~~~LfDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  378 EHVQLFDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHhHHHHHHHHHHccCccccccHHHHhc
Confidence            2456999999999999999999999985

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1e-33  Score=261.67  Aligned_cols=179  Identities=21%  Similarity=0.186  Sum_probs=149.5

Q ss_pred             eccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEeecCCCChh
Q 043902          168 GSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLD  246 (477)
Q Consensus       168 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~  246 (477)
                      |.+|.||+++.. +++.+|+|.++...     .+..|...+....|||++++++++     ...+..++||||+++|+|.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~   73 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGKLW   73 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCCHH
Confidence            889999999865 78999999997543     233455555666799999999985     4567899999999999999


Q ss_pred             hhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccccccCCCCC
Q 043902          247 QWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS  326 (477)
Q Consensus       247 ~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  326 (477)
                      +++...       ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++++|||.+.....      
T Consensus        74 ~~l~~~-------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~------  137 (237)
T cd05576          74 SHISKF-------LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED------  137 (237)
T ss_pred             HHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccc------
Confidence            998643       3489999999999999999999998   999999999999999999999999998765421      


Q ss_pred             CCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          327 KNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       327 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                          ......++..|+|||.. .+.++.++||||+|+++|||++|+.|+..
T Consensus       138 ----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~  184 (237)
T cd05576         138 ----SCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC  184 (237)
T ss_pred             ----ccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence                11223456779999998 45689999999999999999999988753

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=237.76  Aligned_cols=198  Identities=24%  Similarity=0.397  Sum_probs=168.2

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      +|...++||+|.||+||+|+.. +++.||+|.++...  .+......+|+-+++.++|.|||++++..     ..+....
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCceeE
Confidence            4666789999999999999965 68899999998553  34456789999999999999999999983     5677889


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +|+|||. .+|..+...-.      ..++...+..++.|+++||.++|++   ++.|||+||.|.+++.+|+.|++|||+
T Consensus        78 lvfe~cd-qdlkkyfdsln------g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfgl  147 (292)
T KOG0662|consen   78 LVFEFCD-QDLKKYFDSLN------GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGL  147 (292)
T ss_pred             EeHHHhh-HHHHHHHHhcC------CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccch
Confidence            9999994 58888886554      5688999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccccC--CCCcccceeehHHHHHHHhh-CCCCCCcc
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFT-GKRPTDDM  377 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~  377 (477)
                      ++.+..       ........+-|..|++|.++-|  -|+...|+||-||++.|+.. |++.|.+.
T Consensus       148 arafgi-------pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~  206 (292)
T KOG0662|consen  148 ARAFGI-------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN  206 (292)
T ss_pred             hhhcCC-------ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC
Confidence            987621       2334455667999999999943  48999999999999999988 77667654

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2e-33  Score=287.91  Aligned_cols=208  Identities=22%  Similarity=0.241  Sum_probs=142.9

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-C----CCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeeccc-ccCC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-D----GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSS-VDYE  228 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~  228 (477)
                      ..++|+..+.||+|+||.||+|+.. +    +..||+|.++.....  +.+..+  .+.+..+.++..++..+.. ....
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            5678999999999999999999975 4    689999987643221  111111  1222222333322221111 1114


Q ss_pred             CCceeeEEEeecCCCChhhhcccCCCcc-------------cccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCC
Q 043902          229 GNDFKALVFEFMRNGNLDQWLHPSTDEY-------------CHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLK  295 (477)
Q Consensus       229 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk  295 (477)
                      .....++|+||+++++|.+++......+             ..........+..++.|++.||.|||++   +|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence            5667899999999999999987542100             0001122344567999999999999999   99999999


Q ss_pred             CCCeEecC-CCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cC----------------------CC
Q 043902          296 SSNVLLDE-GMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NG----------------------HV  351 (477)
Q Consensus       296 p~NIll~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~----------------------~~  351 (477)
                      |+|||++. ++.+||+|||+++.+...      .........+++.|+|||.+ ..                      .+
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~------~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~  356 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVG------INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL  356 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccc------cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence            99999985 579999999999765221      11223345688999999965 11                      13


Q ss_pred             CcccceeehHHHHHHHhhCCCCCC
Q 043902          352 SILGDIYSYGILLLEIFTGKRPTD  375 (477)
Q Consensus       352 ~~~~Dv~S~Gvvl~elltg~~p~~  375 (477)
                      +.++|||||||++|||+++..|++
T Consensus       357 ~~k~DVwSlGviL~el~~~~~~~~  380 (566)
T PLN03225        357 PDRFDIYSAGLIFLQMAFPNLRSD  380 (566)
T ss_pred             CCCcccHHHHHHHHHHHhCcCCCc
Confidence            456799999999999999877654

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-33  Score=280.87  Aligned_cols=263  Identities=24%  Similarity=0.327  Sum_probs=211.4

Q ss_pred             HHHHHHhhcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeeccchhhHHHHHHHHHHhcC-CCCCcceeeeeccccc
Q 043902          149 YLKISNATDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSI-RHRNILKIVSSCSSVD  226 (477)
Q Consensus       149 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  226 (477)
                      +..+.+.++.|++.++||.|.+|.||+++. ++++.+|+|++....... ++...|.++++.. .|||++.++|++...+
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            344556678899999999999999999985 579999999988665443 6778889998887 6999999999988777


Q ss_pred             CCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCc
Q 043902          227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI  306 (477)
Q Consensus       227 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~  306 (477)
                      ...++.++||||||.+||..++++...     ...+.|..+..|+..++.|+.+||.+   .++|||||-.|||++.++.
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-----g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~  161 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-----GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAE  161 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhc-----ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCc
Confidence            778899999999999999999998664     36799999999999999999999999   9999999999999999999


Q ss_pred             EEEecccccccccccCCCCCCCccccCCCcccccccCccccc--C----CCCcccceeehHHHHHHHhhCCCCCCccccc
Q 043902          307 AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--G----HVSILGDIYSYGILLLEIFTGKRPTDDMFKD  380 (477)
Q Consensus       307 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~----~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~  380 (477)
                      +||.|||.+..+.       ..........||+.|||||++.  .    .|+..+|+||+|++..||--|.+|+-++..-
T Consensus       162 VKLvDFGvSaQld-------sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm  234 (953)
T KOG0587|consen  162 VKLVDFGVSAQLD-------STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM  234 (953)
T ss_pred             EEEeeeeeeeeee-------cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh
Confidence            9999999998762       2344456678999999999982  1    3788999999999999999999998765322


Q ss_pred             ccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHH
Q 043902          381 DLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKF  460 (477)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e  460 (477)
                      ..-+ .     +|..    ..+.+.                          .++.-.+++.+++..||..|-.+||++.+
T Consensus       235 raLF-~-----IpRN----PPPkLk--------------------------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~  278 (953)
T KOG0587|consen  235 RALF-L-----IPRN----PPPKLK--------------------------RPKKWSKKFNDFISTCLVKDYEQRPSTEE  278 (953)
T ss_pred             hhhc-c-----CCCC----CCcccc--------------------------chhhHHHHHHHHHHHHHhhccccCcchhh
Confidence            1000 0     0000    000000                          01111455889999999999999999999


Q ss_pred             HHH
Q 043902          461 VVN  463 (477)
Q Consensus       461 vl~  463 (477)
                      +++
T Consensus       279 ll~  281 (953)
T KOG0587|consen  279 LLK  281 (953)
T ss_pred             hcc
Confidence            874

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-34  Score=261.53  Aligned_cols=202  Identities=26%  Similarity=0.373  Sum_probs=171.7

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec---cchhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ---QQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~  230 (477)
                      ..+|..+.+||+|+||.|.+|..+ +.+.+|||+++..   +.+..+--+.|-++|+-- +-|.++++..+     +++.
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc-----FQTm  422 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC-----FQTM  422 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH-----hhhh
Confidence            357888999999999999999865 5678999999854   344455667787888766 56788888776     5778


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +.+|+||||+.||+|--.+++-       ..+.+..+.-++.+||-||-+||++   +|+.||||.+||++|.+|++||+
T Consensus       423 DRLyFVMEyvnGGDLMyhiQQ~-------GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~  492 (683)
T KOG0696|consen  423 DRLYFVMEYVNGGDLMYHIQQV-------GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIA  492 (683)
T ss_pred             hheeeEEEEecCchhhhHHHHh-------cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEee
Confidence            8999999999999998888754       5577888999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccc
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFK  379 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~  379 (477)
                      |||+++.-.       ..........||+.|+|||++ ...|+..+|+|||||+||||+.|++||+...+
T Consensus       493 DFGmcKEni-------~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE  555 (683)
T KOG0696|consen  493 DFGMCKENI-------FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE  555 (683)
T ss_pred             ecccccccc-------cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence            999997531       133445567899999999999 77899999999999999999999999987543

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-34  Score=268.02  Aligned_cols=193  Identities=27%  Similarity=0.473  Sum_probs=164.0

Q ss_pred             CCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEe
Q 043902          162 ENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFE  238 (477)
Q Consensus       162 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  238 (477)
                      .++||+|.||+||-|..+ +|+.||||++.+..  .....++.+|+.+|+++.||.||.+...|     ++.+..++|||
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~ervFVVME  643 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPERVFVVME  643 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCceEEEEeh
Confidence            478999999999999864 89999999997442  23337789999999999999999998774     78889999999


Q ss_pred             ecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC---CcEEEeccccc
Q 043902          239 FMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG---MIAHVGDFGLA  315 (477)
Q Consensus       239 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~DfG~a  315 (477)
                      -+.|.=|+-.|....      .++++..-..+..||+.||.|||.+   +|+|+||||+|||+.+.   -.+||+|||+|
T Consensus       644 Kl~GDMLEMILSsEk------gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfA  714 (888)
T KOG4236|consen  644 KLHGDMLEMILSSEK------GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFA  714 (888)
T ss_pred             hhcchHHHHHHHhhc------ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccce
Confidence            996544555555443      5688888888999999999999999   99999999999999643   37999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      +++.+        .......+||+.|.|||++ +..|...-|+||.||++|--++|..||..
T Consensus       715 RiIgE--------ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE  768 (888)
T KOG4236|consen  715 RIIGE--------KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE  768 (888)
T ss_pred             eecch--------hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence            98843        3344567899999999999 55689999999999999999999999965

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.5e-32  Score=274.46  Aligned_cols=213  Identities=22%  Similarity=0.288  Sum_probs=156.1

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEe-----------------CCCCEEEEEEeeeccchhhHHH--------------HHH
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTL-----------------ADGETAAIKVLKLQQQGALKSF--------------IDE  203 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~e  203 (477)
                      ..++|++.++||+|+||.||+|..                 .+++.||||.++.......++|              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            367899999999999999999963                 2456899999876543333333              346


Q ss_pred             HHHHhcCCCCCc-----ceeeeeccccc---CCCCceeeEEEeecCCCChhhhcccCCCcc-----------------cc
Q 043902          204 CNALTSIRHRNI-----LKIVSSCSSVD---YEGNDFKALVFEFMRNGNLDQWLHPSTDEY-----------------CH  258 (477)
Q Consensus       204 ~~~l~~l~h~ni-----v~l~~~~~~~~---~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-----------------~~  258 (477)
                      +.++.+++|.++     ++++++|....   ....+..++||||+++++|.++++......                 ..
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            677777766554     67778765321   112456899999999999999997532110                 01


Q ss_pred             cccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCccc
Q 043902          259 FKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS  338 (477)
Q Consensus       259 ~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt  338 (477)
                      ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++......      .........++
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~------~~~~~~~g~~t  373 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG------INFNPLYGMLD  373 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccC------CccCccccCCC
Confidence            13457788999999999999999998   9999999999999999999999999999754221      01111122347


Q ss_pred             ccccCcccccC-C----------------------CCcccceeehHHHHHHHhhCCC-CCCc
Q 043902          339 VGYIPPEYING-H----------------------VSILGDIYSYGILLLEIFTGKR-PTDD  376 (477)
Q Consensus       339 ~~y~aPE~~~~-~----------------------~~~~~Dv~S~Gvvl~elltg~~-p~~~  376 (477)
                      +.|+|||.+.. .                      ...+.||||+||++|+|++|.. |+..
T Consensus       374 p~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~  435 (507)
T PLN03224        374 PRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN  435 (507)
T ss_pred             cceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence            89999998732 1                      1134799999999999999875 6643

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-33  Score=273.40  Aligned_cols=239  Identities=23%  Similarity=0.276  Sum_probs=185.6

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCCce
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .++.|.....+|.|+|+.|-.+... +++..++|++....    .+-.+|+.++... .||||+++.+.|     .+..+
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~  390 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKE  390 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeeccee-----cCCce
Confidence            3677888888999999999998754 78899999998652    2334577666655 799999999995     67888


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEe-cCCCcEEEec
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL-DEGMIAHVGD  311 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll-~~~~~~kl~D  311 (477)
                      .++|||.+.++-+.+.+....        .....+..|+.+|+.|+.|||++   |++||||||+|||+ ++.++++|+|
T Consensus       391 ~~~v~e~l~g~ell~ri~~~~--------~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrlty  459 (612)
T KOG0603|consen  391 IYLVMELLDGGELLRRIRSKP--------EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTY  459 (612)
T ss_pred             eeeeehhccccHHHHHHHhcc--------hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEE
Confidence            999999999988877665432        23367778999999999999999   99999999999999 6999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      ||.++.....          ....+-|..|.|||++ ...+++++|+||||++||+|++|+.||.....+ ..+.     
T Consensus       460 FG~a~~~~~~----------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~-----  523 (612)
T KOG0603|consen  460 FGFWSELERS----------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIH-----  523 (612)
T ss_pred             echhhhCchh----------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHH-----
Confidence            9999876221          2233568899999999 456999999999999999999999999764322 1110     


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                             ..+..   ..                        +.+.......+|+.+||+.||.+||+|.++..
T Consensus       524 -------~~i~~---~~------------------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  524 -------TRIQM---PK------------------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             -------HhhcC---Cc------------------------cccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence                   00000   00                        00112334788999999999999999999864

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=3e-32  Score=252.12  Aligned_cols=237  Identities=27%  Similarity=0.344  Sum_probs=186.2

Q ss_pred             ccceEEEEEeC-CCCEEEEEEeeeccchh-hHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEeecCCCChh
Q 043902          169 SFGSVYKGTLA-DGETAAIKVLKLQQQGA-LKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLD  246 (477)
Q Consensus       169 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~  246 (477)
                      +||.||+|... +|+.+++|++....... .+.+.+|++.+++++|+|++++++++     ......++++||+++++|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVF-----EDEDKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhhe-----eeCCEEEEEEeCCCCCCHH
Confidence            58999999986 58999999998655433 68899999999999999999999986     3456789999999999999


Q ss_pred             hhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccccccCCCCC
Q 043902          247 QWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS  326 (477)
Q Consensus       247 ~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  326 (477)
                      +++....       .+++..++.++.+++.++.|||+.   +++|+||+|+||++++++.++|+|||.+.......    
T Consensus        76 ~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----  141 (244)
T smart00220       76 DLLKKRG-------RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----  141 (244)
T ss_pred             HHHHhcc-------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc----
Confidence            9987542       288999999999999999999999   99999999999999999999999999998763211    


Q ss_pred             CCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCchhHHHhhhhhh
Q 043902          327 KNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSML  405 (477)
Q Consensus       327 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  405 (477)
                          ......++..|+|||.. ...++.++||||||+++|++++|..||.......             ...+.+.....
T Consensus       142 ----~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-------------~~~~~~~~~~~  204 (244)
T smart00220      142 ----LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-------------ELFKKIGKPKP  204 (244)
T ss_pred             ----ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-------------HHHHHHhccCC
Confidence                23345578889999998 5678899999999999999999999986521110             11111110000


Q ss_pred             hhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          406 LEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       406 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      ..        ...              .......+.+++.+|+..+|++||++.++++
T Consensus       205 ~~--------~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      205 PF--------PPP--------------EWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             CC--------ccc--------------cccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            00        000              0001344889999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.98  E-value=3.3e-33  Score=277.71  Aligned_cols=246  Identities=24%  Similarity=0.368  Sum_probs=183.6

Q ss_pred             CCCCCeeeeeccc-eEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCCceeeEE
Q 043902          159 FSEENLIGSGSFG-SVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGNDFKALV  236 (477)
Q Consensus       159 ~~~~~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv  236 (477)
                      |...+++|.|+.| .||+|.+ +|+.||||++-....   ....+|+..|+.- +|||||++++.     ..+..+.|+.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YIa  581 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYIA  581 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEEE
Confidence            3344678999988 5799999 689999998864332   3557899999988 69999999977     4678899999


Q ss_pred             EeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC-----CCcEEEec
Q 043902          237 FEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE-----GMIAHVGD  311 (477)
Q Consensus       237 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-----~~~~kl~D  311 (477)
                      .|.|. -+|.+++.....+.   ........+.+..|+++||++||+.   +||||||||.||||+.     ...++|+|
T Consensus       582 lELC~-~sL~dlie~~~~d~---~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSD  654 (903)
T KOG1027|consen  582 LELCA-CSLQDLIESSGLDV---EMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISD  654 (903)
T ss_pred             ehHhh-hhHHHHHhccccch---hhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecc
Confidence            99994 59999998742111   1112245577889999999999998   9999999999999975     25899999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeee
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~  389 (477)
                      ||+++.+.....    ......+..||-+|+|||++ ...-+.++||||+||++|..+| |..||.+....+.++..-..
T Consensus       655 fglsKkl~~~~s----S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~  730 (903)
T KOG1027|consen  655 FGLSKKLAGGKS----SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNY  730 (903)
T ss_pred             cccccccCCCcc----hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCcc
Confidence            999998743221    12225567899999999999 5556779999999999999999 59999875433322111000


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVV  462 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl  462 (477)
                      .        +.                            ..+...+|  ...+|+.+|++++|..||++.+|+
T Consensus       731 ~--------L~----------------------------~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  731 T--------LV----------------------------HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             c--------ee----------------------------eeccCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence            0        00                            00000111  367899999999999999999998

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=251.76  Aligned_cols=135  Identities=27%  Similarity=0.435  Sum_probs=116.6

Q ss_pred             cCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeeccchhhHHHHHHHHHHhcCC-----C---CCcceeeeecccccC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIR-----H---RNILKIVSSCSSVDY  227 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~~~~  227 (477)
                      .+|.+.++||.|.|++||++.. .+.+.||+|+.+.... ..+..+.|+++|++++     |   ..||+|++++.... 
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG-  155 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG-  155 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC-
Confidence            6888999999999999999985 4678999999986543 3467889999999984     3   36999999976543 


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEe
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL  301 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll  301 (477)
                      .++.++|+|+|+. |-+|..++...     .++.++...+.+|+.||+.||.|||..|  +|+|-||||+|||+
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s-----~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYS-----NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHh-----CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence            6788999999999 77999998765     3477999999999999999999999998  99999999999999

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-32  Score=231.36  Aligned_cols=205  Identities=21%  Similarity=0.318  Sum_probs=164.5

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeec-cchhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCCc
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQ-QQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~  231 (477)
                      ..+.......||+|++|.|-+-++ .+|...|+|.++.. .....++.++|+.+..+. .+|.+|.++|..     ....
T Consensus        44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~-----~reg  118 (282)
T KOG0984|consen   44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGAL-----FREG  118 (282)
T ss_pred             chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhh-----hccc
Confidence            344555667899999999988875 48999999999854 234457788899887665 689999999974     5566


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++.||.| ..||+.+-.+--   .....+++..+-+|+..+.+||.|||++  ..++|||+||+|||++.+|++||||
T Consensus       119 dvwIcME~M-~tSldkfy~~v~---~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCD  192 (282)
T KOG0984|consen  119 DVWICMELM-DTSLDKFYRKVL---KKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICD  192 (282)
T ss_pred             cEEEeHHHh-hhhHHHHHHHHH---hcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcc
Confidence            789999999 448877654321   1236788999999999999999999997  4899999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccccC-----CCCcccceeehHHHHHHHhhCCCCCCccc
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-----HVSILGDIYSYGILLLEIFTGKRPTDDMF  378 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~Dv~S~Gvvl~elltg~~p~~~~~  378 (477)
                      ||.+-.+.+        ....+...|-..|+|||.+..     .|+.|+||||+|+++.||.+++.||+...
T Consensus       193 FGIsG~L~d--------SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  193 FGISGYLVD--------SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             cccceeehh--------hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            999987632        111222456678999999832     48899999999999999999999997643

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-32  Score=259.15  Aligned_cols=198  Identities=26%  Similarity=0.365  Sum_probs=171.2

Q ss_pred             cCCCCCCeeeeeccceEEEEEeCCCC-EEEEEEeeec---cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVLKLQ---QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .++..+..||-|+||.|-++..+... .+|+|+++..   .....+....|-.+|..++.|.||+++..     |.+..+
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-----frd~ky  494 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-----FRDSKY  494 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-----hccchh
Confidence            45556678999999999999876433 4888888743   33444677889999999999999999987     578889


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .|+.||-|-||.|...|+.+       ..++.....-++..+++|+.|||++   +||.|||||+|.++|.+|.+||.||
T Consensus       495 vYmLmEaClGGElWTiLrdR-------g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDF  564 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTILRDR-------GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDF  564 (732)
T ss_pred             hhhhHHhhcCchhhhhhhhc-------CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeeh
Confidence            99999999999999999866       5688888889999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      |+|+.+.        .......++||+.|.|||++ +...+.++|.||+|+++|||+||++||...
T Consensus       565 GFAKki~--------~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~  622 (732)
T KOG0614|consen  565 GFAKKIG--------SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV  622 (732)
T ss_pred             hhHHHhc--------cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence            9999873        23445667899999999998 556789999999999999999999999763

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=3.5e-32  Score=231.97  Aligned_cols=275  Identities=21%  Similarity=0.302  Sum_probs=196.4

Q ss_pred             hhcCCCCCCeeeeeccceEEEEE-eCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCC-CCCcceeeeecccccCCCCce
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIR-HRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ..++|++.+.+|+|.|+.||.|. ..+.+.++||+++.-..   +.+.+|+++|..++ ||||+++++...+   .....
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~D---p~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKD---PESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcC---ccccC
Confidence            35788899999999999999998 45788999999985533   67889999999997 9999999998643   44566


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC-CcEEEec
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG-MIAHVGD  311 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~D  311 (477)
                      ..+|+||+.+.+...+-          +.++...+..++.+++.||.|+|+.   ||.|||+||.|+++|.. -..+|+|
T Consensus       110 paLiFE~v~n~Dfk~ly----------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlID  176 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLY----------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLID  176 (338)
T ss_pred             chhHhhhhccccHHHHh----------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeee
Confidence            78999999998877654          4578888999999999999999999   99999999999999954 4799999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc--cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      +|+|.++.+.        ...+..+.+..|.-||.+  -..++..-|+|||||++..|+..+.||.........+.+.+.
T Consensus       177 WGLAEFYHp~--------~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIak  248 (338)
T KOG0668|consen  177 WGLAEFYHPG--------KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAK  248 (338)
T ss_pred             cchHhhcCCC--------ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHH
Confidence            9999987432        122334567778999999  456899999999999999999999998654333222332222


Q ss_pred             ccCCchhHHHhhhhhh-hhh--cc---cccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          390 MALPSHVMDVLDLSML-LEE--EN---DHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~-~~~--~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      ..-.+.+...++.--. .++  ..   ...+...+...+.-.....       ..+.++++...|.+|-++|||++|...
T Consensus       249 VLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~-------~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  249 VLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLV-------SPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccC-------ChHHHHHHHHHHhhccccccchHHHhc
Confidence            2111222222221100 000  00   0111111111110000000       133778888999999999999999875

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1e-32  Score=241.10  Aligned_cols=200  Identities=25%  Similarity=0.334  Sum_probs=162.6

Q ss_pred             CCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec--cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEE
Q 043902          160 SEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALV  236 (477)
Q Consensus       160 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  236 (477)
                      +..+.||.|+||.||.++.. +|+.||+|.+..-  +-...+.+.+|+++|.-++|.|++..++........--.+.|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            45578999999999999864 8999999988633  23344788999999999999999999887433222222457889


Q ss_pred             EeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccc
Q 043902          237 FEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK  316 (477)
Q Consensus       237 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  316 (477)
                      +|.| ..+|...+-..       ..++...+.-+..||++||+|||+.   +|.||||||.|.|++.+...||+|||+++
T Consensus       136 TELm-QSDLHKIIVSP-------Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLAR  204 (449)
T KOG0664|consen  136 TELM-QSDLHKIIVSP-------QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLAR  204 (449)
T ss_pred             HHHH-HhhhhheeccC-------CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccc
Confidence            9999 45888887643       6688889999999999999999999   99999999999999999999999999998


Q ss_pred             cccccCCCCCCCccccCCCcccccccCcccccC--CCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          317 FLFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ....+      .....+..+-|..|+|||.+.|  .|+.+.||||.||++.|++.++..|..
T Consensus       205 vee~d------~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA  260 (449)
T KOG0664|consen  205 TWDQR------DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA  260 (449)
T ss_pred             ccchh------hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence            65221      2223334456889999999944  699999999999999999988877754

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.7e-31  Score=237.49  Aligned_cols=199  Identities=24%  Similarity=0.384  Sum_probs=170.2

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec---cchhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ---QQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~  230 (477)
                      .++|....+||+|+|+.|..+++. +.+.+|+|+++.+   ......-...|-.+..+. +||.+|-+..+     ++++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc-----fqte  323 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC-----FQTE  323 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-----hccc
Confidence            368889999999999999999865 6889999999854   233344456666666665 79999999887     5788


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ..+++|.||++||+|--+++..       ..+++..+..+...|+-||.|||++   ||+.||||.+|||+|..|++||+
T Consensus       324 srlffvieyv~ggdlmfhmqrq-------rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghiklt  393 (593)
T KOG0695|consen  324 SRLFFVIEYVNGGDLMFHMQRQ-------RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLT  393 (593)
T ss_pred             ceEEEEEEEecCcceeeehhhh-------hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeec
Confidence            8999999999999998887755       4689999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccccC-CCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |+|+++.-.       ..........||+.|+|||.+.| .|+...|+|++||+++||+.|+.||+-
T Consensus       394 dygmcke~l-------~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi  453 (593)
T KOG0695|consen  394 DYGMCKEGL-------GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI  453 (593)
T ss_pred             ccchhhcCC-------CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence            999997542       12334556789999999999955 699999999999999999999999975

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=9e-31  Score=252.34  Aligned_cols=207  Identities=21%  Similarity=0.337  Sum_probs=169.2

Q ss_pred             cCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .-|..++.||-|+||.|.+++. .+...+|.|.++..+   .........|-++|..-..+-||+|+-.     |.+.+.
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS-----FQDkdn  703 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS-----FQDKDN  703 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE-----eccCCc
Confidence            4577788999999999999974 456789999987543   2334566789999999999999999876     588899


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      +|+||||++||++-.+|-..       .-+.+..+..++.++..|+++.|..   |+|||||||+|||||.+|++||+||
T Consensus       704 LYFVMdYIPGGDmMSLLIrm-------gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDF  773 (1034)
T KOG0608|consen  704 LYFVMDYIPGGDMMSLLIRM-------GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDF  773 (1034)
T ss_pred             eEEEEeccCCccHHHHHHHh-------ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeec
Confidence            99999999999999988654       4577888888999999999999999   9999999999999999999999999


Q ss_pred             cccccccc--------cCCCCCC---------------------------CccccCCCcccccccCcccc-cCCCCcccc
Q 043902          313 GLAKFLFE--------ESNTPSK---------------------------NQTMSNGLKGSVGYIPPEYI-NGHVSILGD  356 (477)
Q Consensus       313 G~a~~~~~--------~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~-~~~~~~~~D  356 (477)
                      |++.-+..        ...+...                           ........+||..|+|||++ ...++..+|
T Consensus       774 GLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cd  853 (1034)
T KOG0608|consen  774 GLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCD  853 (1034)
T ss_pred             cccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccch
Confidence            99854321        1100000                           00112346799999999999 667999999


Q ss_pred             eeehHHHHHHHhhCCCCCCccc
Q 043902          357 IYSYGILLLEIFTGKRPTDDMF  378 (477)
Q Consensus       357 v~S~Gvvl~elltg~~p~~~~~  378 (477)
                      +||.||+||||+.|+.||-...
T Consensus       854 wws~gvil~em~~g~~pf~~~t  875 (1034)
T KOG0608|consen  854 WWSVGVILYEMLVGQPPFLADT  875 (1034)
T ss_pred             hhHhhHHHHHHhhCCCCccCCC
Confidence            9999999999999999997643

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=8.4e-31  Score=250.39  Aligned_cols=196  Identities=25%  Similarity=0.411  Sum_probs=167.7

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--------chhhHHHHHHHHHHhcCC---CCCcceeeeeccc
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--------QGALKSFIDECNALTSIR---HRNILKIVSSCSS  224 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~  224 (477)
                      .+|+..+.+|+|+||.|+.|.++ +...|+||.+.+++        .......-.|+++|..++   |+||++++++   
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf---  637 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF---  637 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe---
Confidence            56888999999999999999976 46678999886542        112233456999999997   9999999999   


Q ss_pred             ccCCCCceeeEEEeec-CCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC
Q 043902          225 VDYEGNDFKALVFEFM-RNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE  303 (477)
Q Consensus       225 ~~~~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~  303 (477)
                        |+++++.|++||-. ++-+|.+++.-.       ..+++.+...|+.||+.|+++||++   +|||||||-+||.++.
T Consensus       638 --FEddd~yyl~te~hg~gIDLFd~IE~k-------p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~  705 (772)
T KOG1152|consen  638 --FEDDDYYYLETEVHGEGIDLFDFIEFK-------PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDS  705 (772)
T ss_pred             --eecCCeeEEEecCCCCCcchhhhhhcc-------CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEec
Confidence              58899999999965 456899999755       5699999999999999999999999   9999999999999999


Q ss_pred             CCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccccCC--CCcccceeehHHHHHHHhhCCCCCCc
Q 043902          304 GMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH--VSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       304 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      +|-+||+|||.|...         .......++||..|.|||++.|.  .+..-|||++|++||.++....||..
T Consensus       706 ~g~~klidfgsaa~~---------ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  706 NGFVKLIDFGSAAYT---------KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             CCeEEEeeccchhhh---------cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            999999999999764         34455667899999999999653  47788999999999999999999853

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-30  Score=226.95  Aligned_cols=261  Identities=20%  Similarity=0.300  Sum_probs=194.3

Q ss_pred             HHhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCC
Q 043902          153 SNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       153 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~  230 (477)
                      ....+.|.+.+.||+|.||.+.+++++ +.+.+++|.+...... ..+|.+|...--.| .|.||+.-+++.    ++..
T Consensus        20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt-~~dF~rEfhY~~~Ls~H~hIi~tY~va----Fqt~   94 (378)
T KOG1345|consen   20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT-QADFVREFHYSFFLSPHQHIIDTYEVA----FQTS   94 (378)
T ss_pred             cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh-HHHHHHHhccceeeccchhhhHHHHHH----hhcC
Confidence            345678999999999999999999976 5778999988765433 47899998776666 489999888765    5778


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec--CCCcEE
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD--EGMIAH  308 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~--~~~~~k  308 (477)
                      +..++++||++.|+|.+-+...        .+.+....+++.|+++|+.|+|+.   ++||||||.+||||-  +...+|
T Consensus        95 d~YvF~qE~aP~gdL~snv~~~--------GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvK  163 (378)
T KOG1345|consen   95 DAYVFVQEFAPRGDLRSNVEAA--------GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVK  163 (378)
T ss_pred             ceEEEeeccCccchhhhhcCcc--------cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEE
Confidence            8899999999999999887653        478888899999999999999999   999999999999993  445899


Q ss_pred             EecccccccccccCCCCCCCccccCCCcccccccCcccc----cC--CCCcccceeehHHHHHHHhhCCCCCCccccccc
Q 043902          309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI----NG--HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDL  382 (477)
Q Consensus       309 l~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~  382 (477)
                      |+|||+++..          ........-+..|.|||..    ++  ...+.+|||.||++++.++||..||......+.
T Consensus       164 lcDFG~t~k~----------g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~  233 (378)
T KOG1345|consen  164 LCDFGLTRKV----------GTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK  233 (378)
T ss_pred             eeeccccccc----------CceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc
Confidence            9999998754          1222233446679999987    23  357889999999999999999999975443333


Q ss_pred             ceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHH
Q 043902          383 SIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVV  462 (477)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl  462 (477)
                      .+..|..         +.....                 +.+     ++........++++.++-+..+|++|--..++.
T Consensus       234 ~Y~~~~~---------w~~rk~-----------------~~~-----P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~k  282 (378)
T KOG1345|consen  234 PYWEWEQ---------WLKRKN-----------------PAL-----PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAK  282 (378)
T ss_pred             hHHHHHH---------HhcccC-----------------ccC-----chhhcccCHHHHHHHHHhcCCcccccchhHHHH
Confidence            3332221         110000                 000     011111234478888899999999997777776


Q ss_pred             HHHHHHHH
Q 043902          463 NNLQAIRS  470 (477)
Q Consensus       463 ~~L~~i~~  470 (477)
                      ++-.....
T Consensus       283 k~rk~~w~  290 (378)
T KOG1345|consen  283 KMRKCLWK  290 (378)
T ss_pred             HHHHHHHH
Confidence            66555443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=7.7e-31  Score=254.58  Aligned_cols=254  Identities=24%  Similarity=0.346  Sum_probs=201.8

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      +..++|+..+.+|.|.||.||+++.. .++..|+|+++........-..+|+-++...+||||+.++|.+     -..+.
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsy-----lr~dk   86 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSY-----LRRDK   86 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhh-----hhhcC
Confidence            34578889999999999999999964 7999999999988877778888999999999999999999984     56778


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++.|||+.+|+|++.-+..       ..+++.++...++...+||+|||+.   +-+|||||-.||++++.+.+|++||
T Consensus        87 lwicMEycgggslQdiy~~T-------gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDf  156 (829)
T KOG0576|consen   87 LWICMEYCGGGSLQDIYHVT-------GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADF  156 (829)
T ss_pred             cEEEEEecCCCcccceeeec-------ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeeccc
Confidence            99999999999999977643       6799999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc----cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeee
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI----NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~  388 (477)
                      |.+-.+.       ..-.....+.||+.|||||+.    .|.|..++|||+.|++..|+---++|-.+...         
T Consensus       157 gvsaqit-------ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp---------  220 (829)
T KOG0576|consen  157 GVSAQIT-------ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP---------  220 (829)
T ss_pred             Cchhhhh-------hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch---------
Confidence            9987652       123445678899999999997    46799999999999999999887777433211         


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                           -+...++....-...    ...+..             ..   ...+-++++.|+..+|.+|||++..+.
T Consensus       221 -----mr~l~LmTkS~~qpp----~lkDk~-------------kw---s~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  221 -----MRALFLMTKSGFQPP----TLKDKT-------------KW---SEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             -----HHHHHHhhccCCCCC----cccCCc-------------cc---hHHHHHHHHHHhcCCCccCCChhhhee
Confidence                 111111111110000    000000             00   223678999999999999999987764

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=1.1e-28  Score=222.88  Aligned_cols=209  Identities=31%  Similarity=0.524  Sum_probs=177.5

Q ss_pred             eeeeccceEEEEEeCC-CCEEEEEEeeeccch-hhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEeecCC
Q 043902          165 IGSGSFGSVYKGTLAD-GETAAIKVLKLQQQG-ALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRN  242 (477)
Q Consensus       165 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~  242 (477)
                      ||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++     ......++++||+++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF-----EDENHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeee-----ecCCeEEEEEecCCC
Confidence            6899999999999764 899999999866432 346789999999999999999999985     344778999999999


Q ss_pred             CChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC-CCcEEEeccccccccccc
Q 043902          243 GNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE-GMIAHVGDFGLAKFLFEE  321 (477)
Q Consensus       243 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~DfG~a~~~~~~  321 (477)
                      ++|.+++....      ..+++..++.++.++++++.+||+.   +++|+||+|.||+++. ++.++|+|||.+......
T Consensus        76 ~~l~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~  146 (215)
T cd00180          76 GSLKDLLKENE------GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD  146 (215)
T ss_pred             CcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence            99999987542      3588999999999999999999999   9999999999999999 899999999999865221


Q ss_pred             CCCCCCCccccCCCcccccccCcccccC--CCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCchhHHH
Q 043902          322 SNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDV  399 (477)
Q Consensus       322 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (477)
                      ..       ......+...|++||....  ..+.++|+|++|+++++|                                
T Consensus       147 ~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------  187 (215)
T cd00180         147 KS-------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------  187 (215)
T ss_pred             cc-------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------
Confidence            10       1233457788999999944  788999999999999999                                


Q ss_pred             hhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          400 LDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       400 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                            .                                .+.+++..|++.+|++||++.++++.
T Consensus       188 ------~--------------------------------~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ------P--------------------------------ELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ------H--------------------------------HHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                  0                                16789999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=3.2e-30  Score=230.55  Aligned_cols=199  Identities=26%  Similarity=0.269  Sum_probs=161.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec--cchhhHHHHHHHHHHhcCCCCCcceeeeecccccC-CCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDY-EGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~  231 (477)
                      ..+|...+.+|.|.- .|..+... .++.||+|.+...  .....++..+|...+..++|+|+++++.++..... +.-.
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            356777788888888 66666543 6889999987643  23344678899999999999999999998754221 1234


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..|+|||+| .++|...+..         .++-..+..|..|++.|++|||+.   +|+||||||+||++..+..+||.|
T Consensus        95 e~y~v~e~m-~~nl~~vi~~---------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~d  161 (369)
T KOG0665|consen   95 EVYLVMELM-DANLCQVILM---------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILD  161 (369)
T ss_pred             hHHHHHHhh-hhHHHHHHHH---------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeecc
Confidence            578999999 5699888872         366778889999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ||+|+.-.        .....+..+.|..|+|||++ ...+.+.+||||.||++.||++|+..|.+
T Consensus       162 fg~ar~e~--------~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g  219 (369)
T KOG0665|consen  162 FGLARTED--------TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG  219 (369)
T ss_pred             chhhcccC--------cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC
Confidence            99998641        12345667889999999999 44599999999999999999999998864

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=1.1e-29  Score=239.80  Aligned_cols=285  Identities=21%  Similarity=0.269  Sum_probs=202.1

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCC------CCCcceeeeecccccC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIR------HRNILKIVSSCSSVDY  227 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~~~~  227 (477)
                      ...+|.+....|+|-|++|.+|... .|..||||++...... .+.=+.|+++|++|+      --|+++++..     |
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~-----F  503 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRH-----F  503 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHH-----h
Confidence            3467888889999999999999865 5789999999865432 356678999999995      3478888877     4


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC-Cc
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG-MI  306 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~  306 (477)
                      ...+++|||+|-+ ..+|.++|+.-..    ...+....+..++.|+.-||..|...   +|+|.||||+||||++. ..
T Consensus       504 ~hknHLClVFE~L-slNLRevLKKyG~----nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~i  575 (752)
T KOG0670|consen  504 KHKNHLCLVFEPL-SLNLREVLKKYGR----NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNI  575 (752)
T ss_pred             hhcceeEEEehhh-hchHHHHHHHhCc----ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcce
Confidence            6788999999988 5599999986542    25688899999999999999999998   99999999999999865 57


Q ss_pred             EEEecccccccccccCCCCCCCccccCCCcccccccCcccccC-CCCcccceeehHHHHHHHhhCCCCCCccccccc-ce
Q 043902          307 AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDL-SI  384 (477)
Q Consensus       307 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~-~~  384 (477)
                      +||||||.|....+         ...+.+.-+..|.|||++-| .|+...|+||.||+||||.||+..|.+.....+ .+
T Consensus       576 LKLCDfGSA~~~~e---------neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl  646 (752)
T KOG0670|consen  576 LKLCDFGSASFASE---------NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRL  646 (752)
T ss_pred             eeeccCcccccccc---------ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHH
Confidence            89999999977632         11223334667999999954 799999999999999999999999987655433 12


Q ss_pred             eeeeeccCCchh---HHHhh----hhhhhhhcccccccccc------cccc--hhhhH------HHHHHHHHHHHHHHHH
Q 043902          385 HKFVLMALPSHV---MDVLD----LSMLLEEENDHEKHEEE------DLFP--DIESQ------VAQKKLEECLVSVMRI  443 (477)
Q Consensus       385 ~~~~~~~~~~~~---~~~~d----~~~~~~~~~~~~~~~~~------~~~~--~~~~~------~~~~~~~~~~~~l~~l  443 (477)
                      .--+...+|..+   ..+.|    ..+..-..........+      ...|  ++.+.      +..+. ...+.++.+|
T Consensus       647 ~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq-~~~~~~~rdL  725 (752)
T KOG0670|consen  647 FMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQ-PKIVQQLRDL  725 (752)
T ss_pred             HHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchh-HHHHHHHHHH
Confidence            222333344321   12222    22211100000000000      0011  11111      11111 2236678999


Q ss_pred             hhhcCCCCCCCCCChHHHHH
Q 043902          444 GVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       444 ~~~Cl~~dP~~RPs~~evl~  463 (477)
                      +..|+..||++|.|..|+++
T Consensus       726 Ldkml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  726 LDKMLILDPEKRITVNQALK  745 (752)
T ss_pred             HHHHhccChhhcCCHHHHhc
Confidence            99999999999999999875

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=5.6e-28  Score=221.01  Aligned_cols=198  Identities=31%  Similarity=0.512  Sum_probs=167.8

Q ss_pred             CCCCCeeeeeccceEEEEEeCC-CCEEEEEEeeeccch-hhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEE
Q 043902          159 FSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQG-ALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALV  236 (477)
Q Consensus       159 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  236 (477)
                      |+..+.||.|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+.+++|+|++++++++     ......+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVF-----EDPEPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeee-----ecCCceEEE
Confidence            4567889999999999999764 899999999866544 567899999999999999999999985     445678999


Q ss_pred             EeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccc
Q 043902          237 FEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK  316 (477)
Q Consensus       237 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  316 (477)
                      +||+++++|.+++....      ..+++..+..++.+++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+.
T Consensus        76 ~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~  146 (225)
T smart00221       76 MEYCEGGDLFDYLRKKG------GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLAR  146 (225)
T ss_pred             EeccCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceee
Confidence            99999999999987542      1178999999999999999999999   99999999999999999999999999998


Q ss_pred             cccccCCCCCCCccccCCCcccccccCcccc-c-CCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          317 FLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-N-GHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ......      ........++..|++||.. . ..++.++||||||++++||++|+.||..
T Consensus       147 ~~~~~~------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      147 FIHRDL------AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             EecCcc------cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            763221      0022334567889999997 3 3577899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=5e-29  Score=231.13  Aligned_cols=208  Identities=26%  Similarity=0.375  Sum_probs=167.6

Q ss_pred             HHhhcCCCCCCeeeeeccceEEEEEeC----CCCEEEEEEeeeccchhhHHHHHHHHHHhcC-CCCCcceeeeecccccC
Q 043902          153 SNATDNFSEENLIGSGSFGSVYKGTLA----DGETAAIKVLKLQQQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDY  227 (477)
Q Consensus       153 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  227 (477)
                      ....+.|..+++||+|.|++||++...    ..+.||+|.+......  ....+|+++|..+ .+.||+++.++     +
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~-----~  104 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGC-----F  104 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhh-----h
Confidence            334578889999999999999999753    4678999998765443  5688999999999 48999999988     5


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC-CCc
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE-GMI  306 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~  306 (477)
                      ..++...+|+||++.-...++..          .++...+..++..+..||+++|.+   |||||||||+|+|.+. .+.
T Consensus       105 rnnd~v~ivlp~~~H~~f~~l~~----------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~r  171 (418)
T KOG1167|consen  105 RNNDQVAIVLPYFEHDRFRDLYR----------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQR  171 (418)
T ss_pred             ccCCeeEEEecccCccCHHHHHh----------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCC
Confidence            78889999999999998888874          367889999999999999999999   9999999999999974 457


Q ss_pred             EEEecccccccccccC-----C-------CC-------------------------CCCccccCCCcccccccCcccc--
Q 043902          307 AHVGDFGLAKFLFEES-----N-------TP-------------------------SKNQTMSNGLKGSVGYIPPEYI--  347 (477)
Q Consensus       307 ~kl~DfG~a~~~~~~~-----~-------~~-------------------------~~~~~~~~~~~gt~~y~aPE~~--  347 (477)
                      -.|.|||+|.......     .       .+                         ...........||++|+|||++  
T Consensus       172 g~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k  251 (418)
T KOG1167|consen  172 GVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR  251 (418)
T ss_pred             ceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh
Confidence            7899999997321100     0       00                         0001112235699999999999  


Q ss_pred             cCCCCcccceeehHHHHHHHhhCCCCCCccccc
Q 043902          348 NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKD  380 (477)
Q Consensus       348 ~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~  380 (477)
                      .+..++++||||.||+++.+++++.||.....+
T Consensus       252 ~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd  284 (418)
T KOG1167|consen  252 CPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDD  284 (418)
T ss_pred             ccCcCCccceeeccceeehhhccccccccCccc
Confidence            456899999999999999999999998664444

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=1.1e-27  Score=257.91  Aligned_cols=157  Identities=16%  Similarity=0.201  Sum_probs=112.5

Q ss_pred             cCCC-CCcceeeeeccccc--CCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCC
Q 043902          209 SIRH-RNILKIVSSCSSVD--YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQY  285 (477)
Q Consensus       209 ~l~h-~niv~l~~~~~~~~--~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~  285 (477)
                      .++| +||.+++++|....  .......+.++||+ +++|.++|....      ..+++.+++.++.||++||.|||++ 
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~-   99 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD------RSVDAFECFHVFRQIVEIVNAAHSQ-   99 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc------ccccHHHHHHHHHHHHHHHHHHHhC-
Confidence            4456 68888888763221  11234567788887 669999997432      4589999999999999999999999 


Q ss_pred             CCCeeecCCCCCCeEecCCC-------------------cEEEecccccccccccCCCCC---------CCccccCCCcc
Q 043902          286 DTPIAHCDLKSSNVLLDEGM-------------------IAHVGDFGLAKFLFEESNTPS---------KNQTMSNGLKG  337 (477)
Q Consensus       286 ~~~ivH~dlkp~NIll~~~~-------------------~~kl~DfG~a~~~~~~~~~~~---------~~~~~~~~~~g  337 (477)
                        +|+||||||+||||+..+                   .+|++|||+++..........         ..........|
T Consensus       100 --gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g  177 (793)
T PLN00181        100 --GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAME  177 (793)
T ss_pred             --CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCC
Confidence              999999999999996544                   455566666543211000000         00000112457


Q ss_pred             cccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCC
Q 043902          338 SVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTD  375 (477)
Q Consensus       338 t~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~  375 (477)
                      |+.|+|||++ ...++.++|||||||+||||++|..|+.
T Consensus       178 t~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~  216 (793)
T PLN00181        178 MSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE  216 (793)
T ss_pred             CcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence            8899999998 5679999999999999999999988864

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=3.6e-27  Score=207.46  Aligned_cols=169  Identities=21%  Similarity=0.226  Sum_probs=123.8

Q ss_pred             CChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccccccC
Q 043902          243 GNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES  322 (477)
Q Consensus       243 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  322 (477)
                      |+|.+++....      ..+++..++.++.|++.||.|||++   +      ||+||+++.++.+|+  ||++.....  
T Consensus         1 GsL~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~--   61 (176)
T smart00750        1 VSLADILEVRG------RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTP--   61 (176)
T ss_pred             CcHHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecc--
Confidence            68999987542      4699999999999999999999998   5      999999999999999  999976522  


Q ss_pred             CCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCchhHHHhh
Q 043902          323 NTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLD  401 (477)
Q Consensus       323 ~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  401 (477)
                                ....||..|+|||++ .+.++.++|||||||++|||+||+.||.......            ..+..+..
T Consensus        62 ----------~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~------------~~~~~~~~  119 (176)
T smart00750       62 ----------EQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS------------AILEILLN  119 (176)
T ss_pred             ----------ccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc------------HHHHHHHH
Confidence                      112578999999999 5678999999999999999999999986421110            11111111


Q ss_pred             hhhhhhhcccccccccccccchhhhHHHHHHHHHHH--HHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHh
Q 043902          402 LSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECL--VSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSK  471 (477)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  471 (477)
                      ......   .     ...  +         ......  ..+.+++.+|++.+|.+||++.|+++.+..+..+
T Consensus       120 ~~~~~~---~-----~~~--~---------~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      120 GMPADD---P-----RDR--S---------NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             HhccCC---c-----ccc--c---------cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence            100000   0     000  0         000111  2488999999999999999999999998776543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=9.6e-25  Score=209.57  Aligned_cols=170  Identities=21%  Similarity=0.190  Sum_probs=128.8

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEEeC--CCCEEEEEEeeec-----cchhhHHHHHHHHHHhcCCCCCcceeeeeccccc
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGTLA--DGETAAIKVLKLQ-----QQGALKSFIDECNALTSIRHRNILKIVSSCSSVD  226 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  226 (477)
                      ...++|+..+.||+|+||.||+|...  +++.+|||++...     .......|.+|+++|++++|+|+++.+..+    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            44678999999999999999999864  5788899987532     122346789999999999999998543221    


Q ss_pred             CCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCC-CCCCeEecCCC
Q 043902          227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDL-KSSNVLLDEGM  305 (477)
Q Consensus       227 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dl-kp~NIll~~~~  305 (477)
                          +..++||||+++++|... ...          .   ...++.++++||.|||+.   +|+|||| ||+|||++.++
T Consensus        91 ----~~~~LVmE~~~G~~L~~~-~~~----------~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~  149 (365)
T PRK09188         91 ----GKDGLVRGWTEGVPLHLA-RPH----------G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDG  149 (365)
T ss_pred             ----CCcEEEEEccCCCCHHHh-Ccc----------c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCC
Confidence                236999999999999632 110          1   145788999999999999   9999999 99999999999


Q ss_pred             cEEEecccccccccccCCCCCC-CccccCCCcccccccCccccc
Q 043902          306 IAHVGDFGLAKFLFEESNTPSK-NQTMSNGLKGSVGYIPPEYIN  348 (477)
Q Consensus       306 ~~kl~DfG~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~  348 (477)
                      .+||+|||+|+.+......... .........++..|.|||++.
T Consensus       150 ~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        150 EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            9999999999976432111110 011123566888999999983

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.92  E-value=5e-26  Score=199.20  Aligned_cols=248  Identities=22%  Similarity=0.352  Sum_probs=183.3

Q ss_pred             CCCeeeeeccceEEEEEeCCCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEe
Q 043902          161 EENLIGSGSFGSVYKGTLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFE  238 (477)
Q Consensus       161 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  238 (477)
                      ...+|.+...|..|+|+++ |..+++|+++...  ......|..|.-.|..+.||||..++|.|.     ......++..
T Consensus       194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacn-----sppnlv~isq  267 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACN-----SPPNLVIISQ  267 (448)
T ss_pred             hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhcc-----CCCCceEeee
Confidence            3456888999999999995 5667788887543  223367899999999999999999999984     4466889999


Q ss_pred             ecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccc
Q 043902          239 FMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFL  318 (477)
Q Consensus       239 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  318 (477)
                      ||+.|+|+..|+....     -..+..+..+++.++|+|++|||+. .+-|.---|.+..+++|++.+++|+ .+-+++.
T Consensus       268 ~mp~gslynvlhe~t~-----vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kfs  340 (448)
T KOG0195|consen  268 YMPFGSLYNVLHEQTS-----VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFS  340 (448)
T ss_pred             eccchHHHHHHhcCcc-----EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccceee
Confidence            9999999999997753     4577889999999999999999996 4445555789999999999998874 2222211


Q ss_pred             cccCCCCCCCccccCCCcccccccCcccccCC----CCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCc
Q 043902          319 FEESNTPSKNQTMSNGLKGSVGYIPPEYINGH----VSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPS  394 (477)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  394 (477)
                                 ....+..-.+.|++||.+..+    .-.++|+|||++++||+.|...||.+...-+....-.       
T Consensus       341 -----------fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia-------  402 (448)
T KOG0195|consen  341 -----------FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA-------  402 (448)
T ss_pred             -----------eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-------
Confidence                       112233446789999999432    3467899999999999999999997643221110000       


Q ss_pred             hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHH
Q 043902          395 HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIR  469 (477)
Q Consensus       395 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  469 (477)
                                            -|.+.+.+.        ......+.+|+.-|+..||.+||.+..|+-.|++++
T Consensus       403 ----------------------leglrv~ip--------pgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  403 ----------------------LEGLRVHIP--------PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ----------------------hccccccCC--------CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                                  000000010        111234788999999999999999999999998864

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=5.6e-23  Score=198.03  Aligned_cols=267  Identities=19%  Similarity=0.207  Sum_probs=191.6

Q ss_pred             CCCCCCeeeeeccceEEEEEeCCC--CEEEEEEeeeccchhhHHHHHHHHHHhcCCC----CCcceeeeecccccCCCCc
Q 043902          158 NFSEENLIGSGSFGSVYKGTLADG--ETAAIKVLKLQQQGALKSFIDECNALTSIRH----RNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~~~~~~~~~~  231 (477)
                      +|.+.+.||+|+||.||.+.....  ..+|+|............+..|+.++..+..    +++..+++...    ....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            899999999999999999997543  4788888876543322367788888888863    57888887731    3566


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC-----Cc
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG-----MI  306 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-----~~  306 (477)
                      +.++||+.. |.+|.++.....     ...++....+.|+.|++.+|.+||+.   |++||||||+|+.+...     ..
T Consensus        95 ~~~iVM~l~-G~sL~dl~~~~~-----~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~  165 (322)
T KOG1164|consen   95 FNFIVMSLL-GPSLEDLRKRNP-----PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRT  165 (322)
T ss_pred             eeEEEEecc-CccHHHHHHhCC-----CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccce
Confidence            789999988 889999875443     26799999999999999999999999   99999999999999855     46


Q ss_pred             EEEecccccc--cccccCCCC-CCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCccccccc
Q 043902          307 AHVGDFGLAK--FLFEESNTP-SKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDL  382 (477)
Q Consensus       307 ~kl~DfG~a~--~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~  382 (477)
                      +.|.|||+++  .+....... ...........||..|+++... ....+.+.|+||++.++.|++.|..||........
T Consensus       166 ~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~  245 (322)
T KOG1164|consen  166 LYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL  245 (322)
T ss_pred             EEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch
Confidence            9999999998  432221111 1111113456799999999998 45689999999999999999999999855321110


Q ss_pred             ceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHH
Q 043902          383 SIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVV  462 (477)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl  462 (477)
                                   ...+........       ..      .        ....++..+.++...+-..+..++|....+.
T Consensus       246 -------------~~~~~~~~~~~~-------~~------~--------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~  291 (322)
T KOG1164|consen  246 -------------KSKFEKDPRKLL-------TD------R--------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLA  291 (322)
T ss_pred             -------------HHHHHHHhhhhc-------cc------c--------ccCCChHHHHHHHHHhhccCCcCCCCHHHHH
Confidence                         000000000000       00      0        0000123355555556668999999999999


Q ss_pred             HHHHHHHHh
Q 043902          463 NNLQAIRSK  471 (477)
Q Consensus       463 ~~L~~i~~~  471 (477)
                      ..|++....
T Consensus       292 ~~l~~~~~~  300 (322)
T KOG1164|consen  292 ELLKDVFDS  300 (322)
T ss_pred             HHHHHHHHh
Confidence            998877655

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=4.3e-23  Score=177.91  Aligned_cols=206  Identities=23%  Similarity=0.354  Sum_probs=169.9

Q ss_pred             hhcCCCCCCeeeeeccceEEEEE-eCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCC-CCcceeeeecccccCCCCce
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRH-RNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~~~~  232 (477)
                      ..+.|..++.||.|+||.+|.|. ..+|..||||+-+.....  .++.-|.++...+++ ..|..+..+.     .+..+
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~y   85 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYG-----TEKDY   85 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhc-----ccccc
Confidence            35689999999999999999997 568999999987654433  567788888888875 5666666553     56677


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC---CcEEE
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG---MIAHV  309 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl  309 (477)
                      -.+|||.. |.||++++.-..      ..++...++.++-|++.-++|+|.+   +++||||||+|+|..-+   ..+.+
T Consensus        86 nvlVMdLL-GPsLEdLfnfC~------R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~L  155 (341)
T KOG1163|consen   86 NVLVMDLL-GPSLEDLFNFCS------RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYL  155 (341)
T ss_pred             ceeeeecc-CccHHHHHHHHh------hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEE
Confidence            88999998 889999886433      5689999999999999999999999   99999999999999633   46889


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCcccccC-CCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      +|||+|+.+.+................||.+|.+-....| ..+.+.|+=|+|.+|..+--|..||.+.
T Consensus       156 IDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl  224 (341)
T KOG1163|consen  156 IDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL  224 (341)
T ss_pred             EeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence            9999999886655555555666677889999998877743 5788999999999999999999999764

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=8.7e-22  Score=177.44  Aligned_cols=205  Identities=20%  Similarity=0.341  Sum_probs=171.8

Q ss_pred             hcCCCCCCeeeeeccceEEEEE-eCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCC-CCCcceeeeecccccCCCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIR-HRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .-.|.+.++||+|.||.++.|+ +-+++.||||.-...+..  .++..|.+..+.|. .++|..++-+.     ..+.+-
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--PQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~N   99 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--PQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYN   99 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCCc--chHHHHHHHHHHHcCCCCCCceeeec-----cccchh
Confidence            3478999999999999999998 458999999976544332  57778888888884 68888887652     556667


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC-----CcEE
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG-----MIAH  308 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-----~~~k  308 (477)
                      .||+|.. |.||+++..-..      ..++...+..+|.|+..-++|+|++   .+|.|||||+|+||...     ..+.
T Consensus       100 iLVidLL-GPSLEDLFD~Cg------R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~Ih  169 (449)
T KOG1165|consen  100 ILVIDLL-GPSLEDLFDLCG------RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIH  169 (449)
T ss_pred             hhhhhhh-CcCHHHHHHHhc------CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEE
Confidence            8999998 889999886443      6799999999999999999999999   99999999999999643     3689


Q ss_pred             EecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       309 l~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      |+|||+|+.+.+.............+..||.+||+-... ....+.+.|.=|+|-++...+-|..||...
T Consensus       170 iiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL  239 (449)
T KOG1165|consen  170 IIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  239 (449)
T ss_pred             EEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence            999999999877666666666667788899999998877 446899999999999999999999999764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=9.7e-23  Score=208.55  Aligned_cols=255  Identities=22%  Similarity=0.259  Sum_probs=178.8

Q ss_pred             CCCCeeeeeccceEEEEEeC-CCCEEEEEEeee---c--cc-hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          160 SEENLIGSGSFGSVYKGTLA-DGETAAIKVLKL---Q--QQ-GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       160 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~--~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ....++|.|.+|.|+..... .....+.|.++.   .  .. .....+..|+-+-..+.|+|++..+..+.     ....
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~-----~~~~  395 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQ-----EIDG  395 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHh-----hccc
Confidence            35678999999988777643 344444443321   1  11 11122566777788899999988777642     2222


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      ..-+|||+++ +|..++...       ..++..++..++.|+..|+.|+|+.   ||.|||+|++|++++.++.+||+||
T Consensus       396 ~~~~mE~~~~-Dlf~~~~~~-------~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Df  464 (601)
T KOG0590|consen  396 ILQSMEYCPY-DLFSLVMSN-------GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDF  464 (601)
T ss_pred             chhhhhcccH-HHHHHHhcc-------cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeec
Confidence            3334999999 999998754       3588889999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCccccc-CCC-CcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHV-SILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~-~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      |.+.......   ........+..|+..|+|||.+. .+| ....||||.|+++..|.+|+.||.....++..+..   .
T Consensus       465 g~~~vf~~~~---e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~---~  538 (601)
T KOG0590|consen  465 GAASVFRYPW---EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT---N  538 (601)
T ss_pred             CcceeeccCc---chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh---h
Confidence            9997653211   11224566788999999999994 455 45679999999999999999999875444332100   0


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      ....+.                  ...         ..........+.....++.++|+.||.+|-|+++|++
T Consensus       539 ~~~~~~------------------~~~---------~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  539 NYSDQR------------------NIF---------EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccccc------------------ccc---------cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            000000                  000         0011112222344678899999999999999999985

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.87  E-value=5e-22  Score=175.61  Aligned_cols=139  Identities=21%  Similarity=0.174  Sum_probs=107.1

Q ss_pred             CCeeeeeccceEEEEEeCCCCEEEEEEeeeccch--h-------hHH-----------------HHHHHHHHhcCCCCCc
Q 043902          162 ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQG--A-------LKS-----------------FIDECNALTSIRHRNI  215 (477)
Q Consensus       162 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~e~~~l~~l~h~ni  215 (477)
                      ...||+|+||.||+|...+|+.||||+++.....  .       ...                 ...|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999888999999999754211  0       012                 2349999999988776


Q ss_pred             ceeeeecccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHH-HcCCCCCeeecCC
Q 043902          216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYL-HNQYDTPIAHCDL  294 (477)
Q Consensus       216 v~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~dl  294 (477)
                      .....+.     .  ...++||||++++++.......       ..++......++.|++.+|.|+ |+.   +|+||||
T Consensus        82 ~~p~~~~-----~--~~~~iVmE~i~g~~l~~~~~~~-------~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDl  144 (190)
T cd05147          82 PCPEPIL-----L--KSHVLVMEFIGDDGWAAPRLKD-------APLSESKARELYLQVIQIMRILYQDC---RLVHADL  144 (190)
T ss_pred             CCCcEEE-----e--cCCEEEEEEeCCCCCcchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence            4333221     1  1238999999988776543211       3578899999999999999999 687   9999999


Q ss_pred             CCCCeEecCCCcEEEecccccccc
Q 043902          295 KSSNVLLDEGMIAHVGDFGLAKFL  318 (477)
Q Consensus       295 kp~NIll~~~~~~kl~DfG~a~~~  318 (477)
                      ||+||++++ +.++|+|||+|...
T Consensus       145 kP~NIli~~-~~v~LiDFG~a~~~  167 (190)
T cd05147         145 SEYNLLYHD-GKLYIIDVSQSVEH  167 (190)
T ss_pred             CHHHEEEEC-CcEEEEEccccccC
Confidence            999999984 68999999999643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.87  E-value=5e-23  Score=210.75  Aligned_cols=254  Identities=20%  Similarity=0.231  Sum_probs=179.0

Q ss_pred             CCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeecc-chhhHHHHHHHHH--HhcCCCCCcceeeeecccccCCCCceee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQ-QGALKSFIDECNA--LTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      ++...+.||.+.|=+|.+|+.+.|. |+||++-... .-....|.++++-  ...++|||.+++.-+     .......|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~-----~~t~kAAy   97 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKV-----LVTDKAAY   97 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHH-----HHhhHHHH
Confidence            5667789999999999999998887 8999986554 3334444443333  455689999988765     35566678


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +|-+|... +|+|.+..+       .-+...+..-|+.|++.||..+|..   +|+|||||.+||||+.-..+.|+||..
T Consensus        98 lvRqyvkh-nLyDRlSTR-------PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAs  166 (1431)
T KOG1240|consen   98 LVRQYVKH-NLYDRLSTR-------PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFAS  166 (1431)
T ss_pred             HHHHHHhh-hhhhhhccc-------hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccc
Confidence            88899855 999988754       5677888888999999999999999   999999999999999999999999987


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-c-C----------CCCcccceeehHHHHHHHhh-CCCCCCcccccc
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-N-G----------HVSILGDIYSYGILLLEIFT-GKRPTDDMFKDD  381 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~-~----------~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~  381 (477)
                      -+..+-....+............-..|+|||.+ . +          ..+++-||||+||++.||++ |++||.-..   
T Consensus       167 FKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ---  243 (1431)
T KOG1240|consen  167 FKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ---  243 (1431)
T ss_pred             cCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH---
Confidence            654322222222222222223334579999987 2 1          14778899999999999999 788885310   


Q ss_pred             cceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHH
Q 043902          382 LSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFV  461 (477)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev  461 (477)
                        +-.+-...       -.|+..                        ..+..+  ...+..++..|++.||++|-|+++.
T Consensus       244 --L~aYr~~~-------~~~~e~------------------------~Le~Ie--d~~~Rnlil~Mi~rdPs~RlSAedy  288 (1431)
T KOG1240|consen  244 --LLAYRSGN-------ADDPEQ------------------------LLEKIE--DVSLRNLILSMIQRDPSKRLSAEDY  288 (1431)
T ss_pred             --HHhHhccC-------ccCHHH------------------------HHHhCc--CccHHHHHHHHHccCchhccCHHHH
Confidence              00000000       000000                        000011  1137789999999999999999999


Q ss_pred             HHHHH
Q 043902          462 VNNLQ  466 (477)
Q Consensus       462 l~~L~  466 (477)
                      ++.-.
T Consensus       289 L~~yr  293 (1431)
T KOG1240|consen  289 LQKYR  293 (1431)
T ss_pred             HHhhh
Confidence            98643

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.87  E-value=3.4e-22  Score=178.45  Aligned_cols=174  Identities=13%  Similarity=0.125  Sum_probs=132.3

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhh---HH------HHHHHHHHhcCCCCCcceeeeecccc
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGAL---KS------FIDECNALTSIRHRNILKIVSSCSSV  225 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---~~------~~~e~~~l~~l~h~niv~l~~~~~~~  225 (477)
                      ..++|...+++|.|+||.||++.. ++..+|+|+++.......   ..      +.+|+..+.+++|++|..+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            468999999999999999999766 577899999975432221   22      67899999999999999998874321


Q ss_pred             cC---CCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec
Q 043902          226 DY---EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD  302 (477)
Q Consensus       226 ~~---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~  302 (477)
                      ..   ......++||||++|.+|.++..           ++.    ....+++.++..+|+.   +++|||++|+||+++
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~  169 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVS  169 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-----------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEe
Confidence            11   11345889999999999988732           222    2456999999999999   999999999999999


Q ss_pred             CCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcc-cc-cCCCCcccceeehHHHHHHHh
Q 043902          303 EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPE-YI-NGHVSILGDIYSYGILLLEIF  368 (477)
Q Consensus       303 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE-~~-~~~~~~~~Dv~S~Gvvl~ell  368 (477)
                      .++ ++|+|||......+.       .             |-+ +. ...+..++|+||||+++.-..
T Consensus       170 ~~g-i~liDfg~~~~~~e~-------~-------------a~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        170 KNG-LRIIDLSGKRCTAQR-------K-------------AKDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCC-EEEEECCCcccccch-------h-------------hHHHHHHHhHhcccccccceeEeehHHH
Confidence            988 999999988654110       0             001 12 344667999999999987654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.87  E-value=5.9e-21  Score=184.87  Aligned_cols=203  Identities=33%  Similarity=0.520  Sum_probs=165.3

Q ss_pred             CCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccch---hhHHHHHHHHHHhcCCCC-CcceeeeecccccCCCCceee
Q 043902          159 FSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQG---ALKSFIDECNALTSIRHR-NILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       159 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~~~~~~  234 (477)
                      |...+.||.|+||.||++...  ..+++|.+......   ....+.+|...+..+.|+ +++++.+.+     ......+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~   74 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSLY   74 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEEE
Confidence            566788999999999999976  88999998755432   367899999999999988 799999985     3444479


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC-cEEEeccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM-IAHVGDFG  313 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~DfG  313 (477)
                      ++++++.++++.+++......    ..+.......+..|++.++.|+|+.   +++|||+||+||+++... .++++|||
T Consensus        75 ~~~~~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg  147 (384)
T COG0515          75 LVMEYVDGGSLEDLLKKIGRK----GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFG  147 (384)
T ss_pred             EEEecCCCCcHHHHHHhcccc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccC
Confidence            999999999999777644210    2688899999999999999999999   999999999999999988 79999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCccccc----CCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN----GHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      .++........... ........|+..|+|||.+.    ...+...|+||+|++++++++|..||..
T Consensus       148 ~~~~~~~~~~~~~~-~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~  213 (384)
T COG0515         148 LAKLLPDPGSTSSI-PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG  213 (384)
T ss_pred             cceecCCCCccccc-cccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            99855221111000 01345677999999999994    3688999999999999999999999654

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.85  E-value=1.5e-21  Score=190.82  Aligned_cols=218  Identities=26%  Similarity=0.395  Sum_probs=160.9

Q ss_pred             HhcCCCCCcceeeeecccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCC
Q 043902          207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYD  286 (477)
Q Consensus       207 l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~  286 (477)
                      |+.+.|.|+.+++|.|.     ++...++|.+|+..|+|.+.+....      ..+++.-...+..+++.||.|||+.  
T Consensus         1 l~~l~h~n~~~f~g~~~-----~~~~~~~i~~~c~rGsl~D~i~~~~------~~~d~~F~~s~~rdi~~Gl~ylh~s--   67 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASV-----DGPEMIVIWEYCSRGSLLDILSNED------IKLDYFFILSFIRDISKGLAYLHNS--   67 (484)
T ss_pred             CcccchhhhhhheeeEe-----cCCceEEEEeeecCccHHhHHhccc------cCccHHHHHHHHHHHHHHHHHHhcC--
Confidence            45688999999999984     3377899999999999999998743      6789999999999999999999997  


Q ss_pred             CCe-eecCCCCCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccccCC--------CCcccce
Q 043902          287 TPI-AHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH--------VSILGDI  357 (477)
Q Consensus       287 ~~i-vH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~Dv  357 (477)
                       +| .|+.++++|+++|..+.+||+|||+......     ...........-..-|.|||.+.+.        .+.++||
T Consensus        68 -~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~-----~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdi  141 (484)
T KOG1023|consen   68 -PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEE-----TAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDI  141 (484)
T ss_pred             -cceeeeeeccccceeeeeEEEEechhhhcccccc-----cccccccchhHHHHhccCHHHhcccccccccccccccCCe
Confidence             44 9999999999999999999999999877632     0011111222245679999998432        5788999


Q ss_pred             eehHHHHHHHhhCCCCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHH
Q 043902          358 YSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECL  437 (477)
Q Consensus       358 ~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (477)
                      ||||++++|+++.+.||+.......             ..+++.. +..        ...+...|.+....      +..
T Consensus       142 Ys~~ii~~ei~~r~~~~~~~~~~~~-------------~~eii~~-~~~--------~~~~~~rP~i~~~~------e~~  193 (484)
T KOG1023|consen  142 YSFGIIMYEILFRSGPFDLRNLVED-------------PDEIILR-VKK--------GGSNPFRPSIELLN------ELP  193 (484)
T ss_pred             ehHHHHHHHHHhccCccccccccCC-------------hHHHHHH-HHh--------cCCCCcCcchhhhh------hcc
Confidence            9999999999999999976322211             0112211 000        00111222222111      223


Q ss_pred             HHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHh
Q 043902          438 VSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSK  471 (477)
Q Consensus       438 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  471 (477)
                      ..+..++.+||..+|.+||++++|-..++.+...
T Consensus       194 ~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  194 PELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             hHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            3588999999999999999999999988877653

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.85  E-value=1e-20  Score=167.98  Aligned_cols=138  Identities=20%  Similarity=0.186  Sum_probs=109.0

Q ss_pred             CCeeeeeccceEEEEEeCCCCEEEEEEeeeccch--------------------------hhHHHHHHHHHHhcCCCCCc
Q 043902          162 ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQG--------------------------ALKSFIDECNALTSIRHRNI  215 (477)
Q Consensus       162 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~ni  215 (477)
                      ...||+|++|.||+|...+|+.||||+++.....                          ....+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999999878999999999854211                          01224578999999999987


Q ss_pred             ceeeeecccccCCCCceeeEEEeecCCCChhhh-cccCCCcccccccCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecC
Q 043902          216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQW-LHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN-QYDTPIAHCD  293 (477)
Q Consensus       216 v~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~d  293 (477)
                      .....+.     ..  ..++||||++++++... +..        ..++......++.|++.++.++|+ .   +|+|||
T Consensus        82 ~~p~~~~-----~~--~~~lVmE~~~g~~~~~~~l~~--------~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrD  143 (190)
T cd05145          82 PVPEPIL-----LK--KNVLVMEFIGDDGSPAPRLKD--------VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGD  143 (190)
T ss_pred             CCceEEE-----ec--CCEEEEEEecCCCchhhhhhh--------ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCC
Confidence            5443332     11  24899999998855432 321        346788899999999999999999 8   999999


Q ss_pred             CCCCCeEecCCCcEEEecccccccc
Q 043902          294 LKSSNVLLDEGMIAHVGDFGLAKFL  318 (477)
Q Consensus       294 lkp~NIll~~~~~~kl~DfG~a~~~  318 (477)
                      |||+||+++ ++.++|+|||++...
T Consensus       144 lkP~NIll~-~~~~~liDFG~a~~~  167 (190)
T cd05145         144 LSEYNILYH-DGKPYIIDVSQAVEL  167 (190)
T ss_pred             CChhhEEEE-CCCEEEEEcccceec
Confidence            999999999 789999999999765

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=1.4e-20  Score=164.43  Aligned_cols=190  Identities=17%  Similarity=0.067  Sum_probs=135.6

Q ss_pred             CCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccch----hhHHHHHHHHHHhcCC-CCCcceeeeecccccCCCCceee
Q 043902          160 SEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQG----ALKSFIDECNALTSIR-HRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       160 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      .+...|++|+||+||.+.. ++.+++.+.+.....-    ....+.+|+++|+++. |+++++++++.         ..+
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~~   74 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GRH   74 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CEE
Confidence            3567899999999998776 6788888877744321    1235789999999995 58899998761         258


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCC-CCCCeEecCCCcEEEeccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDL-KSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dl-kp~NIll~~~~~~kl~DfG  313 (477)
                      ++|||+.|.+|...+..              ....++.|++++|.++|++   ||+|||| ||+|||++.++.++|+|||
T Consensus        75 lvmeyI~G~~L~~~~~~--------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG  137 (218)
T PRK12274         75 LDRSYLAGAAMYQRPPR--------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQ  137 (218)
T ss_pred             EEEeeecCccHHhhhhh--------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECC
Confidence            99999999998654321              1134778999999999999   9999999 7999999999999999999


Q ss_pred             ccccccccCCC----CCCC--ccccCCCcccccccCccccc--CCCC-cccceeehHHHHHHHhhCCCCCCc
Q 043902          314 LAKFLFEESNT----PSKN--QTMSNGLKGSVGYIPPEYIN--GHVS-ILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       314 ~a~~~~~~~~~----~~~~--~~~~~~~~gt~~y~aPE~~~--~~~~-~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ++.........    ...+  .....-...++.|++|+...  ...+ ...+.++-|.-+|.++||..+.-.
T Consensus       138 ~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        138 LAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             CceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            99854221100    0000  00000112355566666441  1233 567899999999999999988543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.82  E-value=3.6e-20  Score=170.45  Aligned_cols=202  Identities=22%  Similarity=0.314  Sum_probs=129.7

Q ss_pred             CCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCC----------CCcceeeeeccc
Q 043902          159 FSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRH----------RNILKIVSSCSS  224 (477)
Q Consensus       159 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~~~  224 (477)
                      +...+.||.|+++.||.++.. +|+.+|+|++....   ....+++.+|.-....+.+          -.++-.++....
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            345678999999999999976 58999999987543   2345666666655544332          111111111110


Q ss_pred             cc-------CCCCc-----eeeEEEeecCCCChhhhccc---CCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 043902          225 VD-------YEGND-----FKALVFEFMRNGNLDQWLHP---STDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPI  289 (477)
Q Consensus       225 ~~-------~~~~~-----~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i  289 (477)
                      ..       ..+..     ..+++|+-+ .++|.+++..   ...   ....+....++.+..|+.+.+++||+.   |+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~---~~~~l~~~arl~lT~Q~I~lvA~Lh~~---Gl  166 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQ---THSPLAFAARLSLTVQMIRLVANLHSY---GL  166 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTT---TSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhccc---ccchhHHHHHHHHHHHHHHHHHHHhhc---ce
Confidence            00       00111     235677777 5688887642   111   113345566778889999999999999   99


Q ss_pred             eecCCCCCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccccC---------CCCcccceeeh
Q 043902          290 AHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING---------HVSILGDIYSY  360 (477)
Q Consensus       290 vH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~Dv~S~  360 (477)
                      +|+||+|+|++++.+|.++|+||+.......         .... ...+..|.+||....         .++.+.|.|++
T Consensus       167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~---------~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~L  236 (288)
T PF14531_consen  167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGT---------RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQL  236 (288)
T ss_dssp             EEST-SGGGEEE-TTS-EEE--GGGEEETTE---------EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHH
T ss_pred             EecccceeeEEEcCCCCEEEcChHHHeecCc---------eeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHH
Confidence            9999999999999999999999998765421         1111 334577999998721         37889999999


Q ss_pred             HHHHHHHhhCCCCCCcc
Q 043902          361 GILLLEIFTGKRPTDDM  377 (477)
Q Consensus       361 Gvvl~elltg~~p~~~~  377 (477)
                      |+++|.|++|+.||+..
T Consensus       237 G~~ly~lWC~~lPf~~~  253 (288)
T PF14531_consen  237 GITLYSLWCGRLPFGLS  253 (288)
T ss_dssp             HHHHHHHHHSS-STCCC
T ss_pred             HHHHHHHHHccCCCCCC
Confidence            99999999999999754

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.81  E-value=1.6e-19  Score=166.66  Aligned_cols=206  Identities=22%  Similarity=0.244  Sum_probs=141.3

Q ss_pred             CCCCcceeeeeccccc----------------------CCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHH
Q 043902          211 RHRNILKIVSSCSSVD----------------------YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL  268 (477)
Q Consensus       211 ~h~niv~l~~~~~~~~----------------------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~  268 (477)
                      +|||||++.+++.+.-                      ...+...|+||..++. +|..++-.+        ..+.....
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~--------~~s~r~~~  344 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR--------HRSYRTGR  344 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC--------CCchHHHH
Confidence            5999999988754320                      2245568899998855 899988654        35667788


Q ss_pred             HHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec--CCC--cEEEecccccccccccCCCCCCCccccCCCcccccccCc
Q 043902          269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD--EGM--IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP  344 (477)
Q Consensus       269 ~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~--~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  344 (477)
                      -|+.|+++|+.|||.+   +|.|||+|++|||+.  ++.  ...|+|||++..-....-. -......-...|...-|||
T Consensus       345 ~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlq-lpy~S~~Vd~GGNa~lmAP  420 (598)
T KOG4158|consen  345 VILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQ-LPYESDEVDLGGNAKLMAP  420 (598)
T ss_pred             HHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccc-cccccccccCCCcceecch
Confidence            8999999999999999   999999999999993  333  5789999988532110000 0001112234577789999


Q ss_pred             ccccC---C----CCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhccccccccc
Q 043902          345 EYING---H----VSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEE  417 (477)
Q Consensus       345 E~~~~---~----~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~  417 (477)
                      |+.+.   +    .-.|+|.|+.|.+.||+++...||....+-..+...+-                             
T Consensus       421 Ei~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq-----------------------------  471 (598)
T KOG4158|consen  421 EIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ-----------------------------  471 (598)
T ss_pred             hhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh-----------------------------
Confidence            99843   2    24689999999999999999999975222111111111                             


Q ss_pred             ccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHH
Q 043902          418 EDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQ  466 (477)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  466 (477)
                      |..+|.+.        +.|+.-+.+++...++.||++|||..=....|.
T Consensus       472 e~qLPalp--------~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  472 ESQLPALP--------SRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             hhhCCCCc--------ccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence            11112221        223444778899999999999999876666654

>PRK10345 hypothetical protein; Provisional

Probab=99.80  E-value=3.8e-19  Score=158.58  Aligned_cols=140  Identities=19%  Similarity=0.272  Sum_probs=105.4

Q ss_pred             CCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcC-----CCCCcceeeeecccccCCCCce-
Q 043902          159 FSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSI-----RHRNILKIVSSCSSVDYEGNDF-  232 (477)
Q Consensus       159 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~~~~~~~-  232 (477)
                      ++..+.||+|+||.||. .-.++.. +||++........+.+.+|++++.++     .||||++++|++...  .+.+. 
T Consensus         4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~--~g~g~v   79 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD--CGTGYV   79 (210)
T ss_pred             cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC--CCCeEE
Confidence            44568999999999996 3224444 79988765444557899999999999     579999999996321  11133 


Q ss_pred             eeEEEee--cCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHH-HHHHcCCCCCeeecCCCCCCeEecC----CC
Q 043902          233 KALVFEF--MRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL-DYLHNQYDTPIAHCDLKSSNVLLDE----GM  305 (477)
Q Consensus       233 ~~lv~e~--~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~ivH~dlkp~NIll~~----~~  305 (477)
                      ..+|+||  +++|+|.+++...        .+++.  ..++.+++.++ .|||++   +|+||||||+||+++.    +.
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~--------~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~  146 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQC--------RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEV  146 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHcc--------cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCC
Confidence            3378999  5579999999643        24444  35677888777 899999   9999999999999974    34


Q ss_pred             cEEEeccccc
Q 043902          306 IAHVGDFGLA  315 (477)
Q Consensus       306 ~~kl~DfG~a  315 (477)
                      .++|+||+-+
T Consensus       147 ~~~LiDg~G~  156 (210)
T PRK10345        147 IPVVCDNIGE  156 (210)
T ss_pred             cEEEEECCCC
Confidence            8999994443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=1.7e-19  Score=188.32  Aligned_cols=197  Identities=22%  Similarity=0.221  Sum_probs=154.4

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCC---CCCcceeeeecccccCCCC
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIR---HRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~~  230 (477)
                      ...+.|.+.+.||+|+||+||+|...+|+.||+|+-+....-   +|.--.+++.||+   -+.|..+...+     -..
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~-----~~~  766 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAH-----VFQ  766 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHH-----ccC
Confidence            345678888999999999999999888999999998755432   2222334455555   22333333322     223


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec-------C
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD-------E  303 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~-------~  303 (477)
                      +.-++|+||.+.|+|.+++...       +.++|..+..++.|+++.+.+||..   +||||||||+|.||.       +
T Consensus       767 ~~S~lv~ey~~~Gtlld~~N~~-------~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~  836 (974)
T KOG1166|consen  767 NASVLVSEYSPYGTLLDLINTN-------KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSD  836 (974)
T ss_pred             CcceeeeeccccccHHHhhccC-------CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCc
Confidence            4468999999999999999844       6799999999999999999999999   999999999999994       3


Q ss_pred             CCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccccC-CCCcccceeehHHHHHHHhhCCCC
Q 043902          304 GMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRP  373 (477)
Q Consensus       304 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~S~Gvvl~elltg~~p  373 (477)
                      ...++|+|||.+-.+.-     ........+.++|-.+-.+|+..| .++..+|-|.++-+++-|+.|+..
T Consensus       837 ~~~l~lIDfG~siDm~l-----fp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  837 SKGLYLIDFGRSIDMKL-----FPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             ccceEEEecccceeeeE-----cCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            44699999999976522     223345667788999999999955 699999999999999999999754

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.79  E-value=1.5e-20  Score=183.62  Aligned_cols=186  Identities=29%  Similarity=0.366  Sum_probs=154.4

Q ss_pred             eeeeeccceEEEEEe----CCCCEEEEEEeeeccc--hhhHHHHHHHHHHhcCC-CCCcceeeeecccccCCCCceeeEE
Q 043902          164 LIGSGSFGSVYKGTL----ADGETAAIKVLKLQQQ--GALKSFIDECNALTSIR-HRNILKIVSSCSSVDYEGNDFKALV  236 (477)
Q Consensus       164 ~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv  236 (477)
                      ++|+|.||.|++++.    ..|..+|.|+.+....  ........|..++...+ ||.++++.-.     ++.+...+++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhya-----fqt~~kl~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYA-----FQTDGKLYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeee-----eccccchhHh
Confidence            379999999998753    3477899998875431  11125566888888886 9999998765     5778889999


Q ss_pred             EeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccc
Q 043902          237 FEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK  316 (477)
Q Consensus       237 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  316 (477)
                      ++|..+|.|...+...       ..+++.....+...++-++.++|..   +++|||+|++||+++.+|++++.|||+++
T Consensus        76 ld~~rgg~lft~l~~~-------~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglsk  145 (612)
T KOG0603|consen   76 LDFLRGGDLFTRLSKE-------VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSK  145 (612)
T ss_pred             hhhcccchhhhccccC-------CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhh
Confidence            9999999999888765       4567777788889999999999999   99999999999999999999999999998


Q ss_pred             cccccCCCCCCCccccCCCcccccccCcccccCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          317 FLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ...+..           ..+||..|||||+.+ .....+|.||||++++||+||..||..
T Consensus       146 e~v~~~-----------~~cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  146 EAVKEK-----------IACGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             HhHhhh-----------hcccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            763321           117899999999998 457889999999999999999999965

>smart00090 RIO RIO-like kinase

Probab=99.78  E-value=1.9e-18  Score=158.06  Aligned_cols=144  Identities=17%  Similarity=0.134  Sum_probs=111.7

Q ss_pred             hhcCCCCCCeeeeeccceEEEEE--eCCCCEEEEEEeeeccch------------------------hhHHHHHHHHHHh
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGT--LADGETAAIKVLKLQQQG------------------------ALKSFIDECNALT  208 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~  208 (477)
                      ...-|++.+.||+|++|.||+|.  ..+|+.||+|+++.....                        ....+..|++.+.
T Consensus        26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~  105 (237)
T smart00090       26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ  105 (237)
T ss_pred             cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence            33457788999999999999998  568999999998753210                        0123568999999


Q ss_pred             cCCCC--CcceeeeecccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCC
Q 043902          209 SIRHR--NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYD  286 (477)
Q Consensus       209 ~l~h~--niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~  286 (477)
                      ++.+.  .+.+++++         ...++||||+++++|.......       ..+.......++.|++.++.+||+.  
T Consensus       106 ~L~~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~--  167 (237)
T smart00090      106 RLYEAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLKD-------VEPEEEEEFELYDDILEEMRKLYKE--  167 (237)
T ss_pred             HHHhcCCCCCeeeEe---------cCceEEEEEecCCccccccccc-------CCcchHHHHHHHHHHHHHHHHHHhc--
Confidence            99753  34444443         1247999999998887654322       2345566789999999999999999  


Q ss_pred             CC-eeecCCCCCCeEecCCCcEEEecccccccc
Q 043902          287 TP-IAHCDLKSSNVLLDEGMIAHVGDFGLAKFL  318 (477)
Q Consensus       287 ~~-ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  318 (477)
                       + ++||||||+||+++ ++.++|+|||.+...
T Consensus       168 -g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      168 -GELVHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             -CCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence             9 99999999999999 789999999998754

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=3.5e-18  Score=154.80  Aligned_cols=134  Identities=23%  Similarity=0.333  Sum_probs=109.9

Q ss_pred             CeeeeeccceEEEEEeCCCCEEEEEEeeeccch--------hhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          163 NLIGSGSFGSVYKGTLADGETAAIKVLKLQQQG--------ALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      +.||+|++|.||+|.. +|..+++|+.......        ....+.+|++++..++|+++.....++.     .....+
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~~   75 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV-----DPENFI   75 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE-----eCCCCE
Confidence            5799999999999988 6788999986643211        1245788999999999998876665542     334578


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +||||++|++|.+++...          .+ .+..++.+++.+|.++|+.   +++|||++|+||+++ ++.++|+|||.
T Consensus        76 lv~e~~~G~~L~~~~~~~----------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~  140 (211)
T PRK14879         76 IVMEYIEGEPLKDLINSN----------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGL  140 (211)
T ss_pred             EEEEEeCCcCHHHHHHhc----------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCc
Confidence            999999999999988532          12 7889999999999999999   999999999999999 78899999999


Q ss_pred             ccc
Q 043902          315 AKF  317 (477)
Q Consensus       315 a~~  317 (477)
                      +..
T Consensus       141 a~~  143 (211)
T PRK14879        141 AEF  143 (211)
T ss_pred             ccC
Confidence            864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.75  E-value=1.1e-17  Score=149.65  Aligned_cols=142  Identities=20%  Similarity=0.183  Sum_probs=110.8

Q ss_pred             HHHhhcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccch----------------------hhHHHHHHHHHHhc
Q 043902          152 ISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQG----------------------ALKSFIDECNALTS  209 (477)
Q Consensus       152 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~  209 (477)
                      +......|...+.||+|+||.||++...+|+.||||+++.....                      ....+..|...+.+
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   89 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA   89 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence            33344457788999999999999999888999999987643210                      01235678888988


Q ss_pred             CCCCC--cceeeeecccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 043902          210 IRHRN--ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDT  287 (477)
Q Consensus       210 l~h~n--iv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~  287 (477)
                      +.|++  +...++.         ...++||||+++++|......             .....++.+++.++.++|+.   
T Consensus        90 l~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~-------------~~~~~~~~~i~~~l~~lh~~---  144 (198)
T cd05144          90 LYEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL-------------EDPEEVLDEILEEIVKAYKH---  144 (198)
T ss_pred             HHHcCCCCCceeec---------CCceEEEEEeCCcchhhcccc-------------ccHHHHHHHHHHHHHHHHHC---
Confidence            87774  4444432         235899999999999765421             23457889999999999998   


Q ss_pred             CeeecCCCCCCeEecCCCcEEEecccccccc
Q 043902          288 PIAHCDLKSSNVLLDEGMIAHVGDFGLAKFL  318 (477)
Q Consensus       288 ~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  318 (477)
                      +++||||+|+||++++++.++|+|||.+...
T Consensus       145 gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         145 GIIHGDLSEFNILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             CCCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence            9999999999999999999999999999654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.74  E-value=3.9e-19  Score=170.63  Aligned_cols=128  Identities=27%  Similarity=0.445  Sum_probs=107.0

Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      .+.++.|+++...+|.+||..+.    .....++...+.++.|++.|+.|   +   +.+|+|+||.||+...+..+||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~----~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIg  398 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRR----TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIG  398 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCC----cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhh
Confidence            35789999999999999997554    23567888999999999999999   5   89999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCccccc-CCCCcccceeehHHHHHHHhh
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT  369 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~S~Gvvl~ellt  369 (477)
                      |||+........ .........+...||..||+||.+. .+|+.|+||||||++|+|+++
T Consensus       399 DFgl~ts~~~~~-~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  399 DFGLVTSQDKDE-TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             hhhheeecccCC-cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            999987664322 1111233445678999999999995 579999999999999999998

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.73  E-value=3.1e-17  Score=168.86  Aligned_cols=138  Identities=24%  Similarity=0.284  Sum_probs=108.5

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEe-ee-cc------chhhHHHHHHHHHHhcCCCCCcceeeeecccccC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVL-KL-QQ------QGALKSFIDECNALTSIRHRNILKIVSSCSSVDY  227 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~-~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  227 (477)
                      ...|...+.||+|+||.||+|.+.+. .+++|+. .. ..      ....+.+.+|++++.+++|++++....++.    
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~----  406 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV----  406 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE----
Confidence            44556788999999999999987544 3444432 21 11      112356889999999999999988766642    


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcE
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIA  307 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~  307 (477)
                       .....++||||+++++|.+++.               ....++.+++++|.|||+.   +++||||||+||++ +++.+
T Consensus       407 -~~~~~~lv~E~~~g~~L~~~l~---------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~  466 (535)
T PRK09605        407 -DPEEKTIVMEYIGGKDLKDVLE---------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRL  466 (535)
T ss_pred             -eCCCCEEEEEecCCCcHHHHHH---------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcE
Confidence             2345689999999999998774               3467899999999999999   99999999999999 57789


Q ss_pred             EEecccccccc
Q 043902          308 HVGDFGLAKFL  318 (477)
Q Consensus       308 kl~DfG~a~~~  318 (477)
                      +|+|||+++..
T Consensus       467 ~liDFGla~~~  477 (535)
T PRK09605        467 YLIDFGLGKYS  477 (535)
T ss_pred             EEEeCcccccC
Confidence            99999999753

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.71  E-value=4.3e-17  Score=146.22  Aligned_cols=130  Identities=24%  Similarity=0.329  Sum_probs=102.8

Q ss_pred             eeeeeccceEEEEEeCCCCEEEEEEeeecc--c------hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          164 LIGSGSFGSVYKGTLADGETAAIKVLKLQQ--Q------GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       164 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      .||+|+||.||+|.+ +|..+++|......  .      .....+.+|++++..++|+++.....++     ......++
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~-----~~~~~~~l   74 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYD-----VDPDNKTI   74 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEE-----EECCCCEE
Confidence            489999999999996 57889999865321  1      1135677899999999887654433332     12334689


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      ||||++|++|.+++....       .       .++.+++.+|.+||+.   +++|||++|.||+++ ++.++++|||++
T Consensus        75 v~e~~~g~~l~~~~~~~~-------~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a  136 (199)
T TIGR03724        75 VMEYIEGKPLKDVIEEGN-------D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLG  136 (199)
T ss_pred             EEEEECCccHHHHHhhcH-------H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCC
Confidence            999999999998875321       0       7899999999999999   999999999999999 789999999998


Q ss_pred             cc
Q 043902          316 KF  317 (477)
Q Consensus       316 ~~  317 (477)
                      ..
T Consensus       137 ~~  138 (199)
T TIGR03724       137 KY  138 (199)
T ss_pred             cC
Confidence            64

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.66  E-value=4.1e-16  Score=138.37  Aligned_cols=135  Identities=21%  Similarity=0.242  Sum_probs=96.9

Q ss_pred             CCeeeeeccceEEEEEeCCCCEEEEEEeeeccchh--hHH----------------------HHHHHHHHhcCCCC--Cc
Q 043902          162 ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGA--LKS----------------------FIDECNALTSIRHR--NI  215 (477)
Q Consensus       162 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~e~~~l~~l~h~--ni  215 (477)
                      .+.||+|+||.||+|...+|+.||||+++......  ...                      ...|.+.+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999998889999999987532211  011                      12455555555433  23


Q ss_pred             ceeeeecccccCCCCceeeEEEeecCCCChhh-hcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecC
Q 043902          216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQ-WLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN-QYDTPIAHCD  293 (477)
Q Consensus       216 v~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~d  293 (477)
                      .+.+++         ...++||||++++++.. .+....        .. .....++.+++.++.++|. .   +|+|+|
T Consensus        82 ~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~--------~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~D  140 (187)
T cd05119          82 PKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR--------LL-EDPEELYDQILELMRKLYREA---GLVHGD  140 (187)
T ss_pred             CceEec---------CCCEEEEEEeCCCCccChhhhhhh--------hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCC
Confidence            444432         13589999999965432 111110        11 5677899999999999999 7   999999


Q ss_pred             CCCCCeEecCCCcEEEecccccccc
Q 043902          294 LKSSNVLLDEGMIAHVGDFGLAKFL  318 (477)
Q Consensus       294 lkp~NIll~~~~~~kl~DfG~a~~~  318 (477)
                      |||+||+++ ++.++|+|||.+...
T Consensus       141 l~p~Nili~-~~~~~liDfg~a~~~  164 (187)
T cd05119         141 LSEYNILVD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             CChhhEEEE-CCcEEEEECcccccc
Confidence            999999999 889999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.64  E-value=2.6e-15  Score=137.69  Aligned_cols=140  Identities=14%  Similarity=0.145  Sum_probs=105.9

Q ss_pred             CCeee-eeccceEEEEEeCCCCEEEEEEeeecc-------------chhhHHHHHHHHHHhcCCCCCc--ceeeeecccc
Q 043902          162 ENLIG-SGSFGSVYKGTLADGETAAIKVLKLQQ-------------QGALKSFIDECNALTSIRHRNI--LKIVSSCSSV  225 (477)
Q Consensus       162 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~  225 (477)
                      ...|| .||.|+||.+... +..++||.++...             ......+.+|++++.+++|+++  ++.++++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            45788 8999999999884 7789999885321             1123567889999999998775  6677664221


Q ss_pred             cCCCCceeeEEEeecCC-CChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC
Q 043902          226 DYEGNDFKALVFEFMRN-GNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG  304 (477)
Q Consensus       226 ~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~  304 (477)
                      . ......++|||++++ .+|.+++...        .++..    .+.+++.++.+||+.   ||+||||||.|||++.+
T Consensus       115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~~--------~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~  178 (239)
T PRK01723        115 H-GLFYRADILIERIEGARDLVALLQEA--------PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPD  178 (239)
T ss_pred             c-CcceeeeEEEEecCCCCCHHHHHhcC--------CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCC
Confidence            0 111123599999997 6899887542        23333    356899999999999   99999999999999998


Q ss_pred             CcEEEecccccccc
Q 043902          305 MIAHVGDFGLAKFL  318 (477)
Q Consensus       305 ~~~kl~DfG~a~~~  318 (477)
                      +.++|+|||.+...
T Consensus       179 ~~v~LIDfg~~~~~  192 (239)
T PRK01723        179 GKFWLIDFDRGELR  192 (239)
T ss_pred             CCEEEEECCCcccC
Confidence            89999999998753

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.64  E-value=2.7e-16  Score=161.71  Aligned_cols=171  Identities=29%  Similarity=0.397  Sum_probs=120.8

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ...+|..++.|..|+||.||.++++ ..+.+|+|+=+ +..     +           -+||..+.+           ..
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~l-----i-----------lRnilt~a~-----------np  132 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QNL-----I-----------LRNILTFAG-----------NP  132 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhcccc-cch-----h-----------hhccccccC-----------Cc
Confidence            3568899999999999999999876 46677774322 110     0           112332222           12


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++|      |+-...++..       ..++.        +++.+++|||+-   +|+|||+||+|.+|+.-|++|++|||
T Consensus       133 fvv------gDc~tllk~~-------g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfg  188 (1205)
T KOG0606|consen  133 FVV------GDCATLLKNI-------GPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFG  188 (1205)
T ss_pred             cee------chhhhhcccC-------CCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchh
Confidence            233      4444444432       12222        237899999998   99999999999999999999999999


Q ss_pred             ccccccccCC--------CCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          314 LAKFLFEESN--------TPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       314 ~a~~~~~~~~--------~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      +++.......        ............+||+.|+|||++ ...|+..+|+|++|+++||.+.|..||...
T Consensus       189 Lsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd  261 (1205)
T KOG0606|consen  189 LSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD  261 (1205)
T ss_pred             hhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence            9976432111        111112234456899999999999 556999999999999999999999999764

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.64  E-value=2.8e-15  Score=127.95  Aligned_cols=136  Identities=24%  Similarity=0.294  Sum_probs=112.0

Q ss_pred             CCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCC--CCcceeeeecccccCCCCceeeEEEe
Q 043902          161 EENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRH--RNILKIVSSCSSVDYEGNDFKALVFE  238 (477)
Q Consensus       161 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~e  238 (477)
                      +.+.||+|.++.||++...+ ..+++|..+....  ...+.+|+..+..++|  .++++++++.     ...+..++++|
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~e   73 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLME   73 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEEE
Confidence            45789999999999999854 7899999875443  4678899999999976  5888888874     34467899999


Q ss_pred             ecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccc
Q 043902          239 FMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFL  318 (477)
Q Consensus       239 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  318 (477)
                      |++++++..+              +......++.+++++++++|.....+++|+|++|+||++++.+.+++.|||.+...
T Consensus        74 ~~~g~~~~~~--------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          74 WIEGETLDEV--------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             ecCCeecccC--------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            9988777543              44566778999999999999864447999999999999999899999999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.64  E-value=5.1e-17  Score=166.63  Aligned_cols=255  Identities=21%  Similarity=0.267  Sum_probs=186.2

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCC--CCEEEEEEeeecc--chhhHHHHHHHHHHhcCC-CCCcceeeeecccccCCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLAD--GETAAIKVLKLQQ--QGALKSFIDECNALTSIR-HRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~  230 (477)
                      ...|...+.||+|.|+.|-......  ...+|+|.+....  .........|..+-..+. |+|++.+++.     ....
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~-----~~~~   93 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEP-----SSSP   93 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCc-----cCCC
Confidence            4567778889999999999887643  4456666665433  222234445777777776 9999999988     4667


Q ss_pred             ceeeEEEeecCCCChhhhc-ccCCCcccccccCCHHHHHHHHHHHHHHHHHHH-cCCCCCeeecCCCCCCeEecCCC-cE
Q 043902          231 DFKALVFEFMRNGNLDQWL-HPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH-NQYDTPIAHCDLKSSNVLLDEGM-IA  307 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l-~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~ivH~dlkp~NIll~~~~-~~  307 (477)
                      +..+++++|..++++.+.+ ....      ...+....-.++.|+..++.|+| ..   ++.|+|+||+|.+++..+ ..
T Consensus        94 ~~~~~~~~~s~g~~~f~~i~~~~~------~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l  164 (601)
T KOG0590|consen   94 RSYLLSLSYSDGGSLFSKISHPDS------TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSAL  164 (601)
T ss_pred             cccccccCcccccccccccccCCc------cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcc
Confidence            7889999999999999888 3321      24566667788999999999999 77   999999999999999999 99


Q ss_pred             EEecccccccccccCCCCCCCccccCCCcc-cccccCcccccC--CCCcccceeehHHHHHHHhhCCCCCCcccccccce
Q 043902          308 HVGDFGLAKFLFEESNTPSKNQTMSNGLKG-SVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSI  384 (477)
Q Consensus       308 kl~DfG~a~~~~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~  384 (477)
                      +++|||+|..+...    ...........| ++.|+|||...+  ...+..|+||.|+++.-+++|..|+..........
T Consensus       165 ~~~df~~At~~~~~----~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~  240 (601)
T KOG0590|consen  165 KIADFGLATAYRNK----NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY  240 (601)
T ss_pred             cCCCchhhcccccc----CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc
Confidence            99999999876331    122333445567 999999999955  56889999999999999999999998765555444


Q ss_pred             eeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHH
Q 043902          385 HKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVV  462 (477)
Q Consensus       385 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl  462 (477)
                      ..|.......                      ....+..            ......++...++..+|+.|.+.+++.
T Consensus       241 ~~~~~~~~~~----------------------~~~~~~~------------~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  241 SSWKSNKGRF----------------------TQLPWNS------------ISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             eeeccccccc----------------------ccCcccc------------CChhhhhcccccccCCchhcccccccc
Confidence            4443321000                      0000000            012366778888889999999988764

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.58  E-value=2e-15  Score=136.61  Aligned_cols=162  Identities=22%  Similarity=0.332  Sum_probs=122.8

Q ss_pred             HHHhcCCCCCcceeeeecccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcC
Q 043902          205 NALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ  284 (477)
Q Consensus       205 ~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~  284 (477)
                      ..+-++-|.|||++..|+.+..+++.....+++|||..|++..+|+....   ....+......+|+.||..||.|||+ 
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~---~~~a~~~~~wkkw~tqIlsal~yLhs-  194 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK---NQKALFQKAWKKWCTQILSALSYLHS-  194 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH---hhhhhhHHHHHHHHHHHHhhhhhhhc-
Confidence            44556679999999999877766677788999999999999999986542   22567788888999999999999999 


Q ss_pred             CCCCeeecCCCCCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHH
Q 043902          285 YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGIL  363 (477)
Q Consensus       285 ~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvv  363 (477)
                      |.|+|+|+++.-+.|++..++-+|++--.-......   .............+-++|.|||+- ..+.+..+|||+||+.
T Consensus       195 ~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s---~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmc  271 (458)
T KOG1266|consen  195 CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPS---VNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMC  271 (458)
T ss_pred             cCCccccCCcchhheeecCCceEEecccCccccchh---hhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHH
Confidence            589999999999999999999888843211111000   000011112223456889999987 4567889999999999


Q ss_pred             HHHHhhCCCC
Q 043902          364 LLEIFTGKRP  373 (477)
Q Consensus       364 l~elltg~~p  373 (477)
                      .+||..+..-
T Consensus       272 AlemailEiq  281 (458)
T KOG1266|consen  272 ALEMAILEIQ  281 (458)
T ss_pred             HHHHHHheec
Confidence            9999887654

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.54  E-value=4.3e-14  Score=140.82  Aligned_cols=145  Identities=19%  Similarity=0.260  Sum_probs=102.1

Q ss_pred             cCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhh---------------------------------------
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGAL---------------------------------------  197 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------------------------------------  197 (477)
                      ..|+ .+.||.|++|.||+|++++|+.||||+.+.......                                       
T Consensus       118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~  196 (437)
T TIGR01982       118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR  196 (437)
T ss_pred             hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence            3444 368999999999999999999999999864321100                                       


Q ss_pred             -HHHHHHHHHHhcC----CCCCcceeeeecccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHH
Q 043902          198 -KSFIDECNALTSI----RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI  272 (477)
Q Consensus       198 -~~~~~e~~~l~~l----~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~  272 (477)
                       -+|.+|++.+.++    +|.+-+.+-..+.    +.....++||||++|++|.++.....      ...   ....++.
T Consensus       197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~----~~~~~~vLvmE~i~G~~L~~~~~~~~------~~~---~~~~ia~  263 (437)
T TIGR01982       197 ELDLRREAANASELGENFKNDPGVYVPEVYW----DRTSERVLTMEWIDGIPLSDIAALDE------AGL---DRKALAE  263 (437)
T ss_pred             HHCHHHHHHHHHHHHHhcCCCCCEEeCCEeh----hhcCCceEEEEeECCcccccHHHHHh------cCC---CHHHHHH
Confidence             0244555555554    2333333333332    22344789999999999988764321      112   2345666


Q ss_pred             HHHH-HHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccc
Q 043902          273 DVAS-ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFL  318 (477)
Q Consensus       273 ~ia~-~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  318 (477)
                      .++. .+..+|..   |++|+|++|.||+++.++.++++|||++..+
T Consensus       264 ~~~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l  307 (437)
T TIGR01982       264 NLARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRL  307 (437)
T ss_pred             HHHHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence            6666 47888988   9999999999999999999999999999766

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PLN03150 hypothetical protein; Provisional

Probab=99.52  E-value=1.8e-14  Score=149.98  Aligned_cols=90  Identities=37%  Similarity=0.575  Sum_probs=72.0

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccccc--ccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGI--FANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~--~~~~~~~~~~~n~   78 (477)
                      |+|++|+|+|.+|.++++|++|+.|||++|+|+|.+|..+++|++|+.|+|++|+|+|.+|....  ..++..+.+.+|+
T Consensus       447 L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~  526 (623)
T PLN03150        447 INLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNA  526 (623)
T ss_pred             EECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCc
Confidence            57888888888888888888888888888888888888888888899999999988888887632  2344567788899


Q ss_pred             ccccccccccCCccc
Q 043902           79 KLCGGIQKLQLPECS   93 (477)
Q Consensus        79 ~l~g~~~~~~~~~~~   93 (477)
                      .+||.+.   ++.|.
T Consensus       527 ~lc~~p~---l~~C~  538 (623)
T PLN03150        527 GLCGIPG---LRACG  538 (623)
T ss_pred             cccCCCC---CCCCc
Confidence            9998542   35664

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.46  E-value=9.4e-14  Score=136.39  Aligned_cols=201  Identities=26%  Similarity=0.333  Sum_probs=154.2

Q ss_pred             CCCCCCeeee--eccceEEEEEe---CCCCEEEEEEeeeccc--hhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCC
Q 043902          158 NFSEENLIGS--GSFGSVYKGTL---ADGETAAIKVLKLQQQ--GALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEG  229 (477)
Q Consensus       158 ~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  229 (477)
                      .|...+.+|.  |.+|.||.+..   .++..+|+|.-+....  .....-.+|+....++ .|+|.++....     +++
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~-----~e~  189 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA-----WEG  189 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc-----ccc
Confidence            4456678899  99999999986   3688899998654332  2223335666666666 49999995555     678


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHH----HHHHHHcCCCCCeeecCCCCCCeEecCC-
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS----ALDYLHNQYDTPIAHCDLKSSNVLLDEG-  304 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~ivH~dlkp~NIll~~~-  304 (477)
                      .+..++-+|++ +.+|.++.+..-      ..++....+....+..+    ||.++|+.   +++|-|+||.||+...+ 
T Consensus       190 ~~~lfiqtE~~-~~sl~~~~~~~~------~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~  259 (524)
T KOG0601|consen  190 SGILFIQTELC-GESLQSYCHTPC------NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDW  259 (524)
T ss_pred             CCcceeeeccc-cchhHHhhhccc------ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheeccccc
Confidence            88899999988 468888776432      33666777788888888    99999999   99999999999999999 


Q ss_pred             CcEEEecccccccccccCCCCCCCccccCCCcccccccCcccccCCCCcccceeehHHHHHHHhhCCCCCC
Q 043902          305 MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTD  375 (477)
Q Consensus       305 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~  375 (477)
                      ...+++|||+...+.+..-...  ........|...|++||..++-++.++|+||+|.++.+..+|..+..
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~--~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~  328 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSV--FKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPS  328 (524)
T ss_pred             ceeecCCcceeEEccCCccccc--eeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhccccc
Confidence            8999999999987744321111  11122335778899999999999999999999999999999877653

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.41  E-value=2.5e-12  Score=127.72  Aligned_cols=169  Identities=22%  Similarity=0.242  Sum_probs=125.3

Q ss_pred             eCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEeecCCCChhhhcccCCCccc
Q 043902          178 LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYC  257 (477)
Q Consensus       178 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~  257 (477)
                      ..++.+|.|...+...........+.++.|+.+|||||+++++.     ++..+..|+|+|.+.  .|..++..      
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t-----~e~~~~~ylvTErV~--Pl~~~lk~------  100 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDT-----TEEEGTLYLVTERVR--PLETVLKE------  100 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhh-----hcccCceEEEeeccc--cHHHHHHH------
Confidence            44788999998886665444567788999999999999999988     467778999999873  56666643      


Q ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcc
Q 043902          258 HFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG  337 (477)
Q Consensus       258 ~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~g  337 (477)
                          ++...+.-.+.||+.||.|||+.|  +++|++|.-+.|+|+..|+.||++|-++.......       ........
T Consensus       101 ----l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~-------~~~~~~~~  167 (690)
T KOG1243|consen  101 ----LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFN-------APAKSLYL  167 (690)
T ss_pred             ----hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCC-------cccccchh
Confidence                335566667899999999999765  99999999999999999999999999886541110       01111122


Q ss_pred             cccccCcccccCCCCcccceeehHHHHHHHhhCCCC
Q 043902          338 SVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRP  373 (477)
Q Consensus       338 t~~y~aPE~~~~~~~~~~Dv~S~Gvvl~elltg~~p  373 (477)
                      -..|..|+.+.. -+-..|.|-|||+++|++.|..+
T Consensus       168 ~~s~~~P~~~~~-s~~s~D~~~Lg~li~el~ng~~~  202 (690)
T KOG1243|consen  168 IESFDDPEEIDP-SEWSIDSWGLGCLIEELFNGSLL  202 (690)
T ss_pred             hhcccChhhcCc-cccchhhhhHHHHHHHHhCcccC
Confidence            234566665411 11446999999999999999433

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.37  E-value=1.9e-12  Score=130.52  Aligned_cols=148  Identities=19%  Similarity=0.201  Sum_probs=95.3

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCC-CCEEEEEEeeeccch----------------------------------hhH--
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQG----------------------------------ALK--  198 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~--  198 (477)
                      ...|+. +.||+|++|.||+|++++ |+.||||+.+..-..                                  ..+  
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            456776 789999999999999987 999999999743110                                  001  


Q ss_pred             ----HHHHHHHHHhcCC----CCCcceeeeecccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHH
Q 043902          199 ----SFIDECNALTSIR----HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI  270 (477)
Q Consensus       199 ----~~~~e~~~l~~l~----h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i  270 (477)
                          ++.+|+..+.+++    +.+.+.+-.++    ++-....++||||+.|+++.++-.-.... .....+....+..+
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~----~d~st~~VLvmE~i~G~~l~d~~~l~~~g-~d~~~la~~~v~~~  272 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVY----WDYCSETVMVMERMYGIPVSDVAALRAAG-TDMKLLAERGVEVF  272 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceee----cccCCCceEEEeeecCccHHhHHHHHhcC-CCHHHHHHHHHHHH
Confidence                2344554444442    33334333332    12234578999999999998742211100 00112333333333


Q ss_pred             HHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC----cEEEeccccccccc
Q 043902          271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM----IAHVGDFGLAKFLF  319 (477)
Q Consensus       271 ~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~DfG~a~~~~  319 (477)
                      +.|+       ...   |++|+|+||.||+++.++    .+++.|||++..+.
T Consensus       273 ~~Qi-------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        273 FTQV-------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             HHHH-------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            4443       345   999999999999999888    99999999998763

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.35  E-value=4.2e-12  Score=110.65  Aligned_cols=131  Identities=19%  Similarity=0.147  Sum_probs=95.8

Q ss_pred             CCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcc-eeeeecccccCCCCceeeEEEeec
Q 043902          162 ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL-KIVSSCSSVDYEGNDFKALVFEFM  240 (477)
Q Consensus       162 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~~~~~~lv~e~~  240 (477)
                      .+.|+.|.++.||+++.. +..+++|+...... ....+.+|+..+..+.+.+++ +++.+.       ....++||||+
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-------~~~~~lv~e~i   73 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-------PETGVLITEFI   73 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-------CCCCeEEEEec
Confidence            357899999999999875 77899999765432 123567899999988655543 455432       12347999999


Q ss_pred             CCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCC--CCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          241 RNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQY--DTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       241 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      ++.++....               .....++.+++++|+.||+..  ...++|+|++|.||+++ ++.++++|||.+..
T Consensus        74 ~G~~l~~~~---------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          74 EGSELLTED---------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             CCCcccccc---------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            998875430               011235678999999999972  12369999999999999 56899999999864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.29  E-value=4.7e-11  Score=104.64  Aligned_cols=135  Identities=21%  Similarity=0.189  Sum_probs=97.3

Q ss_pred             CeeeeeccceEEEEEeCC-------CCEEEEEEeeecc------------c----------hhhHHH----HHHHHHHhc
Q 043902          163 NLIGSGSFGSVYKGTLAD-------GETAAIKVLKLQQ------------Q----------GALKSF----IDECNALTS  209 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~------------~----------~~~~~~----~~e~~~l~~  209 (477)
                      ..||.|.-+.||.|...+       +..+|||+.+...            .          ...+.+    .+|.+.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999997543       4799999986321            0          011223    379999999


Q ss_pred             CCC--CCcceeeeecccccCCCCceeeEEEeecCCCChhh-hcccCCCcccccccCCHHHHHHHHHHHHHHHHHH-HcCC
Q 043902          210 IRH--RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQ-WLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYL-HNQY  285 (477)
Q Consensus       210 l~h--~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~  285 (477)
                      +..  -++.+++++         ...++||||+.++.+.. .+..        ..++..+...+..+++.+|..| |.. 
T Consensus        83 l~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lkd--------~~~~~~~~~~i~~~i~~~l~~l~H~~-  144 (197)
T cd05146          83 MQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLKD--------AKLNDEEMKNAYYQVLSMMKQLYKEC-  144 (197)
T ss_pred             HHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhhc--------cccCHHHHHHHHHHHHHHHHHHHHhC-
Confidence            853  566677654         23589999997654321 1221        1244456677889999999999 777 


Q ss_pred             CCCeeecCCCCCCeEecCCCcEEEecccccccc
Q 043902          286 DTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFL  318 (477)
Q Consensus       286 ~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  318 (477)
                        +++||||++.||++++ +.+.|+|||.+...
T Consensus       145 --glVHGDLs~~NIL~~~-~~v~iIDF~qav~~  174 (197)
T cd05146         145 --NLVHADLSEYNMLWHD-GKVWFIDVSQSVEP  174 (197)
T ss_pred             --CeecCCCCHHHEEEEC-CcEEEEECCCceeC
Confidence              9999999999999974 57999999988643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.25  E-value=7.3e-12  Score=123.26  Aligned_cols=196  Identities=22%  Similarity=0.213  Sum_probs=143.7

Q ss_pred             HHhhcCCCCCCeeeeeccceEEEEEeC--CCCEEEEEEeeeccchhh--HHHHHHHHHHhcC-CCCCcceeeeecccccC
Q 043902          153 SNATDNFSEENLIGSGSFGSVYKGTLA--DGETAAIKVLKLQQQGAL--KSFIDECNALTSI-RHRNILKIVSSCSSVDY  227 (477)
Q Consensus       153 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  227 (477)
                      .....+|..+..||.|.|+.|+....+  ++..|++|.+........  ..-..|+.+...+ .|.++++....     |
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----W  335 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-----W  335 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC-----c
Confidence            334568888999999999999998754  678899998764432222  2234566666666 47788776555     3


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC-Cc
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG-MI  306 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~  306 (477)
                      ......++--||+.++++.......       ..+++..++.+..|++.++.++|+.   .++|+|++|+||++..+ +.
T Consensus       336 ~~~r~~~ip~e~~~~~s~~l~~~~~-------~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~  405 (524)
T KOG0601|consen  336 SQLRQGYIPLEFCEGGSSSLRSVTS-------QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFF  405 (524)
T ss_pred             cccccccCchhhhcCcchhhhhHHH-------HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhh
Confidence            4555667889999999887665322       5578888999999999999999998   99999999999999886 88


Q ss_pred             EEEecccccccccccCCCCCCCccccCCCccccccc-Ccccc--cCCCCcccceeehHHHHHHHhhCCCC
Q 043902          307 AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI-PPEYI--NGHVSILGDIYSYGILLLEIFTGKRP  373 (477)
Q Consensus       307 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~-aPE~~--~~~~~~~~Dv~S~Gvvl~elltg~~p  373 (477)
                      .+++|||.+..+.-         ... .....-++. .+|.+  ...+..+.|+||||..+.|.++|..-
T Consensus       406 ~~~~~~~~~t~~~~---------~~~-~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l  465 (524)
T KOG0601|consen  406 SKLGDFGCWTRLAF---------SSG-VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL  465 (524)
T ss_pred             hhccccccccccce---------ecc-cccccccccccchhhccccccccccccccccccccccccCccc
Confidence            99999999864311         111 111223333 24544  44578899999999999999998754

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.21  E-value=2.2e-10  Score=104.46  Aligned_cols=146  Identities=19%  Similarity=0.197  Sum_probs=109.3

Q ss_pred             CCeeeeeccceEEEEEeCCCCEEEEEEeeeccc-hhhHHHHHHHHHHhcCCC--CCcceeeeecccccCCCCceeeEEEe
Q 043902          162 ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQ-GALKSFIDECNALTSIRH--RNILKIVSSCSSVDYEGNDFKALVFE  238 (477)
Q Consensus       162 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~e  238 (477)
                      .+.|+.|..+.||++...+|+.+++|....... .....+..|.++++.+++  .++.+++.++....  ..+..++|||
T Consensus         3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e   80 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVME   80 (223)
T ss_pred             ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEE
Confidence            357899999999999987778999999765432 134578899999999975  44677777743211  1135689999


Q ss_pred             ecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------
Q 043902          239 FMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQY---------------------------------  285 (477)
Q Consensus       239 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---------------------------------  285 (477)
                      |+++.++.+.+..        ..++..+...++.+++++|..||+..                                 
T Consensus        81 ~i~G~~l~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (223)
T cd05154          81 RVDGRVLRDRLLR--------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTD  152 (223)
T ss_pred             EeCCEecCCCCCC--------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccc
Confidence            9999888775531        13566777788888888888888521                                 


Q ss_pred             --------------------CCCeeecCCCCCCeEecC--CCcEEEeccccccc
Q 043902          286 --------------------DTPIAHCDLKSSNVLLDE--GMIAHVGDFGLAKF  317 (477)
Q Consensus       286 --------------------~~~ivH~dlkp~NIll~~--~~~~kl~DfG~a~~  317 (477)
                                          ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         153 EPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             ccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                245799999999999998  66789999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PLN03150 hypothetical protein; Provisional

Probab=99.19  E-value=3.3e-11  Score=125.80  Aligned_cols=84  Identities=33%  Similarity=0.621  Sum_probs=73.5

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~~   79 (477)
                      |+|++|.|+|.+|.++++|++|+.|+|++|+|+|.+|..++.|++|+.|||++|+|+|.+|.. ..+.++..+.+.+|+ 
T Consensus       423 L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~-  501 (623)
T PLN03150        423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNS-  501 (623)
T ss_pred             EECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCc-
Confidence            579999999999999999999999999999999999999999999999999999999999986 345666666666664 


Q ss_pred             cccccc
Q 043902           80 LCGGIQ   85 (477)
Q Consensus        80 l~g~~~   85 (477)
                      +.|..|
T Consensus       502 l~g~iP  507 (623)
T PLN03150        502 LSGRVP  507 (623)
T ss_pred             ccccCC
Confidence            555543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.15  E-value=3.7e-09  Score=99.77  Aligned_cols=274  Identities=14%  Similarity=0.127  Sum_probs=165.2

Q ss_pred             CCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcC-CCCCcceeeeeccc--ccCCCCceeeEEE
Q 043902          161 EENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSI-RHRNILKIVSSCSS--VDYEGNDFKALVF  237 (477)
Q Consensus       161 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~--~~~~~~~~~~lv~  237 (477)
                      ....||+|+-+.+|-.---  ...+-|++.........   +.++.|... .||-+-.-+.+=..  ..-.......+.|
T Consensus        15 ~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecchh--hchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            4567999999999975321  22355777655433222   233444444 46544331111000  0012233366778


Q ss_pred             eecCCC-ChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccc
Q 043902          238 EFMRNG-NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK  316 (477)
Q Consensus       238 e~~~~g-~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  316 (477)
                      ..+++. ....+..... .........|...++.+..+|.+.+.||..   |.+-||+.++|+|+++++.+.|.|-..-.
T Consensus        90 P~v~g~~pI~~~y~p~t-RRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          90 PKVSGKEPIHMIYSPAT-RRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             ccCCCccchhhhcCchh-hcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence            877664 2344443221 112346689999999999999999999999   99999999999999999999998854332


Q ss_pred             cccccCCCCCCCccccCCCcccccccCccccc-C-----CCCcccceeehHHHHHHHhhC-CCCCCcccccccceeeeee
Q 043902          317 FLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-G-----HVSILGDIYSYGILLLEIFTG-KRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~-----~~~~~~Dv~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~  389 (477)
                      ..        .......+.+|...|.+||..+ +     ..+...|-|.+||++++++.| +.||.+......       
T Consensus       166 i~--------~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~-------  230 (637)
T COG4248         166 IN--------ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISD-------  230 (637)
T ss_pred             ec--------cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCC-------
Confidence            21        1233445667899999999874 2     357789999999999999985 999976422110       


Q ss_pred             ccCCchhH-HHhhhhhhhhhcccccc--cccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCC--CCCCCCChHHHHHH
Q 043902          390 MALPSHVM-DVLDLSMLLEEENDHEK--HEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAA--SPRDRVGMKFVVNN  464 (477)
Q Consensus       390 ~~~~~~~~-~~~d~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~--dP~~RPs~~evl~~  464 (477)
                        -|.... ++-.-............  ...+..+..+            +..+.-+..+|+..  +|.-|||++-++..
T Consensus       231 --ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~L------------pp~vqAlF~qaF~~~~~~~~RP~a~aW~aA  296 (637)
T COG4248         231 --APNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSML------------PPDVQALFQQAFTESGVATPRPTAKAWVAA  296 (637)
T ss_pred             --CCCcchhhhhcceeeechhccCCCCCCCCCCChhhc------------CHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Confidence              000000 00000000000000000  0111111111            23366677788875  46789999999999


Q ss_pred             HHHHHHhh
Q 043902          465 LQAIRSKI  472 (477)
Q Consensus       465 L~~i~~~~  472 (477)
                      |..+++++
T Consensus       297 l~al~~~L  304 (637)
T COG4248         297 LDALRQQL  304 (637)
T ss_pred             HHHHHHhh
Confidence            99998875

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.11  E-value=1e-10  Score=129.93  Aligned_cols=83  Identities=40%  Similarity=0.584  Sum_probs=67.3

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccccc-ccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGI-FANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-~~~~~~~~~~~n~~   79 (477)
                      |+|++|+++|.+|.++++|++|++|+|++|.++|.+|..|+.|++|+.|+|++|+++|.+|.... +.++..+.+.+|+ 
T Consensus       504 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~-  582 (968)
T PLN00113        504 LKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNH-  582 (968)
T ss_pred             EECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCc-
Confidence            57888889888999999999999999999999999999999999999999999999998887633 4556666666665 


Q ss_pred             ccccc
Q 043902           80 LCGGI   84 (477)
Q Consensus        80 l~g~~   84 (477)
                      +.|..
T Consensus       583 l~~~~  587 (968)
T PLN00113        583 LHGSL  587 (968)
T ss_pred             ceeeC
Confidence            44443

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.11  E-value=5.8e-10  Score=97.48  Aligned_cols=125  Identities=23%  Similarity=0.273  Sum_probs=82.6

Q ss_pred             eEEEEEeCCCCEEEEEEeeeccc--------------------------hhhHHHHHHHHHHhcCCCC--Ccceeeeecc
Q 043902          172 SVYKGTLADGETAAIKVLKLQQQ--------------------------GALKSFIDECNALTSIRHR--NILKIVSSCS  223 (477)
Q Consensus       172 ~Vy~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~~l~h~--niv~l~~~~~  223 (477)
                      .||.|...+|..+|+|+.+....                          .......+|.+.|.++..-  ++.+++++- 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            48999988999999999863210                          0123467899999999755  567777651 


Q ss_pred             cccCCCCceeeEEEeecC--CCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHH-HHcCCCCCeeecCCCCCCeE
Q 043902          224 SVDYEGNDFKALVFEFMR--NGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDY-LHNQYDTPIAHCDLKSSNVL  300 (477)
Q Consensus       224 ~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~-LH~~~~~~ivH~dlkp~NIl  300 (477)
                              ...+||||++  |..+..+....         ++......++.+++..+.. +|..   +++||||.+.||+
T Consensus        80 --------~~~ivME~I~~~G~~~~~l~~~~---------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIl  139 (188)
T PF01163_consen   80 --------RNVIVMEYIGEDGVPLPRLKDVD---------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNIL  139 (188)
T ss_dssp             --------TTEEEEE--EETTEEGGCHHHCG---------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEE
T ss_pred             --------CCEEEEEecCCCccchhhHHhcc---------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEE
Confidence                    2479999998  54554433211         1133455677788886665 4677   9999999999999


Q ss_pred             ecCCCcEEEecccccccc
Q 043902          301 LDEGMIAHVGDFGLAKFL  318 (477)
Q Consensus       301 l~~~~~~kl~DfG~a~~~  318 (477)
                      ++++ .+.|+|||.+...
T Consensus       140 v~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  140 VDDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             EETT-CEEE--GTTEEET
T ss_pred             eecc-eEEEEecCcceec
Confidence            9988 8999999988653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.09  E-value=7.2e-10  Score=93.30  Aligned_cols=141  Identities=23%  Similarity=0.290  Sum_probs=99.4

Q ss_pred             CCCeeeeeccceEEEEEeCCCCEEEEEEeeec--------cchhhHHHHHHHHHHhcCCCCCc--ceeeeecccccCCCC
Q 043902          161 EENLIGSGSFGSVYKGTLADGETAAIKVLKLQ--------QQGALKSFIDECNALTSIRHRNI--LKIVSSCSSVDYEGN  230 (477)
Q Consensus       161 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--------~~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~~~~~~  230 (477)
                      ...++-+|+-+.|+++.+ .|+...||.--..        ..-..++..+|++.|.+++--.|  .+++.       .+.
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~-------~D~   82 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF-------IDT   82 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE-------Eec
Confidence            567899999999999998 4777777643211        11223567889999999863333  22222       223


Q ss_pred             ceeeEEEeecCC-CChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC---c
Q 043902          231 DFKALVFEFMRN-GNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM---I  306 (477)
Q Consensus       231 ~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~---~  306 (477)
                      ..-.++|||+++ .++.+++.....     ..........++.+|-+.+.-||.+   +|+||||..+||++..++   .
T Consensus        83 ~~~~i~ME~~~g~~~vk~~i~~~~~-----~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~  154 (229)
T KOG3087|consen   83 YGGQIYMEFIDGASTVKDFILSTME-----DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQIT  154 (229)
T ss_pred             CCCeEEEEeccchhHHHHHHHHHcc-----CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCc
Confidence            345799999977 477887764431     1122233367888999999999999   999999999999996554   5


Q ss_pred             EEEeccccccc
Q 043902          307 AHVGDFGLAKF  317 (477)
Q Consensus       307 ~kl~DfG~a~~  317 (477)
                      +.++|||++..
T Consensus       155 ~~lIdfgls~~  165 (229)
T KOG3087|consen  155 PILIDFGLSSV  165 (229)
T ss_pred             eEEEeecchhc
Confidence            68999999864

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.09  E-value=1e-09  Score=92.90  Aligned_cols=129  Identities=25%  Similarity=0.347  Sum_probs=95.3

Q ss_pred             CeeeeeccceEEEEEeCCCCEEEEEEeeec--c------chhhHHHHHHHHHHhcCCCC--CcceeeeecccccCCCCce
Q 043902          163 NLIGSGSFGSVYKGTLADGETAAIKVLKLQ--Q------QGALKSFIDECNALTSIRHR--NILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~------~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~~~~~~~  232 (477)
                      ..+++|+-+.+|.+.+. |..+++|.-...  .      .-......+|++++.+++--  +...++++       +...
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv-------D~~~   73 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV-------DPDN   73 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-------cCCC
Confidence            35789999999999774 445666643221  1      11234667899999988533  34444443       3445


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      ..++|||++|..|.+.+...              ...++..+-.-+.-||..   +|+|+||.++||++..+. +.++||
T Consensus        74 ~~I~me~I~G~~lkd~l~~~--------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDf  135 (204)
T COG3642          74 GLIVMEYIEGELLKDALEEA--------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDF  135 (204)
T ss_pred             CEEEEEEeCChhHHHHHHhc--------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEEC
Confidence            68999999999999888643              245677788888899999   999999999999998775 999999


Q ss_pred             ccccc
Q 043902          313 GLAKF  317 (477)
Q Consensus       313 G~a~~  317 (477)
                      |++..
T Consensus       136 GLg~~  140 (204)
T COG3642         136 GLGEF  140 (204)
T ss_pred             Ccccc
Confidence            99975

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.07  E-value=1.2e-09  Score=105.47  Aligned_cols=178  Identities=19%  Similarity=0.213  Sum_probs=133.2

Q ss_pred             ccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEeecCC-CChh
Q 043902          169 SFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRN-GNLD  246 (477)
Q Consensus       169 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-g~L~  246 (477)
                      ...+.|++... ||..|++|+++..+.........-++.++++.|+|+|++..++.... .++...++||+|.++ ++|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHH
Confidence            44688999854 89999999996444333334456688999999999999999876443 345678999999987 4676


Q ss_pred             hhcccCCCc--------ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccc
Q 043902          247 QWLHPSTDE--------YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFL  318 (477)
Q Consensus       247 ~~l~~~~~~--------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  318 (477)
                      ++-......        .......++..+|.++.|+..||.++|+.   |+.-+-|.+++|+++.+..++|+..|.....
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence            654332211        22335678899999999999999999999   9999999999999999999999998887665


Q ss_pred             cccCCCCCCCccccCCCcccccccCcccccCCCCcccceeehHHHHHHHhhCCCC
Q 043902          319 FEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRP  373 (477)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~S~Gvvl~elltg~~p  373 (477)
                      ..+..                     |-+.  --.+-|.=.||.+++.|.||..-
T Consensus       444 ~~d~~---------------------~~le--~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  444 QEDPT---------------------EPLE--SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             cCCCC---------------------cchh--HHhhhhHHHHHHHHHHHhhcccc
Confidence            32110                     1111  12345888899999999999654

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.03  E-value=6e-09  Score=96.71  Aligned_cols=146  Identities=14%  Similarity=0.072  Sum_probs=100.9

Q ss_pred             CeeeeeccceEEEEEeCCCCEEEEEEeeeccch-----------hhHHHHHHHHHHhcCCCCC--cceeeeecccccCCC
Q 043902          163 NLIGSGSFGSVYKGTLADGETAAIKVLKLQQQG-----------ALKSFIDECNALTSIRHRN--ILKIVSSCSSVDYEG  229 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~  229 (477)
                      +.+-.-....|.++.+ +|+.+.||........           ....+.+|...+.++...+  ++.++++........
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4444444455777766 6788999977533211           1124788999988884333  344455532111111


Q ss_pred             CceeeEEEeecCCC-ChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC-----
Q 043902          230 NDFKALVFEFMRNG-NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE-----  303 (477)
Q Consensus       230 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-----  303 (477)
                      ....++|||++++. +|.+++.....     ...+......++.+++..+.-||..   ||+|+|++++|||++.     
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~-----~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~  178 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWAT-----NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGR  178 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCC
Confidence            33578999999886 89988753211     2345667788999999999999999   9999999999999975     


Q ss_pred             --CCcEEEeccccccc
Q 043902          304 --GMIAHVGDFGLAKF  317 (477)
Q Consensus       304 --~~~~kl~DfG~a~~  317 (477)
                        +..+.++||+.+..
T Consensus       179 ~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        179 EEDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCCceEEEEECCcccc
Confidence              46899999998853

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.96  E-value=4.7e-09  Score=94.25  Aligned_cols=133  Identities=22%  Similarity=0.214  Sum_probs=96.4

Q ss_pred             CCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccc----------------------hhhHHHHHHHHHHhcCCCC--Cc
Q 043902          160 SEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQ----------------------GALKSFIDECNALTSIRHR--NI  215 (477)
Q Consensus       160 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~--ni  215 (477)
                      .+...||-|.-+.||.|..+.|..+|||.-+....                      -......+|.+.|++|...  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            34578999999999999999999999997542210                      0123467899999999654  67


Q ss_pred             ceeeeecccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCC
Q 043902          216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLK  295 (477)
Q Consensus       216 v~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk  295 (477)
                      .+.+++         +...+||||++|-.|...-            ++....-.++..|++-+.-+-..   ||||||++
T Consensus       174 P~P~~~---------nRHaVvMe~ieG~eL~~~r------------~~~en~~~il~~il~~~~~~~~~---GiVHGDlS  229 (304)
T COG0478         174 PKPIAW---------NRHAVVMEYIEGVELYRLR------------LDVENPDEILDKILEEVRKAYRR---GIVHGDLS  229 (304)
T ss_pred             CCcccc---------ccceeeeehcccceeeccc------------CcccCHHHHHHHHHHHHHHHHHc---CccccCCc
Confidence            776654         4568999999886665432            12223334444455545444455   99999999


Q ss_pred             CCCeEecCCCcEEEecccccc
Q 043902          296 SSNVLLDEGMIAHVGDFGLAK  316 (477)
Q Consensus       296 p~NIll~~~~~~kl~DfG~a~  316 (477)
                      +-||+++++|.+.++||--+.
T Consensus       230 efNIlV~~dg~~~vIDwPQ~v  250 (304)
T COG0478         230 EFNILVTEDGDIVVIDWPQAV  250 (304)
T ss_pred             hheEEEecCCCEEEEeCcccc
Confidence            999999999999999996553

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.89  E-value=1.1e-09  Score=77.34  Aligned_cols=55  Identities=49%  Similarity=0.632  Sum_probs=49.4

Q ss_pred             CeecCCcccccCc-hhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccc
Q 043902            1 LYLGNNSFKGTIP-VSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL   56 (477)
Q Consensus         1 l~l~~n~~~g~~p-~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l   56 (477)
                      |+|++|+|+ .|| ..|.++++|++|++++|+|+..-|..|..|++|++|++++|+|
T Consensus         6 L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    6 LDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             EEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             EECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            589999999 566 5699999999999999999966677999999999999999986

...

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.88  E-value=5.3e-10  Score=116.19  Aligned_cols=210  Identities=23%  Similarity=0.301  Sum_probs=138.1

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      ..+.+.+.+-+.+|.++.++.+.-. .|...+.|+.....   ....+....+-.++-..++|-++...--     +...
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-----~~~r  876 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-----FPCR  876 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-----CCCC
Confidence            3456667777888999988887643 34333344332111   1111222222222222234444443322     2456


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ...+++++|..+++|...|+...       ..+..-.......+..++.|||+.   .+.|+|++|.|++...++..+++
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~~~-------~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~  946 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHNSG-------CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLT  946 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhcCC-------CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccC
Confidence            67899999999999999998653       234444455666788999999997   79999999999999999999999


Q ss_pred             cccccccccccC---------------------CC---CCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHH
Q 043902          311 DFGLAKFLFEES---------------------NT---PSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLL  365 (477)
Q Consensus       311 DfG~a~~~~~~~---------------------~~---~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~  365 (477)
                      |||.........                     ..   ............||..|.+||.. .......+|+|++|++++
T Consensus       947 ~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~ 1026 (1205)
T KOG0606|consen  947 DFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLF 1026 (1205)
T ss_pred             ccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhh
Confidence            998433221100                     00   00001223445689999999998 556788999999999999


Q ss_pred             HHhhCCCCCCcccc
Q 043902          366 EIFTGKRPTDDMFK  379 (477)
Q Consensus       366 elltg~~p~~~~~~  379 (477)
                      |.++|.+||.....
T Consensus      1027 e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 1027 EVLTGIPPFNAETP 1040 (1205)
T ss_pred             hhhcCCCCCCCcch
Confidence            99999999976443

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=98.83  E-value=5.8e-10  Score=92.30  Aligned_cols=75  Identities=31%  Similarity=0.518  Sum_probs=67.6

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~   78 (477)
                      |-||+|+++ .+|+.+..|.+|+.|++++|+++ .+|.++++|++|+.|+++-|+|. .+|.. ++++.+..+++..||
T Consensus        38 LtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynn  113 (264)
T KOG0617|consen   38 LTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNN  113 (264)
T ss_pred             hhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccc
Confidence            468999999 99999999999999999999999 99999999999999999999999 67776 557777777777775

>PRK09902 hypothetical protein; Provisional

Probab=98.80  E-value=1.1e-07  Score=83.75  Aligned_cols=148  Identities=18%  Similarity=0.113  Sum_probs=106.5

Q ss_pred             CCCeeeeeccceEEEEEeCCCCEEEEEEeeecc------chhhHHHHHHHHHHhcCCC--CCcceeeeecccccCCCCce
Q 043902          161 EENLIGSGSFGSVYKGTLADGETAAIKVLKLQQ------QGALKSFIDECNALTSIRH--RNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       161 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~~~~  232 (477)
                      +.---|+||-+.|++..+. |..+-+|.-....      .-....|.+|+..+.++..  -.+.+.+ ++........-.
T Consensus        22 e~pN~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~r   99 (216)
T PRK09902         22 EEPNYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWR   99 (216)
T ss_pred             cCCCcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceE
Confidence            3334577899999998874 4568888754111      2245789999999999853  3355554 332211223345


Q ss_pred             eeEEEeecCC-CChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCc--EEE
Q 043902          233 KALVFEFMRN-GNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI--AHV  309 (477)
Q Consensus       233 ~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~--~kl  309 (477)
                      .+||+|-+++ -+|.+++....     ..+.+...+..+..+++..+.-||+.   ++.|+|+.+.||+++.++.  +++
T Consensus       100 A~LVTe~L~g~~~L~~~l~~~~-----~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~l  171 (216)
T PRK09902        100 ALLVTEDMAGFISIADWYAQHA-----VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGF  171 (216)
T ss_pred             EEEEEEeCCCCccHHHHHhcCC-----cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEE
Confidence            6799997754 58998886532     13467788889999999999999999   9999999999999986666  999


Q ss_pred             ecccccccc
Q 043902          310 GDFGLAKFL  318 (477)
Q Consensus       310 ~DfG~a~~~  318 (477)
                      +||--++..
T Consensus       172 IDlEk~r~~  180 (216)
T PRK09902        172 LDLEKSRRR  180 (216)
T ss_pred             EEhhccchh
Confidence            999877643

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.75  E-value=3.5e-09  Score=106.08  Aligned_cols=100  Identities=18%  Similarity=0.398  Sum_probs=74.5

Q ss_pred             HHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccccccCCCCCC--CccccCCCcccccccCccccc-
Q 043902          272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK--NQTMSNGLKGSVGYIPPEYIN-  348 (477)
Q Consensus       272 ~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~-  348 (477)
                      .+++.||.|+|..  +++||++|.|++|.++.++.+||+.|+.+.........+-.  +............|.|||++. 
T Consensus       106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            3455999999986  59999999999999999999999999988655331111111  111122233467799999994 


Q ss_pred             CCCCcccceeehHHHHHHHhhCCCC
Q 043902          349 GHVSILGDIYSYGILLLEIFTGKRP  373 (477)
Q Consensus       349 ~~~~~~~Dv~S~Gvvl~elltg~~p  373 (477)
                      ...+.++|+||+||++|.+..|..+
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~  208 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKS  208 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcc
Confidence            4578999999999999999954443

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=98.75  E-value=2.5e-09  Score=88.60  Aligned_cols=82  Identities=26%  Similarity=0.395  Sum_probs=68.1

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccC-cCcccccccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDG-EISREGIFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g-~~p~~~~~~~~~~~~~~~n~~   79 (477)
                      |+++||+++ .+|.++++|++|+.|+++.|+|. .+|..||+++.|+.|||++|+|+. .+|..+..+......+.+.|.
T Consensus        61 ln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dnd  138 (264)
T KOG0617|consen   61 LNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDND  138 (264)
T ss_pred             hhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCC
Confidence            689999999 99999999999999999999999 999999999999999999999986 577775544444444455555


Q ss_pred             ccccc
Q 043902           80 LCGGI   84 (477)
Q Consensus        80 l~g~~   84 (477)
                      +.--+
T Consensus       139 fe~lp  143 (264)
T KOG0617|consen  139 FEILP  143 (264)
T ss_pred             cccCC
Confidence            55444

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.73  E-value=1.1e-07  Score=85.32  Aligned_cols=110  Identities=23%  Similarity=0.219  Sum_probs=83.9

Q ss_pred             HHHHHHHHHHhcCC--CCCcceeeeecccccCCCCceeeEEEeecCCC-ChhhhcccCCCcccccccCCHHHHHHHHHHH
Q 043902          198 KSFIDECNALTSIR--HRNILKIVSSCSSVDYEGNDFKALVFEFMRNG-NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV  274 (477)
Q Consensus       198 ~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i  274 (477)
                      ....+|...+.++.  .-.+.+.+++..... ......++|+|++++. +|.+++....       ..+......++.++
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~~~~~~-------~~~~~~~~~ll~~l  127 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDLLQQWE-------QLDPSQRRELLRAL  127 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHHHHhhc-------ccchhhHHHHHHHH
Confidence            46778888888774  334556666643211 1124468999999884 7999887532       25566778899999


Q ss_pred             HHHHHHHHcCCCCCeeecCCCCCCeEecCCC---cEEEecccccccc
Q 043902          275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGM---IAHVGDFGLAKFL  318 (477)
Q Consensus       275 a~~L~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~DfG~a~~~  318 (477)
                      +..++-||..   ||+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       128 ~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  128 ARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999999   999999999999999887   8999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.62  E-value=2.1e-07  Score=93.70  Aligned_cols=145  Identities=19%  Similarity=0.238  Sum_probs=93.6

Q ss_pred             cCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchh------------------------------hH--------
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGA------------------------------LK--------  198 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------~~--------  198 (477)
                      ..|+. +.|+.++-|.||+|++++|+.||||+.+..-...                              .+        
T Consensus       126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~  204 (517)
T COG0661         126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE  204 (517)
T ss_pred             HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence            34443 6899999999999999999999999986431110                              00        


Q ss_pred             --HHHHHHHHHhcCC----CCCcceeeeecccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHH
Q 043902          199 --SFIDECNALTSIR----HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI  272 (477)
Q Consensus       199 --~~~~e~~~l~~l~----h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~  272 (477)
                        ++.+|...+.+++    ...-+++-.+|    ++-.....++|||++|-.+.+......      ...+...   ++.
T Consensus       205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~----we~t~~~VLtmE~i~Gi~i~d~~~l~~------~g~d~k~---ia~  271 (517)
T COG0661         205 ELDYRREAANAERFRENFKDDPDVYVPKVY----WEYTTRRVLTMEWIDGIKISDIAALKS------AGIDRKE---LAE  271 (517)
T ss_pred             HhCHHHHHHHHHHHHHHcCCCCCeEeceee----hhccCCcEEEEEeeCCEecccHHHHHh------cCCCHHH---HHH
Confidence              1344555555442    22222333333    344456789999999998888743222      2233223   222


Q ss_pred             HHHHH-HHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccc
Q 043902          273 DVASA-LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFL  318 (477)
Q Consensus       273 ~ia~~-L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  318 (477)
                      .++++ +..+-..   |+.|.|.+|.||+++.++...+.|||+...+
T Consensus       272 ~~~~~f~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l  315 (517)
T COG0661         272 LLVRAFLRQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRL  315 (517)
T ss_pred             HHHHHHHHHHHhc---CccccCCCccceEEecCCcEEEEcCcceecC
Confidence            22221 2222223   9999999999999999999999999999776

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.62  E-value=2.9e-08  Score=64.30  Aligned_cols=40  Identities=45%  Similarity=0.652  Sum_probs=34.3

Q ss_pred             CCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCc
Q 043902           20 RGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEIS   61 (477)
Q Consensus        20 ~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p   61 (477)
                      ++|++|+|++|+|+ .||..|++|++|+.|+|++|+|+ .+|
T Consensus         1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~-~i~   40 (44)
T PF12799_consen    1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS-DIS   40 (44)
T ss_dssp             TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS-BEG
T ss_pred             CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC-CCc
Confidence            57999999999999 89988999999999999999999 444

...

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.59  E-value=7.3e-07  Score=78.77  Aligned_cols=142  Identities=13%  Similarity=0.150  Sum_probs=93.2

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHH---------HHHHHHHHhcCC---CCCcceeeeec
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKS---------FIDECNALTSIR---HRNILKIVSSC  222 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~---h~niv~l~~~~  222 (477)
                      ...+|...+++-......|.+-.. +|..+++|..+.......+.         ..+.+..+.+++   -.....++.++
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            346777778888877777777777 57899999887554322222         123333333432   22333333332


Q ss_pred             ccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec
Q 043902          223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD  302 (477)
Q Consensus       223 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~  302 (477)
                      .-..+.-....+++|||++|..|.++..           ++.    .++..+++++.-||..   |++|+|..|.|++++
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~  169 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVS  169 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-----------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEE
Confidence            2222222344578999999988866532           222    2456678889999999   999999999999998


Q ss_pred             CCCcEEEecccccc
Q 043902          303 EGMIAHVGDFGLAK  316 (477)
Q Consensus       303 ~~~~~kl~DfG~a~  316 (477)
                      +++ +++.||+..+
T Consensus       170 ~~~-i~iID~~~k~  182 (229)
T PF06176_consen  170 NNG-IRIIDTQGKR  182 (229)
T ss_pred             CCc-EEEEECcccc
Confidence            665 8999998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.46  E-value=2.3e-06  Score=76.41  Aligned_cols=151  Identities=19%  Similarity=0.179  Sum_probs=98.9

Q ss_pred             cHHHHHHhhcCCCCCCe---eeeeccceEEEEEeCCCCEEEEEEeeeccchh-------------------h-----HHH
Q 043902          148 SYLKISNATDNFSEENL---IGSGSFGSVYKGTLADGETAAIKVLKLQQQGA-------------------L-----KSF  200 (477)
Q Consensus       148 ~~~~~~~~~~~~~~~~~---lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------~-----~~~  200 (477)
                      +...+....++..+...   |+.|.-+.||+|...++..+|+|+++......                   .     .-.
T Consensus        36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~  115 (268)
T COG1718          36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA  115 (268)
T ss_pred             HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence            33444444455554444   45566678999998889999999997432111                   0     113


Q ss_pred             HHHHHHHhcCC--CCCcceeeeecccccCCCCceeeEEEeecCCCC-hhhhcccCCCcccccccCCHHHHHHHHHHHHHH
Q 043902          201 IDECNALTSIR--HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGN-LDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA  277 (477)
Q Consensus       201 ~~e~~~l~~l~--h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~  277 (477)
                      .+|...|.++.  +-.+.+.+++.         .-.|||||+.... -.-.|+.        ..+...+...+..++++.
T Consensus       116 ~kEf~NL~R~~eAGVrvP~Pi~~~---------~nVLvMEfIg~~g~pAP~LkD--------v~~e~~e~~~~~~~~v~~  178 (268)
T COG1718         116 RKEFRNLKRAYEAGVRVPEPIAFR---------NNVLVMEFIGDDGLPAPRLKD--------VPLELEEAEGLYEDVVEY  178 (268)
T ss_pred             HHHHHHHHHHHHcCCCCCCceeec---------CCeEEEEeccCCCCCCCCccc--------CCcCchhHHHHHHHHHHH
Confidence            45777777773  44555555542         2479999996531 1111111        122333566777888888


Q ss_pred             HHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccc
Q 043902          278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFL  318 (477)
Q Consensus       278 L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  318 (477)
                      +.-|-..  .++||+||+.=|||+. ++.+.|+|||-|...
T Consensus       179 ~~~l~~~--a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         179 MRRLYKE--AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             HHHHHHh--cCcccccchhhheEEE-CCeEEEEECcccccc
Confidence            8888762  2999999999999999 779999999988644

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.42  E-value=3.3e-06  Score=76.82  Aligned_cols=144  Identities=13%  Similarity=0.137  Sum_probs=82.3

Q ss_pred             CeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCC--cceeeeecccccCCCCceeeEEEeec
Q 043902          163 NLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRN--ILKIVSSCSSVDYEGNDFKALVFEFM  240 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~~~~~~lv~e~~  240 (477)
                      ..||+|..+.||+.   .|..+++|......  ......+|.+.+..+..-.  +.+.++++     ...+...+|||++
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i   76 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELI   76 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeec
Confidence            57899999999984   25567888876533  2245688999998885433  45666664     3344567899999


Q ss_pred             CCCC-hhhhcccCCC--------------cc--cccccCCHHHHH-HHHH----------HHHH-HHHHHHcC-CCCCee
Q 043902          241 RNGN-LDQWLHPSTD--------------EY--CHFKKLSLMQRL-NIVI----------DVAS-ALDYLHNQ-YDTPIA  290 (477)
Q Consensus       241 ~~g~-L~~~l~~~~~--------------~~--~~~~~l~~~~~~-~i~~----------~ia~-~L~~LH~~-~~~~iv  290 (477)
                      +|.+ +...+.....              ..  ............ .+..          .+.. ...+|... ..+.++
T Consensus        77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~  156 (226)
T TIGR02172        77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL  156 (226)
T ss_pred             CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence            8863 2222211000              00  000000111000 0000          0011 12222211 134679


Q ss_pred             ecCCCCCCeEecCCCcEEEeccccccc
Q 043902          291 HCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       291 H~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      |+|+.|.||++++++ +.++||+.+..
T Consensus       157 HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       157 HGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            999999999999888 99999998754

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.37  E-value=2.4e-06  Score=85.73  Aligned_cols=142  Identities=18%  Similarity=0.248  Sum_probs=91.5

Q ss_pred             CCeeeeeccceEEEEEeCCCCEEEEEEeeeccchh-------------------------------hH------HHHHHH
Q 043902          162 ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGA-------------------------------LK------SFIDEC  204 (477)
Q Consensus       162 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------~~------~~~~e~  204 (477)
                      .+.||.-+.|.||+|++++|+.||||+-+..-...                               .+      +|.+|+
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            36899999999999999999999999876331110                               00      244555


Q ss_pred             HHHhcC----CCCCc---ceeeeecccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHH
Q 043902          205 NALTSI----RHRNI---LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA  277 (477)
Q Consensus       205 ~~l~~l----~h~ni---v~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~  277 (477)
                      +...++    +|-+.   |.+-.++    ++-.....|+||||+|..+.+.-.-..      ..++...+..-+.+...-
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy----~~~st~RVLtME~~~G~~i~Dl~~i~~------~gi~~~~i~~~l~~~~~~  315 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVY----WDLSTKRVLTMEYVDGIKINDLDAIDK------RGISPHDILNKLVEAYLE  315 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeeh----hhcCcceEEEEEecCCccCCCHHHHHH------cCCCHHHHHHHHHHHHHH
Confidence            544333    35441   1122222    344556899999999987766533221      335555444433333222


Q ss_pred             HHHHHcCCCCCeeecCCCCCCeEecC----CCcEEEecccccccc
Q 043902          278 LDYLHNQYDTPIAHCDLKSSNVLLDE----GMIAHVGDFGLAKFL  318 (477)
Q Consensus       278 L~~LH~~~~~~ivH~dlkp~NIll~~----~~~~kl~DfG~a~~~  318 (477)
                      +-+-     .|++|+|=+|.||+++.    ++.+.+-|||+....
T Consensus       316 qIf~-----~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  316 QIFK-----TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             HHHh-----cCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence            2222     28999999999999983    678999999998765

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=98.34  E-value=8.5e-08  Score=94.69  Aligned_cols=76  Identities=26%  Similarity=0.383  Sum_probs=55.7

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcc-cCCCCCCCeEEcccccccCcCcccccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQF-FSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~   78 (477)
                      ||||+|+|+ ..|..+.+-+++.+|+||+|++. +||.+ |.+|+.|-+||||+|+|....|..-.+..+..+.+++|+
T Consensus       108 lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NP  184 (1255)
T KOG0444|consen  108 LDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNP  184 (1255)
T ss_pred             eecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCCh
Confidence            577888888 78888888888888888888887 77765 467778888888888888655555555666666666664

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.32  E-value=2.4e-07  Score=79.79  Aligned_cols=72  Identities=33%  Similarity=0.418  Sum_probs=20.1

Q ss_pred             CeecCCcccccCchhcc-CCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc--ccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLK-SLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE--GIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~-~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~~~~~~~~~~n   77 (477)
                      |+|++|+|+ .|. .++ .|++|+.||||+|.++ .|+ .+..|++|+.|+|++|+++ .++..  ..+.++..+.+.+|
T Consensus        24 L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N   98 (175)
T PF14580_consen   24 LNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNN   98 (175)
T ss_dssp             --------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS
T ss_pred             ccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCC
Confidence            567777777 564 455 5777777777777777 554 3666777777777777777 34322  12455555555444

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.27  E-value=4.9e-06  Score=73.14  Aligned_cols=105  Identities=19%  Similarity=0.224  Sum_probs=83.1

Q ss_pred             HHHHHHHhcCCC-CCcceeeeecccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHH
Q 043902          201 IDECNALTSIRH-RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD  279 (477)
Q Consensus       201 ~~e~~~l~~l~h-~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~  279 (477)
                      .+|.-+++.+.+ +++++++|+|.         .++|+||...+++...-...    ......+|..+.+||.++++.+.
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG---------~~~v~E~~~~~~~~~~~~~l----~~~~~~~w~~R~~iA~~lL~~l~   73 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG---------RFYVVEYVGAGSLYGIYRPL----SQFLQSPWEQRAKIALQLLELLE   73 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC---------CEEEEEeecCcccccccccc----ccccccCHHHHHHHHHHHHHHHH
Confidence            357888888876 69999999994         37899999877664321000    01234689999999999999999


Q ss_pred             HHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccc
Q 043902          280 YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFL  318 (477)
Q Consensus       280 ~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  318 (477)
                      ++++.....+.-.|++++|+-+++++.+|+.|...+...
T Consensus        74 ~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   74 ELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             HHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            999965546888999999999999999999999877543

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=98.27  E-value=2.3e-07  Score=87.12  Aligned_cols=75  Identities=31%  Similarity=0.414  Sum_probs=58.5

Q ss_pred             CeecCCcccccCchhcc-CCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLK-SLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~-~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~   78 (477)
                      |+++.|+++ .+|.+.+ +|.+|..|||.+|+|+ .+|..+.-|.+|.+||||+|.+++..++.+.+ .+..+.+.||+
T Consensus       233 lh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNP  308 (565)
T KOG0472|consen  233 LHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNP  308 (565)
T ss_pred             HHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCc
Confidence            456778888 8888865 8888888888888888 88888888888888888888888655544433 67777777775

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.25  E-value=1.3e-05  Score=73.35  Aligned_cols=148  Identities=21%  Similarity=0.255  Sum_probs=84.8

Q ss_pred             CCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCC--CcceeeeecccccCCCCceeeEEEee
Q 043902          162 ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHR--NILKIVSSCSSVDYEGNDFKALVFEF  239 (477)
Q Consensus       162 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~~~~~~~~~lv~e~  239 (477)
                      ++.++.|..+.||++...+ ..+++|.....  .......+|..++..+...  .+.+++.++..  .......+++|++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~--~~~~~~~~~~~~~   76 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTS--DEFNGFPYLLMEY   76 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEE--TEETSEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeeccc--ccccccceEEEEE
Confidence            3578999999999999876 69999997655  3346677888888877432  35666664321  1223347899999


Q ss_pred             cCCCChhh----------------hc---ccCCCcccccccCCHHH---------HHHH------------HHHHHH-HH
Q 043902          240 MRNGNLDQ----------------WL---HPSTDEYCHFKKLSLMQ---------RLNI------------VIDVAS-AL  278 (477)
Q Consensus       240 ~~~g~L~~----------------~l---~~~~~~~~~~~~l~~~~---------~~~i------------~~~ia~-~L  278 (477)
                      +++.++..                .+   +....   .........         ....            ...+.+ .+
T Consensus        77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (239)
T PF01636_consen   77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPP---PFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL  153 (239)
T ss_dssp             ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHT---TCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred             eccccccccccccccccccccchhhhhhcccccc---cccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence            99988877                11   11100   000000000         0000            111222 23


Q ss_pred             HHHHc----CCCCCeeecCCCCCCeEec-CCCcEEEeccccccc
Q 043902          279 DYLHN----QYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKF  317 (477)
Q Consensus       279 ~~LH~----~~~~~ivH~dlkp~NIll~-~~~~~kl~DfG~a~~  317 (477)
                      ..++.    .....++|+|+.|.||+++ +++.+.|.||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            33332    1234799999999999999 566667999988754

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.24  E-value=5.4e-07  Score=63.48  Aligned_cols=59  Identities=32%  Similarity=0.403  Sum_probs=46.2

Q ss_pred             CCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCC
Q 043902           20 RGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGND   78 (477)
Q Consensus        20 ~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~   78 (477)
                      ++|++|+|++|+|+..-+..|..+++|++|++++|+++...|.. ..+.++..+.+.+|+
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            57999999999999444468999999999999999999554444 335666677776664

...

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=98.24  E-value=3.5e-07  Score=85.93  Aligned_cols=54  Identities=39%  Similarity=0.596  Sum_probs=38.3

Q ss_pred             eecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEccccccc
Q 043902            2 YLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELD   57 (477)
Q Consensus         2 ~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~   57 (477)
                      .+++|.++ -+|..++.+++|+.|+|++|-|. .+|..++.+..|+.||+|+|+|.
T Consensus       418 ~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr  471 (565)
T KOG0472|consen  418 VLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR  471 (565)
T ss_pred             HhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc
Confidence            35556665 67777777777777777777766 77777777777777777777775

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.23  E-value=7.2e-07  Score=57.73  Aligned_cols=35  Identities=37%  Similarity=0.555  Sum_probs=31.4

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVP   37 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p   37 (477)
                      |+|++|+|+ .||+++++|++|+.|+|++|+|+ .+|
T Consensus         6 L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~-~i~   40 (44)
T PF12799_consen    6 LDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS-DIS   40 (44)
T ss_dssp             EEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS-BEG
T ss_pred             EEccCCCCc-ccCchHhCCCCCCEEEecCCCCC-CCc
Confidence            689999999 89999999999999999999999 554

...

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.22  E-value=3.1e-07  Score=91.41  Aligned_cols=184  Identities=17%  Similarity=0.145  Sum_probs=130.4

Q ss_pred             CCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCC-cceeeeecccccCCCCceeeEEEe
Q 043902          160 SEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRN-ILKIVSSCSSVDYEGNDFKALVFE  238 (477)
Q Consensus       160 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~~~~~~lv~e  238 (477)
                      ...+-+++|+++++++.+-...+....+.+...     ....-++++|.+++||| .+..++-     ++.+.+.+++++
T Consensus       245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d-----~~~E~~~~i~~~  314 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLED-----YDGEDYLWIPMR  314 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCccccccc-----CCcccccchhhh
Confidence            334557899999999987543344445555432     33456889999999999 4444443     466778899999


Q ss_pred             ecCCC-ChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          239 FMRNG-NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       239 ~~~~g-~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      ++.++ +-........      ..+...+...+...-+++++++|+.   .=+|+|    ||+..+ ...+..||+....
T Consensus       315 i~s~~rs~~~~~~~se------~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~  380 (829)
T KOG0576|consen  315 ICSTGRSSALEMTVSE------IALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQ  380 (829)
T ss_pred             hhcCCccccccCChhh------Hhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcc
Confidence            99877 2222221111      3345556667788888999999986   558888    777655 5789999999876


Q ss_pred             ccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCC
Q 043902          318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTD  375 (477)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~  375 (477)
                      +..        ........++..|+|||+. .+.+..+.|+|+.|+-..++--|-+|-.
T Consensus       381 L~~--------~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  381 LTR--------TMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             cCc--------ccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            632        1134556789999999987 6778999999999998777777777753

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=98.14  E-value=4.9e-07  Score=89.50  Aligned_cols=60  Identities=30%  Similarity=0.411  Sum_probs=45.8

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE   63 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~   63 (477)
                      +|||.|+|. .+|..+-++.+|+.|+||+|.|| .+-...+...+|+.||||.|+|+ .+|+.
T Consensus       227 vDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~a  286 (1255)
T KOG0444|consen  227 VDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDA  286 (1255)
T ss_pred             ccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHH
Confidence            467888888 88888888888888888888887 66666677777777777777777 56655

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.11  E-value=3.6e-07  Score=73.16  Aligned_cols=55  Identities=33%  Similarity=0.544  Sum_probs=45.3

Q ss_pred             eecCCcccccCchhccCC-CCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccC
Q 043902            2 YLGNNSFKGTIPVSLKSL-RGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDG   58 (477)
Q Consensus         2 ~l~~n~~~g~~p~~~~~l-~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g   58 (477)
                      +|++|.|. .+|..|... +.++.|+|++|.|+ .+|.++..|+.|+.||+++|.|.-
T Consensus        59 ~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~~  114 (177)
T KOG4579|consen   59 SLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLNA  114 (177)
T ss_pred             ecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCcccc
Confidence            67888888 788776554 47888888888888 888888888888888888888884

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.09  E-value=4.7e-05  Score=70.39  Aligned_cols=141  Identities=13%  Similarity=0.093  Sum_probs=83.0

Q ss_pred             eeeecc-ceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCC-CCCcceeeeecccccCCCCceeeEEEeecCC
Q 043902          165 IGSGSF-GSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIR-HRNILKIVSSCSSVDYEGNDFKALVFEFMRN  242 (477)
Q Consensus       165 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~  242 (477)
                      |..|.+ ..||+.... +..+.+|+.....   .....+|++++..+. +--+.+++++.     ...+..++|||+++|
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~-----~~~~~~~lv~e~i~G   76 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYG-----SDDGRAWLLTSAVPG   76 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEE-----ecCCccEEEEEeeCC
Confidence            445555 789999864 4788888876543   235667888887773 34455666663     223457899999999


Q ss_pred             CChhhhcc-------------------cCCCcccccccCC--HHHHHHHHH--------------------HHHHHHHHH
Q 043902          243 GNLDQWLH-------------------PSTDEYCHFKKLS--LMQRLNIVI--------------------DVASALDYL  281 (477)
Q Consensus       243 g~L~~~l~-------------------~~~~~~~~~~~l~--~~~~~~i~~--------------------~ia~~L~~L  281 (477)
                      .++.....                   .....   .....  ....+....                    .+...+..|
T Consensus        77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  153 (244)
T cd05150          77 VPAAALWEELEPERLVDALAEALRRLHALPVA---DCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAEL  153 (244)
T ss_pred             ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcc---cCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHH
Confidence            87764421                   10000   00110  000000000                    011112222


Q ss_pred             Hc----CCCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          282 HN----QYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       282 H~----~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      -.    ...+.++|+|+.|.||+++++..+.|+||+.+..
T Consensus       154 ~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         154 EATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             HhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            11    1234699999999999999987788999998753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.07  E-value=2.1e-05  Score=66.56  Aligned_cols=128  Identities=20%  Similarity=0.247  Sum_probs=87.9

Q ss_pred             CCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcc-eeeeecccccCCCCceeeEEEe
Q 043902          160 SEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL-KIVSSCSSVDYEGNDFKALVFE  238 (477)
Q Consensus       160 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~~~~~~lv~e  238 (477)
                      ...+.|++|.+|.||++.+. |..+|+|+-+..+.  ...+..|+++|..+.-.++. +++.|.         .-.+.||
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg---------~~~i~me   92 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYG---------EDFIRME   92 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEec---------hhhhhhh
Confidence            35678999999999999995 56889888775543  37889999999999866654 444441         2345699


Q ss_pred             ecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCC--CCeEecCCCcEEEecccccc
Q 043902          239 FMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKS--SNVLLDEGMIAHVGDFGLAK  316 (477)
Q Consensus       239 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp--~NIll~~~~~~kl~DfG~a~  316 (477)
                      |+.|-+|.++-...          +-.+    ...+++.-.-|-..   ||-|+.|.-  .||++.+ ..+.|+||..|.
T Consensus        93 ~i~G~~L~~~~~~~----------~rk~----l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~-~~~~iIDFd~At  154 (201)
T COG2112          93 YIDGRPLGKLEIGG----------DRKH----LLRVLEKAYKLDRL---GIEHGELSRPWKNVLVND-RDVYIIDFDSAT  154 (201)
T ss_pred             hhcCcchhhhhhcc----------cHHH----HHHHHHHHHHHHHh---ccchhhhcCCceeEEecC-CcEEEEEccchh
Confidence            99887887654321          1222    33344443334444   899998864  4555544 489999999887


Q ss_pred             c
Q 043902          317 F  317 (477)
Q Consensus       317 ~  317 (477)
                      .
T Consensus       155 ~  155 (201)
T COG2112         155 F  155 (201)
T ss_pred             h
Confidence            4

>PRK10593 hypothetical protein; Provisional

Probab=98.06  E-value=0.0001  Score=70.17  Aligned_cols=82  Identities=10%  Similarity=0.094  Sum_probs=58.6

Q ss_pred             CCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCC---CCcceeeeecccccCCCCceeeE
Q 043902          159 FSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRH---RNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       159 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      ....+.||.|..+.||+....++ .+++|..+...  ....+..|.+.|+.+.-   -.+.+++++|...  ...+..++
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~--~~~g~~~L   90 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE--QSPGPDVL   90 (297)
T ss_pred             hheeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccC--CcCCCeEE
Confidence            34456899999999999987656 46777754321  22578899999988843   4678888876421  22455899


Q ss_pred             EEeecCCCCh
Q 043902          236 VFEFMRNGNL  245 (477)
Q Consensus       236 v~e~~~~g~L  245 (477)
                      |||+++++++
T Consensus        91 VmE~i~G~~~  100 (297)
T PRK10593         91 LLERLRGVSV  100 (297)
T ss_pred             EEeccCCEec
Confidence            9999998765

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.05  E-value=0.0001  Score=65.11  Aligned_cols=135  Identities=21%  Similarity=0.280  Sum_probs=92.3

Q ss_pred             CCCCeeeeeccceEEEEEeCCCCEEEEEEeeecc----------------chhhHHHHHHHHHHhcCC------CCCcce
Q 043902          160 SEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQ----------------QGALKSFIDECNALTSIR------HRNILK  217 (477)
Q Consensus       160 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv~  217 (477)
                      +....||+|+.-.||.-  ++....+||+.+...                .....+..+|+....++.      +.+|.+
T Consensus         4 ~~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    4 SESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            34568999999999973  456677899887655                223456677777666555      888999


Q ss_pred             eeeecccccCCCCceeeEEEeecCC------CChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeee
Q 043902          218 IVSSCSSVDYEGNDFKALVFEFMRN------GNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAH  291 (477)
Q Consensus       218 l~~~~~~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH  291 (477)
                      ++|+.     +++....+|+|.+.+      -+|.+++...        .++. ...+.   +-+-..||-+.   .|+.
T Consensus        82 ~~G~v-----eT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--------~~~~-~~~~~---L~~f~~~l~~~---~Iv~  141 (199)
T PF10707_consen   82 FYGFV-----ETNLGLGLVVELIRDADGNISPTLEDYLKEG--------GLTE-ELRQA---LDEFKRYLLDH---HIVI  141 (199)
T ss_pred             EeEEE-----ecCCceEEEEEEEECCCCCcCccHHHHHHcC--------CccH-HHHHH---HHHHHHHHHHc---CCee
Confidence            99984     666677899998654      2677777543        2444 33333   33445566666   8999


Q ss_pred             cCCCCCCeEecCCC----cEEEec-ccccc
Q 043902          292 CDLKSSNVLLDEGM----IAHVGD-FGLAK  316 (477)
Q Consensus       292 ~dlkp~NIll~~~~----~~kl~D-fG~a~  316 (477)
                      +|++|+||++....    .+.|+| ||...
T Consensus       142 ~dl~~~NIv~~~~~~~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  142 RDLNPHNIVVQRRDSGEFRLVLIDGLGEKE  171 (199)
T ss_pred             cCCCcccEEEEecCCCceEEEEEeCCCCcc
Confidence            99999999995322    567777 55543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.05  E-value=1.3e-06  Score=79.19  Aligned_cols=74  Identities=28%  Similarity=0.273  Sum_probs=58.5

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n   77 (477)
                      ||||+|.|+ .|-.++.-++.++.|+||+|.++ .+-. +..|++|+.||||+|.|+...-....+.+...+.+++|
T Consensus       289 lDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~La~N  362 (490)
T KOG1259|consen  289 LDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLKLAQN  362 (490)
T ss_pred             ccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhHhhhhhHhhhcCEeeeehhhh
Confidence            689999999 99999999999999999999999 7765 88999999999999999843222233444444555555

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.04  E-value=5.4e-05  Score=69.56  Aligned_cols=77  Identities=10%  Similarity=0.170  Sum_probs=46.6

Q ss_pred             Ceeeeeccc-eEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCC---CcceeeeecccccCCCCceeeEEEe
Q 043902          163 NLIGSGSFG-SVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHR---NILKIVSSCSSVDYEGNDFKALVFE  238 (477)
Q Consensus       163 ~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~~~~~~~~~~lv~e  238 (477)
                      +.|+.|+.. .||+.    +..+++|..+...  ....+.+|.+.+..+...   .+.++++.+..  .+.....+++|+
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~--~~~~~~~~~l~~   74 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEP--GEGYPWPWSVYR   74 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCC--ccCCCcceEEEE
Confidence            457767666 58975    2357778755422  235788899998877532   34444443211  111234588999


Q ss_pred             ecCCCChhh
Q 043902          239 FMRNGNLDQ  247 (477)
Q Consensus       239 ~~~~g~L~~  247 (477)
                      +++|.++.+
T Consensus        75 ~i~G~~l~~   83 (235)
T cd05155          75 WLEGETATA   83 (235)
T ss_pred             eecCCCCCc
Confidence            999877643

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.02  E-value=2.7e-06  Score=73.26  Aligned_cols=74  Identities=30%  Similarity=0.422  Sum_probs=33.2

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCccc-CCCCCCCeEEcccccccCcCccc---ccccccchhhhhc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFF-SKLLSLRHLNLSYNELDGEISRE---GIFANASAISIVG   76 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~l~~L~~l~l~~N~l~g~~p~~---~~~~~~~~~~~~~   76 (477)
                      |+|++|.|+ .|+ .+..|++|++|+|++|+++ .++..+ ..+++|+.|+|++|++.. +-..   ..+.++..+.+.+
T Consensus        47 L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~-l~~l~~L~~l~~L~~L~L~~  122 (175)
T PF14580_consen   47 LDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISD-LNELEPLSSLPKLRVLSLEG  122 (175)
T ss_dssp             EE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---S-CCCCGGGGG-TT--EEE-TT
T ss_pred             EECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCC-hHHhHHHHcCCCcceeeccC
Confidence            689999999 776 5889999999999999999 776655 469999999999999984 3322   3356666677777


Q ss_pred             CC
Q 043902           77 ND   78 (477)
Q Consensus        77 n~   78 (477)
                      ||
T Consensus       123 NP  124 (175)
T PF14580_consen  123 NP  124 (175)
T ss_dssp             -G
T ss_pred             Cc
Confidence            74

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=97.98  E-value=7.1e-07  Score=71.52  Aligned_cols=77  Identities=27%  Similarity=0.429  Sum_probs=34.7

Q ss_pred             eecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcCCccc
Q 043902            2 YLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGNDKLC   81 (477)
Q Consensus         2 ~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~~l~   81 (477)
                      +|++|.|+ .+|.++..++.|+.|++++|.|. ..|..|..|.+|-.|+..+|.+. +||......+...+.-.+|+.+.
T Consensus        83 Nl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~  159 (177)
T KOG4579|consen   83 NLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLG  159 (177)
T ss_pred             hcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCccc
Confidence            44444444 44444444444555555544444 44444444444444444444444 44433223333333333444333

>PLN02876 acyl-CoA dehydrogenase

Probab=97.97  E-value=0.00011  Score=79.94  Aligned_cols=82  Identities=11%  Similarity=0.222  Sum_probs=56.8

Q ss_pred             CCeeeeeccceEEEEEeCCC---CEEEEEEeeecc-chhhHHHHHHHHHHhcCC-CCCc--ceeeeecccccCCCCceee
Q 043902          162 ENLIGSGSFGSVYKGTLADG---ETAAIKVLKLQQ-QGALKSFIDECNALTSIR-HRNI--LKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       162 ~~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni--v~l~~~~~~~~~~~~~~~~  234 (477)
                      .+.++.|.+..+|+....++   ..+++|+..... ......+.+|.++++.+. |.++  .+++.+|...  ...+..+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCCce
Confidence            46789999999999887654   367777754322 122356889999999985 6654  7888877432  1224578


Q ss_pred             EEEeecCCCCh
Q 043902          235 LVFEFMRNGNL  245 (477)
Q Consensus       235 lv~e~~~~g~L  245 (477)
                      +||||++|..+
T Consensus       121 lVME~v~G~~~  131 (822)
T PLN02876        121 YIMEYLEGRIF  131 (822)
T ss_pred             EEEEecCCccc
Confidence            99999988653

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.90  E-value=0.00011  Score=64.28  Aligned_cols=130  Identities=22%  Similarity=0.347  Sum_probs=91.7

Q ss_pred             cCCCCCCeeeeecc-ceEEEEEeCCCCEEEEEEeee---cc--------c----------hhhHHHHHHHHHHhcCC---
Q 043902          157 DNFSEENLIGSGSF-GSVYKGTLADGETAAIKVLKL---QQ--------Q----------GALKSFIDECNALTSIR---  211 (477)
Q Consensus       157 ~~~~~~~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~---~~--------~----------~~~~~~~~e~~~l~~l~---  211 (477)
                      .+++..+.||.|.- |.||+++. +|+.+|+|+++.   ..        .          .....|..|++...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67888999999999 99999999 578999999431   00        0          12346889999988884   


Q ss_pred             CCCc--ceeeeeccccc-------------CCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHH
Q 043902          212 HRNI--LKIVSSCSSVD-------------YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS  276 (477)
Q Consensus       212 h~ni--v~l~~~~~~~~-------------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~  276 (477)
                      +.++  |+.+||.....             ........||.||++...                .++.    .-+.+|.+
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~~~----~~~~~~~~  175 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PLQI----RDIPQMLR  175 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------ccch----hHHHHHHH
Confidence            4456  88888853220             011223457777775532                1222    23456777


Q ss_pred             HHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       277 ~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      -|..+|..   +|+-+|+++.|..     .-||+|||.+
T Consensus       176 dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  176 DLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            78889998   9999999999987     4589999865

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=97.81  E-value=3.2e-06  Score=87.53  Aligned_cols=77  Identities=29%  Similarity=0.405  Sum_probs=52.3

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccC-cCcccccccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDG-EISREGIFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g-~~p~~~~~~~~~~~~~~~n~~   79 (477)
                      |+||+|+|+ +||.++.++..|++|...+|+|. .+| .+..+++|+++|||.|+|+- .+|.....+++..+++.||.+
T Consensus       412 L~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  412 LNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR  488 (1081)
T ss_pred             Hhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence            455666666 66666666666666666666666 666 67778888889999999874 344443347788888888875


Q ss_pred             c
Q 043902           80 L   80 (477)
Q Consensus        80 l   80 (477)
                      +
T Consensus       489 l  489 (1081)
T KOG0618|consen  489 L  489 (1081)
T ss_pred             c
Confidence            4

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=97.73  E-value=1.3e-05  Score=79.10  Aligned_cols=81  Identities=26%  Similarity=0.333  Sum_probs=60.8

Q ss_pred             CeecCCcccccCchh---ccCCCCCCeEECCCCccCcccCc-ccCCCCCCCeEEcccccccCcCcccccccccchhhhhc
Q 043902            1 LYLGNNSFKGTIPVS---LKSLRGLAELDLSCNNLSGKVPQ-FFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVG   76 (477)
Q Consensus         1 l~l~~n~~~g~~p~~---~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~   76 (477)
                      |||++|.|++.|-+.   |..|++|+.|+|.+|+|. .||. +|..|.+|++|||.+|.+...-|..+.-+.+..+.+..
T Consensus       370 LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk-~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nS  448 (873)
T KOG4194|consen  370 LDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK-SIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNS  448 (873)
T ss_pred             hcCcCCeEEEEEecchhhhccchhhhheeecCceee-ecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcc
Confidence            678888888887653   777888888888888888 7774 78888888888888888886666665555666666665


Q ss_pred             CCcccc
Q 043902           77 NDKLCG   82 (477)
Q Consensus        77 n~~l~g   82 (477)
                      .+.+|-
T Consensus       449 ssflCD  454 (873)
T KOG4194|consen  449 SSFLCD  454 (873)
T ss_pred             cceEEe
Confidence            555553

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.72  E-value=0.00036  Score=64.04  Aligned_cols=74  Identities=12%  Similarity=0.196  Sum_probs=48.3

Q ss_pred             CeeeeeccceEEEEEeCC--CCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCC-cceeeeecccccCCCCceeeEEEee
Q 043902          163 NLIGSGSFGSVYKGTLAD--GETAAIKVLKLQQQGALKSFIDECNALTSIRHRN-ILKIVSSCSSVDYEGNDFKALVFEF  239 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~~~~~~lv~e~  239 (477)
                      +.|..|-...+|+....+  +..+++|+....... .....+|+.++..+...+ ..++++.+     .    ..++|||
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~----~~~l~e~   73 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATF-----Q----NGLIYEF   73 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEe-----C----CcEEEEe
Confidence            467788888999998764  678999987643222 123346888888874333 34444432     1    2489999


Q ss_pred             cCCCChh
Q 043902          240 MRNGNLD  246 (477)
Q Consensus       240 ~~~g~L~  246 (477)
                      ++|.++.
T Consensus        74 i~G~~l~   80 (235)
T cd05157          74 IPGRTLE   80 (235)
T ss_pred             eCCCcCC
Confidence            9987653

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=97.71  E-value=2.7e-06  Score=88.07  Aligned_cols=75  Identities=28%  Similarity=0.407  Sum_probs=43.8

Q ss_pred             CeecCCcccccCchh-ccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVS-LKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~-~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~   78 (477)
                      |+|++|+|. .+|.+ +.+|..|+.|+||+|.|+ .||.++.++..|++|...+|+|. .+|....+..+..++++.|+
T Consensus       388 LhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fPe~~~l~qL~~lDlS~N~  463 (1081)
T KOG0618|consen  388 LHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFPELAQLPQLKVLDLSCNN  463 (1081)
T ss_pred             eeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-echhhhhcCcceEEecccch
Confidence            455666665 55554 566666666666666666 66666666666666666666666 55544444455555555554

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=97.70  E-value=1.2e-05  Score=84.94  Aligned_cols=74  Identities=24%  Similarity=0.363  Sum_probs=46.7

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~~   79 (477)
                      |+|++|+|+ .+|...   ++|+.|+|++|+|+ .||..+   .+|+.|+|++|+|+ .+|.. ..+.++..+.+.+| .
T Consensus       387 LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N-~  456 (788)
T PRK15387        387 LIVSGNRLT-SLPVLP---SELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN-P  456 (788)
T ss_pred             EEecCCccc-CCCCcc---cCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCC-C
Confidence            466677777 466432   56777888888877 577543   35777888888887 67765 23445555555555 4


Q ss_pred             ccccc
Q 043902           80 LCGGI   84 (477)
Q Consensus        80 l~g~~   84 (477)
                      +++..
T Consensus       457 Ls~~~  461 (788)
T PRK15387        457 LSERT  461 (788)
T ss_pred             CCchH
Confidence            55543

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.68  E-value=0.00025  Score=66.07  Aligned_cols=140  Identities=13%  Similarity=0.073  Sum_probs=79.1

Q ss_pred             eeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCc-ceeeeecccccCCCCceeeEEEeecCC
Q 043902          164 LIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI-LKIVSSCSSVDYEGNDFKALVFEFMRN  242 (477)
Q Consensus       164 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~~~~~~lv~e~~~~  242 (477)
                      .+..|-...+|+... ++..+++|+.........-...+|.++++.+....+ .++++.+       .  .++|+||++|
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~-------~--~~~v~e~i~G   72 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN-------E--HWLLVEWLEG   72 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe-------C--CEEEEEeccC
Confidence            355677889999884 567888887654322211235678888888854333 3444432       1  3689999998


Q ss_pred             CChhhh-----------------cccCCCcccccccCCHHHH-HHHHH---------HHHHHHHHHHcC-----CCCCee
Q 043902          243 GNLDQW-----------------LHPSTDEYCHFKKLSLMQR-LNIVI---------DVASALDYLHNQ-----YDTPIA  290 (477)
Q Consensus       243 g~L~~~-----------------l~~~~~~~~~~~~l~~~~~-~~i~~---------~ia~~L~~LH~~-----~~~~iv  290 (477)
                      ..+...                 ++....   ....++.... ..+..         .+...+..+-..     ....++
T Consensus        73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~---~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  149 (256)
T TIGR02721        73 EVITLDQFVALDLLLELAALLHQLHSQPR---FGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL  149 (256)
T ss_pred             cccccccccCchhHHHHHHHHHHHhCCCC---CCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence            765421                 111110   0011222111 11111         111112222211     123689


Q ss_pred             ecCCCCCCeEecCCCcEEEeccccccc
Q 043902          291 HCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       291 H~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      |+|+.|.||++++++ +.++||..+..
T Consensus       150 H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       150 HMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            999999999999877 78999988754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=97.65  E-value=1.1e-05  Score=75.98  Aligned_cols=82  Identities=23%  Similarity=0.241  Sum_probs=54.2

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccccc-ccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGI-FANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-~~~~~~~~~~~n~~   79 (477)
                      |+|++|++++.-+.+|..+..|++|.|..|+|.-.--..|..|..|+.|+|.+|+|+-.-|..+. +..+..+.+.+|+.
T Consensus       279 lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~  358 (498)
T KOG4237|consen  279 LNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPF  358 (498)
T ss_pred             eccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcc
Confidence            46777777766666677777777777777777733334567777778888888888755454322 44556666777776


Q ss_pred             ccc
Q 043902           80 LCG   82 (477)
Q Consensus        80 l~g   82 (477)
                      .|.
T Consensus       359 ~Cn  361 (498)
T KOG4237|consen  359 NCN  361 (498)
T ss_pred             cCc
Confidence            664

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.58  E-value=0.00015  Score=67.42  Aligned_cols=145  Identities=20%  Similarity=0.248  Sum_probs=99.3

Q ss_pred             CccHHHHHHhh---cCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccc-----------------h-----hhHHH
Q 043902          146 GLSYLKISNAT---DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQ-----------------G-----ALKSF  200 (477)
Q Consensus       146 ~~~~~~~~~~~---~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------------~-----~~~~~  200 (477)
                      ++.++-+....   .-+++.+.||-|.-+.||.+...+|+..++|.-+....                 .     ..-..
T Consensus        78 GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa  157 (465)
T KOG2268|consen   78 GYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA  157 (465)
T ss_pred             cchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence            45555444433   34678899999999999999999999999996432110                 0     01235


Q ss_pred             HHHHHHHhcCC-C-CCcceeeeecccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHH
Q 043902          201 IDECNALTSIR-H-RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL  278 (477)
Q Consensus       201 ~~e~~~l~~l~-h-~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L  278 (477)
                      .+|...|+.+. | --+.+.+++         +..++|||++.+-.|...-+-.          +...   +...+..-+
T Consensus       158 ~kEfafmkaL~e~gfpVPkpiD~---------~RH~Vvmelv~g~Pl~~v~~v~----------d~~~---ly~~lm~~I  215 (465)
T KOG2268|consen  158 TKEFAFMKALYERGFPVPKPIDH---------NRHCVVMELVDGYPLRQVRHVE----------DPPT---LYDDLMGLI  215 (465)
T ss_pred             HHHHHHHHHHHHcCCCCCCcccc---------cceeeHHHhhcccceeeeeecC----------ChHH---HHHHHHHHH
Confidence            67888888884 3 334555554         3468999999998887654322          2222   333344444


Q ss_pred             HHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       279 ~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      .-|..+   |+||+|..-=||+++++..++++||--.
T Consensus       216 v~la~~---GlIHgDFNEFNimv~dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  216 VRLANH---GLIHGDFNEFNIMVKDDDKIVVIDFPQM  249 (465)
T ss_pred             HHHHHc---CceecccchheeEEecCCCEEEeechHh
Confidence            556666   9999999999999999999999999544

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=97.57  E-value=3.6e-06  Score=82.70  Aligned_cols=77  Identities=22%  Similarity=0.266  Sum_probs=54.9

Q ss_pred             eecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcCCccc
Q 043902            2 YLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGNDKLC   81 (477)
Q Consensus         2 ~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~~l~   81 (477)
                      ||+.|+|+ .+|.++..+..|+.|.|.+|.+. .||..+.+|..|++|||+.|+++ .+|....+..+..+...+|+.-|
T Consensus        81 DlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lpLkvli~sNNkl~~  157 (722)
T KOG0532|consen   81 DLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLPLKVLIVSNNKLTS  157 (722)
T ss_pred             hccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCcceeEEEecCcccc
Confidence            67778887 88888887778888888888887 78888888888888888888887 66665555555554444444333

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.56  E-value=0.00018  Score=77.07  Aligned_cols=157  Identities=20%  Similarity=0.163  Sum_probs=108.1

Q ss_pred             HHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHH
Q 043902          199 SFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL  278 (477)
Q Consensus       199 ~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L  278 (477)
                      ....|...+.+..|+|++.++.|..... ..+-...+..+++..-++...+...       ..++....+.+..+...||
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~-~~g~~~~v~~~~~s~~~~~~~~q~v-------~~i~~~~~r~~~~~~~~GL  299 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERL-FRGIVLDVLQEICSKVELRSLLQSV-------GSIPLETLRILHQKLLEGL  299 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhh-cchHHHHHHHhhcCccchHHHHhhc-------cccCHHHHHHHHHHHhhhH
Confidence            3445677788889999999998853211 1111233556778777888777654       4578888889999999999


Q ss_pred             HHHHcCCCCCeeecCCCCC---CeEecCCCcEEEe--cccccccccccCCCCCCCccccCCCcccccccCcccccCC---
Q 043902          279 DYLHNQYDTPIAHCDLKSS---NVLLDEGMIAHVG--DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH---  350 (477)
Q Consensus       279 ~~LH~~~~~~ivH~dlkp~---NIll~~~~~~kl~--DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---  350 (477)
                      .|+|+.   ...|.-+..+   +.-.+..+...++  ||+.++.+.+.        ........+..|.|||....+   
T Consensus       300 ~~~h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~--------~~~~~~~~~~~~~~~e~~~~~~~~  368 (1351)
T KOG1035|consen  300 AYLHSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDN--------EKSFSDLLAEIRNADEDLKENTAK  368 (1351)
T ss_pred             HHHHHh---ccceeEEecccccccccCccceeecchhhhcccccCCCc--------ccchhhcCccccccccccccccch
Confidence            999998   5555555444   4555666777777  88888765321        112223345567888887433   


Q ss_pred             CCcccceeehHHHHHHHhhCCCCC
Q 043902          351 VSILGDIYSYGILLLEIFTGKRPT  374 (477)
Q Consensus       351 ~~~~~Dv~S~Gvvl~elltg~~p~  374 (477)
                      .....|+|.+|.....+..|..+-
T Consensus       369 ~~r~~dL~~lgll~~~~~~~~~i~  392 (1351)
T KOG1035|consen  369 KSRLTDLWCLGLLLLQLSQGEDIS  392 (1351)
T ss_pred             hhhhhHHHHHHHHHhhhhhcCccc
Confidence            344569999999999999887653

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=97.56  E-value=5.7e-06  Score=81.32  Aligned_cols=74  Identities=28%  Similarity=0.402  Sum_probs=39.6

Q ss_pred             eecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcCC
Q 043902            2 YLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGND   78 (477)
Q Consensus         2 ~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~   78 (477)
                      .++||+++ .+|.+++.+..|..||.|.|++. .+|+.++.|.+|+.|++..|++. .+|.+.....+..++|+.|+
T Consensus       149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~LpLi~lDfScNk  222 (722)
T KOG0532|consen  149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLPLIRLDFSCNK  222 (722)
T ss_pred             EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCceeeeecccCc
Confidence            35556665 56666665555666666666655 55555555555555555555555 33333334444445555443

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.55  E-value=0.0014  Score=64.33  Aligned_cols=76  Identities=17%  Similarity=0.194  Sum_probs=54.3

Q ss_pred             CCeeeeeccceEEEEEeCCC-CEEEEEEeeec-----c--chhhHHHHHHHHHHhcCC---CCCcceeeeecccccCCCC
Q 043902          162 ENLIGSGSFGSVYKGTLADG-ETAAIKVLKLQ-----Q--QGALKSFIDECNALTSIR---HRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       162 ~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~~  230 (477)
                      .+.||.|.+..||++...+| +.++||.-...     .  .-....+..|.+.|..+.   ..++.+++.+       +.
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~-------D~  103 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY-------DE  103 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE-------CC
Confidence            35789999999999998877 48999985411     1  223456777888888763   3467778876       23


Q ss_pred             ceeeEEEeecCCCC
Q 043902          231 DFKALVFEFMRNGN  244 (477)
Q Consensus       231 ~~~~lv~e~~~~g~  244 (477)
                      +..++||||+++..
T Consensus       104 ~~~~lVME~L~~~~  117 (401)
T PRK09550        104 ELAVTVMEDLSDHK  117 (401)
T ss_pred             CCCEEEEecCCCcc
Confidence            44689999998643

>PRK05231 homoserine kinase; Provisional

Probab=97.55  E-value=0.0023  Score=61.76  Aligned_cols=152  Identities=15%  Similarity=0.134  Sum_probs=78.1

Q ss_pred             CCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCC--CCcceeeeeccccc-CCCCceeeEEEe
Q 043902          162 ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRH--RNILKIVSSCSSVD-YEGNDFKALVFE  238 (477)
Q Consensus       162 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~-~~~~~~~~lv~e  238 (477)
                      .+.++.|....+|+....+| .+++|++.....   .....|...+..+..  -.+.+.+....... ....+..+++++
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            35577788789999987655 688898762222   233334444444421  12333332210000 112445789999


Q ss_pred             ecCCCChhh-----------h---cccCCCcccc----cccC-CHHHHHH------------HH-HHHHHHHHHHHcC--
Q 043902          239 FMRNGNLDQ-----------W---LHPSTDEYCH----FKKL-SLMQRLN------------IV-IDVASALDYLHNQ--  284 (477)
Q Consensus       239 ~~~~g~L~~-----------~---l~~~~~~~~~----~~~l-~~~~~~~------------i~-~~ia~~L~~LH~~--  284 (477)
                      |++|..+..           .   ++.....+..    ...+ .|.....            .. ..+...+..+...  
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            998874321           1   1111111100    0111 1111111            11 1111222333211  


Q ss_pred             --CCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          285 --YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       285 --~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                        ...+++|+|+.|.||+++.+...-|+||+.+..
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence              245899999999999999776668999998753

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	477
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-35
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-34
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-27
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-27
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-22
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-22
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-22
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		8e-22
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-20
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-19
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		7e-19
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-19
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-19
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-18
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-18
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-18
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-18
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-18
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-18
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-18
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-18
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-18
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-18
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		7e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		7e-18
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		8e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-17
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-17
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-17
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-17
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-17
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-17
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-17
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-17
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-17
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-17
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-17
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-17
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-17
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-16
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-16
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-16
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-16
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-16
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		7e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		8e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		8e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		8e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		9e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		9e-16
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-15
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-15
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-15
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-15
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-15
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-15
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-15
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-15
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-15
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-15
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-15
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-15
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-15
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-15
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-15
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-15
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-15
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-15
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-15
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-15
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-15
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-15
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-15
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		6e-15
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-15
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		6e-15
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-15
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		6e-15
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		6e-15
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		6e-15
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		6e-15
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		7e-15
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-15
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		7e-15
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		7e-15
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		7e-15
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-15
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-15
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		8e-15
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-14
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-14
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-14
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-14
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-14
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-14
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-14
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-14
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-14
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		6e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		7e-14
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		8e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-13
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-13
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-13
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-13
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-13
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-13
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		8e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		9e-13
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-12
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-12
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-12
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-12
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-12
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-12
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-12
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-12
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-12
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-12
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-12
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-12
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-12
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-12
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-12
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-12
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-12
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-12
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		6e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		6e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		6e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-12
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		9e-12
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		9e-12
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-11
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		6e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		7e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		7e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		7e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		7e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		8e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		8e-11
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		8e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		9e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		9e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-10
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-10
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-10
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-10
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-10
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-10
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-10
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-10
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-10
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-10
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-10
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-10
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		2e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-10
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		2e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-10
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-10
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-10
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-10
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-10
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-10
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-10
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-10
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-10
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-10
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-10
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-10
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-10
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		6e-10
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		8e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		9e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-10
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		9e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		9e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-09
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-09
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-09
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-09
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-09
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-09
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-09
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-09
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-09
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-09
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-09
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-09
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-09
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-09
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-09
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-09
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-09
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-09
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-09
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-09
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-09
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-09
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-09
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-09
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-09
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		7e-09
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		8e-09
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-09
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		8e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		8e-09
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-08
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-08
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		6e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		6e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		7e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		7e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		7e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		8e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		9e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-07
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-07
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-07
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-07
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-07
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-07
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-07
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-07
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-07
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-07
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-07
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-07
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-07
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-07
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-07
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-07
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-07
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-07
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-07
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-07
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-07
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-07
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-07
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		7e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		7e-07
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-07
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-07
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		9e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		9e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		9e-07
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-06
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-06
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-06
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-06
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-06
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-06
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-06
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-06
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-06
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-06
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-06
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-06
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-06
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-06
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-06
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-06
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-06
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-06
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-06
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-06
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-06
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		6e-06
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-06
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		7e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		7e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		7e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		7e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		7e-06
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		7e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		7e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		7e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		7e-06
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		7e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		8e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		8e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		8e-06
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-06
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-06
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		8e-06
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		8e-06
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		9e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-06
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		9e-06
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		9e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		9e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		9e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-05
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-05
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-05
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-05
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-05
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-05
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-05
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-05
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-05
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-05
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-05
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-05
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-05
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-05
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-05
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-05
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-05
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-05
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-05
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-05
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-05
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-05
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-05
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-05
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-05
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-05
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-05
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-05
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-05
2v62_A	345	Structure Of Vaccinia-Related Kinase 2 Length = 345		2e-05
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-05
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-05
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-05
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-05
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-05
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-05
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-05
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-05
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-05
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-05
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-05
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-05
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-05
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-05
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-05
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-05
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		2e-05
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-05
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		3e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-05
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-05
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-05
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-05
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-05
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-05
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-05
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-05
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-05
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-05
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-05
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-05
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-05
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-05
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-05
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-05
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-05
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-05
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-05
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		4e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-05
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-05
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-05
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-05
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-05
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-05
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-05
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-05
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-05
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-05
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		5e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		5e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		5e-05
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-05
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-05
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-05
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-05
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-05
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-05
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-05
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-05
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-05
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-05
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-05
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-05
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-05
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-05
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-05
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-05
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-05
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-05
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-05
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-05
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-05
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-05
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-05
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-05
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-05
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-05
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		6e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-05
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-05
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-05
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-05
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		6e-05
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-05
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-05
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		7e-05
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-05
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-05
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-05
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		7e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		7e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		7e-05
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		8e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		8e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-05
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		8e-05
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		8e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		8e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		8e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		9e-05
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		9e-05
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		9e-05
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		9e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		9e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		9e-05
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-04
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-04
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-04
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-04
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-04
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-04
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-04
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		1e-04
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-04
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-04
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-04
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-04
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		1e-04
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-04
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-04
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-04
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-04
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-04
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-04
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-04
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-04
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-04
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-04
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-04
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-04
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-04
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-04
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-04
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-04
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-04
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-04
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-04
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-04
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-04
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-04
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-04
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-04
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		6e-04
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		7e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-04
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		7e-04
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		8e-04
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		8e-04
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		9e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		9e-04
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-04
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  145 bits (367), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 102/323 (31%), Positives = 163/323 (50%), Gaps = 36/323 (11%)
Query: 147 LSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQ-QGALKSFIDECN 205
            S  ++  A+DNFS +N++G G FG VYKG LADG   A+K LK ++ QG    F  E  
Sbjct: 28  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVE 87
Query: 206 ALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM 265
            ++   HRN+L++   C +        + LV+ +M NG++   L    +       L   
Sbjct: 88  MISMAVHRNLLRLRGFCMTPTE-----RLLVYPYMANGSVASCLRERPESQ---PPLDWP 139
Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
           +R  I +  A  L YLH+  D  I H D+K++N+LLDE   A VGDFGLAK +       
Sbjct: 140 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM------D 193
Query: 326 SKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSI 384
            K+  +   ++G++G+I PEY++ G  S   D++ YG++LLE+ TG+R  D         
Sbjct: 194 YKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD--------- 244
Query: 385 HKFVLMALPSHVMDVLDLSMLLXXXXXXXXXXXXXLFPDIESQVAQKKLEECLVSVMRIG 444
                +A  ++  DV    MLL                D++ Q   K  +E +  ++++ 
Sbjct: 245 -----LARLANDDDV----MLLDWVKGLLKEKKLEALVDVDLQGNYK--DEEVEQLIQVA 293
Query: 445 VMCSAASPRDRVGMKFVVNNLQA 467
           ++C+ +SP +R  M  VV  L+ 
Sbjct: 294 LLCTQSSPMERPKMSEVVRMLEG 316

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 101/323 (31%), Positives = 161/323 (49%), Gaps = 36/323 (11%)
Query: 147 LSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQ-QGALKSFIDECN 205
            S  ++  A+DNF  +N++G G FG VYKG LADG   A+K LK ++ QG    F  E  
Sbjct: 20  FSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVE 79
Query: 206 ALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM 265
            ++   HRN+L++   C +        + LV+ +M NG++   L    +       L   
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTE-----RLLVYPYMANGSVASCLRERPESQ---PPLDWP 131
Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
           +R  I +  A  L YLH+  D  I H D+K++N+LLDE   A VGDFGLAK +       
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM------D 185
Query: 326 SKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSI 384
            K+  +   ++G +G+I PEY++ G  S   D++ YG++LLE+ TG+R  D         
Sbjct: 186 YKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD--------- 236
Query: 385 HKFVLMALPSHVMDVLDLSMLLXXXXXXXXXXXXXLFPDIESQVAQKKLEECLVSVMRIG 444
                +A  ++  DV    MLL                D++ Q   K  +E +  ++++ 
Sbjct: 237 -----LARLANDDDV----MLLDWVKGLLKEKKLEALVDVDLQGNYK--DEEVEQLIQVA 285
Query: 445 VMCSAASPRDRVGMKFVVNNLQA 467
           ++C+ +SP +R  M  VV  L+ 
Sbjct: 286 LLCTQSSPMERPKMSEVVRMLEG 308

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 93/316 (29%), Positives = 148/316 (46%), Gaps = 39/316 (12%)
Query: 152 ISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIR 211
           +  AT+NF  + LIG G FG VYKG L DG   A+K    +    ++ F  E   L+  R
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H +++ ++  C     E N+   L++++M NGNL + L+ S         +S  QRL I 
Sbjct: 94  HPHLVSLIGFCD----ERNEM-ILIYKYMENGNLKRHLYGSD---LPTMSMSWEQRLEIC 145
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
           I  A  L YLH +    I H D+KS N+LLDE  +  + DFG++K       T      +
Sbjct: 146 IGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISK-----KGTELDQTHL 197
Query: 332 SNGLKGSVGYIPPEY-INGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM 390
              +KG++GYI PEY I G ++   D+YS+G++L E+   +                ++ 
Sbjct: 198 XXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA--------------IVQ 243
Query: 391 ALPSHVMDVLDLSMLLXXXXXXXXXXXXXLFPDIESQVAQKKLEECLVSVMRIGVMCSAA 450
           +LP  ++++ + ++               L   ++  +A K   E L       V C A 
Sbjct: 244 SLPREMVNLAEWAV--------ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLAL 295
Query: 451 SPRDRVGMKFVVNNLQ 466
           S  DR  M  V+  L+
Sbjct: 296 SSEDRPSMGDVLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 93/316 (29%), Positives = 148/316 (46%), Gaps = 39/316 (12%)
Query: 152 ISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIR 211
           +  AT+NF  + LIG G FG VYKG L DG   A+K    +    ++ F  E   L+  R
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H +++ ++  C     E N+   L++++M NGNL + L+ S         +S  QRL I 
Sbjct: 94  HPHLVSLIGFCD----ERNEM-ILIYKYMENGNLKRHLYGSD---LPTMSMSWEQRLEIC 145
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
           I  A  L YLH +    I H D+KS N+LLDE  +  + DFG++K       T      +
Sbjct: 146 IGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISK-----KGTELGQTHL 197
Query: 332 SNGLKGSVGYIPPEY-INGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM 390
              +KG++GYI PEY I G ++   D+YS+G++L E+   +                ++ 
Sbjct: 198 XXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA--------------IVQ 243
Query: 391 ALPSHVMDVLDLSMLLXXXXXXXXXXXXXLFPDIESQVAQKKLEECLVSVMRIGVMCSAA 450
           +LP  ++++ + ++               L   ++  +A K   E L       V C A 
Sbjct: 244 SLPREMVNLAEWAV--------ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLAL 295
Query: 451 SPRDRVGMKFVVNNLQ 466
           S  DR  M  V+  L+
Sbjct: 296 SSEDRPSMGDVLWKLE 311

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/247 (31%), Positives = 122/247 (49%), Gaps = 42/247 (17%)
Query: 147 LSYLKISNATDNFSEE------NLIGSGSFGSVYKGTLADGETAAIKVL---------KL 191
            S+ ++ N T+NF E       N +G G FG VYKG + +  T A+K L         +L
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 192 QQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHP 251
           +QQ     F  E   +   +H N+++++   S    +G+D   LV+ +M NG+L   L  
Sbjct: 74  KQQ-----FDQEIKVMAKCQHENLVELLGFSS----DGDDL-CLVYVYMPNGSLLDRLS- 122
Query: 252 STDEYC--HFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV 309
                C      LS   R  I    A+ +++LH  +     H D+KS+N+LLDE   A +
Sbjct: 123 -----CLDGTPPLSWHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKI 174
Query: 310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFT 369
            DFGLA+     ++       M + + G+  Y+ PE + G ++   DIYS+G++LLEI T
Sbjct: 175 SDFGLAR-----ASEKFAQTVMXSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIIT 229
Query: 370 GKRPTDD 376
           G    D+
Sbjct: 230 GLPAVDE 236

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 77/247 (31%), Positives = 121/247 (48%), Gaps = 42/247 (17%)
Query: 147 LSYLKISNATDNFSEE------NLIGSGSFGSVYKGTLADGETAAIKVL---------KL 191
            S+ ++ N T+NF E       N +G G FG VYKG + +  T A+K L         +L
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 67
Query: 192 QQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHP 251
           +QQ     F  E   +   +H N+++++   S    +G+D   LV+ +M NG+L   L  
Sbjct: 68  KQQ-----FDQEIKVMAKCQHENLVELLGFSS----DGDDL-CLVYVYMPNGSLLDRLS- 116
Query: 252 STDEYC--HFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV 309
                C      LS   R  I    A+ +++LH  +     H D+KS+N+LLDE   A +
Sbjct: 117 -----CLDGTPPLSWHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKI 168
Query: 310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFT 369
            DFGLA+     ++       M   + G+  Y+ PE + G ++   DIYS+G++LLEI T
Sbjct: 169 SDFGLAR-----ASEKFAQXVMXXRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIIT 223
Query: 370 GKRPTDD 376
           G    D+
Sbjct: 224 GLPAVDE 230

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 77/247 (31%), Positives = 121/247 (48%), Gaps = 42/247 (17%)
Query: 147 LSYLKISNATDNFSEE------NLIGSGSFGSVYKGTLADGETAAIKVL---------KL 191
            S+ ++ N T+NF E       N +G G FG VYKG + +  T A+K L         +L
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 192 QQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHP 251
           +QQ     F  E   +   +H N+++++   S    +G+D   LV+ +M NG+L   L  
Sbjct: 74  KQQ-----FDQEIKVMAKCQHENLVELLGFSS----DGDDL-CLVYVYMPNGSLLDRLS- 122
Query: 252 STDEYC--HFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV 309
                C      LS   R  I    A+ +++LH  +     H D+KS+N+LLDE   A +
Sbjct: 123 -----CLDGTPPLSWHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKI 174
Query: 310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFT 369
            DFGLA+     ++       M   + G+  Y+ PE + G ++   DIYS+G++LLEI T
Sbjct: 175 SDFGLAR-----ASEKFAQTVMXXRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIIT 229
Query: 370 GKRPTDD 376
           G    D+
Sbjct: 230 GLPAVDE 236

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 104/215 (48%), Gaps = 28/215 (13%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKL--QQQGALKSFIDECNALTSIRHRNILKIVSSC 222
           IGSGSFG+VYKG        A+K+LK+        ++F +E   L   RH NIL  +   
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG-- 99
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
               Y   D  A+V ++    +L + LH          K  + Q ++I    A  +DYLH
Sbjct: 100 ----YMTKDNLAIVTQWCEGSSLYKHLH------VQETKFQMFQLIDIARQTAQGMDYLH 149
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
            +    I H D+KS+N+ L EG+   +GDFGLA      S +    Q       GSV ++
Sbjct: 150 AK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT-----GSVLWM 201
Query: 343 PPEYI----NGHVSILGDIYSYGILLLEIFTGKRP 373
            PE I    N   S   D+YSYGI+L E+ TG+ P
Sbjct: 202 APEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 75/247 (30%), Positives = 117/247 (47%), Gaps = 42/247 (17%)
Query: 147 LSYLKISNATDNFSEE------NLIGSGSFGSVYKGTLADGETAAIKVL---------KL 191
            S+ ++ N T+NF E       N  G G FG VYKG + +  T A+K L         +L
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 64
Query: 192 QQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHP 251
           +QQ     F  E       +H N+++++   S    +G+D   LV+ +  NG+L   L  
Sbjct: 65  KQQ-----FDQEIKVXAKCQHENLVELLGFSS----DGDDL-CLVYVYXPNGSLLDRLS- 113
Query: 252 STDEYC--HFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV 309
                C      LS   R  I    A+ +++LH  +     H D+KS+N+LLDE   A +
Sbjct: 114 -----CLDGTPPLSWHXRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKI 165
Query: 310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFT 369
            DFGLA+     ++         + + G+  Y  PE + G ++   DIYS+G++LLEI T
Sbjct: 166 SDFGLAR-----ASEKFAQXVXXSRIVGTTAYXAPEALRGEITPKSDIYSFGVVLLEIIT 220
Query: 370 GKRPTDD 376
           G    D+
Sbjct: 221 GLPAVDE 227

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 124/244 (50%), Gaps = 34/244 (13%)
Query: 147 LSYLKISNATDNFSEENLIGSGSFGSVYKGTL-ADGET---AAIKVLKL-QQQGALKSFI 201
           +SY+KI         E +IG+G FG V +G L A G+     AIK LK    +   + F+
Sbjct: 15  VSYVKI---------EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFL 65
Query: 202 DECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVF-EFMRNGNLDQWLHPSTDEYCHFK 260
            E + +    H NI+++    +      N    ++  EFM NG LD +L  +  ++    
Sbjct: 66  SEASIMGQFEHPNIIRLEGVVT------NSMPVMILTEFMENGALDSFLRLNDGQF---- 115
Query: 261 KLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFE 320
             +++Q + ++  +AS + YL    +    H DL + N+L++  ++  V DFGL++FL E
Sbjct: 116 --TVIQLVGMLRGIASGMRYLA---EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEE 170
Query: 321 ESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMF 378
            S+ P+  +T S G K  + +  PE I     +   D +SYGI++ E+ + G+RP  DM 
Sbjct: 171 NSSDPT--ETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMS 228
Query: 379 KDDL 382
             D+
Sbjct: 229 NQDV 232

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 75/225 (33%), Positives = 109/225 (48%), Gaps = 32/225 (14%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQ----QQGALKSFIDECNALTSIRHRNILKIVS 220
           IGSGSFG+VYKG        A+K+L +     QQ  L++F +E   L   RH NIL  + 
Sbjct: 20  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 75
Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDY 280
                 Y      A+V ++    +L   LH S  ++   KKL     ++I    A  +DY
Sbjct: 76  ------YSTKPQLAIVTQWCEGSSLYHHLHASETKF-EMKKL-----IDIARQTARGMDY 123
Query: 281 LHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG 340
           LH +    I H DLKS+N+ L E     +GDFGLA      S +    Q     L GS+ 
Sbjct: 124 LHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQ-----LSGSIL 175
Query: 341 YIPPEYI----NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD 381
           ++ PE I    +   S   D+Y++GI+L E+ TG+ P  ++   D
Sbjct: 176 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 220

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 76/225 (33%), Positives = 111/225 (49%), Gaps = 32/225 (14%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQ----QQGALKSFIDECNALTSIRHRNILKIVS 220
           IGSGSFG+VYKG        A+K+L +     QQ  L++F +E   L   RH NIL  + 
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 87
Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDY 280
                 Y      A+V ++    +L   LH S  ++   KKL     ++I    A  +DY
Sbjct: 88  ------YSTKPQLAIVTQWCEGSSLYHHLHASETKF-EMKKL-----IDIARQTARGMDY 135
Query: 281 LHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG 340
           LH +    I H DLKS+N+ L E     +GDFGLA    E+S     +Q     L GS+ 
Sbjct: 136 LHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLAT---EKSRWSGSHQF--EQLSGSIL 187
Query: 341 YIPPEYI----NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD 381
           ++ PE I    +   S   D+Y++GI+L E+ TG+ P  ++   D
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 232

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 75/225 (33%), Positives = 112/225 (49%), Gaps = 32/225 (14%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQ----QQGALKSFIDECNALTSIRHRNILKIVS 220
           IGSGSFG+VYKG        A+K+L +     QQ  L++F +E   L   RH NIL  + 
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 87
Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDY 280
             ++         A+V ++    +L   LH S  ++   KKL     ++I    A  +DY
Sbjct: 88  YSTAPQL------AIVTQWCEGSSLYHHLHASETKF-EMKKL-----IDIARQTARGMDY 135
Query: 281 LHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG 340
           LH +    I H DLKS+N+ L E     +GDFGLA    E+S     +Q     L GS+ 
Sbjct: 136 LHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLAT---EKSRWSGSHQF--EQLSGSIL 187
Query: 341 YIPPEYI----NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD 381
           ++ PE I    +   S   D+Y++GI+L E+ TG+ P  ++   D
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 232

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 123/244 (50%), Gaps = 34/244 (13%)
Query: 147 LSYLKISNATDNFSEENLIGSGSFGSVYKGTL-ADGET---AAIKVLKL-QQQGALKSFI 201
           +SY+KI         E +IG+G FG V +G L A G+     AIK LK    +   + F+
Sbjct: 13  VSYVKI---------EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFL 63
Query: 202 DECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVF-EFMRNGNLDQWLHPSTDEYCHFK 260
            E + +    H NI+++    +      N    ++  EFM NG LD +L  +  ++    
Sbjct: 64  SEASIMGQFEHPNIIRLEGVVT------NSMPVMILTEFMENGALDSFLRLNDGQF---- 113
Query: 261 KLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFE 320
             +++Q + ++  +AS + YL    +    H DL + N+L++  ++  V DFGL++FL E
Sbjct: 114 --TVIQLVGMLRGIASGMRYLA---EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEE 168
Query: 321 ESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMF 378
            S+ P+   T S G K  + +  PE I     +   D +SYGI++ E+ + G+RP  DM 
Sbjct: 169 NSSDPT--YTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMS 226
Query: 379 KDDL 382
             D+
Sbjct: 227 NQDV 230

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 109/225 (48%), Gaps = 32/225 (14%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQ----QQGALKSFIDECNALTSIRHRNILKIVS 220
           IGSGSFG+VYKG        A+K+L +     QQ  L++F +E   L   RH NIL  + 
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 71
Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDY 280
                 Y      A+V ++    +L   LH          K  +++ ++I    A  +DY
Sbjct: 72  ------YSTKPQLAIVTQWCEGSSLYHHLHIIE------TKFEMIKLIDIARQTAQGMDY 119
Query: 281 LHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG 340
           LH +    I H DLKS+N+ L E +   +GDFGLA    E+S     +Q     L GS+ 
Sbjct: 120 LHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLAT---EKSRWSGSHQF--EQLSGSIL 171
Query: 341 YIPPEYINGH----VSILGDIYSYGILLLEIFTGKRPTDDMFKDD 381
           ++ PE I        S   D+Y++GI+L E+ TG+ P  ++   D
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 216

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 107/225 (47%), Gaps = 32/225 (14%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQ----QQGALKSFIDECNALTSIRHRNILKIVS 220
           IGSGSFG+VYKG        A+K+L +     QQ  L++F +E   L   RH NIL  + 
Sbjct: 18  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 73
Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDY 280
                 Y      A+V ++    +L   LH          K  +++ ++I    A  +DY
Sbjct: 74  ------YSTKPQLAIVTQWCEGSSLYHHLHIIE------TKFEMIKLIDIARQTAQGMDY 121
Query: 281 LHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG 340
           LH +    I H DLKS+N+ L E +   +GDFGLA      S +    Q     L GS+ 
Sbjct: 122 LHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ-----LSGSIL 173
Query: 341 YIPPEYINGH----VSILGDIYSYGILLLEIFTGKRPTDDMFKDD 381
           ++ PE I        S   D+Y++GI+L E+ TG+ P  ++   D
Sbjct: 174 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 218

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 109/225 (48%), Gaps = 32/225 (14%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQ----QQGALKSFIDECNALTSIRHRNILKIVS 220
           IGSGSFG+VYKG        A+K+L +     QQ  L++F +E   L   RH NIL  + 
Sbjct: 36  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 91
Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDY 280
                 Y      A+V ++    +L   LH          K  +++ ++I    A  +DY
Sbjct: 92  ------YSTKPQLAIVTQWCEGSSLYHHLHIIE------TKFEMIKLIDIARQTAQGMDY 139
Query: 281 LHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG 340
           LH +    I H DLKS+N+ L E +   +GDFGLA    E+S     +Q     L GS+ 
Sbjct: 140 LHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLAT---EKSRWSGSHQF--EQLSGSIL 191
Query: 341 YIPPEYINGH----VSILGDIYSYGILLLEIFTGKRPTDDMFKDD 381
           ++ PE I        S   D+Y++GI+L E+ TG+ P  ++   D
Sbjct: 192 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 236

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 109/225 (48%), Gaps = 32/225 (14%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQ----QQGALKSFIDECNALTSIRHRNILKIVS 220
           IGSGSFG+VYKG        A+K+L +     QQ  L++F +E   L   RH NIL  + 
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 99
Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDY 280
                 Y      A+V ++    +L   LH          K  +++ ++I    A  +DY
Sbjct: 100 ------YSTKPQLAIVTQWCEGSSLYHHLHIIE------TKFEMIKLIDIARQTAQGMDY 147
Query: 281 LHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG 340
           LH +    I H DLKS+N+ L E +   +GDFGLA    E+S     +Q     L GS+ 
Sbjct: 148 LHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLAT---EKSRWSGSHQF--EQLSGSIL 199
Query: 341 YIPPEYINGH----VSILGDIYSYGILLLEIFTGKRPTDDMFKDD 381
           ++ PE I        S   D+Y++GI+L E+ TG+ P  ++   D
Sbjct: 200 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 244

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 107/225 (47%), Gaps = 32/225 (14%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQ----QQGALKSFIDECNALTSIRHRNILKIVS 220
           IGSGSFG+VYKG        A+K+L +     QQ  L++F +E   L   RH NIL  + 
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 71
Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDY 280
                 Y      A+V ++    +L   LH          K  +++ ++I    A  +DY
Sbjct: 72  ------YSTKPQLAIVTQWCEGSSLYHHLHIIE------TKFEMIKLIDIARQTAQGMDY 119
Query: 281 LHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG 340
           LH +    I H DLKS+N+ L E +   +GDFGLA      S +    Q     L GS+ 
Sbjct: 120 LHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ-----LSGSIL 171
Query: 341 YIPPEYINGH----VSILGDIYSYGILLLEIFTGKRPTDDMFKDD 381
           ++ PE I        S   D+Y++GI+L E+ TG+ P  ++   D
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 216

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 112/216 (51%), Gaps = 21/216 (9%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGA--LKSFIDECNALTSIRHRNILKIVSSC 222
           IG+GSFG+V++     G   A+K+L  Q   A  +  F+ E   +  +RH NI+  + + 
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +          ++V E++  G+L + LH S       ++L   +RL++  DVA  ++YLH
Sbjct: 104 TQPPN-----LSIVTEYLSRGSLYRLLHKSGAR----EQLDERRRLSMAYDVAKGMNYLH 154
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
           N+ + PI H DLKS N+L+D+     V DFGL++         +     S    G+  ++
Sbjct: 155 NR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK-------ASXFLXSKXAAGTPEWM 206
Query: 343 PPEYINGHVS-ILGDIYSYGILLLEIFTGKRPTDDM 377
            PE +    S    D+YS+G++L E+ T ++P  ++
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 107/225 (47%), Gaps = 32/225 (14%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQ----QQGALKSFIDECNALTSIRHRNILKIVS 220
           IGSGSFG+VYKG        A+K+L +     QQ  L++F +E   L   RH NIL  + 
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 76
Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDY 280
                 Y      A+V ++    +L   LH          K  +++ ++I    A  +DY
Sbjct: 77  ------YSTKPQLAIVTQWCEGSSLYHHLHIIE------TKFEMIKLIDIARQTAQGMDY 124
Query: 281 LHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG 340
           LH +    I H DLKS+N+ L E +   +GDFGLA      S +    Q     L GS+ 
Sbjct: 125 LHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ-----LSGSIL 176
Query: 341 YIPPEYINGH----VSILGDIYSYGILLLEIFTGKRPTDDMFKDD 381
           ++ PE I        S   D+Y++GI+L E+ TG+ P  ++   D
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 221

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 107/225 (47%), Gaps = 32/225 (14%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQ----QQGALKSFIDECNALTSIRHRNILKIVS 220
           IGSGSFG+VYKG        A+K+L +     QQ  L++F +E   L   RH NIL  + 
Sbjct: 43  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 98
Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDY 280
                 Y      A+V ++    +L   LH          K  +++ ++I    A  +DY
Sbjct: 99  ------YSTKPQLAIVTQWCEGSSLYHHLHIIE------TKFEMIKLIDIARQTAQGMDY 146
Query: 281 LHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG 340
           LH +    I H DLKS+N+ L E +   +GDFGLA      S +    Q     L GS+ 
Sbjct: 147 LHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ-----LSGSIL 198
Query: 341 YIPPEYINGH----VSILGDIYSYGILLLEIFTGKRPTDDMFKDD 381
           ++ PE I        S   D+Y++GI+L E+ TG+ P  ++   D
Sbjct: 199 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 243

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 107/225 (47%), Gaps = 32/225 (14%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQ----QQGALKSFIDECNALTSIRHRNILKIVS 220
           IGSGSFG+VYKG        A+K+L +     QQ  L++F +E   L   RH NIL  + 
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 76
Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDY 280
                 Y      A+V ++    +L   LH          K  +++ ++I    A  +DY
Sbjct: 77  ------YSTKPQLAIVTQWCEGSSLYHHLHIIE------TKFEMIKLIDIARQTAQGMDY 124
Query: 281 LHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG 340
           LH +    I H DLKS+N+ L E +   +GDFGLA      S +    Q     L GS+ 
Sbjct: 125 LHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ-----LSGSIL 176
Query: 341 YIPPEYINGH----VSILGDIYSYGILLLEIFTGKRPTDDMFKDD 381
           ++ PE I        S   D+Y++GI+L E+ TG+ P  ++   D
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 221

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 107/225 (47%), Gaps = 32/225 (14%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQ----QQGALKSFIDECNALTSIRHRNILKIVS 220
           IGSGSFG+VYKG        A+K+L +     QQ  L++F +E   L   RH NIL  + 
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 99
Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDY 280
                 Y      A+V ++    +L   LH          K  +++ ++I    A  +DY
Sbjct: 100 ------YSTKPQLAIVTQWCEGSSLYHHLHIIE------TKFEMIKLIDIARQTAQGMDY 147
Query: 281 LHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG 340
           LH +    I H DLKS+N+ L E +   +GDFGLA      S +    Q     L GS+ 
Sbjct: 148 LHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ-----LSGSIL 199
Query: 341 YIPPEYINGH----VSILGDIYSYGILLLEIFTGKRPTDDMFKDD 381
           ++ PE I        S   D+Y++GI+L E+ TG+ P  ++   D
Sbjct: 200 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 244

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 108/225 (48%), Gaps = 32/225 (14%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQ----QQGALKSFIDECNALTSIRHRNILKIVS 220
           IGSGSFG+VYKG        A+K+L +     QQ  L++F +E   L   RH NIL  + 
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 71
Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDY 280
             ++         A+V ++    +L   LH          K  +++ ++I    A  +DY
Sbjct: 72  YSTAPQL------AIVTQWCEGSSLYHHLHIIE------TKFEMIKLIDIARQTAQGMDY 119
Query: 281 LHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG 340
           LH +    I H DLKS+N+ L E +   +GDFGLA      S +    Q     L GS+ 
Sbjct: 120 LHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ-----LSGSIL 171
Query: 341 YIPPEYINGH----VSILGDIYSYGILLLEIFTGKRPTDDMFKDD 381
           ++ PE I        S   D+Y++GI+L E+ TG+ P  ++   D
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 216

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 113/240 (47%), Gaps = 25/240 (10%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSS 224
           +G G FG V+ GT       AIK LK       ++F+ E   +  +RH  ++++ +  S 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS- 73
Query: 225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ 284
                 +   +V E+M  G+L  +L   T +Y     L L Q +++   +AS + Y+   
Sbjct: 74  -----EEPIXIVTEYMSKGSLLDFLKGETGKY-----LRLPQLVDMAAQIASGMAYVERM 123
Query: 285 YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
                 H DL+++N+L+ E ++  V DFGLA+ +  E N      T   G K  + +  P
Sbjct: 124 N---YVHRDLRAANILVGENLVCKVADFGLARLI--EDN----EXTARQGAKFPIKWTAP 174
Query: 345 E-YINGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL--SIHKFVLMALPSHVMDVL 400
           E  + G  +I  D++S+GILL E+ T G+ P   M   ++   + +   M  P    + L
Sbjct: 175 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 234

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 113/218 (51%), Gaps = 25/218 (11%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGA--LKSFIDECNALTSIRHRNILKIVSSC 222
           IG+GSFG+V++     G   A+K+L  Q   A  +  F+ E   +  +RH NI+  + + 
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +          ++V E++  G+L + LH S       ++L   +RL++  DVA  ++YLH
Sbjct: 104 TQPPN-----LSIVTEYLSRGSLYRLLHKSGAR----EQLDERRRLSMAYDVAKGMNYLH 154
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM--SNGLKGSVG 340
           N+ + PI H +LKS N+L+D+     V DFGL++          K  T   S    G+  
Sbjct: 155 NR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL---------KASTFLSSKSAAGTPE 204
Query: 341 YIPPEYINGHVS-ILGDIYSYGILLLEIFTGKRPTDDM 377
           ++ PE +    S    D+YS+G++L E+ T ++P  ++
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 111/225 (49%), Gaps = 29/225 (12%)
Query: 165 IGSGSFGSVYKGTL------ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKI 218
           +G G+FG V+           D    A+K LK   + A + F  E   LT ++H++I++ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHP--------STDEYCHFKKLSLMQRLNI 270
              C+    EG     +VFE+MR+G+L+++L          +  E      L L Q L +
Sbjct: 86  FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 140
Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
              VA+ + YL   +     H DL + N L+ +G++  +GDFG+++ ++         +T
Sbjct: 141 ASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 197
Query: 331 MSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRP 373
           M       + ++PPE I     +   D++S+G++L EIFT GK+P
Sbjct: 198 ML-----PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 113/240 (47%), Gaps = 25/240 (10%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSS 224
           +G G FG V+ GT       AIK LK       ++F+ E   +  +RH  ++++ +  S 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS- 76
Query: 225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ 284
                 +   +V E+M  G+L  +L   T +Y     L L Q +++   +AS + Y+   
Sbjct: 77  -----EEPIYIVTEYMSKGSLLDFLKGETGKY-----LRLPQLVDMAAQIASGMAYVERM 126
Query: 285 YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
                 H DL+++N+L+ E ++  V DFGLA+ +  E N      T   G K  + +  P
Sbjct: 127 N---YVHRDLRAANILVGENLVCKVADFGLARLI--EDN----EYTARQGAKFPIKWTAP 177
Query: 345 E-YINGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL--SIHKFVLMALPSHVMDVL 400
           E  + G  +I  D++S+GILL E+ T G+ P   M   ++   + +   M  P    + L
Sbjct: 178 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 237

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 111/225 (49%), Gaps = 29/225 (12%)
Query: 165 IGSGSFGSVYKGTL------ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKI 218
           +G G+FG V+           D    A+K LK   + A + F  E   LT ++H++I++ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHP--------STDEYCHFKKLSLMQRLNI 270
              C+    EG     +VFE+MR+G+L+++L          +  E      L L Q L +
Sbjct: 80  FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 134
Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
              VA+ + YL   +     H DL + N L+ +G++  +GDFG+++ ++         +T
Sbjct: 135 ASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 191
Query: 331 MSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRP 373
           M       + ++PPE I     +   D++S+G++L EIFT GK+P
Sbjct: 192 ML-----PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 115/242 (47%), Gaps = 29/242 (11%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNILKIVSSC 222
           +G G FG V+ GT       AIK LK    G +  ++F+ E   +  +RH  ++++ +  
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 79
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           S       +   +V E+M  G+L  +L   T +Y     L L Q +++   +AS + Y+ 
Sbjct: 80  S------EEPIYIVTEYMNKGSLLDFLKGETGKY-----LRLPQLVDMSAQIASGMAYVE 128
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
                   H DL+++N+L+ E ++  V DFGLA+ +  E N      T   G K  + + 
Sbjct: 129 RMN---YVHRDLRAANILVGENLVCKVADFGLARLI--EDN----EWTARQGAKFPIKWT 179
Query: 343 PPE-YINGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL--SIHKFVLMALPSHVMD 398
            PE  + G  +I  D++S+GILL E+ T G+ P   M   ++   + +   M  P    +
Sbjct: 180 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 239
Query: 399 VL 400
            L
Sbjct: 240 SL 241

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 111/225 (49%), Gaps = 29/225 (12%)
Query: 165 IGSGSFGSVYKGTL------ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKI 218
           +G G+FG V+           D    A+K LK   + A + F  E   LT ++H++I++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHP--------STDEYCHFKKLSLMQRLNI 270
              C+    EG     +VFE+MR+G+L+++L          +  E      L L Q L +
Sbjct: 109 FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
              VA+ + YL   +     H DL + N L+ +G++  +GDFG+++ ++         +T
Sbjct: 164 ASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 331 MSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRP 373
           M       + ++PPE I     +   D++S+G++L EIFT GK+P
Sbjct: 221 ML-----PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 115/242 (47%), Gaps = 29/242 (11%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNILKIVSSC 222
           +G G FG V+ GT       AIK LK    G +  ++F+ E   +  +RH  ++++ +  
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 79
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           S       +   +V E+M  G+L  +L   T +Y     L L Q +++   +AS + Y+ 
Sbjct: 80  S------EEPIYIVTEYMNKGSLLDFLKGETGKY-----LRLPQLVDMSAQIASGMAYVE 128
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
                   H DL+++N+L+ E ++  V DFGLA+ +  E N      T   G K  + + 
Sbjct: 129 RMN---YVHRDLRAANILVGENLVCKVADFGLARLI--EDN----EYTARQGAKFPIKWT 179
Query: 343 PPE-YINGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL--SIHKFVLMALPSHVMD 398
            PE  + G  +I  D++S+GILL E+ T G+ P   M   ++   + +   M  P    +
Sbjct: 180 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 239
Query: 399 VL 400
            L
Sbjct: 240 SL 241

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 113/240 (47%), Gaps = 25/240 (10%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSS 224
           +G G FG V+ GT       AIK LK       ++F+ E   +  +RH  ++++ +  S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS- 249
Query: 225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ 284
                 +   +V E+M  G+L  +L   T +Y     L L Q +++   +AS + Y+   
Sbjct: 250 -----EEPIYIVTEYMSKGSLLDFLKGETGKY-----LRLPQLVDMAAQIASGMAYVERM 299
Query: 285 YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
                 H DL+++N+L+ E ++  V DFGLA+ +  E N      T   G K  + +  P
Sbjct: 300 ---NYVHRDLRAANILVGENLVCKVADFGLARLI--EDN----EYTARQGAKFPIKWTAP 350
Query: 345 E-YINGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL--SIHKFVLMALPSHVMDVL 400
           E  + G  +I  D++S+GILL E+ T G+ P   M   ++   + +   M  P    + L
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 410

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 113/240 (47%), Gaps = 25/240 (10%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSS 224
           +G G FG V+ GT       AIK LK       ++F+ E   +  +RH  ++++ +  S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS- 249
Query: 225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ 284
                 +   +V E+M  G+L  +L   T +Y     L L Q +++   +AS + Y+   
Sbjct: 250 -----EEPIYIVTEYMSKGSLLDFLKGETGKY-----LRLPQLVDMAAQIASGMAYVERM 299
Query: 285 YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
                 H DL+++N+L+ E ++  V DFGLA+ +  E N      T   G K  + +  P
Sbjct: 300 ---NYVHRDLRAANILVGENLVCKVADFGLARLI--EDN----EYTARQGAKFPIKWTAP 350
Query: 345 E-YINGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL--SIHKFVLMALPSHVMDVL 400
           E  + G  +I  D++S+GILL E+ T G+ P   M   ++   + +   M  P    + L
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 410

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 108/226 (47%), Gaps = 30/226 (13%)
Query: 165 IGSGSFGSVYKGTL------ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKI 218
           +G G+FG V+           D    A+K LK     A K F  E   LT+++H +I+K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHF---------KKLSLMQRLN 269
              C        D   +VFE+M++G+L+++L     +              +L L Q L+
Sbjct: 83  YGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
           I   +AS + YL +Q+     H DL + N L+   ++  +GDFG+++ ++          
Sbjct: 138 IASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 330 TMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRP 373
           TM       + ++PPE I     +   D++S+G++L EIFT GK+P
Sbjct: 195 TML-----PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 114/240 (47%), Gaps = 25/240 (10%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSS 224
           +G G FG V+ GT       AIK LK     + ++F+ E   +  +RH  ++++ +  S 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS- 332
Query: 225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ 284
                 +   +V E+M  G+L  +L   T +Y     L L Q +++   +AS + Y+   
Sbjct: 333 -----EEPIYIVTEYMSKGSLLDFLKGETGKY-----LRLPQLVDMAAQIASGMAYVERM 382
Query: 285 YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
                 H DL+++N+L+ E ++  V DFGLA+ +  E N      T   G K  + +  P
Sbjct: 383 N---YVHRDLRAANILVGENLVCKVADFGLARLI--EDN----EYTARQGAKFPIKWTAP 433
Query: 345 E-YINGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL--SIHKFVLMALPSHVMDVL 400
           E  + G  +I  D++S+GILL E+ T G+ P   M   ++   + +   M  P    + L
Sbjct: 434 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 493

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 113/240 (47%), Gaps = 25/240 (10%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSS 224
           +G G FG V+ GT       AIK LK       ++F+ E   +  +RH  ++++ +  S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS- 249
Query: 225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ 284
                 +   +V E+M  G+L  +L   T +Y     L L Q +++   +AS + Y+   
Sbjct: 250 -----EEPIYIVGEYMSKGSLLDFLKGETGKY-----LRLPQLVDMAAQIASGMAYVERM 299
Query: 285 YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
                 H DL+++N+L+ E ++  V DFGLA+ +  E N      T   G K  + +  P
Sbjct: 300 ---NYVHRDLRAANILVGENLVCKVADFGLARLI--EDN----EYTARQGAKFPIKWTAP 350
Query: 345 E-YINGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL--SIHKFVLMALPSHVMDVL 400
           E  + G  +I  D++S+GILL E+ T G+ P   M   ++   + +   M  P    + L
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 410

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 112/240 (46%), Gaps = 25/240 (10%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSS 224
           +G G FG V+ GT       AIK LK       ++F+ E   +  IRH  ++++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKIRHEKLVQLYAVVS- 83
Query: 225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ 284
                 +   +V E+M  G+L  +L     +Y     L L Q +++   +AS + Y+   
Sbjct: 84  -----EEPIYIVTEYMSKGSLLDFLKGEMGKY-----LRLPQLVDMAAQIASGMAYVERM 133
Query: 285 YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
                 H DL+++N+L+ E ++  V DFGLA+ +  E N      T   G K  + +  P
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLI--EDN----EYTARQGAKFPIKWTAP 184
Query: 345 E-YINGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL--SIHKFVLMALPSHVMDVL 400
           E  + G  +I  D++S+GILL E+ T G+ P   M   ++   + +   M  P    + L
Sbjct: 185 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 244

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 112/240 (46%), Gaps = 25/240 (10%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSS 224
           +G G FG V+ GT       AIK LK       ++F+ E   +  +RH  ++++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS- 83
Query: 225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ 284
                 +   +V E+M  G+L  +L     +Y     L L Q +++   +AS + Y+   
Sbjct: 84  -----EEPIYIVIEYMSKGSLLDFLKGEMGKY-----LRLPQLVDMAAQIASGMAYVERM 133
Query: 285 YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
                 H DL+++N+L+ E ++  V DFGLA+ +  E N      T   G K  + +  P
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLI--EDN----EXTARQGAKFPIKWTAP 184
Query: 345 E-YINGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL--SIHKFVLMALPSHVMDVL 400
           E  + G  +I  D++S+GILL E+ T G+ P   M   ++   + +   M  P    + L
Sbjct: 185 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 244

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 118/231 (51%), Gaps = 29/231 (12%)
Query: 162 ENLIGSGSFGSVYKGTLA-DGET---AAIKVLKL-QQQGALKSFIDECNALTSIRHRNIL 216
           E +IG+G FG V  G L   G+     AIK LK    +   + F+ E + +    H N++
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 217 K---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
               +V+  + V         ++ EFM NG+LD +L  +  ++      +++Q + ++  
Sbjct: 98  HLEGVVTKSTPV--------MIITEFMENGSLDSFLRQNDGQF------TVIQLVGMLRG 143
Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +A+ + YL    D    H DL + N+L++  ++  V DFGL++FL ++++ P+    +  
Sbjct: 144 IAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSAL-- 198
Query: 334 GLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL 382
           G K  + +  PE I     +   D++SYGI++ E+ + G+RP  DM   D+
Sbjct: 199 GGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 249

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 114/242 (47%), Gaps = 29/242 (11%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNILKIVSSC 222
           +G G FG V+ GT       AIK LK    G +  ++F+ E   +  +RH  ++++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           S       +   +V E+M  G+L  +L     +Y     L L Q +++   +AS + Y+ 
Sbjct: 83  S------EEPIYIVIEYMSKGSLLDFLKGEMGKY-----LRLPQLVDMAAQIASGMAYVE 131
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
                   H DL+++N+L+ E ++  V DFGLA+ +  E N      T   G K  + + 
Sbjct: 132 RMN---YVHRDLRAANILVGENLVCKVADFGLARLI--EDN----EYTARQGAKFPIKWT 182
Query: 343 PPE-YINGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL--SIHKFVLMALPSHVMD 398
            PE  + G  +I  D++S+GILL E+ T G+ P   M   ++   + +   M  P    +
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 242
Query: 399 VL 400
            L
Sbjct: 243 SL 244

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 112/240 (46%), Gaps = 25/240 (10%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSS 224
           +G G FG V+ GT       AIK LK       ++F+ E   +  +RH  ++++ +  S 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS- 72
Query: 225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ 284
                 +   +V E+M  G+L  +L     +Y     L L Q +++   +AS + Y+   
Sbjct: 73  -----EEPIYIVTEYMSKGSLLDFLKGEMGKY-----LRLPQLVDMAAQIASGMAYVERM 122
Query: 285 YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
                 H DL+++N+L+ E ++  V DFGLA+ +  E N      T   G K  + +  P
Sbjct: 123 N---YVHRDLRAANILVGENLVCKVADFGLARLI--EDN----EYTARQGAKFPIKWTAP 173
Query: 345 E-YINGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL--SIHKFVLMALPSHVMDVL 400
           E  + G  +I  D++S+GILL E+ T G+ P   M   ++   + +   M  P    + L
Sbjct: 174 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 233

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 110/223 (49%), Gaps = 27/223 (12%)
Query: 165 IGSGSFGSVYKGTL------ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKI 218
           +G G+FG V+           D    A+K LK     A K F  E   LT+++H +I+K 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHF------KKLSLMQRLNIVI 272
              C     EG+    +VFE+M++G+L+++L     +           +L+  Q L+I  
Sbjct: 81  YGVCV----EGDPL-IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQ 135
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            +A+ + YL +Q+     H DL + N L+ E ++  +GDFG+++ ++          TM 
Sbjct: 136 QIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 192
Query: 333 NGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRP 373
                 + ++PPE I     +   D++S G++L EIFT GK+P
Sbjct: 193 -----PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 112/240 (46%), Gaps = 25/240 (10%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSS 224
           +G G FG V+ GT       AIK LK       ++F+ E   +  +RH  ++++ +  S 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS- 74
Query: 225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ 284
                 +   +V E+M  G+L  +L     +Y     L L Q +++   +AS + Y+   
Sbjct: 75  -----EEPIYIVTEYMSKGSLLDFLKGEMGKY-----LRLPQLVDMAAQIASGMAYVERM 124
Query: 285 YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
                 H DL+++N+L+ E ++  V DFGLA+ +  E N      T   G K  + +  P
Sbjct: 125 N---YVHRDLRAANILVGENLVCKVADFGLARLI--EDN----EYTARQGAKFPIKWTAP 175
Query: 345 E-YINGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL--SIHKFVLMALPSHVMDVL 400
           E  + G  +I  D++S+GILL E+ T G+ P   M   ++   + +   M  P    + L
Sbjct: 176 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 235

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 109/224 (48%), Gaps = 30/224 (13%)
Query: 160 SEENLIGSGSFGSVYKGTLADGE-----TAAIKVLKLQQQGALK-SFIDECNALTSIRHR 213
           + + +IG+G FG VYKG L           AIK LK       +  F+ E   +    H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 214 NILKIVSSCSSVDYEGNDFKAL--VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           NI+++    S        +K +  + E+M NG LD++L     E+      S++Q + ++
Sbjct: 107 NIIRLEGVISK-------YKPMMIITEYMENGALDKFLREKDGEF------SVLQLVGML 153
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
             +A+ + YL N       H DL + N+L++  ++  V DFGL++ L    + P    T 
Sbjct: 154 RGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL---EDDPEATYTT 207
Query: 332 SNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRP 373
           S G K  + +  PE I+    +   D++S+GI++ E+ T G+RP
Sbjct: 208 SGG-KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 114/242 (47%), Gaps = 29/242 (11%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNILKIVSSC 222
           +G G FG V+ GT       AIK LK    G +  ++F+ E   +  +RH  ++++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           S       +   +V E+M  G+L  +L     +Y     L L Q +++   +AS + Y+ 
Sbjct: 83  S------EEPIYIVTEYMSKGSLLDFLKGEMGKY-----LRLPQLVDMAAQIASGMAYVE 131
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
                   H DL+++N+L+ E ++  V DFGLA+ +  E N      T   G K  + + 
Sbjct: 132 RMN---YVHRDLRAANILVGENLVCKVADFGLARLI--EDN----EYTARQGAKFPIKWT 182
Query: 343 PPE-YINGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL--SIHKFVLMALPSHVMD 398
            PE  + G  +I  D++S+GILL E+ T G+ P   M   ++   + +   M  P    +
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 242
Query: 399 VL 400
            L
Sbjct: 243 SL 244

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 112/240 (46%), Gaps = 25/240 (10%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSS 224
           +G G FG V+ GT       AIK LK       ++F+ E   +  +RH  ++++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS- 83
Query: 225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ 284
                 +   +V E+M  G+L  +L     +Y     L L Q +++   +AS + Y+   
Sbjct: 84  -----EEPIYIVCEYMSKGSLLDFLKGEMGKY-----LRLPQLVDMAAQIASGMAYVERM 133
Query: 285 YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
                 H DL+++N+L+ E ++  V DFGLA+ +  E N      T   G K  + +  P
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLI--EDN----EYTARQGAKFPIKWTAP 184
Query: 345 E-YINGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL--SIHKFVLMALPSHVMDVL 400
           E  + G  +I  D++S+GILL E+ T G+ P   M   ++   + +   M  P    + L
Sbjct: 185 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 244

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 111/240 (46%), Gaps = 25/240 (10%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSS 224
           +G G FG V+ GT       AIK LK       ++F+ E   +  +RH  ++++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS- 83
Query: 225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ 284
                 +   +V E+M  G L  +L     +Y     L L Q +++   +AS + Y+   
Sbjct: 84  -----EEPIYIVMEYMSKGCLLDFLKGEMGKY-----LRLPQLVDMAAQIASGMAYVERM 133
Query: 285 YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
                 H DL+++N+L+ E ++  V DFGLA+ +  E N      T   G K  + +  P
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLI--EDN----EYTARQGAKFPIKWTAP 184
Query: 345 E-YINGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL--SIHKFVLMALPSHVMDVL 400
           E  + G  +I  D++S+GILL E+ T G+ P   M   ++   + +   M  P    + L
Sbjct: 185 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 244

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 111/240 (46%), Gaps = 25/240 (10%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSS 224
           +G G FG V+ GT       AIK LK       ++F+ E   +  +RH  ++++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS- 83
Query: 225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ 284
                 +   +V E+M  G L  +L     +Y     L L Q +++   +AS + Y+   
Sbjct: 84  -----EEPIYIVTEYMSKGCLLDFLKGEMGKY-----LRLPQLVDMAAQIASGMAYVERM 133
Query: 285 YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
                 H DL+++N+L+ E ++  V DFGLA+ +  E N      T   G K  + +  P
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLI--EDN----EYTARQGAKFPIKWTAP 184
Query: 345 E-YINGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL--SIHKFVLMALPSHVMDVL 400
           E  + G  +I  D++S+GILL E+ T G+ P   M   ++   + +   M  P    + L
Sbjct: 185 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 244

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 111/240 (46%), Gaps = 25/240 (10%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSS 224
           +G G FG V+ GT       AIK LK       ++F+ E   +  +RH  ++++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS- 83
Query: 225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ 284
                 +   +V E+M  G+L  +L     +Y     L L Q +++   +AS + Y+   
Sbjct: 84  -----EEPIYIVTEYMSKGSLLDFLKGEMGKY-----LRLPQLVDMAAQIASGMAYVERM 133
Query: 285 YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
                 H DL ++N+L+ E ++  V DFGLA+ +  E N      T   G K  + +  P
Sbjct: 134 N---YVHRDLAAANILVGENLVCKVADFGLARLI--EDN----EYTARQGAKFPIKWTAP 184
Query: 345 E-YINGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL--SIHKFVLMALPSHVMDVL 400
           E  + G  +I  D++S+GILL E+ T G+ P   M   ++   + +   M  P    + L
Sbjct: 185 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 244

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 125/254 (49%), Gaps = 32/254 (12%)
Query: 139 PSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTL---ADGE-TAAIKVLKL-QQ 193
           P    Q+   + K  +AT N S + ++G+G FG V  G L   +  E + AIK LK+   
Sbjct: 16  PRGSTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 74
Query: 194 QGALKSFIDECNALTSIRHRNILK---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH 250
           +   + F+ E + +    H NI++   +V+    V         +V E+M NG+LD +L 
Sbjct: 75  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFLR 126
Query: 251 PSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG 310
                  H  + +++Q + ++  +AS + YL    D    H DL + N+L++  ++  V 
Sbjct: 127 K------HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVS 177
Query: 311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT 369
           DFGL++ L ++   P    T   G K  + +  PE I     +   D++SYGI+L E+ +
Sbjct: 178 DFGLSRVLEDD---PEAAYTTRGG-KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233
Query: 370 -GKRPTDDMFKDDL 382
            G+RP  +M   D+
Sbjct: 234 YGERPYWEMSNQDV 247

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 123/249 (49%), Gaps = 32/249 (12%)
Query: 144 QSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTL---ADGE-TAAIKVLKL-QQQGALK 198
           Q+   + K  +AT N S + ++G+G FG V  G L   +  E + AIK LK+   +   +
Sbjct: 33  QTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 199 SFIDECNALTSIRHRNILK---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDE 255
            F+ E + +    H NI++   +V+    V         +V E+M NG+LD +L      
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFLRK---- 139
Query: 256 YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA 315
             H  + +++Q + ++  +AS + YL    D    H DL + N+L++  ++  V DFGLA
Sbjct: 140 --HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLA 194
Query: 316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRP 373
           + L    + P    T   G K  + +  PE I     +   D++SYGI+L E+ + G+RP
Sbjct: 195 RVL---EDDPEAAYTTRGG-KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
Query: 374 TDDMFKDDL 382
             +M   D+
Sbjct: 251 YWEMSNQDV 259

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 117/231 (50%), Gaps = 29/231 (12%)
Query: 162 ENLIGSGSFGSVYKGTLA-DGET---AAIKVLKL-QQQGALKSFIDECNALTSIRHRNIL 216
           E +IG+G FG V  G L   G+     AIK LK    +   + F+ E + +    H N++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 217 K---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
               +V+  + V         ++ EFM NG+LD +L  +  ++      +++Q + ++  
Sbjct: 72  HLEGVVTKSTPV--------MIITEFMENGSLDSFLRQNDGQF------TVIQLVGMLRG 117
Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +A+ + YL    D    H  L + N+L++  ++  V DFGL++FL ++++ P+    +  
Sbjct: 118 IAAGMKYLA---DMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSAL-- 172
Query: 334 GLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL 382
           G K  + +  PE I     +   D++SYGI++ E+ + G+RP  DM   D+
Sbjct: 173 GGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 223

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 119/246 (48%), Gaps = 35/246 (14%)
Query: 130 KTSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVL 189
           +T + Q     +EW+     LK+            +G+G FG V+ G        A+K L
Sbjct: 1   QTQKPQKPWWEDEWEVPRETLKLVER---------LGAGQFGEVWMGYYNGHTKVAVKSL 51
Query: 190 KLQQQGALK--SFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQ 247
           K   QG++   +F+ E N +  ++H+ ++++ +  +       +   ++ E+M NG+L  
Sbjct: 52  K---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVD 102
Query: 248 WLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIA 307
           +L   +       KL++ + L++   +A  + ++  +      H DL+++N+L+ + +  
Sbjct: 103 FLKTPSG-----IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSC 154
Query: 308 HVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLE 366
            + DFGLA+ +  E N      T   G K  + +  PE IN G  +I  D++S+GILL E
Sbjct: 155 KIADFGLARLI--EDN----EXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTE 208
Query: 367 IFTGKR 372
           I T  R
Sbjct: 209 IVTHGR 214

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 108/232 (46%), Gaps = 39/232 (16%)
Query: 158 NFSE---ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFID----ECNALTSI 210
           +F+E   E +IG G FG VY+     G+  A+K  +      +   I+    E      +
Sbjct: 5   DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
           +H NI+ +   C     E N    LV EF R G L++ L          K++     +N 
Sbjct: 64  KHPNIIALRGVCLK---EPN--LCLVMEFARGGPLNRVLS--------GKRIPPDILVNW 110
Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM--------IAHVGDFGLAKFLFEES 322
            + +A  ++YLH++   PI H DLKSSN+L+ + +        I  + DFGLA+      
Sbjct: 111 AVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR------ 164
Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
                ++T      G+  ++ PE I   +   G D++SYG+LL E+ TG+ P
Sbjct: 165 ---EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 119/246 (48%), Gaps = 35/246 (14%)
Query: 130 KTSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVL 189
           +T + Q     +EW+     LK+            +G+G FG V+ G        A+K L
Sbjct: 3   QTQKPQKPWWEDEWEVPRETLKLVER---------LGAGQFGEVWMGYYNGHTKVAVKSL 53
Query: 190 KLQQQGALK--SFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQ 247
           K   QG++   +F+ E N +  ++H+ ++++ +  +       +   ++ E+M NG+L  
Sbjct: 54  K---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVD 104
Query: 248 WLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIA 307
           +L   +       KL++ + L++   +A  + ++  +      H DL+++N+L+ + +  
Sbjct: 105 FLKTPSG-----IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSC 156
Query: 308 HVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLE 366
            + DFGLA+ +  E N      T   G K  + +  PE IN G  +I  D++S+GILL E
Sbjct: 157 KIADFGLARLI--EDN----EXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTE 210
Query: 367 IFTGKR 372
           I T  R
Sbjct: 211 IVTHGR 216

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 120/247 (48%), Gaps = 35/247 (14%)
Query: 129 VKTSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKV 188
           ++T + Q     +EW+     LK+            +G+G FG V+ G        A+K 
Sbjct: 4   MQTQKPQKPWWEDEWEVPRETLKLVER---------LGAGQFGEVWMGYYNGHTKVAVKS 54
Query: 189 LKLQQQGALK--SFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLD 246
           LK   QG++   +F+ E N +  ++H+ ++++ +  +       +   ++ E+M NG+L 
Sbjct: 55  LK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLV 105
Query: 247 QWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI 306
            +L   +       KL++ + L++   +A  + ++  +      H DL+++N+L+ + + 
Sbjct: 106 DFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLS 157
Query: 307 AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLL 365
             + DFGLA+ +  E N      T   G K  + +  PE IN G  +I  D++S+GILL 
Sbjct: 158 CKIADFGLARLI--EDN----EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLT 211
Query: 366 EIFTGKR 372
           EI T  R
Sbjct: 212 EIVTHGR 218

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 27/216 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNILKIVSSC 222
           IGSG FG V+ G   + +  AIK ++   +GA+  + FI+E   +  + H  ++++   C
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
                       LVFEFM +G L  +L         F   +L   L + +DV   + YL 
Sbjct: 72  LE-----QAPICLVFEFMEHGCLSDYLRTQRG---LFAAETL---LGMCLDVCEGMAYLE 120
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
              +  + H DL + N L+ E  +  V DFG+ +F+ ++  T       S G K  V + 
Sbjct: 121 ---EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS------STGTKFPVKWA 171
Query: 343 PPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDD 376
            PE  +    S   D++S+G+L+ E+F+ GK P ++
Sbjct: 172 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 207

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 123/249 (49%), Gaps = 32/249 (12%)
Query: 144 QSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTL---ADGE-TAAIKVLKL-QQQGALK 198
           Q+   + K  +AT N S + ++G+G FG V  G L   +  E + AIK LK+   +   +
Sbjct: 33  QTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 199 SFIDECNALTSIRHRNILK---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDE 255
            F+ E + +    H NI++   +V+    V         +V E+M NG+LD +L      
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFLRK---- 139
Query: 256 YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA 315
             H  + +++Q + ++  +AS + YL    D    H DL + N+L++  ++  V DFGL+
Sbjct: 140 --HDAQFTVIQLVGMLRGIASGMKYLS---DMGFVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRP 373
           + L    + P    T   G K  + +  PE I     +   D++SYGI+L E+ + G+RP
Sbjct: 195 RVL---EDDPEAAYTTRGG-KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
Query: 374 TDDMFKDDL 382
             +M   D+
Sbjct: 251 YWEMSNQDV 259

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 119/246 (48%), Gaps = 35/246 (14%)
Query: 130 KTSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVL 189
           +T + Q     +EW+     LK+            +G+G FG V+ G        A+K L
Sbjct: 1   QTQKPQKPWWEDEWEVPRETLKLVER---------LGAGQFGEVWMGYYNGHTKVAVKSL 51
Query: 190 KLQQQGALK--SFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQ 247
           K   QG++   +F+ E N +  ++H+ ++++ +  +       +   ++ E+M NG+L  
Sbjct: 52  K---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVD 102
Query: 248 WLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIA 307
           +L   +       KL++ + L++   +A  + ++  +      H DL+++N+L+ + +  
Sbjct: 103 FLKTPSG-----IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSC 154
Query: 308 HVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLE 366
            + DFGLA+ +  E N      T   G K  + +  PE IN G  +I  D++S+GILL E
Sbjct: 155 KIADFGLARLI--EDN----EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTE 208
Query: 367 IFTGKR 372
           I T  R
Sbjct: 209 IVTHGR 214

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 117/235 (49%), Gaps = 31/235 (13%)
Query: 158 NFSEENLIGSGSFGSVYKGTL---ADGE-TAAIKVLKL-QQQGALKSFIDECNALTSIRH 212
           N S + ++G+G FG V  G L   +  E + AIK LK+   +   + F+ E + +    H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 213 RNILK---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN 269
            NI++   +V+    V         +V E+M NG+LD +L        H  + +++Q + 
Sbjct: 77  PNIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFLRK------HDAQFTVIQLVG 122
Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
           ++  +AS + YL    D    H DL + N+L++  ++  V DFGL++ L ++   P    
Sbjct: 123 MLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD---PEAAY 176
Query: 330 TMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL 382
           T   G K  + +  PE I     +   D++SYGI+L E+ + G+RP  +M   D+
Sbjct: 177 TTRGG-KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 230

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 111/240 (46%), Gaps = 25/240 (10%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSS 224
           +G G FG V+ GT       AIK LK       ++F+ E   +  +RH  ++++ +  S 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS- 250
Query: 225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ 284
                 +   +V E+M  G+L  +L     +Y     L L Q +++   +AS + Y+   
Sbjct: 251 -----EEPIYIVTEYMSKGSLLDFLKGEMGKY-----LRLPQLVDMAAQIASGMAYVERM 300
Query: 285 YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
                 H DL+++N+L+ E ++  V DFGL + +  E N      T   G K  + +  P
Sbjct: 301 N---YVHRDLRAANILVGENLVCKVADFGLGRLI--EDN----EYTARQGAKFPIKWTAP 351
Query: 345 E-YINGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL--SIHKFVLMALPSHVMDVL 400
           E  + G  +I  D++S+GILL E+ T G+ P   M   ++   + +   M  P    + L
Sbjct: 352 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 411

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 27/216 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNILKIVSSC 222
           IGSG FG V+ G   + +  AIK ++   +GA+  + FI+E   +  + H  ++++   C
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
                       LVFEFM +G L  +L         F   +L   L + +DV   + YL 
Sbjct: 70  LE-----QAPICLVFEFMEHGCLSDYLRTQRG---LFAAETL---LGMCLDVCEGMAYLE 118
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
              +  + H DL + N L+ E  +  V DFG+ +F+ ++  T       S G K  V + 
Sbjct: 119 ---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS------STGTKFPVKWA 169
Query: 343 PPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDD 376
            PE  +    S   D++S+G+L+ E+F+ GK P ++
Sbjct: 170 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 27/216 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNILKIVSSC 222
           IGSG FG V+ G   + +  AIK ++   +GA+  + FI+E   +  + H  ++++   C
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
                       LVFEFM +G L  +L         F   +L   L + +DV   + YL 
Sbjct: 72  LE-----QAPICLVFEFMEHGCLSDYLRTQRG---LFAAETL---LGMCLDVCEGMAYLE 120
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
              +  + H DL + N L+ E  +  V DFG+ +F+ ++  T       S G K  V + 
Sbjct: 121 ---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS------STGTKFPVKWA 171
Query: 343 PPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDD 376
            PE  +    S   D++S+G+L+ E+F+ GK P ++
Sbjct: 172 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 207

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 123/249 (49%), Gaps = 32/249 (12%)
Query: 144 QSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTL---ADGE-TAAIKVLKL-QQQGALK 198
           Q+   + K  +AT N S + ++G+G FG V  G L   +  E + AIK LK+   +   +
Sbjct: 31  QTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 89
Query: 199 SFIDECNALTSIRHRNILK---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDE 255
            F+ E + +    H NI++   +V+    V         +V E+M NG+LD +L      
Sbjct: 90  DFLGEASIMGQFDHPNIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFLRK---- 137
Query: 256 YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA 315
             H  + +++Q + ++  +AS + YL    D    H DL + N+L++  ++  V DFGL+
Sbjct: 138 --HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLS 192
Query: 316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRP 373
           + L    + P    T   G K  + +  PE I     +   D++SYGI+L E+ + G+RP
Sbjct: 193 RVL---EDDPEAAYTTRGG-KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 248
Query: 374 TDDMFKDDL 382
             +M   D+
Sbjct: 249 YWEMSNQDV 257

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 118/245 (48%), Gaps = 35/245 (14%)
Query: 131 TSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLK 190
           T + Q     +EW+     LK+            +G+G FG V+ G        A+K LK
Sbjct: 1   TQKPQKPWWEDEWEVPRETLKLVER---------LGAGQFGEVWMGYYNGHTKVAVKSLK 51
Query: 191 LQQQGALK--SFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQW 248
              QG++   +F+ E N +  ++H+ ++++ +  +       +   ++ E+M NG+L  +
Sbjct: 52  ---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDF 102
Query: 249 LHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH 308
           L   +       KL++ + L++   +A  + ++  +      H DL+++N+L+ + +   
Sbjct: 103 LKTPSG-----IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCK 154
Query: 309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEI 367
           + DFGLA+ +  E N      T   G K  + +  PE IN G  +I  D++S+GILL EI
Sbjct: 155 IADFGLARLI--EDN----EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 208
Query: 368 FTGKR 372
            T  R
Sbjct: 209 VTHGR 213

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 27/216 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNILKIVSSC 222
           IGSG FG V+ G   + +  AIK ++   +GA+  + FI+E   +  + H  ++++   C
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
                       LVFEFM +G L  +L         F   +L   L + +DV   + YL 
Sbjct: 75  LE-----QAPICLVFEFMEHGCLSDYLRTQRG---LFAAETL---LGMCLDVCEGMAYLE 123
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
              +  + H DL + N L+ E  +  V DFG+ +F+ ++  T       S G K  V + 
Sbjct: 124 ---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS------STGTKFPVKWA 174
Query: 343 PPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDD 376
            PE  +    S   D++S+G+L+ E+F+ GK P ++
Sbjct: 175 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 210

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 123/249 (49%), Gaps = 32/249 (12%)
Query: 144 QSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTL---ADGE-TAAIKVLKL-QQQGALK 198
           Q+   + K  +AT N S + ++G+G FG V  G L   +  E + AIK LK+   +   +
Sbjct: 33  QTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 199 SFIDECNALTSIRHRNILK---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDE 255
            F+ E + +    H NI++   +V+    V         +V E+M NG+LD +L      
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFLRK---- 139
Query: 256 YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA 315
             H  + +++Q + ++  +AS + YL    D    H DL + N+L++  ++  V DFGL+
Sbjct: 140 --HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRP 373
           + L    + P    T   G K  + +  PE I     +   D++SYGI+L E+ + G+RP
Sbjct: 195 RVL---EDDPEAAYTTRGG-KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
Query: 374 TDDMFKDDL 382
             +M   D+
Sbjct: 251 YWEMSNQDV 259

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 123/249 (49%), Gaps = 32/249 (12%)
Query: 144 QSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTL---ADGE-TAAIKVLKL-QQQGALK 198
           Q+   + K  +AT N S + ++G+G FG V  G L   +  E + AIK LK+   +   +
Sbjct: 33  QTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 199 SFIDECNALTSIRHRNILK---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDE 255
            F+ E + +    H NI++   +V+    V         +V E+M NG+LD +L      
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFLRK---- 139
Query: 256 YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA 315
             H  + +++Q + ++  +AS + YL    D    H DL + N+L++  ++  V DFGL+
Sbjct: 140 --HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRP 373
           + L    + P    T   G K  + +  PE I     +   D++SYGI+L E+ + G+RP
Sbjct: 195 RVL---EDDPEAAYTTRGG-KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
Query: 374 TDDMFKDDL 382
             +M   D+
Sbjct: 251 YWEMSNQDV 259

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 123/249 (49%), Gaps = 32/249 (12%)
Query: 144 QSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTL---ADGE-TAAIKVLKL-QQQGALK 198
           Q+   + K  +AT N S + ++G+G FG V  G L   +  E + AIK LK+   +   +
Sbjct: 33  QTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 199 SFIDECNALTSIRHRNILK---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDE 255
            F+ E + +    H NI++   +V+    V         +V E+M NG+LD +L      
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFLRK---- 139
Query: 256 YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA 315
             H  + +++Q + ++  +AS + YL    D    H DL + N+L++  ++  V DFGL+
Sbjct: 140 --HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRP 373
           + L    + P    T   G K  + +  PE I     +   D++SYGI+L E+ + G+RP
Sbjct: 195 RVL---EDDPEAAYTTRGG-KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
Query: 374 TDDMFKDDL 382
             +M   D+
Sbjct: 251 YWEMSNQDV 259

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 123/249 (49%), Gaps = 32/249 (12%)
Query: 144 QSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTL---ADGE-TAAIKVLKL-QQQGALK 198
           Q+   + K  +AT N S + ++G+G FG V  G L   +  E + AIK LK+   +   +
Sbjct: 33  QTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 199 SFIDECNALTSIRHRNILK---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDE 255
            F+ E + +    H NI++   +V+    V         +V E+M NG+LD +L      
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFLRK---- 139
Query: 256 YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA 315
             H  + +++Q + ++  +AS + YL    D    H DL + N+L++  ++  V DFGL+
Sbjct: 140 --HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRP 373
           + L    + P    T   G K  + +  PE I     +   D++SYGI+L E+ + G+RP
Sbjct: 195 RVL---EDDPEAAYTTRGG-KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
Query: 374 TDDMFKDDL 382
             +M   D+
Sbjct: 251 YWEMSNQDV 259

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 122/249 (48%), Gaps = 32/249 (12%)
Query: 144 QSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTL---ADGE-TAAIKVLKL-QQQGALK 198
           Q+   + K  +AT N S + ++G+G FG V  G L   +  E + AIK LK+   +   +
Sbjct: 33  QTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 199 SFIDECNALTSIRHRNILK---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDE 255
            F+ E + +    H NI++   +V+    V         +V E+M NG+LD +L      
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFLRK---- 139
Query: 256 YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA 315
             H  + +++Q + ++  +AS + YL    D    H DL + N+L++  ++  V DFGL 
Sbjct: 140 --HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLG 194
Query: 316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRP 373
           + L    + P    T   G K  + +  PE I     +   D++SYGI+L E+ + G+RP
Sbjct: 195 RVL---EDDPEAAYTTRGG-KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
Query: 374 TDDMFKDDL 382
             +M   D+
Sbjct: 251 YWEMSNQDV 259

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSS 224
           +G+G FG V+ GT       AIK LK       +SF++E   +  ++H  ++++ +  S 
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSP-ESFLEEAQIMKKLKHDKLVQLYAVVSE 75
Query: 225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ 284
                 +   +V E+M  G+L  +L          + L L   +++   VA+ + Y+   
Sbjct: 76  ------EPIYIVTEYMNKGSLLDFLKDGEG-----RALKLPNLVDMAAQVAAGMAYIERM 124
Query: 285 YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
                 H DL+S+N+L+  G+I  + DFGLA+ +  E N  +  Q    G K  + +  P
Sbjct: 125 N---YIHRDLRSANILVGNGLICKIADFGLARLI--EDNEXTARQ----GAKFPIKWTAP 175
Query: 345 E-YINGHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
           E  + G  +I  D++S+GILL E+ T G+ P   M
Sbjct: 176 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 210

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 111/211 (52%), Gaps = 22/211 (10%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSS 224
           +G+G FG V+ G   +    A+K LK     ++++F++E N + +++H  ++++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ 284
                 +   ++ E+M  G+L  +L   +DE     K+ L + ++    +A  + Y+  +
Sbjct: 80  -----EEPIYIITEYMAKGSLLDFL--KSDE---GGKVLLPKLIDFSAQIAEGMAYIERK 129
Query: 285 YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
                 H DL+++NVL+ E ++  + DFGLA+ +  E N      T   G K  + +  P
Sbjct: 130 ---NYIHRDLRAANVLVSESLMCKIADFGLARVI--EDN----EYTAREGAKFPIKWTAP 180
Query: 345 EYIN-GHVSILGDIYSYGILLLEIFT-GKRP 373
           E IN G  +I  D++S+GILL EI T GK P
Sbjct: 181 EAINFGCFTIKSDVWSFGILLYEIVTYGKIP 211

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 108/211 (51%), Gaps = 26/211 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALK--SFIDECNALTSIRHRNILKIVSSC 222
           +G+G FG V+ G        A+K LK   QG++   +F+ E N +  ++H+ ++++ +  
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 86
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +       +   ++ E+M NG+L  +L   +       KL++ + L++   +A  + ++ 
Sbjct: 87  T------QEPIYIITEYMENGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIE 135
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
            +      H DL+++N+L+ + +   + DFGLA+ +  E N      T   G K  + + 
Sbjct: 136 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLI--EDN----EXTAREGAKFPIKWT 186
Query: 343 PPEYIN-GHVSILGDIYSYGILLLEIFTGKR 372
            PE IN G  +I  D++S+GILL EI T  R
Sbjct: 187 APEAINYGTFTIKSDVWSFGILLTEIVTHGR 217

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKS--FIDECNALTSIRHRNILKIVSSC 222
           IGSG FG V+ G   + +  AIK +K   +G++    FI+E   +  + H  ++++   C
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIK---EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
                       LVFEFM +G L  +L      +      +    L + +DV   + YL 
Sbjct: 92  LE-----QAPICLVFEFMEHGCLSDYLRTQRGLF------AAETLLGMCLDVCEGMAYLE 140
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
              +  + H DL + N L+ E  +  V DFG+ +F+ ++  T       S G K  V + 
Sbjct: 141 ---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS------STGTKFPVKWA 191
Query: 343 PPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDD 376
            PE  +    S   D++S+G+L+ E+F+ GK P ++
Sbjct: 192 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 227

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 108/211 (51%), Gaps = 26/211 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALK--SFIDECNALTSIRHRNILKIVSSC 222
           +G+G FG V+ G        A+K LK   QG++   +F+ E N +  ++H+ ++++ +  
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 79
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +       +   ++ E+M NG+L  +L   +       KL++ + L++   +A  + ++ 
Sbjct: 80  T------QEPIYIITEYMENGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIE 128
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
            +      H DL+++N+L+ + +   + DFGLA+ +  E N      T   G K  + + 
Sbjct: 129 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLI--EDN----EXTAREGAKFPIKWT 179
Query: 343 PPEYIN-GHVSILGDIYSYGILLLEIFTGKR 372
            PE IN G  +I  D++S+GILL EI T  R
Sbjct: 180 APEAINYGTFTIKSDVWSFGILLTEIVTHGR 210

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 108/211 (51%), Gaps = 26/211 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALK--SFIDECNALTSIRHRNILKIVSSC 222
           +G+G FG V+ G        A+K LK   QG++   +F+ E N +  ++H+ ++++ +  
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 78
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +       +   ++ E+M NG+L  +L   +       KL++ + L++   +A  + ++ 
Sbjct: 79  T------QEPIYIITEYMENGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIE 127
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
            +      H DL+++N+L+ + +   + DFGLA+ +  E N      T   G K  + + 
Sbjct: 128 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLI--EDN----EXTAREGAKFPIKWT 178
Query: 343 PPEYIN-GHVSILGDIYSYGILLLEIFTGKR 372
            PE IN G  +I  D++S+GILL EI T  R
Sbjct: 179 APEAINYGTFTIKSDVWSFGILLTEIVTHGR 209

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 108/211 (51%), Gaps = 26/211 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALK--SFIDECNALTSIRHRNILKIVSSC 222
           +G+G FG V+ G        A+K LK   QG++   +F+ E N +  ++H+ ++++ +  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +       +   ++ E+M NG+L  +L   +       KL++ + L++   +A  + ++ 
Sbjct: 78  T------QEPIYIITEYMENGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIE 126
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
            +      H DL+++N+L+ + +   + DFGLA+ +  E N      T   G K  + + 
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLI--EDN----EXTAREGAKFPIKWT 177
Query: 343 PPEYIN-GHVSILGDIYSYGILLLEIFTGKR 372
            PE IN G  +I  D++S+GILL EI T  R
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 108/211 (51%), Gaps = 26/211 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALK--SFIDECNALTSIRHRNILKIVSSC 222
           +G+G FG V+ G        A+K LK   QG++   +F+ E N +  ++H+ ++++ +  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +       +   ++ E+M NG+L  +L   +       KL++ + L++   +A  + ++ 
Sbjct: 78  T------QEPIYIITEYMENGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIE 126
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
            +      H DL+++N+L+ + +   + DFGLA+ +  E N      T   G K  + + 
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLI--EDN----EXTAREGAKFPIKWT 177
Query: 343 PPEYIN-GHVSILGDIYSYGILLLEIFTGKR 372
            PE IN G  +I  D++S+GILL EI T  R
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 116/235 (49%), Gaps = 31/235 (13%)
Query: 158 NFSEENLIGSGSFGSVYKGTL---ADGE-TAAIKVLKL-QQQGALKSFIDECNALTSIRH 212
           N S + ++G+G FG V  G L   +  E + AIK LK+   +   + F+ E + +    H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 213 RNILK---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN 269
            NI++   +V+    V         +V E M NG+LD +L        H  + +++Q + 
Sbjct: 77  PNIIRLEGVVTKSKPV--------MIVTEXMENGSLDSFLRK------HDAQFTVIQLVG 122
Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
           ++  +AS + YL    D    H DL + N+L++  ++  V DFGL++ L ++   P    
Sbjct: 123 MLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD---PEAAY 176
Query: 330 TMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL 382
           T   G K  + +  PE I     +   D++SYGI+L E+ + G+RP  +M   D+
Sbjct: 177 TTRGG-KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 230

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 111/211 (52%), Gaps = 22/211 (10%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSS 224
           +G+G FG V+ G   +    A+K LK     ++++F++E N + +++H  ++++ +  + 
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ 284
                 +   ++ EFM  G+L  +L   +DE     K+ L + ++    +A  + Y+  +
Sbjct: 79  -----EEPIYIITEFMAKGSLLDFLK--SDE---GGKVLLPKLIDFSAQIAEGMAYIERK 128
Query: 285 YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
                 H DL+++NVL+ E ++  + DFGLA+ +  E N      T   G K  + +  P
Sbjct: 129 ---NYIHRDLRAANVLVSESLMCKIADFGLARVI--EDN----EYTAREGAKFPIKWTAP 179
Query: 345 EYIN-GHVSILGDIYSYGILLLEIFT-GKRP 373
           E IN G  +I  +++S+GILL EI T GK P
Sbjct: 180 EAINFGCFTIKSNVWSFGILLYEIVTYGKIP 210

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 111/217 (51%), Gaps = 27/217 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALK--SFIDECNALTSIRHRNILKIVSSC 222
           +G+G FG V+ G        A+K LK   QG++   +F+ E N +  ++H+ ++++ +  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +       +   ++ E+M NG+L  +L   +       KL++ + L++   +A  + ++ 
Sbjct: 78  T------QEPIYIITEYMENGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIE 126
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
            +      H DL+++N+L+ + +   + DFGLA+ +  E N      T   G K  + + 
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLI--EDN----EYTAREGAKFPIKWT 177
Query: 343 PPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
            PE IN G  +I  D++S+GILL EI T G+ P   M
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 111/217 (51%), Gaps = 27/217 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALK--SFIDECNALTSIRHRNILKIVSSC 222
           +G+G FG V+ G        A+K LK   QG++   +F+ E N +  ++H+ ++++ +  
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 72
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +       +   ++ E+M NG+L  +L   +       KL++ + L++   +A  + ++ 
Sbjct: 73  T------QEPIYIITEYMENGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIE 121
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
            +      H DL+++N+L+ + +   + DFGLA+ +  E N      T   G K  + + 
Sbjct: 122 ER---NYIHRDLRAANILVSDTLSCKIADFGLARLI--EDN----EYTAREGAKFPIKWT 172
Query: 343 PPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
            PE IN G  +I  D++S+GILL EI T G+ P   M
Sbjct: 173 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 209

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 108/228 (47%), Gaps = 25/228 (10%)
Query: 162 ENLIGSGSFGSVYKGTL-ADGE---TAAIKVLKL-QQQGALKSFIDECNALTSIRHRNIL 216
           E +IGSG  G V  G L   G+     AIK LK    +   + F+ E + +    H NI+
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           ++    +           +V E+M NG+LD +L        H  + ++MQ + ++  V +
Sbjct: 114 RLEGVVTR-----GRLAMIVTEYMENGSLDTFLR------THDGQFTIMQLVGMLRGVGA 162
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            + YL    D    H DL + NVL+D  ++  V DFGL++ L    + P    T + G K
Sbjct: 163 GMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL---EDDPDAAXTTTGG-K 215
Query: 337 GSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDDL 382
             + +  PE I     S   D++S+G+++ E+   G+RP  +M   D+
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV 263

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 165 IGSGSFGSVYKGTLADGE-TAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           +G G FG VY+G       T A+K LK +    ++ F+ E   +  I+H N+++++  C+
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 224 SVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN 283
                      ++ EFM  GNL  +L       C+ +++S +  L +   ++SA++YL  
Sbjct: 78  R-----EPPFYIITEFMTYGNLLDYLRE-----CNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 284 QYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIP 343
           +      H DL + N L+ E  +  V DFGL++ +           T   G K  + +  
Sbjct: 128 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLM------TGDTXTAHAGAKFPIKWTA 178
Query: 344 PEYIN-GHVSILGDIYSYGILLLEIFT 369
           PE +     SI  D++++G+LL EI T
Sbjct: 179 PESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 110/218 (50%), Gaps = 23/218 (10%)
Query: 162 ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSS 221
           E  +G+G FG V+  T       A+K +K     ++++F+ E N + +++H  ++K+ + 
Sbjct: 20  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAV 78
Query: 222 CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYL 281
            +       +   ++ EFM  G+L  +L   +DE     K  L + ++    +A  + ++
Sbjct: 79  VT------KEPIYIITEFMAKGSLLDFL--KSDEGS---KQPLPKLIDFSAQIAEGMAFI 127
Query: 282 HNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGY 341
             +      H DL+++N+L+   ++  + DFGLA+ +  E N      T   G K  + +
Sbjct: 128 EQRN---YIHRDLRAANILVSASLVCKIADFGLARVI--EDN----EYTAREGAKFPIKW 178
Query: 342 IPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
             PE IN G  +I  D++S+GILL+EI T G+ P   M
Sbjct: 179 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 216

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 108/228 (47%), Gaps = 25/228 (10%)
Query: 162 ENLIGSGSFGSVYKGTL-ADGE---TAAIKVLKL-QQQGALKSFIDECNALTSIRHRNIL 216
           E +IGSG  G V  G L   G+     AIK LK    +   + F+ E + +    H NI+
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           ++    +           +V E+M NG+LD +L        H  + ++MQ + ++  V +
Sbjct: 114 RLEGVVTR-----GRLAMIVTEYMENGSLDTFLR------THDGQFTIMQLVGMLRGVGA 162
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            + YL    D    H DL + NVL+D  ++  V DFGL++ L    + P    T + G K
Sbjct: 163 GMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL---EDDPDAAYTTTGG-K 215
Query: 337 GSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDDL 382
             + +  PE I     S   D++S+G+++ E+   G+RP  +M   D+
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV 263

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 122/249 (48%), Gaps = 32/249 (12%)
Query: 144 QSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTL---ADGE-TAAIKVLKL-QQQGALK 198
           Q+   + K  +AT N S + ++G+G FG V  G L   +  E + AIK LK+   +   +
Sbjct: 33  QTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 199 SFIDECNALTSIRHRNILK---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDE 255
            F+ E + +    H NI++   +V+    V         +V E M NG+LD +L      
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPV--------MIVTEXMENGSLDSFLRK---- 139
Query: 256 YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA 315
             H  + +++Q + ++  +AS + YL    D    H DL + N+L++  ++  V DFGL+
Sbjct: 140 --HDAQFTVIQLVGMLRGIASGMKYLS---DMGAVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRP 373
           + L    + P    T   G K  + +  PE I     +   D++SYGI+L E+ + G+RP
Sbjct: 195 RVL---EDDPEAAYTTRGG-KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
Query: 374 TDDMFKDDL 382
             +M   D+
Sbjct: 251 YWEMSNQDV 259

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 122/249 (48%), Gaps = 32/249 (12%)
Query: 144 QSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTL---ADGE-TAAIKVLKL-QQQGALK 198
           Q+   + K  +AT N S + ++G+G FG V  G L   +  E + AIK LK+   +   +
Sbjct: 33  QTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 199 SFIDECNALTSIRHRNILK---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDE 255
            F+ E + +    H NI++   +V+    V         +V E M NG+LD +L      
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPV--------MIVTEXMENGSLDSFLRK---- 139
Query: 256 YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA 315
             H  + +++Q + ++  +AS + YL    D    H DL + N+L++  ++  V DFGL+
Sbjct: 140 --HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRP 373
           + L    + P    T   G K  + +  PE I     +   D++SYGI+L E+ + G+RP
Sbjct: 195 RVL---EDDPEAAYTTRGG-KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
Query: 374 TDDMFKDDL 382
             +M   D+
Sbjct: 251 YWEMSNQDV 259

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 109/224 (48%), Gaps = 22/224 (9%)
Query: 148 SYLKISNATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVLKLQQQGALKSFIDECNA 206
           +Y K      + + ++ +G G +G VY+G       T A+K LK +    ++ F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           +  I+H N+++++  C+    E   +  ++ EFM  GNL  +L       C+ +++S + 
Sbjct: 63  MKEIKHPNLVQLLGVCTR---EPPFY--IIIEFMTYGNLLDYLRE-----CNRQEVSAVV 112
Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
            L +   ++SA++YL  +      H DL + N L+ E  +  V DFGL++ +        
Sbjct: 113 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM------TG 163
Query: 327 KNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT 369
              T   G K  + +  PE +     SI  D++++G+LL EI T
Sbjct: 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 109/224 (48%), Gaps = 22/224 (9%)
Query: 148 SYLKISNATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVLKLQQQGALKSFIDECNA 206
           +Y K      + + ++ +G G +G VY+G       T A+K LK +    ++ F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           +  I+H N+++++  C+    E   +  ++ EFM  GNL  +L       C+ +++S + 
Sbjct: 63  MKEIKHPNLVQLLGVCTR---EPPFY--IIIEFMTYGNLLDYLRE-----CNRQEVSAVV 112
Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
            L +   ++SA++YL  +      H DL + N L+ E  +  V DFGL++ +        
Sbjct: 113 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM------TG 163
Query: 327 KNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT 369
              T   G K  + +  PE +     SI  D++++G+LL EI T
Sbjct: 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 30/230 (13%)
Query: 162 ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSS 221
           E ++G G+FG V K   A      + + +++ +   K+FI E   L+ + H NI+K+  +
Sbjct: 14  EEVVGRGAFGVVCK---AKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGA 70
Query: 222 CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYL 281
           C +          LV E+   G+L   LH +          +    ++  +  +  + YL
Sbjct: 71  CLNP-------VCLVMEYAEGGSLYNVLHGAEP----LPYYTAAHAMSWCLQCSQGVAYL 119
Query: 282 HNQYDTPIAHCDLKSSNVLL-DEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG 340
           H+     + H DLK  N+LL   G +  + DFG A             QT     KGS  
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----------CDIQTHMTNNKGSAA 169
Query: 341 YIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDM----FKDDLSIH 385
           ++ PE   G + S   D++S+GI+L E+ T ++P D++    F+   ++H
Sbjct: 170 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH 219

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 30/230 (13%)
Query: 162 ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSS 221
           E ++G G+FG V K   A      + + +++ +   K+FI E   L+ + H NI+K+  +
Sbjct: 13  EEVVGRGAFGVVCK---AKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 222 CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYL 281
           C +          LV E+   G+L   LH +          +    ++  +  +  + YL
Sbjct: 70  CLNP-------VCLVMEYAEGGSLYNVLHGAEP----LPYYTAAHAMSWCLQCSQGVAYL 118
Query: 282 HNQYDTPIAHCDLKSSNVLL-DEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG 340
           H+     + H DLK  N+LL   G +  + DFG A             QT     KGS  
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----------CDIQTHMTNNKGSAA 168
Query: 341 YIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDM----FKDDLSIH 385
           ++ PE   G + S   D++S+GI+L E+ T ++P D++    F+   ++H
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH 218

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 165 IGSGSFGSVYKGTLADGE-TAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           +G G +G VY+G       T A+K LK +    ++ F+ E   +  I+H N+++++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 224 SVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN 283
                      ++ EFM  GNL  +L       C+ +++S +  L +   ++SA++YL  
Sbjct: 78  R-----EPPFYIIIEFMTYGNLLDYLRE-----CNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 284 QYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIP 343
           +      H DL + N L+ E  +  V DFGL++ +           T   G K  + +  
Sbjct: 128 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLM------TGDTXTAHAGAKFPIKWTA 178
Query: 344 PEYIN-GHVSILGDIYSYGILLLEIFT 369
           PE +     SI  D++++G+LL EI T
Sbjct: 179 PESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 110/227 (48%), Gaps = 22/227 (9%)
Query: 145 SGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVLKLQQQGALKSFIDE 203
           S  +Y K      + + ++ +G G +G VY+G       T A+K LK +    ++ F+ E
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKE 64
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              +  I+H N+++++  C+    E   +  ++ EFM  GNL  +L       C+ +++S
Sbjct: 65  AAVMKEIKHPNLVQLLGVCTR---EPPFY--IITEFMTYGNLLDYLRE-----CNRQEVS 114
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
            +  L +   ++SA++YL  +      H DL + N L+ E  +  V DFGL++ +     
Sbjct: 115 AVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM----- 166
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT 369
                 T   G K  + +  PE +     SI  D++++G+LL EI T
Sbjct: 167 -TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 109/224 (48%), Gaps = 22/224 (9%)
Query: 148 SYLKISNATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVLKLQQQGALKSFIDECNA 206
           +Y K      + + ++ +G G +G VY+G       T A+K LK +    ++ F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           +  I+H N+++++  C+    E   +  ++ EFM  GNL  +L       C+ +++S + 
Sbjct: 63  MKEIKHPNLVQLLGVCTR---EPPFY--IITEFMTYGNLLDYLRE-----CNRQEVSAVV 112
Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
            L +   ++SA++YL  +      H DL + N L+ E  +  V DFGL++ +        
Sbjct: 113 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM------TG 163
Query: 327 KNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT 369
              T   G K  + +  PE +     SI  D++++G+LL EI T
Sbjct: 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 104/229 (45%), Gaps = 29/229 (12%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECN--ALTSIRHRN 214
           DN     LIG G +G+VYKG+L D    A+KV     +   ++FI+E N   +  + H N
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDN 68
Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
           I + +     V  +G     LV E+  NG+L ++L   T ++    +L+          V
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH--------SV 120
Query: 275 ASALDYLHNQ------YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA-KFLFEESNTPSK 327
              L YLH +      Y   I+H DL S NVL+       + DFGL+ +        P +
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILG--------DIYSYGILLLEIF 368
               +    G++ Y+ PE + G V++          D+Y+ G++  EIF
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 115/235 (48%), Gaps = 25/235 (10%)
Query: 158 NFSEENLIGSGSFGSVYKGTLADGE----TAAIKVL-KLQQQGALKSFIDECNALTSIRH 212
           +F+E  +IG G FG VY GTL D +      A+K L ++   G +  F+ E   +    H
Sbjct: 32  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 89
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            N+L ++  C  +  EG+    +V  +M++G+L  ++   T         ++   +   +
Sbjct: 90  PNVLSLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNET------HNPTVKDLIGFGL 139
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            VA  + YL ++      H DL + N +LDE     V DFGLA+ ++++      N+T  
Sbjct: 140 QVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKT-- 194
Query: 333 NGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH 385
            G K  V ++  E +     +   D++S+G+LL E+ T G  P  D+   D++++
Sbjct: 195 -GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 248

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 109/224 (48%), Gaps = 22/224 (9%)
Query: 148 SYLKISNATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVLKLQQQGALKSFIDECNA 206
           +Y K      + + ++ +G G +G VY+G       T A+K LK +    ++ F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           +  I+H N+++++  C+    E   +  ++ EFM  GNL  +L       C+ +++S + 
Sbjct: 63  MKEIKHPNLVQLLGVCTR---EPPFY--IITEFMTYGNLLDYLRE-----CNRQEVSAVV 112
Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
            L +   ++SA++YL  +      H DL + N L+ E  +  V DFGL++ +        
Sbjct: 113 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM------TG 163
Query: 327 KNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT 369
              T   G K  + +  PE +     SI  D++++G+LL EI T
Sbjct: 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 116/241 (48%), Gaps = 31/241 (12%)
Query: 131 TSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL 189
           TS   S+P  ++W+   +         + + ++ +G G +G VY+G       T A+K L
Sbjct: 1   TSMDPSSPNYDKWEMERT---------DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL 51
Query: 190 KLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWL 249
           K +    ++ F+ E   +  I+H N+++++  C+    E   +  ++ EFM  GNL  +L
Sbjct: 52  K-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR---EPPFY--IIIEFMTYGNLLDYL 105
Query: 250 HPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV 309
                  C+ ++++ +  L +   ++SA++YL  +      H DL + N L+ E  +  V
Sbjct: 106 RE-----CNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKV 157
Query: 310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIF 368
            DFGL++ +           T   G K  + +  PE +     SI  D++++G+LL EI 
Sbjct: 158 ADFGLSRLM------TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 211
Query: 369 T 369
           T
Sbjct: 212 T 212

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 27/216 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNILKIVSSC 222
           IGSG FG V+ G   + +  AIK ++   +GA+  + FI+E   +  + H  ++++   C
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
                       LV EFM +G L  +L         F   +L   L + +DV   + YL 
Sbjct: 73  LE-----QAPICLVTEFMEHGCLSDYLRTQRG---LFAAETL---LGMCLDVCEGMAYLE 121
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
              +  + H DL + N L+ E  +  V DFG+ +F+ ++  T       S G K  V + 
Sbjct: 122 ---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS------STGTKFPVKWA 172
Query: 343 PPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDD 376
            PE  +    S   D++S+G+L+ E+F+ GK P ++
Sbjct: 173 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 208

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 110/218 (50%), Gaps = 23/218 (10%)
Query: 162 ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSS 221
           E  +G+G FG V+  T       A+K +K     ++++F+ E N + +++H  ++K+ + 
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 222 CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYL 281
            +       +   ++ EFM  G+L  +L   +DE     K  L + ++    +A  + ++
Sbjct: 252 VT------KEPIYIITEFMAKGSLLDFL--KSDEGS---KQPLPKLIDFSAQIAEGMAFI 300
Query: 282 HNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGY 341
             +      H DL+++N+L+   ++  + DFGLA+ +  E N      T   G K  + +
Sbjct: 301 EQRN---YIHRDLRAANILVSASLVCKIADFGLARVI--EDN----EYTAREGAKFPIKW 351
Query: 342 IPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
             PE IN G  +I  D++S+GILL+EI T G+ P   M
Sbjct: 352 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 109/231 (47%), Gaps = 31/231 (13%)
Query: 162 ENLIGSGSFGSVYKGTL-ADGE---TAAIKVLKL-QQQGALKSFIDECNALTSIRHRNIL 216
           E +IG G FG V  G L   G+     AIK LK        + F+ E + +    H NI+
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 217 K---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
               +V+ C  V         ++ E+M NG+LD +L  +   +      +++Q + ++  
Sbjct: 79  HLEGVVTKCKPV--------MIITEYMENGSLDAFLRKNDGRF------TVIQLVGMLRG 124
Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           + S + YL    D    H DL + N+L++  ++  V DFG+++ L    + P    T   
Sbjct: 125 IGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVL---EDDPEAAYTTRG 178
Query: 334 GLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL 382
           G K  + +  PE I     +   D++SYGI++ E+ + G+RP  DM   D+
Sbjct: 179 G-KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 228

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 109/231 (47%), Gaps = 31/231 (13%)
Query: 162 ENLIGSGSFGSVYKGTL-ADGE---TAAIKVLKL-QQQGALKSFIDECNALTSIRHRNIL 216
           E +IG G FG V  G L   G+     AIK LK        + F+ E + +    H NI+
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 217 K---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
               +V+ C  V         ++ E+M NG+LD +L  +   +      +++Q + ++  
Sbjct: 73  HLEGVVTKCKPV--------MIITEYMENGSLDAFLRKNDGRF------TVIQLVGMLRG 118
Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           + S + YL    D    H DL + N+L++  ++  V DFG+++ L    + P    T   
Sbjct: 119 IGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVL---EDDPEAAYTTRG 172
Query: 334 GLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL 382
           G K  + +  PE I     +   D++SYGI++ E+ + G+RP  DM   D+
Sbjct: 173 G-KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 222

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 112/231 (48%), Gaps = 31/231 (13%)
Query: 162 ENLIGSGSFGSVYKGTLA-DGE---TAAIKVLKL-QQQGALKSFIDECNALTSIRHRNIL 216
           E +IG+G FG V  G L   G+     AIK LK+   +   + F+ E + +    H N++
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 217 K---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
               +V+    V         +V EFM NG LD +L        H  + +++Q + ++  
Sbjct: 108 HLEGVVTRGKPV--------MIVIEFMENGALDAFLRK------HDGQFTVIQLVGMLRG 153
Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +A+ + YL    D    H DL + N+L++  ++  V DFGL++ +    + P    T + 
Sbjct: 154 IAAGMRYLA---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVI---EDDPEAVYTTTG 207
Query: 334 GLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL 382
           G K  V +  PE I     +   D++SYGI++ E+ + G+RP  DM   D+
Sbjct: 208 G-KIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 257

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 109/231 (47%), Gaps = 31/231 (13%)
Query: 162 ENLIGSGSFGSVYKGTL-ADGE---TAAIKVLKL-QQQGALKSFIDECNALTSIRHRNIL 216
           E +IG G FG V  G L   G+     AIK LK        + F+ E + +    H NI+
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 217 K---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
               +V+ C  V         ++ E+M NG+LD +L  +   +      +++Q + ++  
Sbjct: 94  HLEGVVTKCKPV--------MIITEYMENGSLDAFLRKNDGRF------TVIQLVGMLRG 139
Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           + S + YL    D    H DL + N+L++  ++  V DFG+++ L    + P    T   
Sbjct: 140 IGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVL---EDDPEAAYTTRG 193
Query: 334 GLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL 382
           G K  + +  PE I     +   D++SYGI++ E+ + G+RP  DM   D+
Sbjct: 194 G-KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 243

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 107/224 (47%), Gaps = 22/224 (9%)
Query: 148 SYLKISNATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVLKLQQQGALKSFIDECNA 206
           +Y K      + + ++ +G G +G VY+G       T A+K LK +    ++ F+ E   
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 63
Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           +  I+H N+++++  C+           ++ EFM  GNL  +L       C+ ++++ + 
Sbjct: 64  MKEIKHPNLVQLLGVCTR-----EPPFYIIIEFMTYGNLLDYLRE-----CNRQEVNAVV 113
Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
            L +   ++SA++YL  +      H DL + N L+ E  +  V DFGL++ +        
Sbjct: 114 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM------TG 164
Query: 327 KNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT 369
              T   G K  + +  PE +     SI  D++++G+LL EI T
Sbjct: 165 DTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 112/225 (49%), Gaps = 27/225 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKS--FIDECNALTSIRHRNILKIVSSC 222
           +G+G FG V  G        AIK++K   +G++    FI+E   + ++ H  ++++   C
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +    +   F  ++ E+M NG L  +L     E  H  +    Q L +  DV  A++YL 
Sbjct: 74  TK---QRPIF--IITEYMANGCLLNYLR----EMRH--RFQTQQLLEMCKDVCEAMEYLE 122
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
           ++      H DL + N L+++  +  V DFGL++++ ++  T S+      G K  V + 
Sbjct: 123 SK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSR------GSKFPVRWS 173
Query: 343 PPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH 385
           PPE +     S   DI+++G+L+ EI++ GK P +     + + H
Sbjct: 174 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 218

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 111/217 (51%), Gaps = 27/217 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALK--SFIDECNALTSIRHRNILKIVSSC 222
           +G+G FG V+ G        A+K LK   QG++   +F+ E N +  ++H+ ++++ +  
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 73
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +       +   ++ E+M NG+L  +L   +       KL++ + L++   +A  + ++ 
Sbjct: 74  T------QEPIYIITEYMENGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIE 122
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
            +      H +L+++N+L+ + +   + DFGLA+ +  E N      T   G K  + + 
Sbjct: 123 ERN---YIHRNLRAANILVSDTLSCKIADFGLARLI--EDN----EYTAREGAKFPIKWT 173
Query: 343 PPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
            PE IN G  +I  D++S+GILL EI T G+ P   M
Sbjct: 174 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 210

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 110/228 (48%), Gaps = 22/228 (9%)
Query: 144 QSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVLKLQQQGALKSFID 202
           Q   +Y K      + + ++ +G G +G VY+G       T A+K LK +    ++ F+ 
Sbjct: 13  QGSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLK 71
Query: 203 ECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKL 262
           E   +  I+H N+++++  C+    E   +  ++ EFM  GNL  +L       C+ +++
Sbjct: 72  EAAVMKEIKHPNLVQLLGVCTR---EPPFY--IITEFMTYGNLLDYLRE-----CNRQEV 121
Query: 263 SLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES 322
           + +  L +   ++SA++YL  +      H DL + N L+ E  +  V DFGL++ +    
Sbjct: 122 NAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM---- 174
Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT 369
                  T   G K  + +  PE +     SI  D++++G+LL EI T
Sbjct: 175 --TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 110/227 (48%), Gaps = 22/227 (9%)
Query: 145 SGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVLKLQQQGALKSFIDE 203
           S  +Y K      + + ++ +G G +G VY+G       T A+K LK +    ++ F+ E
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKE 64
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              +  I+H N+++++  C+    E   +  ++ EFM  GNL  +L       C+ ++++
Sbjct: 65  AAVMKEIKHPNLVQLLGVCTR---EPPFY--IITEFMTYGNLLDYLRE-----CNRQEVN 114
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
            +  L +   ++SA++YL  +      H DL + N L+ E  +  V DFGL++ +     
Sbjct: 115 AVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM----- 166
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT 369
                 T   G K  + +  PE +     SI  D++++G+LL EI T
Sbjct: 167 -TGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 115/235 (48%), Gaps = 25/235 (10%)
Query: 158 NFSEENLIGSGSFGSVYKGTLADGE----TAAIKVL-KLQQQGALKSFIDECNALTSIRH 212
           +F+E  +IG G FG VY GTL D +      A+K L ++   G +  F+ E   +    H
Sbjct: 52  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 109
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            N+L ++  C  +  EG+    +V  +M++G+L  ++   T         ++   +   +
Sbjct: 110 PNVLSLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNET------HNPTVKDLIGFGL 159
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            VA  + YL ++      H DL + N +LDE     V DFGLA+ ++++      N+T  
Sbjct: 160 QVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT-- 214
Query: 333 NGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH 385
            G K  V ++  E +     +   D++S+G+LL E+ T G  P  D+   D++++
Sbjct: 215 -GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 268

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 110/227 (48%), Gaps = 22/227 (9%)
Query: 145 SGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVLKLQQQGALKSFIDE 203
           S  +Y K      + + ++ +G G +G VY+G       T A+K LK +    ++ F+ E
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKE 64
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              +  I+H N+++++  C+    E   +  ++ EFM  GNL  +L       C+ ++++
Sbjct: 65  AAVMKEIKHPNLVQLLGVCTR---EPPFY--IITEFMTYGNLLDYLRE-----CNRQEVN 114
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
            +  L +   ++SA++YL  +      H DL + N L+ E  +  V DFGL++ +     
Sbjct: 115 AVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM----- 166
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT 369
                 T   G K  + +  PE +     SI  D++++G+LL EI T
Sbjct: 167 -TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 22/207 (10%)
Query: 165 IGSGSFGSVYKGTLADGE-TAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           +G G +G VY+G       T A+K LK +    ++ F+ E   +  I+H N+++++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 224 SVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN 283
                      ++ EFM  GNL  +L       C+ +++S +  L +   ++SA++YL  
Sbjct: 78  R-----EPPFYIITEFMTYGNLLDYLRE-----CNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 284 QYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIP 343
           +      H DL + N L+ E  +  V DFGL++ +  ++ T         G K  + +  
Sbjct: 128 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHA------GAKFPIKWTA 178
Query: 344 PEYIN-GHVSILGDIYSYGILLLEIFT 369
           PE +     SI  D++++G+LL EI T
Sbjct: 179 PESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 115/235 (48%), Gaps = 25/235 (10%)
Query: 158 NFSEENLIGSGSFGSVYKGTLADGE----TAAIKVL-KLQQQGALKSFIDECNALTSIRH 212
           +F+E  +IG G FG VY GTL D +      A+K L ++   G +  F+ E   +    H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            N+L ++  C  +  EG+    +V  +M++G+L  ++   T         ++   +   +
Sbjct: 91  PNVLSLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNET------HNPTVKDLIGFGL 140
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            VA  + YL ++      H DL + N +LDE     V DFGLA+ ++++      N+T  
Sbjct: 141 QVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT-- 195
Query: 333 NGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH 385
            G K  V ++  E +     +   D++S+G+LL E+ T G  P  D+   D++++
Sbjct: 196 -GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 249

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 115/235 (48%), Gaps = 25/235 (10%)
Query: 158 NFSEENLIGSGSFGSVYKGTLADGE----TAAIKVL-KLQQQGALKSFIDECNALTSIRH 212
           +F+E  +IG G FG VY GTL D +      A+K L ++   G +  F+ E   +    H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            N+L ++  C  +  EG+    +V  +M++G+L  ++   T         ++   +   +
Sbjct: 91  PNVLSLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNET------HNPTVKDLIGFGL 140
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            VA  + YL ++      H DL + N +LDE     V DFGLA+ ++++      N+T  
Sbjct: 141 QVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT-- 195
Query: 333 NGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH 385
            G K  V ++  E +     +   D++S+G+LL E+ T G  P  D+   D++++
Sbjct: 196 -GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 249

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 115/235 (48%), Gaps = 25/235 (10%)
Query: 158 NFSEENLIGSGSFGSVYKGTLADGET----AAIKVL-KLQQQGALKSFIDECNALTSIRH 212
           +F+E  +IG G FG VY GTL D +      A+K L ++   G +  F+ E   +    H
Sbjct: 25  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 82
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            N+L ++  C  +  EG+    +V  +M++G+L  ++   T         ++   +   +
Sbjct: 83  PNVLSLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNET------HNPTVKDLIGFGL 132
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            VA  + YL ++      H DL + N +LDE     V DFGLA+ ++++      N+T  
Sbjct: 133 QVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT-- 187
Query: 333 NGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH 385
            G K  V ++  E +     +   D++S+G+LL E+ T G  P  D+   D++++
Sbjct: 188 -GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 241

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 115/235 (48%), Gaps = 25/235 (10%)
Query: 158 NFSEENLIGSGSFGSVYKGTLADGE----TAAIKVL-KLQQQGALKSFIDECNALTSIRH 212
           +F+E  +IG G FG VY GTL D +      A+K L ++   G +  F+ E   +    H
Sbjct: 32  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 89
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            N+L ++  C  +  EG+    +V  +M++G+L  ++   T         ++   +   +
Sbjct: 90  PNVLSLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNET------HNPTVKDLIGFGL 139
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            VA  + YL ++      H DL + N +LDE     V DFGLA+ ++++      N+T  
Sbjct: 140 QVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT-- 194
Query: 333 NGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH 385
            G K  V ++  E +     +   D++S+G+LL E+ T G  P  D+   D++++
Sbjct: 195 -GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 248

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 109/224 (48%), Gaps = 22/224 (9%)
Query: 148 SYLKISNATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVLKLQQQGALKSFIDECNA 206
           +Y K      + + ++ +G G +G VY+G       T A+K LK +    ++ F+ E   
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 63
Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           +  I+H N+++++  C+    E   +  ++ EFM  GNL  +L       C+ ++++ + 
Sbjct: 64  MKEIKHPNLVQLLGVCTR---EPPFY--IITEFMTYGNLLDYLRE-----CNRQEVNAVV 113
Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
            L +   ++SA++YL  +      H DL + N L+ E  +  V DFGL++ +        
Sbjct: 114 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM------TG 164
Query: 327 KNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT 369
              T   G K  + +  PE +     SI  D++++G+LL EI T
Sbjct: 165 DTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 115/235 (48%), Gaps = 25/235 (10%)
Query: 158 NFSEENLIGSGSFGSVYKGTLADGE----TAAIKVL-KLQQQGALKSFIDECNALTSIRH 212
           +F+E  +IG G FG VY GTL D +      A+K L ++   G +  F+ E   +    H
Sbjct: 31  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 88
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            N+L ++  C  +  EG+    +V  +M++G+L  ++   T         ++   +   +
Sbjct: 89  PNVLSLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNET------HNPTVKDLIGFGL 138
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            VA  + YL ++      H DL + N +LDE     V DFGLA+ ++++      N+T  
Sbjct: 139 QVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT-- 193
Query: 333 NGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH 385
            G K  V ++  E +     +   D++S+G+LL E+ T G  P  D+   D++++
Sbjct: 194 -GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 247

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 115/235 (48%), Gaps = 25/235 (10%)
Query: 158 NFSEENLIGSGSFGSVYKGTLADGE----TAAIKVL-KLQQQGALKSFIDECNALTSIRH 212
           +F+E  +IG G FG VY GTL D +      A+K L ++   G +  F+ E   +    H
Sbjct: 30  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            N+L ++  C  +  EG+    +V  +M++G+L  ++   T         ++   +   +
Sbjct: 88  PNVLSLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNET------HNPTVKDLIGFGL 137
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            VA  + YL ++      H DL + N +LDE     V DFGLA+ ++++      N+T  
Sbjct: 138 QVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT-- 192
Query: 333 NGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH 385
            G K  V ++  E +     +   D++S+G+LL E+ T G  P  D+   D++++
Sbjct: 193 -GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 246

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 110/227 (48%), Gaps = 22/227 (9%)
Query: 145 SGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVLKLQQQGALKSFIDE 203
           S  +Y K      + + ++ +G G +G VY+G       T A+K LK +    ++ F+ E
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKE 64
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              +  I+H N+++++  C+    E   +  ++ EFM  GNL  +L       C+ ++++
Sbjct: 65  AAVMKEIKHPNLVQLLGVCTR---EPPFY--IITEFMTYGNLLDYLRE-----CNRQEVN 114
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
            +  L +   ++SA++YL  +      H DL + N L+ E  +  V DFGL++ +     
Sbjct: 115 AVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM----- 166
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT 369
                 T   G K  + +  PE +     SI  D++++G+LL EI T
Sbjct: 167 -TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 115/235 (48%), Gaps = 25/235 (10%)
Query: 158 NFSEENLIGSGSFGSVYKGTLADGE----TAAIKVL-KLQQQGALKSFIDECNALTSIRH 212
           +F+E  +IG G FG VY GTL D +      A+K L ++   G +  F+ E   +    H
Sbjct: 28  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            N+L ++  C  +  EG+    +V  +M++G+L  ++   T         ++   +   +
Sbjct: 86  PNVLSLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNET------HNPTVKDLIGFGL 135
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            VA  + YL ++      H DL + N +LDE     V DFGLA+ ++++      N+T  
Sbjct: 136 QVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT-- 190
Query: 333 NGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH 385
            G K  V ++  E +     +   D++S+G+LL E+ T G  P  D+   D++++
Sbjct: 191 -GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 244

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 109/224 (48%), Gaps = 22/224 (9%)
Query: 148 SYLKISNATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVLKLQQQGALKSFIDECNA 206
           +Y K      + + ++ +G G +G VY+G       T A+K LK +    ++ F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           +  I+H N+++++  C+    E   +  ++ EFM  GNL  +L       C+ ++++ + 
Sbjct: 63  MKEIKHPNLVQLLGVCTR---EPPFY--IITEFMTYGNLLDYLRE-----CNRQEVNAVV 112
Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
            L +   ++SA++YL  +      H DL + N L+ E  +  V DFGL++ +        
Sbjct: 113 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM------TG 163
Query: 327 KNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT 369
              T   G K  + +  PE +     SI  D++++G+LL EI T
Sbjct: 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 109/224 (48%), Gaps = 22/224 (9%)
Query: 148 SYLKISNATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVLKLQQQGALKSFIDECNA 206
           +Y K      + + ++ +G G +G VY+G       T A+K LK +    ++ F+ E   
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 64
Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           +  I+H N+++++  C+    E   +  ++ EFM  GNL  +L       C+ ++++ + 
Sbjct: 65  MKEIKHPNLVQLLGVCTR---EPPFY--IITEFMTYGNLLDYLRE-----CNRQEVNAVV 114
Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
            L +   ++SA++YL  +      H DL + N L+ E  +  V DFGL++ +        
Sbjct: 115 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM------TG 165
Query: 327 KNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT 369
              T   G K  + +  PE +     SI  D++++G+LL EI T
Sbjct: 166 DTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 165 IGSGSFGSV---YKGTLAD--GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIV 219
           +G G+FGSV       L D  GE  A+K L+   +  L+ F  E   L S++H NI+K  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
             C S    G     L+ EF+  G+L ++L    +   H K L    +      +   ++
Sbjct: 81  GVCYSA---GRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQ------ICKGME 131
Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSV 339
           YL  +      H DL + N+L++      +GDFGL K L ++       +    G     
Sbjct: 132 YLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX---XKVKEPGESPIF 185
Query: 340 GYIPPEYINGHVSILGDIYSYGILLLEIFT 369
            Y P        S+  D++S+G++L E+FT
Sbjct: 186 WYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 109/224 (48%), Gaps = 22/224 (9%)
Query: 148 SYLKISNATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVLKLQQQGALKSFIDECNA 206
           +Y K      + + ++ +G G +G VY+G       T A+K LK +    ++ F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           +  I+H N+++++  C+    E   +  ++ EFM  GNL  +L       C+ ++++ + 
Sbjct: 63  MKEIKHPNLVQLLGVCTR---EPPFY--IITEFMTYGNLLDYLRE-----CNRQEVNAVV 112
Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
            L +   ++SA++YL  +      H DL + N L+ E  +  V DFGL++ +        
Sbjct: 113 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM------TG 163
Query: 327 KNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT 369
              T   G K  + +  PE +     SI  D++++G+LL EI T
Sbjct: 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 115/235 (48%), Gaps = 25/235 (10%)
Query: 158 NFSEENLIGSGSFGSVYKGTLADGET----AAIKVL-KLQQQGALKSFIDECNALTSIRH 212
           +F+E  +IG G FG VY GTL D +      A+K L ++   G +  F+ E   +    H
Sbjct: 51  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 108
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            N+L ++  C  +  EG+    +V  +M++G+L  ++   T         ++   +   +
Sbjct: 109 PNVLSLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNET------HNPTVKDLIGFGL 158
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            VA  + YL ++      H DL + N +LDE     V DFGLA+ ++++      N+T  
Sbjct: 159 QVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT-- 213
Query: 333 NGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH 385
            G K  V ++  E +     +   D++S+G+LL E+ T G  P  D+   D++++
Sbjct: 214 -GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 267

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 109/224 (48%), Gaps = 22/224 (9%)
Query: 148 SYLKISNATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVLKLQQQGALKSFIDECNA 206
           +Y K      + + ++ +G G +G VY+G       T A+K LK +    ++ F+ E   
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 66
Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           +  I+H N+++++  C+    E   +  ++ EFM  GNL  +L       C+ ++++ + 
Sbjct: 67  MKEIKHPNLVQLLGVCTR---EPPFY--IITEFMTYGNLLDYLRE-----CNRQEVNAVV 116
Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
            L +   ++SA++YL  +      H DL + N L+ E  +  V DFGL++ +        
Sbjct: 117 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM------TG 167
Query: 327 KNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT 369
              T   G K  + +  PE +     SI  D++++G+LL EI T
Sbjct: 168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 100/237 (42%), Gaps = 46/237 (19%)
Query: 158 NFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           +F E  LIGSG FG V+K     DG+T  I+ +K   + A +    E  AL  + H NI+
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER----EVKALAKLDHVNIV 68
Query: 217 KIVSSCSSVDY---------EGNDFKA---------------LVFEFMRNGNLDQWLHPS 252
                    DY         E +D+                 +  EF   G L+QW+   
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 253 TDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF 312
             E     KL  +  L +   +   +DY+H++    + H DLK SN+ L +     +GDF
Sbjct: 129 RGE-----KLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDF 180
Query: 313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIF 368
           GL         T  KN       KG++ Y+ PE I+        D+Y+ G++L E+ 
Sbjct: 181 GLV--------TSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 109/224 (48%), Gaps = 22/224 (9%)
Query: 148 SYLKISNATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVLKLQQQGALKSFIDECNA 206
           +Y K      + + ++ +G G +G VY+G       T A+K LK +    ++ F+ E   
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 64
Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           +  I+H N+++++  C+    E   +  ++ EFM  GNL  +L       C+ ++++ + 
Sbjct: 65  MKEIKHPNLVQLLGVCTR---EPPFY--IITEFMTYGNLLDYLRE-----CNRQEVNAVV 114
Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
            L +   ++SA++YL  +      H DL + N L+ E  +  V DFGL++ +        
Sbjct: 115 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM------TG 165
Query: 327 KNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT 369
              T   G K  + +  PE +     SI  D++++G+LL EI T
Sbjct: 166 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 109/224 (48%), Gaps = 22/224 (9%)
Query: 148 SYLKISNATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVLKLQQQGALKSFIDECNA 206
           +Y K      + + ++ +G G +G VY+G       T A+K LK +    ++ F+ E   
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 64
Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           +  I+H N+++++  C+    E   +  ++ EFM  GNL  +L       C+ ++++ + 
Sbjct: 65  MKEIKHPNLVQLLGVCTR---EPPFY--IITEFMTYGNLLDYLRE-----CNRQEVNAVV 114
Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
            L +   ++SA++YL  +      H DL + N L+ E  +  V DFGL++ +        
Sbjct: 115 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM------TG 165
Query: 327 KNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT 369
              T   G K  + +  PE +     SI  D++++G+LL EI T
Sbjct: 166 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 100/224 (44%), Gaps = 33/224 (14%)
Query: 158 NFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           +F E  LIGSG FG V+K     DG+T  IK +K   + A +    E  AL  + H NI+
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIV 67
Query: 217 KIVSSCSSVDYE-----GNDFKA------LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM 265
                    DY+      N  ++      +  EF   G L+QW+     E     KL  +
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-----KLDKV 122
Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
             L +   +   +DY+H++    + + DLK SN+ L +     +GDFGL         T 
Sbjct: 123 LALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLV--------TS 171
Query: 326 SKNQTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIF 368
            KN       KG++ Y+ PE I+        D+Y+ G++L E+ 
Sbjct: 172 LKNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 110/225 (48%), Gaps = 27/225 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKS--FIDECNALTSIRHRNILKIVSSC 222
           +G+G FG V  G        AIK++K   +G++    FI+E   + ++ H  ++++   C
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +           ++ E+M NG L  +L     E  H  +    Q L +  DV  A++YL 
Sbjct: 89  TK-----QRPIFIITEYMANGCLLNYLR----EMRH--RFQTQQLLEMCKDVCEAMEYLE 137
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
           ++      H DL + N L+++  +  V DFGL++++ ++       +T S G K  V + 
Sbjct: 138 SK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD------EETSSVGSKFPVRWS 188
Query: 343 PPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH 385
           PPE +     S   DI+++G+L+ EI++ GK P +     + + H
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 233

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 108/211 (51%), Gaps = 26/211 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALK--SFIDECNALTSIRHRNILKIVSSC 222
           +G+G  G V+ G        A+K LK   QG++   +F+ E N +  ++H+ ++++ +  
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +       +   ++ E+M NG+L  +L   +       KL++ + L++   +A  + ++ 
Sbjct: 78  T------QEPIYIITEYMENGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIE 126
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
            +      H DL+++N+L+ + +   + DFGLA+ L E++       T   G K  + + 
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLAR-LIEDAEX-----TAREGAKFPIKWT 177
Query: 343 PPEYIN-GHVSILGDIYSYGILLLEIFTGKR 372
            PE IN G  +I  D++S+GILL EI T  R
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 111/225 (49%), Gaps = 27/225 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKS--FIDECNALTSIRHRNILKIVSSC 222
           +G+G FG V  G        AIK++K   +G++    FI+E   + ++ H  ++++   C
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +    +   F  ++ E+M NG L  +L     E  H  +    Q L +  DV  A++YL 
Sbjct: 69  TK---QRPIF--IITEYMANGCLLNYLR----EMRH--RFQTQQLLEMCKDVCEAMEYLE 117
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
           ++      H DL + N L+++  +  V DFGL++++ ++  T S       G K  V + 
Sbjct: 118 SK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV------GSKFPVRWS 168
Query: 343 PPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH 385
           PPE +     S   DI+++G+L+ EI++ GK P +     + + H
Sbjct: 169 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 213

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 111/225 (49%), Gaps = 27/225 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKS--FIDECNALTSIRHRNILKIVSSC 222
           +G+G FG V  G        AIK++K   +G++    FI+E   + ++ H  ++++   C
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +    +   F  ++ E+M NG L  +L     E  H  +    Q L +  DV  A++YL 
Sbjct: 73  TK---QRPIF--IITEYMANGCLLNYLR----EMRH--RFQTQQLLEMCKDVCEAMEYLE 121
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
           ++      H DL + N L+++  +  V DFGL++++ ++  T S       G K  V + 
Sbjct: 122 SK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV------GSKFPVRWS 172
Query: 343 PPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH 385
           PPE +     S   DI+++G+L+ EI++ GK P +     + + H
Sbjct: 173 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 217

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 111/225 (49%), Gaps = 27/225 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKS--FIDECNALTSIRHRNILKIVSSC 222
           +G+G FG V  G        AIK++K   +G++    FI+E   + ++ H  ++++   C
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +    +   F  ++ E+M NG L  +L     E  H  +    Q L +  DV  A++YL 
Sbjct: 74  TK---QRPIF--IITEYMANGCLLNYLR----EMRH--RFQTQQLLEMCKDVCEAMEYLE 122
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
           ++      H DL + N L+++  +  V DFGL++++ ++  T S       G K  V + 
Sbjct: 123 SK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV------GSKFPVRWS 173
Query: 343 PPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH 385
           PPE +     S   DI+++G+L+ EI++ GK P +     + + H
Sbjct: 174 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 218

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 113/231 (48%), Gaps = 31/231 (13%)
Query: 162 ENLIGSGSFGSVYKGTLA-DGE---TAAIKVLKL-QQQGALKSFIDECNALTSIRHRNIL 216
           E +IG+G FG V  G L   G+     AIK LK+   +   + F+ E + +    H NI+
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 217 K---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
               +V+    V         +V E+M NG+LD +L  +  ++      +++Q + ++  
Sbjct: 87  HLEGVVTKSKPV--------MIVTEYMENGSLDTFLKKNDGQF------TVIQLVGMLRG 132
Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +++ + YL    D    H DL + N+L++  ++  V DFGL++ L    + P    T   
Sbjct: 133 ISAGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVL---EDDPEAAYTTRG 186
Query: 334 GLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL 382
           G K  + +  PE I     +   D++SYGI++ E+ + G+RP  +M   D+
Sbjct: 187 G-KIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDV 236

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 109/225 (48%), Gaps = 27/225 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKS--FIDECNALTSIRHRNILKIVSSC 222
           +G+G FG V  G        AIK++K   +G++    FI+E   + ++ H  ++++   C
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +           ++ E+M NG L  +L     E  H  +    Q L +  DV  A++YL 
Sbjct: 80  TK-----QRPIFIITEYMANGCLLNYLR----EMRH--RFQTQQLLEMCKDVCEAMEYLE 128
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
           ++      H DL + N L+++  +  V DFGL++++ ++  T S       G K  V + 
Sbjct: 129 SK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV------GSKFPVRWS 179
Query: 343 PPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH 385
           PPE +     S   DI+++G+L+ EI++ GK P +     + + H
Sbjct: 180 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 224

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 111/225 (49%), Gaps = 27/225 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKS--FIDECNALTSIRHRNILKIVSSC 222
           +G+G FG V  G        AIK++K   +G++    FI+E   + ++ H  ++++   C
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +    +   F  ++ E+M NG L  +L     E  H  +    Q L +  DV  A++YL 
Sbjct: 89  TK---QRPIF--IITEYMANGCLLNYLR----EMRH--RFQTQQLLEMCKDVCEAMEYLE 137
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
           ++      H DL + N L+++  +  V DFGL++++ ++  T S       G K  V + 
Sbjct: 138 SK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV------GSKFPVRWS 188
Query: 343 PPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH 385
           PPE +     S   DI+++G+L+ EI++ GK P +     + + H
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 233

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 165 IGSGSFGSV---YKGTLAD--GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIV 219
           +G G+FGSV       L D  GE  A+K L+   +  L+ F  E   L S++H NI+K  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
             C S    G     L+ E++  G+L  +L        H +++  ++ L     +   ++
Sbjct: 81  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQ------AHAERIDHIKLLQYTSQICKGME 131
Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSV 339
           YL  +      H DL + N+L++      +GDFGL K L ++       +    G     
Sbjct: 132 YLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX---XKVKEPGESPIF 185
Query: 340 GYIPPEYINGHVSILGDIYSYGILLLEIFT 369
            Y P        S+  D++S+G++L E+FT
Sbjct: 186 WYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 115/235 (48%), Gaps = 25/235 (10%)
Query: 158 NFSEENLIGSGSFGSVYKGTLADGE----TAAIKVL-KLQQQGALKSFIDECNALTSIRH 212
           +F+E  +IG G FG VY GTL D +      A+K L ++   G +  F+ E   +    H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            N+L ++  C  +  EG+    +V  +M++G+L  ++   T         ++   +   +
Sbjct: 91  PNVLSLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNET------HNPTVKDLIGFGL 140
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            VA  + +L ++      H DL + N +LDE     V DFGLA+ ++++      N+T  
Sbjct: 141 QVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT-- 195
Query: 333 NGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH 385
            G K  V ++  E +     +   D++S+G+LL E+ T G  P  D+   D++++
Sbjct: 196 -GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 249

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 115/235 (48%), Gaps = 25/235 (10%)
Query: 158 NFSEENLIGSGSFGSVYKGTLADGET----AAIKVL-KLQQQGALKSFIDECNALTSIRH 212
           +F+E  +IG G FG VY GTL D +      A+K L ++   G +  F+ E   +    H
Sbjct: 92  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 149
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            N+L ++  C  +  EG+    +V  +M++G+L  ++   T         ++   +   +
Sbjct: 150 PNVLSLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNET------HNPTVKDLIGFGL 199
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            VA  + +L ++      H DL + N +LDE     V DFGLA+ ++++      N+T  
Sbjct: 200 QVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT-- 254
Query: 333 NGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH 385
            G K  V ++  E +     +   D++S+G+LL E+ T G  P  D+   D++++
Sbjct: 255 -GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 308

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 115/235 (48%), Gaps = 25/235 (10%)
Query: 158 NFSEENLIGSGSFGSVYKGTLADGE----TAAIKVL-KLQQQGALKSFIDECNALTSIRH 212
           +F+E  +IG G FG VY GTL D +      A+K L ++   G +  F+ E   +    H
Sbjct: 31  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 88
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            N+L ++  C  +  EG+    +V  +M++G+L  ++   T         ++   +   +
Sbjct: 89  PNVLSLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNET------HNPTVKDLIGFGL 138
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            VA  + +L ++      H DL + N +LDE     V DFGLA+ ++++      N+T  
Sbjct: 139 QVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT-- 193
Query: 333 NGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH 385
            G K  V ++  E +     +   D++S+G+LL E+ T G  P  D+   D++++
Sbjct: 194 -GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 247

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 115/235 (48%), Gaps = 25/235 (10%)
Query: 158 NFSEENLIGSGSFGSVYKGTLADGE----TAAIKVL-KLQQQGALKSFIDECNALTSIRH 212
           +F+E  +IG G FG VY GTL D +      A+K L ++   G +  F+ E   +    H
Sbjct: 34  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 91
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            N+L ++  C  +  EG+    +V  +M++G+L  ++   T         ++   +   +
Sbjct: 92  PNVLSLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNET------HNPTVKDLIGFGL 141
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            VA  + +L ++      H DL + N +LDE     V DFGLA+ ++++      N+T  
Sbjct: 142 QVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT-- 196
Query: 333 NGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH 385
            G K  V ++  E +     +   D++S+G+LL E+ T G  P  D+   D++++
Sbjct: 197 -GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 250

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 25/227 (11%)
Query: 153 SNATDNFSEENL-----IGSGSFGSV---YKGTLAD--GETAAIKVLKLQQQGALKSFID 202
           S+    F E +L     +G G+FGSV       L D  GE  A+K L+   +  L+ F  
Sbjct: 19  SHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 78
Query: 203 ECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKL 262
           E   L S++H NI+K    C S    G     L+ E++  G+L  +L    +   H K L
Sbjct: 79  EIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 135
Query: 263 SLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES 322
               +      +   ++YL  +      H DL + N+L++      +GDFGL K L ++ 
Sbjct: 136 QYTSQ------ICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 186
Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFT 369
                 +    G      Y P        S+  D++S+G++L E+FT
Sbjct: 187 EX---XKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 25/222 (11%)
Query: 158 NFSEENL-----IGSGSFGSV---YKGTLAD--GETAAIKVLKLQQQGALKSFIDECNAL 207
            F E +L     +G G+FGSV       L D  GE  A+K L+   +  L+ F  E   L
Sbjct: 5   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 64
Query: 208 TSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQR 267
            S++H NI+K    C S    G     L+ E++  G+L  +L    +   H K L    +
Sbjct: 65  KSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 121
Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
                 +   ++YL  +      H DL + N+L++      +GDFGL K L ++      
Sbjct: 122 ------ICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX--- 169
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFT 369
            +    G      Y P        S+  D++S+G++L E+FT
Sbjct: 170 XKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 115/235 (48%), Gaps = 25/235 (10%)
Query: 158 NFSEENLIGSGSFGSVYKGTLADGE----TAAIKVL-KLQQQGALKSFIDECNALTSIRH 212
           +F+E  +IG G FG VY GTL D +      A+K L ++   G +  F+ E   +    H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            N+L ++  C  +  EG+    +V  +M++G+L  ++   T         ++   +   +
Sbjct: 91  PNVLSLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNET------HNPTVKDLIGFGL 140
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            VA  + +L ++      H DL + N +LDE     V DFGLA+ ++++      N+T  
Sbjct: 141 QVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT-- 195
Query: 333 NGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH 385
            G K  V ++  E +     +   D++S+G+LL E+ T G  P  D+   D++++
Sbjct: 196 -GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 249

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 115/235 (48%), Gaps = 25/235 (10%)
Query: 158 NFSEENLIGSGSFGSVYKGTLADGE----TAAIKVL-KLQQQGALKSFIDECNALTSIRH 212
           +F+E  +IG G FG VY GTL D +      A+K L ++   G +  F+ E   +    H
Sbjct: 38  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 95
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            N+L ++  C  +  EG+    +V  +M++G+L  ++   T         ++   +   +
Sbjct: 96  PNVLSLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNET------HNPTVKDLIGFGL 145
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            VA  + +L ++      H DL + N +LDE     V DFGLA+ ++++      N+T  
Sbjct: 146 QVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT-- 200
Query: 333 NGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH 385
            G K  V ++  E +     +   D++S+G+LL E+ T G  P  D+   D++++
Sbjct: 201 -GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 254

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 22/207 (10%)
Query: 165 IGSGSFGSVYKGTLADGE-TAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           +G G +G VY+G       T A+K LK +    ++ F+ E   +  I+H N+++++  C+
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 224 SVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN 283
                      ++ EFM  GNL  +L       C+ +++S +  L +   ++SA++YL  
Sbjct: 287 R-----EPPFYIITEFMTYGNLLDYLRE-----CNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 284 QYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIP 343
           +      H +L + N L+ E  +  V DFGL++ +  ++       T   G K  + +  
Sbjct: 337 K---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT------YTAHAGAKFPIKWTA 387
Query: 344 PEYIN-GHVSILGDIYSYGILLLEIFT 369
           PE +     SI  D++++G+LL EI T
Sbjct: 388 PESLAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 16/214 (7%)
Query: 163 NLIGSGSFGSVYKGTLA--DGET--AAIKVLKLQQ--QGALKSFIDECNALTSIRHRNIL 216
            ++G G FGSV +G L   DG +   A+K +KL    Q  ++ F+ E   +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           +++  C  +  +G     ++  FM+ G+L  +L  S  E    K + L   L  ++D+A 
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLE-TGPKHIPLQTLLKFMVDIAL 158
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            ++YL N+      H DL + N +L + M   V DFGL+K ++  S    +   ++   K
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIY--SGDYYRQGRIA---K 210
Query: 337 GSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
             V +I  E +   V +   D++++G+ + EI T
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 25/227 (11%)
Query: 153 SNATDNFSEENL-----IGSGSFGSV---YKGTLAD--GETAAIKVLKLQQQGALKSFID 202
           S+    F E +L     +G G+FGSV       L D  GE  A+K L+   +  L+ F  
Sbjct: 19  SHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 78
Query: 203 ECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKL 262
           E   L S++H NI+K    C S    G     L+ E++  G+L  +L    +   H K L
Sbjct: 79  EIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 135
Query: 263 SLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES 322
               +      +   ++YL  +      H DL + N+L++      +GDFGL K L ++ 
Sbjct: 136 QYTSQ------ICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 186
Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFT 369
                 +    G      Y P        S+  D++S+G++L E+FT
Sbjct: 187 EX---XKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 25/222 (11%)
Query: 158 NFSEENL-----IGSGSFGSV---YKGTLAD--GETAAIKVLKLQQQGALKSFIDECNAL 207
            F E +L     +G G+FGSV       L D  GE  A+K L+   +  L+ F  E   L
Sbjct: 4   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 63
Query: 208 TSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQR 267
            S++H NI+K    C S    G     L+ E++  G+L  +L    +   H K L    +
Sbjct: 64  KSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 120
Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
                 +   ++YL  +      H DL + N+L++      +GDFGL K L ++      
Sbjct: 121 ------ICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX--- 168
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFT 369
            +    G      Y P        S+  D++S+G++L E+FT
Sbjct: 169 XKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 25/222 (11%)
Query: 158 NFSEENL-----IGSGSFGSV---YKGTLAD--GETAAIKVLKLQQQGALKSFIDECNAL 207
            F E +L     +G G+FGSV       L D  GE  A+K L+   +  L+ F  E   L
Sbjct: 10  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 69
Query: 208 TSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQR 267
            S++H NI+K    C S    G     L+ E++  G+L  +L    +   H K L    +
Sbjct: 70  KSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 126
Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
                 +   ++YL  +      H DL + N+L++      +GDFGL K L ++      
Sbjct: 127 ------ICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX--- 174
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFT 369
            +    G      Y P        S+  D++S+G++L E+FT
Sbjct: 175 XKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 25/222 (11%)
Query: 158 NFSEENL-----IGSGSFGSV---YKGTLAD--GETAAIKVLKLQQQGALKSFIDECNAL 207
            F E +L     +G G+FGSV       L D  GE  A+K L+   +  L+ F  E   L
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 208 TSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQR 267
            S++H NI+K    C S    G     L+ E++  G+L  +L    +   H K L    +
Sbjct: 66  KSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 122
Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
                 +   ++YL  +      H DL + N+L++      +GDFGL K L ++      
Sbjct: 123 ------ICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX--- 170
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFT 369
            +    G      Y P        S+  D++S+G++L E+FT
Sbjct: 171 XKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 25/222 (11%)
Query: 158 NFSEENL-----IGSGSFGSV---YKGTLAD--GETAAIKVLKLQQQGALKSFIDECNAL 207
            F E +L     +G G+FGSV       L D  GE  A+K L+   +  L+ F  E   L
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 208 TSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQR 267
            S++H NI+K    C S    G     L+ E++  G+L  +L    +   H K L    +
Sbjct: 66  KSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 122
Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
                 +   ++YL  +      H DL + N+L++      +GDFGL K L ++      
Sbjct: 123 ------ICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX--- 170
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFT 369
            +    G      Y P        S+  D++S+G++L E+FT
Sbjct: 171 XKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 25/222 (11%)
Query: 158 NFSEENL-----IGSGSFGSV---YKGTLAD--GETAAIKVLKLQQQGALKSFIDECNAL 207
            F E +L     +G G+FGSV       L D  GE  A+K L+   +  L+ F  E   L
Sbjct: 9   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 68
Query: 208 TSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQR 267
            S++H NI+K    C S    G     L+ E++  G+L  +L    +   H K L    +
Sbjct: 69  KSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 125
Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
                 +   ++YL  +      H DL + N+L++      +GDFGL K L ++      
Sbjct: 126 ------ICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX--- 173
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFT 369
            +    G      Y P        S+  D++S+G++L E+FT
Sbjct: 174 XKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 25/222 (11%)
Query: 158 NFSEENL-----IGSGSFGSV---YKGTLAD--GETAAIKVLKLQQQGALKSFIDECNAL 207
            F E +L     +G G+FGSV       L D  GE  A+K L+   +  L+ F  E   L
Sbjct: 11  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 70
Query: 208 TSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQR 267
            S++H NI+K    C S    G     L+ E++  G+L  +L    +   H K L    +
Sbjct: 71  KSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 127
Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
                 +   ++YL  +      H DL + N+L++      +GDFGL K L ++      
Sbjct: 128 ------ICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX--- 175
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFT 369
            +    G      Y P        S+  D++S+G++L E+FT
Sbjct: 176 XKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 25/222 (11%)
Query: 158 NFSEENL-----IGSGSFGSV---YKGTLAD--GETAAIKVLKLQQQGALKSFIDECNAL 207
            F E +L     +G G+FGSV       L D  GE  A+K L+   +  L+ F  E   L
Sbjct: 12  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 71
Query: 208 TSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQR 267
            S++H NI+K    C S    G     L+ E++  G+L  +L    +   H K L    +
Sbjct: 72  KSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 128
Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
                 +   ++YL  +      H DL + N+L++      +GDFGL K L ++      
Sbjct: 129 ------ICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX--- 176
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFT 369
            +    G      Y P        S+  D++S+G++L E+FT
Sbjct: 177 XKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 25/222 (11%)
Query: 158 NFSEENL-----IGSGSFGSV---YKGTLAD--GETAAIKVLKLQQQGALKSFIDECNAL 207
            F E +L     +G G+FGSV       L D  GE  A+K L+   +  L+ F  E   L
Sbjct: 37  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 96
Query: 208 TSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQR 267
            S++H NI+K    C S    G     L+ E++  G+L  +L    +   H K L    +
Sbjct: 97  KSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 153
Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
                 +   ++YL  +      H DL + N+L++      +GDFGL K L ++      
Sbjct: 154 ------ICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX--- 201
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFT 369
            +    G      Y P        S+  D++S+G++L E+FT
Sbjct: 202 XKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 165 IGSGSFGSV---YKGTLAD--GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIV 219
           +G G+FGSV       L D  GE  A+K L+   +  L+ F  E   L S++H NI+K  
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
             C S    G     L+ E++  G+L  +L    +   H K L    +      +   ++
Sbjct: 85  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGME 135
Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSV 339
           YL  +      H DL + N+L++      +GDFGL K L ++       +    G     
Sbjct: 136 YLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX---XKVKEPGESPIF 189
Query: 340 GYIPPEYINGHVSILGDIYSYGILLLEIFT 369
            Y P        S+  D++S+G++L E+FT
Sbjct: 190 WYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 164 LIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSC 222
           ++G G FG   K T  + GE   +K L    +   ++F+ E   +  + H N+LK +   
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG-- 74
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
             V Y+       + E+++ G L   +     +Y         QR++   D+AS + YLH
Sbjct: 75  --VLYKDKRLN-FITEYIKGGTLRGIIKSMDSQY------PWSQRVSFAKDIASGMAYLH 125
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK------ 336
           +     I H DL S N L+ E     V DFGLA+ + +E   P   +++    +      
Sbjct: 126 SMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 337 -GSVGYIPPEYINGH-VSILGDIYSYGILLLEI 367
            G+  ++ PE ING       D++S+GI+L EI
Sbjct: 183 VGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEI 215

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 114/235 (48%), Gaps = 25/235 (10%)
Query: 158 NFSEENLIGSGSFGSVYKGTLADGE----TAAIKVL-KLQQQGALKSFIDECNALTSIRH 212
           +F+E  +IG G FG VY GTL D +      A+K L ++   G +  F+ E   +    H
Sbjct: 34  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 91
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            N+L ++  C  +  EG+    +V  +M++G+L  ++   T         ++   +   +
Sbjct: 92  PNVLSLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNET------HNPTVKDLIGFGL 141
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            VA  + +L ++      H DL + N +LDE     V DFGLA+ + ++      N+T  
Sbjct: 142 QVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKT-- 196
Query: 333 NGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH 385
            G K  V ++  E +     +   D++S+G+LL E+ T G  P  D+   D++++
Sbjct: 197 -GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 250

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 22/207 (10%)
Query: 165 IGSGSFGSVYKGTLADGE-TAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           +G G +G VY G       T A+K LK +    ++ F+ E   +  I+H N+++++  C+
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 224 SVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN 283
               E   +  +V E+M  GNL  +L       C+ ++++ +  L +   ++SA++YL  
Sbjct: 99  ---LEPPFY--IVTEYMPYGNLLDYLRE-----CNREEVTAVVLLYMATQISSAMEYLEK 148
Query: 284 QYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIP 343
           +      H DL + N L+ E  +  V DFGL++ +           T   G K  + +  
Sbjct: 149 K---NFIHRDLAARNCLVGENHVVKVADFGLSRLM------TGDTYTAHAGAKFPIKWTA 199
Query: 344 PEYINGHV-SILGDIYSYGILLLEIFT 369
           PE +  +  SI  D++++G+LL EI T
Sbjct: 200 PESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 104/230 (45%), Gaps = 33/230 (14%)
Query: 154 NATDNFSEENLIGSGSFGSVYKGT-LADGETAAIK---VLKLQQQGALKSFIDECNALTS 209
           N   NF  E  IG G F  VY+   L DG   A+K   +  L    A    I E + L  
Sbjct: 29  NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQ 88
Query: 210 IRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN 269
           + H N++K  +S      E N+   +V E    G+L + +        HFKK   +    
Sbjct: 89  LNHPNVIKYYASF----IEDNELN-IVLELADAGDLSRMIK-------HFKKQKRLIPER 136
Query: 270 IV----IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
            V    + + SAL+++H++    + H D+K +NV +    +  +GD GL +F        
Sbjct: 137 TVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF------- 186
Query: 326 SKNQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRP 373
           S   T ++ L G+  Y+ PE I  NG+ +   DI+S G LL E+   + P
Sbjct: 187 SSKTTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSP 235

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 109/224 (48%), Gaps = 22/224 (9%)
Query: 148 SYLKISNATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVLKLQQQGALKSFIDECNA 206
           +Y K      + + ++ +G G +G VY+G       T A+K LK +    ++ F+ E   
Sbjct: 250 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 308
Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           +  I+H N+++++  C+           ++ EFM  GNL  +L       C+ ++++ + 
Sbjct: 309 MKEIKHPNLVQLLGVCTR-----EPPFYIITEFMTYGNLLDYLRE-----CNRQEVNAVV 358
Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
            L +   ++SA++YL  +      H +L + N L+ E  +  V DFGL++ +  ++    
Sbjct: 359 LLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT---- 411
Query: 327 KNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT 369
              T   G K  + +  PE +     SI  D++++G+LL EI T
Sbjct: 412 --YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 106/218 (48%), Gaps = 33/218 (15%)
Query: 162 ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSS 221
           E  +G+G FG V+  T       A+K +K     ++++F+ E N + +++H  ++K+ + 
Sbjct: 187 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAV 245
Query: 222 CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYL 281
            +       +   ++ EFM  G+L  +L   +DE     K  L + ++    +A  + ++
Sbjct: 246 VT------KEPIYIITEFMAKGSLLDFL--KSDEGS---KQPLPKLIDFSAQIAEGMAFI 294
Query: 282 HNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGY 341
             +      H DL+++N+L+   ++  + DFGLA+                 G K  + +
Sbjct: 295 EQRN---YIHRDLRAANILVSASLVCKIADFGLARV----------------GAKFPIKW 335
Query: 342 IPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
             PE IN G  +I  D++S+GILL+EI T G+ P   M
Sbjct: 336 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 373

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 25/222 (11%)
Query: 158 NFSEENL-----IGSGSFGSV---YKGTLAD--GETAAIKVLKLQQQGALKSFIDECNAL 207
            F E +L     +G G+FGSV       L D  GE  A+K L+   +  L+ F  E   L
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 208 TSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQR 267
            S++H NI+K    C S    G     L+ E++  G+L  +L    +   H K L    +
Sbjct: 66  KSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 122
Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
                 +   ++YL  +      H DL + N+L++      +GDFGL K L ++      
Sbjct: 123 ------ICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF--- 170
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFT 369
            +    G      Y P        S+  D++S+G++L E+FT
Sbjct: 171 FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 112/238 (47%), Gaps = 40/238 (16%)
Query: 155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGA-------LKSFIDECNA 206
           A +    E  IG G FG V+KG L  D    AIK L L             + F  E   
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           ++++ H NI+K+           ++   +V EF+  G+L    H   D+  H  K S+  
Sbjct: 77  MSNLNHPNIVKLYGLM-------HNPPRMVMEFVPCGDL---YHRLLDK-AHPIKWSV-- 123
Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVL---LDEG--MIAHVGDFGLAKFLFEE 321
           +L +++D+A  ++Y+ NQ + PI H DL+S N+    LDE   + A V DFGL++     
Sbjct: 124 KLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----- 177
Query: 322 SNTPSKNQTMSNGLKGSVGYIPPEYINGH---VSILGDIYSYGILLLEIFTGKRPTDD 376
                ++    +GL G+  ++ PE I       +   D YS+ ++L  I TG+ P D+
Sbjct: 178 -----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 98/220 (44%), Gaps = 29/220 (13%)
Query: 163 NLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALK---SFIDECNALTSIRHRNILKI 218
           + +G G+FG V  G     G   A+K+L  Q+  +L        E   L   RH +I+K+
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
               S+      DF  +V E++  G L        D  C   ++  M+   +   + SA+
Sbjct: 77  YQVIST----PTDF-FMVMEYVSGGEL-------FDYICKHGRVEEMEARRLFQQILSAV 124
Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
           DY H      + H DLK  NVLLD  M A + DFGL       SN  S  + + +   GS
Sbjct: 125 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGL-------SNMMSDGEFLRDSC-GS 173
Query: 339 VGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDD 376
             Y  PE I+G  +     DI+S G++L  +  G  P DD
Sbjct: 174 PNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 97/220 (44%), Gaps = 29/220 (13%)
Query: 163 NLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALK---SFIDECNALTSIRHRNILKI 218
           + +G G+FG V  G     G   A+K+L  Q+  +L        E   L   RH +I+K+
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
               S+      DF  +V E++  G L        D  C   ++  M+   +   + SA+
Sbjct: 77  YQVIST----PTDF-FMVMEYVSGGEL-------FDYICKHGRVEEMEARRLFQQILSAV 124
Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
           DY H      + H DLK  NVLLD  M A + DFGL       SN  S  + +     GS
Sbjct: 125 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGL-------SNMMSDGEFLRTSC-GS 173
Query: 339 VGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDD 376
             Y  PE I+G  +     DI+S G++L  +  G  P DD
Sbjct: 174 PNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 98/227 (43%), Gaps = 25/227 (11%)
Query: 153 SNATDNFSEENL-----IGSGSFGSV---YKGTLAD--GETAAIKVLKLQQQGALKSFID 202
           S     F E +L     +G G+FGSV       L D  GE  A+K L+   +  L+ F  
Sbjct: 2   SRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 61
Query: 203 ECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKL 262
           E   L S++H NI+K    C S    G     L+ E++  G+L  +L    +   H K L
Sbjct: 62  EIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 118
Query: 263 SLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES 322
               +      +   ++YL  +      H +L + N+L++      +GDFGL K L ++ 
Sbjct: 119 QYTSQ------ICKGMEYLGTKR---YIHRNLATRNILVENENRVKIGDFGLTKVLPQDK 169
Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFT 369
                 +    G      Y P        S+  D++S+G++L E+FT
Sbjct: 170 EY---YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 116/236 (49%), Gaps = 29/236 (12%)
Query: 148 SYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGET----AAIKVL-KLQQQGALKSFI 201
           + L+I   T+      ++GSG+FG+VYKG  + +GET     AIK+L +     A   F+
Sbjct: 30  AQLRILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFM 88
Query: 202 DECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK 261
           DE   + S+ H ++++++  C S   +      LV + M +G L +++H   D       
Sbjct: 89  DEALIMASMDHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLEYVHEHKD------N 136
Query: 262 LSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEE 321
           +     LN  + +A  + YL  +    + H DL + NVL+       + DFGLA+ L  E
Sbjct: 137 IGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL--E 191
Query: 322 SNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTD 375
            +    N   ++G K  + ++  E I+    +   D++SYG+ + E+ T G +P D
Sbjct: 192 GDEKEYN---ADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 244

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 110/221 (49%), Gaps = 28/221 (12%)
Query: 163 NLIGSGSFGSVYKGT-LADGET----AAIKVL-KLQQQGALKSFIDECNALTSIRHRNIL 216
            ++GSG+FG+VYKG  + +GET     AIK+L +     A   F+DE   + S+ H +++
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           +++  C S   +      LV + M +G L +++H   D       +     LN  + +A 
Sbjct: 81  RLLGVCLSPTIQ------LVTQLMPHGCLLEYVHEHKD------NIGSQLLLNWCVQIAK 128
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            + YL  +    + H DL + NVL+       + DFGLA+ L  E +    N   ++G K
Sbjct: 129 GMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL--EGDEKEYN---ADGGK 180
Query: 337 GSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTD 375
             + ++  E I+    +   D++SYG+ + E+ T G +P D
Sbjct: 181 MPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 221

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 110/238 (46%), Gaps = 40/238 (16%)
Query: 155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGA-------LKSFIDECNA 206
           A +    E  IG G FG V+KG L  D    AIK L L             + F  E   
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           ++++ H NI+K+           ++   +V EF+  G+L    H   D+  H  K S+  
Sbjct: 77  MSNLNHPNIVKLYGLM-------HNPPRMVMEFVPCGDL---YHRLLDK-AHPIKWSV-- 123
Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVL---LDEG--MIAHVGDFGLAKFLFEE 321
           +L +++D+A  ++Y+ NQ + PI H DL+S N+    LDE   + A V DFG        
Sbjct: 124 KLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG-------- 174
Query: 322 SNTPSKNQTMSNGLKGSVGYIPPEYINGH---VSILGDIYSYGILLLEIFTGKRPTDD 376
             T  ++    +GL G+  ++ PE I       +   D YS+ ++L  I TG+ P D+
Sbjct: 175 --TSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 104/218 (47%), Gaps = 25/218 (11%)
Query: 165 IGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKS-FIDECNALTSIRHRNILKIVSSC 222
           IG G+FG V+ G L AD    A+K  +      LK+ F+ E   L    H NI++++  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +           +V E ++ G+   +L           +L +   L +V D A+ ++YL 
Sbjct: 182 TQ-----KQPIYIVMELVQGGDFLTFLRTEG------ARLRVKTLLQMVGDAAAGMEYLE 230
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG-SVGY 341
           ++      H DL + N L+ E  +  + DFG+++   EE++        S GL+   V +
Sbjct: 231 SKC---CIHRDLAARNCLVTEKNVLKISDFGMSR---EEADG---VXAASGGLRQVPVKW 281
Query: 342 IPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
             PE +N G  S   D++S+GILL E F+ G  P  ++
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL 319

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 119/253 (47%), Gaps = 30/253 (11%)
Query: 139 PSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL 197
           PS E     + L+I   T+ F +  ++GSG+FG+VYKG  + +GE   I V  ++ + A 
Sbjct: 33  PSGE-APNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREAT 90
Query: 198 -----KSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPS 252
                K  +DE   + S+ + ++ +++  C +   +      L+ + M  G L  ++   
Sbjct: 91  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREH 144
Query: 253 TDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF 312
            D       +     LN  + +A  ++YL    D  + H DL + NVL+       + DF
Sbjct: 145 KD------NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 195
Query: 313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-G 370
           GLAK L  E     + +  + G K  + ++  E I   + +   D++SYG+ + E+ T G
Sbjct: 196 GLAKLLGAE-----EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 250
Query: 371 KRPTDDMFKDDLS 383
            +P D +   ++S
Sbjct: 251 SKPYDGIPASEIS 263

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 165 IGSGSFGSVY--KGTLADGETA--AIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVS 220
           +G G   +VY  + T+ + + A  AI +   +++  LK F  E +  + + H+NI+ ++ 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDY 280
               VD E +D   LV E++    L +++            LS+   +N    +   LD 
Sbjct: 79  ----VD-EEDDCYYLVMEYIEGPTLSEYIES-------HGPLSVDTAINFTNQI---LDG 123
Query: 281 LHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG 340
           + + +D  I H D+K  N+L+D      + DFG+AK L E S       T +N + G+V 
Sbjct: 124 IKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS------LTQTNHVLGTVQ 177
Query: 341 YIPPEYINGHVSI-LGDIYSYGILLLEIFTGKRP 373
           Y  PE   G  +    DIYS GI+L E+  G+ P
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 165 IGSGSFGSV----YKGTLAD-GETAAIKVLKLQQQG-ALKSFIDECNALTSIRHRNILKI 218
           +G G FG V    Y     + GE  A+K LK +  G  +     E   L ++ H NI+K 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
              C+    +G +   L+ EF+ +G+L ++L  + +      K++L Q+L   + +   +
Sbjct: 89  KGICTE---DGGNGIKLIMEFLPSGSLKEYLPKNKN------KINLKQQLKYAVQICKGM 139
Query: 279 DYL-HNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           DYL   QY     H DL + NVL++      +GDFGL K +     T  +  T+ +    
Sbjct: 140 DYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAI----ETDKEXXTVKDDRDS 191
Query: 338 SVGYIPPE-YINGHVSILGDIYSYGILLLEIFT 369
            V +  PE  +     I  D++S+G+ L E+ T
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 165 IGSGSFGSV----YKGTLAD-GETAAIKVLKLQQQG-ALKSFIDECNALTSIRHRNILKI 218
           +G G FG V    Y     + GE  A+K LK +  G  +     E   L ++ H NI+K 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
              C+    +G +   L+ EF+ +G+L ++L  + +      K++L Q+L   + +   +
Sbjct: 77  KGICTE---DGGNGIKLIMEFLPSGSLKEYLPKNKN------KINLKQQLKYAVQICKGM 127
Query: 279 DYL-HNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           DYL   QY     H DL + NVL++      +GDFGL K +     T  +  T+ +    
Sbjct: 128 DYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAI----ETDKEXXTVKDDRDS 179
Query: 338 SVGYIPPE-YINGHVSILGDIYSYGILLLEIFT 369
            V +  PE  +     I  D++S+G+ L E+ T
Sbjct: 180 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 32/222 (14%)
Query: 165 IGSGSFGSVYKG------TLADGETAAIKVLKLQQQGAL----KSFIDECNALTSIRHR- 213
           +G G+FG V +         A   T A+K+LK   +GA     ++ + E   L  I H  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 91
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKL-----SLMQRL 268
           N++ ++ +C+     G     +V EF + GNL  +L    +E+  +K L     +L   +
Sbjct: 92  NVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLI 147
Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
                VA  +++L ++      H DL + N+LL E  +  + DFGLA+ ++++ +   K 
Sbjct: 148 XYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKG 204
Query: 329 QTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
                  +  + ++ PE I   V +I  D++S+G+LL EIF+
Sbjct: 205 DA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 104/218 (47%), Gaps = 25/218 (11%)
Query: 165 IGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKS-FIDECNALTSIRHRNILKIVSSC 222
           IG G+FG V+ G L AD    A+K  +      LK+ F+ E   L    H NI++++  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +           +V E ++ G+   +L           +L +   L +V D A+ ++YL 
Sbjct: 182 TQ-----KQPIYIVMELVQGGDFLTFLRTEG------ARLRVKTLLQMVGDAAAGMEYLE 230
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG-SVGY 341
           ++      H DL + N L+ E  +  + DFG+++   EE++        S GL+   V +
Sbjct: 231 SKC---CIHRDLAARNCLVTEKNVLKISDFGMSR---EEADG---VYAASGGLRQVPVKW 281
Query: 342 IPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
             PE +N G  S   D++S+GILL E F+ G  P  ++
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL 319

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 113/238 (47%), Gaps = 40/238 (16%)
Query: 155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKL-QQQGA------LKSFIDECNA 206
           A +    E  IG G FG V+KG L  D    AIK L L   +G        + F  E   
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           ++++ H NI+K+           ++   +V EF+  G+L    H   D+  H  K S+  
Sbjct: 77  MSNLNHPNIVKLYGLM-------HNPPRMVMEFVPCGDL---YHRLLDK-AHPIKWSV-- 123
Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVL---LDEG--MIAHVGDFGLAKFLFEE 321
           +L +++D+A  ++Y+ NQ + PI H DL+S N+    LDE   + A V DF L++     
Sbjct: 124 KLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ----- 177
Query: 322 SNTPSKNQTMSNGLKGSVGYIPPEYINGH---VSILGDIYSYGILLLEIFTGKRPTDD 376
                ++    +GL G+  ++ PE I       +   D YS+ ++L  I TG+ P D+
Sbjct: 178 -----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 165 IGSGSFGSVYKGTLADGET------AAIKVLK--LQQQGALKSFIDECNALTSIRHRNIL 216
           +G G+FG VY+G ++           A+K L     +Q  L  F+ E   ++ + H+NI+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKLNHQNIV 97
Query: 217 KIVS-SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           + +  S  S+       + ++ E M  G+L  +L  +         L+++  L++  D+A
Sbjct: 98  RCIGVSLQSLP------RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
               YL   +     H D+ + N LL     G +A +GDFG+A+ ++  S        M 
Sbjct: 152 CGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 208
Query: 333 NGLKGSVGYIPPE-YINGHVSILGDIYSYGILLLEIFT 369
                 V ++PPE ++ G  +   D +S+G+LL EIF+
Sbjct: 209 -----PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 114/242 (47%), Gaps = 29/242 (11%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL-----KSFIDE 203
           L+I   T+ F +  ++GSG+FG+VYKG  + +GE   I V   + + A      K  +DE
Sbjct: 10  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 68
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              + S+ + ++ +++  C +   +      L+ + M  G L  ++    D       + 
Sbjct: 69  AYVMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGXLLDYVREHKD------NIG 116
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
               LN  + +A  ++YL    D  + H DL + NVL+       + DFGLAK L  E  
Sbjct: 117 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-- 171
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDD 381
              + +  + G K  + ++  E I   + +   D++SYG+ + E+ T G +P D +   +
Sbjct: 172 ---EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 228
Query: 382 LS 383
           +S
Sbjct: 229 IS 230

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 27/211 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSS 224
           IG G FG V  G    G   A+K +K       ++F+ E + +T +RH N+++++     
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI-- 68
Query: 225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ 284
           V+ +G  +  +V E+M  G+L  +L            L     L   +DV  A++YL   
Sbjct: 69  VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEYLEG- 120
Query: 285 YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
                 H DL + NVL+ E  +A V DFGL K   E S+T           K  V +  P
Sbjct: 121 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTG-------KLPVKWTAP 168
Query: 345 EYI-NGHVSILGDIYSYGILLLEIFT-GKRP 373
           E +     S   D++S+GILL EI++ G+ P
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGRVP 199

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 27/211 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSS 224
           IG G FG V  G    G   A+K +K       ++F+ E + +T +RH N+++++     
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI-- 74
Query: 225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ 284
           V+ +G  +  +V E+M  G+L  +L            L     L   +DV  A++YL   
Sbjct: 75  VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEYLEG- 126
Query: 285 YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
                 H DL + NVL+ E  +A V DFGL K   E S+T           K  V +  P
Sbjct: 127 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTG-------KLPVKWTAP 174
Query: 345 EYI-NGHVSILGDIYSYGILLLEIFT-GKRP 373
           E +     S   D++S+GILL EI++ G+ P
Sbjct: 175 EALREAAFSTKSDVWSFGILLWEIYSFGRVP 205

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 32/222 (14%)
Query: 165 IGSGSFGSVYKG------TLADGETAAIKVLKLQQQGAL----KSFIDECNALTSIRHR- 213
           +G G+FG V +         A   T A+K+LK   +GA     ++ + E   L  I H  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 91
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKL-----SLMQRL 268
           N++ ++ +C+     G     +V EF + GNL  +L    +E+  +K L     +L   +
Sbjct: 92  NVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLI 147
Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
                VA  +++L ++      H DL + N+LL E  +  + DFGLA+ ++++ +   K 
Sbjct: 148 CYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 204
Query: 329 QTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
                  +  + ++ PE I   V +I  D++S+G+LL EIF+
Sbjct: 205 DA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 27/211 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSS 224
           IG G FG V  G    G   A+K +K       ++F+ E + +T +RH N+++++     
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI-- 83
Query: 225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ 284
           V+ +G  +  +V E+M  G+L  +L            L     L   +DV  A++YL   
Sbjct: 84  VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEYLEG- 135
Query: 285 YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
                 H DL + NVL+ E  +A V DFGL K   E S+T           K  V +  P
Sbjct: 136 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTG-------KLPVKWTAP 183
Query: 345 EYI-NGHVSILGDIYSYGILLLEIFT-GKRP 373
           E +     S   D++S+GILL EI++ G+ P
Sbjct: 184 EALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 165 IGSGSFGSVYKGTLADGET------AAIKVLK--LQQQGALKSFIDECNALTSIRHRNIL 216
           +G G+FG VY+G ++           A+K L     +Q  L  F+ E   ++ + H+NI+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKLNHQNIV 111
Query: 217 KIVS-SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           + +  S  S+       + ++ E M  G+L  +L  +         L+++  L++  D+A
Sbjct: 112 RCIGVSLQSLP------RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
               YL   +     H D+ + N LL     G +A +GDFG+A+ ++  S        M 
Sbjct: 166 CGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 222
Query: 333 NGLKGSVGYIPPE-YINGHVSILGDIYSYGILLLEIFT 369
                 V ++PPE ++ G  +   D +S+G+LL EIF+
Sbjct: 223 -----PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 165 IGSGSFGSVYKGTLADGET------AAIKVLK--LQQQGALKSFIDECNALTSIRHRNIL 216
           +G G+FG VY+G ++           A+K L     +Q  L  F+ E   ++   H+NI+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIV 96
Query: 217 KIVS-SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           + +  S  S+       + ++ E M  G+L  +L  +         L+++  L++  D+A
Sbjct: 97  RCIGVSLQSLP------RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
               YL   +     H D+ + N LL     G +A +GDFG+A+ ++  S        M 
Sbjct: 151 CGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 207
Query: 333 NGLKGSVGYIPPE-YINGHVSILGDIYSYGILLLEIFT 369
                 V ++PPE ++ G  +   D +S+G+LL EIF+
Sbjct: 208 -----PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 108/237 (45%), Gaps = 30/237 (12%)
Query: 145 SGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDEC 204
           SGL +L         +    +G G +G V++G+   GE  A+K+   + +   KS+  E 
Sbjct: 25  SGLPFLVQRTVARQITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRET 80
Query: 205 NALTSI--RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKL 262
               ++  RH NIL  ++S  +  +       L+  +   G+L  +L  +T        L
Sbjct: 81  ELYNTVMLRHENILGFIASDMTSRHSSTQL-WLITHYHEMGSLYDYLQLTT--------L 131
Query: 263 SLMQRLNIVIDVASALDYLH-----NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF 317
             +  L IV+ +AS L +LH      Q    IAH DLKS N+L+ +     + D GLA  
Sbjct: 132 DTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM 191
Query: 318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSI-------LGDIYSYGILLLEI 367
               S + ++    +N   G+  Y+ PE ++  + +         DI+++G++L E+
Sbjct: 192 ---HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 114/242 (47%), Gaps = 29/242 (11%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL-----KSFIDE 203
           L+I   T+ F +  ++GSG+FG+VYKG  + +GE   I V   + + A      K  +DE
Sbjct: 10  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 68
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              + S+ + ++ +++  C +   +      L+ + M  G L  ++    D       + 
Sbjct: 69  AYVMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKD------NIG 116
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
               LN  + +A  ++YL    D  + H DL + NVL+       + DFGLAK L  E  
Sbjct: 117 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-- 171
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDD 381
              + +  + G K  + ++  E I   + +   D++SYG+ + E+ T G +P D +   +
Sbjct: 172 ---EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 228
Query: 382 LS 383
           +S
Sbjct: 229 IS 230

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 114/242 (47%), Gaps = 29/242 (11%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL-----KSFIDE 203
           L+I   T+ F +  ++GSG+FG+VYKG  + +GE   I V   + + A      K  +DE
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              + S+ + ++ +++  C +   +      L+ + M  G L  ++    D       + 
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKD------NIG 115
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
               LN  + +A  ++YL    D  + H DL + NVL+       + DFGLAK L  E  
Sbjct: 116 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-- 170
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDD 381
              + +  + G K  + ++  E I   + +   D++SYG+ + E+ T G +P D +   +
Sbjct: 171 ---EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
Query: 382 LS 383
           +S
Sbjct: 228 IS 229

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 165 IGSGSFGSVYKGTLADGET------AAIKVLK--LQQQGALKSFIDECNALTSIRHRNIL 216
           +G G+FG VY+G ++           A+K L     +Q  L  F+ E   ++   H+NI+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIV 103
Query: 217 KIVS-SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           + +  S  S+       + ++ E M  G+L  +L  +         L+++  L++  D+A
Sbjct: 104 RCIGVSLQSLP------RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 157
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
               YL   +     H D+ + N LL     G +A +GDFG+A+ ++  S        M 
Sbjct: 158 CGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 214
Query: 333 NGLKGSVGYIPPE-YINGHVSILGDIYSYGILLLEIFT 369
                 V ++PPE ++ G  +   D +S+G+LL EIF+
Sbjct: 215 -----PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 165 IGSGSFGSVYKGTLADGET------AAIKVLK--LQQQGALKSFIDECNALTSIRHRNIL 216
           +G G+FG VY+G ++           A+K L     +Q  L  F+ E   ++   H+NI+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIV 88
Query: 217 KIVS-SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           + +  S  S+       + ++ E M  G+L  +L  +         L+++  L++  D+A
Sbjct: 89  RCIGVSLQSLP------RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 142
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
               YL   +     H D+ + N LL     G +A +GDFG+A+ ++  S        M 
Sbjct: 143 CGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 199
Query: 333 NGLKGSVGYIPPE-YINGHVSILGDIYSYGILLLEIFT 369
                 V ++PPE ++ G  +   D +S+G+LL EIF+
Sbjct: 200 -----PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 118/253 (46%), Gaps = 30/253 (11%)
Query: 139 PSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL 197
           PS E     + L+I   T+ F +  ++GSG+FG+VYKG  + +GE   I V   + + A 
Sbjct: 3   PSGE-APNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 60
Query: 198 -----KSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPS 252
                K  +DE   + S+ + ++ +++  C +   +      L+ + M  G L  ++   
Sbjct: 61  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREH 114
Query: 253 TDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF 312
            D       +     LN  + +A  ++YL    D  + H DL + NVL+       + DF
Sbjct: 115 KD------NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 165
Query: 313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-G 370
           GLAK L  E     + +  + G K  + ++  E I   + +   D++SYG+ + E+ T G
Sbjct: 166 GLAKLLGAE-----EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 220
Query: 371 KRPTDDMFKDDLS 383
            +P D +   ++S
Sbjct: 221 SKPYDGIPASEIS 233

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 116/246 (47%), Gaps = 29/246 (11%)
Query: 146 GLSYLKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL-----KS 199
            ++ L+I   T+ F +  ++GSG+FG+VYKG  + +GE   I V   + + A      K 
Sbjct: 2   AMALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 60
Query: 200 FIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHF 259
            +DE   + S+ + ++ +++  C +   +      L+ + M  G L  ++    D     
Sbjct: 61  ILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD----- 109
Query: 260 KKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLF 319
             +     LN  + +A  ++YL    D  + H DL + NVL+       + DFGLAK L 
Sbjct: 110 -NIGSQYLLNWCVQIAEGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 165
Query: 320 EESNTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDM 377
            E     + +  + G K  + ++  E I   + +   D++SYG+ + E+ T G +P D +
Sbjct: 166 AE-----EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 220
Query: 378 FKDDLS 383
              ++S
Sbjct: 221 PASEIS 226

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 165 IGSGSFGSVYKGTLADGET------AAIKVLK--LQQQGALKSFIDECNALTSIRHRNIL 216
           +G G+FG VY+G ++           A+K L     +Q  L  F+ E   ++   H+NI+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIV 96
Query: 217 KIVS-SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           + +  S  S+       + ++ E M  G+L  +L  +         L+++  L++  D+A
Sbjct: 97  RCIGVSLQSLP------RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
               YL   +     H D+ + N LL     G +A +GDFG+A+ ++  S        M 
Sbjct: 151 CGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 207
Query: 333 NGLKGSVGYIPPE-YINGHVSILGDIYSYGILLLEIFT 369
                 V ++PPE ++ G  +   D +S+G+LL EIF+
Sbjct: 208 -----PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 165 IGSGSFGSVYKGTLADGET------AAIKVLK--LQQQGALKSFIDECNALTSIRHRNIL 216
           +G G+FG VY+G ++           A+K L     +Q  L  F+ E   ++   H+NI+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIV 123
Query: 217 KIVS-SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           + +  S  S+       + ++ E M  G+L  +L  +         L+++  L++  D+A
Sbjct: 124 RCIGVSLQSLP------RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 177
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
               YL   +     H D+ + N LL     G +A +GDFG+A+ ++  S        M 
Sbjct: 178 CGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 234
Query: 333 NGLKGSVGYIPPE-YINGHVSILGDIYSYGILLLEIFT 369
                 V ++PPE ++ G  +   D +S+G+LL EIF+
Sbjct: 235 -----PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 165 IGSGSFGSVYKGTLADGET------AAIKVLK--LQQQGALKSFIDECNALTSIRHRNIL 216
           +G G+FG VY+G ++           A+K L     +Q  L  F+ E   ++   H+NI+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIV 97
Query: 217 KIVS-SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           + +  S  S+       + ++ E M  G+L  +L  +         L+++  L++  D+A
Sbjct: 98  RCIGVSLQSLP------RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
               YL   +     H D+ + N LL     G +A +GDFG+A+ ++  S        M 
Sbjct: 152 CGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 208
Query: 333 NGLKGSVGYIPPE-YINGHVSILGDIYSYGILLLEIFT 369
                 V ++PPE ++ G  +   D +S+G+LL EIF+
Sbjct: 209 -----PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 114/242 (47%), Gaps = 29/242 (11%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL-----KSFIDE 203
           L+I   T+ F +  ++GSG+FG+VYKG  + +GE   I V   + + A      K  +DE
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              + S+ + ++ +++  C +   +      L+ + M  G L  ++    D       + 
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKD------NIG 117
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
               LN  + +A  ++YL    D  + H DL + NVL+       + DFGLAK L  E  
Sbjct: 118 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-- 172
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDD 381
              + +  + G K  + ++  E I   + +   D++SYG+ + E+ T G +P D +   +
Sbjct: 173 ---EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229
Query: 382 LS 383
           +S
Sbjct: 230 IS 231

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 114/242 (47%), Gaps = 29/242 (11%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL-----KSFIDE 203
           L+I   T+ F +  ++GSG+FG+VYKG  + +GE   I V   + + A      K  +DE
Sbjct: 12  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 70
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              + S+ + ++ +++  C +   +      L+ + M  G L  ++    D       + 
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKD------NIG 118
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
               LN  + +A  ++YL    D  + H DL + NVL+       + DFGLAK L  E  
Sbjct: 119 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-- 173
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDD 381
              + +  + G K  + ++  E I   + +   D++SYG+ + E+ T G +P D +   +
Sbjct: 174 ---EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 230
Query: 382 LS 383
           +S
Sbjct: 231 IS 232

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 165 IGSGSFGSVYKGTLADGET------AAIKVLK--LQQQGALKSFIDECNALTSIRHRNIL 216
           +G G+FG VY+G ++           A+K L     +Q  L  F+ E   ++   H+NI+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIV 113
Query: 217 KIVS-SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           + +  S  S+       + ++ E M  G+L  +L  +         L+++  L++  D+A
Sbjct: 114 RCIGVSLQSLP------RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 167
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
               YL   +     H D+ + N LL     G +A +GDFG+A+ ++  S        M 
Sbjct: 168 CGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 224
Query: 333 NGLKGSVGYIPPE-YINGHVSILGDIYSYGILLLEIFT 369
                 V ++PPE ++ G  +   D +S+G+LL EIF+
Sbjct: 225 -----PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 114/242 (47%), Gaps = 29/242 (11%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL-----KSFIDE 203
           L+I   T+ F +  ++GSG+FG+VYKG  + +GE   I V   + + A      K  +DE
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              + S+ + ++ +++  C +   +      L+ + M  G L  ++    D       + 
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD------NIG 115
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
               LN  + +A  ++YL    D  + H DL + NVL+       + DFGLAK L  E  
Sbjct: 116 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-- 170
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDD 381
              + +  + G K  + ++  E I   + +   D++SYG+ + E+ T G +P D +   +
Sbjct: 171 ---EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
Query: 382 LS 383
           +S
Sbjct: 228 IS 229

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 27/215 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKS--FIDECNALTSIRHRNILKIVSSC 222
           +GSG FG V  G        A+K++K   +G++    F  E   +  + H  ++K    C
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           S  +Y       +V E++ NG L  +L        H K L   Q L +  DV   + +L 
Sbjct: 73  SK-EYP----IYIVTEYISNGCLLNYLRS------HGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
           +       H DL + N L+D  +   V DFG+ +++ ++          S G K  V + 
Sbjct: 122 SH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS------SVGTKFPVKWS 172
Query: 343 PPEYING-HVSILGDIYSYGILLLEIFT-GKRPTD 375
            PE  +    S   D++++GIL+ E+F+ GK P D
Sbjct: 173 APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYD 207

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 114/242 (47%), Gaps = 29/242 (11%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL-----KSFIDE 203
           L+I   T+ F +  ++GSG+FG+VYKG  + +GE   I V   + + A      K  +DE
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              + S+ + ++ +++  C +   +      L+ + M  G L  ++    D       + 
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGXLLDYVREHKD------NIG 115
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
               LN  + +A  ++YL    D  + H DL + NVL+       + DFGLAK L  E  
Sbjct: 116 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-- 170
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDD 381
              + +  + G K  + ++  E I   + +   D++SYG+ + E+ T G +P D +   +
Sbjct: 171 ---EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
Query: 382 LS 383
           +S
Sbjct: 228 IS 229

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 165 IGSGSFGSVYKGTLADGET------AAIKVLK--LQQQGALKSFIDECNALTSIRHRNIL 216
           +G G+FG VY+G ++           A+K L     +Q  L  F+ E   ++   H+NI+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIV 111
Query: 217 KIVS-SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           + +  S  S+       + ++ E M  G+L  +L  +         L+++  L++  D+A
Sbjct: 112 RCIGVSLQSLP------RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
               YL   +     H D+ + N LL     G +A +GDFG+A+ ++  S        M 
Sbjct: 166 CGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 222
Query: 333 NGLKGSVGYIPPE-YINGHVSILGDIYSYGILLLEIFT 369
                 V ++PPE ++ G  +   D +S+G+LL EIF+
Sbjct: 223 -----PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 165 IGSGSFGSVYKGTLADGET------AAIKVLK--LQQQGALKSFIDECNALTSIRHRNIL 216
           +G G+FG VY+G ++           A+K L     +Q  L  F+ E   ++   H+NI+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDEL-DFLMEALIISKFNHQNIV 111
Query: 217 KIVS-SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           + +  S  S+       + ++ E M  G+L  +L  +         L+++  L++  D+A
Sbjct: 112 RCIGVSLQSLP------RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
               YL   +     H D+ + N LL     G +A +GDFG+A+ ++  S        M 
Sbjct: 166 CGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 222
Query: 333 NGLKGSVGYIPPE-YINGHVSILGDIYSYGILLLEIFT 369
                 V ++PPE ++ G  +   D +S+G+LL EIF+
Sbjct: 223 -----PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 114/242 (47%), Gaps = 29/242 (11%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL-----KSFIDE 203
           L+I   T+ F +  ++GSG+FG+VYKG  + +GE   I V   + + A      K  +DE
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              + S+ + ++ +++  C +   +      L+ + M  G L  ++    D       + 
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD------NIG 115
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
               LN  + +A  ++YL    D  + H DL + NVL+       + DFGLAK L  E  
Sbjct: 116 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-- 170
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDD 381
              + +  + G K  + ++  E I   + +   D++SYG+ + E+ T G +P D +   +
Sbjct: 171 ---EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
Query: 382 LS 383
           +S
Sbjct: 228 IS 229

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 165 IGSGSFGSVYKGTLADGET------AAIKVLK--LQQQGALKSFIDECNALTSIRHRNIL 216
           +G G+FG VY+G ++           A+K L     +Q  L  F+ E   ++   H+NI+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIV 97
Query: 217 KIVS-SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           + +  S  S+       + ++ E M  G+L  +L  +         L+++  L++  D+A
Sbjct: 98  RCIGVSLQSLP------RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
               YL   +     H D+ + N LL     G +A +GDFG+A+ ++  S        M 
Sbjct: 152 CGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAML 208
Query: 333 NGLKGSVGYIPPE-YINGHVSILGDIYSYGILLLEIFT 369
                 V ++PPE ++ G  +   D +S+G+LL EIF+
Sbjct: 209 -----PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 114/242 (47%), Gaps = 29/242 (11%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL-----KSFIDE 203
           L+I   T+ F +  ++GSG+FG+VYKG  + +GE   I V   + + A      K  +DE
Sbjct: 19  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 77
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              + S+ + ++ +++  C +   +      L+ + M  G L  ++    D       + 
Sbjct: 78  AYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD------NIG 125
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
               LN  + +A  ++YL    D  + H DL + NVL+       + DFGLAK L  E  
Sbjct: 126 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-- 180
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDD 381
              + +  + G K  + ++  E I   + +   D++SYG+ + E+ T G +P D +   +
Sbjct: 181 ---EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 237
Query: 382 LS 383
           +S
Sbjct: 238 IS 239

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 27/211 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSS 224
           IG G FG V  G    G   A+K +K       ++F+ E + +T +RH N+++++     
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI-- 255
Query: 225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ 284
           V+ +G  +  +V E+M  G+L  +L            L     L   +DV  A++YL   
Sbjct: 256 VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEYLEGN 308
Query: 285 YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
                 H DL + NVL+ E  +A V DFGL K   E S+T           K  V +  P
Sbjct: 309 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTG-------KLPVKWTAP 355
Query: 345 EYI-NGHVSILGDIYSYGILLLEIFT-GKRP 373
           E +     S   D++S+GILL EI++ G+ P
Sbjct: 356 EALREKKFSTKSDVWSFGILLWEIYSFGRVP 386

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 114/242 (47%), Gaps = 29/242 (11%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL-----KSFIDE 203
           L+I   T+ F +  ++GSG+FG+VYKG  + +GE   I V   + + A      K  +DE
Sbjct: 12  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 70
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              + S+ + ++ +++  C +   +      L+ + M  G L  ++    D       + 
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD------NIG 118
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
               LN  + +A  ++YL    D  + H DL + NVL+       + DFGLAK L  E  
Sbjct: 119 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-- 173
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDD 381
              + +  + G K  + ++  E I   + +   D++SYG+ + E+ T G +P D +   +
Sbjct: 174 ---EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 230
Query: 382 LS 383
           +S
Sbjct: 231 IS 232

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 104/236 (44%), Gaps = 44/236 (18%)
Query: 158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           +F E  ++G G+FG V K   A D    AIK ++  ++  L + + E   L S+ H+ ++
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLNHQYVV 65
Query: 217 K----------IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPST-----DEYCHFKK 261
           +           V   ++V  +   F  +  E+  NG L   +H        DEY    +
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLF--IQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 262 LSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK----- 316
                       +  AL Y+H+Q    I H DLK  N+ +DE     +GDFGLAK     
Sbjct: 124 -----------QILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 317 ---FLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEI 367
                 +  N P  +  +++ + G+  Y+  E ++  GH +   D+YS GI+  E+
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 109/226 (48%), Gaps = 36/226 (15%)
Query: 165 IGSGSFGSVYKG------TLADGETAAIKVLKLQQQGAL----KSFIDECNALTSIRHR- 213
           +G G+FG V +         A   T A+K+LK   +GA     ++ + E   L  I H  
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 93
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK---------LSL 264
           N++ ++ +C+     G     +V EF + GNL  +L    +E+  +K+         L+L
Sbjct: 94  NVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTL 149
Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNT 324
              +     VA  +++L ++      H DL + N+LL E  +  + DFGLA+ ++++ + 
Sbjct: 150 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 206
Query: 325 PSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
             K        +  + ++ PE I   V +I  D++S+G+LL EIF+
Sbjct: 207 VRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 114/242 (47%), Gaps = 29/242 (11%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL-----KSFIDE 203
           L+I   T+ F +  ++GSG+FG+VYKG  + +GE   I V   + + A      K  +DE
Sbjct: 15  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 73
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              + S+ + ++ +++  C +   +      L+ + M  G L  ++    D       + 
Sbjct: 74  AYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD------NIG 121
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
               LN  + +A  ++YL    D  + H DL + NVL+       + DFGLAK L  E  
Sbjct: 122 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-- 176
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDD 381
              + +  + G K  + ++  E I   + +   D++SYG+ + E+ T G +P D +   +
Sbjct: 177 ---EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 233
Query: 382 LS 383
           +S
Sbjct: 234 IS 235

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 114/242 (47%), Gaps = 29/242 (11%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL-----KSFIDE 203
           L+I   T+ F +  ++GSG+FG+VYKG  + +GE   I V   + + A      K  +DE
Sbjct: 12  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 70
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              + S+ + ++ +++  C +   +      L+ + M  G L  ++    D       + 
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD------NIG 118
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
               LN  + +A  ++YL    D  + H DL + NVL+       + DFGLAK L  E  
Sbjct: 119 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-- 173
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDD 381
              + +  + G K  + ++  E I   + +   D++SYG+ + E+ T G +P D +   +
Sbjct: 174 ---EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 230
Query: 382 LS 383
           +S
Sbjct: 231 IS 232

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 114/242 (47%), Gaps = 29/242 (11%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL-----KSFIDE 203
           L+I   T+ F +  ++GSG+FG+VYKG  + +GE   I V   + + A      K  +DE
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              + S+ + ++ +++  C +   +      L+ + M  G L  ++    D       + 
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD------NIG 117
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
               LN  + +A  ++YL    D  + H DL + NVL+       + DFGLAK L  E  
Sbjct: 118 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-- 172
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDD 381
              + +  + G K  + ++  E I   + +   D++SYG+ + E+ T G +P D +   +
Sbjct: 173 ---EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229
Query: 382 LS 383
           +S
Sbjct: 230 IS 231

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 114/242 (47%), Gaps = 29/242 (11%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL-----KSFIDE 203
           L+I   T+ F +  ++GSG+FG+VYKG  + +GE   I V   + + A      K  +DE
Sbjct: 12  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 70
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              + S+ + ++ +++  C +   +      L+ + M  G L  ++    D       + 
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD------NIG 118
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
               LN  + +A  ++YL    D  + H DL + NVL+       + DFGLAK L  E  
Sbjct: 119 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-- 173
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDD 381
              + +  + G K  + ++  E I   + +   D++SYG+ + E+ T G +P D +   +
Sbjct: 174 ---EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 230
Query: 382 LS 383
           +S
Sbjct: 231 IS 232

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 114/242 (47%), Gaps = 29/242 (11%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL-----KSFIDE 203
           L+I   T+ F +  ++GSG+FG+VYKG  + +GE   I V   + + A      K  +DE
Sbjct: 16  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 74
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              + S+ + ++ +++  C +   +      L+ + M  G L  ++    D       + 
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD------NIG 122
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
               LN  + +A  ++YL    D  + H DL + NVL+       + DFGLAK L  E  
Sbjct: 123 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-- 177
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDD 381
              + +  + G K  + ++  E I   + +   D++SYG+ + E+ T G +P D +   +
Sbjct: 178 ---EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 234
Query: 382 LS 383
           +S
Sbjct: 235 IS 236

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 114/242 (47%), Gaps = 29/242 (11%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL-----KSFIDE 203
           L+I   T+ F +  ++GSG+FG+VYKG  + +GE   I V   + + A      K  +DE
Sbjct: 3   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              + S+ + ++ +++  C +   +      L+ + M  G L  ++    D       + 
Sbjct: 62  AYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD------NIG 109
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
               LN  + +A  ++YL    D  + H DL + NVL+       + DFGLAK L  E  
Sbjct: 110 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-- 164
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDD 381
              + +  + G K  + ++  E I   + +   D++SYG+ + E+ T G +P D +   +
Sbjct: 165 ---EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221
Query: 382 LS 383
           +S
Sbjct: 222 IS 223

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/242 (23%), Positives = 110/242 (45%), Gaps = 43/242 (17%)
Query: 158 NFSEENLI-----GSGSFGSVYKGTL------ADGETAAIKVLKLQQQGA-LKSFIDECN 205
            F  +NL+     G G FG V K T       A   T A+K+LK     + L+  + E N
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 206 ALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTD----------- 254
            L  + H +++K+  +CS      +    L+ E+ + G+L  +L  S             
Sbjct: 79  VLKQVNHPHVIKLYGACSQ-----DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 255 ------EYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH 308
                 ++   + L++   ++    ++  + YL    +  + H DL + N+L+ EG    
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMK 190
Query: 309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEI 367
           + DFGL++ ++EE +   ++Q      +  V ++  E +  H+ +   D++S+G+LL EI
Sbjct: 191 ISDFGLSRDVYEEDSXVKRSQG-----RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 368 FT 369
            T
Sbjct: 246 VT 247

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/242 (23%), Positives = 110/242 (45%), Gaps = 43/242 (17%)
Query: 158 NFSEENLI-----GSGSFGSVYKGTL------ADGETAAIKVLKLQQQGA-LKSFIDECN 205
            F  +NL+     G G FG V K T       A   T A+K+LK     + L+  + E N
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 206 ALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTD----------- 254
            L  + H +++K+  +CS      +    L+ E+ + G+L  +L  S             
Sbjct: 79  VLKQVNHPHVIKLYGACSQ-----DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 255 ------EYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH 308
                 ++   + L++   ++    ++  + YL    +  + H DL + N+L+ EG    
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMSLVHRDLAARNILVAEGRKMK 190
Query: 309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEI 367
           + DFGL++ ++EE +   ++Q      +  V ++  E +  H+ +   D++S+G+LL EI
Sbjct: 191 ISDFGLSRDVYEEDSXVKRSQG-----RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 368 FT 369
            T
Sbjct: 246 VT 247

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 116/236 (49%), Gaps = 32/236 (13%)
Query: 151 KISNATDNFSEENLIGSGSFGSVYKGTL---ADGE---TAAIKVLKLQQQGALKS-FIDE 203
           +IS +   F EE  +G   FG VYKG L   A GE     AIK LK + +G L+  F  E
Sbjct: 22  EISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 79
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWL-----HP---STDE 255
                 ++H N++ ++   +      +   +++F +  +G+L ++L     H    STD+
Sbjct: 80  AMLRARLQHPNVVCLLGVVTK-----DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDD 134
Query: 256 YCHFKK-LSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL 314
               K  L     +++V  +A+ ++YL + +   + H DL + NVL+ + +   + D GL
Sbjct: 135 DRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGL 191
Query: 315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT 369
               F E       + + N L   + ++ PE I  G  SI  DI+SYG++L E+F+
Sbjct: 192 ----FREVYAADYYKLLGNSLL-PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 107/238 (44%), Gaps = 27/238 (11%)
Query: 152 ISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVL---KLQQQGALKSFIDECNAL 207
           I    ++F   NL+G GSF  VY+  ++  G   AIK++    + + G ++   +E    
Sbjct: 6   IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 208 TSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQR 267
             ++H +IL++ +      +E +++  LV E   NG ++++L      +   +    M +
Sbjct: 66  CQLKHPSILELYNY-----FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ 120
Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
                 + + + YLH+     I H DL  SN+LL   M   + DFGLA  L      P +
Sbjct: 121 ------IITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQL----KMPHE 167
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSIL-GDIYSYGILLLEIFTGKRPTD-DMFKDDLS 383
                  L G+  YI PE        L  D++S G +   +  G+ P D D  K+ L+
Sbjct: 168 KHYT---LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN 222

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 34/224 (15%)
Query: 165 IGSGSFGSVYKG------TLADGETAAIKVLKLQQQGAL----KSFIDECNALTSIRHR- 213
           +G G+FG V +         A   T A+K+LK   +GA     ++ + E   L  I H  
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 93
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK-------LSLMQ 266
           N++ ++ +C+     G     +V EF + GNL  +L    +E+  +K        L+L  
Sbjct: 94  NVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEH 149
Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
            +     VA  +++L ++      H DL + N+LL E  +  + DFGLA+ + ++ +   
Sbjct: 150 LIXYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 206
Query: 327 KNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
           K        +  + ++ PE I   V +I  D++S+G+LL EIF+
Sbjct: 207 KGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 114/242 (47%), Gaps = 29/242 (11%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL-----KSFIDE 203
           L+I   T+ F +  ++GSG+FG+VYKG  + +GE   I V   + + A      K  +DE
Sbjct: 34  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 92
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              + S+ + ++ +++  C +   +      L+ + M  G L  ++    D       + 
Sbjct: 93  AYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD------NIG 140
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
               LN  + +A  ++YL    D  + H DL + NVL+       + DFGLAK L  E  
Sbjct: 141 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-- 195
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDD 381
              + +  + G K  + ++  E I   + +   D++SYG+ + E+ T G +P D +   +
Sbjct: 196 ---EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 252
Query: 382 LS 383
           +S
Sbjct: 253 IS 254

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 116/236 (49%), Gaps = 32/236 (13%)
Query: 151 KISNATDNFSEENLIGSGSFGSVYKGTL---ADGE---TAAIKVLKLQQQGALKS-FIDE 203
           +IS +   F EE  +G   FG VYKG L   A GE     AIK LK + +G L+  F  E
Sbjct: 5   EISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 62
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWL-----HP---STDE 255
                 ++H N++ ++   +      +   +++F +  +G+L ++L     H    STD+
Sbjct: 63  AMLRARLQHPNVVCLLGVVTK-----DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDD 117
Query: 256 YCHFKK-LSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL 314
               K  L     +++V  +A+ ++YL + +   + H DL + NVL+ + +   + D GL
Sbjct: 118 DRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGL 174
Query: 315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT 369
               F E       + + N L   + ++ PE I  G  SI  DI+SYG++L E+F+
Sbjct: 175 ----FREVYAADYYKLLGNSLL-PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 30/217 (13%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSI--RHRNILKIVSSC 222
           +G G +G V++G+   GE  A+K+   + +   KS+  E     ++  RH NIL  ++S 
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASD 71
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
            +  +       L+  +   G+L  +L  +T        L  +  L IV+ +AS L +LH
Sbjct: 72  MTSRHSSTQL-WLITHYHEMGSLYDYLQLTT--------LDTVSCLRIVLSIASGLAHLH 122
Query: 283 -----NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
                 Q    IAH DLKS N+L+ +     + D GLA      S + ++    +N   G
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM---HSQSTNQLDVGNNPRVG 179
Query: 338 SVGYIPPEYINGHVSI-------LGDIYSYGILLLEI 367
           +  Y+ PE ++  + +         DI+++G++L E+
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/242 (23%), Positives = 110/242 (45%), Gaps = 43/242 (17%)
Query: 158 NFSEENLI-----GSGSFGSVYKGTL------ADGETAAIKVLKLQQQGA-LKSFIDECN 205
            F  +NL+     G G FG V K T       A   T A+K+LK     + L+  + E N
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 206 ALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTD----------- 254
            L  + H +++K+  +CS      +    L+ E+ + G+L  +L  S             
Sbjct: 79  VLKQVNHPHVIKLYGACSQ-----DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 255 ------EYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH 308
                 ++   + L++   ++    ++  + YL    +  + H DL + N+L+ EG    
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMK 190
Query: 309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEI 367
           + DFGL++ ++EE +   ++Q      +  V ++  E +  H+ +   D++S+G+LL EI
Sbjct: 191 ISDFGLSRDVYEEDSYVKRSQG-----RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 368 FT 369
            T
Sbjct: 246 VT 247

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 108/226 (47%), Gaps = 36/226 (15%)
Query: 165 IGSGSFGSVYKG------TLADGETAAIKVLKLQQQGAL----KSFIDECNALTSIRHR- 213
           +G G+FG V +         A   T A+K+LK   +GA     ++ + E   L  I H  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 91
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK---------LSL 264
           N++ ++ +C+     G     +V EF + GNL  +L    +E+  +K          L+L
Sbjct: 92  NVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNT 324
              +     VA  +++L ++      H DL + N+LL E  +  + DFGLA+ ++++ + 
Sbjct: 148 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDX 204
Query: 325 PSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
             K        +  + ++ PE I   V +I  D++S+G+LL EIF+
Sbjct: 205 VRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 114/244 (46%), Gaps = 48/244 (19%)
Query: 168 GSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSS---CSS 224
           G FG V+K  L + E  A+K+  +Q + + ++   E  +L  ++H NIL+ + +    +S
Sbjct: 35  GRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEY-EVYSLPGMKHENILQFIGAEKRGTS 92
Query: 225 VDYEGNDFKALVFEFMRNGNLDQWLHP---STDEYCHFKKLSLMQRLNIVIDVASALDYL 281
           VD +      L+  F   G+L  +L     S +E CH           I   +A  L YL
Sbjct: 93  VDVD----LWLITAFHEKGSLSDFLKANVVSWNELCH-----------IAETMARGLAYL 137
Query: 282 H-------NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
           H       + +   I+H D+KS NVLL   + A + DFGLA   FE      K+   ++G
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA-LKFE----AGKSAGDTHG 192
Query: 335 LKGSVGYIPPEYINGHVSILG------DIYSYGILLLEIFT----GKRPTDDM---FKDD 381
             G+  Y+ PE + G ++         D+Y+ G++L E+ +       P D+    F+++
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252
Query: 382 LSIH 385
           +  H
Sbjct: 253 IGQH 256

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 101/218 (46%), Gaps = 28/218 (12%)
Query: 165 IGSGSFGSVYKGTLADGET------AAIKVLK--LQQQGALKSFIDECNALTSIRHRNIL 216
           +G G+FG VY+G ++           A+K L     +Q  L  F+ E   ++   H+NI+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIV 114
Query: 217 KIVS-SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           + +  S  S+       + ++ E M  G+L  +L  +         L+++  L++  D+A
Sbjct: 115 RCIGVSLQSLP------RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 168
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
               YL   +     H D+ + N LL     G +A +GDFG+A+ ++           M 
Sbjct: 169 CGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML 225
Query: 333 NGLKGSVGYIPPE-YINGHVSILGDIYSYGILLLEIFT 369
                 V ++PPE ++ G  +   D +S+G+LL EIF+
Sbjct: 226 -----PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 113/246 (45%), Gaps = 43/246 (17%)
Query: 165 IGSGSFGSVYKGTLADG-------ETAAIKVLKLQQQGALKS-FIDECNALTSIRHRNIL 216
           IG G+FG V++   A G          A+K+LK +    +++ F  E   +    + NI+
Sbjct: 55  IGEGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHP-STDEYCHF---------------- 259
           K++  C+           L+FE+M  G+L+++L   S    C                  
Sbjct: 114 KLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 260 KKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLF 319
             LS  ++L I   VA+ + YL  +      H DL + N L+ E M+  + DFGL++ ++
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY 225
Query: 320 EESNTPSKNQTMSNGLKG-SVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDD 376
                 S +   ++G     + ++PPE I     +   D+++YG++L EIF+ G +P   
Sbjct: 226 ------SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279
Query: 377 MFKDDL 382
           M  +++
Sbjct: 280 MAHEEV 285

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 30/217 (13%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSI--RHRNILKIVSSC 222
           +G G +G V++G+   GE  A+K+   + +   KS+  E     ++  RH NIL  ++S 
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASD 71
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
            +  +       L+  +   G+L  +L  +T        L  +  L IV+ +AS L +LH
Sbjct: 72  MTSRHSSTQL-WLITHYHEMGSLYDYLQLTT--------LDTVSCLRIVLSIASGLAHLH 122
Query: 283 -----NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
                 Q    IAH DLKS N+L+ +     + D GLA      S + ++    +N   G
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM---HSQSTNQLDVGNNPRVG 179
Query: 338 SVGYIPPEYINGHVSI-------LGDIYSYGILLLEI 367
           +  Y+ PE ++  + +         DI+++G++L E+
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 101/218 (46%), Gaps = 28/218 (12%)
Query: 165 IGSGSFGSVYKGTLADGET------AAIKVLK--LQQQGALKSFIDECNALTSIRHRNIL 216
           +G G+FG VY+G ++           A+K L     +Q  L  F+ E   ++   H+NI+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIV 137
Query: 217 KIVS-SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           + +  S  S+       + ++ E M  G+L  +L  +         L+++  L++  D+A
Sbjct: 138 RCIGVSLQSLP------RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
               YL   +     H D+ + N LL     G +A +GDFG+A+ ++           M 
Sbjct: 192 CGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML 248
Query: 333 NGLKGSVGYIPPE-YINGHVSILGDIYSYGILLLEIFT 369
                 V ++PPE ++ G  +   D +S+G+LL EIF+
Sbjct: 249 -----PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 108/226 (47%), Gaps = 36/226 (15%)
Query: 165 IGSGSFGSVYKG------TLADGETAAIKVLKLQQQGAL----KSFIDECNALTSIRHR- 213
           +G G+FG V +         A   T A+K+LK   +GA     ++ + E   L  I H  
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 128
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK---------LSL 264
           N++ ++ +C+     G     +V EF + GNL  +L    +E+  +K          L+L
Sbjct: 129 NVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 184
Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNT 324
              +     VA  +++L ++      H DL + N+LL E  +  + DFGLA+ ++++ + 
Sbjct: 185 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 241
Query: 325 PSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
             K        +  + ++ PE I   V +I  D++S+G+LL EIF+
Sbjct: 242 VRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 108/226 (47%), Gaps = 36/226 (15%)
Query: 165 IGSGSFGSVYKG------TLADGETAAIKVLKLQQQGAL----KSFIDECNALTSIRHR- 213
           +G G+FG V +         A   T A+K+LK   +GA     ++ + E   L  I H  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 91
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK---------LSL 264
           N++ ++ +C+     G     +V EF + GNL  +L    +E+  +K          L+L
Sbjct: 92  NVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNT 324
              +     VA  +++L ++      H DL + N+LL E  +  + DFGLA+ ++++ + 
Sbjct: 148 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 204
Query: 325 PSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
             K        +  + ++ PE I   V +I  D++S+G+LL EIF+
Sbjct: 205 VRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 113/242 (46%), Gaps = 29/242 (11%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL-----KSFIDE 203
           L+I   T+ F +  ++GSG+FG+VYKG  + +GE   I V   + + A      K  +DE
Sbjct: 13  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 71
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              + S+ + ++ +++  C +   +      L+ + M  G L  ++    D       + 
Sbjct: 72  AYVMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKD------NIG 119
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
               LN  + +A  ++YL    D  + H DL + NVL+       + DFG AK L  E  
Sbjct: 120 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE-- 174
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDD 381
              + +  + G K  + ++  E I   + +   D++SYG+ + E+ T G +P D +   +
Sbjct: 175 ---EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 231
Query: 382 LS 383
           +S
Sbjct: 232 IS 233

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 113/242 (46%), Gaps = 29/242 (11%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL-----KSFIDE 203
           L+I   T+ F +  ++GSG+FG+VYKG  + +GE   I V   + + A      K  +DE
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              + S+ + ++ +++  C +   +      L+ + M  G L  ++    D       + 
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKD------NIG 117
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
               LN  + +A  ++YL    D  + H DL + NVL+       + DFG AK L  E  
Sbjct: 118 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE-- 172
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDD 381
              + +  + G K  + ++  E I   + +   D++SYG+ + E+ T G +P D +   +
Sbjct: 173 ---EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229
Query: 382 LS 383
           +S
Sbjct: 230 IS 231

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 96/223 (43%), Gaps = 35/223 (15%)
Query: 163 NLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALK---SFIDECNALTSIRHRNILK- 217
           + +G G+FG V  G     G   A+K+L  Q+  +L        E   L   RH +I+K 
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 218 --IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
             ++S+ S +         +V E++  G L        D  C   +L   +   +   + 
Sbjct: 82  YQVISTPSDI--------FMVMEYVSGGEL-------FDYICKNGRLDEKESRRLFQQIL 126
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
           S +DY H      + H DLK  NVLLD  M A + DFGL       SN  S  + +    
Sbjct: 127 SGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGL-------SNMMSDGEFLRXSC 176
Query: 336 KGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDD 376
            GS  Y  PE I+G  +     DI+S G++L  +  G  P DD
Sbjct: 177 -GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 36/220 (16%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSI--RHRNILKIVSSC 222
           IG G +G V+ G    GE  A+KV    ++    S+  E     ++  RH NIL  +++ 
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFIAA- 99
Query: 223 SSVDYEGNDFKA---LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
              D +G        L+ ++  NG+L  +L  +T        L     L +     S L 
Sbjct: 100 ---DIKGTGSWTQLYLITDYHENGSLYDYLKSTT--------LDAKSMLKLAYSSVSGLC 148
Query: 280 YLHN-----QYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
           +LH      Q    IAH DLKS N+L+ +     + D GLA     ++N   +     N 
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN---EVDIPPNT 205
Query: 335 LKGSVGYIPPEYINGHVS-------ILGDIYSYGILLLEI 367
             G+  Y+PPE ++  ++       I+ D+YS+G++L E+
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 117/246 (47%), Gaps = 40/246 (16%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKGTLADGET-------AAIKVLKLQQQGALK-SFI 201
           LK     +N     ++GSG+FG V   T A G +        A+K+LK +   + + + +
Sbjct: 38  LKWEFPRENLEFGKVLGSGAFGKVMNAT-AYGISKTGVSIQVAVKMLKEKADSSEREALM 96
Query: 202 DECNALTSI-RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTD------ 254
            E   +T +  H NI+ ++ +C+     G  +  L+FE+   G+L  +L    +      
Sbjct: 97  SELKMMTQLGSHENIVNLLGACT---LSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDE 151
Query: 255 -EYCHFKKLSLMQRLNIVI---------DVASALDYLHNQYDTPIAHCDLKSSNVLLDEG 304
            EY + K+L   + LN++           VA  +++L  +      H DL + NVL+  G
Sbjct: 152 IEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHG 208
Query: 305 MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGIL 363
            +  + DFGLA+ +  +SN       +    +  V ++ PE +  G  +I  D++SYGIL
Sbjct: 209 KVVKICDFGLARDIMSDSNY-----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 263
Query: 364 LLEIFT 369
           L EIF+
Sbjct: 264 LWEIFS 269

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 113/242 (46%), Gaps = 29/242 (11%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL-----KSFIDE 203
           L+I   T+ F +  ++ SG+FG+VYKG  + +GE   I V   + + A      K  +DE
Sbjct: 16  LRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 74
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              + S+ + ++ +++  C +   +      L+ + M  G L  ++    D       + 
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKD------NIG 122
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
               LN  + +A  ++YL    D  + H DL + NVL+       + DFGLAK L  E  
Sbjct: 123 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-- 177
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDD 381
              + +  + G K  + ++  E I   + +   D++SYG+ + E+ T G +P D +   +
Sbjct: 178 ---EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 234
Query: 382 LS 383
           +S
Sbjct: 235 IS 236

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 113/242 (46%), Gaps = 29/242 (11%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL-----KSFIDE 203
           L+I   T+ F +  ++GSG+FG+VYKG  + +GE   I V   + + A      K  +DE
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              + S+ + ++ +++  C +   +      L+ + M  G L  ++    D       + 
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKD------NIG 117
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
               LN  + +A  ++YL    D  + H DL + NVL+       + DFG AK L  E  
Sbjct: 118 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE-- 172
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDD 381
              + +  + G K  + ++  E I   + +   D++SYG+ + E+ T G +P D +   +
Sbjct: 173 ---EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229
Query: 382 LS 383
           +S
Sbjct: 230 IS 231

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 107/225 (47%), Gaps = 35/225 (15%)
Query: 165 IGSGSFGSVYKG------TLADGETAAIKVLKLQQQGAL----KSFIDECNALTSIRHR- 213
           +G G+FG V +         A   T A+K+LK   +GA     ++ + E   L  I H  
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 92
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK--------LSLM 265
           N++ ++ +C+     G     +V EF + GNL  +L    +E+  +K         L+L 
Sbjct: 93  NVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLE 148
Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
             +     VA  +++L ++      H DL + N+LL E  +  + DFGLA+ + ++ +  
Sbjct: 149 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 205
Query: 326 SKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
            K        +  + ++ PE I   V +I  D++S+G+LL EIF+
Sbjct: 206 RKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 113/242 (46%), Gaps = 29/242 (11%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL-----KSFIDE 203
           L+I   T+ F +  ++GSG+FG+VYKG  + +GE   I V   + + A      K  +DE
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              + S+ + ++ +++  C +   +      L+ + M  G L  ++    D       + 
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD------NIG 115
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
               LN  + +A  ++YL    D  + H DL + NVL+       + DFG AK L  E  
Sbjct: 116 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE-- 170
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDD 381
              + +  + G K  + ++  E I   + +   D++SYG+ + E+ T G +P D +   +
Sbjct: 171 ---EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
Query: 382 LS 383
           +S
Sbjct: 228 IS 229

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 122/265 (46%), Gaps = 29/265 (10%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL-----KSFIDE 203
           L+I   T+ F +  ++GSG+FG+VYKG  + +GE   I V   + + A      K  +DE
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              + S+ + ++ +++  C +   +      L+ + M  G L  ++    D       + 
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD------NIG 117
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
               LN  + +A  ++YL    D  + H DL + NVL+       + DFG AK L  E  
Sbjct: 118 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE-- 172
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDD 381
              + +  + G K  + ++  E I   + +   D++SYG+ + E+ T G +P D +   +
Sbjct: 173 ---EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229
Query: 382 LSIHKFVLMALPSHVMDVLDLSMLL 406
           +S        LP   +  +D+ M++
Sbjct: 230 ISSILEKGERLPQPPICTIDVYMIM 254

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 113/242 (46%), Gaps = 29/242 (11%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL-----KSFIDE 203
           L+I   T+ F +  ++GSG+FG+VYKG  + +GE   I V   + + A      K  +DE
Sbjct: 16  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 74
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              + S+ + ++ +++  C +   +      L+ + M  G L  ++    D       + 
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD------NIG 122
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
               LN  + +A  ++YL    D  + H DL + NVL+       + DFG AK L  E  
Sbjct: 123 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE-- 177
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDD 381
              + +  + G K  + ++  E I   + +   D++SYG+ + E+ T G +P D +   +
Sbjct: 178 ---EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 234
Query: 382 LS 383
           +S
Sbjct: 235 IS 236

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 113/228 (49%), Gaps = 39/228 (17%)
Query: 158 NFSEENLIGSGSFGSVY---KGTLAD-GETAAIKVLK---LQQQGALKSFIDECNALTSI 210
           +F    ++G GSFG V+   K T  D G   A+KVLK   L+ +  +++ + E + L  +
Sbjct: 29  HFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKM-ERDILADV 87
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPS---TDEYCHFKKLSLMQR 267
            H  ++K+  +  +   EG  +  L+ +F+R G+L   L      T+E   F        
Sbjct: 88  NHPFVVKLHYAFQT---EGKLY--LILDFLRGGDLFTRLSKEVMFTEEDVKF-------- 134
Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
              + ++A  LD+LH+     I + DLK  N+LLDE     + DFGL+K   +       
Sbjct: 135 --YLAELALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAID------- 182
Query: 328 NQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRP 373
           ++  +    G+V Y+ PE +N  GH S   D +SYG+L+ E+ TG  P
Sbjct: 183 HEKKAYSFCGTVEYMAPEVVNRQGH-SHSADWWSYGVLMFEMLTGSLP 229

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 113/242 (46%), Gaps = 29/242 (11%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL-----KSFIDE 203
           L+I   T+ F +  ++ SG+FG+VYKG  + +GE   I V   + + A      K  +DE
Sbjct: 9   LRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              + S+ + ++ +++  C +   +      L+ + M  G L  ++    D       + 
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD------NIG 115
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
               LN  + +A  ++YL    D  + H DL + NVL+       + DFGLAK L  E  
Sbjct: 116 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-- 170
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDD 381
              + +  + G K  + ++  E I   + +   D++SYG+ + E+ T G +P D +   +
Sbjct: 171 ---EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
Query: 382 LS 383
           +S
Sbjct: 228 IS 229

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 108/226 (47%), Gaps = 36/226 (15%)
Query: 165 IGSGSFGSVYKG------TLADGETAAIKVLKLQQQGAL----KSFIDECNALTSIRHR- 213
           +G G+FG V +         A   T A+K+LK   +GA     ++ + E   L  I H  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 82
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK---------LSL 264
           N++ ++ +C+     G     ++ EF + GNL  +L    +E+  +K          L+L
Sbjct: 83  NVVNLLGACTK---PGGPL-MVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 138
Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNT 324
              +     VA  +++L ++      H DL + N+LL E  +  + DFGLA+ ++++ + 
Sbjct: 139 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 195
Query: 325 PSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
             K        +  + ++ PE I   V +I  D++S+G+LL EIF+
Sbjct: 196 VRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 109/225 (48%), Gaps = 33/225 (14%)
Query: 165 IGSGSFGSVY--------KGTLADGETAAIKVLKLQ-QQGALKSFIDECNALTSI-RHRN 214
           +G G+FG V         K    +  T A+K+LK    +  L   + E   +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCH------FKKLSLM 265
           I+ ++ +C+    +G  +  ++ E+   GNL ++L    P   EY +       ++++  
Sbjct: 103 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
             ++    +A  ++YL +Q      H DL + NVL+ E  +  + DFGLA+    + N  
Sbjct: 158 DLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLAR----DINNI 210
Query: 326 SKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
              +  +NG +  V ++ PE +   V +   D++S+G+L+ EIFT
Sbjct: 211 DXXKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 113/242 (46%), Gaps = 29/242 (11%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL-----KSFIDE 203
           L+I   T+ F +  ++ SG+FG+VYKG  + +GE   I V   + + A      K  +DE
Sbjct: 16  LRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 74
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              + S+ + ++ +++  C +   +      L+ + M  G L  ++    D       + 
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD------NIG 122
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
               LN  + +A  ++YL    D  + H DL + NVL+       + DFGLAK L  E  
Sbjct: 123 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-- 177
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDD 381
              + +  + G K  + ++  E I   + +   D++SYG+ + E+ T G +P D +   +
Sbjct: 178 ---EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 234
Query: 382 LS 383
           +S
Sbjct: 235 IS 236

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 107/226 (47%), Gaps = 36/226 (15%)
Query: 165 IGSGSFGSVYKG------TLADGETAAIKVLKLQQQGAL----KSFIDECNALTSIRHR- 213
           +G G+FG V +         A   T A+K+LK   +GA     ++ + E   L  I H  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 91
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK---------LSL 264
           N++ ++ +C+     G     +V EF + GNL  +L    +E+  +K          L+L
Sbjct: 92  NVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNT 324
              +     VA  +++L ++      H DL + N+LL E  +  + DFGLA+ + ++ + 
Sbjct: 148 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 325 PSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
             K        +  + ++ PE I   V +I  D++S+G+LL EIF+
Sbjct: 205 VRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 108/226 (47%), Gaps = 36/226 (15%)
Query: 165 IGSGSFGSVYKG------TLADGETAAIKVLKLQQQGAL----KSFIDECNALTSIRHR- 213
           +G G+FG V +         A   T A+K+LK   +GA     ++ + E   L  I H  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 82
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK---------LSL 264
           N++ ++ +C+     G     ++ EF + GNL  +L    +E+  +K          L+L
Sbjct: 83  NVVNLLGACTK---PGGPL-MVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 138
Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNT 324
              +     VA  +++L ++      H DL + N+LL E  +  + DFGLA+ ++++ + 
Sbjct: 139 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 195
Query: 325 PSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
             K        +  + ++ PE I   V +I  D++S+G+LL EIF+
Sbjct: 196 VRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 107/226 (47%), Gaps = 36/226 (15%)
Query: 165 IGSGSFGSVYKG------TLADGETAAIKVLKLQQQGAL----KSFIDECNALTSIRHR- 213
           +G G+FG V +         A   T A+K+LK   +GA     ++ + E   L  I H  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 82
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK---------LSL 264
           N++ ++ +C+     G     +V EF + GNL  +L    +E+  +K          L+L
Sbjct: 83  NVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 138
Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNT 324
              +     VA  +++L ++      H DL + N+LL E  +  + DFGLA+ + ++ + 
Sbjct: 139 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 195
Query: 325 PSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
             K        +  + ++ PE I   V +I  D++S+G+LL EIF+
Sbjct: 196 VRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 103/236 (43%), Gaps = 44/236 (18%)
Query: 158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           +F E  ++G G+FG V K   A D    AIK ++  ++  L + + E   L S+ H+ ++
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLNHQYVV 65
Query: 217 K----------IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPST-----DEYCHFKK 261
           +           V   ++V  +   F  +  E+  N  L   +H        DEY    +
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLF--IQMEYCENRTLYDLIHSENLNQQRDEYWRLFR 123
Query: 262 LSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK----- 316
                       +  AL Y+H+Q    I H DLK  N+ +DE     +GDFGLAK     
Sbjct: 124 -----------QILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 317 ---FLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEI 367
                 +  N P  +  +++ + G+  Y+  E ++  GH +   D+YS GI+  E+
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 105/225 (46%), Gaps = 22/225 (9%)
Query: 158 NFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL-QQQGALKSFIDECNALTSIRHRNI 215
           +F     +G G FG V++     D    AIK ++L  ++ A +  + E  AL  + H  I
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 216 LKIVSSC----SSVDYEGNDFKALVF---EFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
           ++  ++     ++   + +  K  ++   +  R  NL  W++      C  ++      L
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR----CTIEERERSVCL 121
Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN----- 323
           +I + +A A+++LH++    + H DLK SN+      +  VGDFGL   + ++       
Sbjct: 122 HIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEI 367
           TP        G  G+  Y+ PE I+G+  S   DI+S G++L E+
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 109/225 (48%), Gaps = 33/225 (14%)
Query: 165 IGSGSFGSVY--------KGTLADGETAAIKVLKLQ-QQGALKSFIDECNALTSI-RHRN 214
           +G G+FG V         K    +  T A+K+LK    +  L   + E   +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCH------FKKLSLM 265
           I+ ++ +C+    +G  +  ++ E+   GNL ++L    P   EY +       ++++  
Sbjct: 103 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
             ++    +A  ++YL +Q      H DL + NVL+ E  +  + DFGLA+    + N  
Sbjct: 158 DLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLAR----DINNI 210
Query: 326 SKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
              +  +NG +  V ++ PE +   V +   D++S+G+L+ EIFT
Sbjct: 211 DYYKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 109/223 (48%), Gaps = 39/223 (17%)
Query: 163 NLIGSGSFGSVYKGTLADGETA----AIKVLK---LQQQGALKSFIDECNALTSIRHRNI 215
            ++G GSFG V+      G  A    A+KVLK   L+ +  +++ + E + L  + H  I
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVNHPFI 88
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPS---TDEYCHFKKLSLMQRLNIVI 272
           +K+  +  +   EG  +  L+ +F+R G+L   L      T+E   F           + 
Sbjct: 89  VKLHYAFQT---EGKLY--LILDFLRGGDLFTRLSKEVMFTEEDVKF----------YLA 133
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           ++A ALD+LH+     I + DLK  N+LLDE     + DFGL+K    ES    K    +
Sbjct: 134 ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKK---A 183
Query: 333 NGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRP 373
               G+V Y+ PE +N  GH     D +S+G+L+ E+ TG  P
Sbjct: 184 YSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLP 225

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 109/223 (48%), Gaps = 39/223 (17%)
Query: 163 NLIGSGSFGSVYKGTLADGETA----AIKVLK---LQQQGALKSFIDECNALTSIRHRNI 215
            ++G GSFG V+      G  A    A+KVLK   L+ +  +++ + E + L  + H  I
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVNHPFI 89
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPS---TDEYCHFKKLSLMQRLNIVI 272
           +K+  +  +   EG  +  L+ +F+R G+L   L      T+E   F           + 
Sbjct: 90  VKLHYAFQT---EGKLY--LILDFLRGGDLFTRLSKEVMFTEEDVKF----------YLA 134
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           ++A ALD+LH+     I + DLK  N+LLDE     + DFGL+K    ES    K    +
Sbjct: 135 ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKK---A 184
Query: 333 NGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRP 373
               G+V Y+ PE +N  GH     D +S+G+L+ E+ TG  P
Sbjct: 185 YSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLP 226

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 26/218 (11%)
Query: 165 IGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           +G+G FG V +    D GE  AIK  + +Q+ + K+    C  +  ++  N   +VS+  
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIK--QCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 224 SVD----YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
             D       ND   L  E+   G+L ++L+   +  C  K+  +     ++ D++SAL 
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIR---TLLSDISSALR 135
Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEG---MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
           YLH   +  I H DLK  N++L  G   +I  + D G AK L +          +     
Sbjct: 136 YLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--------LCTEFV 184
Query: 337 GSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRP 373
           G++ Y+ PE +     ++  D +S+G L  E  TG RP
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 109/225 (48%), Gaps = 33/225 (14%)
Query: 165 IGSGSFGSVY--------KGTLADGETAAIKVLKLQ-QQGALKSFIDECNALTSI-RHRN 214
           +G G+FG V         K    +  T A+K+LK    +  L   + E   +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCH------FKKLSLM 265
           I+ ++ +C+    +G  +  ++ E+   GNL ++L    P   EY +       ++++  
Sbjct: 103 IITLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
             ++    +A  ++YL +Q      H DL + NVL+ E  +  + DFGLA+    + N  
Sbjct: 158 DLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNI 210
Query: 326 SKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
              +  +NG +  V ++ PE +   V +   D++S+G+L+ EIFT
Sbjct: 211 DYYKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 26/218 (11%)
Query: 165 IGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           +G+G FG V +    D GE  AIK  + +Q+ + K+    C  +  ++  N   +VS+  
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIK--QCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 80
Query: 224 SVD----YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
             D       ND   L  E+   G+L ++L+   +  C  K+  +     ++ D++SAL 
Sbjct: 81  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIR---TLLSDISSALR 136
Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEG---MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
           YLH   +  I H DLK  N++L  G   +I  + D G AK L +          +     
Sbjct: 137 YLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--------LCTEFV 185
Query: 337 GSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRP 373
           G++ Y+ PE +     ++  D +S+G L  E  TG RP
Sbjct: 186 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 109/225 (48%), Gaps = 33/225 (14%)
Query: 165 IGSGSFGSVY--------KGTLADGETAAIKVLKLQ-QQGALKSFIDECNALTSI-RHRN 214
           +G G+FG V         K    +  T A+K+LK    +  L   + E   +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCH------FKKLSLM 265
           I+ ++ +C+    +G  +  ++ E+   GNL ++L    P   EY +       ++++  
Sbjct: 103 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
             ++    +A  ++YL +Q      H DL + NVL+ E  +  + DFGLA+    + N  
Sbjct: 158 DLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNI 210
Query: 326 SKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
              +  +NG +  V ++ PE +   V +   D++S+G+L+ EIFT
Sbjct: 211 DYYKNTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 109/223 (48%), Gaps = 39/223 (17%)
Query: 163 NLIGSGSFGSVYKGTLADGETA----AIKVLK---LQQQGALKSFIDECNALTSIRHRNI 215
            ++G GSFG V+      G  A    A+KVLK   L+ +  +++ + E + L  + H  I
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVNHPFI 88
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPS---TDEYCHFKKLSLMQRLNIVI 272
           +K+  +  +   EG  +  L+ +F+R G+L   L      T+E   F           + 
Sbjct: 89  VKLHYAFQT---EGKLY--LILDFLRGGDLFTRLSKEVMFTEEDVKF----------YLA 133
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           ++A ALD+LH+     I + DLK  N+LLDE     + DFGL+K    ES    K    +
Sbjct: 134 ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKK---A 183
Query: 333 NGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRP 373
               G+V Y+ PE +N  GH     D +S+G+L+ E+ TG  P
Sbjct: 184 YSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLP 225

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 108/225 (48%), Gaps = 33/225 (14%)
Query: 165 IGSGSFGSVY--------KGTLADGETAAIKVLKLQ-QQGALKSFIDECNALTSI-RHRN 214
           +G G FG V         K    +  T A+K+LK    +  L   + E   +  I +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCH------FKKLSLM 265
           I+ ++ +C+    +G  +  ++ E+   GNL ++L    P   EY +       ++++  
Sbjct: 149 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
             ++    +A  ++YL +Q      H DL + NVL+ E  +  + DFGLA+    + N  
Sbjct: 204 DLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLAR----DINNI 256
Query: 326 SKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
              +  +NG +  V ++ PE +   V +   D++S+G+L+ EIFT
Sbjct: 257 DYYKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 46/230 (20%)
Query: 168 GSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDY 227
           G FG V+K  L + +  A+K+  LQ + + +S   E  +   ++H N+L+ +++    + 
Sbjct: 26  GRFGCVWKAQLMN-DFVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAA----EK 79
Query: 228 EGNDFKA---LVFEFMRNGNLDQWLHP---STDEYCHFKKLSLMQRLNIVIDVASALDYL 281
            G++ +    L+  F   G+L  +L     + +E CH           +   ++  L YL
Sbjct: 80  RGSNLEVELWLITAFHDKGSLTDYLKGNIITWNELCH-----------VAETMSRGLSYL 128
Query: 282 HNQYDTP----------IAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
           H   D P          IAH D KS NVLL   + A + DFGLA   FE    P K    
Sbjct: 129 HE--DVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLA-VRFE----PGKPPGD 181
Query: 332 SNGLKGSVGYIPPEYINGHVSILG------DIYSYGILLLEIFTGKRPTD 375
           ++G  G+  Y+ PE + G ++         D+Y+ G++L E+ +  +  D
Sbjct: 182 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 109/225 (48%), Gaps = 33/225 (14%)
Query: 165 IGSGSFGSVY--------KGTLADGETAAIKVLKLQ-QQGALKSFIDECNALTSI-RHRN 214
           +G G+FG V         K    +  T A+K+LK    +  L   + E   +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCH------FKKLSLM 265
           I+ ++ +C+    +G  +  ++ E+   GNL ++L    P   EY +       ++++  
Sbjct: 103 IIHLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
             ++    +A  ++YL +Q      H DL + NVL+ E  +  + DFGLA+    + N  
Sbjct: 158 DLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNI 210
Query: 326 SKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
              +  +NG +  V ++ PE +   V +   D++S+G+L+ EIFT
Sbjct: 211 DYYKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 109/225 (48%), Gaps = 33/225 (14%)
Query: 165 IGSGSFGSVY--------KGTLADGETAAIKVLKLQ-QQGALKSFIDECNALTSI-RHRN 214
           +G G+FG V         K    +  T A+K+LK    +  L   + E   +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCH------FKKLSLM 265
           I+ ++ +C+    +G  +  ++ E+   GNL ++L    P   EY +       ++++  
Sbjct: 103 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
             ++    +A  ++YL +Q      H DL + NVL+ E  +  + DFGLA+    + N  
Sbjct: 158 DLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNI 210
Query: 326 SKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
              +  +NG +  V ++ PE +   V +   D++S+G+L+ EIFT
Sbjct: 211 DYYKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 107/226 (47%), Gaps = 36/226 (15%)
Query: 165 IGSGSFGSVYKG------TLADGETAAIKVLKLQQQGAL----KSFIDECNALTSIRHR- 213
           +G G+FG V +         A   T A+K+LK   +GA     ++ + E   L  I H  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 82
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK---------LSL 264
           N++ ++ +C+     G     ++ EF + GNL  +L    +E+  +K          L+L
Sbjct: 83  NVVNLLGACTK---PGGPL-MVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 138
Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNT 324
              +     VA  +++L ++      H DL + N+LL E  +  + DFGLA+ + ++ + 
Sbjct: 139 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 195
Query: 325 PSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
             K        +  + ++ PE I   V +I  D++S+G+LL EIF+
Sbjct: 196 VRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 108/225 (48%), Gaps = 33/225 (14%)
Query: 165 IGSGSFGSVY--------KGTLADGETAAIKVLKLQ-QQGALKSFIDECNALTSI-RHRN 214
           +G G FG V         K    +  T A+K+LK    +  L   + E   +  I +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCH------FKKLSLM 265
           I+ ++ +C+    +G  +  ++ E+   GNL ++L    P   EY +       ++++  
Sbjct: 90  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 144
Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
             ++    +A  ++YL +Q      H DL + NVL+ E  +  + DFGLA+    + N  
Sbjct: 145 DLVSCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLAR----DINNI 197
Query: 326 SKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
              +  +NG +  V ++ PE +   V +   D++S+G+L+ EIFT
Sbjct: 198 DYYKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           ++F    ++G GSF +V     LA     AIK+L+ +        I E       R R++
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDV 83
Query: 216 LKIVSSCSSVD--YEGNDFKALVF--EFMRNGNLDQWLHP--STDEYCHFKKLSLMQRLN 269
           +  +     V   +   D + L F   + +NG L +++    S DE C         R  
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC--------TRF- 134
Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
              ++ SAL+YLH +    I H DLK  N+LL+E M   + DFG AK L     +P   Q
Sbjct: 135 YTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL-----SPESKQ 186
Query: 330 TMSNGLKGSVGYIPPEYINGHVSIL-GDIYSYGILLLEIFTGKRP 373
             +N   G+  Y+ PE +    +    D+++ G ++ ++  G  P
Sbjct: 187 ARANAFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           ++F    ++G GSF +V     LA     AIK+L+ +        I E       R R++
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDV 63
Query: 216 LKIVSSCSSVD--YEGNDFKALVF--EFMRNGNLDQWLHP--STDEYCHFKKLSLMQRLN 269
           +  +     V   +   D + L F   + +NG L +++    S DE C         R  
Sbjct: 64  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC--------TRF- 114
Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
              ++ SAL+YLH +    I H DLK  N+LL+E M   + DFG AK L     +P   Q
Sbjct: 115 YTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL-----SPESKQ 166
Query: 330 TMSNGLKGSVGYIPPEYINGHVSIL-GDIYSYGILLLEIFTGKRP 373
             +N   G+  Y+ PE +    +    D+++ G ++ ++  G  P
Sbjct: 167 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 155 ATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNALTSI 210
           A ++F     +G G FG+VY       +   A+KVL   +L++ G       E    + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM--QRL 268
           RH NIL++        +       L+ E+   G +          Y   +KLS    QR 
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPRGEV----------YKELQKLSKFDEQRT 115
Query: 269 NIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
              I ++A+AL Y H++    + H D+K  N+LL       + DFG +       + PS 
Sbjct: 116 ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS------VHAPSS 166
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
            +T    L G++ Y+PPE I G +     D++S G+L  E   GK P
Sbjct: 167 RRTT---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           ++F    ++G GSF +V     LA     AIK+L+ +        I E       R R++
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDV 62
Query: 216 LKIVSSCSSVD--YEGNDFKALVF--EFMRNGNLDQWLHP--STDEYCHFKKLSLMQRLN 269
           +  +     V   +   D + L F   + +NG L +++    S DE C         R  
Sbjct: 63  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC--------TRF- 113
Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
              ++ SAL+YLH +    I H DLK  N+LL+E M   + DFG AK L     +P   Q
Sbjct: 114 YTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL-----SPESKQ 165
Query: 330 TMSNGLKGSVGYIPPEYINGHVSIL-GDIYSYGILLLEIFTGKRP 373
             +N   G+  Y+ PE +    +    D+++ G ++ ++  G  P
Sbjct: 166 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           ++F    ++G GSF +V     LA     AIK+L+ +        I E       R R++
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDV 82
Query: 216 LKIVSSCSSVD--YEGNDFKALVF--EFMRNGNLDQWLHP--STDEYCHFKKLSLMQRLN 269
           +  +     V   +   D + L F   + +NG L +++    S DE C         R  
Sbjct: 83  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC--------TRF- 133
Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
              ++ SAL+YLH +    I H DLK  N+LL+E M   + DFG AK L     +P   Q
Sbjct: 134 YTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL-----SPESKQ 185
Query: 330 TMSNGLKGSVGYIPPEYINGHVSIL-GDIYSYGILLLEIFTGKRP 373
             +N   G+  Y+ PE +    +    D+++ G ++ ++  G  P
Sbjct: 186 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           ++F    ++G GSF +V     LA     AIK+L+ +        I E       R R++
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDV 61
Query: 216 LKIVSSCSSVD--YEGNDFKALVF--EFMRNGNLDQWLHP--STDEYCHFKKLSLMQRLN 269
           +  +     V   +   D + L F   + +NG L +++    S DE C         R  
Sbjct: 62  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC--------TRF- 112
Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
              ++ SAL+YLH +    I H DLK  N+LL+E M   + DFG AK L     +P   Q
Sbjct: 113 YTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL-----SPESKQ 164
Query: 330 TMSNGLKGSVGYIPPEYINGHVSIL-GDIYSYGILLLEIFTGKRP 373
             +N   G+  Y+ PE +    +    D+++ G ++ ++  G  P
Sbjct: 165 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 108/225 (48%), Gaps = 33/225 (14%)
Query: 165 IGSGSFGSVY--------KGTLADGETAAIKVLKLQ-QQGALKSFIDECNALTSI-RHRN 214
           +G G FG V         K    +  T A+K+LK    +  L   + E   +  I +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCH------FKKLSLM 265
           I+ ++ +C+    +G  +  ++ E+   GNL ++L    P   EY +       ++++  
Sbjct: 95  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 149
Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
             ++    +A  ++YL +Q      H DL + NVL+ E  +  + DFGLA+    + N  
Sbjct: 150 DLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNI 202
Query: 326 SKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
              +  +NG +  V ++ PE +   V +   D++S+G+L+ EIFT
Sbjct: 203 DYYKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           ++F    ++G GSF +V     LA     AIK+L+ +        I E       R R++
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDV 60
Query: 216 LKIVSSCSSVD--YEGNDFKALVF--EFMRNGNLDQWLHP--STDEYCHFKKLSLMQRLN 269
           +  +     V   +   D + L F   + +NG L +++    S DE C         R  
Sbjct: 61  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC--------TRF- 111
Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
              ++ SAL+YLH +    I H DLK  N+LL+E M   + DFG AK L     +P   Q
Sbjct: 112 YTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL-----SPESKQ 163
Query: 330 TMSNGLKGSVGYIPPEYINGHVSIL-GDIYSYGILLLEIFTGKRP 373
             +N   G+  Y+ PE +    +    D+++ G ++ ++  G  P
Sbjct: 164 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 155 ATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNALTSI 210
           A ++F     +G G FG+VY       +   A+KVL   +L++ G       E    + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM--QRL 268
           RH NIL++        +       L+ E+   G +          Y   +KLS    QR 
Sbjct: 67  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSKFDEQRT 111
Query: 269 NIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
              I ++A+AL Y H++    + H D+K  N+LL       + DFG +       + PS 
Sbjct: 112 ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS------CHAPSS 162
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
            +T    L G++ Y+PPE I G +     D++S G+L  E   GK P
Sbjct: 163 RRTT---LSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 108/225 (48%), Gaps = 33/225 (14%)
Query: 165 IGSGSFGSVY--------KGTLADGETAAIKVLKLQ-QQGALKSFIDECNALTSI-RHRN 214
           +G G FG V         K    +  T A+K+LK    +  L   + E   +  I +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCH------FKKLSLM 265
           I+ ++ +C+    +G  +  ++ E+   GNL ++L    P   EY +       ++++  
Sbjct: 92  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 146
Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
             ++    +A  ++YL +Q      H DL + NVL+ E  +  + DFGLA+    + N  
Sbjct: 147 DLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNI 199
Query: 326 SKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
              +  +NG +  V ++ PE +   V +   D++S+G+L+ EIFT
Sbjct: 200 DYYKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 112/224 (50%), Gaps = 27/224 (12%)
Query: 161 EENLIGSGSFGSVYKGTL---ADGETAAIKVLKLQQQG-ALK-SFIDECNALTSIRHRNI 215
           E+  +GSG+FG+V KG        +T A+K+LK +    ALK   + E N +  + +  I
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           ++++  C +  +       LV E    G L+++L  +     H K  ++++   +V  V+
Sbjct: 75  VRMIGICEAESW------MLVMEMAELGPLNKYLQQNR----HVKDKNIIE---LVHQVS 121
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
             + YL    ++   H DL + NVLL     A + DFGL+K L  + N   K QT     
Sbjct: 122 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENX-YKAQTHG--- 174
Query: 336 KGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDM 377
           K  V +  PE IN +  S   D++S+G+L+ E F+ G++P   M
Sbjct: 175 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 218

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           ++F    ++G GSF +V     LA     AIK+L+ +        I E       R R++
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDV 67
Query: 216 LKIVSSCSSVD--YEGNDFKALVF--EFMRNGNLDQWLHP--STDEYCHFKKLSLMQRLN 269
           +  +     V   +   D + L F   + +NG L +++    S DE C         R  
Sbjct: 68  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC--------TRF- 118
Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
              ++ SAL+YLH +    I H DLK  N+LL+E M   + DFG AK L     +P   Q
Sbjct: 119 YTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL-----SPESKQ 170
Query: 330 TMSNGLKGSVGYIPPEYINGHVSIL-GDIYSYGILLLEIFTGKRP 373
             +N   G+  Y+ PE +    +    D+++ G ++ ++  G  P
Sbjct: 171 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 103/223 (46%), Gaps = 31/223 (13%)
Query: 162 ENLIGSGSFGSVYKGTLA-DG--ETAAIKVLK-LQQQGALKSFIDECNALTSI-RHRNIL 216
           +++IG G+FG V K  +  DG    AAIK +K    +   + F  E   L  +  H NI+
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPS----TDEYCHFKK-----LSLMQR 267
            ++ +C     E   +  L  E+  +GNL  +L  S    TD            LS  Q 
Sbjct: 90  NLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
           L+   DVA  +DYL  +      H DL + N+L+ E  +A + DFGL++           
Sbjct: 145 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYV 196
Query: 328 NQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
            +TM    +  V ++  E +N  V +   D++SYG+LL EI +
Sbjct: 197 KKTMG---RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 109/243 (44%), Gaps = 39/243 (16%)
Query: 153 SNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQ--QQGALKSFIDECNALTS 209
           + + D +     +G G++G VYK       ET AIK ++L+  ++G   + I E + L  
Sbjct: 30  ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKE 89
Query: 210 IRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN 269
           ++HRNI+++ S         N    L+FE+  N +L +++  + D      K  L Q +N
Sbjct: 90  LQHRNIIELKSVIHH-----NHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLIN 143
Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLL-----DEGMIAHVGDFGLAKFLFEESNT 324
                   +++ H++      H DLK  N+LL      E  +  +GDFGLA+        
Sbjct: 144 -------GVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF----GI 189
Query: 325 PSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDD 376
           P +  T       ++ Y PPE + G  H S   DI+S   +  E      +F G    D 
Sbjct: 190 PIRQFTHE---IITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ 246
Query: 377 MFK 379
           +FK
Sbjct: 247 LFK 249

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 112/224 (50%), Gaps = 27/224 (12%)
Query: 161 EENLIGSGSFGSVYKGTL---ADGETAAIKVLKLQQQG-ALK-SFIDECNALTSIRHRNI 215
           E+  +GSG+FG+V KG        +T A+K+LK +    ALK   + E N +  + +  I
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           ++++  C +  +       LV E    G L+++L  +     H K  ++++   +V  V+
Sbjct: 81  VRMIGICEAESW------MLVMEMAELGPLNKYLQQNR----HVKDKNIIE---LVHQVS 127
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
             + YL    ++   H DL + NVLL     A + DFGL+K L  + N   K QT     
Sbjct: 128 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-YKAQTHG--- 180
Query: 336 KGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDM 377
           K  V +  PE IN +  S   D++S+G+L+ E F+ G++P   M
Sbjct: 181 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 32/226 (14%)
Query: 156 TDNFSEENLIGSGSFGSVY--KGTLADGETAAIKVL---KLQQQGALKSFIDECNALTSI 210
           +D +  + ++G GSFG V   K  +  G+  A+KV+   +++Q+   +S + E   L  +
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 89
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
            H NI+K+        +E   +  LV E    G L        DE    K+ S +    I
Sbjct: 90  DHPNIMKLYEF-----FEDKGYFYLVGEVYTGGEL-------FDEIISRKRFSEVDAARI 137
Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLFEESNTPSK 327
           +  V S + Y+H      I H DLK  N+LL+   +     + DFGL+   FE S     
Sbjct: 138 IRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH-FEAS----- 188
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRP 373
            + M + + G+  YI PE ++G      D++S G++L  + +G  P
Sbjct: 189 -KKMKDKI-GTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPP 232

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           ++F    ++G GSF +V     LA     AIK+L+ +        I E       R R++
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDV 85
Query: 216 LKIVSSCSSVD--YEGNDFKALVF--EFMRNGNLDQWLHP--STDEYCHFKKLSLMQRLN 269
           +  +     V   +   D + L F   + +NG L +++    S DE C         R  
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETC--------TRF- 136
Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
              ++ SAL+YLH +    I H DLK  N+LL+E M   + DFG AK L     +P   Q
Sbjct: 137 YTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL-----SPESKQ 188
Query: 330 TMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
             +N   G+  Y+ PE +     S   D+++ G ++ ++  G  P
Sbjct: 189 ARANSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           ++F    ++G GSF +V     LA     AIK+L+ +        I E       R R++
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDV 86
Query: 216 LKIVSSCSSVD--YEGNDFKALVF--EFMRNGNLDQWLHP--STDEYCHFKKLSLMQRLN 269
           +  +     V   +   D + L F   + +NG L +++    S DE C         R  
Sbjct: 87  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC--------TRF- 137
Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
              ++ SAL+YLH +    I H DLK  N+LL+E M   + DFG AK L     +P   Q
Sbjct: 138 YTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL-----SPESKQ 189
Query: 330 TMSNGLKGSVGYIPPEYINGHVSIL-GDIYSYGILLLEIFTGKRP 373
             +N   G+  Y+ PE +    +    D+++ G ++ ++  G  P
Sbjct: 190 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 112/224 (50%), Gaps = 27/224 (12%)
Query: 161 EENLIGSGSFGSVYKGTL---ADGETAAIKVLKLQQQG-ALK-SFIDECNALTSIRHRNI 215
           E+  +GSG+FG+V KG        +T A+K+LK +    ALK   + E N +  + +  I
Sbjct: 29  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 88
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           ++++  C +  +       LV E    G L+++L  +     H K  ++++   +V  V+
Sbjct: 89  VRMIGICEAESW------MLVMEMAELGPLNKYLQQNR----HVKDKNIIE---LVHQVS 135
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
             + YL    ++   H DL + NVLL     A + DFGL+K L  + N   K QT     
Sbjct: 136 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-YKAQTHG--- 188
Query: 336 KGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDM 377
           K  V +  PE IN +  S   D++S+G+L+ E F+ G++P   M
Sbjct: 189 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 232

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 112/224 (50%), Gaps = 27/224 (12%)
Query: 161 EENLIGSGSFGSVYKGTL---ADGETAAIKVLKLQQQG-ALK-SFIDECNALTSIRHRNI 215
           E+  +GSG+FG+V KG        +T A+K+LK +    ALK   + E N +  + +  I
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           ++++  C +  +       LV E    G L+++L  +     H K  ++++   +V  V+
Sbjct: 91  VRMIGICEAESW------MLVMEMAELGPLNKYLQQNR----HVKDKNIIE---LVHQVS 137
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
             + YL    ++   H DL + NVLL     A + DFGL+K L  + N   K QT     
Sbjct: 138 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-YKAQTHG--- 190
Query: 336 KGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDM 377
           K  V +  PE IN +  S   D++S+G+L+ E F+ G++P   M
Sbjct: 191 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 234

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 112/224 (50%), Gaps = 27/224 (12%)
Query: 161 EENLIGSGSFGSVYKGTL---ADGETAAIKVLKLQQQG-ALK-SFIDECNALTSIRHRNI 215
           E+  +GSG+FG+V KG        +T A+K+LK +    ALK   + E N +  + +  I
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           ++++  C +  +       LV E    G L+++L  +     H K  ++++   +V  V+
Sbjct: 91  VRMIGICEAESW------MLVMEMAELGPLNKYLQQNR----HVKDKNIIE---LVHQVS 137
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
             + YL    ++   H DL + NVLL     A + DFGL+K L  + N   K QT     
Sbjct: 138 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-YKAQTHG--- 190
Query: 336 KGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDM 377
           K  V +  PE IN +  S   D++S+G+L+ E F+ G++P   M
Sbjct: 191 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 234

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 103/223 (46%), Gaps = 31/223 (13%)
Query: 162 ENLIGSGSFGSVYKGTLA-DG--ETAAIKVLK-LQQQGALKSFIDECNALTSI-RHRNIL 216
           +++IG G+FG V K  +  DG    AAIK +K    +   + F  E   L  +  H NI+
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPS----TDEYCHFKK-----LSLMQR 267
            ++ +C     E   +  L  E+  +GNL  +L  S    TD            LS  Q 
Sbjct: 80  NLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
           L+   DVA  +DYL  +      H DL + N+L+ E  +A + DFGL++           
Sbjct: 135 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYV 186
Query: 328 NQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
            +TM    +  V ++  E +N  V +   D++SYG+LL EI +
Sbjct: 187 KKTMG---RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           ++F    ++G GSF +V     LA     AIK+L+ +        I E       R R++
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDV 83
Query: 216 LKIVSSCSSVD--YEGNDFKALVF--EFMRNGNLDQWLHP--STDEYCHFKKLSLMQRLN 269
           +  +     V   +   D + L F   + +NG L +++    S DE C         R  
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC--------TRF- 134
Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
              ++ SAL+YLH +    I H DLK  N+LL+E M   + DFG AK L     +P   Q
Sbjct: 135 YTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL-----SPESKQ 186
Query: 330 TMSNGLKGSVGYIPPEYINGHVSIL-GDIYSYGILLLEIFTGKRP 373
             +N   G+  Y+ PE +    +    D+++ G ++ ++  G  P
Sbjct: 187 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 112/224 (50%), Gaps = 27/224 (12%)
Query: 161 EENLIGSGSFGSVYKGTL---ADGETAAIKVLKLQQQG-ALK-SFIDECNALTSIRHRNI 215
           E+  +GSG+FG+V KG        +T A+K+LK +    ALK   + E N +  + +  I
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           ++++  C +  +       LV E    G L+++L  +     H K  ++++   +V  V+
Sbjct: 71  VRMIGICEAESW------MLVMEMAELGPLNKYLQQNR----HVKDKNIIE---LVHQVS 117
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
             + YL    ++   H DL + NVLL     A + DFGL+K L  + N   K QT     
Sbjct: 118 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-YKAQTHG--- 170
Query: 336 KGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDM 377
           K  V +  PE IN +  S   D++S+G+L+ E F+ G++P   M
Sbjct: 171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 214

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 32/226 (14%)
Query: 156 TDNFSEENLIGSGSFGSVY--KGTLADGETAAIKVL---KLQQQGALKSFIDECNALTSI 210
           +D +  + ++G GSFG V   K  +  G+  A+KV+   +++Q+   +S + E   L  +
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
            H NI+K+        +E   +  LV E    G L        DE    K+ S +    I
Sbjct: 84  DHPNIMKLYEF-----FEDKGYFYLVGEVYTGGEL-------FDEIISRKRFSEVDAARI 131
Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLFEESNTPSK 327
           +  V S + Y+H      I H DLK  N+LL+   +     + DFGL+   FE S     
Sbjct: 132 IRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH-FEAS----- 182
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRP 373
            + M + + G+  YI PE ++G      D++S G++L  + +G  P
Sbjct: 183 -KKMKDKI-GTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPP 226

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 112/224 (50%), Gaps = 27/224 (12%)
Query: 161 EENLIGSGSFGSVYKGTL---ADGETAAIKVLKLQQQG-ALK-SFIDECNALTSIRHRNI 215
           E+  +GSG+FG+V KG        +T A+K+LK +    ALK   + E N +  + +  I
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           ++++  C +  +       LV E    G L+++L  +     H K  ++++   +V  V+
Sbjct: 75  VRMIGICEAESW------MLVMEMAELGPLNKYLQQNR----HVKDKNIIE---LVHQVS 121
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
             + YL    ++   H DL + NVLL     A + DFGL+K L  + N   K QT     
Sbjct: 122 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-YKAQTHG--- 174
Query: 336 KGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDM 377
           K  V +  PE IN +  S   D++S+G+L+ E F+ G++P   M
Sbjct: 175 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 218

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 112/224 (50%), Gaps = 27/224 (12%)
Query: 161 EENLIGSGSFGSVYKGTL---ADGETAAIKVLKLQQQG-ALK-SFIDECNALTSIRHRNI 215
           E+  +GSG+FG+V KG        +T A+K+LK +    ALK   + E N +  + +  I
Sbjct: 9   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 68
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           ++++  C +  +       LV E    G L+++L  +     H K  ++++   +V  V+
Sbjct: 69  VRMIGICEAESW------MLVMEMAELGPLNKYLQQNR----HVKDKNIIE---LVHQVS 115
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
             + YL    ++   H DL + NVLL     A + DFGL+K L  + N   K QT     
Sbjct: 116 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-YKAQTHG--- 168
Query: 336 KGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDM 377
           K  V +  PE IN +  S   D++S+G+L+ E F+ G++P   M
Sbjct: 169 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 212

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           ++F    ++G GSF +V     LA     AIK+L+ +        I E       R R++
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDV 83
Query: 216 LKIVSSCSSVD--YEGNDFKALVF--EFMRNGNLDQWLHP--STDEYCHFKKLSLMQRLN 269
           +  +     V   +   D + L F   + +NG L +++    S DE C         R  
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC--------TRF- 134
Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
              ++ SAL+YLH +    I H DLK  N+LL+E M   + DFG AK L     +P   Q
Sbjct: 135 YTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL-----SPESKQ 186
Query: 330 TMSNGLKGSVGYIPPEYINGHVSIL-GDIYSYGILLLEIFTGKRP 373
             +N   G+  Y+ PE +    +    D+++ G ++ ++  G  P
Sbjct: 187 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           ++F    ++G GSF +V     LA     AIK+L+ +        I E       R R++
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDV 85
Query: 216 LKIVSSCSSVD--YEGNDFKALVF--EFMRNGNLDQWLHP--STDEYCHFKKLSLMQRLN 269
           +  +     V   +   D + L F   + +NG L +++    S DE C         R  
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC--------TRF- 136
Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
              ++ SAL+YLH +    I H DLK  N+LL+E M   + DFG AK L     +P   Q
Sbjct: 137 YTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL-----SPESKQ 188
Query: 330 TMSNGLKGSVGYIPPEYINGHVSIL-GDIYSYGILLLEIFTGKRP 373
             +N   G+  Y+ PE +    +    D+++ G ++ ++  G  P
Sbjct: 189 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           ++F    ++G GSF +V     LA     AIK+L+ +        I E       R R++
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDV 85
Query: 216 LKIVSSCSSVD--YEGNDFKALVF--EFMRNGNLDQWLHP--STDEYCHFKKLSLMQRLN 269
           +  +     V   +   D + L F   + +NG L +++    S DE C         R  
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC--------TRF- 136
Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
              ++ SAL+YLH +    I H DLK  N+LL+E M   + DFG AK L     +P   Q
Sbjct: 137 YTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL-----SPESKQ 188
Query: 330 TMSNGLKGSVGYIPPEYINGHVSIL-GDIYSYGILLLEIFTGKRP 373
             +N   G+  Y+ PE +    +    D+++ G ++ ++  G  P
Sbjct: 189 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           ++F    ++G GSF +V     LA     AIK+L+ +        I E       R R++
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDV 85
Query: 216 LKIVSSCSSVD--YEGNDFKALVF--EFMRNGNLDQWLHP--STDEYCHFKKLSLMQRLN 269
           +  +     V   +   D + L F   + +NG L +++    S DE C         R  
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC--------TRF- 136
Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
              ++ SAL+YLH +    I H DLK  N+LL+E M   + DFG AK L     +P   Q
Sbjct: 137 YTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL-----SPESKQ 188
Query: 330 TMSNGLKGSVGYIPPEYINGHVSIL-GDIYSYGILLLEIFTGKRP 373
             +N   G+  Y+ PE +    +    D+++ G ++ ++  G  P
Sbjct: 189 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           ++F    ++G GSF +V     LA     AIK+L+ +        I E       R R++
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDV 82
Query: 216 LKIVSSCSSVD--YEGNDFKALVF--EFMRNGNLDQWLHP--STDEYCHFKKLSLMQRLN 269
           +  +     V   +   D + L F   + +NG L +++    S DE C         R  
Sbjct: 83  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC--------TRF- 133
Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
              ++ SAL+YLH +    I H DLK  N+LL+E M   + DFG AK L     +P   Q
Sbjct: 134 YTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL-----SPESKQ 185
Query: 330 TMSNGLKGSVGYIPPEYINGHVSIL-GDIYSYGILLLEIFTGKRP 373
             +N   G+  Y+ PE +    +    D+++ G ++ ++  G  P
Sbjct: 186 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 98/228 (42%), Gaps = 38/228 (16%)
Query: 159 FSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILK 217
           F++ + IG GSFG VYKG      E  AIK++ L+                    +  + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLE-----------EAEDEIEDIQQEIT 69
Query: 218 IVSSCSS---VDYEGNDFKA----LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
           ++S C S     Y G+  K+    ++ E++  G+    L P   E  +           I
Sbjct: 70  VLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIA--------TI 121
Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
           + ++   LDYLH++      H D+K++NVLL E     + DFG+A  L       +  Q 
Sbjct: 122 LREILKGLDYLHSERKI---HRDIKAANVLLSEQGDVKLADFGVAGQL-------TDTQI 171
Query: 331 MSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM 377
             N   G+  ++ PE I         DI+S GI  +E+  G+ P  D+
Sbjct: 172 KRNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 219

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 102/232 (43%), Gaps = 35/232 (15%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECN 205
           +K   A ++F     +G G FG+VY       +   A+KVL   +L++ G       E  
Sbjct: 1   MKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 206 ALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM 265
             + +RH NIL++        +       L+ E+   G +          Y   +KLS  
Sbjct: 61  IQSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSKF 105
Query: 266 --QRLNIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES 322
             QR    I ++A+AL Y H++    + H D+K  N+LL       + DFG +       
Sbjct: 106 DEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS------V 156
Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
           + PS  +T    L G++ Y+PPE I G +     D++S G+L  E   GK P
Sbjct: 157 HAPSSRRT---DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 157 DNFSEENLIGSGSFGS-VYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           ++F    ++G GSF + V    LA     AIK+L+ +        I E       R R++
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDV 83
Query: 216 LKIVSSCSSVD--YEGNDFKALVF--EFMRNGNLDQWLHP--STDEYCHFKKLSLMQRLN 269
           +  +     V   +   D + L F   + +NG L +++    S DE C         R  
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC--------TRF- 134
Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
              ++ SAL+YLH +    I H DLK  N+LL+E M   + DFG AK L     +P   Q
Sbjct: 135 YTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL-----SPESKQ 186
Query: 330 TMSNGLKGSVGYIPPEYINGHVSIL-GDIYSYGILLLEIFTGKRP 373
             +N   G+  Y+ PE +    +    D+++ G ++ ++  G  P
Sbjct: 187 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           ++F    ++G GSF +V     LA     AIK+L+ +        I E       R R++
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDV 85
Query: 216 LKIVSSCSSVD--YEGNDFKALVF--EFMRNGNLDQWLHP--STDEYCHFKKLSLMQRLN 269
           +  +     V   +   D + L F   + +NG L +++    S DE C         R  
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC--------TRF- 136
Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
              ++ SAL+YLH +    I H DLK  N+LL+E M   + DFG AK L     +P   Q
Sbjct: 137 YTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL-----SPESKQ 188
Query: 330 TMSNGLKGSVGYIPPEYINGHVSIL-GDIYSYGILLLEIFTGKRP 373
             +N   G+  Y+ PE +    +    D+++ G ++ ++  G  P
Sbjct: 189 ARANXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           ++F    ++G GSF +V     LA     AIK+L+ +        I E       R R++
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDV 86
Query: 216 LKIVSSCSSVD--YEGNDFKALVF--EFMRNGNLDQWLHP--STDEYCHFKKLSLMQRLN 269
           +  +     V   +   D + L F   + +NG L +++    S DE C         R  
Sbjct: 87  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC--------TRF- 137
Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
              ++ SAL+YLH +    I H DLK  N+LL+E M   + DFG AK L     +P   Q
Sbjct: 138 YTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL-----SPESKQ 189
Query: 330 TMSNGLKGSVGYIPPEYINGHVSIL-GDIYSYGILLLEIFTGKRP 373
             +N   G+  Y+ PE +    +    D+++ G ++ ++  G  P
Sbjct: 190 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           ++F    ++G GSF +V     LA     AIK+L+ +        I E       R R++
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDV 85
Query: 216 LKIVSSCSSVD--YEGNDFKALVF--EFMRNGNLDQWLHP--STDEYCHFKKLSLMQRLN 269
           +  +     V   +   D + L F   + +NG L +++    S DE C         R  
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC--------TRF- 136
Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
              ++ SAL+YLH +    I H DLK  N+LL+E M   + DFG AK L     +P   Q
Sbjct: 137 YTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL-----SPESKQ 188
Query: 330 TMSNGLKGSVGYIPPEYINGHVSIL-GDIYSYGILLLEIFTGKRP 373
             +N   G+  Y+ PE +    +    D+++ G ++ ++  G  P
Sbjct: 189 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 35/227 (15%)
Query: 155 ATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNALTSI 210
           A ++F     +G G FG+VY       +   A+KVL   +L++ G       E    + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM--QRL 268
           RH NIL++        +       L+ E+   G +          Y   +KLS    QR 
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPRGEV----------YKELQKLSKFDEQRT 115
Query: 269 NIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
              I ++A+AL Y H++    + H D+K  N+LL       + DFG +       + PS 
Sbjct: 116 ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS------VHAPSS 166
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
            +     L G++ Y+PPE I G +     D++S G+L  E   GK P
Sbjct: 167 RRXX---LXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 110/253 (43%), Gaps = 36/253 (14%)
Query: 155 ATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNALTSI 210
           A ++F     +G G FG+VY     + +   A+KVL   +L++ G       E    + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM--QRL 268
           RH NIL++        +  +    L+ E+   G +          Y   +KLS    QR 
Sbjct: 66  RHPNILRLYGY-----FHDSTRVYLILEYAPLGTV----------YRELQKLSKFDEQRT 110
Query: 269 NIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
              I ++A+AL Y H++    + H D+K  N+LL       + DFG +       + PS 
Sbjct: 111 ATYITELANALSYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWS------VHAPSS 161
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRPTD-DMFKDDLSIH 385
            +     L G++ Y+PPE I G +     D++S G+L  E   GK P + + ++D     
Sbjct: 162 RRA---ALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRI 218
Query: 386 KFVLMALPSHVMD 398
             V    P  V +
Sbjct: 219 SRVEFTFPDFVTE 231

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           ++F    ++G GSF +V     LA     AIK+L+ +        I E       R R++
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDV 88
Query: 216 LKIVSSCSSVD--YEGNDFKALVF--EFMRNGNLDQWLHP--STDEYCHFKKLSLMQRLN 269
           +  +     V   +   D + L F   + +NG L +++    S DE C         R  
Sbjct: 89  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC--------TRF- 139
Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
              ++ SAL+YLH +    I H DLK  N+LL+E M   + DFG AK L     +P   Q
Sbjct: 140 YTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL-----SPESKQ 191
Query: 330 TMSNGLKGSVGYIPPEYINGHVSIL-GDIYSYGILLLEIFTGKRP 373
             +N   G+  Y+ PE +    +    D+++ G ++ ++  G  P
Sbjct: 192 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 101/231 (43%), Gaps = 35/231 (15%)
Query: 151 KISNATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNA 206
           K   A ++F     +G G FG+VY       +   A+KVL   +L++ G       E   
Sbjct: 1   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 60
Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM- 265
            + +RH NIL++        +       L+ E+   G +          Y   +KLS   
Sbjct: 61  QSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSKFD 105
Query: 266 -QRLNIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
            QR    I ++A+AL Y H++    + H D+K  N+LL       + DFG +       +
Sbjct: 106 EQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS------VH 156
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
            PS  +T    L G++ Y+PPE I G +     D++S G+L  E   GK P
Sbjct: 157 APSSRRTT---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 204

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 101/231 (43%), Gaps = 35/231 (15%)
Query: 151 KISNATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNA 206
           K   A ++F     +G G FG+VY       +   A+KVL   +L++ G       E   
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM- 265
            + +RH NIL++        +       L+ E+   G +          Y   +KLS   
Sbjct: 65  QSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSKFD 109
Query: 266 -QRLNIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
            QR    I ++A+AL Y H++    + H D+K  N+LL       + DFG +       +
Sbjct: 110 EQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS------VH 160
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
            PS  +T    L G++ Y+PPE I G +     D++S G+L  E   GK P
Sbjct: 161 APSSRRTT---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 155 ATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNALTSI 210
           A ++F     +G G FG+VY       +   A+KVL   +L++ G       E    + +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM--QRL 268
           RH NIL++        +       L+ E+   G +          Y   +KLS    QR 
Sbjct: 92  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSKFDEQRT 136
Query: 269 NIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
              I ++A+AL Y H++    + H D+K  N+LL       + DFG +       + PS 
Sbjct: 137 ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS------VHAPSS 187
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
            +T    L G++ Y+PPE I G +     D++S G+L  E   GK P
Sbjct: 188 RRTT---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 155 ATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNALTSI 210
           A ++F     +G G FG+VY       +   A+KVL   +L++ G       E    + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM--QRL 268
           RH NIL++        +       L+ E+   G +          Y   +KLS    QR 
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSKFDEQRT 113
Query: 269 NIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
              I ++A+AL Y H++    + H D+K  N+LL       + DFG +       + PS 
Sbjct: 114 ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS------VHAPSS 164
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
            +T    L G++ Y+PPE I G +     D++S G+L  E   GK P
Sbjct: 165 RRTT---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 155 ATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNALTSI 210
           A ++F     +G G FG+VY       +   A+KVL   +L++ G       E    + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM--QRL 268
           RH NIL++        +       L+ E+   G +          Y   +KLS    QR 
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSKFDEQRT 115
Query: 269 NIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
              I ++A+AL Y H++    + H D+K  N+LL       + DFG +       + PS 
Sbjct: 116 ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS------VHAPSS 166
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
            +T    L G++ Y+PPE I G +     D++S G+L  E   GK P
Sbjct: 167 RRTT---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 120/243 (49%), Gaps = 29/243 (11%)
Query: 161 EENLIGSGSFGSVYKGTL---ADGETAAIKVLKLQQQG-ALK-SFIDECNALTSIRHRNI 215
           E+  +GSG+FG+V KG        +T A+K+LK +    ALK   + E N +  + +  I
Sbjct: 373 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 432
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           ++++  C +  +       LV E    G L+++L  +     H K  ++++   +V  V+
Sbjct: 433 VRMIGICEAESW------MLVMEMAELGPLNKYLQQNR----HVKDKNIIE---LVHQVS 479
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
             + YL    ++   H DL + NVLL     A + DFGL+K L  + N   K QT     
Sbjct: 480 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-YKAQTHG--- 532
Query: 336 KGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLS--IHKFVLMA 391
           K  V +  PE IN +  S   D++S+G+L+ E F+ G++P   M   +++  + K   M 
Sbjct: 533 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG 592
Query: 392 LPS 394
            P+
Sbjct: 593 CPA 595

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 32/226 (14%)
Query: 156 TDNFSEENLIGSGSFGSVY--KGTLADGETAAIKVL---KLQQQGALKSFIDECNALTSI 210
           +D +  + ++G GSFG V   K  +  G+  A+KV+   +++Q+   +S + E   L  +
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
            H NI+K+        +E   +  LV E    G L        DE    K+ S +    I
Sbjct: 107 DHPNIMKLYEF-----FEDKGYFYLVGEVYTGGEL-------FDEIISRKRFSEVDAARI 154
Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLFEESNTPSK 327
           +  V S + Y+H      I H DLK  N+LL+   +     + DFGL+   FE S     
Sbjct: 155 IRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH-FEAS----- 205
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRP 373
            + M + + G+  YI PE ++G      D++S G++L  + +G  P
Sbjct: 206 -KKMKDKI-GTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPP 249

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 102/233 (43%), Gaps = 35/233 (15%)
Query: 151 KISNATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNA 206
           K   A ++F     +G G FG+VY       +   A+KVL   +L++ G       E   
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM- 265
            + +RH NIL++        +       L+ E+   G +          Y   +KLS   
Sbjct: 62  QSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSKFD 106
Query: 266 -QRLNIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
            QR    I ++A+AL Y H++    + H D+K  N+LL       + DFG +       +
Sbjct: 107 EQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS------VH 157
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRPTD 375
            PS  +T    L G++ Y+PPE I G +     D++S G+L  E   GK P +
Sbjct: 158 APSSRRTX---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 115/244 (47%), Gaps = 45/244 (18%)
Query: 165 IGSGSFGSVYKGTLADG-----------ETAAIKVLKLQ-QQGALKSFIDECNALTSI-R 211
           +G G+FG V    LA+               A+K+LK    +  L   I E   +  I +
Sbjct: 21  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCH------FKKL 262
           H+NI+ ++ +C+    +G  +  ++ E+   GNL ++L    P   EYC+       ++L
Sbjct: 78  HKNIINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 132
Query: 263 SLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES 322
           S    ++    VA  ++YL ++      H DL + NVL+ E  +  + DFGLA+ +    
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT------GKRPTD 375
                 +  +NG +  V ++ PE +   + +   D++S+G+LL EIFT         P +
Sbjct: 190 YY----KKTTNG-RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244
Query: 376 DMFK 379
           ++FK
Sbjct: 245 ELFK 248

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 108/225 (48%), Gaps = 33/225 (14%)
Query: 165 IGSGSFGSVY--------KGTLADGETAAIKVLKLQ-QQGALKSFIDECNALTSI-RHRN 214
           +G G+FG V         K    +  T A+K+LK    +  L   + E   +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCH------FKKLSLM 265
           I+ ++ +C+    +G  +  ++ E+   GNL ++L    P   E  +       ++++  
Sbjct: 103 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFK 157
Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
             ++    +A  ++YL +Q      H DL + NVL+ E  +  + DFGLA+    + N  
Sbjct: 158 DLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLAR----DINNI 210
Query: 326 SKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
              +  +NG +  V ++ PE +   V +   D++S+G+L+ EIFT
Sbjct: 211 DXXKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 32/226 (14%)
Query: 156 TDNFSEENLIGSGSFGSVY--KGTLADGETAAIKVL---KLQQQGALKSFIDECNALTSI 210
           +D +  + ++G GSFG V   K  +  G+  A+KV+   +++Q+   +S + E   L  +
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
            H NI+K+        +E   +  LV E    G L        DE    K+ S +    I
Sbjct: 108 DHPNIMKLYEF-----FEDKGYFYLVGEVYTGGEL-------FDEIISRKRFSEVDAARI 155
Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLFEESNTPSK 327
           +  V S + Y+H      I H DLK  N+LL+   +     + DFGL+   FE S     
Sbjct: 156 IRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH-FEAS----- 206
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRP 373
            + M + + G+  YI PE ++G      D++S G++L  + +G  P
Sbjct: 207 -KKMKDKI-GTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPP 250

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 155 ATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNALTSI 210
           A ++F     +G G FG+VY       +   A+KVL   +L++ G       E    + +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM--QRL 268
           RH NIL++        +       L+ E+   G +          Y   +KLS    QR 
Sbjct: 83  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSKFDEQRT 127
Query: 269 NIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
              I ++A+AL Y H++    + H D+K  N+LL       + DFG +       + PS 
Sbjct: 128 ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS------VHAPSS 178
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
            +T    L G++ Y+PPE I G +     D++S G+L  E   GK P
Sbjct: 179 RRTT---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 155 ATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNALTSI 210
           A ++F     +G G FG+VY       +   A+KVL   +L++ G       E    + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM--QRL 268
           RH NIL++        +       L+ E+   G +          Y   +KLS    QR 
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSKFDEQRT 110
Query: 269 NIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
              I ++A+AL Y H++    + H D+K  N+LL       + DFG +       + PS 
Sbjct: 111 ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS------VHAPSS 161
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
            +T    L G++ Y+PPE I G +     D++S G+L  E   GK P
Sbjct: 162 RRTT---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 120/243 (49%), Gaps = 29/243 (11%)
Query: 161 EENLIGSGSFGSVYKGTL---ADGETAAIKVLKLQQQG-ALK-SFIDECNALTSIRHRNI 215
           E+  +GSG+FG+V KG        +T A+K+LK +    ALK   + E N +  + +  I
Sbjct: 374 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 433
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           ++++  C +  +       LV E    G L+++L  +     H K  ++++   +V  V+
Sbjct: 434 VRMIGICEAESW------MLVMEMAELGPLNKYLQQNR----HVKDKNIIE---LVHQVS 480
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
             + YL    ++   H DL + NVLL     A + DFGL+K L  + N   K QT     
Sbjct: 481 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-YKAQTHG--- 533
Query: 336 KGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLS--IHKFVLMA 391
           K  V +  PE IN +  S   D++S+G+L+ E F+ G++P   M   +++  + K   M 
Sbjct: 534 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG 593
Query: 392 LPS 394
            P+
Sbjct: 594 CPA 596

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 101/231 (43%), Gaps = 35/231 (15%)
Query: 151 KISNATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNA 206
           K   A ++F     +G G FG+VY       +   A+KVL   +L++ G       E   
Sbjct: 6   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 65
Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM- 265
            + +RH NIL++        +       L+ E+   G +          Y   +KLS   
Sbjct: 66  QSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSKFD 110
Query: 266 -QRLNIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
            QR    I ++A+AL Y H++    + H D+K  N+LL       + DFG +       +
Sbjct: 111 EQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS------VH 161
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
            PS  +T    L G++ Y+PPE I G +     D++S G+L  E   GK P
Sbjct: 162 APSSRRTT---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 209

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 108/225 (48%), Gaps = 33/225 (14%)
Query: 165 IGSGSFGSVY--------KGTLADGETAAIKVLKLQ-QQGALKSFIDECNALTSI-RHRN 214
           +G G+FG V         K    +  T A+K+LK    +  L   + E   +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCH------FKKLSLM 265
           I+ ++ +C+    +G  +  ++  +   GNL ++L    P   EY +       ++++  
Sbjct: 103 IINLLGACTQ---DGPLY--VIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
             ++    +A  ++YL +Q      H DL + NVL+ E  +  + DFGLA+    + N  
Sbjct: 158 DLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNI 210
Query: 326 SKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
              +  +NG +  V ++ PE +   V +   D++S+G+L+ EIFT
Sbjct: 211 DYYKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 116/244 (47%), Gaps = 45/244 (18%)
Query: 165 IGSGSFGSVYKGTLADG-----------ETAAIKVLKLQ-QQGALKSFIDECNALTSI-R 211
           +G G+FG V    LA+               A+K+LK    +  L   I E   +  I +
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCH------FKKL 262
           H+NI+ ++ +C+    +G  +  ++ E+   GNL ++L    P   EYC+       ++L
Sbjct: 93  HKNIINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 147
Query: 263 SLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES 322
           S    ++    VA  ++YL ++      H DL + NVL+ E  +  + DFGLA+    + 
Sbjct: 148 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DI 200
Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT------GKRPTD 375
           +     +  +NG +  V ++ PE +   + +   D++S+G+LL EIFT         P +
Sbjct: 201 HHIDYYKKTTNG-RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 259
Query: 376 DMFK 379
           ++FK
Sbjct: 260 ELFK 263

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 155 ATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNALTSI 210
           A ++F     +G G FG+VY       +   A+KVL   +L++ G       E    + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM--QRL 268
           RH NIL++        +       L+ E+   G +          Y   +KLS    QR 
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSKFDEQRT 110
Query: 269 NIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
              I ++A+AL Y H++    + H D+K  N+LL       + DFG +       + PS 
Sbjct: 111 ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS------VHAPSS 161
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
            +T    L G++ Y+PPE I G +     D++S G+L  E   GK P
Sbjct: 162 RRT---DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 155 ATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNALTSI 210
           A ++F     +G G FG+VY       +   A+KVL   +L++ G       E    + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM--QRL 268
           RH NIL++        +       L+ E+   G +          Y   +KLS    QR 
Sbjct: 67  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSKFDEQRT 111
Query: 269 NIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
              I ++A+AL Y H++    + H D+K  N+LL       + DFG +       + PS 
Sbjct: 112 ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS------VHAPSS 162
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
            +T    L G++ Y+PPE I G +     D++S G+L  E   GK P
Sbjct: 163 RRT---DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 165 IGSGSFGSVYKGTL--ADGETA--AIKVLK---LQQQGALKSFIDECNALTSIRHRNILK 217
           +G GSFG V +G      G+T   A+K LK   L Q  A+  FI E NA+ S+ HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
           +     +   +      +V E    G+L   L        HF  L  + R    + VA  
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSL---LDRLRKHQGHF-LLGTLSR--YAVQVAEG 123
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YL ++      H DL + N+LL    +  +GDFGL + L +  +    +  M    K 
Sbjct: 124 MGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD----HXVMQEHRKV 176
Query: 338 SVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRP 373
              +  PE +     S   D + +G+ L E+FT G+ P
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 155 ATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNALTSI 210
           A ++F     +G G FG+VY       +   A+KVL   +L++ G       E    + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM--QRL 268
           RH NIL++        +       L+ E+   G +          Y   +KLS    QR 
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSKFDEQRT 115
Query: 269 NIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
              I ++A+AL Y H++    + H D+K  N+LL       + DFG +       + PS 
Sbjct: 116 ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS------VHAPSS 166
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
            +T    L G++ Y+PPE I G +     D++S G+L  E   GK P
Sbjct: 167 RRT---DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 48/237 (20%)
Query: 158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           +F E  ++G G+FG V K   A D    AIK ++  ++  L + + E   L S+ H+ ++
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVXLLASLNHQYVV 65
Query: 217 KIVSSCSSVDYEGNDF---------KALVF---EFMRNGNLDQWLHPST-----DEYCHF 259
           +  ++      E  +F         K+ +F   E+  N  L   +H        DEY   
Sbjct: 66  RYYAAW----LERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 260 KKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK--- 316
            +            +  AL Y+H+Q    I H +LK  N+ +DE     +GDFGLAK   
Sbjct: 122 FR-----------QILEALSYIHSQ---GIIHRNLKPXNIFIDESRNVKIGDFGLAKNVH 167
Query: 317 -----FLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLE 366
                   +  N P  +  +++ + G+  Y+  E ++  GH +   D YS GI+  E
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAI-GTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 155 ATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNALTSI 210
           A ++F     +G G FG+VY       +   A+KVL   +L++ G       E    + +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM--QRL 268
           RH NIL++        +       L+ E+   G +          Y   +KLS    QR 
Sbjct: 63  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSKFDEQRT 107
Query: 269 NIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
              I ++A+AL Y H++    + H D+K  N+LL       + DFG +       + PS 
Sbjct: 108 ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS------VHAPSS 158
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRPTD 375
            +T    L G++ Y+PPE I G +     D++S G+L  E   GK P +
Sbjct: 159 RRTT---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 204

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 155 ATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNALTSI 210
           A ++F     +G G FG+VY       +   A+KVL   +L++ G       E    + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM--QRL 268
           RH NIL++        +       L+ E+   G +          Y   +KLS    QR 
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSKFDEQRT 110
Query: 269 NIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
              I ++A+AL Y H++    + H D+K  N+LL       + DFG +       + PS 
Sbjct: 111 ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS------VHAPSS 161
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
            +T    L G++ Y+PPE I G +     D++S G+L  E   GK P
Sbjct: 162 RRTE---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 89/215 (41%), Gaps = 26/215 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKS----FIDECNALTSIRHRNILKIVS 220
           IG GSF +VYKG L    T  +   +LQ +   KS    F +E   L  ++H NI++   
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDY 280
           S  S   +G     LV E   +G L  +L         FK   +    +    +   L +
Sbjct: 93  SWEST-VKGKKCIVLVTELXTSGTLKTYLK-------RFKVXKIKVLRSWCRQILKGLQF 144
Query: 281 LHNQYDTPIAHCDLKSSNVLLD--EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
           LH +   PI H DLK  N+ +    G +  +GD GLA           K  + +  + G+
Sbjct: 145 LHTR-TPPIIHRDLKCDNIFITGPTGSV-KIGDLGLATL---------KRASFAKAVIGT 193
Query: 339 VGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRP 373
             +  PE          D+Y++G   LE  T + P
Sbjct: 194 PEFXAPEXYEEKYDESVDVYAFGXCXLEXATSEYP 228

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 47/96 (48%), Gaps = 4/96 (4%)
Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L LG+N   G+IP  +  LRGL  LDLS N L G++PQ  S L  L  ++LS N L G I
Sbjct: 661 LNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPI 720
Query: 61  SREGIFANASAISIVGNDKLCGGIQKLQLPECSRKN 96
              G F        + N  LCG      LP C   N
Sbjct: 721 PEMGQFETFPPAKFLNNPGLCG----YPLPRCDPSN 752

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           ++F    ++G GSF +V     LA     AIK+L+ +        I E       R R++
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDV 90
Query: 216 LKIVSSCSSVD--YEGNDFKALVF--EFMRNGNLDQWLHP--STDEYCHFKKLSLMQRLN 269
           +  +     V   +   D + L F   + +NG L +++    S DE C         R  
Sbjct: 91  MSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC--------TRF- 141
Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
              ++ SAL+YLH +    I H DLK  N+LL+E M   + DFG AK L     +P   Q
Sbjct: 142 YTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL-----SPESKQ 193
Query: 330 TMSNGLKGSVGYIPPEYINGHVSIL-GDIYSYGILLLEIFTGKRP 373
             +N   G+  Y+ PE +    +    D+++ G ++ ++  G  P
Sbjct: 194 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 165 IGSGSFGSVYKGTL--ADGETA--AIKVLK---LQQQGALKSFIDECNALTSIRHRNILK 217
           +G GSFG V +G      G+T   A+K LK   L Q  A+  FI E NA+ S+ HRN+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
           +     +   +      +V E    G+L   L        HF  L  + R    + VA  
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSL---LDRLRKHQGHF-LLGTLSR--YAVQVAEG 133
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YL ++      H DL + N+LL    +  +GDFGL + L +  +    +  M    K 
Sbjct: 134 MGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD----HXVMQEHRKV 186
Query: 338 SVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRP 373
              +  PE +     S   D + +G+ L E+FT G+ P
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 47/96 (48%), Gaps = 4/96 (4%)
Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L LG+N   G+IP  +  LRGL  LDLS N L G++PQ  S L  L  ++LS N L G I
Sbjct: 658 LNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPI 717
Query: 61  SREGIFANASAISIVGNDKLCGGIQKLQLPECSRKN 96
              G F        + N  LCG      LP C   N
Sbjct: 718 PEMGQFETFPPAKFLNNPGLCG----YPLPRCDPSN 749

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 109/244 (44%), Gaps = 27/244 (11%)
Query: 165 IGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           IG GS G V   T    G+  A+K + L++Q   +   +E   +    H N++ + SS  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSS-- 110
Query: 224 SVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN 283
              Y   D   +V EF+  G L       TD   H  +++  Q   + + V  AL YLHN
Sbjct: 111 ---YLVGDELWVVMEFLEGGAL-------TDIVTH-TRMNEEQIATVCLSVLRALSYLHN 159
Query: 284 QYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIP 343
           Q    + H D+KS ++LL       + DFG    +       SK       L G+  ++ 
Sbjct: 160 Q---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQV-------SKEVPKRKXLVGTPYWMA 209
Query: 344 PEYING-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDL 402
           PE I+        DI+S GI+++E+  G+ P  +  +  L   + +  +LP  V D+  +
Sbjct: 210 PEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN--EPPLQAMRRIRDSLPPRVKDLHKV 267
Query: 403 SMLL 406
           S +L
Sbjct: 268 SSVL 271

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 99/227 (43%), Gaps = 35/227 (15%)
Query: 155 ATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNALTSI 210
           A ++F     +G G FG+VY       +   A+KVL   +L++ G       E    + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM--QRL 268
           RH NIL++        +       L+ E+   G +          Y   +KLS    QR 
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSKFDEQRT 115
Query: 269 NIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
              I ++A+AL Y H++    + H D+K  N+LL       + DFG +       + PS 
Sbjct: 116 ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS------VHAPSS 166
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
            +T    L G++ Y+PPE I G       D++S G+L  E   GK P
Sbjct: 167 RRTT---LCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 108/225 (48%), Gaps = 33/225 (14%)
Query: 165 IGSGSFGSVY--------KGTLADGETAAIKVLKLQ-QQGALKSFIDECNALTSI-RHRN 214
           +G G+FG V         K    +  T A+K+LK    +  L   + E   +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCH------FKKLSLM 265
           I+ ++ +C+    +G  +  ++  +   GNL ++L    P   EY +       ++++  
Sbjct: 103 IINLLGACTQ---DGPLY--VIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
             ++    +A  ++YL +Q      H DL + NVL+ E  +  + DFGLA+    + N  
Sbjct: 158 DLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNI 210
Query: 326 SKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
              +  +NG +  V ++ PE +   V +   D++S+G+L+ EIFT
Sbjct: 211 DYYKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 31/223 (13%)
Query: 162 ENLIGSGSFGSVYKGTLA-DG--ETAAIKVLK-LQQQGALKSFIDECNALTSI-RHRNIL 216
           +++IG G+FG V K  +  DG    AAIK +K    +   + F  E   L  +  H NI+
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPS----TDEYCHFKK-----LSLMQR 267
            ++ +C     E   +  L  E+  +GNL  +L  S    TD            LS  Q 
Sbjct: 87  NLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
           L+   DVA  +DYL  +      H +L + N+L+ E  +A + DFGL++           
Sbjct: 142 LHFAADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSR-----GQEVYV 193
Query: 328 NQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
            +TM    +  V ++  E +N  V +   D++SYG+LL EI +
Sbjct: 194 KKTMG---RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 106/240 (44%), Gaps = 33/240 (13%)
Query: 141 NEWQSGLSYLKISNATDNFSEENLIGSGSFGSVY----KGTLADGETAAIKVLKLQQQGA 196
           +EW+     + +S           +G GSFG VY    KG + D     + +  + +  +
Sbjct: 11  DEWEVAREKITMSRE---------LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 61
Query: 197 LKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PST 253
           ++  I+  N  + ++  N   +V     V  +G     ++ E M  G+L  +L    P  
Sbjct: 62  MRERIEFLNEASVMKEFNCHHVVRLLGVVS-QGQP-TLVIMELMTRGDLKSYLRSLRPEM 119
Query: 254 DEYCHFKKLSLMQRLNIVIDVASALDYLH-NQYDTPIAHCDLKSSNVLLDEGMIAHVGDF 312
           +        SL + + +  ++A  + YL+ N++     H DL + N ++ E     +GDF
Sbjct: 120 ENNPVLAPPSLSKMIQMAGEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDF 175
Query: 313 GLAKFLFEESNTPSKNQTMSNGLKG--SVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT 369
           G+ + ++E             G KG   V ++ PE + +G  +   D++S+G++L EI T
Sbjct: 176 GMTRDIYE-------TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 165 IGSGSFGSVYKGTL--ADGETA--AIKVLK---LQQQGALKSFIDECNALTSIRHRNILK 217
           +G GSFG V +G      G+T   A+K LK   L Q  A+  FI E NA+ S+ HRN+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
           +     +   +      +V E    G+L   L        HF  L  + R    + VA  
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSL---LDRLRKHQGHF-LLGTLSR--YAVQVAEG 127
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YL ++      H DL + N+LL    +  +GDFGL + L +  +    +  M    K 
Sbjct: 128 MGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD----HYVMQEHRKV 180
Query: 338 SVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRP 373
              +  PE +     S   D + +G+ L E+FT G+ P
Sbjct: 181 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 165 IGSGSFGSVYKGTL--ADGETA--AIKVLK---LQQQGALKSFIDECNALTSIRHRNILK 217
           +G GSFG V +G      G+T   A+K LK   L Q  A+  FI E NA+ S+ HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
           +     +   +      +V E    G+L   L        HF  L  + R    + VA  
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSL---LDRLRKHQGHF-LLGTLSR--YAVQVAEG 123
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YL ++      H DL + N+LL    +  +GDFGL + L +  +    +  M    K 
Sbjct: 124 MGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD----HYVMQEHRKV 176
Query: 338 SVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRP 373
              +  PE +     S   D + +G+ L E+FT G+ P
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 165 IGSGSFGSVYKGTL--ADGETA--AIKVLK---LQQQGALKSFIDECNALTSIRHRNILK 217
           +G GSFG V +G      G+T   A+K LK   L Q  A+  FI E NA+ S+ HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
           +     +   +      +V E    G+L   L        HF  L  + R    + VA  
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSL---LDRLRKHQGHF-LLGTLSR--YAVQVAEG 123
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YL ++      H DL + N+LL    +  +GDFGL + L +  +    +  M    K 
Sbjct: 124 MGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD----HYVMQEHRKV 176
Query: 338 SVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRP 373
              +  PE +     S   D + +G+ L E+FT G+ P
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 90/214 (42%), Gaps = 29/214 (13%)
Query: 165 IGSGSFGSV----YKGT-LADGETAAIKVLKL----QQQGALKSFIDECNALTSIRHRNI 215
           +G G FG V    Y  T    GE  A+K LK     Q +   K  ID    L ++ H +I
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEID---ILRTLYHEHI 78
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           +K    C     +G     LV E++  G+L  +L   +        + L Q L     + 
Sbjct: 79  IKYKGCCED---QGEKSLQLVMEYVPLGSLRDYLPRHS--------IGLAQLLLFAQQIC 127
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
             + YLH+Q+     H +L + NVLLD   +  +GDFGLAK + E        +   +G 
Sbjct: 128 EGMAYLHSQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY---YRVREDGD 181
Query: 336 KGSVGYIPPEYINGHVSILGDIYSYGILLLEIFT 369
                Y P            D++S+G+ L E+ T
Sbjct: 182 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 106/240 (44%), Gaps = 33/240 (13%)
Query: 141 NEWQSGLSYLKISNATDNFSEENLIGSGSFGSVY----KGTLADGETAAIKVLKLQQQGA 196
           +EW+     + +S           +G GSFG VY    KG + D     + +  + +  +
Sbjct: 18  DEWEVAREKITMSRE---------LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 68
Query: 197 LKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PST 253
           ++  I+  N  + ++  N   +V     V  +G     ++ E M  G+L  +L    P  
Sbjct: 69  MRERIEFLNEASVMKEFNCHHVVRLLGVVS-QGQP-TLVIMELMTRGDLKSYLRSLRPEM 126
Query: 254 DEYCHFKKLSLMQRLNIVIDVASALDYLH-NQYDTPIAHCDLKSSNVLLDEGMIAHVGDF 312
           +        SL + + +  ++A  + YL+ N++     H DL + N ++ E     +GDF
Sbjct: 127 ENNPVLAPPSLSKMIQMAGEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDF 182
Query: 313 GLAKFLFEESNTPSKNQTMSNGLKG--SVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT 369
           G+ + ++E             G KG   V ++ PE + +G  +   D++S+G++L EI T
Sbjct: 183 GMTRDIYE-------TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 165 IGSGSFGSVYKGTL--ADGETA--AIKVLK---LQQQGALKSFIDECNALTSIRHRNILK 217
           +G GSFG V +G      G+T   A+K LK   L Q  A+  FI E NA+ S+ HRN+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
           +     +   +      +V E    G+L   L        HF  L  + R    + VA  
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSL---LDRLRKHQGHF-LLGTLSR--YAVQVAEG 133
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YL ++      H DL + N+LL    +  +GDFGL + L +  +    +  M    K 
Sbjct: 134 MGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD----HYVMQEHRKV 186
Query: 338 SVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRP 373
              +  PE +     S   D + +G+ L E+FT G+ P
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 108/237 (45%), Gaps = 30/237 (12%)
Query: 145 SGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDEC 204
           SGL  L           +  IG G FG V++G    GE  A+K+   +++   +S+  E 
Sbjct: 30  SGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE---RSWFREA 85
Query: 205 NALTSI--RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKL 262
               ++  RH NIL  +++ +  +        LV ++  +G+L  +L+  T        +
Sbjct: 86  EIYQTVMLRHENILGFIAADNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYT--------V 136
Query: 263 SLMQRLNIVIDVASALDYLH-----NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF 317
           ++   + + +  AS L +LH      Q    IAH DLKS N+L+ +     + D GLA  
Sbjct: 137 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-- 194
Query: 318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSI-------LGDIYSYGILLLEI 367
           +  +S T + +    N   G+  Y+ PE ++  +++         DIY+ G++  EI
Sbjct: 195 VRHDSATDTID-IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 106/240 (44%), Gaps = 33/240 (13%)
Query: 141 NEWQSGLSYLKISNATDNFSEENLIGSGSFGSVY----KGTLADGETAAIKVLKLQQQGA 196
           +EW+     + +S           +G GSFG VY    KG + D     + +  + +  +
Sbjct: 9   DEWEVAREKITMSRE---------LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 59
Query: 197 LKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PST 253
           ++  I+  N  + ++  N   +V     V  +G     ++ E M  G+L  +L    P  
Sbjct: 60  MRERIEFLNEASVMKEFNCHHVVRLLGVVS-QGQP-TLVIMELMTRGDLKSYLRSLRPEM 117
Query: 254 DEYCHFKKLSLMQRLNIVIDVASALDYLH-NQYDTPIAHCDLKSSNVLLDEGMIAHVGDF 312
           +        SL + + +  ++A  + YL+ N++     H DL + N ++ E     +GDF
Sbjct: 118 ENNPVLAPPSLSKMIQMAGEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDF 173
Query: 313 GLAKFLFEESNTPSKNQTMSNGLKG--SVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT 369
           G+ + ++E             G KG   V ++ PE + +G  +   D++S+G++L EI T
Sbjct: 174 GMTRDIYE-------TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 165 IGSGSFGSVYKGTL--ADGETA--AIKVLK---LQQQGALKSFIDECNALTSIRHRNILK 217
           +G GSFG V +G      G+T   A+K LK   L Q  A+  FI E NA+ S+ HRN+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
           +     +   +      +V E    G+L   L        HF  L  + R    + VA  
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSL---LDRLRKHQGHF-LLGTLSR--YAVQVAEG 127
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YL ++      H DL + N+LL    +  +GDFGL + L +  +    +  M    K 
Sbjct: 128 MGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD----HYVMQEHRKV 180
Query: 338 SVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRP 373
              +  PE +     S   D + +G+ L E+FT G+ P
Sbjct: 181 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 106/240 (44%), Gaps = 33/240 (13%)
Query: 141 NEWQSGLSYLKISNATDNFSEENLIGSGSFGSVY----KGTLADGETAAIKVLKLQQQGA 196
           +EW+     + +S           +G GSFG VY    KG + D     + +  + +  +
Sbjct: 11  DEWEVAREKITMSRE---------LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 61
Query: 197 LKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PST 253
           ++  I+  N  + ++  N   +V     V  +G     ++ E M  G+L  +L    P  
Sbjct: 62  MRERIEFLNEASVMKEFNCHHVVRLLGVVS-QGQP-TLVIMELMTRGDLKSYLRSLRPEM 119
Query: 254 DEYCHFKKLSLMQRLNIVIDVASALDYLH-NQYDTPIAHCDLKSSNVLLDEGMIAHVGDF 312
           +        SL + + +  ++A  + YL+ N++     H DL + N ++ E     +GDF
Sbjct: 120 ENNPVLAPPSLSKMIQMAGEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDF 175
Query: 313 GLAKFLFEESNTPSKNQTMSNGLKG--SVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT 369
           G+ + ++E             G KG   V ++ PE + +G  +   D++S+G++L EI T
Sbjct: 176 GMTRDIYE-------TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 103/217 (47%), Gaps = 30/217 (13%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSI--RHRNILKIVSSC 222
           IG G FG V++G    GE  A+K+   +++   +S+  E     ++  RH NIL  +++ 
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +  +        LV ++  +G+L  +L+  T        +++   + + +  AS L +LH
Sbjct: 67  NKDNGTWTQL-WLVSDYHEHGSLFDYLNRYT--------VTVEGMIKLALSTASGLAHLH 117
Query: 283 -----NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
                 Q    IAH DLKS N+L+ +     + D GLA  +  +S T + +    N   G
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTID-IAPNHRVG 174
Query: 338 SVGYIPPEYINGHVSI-------LGDIYSYGILLLEI 367
           +  Y+ PE ++  +++         DIY+ G++  EI
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 101/233 (43%), Gaps = 35/233 (15%)
Query: 151 KISNATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNA 206
           K   A ++F     +G G FG+VY       +   A+KVL   +L++ G       E   
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM- 265
            + +RH NIL++        +       L+ E+   G +          Y   +KLS   
Sbjct: 62  QSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSKFD 106
Query: 266 -QRLNIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
            QR    I ++A+AL Y H++    + H D+K  N+LL       + DFG +       +
Sbjct: 107 EQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS------VH 157
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRPTD 375
            PS  +     L G++ Y+PPE I G +     D++S G+L  E   GK P +
Sbjct: 158 APSSRRA---ALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 103/217 (47%), Gaps = 30/217 (13%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSI--RHRNILKIVSSC 222
           IG G FG V++G    GE  A+K+   +++   +S+  E     ++  RH NIL  +++ 
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAAD 69
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +  +        LV ++  +G+L  +L+  T        +++   + + +  AS L +LH
Sbjct: 70  NKDNGTWTQL-WLVSDYHEHGSLFDYLNRYT--------VTVEGMIKLALSTASGLAHLH 120
Query: 283 -----NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
                 Q    IAH DLKS N+L+ +     + D GLA  +  +S T + +    N   G
Sbjct: 121 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTID-IAPNHRVG 177
Query: 338 SVGYIPPEYINGHVSI-------LGDIYSYGILLLEI 367
           +  Y+ PE ++  +++         DIY+ G++  EI
Sbjct: 178 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 103/217 (47%), Gaps = 30/217 (13%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSI--RHRNILKIVSSC 222
           IG G FG V++G    GE  A+K+   +++   +S+  E     ++  RH NIL  +++ 
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAAD 67
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +  +        LV ++  +G+L  +L+  T        +++   + + +  AS L +LH
Sbjct: 68  NKDNGTWTQL-WLVSDYHEHGSLFDYLNRYT--------VTVEGMIKLALSTASGLAHLH 118
Query: 283 -----NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
                 Q    IAH DLKS N+L+ +     + D GLA  +  +S T + +    N   G
Sbjct: 119 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTID-IAPNHRVG 175
Query: 338 SVGYIPPEYINGHVSI-------LGDIYSYGILLLEI 367
           +  Y+ PE ++  +++         DIY+ G++  EI
Sbjct: 176 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 88/211 (41%), Gaps = 23/211 (10%)
Query: 165 IGSGSFGSV----YKGT-LADGETAAIKVLKLQQQGALKS-FIDECNALTSIRHRNILKI 218
           +G G FG V    Y  T    GE  A+K LK       +S +  E + L ++ H +I+K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
              C      G     LV E++  G+L  +L   +        + L Q L     +   +
Sbjct: 99  KGCCEDA---GAASLQLVMEYVPLGSLRDYLPRHS--------IGLAQLLLFAQQICEGM 147
Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
            YLH Q+     H DL + NVLLD   +  +GDFGLAK + E        +   +G    
Sbjct: 148 AYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEX---YRVREDGDSPV 201
Query: 339 VGYIPPEYINGHVSILGDIYSYGILLLEIFT 369
             Y P            D++S+G+ L E+ T
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 24/216 (11%)
Query: 165 IGSGSFGSVY----KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVS 220
           +G GSFG VY    KG + D     + +  + +  +++  I+  N  + ++  N   +V 
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCHFKKLSLMQRLNIVIDVASA 277
               V  +G     ++ E M  G+L  +L    P  +        SL + + +  ++A  
Sbjct: 80  LLGVVS-QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 137
Query: 278 LDYLH-NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
           + YL+ N++     H DL + N ++ E     +GDFG+ + ++E             G K
Sbjct: 138 MAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-------TDYYRKGGK 186
Query: 337 G--SVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT 369
           G   V ++ PE + +G  +   D++S+G++L EI T
Sbjct: 187 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLADGETA-AIKVLKLQ---QQGALKSFIDECNALTSIRH 212
           D+F     IG GSFG V      D +   A+K +  Q   ++  +++   E   +  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             ++ +  S     ++  +   +V + +  G+L   L  +     HFK+ ++      + 
Sbjct: 75  PFLVNLWYS-----FQDEEDMFMVVDLLLGGDLRYHLQQNV----HFKEETVKL---FIC 122
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           ++  ALDYL NQ    I H D+K  N+LLDE    H+ DF +A  L      P + Q  +
Sbjct: 123 ELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAML------PRETQITT 173
Query: 333 NGLKGSVGYIPPEYINGH----VSILGDIYSYGILLLEIFTGKRP 373
             + G+  Y+ PE  +       S   D +S G+   E+  G+RP
Sbjct: 174 --MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 103/217 (47%), Gaps = 30/217 (13%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSI--RHRNILKIVSSC 222
           IG G FG V++G    GE  A+K+   +++   +S+  E     ++  RH NIL  +++ 
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAAD 72
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           +  +        LV ++  +G+L  +L+  T        +++   + + +  AS L +LH
Sbjct: 73  NKDNGTWTQL-WLVSDYHEHGSLFDYLNRYT--------VTVEGMIKLALSTASGLAHLH 123
Query: 283 -----NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
                 Q    IAH DLKS N+L+ +     + D GLA  +  +S T + +    N   G
Sbjct: 124 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTID-IAPNHRVG 180
Query: 338 SVGYIPPEYINGHVSI-------LGDIYSYGILLLEI 367
           +  Y+ PE ++  +++         DIY+ G++  EI
Sbjct: 181 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 108/237 (45%), Gaps = 30/237 (12%)
Query: 145 SGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDEC 204
           SGL  L           +  IG G FG V++G    GE  A+K+   +++   +S+  E 
Sbjct: 17  SGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE---RSWFREA 72
Query: 205 NALTSI--RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKL 262
               ++  RH NIL  +++ +  +        LV ++  +G+L  +L+  T        +
Sbjct: 73  EIYQTVMLRHENILGFIAADNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYT--------V 123
Query: 263 SLMQRLNIVIDVASALDYLH-----NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF 317
           ++   + + +  AS L +LH      Q    IAH DLKS N+L+ +     + D GLA  
Sbjct: 124 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-- 181
Query: 318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSI-------LGDIYSYGILLLEI 367
           +  +S T + +    N   G+  Y+ PE ++  +++         DIY+ G++  EI
Sbjct: 182 VRHDSATDTID-IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 155 ATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNALTSI 210
           A ++F     +G G FG+VY       +   A+KVL   +L++ G       E    + +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM--QRL 268
           RH NIL++        +       L+ E+   G +          Y   +KLS    QR 
Sbjct: 92  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSKFDEQRT 136
Query: 269 NIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
              I ++A+AL Y H++    + H D+K  N+LL       + DFG +       + PS 
Sbjct: 137 ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS------VHAPS- 186
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
             +  + L G++ Y+PPE I G +     D++S G+L  E   GK P
Sbjct: 187 --SRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 24/216 (11%)
Query: 165 IGSGSFGSVY----KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVS 220
           +G GSFG VY    KG + D     + +  + +  +++  I+  N  + ++  N   +V 
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCHFKKLSLMQRLNIVIDVASA 277
               V  +G     ++ E M  G+L  +L    P  +        SL + + +  ++A  
Sbjct: 87  LLGVVS-QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 144
Query: 278 LDYLH-NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
           + YL+ N++     H DL + N ++ E     +GDFG+ + ++E             G K
Sbjct: 145 MAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-------TDYYRKGGK 193
Query: 337 G--SVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT 369
           G   V ++ PE + +G  +   D++S+G++L EI T
Sbjct: 194 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 24/216 (11%)
Query: 165 IGSGSFGSVY----KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVS 220
           +G GSFG VY    KG + D     + +  + +  +++  I+  N  + ++  N   +V 
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCHFKKLSLMQRLNIVIDVASA 277
               V  +G     ++ E M  G+L  +L    P  +        SL + + +  ++A  
Sbjct: 115 LLGVVS-QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 172
Query: 278 LDYLH-NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
           + YL+ N++     H DL + N ++ E     +GDFG+ + ++E             G K
Sbjct: 173 MAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-------TDYYRKGGK 221
Query: 337 G--SVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT 369
           G   V ++ PE + +G  +   D++S+G++L EI T
Sbjct: 222 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 102/235 (43%), Gaps = 38/235 (16%)
Query: 152 ISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIR 211
           I++  + F++   IG GSFG V+KG   D  T        QQ  A+K    E        
Sbjct: 18  IADPEELFTKLERIGKGSFGEVFKGI--DNRT--------QQVVAIKIIDLEEAEDEIED 67
Query: 212 HRNILKIVSSCSS---VDYEGNDFKA----LVFEFMRNGN-LDQWLHPSTDEYCHFKKLS 263
            +  + ++S C S     Y G+  K     ++ E++  G+ LD       DE+       
Sbjct: 68  IQQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEF------- 120
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
             Q   ++ ++   LDYLH++      H D+K++NVLL E     + DFG+A  L     
Sbjct: 121 --QIATMLKEILKGLDYLHSEKKI---HRDIKAANVLLSEQGDVKLADFGVAGQL----- 170
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFTGKRPTDDM 377
             +  Q   N   G+  ++ PE I         DI+S GI  +E+  G+ P  DM
Sbjct: 171 --TDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 223

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 155 ATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNALTSI 210
           A ++F     +G G FG+VY       +   A+KVL   +L++ G       E    + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM--QRL 268
           RH NIL++        +       L+ E+   G +          Y   +KLS    QR 
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSKFDEQRT 113
Query: 269 NIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
              I ++A+AL Y H++    + H D+K  N+LL       + DFG +       + PS 
Sbjct: 114 ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS------VHAPSS 164
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
            +   + L G++ Y+PPE I G +     D++S G+L  E   GK P
Sbjct: 165 RR---DDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 35/229 (15%)
Query: 155 ATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNALTSI 210
           A ++F     +G G FG+VY       +   A+KVL   +L++ G       E    + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM--QRL 268
           RH NIL++        +       L+ E+   G +          Y   +KLS    QR 
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSKFDEQRT 113
Query: 269 NIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
              I ++A+AL Y H++    + H D+K  N+LL       + DFG +       + PS 
Sbjct: 114 ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS------VHAPSS 164
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRPTD 375
            +     L G++ Y+PPE I G +     D++S G+L  E   GK P +
Sbjct: 165 RRA---ALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 107/227 (47%), Gaps = 32/227 (14%)
Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D+F + + +G+G+ G V+K +    G   A K++ L+ + A+++ I        IR   +
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--------IRELQV 60
Query: 216 LKIVSSCSSVDYEGNDFK----ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           L   +S   V + G  +     ++  E M  G+LDQ L  +        ++       + 
Sbjct: 61  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-------RIPEQILGKVS 113
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
           I V   L YL  ++   I H D+K SN+L++      + DFG++  L +E         M
Sbjct: 114 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE---------M 162
Query: 332 SNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDM 377
           +N   G+  Y+ PE + G H S+  DI+S G+ L+E+  G+ P   M
Sbjct: 163 ANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPM 209

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 155 ATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNALTSI 210
           A ++F     +G G FG+VY       +   A+KVL   +L++ G       E    + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM--QRL 268
           RH NIL++        +       L+ E+   G +          Y   +KLS    QR 
Sbjct: 67  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSKFDEQRT 111
Query: 269 NIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
              I ++A+AL Y H++    + H D+K  N+LL       + DFG +       + PS 
Sbjct: 112 ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS------VHAPSS 162
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
            +   + L G++ Y+PPE I G +     D++S G+L  E   GK P
Sbjct: 163 RR---DTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 155 ATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNALTSI 210
           A ++F     +G G FG+VY       +   A+KVL   +L++ G       E    + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM--QRL 268
           RH NIL++        +       L+ E+   G +          Y   +KLS    QR 
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSKFDEQRT 113
Query: 269 NIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
              I ++A+AL Y H++    + H D+K  N+LL       + +FG +       + PS 
Sbjct: 114 ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIANFGWS------VHAPSS 164
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRPTD 375
            +T    L G++ Y+PPE I G +     D++S G+L  E   GK P +
Sbjct: 165 RRTT---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 89/214 (41%), Gaps = 29/214 (13%)
Query: 165 IGSGSFGSV----YKGT-LADGETAAIKVLKL----QQQGALKSFIDECNALTSIRHRNI 215
           +G G FG V    Y  T    GE  A+K LK     Q +   K  ID    L ++ H +I
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEID---ILRTLYHEHI 78
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           +K    C     +G     LV E++  G+L  +L   +        + L Q L     + 
Sbjct: 79  IKYKGCCED---QGEKSLQLVMEYVPLGSLRDYLPRHS--------IGLAQLLLFAQQIC 127
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
             + YLH Q+     H +L + NVLLD   +  +GDFGLAK + E        +   +G 
Sbjct: 128 EGMAYLHAQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY---YRVREDGD 181
Query: 336 KGSVGYIPPEYINGHVSILGDIYSYGILLLEIFT 369
                Y P            D++S+G+ L E+ T
Sbjct: 182 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 155 ATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNALTSI 210
           A ++F     +G G FG+VY       +   A+KVL   +L++ G       E    + +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM--QRL 268
           RH NIL++        +       L+ E+   G +          Y   +KLS    QR 
Sbjct: 68  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSKFDEQRT 112
Query: 269 NIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
              I ++A+AL Y H++    + H D+K  N+LL       + +FG +       + PS 
Sbjct: 113 ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIANFGWS------VHAPSS 163
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
            +T    L G++ Y+PPE I G +     D++S G+L  E   GK P
Sbjct: 164 RRTT---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 106/240 (44%), Gaps = 33/240 (13%)
Query: 141 NEWQSGLSYLKISNATDNFSEENLIGSGSFGSVY----KGTLADGETAAIKVLKLQQQGA 196
           +EW+     + +S           +G GSFG VY    KG + D     + +  + +  +
Sbjct: 18  DEWEVAREKITMSRE---------LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 68
Query: 197 LKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PST 253
           ++  I+  N  + ++  N   +V     V  +G     ++ E M  G+L  +L    P+ 
Sbjct: 69  MRERIEFLNEASVMKEFNCHHVVRLLGVVS-QGQP-TLVIMELMTRGDLKSYLRSLRPAM 126
Query: 254 DEYCHFKKLSLMQRLNIVIDVASALDYLH-NQYDTPIAHCDLKSSNVLLDEGMIAHVGDF 312
                    SL + + +  ++A  + YL+ N++     H DL + N ++ E     +GDF
Sbjct: 127 ANNPVLAPPSLSKMIQMAGEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDF 182
Query: 313 GLAKFLFEESNTPSKNQTMSNGLKG--SVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT 369
           G+ + ++E             G KG   V ++ PE + +G  +   D++S+G++L EI T
Sbjct: 183 GMTRDIYE-------TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 105/240 (43%), Gaps = 33/240 (13%)
Query: 141 NEWQSGLSYLKISNATDNFSEENLIGSGSFGSVY----KGTLADGETAAIKVLKLQQQGA 196
           +EW+     + +S           +G GSFG VY    KG + D     + +  + +  +
Sbjct: 3   DEWEVAREKITMSRE---------LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 53
Query: 197 LKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PST 253
           ++  I+  N  + ++  N   +V     V  +G     ++ E M  G+L  +L    P  
Sbjct: 54  MRERIEFLNEASVMKEFNCHHVVRLLGVVS-QGQP-TLVIMELMTRGDLKSYLRSLRPEM 111
Query: 254 DEYCHFKKLSLMQRLNIVIDVASALDYLH-NQYDTPIAHCDLKSSNVLLDEGMIAHVGDF 312
           +        SL + + +  ++A  + YL+ N++     H DL + N ++ E     +GDF
Sbjct: 112 ENNPVLAPPSLSKMIQMAGEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDF 167
Query: 313 GLAKFLFEESNTPSKNQTMSNGLKG--SVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT 369
           G+ + + E             G KG   V ++ PE + +G  +   D++S+G++L EI T
Sbjct: 168 GMTRDIXE-------TDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 101/233 (43%), Gaps = 35/233 (15%)
Query: 151 KISNATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNA 206
           K   A ++F     +G G FG+VY       +   A+KVL   +L++ G       E   
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM- 265
            + +RH NIL++        +       L+ E+   G +          Y   +KLS   
Sbjct: 65  QSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSKFD 109
Query: 266 -QRLNIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
            QR    I ++A+AL Y H++    + H D+K  N+LL       + DFG +       +
Sbjct: 110 EQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS------VH 160
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRPTD 375
            PS  +     L G++ Y+PPE I G +     D++S G+L  E   GK P +
Sbjct: 161 APSSRRXX---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 35/227 (15%)
Query: 155 ATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNALTSI 210
           A ++F     +G G FG+VY       +   A+KVL   +L++ G       E    + +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM--QRL 268
           RH NIL++        +       L+ E+   G +          Y   +KLS    QR 
Sbjct: 68  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSKFDEQRT 112
Query: 269 NIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
              I ++A+AL Y H++    + H D+K  N+LL       + DFG +       + PS 
Sbjct: 113 ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS------VHAPSS 163
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
            +     L G++ Y+PPE I G +     D++S G+L  E   GK P
Sbjct: 164 RRXX---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 102/226 (45%), Gaps = 32/226 (14%)
Query: 156 TDNFSEENLIGSGSFGSVY--KGTLADGETAAIKVL---KLQQQGALKSFIDECNALTSI 210
           +D +  + ++G GSFG V   K  +  G+  A+KV+   +++Q+   +S + E   L  +
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
            H NI K+        +E   +  LV E    G L        DE    K+ S +    I
Sbjct: 84  DHPNIXKLYEF-----FEDKGYFYLVGEVYTGGEL-------FDEIISRKRFSEVDAARI 131
Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLFEESNTPSK 327
           +  V S + Y H      I H DLK  N+LL+   +     + DFGL+     E++   K
Sbjct: 132 IRQVLSGITYXHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKXK 186
Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRP 373
           ++       G+  YI PE ++G      D++S G++L  + +G  P
Sbjct: 187 DKI------GTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPP 226

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 101/233 (43%), Gaps = 35/233 (15%)
Query: 151 KISNATDNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNA 206
           K   A ++F     +G G FG+VY       +   A+KVL   +L++ G       E   
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM- 265
            + +RH NIL++        +       L+ E+   G +          Y   +KLS   
Sbjct: 62  QSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSKFD 106
Query: 266 -QRLNIVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
            QR    I ++A+AL Y H++    + H D+K  N+LL       + DFG +       +
Sbjct: 107 EQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS------VH 157
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRPTD 375
            PS  +     L G++ Y+PPE I G +     D++S G+L  E   GK P +
Sbjct: 158 APSSRRXX---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 106/240 (44%), Gaps = 33/240 (13%)
Query: 141 NEWQSGLSYLKISNATDNFSEENLIGSGSFGSVY----KGTLADGETAAIKVLKLQQQGA 196
           +EW+     + +S           +G GSFG VY    KG + D     + +  + +  +
Sbjct: 8   DEWEVAREKITMSRE---------LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 58
Query: 197 LKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PST 253
           ++  I+  N  + ++  N   +V     V  +G     ++ E M  G+L  +L    P+ 
Sbjct: 59  MRERIEFLNEASVMKEFNCHHVVRLLGVVS-QGQP-TLVIMELMTRGDLKSYLRSLRPAM 116
Query: 254 DEYCHFKKLSLMQRLNIVIDVASALDYLH-NQYDTPIAHCDLKSSNVLLDEGMIAHVGDF 312
                    SL + + +  ++A  + YL+ N++     H DL + N ++ E     +GDF
Sbjct: 117 ANNPVLAPPSLSKMIQMAGEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDF 172
Query: 313 GLAKFLFEESNTPSKNQTMSNGLKG--SVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT 369
           G+ + ++E             G KG   V ++ PE + +G  +   D++S+G++L EI T
Sbjct: 173 GMTRDIYE-------TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 105/240 (43%), Gaps = 33/240 (13%)
Query: 141 NEWQSGLSYLKISNATDNFSEENLIGSGSFGSVY----KGTLADGETAAIKVLKLQQQGA 196
           +EW+     + +S           +G GSFG VY    KG + D     + +  + +  +
Sbjct: 12  DEWEVAREKITMSRE---------LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 62
Query: 197 LKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PST 253
           ++  I+  N  + ++  N   +V     V  +G     ++ E M  G+L  +L    P  
Sbjct: 63  MRERIEFLNEASVMKEFNCHHVVRLLGVVS-QGQP-TLVIMELMTRGDLKSYLRSLRPEM 120
Query: 254 DEYCHFKKLSLMQRLNIVIDVASALDYLH-NQYDTPIAHCDLKSSNVLLDEGMIAHVGDF 312
           +        SL + + +  ++A  + YL+ N++     H DL + N ++ E     +GDF
Sbjct: 121 ENNPVLAPPSLSKMIQMAGEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDF 176
Query: 313 GLAKFLFEESNTPSKNQTMSNGLKG--SVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT 369
           G+ + + E             G KG   V ++ PE + +G  +   D++S+G++L EI T
Sbjct: 177 GMTRDIXE-------TDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 105/240 (43%), Gaps = 33/240 (13%)
Query: 141 NEWQSGLSYLKISNATDNFSEENLIGSGSFGSVY----KGTLADGETAAIKVLKLQQQGA 196
           +EW+     + +S           +G GSFG VY    KG + D     + +  + +  +
Sbjct: 5   DEWEVAREKITMSRE---------LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 55
Query: 197 LKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PST 253
           ++  I+  N  + ++  N   +V     V  +G     ++ E M  G+L  +L    P  
Sbjct: 56  MRERIEFLNEASVMKEFNCHHVVRLLGVVS-QGQP-TLVIMELMTRGDLKSYLRSLRPEM 113
Query: 254 DEYCHFKKLSLMQRLNIVIDVASALDYLH-NQYDTPIAHCDLKSSNVLLDEGMIAHVGDF 312
           +        SL + + +  ++A  + YL+ N++     H DL + N  + E     +GDF
Sbjct: 114 ENNPVLAPPSLSKMIQMAGEIADGMAYLNANKF----VHRDLAARNCXVAEDFTVKIGDF 169
Query: 313 GLAKFLFEESNTPSKNQTMSNGLKG--SVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT 369
           G+ + ++E             G KG   V ++ PE + +G  +   D++S+G++L EI T
Sbjct: 170 GMTRDIYE-------TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 113/241 (46%), Gaps = 40/241 (16%)
Query: 154 NATDNFSEENL-----IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKS--FIDECNA 206
           N    F   NL     +G+G+FG V + T A G      VLK+  +  LKS    DE  A
Sbjct: 38  NEKWEFPRNNLQFGKTLGAGAFGKVVEAT-AFGLGKEDAVLKVAVK-MLKSTAHADEKEA 95
Query: 207 LTSI--------RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDE 255
           L S         +H NI+ ++ +C+     G     ++ E+   G+L  +L    P   E
Sbjct: 96  LMSELKIMSHLGQHENIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKRPPGLE 150
Query: 256 YCH------FKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV 309
           Y +       ++LS    L+    VA  + +L ++      H D+ + NVLL  G +A +
Sbjct: 151 YSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKI 207
Query: 310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIF 368
           GDFGLA+ +  +SN   K        +  V ++ PE I   V ++  D++SYGILL EIF
Sbjct: 208 GDFGLARDIMNDSNYIVKGNA-----RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 262
Query: 369 T 369
           +
Sbjct: 263 S 263

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 89/211 (42%), Gaps = 23/211 (10%)
Query: 165 IGSGSFGSV----YKGT-LADGETAAIKVLKLQQQGALKS-FIDECNALTSIRHRNILKI 218
           +G G FG V    Y  T    GE  A+K LK      L+S +  E   L ++ H +I+K 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
              C     +G     LV E++  G+L  +L      +C    + L Q L     +   +
Sbjct: 77  KGCCED---QGEKSVQLVMEYVPLGSLRDYL----PRHC----VGLAQLLLFAQQICEGM 125
Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
            YLH Q+     H  L + NVLLD   +  +GDFGLAK + E        +   +G    
Sbjct: 126 AYLHAQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEY---YRVREDGDSPV 179
Query: 339 VGYIPPEYINGHVSILGDIYSYGILLLEIFT 369
             Y P            D++S+G+ L E+ T
Sbjct: 180 FWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 108/225 (48%), Gaps = 36/225 (16%)
Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D+F + + +G+G+ G V+K +    G   A K++ L+ + A+++ I        IR   +
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--------IRELQV 119
Query: 216 LKIVSSCSSVDYEGNDFK----ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL--N 269
           L   +S   V + G  +     ++  E M  G+LDQ L          K   + +++   
Sbjct: 120 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---------KAGRIPEQILGK 170
Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
           + I V   L YL  ++   I H D+K SN+L++      + DFG++  L +         
Sbjct: 171 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--------- 219
Query: 330 TMSNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRP 373
           +M+N   G+  Y+ PE + G H S+  DI+S G+ L+E+  G+ P
Sbjct: 220 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 89/211 (42%), Gaps = 23/211 (10%)
Query: 165 IGSGSFGSV----YKGT-LADGETAAIKVLKLQQQGALKS-FIDECNALTSIRHRNILKI 218
           +G G FG V    Y  T    GE  A+K LK      L+S +  E   L ++ H +I+K 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
              C     +G     LV E++  G+L  +L      +C    + L Q L     +   +
Sbjct: 76  KGCCED---QGEKSVQLVMEYVPLGSLRDYL----PRHC----VGLAQLLLFAQQICEGM 124
Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
            YLH Q+     H  L + NVLLD   +  +GDFGLAK + E        +   +G    
Sbjct: 125 AYLHAQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEY---YRVREDGDSPV 178
Query: 339 VGYIPPEYINGHVSILGDIYSYGILLLEIFT 369
             Y P            D++S+G+ L E+ T
Sbjct: 179 FWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 28/221 (12%)
Query: 163 NLIGSGSFGSVYKGT-LADGETA----AIKVLKLQQQ-GALKSFIDECNALTSIRHRNIL 216
            ++GSG+FG+VYKG  + DGE      AIKVL+      A K  +DE   +  +    + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           +++  C +   +      LV + M  G L   +  +        +L     LN  + +A 
Sbjct: 83  RLLGICLTSTVQ------LVTQLMPYGCLLDHVRENR------GRLGSQDLLNWCMQIAK 130
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            + YL    D  + H DL + NVL+       + DFGLA+ L        + +  ++G K
Sbjct: 131 GMSYLE---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLL-----DIDETEYHADGGK 182
Query: 337 GSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTD 375
             + ++  E I     +   D++SYG+ + E+ T G +P D
Sbjct: 183 VPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYD 223

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 154 NATDNFSEENL-----IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKS--FIDECNA 206
           N    F   NL     +G+G+FG V + T A G      VLK+  +  LKS    DE  A
Sbjct: 38  NEKWEFPRNNLQFGKTLGAGAFGKVVEAT-AFGLGKEDAVLKVAVK-MLKSTAHADEKEA 95
Query: 207 LTSI--------RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTD---E 255
           L S         +H NI+ ++ +C+     G     ++ E+   G+L  +L    +   +
Sbjct: 96  LMSELKIMSHLGQHENIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKAEADLD 150
Query: 256 YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA 315
               + L L   L+    VA  + +L ++      H D+ + NVLL  G +A +GDFGLA
Sbjct: 151 KEDGRPLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLA 207
Query: 316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
           + +  +SN   K        +  V ++ PE I   V ++  D++SYGILL EIF+
Sbjct: 208 RDIMNDSNYIVKGNA-----RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 32/223 (14%)
Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D+F + + +G+G+ G V+K +    G   A K++ L+ + A+++ I        IR   +
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--------IRELQV 57
Query: 216 LKIVSSCSSVDYEGNDFK----ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           L   +S   V + G  +     ++  E M  G+LDQ L  +        ++       + 
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-------RIPEQILGKVS 110
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
           I V   L YL  ++   I H D+K SN+L++      + DFG++  L +         +M
Sbjct: 111 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---------SM 159
Query: 332 SNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRP 373
           +N   G+  Y+ PE + G H S+  DI+S G+ L+E+  G+ P
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 40/230 (17%)
Query: 158 NFSEENLIGSGSFGSV---YKGTLADGETAAIKVL--KLQQQGALKSFID-ECNALTSIR 211
           N+     +G GSFG V   Y  T   G+  A+K++  K+  +  ++  I+ E + L  +R
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 62
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H +I+K+     S      D   +V E+  N   D  +           K+S  +     
Sbjct: 63  HPHIIKLYDVIKS-----KDEIIMVIEYAGNELFDYIVQRD--------KMSEQEARRFF 109
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
             + SA++Y H      I H DLK  N+LLDE +   + DFGL+  +           T 
Sbjct: 110 QQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-----------TD 155
Query: 332 SNGLKGSVG---YIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDD 376
            N LK S G   Y  PE I+G  +     D++S G++L  +   + P DD
Sbjct: 156 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 205

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 108/227 (47%), Gaps = 29/227 (12%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKS--FIDECNALTSI---- 210
           +N      +G+G+FG V + T A G      VLK+  +  LKS    DE  AL S     
Sbjct: 38  NNLQFGKTLGAGAFGKVVEAT-AFGLGKEDAVLKVAVK-MLKSTAHADEKEALMSELKIM 95
Query: 211 ----RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTD---EYCHFKKLS 263
               +H NI+ ++ +C+     G     ++ E+   G+L  +L    +   +    + L 
Sbjct: 96  SHLGQHENIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKAEADLDKEDGRPLE 150
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
           L   L+    VA  + +L ++      H D+ + NVLL  G +A +GDFGLA+ +  +SN
Sbjct: 151 LRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 207
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
              K        +  V ++ PE I   V ++  D++SYGILL EIF+
Sbjct: 208 YIVKGNA-----RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 101/228 (44%), Gaps = 25/228 (10%)
Query: 148 SYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNA 206
           S + + +    ++    IG G+ G+VY    +A G+  AI+ + LQQQ   +  I+E   
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           +   ++ NI+  + S     Y   D   +V E++  G+L         E C    +   Q
Sbjct: 71  MRENKNPNIVNYLDS-----YLVGDELWVVMEYLAGGSLTD----VVTETC----MDEGQ 117
Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
              +  +   AL++LH+     + H D+KS N+LL       + DFG    +  E    S
Sbjct: 118 IAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---S 171
Query: 327 KNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFTGKRP 373
           K  TM     G+  ++ PE +         DI+S GI+ +E+  G+ P
Sbjct: 172 KRSTMV----GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 40/230 (17%)
Query: 158 NFSEENLIGSGSFGSV---YKGTLADGETAAIKVL--KLQQQGALKSFID-ECNALTSIR 211
           N+     +G GSFG V   Y  T   G+  A+K++  K+  +  ++  I+ E + L  +R
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 72
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H +I+K+     S      D   +V E+  N   D  +           K+S  +     
Sbjct: 73  HPHIIKLYDVIKS-----KDEIIMVIEYAGNELFDYIVQRD--------KMSEQEARRFF 119
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
             + SA++Y H      I H DLK  N+LLDE +   + DFGL+  +           T 
Sbjct: 120 QQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-----------TD 165
Query: 332 SNGLKGSVG---YIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDD 376
            N LK S G   Y  PE I+G  +     D++S G++L  +   + P DD
Sbjct: 166 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 215

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 106/245 (43%), Gaps = 40/245 (16%)
Query: 144 QSGLSYLK--ISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFI 201
           QSGL  ++   ++  + F++   IG GSFG V+KG   D  T  +  +K+         I
Sbjct: 7   QSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKI---------I 55
Query: 202 D-ECNALTSIRHRNILKIVSSCSS---VDYEGNDFK----ALVFEFMRNGNLDQWLHPST 253
           D E         +  + ++S C S     Y G+  K     ++ E++  G+    L P  
Sbjct: 56  DLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP 115
Query: 254 DEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG 313
                   L   Q   I+ ++   LDYLH++      H D+K++NVLL E     + DFG
Sbjct: 116 --------LDETQIATILREILKGLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFG 164
Query: 314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFTGKR 372
           +A  L       +  Q   N   G+  ++ PE I         DI+S GI  +E+  G+ 
Sbjct: 165 VAGQL-------TDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEP 217
Query: 373 PTDDM 377
           P  ++
Sbjct: 218 PHSEL 222

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 32/223 (14%)
Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D+F + + +G+G+ G V+K +    G   A K++ L+ + A+++ I        IR   +
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--------IRELQV 84
Query: 216 LKIVSSCSSVDYEGNDFK----ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           L   +S   V + G  +     ++  E M  G+LDQ L  +        ++       + 
Sbjct: 85  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-------RIPEQILGKVS 137
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
           I V   L YL  ++   I H D+K SN+L++      + DFG++  L +         +M
Sbjct: 138 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---------SM 186
Query: 332 SNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRP 373
           +N   G+  Y+ PE + G H S+  DI+S G+ L+E+  G+ P
Sbjct: 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 40/230 (17%)
Query: 158 NFSEENLIGSGSFGSV---YKGTLADGETAAIKVL--KLQQQGALKSFID-ECNALTSIR 211
           N+     +G GSFG V   Y  T   G+  A+K++  K+  +  ++  I+ E + L  +R
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 66
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H +I+K+     S      D   +V E+  N   D  +           K+S  +     
Sbjct: 67  HPHIIKLYDVIKS-----KDEIIMVIEYAGNELFDYIVQRD--------KMSEQEARRFF 113
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
             + SA++Y H      I H DLK  N+LLDE +   + DFGL+  +           T 
Sbjct: 114 QQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-----------TD 159
Query: 332 SNGLKGSVG---YIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDD 376
            N LK S G   Y  PE I+G  +     D++S G++L  +   + P DD
Sbjct: 160 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 209

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 40/230 (17%)
Query: 158 NFSEENLIGSGSFGSV---YKGTLADGETAAIKVL--KLQQQGALKSFID-ECNALTSIR 211
           N+     +G GSFG V   Y  T   G+  A+K++  K+  +  ++  I+ E + L  +R
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 71
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H +I+K+     S      D   +V E+  N   D  +           K+S  +     
Sbjct: 72  HPHIIKLYDVIKS-----KDEIIMVIEYAGNELFDYIVQRD--------KMSEQEARRFF 118
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
             + SA++Y H      I H DLK  N+LLDE +   + DFGL+  +           T 
Sbjct: 119 QQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-----------TD 164
Query: 332 SNGLKGSVG---YIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDD 376
            N LK S G   Y  PE I+G  +     D++S G++L  +   + P DD
Sbjct: 165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 32/223 (14%)
Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D+F + + +G+G+ G V+K +    G   A K++ L+ + A+++ I        IR   +
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--------IRELQV 57
Query: 216 LKIVSSCSSVDYEGNDFK----ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           L   +S   V + G  +     ++  E M  G+LDQ L  +        ++       + 
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-------RIPEQILGKVS 110
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
           I V   L YL  ++   I H D+K SN+L++      + DFG++  L +         +M
Sbjct: 111 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---------SM 159
Query: 332 SNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRP 373
           +N   G+  Y+ PE + G H S+  DI+S G+ L+E+  G+ P
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 32/223 (14%)
Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D+F + + +G+G+ G V+K +    G   A K++ L+ + A+++ I        IR   +
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--------IRELQV 57
Query: 216 LKIVSSCSSVDYEGNDFK----ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           L   +S   V + G  +     ++  E M  G+LDQ L  +        ++       + 
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-------RIPEQILGKVS 110
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
           I V   L YL  ++   I H D+K SN+L++      + DFG++  L +         +M
Sbjct: 111 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---------SM 159
Query: 332 SNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRP 373
           +N   G+  Y+ PE + G H S+  DI+S G+ L+E+  G+ P
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 42/223 (18%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSI--RHRNILKIVSSC 222
           +G G +G V++G L  GE+ A+K+   + +   +S+  E     ++  RH NIL  ++S 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDE---QSWFRETEIYNTVLLRHDNILGFIAS- 70
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWL------HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
                   D  +      RN +   WL      H S  ++   + L     L + +  A 
Sbjct: 71  --------DMTS------RNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAAC 116
Query: 277 ALDYLH-----NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
            L +LH      Q    IAH D KS NVL+   +   + D GLA    + S+        
Sbjct: 117 GLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIG--- 173
Query: 332 SNGLKGSVGYIPPEYINGHVSI-------LGDIYSYGILLLEI 367
           +N   G+  Y+ PE ++  +           DI+++G++L EI
Sbjct: 174 NNPRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 32/223 (14%)
Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D+F + + +G+G+ G V+K +    G   A K++ L+ + A+++ I        IR   +
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--------IRELQV 57
Query: 216 LKIVSSCSSVDYEGNDFK----ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           L   +S   V + G  +     ++  E M  G+LDQ L  +        ++       + 
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-------RIPEQILGKVS 110
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
           I V   L YL  ++   I H D+K SN+L++      + DFG++  L +         +M
Sbjct: 111 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---------SM 159
Query: 332 SNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRP 373
           +N   G+  Y+ PE + G H S+  DI+S G+ L+E+  G+ P
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 32/223 (14%)
Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D+F + + +G+G+ G V+K +    G   A K++ L+ + A+++ I        IR   +
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--------IRELQV 57
Query: 216 LKIVSSCSSVDYEGNDFK----ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           L   +S   V + G  +     ++  E M  G+LDQ L  +        ++       + 
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-------RIPEQILGKVS 110
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
           I V   L YL  ++   I H D+K SN+L++      + DFG++  L +         +M
Sbjct: 111 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---------SM 159
Query: 332 SNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRP 373
           +N   G+  Y+ PE + G H S+  DI+S G+ L+E+  G+ P
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 107/225 (47%), Gaps = 18/225 (8%)
Query: 158 NFSEENLIGSGSFGSVYKGTLA--DGE--TAAIKVLK--LQQQGALKSFIDECNALTSIR 211
            F+   ++G G FGSV +  L   DG     A+K+LK  +     ++ F+ E   +    
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 212 HRNILKIVSSCSSVDYEGN-DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
           H ++ K+V        +G      ++  FM++G+L  +L  S      F  L L   +  
Sbjct: 84  HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN-LPLQTLVRF 142
Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
           ++D+A  ++YL ++      H DL + N +L E M   V DFGL++ ++  S    +   
Sbjct: 143 MVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIY--SGDYYRQGC 197
Query: 331 MSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRP 373
            S   K  V ++  E +  ++ ++  D++++G+ + EI T G+ P
Sbjct: 198 AS---KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 114/244 (46%), Gaps = 45/244 (18%)
Query: 165 IGSGSFGSVYKGTLADG-----------ETAAIKVLKLQ-QQGALKSFIDECNALTSI-R 211
           +G G+FG V    LA+               A+K+LK    +  L   I E   +  I +
Sbjct: 29  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 85
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCH------FKKL 262
           H+NI+ ++ +C+    +G  +  ++ E+   GNL ++L    P   EY +       ++L
Sbjct: 86  HKNIINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 140
Query: 263 SLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES 322
           S    ++    VA  ++YL ++      H DL + NVL+ E  +  + DFGLA+ +    
Sbjct: 141 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 197
Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT------GKRPTD 375
                 +  +NG +  V ++ PE +   + +   D++S+G+LL EIFT         P +
Sbjct: 198 YY----KKTTNG-RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 252
Query: 376 DMFK 379
           ++FK
Sbjct: 253 ELFK 256

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 99/216 (45%), Gaps = 28/216 (12%)
Query: 165 IGSGSFGSVYKGTLAD---GETAA-IKVLKLQQQGALKS---FIDECNALTSIRHRNILK 217
           +G GSFG VY+G   D   GE    + V  + +  +L+    F++E + +      ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCHFKKLSLMQRLNIVIDV 274
           ++   S           +V E M +G+L  +L    P  +        +L + + +  ++
Sbjct: 85  LLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
           A  + YL+ +      H DL + N ++       +GDFG+ + ++E +           G
Sbjct: 140 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETA-------YYRKG 189
Query: 335 LKG--SVGYIPPEYI-NGHVSILGDIYSYGILLLEI 367
            KG   V ++ PE + +G  +   D++S+G++L EI
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 97/218 (44%), Gaps = 22/218 (10%)
Query: 162 ENLIGSGSFGSVYKGTLADGET----AAIKVL-KLQQQGALKSFIDECNALTSIRHRNIL 216
           + +IG G FG VY G   D        AIK L ++ +   +++F+ E   +  + H N+L
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            ++     +         ++  +M +G+L Q++          +  ++   ++  + VA 
Sbjct: 86  ALIG----IMLPPEGLPHVLLPYMCHGDLLQFIRSPQ------RNPTVKDLISFGLQVAR 135
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            ++YL  Q      H DL + N +LDE     V DFGLA+ + +      +    +   +
Sbjct: 136 GMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHA---R 189
Query: 337 GSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
             V +   E +  +  +   D++S+G+LL E+ T   P
Sbjct: 190 LPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 32/223 (14%)
Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D+F + + +G+G+ G V+K +    G   A K++ L+ + A+++ I        IR   +
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--------IRELQV 76
Query: 216 LKIVSSCSSVDYEGNDFK----ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           L   +S   V + G  +     ++  E M  G+LDQ L  +        ++       + 
Sbjct: 77  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-------RIPEQILGKVS 129
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
           I V   L YL  ++   I H D+K SN+L++      + DFG++  L +         +M
Sbjct: 130 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---------SM 178
Query: 332 SNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRP 373
           +N   G+  Y+ PE + G H S+  DI+S G+ L+E+  G+ P
Sbjct: 179 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 25/228 (10%)
Query: 148 SYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNA 206
           S + + +    ++    IG G+ G+VY    +A G+  AI+ + LQQQ   +  I+E   
Sbjct: 12  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 71
Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           +   ++ NI+  + S     Y   D   +V E++  G+L         E C    +   Q
Sbjct: 72  MRENKNPNIVNYLDS-----YLVGDELWVVMEYLAGGSLTD----VVTETC----MDEGQ 118
Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
              +  +   AL++LH+     + H D+KS N+LL  GM    G   L  F F    TP 
Sbjct: 119 IAAVCRECLQALEFLHSNQ---VIHRDIKSDNILL--GMD---GSVKLTDFGFCAQITPE 170
Query: 327 KNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFTGKRP 373
             Q+  + + G+  ++ PE +         DI+S GI+ +E+  G+ P
Sbjct: 171 --QSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 101/238 (42%), Gaps = 38/238 (15%)
Query: 149 YLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFID-ECNAL 207
           Y +  +  + F++   IG GSFG V+KG   D  T  +  +K+         ID E    
Sbjct: 19  YFQSMDPEELFTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKI---------IDLEEAED 67
Query: 208 TSIRHRNILKIVSSCSS---VDYEGNDFK----ALVFEFMRNGNLDQWLHPSTDEYCHFK 260
                +  + ++S C S     Y G+  K     ++ E++  G+    L P         
Sbjct: 68  EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP------- 120
Query: 261 KLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFE 320
            L   Q   I+ ++   LDYLH++      H D+K++NVLL E     + DFG+A  L  
Sbjct: 121 -LDETQIATILREILKGLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQL-- 174
Query: 321 ESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM 377
                +  Q   N   G+  ++ PE I         DI+S GI  +E+  G+ P  ++
Sbjct: 175 -----TDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 227

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 98/216 (45%), Gaps = 28/216 (12%)
Query: 165 IGSGSFGSVYKGTLAD---GETAA-IKVLKLQQQGALKS---FIDECNALTSIRHRNILK 217
           +G GSFG VY+G   D   GE    + V  + +  +L+    F++E + +      ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCHFKKLSLMQRLNIVIDV 274
           ++   S           +V E M +G+L  +L    P  +        +L + + +  ++
Sbjct: 85  LLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
           A  + YL+ +      H DL + N ++       +GDFG+ + ++E             G
Sbjct: 140 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE-------TDYYRKG 189
Query: 335 LKG--SVGYIPPEYI-NGHVSILGDIYSYGILLLEI 367
            KG   V ++ PE + +G  +   D++S+G++L EI
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 103/232 (44%), Gaps = 17/232 (7%)
Query: 148 SYLKISNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECN 205
           S L  S   D++  + +IGSG+   V     A   E  AIK + L++ Q ++   + E  
Sbjct: 1   SALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQ 60
Query: 206 ALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGN-LDQWLHPSTDEYCHFKKLSL 264
           A++   H NI+   +S     +   D   LV + +  G+ LD   H           L  
Sbjct: 61  AMSQCHHPNIVSYYTS-----FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 115
Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNT 324
                I+ +V   L+YLH        H D+K+ N+LL E     + DFG++ FL    + 
Sbjct: 116 STIATILREVLEGLEYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI 172
Query: 325 PSKNQTMSNGLKGSVGYIPPEY---INGHVSILGDIYSYGILLLEIFTGKRP 373
            ++N+       G+  ++ PE    + G+     DI+S+GI  +E+ TG  P
Sbjct: 173 -TRNKVRKT-FVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATGAAP 221

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 114/244 (46%), Gaps = 45/244 (18%)
Query: 165 IGSGSFGSVYKGTLADG-----------ETAAIKVLKLQ-QQGALKSFIDECNALTSI-R 211
           +G G+FG V    LA+               A+K+LK    +  L   I E   +  I +
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCH------FKKL 262
           H+NI+ ++ +C+    +G  +  ++ E+   GNL ++L    P   EY +       ++L
Sbjct: 93  HKNIINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 147
Query: 263 SLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES 322
           S    ++    VA  ++YL ++      H DL + NVL+ E  +  + DFGLA+ +    
Sbjct: 148 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT------GKRPTD 375
                 +  +NG +  V ++ PE +   + +   D++S+G+LL EIFT         P +
Sbjct: 205 YY----KKTTNG-RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 259
Query: 376 DMFK 379
           ++FK
Sbjct: 260 ELFK 263

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 25/228 (10%)
Query: 148 SYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNA 206
           S + + +    ++    IG G+ G+VY    +A G+  AI+ + LQQQ   +  I+E   
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           +   ++ NI+  + S     Y   D   +V E++  G+L         E C    +   Q
Sbjct: 71  MRENKNPNIVNYLDS-----YLVGDELWVVMEYLAGGSLTD----VVTETC----MDEGQ 117
Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
              +  +   AL++LH+     + H D+KS N+LL  GM    G   L  F F    TP 
Sbjct: 118 IAAVCRECLQALEFLHSNQ---VIHRDIKSDNILL--GMD---GSVKLTDFGFCAQITPE 169
Query: 327 KNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFTGKRP 373
             Q+  + + G+  ++ PE +         DI+S GI+ +E+  G+ P
Sbjct: 170 --QSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 98/216 (45%), Gaps = 28/216 (12%)
Query: 165 IGSGSFGSVYKGTLAD---GETAA-IKVLKLQQQGALKS---FIDECNALTSIRHRNILK 217
           +G GSFG VY+G   D   GE    + V  + +  +L+    F++E + +      ++++
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCHFKKLSLMQRLNIVIDV 274
           ++   S           +V E M +G+L  +L    P  +        +L + + +  ++
Sbjct: 84  LLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 138
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
           A  + YL+ +      H DL + N ++       +GDFG+ + ++E             G
Sbjct: 139 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE-------TDYYRKG 188
Query: 335 LKG--SVGYIPPEYI-NGHVSILGDIYSYGILLLEI 367
            KG   V ++ PE + +G  +   D++S+G++L EI
Sbjct: 189 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 224

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 25/228 (10%)
Query: 148 SYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNA 206
           S + + +    ++    IG G+ G+VY    +A G+  AI+ + LQQQ   +  I+E   
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           +   ++ NI+  + S     Y   D   +V E++  G+L         E C    +   Q
Sbjct: 71  MRENKNPNIVNYLDS-----YLVGDELWVVMEYLAGGSLTD----VVTETC----MDEGQ 117
Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
              +  +   AL++LH+     + H D+KS N+LL  GM    G   L  F F    TP 
Sbjct: 118 IAAVCRECLQALEFLHSNQ---VIHRDIKSDNILL--GMD---GSVKLTDFGFCAQITPE 169
Query: 327 KNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFTGKRP 373
             Q+  + + G+  ++ PE +         DI+S GI+ +E+  G+ P
Sbjct: 170 --QSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 114/244 (46%), Gaps = 45/244 (18%)
Query: 165 IGSGSFGSVYKGTLADG-----------ETAAIKVLKLQ-QQGALKSFIDECNALTSI-R 211
           +G G+FG V    LA+               A+K+LK    +  L   I E   +  I +
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCH------FKKL 262
           H+NI+ ++ +C+    +G  +  ++ E+   GNL ++L    P   EY +       ++L
Sbjct: 93  HKNIINLLGACTQ---DGPLY--VIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQL 147
Query: 263 SLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES 322
           S    ++    VA  ++YL ++      H DL + NVL+ E  +  + DFGLA+ +    
Sbjct: 148 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT------GKRPTD 375
                 +  +NG +  V ++ PE +   + +   D++S+G+LL EIFT         P +
Sbjct: 205 YY----KKTTNG-RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 259
Query: 376 DMFK 379
           ++FK
Sbjct: 260 ELFK 263

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 104/232 (44%), Gaps = 17/232 (7%)
Query: 148 SYLKISNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECN 205
           S L  S   D++  + +IGSG+   V     A   E  AIK + L++ Q ++   + E  
Sbjct: 6   SALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQ 65
Query: 206 ALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGN-LDQWLHPSTDEYCHFKKLSL 264
           A++   H NI+   +S     +   D   LV + +  G+ LD   H           L  
Sbjct: 66  AMSQCHHPNIVSYYTS-----FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120
Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNT 324
                I+ +V   L+YLH        H D+K+ N+LL E     + DFG++ FL    + 
Sbjct: 121 STIATILREVLEGLEYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI 177
Query: 325 PSKNQTMSNGLKGSVGYIPP---EYINGHVSILGDIYSYGILLLEIFTGKRP 373
            ++N+     + G+  ++ P   E + G+     DI+S+GI  +E+ TG  P
Sbjct: 178 -TRNKVRKTFV-GTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATGAAP 226

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 114/244 (46%), Gaps = 45/244 (18%)
Query: 165 IGSGSFGSVYKGTLADG-----------ETAAIKVLKLQ-QQGALKSFIDECNALTSI-R 211
           +G G+FG V    LA+               A+K+LK    +  L   I E   +  I +
Sbjct: 25  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 81
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCH------FKKL 262
           H+NI+ ++ +C+    +G  +  ++ E+   GNL ++L    P   EY +       ++L
Sbjct: 82  HKNIINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 136
Query: 263 SLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES 322
           S    ++    VA  ++YL ++      H DL + NVL+ E  +  + DFGLA+ +    
Sbjct: 137 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 193
Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT------GKRPTD 375
                 +  +NG +  V ++ PE +   + +   D++S+G+LL EIFT         P +
Sbjct: 194 YY----KKTTNG-RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 248
Query: 376 DMFK 379
           ++FK
Sbjct: 249 ELFK 252

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 32/223 (14%)
Query: 157 DNFSEENLIGSGSFGSVYK-GTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D+F   + +G+G+ G V K      G   A K++ L+ + A+++ I        IR   +
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQI--------IRELQV 67
Query: 216 LKIVSSCSSVDYEGNDFK----ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           L   +S   V + G  +     ++  E M  G+LDQ L  +       K++       + 
Sbjct: 68  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA-------KRIPEEILGKVS 120
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
           I V   L YL  ++   I H D+K SN+L++      + DFG++  L +         +M
Sbjct: 121 IAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---------SM 169
Query: 332 SNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRP 373
           +N   G+  Y+ PE + G H S+  DI+S G+ L+E+  G+ P
Sbjct: 170 ANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 114/244 (46%), Gaps = 45/244 (18%)
Query: 165 IGSGSFGSVYKGTLADG-----------ETAAIKVLKLQ-QQGALKSFIDECNALTSI-R 211
           +G G+FG V    LA+               A+K+LK    +  L   I E   +  I +
Sbjct: 28  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 84
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCH------FKKL 262
           H+NI+ ++ +C+    +G  +  ++ E+   GNL ++L    P   EY +       ++L
Sbjct: 85  HKNIINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 139
Query: 263 SLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES 322
           S    ++    VA  ++YL ++      H DL + NVL+ E  +  + DFGLA+ +    
Sbjct: 140 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 196
Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT------GKRPTD 375
                 +  +NG +  V ++ PE +   + +   D++S+G+LL EIFT         P +
Sbjct: 197 YY----KKTTNG-RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 251
Query: 376 DMFK 379
           ++FK
Sbjct: 252 ELFK 255

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 100/227 (44%), Gaps = 49/227 (21%)
Query: 165 IGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           +G GS+GSVYK    + G+  AIK      Q  ++S + E      I+  +I++   S  
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIK------QVPVESDLQEI-----IKEISIMQQCDSPH 85
Query: 224 SVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL-----------NIVI 272
            V Y G+ FK          N D W+     EYC    +S + RL            I+ 
Sbjct: 86  VVKYYGSYFK----------NTDLWI---VMEYCGAGSVSDIIRLRNKTLTEDEIATILQ 132
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
                L+YLH        H D+K+ N+LL+    A + DFG+A  L       +      
Sbjct: 133 STLKGLEYLHFMRKI---HRDIKAGNILLNTEGHAKLADFGVAGQL-------TDXMAKR 182
Query: 333 NGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDM 377
           N + G+  ++ PE I   G+ + + DI+S GI  +E+  GK P  D+
Sbjct: 183 NXVIGTPFWMAPEVIQEIGY-NCVADIWSLGITAIEMAEGKPPYADI 228

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 35/225 (15%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNALTSIRH 212
           ++F     +G G FG+VY       +   A+KVL   +L++ G       E    + +RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM--QRLNI 270
            NIL++        +       L+ E+   G +          Y   +KLS    QR   
Sbjct: 72  PNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSRFDEQRTAT 116
Query: 271 VI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
            I ++A+AL Y H++    + H D+K  N+LL       + DFG +       + PS  +
Sbjct: 117 YITELANALSYCHSKR---VIHRDIKPENLLLGSNGELKIADFGWS------VHAPSSRR 167
Query: 330 TMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
           T    L G++ Y+PPE I G +     D++S G+L  E   G  P
Sbjct: 168 TT---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 28/219 (12%)
Query: 157 DNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           DNF +   IG GS G V   T+ + G+  A+K + L++Q   +   +E   +   +H N+
Sbjct: 32  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 88
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           +++ +S     Y   D   +V EF+  G L       TD   H  +++  Q   + + V 
Sbjct: 89  VEMYNS-----YLVGDELWVVMEFLEGGAL-------TDIVTH-TRMNEEQIAAVCLAVL 135
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
            AL  LH Q    + H D+KS ++LL       + DFG    +       SK       L
Sbjct: 136 QALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV-------SKEVPRRKXL 185
Query: 336 KGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRP 373
            G+  ++ PE I+        DI+S GI+++E+  G+ P
Sbjct: 186 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 107/236 (45%), Gaps = 43/236 (18%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKS--FIDECNALTSI---- 210
           +N      +G+G+FG V + T A G      VLK+  +  LKS    DE  AL S     
Sbjct: 46  NNLQFGKTLGAGAFGKVVEAT-AFGLGKEDAVLKVAVK-MLKSTAHADEKEALMSELKIM 103
Query: 211 ----RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
               +H NI+ ++ +C+     G     ++ E+   G+L  +L   +      + L    
Sbjct: 104 SHLGQHENIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKS------RVLETDP 152
Query: 267 RLNIVIDVASALDYLHNQYDTPIA------------HCDLKSSNVLLDEGMIAHVGDFGL 314
              I    AS  D LH  + + +A            H D+ + NVLL  G +A +GDFGL
Sbjct: 153 AFAIANSTASTRDLLH--FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL 210
Query: 315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
           A+ +  +SN   K        +  V ++ PE I   V ++  D++SYGILL EIF+
Sbjct: 211 ARDIMNDSNYIVKGNA-----RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 108/231 (46%), Gaps = 33/231 (14%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKS--FIDECNALTSI---- 210
           +N      +G+G+FG V + T A G      VLK+  +  LKS    DE  AL S     
Sbjct: 46  NNLQFGKTLGAGAFGKVVEAT-AFGLGKEDAVLKVAVK-MLKSTAHADEKEALMSELKIM 103
Query: 211 ----RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHP-----STDEYCHFKK 261
               +H NI+ ++ +C+     G     ++ E+   G+L  +L        TD       
Sbjct: 104 SHLGQHENIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 262 LSLMQR--LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLF 319
            +L  R  L+    VA  + +L ++      H D+ + NVLL  G +A +GDFGLA+ + 
Sbjct: 159 STLSTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 215
Query: 320 EESNTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
            +SN   K        +  V ++ PE I   V ++  D++SYGILL EIF+
Sbjct: 216 NDSNYIVKGNA-----RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 23/223 (10%)
Query: 154 NATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQ-QQGALKSFIDECNALTSIR 211
           +++  F +   +G+G++ +VYKG     G   A+K +KL  ++G   + I E + +  ++
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPST-DEYCHFKKLSLMQRLNI 270
           H NI+++      V +  N    LVFEFM N +L +++   T        +L+L++    
Sbjct: 62  HENIVRLYD----VIHTENKL-TLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
              +   L + H   +  I H DLK  N+L+++     +GDFGLA+      NT S    
Sbjct: 116 --QLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV 170
Query: 331 MSNGLKGSVGYIPPEYINGH--VSILGDIYSYGILLLEIFTGK 371
                  ++ Y  P+ + G    S   DI+S G +L E+ TGK
Sbjct: 171 -------TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 28/219 (12%)
Query: 157 DNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           DNF +   IG GS G V   T+ + G+  A+K + L++Q   +   +E   +   +H N+
Sbjct: 34  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 90
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           +++ +S     Y   D   +V EF+  G L       TD   H  +++  Q   + + V 
Sbjct: 91  VEMYNS-----YLVGDELWVVMEFLEGGAL-------TDIVTH-TRMNEEQIAAVCLAVL 137
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
            AL  LH Q    + H D+KS ++LL       + DFG    +       SK       L
Sbjct: 138 QALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV-------SKEVPRRKXL 187
Query: 336 KGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRP 373
            G+  ++ PE I+        DI+S GI+++E+  G+ P
Sbjct: 188 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 38/228 (16%)
Query: 159 FSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFID-ECNALTSIRHRNILK 217
           F++   IG GSFG V+KG   D  T  +  +K+         ID E         +  + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKI---------IDLEEAEDEIEDIQQEIT 57
Query: 218 IVSSCSS---VDYEGNDFK----ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
           ++S C S     Y G+  K     ++ E++  G+    L P          L   Q   I
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--------LDETQIATI 109
Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
           + ++   LDYLH++      H D+K++NVLL E     + DFG+A  L       +  Q 
Sbjct: 110 LREILKGLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQL-------TDTQI 159
Query: 331 MSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFTGKRPTDDM 377
             N   G+  ++ PE I         DI+S GI  +E+  G+ P  ++
Sbjct: 160 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 103/236 (43%), Gaps = 36/236 (15%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLK---LQQQGALKSFIDECNALTSIRH 212
           DNF    ++G GSFG V    + + G+  A+KVLK   + Q   ++  + E   L+  R+
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
              L  +  C    ++  D    V EF+  G+L   +  S       ++    +      
Sbjct: 83  HPFLTQLFCC----FQTPDRLFFVMEFVNGGDLMFHIQKS-------RRFDEARARFYAA 131
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           ++ SAL +LH   D  I + DLK  NVLLD      + DFG+ K            + + 
Sbjct: 132 EIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK------------EGIC 176
Query: 333 NGLK-----GSVGYIPPEYINGHV-SILGDIYSYGILLLEIFTGKRPTDDMFKDDL 382
           NG+      G+  YI PE +   +     D ++ G+LL E+  G  P +   +DDL
Sbjct: 177 NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL 232

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 28/213 (13%)
Query: 171 GSVYKGTLADGETAAIKVLKLQQQGALKS--FIDECNALTSIRHRNILKIVSSCSSVDYE 228
           G ++KG    G    +KVLK++     KS  F +EC  L    H N+L ++ +C S    
Sbjct: 24  GELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS---P 79
Query: 229 GNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTP 288
                 L+  +M  G+L   LH  T+       +   Q +   +D+A  + +LH   +  
Sbjct: 80  PAPHPTLITHWMPYGSLYNVLHEGTNFV-----VDQSQAVKFALDMARGMAFLHT-LEPL 133
Query: 289 IAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN 348
           I    L S +V++DE M A +      KF F+           S G   +  ++ PE + 
Sbjct: 134 IPRHALNSRSVMIDEDMTARIS-MADVKFSFQ-----------SPGRMYAPAWVAPEALQ 181
Query: 349 GHVSIL----GDIYSYGILLLEIFTGKRPTDDM 377
                      D++S+ +LL E+ T + P  D+
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 38/228 (16%)
Query: 159 FSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFID-ECNALTSIRHRNILK 217
           F++   IG GSFG V+KG   D  T  +  +K+         ID E         +  + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKI---------IDLEEAEDEIEDIQQEIT 57
Query: 218 IVSSCSS---VDYEGNDFK----ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
           ++S C S     Y G+  K     ++ E++  G+    L P          L   Q   I
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--------LDETQIATI 109
Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
           + ++   LDYLH++      H D+K++NVLL E     + DFG+A  L       +  Q 
Sbjct: 110 LREILKGLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQL-------TDTQI 159
Query: 331 MSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFTGKRPTDDM 377
             N   G+  ++ PE I         DI+S GI  +E+  G+ P  ++
Sbjct: 160 KRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 28/219 (12%)
Query: 157 DNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           DNF +   IG GS G V   T+ + G+  A+K + L++Q   +   +E   +   +H N+
Sbjct: 23  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           +++ +S     Y   D   +V EF+  G L       TD   H  +++  Q   + + V 
Sbjct: 80  VEMYNS-----YLVGDELWVVMEFLEGGAL-------TDIVTH-TRMNEEQIAAVCLAVL 126
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
            AL  LH Q    + H D+KS ++LL       + DFG    +       SK       L
Sbjct: 127 QALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV-------SKEVPRRKXL 176
Query: 336 KGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRP 373
            G+  ++ PE I+        DI+S GI+++E+  G+ P
Sbjct: 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 112/244 (45%), Gaps = 45/244 (18%)
Query: 165 IGSGSFGSVYKGTLADG-----------ETAAIKVLKLQ-QQGALKSFIDECNALTSI-R 211
           +G G+FG V    LA+               A+K+LK    +  L   I E   +  I +
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHF---------KKL 262
           H+NI+ ++ +C+    +G  +  ++ E+   GNL ++L         F         ++L
Sbjct: 93  HKNIINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQL 147
Query: 263 SLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES 322
           S    ++    VA  ++YL ++      H DL + NVL+ E  +  + DFGLA+    + 
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLAR----DI 200
Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT------GKRPTD 375
           +     +  +NG +  V ++ PE +   + +   D++S+G+LL EIFT         P +
Sbjct: 201 HHIDXXKKTTNG-RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 259
Query: 376 DMFK 379
           ++FK
Sbjct: 260 ELFK 263

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 28/219 (12%)
Query: 163 NLIGSGSFGSVYKGT-LADGETAAIKVL--KLQQQGALKSF---IDECNALTSIRHRNIL 216
            ++GSG FG+V+KG  + +GE+  I V    ++ +   +SF    D   A+ S+ H +I+
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           +++  C     +      LV +++  G+L   +        H   L     LN  + +A 
Sbjct: 97  RLLGLCPGSSLQ------LVTQYLPLGSLLDHVR------QHRGALGPQLLLNWGVQIAK 144
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            + YL       + H +L + NVLL       V DFG+A  L      P   Q + +  K
Sbjct: 145 GMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL-----PPDDKQLLYSEAK 196
Query: 337 GSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRP 373
             + ++  E I+ G  +   D++SYG+ + E+ T G  P
Sbjct: 197 TPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 235

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 32/218 (14%)
Query: 165 IGSGSFGSVYKGTLADGET-AAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           +G G+FG VYK    +    AA KV+  + +  L+ ++ E + L S  H NI+K++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 224 SVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN 283
              YE N +  ++ EF   G +D  +          + L+  Q   +      AL+YLH 
Sbjct: 105 ---YENNLW--ILIEFCAGGAVDAVMLELE------RPLTESQIQVVCKQTLDALNYLH- 152
Query: 284 QYDTPIAHCDLKSSNVL--LDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGY 341
             D  I H DLK+ N+L  LD       GD  LA F     NT  +     +   G+  +
Sbjct: 153 --DNKIIHRDLKAGNILFTLD-------GDIKLADFGVSAKNT--RTIQRRDSFIGTPYW 201
Query: 342 IPPEYINGHVS------ILGDIYSYGILLLEIFTGKRP 373
           + PE +    S         D++S GI L+E+   + P
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 110/255 (43%), Gaps = 41/255 (16%)
Query: 135 QSAPPSNE---WQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLK 190
           QS  P +E   W +   + +       +  +++IG G    V +    A G   A+K+++
Sbjct: 75  QSMGPEDELPDWAAAKEFYQ------KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIME 128
Query: 191 LQQQGALKSFIDECNALTSIRHRNILKIVSSCSSV-----DYEGNDFKALVFEFMRNGNL 245
           +  +      ++E    T  R  +IL+ V+    +      YE + F  LVF+ MR G L
Sbjct: 129 VTAERLSPEQLEEVREATR-RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL 187
Query: 246 DQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM 305
             +L   T++      LS  +  +I+  +  A+ +LH      I H DLK  N+LLD+ M
Sbjct: 188 FDYL---TEKVA----LSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNM 237
Query: 306 IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILG-------DIY 358
              + DFG +  L      P +       L G+ GY+ PE +   +           D++
Sbjct: 238 QIRLSDFGFSCHL-----EPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLW 289
Query: 359 SYGILLLEIFTGKRP 373
           + G++L  +  G  P
Sbjct: 290 ACGVILFTLLAGSPP 304

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 115/244 (47%), Gaps = 45/244 (18%)
Query: 165 IGSGSFGSVYKGTLADG-----------ETAAIKVLKLQ-QQGALKSFIDECNALTSI-R 211
           +G G+FG V    LA+               A+K+LK    +  L   I E   +  I +
Sbjct: 77  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCH------FKKL 262
           H+NI+ ++ +C+    +G  +  ++ E+   GNL ++L    P   EY +       ++L
Sbjct: 134 HKNIINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 263 SLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES 322
           S    ++    VA  ++YL ++      H DL + NVL+ E  +  + DFGLA+    + 
Sbjct: 189 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DI 241
Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT------GKRPTD 375
           +     +  +NG +  V ++ PE +   + +   D++S+G+LL EIFT         P +
Sbjct: 242 HHIDYYKKTTNG-RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300
Query: 376 DMFK 379
           ++FK
Sbjct: 301 ELFK 304

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 28/219 (12%)
Query: 157 DNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           DNF +   IG GS G V   T+ + G+  A+K + L++Q   +   +E   +   +H N+
Sbjct: 27  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 83
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           +++ +S     Y   D   +V EF+  G L       TD   H  +++  Q   + + V 
Sbjct: 84  VEMYNS-----YLVGDELWVVMEFLEGGAL-------TDIVTH-TRMNEEQIAAVCLAVL 130
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
            AL  LH Q    + H D+KS ++LL       + DFG    +       SK       L
Sbjct: 131 QALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV-------SKEVPRRKXL 180
Query: 336 KGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRP 373
            G+  ++ PE I+        DI+S GI+++E+  G+ P
Sbjct: 181 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 28/219 (12%)
Query: 157 DNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           DNF +   IG GS G V   T+ + G+  A+K + L++Q   +   +E   +   +H N+
Sbjct: 154 DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 210
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           +++ +S     Y   D   +V EF+  G L       TD   H  +++  Q   + + V 
Sbjct: 211 VEMYNS-----YLVGDELWVVMEFLEGGAL-------TDIVTH-TRMNEEQIAAVCLAVL 257
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
            AL  LH Q    + H D+KS ++LL       + DFG    +       SK       L
Sbjct: 258 QALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV-------SKEVPRRKXL 307
Query: 336 KGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRP 373
            G+  ++ PE I+        DI+S GI+++E+  G+ P
Sbjct: 308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 165 IGSGSFGSVYKGTLAD---GETAA-IKVLKLQQQGALK---SFIDECNALTSIRHRNILK 217
           +G GSFG VY+G   D   GE    + V  + +  +L+    F++E + +      ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQW---LHPSTDEYCHFKKLSLMQRLNIVIDV 274
           ++   S           +V E M +G+L  +   L P  +        +L + + +  ++
Sbjct: 85  LLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
           A  + YL+ +      H DL + N ++       +GDFG+ + + E             G
Sbjct: 140 ADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE-------TDXXRKG 189
Query: 335 LKG--SVGYIPPEYI-NGHVSILGDIYSYGILLLEI 367
            KG   V ++ PE + +G  +   D++S+G++L EI
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 165 IGSGSFGSVYKGTLAD---GETAA-IKVLKLQQQGALK---SFIDECNALTSIRHRNILK 217
           +G GSFG VY+G   D   GE    + V  + +  +L+    F++E + +      ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQW---LHPSTDEYCHFKKLSLMQRLNIVIDV 274
           ++   S           +V E M +G+L  +   L P  +        +L + + +  ++
Sbjct: 85  LLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
           A  + YL+ +      H DL + N ++       +GDFG+ + + E             G
Sbjct: 140 ADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE-------TDXXRKG 189
Query: 335 LKG--SVGYIPPEYI-NGHVSILGDIYSYGILLLEI 367
            KG   V ++ PE + +G  +   D++S+G++L EI
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 165 IGSGSFGSVYKGTLAD---GETAA-IKVLKLQQQGALK---SFIDECNALTSIRHRNILK 217
           +G GSFG VY+G   D   GE    + V  + +  +L+    F++E + +      ++++
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQW---LHPSTDEYCHFKKLSLMQRLNIVIDV 274
           ++   S           +V E M +G+L  +   L P  +        +L + + +  ++
Sbjct: 82  LLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 136
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
           A  + YL+ +      H DL + N ++       +GDFG+ + + E             G
Sbjct: 137 ADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE-------TDXXRKG 186
Query: 335 LKG--SVGYIPPEYI-NGHVSILGDIYSYGILLLEI 367
            KG   V ++ PE + +G  +   D++S+G++L EI
Sbjct: 187 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 28/219 (12%)
Query: 163 NLIGSGSFGSVYKGT-LADGETAAIKVL--KLQQQGALKSF---IDECNALTSIRHRNIL 216
            ++GSG FG+V+KG  + +GE+  I V    ++ +   +SF    D   A+ S+ H +I+
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           +++  C     +      LV +++  G+L   +        H   L     LN  + +A 
Sbjct: 79  RLLGLCPGSSLQ------LVTQYLPLGSLLDHVR------QHRGALGPQLLLNWGVQIAK 126
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            + YL       + H +L + NVLL       V DFG+A  L      P   Q + +  K
Sbjct: 127 GMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL-----PPDDKQLLYSEAK 178
Query: 337 GSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRP 373
             + ++  E I+ G  +   D++SYG+ + E+ T G  P
Sbjct: 179 TPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 28/219 (12%)
Query: 157 DNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           DNF +   IG GS G V   T+ + G+  A+K + L++Q   +   +E   +   +H N+
Sbjct: 77  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 133
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           +++ +S     Y   D   +V EF+  G L       TD   H  +++  Q   + + V 
Sbjct: 134 VEMYNS-----YLVGDELWVVMEFLEGGAL-------TDIVTH-TRMNEEQIAAVCLAVL 180
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
            AL  LH Q    + H D+KS ++LL       + DFG    +       SK       L
Sbjct: 181 QALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV-------SKEVPRRKXL 230
Query: 336 KGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRP 373
            G+  ++ PE I+        DI+S GI+++E+  G+ P
Sbjct: 231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 106/254 (41%), Gaps = 26/254 (10%)
Query: 145 SGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKL--QQQGALKSFID 202
           SG   L      + + +   +G G++G VYK   + G   A+K ++L  + +G   + I 
Sbjct: 9   SGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR 68
Query: 203 ECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKL 262
           E + L  + H NI+ ++    S          LVFEFM        L    DE       
Sbjct: 69  EISLLKELHHPNIVSLIDVIHS-----ERCLTLVFEFMEKD-----LKKVLDE-----NK 113
Query: 263 SLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES 322
           + +Q   I I +   L  + + +   I H DLK  N+L++      + DFGLA+      
Sbjct: 114 TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAF---- 169
Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDDMFKD 380
             P ++ T       ++ Y  P+ + G    S   DI+S G +  E+ TGK     +  D
Sbjct: 170 GIPVRSYTHE---VVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD 226
Query: 381 DLSIHKFVLMALPS 394
           D     F ++  P+
Sbjct: 227 DQLPKIFSILGTPN 240

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 32/218 (14%)
Query: 165 IGSGSFGSVYKGTLADGET-AAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           +G G+FG VYK    +    AA KV+  + +  L+ ++ E + L S  H NI+K++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 224 SVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN 283
              YE N +  ++ EF   G +D  +          + L+  Q   +      AL+YLH 
Sbjct: 105 ---YENNLW--ILIEFCAGGAVDAVMLELE------RPLTESQIQVVCKQTLDALNYLH- 152
Query: 284 QYDTPIAHCDLKSSNVL--LDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGY 341
             D  I H DLK+ N+L  LD       GD  LA F     NT  +     +   G+  +
Sbjct: 153 --DNKIIHRDLKAGNILFTLD-------GDIKLADFGVSAKNT--RXIQRRDSFIGTPYW 201
Query: 342 IPPEYINGHVS------ILGDIYSYGILLLEIFTGKRP 373
           + PE +    S         D++S GI L+E+   + P
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 101/236 (42%), Gaps = 39/236 (16%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTS 209
           L I    ++FS   +IG G FG VY    AD  T  +  +K   +  +K    E  AL  
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNE 239
Query: 210 IRHRNILKIVSS-------CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKL 262
              R +L +VS+       C S  +   D  + + + M  G+L          + H  + 
Sbjct: 240 ---RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL----------HYHLSQH 286
Query: 263 SLMQRLNIVIDVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLF 319
            +    ++    A     L+++HN++   + + DLK +N+LLDE     + D GLA    
Sbjct: 287 GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF- 342
Query: 320 EESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSI--LGDIYSYGILLLEIFTGKRP 373
                 SK +  ++   G+ GY+ PE +   V+     D +S G +L ++  G  P
Sbjct: 343 ------SKKKPHAS--VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 101/236 (42%), Gaps = 39/236 (16%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTS 209
           L I    ++FS   +IG G FG VY    AD  T  +  +K   +  +K    E  AL  
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNE 239
Query: 210 IRHRNILKIVSS-------CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKL 262
              R +L +VS+       C S  +   D  + + + M  G+L          + H  + 
Sbjct: 240 ---RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL----------HYHLSQH 286
Query: 263 SLMQRLNIVIDVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLF 319
            +    ++    A     L+++HN++   + + DLK +N+LLDE     + D GLA    
Sbjct: 287 GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF- 342
Query: 320 EESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSI--LGDIYSYGILLLEIFTGKRP 373
                 SK +  ++   G+ GY+ PE +   V+     D +S G +L ++  G  P
Sbjct: 343 ------SKKKPHAS--VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 106/254 (41%), Gaps = 26/254 (10%)
Query: 145 SGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKL--QQQGALKSFID 202
           SG   L      + + +   +G G++G VYK   + G   A+K ++L  + +G   + I 
Sbjct: 9   SGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR 68
Query: 203 ECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKL 262
           E + L  + H NI+ ++    S          LVFEFM        L    DE       
Sbjct: 69  EISLLKELHHPNIVSLIDVIHS-----ERCLTLVFEFMEKD-----LKKVLDE-----NK 113
Query: 263 SLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES 322
           + +Q   I I +   L  + + +   I H DLK  N+L++      + DFGLA+      
Sbjct: 114 TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAF---- 169
Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDDMFKD 380
             P ++ T       ++ Y  P+ + G    S   DI+S G +  E+ TGK     +  D
Sbjct: 170 GIPVRSYTHE---VVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD 226
Query: 381 DLSIHKFVLMALPS 394
           D     F ++  P+
Sbjct: 227 DQLPKIFSILGTPN 240

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 165 IGSGSFGSVYK-GTLADGETAAIKVLKL--QQQGALKSFIDECNALTSIRHRNILK---- 217
           IG+GS+G   K    +DG+    K L      +   +  + E N L  ++H NI++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
           I+   ++  Y       +V E+   G+L   +   T E  +  +  +   L ++  +  A
Sbjct: 74  IIDRTNTTLY-------IVMEYCEGGDLASVITKGTKERQYLDEEFV---LRVMTQLTLA 123
Query: 278 LDYLHNQYD--TPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
           L   H + D    + H DLK +NV LD      +GDFGLA+ L       + + + +   
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-------NHDTSFAKAF 176
Query: 336 KGSVGYIPPEYING-HVSILGDIYSYGILLLEI 367
            G+  Y+ PE +N    +   DI+S G LL E+
Sbjct: 177 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 100/234 (42%), Gaps = 50/234 (21%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQ--QQGALKSFID-ECNALTSIRHRNILKIVS 220
           +G GSFG V   T     +  A+K +  Q  ++  +   ++ E + L  +RH +I+K+  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 221 SCSS-------VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
             ++       ++Y G +    + E  R          + DE   F +            
Sbjct: 77  VITTPTDIVMVIEYAGGELFDYIVEKKRM---------TEDEGRRFFQ-----------Q 116
Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +  A++Y H      I H DLK  N+LLD+ +   + DFGL+  +           T  N
Sbjct: 117 IICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIM-----------TDGN 162
Query: 334 GLKGSVG---YIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDL 382
            LK S G   Y  PE ING  +     D++S GI+L  +  G+ P DD F  +L
Sbjct: 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL 216

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 101/236 (42%), Gaps = 39/236 (16%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTS 209
           L I    ++FS   +IG G FG VY    AD  T  +  +K   +  +K    E  AL  
Sbjct: 181 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNE 238
Query: 210 IRHRNILKIVSS-------CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKL 262
              R +L +VS+       C S  +   D  + + + M  G+L          + H  + 
Sbjct: 239 ---RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL----------HYHLSQH 285
Query: 263 SLMQRLNIVIDVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLF 319
            +    ++    A     L+++HN++   + + DLK +N+LLDE     + D GLA    
Sbjct: 286 GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF- 341
Query: 320 EESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSI--LGDIYSYGILLLEIFTGKRP 373
                 SK +  ++   G+ GY+ PE +   V+     D +S G +L ++  G  P
Sbjct: 342 ------SKKKPHAS--VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 101/236 (42%), Gaps = 39/236 (16%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTS 209
           L I    ++FS   +IG G FG VY    AD  T  +  +K   +  +K    E  AL  
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNE 239
Query: 210 IRHRNILKIVSS-------CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKL 262
              R +L +VS+       C S  +   D  + + + M  G+L          + H  + 
Sbjct: 240 ---RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL----------HYHLSQH 286
Query: 263 SLMQRLNIVIDVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLF 319
            +    ++    A     L+++HN++   + + DLK +N+LLDE     + D GLA    
Sbjct: 287 GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF- 342
Query: 320 EESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSI--LGDIYSYGILLLEIFTGKRP 373
                 SK +  ++   G+ GY+ PE +   V+     D +S G +L ++  G  P
Sbjct: 343 ------SKKKPHAS--VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 108/235 (45%), Gaps = 32/235 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKS--FIDECNALTSI---- 210
           +N      +G+G+FG V + T A G      VLK+  +  LKS    DE  AL S     
Sbjct: 31  NNLQFGKTLGAGAFGKVVEAT-AFGLGKEDAVLKVAVK-MLKSTAHADEKEALMSELKIM 88
Query: 211 ----RHRNILKIVSSCSS-------VDY--EGN--DFKALVFEFMRNGNLDQWLHPSTDE 255
               +H NI+ ++ +C+         +Y   G+  +F     E M   +L     P   +
Sbjct: 89  SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLD 148
Query: 256 YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA 315
               + L L   L+    VA  + +L ++      H D+ + NVLL  G +A +GDFGLA
Sbjct: 149 KEDGRPLELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLA 205
Query: 316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
           + +  +SN   K        +  V ++ PE I   V ++  D++SYGILL EIF+
Sbjct: 206 RDIMNDSNYIVKGNA-----RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 35/227 (15%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNALTSIRH 212
           D+F     +G G FG+VY       +   A+KVL   +L+++G       E    + +RH
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNI 270
            NIL++ +      +       L+ EF   G L + L  H   DE    +  + M+ L  
Sbjct: 75  PNILRMYNY-----FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQ---RSATFMEEL-- 124
Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS-KNQ 329
               A AL Y H   +  + H D+K  N+L+       + DFG +       + PS + +
Sbjct: 125 ----ADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS------VHAPSLRRR 171
Query: 330 TMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRPTD 375
            M     G++ Y+PPE I G       D++  G+L  E   G  P D
Sbjct: 172 XMC----GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 32/218 (14%)
Query: 165 IGSGSFGSVYKGTLADGET-AAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           +G G+FG VYK    +    AA KV+  + +  L+ ++ E + L S  H NI+K++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 224 SVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN 283
              YE N +  ++ EF   G +D  +          + L+  Q   +      AL+YLH 
Sbjct: 105 ---YENNLW--ILIEFCAGGAVDAVMLELE------RPLTESQIQVVCKQTLDALNYLH- 152
Query: 284 QYDTPIAHCDLKSSNVL--LDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGY 341
             D  I H DLK+ N+L  LD       GD  LA F     NT  +     +   G+  +
Sbjct: 153 --DNKIIHRDLKAGNILFTLD-------GDIKLADFGVSAKNT--RXIQRRDXFIGTPYW 201
Query: 342 IPPEYINGHVS------ILGDIYSYGILLLEIFTGKRP 373
           + PE +    S         D++S GI L+E+   + P
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 35/227 (15%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNALTSIRH 212
           D+F     +G G FG+VY       +   A+KVL   +L+++G       E    + +RH
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNI 270
            NIL++ +      +       L+ EF   G L + L  H   DE    +  + M+ L  
Sbjct: 74  PNILRMYNY-----FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQ---RSATFMEEL-- 123
Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS-KNQ 329
               A AL Y H +    + H D+K  N+L+       + DFG +       + PS + +
Sbjct: 124 ----ADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS------VHAPSLRRR 170
Query: 330 TMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRPTD 375
            M     G++ Y+PPE I G       D++  G+L  E   G  P D
Sbjct: 171 XMC----GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 165 IGSGSFGSVYK-GTLADGETAAIKVLKL--QQQGALKSFIDECNALTSIRHRNILK---- 217
           IG+GS+G   K    +DG+    K L      +   +  + E N L  ++H NI++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
           I+   ++  Y       +V E+   G+L   +   T E  +  +  +   L ++  +  A
Sbjct: 74  IIDRTNTTLY-------IVMEYCEGGDLASVITKGTKERQYLDEEFV---LRVMTQLTLA 123
Query: 278 LDYLHNQYD--TPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
           L   H + D    + H DLK +NV LD      +GDFGLA+ L       + ++  +   
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-------NHDEDFAKEF 176
Query: 336 KGSVGYIPPEYING-HVSILGDIYSYGILLLEI 367
            G+  Y+ PE +N    +   DI+S G LL E+
Sbjct: 177 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 165 IGSGSFGSVYK-GTLADGETAAIKVLKL--QQQGALKSFIDECNALTSIRHRNILK---- 217
           IG+GS+G   K    +DG+    K L      +   +  + E N L  ++H NI++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
           I+   ++  Y       +V E+   G+L   +   T E  +  +  +   L ++  +  A
Sbjct: 74  IIDRTNTTLY-------IVMEYCEGGDLASVITKGTKERQYLDEEFV---LRVMTQLTLA 123
Query: 278 LDYLHNQYD--TPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
           L   H + D    + H DLK +NV LD      +GDFGLA+ L       + + + +   
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-------NHDTSFAKTF 176
Query: 336 KGSVGYIPPEYING-HVSILGDIYSYGILLLEI 367
            G+  Y+ PE +N    +   DI+S G LL E+
Sbjct: 177 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 98/225 (43%), Gaps = 35/225 (15%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNALTSIRH 212
           ++F     +G G FG+VY       +   A+KVL   +L++ G       E    + +RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM--QRLNI 270
            NIL++        +       L+ E+   G +          Y   +KLS    QR   
Sbjct: 72  PNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSRFDEQRTAT 116
Query: 271 VI-DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
            I ++A+AL Y H++    + H D+K  N+LL       + DFG +       + PS  +
Sbjct: 117 YITELANALSYCHSKR---VIHRDIKPENLLLGSNGELKIADFGWS------VHAPSSRR 167
Query: 330 TMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
              + L G++ Y+PPE I G +     D++S G+L  E   G  P
Sbjct: 168 ---DTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           IG G+ G+VY    +A G+  AI+ + LQQQ   +  I+E   +   ++ NI+  + S  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-- 86
Query: 224 SVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN 283
              Y   D   +V E++  G+L         E C    +   Q   +  +   AL++LH+
Sbjct: 87  ---YLVGDELWVVMEYLAGGSLTD----VVTETC----MDEGQIAAVCRECLQALEFLHS 135
Query: 284 QYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIP 343
                + H ++KS N+LL       + DFG    +  E    SK  TM     G+  ++ 
Sbjct: 136 NQ---VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQ---SKRSTMV----GTPYWMA 185
Query: 344 PEYINGHV-SILGDIYSYGILLLEIFTGKRP 373
           PE +         DI+S GI+ +E+  G+ P
Sbjct: 186 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/216 (22%), Positives = 98/216 (45%), Gaps = 28/216 (12%)
Query: 165 IGSGSFGSVYKGTLAD---GETAA-IKVLKLQQQGALK---SFIDECNALTSIRHRNILK 217
           +G GSFG VY+G   D   GE    + V  + +  +L+    F++E + +      ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQW---LHPSTDEYCHFKKLSLMQRLNIVIDV 274
           ++   S           +V E M +G+L  +   L P  +        +L + + +  ++
Sbjct: 85  LLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
           A  + YL+ +      H +L + N ++       +GDFG+ + ++E             G
Sbjct: 140 ADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYE-------TDYYRKG 189
Query: 335 LKG--SVGYIPPEYI-NGHVSILGDIYSYGILLLEI 367
            KG   V ++ PE + +G  +   D++S+G++L EI
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/226 (22%), Positives = 96/226 (42%), Gaps = 20/226 (8%)
Query: 153 SNATDNFSEENLIGSGSFGSVY-KGTLADGETAAIKVLKL---QQQGALKSFIDECNALT 208
           S+ +D +    ++G G    V+    L D    A+KVL+    +       F  E     
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
           ++ H  I+ +  +  + +        +V E++    L   +H           ++  + +
Sbjct: 68  ALNHPAIVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTE-------GPMTPKRAI 119
Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
            ++ D   AL++ H      I H D+K +N+++       V DFG+A+ + +  N+    
Sbjct: 120 EVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS---- 172
Query: 329 QTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
            T +  + G+  Y+ PE   G  V    D+YS G +L E+ TG+ P
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/226 (22%), Positives = 96/226 (42%), Gaps = 20/226 (8%)
Query: 153 SNATDNFSEENLIGSGSFGSVY-KGTLADGETAAIKVLKL---QQQGALKSFIDECNALT 208
           S+ +D +    ++G G    V+    L D    A+KVL+    +       F  E     
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
           ++ H  I+ +  +  + +        +V E++    L   +H           ++  + +
Sbjct: 68  ALNHPAIVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTE-------GPMTPKRAI 119
Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
            ++ D   AL++ H      I H D+K +N+++       V DFG+A+ + +  N+    
Sbjct: 120 EVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS---- 172
Query: 329 QTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
            T +  + G+  Y+ PE   G  V    D+YS G +L E+ TG+ P
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/216 (22%), Positives = 98/216 (45%), Gaps = 28/216 (12%)
Query: 165 IGSGSFGSVYKGTLAD---GETAA-IKVLKLQQQGALK---SFIDECNALTSIRHRNILK 217
           +G GSFG VY+G   D   GE    + V  + +  +L+    F++E + +      ++++
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQW---LHPSTDEYCHFKKLSLMQRLNIVIDV 274
           ++   S           +V E M +G+L  +   L P  +        +L + + +  ++
Sbjct: 86  LLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 140
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
           A  + YL+ +      H +L + N ++       +GDFG+ + ++E             G
Sbjct: 141 ADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYE-------TDYYRKG 190
Query: 335 LKG--SVGYIPPEYI-NGHVSILGDIYSYGILLLEI 367
            KG   V ++ PE + +G  +   D++S+G++L EI
Sbjct: 191 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 226

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 97/226 (42%), Gaps = 20/226 (8%)
Query: 153 SNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKL---QQQGALKSFIDECNALT 208
           S+ +D +    ++G G    V+    L D    A+KVL+    +       F  E     
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
           ++ H  I+ +  +  + +        +V E++    L   +H           ++  + +
Sbjct: 68  ALNHPAIVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTE-------GPMTPKRAI 119
Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
            ++ D   AL++ H      I H D+K +N+L+       V DFG+A+ + +  N  S  
Sbjct: 120 EVIADACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGN--SVX 174
Query: 329 QTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
           QT +  + G+  Y+ PE   G  V    D+YS G +L E+ TG+ P
Sbjct: 175 QTAA--VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 102/234 (43%), Gaps = 44/234 (18%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFID-----E 203
           L + +    + + + +G G F +VYK    +  +  AIK +KL  +   K  I+     E
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNG------NLDQWLHPSTDEYC 257
              L  + H NI+ ++ +     ++ N   +LVF+FM         +    L PS     
Sbjct: 63  IKLLQELSHPNIIGLLDAFG---HKSN--ISLVFDFMETDLEVIIKDNSLVLTPS----- 112
Query: 258 HFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF 317
           H K   LM            L+YLH  +   I H DLK +N+LLDE  +  + DFGLAK 
Sbjct: 113 HIKAYMLM--------TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161
Query: 318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILG---DIYSYGILLLEIF 368
            F   N    +Q ++        Y  PE + G   + G   D+++ G +L E+ 
Sbjct: 162 -FGSPNRAYXHQVVTR------WYRAPELLFG-ARMYGVGVDMWAVGCILAELL 207

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 36/216 (16%)
Query: 165 IGSGSFGSVYKGT--LADGETAAIKVLKLQ-QQGALKSFIDECNALTSIRHRNILK---I 218
           +G G++ +VYKG   L D    A+K ++L+ ++GA  + I E + L  ++H NI+    I
Sbjct: 10  LGEGTYATVYKGKSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEY-CHFKKLSLMQRLNIVIDVASA 277
           + +  S+         LVFE++ + +L Q+L    +    H  KL L Q L         
Sbjct: 69  IHTEKSL--------TLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLR-------G 112
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           L Y H Q    + H DLK  N+L++E     + DFGLA+      + P+K  T  N +  
Sbjct: 113 LAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLAR----AKSIPTK--TYDNEVV- 162
Query: 338 SVGYIPPEYINGHV--SILGDIYSYGILLLEIFTGK 371
           ++ Y PP+ + G    S   D++  G +  E+ TG+
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 97/240 (40%), Gaps = 38/240 (15%)
Query: 145 SGLSYLKISNATDNFSEENLIGSGSFGSVY--KGTLADGETAAIKVLK------LQQQGA 196
           SG   L     +D +     +GSG++G V   K  L  G   AIK++K          GA
Sbjct: 9   SGRENLYFQGLSDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGA 67
Query: 197 LKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEY 256
           L   +DE   L  + H NI+K+        +E      LV E  R G L        DE 
Sbjct: 68  L---LDEVAVLKQLDHPNIMKLYEF-----FEDKRNYYLVMEVYRGGEL-------FDEI 112
Query: 257 CHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFG 313
              +K S +    I+  V S   YLH      I H DLK  N+LL+      +  + DFG
Sbjct: 113 ILRQKFSEVDAAVIMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFG 169
Query: 314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRP 373
           L+   FE          M   L G+  YI PE +        D++S G++L  +  G  P
Sbjct: 170 LSAH-FEVGGK------MKERL-GTAYYIAPEVLRKKYDEKCDVWSCGVILYILLCGYPP 221

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 96/240 (40%), Gaps = 44/240 (18%)
Query: 152 ISNATD------NFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQ--QGALKSFID 202
           I++ATD      N+  +  IG G+F  V     +  G   A+K++   Q    +L+    
Sbjct: 4   ITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR 63
Query: 203 ECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFK 260
           E   +  + H NI+K+         E      LV E+   G +  +L  H    E     
Sbjct: 64  EVRIMKILNHPNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA 118
Query: 261 KLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFE 320
           K            + SA+ Y H +Y   I H DLK+ N+LLD  M   + DFG       
Sbjct: 119 KFR---------QIVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGF------ 160
Query: 321 ESNTPSKNQTMSNGLK---GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTD 375
                S   T+ N L    GS  Y  PE   G  +     D++S G++L  + +G  P D
Sbjct: 161 -----SNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 32/234 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIRHR 213
           +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
           NI+K++     V +  N    LVFEF+   +L +++  S         + L    + +  
Sbjct: 63  NIVKLLD----VIHTENKL-YLVFEFLHQ-DLKKFMDASA-----LTGIPLPLIKSYLFQ 111
Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +   L + H+     + H DLK  N+L++      + DFGLA+        P +  T   
Sbjct: 112 LLQGLSFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF----GVPVRTYTHE- 163
Query: 334 GLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
               ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 164 --VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 215

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 112/241 (46%), Gaps = 37/241 (15%)
Query: 154 NATDNFS---------EENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFI-D 202
            +TD+FS         +E+++G G+   V     L   +  A+K+++ +Q G ++S +  
Sbjct: 1   GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFR 59
Query: 203 ECNALTSIR-HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK 261
           E   L   + HRN+L+++      D        LVFE MR G++   +H       HF +
Sbjct: 60  EVEMLYQCQGHRNVLELIEFFEEEDR-----FYLVFEKMRGGSILSHIHKRR----HFNE 110
Query: 262 LSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFL 318
           L   +   +V DVASALD+LHN+    IAH DLK  N+L +   +     + DFGL   +
Sbjct: 111 L---EASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGI 164
Query: 319 FEESNTPSKNQTMSNGLKGSVGYIPPEYING---HVSILG---DIYSYGILLLEIFTGKR 372
               +    +        GS  Y+ PE +       SI     D++S G++L  + +G  
Sbjct: 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224
Query: 373 P 373
           P
Sbjct: 225 P 225

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 99/226 (43%), Gaps = 31/226 (13%)
Query: 164 LIGSGSFGSVYKGT-LADGETAAIKVLKL--QQQGALKSFIDECNALTSIRHRNILKIVS 220
           L+G+G++G VYKG  +  G+ AAIKV+ +   ++  +K  I+     +   HRNI     
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS--HHRNIATYYG 88
Query: 221 SCSSVDYEGNDFK-ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL--NIVIDVASA 277
           +    +  G D +  LV EF   G++       TD   + K  +L +     I  ++   
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSV-------TDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           L +LH      + H D+K  NVLL E     + DFG++  L        +     N   G
Sbjct: 142 LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-------DRTVGRRNTFIG 191
Query: 338 SVGYIPPEYI------NGHVSILGDIYSYGILLLEIFTGKRPTDDM 377
           +  ++ PE I      +       D++S GI  +E+  G  P  DM
Sbjct: 192 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 32/234 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIRHR 213
           +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
           NI+K++     V +  N    LVFEF+   +L +++  S         + L    + +  
Sbjct: 70  NIVKLLD----VIHTENKL-YLVFEFLHQ-DLKKFMDASA-----LTGIPLPLIKSYLFQ 118
Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +   L + H+     + H DLK  N+L++      + DFGLA+        P +  T   
Sbjct: 119 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF----GVPVRTYTHE- 170
Query: 334 GLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
               ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 171 --VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 222

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 106/219 (48%), Gaps = 33/219 (15%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIK--VLKLQQQGALKSFIDECNALTSIRHRNILKIVSS 221
           IG G+FG V+K      G+  A+K  +++ +++G   + + E   L  ++H N++ ++  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 222 CSSVDYEGNDFKA---LVFEFMRN---GNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           C +     N  KA   LVF+F  +   G L   L           K +L +   ++  + 
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVL----------VKFTLSEIKRVMQMLL 135
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK-FLFEESNTPSK--NQTMS 332
           + L Y+H      I H D+K++NVL+    +  + DFGLA+ F   +++ P++  N+ + 
Sbjct: 136 NGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV- 191
Query: 333 NGLKGSVGYIPPEYINGHVSILG--DIYSYGILLLEIFT 369
                ++ Y PPE + G        D++  G ++ E++T
Sbjct: 192 -----TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 32/234 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIRHR 213
           +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
           NI+K++     V +  N    LVFEF+   +L +++  S         + L    + +  
Sbjct: 62  NIVKLLD----VIHTENKL-YLVFEFLHQ-DLKKFMDASA-----LTGIPLPLIKSYLFQ 110
Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +   L + H+     + H DLK  N+L++      + DFGLA+        P +  T   
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF----GVPVRTYTHE- 162
Query: 334 GLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
               ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 163 --VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 214

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 32/234 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIRHR 213
           +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
           NI+K++     V +  N    LVFEF+   +L +++  S         + L    + +  
Sbjct: 67  NIVKLLD----VIHTENKL-YLVFEFLHQ-DLKKFMDASA-----LTGIPLPLIKSYLFQ 115
Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +   L + H+     + H DLK  N+L++      + DFGLA+        P +  T   
Sbjct: 116 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF----GVPVRTYTHE- 167
Query: 334 GLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
               ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 168 --VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 219

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 32/234 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIRHR 213
           +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
           NI+K++     V +  N    LVFEF+   +L +++  S         + L    + +  
Sbjct: 63  NIVKLLD----VIHTENKL-YLVFEFLHQ-DLKKFMDASA-----LTGIPLPLIKSYLFQ 111
Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +   L + H+     + H DLK  N+L++      + DFGLA+        P +  T   
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF----GVPVRTYTHE- 163
Query: 334 GLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
               ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 164 --VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 215

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 32/234 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIRHR 213
           +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
           NI+K++     V +  N    LVFEF+   +L +++  S         + L    + +  
Sbjct: 62  NIVKLLD----VIHTENKL-YLVFEFLHQ-DLKKFMDASA-----LTGIPLPLIKSYLFQ 110
Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +   L + H+     + H DLK  N+L++      + DFGLA+        P +  T   
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF----GVPVRTYTHE- 162
Query: 334 GLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
               ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 163 --VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 214

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 105/236 (44%), Gaps = 32/236 (13%)
Query: 155 ATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIR 211
           + +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H NI+K++     V +  N    LVFEF+   +L +++  S         + L    + +
Sbjct: 62  HPNIVKLLD----VIHTENKL-YLVFEFLHQ-DLKKFMDASA-----LTGIPLPLIKSYL 110
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
             +   L + H+     + H DLK  N+L++      + DFGLA+        P +  T 
Sbjct: 111 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF----GVPVRTYTH 163
Query: 332 SNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
                 ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 164 E---VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 216

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 31/223 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLADGE-TAAIKVL---KLQQQGALKSFIDECNALTSIRH 212
           D+F     +G G FG+VY           A+KVL   +++++G       E      + H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            NIL++ +      +       L+ E+   G L + L  S    C F +    +   I+ 
Sbjct: 83  PNILRLYNY-----FYDRRRIYLILEYAPRGELYKELQKS----CTFDE---QRTATIME 130
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS-KNQTM 331
           ++A AL Y H +    + H D+K  N+LL       + DFG +       + PS + +TM
Sbjct: 131 ELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWS------VHAPSLRRKTM 181
Query: 332 SNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
                G++ Y+PPE I G +     D++  G+L  E+  G  P
Sbjct: 182 C----GTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPP 220

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSC 222
           IG G++G VYK     GET A+K ++L++  +G   + I E + L  ++H NI+K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
            +          LVFE     +LDQ L    D  C     S+  + + ++ + + + Y H
Sbjct: 70  HT-----KKRLVLVFE-----HLDQDLKKLLD-VCEGGLESVTAK-SFLLQLLNGIAYCH 117
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
              D  + H DLK  N+L++      + DFGLA+        P +  T       ++ Y 
Sbjct: 118 ---DRRVLHRDLKPQNLLINREGELKIADFGLARAF----GIPVRKYTHE---VVTLWYR 167
Query: 343 PPEYING--HVSILGDIYSYGILLLEIFTG 370
            P+ + G    S   DI+S G +  E+  G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 104/234 (44%), Gaps = 32/234 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIRHR 213
           +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
           NI+K++    +   E   +  LVFEF+   +L +++  S         + L    + +  
Sbjct: 63  NIVKLLDVIHT---ENKLY--LVFEFLHQ-DLKKFMDASA-----LTGIPLPLIKSYLFQ 111
Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +   L + H+     + H DLK  N+L++      + DFGLA+        P +  T   
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF----GVPVRTYTHE- 163
Query: 334 GLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
               ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 164 --VVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 215

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSC 222
           IG G++G VYK     GET A+K ++L++  +G   + I E + L  ++H NI+K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
            +          LVFE     +LDQ L    D  C     S+  + + ++ + + + Y H
Sbjct: 70  HT-----KKRLVLVFE-----HLDQDLKKLLD-VCEGGLESVTAK-SFLLQLLNGIAYCH 117
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
              D  + H DLK  N+L++      + DFGLA+        P +  T       ++ Y 
Sbjct: 118 ---DRRVLHRDLKPQNLLINREGELKIADFGLARAF----GIPVRKYTHE---VVTLWYR 167
Query: 343 PPEYING--HVSILGDIYSYGILLLEIFTG 370
            P+ + G    S   DI+S G +  E+  G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 32/234 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIRHR 213
           +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
           NI+K++     V +  N    LVFEF+   +L +++  S         + L    + +  
Sbjct: 63  NIVKLLD----VIHTENKL-YLVFEFLHQ-DLKKFMDASA-----LTGIPLPLIKSYLFQ 111
Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +   L + H+     + H DLK  N+L++      + DFGLA+        P +  T   
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF----GVPVRTYTHE- 163
Query: 334 GLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
               ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 164 --VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 215

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 32/234 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIRHR 213
           +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
           NI+K++     V +  N    LVFEF+   +L +++  S         + L    + +  
Sbjct: 70  NIVKLLD----VIHTENKL-YLVFEFLHQ-DLKKFMDASA-----LTGIPLPLIKSYLFQ 118
Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +   L + H+     + H DLK  N+L++      + DFGLA+        P +  T   
Sbjct: 119 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF----GVPVRTYTHE- 170
Query: 334 GLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
               ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 171 --VVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 222

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSC 222
           IG G++G VYK     GET A+K ++L++  +G   + I E + L  ++H NI+K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
            +          LVFE     +LDQ L    D  C     S+  + + ++ + + + Y H
Sbjct: 70  HT-----KKRLVLVFE-----HLDQDLKKLLD-VCEGGLESVTAK-SFLLQLLNGIAYCH 117
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
              D  + H DLK  N+L++      + DFGLA+        P +  T       ++ Y 
Sbjct: 118 ---DRRVLHRDLKPQNLLINREGELKIADFGLARAF----GIPVRKYTHE---IVTLWYR 167
Query: 343 PPEYING--HVSILGDIYSYGILLLEIFTG 370
            P+ + G    S   DI+S G +  E+  G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 109/240 (45%), Gaps = 40/240 (16%)
Query: 165 IGSGSFGSVYKGTL-----ADGE-TAAIKVLK----LQQQGALKSFIDECNALTSI-RHR 213
           +G+G+FG V + T      +D   T A+K+LK    L ++ AL S   E   L+ +  H 
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS---ELKVLSYLGNHM 110
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEY-CHFKKLSLMQRL---- 268
           NI+ ++ +C+           ++ E+   G+L  +L    D + C     ++M+      
Sbjct: 111 NIVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 269 ------NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES 322
                 +    VA  + +L ++      H DL + N+LL  G I  + DFGLA+ +  +S
Sbjct: 166 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARHIKNDS 222
Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKD 380
           N   K        +  V ++ PE I N   +   D++SYGI L E+F+ G  P   M  D
Sbjct: 223 NYVVKGNA-----RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 277

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 67/139 (48%), Gaps = 23/139 (16%)
Query: 241 RNGNLDQWLHPSTDEYCHFKKLSLMQR-----LNIVIDVASALDYLHNQYDTPIAHCDLK 295
           R  NL  W++         ++ SL  R     L+I I +A A+++LH++    + H DLK
Sbjct: 144 RKENLKDWMN---------RRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLK 191
Query: 296 SSNVLLDEGMIAHVGDFGLAKFLFEESN-----TPSKNQTMSNGLKGSVGYIPPEYING- 349
            SN+      +  VGDFGL   + ++       TP        G  G+  Y+ PE I+G 
Sbjct: 192 PSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGN 251
Query: 350 HVSILGDIYSYGILLLEIF 368
           + S   DI+S G++L E+ 
Sbjct: 252 NYSHKVDIFSLGLILFELL 270

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 93/237 (39%), Gaps = 54/237 (22%)
Query: 159 FSEENLIGSGSFGSVYKGT-LADGETAAIKVLKL---QQQGALKSFIDECNALTSIRHRN 214
           FS+   IG GSFG+VY    + + E  AIK +     Q     +  I E   L  +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYC----------HFKKLSL 264
                    ++ Y G         ++R      WL     EYC          H K L  
Sbjct: 77  ---------TIQYRGC--------YLREHT--AWL---VMEYCLGSASDLLEVHKKPLQE 114
Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNT 324
           ++   +       L YLH+     + H D+K+ N+LL E  +  +GDFG A  +      
Sbjct: 115 VEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------ 165
Query: 325 PSKNQTMSNGLKGSVGYIPPEYI----NGHVSILGDIYSYGILLLEIFTGKRPTDDM 377
                  +N   G+  ++ PE I     G      D++S GI  +E+   K P  +M
Sbjct: 166 -----APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 89/190 (46%), Gaps = 24/190 (12%)
Query: 190 KLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNL---D 246
           K+  +     F +E   +T I++   L    +C  +     D   +++E+M N ++   D
Sbjct: 80  KISIKSKYDDFKNELQIITDIKNEYCL----TCEGI-ITNYDEVYIIYEYMENDSILKFD 134
Query: 247 QWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI 306
           ++       Y  F  + +++   I+  V ++  Y+HN+    I H D+K SN+L+D+   
Sbjct: 135 EYFFVLDKNYTCFIPIQVIK--CIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGR 190
Query: 307 AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILG---DIYSYGIL 363
             + DFG ++++ ++            G +G+  ++PPE+ +   S  G   DI+S GI 
Sbjct: 191 VKLSDFGESEYMVDKK---------IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGIC 241
Query: 364 LLEIFTGKRP 373
           L  +F    P
Sbjct: 242 LYVMFYNVVP 251

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 31/222 (13%)
Query: 165 IGSGSFGSVYKGTLADGET---AAIKVLKLQQQGALKSFIDECNALTSIRHR----NILK 217
           +G G+FGSV +G     +     AIKVLK   QG  K+  +E      I H+     I++
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLK---QGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
           ++  C +      +   LV E    G L ++L    +E      + +     ++  V+  
Sbjct: 75  LIGVCQA------EALMLVMEMAGGGPLHKFLVGKREE------IPVSNVAELLHQVSMG 122
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YL    +    H DL + NVLL     A + DFGL+K L  + +      T  +  K 
Sbjct: 123 MKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY----YTARSAGKW 175
Query: 338 SVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
            + +  PE IN    S   D++SYG+ + E  + G++P   M
Sbjct: 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 93/237 (39%), Gaps = 54/237 (22%)
Query: 159 FSEENLIGSGSFGSVYKGT-LADGETAAIKVLKL---QQQGALKSFIDECNALTSIRHRN 214
           FS+   IG GSFG+VY    + + E  AIK +     Q     +  I E   L  +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYC----------HFKKLSL 264
                    ++ Y G         ++R      WL     EYC          H K L  
Sbjct: 116 ---------TIQYRGC--------YLREHT--AWL---VMEYCLGSASDLLEVHKKPLQE 153
Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNT 324
           ++   +       L YLH+     + H D+K+ N+LL E  +  +GDFG A  +      
Sbjct: 154 VEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------ 204
Query: 325 PSKNQTMSNGLKGSVGYIPPEYI----NGHVSILGDIYSYGILLLEIFTGKRPTDDM 377
                  +N   G+  ++ PE I     G      D++S GI  +E+   K P  +M
Sbjct: 205 -----APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 109/240 (45%), Gaps = 40/240 (16%)
Query: 165 IGSGSFGSVYKGTL-----ADGE-TAAIKVLK----LQQQGALKSFIDECNALTSI-RHR 213
           +G+G+FG V + T      +D   T A+K+LK    L ++ AL S   E   L+ +  H 
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS---ELKVLSYLGNHM 103
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEY-CHFKKLSLMQRL---- 268
           NI+ ++ +C+           ++ E+   G+L  +L    D + C     ++M+      
Sbjct: 104 NIVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 158
Query: 269 ------NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES 322
                 +    VA  + +L ++      H DL + N+LL  G I  + DFGLA+ +  +S
Sbjct: 159 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS 215
Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKD 380
           N   K        +  V ++ PE I N   +   D++SYGI L E+F+ G  P   M  D
Sbjct: 216 NYVVKGNA-----RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 270

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 97/235 (41%), Gaps = 25/235 (10%)
Query: 145 SGLSYLKISNATDN-FSEENLIGSGSFGSVY-KGTLADGETAAIKVL-KLQQQGALKSFI 201
           SG   L      D+ F  +  +GSG+FG V+     + G    IK + K + Q  ++   
Sbjct: 9   SGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE 68
Query: 202 DECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK 261
            E   L S+ H NI+KI        +E      +V E    G L   L          K 
Sbjct: 69  AEIEVLKSLDHPNIIKIFEV-----FEDYHNMYIVMETCEGGEL---LERIVSAQARGKA 120
Query: 262 LSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIA---HVGDFGLAKFL 318
           LS      ++  + +AL Y H+Q+   + H DLK  N+L  +        + DFGLA+  
Sbjct: 121 LSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177
Query: 319 FEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRP 373
                   K+   S    G+  Y+ PE     V+   DI+S G+++  + TG  P
Sbjct: 178 --------KSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLP 224

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 108/237 (45%), Gaps = 40/237 (16%)
Query: 165 IGSGSFGSVYKGTL-----ADGE-TAAIKVLK----LQQQGALKSFIDECNALTSI-RHR 213
           +G+G+FG V + T      +D   T A+K+LK    L ++ AL S   E   L+ +  H 
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS---ELKVLSYLGNHM 87
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEY-CHFKKLSLMQRL---- 268
           NI+ ++ +C+           ++ E+   G+L  +L    D + C     ++M+      
Sbjct: 88  NIVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 269 ------NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES 322
                 +    VA  + +L ++      H DL + N+LL  G I  + DFGLA+ +  +S
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
           N   K        +  V ++ PE I N   +   D++SYGI L E+F+ G  P   M
Sbjct: 200 NYVVKGNA-----RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 108/237 (45%), Gaps = 40/237 (16%)
Query: 165 IGSGSFGSVYKGTL-----ADGE-TAAIKVLK----LQQQGALKSFIDECNALTSI-RHR 213
           +G+G+FG V + T      +D   T A+K+LK    L ++ AL S   E   L+ +  H 
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS---ELKVLSYLGNHM 105
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEY-CHFKKLSLMQRL---- 268
           NI+ ++ +C+           ++ E+   G+L  +L    D + C     ++M+      
Sbjct: 106 NIVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 160
Query: 269 ------NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES 322
                 +    VA  + +L ++      H DL + N+LL  G I  + DFGLA+ +  +S
Sbjct: 161 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 217
Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
           N   K        +  V ++ PE I N   +   D++SYGI L E+F+ G  P   M
Sbjct: 218 NYVVKGNA-----RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 269

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 105/219 (47%), Gaps = 33/219 (15%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIK--VLKLQQQGALKSFIDECNALTSIRHRNILKIVSS 221
           IG G+FG V+K      G+  A+K  +++ +++G   + + E   L  ++H N++ ++  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 222 CSSVDYEGNDFKA---LVFEFMRN---GNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           C +     N  K    LVF+F  +   G L   L           K +L +   ++  + 
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL----------VKFTLSEIKRVMQMLL 134
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK-FLFEESNTPSK--NQTMS 332
           + L Y+H      I H D+K++NVL+    +  + DFGLA+ F   +++ P++  N+ + 
Sbjct: 135 NGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV- 190
Query: 333 NGLKGSVGYIPPEYINGHVSILG--DIYSYGILLLEIFT 369
                ++ Y PPE + G        D++  G ++ E++T
Sbjct: 191 -----TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 108/237 (45%), Gaps = 40/237 (16%)
Query: 165 IGSGSFGSVYKGTL-----ADGE-TAAIKVLK----LQQQGALKSFIDECNALTSI-RHR 213
           +G+G+FG V + T      +D   T A+K+LK    L ++ AL S   E   L+ +  H 
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS---ELKVLSYLGNHM 110
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEY-CHFKKLSLMQRL---- 268
           NI+ ++ +C+           ++ E+   G+L  +L    D + C     ++M+      
Sbjct: 111 NIVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 269 ------NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES 322
                 +    VA  + +L ++      H DL + N+LL  G I  + DFGLA+ +  +S
Sbjct: 166 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 222
Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
           N   K        +  V ++ PE I N   +   D++SYGI L E+F+ G  P   M
Sbjct: 223 NYVVKGNA-----RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 274

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 39/175 (22%), Positives = 77/175 (44%), Gaps = 16/175 (9%)
Query: 200 FIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHF 259
           F  E     ++ H  I+ + ++  + +        +V E++    L   +H         
Sbjct: 59  FRREAQNAAALNHPAIVAVYATGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTE------- 110
Query: 260 KKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLF 319
             ++  + + ++ D   AL++ H      I H D+K +N+++       V DFG+A+ + 
Sbjct: 111 GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA 167
Query: 320 EESNTPSKNQTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
           +  N+     T +  + G+  Y+ PE   G  V    D+YS G +L E+ TG+ P
Sbjct: 168 DSGNS----VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 105/219 (47%), Gaps = 33/219 (15%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIK--VLKLQQQGALKSFIDECNALTSIRHRNILKIVSS 221
           IG G+FG V+K      G+  A+K  +++ +++G   + + E   L  ++H N++ ++  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 222 CSSVDYEGNDFKA---LVFEFMRN---GNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           C +     N  K    LVF+F  +   G L   L           K +L +   ++  + 
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL----------VKFTLSEIKRVMQMLL 135
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK-FLFEESNTPSK--NQTMS 332
           + L Y+H      I H D+K++NVL+    +  + DFGLA+ F   +++ P++  N+ + 
Sbjct: 136 NGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV- 191
Query: 333 NGLKGSVGYIPPEYINGHVSILG--DIYSYGILLLEIFT 369
                ++ Y PPE + G        D++  G ++ E++T
Sbjct: 192 -----TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 105/219 (47%), Gaps = 33/219 (15%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIK--VLKLQQQGALKSFIDECNALTSIRHRNILKIVSS 221
           IG G+FG V+K      G+  A+K  +++ +++G   + + E   L  ++H N++ ++  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 222 CSSVDYEGNDFKA---LVFEFMRN---GNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           C +     N  K    LVF+F  +   G L   L           K +L +   ++  + 
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL----------VKFTLSEIKRVMQMLL 135
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK-FLFEESNTPSK--NQTMS 332
           + L Y+H      I H D+K++NVL+    +  + DFGLA+ F   +++ P++  N+ + 
Sbjct: 136 NGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV- 191
Query: 333 NGLKGSVGYIPPEYINGHVSILG--DIYSYGILLLEIFT 369
                ++ Y PPE + G        D++  G ++ E++T
Sbjct: 192 -----TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 32/236 (13%)
Query: 155 ATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIR 211
           + +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H NI+K++     V +  N    LVFEF+   +L +++  S         + L    + +
Sbjct: 61  HPNIVKLLD----VIHTENKL-YLVFEFLHQ-DLKKFMDASA-----LTGIPLPLIKSYL 109
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
             +   L + H+     + H DLK  N+L++      + DFGLA+       T       
Sbjct: 110 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 165
Query: 332 SNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
                 ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 166 ------TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 215

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 102/234 (43%), Gaps = 32/234 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIRHR 213
           +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
           NI+K++     V +  N    LVFEF+   +L +++  S         + L    + +  
Sbjct: 62  NIVKLLD----VIHTENKL-YLVFEFLHQ-DLKKFMDASA-----LTGIPLPLIKSYLFQ 110
Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +   L + H+     + H DLK  N+L++      + DFGLA+       T         
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--- 164
Query: 334 GLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
               ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 165 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 214

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 32/237 (13%)
Query: 154 NATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSI 210
            + +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  +
Sbjct: 4   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
            H NI+K++     V +  N    LVFEF+   +L +++  S         + L    + 
Sbjct: 64  NHPNIVKLLD----VIHTENKL-YLVFEFLHQ-DLKKFMDASA-----LTGIPLPLIKSY 112
Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
           +  +   L + H+     + H DLK  N+L++      + DFGLA+       T      
Sbjct: 113 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 169
Query: 331 MSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
                  ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 170 -------TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 219

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 32/236 (13%)
Query: 155 ATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIR 211
           + +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H NI+K++     V +  N    LVFEF+   +L +++  S         + L    + +
Sbjct: 61  HPNIVKLLD----VIHTENKL-YLVFEFLHQ-DLKKFMDASA-----LTGIPLPLIKSYL 109
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
             +   L + H+     + H DLK  N+L++      + DFGLA+       T       
Sbjct: 110 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 165
Query: 332 SNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
                 ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 166 ------TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 215

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 107/256 (41%), Gaps = 45/256 (17%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRN--ILKIVS 220
           IGSG    V++      +  AIK + L++     L S+ +E   L  ++  +  I+++  
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY- 75
Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLD--QWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
                DYE  D    ++  M  GN+D   WL          K +   +R +   ++  A+
Sbjct: 76  -----DYEITD--QYIYMVMECGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAV 121
Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
             +H      I H DLK +N L+ +GM+  + DFG+A  +      P     + +   G+
Sbjct: 122 HTIHQH---GIVHSDLKPANFLIVDGMLKLI-DFGIANQM-----QPDTTSVVKDSQVGT 172
Query: 339 VGYIPPEYINGHVS------------ILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHK 386
           V Y+PPE I    S               D++S G +L  +  GK P   +      +H 
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 232
Query: 387 FVLMALPSHVMDVLDL 402
            +    P+H ++  D+
Sbjct: 233 II---DPNHEIEFPDI 245

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 94/229 (41%), Gaps = 38/229 (16%)
Query: 156 TDNFSEENLIGSGSFGSVY--KGTLADGETAAIKVLK------LQQQGALKSFIDECNAL 207
           +D +     +GSG++G V   K  L  G   AIK++K          GAL   +DE   L
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGAL---LDEVAVL 58
Query: 208 TSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQR 267
             + H NI+K+        +E      LV E  R G L        DE    +K S +  
Sbjct: 59  KQLDHPNIMKLYEF-----FEDKRNYYLVMEVYRGGEL-------FDEIILRQKFSEVDA 106
Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLFEESNT 324
             I+  V S   YLH      I H DLK  N+LL+      +  + DFGL+   FE    
Sbjct: 107 AVIMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAH-FEVGGK 162
Query: 325 PSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRP 373
                 M   L G+  YI PE +        D++S G++L  +  G  P
Sbjct: 163 ------MKERL-GTAYYIAPEVLRKKYDEKCDVWSCGVILYILLCGYPP 204

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 32/236 (13%)
Query: 155 ATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIR 211
           + +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H NI+K++     V +  N    LVFEF+   +L +++  S         + L    + +
Sbjct: 62  HPNIVKLLD----VIHTENKL-YLVFEFLHQ-DLKKFMDASA-----LTGIPLPLIKSYL 110
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
             +   L + H+     + H DLK  N+L++      + DFGLA+       T       
Sbjct: 111 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 166
Query: 332 SNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
                 ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 167 ------TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 216

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 103/234 (44%), Gaps = 32/234 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIRHR 213
           +NF +   IG G++G VYK      GE  A+  ++L  + +G   + I E + L  + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
           NI+K++     V +  N    LVFEF+   +L +++  S         + L    + +  
Sbjct: 63  NIVKLLD----VIHTENKL-YLVFEFLHQ-DLKKFMDASA-----LTGIPLPLIKSYLFQ 111
Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +   L + H+     + H DLK  N+L++      + DFGLA+        P +  T   
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF----GVPVRTYTHE- 163
Query: 334 GLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
               ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 164 --VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 215

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 102/234 (43%), Gaps = 32/234 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIRHR 213
           +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
           NI+K++     V +  N    LVFEF+   +L +++  S         + L    + +  
Sbjct: 62  NIVKLLD----VIHTENKL-YLVFEFLHQ-DLKKFMDASA-----LTGIPLPLIKSYLFQ 110
Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +   L + H+     + H DLK  N+L++      + DFGLA+       T         
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--- 164
Query: 334 GLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
               ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 165 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 214

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 103/234 (44%), Gaps = 32/234 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIRHR 213
           +NF +   IG G++G VYK      GE  A+  ++L  + +G   + I E + L  + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
           NI+K++     V +  N    LVFEF+   +L +++  S         + L    + +  
Sbjct: 62  NIVKLLD----VIHTENKL-YLVFEFLHQ-DLKKFMDASA-----LTGIPLPLIKSYLFQ 110
Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +   L + H+     + H DLK  N+L++      + DFGLA+        P +  T   
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF----GVPVRTYTHE- 162
Query: 334 GLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
               ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 163 --VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 214

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 32/236 (13%)
Query: 155 ATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIR 211
           + +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H NI+K++     V +  N    LVFEF+   +L +++  S         + L    + +
Sbjct: 61  HPNIVKLLD----VIHTENKL-YLVFEFLHQ-DLKKFMDASA-----LTGIPLPLIKSYL 109
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
             +   L + H+     + H DLK  N+L++      + DFGLA+       T       
Sbjct: 110 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 165
Query: 332 SNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
                 ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 166 ------TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 215

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 107/256 (41%), Gaps = 45/256 (17%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRN--ILKIVS 220
           IGSG    V++      +  AIK + L++     L S+ +E   L  ++  +  I+++  
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY- 74
Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLD--QWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
                DYE  D    ++  M  GN+D   WL          K +   +R +   ++  A+
Sbjct: 75  -----DYEITD--QYIYMVMECGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAV 120
Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
             +H      I H DLK +N L+ +GM+  + DFG+A  +      P     + +   G+
Sbjct: 121 HTIHQH---GIVHSDLKPANFLIVDGMLKLI-DFGIANQM-----QPDTTSVVKDSQVGT 171
Query: 339 VGYIPPEYINGHVS------------ILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHK 386
           V Y+PPE I    S               D++S G +L  +  GK P   +      +H 
Sbjct: 172 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 231
Query: 387 FVLMALPSHVMDVLDL 402
            +    P+H ++  D+
Sbjct: 232 II---DPNHEIEFPDI 244

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 107/256 (41%), Gaps = 45/256 (17%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRN--ILKIVS 220
           IGSG    V++      +  AIK + L++     L S+ +E   L  ++  +  I+++  
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY- 78
Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLD--QWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
                DYE  D    ++  M  GN+D   WL          K +   +R +   ++  A+
Sbjct: 79  -----DYEITD--QYIYMVMECGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAV 124
Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
             +H      I H DLK +N L+ +GM+  + DFG+A  +      P     + +   G+
Sbjct: 125 HTIHQH---GIVHSDLKPANFLIVDGMLKLI-DFGIANQM-----QPDTTSVVKDSQVGT 175
Query: 339 VGYIPPEYINGHVS------------ILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHK 386
           V Y+PPE I    S               D++S G +L  +  GK P   +      +H 
Sbjct: 176 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 235
Query: 387 FVLMALPSHVMDVLDL 402
            +    P+H ++  D+
Sbjct: 236 II---DPNHEIEFPDI 248

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 32/236 (13%)
Query: 155 ATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIR 211
           + +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H NI+K++     V +  N    LVFEF+   +L +++  S         + L    + +
Sbjct: 62  HPNIVKLLD----VIHTENKL-YLVFEFLHQ-DLKKFMDASA-----LTGIPLPLIKSYL 110
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
             +   L + H+     + H DLK  N+L++      + DFGLA+       T       
Sbjct: 111 FQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 166
Query: 332 SNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
                 ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 167 ------TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 216

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 32/236 (13%)
Query: 155 ATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIR 211
           + +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H NI+K++     V +  N    LVFEF+   +L +++  S         + L    + +
Sbjct: 63  HPNIVKLLD----VIHTENKL-YLVFEFLHQ-DLKKFMDASA-----LTGIPLPLIKSYL 111
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
             +   L + H+     + H DLK  N+L++      + DFGLA+       T       
Sbjct: 112 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 167
Query: 332 SNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
                 ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 168 ------TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 217

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 32/236 (13%)
Query: 155 ATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIR 211
           + +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H NI+K++     V +  N    LVFEF+   +L +++  S         + L    + +
Sbjct: 64  HPNIVKLLD----VIHTENKL-YLVFEFLHQ-DLKKFMDASA-----LTGIPLPLIKSYL 112
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
             +   L + H+     + H DLK  N+L++      + DFGLA+       T       
Sbjct: 113 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 168
Query: 332 SNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
                 ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 169 ------TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 218

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 32/236 (13%)
Query: 155 ATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIR 211
           + +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H NI+K++     V +  N    LVFEF+   +L +++  S         + L    + +
Sbjct: 64  HPNIVKLLD----VIHTENKL-YLVFEFLHQ-DLKKFMDASA-----LTGIPLPLIKSYL 112
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
             +   L + H+     + H DLK  N+L++      + DFGLA+       T       
Sbjct: 113 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 168
Query: 332 SNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
                 ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 169 ------TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 218

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 32/236 (13%)
Query: 155 ATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIR 211
           + +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H NI+K++     V +  N    LVFEF+   +L +++  S         + L    + +
Sbjct: 63  HPNIVKLLD----VIHTENKL-YLVFEFLHQ-DLKKFMDASA-----LTGIPLPLIKSYL 111
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
             +   L + H+     + H DLK  N+L++      + DFGLA+       T       
Sbjct: 112 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 167
Query: 332 SNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
                 ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 168 ------TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 217

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 107/256 (41%), Gaps = 45/256 (17%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRN--ILKIVS 220
           IGSG    V++      +  AIK + L++     L S+ +E   L  ++  +  I+++  
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY- 94
Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLD--QWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
                DYE  D    ++  M  GN+D   WL          K +   +R +   ++  A+
Sbjct: 95  -----DYEITD--QYIYMVMECGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAV 140
Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
             +H      I H DLK +N L+ +GM+  + DFG+A  +      P     + +   G+
Sbjct: 141 HTIHQH---GIVHSDLKPANFLIVDGMLKLI-DFGIANQM-----QPDTTSVVKDSQVGT 191
Query: 339 VGYIPPEYINGHVS------------ILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHK 386
           V Y+PPE I    S               D++S G +L  +  GK P   +      +H 
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 251
Query: 387 FVLMALPSHVMDVLDL 402
            +    P+H ++  D+
Sbjct: 252 II---DPNHEIEFPDI 264

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 102/234 (43%), Gaps = 32/234 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIRHR 213
           +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
           NI+K++     V +  N    LVFEF+   +L +++  S         + L    + +  
Sbjct: 64  NIVKLLD----VIHTENKL-YLVFEFLHQ-DLKKFMDASA-----LTGIPLPLIKSYLFQ 112
Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +   L + H+     + H DLK  N+L++      + DFGLA+       T         
Sbjct: 113 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--- 166
Query: 334 GLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
               ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 167 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 216

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 105/231 (45%), Gaps = 35/231 (15%)
Query: 163 NLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFID-------ECNALTSIRHRNI 215
           +L+G GS+G V +  + D ET   + +K+ ++  L+   +       E   L  +RH+N+
Sbjct: 11  DLLGEGSYGKVKE--VLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           +++V    +   E      +V E+   G   Q +  S  E    K+  + Q       + 
Sbjct: 69  IQLVDVLYN---EEKQKMYMVMEYCVCGM--QEMLDSVPE----KRFPVCQAHGYFCQLI 119
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFL--FEESNTPSKNQTMSN 333
             L+YLH+Q    I H D+K  N+LL  G    +   G+A+ L  F   +T   +Q    
Sbjct: 120 DGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ---- 172
Query: 334 GLKGSVGYIPPEYINGHVSILG---DIYSYGILLLEIFTGKRP--TDDMFK 379
              GS  + PPE  NG  +  G   DI+S G+ L  I TG  P   D+++K
Sbjct: 173 ---GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK 220

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 32/236 (13%)
Query: 155 ATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIR 211
           + +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H NI+K++     V +  N    LVFEF+   +L +++  S         + L    + +
Sbjct: 63  HPNIVKLLD----VIHTENKL-YLVFEFLHQ-DLKKFMDASA-----LTGIPLPLIKSYL 111
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
             +   L + H+     + H DLK  N+L++      + DFGLA+       T       
Sbjct: 112 FQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 167
Query: 332 SNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
                 ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 168 ------TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 217

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/175 (22%), Positives = 76/175 (43%), Gaps = 16/175 (9%)
Query: 200 FIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHF 259
           F  E     ++ H  I+ +  +  + +        +V E++    L   +H         
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTE------- 110
Query: 260 KKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLF 319
             ++  + + ++ D   AL++ H      I H D+K +N+++       V DFG+A+ + 
Sbjct: 111 GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA 167
Query: 320 EESNTPSKNQTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
           +  N+     T +  + G+  Y+ PE   G  V    D+YS G +L E+ TG+ P
Sbjct: 168 DSGNS----VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/226 (21%), Positives = 95/226 (42%), Gaps = 20/226 (8%)
Query: 153 SNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKL---QQQGALKSFIDECNALT 208
           S+ +D +    ++G G    V+    L      A+KVL+    +       F  E     
Sbjct: 25  SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 84
Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
           ++ H  I+ +  +  + +        +V E++    L   +H           ++  + +
Sbjct: 85  ALNHPAIVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTE-------GPMTPKRAI 136
Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
            ++ D   AL++ H      I H D+K +N+++       V DFG+A+ + +  N+    
Sbjct: 137 EVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS---- 189
Query: 329 QTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
            T +  + G+  Y+ PE   G  V    D+YS G +L E+ TG+ P
Sbjct: 190 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 159 FSEENL-----IGSGSFGSV---YKGTLADGETAAIKVLKLQQQGA--LKSFIDECNALT 208
           F E +L     +G G+FGSV       L D   A + V +LQ  G    + F  E   L 
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 63
Query: 209 SIRHRNILKIVSSCSSVDY-EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQR 267
           ++    I+K       V Y  G     LV E++ +G L  +L        H  +L   + 
Sbjct: 64  ALHSDFIVKY----RGVSYGPGRPELRLVMEYLPSGCLRDFLQR------HRARLDASRL 113
Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
           L     +   ++YL ++      H DL + N+L++      + DFGLAK L  + +    
Sbjct: 114 LLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDX--- 167
Query: 328 NQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
              +    +  + +  PE ++ ++ S   D++S+G++L E+FT
Sbjct: 168 -XVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 106/250 (42%), Gaps = 52/250 (20%)
Query: 142 EWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETA-AIKVLKLQQ------- 193
           E + G SY K+            +GSG++G V      +G +  AIKV+K  Q       
Sbjct: 31  EGKIGESYFKVRK----------LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYS 80
Query: 194 ------QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNL-D 246
                 +   +   +E + L S+ H NI+K+        +E   +  LV EF   G L +
Sbjct: 81  DDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV-----FEDKKYFYLVTEFYEGGELFE 135
Query: 247 QWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG-- 304
           Q ++    + C           NI+  + S + YLH      I H D+K  N+LL+    
Sbjct: 136 QIINRHKFDEC--------DAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNS 184
Query: 305 -MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGIL 363
            +   + DFGL+ F        SK+  + + L G+  YI PE +    +   D++S G++
Sbjct: 185 LLNIKIVDFGLSSFF-------SKDYKLRDRL-GTAYYIAPEVLKKKYNEKCDVWSCGVI 236
Query: 364 LLEIFTGKRP 373
           +  +  G  P
Sbjct: 237 MYILLCGYPP 246

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 32/236 (13%)
Query: 155 ATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIR 211
           + +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H NI+K++     V +  N    LVFEF+   +L +++  S         + L    + +
Sbjct: 61  HPNIVKLLD----VIHTENKL-YLVFEFLHQ-DLKKFMDASA-----LTGIPLPLIKSYL 109
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
             +   L + H+     + H DLK  N+L++      + DFGLA+       T       
Sbjct: 110 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 165
Query: 332 SNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
                 ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 166 ------TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 215

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 111/240 (46%), Gaps = 37/240 (15%)
Query: 155 ATDNFS---------EENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFI-DE 203
           +TD+FS         +E+++G G+   V     L   +  A+K+++ +Q G ++S +  E
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFRE 60
Query: 204 CNALTSIR-HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKL 262
              L   + HRN+L+++      D        LVFE MR G++   +H       HF +L
Sbjct: 61  VEMLYQCQGHRNVLELIEFFEEEDR-----FYLVFEKMRGGSILSHIHKRR----HFNEL 111
Query: 263 SLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLF 319
              +   +V DVASALD+LHN+    IAH DLK  N+L +   +     + DF L   + 
Sbjct: 112 ---EASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165
Query: 320 EESNTPSKNQTMSNGLKGSVGYIPPEYING---HVSILG---DIYSYGILLLEIFTGKRP 373
              +    +        GS  Y+ PE +       SI     D++S G++L  + +G  P
Sbjct: 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 104/236 (44%), Gaps = 32/236 (13%)
Query: 155 ATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIR 211
           + +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H NI+K++     V +  N    LVFEF+ + +L +++  S         + L    + +
Sbjct: 64  HPNIVKLLD----VIHTENKL-YLVFEFL-SMDLKKFMDASA-----LTGIPLPLIKSYL 112
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
             +   L + H+     + H DLK  N+L++      + DFGLA+       T       
Sbjct: 113 FQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 168
Query: 332 SNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
                 ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 169 ------TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 218

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/256 (24%), Positives = 107/256 (41%), Gaps = 45/256 (17%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRN--ILKIVS 220
           IGSG    V++      +  AIK + L++     L S+ +E   L  ++  +  I+++  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY- 122
Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLD--QWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
                DYE  D    ++  M  GN+D   WL          K +   +R +   ++  A+
Sbjct: 123 -----DYEITD--QYIYMVMECGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAV 168
Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
             +H      I H DLK +N L+ +GM+  + DFG+A  +      P     + +   G+
Sbjct: 169 HTIHQH---GIVHSDLKPANFLIVDGMLKLI-DFGIANQM-----QPDTTSVVKDSQVGT 219
Query: 339 VGYIPPEYINGHVS------------ILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHK 386
           V Y+PPE I    S               D++S G +L  +  GK P   +      I K
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---QISK 276
Query: 387 FVLMALPSHVMDVLDL 402
              +  P+H ++  D+
Sbjct: 277 LHAIIDPNHEIEFPDI 292

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 92/221 (41%), Gaps = 39/221 (17%)
Query: 164 LIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALK-----SFIDECNALTSIRHRNILK- 217
           ++G GSFG V K    D  T     +K+  + + K     + + E   L  + H NI+K 
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 218 --IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
             I+   SS          +V E    G L        DE    K+ S      I+  V 
Sbjct: 87  FEILEDSSSF--------YIVGELYTGGEL-------FDEIIKRKRFSEHDAARIIKQVF 131
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           S + Y+H      I H DLK  N+LL+   +     + DFGL+     + NT  K++   
Sbjct: 132 SGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRI-- 184
Query: 333 NGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRP 373
               G+  YI PE + G      D++S G++L  + +G  P
Sbjct: 185 ----GTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 107/256 (41%), Gaps = 45/256 (17%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRN--ILKIVS 220
           IGSG    V++      +  AIK + L++     L S+ +E   L  ++  +  I+++  
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY- 94
Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLD--QWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
                DYE  D    ++  M  GN+D   WL          K +   +R +   ++  A+
Sbjct: 95  -----DYEITD--QYIYMVMECGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAV 140
Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
             +H      I H DLK +N L+ +GM+  + DFG+A  +      P     + +   G+
Sbjct: 141 HTIHQH---GIVHSDLKPANFLIVDGMLKLI-DFGIANQM-----QPDXXXVVKDSQVGT 191
Query: 339 VGYIPPEYINGHVS------------ILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHK 386
           V Y+PPE I    S               D++S G +L  +  GK P   +      +H 
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 251
Query: 387 FVLMALPSHVMDVLDL 402
            +    P+H ++  D+
Sbjct: 252 II---DPNHEIEFPDI 264

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 104/236 (44%), Gaps = 32/236 (13%)
Query: 155 ATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIR 211
           + +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H NI+K++     V +  N    LVFEF+ + +L +++  S         + L    + +
Sbjct: 62  HPNIVKLLD----VIHTENKL-YLVFEFL-SMDLKKFMDASA-----LTGIPLPLIKSYL 110
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
             +   L + H+     + H DLK  N+L++      + DFGLA+       T       
Sbjct: 111 FQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 166
Query: 332 SNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
                 ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 167 ------TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 216

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 107/256 (41%), Gaps = 45/256 (17%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRN--ILKIVS 220
           IGSG    V++      +  AIK + L++     L S+ +E   L  ++  +  I+++  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY- 122
Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLD--QWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
                DYE  D    ++  M  GN+D   WL          K +   +R +   ++  A+
Sbjct: 123 -----DYEITD--QYIYMVMECGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAV 168
Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
             +H      I H DLK +N L+ +GM+  + DFG+A  +      P     + +   G+
Sbjct: 169 HTIHQH---GIVHSDLKPANFLIVDGMLKLI-DFGIANQM-----QPDTTSVVKDSQVGT 219
Query: 339 VGYIPPEYINGHVS------------ILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHK 386
           V Y+PPE I    S               D++S G +L  +  GK P   +      +H 
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 279
Query: 387 FVLMALPSHVMDVLDL 402
            +    P+H ++  D+
Sbjct: 280 II---DPNHEIEFPDI 292

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 107/256 (41%), Gaps = 45/256 (17%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRN--ILKIVS 220
           IGSG    V++      +  AIK + L++     L S+ +E   L  ++  +  I+++  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY- 122
Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLD--QWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
                DYE  D    ++  M  GN+D   WL          K +   +R +   ++  A+
Sbjct: 123 -----DYEITD--QYIYMVMECGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAV 168
Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
             +H      I H DLK +N L+ +GM+  + DFG+A  +      P     + +   G+
Sbjct: 169 HTIHQH---GIVHSDLKPANFLIVDGMLKLI-DFGIANQM-----QPDTTSVVKDSQVGA 219
Query: 339 VGYIPPEYINGHVS------------ILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHK 386
           V Y+PPE I    S               D++S G +L  +  GK P   +      +H 
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 279
Query: 387 FVLMALPSHVMDVLDL 402
            +    P+H ++  D+
Sbjct: 280 II---DPNHEIEFPDI 292

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 89/228 (39%), Gaps = 38/228 (16%)
Query: 158 NFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRN 214
           N+     IG G+F  V     +  G+  A+K++   Q    +L+    E   +  + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVI 272
           I+K+         E      LV E+   G +  +L  H    E     K           
Sbjct: 75  IVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR--------- 120
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            + SA+ Y H ++   I H DLK+ N+LLD  M   + DFG            S   T  
Sbjct: 121 QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGF-----------SNEFTFG 166
Query: 333 NGLK---GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTD 375
           N L    GS  Y  PE   G  +     D++S G++L  + +G  P D
Sbjct: 167 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 32/236 (13%)
Query: 155 ATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIR 211
           + +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H NI+K++     V +  N    LVFEF+   +L  ++  S         + L    + +
Sbjct: 61  HPNIVKLLD----VIHTENKL-YLVFEFLHQ-DLKDFMDASA-----LTGIPLPLIKSYL 109
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
             +   L + H+     + H DLK  N+L++      + DFGLA+       T       
Sbjct: 110 FQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 165
Query: 332 SNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
                 ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 166 ------TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 215

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 92/221 (41%), Gaps = 39/221 (17%)
Query: 164 LIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALK-----SFIDECNALTSIRHRNILK- 217
           ++G GSFG V K    D  T     +K+  + + K     + + E   L  + H NI+K 
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 218 --IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
             I+   SS          +V E    G L        DE    K+ S      I+  V 
Sbjct: 87  FEILEDSSSF--------YIVGELYTGGEL-------FDEIIKRKRFSEHDAARIIKQVF 131
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           S + Y+H      I H DLK  N+LL+   +     + DFGL+     + NT  K++   
Sbjct: 132 SGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRI-- 184
Query: 333 NGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRP 373
               G+  YI PE + G      D++S G++L  + +G  P
Sbjct: 185 ----GTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 87/221 (39%), Gaps = 38/221 (17%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSS 221
           IG G+F  V     +  G+  A+K++   Q    +L+    E   +  + H NI+K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 222 CSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
                 E      LV E+   G +  +L  H    E     K            + SA+ 
Sbjct: 82  I-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---------QIVSAVQ 127
Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK--- 336
           Y H ++   I H DLK+ N+LLD  M   + DFG            S   T  N L    
Sbjct: 128 YCHQKF---IVHRDLKAENLLLDADMNIKIADFGF-----------SNEFTFGNKLDTFC 173
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTD 375
           GS  Y  PE   G  +     D++S G++L  + +G  P D
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 32/236 (13%)
Query: 155 ATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIR 211
           + +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H NI+K++     V +  N    LVFEF+   +L  ++  S         + L    + +
Sbjct: 64  HPNIVKLLD----VIHTENKL-YLVFEFLHQ-DLKTFMDASA-----LTGIPLPLIKSYL 112
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
             +   L + H+     + H DLK  N+L++      + DFGLA+       T       
Sbjct: 113 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 168
Query: 332 SNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
                 ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 169 ------TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 218

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 92/221 (41%), Gaps = 39/221 (17%)
Query: 164 LIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALK-----SFIDECNALTSIRHRNILK- 217
           ++G GSFG V K    D  T     +K+  + + K     + + E   L  + H NI+K 
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 218 --IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
             I+   SS          +V E    G L        DE    K+ S      I+  V 
Sbjct: 87  FEILEDSSSF--------YIVGELYTGGEL-------FDEIIKRKRFSEHDAARIIKQVF 131
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           S + Y+H      I H DLK  N+LL+   +     + DFGL+     + NT  K++   
Sbjct: 132 SGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRI-- 184
Query: 333 NGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRP 373
               G+  YI PE + G      D++S G++L  + +G  P
Sbjct: 185 ----GTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 89/228 (39%), Gaps = 38/228 (16%)
Query: 158 NFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRN 214
           N+     IG G+F  V     +  G+  A+K++   Q    +L+    E   +  + H N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVI 272
           I+K+         E      LV E+   G +  +L  H    E     K           
Sbjct: 68  IVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR--------- 113
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            + SA+ Y H ++   I H DLK+ N+LLD  M   + DFG            S   T  
Sbjct: 114 QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGF-----------SNEFTFG 159
Query: 333 NGLK---GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTD 375
           N L    GS  Y  PE   G  +     D++S G++L  + +G  P D
Sbjct: 160 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 32/236 (13%)
Query: 155 ATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIR 211
           + +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H NI+K++     V +  N    LVFEF+ + +L  ++  S         + L    + +
Sbjct: 64  HPNIVKLLD----VIHTENKL-YLVFEFL-SMDLKDFMDASA-----LTGIPLPLIKSYL 112
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
             +   L + H+     + H DLK  N+L++      + DFGLA+       T       
Sbjct: 113 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 168
Query: 332 SNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
                 ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 169 ------TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 218

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 46/225 (20%)
Query: 165 IGSGSFGSVYK-GTLADGETAAIKVLKLQQQGALKSFI---DECNALTSIRHRNILKIVS 220
           +G+GSFG V+   +  +G   A+KVLK +    LK      DE   L+ + H  I+++  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN------IVIDV 274
           +     ++      ++ +++  G L             F  L   QR           +V
Sbjct: 74  T-----FQDAQQIFMIMDYIEGGEL-------------FSLLRKSQRFPNPVAKFYAAEV 115
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
             AL+YLH++    I + DLK  N+LLD+     + DFG AK++            ++  
Sbjct: 116 CLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV----------PDVTYX 162
Query: 335 LKGSVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTDD 376
           L G+  YI PE ++    + SI  D +S+GIL+ E+  G  P  D
Sbjct: 163 LCGTPDYIAPEVVSTKPYNKSI--DWWSFGILIYEMLAGYTPFYD 205

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 98/222 (44%), Gaps = 31/222 (13%)
Query: 165 IGSGSFGSVYKGTLADGET---AAIKVLKLQQQGALKSFIDECNALTSIRHR----NILK 217
           +G G+FGSV +G     +     AIKVLK   QG  K+  +E      I H+     I++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLK---QGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
           ++  C +      +   LV E    G L ++L    +E      + +     ++  V+  
Sbjct: 401 LIGVCQA------EALMLVMEMAGGGPLHKFLVGKREE------IPVSNVAELLHQVSMG 448
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YL  +      H +L + NVLL     A + DFGL+K L  + +      T  +  K 
Sbjct: 449 MKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY----YTARSAGKW 501
Query: 338 SVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
            + +  PE IN    S   D++SYG+ + E  + G++P   M
Sbjct: 502 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 28/220 (12%)
Query: 165 IGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           +G G+FG VYK    + G  AA KV++ + +  L+ +I E   L +  H  I+K++ +  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA-- 84
Query: 224 SVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN 283
              Y  +    ++ EF   G +D  +    D     + L+  Q   +   +  AL++LH+
Sbjct: 85  ---YYHDGKLWIMIEFCPGGAVDA-IMLELD-----RGLTEPQIQVVCRQMLEALNFLHS 135
Query: 284 QYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIP 343
           +    I H DLK+ NVL+        GD  LA F     N   K     +   G+  ++ 
Sbjct: 136 KR---IIHRDLKAGNVLM-----TLEGDIRLADFGVSAKNL--KTLQKRDSFIGTPYWMA 185
Query: 344 PEYI------NGHVSILGDIYSYGILLLEIFTGKRPTDDM 377
           PE +      +       DI+S GI L+E+   + P  ++
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 28/220 (12%)
Query: 165 IGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           +G G+FG VYK    + G  AA KV++ + +  L+ +I E   L +  H  I+K++ +  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA-- 76
Query: 224 SVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN 283
              Y  +    ++ EF   G +D  +    D     + L+  Q   +   +  AL++LH+
Sbjct: 77  ---YYHDGKLWIMIEFCPGGAVDA-IMLELD-----RGLTEPQIQVVCRQMLEALNFLHS 127
Query: 284 QYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIP 343
           +    I H DLK+ NVL+        GD  LA F     N   K     +   G+  ++ 
Sbjct: 128 KR---IIHRDLKAGNVLM-----TLEGDIRLADFGVSAKNL--KTLQKRDSFIGTPYWMA 177
Query: 344 PEYI------NGHVSILGDIYSYGILLLEIFTGKRPTDDM 377
           PE +      +       DI+S GI L+E+   + P  ++
Sbjct: 178 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 217

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 30/231 (12%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALT 208
           L+I    ++F    ++G GSFG V+        +  AIK LK  +   L     EC    
Sbjct: 11  LQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALK--KDVVLMDDDVEC---- 64
Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKA-----LVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
           ++  + +L +      + +    F+       V E++  G+L   +     + CH  K  
Sbjct: 65  TMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-----QSCH--KFD 117
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
           L +      ++   L +LH++    I + DLK  N+LLD+     + DFG+ K      N
Sbjct: 118 LSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK-----EN 169
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
                +T  N   G+  YI PE + G   +   D +S+G+LL E+  G+ P
Sbjct: 170 MLGDAKT--NEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 107/232 (46%), Gaps = 26/232 (11%)
Query: 152 ISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQG--ALKSFIDECNALT 208
           + N + +F  ++L+G G++G V   T    GE  AIK ++   +   AL++ + E   L 
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT-LREIKILK 64
Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPS--TDEYCHFKKLSLMQ 266
             +H NI+ I +      +E  +   ++ E M+  +L + +     +D++  +       
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQY------- 116
Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
               +     A+  LH    + + H DLK SN+L++      V DFGLA+ + E +   S
Sbjct: 117 ---FIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 327 KNQTMSNGLKGSVG---YIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRP 373
           +     +G+   V    Y  PE +  +   S   D++S G +L E+F  +RP
Sbjct: 171 EPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRP 221

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 159 FSEENL-----IGSGSFGSV---YKGTLADGETAAIKVLKLQQQGA--LKSFIDECNALT 208
           F E +L     +G G+FGSV       L D   A + V +LQ  G    + F  E   L 
Sbjct: 7   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 66
Query: 209 SIRHRNILKIVSSCSSVDY-EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQR 267
           ++    I+K       V Y  G     LV E++ +G L  +L        H  +L   + 
Sbjct: 67  ALHSDFIVKY----RGVSYGPGRQSLRLVMEYLPSGCLRDFLQR------HRARLDASRL 116
Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
           L     +   ++YL ++      H DL + N+L++      + DFGLAK L  + +    
Sbjct: 117 LLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY--- 170
Query: 328 NQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
              +    +  + +  PE ++ ++ S   D++S+G++L E+FT
Sbjct: 171 -YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 30/214 (14%)
Query: 165 IGSGSFG-SVYKGTLADGETAAIKVLKLQQQGA--LKSFIDECNALTSIRHRNILKIVSS 221
           IG GSFG ++   +  DG    IK + + +  +   +    E   L +++H NI++   S
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 222 CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQR---LNIVIDVASAL 278
                +E N    +V ++   G+L + ++         +K  L Q    L+  + +  AL
Sbjct: 92  -----FEENGSLYIVMDYCEGGDLFKRINA--------QKGVLFQEDQILDWFVQICLAL 138
Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
            ++H   D  I H D+KS N+ L +     +GDFG+A+ L       +    ++    G+
Sbjct: 139 KHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-------NSTVELARACIGT 188
Query: 339 VGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGK 371
             Y+ PE   N   +   DI++ G +L E+ T K
Sbjct: 189 PYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 32/236 (13%)
Query: 155 ATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIR 211
           + +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H NI+K++     V +  N    LVFEF+ + +L  ++  S         + L    + +
Sbjct: 63  HPNIVKLLD----VIHTENKL-YLVFEFL-SMDLKDFMDASA-----LTGIPLPLIKSYL 111
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
             +   L + H+     + H DLK  N+L++      + DFGLA+       T       
Sbjct: 112 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 167
Query: 332 SNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
                 ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 168 ------TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 217

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 159 FSEENL-----IGSGSFGSV---YKGTLADGETAAIKVLKLQQQGA--LKSFIDECNALT 208
           F E +L     +G G+FGSV       L D   A + V +LQ  G    + F  E   L 
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 67
Query: 209 SIRHRNILKIVSSCSSVDY-EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQR 267
           ++    I+K       V Y  G     LV E++ +G L  +L        H  +L   + 
Sbjct: 68  ALHSDFIVKY----RGVSYGPGRQSLRLVMEYLPSGCLRDFLQR------HRARLDASRL 117
Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
           L     +   ++YL ++      H DL + N+L++      + DFGLAK L  + +    
Sbjct: 118 LLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY--- 171
Query: 328 NQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
              +    +  + +  PE ++ ++ S   D++S+G++L E+FT
Sbjct: 172 -YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 159 FSEENL-----IGSGSFGSV---YKGTLADGETAAIKVLKLQQQGA--LKSFIDECNALT 208
           F E +L     +G G+FGSV       L D   A + V +LQ  G    + F  E   L 
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 79
Query: 209 SIRHRNILKIVSSCSSVDY-EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQR 267
           ++    I+K       V Y  G     LV E++ +G L  +L        H  +L   + 
Sbjct: 80  ALHSDFIVKY----RGVSYGPGRQSLRLVMEYLPSGCLRDFLQR------HRARLDASRL 129
Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
           L     +   ++YL ++      H DL + N+L++      + DFGLAK L  + +    
Sbjct: 130 LLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY--- 183
Query: 328 NQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
              +    +  + +  PE ++ ++ S   D++S+G++L E+FT
Sbjct: 184 -YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 87/221 (39%), Gaps = 38/221 (17%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSS 221
           IG G+F  V     +  G+  A++++   Q    +L+    E   +  + H NI+K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 222 CSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
                 E      LV E+   G +  +L  H    E     K            + SA+ 
Sbjct: 82  I-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---------QIVSAVQ 127
Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK--- 336
           Y H ++   I H DLK+ N+LLD  M   + DFG            S   T  N L    
Sbjct: 128 YCHQKF---IVHRDLKAENLLLDADMNIKIADFGF-----------SNEFTFGNKLDEFC 173
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTD 375
           GS  Y  PE   G  +     D++S G++L  + +G  P D
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 89/228 (39%), Gaps = 38/228 (16%)
Query: 158 NFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRN 214
           N+     IG G+F  V     +  G+  A++++   Q    +L+    E   +  + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVI 272
           I+K+         E      LV E+   G +  +L  H    E     K           
Sbjct: 75  IVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR--------- 120
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            + SA+ Y H ++   I H DLK+ N+LLD  M   + DFG            S   T  
Sbjct: 121 QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGF-----------SNEFTFG 166
Query: 333 NGLK---GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTD 375
           N L    GS  Y  PE   G  +     D++S G++L  + +G  P D
Sbjct: 167 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 155 ATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQ--QQGALKSFIDEC---NALT 208
           AT  +     IG G++G+VYK      G   A+K +++   ++G   S + E      L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
           +  H N+++++  C++   +      LVFE     ++DQ L    D+      L      
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFE-----HVDQDLRTYLDK-APPPGLPAETIK 115
Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
           +++      LD+LH      I H DLK  N+L+  G    + DFGLA+            
Sbjct: 116 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--------SY 164
Query: 329 QTMSNGLKGSVGYIPPEY-INGHVSILGDIYSYGILLLEIFTGK 371
           Q   + +  ++ Y  PE  +    +   D++S G +  E+F  K
Sbjct: 165 QMALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 33/217 (15%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKS-----FIDECNALTSIRHRNILKIV 219
           +GSG++G V      D  T   + +K+ ++ ++ +      ++E   L  + H NI+K+ 
Sbjct: 45  LGSGAYGEVL--LCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
                  +E      LV E  + G L        DE  H  K + +    I+  V S + 
Sbjct: 103 DF-----FEDKRNYYLVMECYKGGEL-------FDEIIHRMKFNEVDAAVIIKQVLSGVT 150
Query: 280 YLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
           YLH      I H DLK  N+LL+   +  +  + DFGL+  +FE       NQ       
Sbjct: 151 YLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA-VFE-------NQKKMKERL 199
Query: 337 GSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRP 373
           G+  YI PE +        D++S G++L  +  G  P
Sbjct: 200 GTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPP 236

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 89/228 (39%), Gaps = 38/228 (16%)
Query: 158 NFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRN 214
           N+     IG G+F  V     +  G+  A+K++   Q    +L+    E   +  + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVI 272
           I+K+         E      LV E+   G +  +L  H    E     K           
Sbjct: 75  IVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR--------- 120
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            + SA+ Y H ++   I H DLK+ N+LLD  M   + DFG            S   T  
Sbjct: 121 QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGF-----------SNEFTFG 166
Query: 333 NGLK---GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTD 375
           N L    G+  Y  PE   G  +     D++S G++L  + +G  P D
Sbjct: 167 NKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 108/232 (46%), Gaps = 26/232 (11%)
Query: 152 ISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQG--ALKSFIDECNALT 208
           + N + +F  ++L+G G++G V   T    GE  AIK ++   +   AL++ + E   L 
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT-LREIKILK 64
Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPS--TDEYCHFKKLSLMQ 266
             +H NI+ I +      +E  +   ++ E M+  +L + +     +D++  +       
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQY------- 116
Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFE---ESN 323
               +     A+  LH    + + H DLK SN+L++      V DFGLA+ + E   +++
Sbjct: 117 ---FIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRP 373
            P+  Q+       +  Y  PE +  +   S   D++S G +L E+F  +RP
Sbjct: 171 EPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRP 221

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 165 IGSGSFGSV-YKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           IG GS G V        G   A+K++ L++Q   +   +E   +   +H N++++  S  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS-- 110
Query: 224 SVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN 283
              Y   +   ++ EF++ G L       TD      +L+  Q   +   V  AL YLH 
Sbjct: 111 ---YLVGEELWVLMEFLQGGAL-------TDIVSQV-RLNEEQIATVCEAVLQALAYLHA 159
Query: 284 QYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIP 343
           Q    + H D+KS ++LL       + DFG    +       SK+      L G+  ++ 
Sbjct: 160 Q---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQI-------SKDVPKRKXLVGTPYWMA 209
Query: 344 PEYINGHV-SILGDIYSYGILLLEIFTGKRP 373
           PE I+  + +   DI+S GI+++E+  G+ P
Sbjct: 210 PEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 102/234 (43%), Gaps = 32/234 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIRHR 213
           +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
           NI+K++     V +  N    LVFE +   +L  ++  S         + L    + +  
Sbjct: 62  NIVKLLD----VIHTENKL-YLVFEHVHQ-DLKTFMDASA-----LTGIPLPLIKSYLFQ 110
Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +   L + H+     + H DLK  N+L++      + DFGLA+        P +  T   
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF----GVPVRTYTHE- 162
Query: 334 GLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
               ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 163 --VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 214

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 101/234 (43%), Gaps = 31/234 (13%)
Query: 148 SYLKISNATDN-FSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKS---FID 202
            +L+    T N F +  ++G G FG V    + A G+  A K L+ ++    K     ++
Sbjct: 174 KWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN 233
Query: 203 ECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKL 262
           E   L  +  R ++ +  +     YE  D   LV   M  G+L   ++       H  + 
Sbjct: 234 EKQILEKVNSRFVVSLAYA-----YETKDALCLVLTLMNGGDLKFHIY-------HMGQA 281
Query: 263 SLMQRLNI--VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFE 320
              +   +    ++   L+ LH +    I + DLK  N+LLD+     + D GLA  + E
Sbjct: 282 GFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338
Query: 321 ESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRP 373
                   QT+  G  G+VGY+ PE + N   +   D ++ G LL E+  G+ P
Sbjct: 339 -------GQTI-KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 108/232 (46%), Gaps = 26/232 (11%)
Query: 152 ISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQG--ALKSFIDECNALT 208
           + N + +F  ++L+G G++G V   T    GE  AIK ++   +   AL++ + E   L 
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT-LREIKILK 64
Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPS--TDEYCHFKKLSLMQ 266
             +H NI+ I +      +E  +   ++ E M+  +L + +     +D++  +       
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQY------- 116
Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFE---ESN 323
               +     A+  LH    + + H DLK SN+L++      V DFGLA+ + E   +++
Sbjct: 117 ---FIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRP 373
            P+  Q+       +  Y  PE +  +   S   D++S G +L E+F  +RP
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRP 221

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 30/231 (12%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALT 208
           L+I    ++F    ++G GSFG V+        +  AIK LK  +   L     EC    
Sbjct: 10  LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK--KDVVLMDDDVEC---- 63
Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKA-----LVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
           ++  + +L +      + +    F+       V E++  G+L   +     + CH  K  
Sbjct: 64  TMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-----QSCH--KFD 116
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
           L +      ++   L +LH++    I + DLK  N+LLD+     + DFG+ K      N
Sbjct: 117 LSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK-----EN 168
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
                +T  N   G+  YI PE + G   +   D +S+G+LL E+  G+ P
Sbjct: 169 MLGDAKT--NXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 28/223 (12%)
Query: 163 NLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSIR-HRNILKIVS 220
            L+G G++  V    +L +G+  A+K+++ Q   +      E   L   + ++NIL+++ 
Sbjct: 19  ELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIE 78
Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDY 280
                 +E +    LVFE ++ G++   +        HF +    +   +V DVA+ALD+
Sbjct: 79  F-----FEDDTRFYLVFEKLQGGSILAHIQKQK----HFNE---REASRVVRDVAAALDF 126
Query: 281 LHNQYDTPIAHCDLKSSNVLLDEG---MIAHVGDFGLAKFL-FEESNTPSKNQTMSNGLK 336
           LH +    IAH DLK  N+L +         + DF L   +    S TP     ++    
Sbjct: 127 LHTK---GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPC- 182
Query: 337 GSVGYIPPEYINGHVSILG------DIYSYGILLLEIFTGKRP 373
           GS  Y+ PE +              D++S G++L  + +G  P
Sbjct: 183 GSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 101/233 (43%), Gaps = 31/233 (13%)
Query: 149 YLKISNATDN-FSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKS---FIDE 203
           +L+    T N F +  ++G G FG V    + A G+  A K L+ ++    K     ++E
Sbjct: 175 WLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE 234
Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              L  +  R ++ +  +     YE  D   LV   M  G+L   ++       H  +  
Sbjct: 235 KQILEKVNSRFVVSLAYA-----YETKDALCLVLTLMNGGDLKFHIY-------HMGQAG 282
Query: 264 LMQRLNI--VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEE 321
             +   +    ++   L+ LH +    I + DLK  N+LLD+     + D GLA  + E 
Sbjct: 283 FPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE- 338
Query: 322 SNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRP 373
                  QT+  G  G+VGY+ PE + N   +   D ++ G LL E+  G+ P
Sbjct: 339 ------GQTI-KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 95/224 (42%), Gaps = 24/224 (10%)
Query: 155 ATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQ--QQGALKSFIDEC---NALT 208
           AT  +     IG G++G+VYK      G   A+K +++   ++G   S + E      L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
           +  H N+++++  C++   +      LVFE     ++DQ L    D+      L      
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFE-----HVDQDLRTYLDK-APPPGLPAETIK 115
Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
           +++      LD+LH      I H DLK  N+L+  G    + DFGLA+            
Sbjct: 116 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--------SY 164
Query: 329 QTMSNGLKGSVGYIPPEY-INGHVSILGDIYSYGILLLEIFTGK 371
           Q     +  ++ Y  PE  +    +   D++S G +  E+F  K
Sbjct: 165 QMALAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 98/226 (43%), Gaps = 32/226 (14%)
Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D   +  ++G G++G VY G  L++    AIK +  +     +   +E      ++H+NI
Sbjct: 22  DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI 81
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH----PSTDEYCHFKKLSLMQRLNIV 271
           ++ + S S      N F  +  E +  G+L   L     P  D   + + +    +    
Sbjct: 82  VQYLGSFSE-----NGFIKIFMEQVPGGSLSALLRSKWGPLKD---NEQTIGFYTK---- 129
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDE-GMIAHVGDFGLAKFLFEESNTPSKNQT 330
             +   L YLH   D  I H D+K  NVL++    +  + DFG +K L       +    
Sbjct: 130 -QILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-------AGINP 178
Query: 331 MSNGLKGSVGYIPPEYINGHVSILG---DIYSYGILLLEIFTGKRP 373
            +    G++ Y+ PE I+      G   DI+S G  ++E+ TGK P
Sbjct: 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 98/226 (43%), Gaps = 32/226 (14%)
Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D   +  ++G G++G VY G  L++    AIK +  +     +   +E      ++H+NI
Sbjct: 8   DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI 67
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH----PSTDEYCHFKKLSLMQRLNIV 271
           ++ + S S      N F  +  E +  G+L   L     P  D   + + +    +    
Sbjct: 68  VQYLGSFSE-----NGFIKIFMEQVPGGSLSALLRSKWGPLKD---NEQTIGFYTK---- 115
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDE-GMIAHVGDFGLAKFLFEESNTPSKNQT 330
             +   L YLH   D  I H D+K  NVL++    +  + DFG +K L       +    
Sbjct: 116 -QILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-------AGINP 164
Query: 331 MSNGLKGSVGYIPPEYINGHVSILG---DIYSYGILLLEIFTGKRP 373
            +    G++ Y+ PE I+      G   DI+S G  ++E+ TGK P
Sbjct: 165 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 210

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 106/244 (43%), Gaps = 43/244 (17%)
Query: 146 GLSYLKISNATDNFSEENLIGSGSFGSV----YKGTLADGETAAIKVLKLQ--QQGALKS 199
           G+S  +  +  D++     +GSG F  V     KGT  +     IK  +L   ++G  + 
Sbjct: 1   GMSTFRQEDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSRE 60
Query: 200 FID-ECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHP----STD 254
            I+ E N L  IRH NI+ +        +E      L+ E +  G L  +L      + D
Sbjct: 61  EIEREVNILREIRHPNIITLHDI-----FENKTDVVLILELVSGGELFDFLAEKESLTED 115
Query: 255 EYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH----VG 310
           E   F K            +   + YLH++    IAH DLK  N++L +  + +    + 
Sbjct: 116 EATQFLK-----------QILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLI 161
Query: 311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFT 369
           DFG+A  +  E+    KN      + G+  ++ PE +N   + +  D++S G++   + +
Sbjct: 162 DFGIAHKI--EAGNEFKN------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
Query: 370 GKRP 373
           G  P
Sbjct: 214 GASP 217

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 109/259 (42%), Gaps = 44/259 (16%)
Query: 157 DNFSEENLIGSGSFGSVY-KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D F     IG+GSFG V     +  G   A+K+L  Q+   LK      N       + I
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN------EKRI 94
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNIVID 273
           L+ V+    V  E        F F  N NL   +   P  D + H +++      +    
Sbjct: 95  LQAVNFPFLVKLE--------FSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFY 146
Query: 274 VAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
            A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K +T
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV--------KGRT 195
Query: 331 MSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHKF 387
               L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++ 
Sbjct: 196 WX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYEK 249
Query: 388 VL---MALPSHV-MDVLDL 402
           ++   +  PSH   D+ DL
Sbjct: 250 IVSGKVRFPSHFSSDLKDL 268

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 109/259 (42%), Gaps = 44/259 (16%)
Query: 157 DNFSEENLIGSGSFGSVY-KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D F     IG+GSFG V     +  G   A+K+L  Q+   LK      N       + I
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN------EKRI 94
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNIVID 273
           L+ V+    V  E        F F  N NL   +   P  D + H +++      +    
Sbjct: 95  LQAVNFPFLVKLE--------FSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFY 146
Query: 274 VAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
            A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K +T
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV--------KGRT 195
Query: 331 MSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHKF 387
               L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++ 
Sbjct: 196 WX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYEK 249
Query: 388 VL---MALPSHV-MDVLDL 402
           ++   +  PSH   D+ DL
Sbjct: 250 IVSGKVRFPSHFSSDLKDL 268

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 105/219 (47%), Gaps = 27/219 (12%)
Query: 159 FSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKI 218
           ++   +IG+GSFG V++  L + +  AIK  K+ Q    K+   E   +  ++H N++ +
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIK--KVLQDKRFKN--RELQIMRIVKHPNVVDL 97
Query: 219 VS-SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI-DVAS 276
            +   S+ D +   F  LV E+     + + ++ ++  Y   K+   M  + + +  +  
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEY-----VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDE--GMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
           +L Y+H+     I H D+K  N+LLD   G++  + DFG AK L   +  P+ +   S  
Sbjct: 153 SLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLI-DFGSAKILI--AGEPNVSXICSRY 206
Query: 335 LKGSVGYIPPEYINGHVSILG--DIYSYGILLLEIFTGK 371
            +       PE I G  +     DI+S G ++ E+  G+
Sbjct: 207 YRA------PELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 95/224 (42%), Gaps = 24/224 (10%)
Query: 155 ATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQ--QQGALKSFIDEC---NALT 208
           AT  +     IG G++G+VYK      G   A+K +++   ++G   S + E      L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
           +  H N+++++  C++   +      LVFE     ++DQ L    D+      L      
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFE-----HVDQDLRTYLDK-APPPGLPAETIK 115
Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
           +++      LD+LH      I H DLK  N+L+  G    + DFGLA+            
Sbjct: 116 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--------SY 164
Query: 329 QTMSNGLKGSVGYIPPEY-INGHVSILGDIYSYGILLLEIFTGK 371
           Q     +  ++ Y  PE  +    +   D++S G +  E+F  K
Sbjct: 165 QMALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 104/240 (43%), Gaps = 35/240 (14%)
Query: 146 GLSYLKISNATDNFSEENLIGSGSFGSVYK-GTLADGETAAIKVLKLQQ-----QGALKS 199
           G+   K     D +     +GSG F  V K    + G   A K +K +Q     +G  + 
Sbjct: 1   GMETFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCRE 60
Query: 200 FID-ECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCH 258
            I+ E + L  + H NI+ +        YE      L+ E +  G L  +L         
Sbjct: 61  EIEREVSILRQVLHPNIITLHDV-----YENRTDVVLILELVSGGELFDFL-------AQ 108
Query: 259 FKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNV-LLDEGM-IAHVG--DFGL 314
            + LS  +  + +  +   ++YLH +    IAH DLK  N+ LLD+ + I H+   DFGL
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
           A  +  E     KN      + G+  ++ PE +N   + +  D++S G++   + +G  P
Sbjct: 166 AHEI--EDGVEFKN------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 101/236 (42%), Gaps = 32/236 (13%)
Query: 155 ATDNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKL--QQQGALKSFIDECNALTSIR 211
           + +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H NI+K++     V +  N    LVFE     ++DQ L    D       + L    + +
Sbjct: 64  HPNIVKLLD----VIHTENKL-YLVFE-----HVDQDLKKFMDASA-LTGIPLPLIKSYL 112
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
             +   L + H+     + H DLK  N+L++      + DFGLA+       T       
Sbjct: 113 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 168
Query: 332 SNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLE------IFTGKRPTDDMFK 379
                 ++ Y  PE + G  + S   DI+S G +  E      +F G    D +F+
Sbjct: 169 ------TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 218

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 27/158 (17%)
Query: 163 NLIGSGSFGSVYKGTLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVS 220
            LIG G FG VY G    GE A I+++ +++  +  LK+F  E  A    RH N++  + 
Sbjct: 39  ELIGKGRFGQVYHGRW-HGEVA-IRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN----IVIDVAS 276
           +C S  +      A++    +   L          Y   +   ++  +N    I  ++  
Sbjct: 97  ACMSPPH-----LAIITSLCKGRTL----------YSVVRDAKIVLDVNKTRQIAQEIVK 141
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL 314
            + YLH +    I H DLKS NV  D G +  + DFGL
Sbjct: 142 GMGYLHAK---GILHKDLKSKNVFYDNGKVV-ITDFGL 175

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 67/152 (44%), Gaps = 26/152 (17%)
Query: 227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYD 286
           +E +DF  +V E  R  +L + LH         +    M++          + YLHN   
Sbjct: 111 FEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQ------TIQGVQYLHNNR- 162
Query: 287 TPIAHCDLKSSNVLLDEGMIAHVGDFGLA---KFLFEESNTPSKNQTMSNGLKGSVGYIP 343
             + H DLK  N+ L++ M   +GDFGLA   +F  E   T          L G+  YI 
Sbjct: 163 --VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT----------LCGTPNYIA 210
Query: 344 PEYI--NGHVSILGDIYSYGILLLEIFTGKRP 373
           PE +   GH S   DI+S G +L  +  GK P
Sbjct: 211 PEVLCKKGH-SFEVDIWSLGCILYTLLVGKPP 241

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 98/224 (43%), Gaps = 29/224 (12%)
Query: 154 NATDNFSEENLIGSGSFGSVYKGTLAD-GETAAIK-VLKLQQQGALKSF-IDECNALTSI 210
            + + +    L+G GS+G V K    D G   AIK  L+      +K   + E   L  +
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQW-LHPSTDEYCHFKKLSLMQRLN 269
           RH N++ ++  C            LVFEF+ +  LD   L P+  +Y       ++Q+  
Sbjct: 82  RHENLVNLLEVCKK-----KKRWYLVFEFVDHTILDDLELFPNGLDY------QVVQKY- 129
Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
            +  + + + + H+     I H D+K  N+L+ +  +  + DFG A+       T +   
Sbjct: 130 -LFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFAR-------TLAAPG 178
Query: 330 TMSNGLKGSVGYIPPEYINGHVSI--LGDIYSYGILLLEIFTGK 371
            + +    +  Y  PE + G V      D+++ G L+ E+F G+
Sbjct: 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 96/227 (42%), Gaps = 32/227 (14%)
Query: 165 IGSGSFGSVYKGTLADGE----TAAIKVLK-LQQQGALKSFIDECNALTSIRHRNILKIV 219
           IG G FG V++G     E      AIK  K        + F+ E   +    H +I+K++
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
              +       +   ++ E    G L  +L     +Y     L L   +     +++AL 
Sbjct: 78  GVIT------ENPVWIIMELCTLGELRSFLQ--VRKY----SLDLASLILYAYQLSTALA 125
Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS- 338
           YL ++      H D+ + NVL+       +GDFGL++++        ++ T     KG  
Sbjct: 126 YLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM--------EDSTYYKASKGKL 174
Query: 339 -VGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL 382
            + ++ PE IN    +   D++ +G+ + EI   G +P   +  +D+
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 221

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 96/227 (42%), Gaps = 32/227 (14%)
Query: 165 IGSGSFGSVYKGTLADGE----TAAIKVLK-LQQQGALKSFIDECNALTSIRHRNILKIV 219
           IG G FG V++G     E      AIK  K        + F+ E   +    H +I+K++
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
              +       +   ++ E    G L  +L     +Y     L L   +     +++AL 
Sbjct: 78  GVIT------ENPVWIIMELCTLGELRSFLQ--VRKY----SLDLASLILYAYQLSTALA 125
Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS- 338
           YL ++      H D+ + NVL+       +GDFGL++++        ++ T     KG  
Sbjct: 126 YLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM--------EDSTYYKASKGKL 174
Query: 339 -VGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL 382
            + ++ PE IN    +   D++ +G+ + EI   G +P   +  +D+
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 221

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 66/150 (44%), Gaps = 22/150 (14%)
Query: 227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYD 286
           +E +DF  +V E  R  +L + LH         +    M++          + YLHN   
Sbjct: 111 FEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQ------TIQGVQYLHNNR- 162
Query: 287 TPIAHCDLKSSNVLLDEGMIAHVGDFGLA-KFLFEESNTPSKNQTMSNGLKGSVGYIPPE 345
             + H DLK  N+ L++ M   +GDFGLA K  F+              L G+  YI PE
Sbjct: 163 --VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--------KKDLCGTPNYIAPE 212
Query: 346 YI--NGHVSILGDIYSYGILLLEIFTGKRP 373
            +   GH S   DI+S G +L  +  GK P
Sbjct: 213 VLCKKGH-SFEVDIWSLGCILYTLLVGKPP 241

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 98/227 (43%), Gaps = 32/227 (14%)
Query: 165 IGSGSFGSVYKGTLADGE----TAAIKVLK-LQQQGALKSFIDECNALTSIRHRNILKIV 219
           IG G FG V++G     E      AIK  K        + F+ E   +    H +I+K++
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSL--MQRLNIVIDVASA 277
              +       +   ++ E    G L  +L          +K SL     +     +++A
Sbjct: 78  GVIT------ENPVWIIMELCTLGELRSFLQ--------VRKFSLDLASLILYAYQLSTA 123
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           L YL ++      H D+ + NVL+       +GDFGL++++  E +T  K    S G K 
Sbjct: 124 LAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTXXK---ASKG-KL 174
Query: 338 SVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL 382
            + ++ PE IN    +   D++ +G+ + EI   G +P   +  +D+
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 221

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 84/214 (39%), Gaps = 25/214 (11%)
Query: 157 DNFSEENLIGSGSFGSVYK-GTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
            +F   + +G GS+G V+K  +  DG   A+K    +     +   D    L  +     
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVK----RSMSPFRGPKDRARKLAEVGSHEK 112
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSL--MQRLNIVID 273
           +     C  ++    +   L  +    G       PS  ++C     SL   Q    + D
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELCG-------PSLQQHCEAWGASLPEAQVWGYLRD 165
Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
              AL +LH+Q    + H D+K +N+ L       +GDFGL      E  T    +    
Sbjct: 166 TLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGL----LVELGTAGAGEVQ-- 216
Query: 334 GLKGSVGYIPPEYINGHVSILGDIYSYGILLLEI 367
             +G   Y+ PE + G      D++S G+ +LE+
Sbjct: 217 --EGDPRYMAPELLQGSYGTAADVFSLGLTILEV 248

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 96/227 (42%), Gaps = 32/227 (14%)
Query: 165 IGSGSFGSVYKGTLADGE----TAAIKVLK-LQQQGALKSFIDECNALTSIRHRNILKIV 219
           IG G FG V++G     E      AIK  K        + F+ E   +    H +I+K++
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
              +       +   ++ E    G L  +L     +Y     L L   +     +++AL 
Sbjct: 80  GVIT------ENPVWIIMELCTLGELRSFLQ--VRKY----SLDLASLILYAYQLSTALA 127
Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS- 338
           YL ++      H D+ + NVL+       +GDFGL++++        ++ T     KG  
Sbjct: 128 YLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM--------EDSTYYKASKGKL 176
Query: 339 -VGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL 382
            + ++ PE IN    +   D++ +G+ + EI   G +P   +  +D+
Sbjct: 177 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 223

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 86/213 (40%), Gaps = 28/213 (13%)
Query: 171 GSVYKGTLADGETAAIKVLKLQQQGALKS--FIDECNALTSIRHRNILKIVSSCSSVDYE 228
           G ++KG    G    +KVLK++     KS  F +EC  L    H N+L ++ +C S    
Sbjct: 24  GELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS---P 79
Query: 229 GNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTP 288
                 L+  +   G+L   LH  T+       +   Q +   +D A    +LH   +  
Sbjct: 80  PAPHPTLITHWXPYGSLYNVLHEGTNFV-----VDQSQAVKFALDXARGXAFLHT-LEPL 133
Query: 289 IAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN 348
           I    L S +V +DE   A +    + KF F+           S G   +  ++ PE + 
Sbjct: 134 IPRHALNSRSVXIDEDXTARISXADV-KFSFQ-----------SPGRXYAPAWVAPEALQ 181
Query: 349 GHVSIL----GDIYSYGILLLEIFTGKRPTDDM 377
                      D +S+ +LL E+ T + P  D+
Sbjct: 182 KKPEDTNRRSADXWSFAVLLWELVTREVPFADL 214

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 87/225 (38%), Gaps = 32/225 (14%)
Query: 158 NFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRN 214
           N+     IG G+F  V     +  G   AIK++   Q    +L+    E   +  + H N
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVI 272
           I+K+         E      L+ E+   G +  +L  H    E     K           
Sbjct: 73  IVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR--------- 118
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            + SA+ Y H +    I H DLK+ N+LLD  M   + DFG +     E     K  T  
Sbjct: 119 QIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSN----EFTVGGKLDTFC 171
Query: 333 NGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTD 375
               GS  Y  PE   G  +     D++S G++L  + +G  P D
Sbjct: 172 ----GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 96/227 (42%), Gaps = 32/227 (14%)
Query: 165 IGSGSFGSVYKGTLADGE----TAAIKVLK-LQQQGALKSFIDECNALTSIRHRNILKIV 219
           IG G FG V++G     E      AIK  K        + F+ E   +    H +I+K++
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
              +       +   ++ E    G L  +L     +Y     L L   +     +++AL 
Sbjct: 81  GVIT------ENPVWIIMELCTLGELRSFLQ--VRKY----SLDLASLILYAYQLSTALA 128
Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS- 338
           YL ++      H D+ + NVL+       +GDFGL++++        ++ T     KG  
Sbjct: 129 YLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM--------EDSTYYKASKGKL 177
Query: 339 -VGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL 382
            + ++ PE IN    +   D++ +G+ + EI   G +P   +  +D+
Sbjct: 178 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 224

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 96/227 (42%), Gaps = 32/227 (14%)
Query: 165 IGSGSFGSVYKGTLADGE----TAAIKVLK-LQQQGALKSFIDECNALTSIRHRNILKIV 219
           IG G FG V++G     E      AIK  K        + F+ E   +    H +I+K++
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
              +       +   ++ E    G L  +L     +Y     L L   +     +++AL 
Sbjct: 75  GVIT------ENPVWIIMELCTLGELRSFLQ--VRKY----SLDLASLILYAYQLSTALA 122
Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS- 338
           YL ++      H D+ + NVL+       +GDFGL++++        ++ T     KG  
Sbjct: 123 YLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM--------EDSTYYKASKGKL 171
Query: 339 -VGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL 382
            + ++ PE IN    +   D++ +G+ + EI   G +P   +  +D+
Sbjct: 172 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 218

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 66/150 (44%), Gaps = 22/150 (14%)
Query: 227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYD 286
           +E +DF  +V E  R  +L + LH         +    M++          + YLHN   
Sbjct: 111 FEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQ------TIQGVQYLHNNR- 162
Query: 287 TPIAHCDLKSSNVLLDEGMIAHVGDFGLA-KFLFEESNTPSKNQTMSNGLKGSVGYIPPE 345
             + H DLK  N+ L++ M   +GDFGLA K  F+              L G+  YI PE
Sbjct: 163 --VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--------KKXLCGTPNYIAPE 212
Query: 346 YI--NGHVSILGDIYSYGILLLEIFTGKRP 373
            +   GH S   DI+S G +L  +  GK P
Sbjct: 213 VLCKKGH-SFEVDIWSLGCILYTLLVGKPP 241

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 66/150 (44%), Gaps = 22/150 (14%)
Query: 227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYD 286
           +E +DF  +V E  R  +L + LH         +    M++          + YLHN   
Sbjct: 95  FEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQ------TIQGVQYLHNNR- 146
Query: 287 TPIAHCDLKSSNVLLDEGMIAHVGDFGLA-KFLFEESNTPSKNQTMSNGLKGSVGYIPPE 345
             + H DLK  N+ L++ M   +GDFGLA K  F+              L G+  YI PE
Sbjct: 147 --VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--------KKDLCGTPNYIAPE 196
Query: 346 YI--NGHVSILGDIYSYGILLLEIFTGKRP 373
            +   GH S   DI+S G +L  +  GK P
Sbjct: 197 VLCKKGH-SFEVDIWSLGCILYTLLVGKPP 225

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 96/227 (42%), Gaps = 32/227 (14%)
Query: 165 IGSGSFGSVYKGTLADGE----TAAIKVLK-LQQQGALKSFIDECNALTSIRHRNILKIV 219
           IG G FG V++G     E      AIK  K        + F+ E   +    H +I+K++
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
              +       +   ++ E    G L  +L     +Y     L L   +     +++AL 
Sbjct: 83  GVIT------ENPVWIIMELCTLGELRSFLQ--VRKY----SLDLASLILYAYQLSTALA 130
Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS- 338
           YL ++      H D+ + NVL+       +GDFGL++++        ++ T     KG  
Sbjct: 131 YLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM--------EDSTYYKASKGKL 179
Query: 339 -VGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL 382
            + ++ PE IN    +   D++ +G+ + EI   G +P   +  +D+
Sbjct: 180 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 226

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 96/227 (42%), Gaps = 32/227 (14%)
Query: 165 IGSGSFGSVYKGTLADGE----TAAIKVLK-LQQQGALKSFIDECNALTSIRHRNILKIV 219
           IG G FG V++G     E      AIK  K        + F+ E   +    H +I+K++
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
              +       +   ++ E    G L  +L     +Y     L L   +     +++AL 
Sbjct: 106 GVIT------ENPVWIIMELCTLGELRSFLQ--VRKY----SLDLASLILYAYQLSTALA 153
Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS- 338
           YL ++      H D+ + NVL+       +GDFGL++++        ++ T     KG  
Sbjct: 154 YLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM--------EDSTYYKASKGKL 202
Query: 339 -VGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL 382
            + ++ PE IN    +   D++ +G+ + EI   G +P   +  +D+
Sbjct: 203 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 249

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 99/228 (43%), Gaps = 34/228 (14%)
Query: 164 LIGSGSFGSVY----KGTLADGETAAIKVLK---LQQQGALKSFIDECNALTSIRHRNIL 216
           ++G GSFG V     KGT    E  AIK+LK   + Q   ++  + E   L  +     L
Sbjct: 26  VLGKGSFGKVMLADRKGT---EELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFL 82
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
             + SC    ++  D    V E++  G+L   +           K    Q +    +++ 
Sbjct: 83  TQLHSC----FQTVDRLYFVMEYVNGGDLMYHIQ-------QVGKFKEPQAVFYAAEISI 131
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
            L +LH +    I + DLK  NV+LD EG I  + DFG+ K    +  T       +   
Sbjct: 132 GLFFLHKR---GIIYRDLKLDNVMLDSEGHIK-IADFGMCKEHMMDGVT-------TREF 180
Query: 336 KGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRPTDDMFKDDL 382
            G+  YI PE I         D ++YG+LL E+  G+ P D   +D+L
Sbjct: 181 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 228

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 98/231 (42%), Gaps = 33/231 (14%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVY--KGTLADGETAAIKVLKLQQQGALKSFIDECNAL 207
           ++ +N    F    ++GSG+F  V+  K  L  G+  A+K +K        S  +E   L
Sbjct: 2   MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVL 60
Query: 208 TSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNL-DQWLHPSTDEYCHFKKLSLMQ 266
             I+H NI+ +        YE      LV + +  G L D+ L      Y   K  SL  
Sbjct: 61  KKIKHENIVTLEDI-----YESTTHYYLVMQLVSGGELFDRILERGV--YTE-KDASL-- 110
Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVGDFGLAKFLFEESN 323
              ++  V SA+ YLH   +  I H DLK  N+L    +E     + DFGL+K       
Sbjct: 111 ---VIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM------ 158
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRP 373
              +N  MS    G+ GY+ PE +     S   D +S G++   +  G  P
Sbjct: 159 --EQNGIMSTAC-GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 102/240 (42%), Gaps = 35/240 (14%)
Query: 146 GLSYLKISNATDNFSEENLIGSGSFGSVYK-GTLADGETAAIKVLKLQQQGALKSFID-- 202
           G+   K     D +     +GSG F  V K    + G   A K +K +Q  A +  +   
Sbjct: 1   GMEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSRE 60
Query: 203 ----ECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCH 258
               E + L  + H N++ +        YE      L+ E +  G L  +L         
Sbjct: 61  EIEREVSILRQVLHHNVITLHDV-----YENRTDVVLILELVSGGELFDFL-------AQ 108
Query: 259 FKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNV-LLDEGM-IAHVG--DFGL 314
            + LS  +  + +  +   ++YLH +    IAH DLK  N+ LLD+ + I H+   DFGL
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
           A  +  E     KN      + G+  ++ PE +N   + +  D++S G++   + +G  P
Sbjct: 166 AHEI--EDGVEFKN------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 102/240 (42%), Gaps = 35/240 (14%)
Query: 146 GLSYLKISNATDNFSEENLIGSGSFGSVYK-GTLADGETAAIKVLKLQQQGALKSFID-- 202
           G+   K     D +     +GSG F  V K    + G   A K +K +Q  A +  +   
Sbjct: 1   GMEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSRE 60
Query: 203 ----ECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCH 258
               E + L  + H N++ +        YE      L+ E +  G L  +L         
Sbjct: 61  EIEREVSILRQVLHHNVITLHDV-----YENRTDVVLILELVSGGELFDFL-------AQ 108
Query: 259 FKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNV-LLDEGM-IAHVG--DFGL 314
            + LS  +  + +  +   ++YLH +    IAH DLK  N+ LLD+ + I H+   DFGL
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
           A  +  E     KN      + G+  ++ PE +N   + +  D++S G++   + +G  P
Sbjct: 166 AHEI--EDGVEFKN------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 102/240 (42%), Gaps = 35/240 (14%)
Query: 146 GLSYLKISNATDNFSEENLIGSGSFGSVYK-GTLADGETAAIKVLKLQQQGALKSFID-- 202
           G+   K     D +     +GSG F  V K    + G   A K +K +Q  A +  +   
Sbjct: 1   GMEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSRE 60
Query: 203 ----ECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCH 258
               E + L  + H N++ +        YE      L+ E +  G L  +L         
Sbjct: 61  EIEREVSILRQVLHHNVITLHDV-----YENRTDVVLILELVSGGELFDFL-------AQ 108
Query: 259 FKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNV-LLDEGM-IAHVG--DFGL 314
            + LS  +  + +  +   ++YLH +    IAH DLK  N+ LLD+ + I H+   DFGL
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
           A  +  E     KN      + G+  ++ PE +N   + +  D++S G++   + +G  P
Sbjct: 166 AHEI--EDGVEFKN------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 102/240 (42%), Gaps = 35/240 (14%)
Query: 146 GLSYLKISNATDNFSEENLIGSGSFGSVYK-GTLADGETAAIKVLKLQQQGALKSFID-- 202
           G+   K     D +     +GSG F  V K    + G   A K +K +Q  A +  +   
Sbjct: 1   GMEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSRE 60
Query: 203 ----ECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCH 258
               E + L  + H N++ +        YE      L+ E +  G L  +L         
Sbjct: 61  EIEREVSILRQVLHHNVITLHDV-----YENRTDVVLILELVSGGELFDFL-------AQ 108
Query: 259 FKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNV-LLDEGM-IAHVG--DFGL 314
            + LS  +  + +  +   ++YLH +    IAH DLK  N+ LLD+ + I H+   DFGL
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
           A  +  E     KN      + G+  ++ PE +N   + +  D++S G++   + +G  P
Sbjct: 166 AHEI--EDGVEFKN------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 109/259 (42%), Gaps = 44/259 (16%)
Query: 157 DNFSEENLIGSGSFGSVY-KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D F     IG+GSFG V     +  G   A+K+L  Q+   LK      N       + I
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN------EKRI 94
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNIVID 273
           L+ V+    V  E        F F  N NL   +   P  + + H +++      +    
Sbjct: 95  LQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY 146
Query: 274 VAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
            A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K +T
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV--------KGRT 195
Query: 331 MSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHKF 387
               L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++ 
Sbjct: 196 WX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYEK 249
Query: 388 VL---MALPSHV-MDVLDL 402
           ++   +  PSH   D+ DL
Sbjct: 250 IVSGKVRFPSHFSSDLKDL 268

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 102/240 (42%), Gaps = 35/240 (14%)
Query: 146 GLSYLKISNATDNFSEENLIGSGSFGSVYK-GTLADGETAAIKVLKLQQQGALKSFID-- 202
           G+   K     D +     +GSG F  V K    + G   A K +K +Q  A +  +   
Sbjct: 1   GMEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSRE 60
Query: 203 ----ECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCH 258
               E + L  + H N++ +        YE      L+ E +  G L  +L         
Sbjct: 61  EIEREVSILRQVLHHNVITLHDV-----YENRTDVVLILELVSGGELFDFL-------AQ 108
Query: 259 FKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNV-LLDEGM-IAHVG--DFGL 314
            + LS  +  + +  +   ++YLH +    IAH DLK  N+ LLD+ + I H+   DFGL
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
           A  +  E     KN      + G+  ++ PE +N   + +  D++S G++   + +G  P
Sbjct: 166 AHEI--EDGVEFKN------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 99/230 (43%), Gaps = 29/230 (12%)
Query: 153 SNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALK-----SFIDEC-- 204
           S AT  +     IG G++G+VYK      G   A+K +++   G        S + E   
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 205 -NALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              L +  H N+++++  C++   +      LVFE     ++DQ L    D+      L 
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFE-----HVDQDLRTYLDK-APPPGLP 118
Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK-FLFEES 322
                +++      LD+LH      I H DLK  N+L+  G    + DFGLA+ + ++ +
Sbjct: 119 AETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA 175
Query: 323 NTPSKNQTMSNGLKGSVGYIPPEY-INGHVSILGDIYSYGILLLEIFTGK 371
            TP         +  ++ Y  PE  +    +   D++S G +  E+F  K
Sbjct: 176 LTP---------VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 107/252 (42%), Gaps = 36/252 (14%)
Query: 134 RQSAPPSNEWQSGLSYLKISNAT-------DNFSEENLIGSGSFGSV-YKGTLADGETAA 185
           R  +P  N   SG   +++S A        + F    L+G G+FG V      A G   A
Sbjct: 124 RSGSPSDN---SGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYA 180
Query: 186 IKVLKLQ---QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRN 242
           +K+LK +    +  +   + E   L + RH  +  +  S     ++ +D    V E+   
Sbjct: 181 MKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS-----FQTHDRLCFVMEYANG 235
Query: 243 GNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD 302
           G L  + H S +     +  S  +      ++ SALDYLH++ +  + + DLK  N++LD
Sbjct: 236 GEL--FFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLD 286
Query: 303 EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYG 361
           +     + DFGL K          K+        G+  Y+ PE + +       D +  G
Sbjct: 287 KDGHIKITDFGLCK-------EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 339
Query: 362 ILLLEIFTGKRP 373
           +++ E+  G+ P
Sbjct: 340 VVMYEMMCGRLP 351

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 107/252 (42%), Gaps = 36/252 (14%)
Query: 134 RQSAPPSNEWQSGLSYLKISNAT-------DNFSEENLIGSGSFGSV-YKGTLADGETAA 185
           R  +P  N   SG   +++S A        + F    L+G G+FG V      A G   A
Sbjct: 121 RSGSPSDN---SGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYA 177
Query: 186 IKVLKLQ---QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRN 242
           +K+LK +    +  +   + E   L + RH  +  +  S     ++ +D    V E+   
Sbjct: 178 MKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS-----FQTHDRLCFVMEYANG 232
Query: 243 GNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD 302
           G L  + H S +     +  S  +      ++ SALDYLH++ +  + + DLK  N++LD
Sbjct: 233 GEL--FFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLD 283
Query: 303 EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYG 361
           +     + DFGL K          K+        G+  Y+ PE + +       D +  G
Sbjct: 284 KDGHIKITDFGLCK-------EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 336
Query: 362 ILLLEIFTGKRP 373
           +++ E+  G+ P
Sbjct: 337 VVMYEMMCGRLP 348

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/217 (20%), Positives = 97/217 (44%), Gaps = 28/217 (12%)
Query: 164 LIGSGSFGSVYKGTLAD--GETAAIKVLKLQQQGAL---KSFIDECNALTSIRHRNILKI 218
           ++G G FG VY+G   +  GE   + V   ++   L   + F+ E   + ++ H +I+K+
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
           +           +   ++ E    G L  +L  + +       L ++  +   + +  A+
Sbjct: 75  IGIIEE------EPTWIIMELYPYGELGHYLERNKN------SLKVLTLVLYSLQICKAM 122
Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
            YL +       H D+   N+L+       +GDFGL++++ +E      +   ++  +  
Sbjct: 123 AYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE------DYYKASVTRLP 173
Query: 339 VGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRP 373
           + ++ PE IN    +   D++ + + + EI + GK+P
Sbjct: 174 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 210

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/217 (20%), Positives = 97/217 (44%), Gaps = 28/217 (12%)
Query: 164 LIGSGSFGSVYKGTLAD--GETAAIKVLKLQQQGAL---KSFIDECNALTSIRHRNILKI 218
           ++G G FG VY+G   +  GE   + V   ++   L   + F+ E   + ++ H +I+K+
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
           +           +   ++ E    G L  +L  + +       L ++  +   + +  A+
Sbjct: 91  IGIIEE------EPTWIIMELYPYGELGHYLERNKN------SLKVLTLVLYSLQICKAM 138
Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
            YL +       H D+   N+L+       +GDFGL++++ +E      +   ++  +  
Sbjct: 139 AYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE------DYYKASVTRLP 189
Query: 339 VGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRP 373
           + ++ PE IN    +   D++ + + + EI + GK+P
Sbjct: 190 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 226

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/217 (20%), Positives = 97/217 (44%), Gaps = 28/217 (12%)
Query: 164 LIGSGSFGSVYKGTLAD--GETAAIKVLKLQQQGAL---KSFIDECNALTSIRHRNILKI 218
           ++G G FG VY+G   +  GE   + V   ++   L   + F+ E   + ++ H +I+K+
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
           +           +   ++ E    G L  +L  + +       L ++  +   + +  A+
Sbjct: 79  IGIIEE------EPTWIIMELYPYGELGHYLERNKN------SLKVLTLVLYSLQICKAM 126
Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
            YL +       H D+   N+L+       +GDFGL++++ +E      +   ++  +  
Sbjct: 127 AYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE------DYYKASVTRLP 177
Query: 339 VGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRP 373
           + ++ PE IN    +   D++ + + + EI + GK+P
Sbjct: 178 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 53/97 (54%), Gaps = 9/97 (9%)
Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           VA  +++L ++      H DL + N+LL E  +  + DFGLA+ +++  +   K  T   
Sbjct: 208 VARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDT--- 261
Query: 334 GLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
             +  + ++ PE I   + S   D++SYG+LL EIF+
Sbjct: 262 --RLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 96/229 (41%), Gaps = 36/229 (15%)
Query: 165 IGSGSFGSVYKGTLADGE----TAAIKVLK-LQQQGALKSFIDECNALTSIRHRNILKIV 219
           IG G FG V++G     E      AIK  K        + F+ E   +    H +I+K++
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSL--MQRLNIVIDVASA 277
              +       +   ++ E    G L  +L          +K SL     +     +++A
Sbjct: 78  GVIT------ENPVWIIMELCTLGELRSFLQ--------VRKFSLDLASLILYAYQLSTA 123
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           L YL ++      H D+ + NVL+       +GDFGL++++        ++ T     KG
Sbjct: 124 LAYLESKR---FVHRDIAARNVLVSATDCVKLGDFGLSRYM--------EDSTYYKASKG 172
Query: 338 S--VGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL 382
              + ++ PE IN    +   D++ +G+ + EI   G +P   +  +D+
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 221

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 110/259 (42%), Gaps = 44/259 (16%)
Query: 157 DNFSEENLIGSGSFGSVY-KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D F     +G+GSFG V     +  G   A+K+L  Q+   LK      N       + I
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN------EKRI 95
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNIVID 273
           L+ V+    V  E        F F  N NL   +   P  + + H +++      +    
Sbjct: 96  LQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY 147
Query: 274 VAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
            A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K +T
Sbjct: 148 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------KGRT 196
Query: 331 MSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHKF 387
            +  L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++ 
Sbjct: 197 WT--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYEK 250
Query: 388 VL---MALPSHV-MDVLDL 402
           ++   +  PSH   D+ DL
Sbjct: 251 IVSGKVRFPSHFSSDLKDL 269

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 99/229 (43%), Gaps = 28/229 (12%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALT 208
           +K  +  D++     +G+G+FG V++ T  A G   A K +    +   ++   E   ++
Sbjct: 44  IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMS 103
Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
            +RH  ++ +  +     +E ++   +++EFM  G L        DE+    K+S  + +
Sbjct: 104 VLRHPTLVNLHDA-----FEDDNEMVMIYEFMSGGEL---FEKVADEH---NKMSEDEAV 152
Query: 269 NIVIDVASALDYLH-NQYDTPIAHCDLKSSNVLLDEGMIAHVG--DFGLAKFLFEESNTP 325
             +  V   L ++H N Y     H DLK  N++        +   DFGL   L      P
Sbjct: 153 EYMRQVCKGLCHMHENNY----VHLDLKPENIMFTTKRSNELKLIDFGLTAHL-----DP 203
Query: 326 SKNQTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
            ++  ++    G+  +  PE   G  V    D++S G+L   + +G  P
Sbjct: 204 KQSVKVTT---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 249

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/109 (28%), Positives = 58/109 (53%), Gaps = 9/109 (8%)
Query: 262 LSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEE 321
           L+L   +     VA  +++L ++      H DL + N+LL E  +  + DFGLA+ ++++
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 244
Query: 322 SNTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
            +   K        +  + ++ PE I   V +I  D++S+G+LL EIF+
Sbjct: 245 PDYVRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 110/259 (42%), Gaps = 44/259 (16%)
Query: 157 DNFSEENLIGSGSFGSVY-KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D F     +G+GSFG V     +  G   A+K+L  Q+   LK      N       + I
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN------EKRI 80
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNIVID 273
           L+ V+    V  E        F F  N NL   +   P  + + H +++      +    
Sbjct: 81  LQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY 132
Query: 274 VAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
            A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K +T
Sbjct: 133 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------KGRT 181
Query: 331 MSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHKF 387
            +  L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++ 
Sbjct: 182 WT--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYEK 235
Query: 388 VL---MALPSHV-MDVLDL 402
           ++   +  PSH   D+ DL
Sbjct: 236 IVSGKVRFPSHFSSDLKDL 254

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 99/229 (43%), Gaps = 28/229 (12%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALT 208
           +K  +  D++     +G+G+FG V++ T  A G   A K +    +   ++   E   ++
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMS 209
Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
            +RH  ++ +  +     +E ++   +++EFM  G L        DE+    K+S  + +
Sbjct: 210 VLRHPTLVNLHDA-----FEDDNEMVMIYEFMSGGEL---FEKVADEH---NKMSEDEAV 258
Query: 269 NIVIDVASALDYLH-NQYDTPIAHCDLKSSNVLLDEGMIAHVG--DFGLAKFLFEESNTP 325
             +  V   L ++H N Y     H DLK  N++        +   DFGL   L      P
Sbjct: 259 EYMRQVCKGLCHMHENNY----VHLDLKPENIMFTTKRSNELKLIDFGLTAHL-----DP 309
Query: 326 SKNQTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
            ++  ++    G+  +  PE   G  V    D++S G+L   + +G  P
Sbjct: 310 KQSVKVTT---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/109 (28%), Positives = 58/109 (53%), Gaps = 9/109 (8%)
Query: 262 LSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEE 321
           L+L   +     VA  +++L ++      H DL + N+LL E  +  + DFGLA+ ++++
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 322 SNTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
            +   K        +  + ++ PE I   V +I  D++S+G+LL EIF+
Sbjct: 247 PDYVRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/109 (28%), Positives = 58/109 (53%), Gaps = 9/109 (8%)
Query: 262 LSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEE 321
           L+L   +     VA  +++L ++      H DL + N+LL E  +  + DFGLA+ ++++
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 251
Query: 322 SNTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
            +   K        +  + ++ PE I   V +I  D++S+G+LL EIF+
Sbjct: 252 PDYVRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 110/259 (42%), Gaps = 44/259 (16%)
Query: 157 DNFSEENLIGSGSFGSVY-KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D F     +G+GSFG V     +  G   A+K+L  Q+   LK      N       + I
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLN------EKRI 94
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNIVID 273
           L+ V+    V  E        F F  N NL   +   P  + + H +++      +    
Sbjct: 95  LQAVNFPFLVKLE--------FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY 146
Query: 274 VAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
            A      +YLH+     + + DLK  N+++D+     V DFGLAK +        K +T
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRV--------KGRT 195
Query: 331 MSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHKF 387
               L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++ 
Sbjct: 196 WX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYEK 249
Query: 388 VL---MALPSHV-MDVLDL 402
           ++   +  PSH   D+ DL
Sbjct: 250 IVSGKVRFPSHFSSDLKDL 268

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 96/229 (41%), Gaps = 36/229 (15%)
Query: 165 IGSGSFGSVYKGTLADGE----TAAIKVLK-LQQQGALKSFIDECNALTSIRHRNILKIV 219
           IG G FG V++G     E      AIK  K        + F+ E   +    H +I+K++
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSL--MQRLNIVIDVASA 277
              +       +   ++ E    G L  +L          +K SL     +     +++A
Sbjct: 458 GVITE------NPVWIIMELCTLGELRSFLQ--------VRKFSLDLASLILYAYQLSTA 503
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           L YL ++      H D+ + NVL+       +GDFGL++++        ++ T     KG
Sbjct: 504 LAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM--------EDSTYYKASKG 552
Query: 338 S--VGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL 382
              + ++ PE IN    +   D++ +G+ + EI   G +P   +  +D+
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 601

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/109 (28%), Positives = 58/109 (53%), Gaps = 9/109 (8%)
Query: 262 LSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEE 321
           L+L   +     VA  +++L ++      H DL + N+LL E  +  + DFGLA+ ++++
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 253
Query: 322 SNTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT 369
            +   K        +  + ++ PE I   V +I  D++S+G+LL EIF+
Sbjct: 254 PDYVRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQ-GALKSFIDECNALTSIRHRNILKIVSSC 222
           +G G++G V         E  A+K++ +++     ++   E      + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHP-----STDEYCHFKKLSLMQRLNIVIDVASA 277
                EGN  + L  E+   G L   + P       D    F +L             + 
Sbjct: 75  R----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------------MAG 117
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YLH      I H D+K  N+LLDE     + DFGLA  +F  +N     + + N + G
Sbjct: 118 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNN----RERLLNKMXG 169
Query: 338 SVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTD 375
           ++ Y+ PE +     H   + D++S GI+L  +  G+ P D
Sbjct: 170 TLPYVAPELLKRREFHAEPV-DVWSCGIVLTAMLAGELPWD 209

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 23/213 (10%)
Query: 164 LIGSGSFGSVYKGTLADGETAAIKVLKLQQQGAL-KSFIDECNALTSIRHRNILKIVSSC 222
            +G G F   ++  ++D +T  +   K+  +  L K    E  ++    HR++       
Sbjct: 28  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 85
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
               +E NDF  +V E  R  +L + LH         K L+  +    +  +     YLH
Sbjct: 86  FHGFFEDNDFVFVVLELCRRRSLLE-LHKRR------KALTEPEARYYLRQIVLGCQYLH 138
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
                 + H DLK  N+ L+E +   +GDFGLA  +         +      L G+  YI
Sbjct: 139 RNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-------EYDGERKKTLCGTPNYI 188
Query: 343 PPEYIN--GHVSILGDIYSYGILLLEIFTGKRP 373
            PE ++  GH S   D++S G ++  +  GK P
Sbjct: 189 APEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPP 220

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQ-GALKSFIDECNALTSIRHRNILKIVSSC 222
           +G G++G V         E  A+K++ +++     ++   E      + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHP-----STDEYCHFKKLSLMQRLNIVIDVASA 277
                EGN  + L  E+   G L   + P       D    F +L             + 
Sbjct: 74  R----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------------MAG 116
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YLH      I H D+K  N+LLDE     + DFGLA  +F  +N     + + N + G
Sbjct: 117 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNN----RERLLNKMXG 168
Query: 338 SVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTD 375
           ++ Y+ PE +     H   + D++S GI+L  +  G+ P D
Sbjct: 169 TLPYVAPELLKRREFHAEPV-DVWSCGIVLTAMLAGELPWD 208

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 88/222 (39%), Gaps = 33/222 (14%)
Query: 159 FSEENLIGSGSFG----SVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRN 214
           ++ EN IG GS+G    +V KGT      AA K+ K   +  +  F  E   + S+ H N
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRI--RRAAKKIPKYFVED-VDRFKQEIEIMKSLDHPN 67
Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
           I+++  +     +E N    LV E    G L        +   H +         I+ DV
Sbjct: 68  IIRLYET-----FEDNTDIYLVMELCTGGEL-------FERVVHKRVFRESDAARIMKDV 115
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
            SA+ Y H      +AH DLK  N L           + DFGLA           K   M
Sbjct: 116 LSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--------KPGKM 164
Query: 332 SNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRP 373
                G+  Y+ P+ + G      D +S G+++  +  G  P
Sbjct: 165 MRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPP 206

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 23/213 (10%)
Query: 164 LIGSGSFGSVYKGTLADGETAAIKVLKLQQQGAL-KSFIDECNALTSIRHRNILKIVSSC 222
            +G G F   ++  ++D +T  +   K+  +  L K    E  ++    HR++       
Sbjct: 24  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 81
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
               +E NDF  +V E  R  +L + LH         K L+  +    +  +     YLH
Sbjct: 82  FHGFFEDNDFVFVVLELCRRRSLLE-LHKRR------KALTEPEARYYLRQIVLGCQYLH 134
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
                 + H DLK  N+ L+E +   +GDFGLA  +         +      L G+  YI
Sbjct: 135 RNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-------EYDGERKKTLCGTPNYI 184
Query: 343 PPEYIN--GHVSILGDIYSYGILLLEIFTGKRP 373
            PE ++  GH S   D++S G ++  +  GK P
Sbjct: 185 APEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPP 216

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 23/213 (10%)
Query: 164 LIGSGSFGSVYKGTLADGETAAIKVLKLQQQGAL-KSFIDECNALTSIRHRNILKIVSSC 222
            +G G F   ++  ++D +T  +   K+  +  L K    E  ++    HR++       
Sbjct: 24  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 81
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
               +E NDF  +V E  R  +L + LH         K L+  +    +  +     YLH
Sbjct: 82  FHGFFEDNDFVFVVLELCRRRSLLE-LHKRR------KALTEPEARYYLRQIVLGCQYLH 134
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
                 + H DLK  N+ L+E +   +GDFGLA  +         +      L G+  YI
Sbjct: 135 RNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-------EYDGERKKTLCGTPNYI 184
Query: 343 PPEYIN--GHVSILGDIYSYGILLLEIFTGKRP 373
            PE ++  GH S   D++S G ++  +  GK P
Sbjct: 185 APEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPP 216

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 26/222 (11%)
Query: 157 DNFSEENLIGSGSFGSV-YKGTLADGETAAIKVLKLQ---QQGALKSFIDECNALTSIRH 212
           + F    L+G G+FG V      A G   A+K+LK +    +  +   + E   L + RH
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             +  +  S     ++ +D    V E+   G L  + H S +     +  S  +      
Sbjct: 68  PFLTALKYS-----FQTHDRLCFVMEYANGGEL--FFHLSRE-----RVFSEDRARFYGA 115
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           ++ SALDYLH++ +  + + DLK  N++LD+     + DFGL K          K+    
Sbjct: 116 EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-------EGIKDGATM 166
Query: 333 NGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRP 373
               G+  Y+ PE + +       D +  G+++ E+  G+ P
Sbjct: 167 KXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 88/222 (39%), Gaps = 33/222 (14%)
Query: 159 FSEENLIGSGSFG----SVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRN 214
           ++ EN IG GS+G    +V KGT      AA K+ K   +  +  F  E   + S+ H N
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRI--RRAAKKIPKYFVED-VDRFKQEIEIMKSLDHPN 84
Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
           I+++  +     +E N    LV E    G L        +   H +         I+ DV
Sbjct: 85  IIRLYET-----FEDNTDIYLVMELCTGGEL-------FERVVHKRVFRESDAARIMKDV 132
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
            SA+ Y H      +AH DLK  N L           + DFGLA           K   M
Sbjct: 133 LSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--------KPGKM 181
Query: 332 SNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRP 373
                G+  Y+ P+ + G      D +S G+++  +  G  P
Sbjct: 182 MRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPP 223

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 109/259 (42%), Gaps = 44/259 (16%)
Query: 157 DNFSEENLIGSGSFGSVY-KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D F     +G+GSFG V     +  G   A+K+L  Q+   LK      N       + I
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN------EKRI 94
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNIVID 273
           L+ V+    V  E        F F  N NL   +   P  + + H +++      +    
Sbjct: 95  LQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY 146
Query: 274 VAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
            A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K +T
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------KGRT 195
Query: 331 MSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHKF 387
               L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++ 
Sbjct: 196 WX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYEK 249
Query: 388 VL---MALPSHV-MDVLDL 402
           ++   +  PSH   D+ DL
Sbjct: 250 IVSGKVRFPSHFSSDLKDL 268

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 26/222 (11%)
Query: 157 DNFSEENLIGSGSFGSV-YKGTLADGETAAIKVLKLQ---QQGALKSFIDECNALTSIRH 212
           + F    L+G G+FG V      A G   A+K+LK +    +  +   + E   L + RH
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             +  +  S     ++ +D    V E+   G L  + H S +     +  S  +      
Sbjct: 69  PFLTALKYS-----FQTHDRLCFVMEYANGGEL--FFHLSRE-----RVFSEDRARFYGA 116
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           ++ SALDYLH++ +  + + DLK  N++LD+     + DFGL K          K+    
Sbjct: 117 EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-------EGIKDGATM 167
Query: 333 NGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRP 373
               G+  Y+ PE + +       D +  G+++ E+  G+ P
Sbjct: 168 KXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 109/259 (42%), Gaps = 44/259 (16%)
Query: 157 DNFSEENLIGSGSFGSVY-KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D F     +G+GSFG V     +  G   A+K+L  Q+   LK      N       + I
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN------EKRI 94
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNIVID 273
           L+ V+    V  E        F F  N NL   +   P  + + H +++      +    
Sbjct: 95  LQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFY 146
Query: 274 VAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
            A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K +T
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------KGRT 195
Query: 331 MSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHKF 387
               L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++ 
Sbjct: 196 WX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYEK 249
Query: 388 VL---MALPSHV-MDVLDL 402
           ++   +  PSH   D+ DL
Sbjct: 250 IVSGKVRFPSHFSSDLKDL 268

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 109/259 (42%), Gaps = 44/259 (16%)
Query: 157 DNFSEENLIGSGSFGSVY-KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D F     +G+GSFG V     +  G   A+K+L  Q+   LK      N       + I
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN------EKRI 94
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNIVID 273
           L+ V+    V  E        F F  N NL   +   P  + + H +++      +    
Sbjct: 95  LQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFY 146
Query: 274 VAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
            A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K +T
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------KGRT 195
Query: 331 MSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHKF 387
               L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++ 
Sbjct: 196 WX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYEK 249
Query: 388 VL---MALPSHV-MDVLDL 402
           ++   +  PSH   D+ DL
Sbjct: 250 IVSGKVRFPSHFSSDLKDL 268

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 109/259 (42%), Gaps = 44/259 (16%)
Query: 157 DNFSEENLIGSGSFGSVY-KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D F     +G+GSFG V     +  G   A+K+L  Q+   LK      N       + I
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN------EKRI 95
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNIVID 273
           L+ V+    V  E        F F  N NL   +   P  + + H +++      +    
Sbjct: 96  LQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY 147
Query: 274 VAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
            A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K +T
Sbjct: 148 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------KGRT 196
Query: 331 MSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHKF 387
               L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++ 
Sbjct: 197 WX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYEK 250
Query: 388 VL---MALPSHV-MDVLDL 402
           ++   +  PSH   D+ DL
Sbjct: 251 IVSGKVRFPSHFSSDLKDL 269

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 109/259 (42%), Gaps = 44/259 (16%)
Query: 157 DNFSEENLIGSGSFGSVY-KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D F     +G+GSFG V     +  G   A+K+L  Q+   LK      N       + I
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN------EKRI 94
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNIVID 273
           L+ V+    V  E        F F  N NL   +   P  + + H +++      +    
Sbjct: 95  LQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY 146
Query: 274 VAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
            A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K +T
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------KGRT 195
Query: 331 MSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHKF 387
               L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++ 
Sbjct: 196 WX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYEK 249
Query: 388 VL---MALPSHV-MDVLDL 402
           ++   +  PSH   D+ DL
Sbjct: 250 IVSGKVRFPSHFSSDLKDL 268

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 88/225 (39%), Gaps = 32/225 (14%)
Query: 158 NFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRN 214
           N+     IG G+F  V     +  G   AIK++   Q    +L+    E   +  + H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVI 272
           I+K+         E      L+ E+   G +  +L  H    E     K           
Sbjct: 76  IVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR--------- 121
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            + SA+ Y H +    I H DLK+ N+LLD  M   + DFG        SN  +    + 
Sbjct: 122 QIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGF-------SNEFTVGGKL- 170
Query: 333 NGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTD 375
           +   G+  Y  PE   G  +     D++S G++L  + +G  P D
Sbjct: 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 67/138 (48%), Gaps = 21/138 (15%)
Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
            + + +  AL YL  ++   + H D+K SN+LLDE     + DFG++  L ++    +K+
Sbjct: 128 KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK---AKD 182
Query: 329 QTMSNGLKGSVGYIPPEYIN------GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDL 382
           ++      G   Y+ PE I+          I  D++S GI L+E+ TG+ P  +  K D 
Sbjct: 183 RSA-----GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC-KTDF 236
Query: 383 SIHKFVLMA----LPSHV 396
            +   VL      LP H+
Sbjct: 237 EVLTKVLQEEPPLLPGHM 254

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 110/259 (42%), Gaps = 44/259 (16%)
Query: 157 DNFSEENLIGSGSFGSVY-KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D F     +G+GSFG V     +  G   A+K+L  Q+   LK      N       + I
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLN------EKRI 94
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNIVID 273
           L+ V+    V  E        F F  N NL   +   P  + + H +++      +    
Sbjct: 95  LQAVNFPFLVKLE--------FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY 146
Query: 274 VAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
            A      +YLH+     + + DLK  N+++D+     V DFGLAK +        K +T
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRV--------KGRT 195
Query: 331 MSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHKF 387
               L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++ 
Sbjct: 196 WX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYEK 249
Query: 388 VL---MALPSHV-MDVLDL 402
           ++   +  PSH   D+ DL
Sbjct: 250 IVSGKVRFPSHFSSDLKDL 268

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 106/236 (44%), Gaps = 28/236 (11%)
Query: 158 NFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++++  +IG+GSFG VY+  L D GE  AIK  K+ Q    K+   E   +  + H NI+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIV 76
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK-LSLMQRLNIVIDVA 275
           ++        Y   + K +V+  +    + + ++     Y   K+ L ++     +  + 
Sbjct: 77  RL----RYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
            +L Y+H+     I H D+K  N+LLD +  +  + DFG AK L      P+ +   S  
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSRY 187
Query: 335 LKGSVGYIPPEYINGHVSILG--DIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV 388
            +       PE I G        D++S G +L E+  G+     +F  D  + + V
Sbjct: 188 YRA------PELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 233

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 109/259 (42%), Gaps = 44/259 (16%)
Query: 157 DNFSEENLIGSGSFGSVY-KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D F     +G+GSFG V     +  G   A+K+L  Q+   LK      N       + I
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN------EKRI 95
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNIVID 273
           L+ V+    V  E        F F  N NL   +   P  + + H +++      +    
Sbjct: 96  LQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFY 147
Query: 274 VAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
            A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K +T
Sbjct: 148 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------KGRT 196
Query: 331 MSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHKF 387
               L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++ 
Sbjct: 197 WX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYEK 250
Query: 388 VL---MALPSHV-MDVLDL 402
           ++   +  PSH   D+ DL
Sbjct: 251 IVSGKVRFPSHFSSDLKDL 269

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 111/262 (42%), Gaps = 50/262 (19%)
Query: 157 DNFSEENLIGSGSFGSV----YKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRH 212
           D F     +G+GSFG V    +K T   G   A+K+L  Q+   LK      N       
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLN------E 112
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNI 270
           + IL+ V+    V  E        F F  N NL   +   P  + + H +++      + 
Sbjct: 113 KRILQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 164
Query: 271 VIDVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
               A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K
Sbjct: 165 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------K 213
Query: 328 NQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSI 384
            +T    L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I
Sbjct: 214 GRTWX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQI 267
Query: 385 HKFVL---MALPSHV-MDVLDL 402
           ++ ++   +  PSH   D+ DL
Sbjct: 268 YEKIVSGKVRFPSHFSSDLKDL 289

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 96/229 (41%), Gaps = 36/229 (15%)
Query: 165 IGSGSFGSVYKGTLADGE----TAAIKVLK-LQQQGALKSFIDECNALTSIRHRNILKIV 219
           IG G FG V++G     E      AIK  K        + F+ E   +    H +I+K++
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSL--MQRLNIVIDVASA 277
              +       +   ++ E    G L  +L          +K SL     +     +++A
Sbjct: 458 GVITE------NPVWIIMELCTLGELRSFLQ--------VRKFSLDLASLILYAYQLSTA 503
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           L YL ++      H D+ + NVL+       +GDFGL++++        ++ T     KG
Sbjct: 504 LAYLESKR---FVHRDIAARNVLVSATDCVKLGDFGLSRYM--------EDSTYYKASKG 552
Query: 338 S--VGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL 382
              + ++ PE IN    +   D++ +G+ + EI   G +P   +  +D+
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 601

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 111/262 (42%), Gaps = 50/262 (19%)
Query: 157 DNFSEENLIGSGSFGSV----YKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRH 212
           D F     +G+GSFG V    +K T   G   A+K+L  Q+   LK      N       
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLN------E 92
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNI 270
           + IL+ V+    V  E        F F  N NL   +   P  + + H +++      + 
Sbjct: 93  KRILQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 144
Query: 271 VIDVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
               A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K
Sbjct: 145 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------K 193
Query: 328 NQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSI 384
            +T    L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I
Sbjct: 194 GRTWX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQI 247
Query: 385 HKFVL---MALPSHV-MDVLDL 402
           ++ ++   +  PSH   D+ DL
Sbjct: 248 YEKIVSGKVRFPSHFSSDLKDL 269

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 26/222 (11%)
Query: 157 DNFSEENLIGSGSFGSV-YKGTLADGETAAIKVLKLQ---QQGALKSFIDECNALTSIRH 212
           + F    L+G G+FG V      A G   A+K+LK +    +  +   + E   L + RH
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             +  +  S     ++ +D    V E+   G L  + H S +     +  S  +      
Sbjct: 70  PFLTALKYS-----FQTHDRLCFVMEYANGGEL--FFHLSRE-----RVFSEDRARFYGA 117
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           ++ SALDYLH++ +  + + DLK  N++LD+     + DFGL K          K+    
Sbjct: 118 EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-------EGIKDGATM 168
Query: 333 NGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRP 373
               G+  Y+ PE + +       D +  G+++ E+  G+ P
Sbjct: 169 KXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 100/220 (45%), Gaps = 30/220 (13%)
Query: 160 SEENLIGSGSFGSVYK-GTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKI 218
           S+  ++G G FG V+K    A G   A K++K +     +   +E + +  + H N++++
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNL-DQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
             +     +E  +   LV E++  G L D+ +  S +       L+ +  +  +  +   
Sbjct: 152 YDA-----FESKNDIVLVMEYVDGGELFDRIIDESYN-------LTELDTILFMKQICEG 199
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
           + ++H  Y   I H DLK  N+L    D   I  + DFGLA+        P +   ++  
Sbjct: 200 IRHMHQMY---ILHLDLKPENILCVNRDAKQIKII-DFGLAR-----RYKPREKLKVNF- 249
Query: 335 LKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFTGKRP 373
             G+  ++ PE +N   VS   D++S G++   + +G  P
Sbjct: 250 --GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 109/259 (42%), Gaps = 44/259 (16%)
Query: 157 DNFSEENLIGSGSFGSVY-KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D F     +G+GSFG V     +  G   A+K+L  Q+   LK      N       + I
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN------EKRI 94
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNIVID 273
           L+ V+    V  E        F F  N NL   +   P  + + H +++      +    
Sbjct: 95  LQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY 146
Query: 274 VAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
            A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K +T
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------KGRT 195
Query: 331 MSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHKF 387
               L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++ 
Sbjct: 196 WX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYEK 249
Query: 388 VL---MALPSHV-MDVLDL 402
           ++   +  PSH   D+ DL
Sbjct: 250 IVSGKVRFPSHFSSDLKDL 268

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 106/236 (44%), Gaps = 28/236 (11%)
Query: 158 NFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++++  +IG+GSFG VY+  L D GE  AIK  K+ Q  A K+   E   +  + H NI+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFKN--RELQIMRKLDHCNIV 76
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK-LSLMQRLNIVIDVA 275
           ++        Y   + K  V+  +    + + ++     Y   K+ L ++     +  + 
Sbjct: 77  RL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
            +L Y+H+     I H D+K  N+LLD +  +  + DFG AK L      P+ +   S  
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRY 187
Query: 335 LKGSVGYIPPEYINGHVSILG--DIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV 388
            +       PE I G        D++S G +L E+  G+     +F  D  + + V
Sbjct: 188 YRA------PELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 233

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTS-IRHRNILKIVSSC 222
           +G G++G V         E  A+K++ +++       I +   +   + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHP-----STDEYCHFKKLSLMQRLNIVIDVASA 277
                EGN  + L  E+   G L   + P       D    F +L             + 
Sbjct: 74  R----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------------MAG 116
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YLH      I H D+K  N+LLDE     + DFGLA  +F  +N     + + N + G
Sbjct: 117 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNN----RERLLNKMXG 168
Query: 338 SVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTD 375
           ++ Y+ PE +     H   + D++S GI+L  +  G+ P D
Sbjct: 169 TLPYVAPELLKRREFHAEPV-DVWSCGIVLTAMLAGELPWD 208

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTS-IRHRNILKIVSSC 222
           +G G++G V         E  A+K++ +++       I +   +   + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHP-----STDEYCHFKKLSLMQRLNIVIDVASA 277
                EGN  + L  E+   G L   + P       D    F +L             + 
Sbjct: 74  R----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------------MAG 116
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YLH      I H D+K  N+LLDE     + DFGLA  +F  +N     + + N + G
Sbjct: 117 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNN----RERLLNKMXG 168
Query: 338 SVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTD 375
           ++ Y+ PE +     H   + D++S GI+L  +  G+ P D
Sbjct: 169 TLPYVAPELLKRREFHAEPV-DVWSCGIVLTAMLAGELPWD 208

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTS-IRHRNILKIVSSC 222
           +G G++G V         E  A+K++ +++       I +   +   + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHP-----STDEYCHFKKLSLMQRLNIVIDVASA 277
                EGN  + L  E+   G L   + P       D    F +L             + 
Sbjct: 74  R----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------------MAG 116
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YLH      I H D+K  N+LLDE     + DFGLA  +F  +N     + + N + G
Sbjct: 117 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNN----RERLLNKMXG 168
Query: 338 SVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTD 375
           ++ Y+ PE +     H   + D++S GI+L  +  G+ P D
Sbjct: 169 TLPYVAPELLKRREFHAEPV-DVWSCGIVLTAMLAGELPWD 208

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 111/262 (42%), Gaps = 50/262 (19%)
Query: 157 DNFSEENLIGSGSFGSV----YKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRH 212
           D F     +G+GSFG V    +K T   G   A+K+L  Q+   LK      N       
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLN------E 92
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNI 270
           + IL+ V+    V  E        F F  N NL   +   P  + + H +++      + 
Sbjct: 93  KRILQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 144
Query: 271 VIDVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
               A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K
Sbjct: 145 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------K 193
Query: 328 NQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSI 384
            +T    L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I
Sbjct: 194 GRTWX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQI 247
Query: 385 HKFVL---MALPSHV-MDVLDL 402
           ++ ++   +  PSH   D+ DL
Sbjct: 248 YEKIVSGKVRFPSHFSSDLKDL 269

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 111/262 (42%), Gaps = 50/262 (19%)
Query: 157 DNFSEENLIGSGSFGSV----YKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRH 212
           D F     +G+GSFG V    +K T   G   A+K+L  Q+   LK      N       
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLN------E 92
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNI 270
           + IL+ V+    V  E        F F  N NL   +   P  + + H +++      + 
Sbjct: 93  KRILQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 144
Query: 271 VIDVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
               A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K
Sbjct: 145 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------K 193
Query: 328 NQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSI 384
            +T    L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I
Sbjct: 194 GRTWX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQI 247
Query: 385 HKFVL---MALPSHV-MDVLDL 402
           ++ ++   +  PSH   D+ DL
Sbjct: 248 YEKIVSGKVRFPSHFSSDLKDL 269

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 111/262 (42%), Gaps = 50/262 (19%)
Query: 157 DNFSEENLIGSGSFGSV----YKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRH 212
           D F     +G+GSFG V    +K T   G   A+K+L  Q+   LK      N       
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLN------E 84
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNI 270
           + IL+ V+    V  E        F F  N NL   +   P  + + H +++      + 
Sbjct: 85  KRILQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA 136
Query: 271 VIDVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
               A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K
Sbjct: 137 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------K 185
Query: 328 NQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSI 384
            +T    L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I
Sbjct: 186 GRTWX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQI 239
Query: 385 HKFVL---MALPSHV-MDVLDL 402
           ++ ++   +  PSH   D+ DL
Sbjct: 240 YEKIVSGKVRFPSHFSSDLKDL 261

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 23/213 (10%)
Query: 164 LIGSGSFGSVYKGTLADGETAAIKVLKLQQQGAL-KSFIDECNALTSIRHRNILKIVSSC 222
            +G G F   ++  ++D +T  +   K+  +  L K    E  ++    HR++       
Sbjct: 22  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 79
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
               +E NDF  +V E  R  +L + LH         K L+  +    +  +     YLH
Sbjct: 80  FHGFFEDNDFVFVVLELCRRRSLLE-LHKRR------KALTEPEARYYLRQIVLGCQYLH 132
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
                 + H DLK  N+ L+E +   +GDFGLA  +         +      L G+  YI
Sbjct: 133 RNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-------EYDGERKKVLCGTPNYI 182
Query: 343 PPEYIN--GHVSILGDIYSYGILLLEIFTGKRP 373
            PE ++  GH S   D++S G ++  +  GK P
Sbjct: 183 APEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPP 214

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 23/213 (10%)
Query: 164 LIGSGSFGSVYKGTLADGETAAIKVLKLQQQGAL-KSFIDECNALTSIRHRNILKIVSSC 222
            +G G F   ++  ++D +T  +   K+  +  L K    E  ++    HR++       
Sbjct: 46  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 103
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
               +E NDF  +V E  R  +L + LH         K L+  +    +  +     YLH
Sbjct: 104 FHGFFEDNDFVFVVLELCRRRSLLE-LHKRR------KALTEPEARYYLRQIVLGCQYLH 156
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
                 + H DLK  N+ L+E +   +GDFGLA  +         +      L G+  YI
Sbjct: 157 RNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-------EYDGERKKVLCGTPNYI 206
Query: 343 PPEYIN--GHVSILGDIYSYGILLLEIFTGKRP 373
            PE ++  GH S   D++S G ++  +  GK P
Sbjct: 207 APEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPP 238

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 59/112 (52%), Gaps = 15/112 (13%)
Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
            I + +  AL++LH++    + H D+K SNVL++      + DFG++ +L +     S  
Sbjct: 157 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVD-----SVA 209
Query: 329 QTMSNGLKGSVGYIPPEYINGHV-----SILGDIYSYGILLLEIFTGKRPTD 375
           +T+  G K    Y+ PE IN  +     S+  DI+S GI ++E+   + P D
Sbjct: 210 KTIDAGCK---PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 258

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 85/219 (38%), Gaps = 34/219 (15%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSS 221
           IG G+F  V     +  G+  A+K++   Q    +L+    E      + H NI+K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 222 CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYL 281
                 E      LV E+   G +  +L        H +      R      + SA+ Y 
Sbjct: 82  I-----ETEKTLYLVXEYASGGEVFDYL------VAHGRXKEKEARAKFR-QIVSAVQYC 129
Query: 282 HNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK---GS 338
           H ++   I H DLK+ N+LLD      + DFG            S   T  N L    G+
Sbjct: 130 HQKF---IVHRDLKAENLLLDADXNIKIADFGF-----------SNEFTFGNKLDAFCGA 175
Query: 339 VGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTD 375
             Y  PE   G  +     D++S G++L  + +G  P D
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 99/255 (38%), Gaps = 59/255 (23%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSF--------IDECNALTSIRHRNIL 216
           IG GS+G V      + +T AI+ +K+  +  ++            E   +  + H NI 
Sbjct: 34  IGQGSYGVVR--VAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH----------------------PSTD 254
           ++        YE   +  LV E    G+L   L+                      P  +
Sbjct: 92  RLYEV-----YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 255 E-------YCHFKKLSLMQRL----NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL-- 301
           E       +   + L  +QR     NI+  + SAL YLHNQ    I H D+K  N L   
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFST 203
Query: 302 DEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILG---DIY 358
           ++     + DFGL+K  ++ +N      T      G+  ++ PE +N      G   D +
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTK---AGTPYFVAPEVLNTTNESYGPKCDAW 260
Query: 359 SYGILLLEIFTGKRP 373
           S G+LL  +  G  P
Sbjct: 261 SAGVLLHLLLMGAVP 275

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 23/213 (10%)
Query: 164 LIGSGSFGSVYKGTLADGETAAIKVLKLQQQGAL-KSFIDECNALTSIRHRNILKIVSSC 222
            +G G F   ++  ++D +T  +   K+  +  L K    E  ++    HR++       
Sbjct: 48  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 105
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
               +E NDF  +V E  R  +L + LH         K L+  +    +  +     YLH
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLE-LHKRR------KALTEPEARYYLRQIVLGCQYLH 158
Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
                 + H DLK  N+ L+E +   +GDFGLA  +         +      L G+  YI
Sbjct: 159 RNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-------EYDGERKKVLCGTPNYI 208
Query: 343 PPEYIN--GHVSILGDIYSYGILLLEIFTGKRP 373
            PE ++  GH S   D++S G ++  +  GK P
Sbjct: 209 APEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPP 240

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 106/236 (44%), Gaps = 28/236 (11%)
Query: 158 NFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++++  +IG+GSFG VY+  L D GE  AIK  K+ Q  A K+   E   +  + H NI+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFKN--RELQIMRKLDHCNIV 76
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK-LSLMQRLNIVIDVA 275
           ++        Y   + K  V+  +    + + ++     Y   K+ L ++     +  + 
Sbjct: 77  RL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
            +L Y+H+     I H D+K  N+LLD +  +  + DFG AK L      P+ +   S  
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRY 187
Query: 335 LKGSVGYIPPEYINGHVSILG--DIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV 388
            +       PE I G        D++S G +L E+  G+     +F  D  + + V
Sbjct: 188 YRA------PELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 233

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 111/262 (42%), Gaps = 50/262 (19%)
Query: 157 DNFSEENLIGSGSFGSV----YKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRH 212
           D F     +G+GSFG V    +K T   G   A+K+L  Q+   LK      N       
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLN------E 84
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNI 270
           + IL+ V+    V  E        F F  N NL   +   P  + + H +++      + 
Sbjct: 85  KRILQAVNFPFLVKLE--------FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 136
Query: 271 VIDVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
               A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K
Sbjct: 137 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------K 185
Query: 328 NQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSI 384
            +T    L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I
Sbjct: 186 GRTWX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQI 239
Query: 385 HKFVL---MALPSHV-MDVLDL 402
           ++ ++   +  PSH   D+ DL
Sbjct: 240 YEKIVSGKVRFPSHFSSDLKDL 261

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 105/236 (44%), Gaps = 47/236 (19%)
Query: 157 DNFSEENLIGSGSFGSVY---KGTLAD-GETAAIKVLK----LQQQGALKSFIDECNALT 208
           +NF    ++G+G++G V+   K +  D G+  A+KVLK    +Q+    +    E   L 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
            IR    L  +      + + +    L+ +++  G L             F  LS  +R 
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLH----LILDYINGGEL-------------FTHLSQRERF 156
Query: 269 N------IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK-FLFEE 321
                   V ++  AL++LH      I + D+K  N+LLD      + DFGL+K F+ +E
Sbjct: 157 TEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 213
Query: 322 SNTPSKNQTMSNGLKGSVGYIPPEYI----NGHVSILGDIYSYGILLLEIFTGKRP 373
           +         +    G++ Y+ P+ +    +GH   + D +S G+L+ E+ TG  P
Sbjct: 214 TE-------RAYDFCGTIEYMAPDIVRGGDSGHDKAV-DWWSLGVLMYELLTGASP 261

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 109/259 (42%), Gaps = 44/259 (16%)
Query: 157 DNFSEENLIGSGSFGSVY-KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D F     +G+GSFG V     +  G   A+K+L  Q+   LK      N       + I
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN------EKRI 94
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNIVID 273
           L+ V+    V  E        F F  N NL   +   P  + + H +++      +    
Sbjct: 95  LQAVNFPFLVKLE--------FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY 146
Query: 274 VAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
            A      +YLH+     + + DLK  N+++D+     V DFG AK +        K +T
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRV--------KGRT 195
Query: 331 MSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHKF 387
               L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++ 
Sbjct: 196 WX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYEK 249
Query: 388 VL---MALPSHV-MDVLDL 402
           ++   +  PSH   D+ DL
Sbjct: 250 IVSGKVRFPSHFSSDLKDL 268

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 157 DNFSEENLIGSGSFGSV-YKGTLADGETAAIKVLKLQ---QQGALKSFIDECNALTSIRH 212
           ++F    L+G G+FG V      A G   A+K+L+ +    +  +   + E   L + RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV- 271
             +  +  +     ++ +D    V E+   G L  + H S +      ++   +R     
Sbjct: 65  PFLTALKYA-----FQTHDRLCFVMEYANGGEL--FFHLSRE------RVFTEERARFYG 111
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
            ++ SAL+YLH++    + + D+K  N++LD+     + DFGL K         S   TM
Sbjct: 112 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK------EGISDGATM 162
Query: 332 SNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRP 373
                G+  Y+ PE + +       D +  G+++ E+  G+ P
Sbjct: 163 KT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 107/236 (45%), Gaps = 28/236 (11%)
Query: 158 NFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++++  +IG+GSFG VY+  L D GE  AIK  K+ Q  A K+   E   +  + H NI+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFKN--RELQIMRKLDHCNIV 76
Query: 217 KI-VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           ++     SS + +   +  LV +++         H S  +    + L ++     +  + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAK----QTLPVIYVKLYMYQLF 132
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
            +L Y+H+     I H D+K  N+LLD +  +  + DFG AK L      P+ +   S  
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSRY 187
Query: 335 LKGSVGYIPPEYINGHVSILG--DIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV 388
            +       PE I G        D++S G +L E+  G+     +F  D  + + V
Sbjct: 188 YRA------PELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 233

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQ-GALKSFIDECNALTSIRHRNILKIVSSC 222
           +G G++G V         E  A+K++ +++     ++   E      + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHP-----STDEYCHFKKLSLMQRLNIVIDVASA 277
                EGN  + L  E+   G L   + P       D    F +L             + 
Sbjct: 74  R----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------------MAG 116
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YLH      I H D+K  N+LLDE     + DFGLA  +F  +N     + + N + G
Sbjct: 117 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNN----RERLLNKMCG 168
Query: 338 SVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTD 375
           ++ Y+ PE +     H   + D++S GI+L  +  G+ P D
Sbjct: 169 TLPYVAPELLKRREFHAEPV-DVWSCGIVLTAMLAGELPWD 208

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV     +  G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +  +S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 119 FTPATSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 165
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 166 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 212
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H ++  DI+S G ++ E+ TG+
Sbjct: 213 ATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 157 DNFSEENLIGSGSFGSV-YKGTLADGETAAIKVLKLQ---QQGALKSFIDECNALTSIRH 212
           ++F    L+G G+FG V      A G   A+K+L+ +    +  +   + E   L + RH
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV- 271
             +  +  +     ++ +D    V E+   G L  + H S +      ++   +R     
Sbjct: 68  PFLTALKYA-----FQTHDRLCFVMEYANGGEL--FFHLSRE------RVFTEERARFYG 114
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
            ++ SAL+YLH++    + + D+K  N++LD+     + DFGL K         S   TM
Sbjct: 115 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK------EGISDGATM 165
Query: 332 SNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRP 373
                G+  Y+ PE + +       D +  G+++ E+  G+ P
Sbjct: 166 KT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 36/221 (16%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTS-IRHRNILKIVSSC 222
           +G G++G V         E  A+K++ +++       I +   + + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHP-----STDEYCHFKKLSLMQRLNIVIDVASA 277
                EGN  + L  E+   G L   + P       D    F +L             + 
Sbjct: 75  R----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------------MAG 117
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YLH      I H D+K  N+LLDE     + DFGLA  +F  +N     + + N + G
Sbjct: 118 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNN----RERLLNKMCG 169
Query: 338 SVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTD 375
           ++ Y+ PE +     H   + D++S GI+L  +  G+ P D
Sbjct: 170 TLPYVAPELLKRREFHAEPV-DVWSCGIVLTAMLAGELPWD 209

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 79/190 (41%), Gaps = 25/190 (13%)
Query: 191 LQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH 250
           +Q +G ++    E   L  + H N++K+V     +D    D   +VFE +  G       
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQG------- 123
Query: 251 PSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG 310
               E    K LS  Q      D+   ++YLH Q    I H D+K SN+L+ E     + 
Sbjct: 124 -PVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIA 179
Query: 311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILG----DIYSYGILLLE 366
           DFG+       SN    +  + +   G+  ++ PE ++    I      D+++ G+ L  
Sbjct: 180 DFGV-------SNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC 232
Query: 367 IFTGKRPTDD 376
              G+ P  D
Sbjct: 233 FVFGQCPFMD 242

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 157 DNFSEENLIGSGSFGSV-YKGTLADGETAAIKVLKLQ---QQGALKSFIDECNALTSIRH 212
           ++F    L+G G+FG V      A G   A+K+L+ +    +  +   + E   L + RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV- 271
             +  +  +     ++ +D    V E+   G L  + H S +      ++   +R     
Sbjct: 65  PFLTALKYA-----FQTHDRLCFVMEYANGGEL--FFHLSRE------RVFTEERARFYG 111
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
            ++ SAL+YLH++    + + D+K  N++LD+     + DFGL K         S   TM
Sbjct: 112 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK------EGISDGATM 162
Query: 332 SNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRP 373
                G+  Y+ PE + +       D +  G+++ E+  G+ P
Sbjct: 163 KT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTS-IRHRNILKIVSSC 222
           +G G++G V         E  A+K++ +++       I +   +   + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHP-----STDEYCHFKKLSLMQRLNIVIDVASA 277
                EGN  + L  E+   G L   + P       D    F +L             + 
Sbjct: 75  R----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------------MAG 117
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YLH      I H D+K  N+LLDE     + DFGLA  +F  +N     + + N + G
Sbjct: 118 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNN----RERLLNKMCG 169
Query: 338 SVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTD 375
           ++ Y+ PE +     H   + D++S GI+L  +  G+ P D
Sbjct: 170 TLPYVAPELLKRREFHAEPV-DVWSCGIVLTAMLAGELPWD 209

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 104/235 (44%), Gaps = 41/235 (17%)
Query: 157 DNFSEENLIGSGSFGSV----YKGTLADGETAAIKVLKLQQQGALKSFIDECNAL--TSI 210
           +N+  + ++G G    V    +K T  +    A+K++ +   G+  +  +E   L   ++
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKE---YAVKIIDVTGGGSFSA--EEVQELREATL 71
Query: 211 RHRNILKIVSSCSSV-----DYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM 265
           +  +IL+ VS   ++      YE N F  LVF+ M+ G L  +L     E     +    
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETR 127
Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
           + +  +++V  AL  L+      I H DLK  N+LLD+ M   + DFG +  L      P
Sbjct: 128 KIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL-----DP 176
Query: 326 SKNQTMSNGLKGSVGYIPPEYI----NGHVSILG---DIYSYGILLLEIFTGKRP 373
            +       + G+  Y+ PE I    N +    G   D++S G+++  +  G  P
Sbjct: 177 GEKL---RSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 108/245 (44%), Gaps = 30/245 (12%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLK--LQQQGALKSFIDECNALTSIRHR 213
           D +     IG+G++G V        G+  AIK +          K  + E   L   +H 
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 114
Query: 214 NILKIVSSC-SSVDYEGNDFKAL--VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
           NI+ I      +V Y   +FK++  V + M + +L Q +H S       + L+L      
Sbjct: 115 NIIAIKDILRPTVPY--GEFKSVYVVLDLMES-DLHQIIHSS-------QPLTLEHVRYF 164
Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
           +  +   L Y+H+     + H DLK SN+L++E     +GDFG+A+ L     +P+++Q 
Sbjct: 165 LYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGL---CTSPAEHQY 218
Query: 331 MSNGLKGSVGYIPPEY---INGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKF 387
                  +  Y  PE    ++ +   + D++S G +  E+   ++    +F     +H+ 
Sbjct: 219 FMTEYVATRWYRAPELMLSLHEYTQAI-DLWSVGCIFGEMLARRQ----LFPGKNYVHQL 273
Query: 388 VLMAL 392
            L+ +
Sbjct: 274 QLIMM 278

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTS-IRHRNILKIVSSC 222
           +G G++G V         E  A+K++ +++       I +   +   + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHP-----STDEYCHFKKLSLMQRLNIVIDVASA 277
                EGN  + L  E+   G L   + P       D    F +L             + 
Sbjct: 75  R----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------------MAG 117
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YLH      I H D+K  N+LLDE     + DFGLA  +F  +N     + + N + G
Sbjct: 118 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNN----RERLLNKMCG 169
Query: 338 SVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTD 375
           ++ Y+ PE +     H   + D++S GI+L  +  G+ P D
Sbjct: 170 TLPYVAPELLKRREFHAEPV-DVWSCGIVLTAMLAGELPWD 209

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTS-IRHRNILKIVSSC 222
           +G G++G V         E  A+K++ +++       I +   +   + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHP-----STDEYCHFKKLSLMQRLNIVIDVASA 277
                EGN  + L  E+   G L   + P       D    F +L             + 
Sbjct: 74  R----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------------MAG 116
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YLH      I H D+K  N+LLDE     + DFGLA  +F  +N     + + N + G
Sbjct: 117 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNN----RERLLNKMCG 168
Query: 338 SVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTD 375
           ++ Y+ PE +     H   + D++S GI+L  +  G+ P D
Sbjct: 169 TLPYVAPELLKRREFHAEPV-DVWSCGIVLTAMLAGELPWD 208

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTS-IRHRNILKIVSSC 222
           +G G++G V         E  A+K++ +++       I +   +   + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHP-----STDEYCHFKKLSLMQRLNIVIDVASA 277
                EGN  + L  E+   G L   + P       D    F +L             + 
Sbjct: 74  R----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------------MAG 116
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YLH      I H D+K  N+LLDE     + DFGLA  +F  +N     + + N + G
Sbjct: 117 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNN----RERLLNKMCG 168
Query: 338 SVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTD 375
           ++ Y+ PE +     H   + D++S GI+L  +  G+ P D
Sbjct: 169 TLPYVAPELLKRREFHAEPV-DVWSCGIVLTAMLAGELPWD 208

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 31/226 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQ-------QGALKSFIDECNALT 208
           D F +  ++G G FG V+   + A G+  A K L  ++       QGA+     E   L 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV----EKKILA 240
Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
            +  R I+ +  +     +E      LV   M  G++   ++   ++   F++    + +
Sbjct: 241 KVHSRFIVSLAYA-----FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE---PRAI 292
Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
                + S L++LH +    I + DLK  NVLLD+     + D GLA  L          
Sbjct: 293 FYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL-------KAG 342
Query: 329 QTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
           QT + G  G+ G++ PE + G       D ++ G+ L E+   + P
Sbjct: 343 QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 109/259 (42%), Gaps = 44/259 (16%)
Query: 157 DNFSEENLIGSGSFGSVY-KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D F     +G+GSFG V     +  G   A+K+L  Q+   LK      N       + I
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN------EKRI 94
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNIVID 273
           L+ V+    V  E        F F  N NL   +   P  + + H +++      +    
Sbjct: 95  LQAVNFPFLVKLE--------FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY 146
Query: 274 VAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
            A      +YLH+     + + DLK  N+++D+     V DFG AK +        K +T
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV--------KGRT 195
Query: 331 MSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHKF 387
               L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++ 
Sbjct: 196 WX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYEK 249
Query: 388 VL---MALPSHV-MDVLDL 402
           ++   +  PSH   D+ DL
Sbjct: 250 IVSGKVRFPSHFSSDLKDL 268

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 109/259 (42%), Gaps = 44/259 (16%)
Query: 157 DNFSEENLIGSGSFGSVY-KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D F     +G+GSFG V     +  G   A+K+L  Q+   LK      N       + I
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN------EKRI 94
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNIVID 273
           L+ V+    V  E        F F  N NL   +   P  + + H +++      +    
Sbjct: 95  LQAVNFPFLVKLE--------FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFY 146
Query: 274 VAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
            A      +YLH+     + + DLK  N+++D+     V DFG AK +        K +T
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV--------KGRT 195
Query: 331 MSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHKF 387
               L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++ 
Sbjct: 196 WX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYEK 249
Query: 388 VL---MALPSHV-MDVLDL 402
           ++   +  PSH   D+ DL
Sbjct: 250 IVSGKVRFPSHFSSDLKDL 268

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 157 DNFSEENLIGSGSFGSV-YKGTLADGETAAIKVLKLQ---QQGALKSFIDECNALTSIRH 212
           ++F    L+G G+FG V      A G   A+K+L+ +    +  +   + E   L + RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV- 271
             +  +  +     ++ +D    V E+   G L  + H S +      ++   +R     
Sbjct: 65  PFLTALKYA-----FQTHDRLCFVMEYANGGEL--FFHLSRE------RVFTEERARFYG 111
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
            ++ SAL+YLH++    + + D+K  N++LD+     + DFGL K         S   TM
Sbjct: 112 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK------EGISDGATM 162
Query: 332 SNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRP 373
                G+  Y+ PE + +       D +  G+++ E+  G+ P
Sbjct: 163 KX-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTS-IRHRNILKIVSSC 222
           +G G++G V         E  A+K++ +++       I +   +   + H N++K     
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHP-----STDEYCHFKKLSLMQRLNIVIDVASA 277
                EGN  + L  E+   G L   + P       D    F +L             + 
Sbjct: 73  R----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------------MAG 115
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YLH      I H D+K  N+LLDE     + DFGLA  +F  +N     + + N + G
Sbjct: 116 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNN----RERLLNKMCG 167
Query: 338 SVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTD 375
           ++ Y+ PE +     H   + D++S GI+L  +  G+ P D
Sbjct: 168 TLPYVAPELLKRREFHAEPV-DVWSCGIVLTAMLAGELPWD 207

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 111/262 (42%), Gaps = 50/262 (19%)
Query: 157 DNFSEENLIGSGSFGSV----YKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRH 212
           D F     +G+GSFG V    +K T   G   A+K+L  Q+   LK      N       
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLN------E 92
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNI 270
           + IL+ V+    V  E        F F  N NL   +   P  + + H +++      + 
Sbjct: 93  KRILQAVNFPFLVKLE--------FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA 144
Query: 271 VIDVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
               A      +YLH+     + + DLK  N+++D+     V DFG AK +        K
Sbjct: 145 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV--------K 193
Query: 328 NQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSI 384
            +T    L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I
Sbjct: 194 GRTWX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQI 247
Query: 385 HKFVL---MALPSHV-MDVLDL 402
           ++ ++   +  PSH   D+ DL
Sbjct: 248 YEKIVSGKVRFPSHFSSDLKDL 269

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 110/262 (41%), Gaps = 50/262 (19%)
Query: 157 DNFSEENLIGSGSFGSV----YKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRH 212
           D F     +G+GSFG V    +K T   G   A+K+L  Q+   LK      N       
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLN------E 92
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNI 270
           + I + V+    V  E        F F  N NL   L   P  + + H +++      + 
Sbjct: 93  KRIQQAVNFPFLVKLE--------FSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHA 144
Query: 271 VIDVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
               A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K
Sbjct: 145 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV--------K 193
Query: 328 NQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSI 384
            +T    L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I
Sbjct: 194 GRTWX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQI 247
Query: 385 HKFVL---MALPSHV-MDVLDL 402
           ++ ++   +  PSH   D+ DL
Sbjct: 248 YEKIVSGKVRFPSHFSSDLKDL 269

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 108/245 (44%), Gaps = 30/245 (12%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLK--LQQQGALKSFIDECNALTSIRHR 213
           D +     IG+G++G V        G+  AIK +          K  + E   L   +H 
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 113
Query: 214 NILKIVSSC-SSVDYEGNDFKAL--VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
           NI+ I      +V Y   +FK++  V + M + +L Q +H S       + L+L      
Sbjct: 114 NIIAIKDILRPTVPY--GEFKSVYVVLDLMES-DLHQIIHSS-------QPLTLEHVRYF 163
Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
           +  +   L Y+H+     + H DLK SN+L++E     +GDFG+A+ L     +P+++Q 
Sbjct: 164 LYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGL---CTSPAEHQY 217
Query: 331 MSNGLKGSVGYIPPEY---INGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKF 387
                  +  Y  PE    ++ +   + D++S G +  E+   ++    +F     +H+ 
Sbjct: 218 FMTEYVATRWYRAPELMLSLHEYTQAI-DLWSVGCIFGEMLARRQ----LFPGKNYVHQL 272
Query: 388 VLMAL 392
            L+ +
Sbjct: 273 QLIMM 277

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 31/226 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQ-------QGALKSFIDECNALT 208
           D F +  ++G G FG V+   + A G+  A K L  ++       QGA+     E   L 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV----EKKILA 240
Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
            +  R I+ +  +     +E      LV   M  G++   ++   ++   F++    + +
Sbjct: 241 KVHSRFIVSLAYA-----FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE---PRAI 292
Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
                + S L++LH +    I + DLK  NVLLD+     + D GLA  L          
Sbjct: 293 FYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL-------KAG 342
Query: 329 QTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
           QT + G  G+ G++ PE + G       D ++ G+ L E+   + P
Sbjct: 343 QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTS-IRHRNILKIVSSC 222
           +G G++G V         E  A+K++ +++       I +   +   + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHP-----STDEYCHFKKLSLMQRLNIVIDVASA 277
                EGN  + L  E+   G L   + P       D    F +L             + 
Sbjct: 74  R----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------------MAG 116
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YLH      I H D+K  N+LLDE     + DFGLA  +F  +N     + + N + G
Sbjct: 117 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNN----RERLLNKMCG 168
Query: 338 SVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTD 375
           ++ Y+ PE +     H   + D++S GI+L  +  G+ P D
Sbjct: 169 TLPYVAPELLKRREFHAEPV-DVWSCGIVLTAMLAGELPWD 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTS-IRHRNILKIVSSC 222
           +G G++G V         E  A+K++ +++       I +   +   + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHP-----STDEYCHFKKLSLMQRLNIVIDVASA 277
                EGN  + L  E+   G L   + P       D    F +L             + 
Sbjct: 74  R----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------------MAG 116
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YLH      I H D+K  N+LLDE     + DFGLA  +F  +N     + + N + G
Sbjct: 117 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNN----RERLLNKMCG 168
Query: 338 SVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTD 375
           ++ Y+ PE +     H   + D++S GI+L  +  G+ P D
Sbjct: 169 TLPYVAPELLKRREFHAEPV-DVWSCGIVLTAMLAGELPWD 208

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 31/226 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQ-------QGALKSFIDECNALT 208
           D F +  ++G G FG V+   + A G+  A K L  ++       QGA+     E   L 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV----EKKILA 240
Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
            +  R I+ +  +     +E      LV   M  G++   ++   ++   F++    + +
Sbjct: 241 KVHSRFIVSLAYA-----FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE---PRAI 292
Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
                + S L++LH +    I + DLK  NVLLD+     + D GLA  L          
Sbjct: 293 FYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL-------KAG 342
Query: 329 QTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
           QT + G  G+ G++ PE + G       D ++ G+ L E+   + P
Sbjct: 343 QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTS-IRHRNILKIVSSC 222
           +G G++G V         E  A+K++ +++       I +   +   + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHP-----STDEYCHFKKLSLMQRLNIVIDVASA 277
                EGN  + L  E+   G L   + P       D    F +L             + 
Sbjct: 74  R----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------------MAG 116
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YLH      I H D+K  N+LLDE     + DFGLA  +F  +N     + + N + G
Sbjct: 117 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNN----RERLLNKMCG 168
Query: 338 SVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTD 375
           ++ Y+ PE +     H   + D++S GI+L  +  G+ P D
Sbjct: 169 TLPYVAPELLKRREFHAEPV-DVWSCGIVLTAMLAGELPWD 208

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 92/215 (42%), Gaps = 25/215 (11%)
Query: 165 IGSGSFGSVYKGT--LADGETAAIKVLKLQ--QQGALKSFIDECNAL---TSIRHRNILK 217
           IG G++G V+K       G   A+K +++Q  ++G   S I E   L    +  H N+++
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
           +   C+    +      LVFE + + +L  +L    +     + +      +++  +   
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK-----DMMFQLLRG 132
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           LD+LH+     + H DLK  N+L+       + DFGLA+            Q     +  
Sbjct: 133 LDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY--------SFQMALTSVVV 181
Query: 338 SVGYIPPEY-INGHVSILGDIYSYGILLLEIFTGK 371
           ++ Y  PE  +    +   D++S G +  E+F  K
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 92/215 (42%), Gaps = 25/215 (11%)
Query: 165 IGSGSFGSVYKGT--LADGETAAIKVLKLQ--QQGALKSFIDECNAL---TSIRHRNILK 217
           IG G++G V+K       G   A+K +++Q  ++G   S I E   L    +  H N+++
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
           +   C+    +      LVFE + + +L  +L    +     + +      +++  +   
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK-----DMMFQLLRG 132
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           LD+LH+     + H DLK  N+L+       + DFGLA+            Q     +  
Sbjct: 133 LDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY--------SFQMALTSVVV 181
Query: 338 SVGYIPPEY-INGHVSILGDIYSYGILLLEIFTGK 371
           ++ Y  PE  +    +   D++S G +  E+F  K
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 157 DNFSEENLIGSGSFGSV-YKGTLADGETAAIKVLKLQ---QQGALKSFIDECNALTSIRH 212
           ++F    L+G G+FG V      A G   A+K+L+ +    +  +   + E   L + RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV- 271
             +  +  +     ++ +D    V E+   G L  + H S +      ++   +R     
Sbjct: 65  PFLTALKYA-----FQTHDRLCFVMEYANGGEL--FFHLSRE------RVFTEERARFYG 111
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
            ++ SAL+YLH++    + + D+K  N++LD+     + DFGL K         S   TM
Sbjct: 112 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK------EGISDGATM 162
Query: 332 SNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRP 373
                G+  Y+ PE + +       D +  G+++ E+  G+ P
Sbjct: 163 KX-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 104/241 (43%), Gaps = 53/241 (21%)
Query: 157 DNFSEENLIGSGSFGSV----YKGTLADGETAAIKVLKLQQQGALKSFIDECNAL--TSI 210
           +N+  + ++G G    V    +K T  +    A+K++ +   G+  +  +E   L   ++
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKE---YAVKIIDVTGGGSFSA--EEVQELREATL 71
Query: 211 RHRNILKIVSSCSSV-----DYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM 265
           +  +IL+ VS   ++      YE N F  LVF+ M+ G L  +L     E     +    
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETR 127
Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA------KFLF 319
           + +  +++V  AL  L+      I H DLK  N+LLD+ M   + DFG +      + L 
Sbjct: 128 KIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR 181
Query: 320 EESNTPSKNQTMSNGLKGSVGYIPPEYI----NGHVSILG---DIYSYGILLLEIFTGKR 372
           E   TPS              Y+ PE I    N +    G   D++S G+++  +  G  
Sbjct: 182 EVCGTPS--------------YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227
Query: 373 P 373
           P
Sbjct: 228 P 228

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 92/215 (42%), Gaps = 25/215 (11%)
Query: 165 IGSGSFGSVYKGT--LADGETAAIKVLKLQ--QQGALKSFIDECNAL---TSIRHRNILK 217
           IG G++G V+K       G   A+K +++Q  ++G   S I E   L    +  H N+++
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
           +   C+    +      LVFE + + +L  +L    +     + +      +++  +   
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK-----DMMFQLLRG 132
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           LD+LH+     + H DLK  N+L+       + DFGLA+            Q     +  
Sbjct: 133 LDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY--------SFQMALTSVVV 181
Query: 338 SVGYIPPEY-INGHVSILGDIYSYGILLLEIFTGK 371
           ++ Y  PE  +    +   D++S G +  E+F  K
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 104/241 (43%), Gaps = 53/241 (21%)
Query: 157 DNFSEENLIGSGSFGSV----YKGTLADGETAAIKVLKLQQQGALKSFIDECNAL--TSI 210
           +N+  + ++G G    V    +K T  +    A+K++ +   G+  +  +E   L   ++
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKE---YAVKIIDVTGGGSFSA--EEVQELREATL 58
Query: 211 RHRNILKIVSSCSSV-----DYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM 265
           +  +IL+ VS   ++      YE N F  LVF+ M+ G L  +L     E     +    
Sbjct: 59  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETR 114
Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA------KFLF 319
           + +  +++V  AL  L+      I H DLK  N+LLD+ M   + DFG +      + L 
Sbjct: 115 KIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR 168
Query: 320 EESNTPSKNQTMSNGLKGSVGYIPPEYI----NGHVSILG---DIYSYGILLLEIFTGKR 372
           E   TPS              Y+ PE I    N +    G   D++S G+++  +  G  
Sbjct: 169 EVCGTPS--------------YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 214
Query: 373 P 373
           P
Sbjct: 215 P 215

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 31/226 (13%)
Query: 157 DNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQ-------QGALKSFIDECNALT 208
           D F +  ++G G FG V+   + A G+  A K L  ++       QGA+     E   L 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV----EKKILA 240
Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
            +  R I+ +  +     +E      LV   M  G++   ++   ++   F++    + +
Sbjct: 241 KVHSRFIVSLAYA-----FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE---PRAI 292
Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
                + S L++LH +    I + DLK  NVLLD+     + D GLA  L          
Sbjct: 293 FYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL-------KAG 342
Query: 329 QTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
           QT + G  G+ G++ PE + G       D ++ G+ L E+   + P
Sbjct: 343 QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 157 DNFSEENLIGSGSFGSV-YKGTLADGETAAIKVLKLQ---QQGALKSFIDECNALTSIRH 212
           ++F    L+G G+FG V      A G   A+K+L+ +    +  +   + E   L + RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV- 271
             +  +  +     ++ +D    V E+   G L  + H S +      ++   +R     
Sbjct: 65  PFLTALKYA-----FQTHDRLCFVMEYANGGEL--FFHLSRE------RVFTEERARFYG 111
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
            ++ SAL+YLH++    + + D+K  N++LD+     + DFGL K         S   TM
Sbjct: 112 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK------EGISDGATM 162
Query: 332 SNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRP 373
                G+  Y+ PE + +       D +  G+++ E+  G+ P
Sbjct: 163 KX-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 102/237 (43%), Gaps = 43/237 (18%)
Query: 153 SNATDNFSEENLIGSGSFGSV----YKGTLADGETAAIKVLKLQ--QQGALKSFID-ECN 205
           S   D++     +GSG F  V     KGT  +     IK  +L   ++G  +  I+ E N
Sbjct: 1   SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 206 ALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHP----STDEYCHFKK 261
            L  IRH NI+ +        +E      L+ E +  G L  +L      + DE   F K
Sbjct: 61  ILREIRHPNIITLHDI-----FENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK 115
Query: 262 LSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH----VGDFGLAKF 317
                       +   + YLH++    IAH DLK  N++L +  + +    + DFG+A  
Sbjct: 116 -----------QILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161
Query: 318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
           +  E+    KN      + G+  ++ PE +N   + +  D++S G++   + +G  P
Sbjct: 162 I--EAGNEFKN------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 110/258 (42%), Gaps = 41/258 (15%)
Query: 165 IGSGSFGSVYKGTLADG-ETAAIKVLKL--QQQGALKSFIDECNALTSIRHRNILKIVSS 221
           IGSG FG +Y     +  E  A  V+K+  Q+ G L S   E      +  ++ +K    
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS---ELKFYQRVAKKDCIKKWIE 101
Query: 222 CSSVDYEG---------NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
              +DY G          +FK   + FM    L   L   + +   FKK +++Q   + I
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQ---LGI 158
Query: 273 DVASALDYLH-NQYDTPIAHCDLKSSNVLL-----DEGMIAHVGDFGLAKFLFEESNTPS 326
            +   L+Y+H N+Y     H D+K++N+LL     D+    ++ D+GL+   +      +
Sbjct: 159 RMLDVLEYIHENEY----VHGDIKAANLLLGYKNPDQ---VYLADYGLS---YRYCPNGN 208
Query: 327 KNQTMSNGLKGSVGYIPPEYINGH----VSILGDIYSYGILLLEIFTGKRPTDDMFKDDL 382
             Q   N  KG  G I    ++ H    +S   D+   G  +L    GK P +   KD +
Sbjct: 209 HKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268
Query: 383 SIHKF---VLMALPSHVM 397
           ++      +L  LP  V+
Sbjct: 269 AVQTAKTNLLDELPQSVL 286

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPS--TDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +  +  TD++  F          ++  +  
Sbjct: 86  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCAKLTDDHVQF----------LIYQILR 132
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 133 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 179
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 157 DNFSEENLIGSGSFGSV-YKGTLADGETAAIKVLKLQ---QQGALKSFIDECNALTSIRH 212
           ++F    L+G G+FG V      A G   A+K+L+ +    +  +   + E   L + RH
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV- 271
             +  +  +     ++ +D    V E+   G L  + H S +      ++   +R     
Sbjct: 70  PFLTALKYA-----FQTHDRLCFVMEYANGGEL--FFHLSRE------RVFTEERARFYG 116
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
            ++ SAL+YLH++    + + D+K  N++LD+     + DFGL K         S   TM
Sbjct: 117 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK------EGISDGATM 167
Query: 332 SNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRP 373
                G+  Y+ PE + +       D +  G+++ E+  G+ P
Sbjct: 168 KX-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 90  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 136
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MAGFV 183
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 90  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 136
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 183
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 28/236 (11%)
Query: 158 NFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++++  +IG+GSFG VY+  L D GE  AIK  K+ Q    K+   E   +  + H NI+
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIV 77
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK-LSLMQRLNIVIDVA 275
           ++        Y   + K  V+  +    + + ++     Y   K+ L ++     +  + 
Sbjct: 78  RL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 133
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
            +L Y+H+     I H D+K  N+LLD +  +  + DFG AK L      P+ +   S  
Sbjct: 134 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSRY 188
Query: 335 LKGSVGYIPPEYINGHVSILG--DIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV 388
            +       PE I G        D++S G +L E+  G+     +F  D  + + V
Sbjct: 189 YRA------PELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 111/262 (42%), Gaps = 50/262 (19%)
Query: 157 DNFSEENLIGSGSFGSV----YKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRH 212
           D F     +G+GSFG V    +K T   G   A+K+L  Q+   LK      N       
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKET---GNHFAMKILDKQKVVKLKQIEHTLN------E 91
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNI 270
           + IL+ V+    V  E        + F  N NL   +   P  + + H +++      + 
Sbjct: 92  KRILQAVNFPFLVKLE--------YSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 143
Query: 271 VIDVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
               A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K
Sbjct: 144 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------K 192
Query: 328 NQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSI 384
            +T    L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I
Sbjct: 193 GRTWX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQI 246
Query: 385 HKFVL---MALPSHV-MDVLDL 402
           ++ ++   +  PSH   D+ DL
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDL 268

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 102/237 (43%), Gaps = 43/237 (18%)
Query: 153 SNATDNFSEENLIGSGSFGSV----YKGTLADGETAAIKVLKL--QQQGALKSFID-ECN 205
           S   D++     +GSG F  V     KGT  +     IK  +L   ++G  +  I+ E N
Sbjct: 22  SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVN 81
Query: 206 ALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHP----STDEYCHFKK 261
            L  IRH NI+ +        +E      L+ E +  G L  +L      + DE   F K
Sbjct: 82  ILREIRHPNIITLHDI-----FENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK 136
Query: 262 LSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH----VGDFGLAKF 317
                       +   + YLH++    IAH DLK  N++L +  + +    + DFG+A  
Sbjct: 137 -----------QILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 182
Query: 318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
           +  E+    KN      + G+  ++ PE +N   + +  D++S G++   + +G  P
Sbjct: 183 I--EAGNEFKN------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTS-IRHRNILKIVSSC 222
           +G G++G V         E  A+K++ +++       I +   +   + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHP-----STDEYCHFKKLSLMQRLNIVIDVASA 277
                EGN  + L  E+   G L   + P       D    F +L             + 
Sbjct: 74  ---RREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------------MAG 117
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YLH      I H D+K  N+LLDE     + DFGLA  +F  +N     + + N + G
Sbjct: 118 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNN----RERLLNKMCG 169
Query: 338 SVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTD 375
           ++ Y+ PE +     H   + D++S GI+L  +  G+ P D
Sbjct: 170 TLPYVAPELLKRREFHAEPV-DVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTS-IRHRNILKIVSSC 222
           +G G++G V         E  A+K++ +++       I +   +   + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHP-----STDEYCHFKKLSLMQRLNIVIDVASA 277
                EGN  + L  E+   G L   + P       D    F +L             + 
Sbjct: 74  ---RREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------------MAG 117
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YLH      I H D+K  N+LLDE     + DFGLA  +F  +N     + + N + G
Sbjct: 118 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNN----RERLLNKMCG 169
Query: 338 SVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTD 375
           ++ Y+ PE +     H   + D++S GI+L  +  G+ P D
Sbjct: 170 TLPYVAPELLKRREFHAEPV-DVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTS-IRHRNILKIVSSC 222
           +G G++G V         E  A+K++ +++       I +   +   + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHP-----STDEYCHFKKLSLMQRLNIVIDVASA 277
                EGN  + L  E+   G L   + P       D    F +L             + 
Sbjct: 74  ---RREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------------MAG 117
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YLH      I H D+K  N+LLDE     + DFGLA  +F  +N     + + N + G
Sbjct: 118 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNN----RERLLNKMCG 169
Query: 338 SVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTD 375
           ++ Y+ PE +     H   + D++S GI+L  +  G+ P D
Sbjct: 170 TLPYVAPELLKRREFHAEPV-DVWSCGIVLTAMLAGELPWD 209

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 90  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 136
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MAGFV 183
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 111/262 (42%), Gaps = 50/262 (19%)
Query: 157 DNFSEENLIGSGSFGSV----YKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRH 212
           D F     +G+GSFG V    +K T   G   A+K+L  Q+   LK      N       
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKET---GNHFAMKILDKQKVVKLKQIEHTLN------E 91
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNI 270
           + IL+ V+    V  E        + F  N NL   +   P  + + H +++      + 
Sbjct: 92  KRILQAVNFPFLVKLE--------YSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 143
Query: 271 VIDVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
               A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K
Sbjct: 144 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------K 192
Query: 328 NQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSI 384
            +T    L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I
Sbjct: 193 GRTWX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQI 246
Query: 385 HKFVL---MALPSHV-MDVLDL 402
           ++ ++   +  PSH   D+ DL
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDL 268

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 100 FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 146
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 147 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 193
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 194 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 28/236 (11%)
Query: 158 NFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++++  +IG+GSFG VY+  L D GE  AIK  K+ Q    K+   E   +  + H NI+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIV 76
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK-LSLMQRLNIVIDVA 275
           ++        Y   + K  V+  +    + + ++     Y   K+ L ++     +  + 
Sbjct: 77  RL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
            +L Y+H+     I H D+K  N+LLD +  +  + DFG AK L      P+ +   S  
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSRY 187
Query: 335 LKGSVGYIPPEYINGHVSILG--DIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV 388
            +       PE I G        D++S G +L E+  G+     +F  D  + + V
Sbjct: 188 YRA------PELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 233

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 111/262 (42%), Gaps = 50/262 (19%)
Query: 157 DNFSEENLIGSGSFGSV----YKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRH 212
           D F     +G+GSFG V    +K T   G   A+K+L  Q+   LK      N       
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKET---GNHFAMKILDKQKVVKLKQIEHTLN------E 91
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNI 270
           + IL+ V+    V  E        + F  N NL   +   P  + + H +++      + 
Sbjct: 92  KRILQAVNFPFLVKLE--------YSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA 143
Query: 271 VIDVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
               A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K
Sbjct: 144 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------K 192
Query: 328 NQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSI 384
            +T    L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I
Sbjct: 193 GRTWX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQI 246
Query: 385 HKFVL---MALPSHV-MDVLDL 402
           ++ ++   +  PSH   D+ DL
Sbjct: 247 YEKIVSGKVRFPSHFSSDLKDL 268

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 28/236 (11%)
Query: 158 NFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++++  +IG+GSFG VY+  L D GE  AIK  K+ Q    K+   E   +  + H NI+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIV 76
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK-LSLMQRLNIVIDVA 275
           ++        Y   + K  V+  +    + + ++     Y   K+ L ++     +  + 
Sbjct: 77  RL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
            +L Y+H+     I H D+K  N+LLD +  +  + DFG AK L      P+ +   S  
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSRY 187
Query: 335 LKGSVGYIPPEYINGHVSILG--DIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV 388
            +       PE I G        D++S G +L E+  G+     +F  D  + + V
Sbjct: 188 YRA------PELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 233

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 110 FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 156
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 157 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 203
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 204 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 28/236 (11%)
Query: 158 NFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++++  +IG+GSFG VY+  L D GE  AIK  K+ Q    K+   E   +  + H NI+
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIV 80
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK-LSLMQRLNIVIDVA 275
           ++        Y   + K  V+  +    + + ++     Y   K+ L ++     +  + 
Sbjct: 81  RL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 136
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
            +L Y+H+     I H D+K  N+LLD +  +  + DFG AK L      P+ +   S  
Sbjct: 137 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSRY 191
Query: 335 LKGSVGYIPPEYINGHVSILG--DIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV 388
            +       PE I G        D++S G +L E+  G+     +F  D  + + V
Sbjct: 192 YRA------PELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 237

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPS--TDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 90  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKXQKLTDDHVQF----------LIYQILR 136
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE----------MTGYV 183
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 109 FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 155
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 156 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 202
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 203 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 86  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 132
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 133 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 179
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           IGSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 95  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 141
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 142 GLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE----------MTGYV 188
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 189 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 86  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 132
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 133 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MAGFV 179
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVL-------KLQQQGALKSFIDECNALTSIRHRNIL 216
           IGSGSFG +Y GT +A GE  AIK+        +L  +  +   +     + +IR     
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRW---- 72
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHF--KKLSLMQRLNIVIDV 274
                C +   EG D+  +V E          L PS ++  +F  +K SL   L +   +
Sbjct: 73  -----CGA---EG-DYNVMVMEL---------LGPSLEDLFNFCSRKFSLKTVLLLADQM 114
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
            S ++Y+H++      H D+K  N L+    +G + ++ DFGLAK   +           
Sbjct: 115 ISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 171
Query: 332 SNGLKGSVGYIPPEYINGHVSI----LGDIYSYGILLLEIFTGKRP 373
           +  L G+  Y     IN H+ I      D+ S G +L+    G  P
Sbjct: 172 NKNLTGTARYAS---INTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 28/236 (11%)
Query: 158 NFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++++  +IG+GSFG VY+  L D GE  AIK  K+ Q    K+   E   +  + H NI+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIV 88
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK-LSLMQRLNIVIDVA 275
           ++        Y   + K  V+  +    + + ++     Y   K+ L ++     +  + 
Sbjct: 89  RL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
            +L Y+H+     I H D+K  N+LLD +  +  + DFG AK L      P+ +   S  
Sbjct: 145 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSRY 199
Query: 335 LKGSVGYIPPEYINGHVSILG--DIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV 388
            +       PE I G        D++S G +L E+  G+     +F  D  + + V
Sbjct: 200 YRA------PELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 245

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVL-------KLQQQGALKSFIDECNALTSIRHRNIL 216
           IGSGSFG +Y GT +A GE  AIK+        +L  +  +   +     + +IR     
Sbjct: 15  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIR----- 69
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHF--KKLSLMQRLNIVIDV 274
                C +   EG D+  +V E          L PS ++  +F  +K SL   L +   +
Sbjct: 70  ----WCGA---EG-DYNVMVMEL---------LGPSLEDLFNFCSRKFSLKTVLLLADQM 112
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
            S ++Y+H++      H D+K  N L+    +G + ++ DFGLAK   +           
Sbjct: 113 ISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 169
Query: 332 SNGLKGSVGYIPPEYINGHVSI----LGDIYSYGILLLEIFTGKRP 373
           +  L G+  Y     IN H+ I      D+ S G +L+    G  P
Sbjct: 170 NKNLTGTARYAS---INTHLGIEQSRRDDLESLGYVLMYFNLGSLP 212

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTS-IRHRNILKIVSSC 222
           +G G++G V         E  A+K++ +++       I +   +   + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 72
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHP-----STDEYCHFKKLSLMQRLNIVIDVASA 277
                EGN  + L  E+   G L   + P       D    F +L             + 
Sbjct: 73  ---RREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------------MAG 116
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YLH      I H D+K  N+LLDE     + DFGLA  +F  +N     + + N + G
Sbjct: 117 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNN----RERLLNKMCG 168
Query: 338 SVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTD 375
           ++ Y+ PE +     H   + D++S GI+L  +  G+ P D
Sbjct: 169 TLPYVAPELLKRREFHAEPV-DVWSCGIVLTAMLAGELPWD 208

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTS-IRHRNILKIVSSC 222
           +G G++G V         E  A+K++ +++       I +   +   + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHP-----STDEYCHFKKLSLMQRLNIVIDVASA 277
                EGN  + L  E+   G L   + P       D    F +L             + 
Sbjct: 74  ---RREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------------MAG 117
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YLH      I H D+K  N+LLDE     + DFGLA  +F  +N     + + N + G
Sbjct: 118 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNN----RERLLNKMCG 169
Query: 338 SVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTD 375
           ++ Y+ PE +     H   + D++S GI+L  +  G+ P D
Sbjct: 170 TLPYVAPELLKRREFHAEPV-DVWSCGIVLTAMLAGELPWD 209

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 28/236 (11%)
Query: 158 NFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++++  +IG+GSFG VY+  L D GE  AIK  K+ Q    K+   E   +  + H NI+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIV 76
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK-LSLMQRLNIVIDVA 275
           ++        Y   + K  V+  +    + + ++     Y   K+ L ++     +  + 
Sbjct: 77  RL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
            +L Y+H+     I H D+K  N+LLD +  +  + DFG AK L      P+ +   S  
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRY 187
Query: 335 LKGSVGYIPPEYINGHVSILG--DIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV 388
            +       PE I G        D++S G +L E+  G+     +F  D  + + V
Sbjct: 188 YRA------PELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 233

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 28/236 (11%)
Query: 158 NFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++++  +IG+GSFG VY+  L D GE  AIK  K+ Q    K+   E   +  + H NI+
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIV 95
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK-LSLMQRLNIVIDVA 275
           ++        Y   + K  V+  +    + + ++     Y   K+ L ++     +  + 
Sbjct: 96  RL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 151
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
            +L Y+H+     I H D+K  N+LLD +  +  + DFG AK L      P+ +   S  
Sbjct: 152 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSRY 206
Query: 335 LKGSVGYIPPEYINGHVSILG--DIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV 388
            +       PE I G        D++S G +L E+  G+     +F  D  + + V
Sbjct: 207 YRA------PELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 252

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 28/236 (11%)
Query: 158 NFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++++  +IG+GSFG VY+  L D GE  AIK  K+ Q    K+   E   +  + H NI+
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIV 84
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK-LSLMQRLNIVIDVA 275
           ++        Y   + K  V+  +    + + ++     Y   K+ L ++     +  + 
Sbjct: 85  RL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 140
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
            +L Y+H+     I H D+K  N+LLD +  +  + DFG AK L      P+ +   S  
Sbjct: 141 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSRY 195
Query: 335 LKGSVGYIPPEYINGHVSILG--DIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV 388
            +       PE I G        D++S G +L E+  G+     +F  D  + + V
Sbjct: 196 YRA------PELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 241

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 96  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 142
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 143 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 189
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 28/236 (11%)
Query: 158 NFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++++  +IG+GSFG VY+  L D GE  AIK  K+ Q    K+   E   +  + H NI+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIV 88
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK-LSLMQRLNIVIDVA 275
           ++        Y   + K  V+  +    + + ++     Y   K+ L ++     +  + 
Sbjct: 89  RL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
            +L Y+H+     I H D+K  N+LLD +  +  + DFG AK L      P+ +   S  
Sbjct: 145 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSRY 199
Query: 335 LKGSVGYIPPEYINGHVSILG--DIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV 388
            +       PE I G        D++S G +L E+  G+     +F  D  + + V
Sbjct: 200 YRA------PELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 245

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 97  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 143
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 144 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----------MTGYV 190
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 116/278 (41%), Gaps = 37/278 (13%)
Query: 120 LAALVIYHIVKTSRRQSAPPSNEWQSGLSYLKISNATDNFSEENL--------IGSGSFG 171
           L +L      + SR +   P  E   G+   +     D    E +        +G GSFG
Sbjct: 29  LTSLAKTWAARGSRSREPSPKTEDNEGVLLTEKLKPVDYEYREEVHWATHQLRLGRGSFG 88
Query: 172 SVYKGTLADGETA---AIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYE 228
            V++  + D +T    A+K ++L+   A +  +  C  LTS R   +   V     V+  
Sbjct: 89  EVHR--MEDKQTGFQCAVKKVRLEVFRAEE--LMACAGLTSPRIVPLYGAVREGPWVN-- 142
Query: 229 GNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTP 288
                 +  E +  G+L Q +    ++ C    L   + L  +      L+YLH++    
Sbjct: 143 ------IFMELLEGGSLGQLV---KEQGC----LPEDRALYYLGQALEGLEYLHSRR--- 186
Query: 289 IAHCDLKSSNVLL-DEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI 347
           I H D+K+ NVLL  +G  A + DFG A  L  + +   K+    + + G+  ++ PE +
Sbjct: 187 ILHGDVKADNVLLSSDGSHAALCDFGHAVCL--QPDGLGKDLLTGDYIPGTETHMAPEVV 244
Query: 348 NGH-VSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSI 384
            G       D++S   ++L +  G  P    F+  L +
Sbjct: 245 LGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCL 282

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 97  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 143
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 144 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----------MTGYV 190
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 113/260 (43%), Gaps = 46/260 (17%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSF---IDECNALTSIRH 212
           D F     +G+GSFG V      + G   A+K+L  Q+   LK     ++E   L ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             ++K+  S     ++ N    +V E++  G +          + H +++      +   
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEM----------FSHLRRIGRFSEPHARF 145
Query: 273 DVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
             A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------KGR 194
Query: 330 TMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHK 386
           T    L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++
Sbjct: 195 TWX--LAGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYE 248
Query: 387 FVL---MALPSHV-MDVLDL 402
            ++   +  PSH   D+ DL
Sbjct: 249 KIVSGKVRFPSHFSSDLKDL 268

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 101 FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 147
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 148 GLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE----------MTGYV 194
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 195 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 113/260 (43%), Gaps = 46/260 (17%)
Query: 157 DNFSEENLIGSGSFGSVY-KGTLADGETAAIKVLKLQQQGALKSF---IDECNALTSIRH 212
           D F     +G+GSFG V     +  G   A+K+L  Q+   LK     ++E   L ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             ++K+  S     ++ N    +V E++  G +          + H +++      +   
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEM----------FSHLRRIGRFSEPHARF 145
Query: 273 DVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
             A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------KGR 194
Query: 330 TMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHK 386
           T    L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++
Sbjct: 195 TWX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYE 248
Query: 387 FVL---MALPSHV-MDVLDL 402
            ++   +  PSH   D+ DL
Sbjct: 249 KIVSGKVRFPSHFSSDLKDL 268

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 110 FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 156
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 157 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MXGXV 203
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 204 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 97  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 143
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 144 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----------MTGYV 190
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 113/260 (43%), Gaps = 46/260 (17%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSF---IDECNALTSIRH 212
           D F     +G+GSFG V      + G   A+K+L  Q+   LK     ++E   L ++  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             ++K+  S     ++ N    +V E++  G +          + H +++      +   
Sbjct: 88  PFLVKLEFS-----FKDNSNLYMVMEYVAGGEM----------FSHLRRIGRFSEPHARF 132
Query: 273 DVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
             A      +YLH+     + + DLK  N+L+DE     V DFG AK +        K +
Sbjct: 133 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRV--------KGR 181
Query: 330 TMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHK 386
           T    L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++
Sbjct: 182 TWX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYE 235
Query: 387 FVL---MALPSHV-MDVLDL 402
            ++   +  PSH   D+ DL
Sbjct: 236 KIVSGKVRFPSHFSSDLKDL 255

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 95  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 141
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 142 GLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE----------MTGYV 188
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 189 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 113/260 (43%), Gaps = 46/260 (17%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSF---IDECNALTSIRH 212
           D F     +G+GSFG V      + G   A+K+L  Q+   LK     ++E   L ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             ++K+  S     ++ N    +V E++  G +          + H +++      +   
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEM----------FSHLRRIGRFSEPHARF 145
Query: 273 DVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
             A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------KGR 194
Query: 330 TMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHK 386
           T    L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++
Sbjct: 195 TWX--LXGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYE 248
Query: 387 FVL---MALPSHV-MDVLDL 402
            ++   +  PSH   D+ DL
Sbjct: 249 KIVSGKVRFPSHFSSDLKDL 268

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 28/236 (11%)
Query: 158 NFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++++  +IG+GSFG VY+  L D GE  AIK  K+ Q    K+   E   +  + H NI+
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIV 89
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK-LSLMQRLNIVIDVA 275
           ++        Y   + K  V+  +    + + ++     Y   K+ L ++     +  + 
Sbjct: 90  RL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 145
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
            +L Y+H+     I H D+K  N+LLD +  +  + DFG AK L      P+ +   S  
Sbjct: 146 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRY 200
Query: 335 LKGSVGYIPPEYINGHVSILG--DIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV 388
            +       PE I G        D++S G +L E+  G+     +F  D  + + V
Sbjct: 201 YRA------PELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 246

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPS--TDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 90  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKXQKLTDDHVQF----------LIYQILR 136
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 183
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 116/278 (41%), Gaps = 37/278 (13%)
Query: 120 LAALVIYHIVKTSRRQSAPPSNEWQSGLSYLKISNATDNFSEENL--------IGSGSFG 171
           L +L      + SR +   P  E   G+   +     D    E +        +G GSFG
Sbjct: 48  LTSLAKTWAARGSRSREPSPKTEDNEGVLLTEKLKPVDYEYREEVHWATHQLRLGRGSFG 107
Query: 172 SVYKGTLADGETA---AIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYE 228
            V++  + D +T    A+K ++L+   A +  +  C  LTS R   +   V     V+  
Sbjct: 108 EVHR--MEDKQTGFQCAVKKVRLEVFRAEE--LMACAGLTSPRIVPLYGAVREGPWVN-- 161
Query: 229 GNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTP 288
                 +  E +  G+L Q +    ++ C    L   + L  +      L+YLH++    
Sbjct: 162 ------IFMELLEGGSLGQLV---KEQGC----LPEDRALYYLGQALEGLEYLHSRR--- 205
Query: 289 IAHCDLKSSNVLL-DEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI 347
           I H D+K+ NVLL  +G  A + DFG A  L  + +   K+    + + G+  ++ PE +
Sbjct: 206 ILHGDVKADNVLLSSDGSHAALCDFGHAVCL--QPDGLGKSLLTGDYIPGTETHMAPEVV 263
Query: 348 NGH-VSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSI 384
            G       D++S   ++L +  G  P    F+  L +
Sbjct: 264 LGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCL 301

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 28/236 (11%)
Query: 158 NFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++++  +IG+GSFG VY+  L D GE  AIK  K+ Q    K+   E   +  + H NI+
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIV 81
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK-LSLMQRLNIVIDVA 275
           ++        Y   + K  V+  +    + + ++     Y   K+ L ++     +  + 
Sbjct: 82  RL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 137
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
            +L Y+H+     I H D+K  N+LLD +  +  + DFG AK L      P+ +   S  
Sbjct: 138 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRY 192
Query: 335 LKGSVGYIPPEYINGHVSILG--DIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV 388
            +       PE I G        D++S G +L E+  G+     +F  D  + + V
Sbjct: 193 YRA------PELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 238

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 90  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 136
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 183
Query: 337 GSVGYIPPE-YING-HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE  +N  H +   DI+S G ++ E+ TG+
Sbjct: 184 ATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 90  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 136
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 183
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 28/236 (11%)
Query: 158 NFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++++  +IG+GSFG VY+  L D GE  AIK  K+ Q    K+   E   +  + H NI+
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIV 110
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK-LSLMQRLNIVIDVA 275
           ++        Y   + K  V+  +    + + ++     Y   K+ L ++     +  + 
Sbjct: 111 RL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
            +L Y+H+     I H D+K  N+LLD +  +  + DFG AK L      P+ +   S  
Sbjct: 167 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSRY 221
Query: 335 LKGSVGYIPPEYINGHVSILG--DIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV 388
            +       PE I G        D++S G +L E+  G+     +F  D  + + V
Sbjct: 222 YRA------PELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 267

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 90  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 136
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGXV 183
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 90  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 136
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 183
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 23/162 (14%)
Query: 153 SNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSI- 210
           S  T  F E   IGSG FGSV+K     DG   AIK    + +  L   +DE NAL  + 
Sbjct: 3   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVY 58
Query: 211 ------RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSL 264
                 +H ++++  S+ +      +D   +  E+   G+L   +  +     +FK+  L
Sbjct: 59  AHAVLGQHSHVVRYFSAWAE-----DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 113
Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI 306
               ++++ V   L Y+H+     + H D+K SN+ +    I
Sbjct: 114 K---DLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSI 149

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 100/224 (44%), Gaps = 41/224 (18%)
Query: 164 LIGSGSFGSVY---KGTLAD-GETAAIKVLK----LQQQGALKSFIDECNALTSIRHRNI 215
           ++G G +G V+   K T A+ G+  A+KVLK    ++          E N L  ++H  I
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPS----TDEYCHFKKLSLMQRLNIV 271
           + ++ +     ++      L+ E++  G L   L        D  C +           +
Sbjct: 84  VDLIYA-----FQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY-----------L 127
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
            +++ AL +LH +    I + DLK  N++L+      + DFGL K    +        T+
Sbjct: 128 AEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG-------TV 177
Query: 332 SNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRP 373
           ++   G++ Y+ PE +  +GH   + D +S G L+ ++ TG  P
Sbjct: 178 THTFCGTIEYMAPEILMRSGHNRAV-DWWSLGALMYDMLTGAPP 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 90  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 136
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 183
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 90  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 136
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 183
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 108/259 (41%), Gaps = 44/259 (16%)
Query: 157 DNFSEENLIGSGSFGSVY-KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D F     +G+GSFG V     +  G   A+K+L  Q+   LK      N       + I
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN------EKRI 95
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNIVID 273
           L+ V+       E        F F  N NL   +   P  + + H +++      +    
Sbjct: 96  LQAVNFPFLTKLE--------FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY 147
Query: 274 VAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
            A      +YLH+     + + DLK  N+++D+     V DFG AK +        K +T
Sbjct: 148 AAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV--------KGRT 196
Query: 331 MSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHKF 387
               L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++ 
Sbjct: 197 WX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYEK 250
Query: 388 VL---MALPSHV-MDVLDL 402
           ++   +  PSH   D+ DL
Sbjct: 251 IVSGKVRFPSHFSSDLKDL 269

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 90  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 136
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 183
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 114/260 (43%), Gaps = 46/260 (17%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSF---IDECNALTSIRH 212
           D F     +G+GSFG V      + G   A+K+L  Q+   LK     ++E   L ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             ++K+  S     ++ N    +V E++  G +          + H +++      +   
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEM----------FSHLRRIGRFSEPHARF 145
Query: 273 DVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
             A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------KGR 194
Query: 330 TMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHK 386
           T    L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D+ + I++
Sbjct: 195 TWX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADEPIQIYE 248
Query: 387 FVL---MALPSHV-MDVLDL 402
            ++   +  PSH   D+ DL
Sbjct: 249 KIVSGKVRFPSHFSSDLKDL 268

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 108/259 (41%), Gaps = 44/259 (16%)
Query: 157 DNFSEENLIGSGSFGSVY-KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D F     +G+GSFG V     +  G   A+K+L  Q+   LK      N       + I
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN------EKRI 95
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNIVID 273
           L+ V+       E        F F  N NL   +   P  + + H +++      +    
Sbjct: 96  LQAVNFPFLTKLE--------FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY 147
Query: 274 VAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
            A      +YLH+     + + DLK  N+++D+     V DFG AK +        K +T
Sbjct: 148 AAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV--------KGRT 196
Query: 331 MSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHKF 387
               L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++ 
Sbjct: 197 WX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYEK 250
Query: 388 VL---MALPSHV-MDVLDL 402
           ++   +  PSH   D+ DL
Sbjct: 251 IVSGKVRFPSHFSSDLKDL 269

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 102 FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 148
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 149 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 195
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 196 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 12/99 (12%)
Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSV 339
           YLH      I H D+K  N+LLDE     + DFGLA  +F  +N     + + N + G++
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNN----RERLLNKMCGTL 170
Query: 340 GYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTD 375
            Y+ PE +     H   + D++S GI+L  +  G+ P D
Sbjct: 171 PYVAPELLKRREFHAEPV-DVWSCGIVLTAMLAGELPWD 208

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 100/224 (44%), Gaps = 41/224 (18%)
Query: 164 LIGSGSFGSVY---KGTLAD-GETAAIKVLK----LQQQGALKSFIDECNALTSIRHRNI 215
           ++G G +G V+   K T A+ G+  A+KVLK    ++          E N L  ++H  I
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPS----TDEYCHFKKLSLMQRLNIV 271
           + ++ +     ++      L+ E++  G L   L        D  C +           +
Sbjct: 84  VDLIYA-----FQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY-----------L 127
Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
            +++ AL +LH +    I + DLK  N++L+      + DFGL K    +        T+
Sbjct: 128 AEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG-------TV 177
Query: 332 SNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRP 373
           ++   G++ Y+ PE +  +GH   + D +S G L+ ++ TG  P
Sbjct: 178 THXFCGTIEYMAPEILMRSGHNRAV-DWWSLGALMYDMLTGAPP 220

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 102 FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 148
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 149 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 195
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 196 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 90  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 136
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 183
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 108/259 (41%), Gaps = 44/259 (16%)
Query: 157 DNFSEENLIGSGSFGSVY-KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D F     +G+GSFG V     +  G   A+K+L  Q+   LK      N       + I
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN------EKRI 95
Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNIVID 273
           L+ V+       E        F F  N NL   +   P  + + H +++      +    
Sbjct: 96  LQAVNFPFLTKLE--------FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFY 147
Query: 274 VAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
            A      +YLH+     + + DLK  N+++D+     V DFG AK +        K +T
Sbjct: 148 AAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV--------KGRT 196
Query: 331 MSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHKF 387
               L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++ 
Sbjct: 197 WX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYEK 250
Query: 388 VL---MALPSHV-MDVLDL 402
           ++   +  PSH   D+ DL
Sbjct: 251 IVSGKVRFPSHFSSDLKDL 269

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 23/162 (14%)
Query: 153 SNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSI- 210
           S  T  F E   IGSG FGSV+K     DG   AIK    + +  L   +DE NAL  + 
Sbjct: 7   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVY 62
Query: 211 ------RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSL 264
                 +H ++++  S+ +      +D   +  E+   G+L   +  +     +FK+  L
Sbjct: 63  AHAVLGQHSHVVRYFSAWAE-----DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 117
Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI 306
               ++++ V   L Y+H+     + H D+K SN+ +    I
Sbjct: 118 K---DLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSI 153

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 23/162 (14%)
Query: 153 SNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSI- 210
           S  T  F E   IGSG FGSV+K     DG   AIK    + +  L   +DE NAL  + 
Sbjct: 5   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVY 60
Query: 211 ------RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSL 264
                 +H ++++  S+ +      +D   +  E+   G+L   +  +     +FK+  L
Sbjct: 61  AHAVLGQHSHVVRYFSAWAE-----DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 115
Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI 306
               ++++ V   L Y+H+     + H D+K SN+ +    I
Sbjct: 116 K---DLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSI 151

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 23/162 (14%)
Query: 153 SNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSI- 210
           S  T  F E   IGSG FGSV+K     DG   AIK    + +  L   +DE NAL  + 
Sbjct: 5   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVY 60
Query: 211 ------RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSL 264
                 +H ++++  S+ +      +D   +  E+   G+L   +  +     +FK+  L
Sbjct: 61  AHAVLGQHSHVVRYFSAWAE-----DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 115
Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI 306
               ++++ V   L Y+H+     + H D+K SN+ +    I
Sbjct: 116 K---DLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSI 151

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 95  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 141
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 142 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 188
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 189 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 53/105 (50%), Gaps = 13/105 (12%)
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
           +++ AL+YLH +    I + DLK  NVLLD EG I  + D+G+ K      +T S     
Sbjct: 129 EISLALNYLHER---GIIYRDLKLDNVLLDSEGHIK-LTDYGMCKEGLRPGDTTSX---- 180
Query: 332 SNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRPTD 375
                G+  YI PE + G       D ++ G+L+ E+  G+ P D
Sbjct: 181 ---FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 87  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 133
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 134 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 180
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 181 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 89  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 135
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 136 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 182
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 183 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 97  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 143
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 144 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 190
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 44/221 (19%)
Query: 165 IGSGSFGSV---YKGTLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---L 216
           +GSG++GSV   Y   L   +  A+K L    Q  +  +    E   L  ++H N+   L
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 217 KIVSSCSSVDYEGNDFKA--LVFEFMRNGNLDQWLHPS--TDEYCHFKKLSLMQRLNIVI 272
            + +  +S++    DF    LV   M   +L+  +     +DE+  F          +V 
Sbjct: 94  DVFTPATSIE----DFSEVYLVTTLM-GADLNNIVKSQALSDEHVQF----------LVY 138
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            +   L Y+H+     I H DLK SNV ++E     + DFGLA+   EE           
Sbjct: 139 QLLRGLKYIHS---AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE----------M 185
Query: 333 NGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            G   +  Y  PE +    H +   DI+S G ++ E+  GK
Sbjct: 186 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 96  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 142
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 143 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 189
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 92  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 138
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 139 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 185
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 186 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 92  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 138
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 139 GLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE----------MTGYV 185
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 186 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 87  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 133
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 134 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 180
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 181 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 90/233 (38%), Gaps = 34/233 (14%)
Query: 159 FSEENLIGSGSFGSVYKG--TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++  + IG G++G V      L     A  K+   + Q   +  + E   L   RH NI+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNG--NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
            I     +   E      +V + M      L +  H S D  C+F           +  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----------LYQI 137
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT-MSN 333
              L Y+H+     + H DLK SN+LL+      + DFGLA+        P  + T    
Sbjct: 138 LRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVA-----DPDHDHTGFLT 189
Query: 334 GLKGSVGYIPPEYI---NGHVSILGDIYSYGILLLE------IFTGKRPTDDM 377
               +  Y  PE +    G+   + DI+S G +L E      IF GK   D +
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQL 241

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 101 FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 147
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 148 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 194
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 195 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 92  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 138
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 139 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 185
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 186 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 28/236 (11%)
Query: 158 NFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++++  +IG+GSFG VY+  L D GE  AIK  K+ Q    K+   E   +  + H NI+
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIV 110
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK-LSLMQRLNIVIDVA 275
           ++        Y   + K  V+  +    + + ++     Y   K+ L ++     +  + 
Sbjct: 111 RL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
            +L Y+H+     I H D+K  N+LLD +  +  + DFG AK L      P+ +   S  
Sbjct: 167 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRY 221
Query: 335 LKGSVGYIPPEYINGHVSILG--DIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV 388
            +       PE I G        D++S G +L E+  G+     +F  D  + + V
Sbjct: 222 YRA------PELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 267

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 95  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 141
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 142 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 188
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 189 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 92  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 138
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 139 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 185
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 186 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 110 FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 156
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 157 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 203
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 204 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 44/221 (19%)
Query: 165 IGSGSFGSV---YKGTLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---L 216
           +GSG++GSV   Y   L   +  A+K L    Q  +  +    E   L  ++H N+   L
Sbjct: 28  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 217 KIVSSCSSVDYEGNDFKA--LVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVI 272
            + +  +S++    DF    LV   M   +L+  +     +DE+  F          +V 
Sbjct: 86  DVFTPATSIE----DFSEVYLVTTLM-GADLNNIVKCQALSDEHVQF----------LVY 130
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            +   L Y+H+     I H DLK SNV ++E     + DFGLA+   EE           
Sbjct: 131 QLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADEE----------M 177
Query: 333 NGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            G   +  Y  PE +    H +   DI+S G ++ E+  GK
Sbjct: 178 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 86  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 132
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 133 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 179
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 90/233 (38%), Gaps = 34/233 (14%)
Query: 159 FSEENLIGSGSFGSVYKG--TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++  + IG G++G V      L     A  K+   + Q   +  + E   L   RH NI+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNG--NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
            I     +   E      +V + M      L +  H S D  C+F           +  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYF-----------LYQI 137
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT-MSN 333
              L Y+H+     + H DLK SN+LL+      + DFGLA+        P  + T    
Sbjct: 138 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-----DPDHDHTGFLT 189
Query: 334 GLKGSVGYIPPEYI---NGHVSILGDIYSYGILLLE------IFTGKRPTDDM 377
               +  Y  PE +    G+   + DI+S G +L E      IF GK   D +
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQL 241

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 113 FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 159
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 160 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 206
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 207 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 96  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 142
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 143 GLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE----------MTGYV 189
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 90  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 136
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 183
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 109 FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 155
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 156 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 202
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 203 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 102 FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 148
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 149 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 195
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 196 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 88  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 134
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 135 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 181
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 182 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 28/236 (11%)
Query: 158 NFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++++  +IG+GSFG VY+  L D GE  AIK  K+ Q    K+   E   +  + H NI+
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIV 104
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK-LSLMQRLNIVIDVA 275
           ++        Y   + K  V+  +    + + ++     Y   K+ L ++     +  + 
Sbjct: 105 RL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 160
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
            +L Y+H+     I H D+K  N+LLD +  +  + DFG AK L      P+ +   S  
Sbjct: 161 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRY 215
Query: 335 LKGSVGYIPPEYINGHVSILG--DIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV 388
            +       PE I G        D++S G +L E+  G+     +F  D  + + V
Sbjct: 216 YRA------PELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 261

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 28/236 (11%)
Query: 158 NFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++++  +IG+GSFG VY+  L D GE  AIK  K+ Q    K+   E   +  + H NI+
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIV 112
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK-LSLMQRLNIVIDVA 275
           ++        Y   + K  V+  +    + + ++     Y   K+ L ++     +  + 
Sbjct: 113 RL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 168
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
            +L Y+H+     I H D+K  N+LLD +  +  + DFG AK L      P+ +   S  
Sbjct: 169 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRY 223
Query: 335 LKGSVGYIPPEYINGHVSILG--DIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV 388
            +       PE I G        D++S G +L E+  G+     +F  D  + + V
Sbjct: 224 YRA------PELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 269

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 113/260 (43%), Gaps = 46/260 (17%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSF---IDECNALTSIRH 212
           D F     +G+GSFG V      + G   A+K+L  Q+   LK     ++E   L ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             ++K+  S     ++ N    +V E++  G +          + H +++      +   
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEM----------FSHLRRIGRFSEPHARF 145
Query: 273 DVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
             A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------KGR 194
Query: 330 TMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHK 386
           T    L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++
Sbjct: 195 TWX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYE 248
Query: 387 FVL---MALPSHV-MDVLDL 402
            ++   +  PSH   D+ DL
Sbjct: 249 KIVSGKVRFPSHFSSDLKDL 268

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 53/105 (50%), Gaps = 13/105 (12%)
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
           +++ AL+YLH +    I + DLK  NVLLD EG I  + D+G+ K      +T S     
Sbjct: 161 EISLALNYLHER---GIIYRDLKLDNVLLDSEGHIK-LTDYGMCKEGLRPGDTTST---- 212
Query: 332 SNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRPTD 375
                G+  YI PE + G       D ++ G+L+ E+  G+ P D
Sbjct: 213 ---FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 90/233 (38%), Gaps = 34/233 (14%)
Query: 159 FSEENLIGSGSFGSVYKG--TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++  + IG G++G V      L     A  K+   + Q   +  + E   L   RH NI+
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNG--NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
            I     +   E      +V + M      L +  H S D  C+F           +  +
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----------LYQI 131
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT-MSN 333
              L Y+H+     + H DLK SN+LL+      + DFGLA+        P  + T    
Sbjct: 132 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-----DPDHDHTGFLT 183
Query: 334 GLKGSVGYIPPEYI---NGHVSILGDIYSYGILLLE------IFTGKRPTDDM 377
               +  Y  PE +    G+   + DI+S G +L E      IF GK   D +
Sbjct: 184 EYVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQL 235

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 96  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 142
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 143 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYV 189
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 90/233 (38%), Gaps = 34/233 (14%)
Query: 159 FSEENLIGSGSFGSVYKG--TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++  + IG G++G V      L     A  K+   + Q   +  + E   L   RH NI+
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNG--NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
            I     +   E      +V + M      L +  H S D  C+F           +  +
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----------LYQI 131
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT-MSN 333
              L Y+H+     + H DLK SN+LL+      + DFGLA+        P  + T    
Sbjct: 132 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-----DPDHDHTGFLT 183
Query: 334 GLKGSVGYIPPEYI---NGHVSILGDIYSYGILLLE------IFTGKRPTDDM 377
               +  Y  PE +    G+   + DI+S G +L E      IF GK   D +
Sbjct: 184 EYVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQL 235

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 28/236 (11%)
Query: 158 NFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++++  +IG+GSFG VY+  L D GE  AIK  K+ Q    K+   E   +  + H NI+
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIV 114
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK-LSLMQRLNIVIDVA 275
           ++        Y   + K  V+  +    + + ++     Y   K+ L ++     +  + 
Sbjct: 115 RL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 170
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
            +L Y+H+     I H D+K  N+LLD +  +  + DFG AK L      P+ +   S  
Sbjct: 171 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRY 225
Query: 335 LKGSVGYIPPEYINGHVSILG--DIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV 388
            +       PE I G        D++S G +L E+  G+     +F  D  + + V
Sbjct: 226 YRA------PELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 271

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 28/236 (11%)
Query: 158 NFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++++  +IG+GSFG VY+  L D GE  AIK  K+ Q    K+   E   +  + H NI+
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIV 155
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK-LSLMQRLNIVIDVA 275
           ++        Y   + K  V+  +    + + ++     Y   K+ L ++     +  + 
Sbjct: 156 RL----RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 211
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
            +L Y+H+     I H D+K  N+LLD +  +  + DFG AK L      P+ +   S  
Sbjct: 212 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRY 266
Query: 335 LKGSVGYIPPEYINGHVSILG--DIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV 388
            +       PE I G        D++S G +L E+  G+     +F  D  + + V
Sbjct: 267 YRA------PELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 312

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 90/233 (38%), Gaps = 34/233 (14%)
Query: 159 FSEENLIGSGSFGSVYKG--TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++  + IG G++G V      L     A  K+   + Q   +  + E   L   RH NI+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNG--NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
            I     +   E      +V + M      L +  H S D  C+F           +  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----------LYQI 137
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT-MSN 333
              L Y+H+     + H DLK SN+LL+      + DFGLA+        P  + T    
Sbjct: 138 LRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVA-----DPDHDHTGFLT 189
Query: 334 GLKGSVGYIPPEYI---NGHVSILGDIYSYGILLLE------IFTGKRPTDDM 377
               +  Y  PE +    G+   + DI+S G +L E      IF GK   D +
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQL 241

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 90/233 (38%), Gaps = 34/233 (14%)
Query: 159 FSEENLIGSGSFGSVYKG--TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++  + IG G++G V      L     A  K+   + Q   +  + E   L   RH NI+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNG--NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
            I     +   E      +V + M      L +  H S D  C+F           +  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----------LYQI 137
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT-MSN 333
              L Y+H+     + H DLK SN+LL+      + DFGLA+        P  + T    
Sbjct: 138 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-----DPDHDHTGFLT 189
Query: 334 GLKGSVGYIPPEYI---NGHVSILGDIYSYGILLLE------IFTGKRPTDDM 377
               +  Y  PE +    G+   + DI+S G +L E      IF GK   D +
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQL 241

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 53/105 (50%), Gaps = 13/105 (12%)
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
           +++ AL+YLH +    I + DLK  NVLLD EG I  + D+G+ K      +T S     
Sbjct: 114 EISLALNYLHER---GIIYRDLKLDNVLLDSEGHIK-LTDYGMCKEGLRPGDTTSX---- 165
Query: 332 SNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRPTD 375
                G+  YI PE + G       D ++ G+L+ E+  G+ P D
Sbjct: 166 ---FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 90/233 (38%), Gaps = 34/233 (14%)
Query: 159 FSEENLIGSGSFGSVYKG--TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++  + IG G++G V      L     A  K+   + Q   +  + E   L   RH NI+
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNG--NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
            I     +   E      +V + M      L +  H S D  C+F           +  +
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----------LYQI 138
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT-MSN 333
              L Y+H+     + H DLK SN+LL+      + DFGLA+        P  + T    
Sbjct: 139 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-----DPDHDHTGFLT 190
Query: 334 GLKGSVGYIPPEYI---NGHVSILGDIYSYGILLLE------IFTGKRPTDDM 377
               +  Y  PE +    G+   + DI+S G +L E      IF GK   D +
Sbjct: 191 EYVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQL 242

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 90/233 (38%), Gaps = 34/233 (14%)
Query: 159 FSEENLIGSGSFGSVYKG--TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++  + IG G++G V      L     A  K+   + Q   +  + E   L   RH NI+
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 90
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNG--NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
            I     +   E      +V + M      L +  H S D  C+F           +  +
Sbjct: 91  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----------LYQI 139
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT-MSN 333
              L Y+H+     + H DLK SN+LL+      + DFGLA+        P  + T    
Sbjct: 140 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-----DPDHDHTGFLT 191
Query: 334 GLKGSVGYIPPEYI---NGHVSILGDIYSYGILLLE------IFTGKRPTDDM 377
               +  Y  PE +    G+   + DI+S G +L E      IF GK   D +
Sbjct: 192 EYVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQL 243

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 90/233 (38%), Gaps = 34/233 (14%)
Query: 159 FSEENLIGSGSFGSVYKG--TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++  + IG G++G V      L     A  K+   + Q   +  + E   L   RH NI+
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 81
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNG--NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
            I     +   E      +V + M      L +  H S D  C+F           +  +
Sbjct: 82  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----------LYQI 130
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT-MSN 333
              L Y+H+     + H DLK SN+LL+      + DFGLA+        P  + T    
Sbjct: 131 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-----DPDHDHTGFLT 182
Query: 334 GLKGSVGYIPPEYI---NGHVSILGDIYSYGILLLE------IFTGKRPTDDM 377
               +  Y  PE +    G+   + DI+S G +L E      IF GK   D +
Sbjct: 183 EYVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQL 234

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 90/233 (38%), Gaps = 34/233 (14%)
Query: 159 FSEENLIGSGSFGSVYKG--TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++  + IG G++G V      L     A  K+   + Q   +  + E   L   RH NI+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNG--NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
            I     +   E      +V + M      L +  H S D  C+F           +  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----------LYQI 137
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT-MSN 333
              L Y+H+     + H DLK SN+LL+      + DFGLA+        P  + T    
Sbjct: 138 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-----DPDHDHTGFLT 189
Query: 334 GLKGSVGYIPPEYI---NGHVSILGDIYSYGILLLE------IFTGKRPTDDM 377
               +  Y  PE +    G+   + DI+S G +L E      IF GK   D +
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQL 241

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 113/260 (43%), Gaps = 46/260 (17%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSF---IDECNALTSIRH 212
           D F     +G+GSFG V      + G   A+K+L  Q+   LK     ++E   L ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             ++K+  S     ++ N    +V E++  G +          + H +++      +   
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEM----------FSHLRRIGRFXEPHARF 145
Query: 273 DVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
             A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------KGR 194
Query: 330 TMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHK 386
           T    L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++
Sbjct: 195 TWX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYE 248
Query: 387 FVL---MALPSHV-MDVLDL 402
            ++   +  PSH   D+ DL
Sbjct: 249 KIVSGKVRFPSHFSSDLKDL 268

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 113/260 (43%), Gaps = 46/260 (17%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSF---IDECNALTSIRH 212
           D F     +G+GSFG V      + G   A+K+L  Q+   LK     ++E   L ++  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             ++K+  S     ++ N    +V E++  G +          + H +++      +   
Sbjct: 96  PFLVKLEFS-----FKDNSNLYMVMEYVAGGEM----------FSHLRRIGRFXEPHARF 140
Query: 273 DVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
             A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K +
Sbjct: 141 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------KGR 189
Query: 330 TMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHK 386
           T    L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++
Sbjct: 190 TWX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYE 243
Query: 387 FVL---MALPSHV-MDVLDL 402
            ++   +  PSH   D+ DL
Sbjct: 244 KIVSGKVRFPSHFSSDLKDL 263

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 44/221 (19%)
Query: 165 IGSGSFGSV---YKGTLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---L 216
           +GSG++GSV   Y   L   +  A+K L    Q  +  +    E   L  ++H N+   L
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 217 KIVSSCSSVDYEGNDFKA--LVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVI 272
            + +  +S++    DF    LV   M   +L+  +     +DE+  F          +V 
Sbjct: 94  DVFTPATSIE----DFSEVYLVTTLM-GADLNNIVKCQALSDEHVQF----------LVY 138
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            +   L Y+H+     I H DLK SNV ++E     + DFGLA+   EE           
Sbjct: 139 QLLRGLKYIHS---AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE----------M 185
Query: 333 NGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            G   +  Y  PE +    H +   DI+S G ++ E+  GK
Sbjct: 186 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 100/229 (43%), Gaps = 18/229 (7%)
Query: 165 IGSGSFGSV-YKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           +G G F  V     L DG   A+K +   +Q   +    E +      H NIL++V+ C 
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC- 95
Query: 224 SVDYEGNDFKA-LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
            +   G   +A L+  F + G L   +    D+      L+  Q L +++ +   L+ +H
Sbjct: 96  -LRERGAKHEAWLLLPFFKRGTLWNEIERLKDK---GNFLTEDQILWLLLGICRGLEAIH 151
Query: 283 NQYDTPIAHCDLKSSNVLL-DEG--MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSV 339
            +     AH DLK +N+LL DEG  ++  +G    A    E S      Q  +   + ++
Sbjct: 152 AK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA-AQRCTI 207
Query: 340 GYIPPEY--INGHVSI--LGDIYSYGILLLEIFTGKRPTDDMFKDDLSI 384
            Y  PE   +  H  I    D++S G +L  +  G+ P D +F+   S+
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 113/260 (43%), Gaps = 46/260 (17%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSF---IDECNALTSIRH 212
           D F     +G+GSFG V      + G   A+K+L  Q+   LK     ++E   L ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             ++K+  S     ++ N    +V E++  G +          + H +++      +   
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEM----------FSHLRRIGRFSEPHARF 145
Query: 273 DVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
             A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------KGR 194
Query: 330 TMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHK 386
           T    L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++
Sbjct: 195 TWX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYE 248
Query: 387 FVL---MALPSHV-MDVLDL 402
            ++   +  PSH   D+ DL
Sbjct: 249 KIVSGKVRFPSHFSSDLKDL 268

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 113/260 (43%), Gaps = 46/260 (17%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSF---IDECNALTSIRH 212
           D F     +G+GSFG V      + G   A+K+L  Q+   LK     ++E   L ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             ++K+  S     ++ N    +V E++  G +          + H +++      +   
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEM----------FSHLRRIGRFSEPHARF 145
Query: 273 DVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
             A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------KGR 194
Query: 330 TMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHK 386
           T    L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++
Sbjct: 195 TWX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYE 248
Query: 387 FVL---MALPSHV-MDVLDL 402
            ++   +  PSH   D+ DL
Sbjct: 249 KIVSGKVRFPSHFSSDLKDL 268

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 113/260 (43%), Gaps = 46/260 (17%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSF---IDECNALTSIRH 212
           D F     +G+GSFG V      + G   A+K+L  Q+   LK     ++E   L ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             ++K+  S     ++ N    +V E++  G +          + H +++      +   
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEM----------FSHLRRIGRFXEPHARF 145
Query: 273 DVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
             A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------KGR 194
Query: 330 TMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHK 386
           T    L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++
Sbjct: 195 TWX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYE 248
Query: 387 FVL---MALPSHV-MDVLDL 402
            ++   +  PSH   D+ DL
Sbjct: 249 KIVSGKVRFPSHFSSDLKDL 268

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 113/260 (43%), Gaps = 46/260 (17%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSF---IDECNALTSIRH 212
           D F     +G+GSFG V      + G   A+K+L  Q+   LK     ++E   L ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             ++K+  S     ++ N    +V E++  G +          + H +++      +   
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEM----------FSHLRRIGRFSEPHARF 145
Query: 273 DVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
             A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------KGR 194
Query: 330 TMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHK 386
           T    L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++
Sbjct: 195 TWX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYE 248
Query: 387 FVL---MALPSHV-MDVLDL 402
            ++   +  PSH   D+ DL
Sbjct: 249 KIVSGKVRFPSHFSSDLKDL 268

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 113/260 (43%), Gaps = 46/260 (17%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSF---IDECNALTSIRH 212
           D F     +G+GSFG V      + G   A+K+L  Q+   LK     ++E   L ++  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             ++K+  S     ++ N    +V E++  G +          + H +++      +   
Sbjct: 102 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEM----------FSHLRRIGRFSEPHARF 146
Query: 273 DVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
             A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K +
Sbjct: 147 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------KGR 195
Query: 330 TMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHK 386
           T    L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++
Sbjct: 196 TWX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYE 249
Query: 387 FVL---MALPSHV-MDVLDL 402
            ++   +  PSH   D+ DL
Sbjct: 250 KIVSGKVRFPSHFSSDLKDL 269

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 113 FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 159
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E            G  
Sbjct: 160 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MXGYV 206
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 207 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 53/105 (50%), Gaps = 13/105 (12%)
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
           +++ AL+YLH +    I + DLK  NVLLD EG I  + D+G+ K      +T S     
Sbjct: 118 EISLALNYLHER---GIIYRDLKLDNVLLDSEGHIK-LTDYGMCKEGLRPGDTTSX---- 169
Query: 332 SNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRPTD 375
                G+  YI PE + G       D ++ G+L+ E+  G+ P D
Sbjct: 170 ---FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 113/260 (43%), Gaps = 46/260 (17%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSF---IDECNALTSIRH 212
           D F     +G+GSFG V      + G   A+K+L  Q+   LK     ++E   L ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             ++K+  S     ++ N    +V E++  G +          + H +++      +   
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEM----------FSHLRRIGRFXEPHARF 145
Query: 273 DVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
             A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------KGR 194
Query: 330 TMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHK 386
           T    L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++
Sbjct: 195 TWX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYE 248
Query: 387 FVL---MALPSHV-MDVLDL 402
            ++   +  PSH   D+ DL
Sbjct: 249 KIVSGKVRFPSHFSSDLKDL 268

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 113/260 (43%), Gaps = 46/260 (17%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSF---IDECNALTSIRH 212
           D F     +G+GSFG V      + G   A+K+L  Q+   LK     ++E   L ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             ++K+  S     ++ N    +V E++  G +          + H +++      +   
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEM----------FSHLRRIGRFAEPHARF 145
Query: 273 DVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
             A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------KGR 194
Query: 330 TMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHK 386
           T    L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++
Sbjct: 195 TWX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYE 248
Query: 387 FVL---MALPSHV-MDVLDL 402
            ++   +  PSH   D+ DL
Sbjct: 249 KIVSGKVRFPSHFSSDLKDL 268

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 113/260 (43%), Gaps = 46/260 (17%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSF---IDECNALTSIRH 212
           D F     +G+GSFG V      + G   A+K+L  Q+   LK     ++E   L ++  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             ++K+  S     ++ N    +V E++  G +          + H +++      +   
Sbjct: 122 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEM----------FSHLRRIGRFSEPHARF 166
Query: 273 DVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
             A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K  
Sbjct: 167 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------KGA 215
Query: 330 TMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHK 386
           T +  L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++
Sbjct: 216 TWT--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYE 269
Query: 387 FVL---MALPSHV-MDVLDL 402
            ++   +  PSH   D+ DL
Sbjct: 270 KIVSGKVRFPSHFSSDLKDL 289

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 90/233 (38%), Gaps = 34/233 (14%)
Query: 159 FSEENLIGSGSFGSVYKG--TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++  + IG G++G V      L     A  K+   + Q   +  + E   L   RH NI+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNG--NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
            I     +   E      +V + M      L +  H S D  C+F           +  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----------LYQI 137
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT-MSN 333
              L Y+H+     + H DLK SN+LL+      + DFGLA+        P  + T    
Sbjct: 138 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-----DPDHDHTGFLX 189
Query: 334 GLKGSVGYIPPEYI---NGHVSILGDIYSYGILLLE------IFTGKRPTDDM 377
               +  Y  PE +    G+   + DI+S G +L E      IF GK   D +
Sbjct: 190 EXVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQL 241

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 90/233 (38%), Gaps = 34/233 (14%)
Query: 159 FSEENLIGSGSFGSVYKG--TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++  + IG G++G V      L     A  K+   + Q   +  + E   L   RH NI+
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNG--NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
            I     +   E      +V + M      L +  H S D  C+F           +  +
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----------LYQI 138
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT-MSN 333
              L Y+H+     + H DLK SN+LL+      + DFGLA+        P  + T    
Sbjct: 139 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-----DPDHDHTGFLX 190
Query: 334 GLKGSVGYIPPEYI---NGHVSILGDIYSYGILLLE------IFTGKRPTDDM 377
               +  Y  PE +    G+   + DI+S G +L E      IF GK   D +
Sbjct: 191 EXVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQL 242

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 113/260 (43%), Gaps = 46/260 (17%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSF---IDECNALTSIRH 212
           D F     +G+GSFG V      + G   A+K+L  Q+   LK     ++E   L ++  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             ++K+  S     ++ N    +V E++  G +          + H +++      +   
Sbjct: 122 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEM----------FSHLRRIGRFXEPHARF 166
Query: 273 DVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
             A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K +
Sbjct: 167 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------KGR 215
Query: 330 TMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHK 386
           T    L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++
Sbjct: 216 TWX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYE 269
Query: 387 FVL---MALPSHV-MDVLDL 402
            ++   +  PSH   D+ DL
Sbjct: 270 KIVSGKVRFPSHFSSDLKDL 289

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/112 (28%), Positives = 58/112 (51%), Gaps = 15/112 (13%)
Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
            I + +  AL++LH++    + H D+K SNVL++      + DFG++ +L ++       
Sbjct: 113 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV-----A 165
Query: 329 QTMSNGLKGSVGYIPPEYINGHV-----SILGDIYSYGILLLEIFTGKRPTD 375
           + +  G K    Y+ PE IN  +     S+  DI+S GI ++E+   + P D
Sbjct: 166 KDIDAGCK---PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 150 LKISNATD-NFSEENL-----IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFID 202
           LKIS     +F+ E+L     IG G++GSV K      G+  A+K         ++S +D
Sbjct: 9   LKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVK--------RIRSTVD 60
Query: 203 ECNALTSIRHRNILKIVSSCSS-VDYEGNDFKA----LVFEFMRNG--NLDQWLHPSTDE 255
           E      +   +++   S C   V + G  F+     +  E M        ++++   D+
Sbjct: 61  EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDD 120
Query: 256 YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA 315
               + L       I +    AL++L    +  I H D+K SN+LLD      + DFG++
Sbjct: 121 VIPEEILG-----KITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173
Query: 316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILG-----DIYSYGILLLEIFTG 370
             L +     S  +T   G +    Y+ PE I+   S  G     D++S GI L E+ TG
Sbjct: 174 GQLVD-----SIAKTRDAGCR---PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225
Query: 371 KRP 373
           + P
Sbjct: 226 RFP 228

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 91/233 (39%), Gaps = 34/233 (14%)
Query: 159 FSEENLIGSGSFGSVYKG--TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++  + IG G++G V      +     A  K+   + Q   +  + E   L + RH NI+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNG--NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
            I     +   E      +V + M      L +  H S D  C+F           +  +
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----------LYQI 135
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT-MSN 333
              L Y+H+     + H DLK SN+LL+      + DFGLA+        P  + T    
Sbjct: 136 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-----DPDHDHTGFLT 187
Query: 334 GLKGSVGYIPPEYI---NGHVSILGDIYSYGILLLE------IFTGKRPTDDM 377
               +  Y  PE +    G+   + DI+S G +L E      IF GK   D +
Sbjct: 188 EYVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQL 239

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 90  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 136
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + D+GLA+   +E            G  
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE----------MTGYV 183
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 90/233 (38%), Gaps = 34/233 (14%)
Query: 159 FSEENLIGSGSFGSVYKG--TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++  + IG G++G V      +     A  K+   + Q   +  + E   L   RH NI+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNG--NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
            I     +   E      +V + M      L +  H S D  C+F           +  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----------LYQI 133
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT-MSN 333
              L Y+H+     + H DLK SN+LL+      + DFGLA+        P  + T    
Sbjct: 134 LRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVA-----DPDHDHTGFLT 185
Query: 334 GLKGSVGYIPPEYI---NGHVSILGDIYSYGILLLE------IFTGKRPTDDM 377
               +  Y  PE +    G+   + DI+S G +L E      IF GK   D +
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQL 237

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 90/233 (38%), Gaps = 34/233 (14%)
Query: 159 FSEENLIGSGSFGSVYKG--TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++  + IG G++G V      +     A  K+   + Q   +  + E   L   RH NI+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNG--NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
            I     +   E      +V + M      L +  H S D  C+F           +  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----------LYQI 133
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT-MSN 333
              L Y+H+     + H DLK SN+LL+      + DFGLA+        P  + T    
Sbjct: 134 LRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVA-----DPDHDHTGFLT 185
Query: 334 GLKGSVGYIPPEYI---NGHVSILGDIYSYGILLLE------IFTGKRPTDDM 377
               +  Y  PE +    G+   + DI+S G +L E      IF GK   D +
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQL 237

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPS--TDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 90  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKSQKLTDDHVQF----------LIYQILR 136
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DFGL +   +E            G  
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE----------MTGYV 183
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 49/225 (21%)
Query: 165 IGSGSFGSVYKGTLADG-ETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSS 221
           IG G++G+V+K    +  E  A+K ++L    +G   S + E   L  ++H+NI+++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 222 CSSVDYEGNDFK-ALVFEFMR----------NGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
             S      D K  LVFEF            NG+LD  +  S                  
Sbjct: 70  LHS------DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKS-----------------F 106
Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
           +  +   L + H++    + H DLK  N+L++      + DFGLA+        P +  +
Sbjct: 107 LFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLADFGLARAF----GIPVRCYS 159
Query: 331 MSNGLKGSVGYIPPEYINGH--VSILGDIYSYGILLLEIFTGKRP 373
                  ++ Y PP+ + G    S   D++S G +  E+    RP
Sbjct: 160 AE---VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARP 201

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 90/233 (38%), Gaps = 34/233 (14%)
Query: 159 FSEENLIGSGSFGSVYKG--TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++  + IG G++G V      +     A  K+   + Q   +  + E   L   RH NI+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNG--NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
            I     +   E      +V + M      L +  H S D  C+F           +  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----------LYQI 133
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT-MSN 333
              L Y+H+     + H DLK SN+LL+      + DFGLA+        P  + T    
Sbjct: 134 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-----DPDHDHTGFLT 185
Query: 334 GLKGSVGYIPPEYI---NGHVSILGDIYSYGILLLE------IFTGKRPTDDM 377
               +  Y  PE +    G+   + DI+S G +L E      IF GK   D +
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQL 237

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 35/221 (15%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           IGSGSFG +Y GT +   E  AIK+  ++ +            L   +   IL+  +   
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------HPQLLYESKIYRILQGGTGIP 66
Query: 224 SVDYEG--NDFKALVFEFMRNGNLDQWLHPSTDEYCHF--KKLSLMQRLNIVIDVASALD 279
           +V + G   D+  LV +          L PS ++  +F  +KLSL   L +   + + ++
Sbjct: 67  NVRWFGVEGDYNVLVMDL---------LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGMIA---HVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
           ++H++      H D+K  N L+  G  A   ++ DFGLAK   + S         +  L 
Sbjct: 118 FVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
Query: 337 GSVGYIPPEYINGHVSI----LGDIYSYGILLLEIFTGKRP 373
           G+  Y     +N H+ I      D+ S G +L+    G  P
Sbjct: 175 GTARYAS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 90/233 (38%), Gaps = 34/233 (14%)
Query: 159 FSEENLIGSGSFGSVYKG--TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++  + IG G++G V      +     A  K+   + Q   +  + E   L   RH NI+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNG--NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
            I     +   E      +V + M      L +  H S D  C+F           +  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----------LYQI 133
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT-MSN 333
              L Y+H+     + H DLK SN+LL+      + DFGLA+        P  + T    
Sbjct: 134 LRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVA-----DPDHDHTGFLT 185
Query: 334 GLKGSVGYIPPEYI---NGHVSILGDIYSYGILLLE------IFTGKRPTDDM 377
               +  Y  PE +    G+   + DI+S G +L E      IF GK   D +
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQL 237

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 90/233 (38%), Gaps = 34/233 (14%)
Query: 159 FSEENLIGSGSFGSVYKG--TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++  + IG G++G V      +     A  K+   + Q   +  + E   L   RH NI+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNG--NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
            I     +   E      +V + M      L +  H S D  C+F           +  +
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----------LYQI 135
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT-MSN 333
              L Y+H+     + H DLK SN+LL+      + DFGLA+        P  + T    
Sbjct: 136 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-----DPDHDHTGFLT 187
Query: 334 GLKGSVGYIPPEYI---NGHVSILGDIYSYGILLLE------IFTGKRPTDDM 377
               +  Y  PE +    G+   + DI+S G +L E      IF GK   D +
Sbjct: 188 EYVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQL 239

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 91/233 (39%), Gaps = 34/233 (14%)
Query: 159 FSEENLIGSGSFGSVYKG--TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++  + IG G++G V      +     A  K+   + Q   +  + E   L + RH NI+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNG--NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
            I     +   E      +V + M      L +  H S D  C+F           +  +
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----------LYQI 135
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT-MSN 333
              L Y+H+     + H DLK SN+LL+      + DFGLA+        P  + T    
Sbjct: 136 LRGLKYIHS---ANVLHRDLKPSNLLLNTTSDLKICDFGLARVA-----DPDHDHTGFLT 187
Query: 334 GLKGSVGYIPPEYI---NGHVSILGDIYSYGILLLE------IFTGKRPTDDM 377
               +  Y  PE +    G+   + DI+S G +L E      IF GK   D +
Sbjct: 188 EYVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQL 239

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 113/260 (43%), Gaps = 46/260 (17%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSF---IDECNALTSIRH 212
           D F     +G+GSFG V      + G   A+K+L  Q+   LK     ++E   L ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             ++K+  S     ++ N    +V E++  G +          + H +++      +   
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEM----------FSHLRRIGRFSEPHARF 145
Query: 273 DVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
             A      +YLH+     + + DLK  N+++D+     V DFG AK +        K +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRV--------KGR 194
Query: 330 TMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHK 386
           T    L G+  Y+ PE I   G+   + D ++ G+L+ E+  G  P    F D  + I++
Sbjct: 195 TWX--LCGTPEYLAPEIIISKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYE 248
Query: 387 FVL---MALPSHV-MDVLDL 402
            ++   +  PSH   D+ DL
Sbjct: 249 KIVSGKVRFPSHFSSDLKDL 268

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 95/226 (42%), Gaps = 45/226 (19%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVL-------KLQQQGALKSFIDECNALTSIRHRNIL 216
           IGSGSFG +Y G  +A GE  AIK+        +L  +      +     + SI+     
Sbjct: 17  IGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQGGVGIPSIKW---- 72
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHF--KKLSLMQRLNIVIDV 274
                C +   EG D+  +V E          L PS ++  +F  +K SL   L +   +
Sbjct: 73  -----CGA---EG-DYNVMVMEL---------LGPSLEDLFNFCSRKFSLKTVLLLADQM 114
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
            S ++Y+H++      H D+K  N L+    +G + ++ DFGLAK   +           
Sbjct: 115 ISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 171
Query: 332 SNGLKGSVGYIPPEYINGHVSI----LGDIYSYGILLLEIFTGKRP 373
           +  L G+  Y     IN H+ I      D+ S G +L+    G  P
Sbjct: 172 NKNLTGTARYAS---INTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 90/233 (38%), Gaps = 34/233 (14%)
Query: 159 FSEENLIGSGSFGSVYKG--TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++  + IG G++G V      +     A  K+   + Q   +  + E   L   RH NI+
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNG--NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
            I     +   E      +V + M      L +  H S D  C+F           +  +
Sbjct: 93  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----------LYQI 141
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT-MSN 333
              L Y+H+     + H DLK SN+LL+      + DFGLA+        P  + T    
Sbjct: 142 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-----DPDHDHTGFLT 193
Query: 334 GLKGSVGYIPPEYI---NGHVSILGDIYSYGILLLE------IFTGKRPTDDM 377
               +  Y  PE +    G+   + DI+S G +L E      IF GK   D +
Sbjct: 194 EYVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQL 245

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 90/233 (38%), Gaps = 34/233 (14%)
Query: 159 FSEENLIGSGSFGSVYKG--TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++  + IG G++G V      +     A  K+   + Q   +  + E   L   RH NI+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNG--NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
            I     +   E      +V + M      L +  H S D  C+F           +  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-----------LYQI 133
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT-MSN 333
              L Y+H+     + H DLK SN+LL+      + DFGLA+        P  + T    
Sbjct: 134 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-----DPDHDHTGFLT 185
Query: 334 GLKGSVGYIPPEYI---NGHVSILGDIYSYGILLLE------IFTGKRPTDDM 377
               +  Y  PE +    G+   + DI+S G +L E      IF GK   D +
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQL 237

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/241 (23%), Positives = 93/241 (38%), Gaps = 34/241 (14%)
Query: 151 KISNATDNFSEENLIGSGSFGSVYKG--TLADGETAAIKVLKLQQQGALKSFIDECNALT 208
           ++ +    ++  + IG G++G V      +     A  K+   + Q   +  + E   L 
Sbjct: 37  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 96
Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNG--NLDQWLHPSTDEYCHFKKLSLMQ 266
             RH NI+ I     +   E      +V + M      L +  H S D  C+F       
Sbjct: 97  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF------- 149
Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
               +  +   L Y+H+     + H DLK SN+LL+      + DFGLA+        P 
Sbjct: 150 ----LYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-----DPD 197
Query: 327 KNQT-MSNGLKGSVGYIPPEYI---NGHVSILGDIYSYGILLLE------IFTGKRPTDD 376
            + T        +  Y  PE +    G+   + DI+S G +L E      IF GK   D 
Sbjct: 198 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQ 256
Query: 377 M 377
           +
Sbjct: 257 L 257

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 94/242 (38%), Gaps = 36/242 (14%)
Query: 151 KISNATDNFSEENLIGSGSFGSVYKG--TLADGETAAIKVLKLQQQGALKSFIDECNALT 208
           ++ +    ++  + IG G++G V      +     A  K+   + Q   +  + E   L 
Sbjct: 37  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 96
Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWL---HPSTDEYCHFKKLSLM 265
             RH NI+ I     +   E      LV   M   +L + L   H S D  C+F      
Sbjct: 97  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQHLSNDHICYF------ 149
Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
                +  +   L Y+H+     + H DLK SN+LL+      + DFGLA+        P
Sbjct: 150 -----LYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVA-----DP 196
Query: 326 SKNQT-MSNGLKGSVGYIPPEYI---NGHVSILGDIYSYGILLLE------IFTGKRPTD 375
             + T        +  Y  PE +    G+   + DI+S G +L E      IF GK   D
Sbjct: 197 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLD 255
Query: 376 DM 377
            +
Sbjct: 256 QL 257

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 90/218 (41%), Gaps = 38/218 (17%)
Query: 165 IGSGSFGSVYKGTLADGETAAIKVLK-----LQQQGALKSFIDECNALTSIRHRNILKIV 219
           +GSG++G+V   +  DG T A   +K      Q +   K    E   L  +RH N++ ++
Sbjct: 33  VGSGAYGAV--CSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 220 SSCSSVDYEGNDFK--ALVFEFMRNGNLDQWLHPSTD--EYCHFKKLSLMQRLNIVIDVA 275
              +  D   +DF    LV  FM            TD  +    +KL   +   +V  + 
Sbjct: 91  DVFTP-DETLDDFTDFYLVMPFM-----------GTDLGKLMKHEKLGEDRIQFLVYQML 138
Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
             L Y+H      I H DLK  N+ ++E     + DFGLA+          +  +   G 
Sbjct: 139 KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR----------QADSEMXGX 185
Query: 336 KGSVGYIPPEYINGHVSILG--DIYSYGILLLEIFTGK 371
             +  Y  PE I   +      DI+S G ++ E+ TGK
Sbjct: 186 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 113/260 (43%), Gaps = 46/260 (17%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSF---IDECNALTSIRH 212
           D F     +G+GSFG V      + G   A+K+L  Q+   LK     ++E   L ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             ++K+  S     ++ N    +V E++  G +          + H +++      +   
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEM----------FSHLRRIGRFSEPHARF 145
Query: 273 DVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
             A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------KGR 194
Query: 330 TMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHK 386
           T    L G+  Y+ PE I   G+   + D ++ G+L+ ++  G  P    F D  + I++
Sbjct: 195 TWX--LCGTPEYLAPEIILSKGYNKAV-DWWALGVLIYQMAAGYPP---FFADQPIQIYE 248
Query: 387 FVL---MALPSHV-MDVLDL 402
            ++   +  PSH   D+ DL
Sbjct: 249 KIVSGKVRFPSHFSSDLKDL 268

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 90  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 136
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + DF LA+   +E            G  
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE----------MTGYV 183
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 89/215 (41%), Gaps = 33/215 (15%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLK--LQQQGALKSFIDECNALTSIRHRNILKIVSS 221
           +GSG++GSV        GE  AIK L    Q +   K    E   L  ++H N++ ++  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 222 CSSVDYEGN--DFKALVFEFMRNGNLDQWLHPSTD-EYCHFKKLSLMQRLNIVIDVASAL 278
            +      N  DF  LV  FM+           TD +     K S  +   +V  +   L
Sbjct: 92  FTPASSLRNFYDF-YLVMPFMQ-----------TDLQKIMGLKFSEEKIQYLVYQMLKGL 139
Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
            Y+H+     + H DLK  N+ ++E     + DFGLA+    E            G   +
Sbjct: 140 KYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----------MTGYVVT 186
Query: 339 VGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
             Y  PE I    H +   DI+S G ++ E+ TGK
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 92/224 (41%), Gaps = 39/224 (17%)
Query: 164 LIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSC 222
           L+GSG FGSVY G  ++D    AIK +   ++  +  + +  N         +LK VSS 
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHV---EKDRISDWGELPNGTRVPMEVVLLKKVSSG 71
Query: 223 SS-----VDY-EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQR---LNIVID 273
            S     +D+ E  D   L+ E M          P  D +    +   +Q     +    
Sbjct: 72  FSGVIRLLDWFERPDSFVLILERME---------PVQDLFDFITERGALQEELARSFFWQ 122
Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLD--EGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
           V  A+ + HN     + H D+K  N+L+D   G +  + DFG    L           T+
Sbjct: 123 VLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLI-DFGSGALL---------KDTV 169
Query: 332 SNGLKGSVGYIPPEYINGHV--SILGDIYSYGILLLEIFTGKRP 373
                G+  Y PPE+I  H        ++S GILL ++  G  P
Sbjct: 170 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 213

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 95/241 (39%), Gaps = 35/241 (14%)
Query: 145 SGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETA----AIK-VLKLQQQGALKS 199
            G  + +  +  D +   +++G+G+F  V    LA+ +      AIK + K   +G   S
Sbjct: 6   EGPRWKQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGS 62
Query: 200 FIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHF 259
             +E   L  I+H NI+ +        YE      L+ + +  G L        D     
Sbjct: 63  MENEIAVLHKIKHPNIVALDDI-----YESGGHLYLIMQLVSGGEL-------FDRIVEK 110
Query: 260 KKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVL---LDEGMIAHVGDFGLAK 316
              +      ++  V  A+ YLH   D  I H DLK  N+L   LDE     + DFGL+K
Sbjct: 111 GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 167
Query: 317 FLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTD 375
                         +S    G+ GY+ PE +     S   D +S G++   +  G  P  
Sbjct: 168 M-------EDPGSVLSTAC-GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY 219
Query: 376 D 376
           D
Sbjct: 220 D 220

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 30/217 (13%)
Query: 164 LIGSGSFGSVYKGTLADGET-AAIKVLKLQ---QQGALKSFIDECNAL-TSIRHRNILKI 218
           +IG GSFG V        E   A+KVL+ +   ++   K  + E N L  +++H  ++ +
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
             S  + D         V +++  G L   L     E C  +  +         ++ASAL
Sbjct: 105 HFSFQTADK-----LYFVLDYINGGELFYHLQ---RERCFLEPRARF----YAAEIASAL 152
Query: 279 DYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
            YLH+     I + DLK  N+LLD +G I  + DFGL K   E ++T       ++   G
Sbjct: 153 GYLHS---LNIVYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNST-------TSTFCG 201
Query: 338 SVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
           +  Y+ PE ++        D +  G +L E+  G  P
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 94/238 (39%), Gaps = 35/238 (14%)
Query: 145 SGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETA----AIK-VLKLQQQGALKS 199
            G  + +  +  D +   +++G+G+F  V    LA+ +      AIK + K   +G   S
Sbjct: 6   EGPRWKQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKKALEGKEGS 62
Query: 200 FIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHF 259
             +E   L  I+H NI+ +        YE      L+ + +  G L        D     
Sbjct: 63  MENEIAVLHKIKHPNIVALDDI-----YESGGHLYLIMQLVSGGEL-------FDRIVEK 110
Query: 260 KKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVL---LDEGMIAHVGDFGLAK 316
              +      ++  V  A+ YLH   D  I H DLK  N+L   LDE     + DFGL+K
Sbjct: 111 GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 167
Query: 317 FLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRP 373
                         +S    G+ GY+ PE +     S   D +S G++   +  G  P
Sbjct: 168 M-------EDPGSVLSTAC-GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 101/231 (43%), Gaps = 40/231 (17%)
Query: 164 LIGSGSFGSVY----KGTLADGETAAIKVLK---LQQQGALKSFIDECNALTSIRHRNIL 216
           ++G GSFG V     KGT    E  A+K+LK   + Q   ++  + E   L        L
Sbjct: 27  VLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 83
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI---D 273
             + SC    ++  D    V E++  G+L            H +++   +  + V    +
Sbjct: 84  TQLHSC----FQTMDRLYFVMEYVNGGDL----------MYHIQQVGRFKEPHAVFYAAE 129
Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           +A  L +L ++    I + DLK  NV+LD EG I  + DFG+ K    +  T       +
Sbjct: 130 IAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIK-IADFGMCKENIWDGVT-------T 178
Query: 333 NGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRPTDDMFKDDL 382
               G+  YI PE I         D +++G+LL E+  G+ P +   +D+L
Sbjct: 179 KXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 229

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 94/238 (39%), Gaps = 35/238 (14%)
Query: 145 SGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETA----AIK-VLKLQQQGALKS 199
            G  + +  +  D +   +++G+G+F  V    LA+ +      AIK + K   +G   S
Sbjct: 6   EGPRWKQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGS 62
Query: 200 FIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHF 259
             +E   L  I+H NI+ +        YE      L+ + +  G L        D     
Sbjct: 63  MENEIAVLHKIKHPNIVALDDI-----YESGGHLYLIMQLVSGGEL-------FDRIVEK 110
Query: 260 KKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVL---LDEGMIAHVGDFGLAK 316
              +      ++  V  A+ YLH   D  I H DLK  N+L   LDE     + DFGL+K
Sbjct: 111 GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 167
Query: 317 FLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRP 373
                         +S    G+ GY+ PE +     S   D +S G++   +  G  P
Sbjct: 168 M-------EDPGSVLSTAC-GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 95/241 (39%), Gaps = 35/241 (14%)
Query: 145 SGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETA----AIK-VLKLQQQGALKS 199
            G  + +  +  D +   +++G+G+F  V    LA+ +      AIK + K   +G   S
Sbjct: 6   EGPRWKQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGS 62
Query: 200 FIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHF 259
             +E   L  I+H NI+ +        YE      L+ + +  G L        D     
Sbjct: 63  MENEIAVLHKIKHPNIVALDDI-----YESGGHLYLIMQLVSGGEL-------FDRIVEK 110
Query: 260 KKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVL---LDEGMIAHVGDFGLAK 316
              +      ++  V  A+ YLH   D  I H DLK  N+L   LDE     + DFGL+K
Sbjct: 111 GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 167
Query: 317 FLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTD 375
                         +S    G+ GY+ PE +     S   D +S G++   +  G  P  
Sbjct: 168 M-------EDPGSVLSTAC-GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY 219
Query: 376 D 376
           D
Sbjct: 220 D 220

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 100/231 (43%), Gaps = 40/231 (17%)
Query: 164 LIGSGSFGSVY----KGTLADGETAAIKVLKLQ---QQGALKSFIDECNALTSIRHRNIL 216
           ++G GSFG V     KGT    E  A+K+LK     Q   ++  + E   L        L
Sbjct: 348 VLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 404
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI---D 273
             + SC    ++  D    V E++  G+L            H +++   +  + V    +
Sbjct: 405 TQLHSC----FQTMDRLYFVMEYVNGGDL----------MYHIQQVGRFKEPHAVFYAAE 450
Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           +A  L +L ++    I + DLK  NV+LD EG I  + DFG+ K    +  T       +
Sbjct: 451 IAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIK-IADFGMCKENIWDGVT-------T 499
Query: 333 NGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRPTDDMFKDDL 382
               G+  YI PE I         D +++G+LL E+  G+ P +   +D+L
Sbjct: 500 KXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 550

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 92/230 (40%), Gaps = 41/230 (17%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVL--KLQQQGALKSFIDECNALTSIR-HRNILKIVS 220
           +G G++G V+K      GE  A+K +    Q     +    E   LT +  H NI+ +++
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 221 SCSSVDYEGNDFKA-LVFEFMRNGNLDQWLHPSTDEYCHFKK--LSLMQRLNIVIDVASA 277
              +     ND    LVF++M            TD +   +   L  + +  +V  +   
Sbjct: 77  VLRA----DNDRDVYLVFDYM-----------ETDLHAVIRANILEPVHKQYVVYQLIKV 121
Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLF--------------EESN 323
           + YLH+     + H D+K SN+LL+      V DFGL++                 E + 
Sbjct: 122 IKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHVSILG--DIYSYGILLLEIFTGK 371
               +Q +      +  Y  PE + G        D++S G +L EI  GK
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 31/214 (14%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLK--LQQQGALKSFIDECNALTSIRHRNILKIVSS 221
           +GSG++GSV        GE  AIK L    Q +   K    E   L  ++H N++ ++  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 222 CSSVDYEGN--DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
            +      N  DF  LV  FM+  +L + +     E    +K+  +     V  +   L 
Sbjct: 110 FTPASSLRNFYDF-YLVMPFMQT-DLQKIMGMEFSE----EKIQYL-----VYQMLKGLK 158
Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSV 339
           Y+H+     + H DLK  N+ ++E     + DFGLA+    E            G   + 
Sbjct: 159 YIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----------MTGYVVTR 205
Query: 340 GYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            Y  PE I    H +   DI+S G ++ E+ TGK
Sbjct: 206 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/234 (23%), Positives = 100/234 (42%), Gaps = 35/234 (14%)
Query: 159 FSEENLIGSGSFGSVYKGTLADGETA---AIKVLKLQQQGALKSFIDE---CNALTSIRH 212
            + +  +G GSFG V++  + D +T    A+K ++L+        ++E   C  L+S R 
Sbjct: 76  MTHQPRVGRGSFGEVHR--MKDKQTGFQCAVKKVRLE-----VFRVEELVACAGLSSPRI 128
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             +   V     V+        +  E +  G+L Q +          K++  +     + 
Sbjct: 129 VPLYGAVREGPWVN--------IFMELLEGGSLGQLI----------KQMGCLPEDRALY 170
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLL-DEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
            +  AL+ L   +   I H D+K+ NVLL  +G  A + DFG A  L  + +   K+   
Sbjct: 171 YLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCL--QPDGLGKSLLT 228
Query: 332 SNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSI 384
            + + G+  ++ PE + G       DI+S   ++L +  G  P    F+  L +
Sbjct: 229 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL 282

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/234 (23%), Positives = 100/234 (42%), Gaps = 35/234 (14%)
Query: 159 FSEENLIGSGSFGSVYKGTLADGETA---AIKVLKLQQQGALKSFIDE---CNALTSIRH 212
            + +  +G GSFG V++  + D +T    A+K ++L+        ++E   C  L+S R 
Sbjct: 60  MTHQPRVGRGSFGEVHR--MKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRI 112
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             +   V     V+        +  E +  G+L Q +          K++  +     + 
Sbjct: 113 VPLYGAVREGPWVN--------IFMELLEGGSLGQLI----------KQMGCLPEDRALY 154
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLL-DEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
            +  AL+ L   +   I H D+K+ NVLL  +G  A + DFG A  L  + +   K+   
Sbjct: 155 YLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCL--QPDGLGKSLLT 212
Query: 332 SNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSI 384
            + + G+  ++ PE + G       DI+S   ++L +  G  P    F+  L +
Sbjct: 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL 266

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 90  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 136
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     +  FGLA+   +E            G  
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE----------MTGYV 183
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 97/236 (41%), Gaps = 37/236 (15%)
Query: 150 LKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGAL--KSFIDECNAL 207
           + I + +D +     IGSG+FG      + D  T  +  +K  ++GA   ++   E    
Sbjct: 13  MPIMHDSDRYDFVKDIGSGNFGVAR--LMRDKLTKELVAVKYIERGAAIDENVQREIINH 70
Query: 208 TSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQR 267
            S+RH NI++      +  +      A++ E+   G L + +       C+  + S  + 
Sbjct: 71  RSLRHPNIVRFKEVILTPTH-----LAIIMEYASGGELYERI-------CNAGRFSEDEA 118
Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH--VGDFGLAKFLFEESNTP 325
                 + S + Y H+     I H DLK  N LLD        + DFG            
Sbjct: 119 RFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGY----------- 164
Query: 326 SKNQTMSNGLKGSVG---YIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDD 376
           SK+  + +  K +VG   YI PE +    +   + D++S G+ L  +  G  P +D
Sbjct: 165 SKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 112/260 (43%), Gaps = 46/260 (17%)
Query: 157 DNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSF---IDECNALTSIRH 212
           D F     +G+GSFG V      + G   A+K+L  Q+   LK     ++E   L ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             ++K+  S     ++ N    +V E++  G +          + H +++      +   
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEM----------FSHLRRIGRFSEPHARF 145
Query: 273 DVAS---ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
             A      +YLH+     + + DLK  N+L+D+     V DFG AK +        K +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--------KGR 194
Query: 330 TMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD-LSIHK 386
           T    L G+  Y+ P  I   G+   + D ++ G+L+ E+  G  P    F D  + I++
Sbjct: 195 TWX--LCGTPEYLAPAIILSKGYNKAV-DWWALGVLIYEMAAGYPP---FFADQPIQIYE 248
Query: 387 FVL---MALPSHV-MDVLDL 402
            ++   +  PSH   D+ DL
Sbjct: 249 KIVSGKVRFPSHFSSDLKDL 268

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 60/126 (47%), Gaps = 20/126 (15%)
Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           V +A+ + H++    + H D+K  N+L+D     A + DFG    L +E  T        
Sbjct: 148 VVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT-------- 196
Query: 333 NGLKGSVGYIPPEYINGHV--SILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM 390
               G+  Y PPE+I+ H   ++   ++S GILL ++  G  P    F+ D  I +  L 
Sbjct: 197 -DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP----FERDQEILEAELH 251
Query: 391 ALPSHV 396
             P+HV
Sbjct: 252 -FPAHV 256

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 90  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 136
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + D GLA+   +E            G  
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE----------MTGYV 183
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFID-ECNALTSIRHRNILKIVSSC 222
           +G G FG V++    +  +T   K +K++  G  +  +  E + L   RHRNIL +  S 
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHES- 69
Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
               +E  +   ++FEF+   ++ + ++ S  E      L+  + ++ V  V  AL +LH
Sbjct: 70  ----FESMEELVMIFEFISGLDIFERINTSAFE------LNEREIVSYVHQVCEALQFLH 119
Query: 283 NQYDTPIAHCDLKSSNVLLD--EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG 340
           +     I H D++  N++          + +FG A+ L      P  N  +   L  +  
Sbjct: 120 SH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-----KPGDNFRL---LFTAPE 168
Query: 341 YIPPEYINGH--VSILGDIYSYGILLLEIFTGKRP 373
           Y  PE ++ H  VS   D++S G L+  + +G  P
Sbjct: 169 YYAPE-VHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 93/233 (39%), Gaps = 34/233 (14%)
Query: 159 FSEENLIGSGSFGSVYKGT--LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           +++   IG G++G V      +     A  K+   + Q   +  + E   L   RH N++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFK--KLSLMQRLNIVIDV 274
            I           +  +A   E MR+  + Q L   TD Y   K  +LS       +  +
Sbjct: 105 GI----------RDILRASTLEAMRDVYIVQDLM-ETDLYKLLKSQQLSNDHICYFLYQI 153
Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT-MSN 333
              L Y+H+     + H DLK SN+L++      + DFGLA+        P  + T    
Sbjct: 154 LRGLKYIHS---ANVLHRDLKPSNLLINTTCDLKICDFGLARI-----ADPEHDHTGFLT 205
Query: 334 GLKGSVGYIPPEYI---NGHVSILGDIYSYGILLLE------IFTGKRPTDDM 377
               +  Y  PE +    G+   + DI+S G +L E      IF GK   D +
Sbjct: 206 EXVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQL 257

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 90  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 136
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + D GLA+   +E            G  
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE----------MTGYV 183
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 54/234 (23%), Positives = 100/234 (42%), Gaps = 35/234 (14%)
Query: 159 FSEENLIGSGSFGSVYKGTLADGETA---AIKVLKLQQQGALKSFIDE---CNALTSIRH 212
            + +  +G GSFG V++  + D +T    A+K ++L+        ++E   C  L+S R 
Sbjct: 74  MTHQPRLGRGSFGEVHR--MKDKQTGFQCAVKKVRLE-----VFRVEELVACAGLSSPRI 126
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             +   V     V+        +  E +  G+L Q +          K++  +     + 
Sbjct: 127 VPLYGAVREGPWVN--------IFMELLEGGSLGQLI----------KQMGCLPEDRALY 168
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLL-DEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
            +  AL+ L   +   I H D+K+ NVLL  +G  A + DFG A  L  + +   K+   
Sbjct: 169 YLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCL--QPDGLGKSLLT 226
Query: 332 SNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSI 384
            + + G+  ++ PE + G       DI+S   ++L +  G  P    F+  L +
Sbjct: 227 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL 280

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 29/228 (12%)
Query: 156 TDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRH 212
           TD++     +G G+F  V +       +  A K++  ++  A   +    E      ++H
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKH 89
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            NI+++  S S    EG  F  LVF+ +  G L + +     EY      S     + + 
Sbjct: 90  PNIVRLHDSISE---EG--FHYLVFDLVTGGELFEDI--VAREY-----YSEADASHCIH 137
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLFEESNTPSKNQ 329
            +  +++++H Q+D  I H DLK  N+LL    +G    + DFGLA  +  E       Q
Sbjct: 138 QILESVNHIH-QHD--IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGE-------Q 187
Query: 330 TMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRPTDD 376
               G  G+ GY+ PE +         DI++ G++L  +  G  P  D
Sbjct: 188 QAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWD 235

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 95/229 (41%), Gaps = 41/229 (17%)
Query: 156 TDNFSEENLIGSGSFGSVYKGTL--ADGETAAIKVLKLQQQGALKSFIDECNALTSI-RH 212
           TD +  +  IG GS+ SV K  +  A     A+K++   ++       +E   L    +H
Sbjct: 21  TDGYEVKEDIGVGSY-SVCKRCIHKATNMEFAVKIIDKSKRDP----TEEIEILLRYGQH 75
Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            NI+ +        Y+   +  +V E M+ G L        D+    K  S  +   ++ 
Sbjct: 76  PNIITLKDV-----YDDGKYVYVVTELMKGGEL-------LDKILRQKFFSEREASAVLF 123
Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVL-LDEG---MIAHVGDFGLAKFLFEESN---TP 325
            +   ++YLH Q    + H DLK SN+L +DE        + DFG AK L  E+    TP
Sbjct: 124 TITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP 180
Query: 326 SKNQTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
                       +  ++ PE +         DI+S G+LL  + TG  P
Sbjct: 181 CY----------TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 94/225 (41%), Gaps = 49/225 (21%)
Query: 165 IGSGSFGSVYKGTLADG-ETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSS 221
           IG G++G+V+K    +  E  A+K ++L    +G   S + E   L  ++H+NI+++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 222 CSSVDYEGNDFK-ALVFEFMR----------NGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
             S      D K  LVFEF            NG+LD  +  S                  
Sbjct: 70  LHS------DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKS-----------------F 106
Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
           +  +   L + H++    + H DLK  N+L++      + +FGLA+        P +  +
Sbjct: 107 LFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAF----GIPVRCYS 159
Query: 331 MSNGLKGSVGYIPPEYINGH--VSILGDIYSYGILLLEIFTGKRP 373
                  ++ Y PP+ + G    S   D++S G +  E+    RP
Sbjct: 160 AE---VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 65/155 (41%), Gaps = 28/155 (18%)
Query: 227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYD 286
           Y+      LV E MR G L        D+    K  S  +   ++  +   ++YLH+Q  
Sbjct: 90  YDDGKHVYLVTELMRGGEL-------LDKILRQKFFSEREASFVLHTIGKTVEYLHSQ-- 140
Query: 287 TPIAHCDLKSSNVL-LDEG---MIAHVGDFGLAKFLFEESN---TPSKNQTMSNGLKGSV 339
             + H DLK SN+L +DE        + DFG AK L  E+    TP            + 
Sbjct: 141 -GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY----------TA 189
Query: 340 GYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
            ++ PE +       G DI+S GILL  +  G  P
Sbjct: 190 NFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 36/217 (16%)
Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNI---LKI 218
           +GSG++GSV        G   A+K L    Q  +  K    E   L  ++H N+   L +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            +   S++ E ND   LV   M   +L+  +     TD++  F          ++  +  
Sbjct: 90  FTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQF----------LIYQILR 136
Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L Y+H+     I H DLK SN+ ++E     + D GLA+   +E            G  
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE----------MTGYV 183
Query: 337 GSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
            +  Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 36/74 (48%), Gaps = 4/74 (5%)
Query: 20  RGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGNDK 79
           + L  LDL  N + G +PQ  ++L  L  LN+S+N L GEI + G        +   N  
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303
Query: 80  LCGGIQKLQLPECS 93
           LCG      LP C+
Sbjct: 304 LCGS----PLPACT 313

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 54/239 (22%), Positives = 102/239 (42%), Gaps = 35/239 (14%)
Query: 147 LSYLKISNATDNFSEENLIGSGSFGSVYK-GTLADGETAAIKVLKLQQ-----QGALKSF 200
           ++  +  N  D +     +GSG F  V K    + G   A K +K ++     +G  +  
Sbjct: 1   MTVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 60
Query: 201 ID-ECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHF 259
           I+ E + L  I+H N++ +        YE      L+ E +  G L  +L          
Sbjct: 61  IEREVSILKEIQHPNVITLHEV-----YENKTDVILILELVAGGELFDFL-------AEK 108
Query: 260 KKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIA----HVGDFGLA 315
           + L+  +    +  + + + YLH+     IAH DLK  N++L +  +      + DFGLA
Sbjct: 109 ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165
Query: 316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
             +  +     KN      + G+  ++ PE +N   + +  D++S G++   + +G  P
Sbjct: 166 HKI--DFGNEFKN------IFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 32/112 (28%), Positives = 55/112 (49%), Gaps = 15/112 (13%)
Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
            I + +  AL++LH++    + H D+K SNVL++        DFG++ +L ++       
Sbjct: 140 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVA----- 192
Query: 329 QTMSNGLKGSVGYIPPEYINGHV-----SILGDIYSYGILLLEIFTGKRPTD 375
           + +  G K    Y  PE IN  +     S+  DI+S GI  +E+   + P D
Sbjct: 193 KDIDAGCKP---YXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYD 241

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 112/256 (43%), Gaps = 40/256 (15%)
Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSI----- 210
           D +  ++LIG GSFG V K     + E  AIK++K +     K+F+++      +     
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-----KAFLNQAQIEVRLLELMN 108
Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
           +H   +K         +   +   LVFE M + NL   L  +     +F+ +SL      
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNT-----NFRGVSLNLTRKF 162
Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLL--DEGMIAHVGDFGLAKFLFEESNTPSKN 328
              + +AL +L    +  I HCDLK  N+LL   +     + DFG         ++    
Sbjct: 163 AQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRXAIKIVDFG---------SSCQLG 212
Query: 329 QTMSNGLKGSVGYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRPTDDMFK-----DDL 382
           Q +   ++ S  Y  PE + G    L  D++S G +L+E+ TG    + +F      D +
Sbjct: 213 QRIYQXIQ-SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG----EPLFSGANEVDQM 267
Query: 383 SIHKFVLMALPSHVMD 398
           +    VL   P+H++D
Sbjct: 268 NKIVEVLGIPPAHILD 283

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 106/263 (40%), Gaps = 36/263 (13%)
Query: 145 SGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGAL--KSFID 202
           +G   L I + +D +     IG+G+FG      + D +   +  +K  ++G    ++   
Sbjct: 7   AGPMDLPIMHDSDRYELVKDIGAGNFGVAR--LMRDKQANELVAVKYIERGEKIDENVKR 64
Query: 203 ECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKL 262
           E     S+RH NI++      +  +      A+V E+   G L + +       C+  + 
Sbjct: 65  EIINHRSLRHPNIVRFKEVILTPTH-----LAIVMEYASGGELFERI-------CNAGRF 112
Query: 263 SLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH--VGDFGLAKFLFE 320
           S  +       + S + Y H      +AH DLK  N LLD        + DFG +K    
Sbjct: 113 SEDEARFFFQQLISGVSYAHAMQ---VAHRDLKLENTLLDGSPAPRLKIADFGYSK---- 165
Query: 321 ESNTPSKNQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMF 378
                S   +      G+  YI PE +    +   + D++S G+ L  +  G  P +D  
Sbjct: 166 ----ASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPE 221
Query: 379 KDD---LSIHKF--VLMALPSHV 396
           +      +IH+   V  A+P +V
Sbjct: 222 EPKNFRKTIHRILNVQYAIPDYV 244

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 88/214 (41%), Gaps = 33/214 (15%)
Query: 165 IGSGSFGSVYKGTLAD-GETAAIK-VLKLQQQGALKSF-IDECNALTSIRHRNILKIVSS 221
           IG GS+G V+K    D G+  AIK  L+ +    +K   + E   L  ++H N++ ++  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 222 CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYL 281
                +       LVFE+  +  L +      D Y       L++  +I      A+++ 
Sbjct: 71  -----FRRKRRLHLVFEYCDHTVLHE-----LDRYQRGVPEHLVK--SITWQTLQAVNFC 118
Query: 282 HNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFL-----FEESNTPSKNQTMSNGLK 336
           H        H D+K  N+L+ +  +  + DFG A+ L     + +    ++       L 
Sbjct: 119 HKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLV 175
Query: 337 GSVGYIPPEYINGHVSILGDIYSYGILLLEIFTG 370
           G   Y PP           D+++ G +  E+ +G
Sbjct: 176 GDTQYGPP----------VDVWAIGCVFAELLSG 199

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 65/155 (41%), Gaps = 28/155 (18%)
Query: 227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYD 286
           Y+      LV E MR G L        D+    K  S  +   ++  +   ++YLH+Q  
Sbjct: 90  YDDGKHVYLVTELMRGGEL-------LDKILRQKFFSEREASFVLHTIGKTVEYLHSQ-- 140
Query: 287 TPIAHCDLKSSNVL-LDEG---MIAHVGDFGLAKFLFEESN---TPSKNQTMSNGLKGSV 339
             + H DLK SN+L +DE        + DFG AK L  E+    TP            + 
Sbjct: 141 -GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY----------TA 189
Query: 340 GYIPPEYINGHVSILG-DIYSYGILLLEIFTGKRP 373
            ++ PE +       G DI+S GILL  +  G  P
Sbjct: 190 NFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	477
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-76
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-70
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-63
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-59
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-53
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-53
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-52
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-51
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-50
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	8e-50
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-49
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-47
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	8e-47
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-46
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-46
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-45
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-45
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-45
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-36
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-34
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-34
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	8e-34
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-33
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-33
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-33
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-33
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	8e-33
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	9e-33
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-32
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-32
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-32
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-32
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-32
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-32
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-32
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-32
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-32
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-32
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-32
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-32
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-32
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-32
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-32
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-32
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-31
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-31
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-31
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-31
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-31
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-31
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-31
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-31
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-31
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-31
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-31
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-30
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-30
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-30
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-29
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-29
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-29
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-29
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-29
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-29
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-14
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	6e-14
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	9e-14
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-13
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-10
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-05
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-29
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-29
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-28
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-28
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-28
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-28
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-28
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	9e-28
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	9e-28
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-27
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-27
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-27
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	7e-27
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	9e-27
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-26
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-26
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-26
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-26
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-26
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-25
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-15
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-15
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-13
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-13
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-13
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-13
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-12
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-12
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-12
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-12
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-12
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-11
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-11
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-11
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-11
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-10
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-09
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-06
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-04
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-25
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-25
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-25
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-25
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-25
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-25
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	7e-25
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	9e-25
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-24
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-24
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-24
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-24
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-23
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-23
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	8e-23
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-22
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-22
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-22
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	9e-22
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-21
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-21
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-21
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-21
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-21
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-21
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-21
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-21
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	8e-21
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-20
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-20
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-20
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-20
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-20
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-20
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-19
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	7e-19
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	8e-19
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-19
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	9e-19
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-18
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-17
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-17
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-17
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-17
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-17
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-17
3an0_A	340	Dual specificity mitogen-activated protein kinase;	7e-17
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	8e-17
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-16
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-16
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-16
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-16
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-16
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-16
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-16
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-16
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-16
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-16
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-16
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-16
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	7e-16
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	7e-16
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	8e-16
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	9e-16
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-15
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-15
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-15
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-15
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-15
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-15
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-15
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-15
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-15
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-15
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-15
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-15
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-15
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-15
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-15
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-15
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	6e-15
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	8e-15
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-14
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-14
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-14
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-14
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-14
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-14
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-14
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-14
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-14
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-14
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-14
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-14
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-14
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-14
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-14
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	7e-14
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	8e-14
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-13
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-13
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-13
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-13
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-13
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-13
3uqc_A	286	Probable conserved transmembrane protein; structur	7e-13
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-12
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-12
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-12
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-12
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	7e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-12
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-11
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-11
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-11
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-11
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-11
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-10
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-10
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-10
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-10
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-09
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-09
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-08
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-06
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-06
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-05
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	7e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-11
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-10
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-10
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-10
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-10
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-06
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-06
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-05
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-10
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-10
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-10
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-10
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	6e-10
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-10
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-10
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	9e-10
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-09
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-07
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-06
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-05
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-05
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-04
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-04
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-09
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-09
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-09
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-09
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-09
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-08
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-08
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-08
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-07
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-07
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-07
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-07
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-06
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-06
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-06
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-04
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-09
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-09
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-08
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-08
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-08
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-08
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-08
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-05
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-04
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-04
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-04
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-09
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-08
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-07
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-07
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-07
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-07
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-05
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-04
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-04
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-08
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-08
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-08
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-08
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-08
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-08
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-08
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-07
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-07
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-08
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-08
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-07
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-07
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-07
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-07
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-05
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-05
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-04
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-04
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	9e-08
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-07
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-06
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-06
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-05
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	9e-08
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-07
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-07
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-06
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-06
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	8e-06
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-05
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-07
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-07
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-06
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	9e-06
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-05
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-05
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-04
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-07
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-05
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-04
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-07
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	7e-05
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	7e-05
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-04
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	9e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-07
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-07
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-06
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	9e-06
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-04
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-04
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-07
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-06
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-05
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-05
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-05
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-05
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	7e-05
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	8e-05
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	7e-07
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	8e-05
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-04
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-07
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-04
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-04
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	8e-07
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-06
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-06
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-05
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-05
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-07
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-06
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-05
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	7e-05
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-04
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	8e-07
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-06
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-05
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-05
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-05
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-05
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	7e-05
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-04
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-04
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	8e-07
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-06
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-05
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-05
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-05
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-05
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-04
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	8e-04
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-06
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-06
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-06
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-04
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-06
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-06
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-04
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-04
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-04
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-06
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-05
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-04
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-06
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	6e-06
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-06
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-05
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	6e-05
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-04
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-04
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-04
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-06
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-06
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	8e-06
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-05
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	9e-05
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-04
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-06
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-06
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	9e-06
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-05
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-05
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-04
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-04
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-04
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-06
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-05
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	9e-05
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-04
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-04
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-06
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-06
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-05
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-05
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-05
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-04
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	9e-06
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-04
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-04
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	9e-04
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-05
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-05
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-05
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-04
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-04
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-04
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-04
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-04
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-04
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-04
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-05
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-04
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-04
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-04
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-04
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-04
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-04
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-04
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-04
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-04
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-04
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-05
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-04
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-04
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-04
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-04
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-04
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	7e-05
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-04
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	7e-05
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	7e-05
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-04
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-04
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-04
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-04
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-04
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-04
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-04
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	5e-04
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	7e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	6e-04
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	7e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	7e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  241 bits (617), Expect = 2e-76
 Identities = 102/332 (30%), Positives = 164/332 (49%), Gaps = 38/332 (11%)

Query: 148 SYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQ-QQGALKSFIDECNA 206
           S  ++  A+DNFS +N++G G FG VYKG LADG   A+K LK +  QG    F  E   
Sbjct: 21  SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEM 80

Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           ++   HRN+L++   C        + + LV+ +M NG++   L    +       L   +
Sbjct: 81  ISMAVHRNLLRLRGFCM----TPTE-RLLVYPYMANGSVASCLRERPESQPP---LDWPK 132

Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
           R  I +  A  L YLH+  D  I H D+K++N+LLDE   A VGDFGLAK L +  +T  
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTH- 190

Query: 327 KNQTMSNGLKGSVGYIPPEY-INGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIH 385
               ++  ++G++G+I PEY   G  S   D++ YG++LLE+ TG+R  D     +    
Sbjct: 191 ----VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246

Query: 386 KFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLF-PDIESQVAQKKLEECLVSVMRIG 444
             +                LL+E+        E L   D++     +++E+    ++++ 
Sbjct: 247 MLLDWVKG-----------LLKEKK------LEALVDVDLQGNYKDEEVEQ----LIQVA 285

Query: 445 VMCSAASPRDRVGMKFVVNNLQAIRSKIRMRE 476
           ++C+ +SP +R  M  VV  L+      R  E
Sbjct: 286 LLCTQSSPMERPKMSEVVRMLEGDGLAERWEE 317

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  225 bits (577), Expect = 2e-70
 Identities = 97/346 (28%), Positives = 159/346 (45%), Gaps = 50/346 (14%)

Query: 130 KTSRRQSAPPSNEWQSGL-----SYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETA 184
           K +   +   S+ +           + +  AT+NF  + LIG G FG VYKG L DG   
Sbjct: 7   KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66

Query: 185 AIKVLKLQ-QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNG 243
           A+K    +  QG ++ F  E   L+  RH +++ ++  C     E N+   L++++M NG
Sbjct: 67  ALKRRTPESSQG-IEEFETEIETLSFCRHPHLVSLIGFC----DERNE-MILIYKYMENG 120

Query: 244 NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE 303
           NL + L+           +S  QRL I I  A  L YLH +    I H D+KS N+LLDE
Sbjct: 121 NLKRHLY---GSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDE 174

Query: 304 GMIAHVGDFGLAKFLFEESNTPSKNQT-MSNGLKGSVGYIPPEYIN-GHVSILGDIYSYG 361
             +  + DFG++K           +QT +S  +KG++GYI PEY   G ++   D+YS+G
Sbjct: 175 NFVPKITDFGISKK------GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFG 228

Query: 362 ILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLF 421
           ++L E+   +                   +LP  ++++ + ++       H   + E + 
Sbjct: 229 VVLFEVLCARSAIV--------------QSLPREMVNLAEWAVES-----HNNGQLEQIV 269

Query: 422 -PDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQ 466
            P++  ++      E L       V C A S  DR  M  V+  L+
Sbjct: 270 DPNLADKIR----PESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  207 bits (530), Expect = 1e-63
 Identities = 85/338 (25%), Positives = 146/338 (43%), Gaps = 62/338 (18%)

Query: 148 SYLKISNATDNFSEE------NLIGSGSFGSVYKGTLADGETAAIKVLKLQ-----QQGA 196
           S+ ++ N T+NF E       N +G G FG VYKG + +  T A+K L        ++  
Sbjct: 16  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL- 73

Query: 197 LKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEY 256
            + F  E   +   +H N+++++   S    +G+D   LV+ +M NG+L   L       
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSS----DGDD-LCLVYVYMPNGSLLDRLSCLDGT- 127

Query: 257 CHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK 316
                LS   R  I    A+ +++LH   +    H D+KS+N+LLDE   A + DFGLA+
Sbjct: 128 ---PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLAR 181

Query: 317 FLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDD 376
              + + T      M++ + G+  Y+ PE + G ++   DIYS+G++LLEI TG    D+
Sbjct: 182 ASEKFAQT-----VMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDE 236

Query: 377 MFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEEC 436
             +        + +              + +EE   E                 KK+ + 
Sbjct: 237 HREP----QLLLDIKEE-----------IEDEEKTIE-------------DYIDKKMNDA 268

Query: 437 ----LVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRS 470
               + ++  +   C       R  +K V   LQ + +
Sbjct: 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  196 bits (500), Expect = 4e-59
 Identities = 68/339 (20%), Positives = 126/339 (37%), Gaps = 45/339 (13%)

Query: 145 SGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDEC 204
             L    +   +       +   G FG V+K  L   E  A+K+  +Q + + +    E 
Sbjct: 12  VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQ-NEYEV 69

Query: 205 NALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSL 264
            +L  ++H NIL+ + +         D   L+  F   G+L  +L  +         +S 
Sbjct: 70  YSLPGMKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFLKANV--------VSW 120

Query: 265 MQRLNIVIDVASALDYLHNQYDT-------PIAHCDLKSSNVLLDEGMIAHVGDFGLAKF 317
            +  +I   +A  L YLH             I+H D+KS NVLL   + A + DFGLA  
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180

Query: 318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILG------DIYSYGILLLEIFTGK 371
                    K+   ++G  G+  Y+ PE + G ++         D+Y+ G++L E+ +  
Sbjct: 181 F-----EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235

Query: 372 RPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQK 431
              D    + +   +  +   PS           LE+  +   H+++   P +     + 
Sbjct: 236 TAADGPVDEYMLPFEEEIGQHPS-----------LEDMQEVVVHKKKR--PVLRDYWQKH 282

Query: 432 KLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRS 470
                L   +     C       R+    V   +  ++ 
Sbjct: 283 AGMAMLCETIE---ECWDHDAEARLSAGCVGERITQMQR 318

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  181 bits (461), Expect = 1e-53
 Identities = 62/234 (26%), Positives = 104/234 (44%), Gaps = 26/234 (11%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
                E ++G G+FG V K      +  AIK ++ + +   K+FI E   L+ + H NI+
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIV 64

Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           K+  +C +          LV E+   G+L   LH +          +    ++  +  + 
Sbjct: 65  KLYGACLNPVC-------LVMEYAEGGSLYNVLHGAE----PLPYYTAAHAMSWCLQCSQ 113

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDE-GMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
            + YLH+     + H DLK  N+LL   G +  + DFG A               M+N  
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD---------IQTHMTNN- 163

Query: 336 KGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV 388
           KGS  ++ PE   G + S   D++S+GI+L E+ T ++P D++      I   V
Sbjct: 164 KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV 217

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  180 bits (460), Expect = 2e-53
 Identities = 65/252 (25%), Positives = 121/252 (48%), Gaps = 30/252 (11%)

Query: 129 VKTSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKV 188
            +    Q A   ++       L I         +  IG+GSFG+V++     G   A+K+
Sbjct: 18  TENLYFQGAMDGDDMDIPWCDLNI---------KEKIGAGSFGTVHRAEW-HGSDVAVKI 67

Query: 189 LKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLD 246
           L  Q      +  F+ E   +  +RH NI+  + + +    +  +  ++V E++  G+L 
Sbjct: 68  LMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT----QPPNL-SIVTEYLSRGSLY 122

Query: 247 QWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI 306
           + LH S       ++L   +RL++  DVA  ++YLHN+ + PI H +LKS N+L+D+   
Sbjct: 123 RLLHKSGAR----EQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYT 177

Query: 307 AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-HVSILGDIYSYGILLL 365
             V DFGL++         +     S    G+  ++ PE +     +   D+YS+G++L 
Sbjct: 178 VKVCDFGLSRLK-------ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILW 230

Query: 366 EIFTGKRPTDDM 377
           E+ T ++P  ++
Sbjct: 231 ELATLQQPWGNL 242

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  179 bits (455), Expect = 2e-52
 Identities = 74/333 (22%), Positives = 125/333 (37%), Gaps = 42/333 (12%)

Query: 155 ATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECN--ALTSIRH 212
             DN     LIG G +G+VYKG+L D    A+KV     +   ++FI+E N   +  + H
Sbjct: 11  DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEH 66

Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            NI + +     V  +G     LV E+  NG+L ++L   T           +    +  
Sbjct: 67  DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--------SDWVSSCRLAH 118

Query: 273 DVASALDYLHNQYDT------PIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
            V   L YLH +          I+H DL S NVL+       + DFGL+  L        
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178

Query: 327 KNQTM-SNGLKGSVGYIPPEYINGHVSILG--------DIYSYGILLLEIFTGKRPTDDM 377
             +   +    G++ Y+ PE + G V++          D+Y+ G++  EIF   R TD  
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM--RCTDLF 236

Query: 378 FKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECL 437
             + +  ++        +     D+ +L+  E            P        K+    +
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREK---------QRPKFPEAW--KENSLAV 285

Query: 438 VSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRS 470
            S+      C       R+  +     +  +  
Sbjct: 286 RSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  173 bits (442), Expect = 4e-51
 Identities = 63/236 (26%), Positives = 107/236 (45%), Gaps = 39/236 (16%)

Query: 158 NFSE---ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQ----GALKSFIDECNALTSI 210
           +F+E   E +IG G FG VY+     G+  A+K  +          +++   E      +
Sbjct: 5   DFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63

Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
           +H NI+ +   C     +  +   LV EF R G L++ L          K++     +N 
Sbjct: 64  KHPNIIALRGVCL----KEPNL-CLVMEFARGGPLNRVLSG--------KRIPPDILVNW 110

Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH--------VGDFGLAKFLFEES 322
            + +A  ++YLH++   PI H DLKSSN+L+ + +           + DFGLA+      
Sbjct: 111 AVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----- 165

Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDM 377
                ++T      G+  ++ PE I     S   D++SYG+LL E+ TG+ P   +
Sbjct: 166 ----WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  172 bits (437), Expect = 2e-50
 Identities = 50/229 (21%), Positives = 91/229 (39%), Gaps = 31/229 (13%)

Query: 158 NFSE---ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGA--LKSFIDECNALTSIRH 212
           +F +      +     G ++KG    G    +KVLK++       + F +EC  L    H
Sbjct: 8   DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66

Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            N+L ++ +C S          L+  +M  G+L   LH  T+       +   Q +   +
Sbjct: 67  PNVLPVLGACQS---PPAPHPTLITHWMPYGSLYNVLHEGTN-----FVVDQSQAVKFAL 118

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           D+A  + +LH   +  I    L S +V++DE M A +    +                 S
Sbjct: 119 DMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSF------------QS 165

Query: 333 NGLKGSVGYIPPEYING----HVSILGDIYSYGILLLEIFTGKRPTDDM 377
            G   +  ++ PE +            D++S+ +LL E+ T + P  D+
Sbjct: 166 PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  170 bits (434), Expect = 8e-50
 Identities = 63/237 (26%), Positives = 103/237 (43%), Gaps = 40/237 (16%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQ-------QGALKSFIDECNALT 208
           +    E  IG G FG V+KG  + D    AIK L L             + F  E   ++
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
           ++ H NI+K+     +          +V EF+  G+L   L            +    +L
Sbjct: 79  NLNHPNIVKLYGLMHNPPR-------MVMEFVPCGDLYHRLL------DKAHPIKWSVKL 125

Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG-----MIAHVGDFGLAKFLFEESN 323
            +++D+A  ++Y+ NQ + PI H DL+S N+ L        + A V DFGL++       
Sbjct: 126 RLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ------ 178

Query: 324 TPSKNQTMSNGLKGSVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTDDM 377
                 ++S GL G+  ++ PE I       +   D YS+ ++L  I TG+ P D+ 
Sbjct: 179 ---SVHSVS-GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  165 bits (419), Expect = 1e-47
 Identities = 70/219 (31%), Positives = 107/219 (48%), Gaps = 28/219 (12%)

Query: 165 IGSGSFGSVYKGTLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSC 222
           IGSGSFG+VYKG    G+ A +K+L +       L++F +E   L   RH NIL  +   
Sbjct: 32  IGSGSFGTVYKGKW-HGDVA-VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH 282
           ++         A+V ++    +L   LH S        K  + + ++I    A  +DYLH
Sbjct: 90  TAPQL------AIVTQWCEGSSLYHHLHASE------TKFEMKKLIDIARQTARGMDYLH 137

Query: 283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI 342
            +    I H DLKS+N+ L E     +GDFGLA    E+S     +Q       GS+ ++
Sbjct: 138 AK---SIIHRDLKSNNIFLHEDNTVKIGDFGLAT---EKSRWSGSHQFEQL--SGSILWM 189

Query: 343 PPEYING----HVSILGDIYSYGILLLEIFTGKRPTDDM 377
            PE I        S   D+Y++GI+L E+ TG+ P  ++
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  163 bits (415), Expect = 8e-47
 Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 23/225 (10%)

Query: 162 ENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVS 220
             ++G G FG   K T    GE   +K L    +   ++F+ E   +  + H N+LK + 
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDY 280
                 Y+       + E+++ G L   +           +    QR++   D+AS + Y
Sbjct: 75  VL----YKDKRL-NFITEYIKGGTLRGIIKS------MDSQYPWSQRVSFAKDIASGMAY 123

Query: 281 LHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK---- 336
           LH+     I H DL S N L+ E     V DFGLA+ + +E   P   +++    +    
Sbjct: 124 LHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180

Query: 337 ---GSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDM 377
              G+  ++ PE ING       D++S+GI+L EI        D 
Sbjct: 181 TVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  162 bits (412), Expect = 2e-46
 Identities = 56/230 (24%), Positives = 99/230 (43%), Gaps = 30/230 (13%)

Query: 162 ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECN--ALTSIRHRNILKIV 219
              +G G +G V++G+   GE  A+K+   +     KS+  E        +RH NIL  +
Sbjct: 13  LECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFI 68

Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
           +S  +  +       L+  +   G+L  +L            L  +  L IV+ +AS L 
Sbjct: 69  ASDMTSRHSSTQL-WLITHYHEMGSLYDYLQL--------TTLDTVSCLRIVLSIASGLA 119

Query: 280 YLH-----NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
           +LH      Q    IAH DLKS N+L+ +     + D GLA      S + ++    +N 
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM---HSQSTNQLDVGNNP 176

Query: 335 LKGSVGYIPPEYINGHVSILG-------DIYSYGILLLEIFTGKRPTDDM 377
             G+  Y+ PE ++  + +         DI+++G++L E+         +
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  161 bits (410), Expect = 5e-46
 Identities = 58/259 (22%), Positives = 96/259 (37%), Gaps = 40/259 (15%)

Query: 131 TSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLK 190
               Q++    EW      L+I           LIG G FG VY G    GE A I+++ 
Sbjct: 16  RKASQTSIFLQEWDIPFEQLEI---------GELIGKGRFGQVYHGRW-HGEVA-IRLID 64

Query: 191 LQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQW 248
           +++  +  LK+F  E  A    RH N++  + +C S         A++    +   L   
Sbjct: 65  IERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-----PPHLAIITSLCKGRTLYSV 119

Query: 249 LHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH 308
           +            L + +   I  ++   + YLH +    I H DLKS NV  D G +  
Sbjct: 120 VRD------AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYDNGKV-V 169

Query: 309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING----------HVSILGDIY 358
           + DFGL            + +       G + ++ PE I              S   D++
Sbjct: 170 ITDFGLFSI--SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVF 227

Query: 359 SYGILLLEIFTGKRPTDDM 377
           + G +  E+   + P    
Sbjct: 228 ALGTIWYELHAREWPFKTQ 246

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  161 bits (409), Expect = 1e-45
 Identities = 57/261 (21%), Positives = 104/261 (39%), Gaps = 39/261 (14%)

Query: 131 TSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLK 190
           TS   S  P    ++    + +         +  IG G FG V++G    GE  A+K+  
Sbjct: 25  TSGSGSGLPLLVQRTIARTIVL---------QESIGKGRFGEVWRGKW-RGEEVAVKIFS 74

Query: 191 LQQQGALKSFIDECN--ALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQW 248
            ++    +S+  E        +RH NIL  +++ +  +        LV ++  +G+L  +
Sbjct: 75  SRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL-WLVSDYHEHGSLFDY 130

Query: 249 LHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH-----NQYDTPIAHCDLKSSNVLLDE 303
           L+           +++   + + +  AS L +LH      Q    IAH DLKS N+L+ +
Sbjct: 131 LNR--------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 182

Query: 304 GMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILG-------D 356
                + D GLA       +         N   G+  Y+ PE ++  +++         D
Sbjct: 183 NGTCCIADLGLAVRH---DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRAD 239

Query: 357 IYSYGILLLEIFTGKRPTDDM 377
           IY+ G++  EI          
Sbjct: 240 IYAMGLVFWEIARRCSIGGIH 260

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  160 bits (406), Expect = 2e-45
 Identities = 74/354 (20%), Positives = 129/354 (36%), Gaps = 56/354 (15%)

Query: 131 TSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLK 190
           +S   S  P    ++    +++            IG G +G V+ G    GE  A+KV  
Sbjct: 20  SSGSGSGLPLLVQRTIAKQIQM---------VKQIGKGRYGEVWMGKW-RGEKVAVKVFF 69

Query: 191 LQQQGALKSFIDECN--ALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQW 248
             +     S+  E        +RH NIL  +++             L+ ++  NG+L  +
Sbjct: 70  TTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL-YLITDYHENGSLYDY 125

Query: 249 LHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH-----NQYDTPIAHCDLKSSNVLLDE 303
           L            L     L +     S L +LH      Q    IAH DLKS N+L+ +
Sbjct: 126 LKS--------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK 177

Query: 304 GMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILG-------D 356
                + D GLA    +  +  ++     N   G+  Y+PPE ++  ++          D
Sbjct: 178 NGTCCIADLGLAV---KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMAD 234

Query: 357 IYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHE 416
           +YS+G++L E+         + +            LP H +   D S     E+  E   
Sbjct: 235 MYSFGLILWEVARRCVSGGIVEE----------YQLPYHDLVPSDPSY----EDMREIVC 280

Query: 417 EEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRS 470
            + L P   ++ +  +    +  +M     C A +P  R+    V   L  +  
Sbjct: 281 IKKLRPSFPNRWSSDECLRQMGKLMT---ECWAHNPASRLTALRVKKTLAKMSE 331

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  135 bits (341), Expect = 2e-36
 Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 24/215 (11%)

Query: 164 LIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGA--LKSFIDECNALTSIRHRNILKIVS 220
            IG GSF +VYKG         A   L+ ++      + F +E   L  ++H NI++   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDY 280
           S  S          LV E M +G L  +L         FK + +    +    +   L +
Sbjct: 93  SWESTVKGKKCI-VLVTELMTSGTLKTYLK-------RFKVMKIKVLRSWCRQILKGLQF 144

Query: 281 LHNQYDTPIAHCDLKSSNVLLD--EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
           LH +   PI H DLK  N+ +    G +  +GD GLA              + +  + G+
Sbjct: 145 LHTR-TPPIIHRDLKCDNIFITGPTGSV-KIGDLGLATLK---------RASFAKAVIGT 193

Query: 339 VGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRP 373
             ++ PE          D+Y++G+ +LE+ T + P
Sbjct: 194 PEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYP 228

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  130 bits (328), Expect = 1e-34
 Identities = 61/225 (27%), Positives = 94/225 (41%), Gaps = 28/225 (12%)

Query: 162 ENLIGSGSFGSVYKGTL--ADGETA--AIKVLK---LQQQGALKSFIDECNALTSIRHRN 214
              +G GSFG V +G      G+T   A+K LK   L Q  A+  FI E NA+ S+ HRN
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
           ++++     +          +V E    G+L   L        H     L       + V
Sbjct: 83  LIRLYGVVLT------PPMKMVTELAPLGSLLDRLR------KHQGHFLLGTLSRYAVQV 130

Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
           A  + YL ++      H DL + N+LL    +  +GDFGL + L +  +       M   
Sbjct: 131 AEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH----YVMQEH 183

Query: 335 LKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
            K    +  PE +     S   D + +G+ L E+FT G+ P   +
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  132 bits (333), Expect = 5e-34
 Identities = 55/218 (25%), Positives = 107/218 (49%), Gaps = 23/218 (10%)

Query: 162 ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSS 221
           E  +G+G FG V+  T       A+K +K     ++++F+ E N + +++H  ++K+ + 
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 222 CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYL 281
            +       +   ++ EFM  G+L  +L           K  L + ++    +A  + ++
Sbjct: 252 VT------KEPIYIITEFMAKGSLLDFLKSDEG-----SKQPLPKLIDFSAQIAEGMAFI 300

Query: 282 HNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGY 341
             +      H DL+++N+L+   ++  + DFGLA+ + +   T  +      G K  + +
Sbjct: 301 EQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE------GAKFPIKW 351

Query: 342 IPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
             PE IN G  +I  D++S+GILL+EI T G+ P   M
Sbjct: 352 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  127 bits (321), Expect = 8e-34
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 31/222 (13%)

Query: 162 ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNILKIV 219
              IGSG FG V+ G   + +  AIK ++   +GA+  + FI+E   +  + H  ++++ 
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLY 69

Query: 220 SSCSSVD--YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
             C              LV EFM +G L  +L             +    L + +DV   
Sbjct: 70  GVCLEQAPIC-------LVTEFMEHGCLSDYLRT------QRGLFAAETLLGMCLDVCEG 116

Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + YL       + H DL + N L+ E  +  V DFG+ +F+ ++  T S       G K 
Sbjct: 117 MAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST------GTKF 167

Query: 338 SVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
            V +  PE  +    S   D++S+G+L+ E+F+ GK P ++ 
Sbjct: 168 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  130 bits (329), Expect = 3e-33
 Identities = 56/221 (25%), Positives = 105/221 (47%), Gaps = 27/221 (12%)

Query: 162 ENLIGSGSFGSVYKGTLADGETA-AIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVS 220
           ++ +G G +G VY+G         A+K LK +    ++ F+ E   +  I+H N+++++ 
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 221 SCSSVD--YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
            C+     Y       ++ EFM  GNL  +L          +++S +  L +   ++SA+
Sbjct: 284 VCTREPPFY-------IITEFMTYGNLLDYLRECNR-----QEVSAVVLLYMATQISSAM 331

Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
           +YL  +      H +L + N L+ E  +  V DFGL++ +  ++ T         G K  
Sbjct: 332 EYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA------GAKFP 382

Query: 339 VGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
           + +  PE +     SI  D++++G+LL EI T G  P   +
Sbjct: 383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  126 bits (320), Expect = 4e-33
 Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 28/224 (12%)

Query: 162 ENLIGSGSFGSVYKGTL-ADGETA----AIKVLKL-QQQGALKSFIDECNALTSIRHRNI 215
             ++GSG+FG+VYKG    +GE      AIK L+      A K  +DE   + S+ + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
            +++  C +          L+ + M  G L  ++    D       +     LN  + +A
Sbjct: 80  CRLLGICLT------STVQLITQLMPFGCLLDYVREHKD------NIGSQYLLNWCVQIA 127

Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
             ++YL ++    + H DL + NVL+       + DFGLAK L  E          + G 
Sbjct: 128 KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE-----YHAEGG 179

Query: 336 KGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
           K  + ++  E I     +   D++SYG+ + E+ T G +P D +
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  125 bits (317), Expect = 4e-33
 Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 27/224 (12%)

Query: 161 EENLIGSGSFGSVYKGTLADGETA---AIKVLK--LQQQGALKSFIDECNALTSIRHRNI 215
           E+  +GSG+FG+V KG     +     A+K+LK            + E N +  + +  I
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80

Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           ++++  C +      +   LV E    G L+++L  +       + +     + +V  V+
Sbjct: 81  VRMIGICEA------ESWMLVMEMAELGPLNKYLQQN-------RHVKDKNIIELVHQVS 127

Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
             + YL         H DL + NVLL     A + DFGL+K L  + N            
Sbjct: 128 MGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY----YKAQTHG 180

Query: 336 KGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
           K  V +  PE IN    S   D++S+G+L+ E F+ G++P   M
Sbjct: 181 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  127 bits (322), Expect = 6e-33
 Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 37/232 (15%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLADGETA-AIKVLKLQQ-QGALKSFIDECNALTSIRHRN 214
           ++      IG G+FG V+ G L    T  A+K  +          F+ E   L    H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 215 ILKIVSSCSSVD--YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
           I++++  C+     Y       +V E ++ G+   +L           +L +   L +V 
Sbjct: 174 IVRLIGVCTQKQPIY-------IVMELVQGGDFLTFLR------TEGARLRVKTLLQMVG 220

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           D A+ ++YL ++      H DL + N L+ E  +  + DFG+++   +            
Sbjct: 221 DAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA------- 270

Query: 333 NGLKGSVGYIP-----PEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
               G +  +P     PE +N G  S   D++S+GILL E F+ G  P  ++
Sbjct: 271 ---SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL 319

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  125 bits (315), Expect = 8e-33
 Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 33/223 (14%)

Query: 162 ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNILKIV 219
              +G+G FG V  G        AIK++K   +G++    FI+E   + ++ H  ++++ 
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLY 85

Query: 220 SSCSSVD--YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
             C+     +       ++ E+M NG L  +L           +    Q L +  DV  A
Sbjct: 86  GVCTKQRPIF-------IITEYMANGCLLNYLRE------MRHRFQTQQLLEMCKDVCEA 132

Query: 278 LDYL-HNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
           ++YL   Q+     H DL + N L+++  +  V DFGL++++ ++  T S       G K
Sbjct: 133 MEYLESKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV------GSK 182

Query: 337 GSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
             V + PPE +     S   DI+++G+L+ EI++ GK P +  
Sbjct: 183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  125 bits (317), Expect = 9e-33
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 29/225 (12%)

Query: 162 ENLIGSGSFGSVYKGTL---ADGETA-AIKVLKL-QQQGALKSFIDECNALTSIRHRNIL 216
           E +IGSG  G V  G L      +   AIK LK    +   + F+ E + +    H NI+
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 217 KIVSSCSSVD--YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
           ++    +             +V E+M NG+LD +L        H  + ++MQ + ++  V
Sbjct: 114 RLEGVVTRGRLAM-------IVTEYMENGSLDTFLRT------HDGQFTIMQLVGMLRGV 160

Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
            + + YL +       H DL + NVL+D  ++  V DFGL++ L ++ +        + G
Sbjct: 161 GAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA----AYTTTG 213

Query: 335 LKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
            K  + +  PE I     S   D++S+G+++ E+   G+RP  +M
Sbjct: 214 GKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  125 bits (315), Expect = 1e-32
 Identities = 54/223 (24%), Positives = 98/223 (43%), Gaps = 25/223 (11%)

Query: 161 EENLIGSGSFGSVYKGTL--ADGETA-AIKVLKL-QQQGALKSFIDECNALTSIRHRNIL 216
            +  +G G+FGSV +G       +   AIKVLK   ++   +  + E   +  + +  I+
Sbjct: 14  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73

Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           +++  C +      +   LV E    G L ++L          +++ +     ++  V+ 
Sbjct: 74  RLIGVCQA------EALMLVMEMAGGGPLHKFLVG------KREEIPVSNVAELLHQVSM 121

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            + YL  +      H DL + NVLL     A + DFGL+K L  + +      T  +  K
Sbjct: 122 GMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY----YTARSAGK 174

Query: 337 GSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
             + +  PE IN    S   D++SYG+ + E  + G++P   M
Sbjct: 175 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  127 bits (322), Expect = 1e-32
 Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 23/218 (10%)

Query: 162 ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSS 221
           E  +G G FG V+ GT       AIK LK     + ++F+ E   +  +RH  ++++ + 
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 222 CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYL 281
            S       +   +V E+M  G+L  +L   T      K L L Q +++   +AS + Y+
Sbjct: 248 VSE------EPIYIVTEYMSKGSLLDFLKGETG-----KYLRLPQLVDMAAQIASGMAYV 296

Query: 282 HNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGY 341
                    H DL+++N+L+ E ++  V DFGLA+ + +   T  +        K  + +
Sbjct: 297 ERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA------KFPIKW 347

Query: 342 IPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
             PE    G  +I  D++S+GILL E+ T G+ P   M
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  124 bits (313), Expect = 2e-32
 Identities = 64/241 (26%), Positives = 99/241 (41%), Gaps = 39/241 (16%)

Query: 153 SNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIR 211
                +F E  LIGSG FG V+K     DG+T  IK +K   + A +    E  AL  + 
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLD 62

Query: 212 HRNILKIVSSCSSVDYEGNDFKA-----------LVFEFMRNGNLDQWLHPSTDEYCHFK 260
           H NI+         DY+                 +  EF   G L+QW+     E    +
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-----EKRRGE 117

Query: 261 KLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFE 320
           KL  +  L +   +   +DY+H++    + + DLK SN+ L +     +GDFGL   L  
Sbjct: 118 KLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSL-- 172

Query: 321 ESNTPSKNQTMSNGLKGSVGYIPPEYING----HVSILGDIYSYGILLLEIFTGKRPTDD 376
                 KN       KG++ Y+ PE I+           D+Y+ G++L E+        +
Sbjct: 173 ------KNDGKRTRSKGTLRYMSPEQISSQDYGKEV---DLYALGLILAELLHVCDTAFE 223

Query: 377 M 377
            
Sbjct: 224 T 224

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  125 bits (315), Expect = 2e-32
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 27/225 (12%)

Query: 162 ENLIGSGSFGSVYKGTLADGE----TAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNI 215
             ++G G FGSV +G L   +      A+K +KL    Q  ++ F+ E   +    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           ++++  C  +  +G     ++  FM+ G+L  +L  S  E    K + L   L  ++D+A
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGP-KHIPLQTLLKFMVDIA 157

Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
             ++YL N+      H DL + N +L + M   V DFGL+K ++                
Sbjct: 158 LGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----------R 204

Query: 336 KGSVGYIP-----PEYINGHV-SILGDIYSYGILLLEIFT-GKRP 373
           +G +  +P      E +   V +   D++++G+ + EI T G  P
Sbjct: 205 QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  129 bits (326), Expect = 2e-32
 Identities = 56/248 (22%), Positives = 106/248 (42%), Gaps = 26/248 (10%)

Query: 136 SAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTL--ADGETA-AIKVLKL- 191
            +P S+  +     L +    +    +  +G G+FGSV +G       +   AIKVLK  
Sbjct: 316 ESPFSDPEELKDKKLFLKR-DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG 374

Query: 192 QQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHP 251
            ++   +  + E   +  + +  I++++  C +      +   LV E    G L ++L  
Sbjct: 375 TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EALMLVMEMAGGGPLHKFLV- 427

Query: 252 STDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD 311
                   +++ +     ++  V+  + YL  +      H +L + NVLL     A + D
Sbjct: 428 -----GKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISD 479

Query: 312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT- 369
           FGL+K L  + +      T  +  K  + +  PE IN    S   D++SYG+ + E  + 
Sbjct: 480 FGLSKALGADDSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSY 535

Query: 370 GKRPTDDM 377
           G++P   M
Sbjct: 536 GQKPYKKM 543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  125 bits (315), Expect = 2e-32
 Identities = 56/254 (22%), Positives = 99/254 (38%), Gaps = 29/254 (11%)

Query: 162 ENLIGSGSFGSVYKGTL-----ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
            + +G G+FGSV            G   A+K L+       + F  E   L ++    I+
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87

Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           K           G     LV E++ +G L  +L        H  +L   + L     +  
Sbjct: 88  KYRGVSYG---PGRQSLRLVMEYLPSGCLRDFLQR------HRARLDASRLLLYSSQICK 138

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            ++YL ++      H DL + N+L++      + DFGLAK L  + +       +    +
Sbjct: 139 GMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY----YVVREPGQ 191

Query: 337 GSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALPS 394
             + +  PE ++    S   D++S+G++L E+FT   +      +         +M    
Sbjct: 192 SPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE------FLRMMGCER 245

Query: 395 HVMDVLDLSMLLEE 408
            V  +  L  LLEE
Sbjct: 246 DVPALSRLLELLEE 259

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  123 bits (312), Expect = 2e-32
 Identities = 57/220 (25%), Positives = 111/220 (50%), Gaps = 27/220 (12%)

Query: 162 ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNILKIV 219
              +G+G FG V+ G        A+K LK   QG++   +F+ E N +  ++H+ ++++ 
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLY 74

Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
           +  +       +   ++ E+M NG+L  +L   +       KL++ + L++   +A  + 
Sbjct: 75  AVVT------QEPIYIITEYMENGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMA 123

Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSV 339
           ++  +      H DL+++N+L+ + +   + DFGLA+ + +   T  +      G K  +
Sbjct: 124 FIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE------GAKFPI 174

Query: 340 GYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
            +  PE IN G  +I  D++S+GILL EI T G+ P   M
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  128 bits (324), Expect = 2e-32
 Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 23/218 (10%)

Query: 162 ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSS 221
           E  +G G FG V+ GT       AIK LK     + ++F+ E   +  +RH  ++++ + 
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 222 CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYL 281
            S       +   +V E+M  G+L  +L   T      K L L Q +++   +AS + Y+
Sbjct: 331 VSE------EPIYIVTEYMSKGSLLDFLKGETG-----KYLRLPQLVDMAAQIASGMAYV 379

Query: 282 HNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGY 341
                    H DL+++N+L+ E ++  V DFGLA+ + +   T  +        K  + +
Sbjct: 380 ERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA------KFPIKW 430

Query: 342 IPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
             PE    G  +I  D++S+GILL E+ T G+ P   M
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  123 bits (311), Expect = 2e-32
 Identities = 59/222 (26%), Positives = 96/222 (43%), Gaps = 31/222 (13%)

Query: 162 ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGAL--KSFIDECNALTSIRHRNILKIV 219
              +GSG FG V  G        A+K++K   +G++    F  E   +  + H  ++K  
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFY 69

Query: 220 SSCSSVD--YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
             CS     Y       +V E++ NG L  +L        H K L   Q L +  DV   
Sbjct: 70  GVCSKEYPIY-------IVTEYISNGCLLNYLRS------HGKGLEPSQLLEMCYDVCEG 116

Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           + +L +       H DL + N L+D  +   V DFG+ +++ ++    S       G K 
Sbjct: 117 MAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV------GTKF 167

Query: 338 SVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
            V +  PE  +    S   D++++GIL+ E+F+ GK P D  
Sbjct: 168 PVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  123 bits (312), Expect = 3e-32
 Identities = 58/250 (23%), Positives = 101/250 (40%), Gaps = 38/250 (15%)

Query: 136 SAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQ 194
           S   + E       L+     D   +  ++G G++G VY G  L++    AIK +  +  
Sbjct: 1   SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60

Query: 195 GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA----LVFEFMRNGNLDQWLH 250
              +   +E      ++H+NI         V Y G+  +     +  E +  G+L   L 
Sbjct: 61  RYSQPLHEEIALHKHLKHKNI---------VQYLGSFSENGFIKIFMEQVPGGSLSALLR 111

Query: 251 PSTDEYCHFKKLSLMQRL--NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD--EGMI 306
                   +  L   ++        +   L YLH+     I H D+K  NVL++   G++
Sbjct: 112 S------KWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVL 162

Query: 307 AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILG---DIYSYGIL 363
             + DFG +K L       +     +    G++ Y+ PE I+      G   DI+S G  
Sbjct: 163 -KISDFGTSKRL-------AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCT 214

Query: 364 LLEIFTGKRP 373
           ++E+ TGK P
Sbjct: 215 IIEMATGKPP 224

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  123 bits (312), Expect = 3e-32
 Identities = 65/286 (22%), Positives = 112/286 (39%), Gaps = 39/286 (13%)

Query: 131 TSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLA-----DGETAA 185
            S ++ A   +       +LK             +G G FG V            GE  A
Sbjct: 4   VSEKKPATEVDPTHFEKRFLKR---------IRDLGEGHFGKVELCRYDPEGDNTGEQVA 54

Query: 186 IKVLKL-QQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGN 244
           +K LK       +     E   L ++ H NI+K    C+    +G +   L+ EF+ +G+
Sbjct: 55  VKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGGNGIKLIMEFLPSGS 111

Query: 245 LDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG 304
           L ++L        +  K++L Q+L   + +   +DYL ++      H DL + NVL++  
Sbjct: 112 LKEYLP------KNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESE 162

Query: 305 MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGIL 363
               +GDFGL K +  +        T+ +     V +  PE +      I  D++S+G+ 
Sbjct: 163 HQVKIGDFGLTKAIETDKEY----YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVT 218

Query: 364 LLEIFT-GKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEE 408
           L E+ T     +  M           ++      M V  L   L+E
Sbjct: 219 LHELLTYCDSDSSPMAL------FLKMIGPTHGQMTVTRLVNTLKE 258

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  126 bits (319), Expect = 4e-32
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 29/219 (13%)

Query: 162 ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGA-LKSFIDECNALTSIRHRNILKIVS 220
              IG G FG V  G    G   A+K +K     A  ++F+ E + +T +RH N+++++ 
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIK---NDATAQAFLAEASVMTQLRHSNLVQLLG 253

Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDY 280
                  E      +V E+M  G+L  +L            L     L   +DV  A++Y
Sbjct: 254 VIV----EEKGGLYIVTEYMAKGSLVDYLRSRGR-----SVLGGDCLLKFSLDVCEAMEY 304

Query: 281 LHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG 340
           L         H DL + NVL+ E  +A V DFGL K             +  +  K  V 
Sbjct: 305 LEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----------STQDTGKLPVK 351

Query: 341 YIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDM 377
           +  PE +     S   D++S+GILL EI++ G+ P   +
Sbjct: 352 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 390

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  123 bits (311), Expect = 4e-32
 Identities = 54/247 (21%), Positives = 103/247 (41%), Gaps = 33/247 (13%)

Query: 139 PSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGE----TAAIKVLK-LQQ 193
             +   + +  + I +       + +IG G FG VY G   D        AIK L  + +
Sbjct: 3   LDSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE 62

Query: 194 QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPST 253
              +++F+ E   +  + H N+L ++        EG     ++  +M +G+L Q++    
Sbjct: 63  MQQVEAFLREGLLMRGLNHPNVLALIGIML--PPEGLPH--VLLPYMCHGDLLQFIR--- 115

Query: 254 DEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG 313
                 +  ++   ++  + VA  ++YL  Q      H DL + N +LDE     V DFG
Sbjct: 116 ---SPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFG 169

Query: 314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIP-----PEYINGHV-SILGDIYSYGILLLEI 367
           LA+ + +      +        +     +P      E +  +  +   D++S+G+LL E+
Sbjct: 170 LARDILDREYYSVQ--------QHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWEL 221

Query: 368 FT-GKRP 373
            T G  P
Sbjct: 222 LTRGAPP 228

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  124 bits (314), Expect = 5e-32
 Identities = 60/281 (21%), Positives = 115/281 (40%), Gaps = 33/281 (11%)

Query: 105 IVIPVTISVPIFILLLAALVIYHIVKTSRRQSAPPSNEWQSGLSYLKISNATDNFSEENL 164
           I     +S  ++    +  + +    T     +  + E    + ++ I  ++       +
Sbjct: 37  ICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEV 96

Query: 165 IGSGSFGSVYKGTLADGE----TAAIKVLK-LQQQGALKSFIDECNALTSIRHRNILKIV 219
           IG G FG VY GTL D +      A+K L  +   G +  F+ E   +    H N+L ++
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156

Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
             C     EG+    +V  +M++G+L  ++   T         ++   +   + VA  + 
Sbjct: 157 GICL--RSEGSPL--VVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMK 206

Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSV 339
           +L ++      H DL + N +LDE     V DFGLA+ ++++                + 
Sbjct: 207 FLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--------NKTG 255

Query: 340 GYIP-----PEYINGHV-SILGDIYSYGILLLEIFT-GKRP 373
             +P      E +     +   D++S+G+LL E+ T G  P
Sbjct: 256 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  122 bits (309), Expect = 6e-32
 Identities = 59/248 (23%), Positives = 114/248 (45%), Gaps = 40/248 (16%)

Query: 137 APPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETA-AIKVLKLQQQG 195
           +P  ++W+   + + +         ++ +G G +G VY+G         A+K LK   + 
Sbjct: 2   SPNYDKWEMERTDITM---------KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---ED 49

Query: 196 AL--KSFIDECNALTSIRHRNILKIVSSCSSVD--YEGNDFKALVFEFMRNGNLDQWLHP 251
            +  + F+ E   +  I+H N+++++  C+     Y       ++ EFM  GNL  +L  
Sbjct: 50  TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY-------IITEFMTYGNLLDYLRE 102

Query: 252 STDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD 311
                   +++S +  L +   ++SA++YL  +      H DL + N L+ E  +  V D
Sbjct: 103 CNR-----QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 154

Query: 312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT- 369
           FGL++ +  ++ T         G K  + +  PE +     SI  D++++G+LL EI T 
Sbjct: 155 FGLSRLMTGDTYTAHA------GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 208

Query: 370 GKRPTDDM 377
           G  P   +
Sbjct: 209 GMSPYPGI 216

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  123 bits (310), Expect = 7e-32
 Identities = 53/248 (21%), Positives = 90/248 (36%), Gaps = 27/248 (10%)

Query: 130 KTSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKV 188
           + S R  A  + +          S    +F   + +G GS+G V+K     DG   A+K 
Sbjct: 30  RVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR 89

Query: 189 LKLQQQGA--LKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNL 245
                +G       + E  +   + +H   +++  +     +E      L  E     +L
Sbjct: 90  SMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA-----WEEGGILYLQTELC-GPSL 143

Query: 246 DQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM 305
            Q              L   Q    + D   AL +LH+Q    + H D+K +N+ L    
Sbjct: 144 QQHCE------AWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRG 194

Query: 306 IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLL 365
              +GDFGL   L     T    +      +G   Y+ PE + G      D++S G+ +L
Sbjct: 195 RCKLGDFGLLVEL----GTAGAGEVQ----EGDPRYMAPELLQGSYGTAADVFSLGLTIL 246

Query: 366 EIFTGKRP 373
           E+      
Sbjct: 247 EVACNMEL 254

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  122 bits (308), Expect = 1e-31
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 22/214 (10%)

Query: 162 ENLIGSGSFGSVYKGTL-----ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
              +G G+FGSV            GE  A+K L+   +  L+ F  E   L S++H NI+
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74

Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           K    C S          L+ E++  G+L  +L        H +++  ++ L     +  
Sbjct: 75  KYKGVCYSAGRRN---LKLIMEYLPYGSLRDYLQ------KHKERIDHIKLLQYTSQICK 125

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            ++YL  +      H DL + N+L++      +GDFGL K L ++         +    +
Sbjct: 126 GMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF----FKVKEPGE 178

Query: 337 GSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT 369
             + +  PE +     S+  D++S+G++L E+FT
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  123 bits (310), Expect = 1e-31
 Identities = 60/229 (26%), Positives = 107/229 (46%), Gaps = 36/229 (15%)

Query: 162 ENLIGSGSFGSVYKGTLADGETA-----AIKVLKLQQQGA----LKSFIDECNALTSIRH 212
           + +IG+G FG VYKG L           AIK LK    G        F+ E   +    H
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGEAGIMGQFSH 105

Query: 213 RNILKIVSSCSSVD--YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
            NI+++    S             ++ E+M NG LD++L           + S++Q + +
Sbjct: 106 HNIIRLEGVISKYKPMM-------IITEYMENGALDKFLRE------KDGEFSVLQLVGM 152

Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
           +  +A+ + YL N       H DL + N+L++  ++  V DFGL++ L ++         
Sbjct: 153 LRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA----TY 205

Query: 331 MSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
            ++G K  + +  PE I+    +   D++S+GI++ E+ T G+RP  ++
Sbjct: 206 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  124 bits (312), Expect = 1e-31
 Identities = 59/225 (26%), Positives = 109/225 (48%), Gaps = 29/225 (12%)

Query: 162 ENLIGSGSFGSVYKGTL---ADGETA-AIKVLKLQ-QQGALKSFIDECNALTSIRHRNIL 216
           + ++G+G FG V  G L   +  E + AIK LK+   +   + F+ E + +    H NI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 217 KIVSSCSSVD--YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
           ++    +             +V E+M NG+LD +L        H  + +++Q + ++  +
Sbjct: 110 RLEGVVTKSKPVM-------IVTEYMENGSLDSFLRK------HDAQFTVIQLVGMLRGI 156

Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
           AS + YL +       H DL + N+L++  ++  V DFGL + L ++          + G
Sbjct: 157 ASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA----YTTRG 209

Query: 335 LKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
            K  + +  PE I     +   D++SYGI+L E+ + G+RP  +M
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  122 bits (309), Expect = 1e-31
 Identities = 56/246 (22%), Positives = 103/246 (41%), Gaps = 31/246 (12%)

Query: 130 KTSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTL-----ADGETA 184
           + +   +    +  Q    +LK             +G G+FGSV            GE  
Sbjct: 23  QGAMGSAFEDRDPTQFEERHLKF---------LQQLGKGNFGSVEMCRYDPLQDNTGEVV 73

Query: 185 AIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGN 244
           A+K L+   +  L+ F  E   L S++H NI+K    C S          L+ E++  G+
Sbjct: 74  AVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYGS 130

Query: 245 LDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG 304
           L  +L        H +++  ++ L     +   ++YL  +      H DL + N+L++  
Sbjct: 131 LRDYLQ------KHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENE 181

Query: 305 MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGIL 363
               +GDFGL K L ++         +    +  + +  PE +     S+  D++S+G++
Sbjct: 182 NRVKIGDFGLTKVLPQDKEY----YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVV 237

Query: 364 LLEIFT 369
           L E+FT
Sbjct: 238 LYELFT 243

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  122 bits (307), Expect = 2e-31
 Identities = 51/224 (22%), Positives = 96/224 (42%), Gaps = 28/224 (12%)

Query: 162 ENLIGSGSFGSVYKGTLADGETA-----AIKVLKLQ-QQGALKSFIDECNALTSIRHRNI 215
             ++GSG FG+V+KG       +      IKV++ +  + + ++  D   A+ S+ H +I
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           ++++  C            LV +++  G+L   +            L     LN  + +A
Sbjct: 78  VRLLGLCPG------SSLQLVTQYLPLGSLLDHVRQHRG------ALGPQLLLNWGVQIA 125

Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
             + YL       + H +L + NVLL       V DFG+A  L  +         + +  
Sbjct: 126 KGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ-----LLYSEA 177

Query: 336 KGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
           K  + ++  E I+ G  +   D++SYG+ + E+ T G  P   +
Sbjct: 178 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL 221

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  120 bits (304), Expect = 2e-31
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 29/219 (13%)

Query: 162 ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGA-LKSFIDECNALTSIRHRNILKIVS 220
              IG G FG V  G    G   A+K +K     A  ++F+ E + +T +RH N+++++ 
Sbjct: 26  LQTIGKGEFGDVMLGD-YRGNKVAVKCIK---NDATAQAFLAEASVMTQLRHSNLVQLLG 81

Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDY 280
                  E      +V E+M  G+L  +L            L     L   +DV  A++Y
Sbjct: 82  VIV----EEKGGLYIVTEYMAKGSLVDYLRSRGR-----SVLGGDCLLKFSLDVCEAMEY 132

Query: 281 LHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG 340
           L         H DL + NVL+ E  +A V DFGL K             +  +  K  V 
Sbjct: 133 LEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----------STQDTGKLPVK 179

Query: 341 YIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
           +  PE +     S   D++S+GILL EI++ G+ P   +
Sbjct: 180 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 218

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  121 bits (306), Expect = 3e-31
 Identities = 50/236 (21%), Positives = 94/236 (39%), Gaps = 14/236 (5%)

Query: 158 NFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           ++     +G G F  V     L DG   A+K +   +Q   +    E +      H NIL
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           ++V+ C       ++   L+  F + G L   +    D+      L+  Q L +++ +  
Sbjct: 90  RLVAYCLRERGAKHEAW-LLLPFFKRGTLWNEIERLKDKG---NFLTEDQILWLLLGICR 145

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L+ +H +     AH DLK +N+LL +     + D G             +  T+ +   
Sbjct: 146 GLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 337 --GSVGYIPPEYINGHVSILG----DIYSYGILLLEIFTGKRPTDDMFKDDLSIHK 386
              ++ Y  PE  +     +     D++S G +L  +  G+ P D +F+   S+  
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  126 bits (317), Expect = 4e-31
 Identities = 43/213 (20%), Positives = 81/213 (38%), Gaps = 27/213 (12%)

Query: 164 LIGSGSFGSVYKG--TLADGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVS 220
            I  G  G +Y       +G    +K L       A    + E   L  + H +I++I +
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDY 280
                D  G+    +V E++   +L +            +KL + + +  ++++  AL Y
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKG---------QKLPVAEAIAYLLEILPALSY 197

Query: 281 LHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG 340
           LH+     + + DLK  N++L E  +  + D G    +                L G+ G
Sbjct: 198 LHSI---GLVYNDLKPENIMLTEEQLK-LIDLGAVSRI-----------NSFGYLYGTPG 242

Query: 341 YIPPEYINGHVSILGDIYSYGILLLEIFTGKRP 373
           +  PE +    ++  DIY+ G  L  +      
Sbjct: 243 FQAPEIVRTGPTVATDIYTVGRTLAALTLDLPT 275

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  120 bits (303), Expect = 4e-31
 Identities = 48/223 (21%), Positives = 90/223 (40%), Gaps = 28/223 (12%)

Query: 162 ENLIGSGSFGSVYKGTLADGETA----AIKVLKL-QQQGALKSFIDECNALTSIRHRNIL 216
              IG G FG V++G     E      AIK  K        + F+ E   +    H +I+
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           K++   +       +   ++ E    G L  +L            L L   +     +++
Sbjct: 80  KLIGVITE------NPVWIIMELCTLGELRSFLQV------RKYSLDLASLILYAYQLST 127

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
           AL YL ++      H D+ + NVL+       +GDFGL++++ +           ++  K
Sbjct: 128 ALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS------TYYKASKGK 178

Query: 337 GSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
             + ++ PE IN    +   D++ +G+ + EI   G +P   +
Sbjct: 179 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 221

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  120 bits (304), Expect = 4e-31
 Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 23/219 (10%)

Query: 162 ENLIGSGSFGSVYKGTLADGE----TAAIKVLK-LQQQGALKSFIDECNALTSIRHRNIL 216
             +IG G FG VY GTL D +      A+K L  +   G +  F+ E   +    H N+L
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            ++  C     EG+    +V  +M++G+L  ++             ++   +   + VA 
Sbjct: 90  SLLGICL--RSEGSPL--VVLPYMKHGDLRNFIR------NETHNPTVKDLIGFGLQVAK 139

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            + YL ++      H DL + N +LDE     V DFGLA+ ++++      N+T   G K
Sbjct: 140 GMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT---GAK 193

Query: 337 GSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRP 373
             V ++  E +     +   D++S+G+LL E+ T G  P
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  120 bits (304), Expect = 6e-31
 Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 28/229 (12%)

Query: 157 DNFSEENLIGSGSFGSVYKGTL-ADGETA----AIKVLKL-QQQGALKSFIDECNALTSI 210
             F +  ++GSG+FG+VYKG    +GE      AIK L+      A K  +DE   + S+
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
            + ++ +++  C +          L+ + M  G L  ++        H   +     LN 
Sbjct: 75  DNPHVCRLLGICLT------STVQLITQLMPFGCLLDYVR------EHKDNIGSQYLLNW 122

Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
            + +A  ++YL ++    + H DL + NVL+       + DFGLAK L  E         
Sbjct: 123 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE-----Y 174

Query: 331 MSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDM 377
            + G K  + ++  E I   + +   D++SYG+ + E+ T G +P D +
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  120 bits (303), Expect = 7e-31
 Identities = 57/252 (22%), Positives = 111/252 (44%), Gaps = 30/252 (11%)

Query: 136 SAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETA----AIKVLK- 190
           S   S+E +  L  + I      F+   ++G G FGSV +  L   + +    A+K+LK 
Sbjct: 4   SLGISDELKEKLEDVLIPE--QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA 61

Query: 191 -LQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL-VFEFMRNGNLDQW 248
            +     ++ F+ E   +    H ++ K+V        +G     + +  FM++G+L  +
Sbjct: 62  DIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAF 121

Query: 249 LHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH 308
           L  S         L L   +  ++D+A  ++YL ++      H DL + N +L E M   
Sbjct: 122 LLASRIGENP-FNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177

Query: 309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIP-----PEYINGHV-SILGDIYSYGI 362
           V DFGL++ ++                +G    +P      E +  ++ ++  D++++G+
Sbjct: 178 VADFGLSRKIYSGDYY----------RQGCASKLPVKWLALESLADNLYTVHSDVWAFGV 227

Query: 363 LLLEIFT-GKRP 373
            + EI T G+ P
Sbjct: 228 TMWEIMTRGQTP 239

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  118 bits (299), Expect = 2e-30
 Identities = 58/231 (25%), Positives = 98/231 (42%), Gaps = 28/231 (12%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQG-ALKSFIDECNALTSIRHRN 214
            +F     +G G FG V++     D    AIK ++L  +  A +  + E  AL  + H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 215 ILKIVSSCSSVDYEGNDFKA-------LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQR 267
           I++  ++    +       +       +  +  R  NL  W+    +  C  ++      
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM----NGRCTIEERERSVC 120

Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLF--EESNTP 325
           L+I + +A A+++LH++    + H DLK SN+      +  VGDFGL   +   EE  T 
Sbjct: 121 LHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177

Query: 326 SKNQTMSNGLKGSVG---YIPPEYING----HVSILGDIYSYGILLLEIFT 369
                      G VG   Y+ PE I+G    H     DI+S G++L E+  
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKV---DIFSLGLILFELLY 225

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  118 bits (297), Expect = 3e-30
 Identities = 43/223 (19%), Positives = 94/223 (42%), Gaps = 28/223 (12%)

Query: 162 ENLIGSGSFGSVYKGTLADGETA----AIKVLKL-QQQGALKSFIDECNALTSIRHRNIL 216
             ++G G FG VY+G   + +      A+K  K        + F+ E   + ++ H +I+
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           K++           +   ++ E    G L  +L        +   L ++  +   + +  
Sbjct: 77  KLIGIIEE------EPTWIIMELYPYGELGHYLE------RNKNSLKVLTLVLYSLQICK 124

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
           A+ YL +       H D+   N+L+       +GDFGL++++ +E          ++  +
Sbjct: 125 AMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY------YKASVTR 175

Query: 337 GSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
             + ++ PE IN    +   D++ + + + EI + GK+P   +
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL 218

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  118 bits (299), Expect = 3e-30
 Identities = 66/263 (25%), Positives = 99/263 (37%), Gaps = 37/263 (14%)

Query: 159 FSEENL-----IGSGSFGSVYKGTL-----ADGETAAIKVLKLQ-QQGALKSFIDECNAL 207
           F +  L     +G G FG V            GE  A+K LK          +  E + L
Sbjct: 28  FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDIL 87

Query: 208 TSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQR 267
            ++ H +I+K    C            LV E++  G+L  +L            + L Q 
Sbjct: 88  RTLYHEHIIKYKGCCEDAGAASL---QLVMEYVPLGSLRDYLPRH--------SIGLAQL 136

Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
           L     +   + YLH Q+     H DL + NVLLD   +  +GDFGLAK + E       
Sbjct: 137 LLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY--- 190

Query: 328 NQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH 385
              +       V +  PE +  +      D++S+G+ L E+ T          K      
Sbjct: 191 -YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL---- 245

Query: 386 KFVLMALPSHVMDVLDLSMLLEE 408
              L+ +    M VL L+ LLE 
Sbjct: 246 --ELIGIAQGQMTVLRLTELLER 266

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  116 bits (293), Expect = 2e-29
 Identities = 59/252 (23%), Positives = 106/252 (42%), Gaps = 31/252 (12%)

Query: 132 SRRQSAPPSNEWQSGLSYLKISNAT--DNFSEENLIGSGSFGSVYKGT-LADGETAAIKV 188
           S+    PP  ++Q   +           NF  E  IG G F  VY+   L DG   A+K 
Sbjct: 5   SQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKK 64

Query: 189 LKLQQQG---ALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNL 245
           +++       A    I E + L  + H N++K  +S     +  ++   +V E    G+L
Sbjct: 65  VQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYAS-----FIEDNELNIVLELADAGDL 119

Query: 246 DQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM 305
            + +     +     +          + + SAL+++H++    + H D+K +NV +    
Sbjct: 120 SRMIKHFKKQKRLIPE---RTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATG 173

Query: 306 IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING----HVSILGDIYSYG 361
           +  +GD GL +F    S+  +   ++     G+  Y+ PE I+       S   DI+S G
Sbjct: 174 VVKLGDLGLGRFF---SSKTTAAHSL----VGTPYYMSPERIHENGYNFKS---DIWSLG 223

Query: 362 ILLLEIFTGKRP 373
            LL E+   + P
Sbjct: 224 CLLYEMAALQSP 235

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  116 bits (293), Expect = 2e-29
 Identities = 52/228 (22%), Positives = 95/228 (41%), Gaps = 39/228 (17%)

Query: 165 IGSGSFGSVYKGTLAD-----GETA-AIKVLK-LQQQGALKSFIDECNALTSIRHRNILK 217
           +G GSFG VY+G          ET  AIK +           F++E + +      ++++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 218 IVSSCSSVD--YEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCHFKKLSLMQRLNIVI 272
           ++   S             ++ E M  G+L  +L    P+          SL + + +  
Sbjct: 93  LLGVVSQGQPTL-------VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           ++A  + YL+        H DL + N ++ E     +GDFG+ + ++E            
Sbjct: 146 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-------- 194

Query: 333 NGLKGSVGYIP-----PEYINGHV-SILGDIYSYGILLLEIFT-GKRP 373
              KG  G +P     PE +   V +   D++S+G++L EI T  ++P
Sbjct: 195 --RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  115 bits (290), Expect = 2e-29
 Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 25/226 (11%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGA--LKSFIDECNALTSIRHR 213
           +++     IG+GS+G   K    +DG+    K L          +  + E N L  ++H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
           NI++       +    N    +V E+   G+L   +   T E  +  +      L ++  
Sbjct: 66  NIVRYYDR---IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE---EFVLRVMTQ 119

Query: 274 VASALDYLH--NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
           +  AL   H  +     + H DLK +NV LD      +GDFGLA+ L       + + + 
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-------NHDTSF 172

Query: 332 SNGLKGSVGYIPPEYING----HVSILGDIYSYGILLLEIFTGKRP 373
           +    G+  Y+ PE +N       S   DI+S G LL E+     P
Sbjct: 173 AKTFVGTPYYMSPEQMNRMSYNEKS---DIWSLGCLLYELCALMPP 215

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  115 bits (290), Expect = 5e-29
 Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 39/228 (17%)

Query: 165 IGSGSFGSVYKGTL-----ADGETA-AIKVLK-LQQQGALKSFIDECNALTSIRHRNILK 217
           +G G+FG VY+G +            A+K L  +  +     F+ E   ++   H+NI++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 218 IVSSCSSVD--YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
            +         +       ++ E M  G+L  +L  +         L+++  L++  D+A
Sbjct: 98  CIGVSLQSLPRF-------ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150

Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
               YL   +     H D+ + N LL     G +A +GDFG+A+ ++  S          
Sbjct: 151 CGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR------- 200

Query: 333 NGLKGSVGYIP-----PEYIN-GHVSILGDIYSYGILLLEIFT-GKRP 373
              KG    +P     PE    G  +   D +S+G+LL EIF+ G  P
Sbjct: 201 ---KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  115 bits (291), Expect = 5e-29
 Identities = 52/224 (23%), Positives = 94/224 (41%), Gaps = 30/224 (13%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGA--LKSFIDECNALTSIRHR 213
           + +     IG GSFG         DG    IK + + +  +   +    E   L +++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
           NI++   S     +E N    +V ++   G+L + +                Q L+  + 
Sbjct: 84  NIVQYRES-----FEENGSLYIVMDYCEGGDLFKRI-----NAQKGVLFQEDQILDWFVQ 133

Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +  AL ++H++    I H D+KS N+ L +     +GDFG+A+ L   ++T    +    
Sbjct: 134 ICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVL---NSTVELARAC-- 185

Query: 334 GLKGSVGYIPPEYING----HVSILGDIYSYGILLLEIFTGKRP 373
              G+  Y+ PE        + S   DI++ G +L E+ T K  
Sbjct: 186 --IGTPYYLSPEICENKPYNNKS---DIWALGCVLYELCTLKHA 224

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  115 bits (290), Expect = 5e-29
 Identities = 29/93 (31%), Positives = 43/93 (46%), Gaps = 5/93 (5%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           ++L  NS    +   +   + L  LDL  N + G +PQ  ++L  L  LN+S+N L GEI
Sbjct: 226 IHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284

Query: 61  SREGIFANASAISIVGNDKLCGGIQKLQLPECS 93
            + G        +   N  LCG      LP C+
Sbjct: 285 PQGGNLQRFDVSAYANNKCLCGSP----LPACT 313

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 72.6 bits (179), Expect = 2e-14
 Identities = 21/60 (35%), Positives = 30/60 (50%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           LY+ + +  G IP  L  ++ L  LD S N LSG +P   S L +L  +    N + G I
Sbjct: 106 LYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 71.4 bits (176), Expect = 6e-14
 Identities = 19/64 (29%), Positives = 29/64 (45%), Gaps = 1/64 (1%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSL-RHLNLSYNELDGE 59
           L    N+  GT+P S+ SL  L  +    N +SG +P  +     L   + +S N L G+
Sbjct: 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGK 189

Query: 60  ISRE 63
           I   
Sbjct: 190 IPPT 193

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 71.0 bits (175), Expect = 9e-14
 Identities = 23/61 (37%), Positives = 36/61 (59%), Gaps = 1/61 (1%)

Query: 1   LYLGN-NSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGE 59
           LY+G  N+  G IP ++  L  L  L ++  N+SG +P F S++ +L  L+ SYN L G 
Sbjct: 81  LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGT 140

Query: 60  I 60
           +
Sbjct: 141 L 141

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 70.3 bits (173), Expect = 1e-13
 Identities = 22/64 (34%), Positives = 33/64 (51%), Gaps = 2/64 (3%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAE-LDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGE 59
           +    N   G IP S  S   L   + +S N L+GK+P  F+ L +L  ++LS N L+G+
Sbjct: 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGD 212

Query: 60  ISRE 63
            S  
Sbjct: 213 ASVL 216

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 60.6 bits (148), Expect = 2e-10
 Identities = 20/63 (31%), Positives = 30/63 (47%), Gaps = 3/63 (4%)

Query: 1   LYLGNNSFKGT--IPVSLKSLRGLAELDLS-CNNLSGKVPQFFSKLLSLRHLNLSYNELD 57
           L L   +      IP SL +L  L  L +   NNL G +P   +KL  L +L +++  + 
Sbjct: 55  LDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS 114

Query: 58  GEI 60
           G I
Sbjct: 115 GAI 117

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 46.4 bits (111), Expect = 1e-05
 Identities = 16/59 (27%), Positives = 24/59 (40%), Gaps = 3/59 (5%)

Query: 5  NNSFKGTIPVSLKSLRGLAELDLSCNNLSG--KVPQFFSKLLSLRHLNLS-YNELDGEI 60
          N ++ G +  +      +  LDLS  NL     +P   + L  L  L +   N L G I
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPI 93

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  114 bits (288), Expect = 6e-29
 Identities = 48/248 (19%), Positives = 99/248 (39%), Gaps = 29/248 (11%)

Query: 153 SNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGA--LKSFIDECNALTS 209
           S  T  F E   IGSG FGSV+K     DG   AIK  K    G+   ++ + E  A   
Sbjct: 7   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66

Query: 210 I-RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
           + +H ++++  S+     +  +D   +  E+   G+L   +  +     +FK+  L    
Sbjct: 67  LGQHSHVVRYFSA-----WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK--- 118

Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK- 327
           ++++ V   L Y+H+     + H D+K SN+ +    I +       +  +  +    K 
Sbjct: 119 DLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKI 175

Query: 328 -------NQTMSNGLKGSVGYIPPEYINGHVSILG--DIYSYGILLLEIFTGKRPTDDMF 378
                    +     +G   ++  E +  + + L   DI++  + ++     +       
Sbjct: 176 GDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL----P 231

Query: 379 KDDLSIHK 386
           ++    H+
Sbjct: 232 RNGDQWHE 239

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  115 bits (290), Expect = 6e-29
 Identities = 57/256 (22%), Positives = 92/256 (35%), Gaps = 38/256 (14%)

Query: 130 KTSRRQSAPPSNEWQSGLSYLKISNA-----TDNFSEENLIGSGSFGSVYKGT-LADGET 183
           K  R       NE       LK  +          + +  +G GSFG V++      G  
Sbjct: 26  KLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQ 85

Query: 184 AAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA----LVFEF 239
            A+K ++L+         +E  A   +    I         V   G   +     +  E 
Sbjct: 86  CAVKKVRLEVFRV-----EELVACAGLSSPRI---------VPLYGAVREGPWVNIFMEL 131

Query: 240 MRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNV 299
           +  G+L Q +            L   + L  +      L+YLH +    I H D+K+ NV
Sbjct: 132 LEGGSLGQLIK-------QMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNV 181

Query: 300 LLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH-VSILGDI 357
           LL  +G  A + DFG A  L  +    S        + G+  ++ PE + G       DI
Sbjct: 182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY--IPGTETHMAPEVVMGKPCDAKVDI 239

Query: 358 YSYGILLLEIFTGKRP 373
           +S   ++L +  G  P
Sbjct: 240 WSSCCMMLHMLNGCHP 255

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  118 bits (298), Expect = 1e-28
 Identities = 51/228 (22%), Positives = 90/228 (39%), Gaps = 38/228 (16%)

Query: 162 ENLIGSGSFGSVYKGTLADGE----TAAIKVLKLQ-QQGALKSFIDECNALTSIRHRNIL 216
              IG G FG V++G     E      AIK  K        + F+ E   +    H +I+
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           K++   +       +   ++ E    G L  +L            L L   +     +++
Sbjct: 455 KLIGVITE------NPVWIIMELCTLGELRSFLQ------VRKFSLDLASLILYAYQLST 502

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
           AL YL ++      H D+ + NVL+       +GDFGL++++ + +             K
Sbjct: 503 ALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-----------K 548

Query: 337 GSVGYIP-----PEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
            S G +P     PE IN    +   D++ +G+ + EI   G +P   +
Sbjct: 549 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  113 bits (286), Expect = 2e-28
 Identities = 56/270 (20%), Positives = 102/270 (37%), Gaps = 40/270 (14%)

Query: 133 RRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQ 192
              S             + +      +S    IGSG    V++      +  AIK + L+
Sbjct: 6   HHSSGVDLGTENLYFQSMSVKG--RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLE 63

Query: 193 Q--QGALKSFIDECNALTSIRHRN--ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQW 248
           +     L S+ +E   L  ++  +  I+++           + +  +V E   N +L+ W
Sbjct: 64  EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY-----EITDQYIYMVMECG-NIDLNSW 117

Query: 249 LHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH 308
           L          K +   +R +   ++  A+  +H      I H DLK +N L+ +GM+  
Sbjct: 118 L-------KKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGML-K 166

Query: 309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILG------------D 356
           + DFG+A  +      P     + +   G+V Y+PPE I    S               D
Sbjct: 167 LIDFGIANQM-----QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 221

Query: 357 IYSYGILLLEIFTGKRPTDDMFKDDLSIHK 386
           ++S G +L  +  GK P   +      +H 
Sbjct: 222 VWSLGCILYYMTYGKTPFQQIINQISKLHA 251

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  112 bits (283), Expect = 3e-28
 Identities = 43/237 (18%), Positives = 99/237 (41%), Gaps = 48/237 (20%)

Query: 162 ENLIGSGSFGSVYKGTLADGETA--------AIKVLKLQQQGALKSFIDECNALTSIRHR 213
              +G G+F  ++KG   +             +KVL    +   +SF +  + ++ + H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 214 NILKI--VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           +++    V  C   +        LV EF++ G+LD +L        +   ++++ +L + 
Sbjct: 73  HLVLNYGVCVCGDENI-------LVQEFVKFGSLDTYLKK------NKNCINILWKLEVA 119

Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLD--------EGMIAHVGDFGLAKFLFEESN 323
             +A+A+ +L       + H ++ + N+LL               + D G++  +  +  
Sbjct: 120 KQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI 176

Query: 324 TPSKNQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFT-GKRPTDDM 377
                       +  + ++PPE I    ++++  D +S+G  L EI + G +P   +
Sbjct: 177 L-----------QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL 222

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  113 bits (284), Expect = 4e-28
 Identities = 60/232 (25%), Positives = 106/232 (45%), Gaps = 43/232 (18%)

Query: 165 IGSGSFGSVYKGTLAD-----GETA-AIKVLKLQQQGALKSFIDECNALTSIRHRNILKI 218
           +G G+FG V+     +      +   A+K LK   + A + F  E   LT ++H++I++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 219 VSSCSSVD--YEGNDFKALVFEFMRNGNLDQWL--------HPSTDEYCHFKKLSLMQRL 268
              C+             +VFE+MR+G+L+++L          +  E      L L Q L
Sbjct: 109 FGVCTEGRPLL-------MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161

Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
            +   VA+ + YL   +     H DL + N L+ +G++  +GDFG+++ ++         
Sbjct: 162 AVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY---- 214

Query: 329 QTMSNGLKGSVGYIP-----PEYINGHV-SILGDIYSYGILLLEIFT-GKRP 373
                   G    +P     PE I     +   D++S+G++L EIFT GK+P
Sbjct: 215 ------RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  113 bits (285), Expect = 4e-28
 Identities = 53/228 (23%), Positives = 95/228 (41%), Gaps = 39/228 (17%)

Query: 165 IGSGSFGSVYKGTL-----ADGETA-AIKVLK-LQQQGALKSFIDECNALTSIRHRNILK 217
           +G G+FG VY+G +            A+K L  +  +     F+ E   ++   H+NI++
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 218 IVSSCSSVD--YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
            +         +       ++ E M  G+L  +L  +         L+++  L++  D+A
Sbjct: 139 CIGVSLQSLPRF-------ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191

Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
               YL   +     H D+ + N LL     G +A +GDFG+A+ ++             
Sbjct: 192 CGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR------- 241

Query: 333 NGLKGSVGYIP-----PEYINGHV-SILGDIYSYGILLLEIFT-GKRP 373
              KG    +P     PE     + +   D +S+G+LL EIF+ G  P
Sbjct: 242 ---KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  112 bits (281), Expect = 6e-28
 Identities = 56/246 (22%), Positives = 99/246 (40%), Gaps = 32/246 (13%)

Query: 156 TDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRN 214
             +F E  ++G G+FG V K     D    AIK ++  ++  L + + E   L S+ H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLNHQY 63

Query: 215 ILKIVSSCSSVDYEGNDFKA--------LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           +++  ++            A        +  E+  NG L   +H               +
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN------LNQQRDE 117

Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
              +   +  AL Y+H+Q    I H DLK  N+ +DE     +GDFGLAK +    +   
Sbjct: 118 YWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174

Query: 327 KNQTMSNG----LKGSVG---YIPPEYINGHVSILG---DIYSYGILLLEIFTGKRPTDD 376
            +     G    L  ++G   Y+  E ++G         D+YS GI+  E+      +  
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIYP--FSTG 231

Query: 377 MFKDDL 382
           M + ++
Sbjct: 232 MERVNI 237

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  113 bits (283), Expect = 9e-28
 Identities = 28/273 (10%), Positives = 64/273 (23%), Gaps = 42/273 (15%)

Query: 152 ISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVL---KLQQQGALKSFIDECNAL 207
           +S           +  G    V+    +   E  A+KV        +  L+   +   A 
Sbjct: 57  LSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAA 116

Query: 208 TSIRHRNIL---------------------KIVSSCSSVDYEGNDFKALVFEFMRNGNLD 246
             +   +                                D        L+       +L+
Sbjct: 117 ARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLE 175

Query: 247 QWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI 306
                    Y       ++    +   +      L ++    + H      N+ +     
Sbjct: 176 LLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGR 232

Query: 307 AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILG---DIYSYGIL 363
             +GD      +       S            V Y P E++N   +      + +  G+ 
Sbjct: 233 LMLGDVSALWKVGTRGPASS----------VPVTYAPREFLNASTATFTHALNAWQLGLS 282

Query: 364 LLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHV 396
           +  ++    P   +        K   + +P   
Sbjct: 283 IYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTD 315

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  111 bits (280), Expect = 9e-28
 Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 44/233 (18%)

Query: 165 IGSGSFGSVYKGTLAD-----GETA-AIKVLKLQQQGALKSFIDECNALTSIRHRNILKI 218
           +G G+FG V+     +      +   A+K LK     A K F  E   LT+++H +I+K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 219 VSSCSSVD--YEGNDFKALVFEFMRNGNLDQWL---------HPSTDEYCHFKKLSLMQR 267
              C   D          +VFE+M++G+L+++L                    +L L Q 
Sbjct: 83  YGVCGDGDPLI-------MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135

Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
           L+I   +AS + YL +Q+     H DL + N L+   ++  +GDFG+++ ++        
Sbjct: 136 LHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 192

Query: 328 NQTMSNGLKGSVGYIP-----PEYIN-GHVSILGDIYSYGILLLEIFT-GKRP 373
             TM          +P     PE I     +   D++S+G++L EIFT GK+P
Sbjct: 193 GHTM----------LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  110 bits (278), Expect = 1e-27
 Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 28/216 (12%)

Query: 164 LIGSGSFGSVYKGT-LADGETAAIKVLKLQQQG---ALKSFIDECNALTSIRHRNILKIV 219
            +G G   +VY           AIK + +  +     LK F  E +  + + H+NI+ ++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 220 SSCSSVDY-EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
                 D  E +D   LV E++    L +++            LS+   +N    +   +
Sbjct: 78  ------DVDEEDDCYYLVMEYIEGPTLSEYIE-------SHGPLSVDTAINFTNQILDGI 124

Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
            + H+     I H D+K  N+L+D      + DFG+AK L E S       T +N + G+
Sbjct: 125 KHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS------LTQTNHVLGT 175

Query: 339 VGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
           V Y  PE   G       DIYS GI+L E+  G+ P
Sbjct: 176 VQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  110 bits (276), Expect = 6e-27
 Identities = 54/240 (22%), Positives = 96/240 (40%), Gaps = 38/240 (15%)

Query: 163 NLIGSGSFGSVYKGTLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRH--RNILKI 218
             IGSG    V++      +  AIK + L++     L S+ +E   L  ++     I+++
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
                      + +  +V E   N +L+ WL          K +   +R +   ++  A+
Sbjct: 75  YDY-----EITDQYIYMVMECG-NIDLNSWL-------KKKKSIDPWERKSYWKNMLEAV 121

Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS 338
             +H      I H DLK +N L+ +GM+  + DFG+A  +      P     + +   G+
Sbjct: 122 HTIHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQM-----QPDTTSVVKDSQVGT 172

Query: 339 VGYIPPEYINGHVSILG------------DIYSYGILLLEIFTGKRPTDDMFKDDLSIHK 386
           V Y+PPE I    S               D++S G +L  +  GK P   +      +H 
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 232

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  109 bits (274), Expect = 6e-27
 Identities = 49/221 (22%), Positives = 90/221 (40%), Gaps = 32/221 (14%)

Query: 164 LIGSGSFGSVYKGT-LADGETAAIKVLKLQQQG---ALKSFIDECNALTSIRHRNILKI- 218
           ++G G    V+    L D    A+KVL+            F  E     ++ H  I+ + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 219 -----VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
                 +    + Y       +V E++    L   +H           ++  + + ++ D
Sbjct: 79  DTGEAETPAGPLPY-------IVMEYVDGVTLRDIVH-------TEGPMTPKRAIEVIAD 124

Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
              AL++ H      I H D+K +N+++       V DFG+A+ + +  N+     T + 
Sbjct: 125 ACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS----VTQTA 177

Query: 334 GLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
            + G+  Y+ PE   G  V    D+YS G +L E+ TG+ P
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  110 bits (277), Expect = 7e-27
 Identities = 58/268 (21%), Positives = 104/268 (38%), Gaps = 38/268 (14%)

Query: 135 QSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQ- 193
                 ++  S  +   IS     +S    IGSG    V++      +  AIK + L++ 
Sbjct: 34  DLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA 93

Query: 194 -QGALKSFIDECNALTSIRH--RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH 250
               L S+ +E   L  ++     I+++           + +  +V E   N +L+ WL 
Sbjct: 94  DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY-----EITDQYIYMVMECG-NIDLNSWLK 147

Query: 251 PSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG 310
                    K +   +R +   ++  A+  +H      I H DLK +N L+ +GM+  + 
Sbjct: 148 -------KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDGML-KLI 196

Query: 311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILG------------DIY 358
           DFG+A  +      P     + +   G+V Y+PPE I    S               D++
Sbjct: 197 DFGIANQM-----QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 251

Query: 359 SYGILLLEIFTGKRPTDDMFKDDLSIHK 386
           S G +L  +  GK P   +      +H 
Sbjct: 252 SLGCILYYMTYGKTPFQQIINQISKLHA 279

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  109 bits (274), Expect = 9e-27
 Identities = 64/236 (27%), Positives = 100/236 (42%), Gaps = 48/236 (20%)

Query: 162 ENLIGSGSFGSVYKGTLADGE---TAAIKVLKLQQQGA----LKSFIDECNALTSI-RHR 213
           +++IG G+FG V K  +        AAIK +K   + A     + F  E   L  +  H 
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK---EYASKDDHRDFAGELEVLCKLGHHP 86

Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWL---------HPSTDEYCHFKKLSL 264
           NI+ ++ +C    Y       L  E+  +GNL  +L                     LS 
Sbjct: 87  NIINLLGACEHRGY-----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141

Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNT 324
            Q L+   DVA  +DYL  +      H DL + N+L+ E  +A + DFGL++        
Sbjct: 142 QQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR-------- 190

Query: 325 PSKNQTMSNGLKGSVGYIP-----PEYINGHV-SILGDIYSYGILLLEIFT-GKRP 373
                     +K ++G +P      E +N  V +   D++SYG+LL EI + G  P
Sbjct: 191 -----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  108 bits (272), Expect = 2e-26
 Identities = 58/239 (24%), Positives = 106/239 (44%), Gaps = 53/239 (22%)

Query: 165 IGSGSFGSVYKGTLADGE------TAAIKVLKLQQQGA----LKSFIDECNALTSI-RHR 213
           +G G+FG V +      +      T A+K+LK   +GA     ++ + E   L  I  H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 91

Query: 214 NILKIVSSCSSVD---YEGNDFKALVFEFMRNGNLDQWL---------HPSTDEYCHFKK 261
           N++ ++ +C+              ++ EF + GNL  +L         +    E  +   
Sbjct: 92  NVVNLLGACTKPGGPLM-------VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144

Query: 262 LSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEE 321
           L+L   +     VA  +++L ++      H DL + N+LL E  +  + DFGLA+ ++++
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 201

Query: 322 SNTPSKNQTMSNGLKGSVGYIP-----PEYINGHV-SILGDIYSYGILLLEIFT-GKRP 373
            +           ++     +P     PE I   V +I  D++S+G+LL EIF+ G  P
Sbjct: 202 PDY----------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  107 bits (269), Expect = 3e-26
 Identities = 60/245 (24%), Positives = 108/245 (44%), Gaps = 59/245 (24%)

Query: 165 IGSGSFGSVYKGTLADGE------TAAIKVLKLQQQGA----LKSFIDECNALTSIRHRN 214
           +G G FG V K T    +      T A+K+LK   + A    L+  + E N L  + H +
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNVLKQVNHPH 87

Query: 215 ILKIVSSCSSVD--YEGNDFKALVFEFMRNGNLDQWL-----------------HPSTDE 255
           ++K+  +CS             L+ E+ + G+L  +L                 + S+ +
Sbjct: 88  VIKLYGACSQDGPLL-------LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140

Query: 256 YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA 315
           +   + L++   ++    ++  + YL       + H DL + N+L+ EG    + DFGL+
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLS 197

Query: 316 KFLFEESNTPSKNQTMSNGLKGSVGYIP-----PEYINGHV-SILGDIYSYGILLLEIFT 369
           + ++EE +           +K S G IP      E +  H+ +   D++S+G+LL EI T
Sbjct: 198 RDVYEEDSY----------VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

Query: 370 -GKRP 373
            G  P
Sbjct: 248 LGGNP 252

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  106 bits (268), Expect = 3e-26
 Identities = 55/240 (22%), Positives = 98/240 (40%), Gaps = 51/240 (21%)

Query: 162 ENLIGSGSFGSVYKGTLAD-----GETA-AIKVLKLQQQGA----LKSFIDECNALTSIR 211
              +G   FG VYKG L          A AIK LK     A     + F  E      ++
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEAMLRARLQ 70

Query: 212 HRNILKIVSSCSSVD--YEGNDFKALVFEFMRNGNLDQWL---------HPSTDEYCHFK 260
           H N++ ++   +             ++F +  +G+L ++L           + D+     
Sbjct: 71  HPNVVCLLGVVTKDQPLS-------MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123

Query: 261 KLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFE 320
            L     +++V  +A+ ++YL + +   + H DL + NVL+ + +   + D GL + ++ 
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYA 180

Query: 321 ESNTPSKNQTMSNGLKGSVGYIP-----PEYIN-GHVSILGDIYSYGILLLEIFT-GKRP 373
                                +P     PE I  G  SI  DI+SYG++L E+F+ G +P
Sbjct: 181 ADYYK----------LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  108 bits (271), Expect = 5e-26
 Identities = 63/283 (22%), Positives = 116/283 (40%), Gaps = 60/283 (21%)

Query: 128 IVKTSRRQSAPPSNEWQSGLSYLKISNATD-NFSEENL-----IGSGSFGSVYKGTLADG 181
           +V+ + R S+       +G+S  ++       F  + L     +G G FG V        
Sbjct: 46  LVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGI 105

Query: 182 E--------TAAIKVLKLQQQGA----LKSFIDECNALTSI-RHRNILKIVSSCSSVD-- 226
           +        T A+K+LK     A    L   + E   +  I +H+NI+ ++ +C+     
Sbjct: 106 DKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 162

Query: 227 YEGNDFKALVFEFMRNGNLDQWL---------HPSTDEYCHFKKLSLMQRLNIVIDVASA 277
           Y       ++ E+   GNL ++L         +         ++++    ++    +A  
Sbjct: 163 Y-------VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARG 215

Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
           ++YL +Q      H DL + NVL+ E  +  + DFGLA+ +                 K 
Sbjct: 216 MEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY----------KKT 262

Query: 338 SVGYIP-----PEYINGHV-SILGDIYSYGILLLEIFT-GKRP 373
           + G +P     PE +   V +   D++S+G+L+ EIFT G  P
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  107 bits (268), Expect = 6e-26
 Identities = 58/281 (20%), Positives = 99/281 (35%), Gaps = 63/281 (22%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKL-QQQGALKSFIDECNALTSIRHRN 214
            +F     +G G FG V++     D    AIK ++L  ++ A +  + E  AL  + H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTD-------------------- 254
           I++  ++      E    +                 PS                      
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 255 ---------------EYCHFKKLSLMQR---------------LNIVIDVASALDYLHNQ 284
                          + C   K +L                  L+I I +A A+++LH++
Sbjct: 126 QLQPSSPKVYLYIQMQLCR--KENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183

Query: 285 YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK--GSVG-- 340
               + H DLK SN+      +  VGDFGL   + ++    +    M       G VG  
Sbjct: 184 G---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240

Query: 341 -YIPPEYINGHV-SILGDIYSYGILLLEIFTGKRPTDDMFK 379
            Y+ PE I+G+  S   DI+S G++L E+        +  +
Sbjct: 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR 281

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  106 bits (267), Expect = 8e-26
 Identities = 56/245 (22%), Positives = 103/245 (42%), Gaps = 48/245 (19%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLADGE--------TAAIKVLK-LQQQGALKSFIDECNAL 207
           D  +    +G G+FG V        +        T A+K+LK    +  L   + E   +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 208 TSI-RHRNILKIVSSCSSVD--YEGNDFKALVFEFMRNGNLDQWL---------HPSTDE 255
             I +H+NI+ ++ +C+     Y       ++ E+   GNL ++L         +     
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLY-------VIVEYASKGNLREYLRARRPPGMEYSYDIN 147

Query: 256 YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA 315
               ++++    ++    +A  ++YL +Q      H DL + NVL+ E  +  + DFGLA
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLA 204

Query: 316 KFLFEESNTPSKNQTMSNGLKGSVGYIP-----PEYINGHV-SILGDIYSYGILLLEIFT 369
           + +                 K + G +P     PE +   V +   D++S+G+L+ EIFT
Sbjct: 205 RDINNIDYY----------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

Query: 370 -GKRP 373
            G  P
Sbjct: 255 LGGSP 259

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  109 bits (275), Expect = 1e-25
 Identities = 39/99 (39%), Positives = 47/99 (47%), Gaps = 4/99 (4%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L LG+N   G+IP  +  LRGL  LDLS N L G++PQ  S L  L  ++LS N L G I
Sbjct: 661 LNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPI 720

Query: 61  SREGIFANASAISIVGNDKLCGGIQKLQLPECSRKNPRK 99
              G F        + N  LCG      LP C   N   
Sbjct: 721 PEMGQFETFPPAKFLNNPGLCG----YPLPRCDPSNADG 755

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 76.9 bits (190), Expect = 4e-15
 Identities = 29/60 (48%), Positives = 33/60 (55%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           LYL NN F G IP +L +   L  L LS N LSG +P     L  LR L L  N L+GEI
Sbjct: 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEI 458

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 76.9 bits (190), Expect = 4e-15
 Identities = 27/63 (42%), Positives = 35/63 (55%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L+L  N   GTIP SL SL  L +L L  N L G++PQ    + +L  L L +N+L GEI
Sbjct: 423 LHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEI 482

Query: 61  SRE 63
              
Sbjct: 483 PSG 485

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 74.9 bits (185), Expect = 2e-14
 Identities = 23/63 (36%), Positives = 32/63 (50%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L  N   G IP  L +   L  + LS N L+G++P++  +L +L  L LS N   G I
Sbjct: 471 LILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNI 530

Query: 61  SRE 63
             E
Sbjct: 531 PAE 533

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 72.2 bits (178), Expect = 1e-13
 Identities = 22/63 (34%), Positives = 30/63 (47%), Gaps = 1/63 (1%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L + +N+F   IP  L     L  LD+S N LSG   +  S    L+ LN+S N+  G I
Sbjct: 205 LDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPI 263

Query: 61  SRE 63
              
Sbjct: 264 PPL 266

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 71.9 bits (177), Expect = 2e-13
 Identities = 26/67 (38%), Positives = 31/67 (46%), Gaps = 1/67 (1%)

Query: 1   LYLGNNSFKGTIPVSLK-SLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGE 59
           L L  N F G IP  L  +   L  LDLS N+  G VP FF     L  L LS N   GE
Sbjct: 274 LSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGE 333

Query: 60  ISREGIF 66
           +  + + 
Sbjct: 334 LPMDTLL 340

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 70.7 bits (174), Expect = 4e-13
 Identities = 23/63 (36%), Positives = 34/63 (53%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L  N  +G IP  L  ++ L  L L  N+L+G++P   S   +L  ++LS N L GEI
Sbjct: 447 LKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEI 506

Query: 61  SRE 63
            + 
Sbjct: 507 PKW 509

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 70.3 bits (173), Expect = 6e-13
 Identities = 23/63 (36%), Positives = 30/63 (47%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           + L NN   G IP  +  L  LA L LS N+ SG +P       SL  L+L+ N  +G I
Sbjct: 495 ISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTI 554

Query: 61  SRE 63
              
Sbjct: 555 PAA 557

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 69.2 bits (170), Expect = 1e-12
 Identities = 22/63 (34%), Positives = 32/63 (50%), Gaps = 3/63 (4%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L +  N   G + VS      L  LD+S NN S  +P       +L+HL++S N+L G+ 
Sbjct: 183 LAISGNKISGDVDVS--RCVNLEFLDVSSNNFSTGIPFLGD-CSALQHLDISGNKLSGDF 239

Query: 61  SRE 63
           SR 
Sbjct: 240 SRA 242

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 68.4 bits (168), Expect = 2e-12
 Identities = 18/63 (28%), Positives = 30/63 (47%), Gaps = 2/63 (3%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L +  N   G    ++ +   L  L++S N   G +P     L SL++L+L+ N+  GEI
Sbjct: 228 LDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEI 285

Query: 61  SRE 63
              
Sbjct: 286 PDF 288

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 67.6 bits (166), Expect = 4e-12
 Identities = 24/65 (36%), Positives = 31/65 (47%), Gaps = 2/65 (3%)

Query: 1   LYLGNNSFKGTIPVSL--KSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDG 58
           L L +N+F G I  +L       L EL L  N  +GK+P   S    L  L+LS+N L G
Sbjct: 373 LDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSG 432

Query: 59  EISRE 63
            I   
Sbjct: 433 TIPSS 437

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 66.9 bits (164), Expect = 6e-12
 Identities = 30/88 (34%), Positives = 45/88 (51%), Gaps = 4/88 (4%)

Query: 1   LYLGNNSFKGTIPV-SLKSLRGLAELDLSCNNLSGKVPQFFSKLL-SLRHLNLSYNELDG 58
           L L +N+F G +P+ +L  +RGL  LDLS N  SG++P+  + L  SL  L+LS N   G
Sbjct: 323 LALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSG 382

Query: 59  EISREGIFANASAISI--VGNDKLCGGI 84
            I         + +    + N+   G I
Sbjct: 383 PILPNLCQNPKNTLQELYLQNNGFTGKI 410

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 66.5 bits (163), Expect = 8e-12
 Identities = 15/63 (23%), Positives = 23/63 (36%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
                  F+G     L  L      +++     G     F    S+  L++SYN L G I
Sbjct: 589 GAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYI 648

Query: 61  SRE 63
            +E
Sbjct: 649 PKE 651

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 64.9 bits (159), Expect = 3e-11
 Identities = 23/68 (33%), Positives = 30/68 (44%), Gaps = 3/68 (4%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQF--FSKLLSLRHLNLSYNELDG 58
           L+L N+   G++    K    L  LDLS N+LSG V           L+ LN+S N LD 
Sbjct: 82  LFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDF 140

Query: 59  EISREGIF 66
                G  
Sbjct: 141 PGKVSGGL 148

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 64.2 bits (157), Expect = 5e-11
 Identities = 21/61 (34%), Positives = 31/61 (50%), Gaps = 3/61 (4%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLL-SLRHLNLSYNELDGE 59
           L + +N F G IP     L+ L  L L+ N  +G++P F S    +L  L+LS N   G 
Sbjct: 252 LNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA 309

Query: 60  I 60
           +
Sbjct: 310 V 310

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 64.2 bits (157), Expect = 5e-11
 Identities = 19/65 (29%), Positives = 30/65 (46%), Gaps = 4/65 (6%)

Query: 1   LYLGNNSFKGTIPVS-LKSLRGLAELDLSCNNLSGKVP---QFFSKLLSLRHLNLSYNEL 56
           L + +N+      VS    L  L  LDLS N++SG              L+HL +S N++
Sbjct: 131 LNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKI 190

Query: 57  DGEIS 61
            G++ 
Sbjct: 191 SGDVD 195

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 63.4 bits (155), Expect = 7e-11
 Identities = 23/66 (34%), Positives = 28/66 (42%), Gaps = 3/66 (4%)

Query: 1   LYLGNNSFKGTIP--VSLKSLRGLAELDLSCNNLSGKVP-QFFSKLLSLRHLNLSYNELD 57
           L L  NS  G +    SL S  GL  L++S N L          KL SL  L+LS N + 
Sbjct: 105 LDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSIS 164

Query: 58  GEISRE 63
           G     
Sbjct: 165 GANVVG 170

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 61.5 bits (150), Expect = 4e-10
 Identities = 22/69 (31%), Positives = 31/69 (44%), Gaps = 1/69 (1%)

Query: 2   YLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEIS 61
               N     +  SL SL GL  L LS ++++G V   F    SL  L+LS N L G ++
Sbjct: 59  SKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVT 117

Query: 62  REGIFANAS 70
                 + S
Sbjct: 118 TLTSLGSCS 126

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 59.2 bits (144), Expect = 2e-09
 Identities = 21/61 (34%), Positives = 25/61 (40%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L NNSF G IP  L   R L  LDL+ N  +G +P    K       N    +    I
Sbjct: 519 LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYI 578

Query: 61  S 61
            
Sbjct: 579 K 579

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 47.6 bits (114), Expect = 8e-06
 Identities = 17/87 (19%), Positives = 31/87 (35%), Gaps = 8/87 (9%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYN--ELDG 58
           L L  N F GTIP ++          ++ N ++GK   +       +  + + N  E  G
Sbjct: 543 LDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQG 598

Query: 59  EISRE-GIFANASAISIVGNDKLCGGI 84
             S +    +  +  +I       G  
Sbjct: 599 IRSEQLNRLSTRNPCNITSR-VYGGHT 624

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 43.0 bits (102), Expect = 2e-04
 Identities = 13/50 (26%), Positives = 21/50 (42%), Gaps = 3/50 (6%)

Query: 22  LAELDLSCNNLS---GKVPQFFSKLLSLRHLNLSYNELDGEISREGIFAN 68
           +  +DLS   L+     V      L  L  L LS + ++G +S     A+
Sbjct: 52  VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSAS 101

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  105 bits (265), Expect = 1e-25
 Identities = 58/240 (24%), Positives = 97/240 (40%), Gaps = 54/240 (22%)

Query: 165 IGSGSFGSVYKGTLADGE------TAAIKVLKLQQQGA----LKSFIDECNALTSI-RHR 213
           +G+G+FG V + T           T A+K+LK     A     ++ + E   L+ +  H 
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 87

Query: 214 NILKIVSSCSSVD--YEGNDFKALVFEFMRNGNLDQWL-----------HPSTDEYCHFK 260
           NI+ ++ +C+             ++ E+   G+L  +L                      
Sbjct: 88  NIVNLLGACTIGGPTL-------VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 261 KLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFE 320
            L L   L+    VA  + +L ++      H DL + N+LL  G I  + DFGLA+ +  
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 321 ESNTPSKNQTMSNGLKGSVGYIP-----PEYINGHV-SILGDIYSYGILLLEIFT-GKRP 373
           +SN           +      +P     PE I   V +   D++SYGI L E+F+ G  P
Sbjct: 198 DSNY----------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  105 bits (264), Expect = 1e-25
 Identities = 47/218 (21%), Positives = 80/218 (36%), Gaps = 28/218 (12%)

Query: 162 ENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILK 217
             L+G G  G VY+          A+K++                E      ++  +++ 
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 218 IVSSCSSVDY-EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           I       D+ E +    +    +   +L   L            L+  + + IV  + S
Sbjct: 99  IH------DFGEIDGQLYVDMRLINGVDLAAMLR-------RQGPLAPPRAVAIVRQIGS 145

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
           ALD  H        H D+K  N+L+     A++ DFG+A    +E  T    Q       
Sbjct: 146 ALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT----QL--GNTV 196

Query: 337 GSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP 373
           G++ Y+ PE  +    +   DIY+   +L E  TG  P
Sbjct: 197 GTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  106 bits (266), Expect = 2e-25
 Identities = 61/339 (17%), Positives = 120/339 (35%), Gaps = 47/339 (13%)

Query: 153 SNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVL-KLQQQGALKSFIDECNALTSI 210
           S +   +   +++G G+  +V++G     G+  AIKV   +     +   + E   L  +
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
            H+NI+K+    +  +      K L+ EF   G+L   L     E  +   L   + L +
Sbjct: 65  NHKNIVKL---FAIEEETTTRHKVLIMEFCPCGSLYTVLE----EPSNAYGLPESEFLIV 117

Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLL----DEGMIAHVGDFGLAKFLFEESNTPS 326
           + DV   +++L       I H ++K  N++     D   +  + DFG A+ L        
Sbjct: 118 LRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-------- 166

Query: 327 KNQTMSNGLKGSVGYIPPEYINGHVSILG---------DIYSYGILLLEIFTGKRPTDDM 377
           ++      L G+  Y+ P+     V             D++S G+      TG  P    
Sbjct: 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226

Query: 378 F--KDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEE 435
              + +  +   ++   PS  +     S + + EN       +       S+  Q  L  
Sbjct: 227 EGPRRNKEVMYKIITGKPSGAI-----SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTP 281

Query: 436 CLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSKIRM 474
            L +++               G          I  ++ +
Sbjct: 282 VLANILEA-------DQEKCWGFDQFFAETSDILHRMVI 313

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  105 bits (263), Expect = 2e-25
 Identities = 59/308 (19%), Positives = 116/308 (37%), Gaps = 40/308 (12%)

Query: 153 SNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVL-KLQQQGALKSFIDECNALTSI 210
           S +   +   +++G G+  +V++G     G+  AIKV   +     +   + E   L  +
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
            H+NI+K+    +  +      K L+ EF   G+L   L     E  +   L   + L +
Sbjct: 65  NHKNIVKL---FAIEEETTTRHKVLIMEFCPCGSLYTVLE----EPSNAYGLPESEFLIV 117

Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLL----DEGMIAHVGDFGLAKFLFEESNTPS 326
           + DV   +++L       I H ++K  N++     D   +  + DFG A+ L        
Sbjct: 118 LRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-------- 166

Query: 327 KNQTMSNGLKGSVGYIPPEYINGHVSILG---------DIYSYGILLLEIFTGKRP--TD 375
           ++      L G+  Y+ P+     V             D++S G+      TG  P    
Sbjct: 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226

Query: 376 DMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEE 435
           +  + +  +   ++   PS       +S + + EN       +       S+  Q  L  
Sbjct: 227 EGPRRNKEVMYKIITGKPSGA-----ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTP 281

Query: 436 CLVSVMRI 443
            L +++  
Sbjct: 282 VLANILEA 289

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  105 bits (264), Expect = 4e-25
 Identities = 61/240 (25%), Positives = 103/240 (42%), Gaps = 54/240 (22%)

Query: 165 IGSGSFGSVYKGTLADGE--------TAAIKVLKLQQQGA----LKSFIDECNALTSI-R 211
           +G G+FG V        +          A+K+LK     A    L   I E   +  I +
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMIGK 133

Query: 212 HRNILKIVSSCSSVD--YEGNDFKALVFEFMRNGNLDQWL---HPSTDEYCHF------K 260
           H+NI+ ++ +C+     Y       ++ E+   GNL ++L    P   EY +       +
Sbjct: 134 HKNIINLLGACTQDGPLY-------VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186

Query: 261 KLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFE 320
           +LS    ++    VA  ++YL ++      H DL + NVL+ E  +  + DFGLA+ +  
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHH 243

Query: 321 ESNTPSKNQTMSNGLKGSVGYIP-----PEYINGHV-SILGDIYSYGILLLEIFT-GKRP 373
                          K + G +P     PE +   + +   D++S+G+LL EIFT G  P
Sbjct: 244 IDYY----------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  106 bits (265), Expect = 5e-25
 Identities = 43/225 (19%), Positives = 92/225 (40%), Gaps = 30/225 (13%)

Query: 158 NFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILK 217
           +F  ++++G G+ G++    + D    A+K +  +        +          H N+++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESD--EHPNVIR 82

Query: 218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
              +      +   F+ +  E      L +++      +   + ++L+Q         S 
Sbjct: 83  YFCT-----EKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQ------QTTSG 130

Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDE-----GMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           L +LH+     I H DLK  N+L+        + A + DFGL K L    ++ S+     
Sbjct: 131 LAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR----R 183

Query: 333 NGLKGSVGYIPPEYING----HVSILGDIYSYGILLLEIFTGKRP 373
           +G+ G+ G+I PE ++     + +   DI+S G +   + +    
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  104 bits (260), Expect = 7e-25
 Identities = 51/228 (22%), Positives = 89/228 (39%), Gaps = 18/228 (7%)

Query: 162 ENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIR-HRNILKIV 219
             ++  G F  VY+   +  G   A+K L   ++   ++ I E   +  +  H NI++  
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92

Query: 220 SSCSSV--DYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
           S+ S    + +    + L+   +  G L ++L            LS    L I      A
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR----GPLSCDTVLKIFYQTCRA 148

Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK- 336
           + ++H Q   PI H DLK  N+LL       + DFG A  +    +     Q  +   + 
Sbjct: 149 VQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207

Query: 337 ----GSVGYIPPE----YINGHVSILGDIYSYGILLLEIFTGKRPTDD 376
                +  Y  PE    Y N  +    DI++ G +L  +   + P +D
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  103 bits (260), Expect = 9e-25
 Identities = 60/244 (24%), Positives = 104/244 (42%), Gaps = 50/244 (20%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLADGE------TAAIKVLKLQQQGA----LKSFIDECNA 206
           +N      +G+G+FG V + T             A+K+LK     A     ++ + E   
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKI 102

Query: 207 LTSI-RHRNILKIVSSCSSVD--YEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCHF- 259
           ++ + +H NI+ ++ +C+             ++ E+   G+L  +L       +    F 
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVL-------VITEYCCYGDLLNFLRRKSRVLETDPAFA 155

Query: 260 ---KKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK 316
                 S    L+    VA  + +L ++      H D+ + NVLL  G +A +GDFGLA+
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLAR 212

Query: 317 FLFEESNTPSKNQTMSNGLKGSVGYIP-----PEYINGHV-SILGDIYSYGILLLEIFT- 369
            +  +SN           +      +P     PE I   V ++  D++SYGILL EIF+ 
Sbjct: 213 DIMNDSNY----------IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 262

Query: 370 GKRP 373
           G  P
Sbjct: 263 GLNP 266

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  105 bits (263), Expect = 1e-24
 Identities = 56/253 (22%), Positives = 94/253 (37%), Gaps = 38/253 (15%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALT-SIRHRNI 215
           +    E ++G GS G+V       G   A+K + +         + E   LT S  H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71

Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           ++   S        + F  +  E   N NL   +        + K       ++++  +A
Sbjct: 72  IRYYCS-----ETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125

Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG-------------DFGLAKFLFEES 322
           S + +LH+     I H DLK  N+L+                      DFGL K L    
Sbjct: 126 SGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182

Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYINGHVSILG--------DIYSYGILLLEIFT-GKRP 373
              S  +T  N   G+ G+  PE +    ++          DI+S G +   I + GK P
Sbjct: 183 ---SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

Query: 374 TDDMFKDDLSIHK 386
             D +  + +I +
Sbjct: 240 FGDKYSRESNIIR 252

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  102 bits (255), Expect = 4e-24
 Identities = 56/242 (23%), Positives = 96/242 (39%), Gaps = 53/242 (21%)

Query: 165 IGSGSFGSVYKGTLADGE------TAAIKVLK-LQQQGALKSFIDECNALTSIRHRNILK 217
           IG G+FG V++               A+K+LK          F  E   +    + NI+K
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 218 IVSSCSSVD--YEGNDFKALVFEFMRNGNLDQWL-----------------HPSTDEYCH 258
           ++  C+             L+FE+M  G+L+++L                   +      
Sbjct: 115 LLGVCAVGKPMC-------LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167

Query: 259 FKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFL 318
              LS  ++L I   VA+ + YL  +      H DL + N L+ E M+  + DFGL++ +
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNI 224

Query: 319 FEESNTPSKNQTMSNGLKGSVGYIP-----PEYINGHV-SILGDIYSYGILLLEIFT-GK 371
           +                      IP     PE I  +  +   D+++YG++L EIF+ G 
Sbjct: 225 YSADYY----------KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274

Query: 372 RP 373
           +P
Sbjct: 275 QP 276

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  101 bits (254), Expect = 5e-24
 Identities = 61/245 (24%), Positives = 101/245 (41%), Gaps = 59/245 (24%)

Query: 165 IGSGSFGSVYKGTLADGE------TAAIKVLKLQQQGA----LKSFIDECNALTSI-RHR 213
           +GSG+FG V   T             A+K+LK   + A     ++ + E   +T +  H 
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKMMTQLGSHE 109

Query: 214 NILKIVSSCSSVD--YEGNDFKALVFEFMRNGNLDQWL----------------HPSTDE 255
           NI+ ++ +C+     Y       L+FE+   G+L  +L                    +E
Sbjct: 110 NIVNLLGACTLSGPIY-------LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162

Query: 256 YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA 315
                 L+    L     VA  +++L  +      H DL + NVL+  G +  + DFGLA
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLA 219

Query: 316 KFLFEESNTPSKNQTMSNGLKGSVGYIP-----PEYINGHV-SILGDIYSYGILLLEIFT 369
           + +  +SN           +      +P     PE +   + +I  D++SYGILL EIF+
Sbjct: 220 RDIMSDSNY----------VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

Query: 370 -GKRP 373
            G  P
Sbjct: 270 LGVNP 274

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  102 bits (254), Expect = 8e-24
 Identities = 37/254 (14%), Positives = 72/254 (28%), Gaps = 54/254 (21%)

Query: 164 LIGSGSFGSVYKGT-LADGETAAIKVLKL-------------QQQGALKSFIDECNALTS 209
           ++G     +  + T    GE+  + V                ++   L+      N   +
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 210 IRHRNILKIVSSCS----------SVDYEGNDFKALVFEFMR-NGNLDQWLHPSTDEYCH 258
             H   +                  +D       +  F + R   NL  +          
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 259 FKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFL 318
            K L    RL + + V   L  LH+     + H  L+  +++LD+     +  F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 319 FEESNTPSKNQTMSNGLKGSVGYIPPEYI-----------NGHVSILGDIYSYGILLLEI 367
              + +P              G+ PPE                ++   D ++ G+ +  I
Sbjct: 262 GASAVSP-----------IGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310

Query: 368 FTGKRPTDDMFKDD 381
           +    P      DD
Sbjct: 311 WCADLP----NTDD 320

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  100 bits (249), Expect = 3e-23
 Identities = 40/255 (15%), Positives = 76/255 (29%), Gaps = 55/255 (21%)

Query: 164 LIGSGSFGSVYKGT-LADGETAAIKVL---KLQQQGALKSFIDECNALTSIRH------- 212
           ++G     +  + T    GE+  + V    +     A+K   +E   L  +R        
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 213 ---------RNILKIVSSCSSV----DYEGNDFKALVFEFMR-NGNLDQWLHPSTDEYCH 258
                     +++K       +    D       +  F + R   NL  +          
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 259 FKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFL 318
            K L    RL + + V   L  LH+     + H  L+  +++LD+     +  F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256

Query: 319 FEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILG------------DIYSYGILLLE 366
                +             S G+ PPE      +I              D ++ G+++  
Sbjct: 257 GARVVSS-----------VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305

Query: 367 IFTGKRPTDDMFKDD 381
           I+    P       D
Sbjct: 306 IWCADLP----ITKD 316

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 97.7 bits (244), Expect = 5e-23
 Identities = 57/256 (22%), Positives = 101/256 (39%), Gaps = 50/256 (19%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVL---KLQQQGALKSFIDECNALTSIRH 212
           ++F     +G G FG+VY           A+KVL   +L++ G       E    + +RH
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 213 RNILKIVSSCSSVD--YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN- 269
            NIL++          Y       L+ E+   G +             +++L  + + + 
Sbjct: 69  PNILRLYGYFHDATRVY-------LILEYAPLGTV-------------YRELQKLSKFDE 108

Query: 270 -----IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNT 324
                 + ++A+AL Y H++    + H D+K  N+LL       + DFG +         
Sbjct: 109 QRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS---- 161

Query: 325 PSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFTGKRPTDDMFKDDLS 383
            S+   +     G++ Y+PPE I G +     D++S G+L  E   GK P +        
Sbjct: 162 -SRRTDLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA--NTYQE 214

Query: 384 IHKFVLMA---LPSHV 396
            +K +       P  V
Sbjct: 215 TYKRISRVEFTFPDFV 230

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 98.5 bits (245), Expect = 8e-23
 Identities = 39/267 (14%), Positives = 79/267 (29%), Gaps = 37/267 (13%)

Query: 142 EWQSGLSYLK----ISNATDNFSEENLIGSGSFGSVYKGT------LADGETAAIKVLKL 191
           EWQ  L  +K        +      +L+G G+F  VY+ T        + +   +KV K 
Sbjct: 46  EWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP 105

Query: 192 QQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHP 251
                          L        +K  S+     +   +   LV E    G L   ++ 
Sbjct: 106 ANPWEFYIGTQLMERLKPSMQHMFMKFYSA-----HLFQNGSVLVGELYSYGTLLNAIN- 159

Query: 252 STDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG- 310
              +    K +     ++  + +   ++ +H+     I H D+K  N +L  G +     
Sbjct: 160 -LYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215

Query: 311 ----------DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-HVSILGDIYS 359
                     D G +  +        K    +     + G+   E ++    +   D + 
Sbjct: 216 DDLSAGLALIDLGQSIDM----KLFPKGTIFT-AKCETSGFQCVEMLSNKPWNYQIDYFG 270

Query: 360 YGILLLEIFTGKRPTDDMFKDDLSIHK 386
               +  +  G          +     
Sbjct: 271 VAATVYCMLFGTYMKVKNEGGECKPEG 297

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 96.6 bits (241), Expect = 3e-22
 Identities = 52/263 (19%), Positives = 96/263 (36%), Gaps = 45/263 (17%)

Query: 130 KTSRRQSAPPSNEWQSGL----SYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETA 184
                 +AP +             L    +   +     +G G F   ++ +     E  
Sbjct: 10  AGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVF 69

Query: 185 AIKVL---KLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMR 241
           A K++    L +    +    E +   S+ H++++          +E NDF  +V E  R
Sbjct: 70  AGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF-----FEDNDFVFVVLELCR 124

Query: 242 NGNLDQWLHPSTDEYCHFKKLSLMQRLN------IVIDVASALDYLHNQYDTPIAHCDLK 295
             +L              +     + L        +  +     YLH      + H DLK
Sbjct: 125 RRSL-------------LELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLK 168

Query: 296 SSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSI 353
             N+ L+E +   +GDFGLA  +  +     + + +     G+  YI PE ++  GH S 
Sbjct: 169 LGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVLC----GTPNYIAPEVLSKKGH-SF 220

Query: 354 LGDIYSYGILLLEIFTGKRPTDD 376
             D++S G ++  +  GK P + 
Sbjct: 221 EVDVWSIGCIMYTLLVGKPPFET 243

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 95.3 bits (238), Expect = 4e-22
 Identities = 46/233 (19%), Positives = 85/233 (36%), Gaps = 57/233 (24%)

Query: 164 LIGSGSFGSVYKGT-LADGETAAIKVL---KLQQQGALKSFIDECNALTSIRHRNILKIV 219
            +G G F   ++ +     E  A K++    L +    +    E +   S+ H++++   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF- 80

Query: 220 SSCSSVDYEGNDFKA---LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN------I 270
                  +   +      +V E  R  +L              +     + L        
Sbjct: 81  -------HGFFEDNDFVFVVLELCRRRSL-------------LELHKRRKALTEPEARYY 120

Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
           +  +     YLH      + H DLK  N+ L+E +   +GDFGLA             + 
Sbjct: 121 LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLA------------TKV 165

Query: 331 MSNGLK-----GSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDD 376
             +G +     G+  YI PE ++  GH S   D++S G ++  +  GK P + 
Sbjct: 166 EYDGERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFET 217

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 94.7 bits (236), Expect = 7e-22
 Identities = 54/236 (22%), Positives = 94/236 (39%), Gaps = 42/236 (17%)

Query: 156 TDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRN 214
            + +     +G G+FG VYK      G  AA KV++ + +  L+ +I E   L +  H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 215 ILKIVSSCSSVDYEGNDFKA----LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
           I         V   G  +      ++ EF   G +D  +          + L+  Q   +
Sbjct: 78  I---------VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD------RGLTEPQIQVV 122

Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
              +  AL++LH++    I H DLK+ NVL+       + DFG++        T  K  +
Sbjct: 123 CRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKN---LKTLQKRDS 176

Query: 331 MSNGLKGSVG---YIPPEYINGHVSILG------DIYSYGILLLEIFTGKRPTDDM 377
                   +G   ++ PE +              DI+S GI L+E+   + P  ++
Sbjct: 177 F-------IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 97.4 bits (242), Expect = 9e-22
 Identities = 54/231 (23%), Positives = 93/231 (40%), Gaps = 22/231 (9%)

Query: 153 SNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFID-ECNALTSI 210
           +     +  +  +G+G FG V +      GE  AIK  + +     +     E   +  +
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69

Query: 211 RHRNILKIVSSC-SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN 269
            H N++              ND   L  E+   G+L ++L+    ++ +   L       
Sbjct: 70  NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN----QFENCCGLKEGPIRT 125

Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDFGLAKFLFEESNTPS 326
           ++ D++SAL YLH      I H DLK  N++L    + +I  + D G AK L        
Sbjct: 126 LLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-------- 174

Query: 327 KNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFTGKRPTDD 376
               +     G++ Y+ PE +     ++  D +S+G L  E  TG RP   
Sbjct: 175 DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 56/227 (24%), Positives = 97/227 (42%), Gaps = 31/227 (13%)

Query: 156 TDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRN 214
              ++    IG G+ G+VY    +A G+  AI+ + LQQQ   +  I+E   +   ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
           I+  + S     Y   D   +V E++  G+L   +            +   Q   +  + 
Sbjct: 79  IVNYLDS-----YLVGDELWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCREC 125

Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
             AL++LH+     + H D+KS N+LL       + DFG    +   +   SK  TM   
Sbjct: 126 LQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTM--- 176

Query: 335 LKGSVG---YIPPEYINGHV-SILGDIYSYGILLLEIFTGKRPTDDM 377
               VG   ++ PE +         DI+S GI+ +E+  G+ P  + 
Sbjct: 177 ----VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 60/240 (25%), Positives = 97/240 (40%), Gaps = 25/240 (10%)

Query: 148 SYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKL-QQQGALKSFIDECN 205
           S L  S   D++  + +IGSG+   V         E  AIK + L + Q ++   + E  
Sbjct: 6   SALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQ 65

Query: 206 ALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNL-DQWLHPSTDEYCHFKKLSL 264
           A++   H NI+   +S     +   D   LV + +  G++ D   H           L  
Sbjct: 66  AMSQCHHPNIVSYYTS-----FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120

Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNT 324
                I+ +V   L+YLH        H D+K+ N+LL E     + DFG++ FL    + 
Sbjct: 121 STIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI 177

Query: 325 P--SKNQTMSNGLKGSVG---YIPPEYINGHVS--ILGDIYSYGILLLEIFTGKRPTDDM 377
                 +T        VG   ++ PE +          DI+S+GI  +E+ TG  P    
Sbjct: 178 TRNKVRKTF-------VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 230

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 94.0 bits (234), Expect = 2e-21
 Identities = 53/251 (21%), Positives = 102/251 (40%), Gaps = 58/251 (23%)

Query: 165 IGSGSFGSVYKGTLA--DGETAAIKVL-----------------KLQQQGALKSFIDECN 205
           +  G F  +    L   D +  A+K                   K+  +     F +E  
Sbjct: 39  LNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95

Query: 206 ALTSIRHRNILK---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWL-HPSTDEYCHFKK 261
            +T I++   L    I+++   V Y       +++E+M N ++ ++  +    +  +   
Sbjct: 96  IITDIKNEYCLTCEGIITNYDEV-Y-------IIYEYMENDSILKFDEYFFVLDKNYTCF 147

Query: 262 LSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEE 321
           + +     I+  V ++  Y+HN+ +  I H D+K SN+L+D+     + DFG +      
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGES------ 199

Query: 322 SNTPSKNQTMSNGLKGSVG---YIPPEYINGHVSILG---DIYSYGILLLEIFTGKRPTD 375
                    +   +KGS G   ++PPE+ +   S  G   DI+S GI L  +F    P  
Sbjct: 200 ------EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP-- 251

Query: 376 DMFKDDLSIHK 386
             F   +S+ +
Sbjct: 252 --FSLKISLVE 260

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 93.2 bits (232), Expect = 3e-21
 Identities = 60/230 (26%), Positives = 100/230 (43%), Gaps = 32/230 (13%)

Query: 154 NATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKL-QQQGALKSFIDECNALTSIR 211
           +  + F++   IG GSFG V+KG      +  AIK++ L + +  ++    E   L+   
Sbjct: 19  DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 78

Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
              + K   S     Y  +    ++ E++  G+    L P          L   Q   I+
Sbjct: 79  SPYVTKYYGS-----YLKDTKLWIIMEYLGGGSALDLLEP--------GPLDETQIATIL 125

Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
            ++   LDYLH++      H D+K++NVLL E     + DFG+A  L   ++T  K  T 
Sbjct: 126 REILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQL---TDTQIKRNTF 179

Query: 332 SNGLKGSVG---YIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM 377
                  VG   ++ PE I         DI+S GI  +E+  G+ P  ++
Sbjct: 180 -------VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 92.7 bits (231), Expect = 3e-21
 Identities = 61/238 (25%), Positives = 97/238 (40%), Gaps = 55/238 (23%)

Query: 157 DNFSEENLIGSGSFGSVYKG-TLADGETAAIKVL---KLQQQGALKSFIDECNALTSIRH 212
           D+F     +G G FG+VY      +    A+KVL   +L+++G       E    + +RH
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 213 RNILKIVSSCSSVD--YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN- 269
            NIL++ +        Y       L+ EF   G L             +K+L    R + 
Sbjct: 74  PNILRMYNYFHDRKRIY-------LMLEFAPRGEL-------------YKELQKHGRFDE 113

Query: 270 -----IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNT 324
                 + ++A AL Y H +    + H D+K  N+L+       + DFG +         
Sbjct: 114 QRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVH------A 164

Query: 325 PS-KNQTMSNGLKGSVGYIPPEYINGH-----VSILGDIYSYGILLLEIFTGKRPTDD 376
           PS + +TM     G++ Y+PPE I G      V    D++  G+L  E   G  P D 
Sbjct: 165 PSLRRRTMC----GTLDYLPPEMIEGKTHDEKV----DLWCAGVLCYEFLVGMPPFDS 214

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 93.2 bits (232), Expect = 4e-21
 Identities = 54/254 (21%), Positives = 103/254 (40%), Gaps = 32/254 (12%)

Query: 130 KTSRRQSAPPSNEWQSGL-SYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIK 187
               +       ++++ L   +   +          IG GS G V        G   A+K
Sbjct: 17  NLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVK 76

Query: 188 VLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQ 247
           ++ L++Q   +   +E   +   +H N++++  S     Y   +   ++ EF++ G L  
Sbjct: 77  MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS-----YLVGEELWVLMEFLQGGALTD 131

Query: 248 WLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIA 307
            +           +L+  Q   +   V  AL YLH Q    + H D+KS ++LL      
Sbjct: 132 IVSQ--------VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRV 180

Query: 308 HVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG---YIPPEYINGHV-SILGDIYSYGIL 363
            + DFG    +   S    K +++       VG   ++ PE I+  + +   DI+S GI+
Sbjct: 181 KLSDFGFCAQI---SKDVPKRKSL-------VGTPYWMAPEVISRSLYATEVDIWSLGIM 230

Query: 364 LLEIFTGKRPTDDM 377
           ++E+  G+ P    
Sbjct: 231 VIEMVDGEPPYFSD 244

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 94.2 bits (234), Expect = 4e-21
 Identities = 48/257 (18%), Positives = 92/257 (35%), Gaps = 34/257 (13%)

Query: 137 APPSNEWQSGLSYLKISNATDN---FSEENLIGSG--SFGSVYKGT-LADGETAAIKVLK 190
           A   +     L +  +S+       +    +IG G     +V        GE   ++ + 
Sbjct: 2   AHHHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN 61

Query: 191 LQQQG--ALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQW 248
           L+      +     E +      H NI+   ++     +  ++   +V  FM  G+    
Sbjct: 62  LEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT-----FIADNELWVVTSFMAYGSA--- 113

Query: 249 LHPSTDEYCHFKKLSLMQRL--NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI 306
                D  C      + +     I+  V  ALDY+H+       H  +K+S++L+     
Sbjct: 114 ----KDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGK 166

Query: 307 AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIP---PEYINGHVS---ILGDIYSY 360
            ++        +    +   + + + +  K SV  +P   PE +  ++       DIYS 
Sbjct: 167 VYLSGLRSNLSM---ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 223

Query: 361 GILLLEIFTGKRPTDDM 377
           GI   E+  G  P  DM
Sbjct: 224 GITACELANGHVPFKDM 240

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 91.8 bits (229), Expect = 5e-21
 Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 32/234 (13%)

Query: 151 KISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVL---KLQQQGALKSFIDECNA 206
            I    ++F   NL+G GSF  VY+   +  G   AIK++    + + G ++   +E   
Sbjct: 5   CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI 64

Query: 207 LTSIRHRNILK---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              ++H +IL+        + V Y       LV E   NG ++++L          K  S
Sbjct: 65  HCQLKHPSILELYNYFEDSNYV-Y-------LVLEMCHNGEMNRYLKN------RVKPFS 110

Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
             +  + +  + + + YLH+     I H DL  SN+LL   M   + DFGLA  L     
Sbjct: 111 ENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167

Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFTGKRPTDD 376
              K+ T+     G+  YI PE        +  D++S G +   +  G+ P D 
Sbjct: 168 ---KHYTLC----GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT 214

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 92.6 bits (230), Expect = 8e-21
 Identities = 60/275 (21%), Positives = 113/275 (41%), Gaps = 39/275 (14%)

Query: 157 DNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D+F + + +G+G+ G V+K +    G   A K++ L+ + A+++ I        IR    
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--------IRE--- 81

Query: 216 LKIVSSCSS---VDYEGNDFKA----LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
           L+++  C+S   V + G  +      +  E M  G+LD              ++      
Sbjct: 82  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-------QVLKKAGRIPEQILG 134

Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
            + I V   L YL  ++   I H D+K SN+L++      + DFG++  L          
Sbjct: 135 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---------I 183

Query: 329 QTMSNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRP-TDDMFKDDLSIHK 386
            +M+N   G+  Y+ PE + G H S+  DI+S G+ L+E+  G+ P      K+   +  
Sbjct: 184 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 243

Query: 387 FVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLF 421
             +    +              +   +      +F
Sbjct: 244 CQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIF 278

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 91.7 bits (228), Expect = 1e-20
 Identities = 65/254 (25%), Positives = 101/254 (39%), Gaps = 34/254 (13%)

Query: 139 PSNEWQSGLSYLKISNATD---NFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQ 194
            S+     L  + +S   D    F    L+G+G++G VYKG  +  G+ AAIKV+ +   
Sbjct: 3   ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD 62

Query: 195 GALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGNDFKA-LVFEFMRNGNLDQWLHPS 252
              +    E N L     HRNI     +    +  G D +  LV EF   G++   +  +
Sbjct: 63  -EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT 121

Query: 253 TDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF 312
                    L       I  ++   L +LH      + H D+K  NVLL E     + DF
Sbjct: 122 KG-----NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDF 173

Query: 313 GLAKFLFEESNTPSKNQTMSNGLKGSVG---YIPPEYINGHVSILG------DIYSYGIL 363
           G++  L     T  +  T        +G   ++ PE I    +         D++S GI 
Sbjct: 174 GVSAQL---DRTVGRRNTF-------IGTPYWMAPEVIACDENPDATYDFKSDLWSLGIT 223

Query: 364 LLEIFTGKRPTDDM 377
            +E+  G  P  DM
Sbjct: 224 AIEMAEGAPPLCDM 237

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 73/342 (21%), Positives = 128/342 (37%), Gaps = 83/342 (24%)

Query: 130 KTSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKV 188
             + +   PP  + +            + F     +G GS+GSVYK      G+  AIK 
Sbjct: 2   LETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ 61

Query: 189 LKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA----LVFEFMRNGN 244
           + ++    L+  I E + +      ++         V Y G+ FK     +V E+   G+
Sbjct: 62  VPVESD--LQEIIKEISIMQQCDSPHV---------VKYYGSYFKNTDLWIVMEYCGAGS 110

Query: 245 LDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG 304
           +   +          K L+  +   I+      L+YLH        H D+K+ N+LL+  
Sbjct: 111 VSDIIR------LRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTE 161

Query: 305 MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG---YIPPEYINGHV-SILGDIYSY 360
             A + DFG+A  L   ++T +K  T+       +G   ++ PE I     + + DI+S 
Sbjct: 162 GHAKLADFGVAGQL---TDTMAKRNTV-------IGTPFWMAPEVIQEIGYNCVADIWSL 211

Query: 361 GILLLEIFTGKRPTDDM--------------------------FKD-------------- 380
           GI  +E+  GK P  D+                          F D              
Sbjct: 212 GITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRA 271

Query: 381 ---DLSIHKFVLMALPSHVM-DVLDLSMLLEEENDHEKHEEE 418
               L  H FV  A    ++ D+++ +M ++ +    +  EE
Sbjct: 272 TATQLLQHPFVRSAKGVSILRDLINEAMDVKLKRQESQQREE 313

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 92.8 bits (231), Expect = 2e-20
 Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 30/230 (13%)

Query: 151 KISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVL---KLQQQGALKSFIDECNA 206
             +  +D +  + ++G GSFG V        G+  A+KV+   +++Q+   +S + E   
Sbjct: 20  STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 79

Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           L  + H NI+K+        +E   +  LV E    G L        DE    K+ S + 
Sbjct: 80  LKQLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGEL-------FDEIISRKRFSEVD 127

Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVGDFGLAKFLFEESN 323
              I+  V S + Y+H      I H DLK  N+LL    +     + DFGL+        
Sbjct: 128 AARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF----- 179

Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRP 373
               ++ M     G+  YI PE ++G      D++S G++L  + +G  P
Sbjct: 180 --EASKKM-KDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPP 226

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 92.1 bits (229), Expect = 3e-20
 Identities = 55/229 (24%), Positives = 91/229 (39%), Gaps = 29/229 (12%)

Query: 151 KISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQ--QGALKSFIDECNAL 207
           K  + ++ +     +GSG++G V            AIK+++       +    ++E   L
Sbjct: 31  KKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVL 90

Query: 208 TSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQR 267
             + H NI+K+        +E      LV E  + G L        DE  H  K + +  
Sbjct: 91  KLLDHPNIMKLYDF-----FEDKRNYYLVMECYKGGEL-------FDEIIHRMKFNEVDA 138

Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVGDFGLAKFLFEESNT 324
             I+  V S + YLH      I H DLK  N+LL   ++  +  + DFGL+         
Sbjct: 139 AVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF------ 189

Query: 325 PSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRP 373
               + M     G+  YI PE +        D++S G++L  +  G  P
Sbjct: 190 -ENQKKM-KERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPP 236

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 90.8 bits (225), Expect = 3e-20
 Identities = 60/294 (20%), Positives = 108/294 (36%), Gaps = 96/294 (32%)

Query: 159 FSEENL-----IGSGSFGSVYKGTL------ADGETAAIKVLKLQ-QQGALKSFIDECNA 206
           F  + L     +G G+FG V +         A   T A+K+LK        ++ + E   
Sbjct: 19  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 78

Query: 207 LTSI-RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--------------- 250
           L  I  H N++ ++ +C+           ++ EF + GNL  +L                
Sbjct: 79  LIHIGHHLNVVNLLGACTKPGGPLM----VIVEFCKFGNLSTYLRSKRNEFVPYKTKGAR 134

Query: 251 -PSTDEYCHFKKLSLMQRLNIV-------------------------------------- 271
                +Y     + L +RL+ +                                      
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEH 194

Query: 272 -----IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
                  VA  +++L ++      H DL + N+LL E  +  + DFGLA+ ++++ +   
Sbjct: 195 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-- 249

Query: 327 KNQTMSNGLKGSVGYIP-----PEYINGHV-SILGDIYSYGILLLEIFT-GKRP 373
                   ++     +P     PE I   V +I  D++S+G+LL EIF+ G  P
Sbjct: 250 --------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 90.9 bits (226), Expect = 8e-20
 Identities = 61/269 (22%), Positives = 104/269 (38%), Gaps = 47/269 (17%)

Query: 129 VKTSRRQSAPPSNEWQSGLSYLK---ISNATDNFSE----ENLIGSGSFGSVYKGT-LAD 180
           +      S+   N +  G++      +        E       +GSG++G V        
Sbjct: 1   MHHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNG 60

Query: 181 GETAAIKVLKLQQ-------------QGALKSFIDECNALTSIRHRNILKIVSSCSSVDY 227
               AIKV+K  Q             +   +   +E + L S+ H NI+K+        +
Sbjct: 61  HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV-----F 115

Query: 228 EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDT 287
           E   +  LV EF   G L        ++  +  K       NI+  + S + YLH     
Sbjct: 116 EDKKYFYLVTEFYEGGEL-------FEQIINRHKFDECDAANIMKQILSGICYLHKH--- 165

Query: 288 PIAHCDLKSSNVLL---DEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPP 344
            I H D+K  N+LL   +  +   + DFGL+ F        SK+  + + L G+  YI P
Sbjct: 166 NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF-------SKDYKLRDRL-GTAYYIAP 217

Query: 345 EYINGHVSILGDIYSYGILLLEIFTGKRP 373
           E +    +   D++S G+++  +  G  P
Sbjct: 218 EVLKKKYNEKCDVWSCGVIMYILLCGYPP 246

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 53/219 (24%), Positives = 89/219 (40%), Gaps = 24/219 (10%)

Query: 151 KISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVL-KLQQQGALKSFIDECNALT 208
                 D F  +  +GSG+FG V+     + G    IK + K + Q  ++    E   L 
Sbjct: 16  FQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLK 75

Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
           S+ H NI+KI        +E      +V E    G L + +  +          S     
Sbjct: 76  SLDHPNIIKIFEV-----FEDYHNMYIVMETCEGGELLERIVSAQARGKAL---SEGYVA 127

Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVGDFGLAKFLFEESNTP 325
            ++  + +AL Y H+Q+   + H DLK  N+L           + DFGLA+         
Sbjct: 128 ELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF------- 177

Query: 326 SKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILL 364
             ++  +N   G+  Y+ PE     V+   DI+S G+++
Sbjct: 178 KSDEHSTNAA-GTALYMAPEVFKRDVTFKCDIWSAGVVM 215

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 86.5 bits (215), Expect = 5e-19
 Identities = 59/228 (25%), Positives = 88/228 (38%), Gaps = 41/228 (17%)

Query: 150 LKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALT 208
           ++ +N    F    ++GSG+F  V+       G+  A+K +K        S  +E   L 
Sbjct: 2   MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLK 61

Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
            I+H NI+ +        YE      LV + +  G L        D        +     
Sbjct: 62  KIKHENIVTLEDI-----YESTTHYYLVMQLVSGGEL-------FDRILERGVYTEKDAS 109

Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVGDFGLAKFLFEESNTP 325
            ++  V SA+ YLH      I H DLK  N+L    +E     + DFGL+K         
Sbjct: 110 LVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME------- 159

Query: 326 SKNQTMSNGLKGSVGYIPPEYINGH-----VSILGDIYSYG----ILL 364
            +N  MS    G+ GY+ PE +        V    D +S G    ILL
Sbjct: 160 -QNGIMSTAC-GTPGYVAPEVLAQKPYSKAV----DCWSIGVITYILL 201

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 86.8 bits (215), Expect = 7e-19
 Identities = 60/297 (20%), Positives = 94/297 (31%), Gaps = 62/297 (20%)

Query: 129 VKTSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIK 187
           +      S+   N +  G S L++      +  +  IG GS+G V            AIK
Sbjct: 1   MHHHHHHSSGRENLYFQGGSLLEL---QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIK 57

Query: 188 V-----LKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRN 242
           +     ++      ++    E   +  + H NI ++        YE   +  LV E    
Sbjct: 58  IMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV-----YEDEQYICLVMELCHG 112

Query: 243 GNL---------------------------------DQWLHPSTDEYCHFKKLSLMQRLN 269
           G+L                                                        N
Sbjct: 113 GHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISN 172

Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLL--DEGMIAHVGDFGLAKFLFEESNTPSK 327
           I+  + SAL YLHNQ    I H D+K  N L   ++     + DFGL+K          +
Sbjct: 173 IMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEF--YKLNNGE 227

Query: 328 NQTMSNGLKGSVGYIPPEYINGHVSILG---DIYSYGILLLEIFTGKRPTDDMFKDD 381
              M     G+  ++ PE +N      G   D +S G+LL  +  G  P    F   
Sbjct: 228 YYGM-TTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP----FPGV 279

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 87.8 bits (218), Expect = 8e-19
 Identities = 56/224 (25%), Positives = 89/224 (39%), Gaps = 29/224 (12%)

Query: 156 TDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRH 212
            + ++   ++G GSFG V K       +  A+KV+           + + E   L  + H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            NI+K+         E +    +V E    G L        DE    K+ S      I+ 
Sbjct: 81  PNIMKLFEI-----LEDSSSFYIVGELYTGGEL-------FDEIIKRKRFSEHDAARIIK 128

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
            V S + Y+H      I H DLK  N+LL   ++     + DFGL+           +N 
Sbjct: 129 QVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-------QQNT 178

Query: 330 TMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRP 373
            M     G+  YI PE + G      D++S G++L  + +G  P
Sbjct: 179 KM-KDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPP 221

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 86.3 bits (214), Expect = 9e-19
 Identities = 60/270 (22%), Positives = 96/270 (35%), Gaps = 54/270 (20%)

Query: 129 VKTSRRQSAPPSNEWQSGLSYLKISNA------TDNFSEENLIGSGSFGSVYKGT-LADG 181
           +         P+      L    ++           FS+   IG GSFG+VY    + + 
Sbjct: 20  LYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNS 79

Query: 182 ETAAIKVLKLQQQGA---LKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA---- 234
           E  AIK +    + +    +  I E   L  +RH N          + Y G   +     
Sbjct: 80  EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT---------IQYRGCYLREHTAW 130

Query: 235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDL 294
           LV E+      D           H K L  ++   +       L YLH+     + H D+
Sbjct: 131 LVMEYCLGSASD-------LLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDV 180

Query: 295 KSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVG---YIPPEYINGHV 351
           K+ N+LL E  +  +GDFG A  +       +   +        VG   ++ PE I    
Sbjct: 181 KAGNILLSEPGLVKLGDFGSASIM-------APANSF-------VGTPYWMAPEVILAMD 226

Query: 352 SI----LGDIYSYGILLLEIFTGKRPTDDM 377
                   D++S GI  +E+   K P  +M
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPPLFNM 256

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 85.8 bits (213), Expect = 9e-19
 Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 33/225 (14%)

Query: 164 LIGSGSFGSVYKGT-LADGETAAIKVL---KLQQQGALKSFID-ECNALTSIRHRNILKI 218
           L+G GS+G V +          A+K+L   KL++    ++ +  E   L  +RH+N++++
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 219 VSSCSSVDYEGNDFKA-LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
           V     V Y     K  +V E+   G  +        +    K+  + Q       +   
Sbjct: 72  VD----VLYNEEKQKMYMVMEYCVCGMQEML------DSVPEKRFPVCQAHGYFCQLIDG 121

Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK- 336
           L+YLH+Q    I H D+K  N+LL  G    +   G+       +          +  + 
Sbjct: 122 LEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGV-------AEAL-HPFAADDTCRT 170

Query: 337 --GSVGYIPPEYINGHVSILG---DIYSYGILLLEIFTGKRPTDD 376
             GS  + PPE  NG  +  G   DI+S G+ L  I TG  P + 
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 83.9 bits (208), Expect = 4e-18
 Identities = 55/220 (25%), Positives = 90/220 (40%), Gaps = 38/220 (17%)

Query: 162 ENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIR-HRNILKIV 219
           E+++G G+   V     L   +  A+K+++ Q          E   L   + HRN+L+++
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN------IVID 273
                  +E  D   LVFE MR G++                +   +  N      +V D
Sbjct: 78  EF-----FEEEDRFYLVFEKMRGGSI-------------LSHIHKRRHFNELEASVVVQD 119

Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
           VASALD+LHN+    IAH DLK  N+L    ++     + DF L   +    +    +  
Sbjct: 120 VASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176

Query: 331 MSNGLKGSVGYIPPEYINGHVSILG------DIYSYGILL 364
                 GS  Y+ PE +              D++S G++L
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 51/218 (23%), Positives = 80/218 (36%), Gaps = 27/218 (12%)

Query: 151 KISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTS 209
              +    ++ EN IG GS+G V            A K +       +  F  E   + S
Sbjct: 3   TKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKS 62

Query: 210 IRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN 269
           + H NI+++  +     +E N    LV E    G L        +   H +         
Sbjct: 63  LDHPNIIRLYET-----FEDNTDIYLVMELCTGGEL-------FERVVHKRVFRESDAAR 110

Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVGDFGLAKFLFEESNTPS 326
           I+ DV SA+ Y H      +AH DLK  N L           + DFGLA           
Sbjct: 111 IMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-------K 160

Query: 327 KNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILL 364
             + M   + G+  Y+ P+ + G      D +S G+++
Sbjct: 161 PGKMMRTKV-GTPYYVSPQVLEGLYGPECDEWSAGVMM 197

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 66/232 (28%), Positives = 93/232 (40%), Gaps = 55/232 (23%)

Query: 164 LIGSGSFGSVYKGT-LADGETAAIKVL---KLQQQGALKSFIDECNALTSIRHRNILKI- 218
            +G G+FG V  G     G   A+K+L   K++    +     E   L   RH +I+K+ 
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 219 -VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA-- 275
            V S  +  +       +V E++  G L             F  +    R+      A  
Sbjct: 78  QVISTPTDFF-------MVMEYVSGGEL-------------FDYICKHGRVEE--MEARR 115

Query: 276 ------SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
                 SA+DY H      + H DLK  NVLLD  M A + DFGL       SN  S  +
Sbjct: 116 LFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGL-------SNMMSDGE 165

Query: 330 TMSNGLK---GSVGYIPPEYINGH--VSILGDIYSYGILLLEIFTGKRPTDD 376
                L+   GS  Y  PE I+G        DI+S G++L  +  G  P DD
Sbjct: 166 F----LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 84.1 bits (208), Expect = 2e-17
 Identities = 48/222 (21%), Positives = 93/222 (41%), Gaps = 32/222 (14%)

Query: 150 LKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALT 208
           +K  +  D++     +G+G+FG V++ T  A G   A K +    +   ++   E   ++
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMS 209

Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
            +RH  ++ +  +     +E ++   +++EFM  G L + +    DE+      S  + +
Sbjct: 210 VLRHPTLVNLHDA-----FEDDNEMVMIYEFMSGGELFEKV---ADEHNKM---SEDEAV 258

Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL-----DEGMIAHVGDFGLAKFLFEESN 323
             +  V   L ++H        H DLK  N++      +E  +    DFGL   L     
Sbjct: 259 EYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLI---DFGLTAHL----- 307

Query: 324 TPSKNQTMSNGLKGSVGYIPPEYING-HVSILGDIYSYGILL 364
                Q++     G+  +  PE   G  V    D++S G+L 
Sbjct: 308 --DPKQSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 81.1 bits (201), Expect = 3e-17
 Identities = 56/223 (25%), Positives = 87/223 (39%), Gaps = 35/223 (15%)

Query: 153 SNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVL---KLQQQGALKSFIDECNALT 208
               + ++   ++G GSFG V K       +  A+KV+     + +    + + E   L 
Sbjct: 18  GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLK 76

Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
            + H NI+K+         E +    +V E    G L        DE    K+ S     
Sbjct: 77  KLDHPNIMKLFEI-----LEDSSSFYIVGELYTGGEL-------FDEIIKRKRFSEHDAA 124

Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVGDFGLAKFLFEESNTP 325
            I+  V S + Y+H      I H DLK  N+LL   ++     + DFGL+          
Sbjct: 125 RIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF------- 174

Query: 326 SKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYG----ILL 364
            +N  M     G+  YI PE + G      D++S G    ILL
Sbjct: 175 QQNTKM-KDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILL 216

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 82.1 bits (203), Expect = 4e-17
 Identities = 41/219 (18%), Positives = 84/219 (38%), Gaps = 26/219 (11%)

Query: 150 LKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALT 208
           +K  +  D +     +GSG+FG V++    A G     K +         +  +E + + 
Sbjct: 44  VKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMN 103

Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
            + H  ++ +  +     +E      L+ EF+  G L   +     E       S  + +
Sbjct: 104 QLHHPKLINLHDA-----FEDKYEMVLILEFLSGGELFDRI---AAEDYKM---SEAEVI 152

Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL--DEGMIAHVGDFGLAKFLFEESNTPS 326
           N +      L ++H      I H D+K  N++    +     + DFGLA  L       +
Sbjct: 153 NYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKL-------N 202

Query: 327 KNQTMSNGLKGSVGYIPPEYING-HVSILGDIYSYGILL 364
            ++ +      +  +  PE ++   V    D+++ G+L 
Sbjct: 203 PDEIVKVTT-ATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 81.7 bits (202), Expect = 5e-17
 Identities = 48/212 (22%), Positives = 92/212 (43%), Gaps = 28/212 (13%)

Query: 158 NFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
             S+  ++G G FG V+K    A G   A K++K +     +   +E + +  + H N++
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           ++  +     +E  +   LV E++  G L   +    DE  +    + +  +  +  +  
Sbjct: 150 QLYDA-----FESKNDIVLVMEYVDGGELFDRI---IDESYNL---TELDTILFMKQICE 198

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
            + ++H  Y   I H DLK  N+L    D   I  + DFGLA+            + +  
Sbjct: 199 GIRHMHQMY---ILHLDLKPENILCVNRDAKQIK-IIDFGLARRY-------KPREKLKV 247

Query: 334 GLKGSVGYIPPEYING-HVSILGDIYSYGILL 364
              G+  ++ PE +N   VS   D++S G++ 
Sbjct: 248 NF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 80.0 bits (198), Expect = 8e-17
 Identities = 53/234 (22%), Positives = 92/234 (39%), Gaps = 45/234 (19%)

Query: 153 SNATDNFSEE----NLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKS-------- 199
           S++T  F E      ++G G    V +       +  A+K++ +   G+  +        
Sbjct: 9   SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68

Query: 200 -FIDECNALTSI-RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYC 257
             + E + L  +  H NI+++  +     YE N F  LVF+ M+ G L        D   
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKGEL-------FDYLT 116

Query: 258 HFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF 317
               LS  +   I+  +   +  LH      I H DLK  N+LLD+ M   + DFG +  
Sbjct: 117 EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173

Query: 318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILG-------DIYSYGILL 364
           L                + G+  Y+ PE I   ++          D++S G+++
Sbjct: 174 LDPGEKL--------REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 78.8 bits (195), Expect = 1e-16
 Identities = 51/227 (22%), Positives = 86/227 (37%), Gaps = 44/227 (19%)

Query: 164 LIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFID-ECNALTSIRHRNILKI--V 219
            +G G++G V         E  A+K++ +++       I  E      + H N++K    
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA---- 275
               ++ Y       L  E+   G L             F ++     +      A    
Sbjct: 74  RREGNIQY-------LFLEYCSGGEL-------------FDRIEPDIGMPE--PDAQRFF 111

Query: 276 ----SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
               + + YLH      I H D+K  N+LLDE     + DFGLA  +F  +N       M
Sbjct: 112 HQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKM 167

Query: 332 SNGLKGSVGYIPPEYINGH--VSILGDIYSYGILLLEIFTGKRPTDD 376
                G++ Y+ PE +      +   D++S GI+L  +  G+ P D 
Sbjct: 168 C----GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 55/245 (22%), Positives = 95/245 (38%), Gaps = 38/245 (15%)

Query: 135 QSAPPSNEWQSGLSYLKISNATDNFSEE----NLIGSGSFGSVYKGT-LADGETAAIKVL 189
             A  +   Q G     + NA+  FS+       +G G+F  V +      G   A K++
Sbjct: 3   HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62

Query: 190 --KLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQ 247
             K       +    E      ++H NI+++  S      +   F  LVF+ +  G L  
Sbjct: 63  NTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQEESFHYLVFDLVTGGEL-- 115

Query: 248 WLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL---DEG 304
                 ++    +  S     + +  +  ++ Y H+     I H +LK  N+LL    +G
Sbjct: 116 -----FEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKG 167

Query: 305 MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYG-- 361
               + DFGLA  +       + ++    G  G+ GY+ PE +     S   DI++ G  
Sbjct: 168 AAVKLADFGLAIEV-------NDSEAWH-GFAGTPGYLSPEVLKKDPYSKPVDIWACGVI 219

Query: 362 --ILL 364
             ILL
Sbjct: 220 LYILL 224

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 45/231 (19%), Positives = 85/231 (36%), Gaps = 52/231 (22%)

Query: 156 TDNFSEENLIGSGSFGSVYKGT-LADGETAAIKV-----LKLQQQGALKSFIDECNALTS 209
            D +    +IG G F  V +      G+  A+K+            + +    E +    
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 210 IRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHF----KKLSLM 265
           ++H +I++++ +     Y  +    +VFEFM   +L                  K+    
Sbjct: 83  LKHPHIVELLET-----YSSDGMLYMVFEFMDGADL-------------CFEIVKRADAG 124

Query: 266 QRL------NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVGDFGLAK 316
                    + +  +  AL Y H+     I H D+K   VLL   +      +G FG+A 
Sbjct: 125 FVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181

Query: 317 FLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILG---DIYSYGILL 364
            L E       +  ++ G  G+  ++ PE +       G   D++  G++L
Sbjct: 182 QLGE-------SGLVAGGRVGTPHFMAPEVVKR--EPYGKPVDVWGCGVIL 223

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 61/248 (24%), Positives = 93/248 (37%), Gaps = 60/248 (24%)

Query: 164 LIGSGSFGSVYKGT-LADGETAAIKVL---KLQQQGALKSFID----------------- 202
            IG GS+G V       D    A+KVL   KL +Q                         
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 203 ------ECNALTSIRHRNILKIVSSCSSVDYEGNDFKA-LVFEFMRNGNLDQWLHPSTDE 255
                 E   L  + H N++K+V     V  + N+    +VFE +  G +         E
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVE----VLDDPNEDHLYMVFELVNQGPVM--------E 127

Query: 256 YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA 315
               K LS  Q      D+   ++YLH Q    I H D+K SN+L+ E     + DFG+ 
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGV- 183

Query: 316 KFLFEESNTPSKNQTMSNGLKGSVG---YIPPEYING-HVSILG---DIYSYGILLLEIF 368
                 SN    +  +   L  +VG   ++ PE ++       G   D+++ G+ L    
Sbjct: 184 ------SNEFKGSDAL---LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234

Query: 369 TGKRPTDD 376
            G+ P  D
Sbjct: 235 FGQCPFMD 242

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 66/232 (28%), Positives = 93/232 (40%), Gaps = 55/232 (23%)

Query: 164 LIGSGSFGSVYKGT-LADGETAAIKVL---KLQQQGALKSFIDECNALTSIRHRNILKI- 218
            +G G+FG V  G     G   A+K+L   K++    +     E   L   RH +I+K+ 
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 219 -VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA-- 275
            V S  S  +       +V E++  G L             F  +    RL+     +  
Sbjct: 83  QVISTPSDIF-------MVMEYVSGGEL-------------FDYICKNGRLDE--KESRR 120

Query: 276 ------SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
                 S +DY H      + H DLK  NVLLD  M A + DFGL       SN  S  +
Sbjct: 121 LFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGL-------SNMMSDGE 170

Query: 330 TMSNGLK---GSVGYIPPEYINGH--VSILGDIYSYGILLLEIFTGKRPTDD 376
                L+   GS  Y  PE I+G        DI+S G++L  +  G  P DD
Sbjct: 171 F----LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 52/222 (23%), Positives = 83/222 (37%), Gaps = 52/222 (23%)

Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLK--------LQQQGALKSFIDECNALTSIRHRNI 215
           +GSG+ G V         +  AI+++          ++     +   E   L  + H  I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN------ 269
           +KI +   + DY       +V E M  G L             F K+   +RL       
Sbjct: 203 IKIKNFFDAEDY------YIVLELMEGGEL-------------FDKVVGNKRLKEATCKL 243

Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVGDFGLAKFLFEESNTPS 326
               +  A+ YLH      I H DLK  NVLL   +E  +  + DFG +K L        
Sbjct: 244 YFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-------- 292

Query: 327 KNQTMSNGLKGSVGYIPPEYINGHV----SILGDIYSYGILL 364
              ++   L G+  Y+ PE +        +   D +S G++L
Sbjct: 293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 78.8 bits (195), Expect = 3e-16
 Identities = 45/203 (22%), Positives = 84/203 (41%), Gaps = 30/203 (14%)

Query: 126 YHIVKTSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETA 184
           +H         A         +S    + + D +     +G G++G VYK       ET 
Sbjct: 3   HHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETV 62

Query: 185 AIKVLKLQQQ--GALKSFIDECNALTSIRHRNILK---IVSSCSSVDYEGNDFKALVFEF 239
           AIK ++L+ +  G   + I E + L  ++HRNI++   ++     + +       L+FE+
Sbjct: 63  AIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL-H-------LIFEY 114

Query: 240 MRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNV 299
               +L +++  + D      K  L Q +       + +++ H++      H DLK  N+
Sbjct: 115 A-ENDLKKYMDKNPDVSMRVIKSFLYQLI-------NGVNFCHSRR---CLHRDLKPQNL 163

Query: 300 LLDEGMIAHVG-----DFGLAKF 317
           LL     +        DFGLA+ 
Sbjct: 164 LLSVSDASETPVLKIGDFGLARA 186

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 78.4 bits (194), Expect = 3e-16
 Identities = 47/196 (23%), Positives = 80/196 (40%), Gaps = 35/196 (17%)

Query: 129 VKTSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKV 188
           +      S+   N +  GL         + + +   +G G++G VYK   + G   A+K 
Sbjct: 1   MHHHHHHSSGRENLYFQGLM--------EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKR 52

Query: 189 LKLQQQ--GALKSFIDECNALTSIRHRNILK---IVSSCSSVDYEGNDFKALVFEFMRNG 243
           ++L  +  G   + I E + L  + H NI+    ++ S   +         LVFEFM   
Sbjct: 53  IRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL-T-------LVFEFM-EK 103

Query: 244 NLDQWL--HPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL 301
           +L + L  + +  +    K   L Q L         + + H      I H DLK  N+L+
Sbjct: 104 DLKKVLDENKTGLQDSQIKIY-LYQLL-------RGVAHCHQHR---ILHRDLKPQNLLI 152

Query: 302 DEGMIAHVGDFGLAKF 317
           +      + DFGLA+ 
Sbjct: 153 NSDGALKLADFGLARA 168

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 49/234 (20%), Positives = 91/234 (38%), Gaps = 36/234 (15%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           ++  +   IG G++GSV K      G+  A+K ++       +  +        +   ++
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQL--------LMDLDV 73

Query: 216 LKIVSSCSS---VDYEGNDFKA----LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
           +    S      V + G  F+     +  E M + + D++             +      
Sbjct: 74  VM--RSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSV--LDDVIPEEILG 128

Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
            I +    AL++L       I H D+K SN+LLD      + DFG++  L    ++ +K 
Sbjct: 129 KITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL---VDSIAKT 183

Query: 329 QTMSNGLKGSVGYIPPEYINGHV-----SILGDIYSYGILLLEIFTGKRPTDDM 377
           +       G   Y+ PE I+         +  D++S GI L E+ TG+ P    
Sbjct: 184 RDA-----GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 77.2 bits (191), Expect = 5e-16
 Identities = 51/228 (22%), Positives = 93/228 (40%), Gaps = 44/228 (19%)

Query: 153 SNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVL---KLQQQGALKSFIDECNALT 208
           +  +DN+  +  +G G+F  V +      G   A K++   KL  +   +    E     
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICR 60

Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
            ++H NI+++  S      +   F  LVF+ +  G L        ++    +  S     
Sbjct: 61  KLQHPNIVRLHDS-----IQEESFHYLVFDLVTGGEL-------FEDIVAREFYSEADAS 108

Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVGDFGLAKFLFEESNTP 325
           + +  +  ++ Y H+     I H +LK  N+LL    +G    + DFGLA  +       
Sbjct: 109 HCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV------- 158

Query: 326 SKNQTMSNGLKGSVGYIPPEYINGH-----VSILGDIYSYG----ILL 364
           + ++   +G  G+ GY+ PE +        V    DI++ G    ILL
Sbjct: 159 NDSEAW-HGFAGTPGYLSPEVLKKDPYSKPV----DIWACGVILYILL 201

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 77.3 bits (191), Expect = 6e-16
 Identities = 49/234 (20%), Positives = 97/234 (41%), Gaps = 37/234 (15%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D+      +G G++G V K   +  G+  A+K ++       +  +        +   +I
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRL--------LMDLDI 58

Query: 216 LKIVSSCSS---VDYEGNDFK----ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
                +      V + G  F+     +  E M + +LD++           + +      
Sbjct: 59  SM--RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFY---KQVIDKGQTIPEDILG 112

Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
            I + +  AL++LH++    + H D+K SNVL++      + DFG++ +L    +  +K+
Sbjct: 113 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL---VDDVAKD 167

Query: 329 QTMSNGLKGSVGYIPPEYINGHV-----SILGDIYSYGILLLEIFTGKRPTDDM 377
                   G   Y+ PE IN  +     S+  DI+S GI ++E+   + P D  
Sbjct: 168 IDA-----GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 77.7 bits (192), Expect = 7e-16
 Identities = 57/229 (24%), Positives = 83/229 (36%), Gaps = 52/229 (22%)

Query: 165 IGSGSFGSVYKGT-LADGETAAIKVL---KLQQQGALKSFIDECNALTSIRHRNILKI-- 218
           IG G+F  V     +  G   AIK++   +L      K F  E   +  + H NI+K+  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFE 81

Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN------IVI 272
           V       Y       L+ E+   G +             F  L    R+          
Sbjct: 82  VIETEKTLY-------LIMEYASGGEV-------------FDYLVAHGRMKEKEARSKFR 121

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            + SA+ Y H +    I H DLK+ N+LLD  M   + DFG        SN  +      
Sbjct: 122 QIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGF-------SNEFTVGGK-- 169

Query: 333 NGLKGSVG---YIPPEYINGHVSI--LGDIYSYGILLLEIFTGKRPTDD 376
             L    G   Y  PE   G        D++S G++L  + +G  P D 
Sbjct: 170 --LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 77.4 bits (191), Expect = 7e-16
 Identities = 51/227 (22%), Positives = 86/227 (37%), Gaps = 44/227 (19%)

Query: 164 LIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFID-ECNALTSIRHRNILKI--V 219
            +G G++G V         E  A+K++ +++       I  E      + H N++K    
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA---- 275
               ++ Y       L  E+   G L             F ++     +      A    
Sbjct: 74  RREGNIQY-------LFLEYCSGGEL-------------FDRIEPDIGMPE--PDAQRFF 111

Query: 276 ----SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
               + + YLH      I H D+K  N+LLDE     + DFGLA  +F  +N       M
Sbjct: 112 HQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKM 167

Query: 332 SNGLKGSVGYIPPEYINGH--VSILGDIYSYGILLLEIFTGKRPTDD 376
                G++ Y+ PE +      +   D++S GI+L  +  G+ P D 
Sbjct: 168 C----GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 77.3 bits (191), Expect = 7e-16
 Identities = 56/270 (20%), Positives = 100/270 (37%), Gaps = 64/270 (23%)

Query: 135 QSAPPSNEWQSGLSYLKISNAT-DNFSEENLIGSGSFGSVY----KGTLADGETAAIKVL 189
           +  P +   Q      +      ++F    ++G GSF +V       T       AIK+L
Sbjct: 7   EPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELAT---SREYAIKIL 63

Query: 190 K---LQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVD--YEGNDFKALVFEFMRNGN 244
           +   + ++  +     E + ++ + H   +K+  +    +  Y           + +NG 
Sbjct: 64  EKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY-------FGLSYAKNGE 116

Query: 245 LDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA--------SALDYLHNQYDTPIAHCDLKS 296
           L              K +  +   +              SAL+YLH +    I H DLK 
Sbjct: 117 L-------------LKYIRKIGSFDE--TCTRFYTAEIVSALEYLHGK---GIIHRDLKP 158

Query: 297 SNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI--NGH---V 351
            N+LL+E M   + DFG AK L  ES      Q  +N   G+  Y+ PE +         
Sbjct: 159 ENILLNEDMHIQITDFGTAKVLSPES-----KQARANSFVGTAQYVSPELLTEKSACKSS 213

Query: 352 SILGDIYSYGILLLEIFTGKRPTDDMFKDD 381
               D+++ G ++ ++  G  P    F+  
Sbjct: 214 ----DLWALGCIIYQLVAGLPP----FRAG 235

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 77.7 bits (192), Expect = 8e-16
 Identities = 57/235 (24%), Positives = 95/235 (40%), Gaps = 45/235 (19%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQ--GALKSFIDECNALTSIRHR 213
             + +   IG G+FG V+K      G+  A+K + ++ +  G   + + E   L  ++H 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76

Query: 214 NILK---IVSSCSSVDYEGNDFKALVFEFMRN---GNLDQWLHPSTDEYCHFKKLSLMQR 267
           N++    I  + +S          LVF+F  +   G L   L   T      K   +MQ 
Sbjct: 77  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS--EIK--RVMQM 132

Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK 327
           L       + L Y+H      I H D+K++NVL+    +  + DFGLA+      N+   
Sbjct: 133 LL------NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183

Query: 328 NQTMSNGLKGSVG---YIPPEYINGHVSILG--------DIYSYGILLLEIFTGK 371
             T        V    Y PPE       +LG        D++  G ++ E++T  
Sbjct: 184 RYT------NRVVTLWYRPPEL------LLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 78.1 bits (193), Expect = 9e-16
 Identities = 45/233 (19%), Positives = 88/233 (37%), Gaps = 41/233 (17%)

Query: 147 LSYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVL--KLQQQGALKSFIDE 203
           ++ +  +  T+ +     +G G+F  V +   +  G+  A  ++  K       +    E
Sbjct: 1   MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60

Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
                 ++H NI+++  S             L+F+ +  G L        ++    +  S
Sbjct: 61  ARICRLLKHPNIVRLHDS-----ISEEGHHYLIFDLVTGGEL-------FEDIVAREYYS 108

Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVGDFGLAKFLFE 320
                + +  +  A+ + H      + H +LK  N+LL    +G    + DFGLA  +  
Sbjct: 109 EADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV-- 163

Query: 321 ESNTPSKNQTMSNGLKGSVGYIPPEYINGH-----VSILGDIYSYG----ILL 364
                 + Q    G  G+ GY+ PE +        V    D+++ G    ILL
Sbjct: 164 ----EGEQQAWF-GFAGTPGYLSPEVLRKDPYGKPV----DLWACGVILYILL 207

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 78.7 bits (194), Expect = 1e-15
 Identities = 56/246 (22%), Positives = 98/246 (39%), Gaps = 50/246 (20%)

Query: 157 DNFSEENLIGSGSFGSVY----KGTLADGETAAIKVLK---LQQQGALKSFIDECNALTS 209
           D F +  ++G G FG V+    K T   G+  A K L    L+++   +  + E   L  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKAT---GKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241

Query: 210 IRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN 269
           +  R I+ +  +     +E      LV   M  G++   ++   ++   F+      R  
Sbjct: 242 VHSRFIVSLAYA-----FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ----EPRAI 292

Query: 270 IVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSK 327
                + S L++LH +    I + DLK  NVLLD +G +  + D GLA  L         
Sbjct: 293 FYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVR-ISDLGLAVELKAGQTKT-- 346

Query: 328 NQTMSNGLKGSVGYIPPEYINGH-----VSILGDIYSYGILLLEIFTGKRP--------- 373
                 G  G+ G++ PE + G      V    D ++ G+ L E+   + P         
Sbjct: 347 -----KGYAGTPGFMAPELLLGEEYDFSV----DYFALGVTLYEMIAARGPFRARGEKVE 397

Query: 374 TDDMFK 379
             ++ +
Sbjct: 398 NKELKQ 403

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 53/232 (22%), Positives = 90/232 (38%), Gaps = 37/232 (15%)

Query: 146 GLSYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFID-- 202
           G+   K     D +     +GSG F  V K    + G   A K +K +Q  A +  +   
Sbjct: 1   GMEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSRE 60

Query: 203 ----ECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCH 258
               E + L  + H N++ +        YE      L+ E +  G L        D    
Sbjct: 61  EIEREVSILRQVLHHNVITLHDV-----YENRTDVVLILELVSGGEL-------FDFLAQ 108

Query: 259 FKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL-----DEGMIAHVGDFG 313
            + LS  +  + +  +   ++YLH +    IAH DLK  N++L         I  + DFG
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIK-LIDFG 164

Query: 314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-HVSILGDIYSYGILL 364
           LA  +              N   G+  ++ PE +N   + +  D++S G++ 
Sbjct: 165 LAHEI-------EDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 53/240 (22%), Positives = 90/240 (37%), Gaps = 33/240 (13%)

Query: 130 KTSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKV 188
           K +                +         +  +++IG G    V +    A G   A+K+
Sbjct: 67  KGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKI 126

Query: 189 L--------KLQQQGALKSFIDECNALTSIR-HRNILKIVSSCSSVDYEGNDFKALVFEF 239
           +          Q +   ++   E + L  +  H +I+ ++ S     YE + F  LVF+ 
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS-----YESSSFMFLVFDL 181

Query: 240 MRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNV 299
           MR G L        D       LS  +  +I+  +  A+ +LH      I H DLK  N+
Sbjct: 182 MRKGEL-------FDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENI 231

Query: 300 LLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYS 359
           LLD+ M   + DFG +  L          + +   L G+ GY+ PE +   +      Y 
Sbjct: 232 LLDDNMQIRLSDFGFSCHL-------EPGEKL-RELCGTPGYLAPEILKCSMDETHPGYG 283

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 48/226 (21%), Positives = 90/226 (39%), Gaps = 38/226 (16%)

Query: 150 LKISNATDNF---SEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECN 205
           +K S    ++    ++  +G GSF    K       +  A+K++  + +   +    E  
Sbjct: 1   MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EIT 57

Query: 206 ALTSIR-HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSL 264
           AL     H NI+K+        +       LV E +  G L        +     K  S 
Sbjct: 58  ALKLCEGHPNIVKLHEV-----FHDQLHTFLVMELLNGGEL-------FERIKKKKHFSE 105

Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVGDFGLAKFLFEE 321
            +   I+  + SA+ ++H+     + H DLK  N+L    ++ +   + DFG A+    +
Sbjct: 106 TEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162

Query: 322 SNTPSKNQTMSNGLKGSVGYIPPEYINGHV---SILGDIYSYGILL 364
                 NQ +      ++ Y  PE +N +    S   D++S G++L
Sbjct: 163 ------NQPLK-TPCFTLHYAAPELLNQNGYDESC--DLWSLGVIL 199

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 52/231 (22%), Positives = 91/231 (39%), Gaps = 35/231 (15%)

Query: 146 GLSYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFID-- 202
           G+   K     D +     +GSG F  V K    + G   A K +K +Q  A +  +   
Sbjct: 1   GMETFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCRE 60

Query: 203 ----ECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCH 258
               E + L  + H NI+ +        YE      L+ E +  G L        D    
Sbjct: 61  EIEREVSILRQVLHPNIITLHDV-----YENRTDVVLILELVSGGEL-------FDFLAQ 108

Query: 259 FKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL----DEGMIAHVGDFGL 314
            + LS  +  + +  +   ++YLH +    IAH DLK  N++L           + DFGL
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165

Query: 315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-HVSILGDIYSYGILL 364
           A  +        ++      + G+  ++ PE +N   + +  D++S G++ 
Sbjct: 166 AHEI--------EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 76.0 bits (188), Expect = 1e-15
 Identities = 54/230 (23%), Positives = 94/230 (40%), Gaps = 43/230 (18%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQ--GALKSFIDECNALTSIRHR 213
             + +   IG G++G+V+K       E  A+K ++L     G   S + E   L  ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 214 NILK---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRL 268
           NI++   ++ S   +         LVFEF  + +L ++        +    K   L Q L
Sbjct: 62  NIVRLHDVLHSDKKL-T-------LVFEFC-DQDLKKYFDSCNGDLDPEIVKSF-LFQLL 111

Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
                    L + H++    + H DLK  N+L++      + +FGLA+        P + 
Sbjct: 112 -------KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAF----GIPVR- 156

Query: 329 QTMSNGLKGSV---GYIPPEYING--HVSILGDIYSYGILLLEIFTGKRP 373
              S      V    Y PP+ + G    S   D++S G +  E+    RP
Sbjct: 157 -CYSA----EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 61/239 (25%), Positives = 94/239 (39%), Gaps = 59/239 (24%)

Query: 157 DNFSEENLIGSGSFGSVY----KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRH 212
           D+F     IG GSFG V       T    +  A+K +        K    E N + ++  
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDT---KKMYAMKYMN-------KQKCVERNEVRNVFK 64

Query: 213 -RNILK------IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM 265
              I++      +V+   S   E + F  +V + +  G+L                L   
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMF--MVVDLLLGGDL-------------RYHLQQN 109

Query: 266 QRLNI------VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLF 319
                      + ++  ALDYL NQ    I H D+K  N+LLDE    H+ DF +A  L 
Sbjct: 110 VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166

Query: 320 EESNTPSKNQTMSNGLKGSVGYIPPEYIN-----GHVSILGDIYSYGILLLEIFTGKRP 373
            E+       TM+    G+  Y+ PE  +     G+ S   D +S G+   E+  G+RP
Sbjct: 167 RETQI----TTMA----GTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRRP 216

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 55/251 (21%), Positives = 93/251 (37%), Gaps = 50/251 (19%)

Query: 148 SYLKISNATDNFSEENL-----IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFI 201
            YL I          +L     +GSG+ G V+K      G   A+K ++          I
Sbjct: 11  GYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRI 70

Query: 202 DECNALTSIRHRNILKIVSSCSS---VDYEGNDFKA----LVFEFMRNG--NLDQWLHPS 252
                   +   +++    S      V   G         +  E M      L + +   
Sbjct: 71  --------LMDLDVVL--KSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGP 120

Query: 253 TDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF 312
             E    K         + + +  AL YL  ++   + H D+K SN+LLDE     + DF
Sbjct: 121 IPERILGK---------MTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDF 169

Query: 313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHV------SILGDIYSYGILLLE 366
           G++  L    +  +K+++      G   Y+ PE I+          I  D++S GI L+E
Sbjct: 170 GISGRL---VDDKAKDRSA-----GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221

Query: 367 IFTGKRPTDDM 377
           + TG+ P  + 
Sbjct: 222 LATGQFPYKNC 232

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 48/207 (23%), Positives = 77/207 (37%), Gaps = 36/207 (17%)

Query: 156 TDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLK--------LQQQGALKSFIDECNA 206
            D +     +GSG+ G V         +  AIK++          ++     +   E   
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           L  + H  I+KI +      ++  D+  +V E M  G L        D+    K+L    
Sbjct: 69  LKKLNHPCIIKIKNF-----FDAEDY-YIVLELMEGGEL-------FDKVVGNKRLKEAT 115

Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVGDFGLAKFLFEESN 323
                  +  A+ YLH      I H DLK  NVLL   +E  +  + DFG +K L     
Sbjct: 116 CKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----- 167

Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGH 350
                 ++   L G+  Y+ PE +   
Sbjct: 168 ---GETSLMRTLCGTPTYLAPEVLVSV 191

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 51/268 (19%), Positives = 99/268 (36%), Gaps = 64/268 (23%)

Query: 138 PPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVL---KLQQ 193
           PP      GL+  +    +  +S  + +GSG+FG V+        +   +K +   K+ +
Sbjct: 6   PPKAVELEGLAACE-GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLE 64

Query: 194 QGALKSFID-----ECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEF--------- 239
              ++         E   L+ + H NI+K++       +E   F  LV E          
Sbjct: 65  DCWIEDPKLGKVTLEIAILSRVEHANIIKVLDI-----FENQGFFQLVMEKHGSGLDLFA 119

Query: 240 --MRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSS 297
              R+  LD+          +       Q       + SA+ YL  +    I H D+K  
Sbjct: 120 FIDRHPRLDE------PLASYI----FRQ-------LVSAVGYLRLKD---IIHRDIKDE 159

Query: 298 NVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK---GSVGYIPPEYINGHVSIL 354
           N+++ E     + DFG        +    + +          G++ Y  PE + G+    
Sbjct: 160 NIVIAEDFTIKLIDFGS-------AAYLERGKL----FYTFCGTIEYCAPEVLMGN-PYR 207

Query: 355 G---DIYSYGILLLEIFTGKRPTDDMFK 379
           G   +++S G+ L  +   + P  ++ +
Sbjct: 208 GPELEMWSLGVTLYTLVFEENPFCELEE 235

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 50/233 (21%), Positives = 88/233 (37%), Gaps = 47/233 (20%)

Query: 150 LKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFID------ 202
            +  N  D +     +GSG F  V K    + G   A K +K ++  + +  +       
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63

Query: 203 ECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKL 262
           E + L  I+H N++ +        YE      L+ E +  G L             F  L
Sbjct: 64  EVSILKEIQHPNVITLHEV-----YENKTDVILILELVAGGEL-------------FDFL 105

Query: 263 SLMQRL------NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL----DEGMIAHVGDF 312
           +  + L        +  + + + YLH+     IAH DLK  N++L           + DF
Sbjct: 106 AEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 162

Query: 313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-HVSILGDIYSYGILL 364
           GLA  +              N   G+  ++ PE +N   + +  D++S G++ 
Sbjct: 163 GLAHKI-------DFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 74.9 bits (185), Expect = 4e-15
 Identities = 42/166 (25%), Positives = 78/166 (46%), Gaps = 23/166 (13%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQ--GALKSFIDECNALTSIRHR 213
           +NF +   IG G++G VYK      GE  A+K ++L  +  G   + I E + L  + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62

Query: 214 NILK---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
           NI+K   ++ + + +         LVFEF+ + +L +++     +      + L    + 
Sbjct: 63  NIVKLLDVIHTENKL--------YLVFEFL-HQDLKKFM-----DASALTGIPLPLIKSY 108

Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK 316
           +  +   L + H+     + H DLK  N+L++      + DFGLA+
Sbjct: 109 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 76.4 bits (188), Expect = 5e-15
 Identities = 57/231 (24%), Positives = 91/231 (39%), Gaps = 44/231 (19%)

Query: 157 DNFSEENLIGSGSFGSVY----KGTLADGETAAIKVLK---LQQQGALKSFIDECNALTS 209
           + F +  ++G G FG V     + T   G+  A K L+   ++++      ++E   L  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQILEK 240

Query: 210 IRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN 269
           +  R ++ +  +     YE  D   LV   M  G+L    H        F       R  
Sbjct: 241 VNSRFVVSLAYA-----YETKDALCLVLTLMNGGDL--KFHIYHMGQAGFP----EARAV 289

Query: 270 IVI-DVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSK 327
               ++   L+ LH +    I + DLK  N+LLD  G I  + D GLA  + E       
Sbjct: 290 FYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIR-ISDLGLAVHVPEGQTI--- 342

Query: 328 NQTMSNGLKGSVGYIPPEYINGH-----VSILGDIYSYGILLLEIFTGKRP 373
                 G  G+VGY+ PE +             D ++ G LL E+  G+ P
Sbjct: 343 -----KGRVGTVGYMAPEVVKNERYTFSP----DWWALGCLLYEMIAGQSP 384

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 75.9 bits (187), Expect = 5e-15
 Identities = 55/254 (21%), Positives = 98/254 (38%), Gaps = 65/254 (25%)

Query: 157 DNFSEENLIGSGSFGSVY----KGTLADGETAAIKVLK---LQQQGALKSFIDECNALTS 209
           D+F    +IG G+F  V     K T   G+  A+K++    + ++G +  F +E + L +
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVN 117

Query: 210 IRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN 269
              R I ++  +     ++  ++  LV E+   G+L                L+L+ +  
Sbjct: 118 GDRRWITQLHFA-----FQDENYLYLVMEYYVGGDL----------------LTLLSKFG 156

Query: 270 IVID----------VASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFL 318
             I           +  A+D +H        H D+K  N+LLD  G I  + DFG    L
Sbjct: 157 ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIR-LADFGSCLKL 212

Query: 319 FEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILG--------DIYSYGILLLEIFTG 370
             +          S    G+  Y+ PE +       G        D ++ G+   E+F G
Sbjct: 213 RADGT------VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266

Query: 371 KRP-----TDDMFK 379
           + P     T + + 
Sbjct: 267 QTPFYADSTAETYG 280

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 74.1 bits (183), Expect = 5e-15
 Identities = 50/224 (22%), Positives = 88/224 (39%), Gaps = 35/224 (15%)

Query: 153 SNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFID------ECN 205
           S   D++     +GSG F  V K      G+  A K +K ++  + +  +       E N
Sbjct: 1   SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60

Query: 206 ALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLM 265
            L  IRH NI+ +        +E      L+ E +  G L        D     + L+  
Sbjct: 61  ILREIRHPNIITLHDI-----FENKTDVVLILELVSGGEL-------FDFLAEKESLTED 108

Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL----DEGMIAHVGDFGLAKFLFEE 321
           +    +  +   + YLH++    IAH DLK  N++L           + DFG+A  +   
Sbjct: 109 EATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--- 162

Query: 322 SNTPSKNQTMSNGLKGSVGYIPPEYING-HVSILGDIYSYGILL 364
                      N   G+  ++ PE +N   + +  D++S G++ 
Sbjct: 163 ----EAGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 74.5 bits (184), Expect = 6e-15
 Identities = 43/169 (25%), Positives = 81/169 (47%), Gaps = 18/169 (10%)

Query: 154 NATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQ-GALKSFIDECNALTSIR 211
           +++  F +   +G+G++ +VYKG     G   A+K +KL  + G   + I E + +  ++
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61

Query: 212 HRNILK---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
           H NI++   ++ + + +         LVFEFM + +L +++   T      + L L    
Sbjct: 62  HENIVRLYDVIHTENKL-T-------LVFEFM-DNDLKKYMDSRTVGNTP-RGLELNLVK 111

Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF 317
                +   L + H      I H DLK  N+L+++     +GDFGLA+ 
Sbjct: 112 YFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARA 157

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 74.2 bits (183), Expect = 8e-15
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 40/226 (17%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQ-GALKSFIDECNALTSIRHRN 214
           + + + + +G G++ +VYKG         A+K ++L+ + GA  + I E + L  ++H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 215 ILK---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWL-HPSTDEYCHFKKLSLMQRLNI 270
           I+    I+ +  S+         LVFE++ + +L Q+L         H  KL L Q L  
Sbjct: 62  IVTLHDIIHTEKSL-T-------LVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLL-- 110

Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
                  L Y H Q    + H DLK  N+L++E     + DFGLA+      + P+K  T
Sbjct: 111 -----RGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAK----SIPTK--T 156

Query: 331 MSNGLKGSVG---YIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
             N     V    Y PP+ + G    S   D++  G +  E+ TG+
Sbjct: 157 YDN----EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 73.3 bits (181), Expect = 1e-14
 Identities = 45/167 (26%), Positives = 79/167 (47%), Gaps = 27/167 (16%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQ--GALKSFIDECNALTSIRHRN 214
           + +     IG G++G VYK     GET A+K ++L+++  G   + I E + L  ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 215 ILK---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLN 269
           I+K   ++ +   +         LVFE + + +L + L       E    K   L+Q L 
Sbjct: 62  IVKLYDVIHTKKRL-V-------LVFEHL-DQDLKKLLDVCEGGLESVTAKSF-LLQLL- 110

Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK 316
                 + + Y H++    + H DLK  N+L++      + DFGLA+
Sbjct: 111 ------NGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLAR 148

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 50/246 (20%), Positives = 94/246 (38%), Gaps = 59/246 (23%)

Query: 157 DNFSEENLIGSGSFGSVY----KGTLADGETAAIKVLK---LQQQGALKSFIDECNALTS 209
           +++    +IG G+FG V     K T    +  A+K+L    + ++     F +E + +  
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 125

Query: 210 IRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN 269
                ++++  +     ++ + +  +V E+M  G+L                ++LM   +
Sbjct: 126 ANSPWVVQLFYA-----FQDDRYLYMVMEYMPGGDL----------------VNLMSNYD 164

Query: 270 IVIDVA--------SALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFE 320
           +    A         ALD +H+       H D+K  N+LLD  G +  + DFG    +  
Sbjct: 165 VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLK-LADFGTCMKM-- 218

Query: 321 ESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILG-----DIYSYGILLLEIFTGKRPTD 375
                 +     +   G+  YI PE +             D +S G+ L E+  G  P  
Sbjct: 219 ----NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP-- 272

Query: 376 DMFKDD 381
             F  D
Sbjct: 273 --FYAD 276

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 60/237 (25%), Positives = 100/237 (42%), Gaps = 56/237 (23%)

Query: 156 TDNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRN 214
             ++++  +IG+GSFG VY+  L D GE  AIK +   ++   +    E   +  + H N
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCN 108

Query: 215 ILKIVSS-CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFK--------KLSLM 265
           I+++     SS + +   +  LV +++      + ++     Y   K        KL + 
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMY 163

Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM-IAHVGDFGLAKFLFEESNT 324
           Q          +L Y+H+     I H D+K  N+LLD    +  + DFG AK L      
Sbjct: 164 QLF-------RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL------ 207

Query: 325 PSKNQTMSNGLKGSVGYI------PPEYINGH----VSILGDIYSYGILLLEIFTGK 371
             + +         V YI       PE I G      SI  D++S G +L E+  G+
Sbjct: 208 -VRGEPN-------VSYICSRYYRAPELIFGATDYTSSI--DVWSAGCVLAELLLGQ 254

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 50/252 (19%), Positives = 95/252 (37%), Gaps = 63/252 (25%)

Query: 157 DNFSEENLIGSGSFGSVY----KGTLADGETAAIKVLK---LQQQGALKSFIDECNALTS 209
           ++F    +IG G+FG V     K      +  A+K+L    + ++     F +E + L +
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFREERDVLVN 130

Query: 210 IRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN 269
              + I  +  +     ++ ++   LV ++   G+L                L+L+ +  
Sbjct: 131 GDSKWITTLHYA-----FQDDNNLYLVMDYYVGGDL----------------LTLLSKFE 169

Query: 270 IVID----------VASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFL 318
             +           +  A+D +H        H D+K  N+L+D  G I  + DFG    L
Sbjct: 170 DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIR-LADFGSCLKL 225

Query: 319 FEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILG------DIYSYGILLLEIFTGKR 372
            E+          S+   G+  YI PE +       G      D +S G+ + E+  G+ 
Sbjct: 226 MED------GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279

Query: 373 P-----TDDMFK 379
           P       + + 
Sbjct: 280 PFYAESLVETYG 291

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 54/280 (19%), Positives = 87/280 (31%), Gaps = 75/280 (26%)

Query: 129 VKTSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIK 187
           V      +              +       +    L+GSG FGSVY G  ++D    AIK
Sbjct: 15  VPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK 74

Query: 188 VL---KLQQQGALKSFID---ECNALTSIRHR--NILKI--VSSCSSVDYEGNDFKALVF 237
            +   ++   G L +      E   L  +      ++++          +E  D   L+ 
Sbjct: 75  HVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-------FERPDSFVLIL 127

Query: 238 EF-----------MRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYD 286
           E               G L +      +    F      Q       V  A+ + HN   
Sbjct: 128 ERPEPVQDLFDFITERGALQE------ELARSF----FWQ-------VLEAVRHCHNCG- 169

Query: 287 TPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK---GSVGYI 342
             + H D+K  N+L+D       + DFG                          G+  Y 
Sbjct: 170 --VLHRDIKDENILIDLNRGELKLIDFGSG------------ALLKDTVYTDFDGTRVYS 215

Query: 343 PPEYINGH------VSILGDIYSYGILLLEIFTGKRPTDD 376
           PPE+I  H            ++S GILL ++  G  P + 
Sbjct: 216 PPEWIRYHRYHGRSA----AVWSLGILLYDMVCGDIPFEH 251

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 74.9 bits (184), Expect = 2e-14
 Identities = 55/239 (23%), Positives = 94/239 (39%), Gaps = 59/239 (24%)

Query: 157 DNFSEENLIGSGSFGSVY----KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRH 212
           ++FS   +IG G FG VY      T   G+  A+K L        K  I      T   +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADT---GKMYAMKCLD-------KKRIKMKQGETLALN 238

Query: 213 -RNILKIVSSCSS---VD----YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSL 264
            R +L +VS+      V     +   D  + + + M  G+L                LS 
Sbjct: 239 ERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL-------------HYHLSQ 285

Query: 265 MQRLNI------VIDVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKF 317
               +         ++   L+++HN++   + + DLK +N+LLD  G +  + D GLA  
Sbjct: 286 HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVR-ISDLGLACD 341

Query: 318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYIN---GHVSILGDIYSYGILLLEIFTGKRP 373
             ++           +   G+ GY+ PE +     + S   D +S G +L ++  G  P
Sbjct: 342 FSKKK---------PHASVGTHGYMAPEVLQKGVAYDSSA-DWFSLGCMLFKLLRGHSP 390

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 43/181 (23%), Positives = 71/181 (39%), Gaps = 36/181 (19%)

Query: 153 SNATDNFSEENLIGSGSFGSVYKG--TLADGETAAIKVLKLQQQGALKSFIDECNALTSI 210
             A   +     IG G++G V+K       G   A+K +++Q         +E   L++I
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-------EEGMPLSTI 59

Query: 211 R------------HRNILKIVSSCSSVDYEGNDFKALVFEFMRN---GNLDQWLHPSTDE 255
           R            H N++++   C+    +      LVFE +       LD+   P    
Sbjct: 60  REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT 119

Query: 256 YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA 315
               K + + Q L         LD+LH+     + H DLK  N+L+       + DFGLA
Sbjct: 120 -ETIKDM-MFQLL-------RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA 167

Query: 316 K 316
           +
Sbjct: 168 R 168

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 46/187 (24%), Positives = 78/187 (41%), Gaps = 47/187 (25%)

Query: 150 LKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALK-----SFIDE 203
           L + +    + + + +G G F +VYK       +  AIK +KL  +   K     + + E
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62

Query: 204 CNALTSIRHRNILK---IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFK 260
              L  + H NI+         S++         LVF+FM     +  L          +
Sbjct: 63  IKLLQELSHPNIIGLLDAFGHKSNI-S-------LVFDFM-----ETDL----------E 99

Query: 261 KLSLMQRLNIVIDVA----------SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG 310
            +  ++  ++V+  +            L+YLH  +   I H DLK +N+LLDE  +  + 
Sbjct: 100 VI--IKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLA 154

Query: 311 DFGLAKF 317
           DFGLAK 
Sbjct: 155 DFGLAKS 161

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 61/232 (26%), Positives = 91/232 (39%), Gaps = 56/232 (24%)

Query: 164 LIGSGSFGSVYKGT-LADGETAAIKVL---KLQQQGALKSFIDECNALTSIRHRNILKI- 218
            +G GSFG V   T     +  A+K +    L++         E + L  +RH +I+K+ 
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 219 -VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA-- 275
            V +  +          +V E+   G L             F  +   +R+    D    
Sbjct: 76  DVITTPTDIV-------MVIEYA-GGEL-------------FDYIVEKKRMTE--DEGRR 112

Query: 276 ------SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
                  A++Y H      I H DLK  N+LLD+ +   + DFGL       SN  +   
Sbjct: 113 FFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGL-------SNIMTDGN 162

Query: 330 TMSNGLK---GSVGYIPPEYINGH--VSILGDIYSYGILLLEIFTGKRPTDD 376
                LK   GS  Y  PE ING        D++S GI+L  +  G+ P DD
Sbjct: 163 F----LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 46/218 (21%), Positives = 84/218 (38%), Gaps = 33/218 (15%)

Query: 154 NATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRH 212
              + +     +G G FG V++    +  +T   K +K++          E + L   RH
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARH 60

Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNL-DQWLHPSTDEYCHFKKLSLMQR--LN 269
           RNIL +  S     +E  +   ++FEF+   ++ ++          +     L +R  ++
Sbjct: 61  RNILHLHES-----FESMEELVMIFEFISGLDIFER---------INTSAFELNEREIVS 106

Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLL--DEGMIAHVGDFGLAKFLFEESNTPSK 327
            V  V  AL +LH+     I H D++  N++          + +FG A+ L         
Sbjct: 107 YVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-------KP 156

Query: 328 NQTMSNGLKGSVGYIPPEYING-HVSILGDIYSYGILL 364
                     +  Y  PE      VS   D++S G L+
Sbjct: 157 GDNFRLLF-TAPEYYAPEVHQHDVVSTATDMWSLGTLV 193

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 72.2 bits (178), Expect = 3e-14
 Identities = 42/178 (23%), Positives = 76/178 (42%), Gaps = 26/178 (14%)

Query: 153 SNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIR 211
           S AT  +     IG G++G+VYK      G   A+K +++   G     +     ++++R
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGL----PISTVR 60

Query: 212 ------------HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHF 259
                       H N+++++  C++   +      LVFE + + +L  +L     +    
Sbjct: 61  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-----DKAPP 114

Query: 260 KKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF 317
             L      +++      LD+LH      I H DLK  N+L+  G    + DFGLA+ 
Sbjct: 115 PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 169

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 58/245 (23%), Positives = 93/245 (37%), Gaps = 60/245 (24%)

Query: 153 SNATDNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSF----IDECNAL 207
               D F  E + G G+FG+V  G     G + AIK  K+ Q      F    +     L
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK--KVIQD---PRFRNRELQIMQDL 73

Query: 208 TSIRHRNILKIVSSCSSVDYEGND--FKALVFEFMRNGNLDQWLHPSTDEYCHFK----- 260
             + H NI+++ S   ++        +  +V E++        LH     Y   +     
Sbjct: 74  AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLHRCCRNYYRRQVAPPP 128

Query: 261 ---KLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM-IAHVGDFGLAK 316
              K+ L Q +        ++  LH      + H D+K  NVL++E      + DFG AK
Sbjct: 129 ILIKVFLFQLI-------RSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180

Query: 317 FLFEESNTPSKNQTMSNGLKGSVGYI------PPEYINGH----VSILGDIYSYGILLLE 366
            L       S ++         V YI       PE I G+     ++  DI+S G +  E
Sbjct: 181 KL-------SPSEPN-------VAYICSRYYRAPELIFGNQHYTTAV--DIWSVGCIFAE 224

Query: 367 IFTGK 371
           +  G+
Sbjct: 225 MMLGE 229

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 72.3 bits (178), Expect = 5e-14
 Identities = 50/225 (22%), Positives = 84/225 (37%), Gaps = 41/225 (18%)

Query: 151 KISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNAL-T 208
                TD +  +  IG GS+    +    A     A+K++   ++       +E   L  
Sbjct: 16  NSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT----EEIEILLR 71

Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
             +H NI+ +        Y+   +  +V E M+ G L        D+    K  S  +  
Sbjct: 72  YGQHPNIITLKDV-----YDDGKYVYVVTELMKGGEL-------LDKILRQKFFSEREAS 119

Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL----DEGMIAHVGDFGLAKFLFEESNT 324
            ++  +   ++YLH Q    + H DLK SN+L            + DFG AK L  E   
Sbjct: 120 AVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--- 173

Query: 325 PSKNQTMSNGLKGSVGYIPPEYINGH-----VSILGDIYSYGILL 364
              N  +      +  ++ PE +             DI+S G+LL
Sbjct: 174 ---NGLLM-TPCYTANFVAPEVLERQGYDAAC----DIWSLGVLL 210

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 72.0 bits (177), Expect = 5e-14
 Identities = 60/248 (24%), Positives = 87/248 (35%), Gaps = 42/248 (16%)

Query: 130 KTSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKV 188
            T+       S      +        +D F  E+ +G G+   VY+       +  A+KV
Sbjct: 26  VTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKV 85

Query: 189 LKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQW 248
           LK       K    E   L  + H NI+K+        +E     +LV E +  G L   
Sbjct: 86  LKKTVD--KKIVRTEIGVLLRLSHPNIIKLKEI-----FETPTEISLVLELVTGGEL--- 135

Query: 249 LHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL---DEGM 305
                D        S     + V  +  A+ YLH      I H DLK  N+L        
Sbjct: 136 ----FDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDA 188

Query: 306 IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH-----VSILGDIYSY 360
              + DFGL+K +            M   + G+ GY  PE + G      V    D++S 
Sbjct: 189 PLKIADFGLSKIVEH-------QVLMK-TVCGTPGYCAPEILRGCAYGPEV----DMWSV 236

Query: 361 G----ILL 364
           G    ILL
Sbjct: 237 GIITYILL 244

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 72.8 bits (179), Expect = 6e-14
 Identities = 59/244 (24%), Positives = 104/244 (42%), Gaps = 53/244 (21%)

Query: 157 DNFSEENLIGSGSFGSVY----KGTLADGETAAIKVLK---LQQQGALKSFIDECNALTS 209
           + F    L+G G+FG V     K T   G   A+K+LK   +  +  +   + E   L +
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204

Query: 210 IRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPS---TDEYCHFKKLSLMQ 266
            RH  +  +  S     ++ +D    V E+   G L   L      +++   F       
Sbjct: 205 SRHPFLTALKYS-----FQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF------- 252

Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTP 325
                 ++ SALDYLH++ +  + + DLK  N++LD +G I  + DFGL K   E     
Sbjct: 253 ---YGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIK-ITDFGLCK---EGIKDG 303

Query: 326 SKNQTMSNGLKGSVGYIPPEYINGH-----VSILGDIYSYGILLLEIFTGKRP-----TD 375
           +  +T      G+  Y+ PE +  +     V    D +  G+++ E+  G+ P      +
Sbjct: 304 ATMKTFC----GTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLPFYNQDHE 355

Query: 376 DMFK 379
            +F+
Sbjct: 356 KLFE 359

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 72.0 bits (177), Expect = 7e-14
 Identities = 57/236 (24%), Positives = 100/236 (42%), Gaps = 55/236 (23%)

Query: 156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
              ++   +IG+GSFG V++  L + +  AIK +   ++   +    E   +  ++H N+
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNV 94

Query: 216 LKIVSS-CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFK--------KLSLMQ 266
           + + +   S+ D +   F  LV E++      + ++ ++  Y   K        KL + Q
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYV-----PETVYRASRHYAKLKQTMPMLLIKLYMYQ 149

Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM-IAHVGDFGLAKFLFEESNTP 325
            L        +L Y+H+     I H D+K  N+LLD    +  + DFG AK L       
Sbjct: 150 LLR-------SLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL------- 192

Query: 326 SKNQTMSNGLKGSVGYI------PPEYING----HVSILGDIYSYGILLLEIFTGK 371
              +         V YI       PE I G      +I  DI+S G ++ E+  G+
Sbjct: 193 IAGEPN-------VSYICSRYYRAPELIFGATNYTTNI--DIWSTGCVMAELMQGQ 239

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 71.6 bits (176), Expect = 8e-14
 Identities = 53/232 (22%), Positives = 85/232 (36%), Gaps = 57/232 (24%)

Query: 164 LIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFID-ECNALTSIRHRNILKI--V 219
            IGSG+FG           E  A+K ++      +   +  E     S+RH NI++   V
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEV 84

Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA---- 275
               +          ++ E+   G L             ++++    R +   D A    
Sbjct: 85  ILTPTHLA-------IIMEYASGGEL-------------YERICNAGRFSE--DEARFFF 122

Query: 276 ----SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH--VGDFGLAKFLFEESNTPSKNQ 329
               S + Y H+     I H DLK  N LLD        + DFG            SK+ 
Sbjct: 123 QQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGY-----------SKSS 168

Query: 330 TMSNGLKGSVG---YIPPEYINGH--VSILGDIYSYGILLLEIFTGKRPTDD 376
            + +  K +VG   YI PE +        + D++S G+ L  +  G  P +D
Sbjct: 169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 71.8 bits (176), Expect = 1e-13
 Identities = 51/239 (21%), Positives = 95/239 (39%), Gaps = 49/239 (20%)

Query: 157 DNFSEENL-IGSGSFGSVYKG---TLADGETAAIKVLKLQQQGALKSFIDECNALTSIRH 212
           D F  E   +G G++G VYK       D +  A+K  +++  G   S   E   L  ++H
Sbjct: 20  DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALK--QIEGTGISMSACREIALLRELKH 77

Query: 213 RNILK----IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKL------ 262
            N++      +S      +       L+F++  + +L   +        + K +      
Sbjct: 78  PNVISLQKVFLSHADRKVW-------LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGM 129

Query: 263 --SLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH----VGDFGLAK 316
             SL+ ++         + YLH  +   + H DLK +N+L+           + D G A+
Sbjct: 130 VKSLLYQIL------DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 180

Query: 317 FLFEESNTPSKNQTMSNGLKGSVG--YIPPEYING--HVSILGDIYSYGILLLEIFTGK 371
                 N+P K   +++     V   Y  PE + G  H +   DI++ G +  E+ T +
Sbjct: 181 LF----NSPLK--PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 46/241 (19%), Positives = 86/241 (35%), Gaps = 33/241 (13%)

Query: 133 RRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKL 191
                    E     S    +N     S+E  +G G F  V +    + G+  A K LK 
Sbjct: 7   HSSGVDLGTENLYFQSMENFNNFYILTSKE--LGRGKFAVVRQCISKSTGQEYAAKFLKK 64

Query: 192 QQQGA--LKSFIDECNALTSIRHR-NILKIVSSCSSVDYEGNDFKALVFEFMRNGNL-DQ 247
           +++G       + E   L   +    ++ +        YE      L+ E+   G +   
Sbjct: 65  RRRGQDCRAEILHEIAVLELAKSCPRVINLHEV-----YENTSEIILILEYAAGGEIFSL 119

Query: 248 WLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL---DEG 304
            L    +       + L++       +   + YLH      I H DLK  N+LL      
Sbjct: 120 CLPELAEMVSENDVIRLIK------QILEGVYYLHQNN---IVHLDLKPQNILLSSIYPL 170

Query: 305 MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-HVSILGDIYSYGIL 363
               + DFG+++ +            +   + G+  Y+ PE +N   ++   D+++ GI+
Sbjct: 171 GDIKIVDFGMSRKI-------GHACELREIM-GTPEYLAPEILNYDPITTATDMWNIGII 222

Query: 364 L 364
            
Sbjct: 223 A 223

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 70.3 bits (173), Expect = 2e-13
 Identities = 42/190 (22%), Positives = 73/190 (38%), Gaps = 25/190 (13%)

Query: 131 TSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVL 189
                      +  +   Y     + + +    L+G GS+G V K      G   AIK  
Sbjct: 2   GHHHHHHSSGVDLGTENLY---FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF 58

Query: 190 KLQQQ--GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQ 247
                     K  + E   L  +RH N++ ++  C     +   +  LVFEF+ +  +  
Sbjct: 59  LESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK---KKRWY--LVFEFV-DHTILD 112

Query: 248 WL--HPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM 305
            L   P+  +Y   +K  L Q +N        + + H+     I H D+K  N+L+ +  
Sbjct: 113 DLELFPNGLDYQVVQKY-LFQIIN-------GIGFCHSHN---IIHRDIKPENILVSQSG 161

Query: 306 IAHVGDFGLA 315
           +  + DFG A
Sbjct: 162 VVKLCDFGFA 171

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 70.3 bits (173), Expect = 2e-13
 Identities = 62/256 (24%), Positives = 103/256 (40%), Gaps = 81/256 (31%)

Query: 157 DNFSEENLIGSGSFGSVY----KGTLADGETAAIKVLKLQQQGALKSFI----------D 202
            +F     +G+GSFG V+    +     G   A+KVLK       K  +          D
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHN---GRYYAMKVLK-------KEIVVRLKQVEHTND 55

Query: 203 ECNALTSIRHRNILKIVSSCSSVD--YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFK 260
           E   L+ + H  I+++  +       +       ++ +++  G L             F 
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQIF-------MIMDYIEGGEL-------------FS 95

Query: 261 KLSLMQRLNIVI------DVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFG 313
            L   QR    +      +V  AL+YLH++    I + DLK  N+LLD  G I  + DFG
Sbjct: 96  LLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIK-ITDFG 151

Query: 314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI--NGH---VSILGDIYSYGILLLEIF 368
            AK++ + + T          L G+  YI PE +    +   +    D +S+GIL+ E+ 
Sbjct: 152 FAKYVPDVTYT----------LCGTPDYIAPEVVSTKPYNKSI----DWWSFGILIYEML 197

Query: 369 TGKRP-----TDDMFK 379
            G  P     T   ++
Sbjct: 198 AGYTPFYDSNTMKTYE 213

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 52/305 (17%), Positives = 105/305 (34%), Gaps = 53/305 (17%)

Query: 164 LIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIR--------HRN 214
            +G G F +V+    + +    A+K+++  +    ++  DE   L  +            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 215 ILKIVSSCSSVDYEGNDFK--ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
              I+      +++G +     +VFE +   NL   +          + + L+    I  
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIK-----KYEHRGIPLIYVKQISK 138

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH------VGDFGLAKFLFEESNTPS 326
            +   LDY+H +    I H D+K  NVL++            + D G A +         
Sbjct: 139 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW--------- 187

Query: 327 KNQTMSNGLKGSVGYIPPEYINGH---VSILGDIYSYGILLLEIFTGKR--PTDDMFKDD 381
            ++  +N ++ +  Y  PE + G         DI+S   L+ E+ TG      D+     
Sbjct: 188 YDEHYTNSIQ-TREYRSPEVLLGAPWGCGA--DIWSTACLIFELITGDFLFEPDEGHSYT 244

Query: 382 LSIHKFVLMALPSHVMDVL---DLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLV 438
                   +      +++L      +L   +          L  +I   +    LE+ L 
Sbjct: 245 KDDDHIAQI------IELLGELPSYLLRNGKYTRTFFNSRGLLRNISK-LKFWPLEDVLT 297

Query: 439 SVMRI 443
              + 
Sbjct: 298 EKYKF 302

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 58/238 (24%), Positives = 95/238 (39%), Gaps = 62/238 (26%)

Query: 157 DNFSEENLIGSGSFGSVY----KGTLADGETAAIKVLKLQQQGALKSF---IDECNALTS 209
           D F     +G+GSFG V     K +   G   A+K+L  Q+   LK     ++E   L +
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97

Query: 210 IRHRNILKIVSSCSSVD--YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQR 267
           +    ++K+  S       Y       +V E++  G +             F  L  + R
Sbjct: 98  VNFPFLVKLEFSFKDNSNLY-------MVMEYVAGGEM-------------FSHLRRIGR 137

Query: 268 LN------IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFE 320
            +          +    +YLH+     + + DLK  N+L+D +G I  V DFG AK +  
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQ-VTDFGFAKRVKG 193

Query: 321 ESNTPSKNQTMSNGLKGSVGYIPPEYI--NGH---VSILGDIYSYGILLLEIFTGKRP 373
            + T          L G+   + PE I   G+   V    D ++ G+L+ E+  G  P
Sbjct: 194 RTWT----------LCGTPEALAPEIILSKGYNKAV----DWWALGVLIYEMAAGYPP 237

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 68.9 bits (169), Expect = 4e-13
 Identities = 51/247 (20%), Positives = 84/247 (34%), Gaps = 77/247 (31%)

Query: 164 LIGSGSFGSVYKGT-LADGETAAIKVL---KLQQQGALKSFID---ECNALTSIR----H 212
           L+G G FG+V+ G  L D    AIKV+   ++     L   +    E   L  +     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 213 RNILKI--VSSCSSVDYEGNDFKALVFEF-----------MRNGNLDQWLHPSTDEYCHF 259
             ++++          +E  +   LV E               G L +           F
Sbjct: 98  PGVIRLLDW-------FETQEGFMLVLERPLPAQDLFDYITEKGPLGE------GPSRCF 144

Query: 260 KKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM----IAHVGDFGLA 315
                 Q       V +A+ + H++    + H D+K  N+L+D       +    DFG  
Sbjct: 145 ----FGQ-------VVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLI---DFGSG 187

Query: 316 KFLFEESNTPSKNQTMSNGLK---GSVGYIPPEYINGHVSILG---DIYSYGILLLEIFT 369
                                   G+  Y PPE+I+ H         ++S GILL ++  
Sbjct: 188 ------------ALLHDEPYTDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVC 234

Query: 370 GKRPTDD 376
           G  P + 
Sbjct: 235 GDIPFER 241

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 70.4 bits (172), Expect = 5e-13
 Identities = 59/259 (22%), Positives = 103/259 (39%), Gaps = 61/259 (23%)

Query: 157 DNFSEENLIGSGSFGSV----YKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRH 212
            +F+   ++G GSFG V     KGT    E  A+K+LK       K  + + + +     
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKILK-------KDVVIQDDDVECTMV 390

Query: 213 -RNILKIVSSC-------SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSL 264
            + +L +           S        +   V E++  G+L   +           +   
Sbjct: 391 EKRVLALPGKPPFLTQLHSCFQTMDRLY--FVMEYVNGGDLMYHIQ-------QVGRFKE 441

Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESN 323
              +    ++A  L +L ++    I + DLK  NV+LD EG I  + DFG+ K    +  
Sbjct: 442 PHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIK-IADFGMCKENIWDGV 497

Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGH-----VSILGDIYSYGILLLEIFTGKRP----- 373
           T     T      G+  YI PE I        V    D +++G+LL E+  G+ P     
Sbjct: 498 TTK---TFC----GTPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAPFEGED 546

Query: 374 TDDMF----KDDLSIHKFV 388
            D++F    + +++  K +
Sbjct: 547 EDELFQSIMEHNVAYPKSM 565

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 67.8 bits (166), Expect = 7e-13
 Identities = 27/217 (12%), Positives = 55/217 (25%), Gaps = 60/217 (27%)

Query: 164 LIGSGSFGSVYKGTLAD---GETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILK 217
             G       ++    D       A+  +  Q       L+  +     L+ I    + +
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 218 IVSSCSSVDY-EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           ++      D         +V E++R G+L +               S +  +  +  +A+
Sbjct: 96  VL------DVVHTRAGGLVVAEWIRGGSLQEVAD---------TSPSPVGAIRAMQSLAA 140

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
           A D  H      +A      S V +       +                           
Sbjct: 141 AADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA----------------------- 174

Query: 337 GSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRP 373
                +P        +   DI   G  L  +   + P
Sbjct: 175 ----TMPD------ANPQDDIRGIGASLYALLVNRWP 201

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 57/246 (23%), Positives = 98/246 (39%), Gaps = 41/246 (16%)

Query: 154 NATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIR- 211
              D++     +G G +  V++   + + E   +K+LK  ++   K    E   L ++R 
Sbjct: 33  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRG 89

Query: 212 HRNILKIVSSCSSVDYEGNDFK-ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
             NI+ +      +  +      ALVFE + N +  Q     TD     +   + + L  
Sbjct: 90  GPNIITLAD----IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDY--DIRFY-MYEILK- 141

Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQ 329
                 ALDY H+     I H D+K  NV++D E     + D+GLA+F           Q
Sbjct: 142 ------ALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-------GQ 185

Query: 330 TMSNGLKGSVGYIPPEYINGH----VSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIH 385
              N    S  +  PE +  +     S+  D++S G +L  +   K P    F    +  
Sbjct: 186 EY-NVRVASRYFKGPELLVDYQMYDYSL--DMWSLGCMLASMIFRKEP---FFHGHDNYD 239

Query: 386 KFVLMA 391
           + V +A
Sbjct: 240 QLVRIA 245

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 40/217 (18%), Positives = 81/217 (37%), Gaps = 45/217 (20%)

Query: 162 ENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSI-RHRNILKIV 219
           + ++G G  G V +      G+  A+K+L             E +         +I+ I+
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCIL 88

Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNL-DQWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
               ++ +       ++ E M  G L  +        +   +   +M+      D+ +A+
Sbjct: 89  DVYENMHHGKRCL-LIIMECMEGGELFSRIQERGDQAFTEREAAEIMR------DIGTAI 141

Query: 279 DYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
            +LH+     IAH D+K  N+L    ++  +  + DFG AK              +    
Sbjct: 142 QFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--------TQNALQ-TP 189

Query: 336 KGSVGYIPPEYINGHVSILG--------DIYSYGILL 364
             +  Y+ PE       +LG        D++S G+++
Sbjct: 190 CYTPYYVAPE-------VLGPEKYDKSCDMWSLGVIM 219

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 66.4 bits (163), Expect = 3e-12
 Identities = 36/164 (21%), Positives = 64/164 (39%), Gaps = 22/164 (13%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQ--GALKSFIDECNALTSIRHR 213
           + + +   IG GS+G V+K      G+  AIK     +      K  + E   L  ++H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWL--HPSTDEYCHFKKLSLMQRLNIV 271
           N++ ++     V         LVFE+  +  +   L  +         K +   Q L   
Sbjct: 63  NLVNLLE----VFRRKRRL-HLVFEYC-DHTVLHELDRYQRGVPEHLVKSI-TWQTLQ-- 113

Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA 315
                A+++ H        H D+K  N+L+ +  +  + DFG A
Sbjct: 114 -----AVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFA 149

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 67.1 bits (164), Expect = 4e-12
 Identities = 60/275 (21%), Positives = 105/275 (38%), Gaps = 64/275 (23%)

Query: 125 IYHIVKTSRRQSAPPSNEWQSGL-----SYLKISNATDNFSE----ENLIGSGSFGSVYK 175
           IY +   ++++          G      SY+++ +  D+ +       +IG GSFG V K
Sbjct: 58  IYFLGLNAKKRQGMTGGPNNGGYDDDQGSYVQVPH--DHVAYRYEVLKVIGKGSFGQVVK 115

Query: 176 GT-LADGETAAIKVLK----LQQQGALKSFIDECNALTSIRHR---NILKIVSSCSSVDY 227
                  +  A+K+++      +Q       +E   L  +R +   N + ++    +  +
Sbjct: 116 AYDHKVHQHVALKMVRNEKRFHRQA-----AEEIRILEHLRKQDKDNTMNVIHMLENFTF 170

Query: 228 EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDT 287
             +    + FE +   NL + +     +   F+  SL         +   LD LH     
Sbjct: 171 RNHIC--MTFELLSM-NLYELI-----KKNKFQGFSLPLVRKFAHSILQCLDALH---KN 219

Query: 288 PIAHCDLKSSNVLLDEGMIAH--VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI--- 342
            I HCDLK  N+LL +   +   V DFG + +  +   T                YI   
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYT----------------YIQSR 263

Query: 343 ---PPEYINGH---VSILGDIYSYGILLLEIFTGK 371
               PE I G    + I  D++S G +L E+ TG 
Sbjct: 264 FYRAPEVILGARYGMPI--DMWSLGCILAELLTGY 296

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 66.5 bits (163), Expect = 4e-12
 Identities = 59/242 (24%), Positives = 100/242 (41%), Gaps = 49/242 (20%)

Query: 157 DNFSEENLIGSGSFGSV----YKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRH 212
           ++F    ++G GSFG V    +K T    +  AIK LK       K  +   + +     
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKT---NQFFAIKALK-------KDVVLMDDDVECTMV 66

Query: 213 -RNILKIVSSC-------SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSL 264
            + +L +            +   + N F   V E++  G+L   +           K  L
Sbjct: 67  EKRVLSLAWEHPFLTHMFCTFQTKENLF--FVMEYLNGGDLMYHIQSC-------HKFDL 117

Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESN 323
            +      ++   L +LH++    I + DLK  N+LLD +G I  + DFG+ K   E   
Sbjct: 118 SRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIK-IADFGMCK---ENML 170

Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGHV-SILGDIYSYGILLLEIFTGKRP-----TDDM 377
             +K  T      G+  YI PE + G   +   D +S+G+LL E+  G+ P      +++
Sbjct: 171 GDAKTNTFC----GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 226

Query: 378 FK 379
           F 
Sbjct: 227 FH 228

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 65.7 bits (161), Expect = 7e-12
 Identities = 54/243 (22%), Positives = 100/243 (41%), Gaps = 52/243 (21%)

Query: 157 DNFSEENLIGSGSFGSV----YKGTLADGETAAIKVLK---LQQQGALKSFIDECNALTS 209
           ++F    L+G G+FG V     K T   G   A+K+L+   +  +  +   + E   L +
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 210 IRHRNILKIVSSCSSVD--YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQR 267
            RH  +  +  +  + D           V E+   G L   L          +  +  + 
Sbjct: 62  TRHPFLTALKYAFQTHDRLC-------FVMEYANGGELFFHLS-------RERVFTEERA 107

Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPS 326
                ++ SAL+YLH++    + + D+K  N++LD +G I  + DFGL K    +  T  
Sbjct: 108 RFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIK-ITDFGLCKEGISDGATMK 163

Query: 327 KNQTMSNGLKGSVGYIPPEYINGH-----VSILGDIYSYGILLLEIFTGKRP-----TDD 376
              T      G+  Y+ PE +  +     V    D +  G+++ E+  G+ P      + 
Sbjct: 164 ---TFC----GTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLPFYNQDHER 212

Query: 377 MFK 379
           +F+
Sbjct: 213 LFE 215

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 65.7 bits (161), Expect = 7e-12
 Identities = 65/246 (26%), Positives = 97/246 (39%), Gaps = 57/246 (23%)

Query: 157 DNFSEENLIGSGSFGSVY----KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRH 212
           DNF    ++G GSFG V     K T   G+  A+KVLK       K  I + + +     
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKET---GDLYAVKVLK-------KDVILQDDDVECTMT 72

Query: 213 -RNILKIVSSC-------SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSL 264
            + IL +  +                 F   V EF+  G+L   +          ++   
Sbjct: 73  EKRILSLARNHPFLTQLFCCFQTPDRLF--FVMEFVNGGDLMFHIQ-------KSRRFDE 123

Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESN 323
            +      ++ SAL +LH++    I + DLK  NVLLD EG    + DFG+ K   E   
Sbjct: 124 ARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCK-LADFGMCK---EGIC 176

Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGH-----VSILGDIYSYGILLLEIFTGKRP----- 373
                 T      G+  YI PE +        V    D ++ G+LL E+  G  P     
Sbjct: 177 NGVTTATFC----GTPDYIAPEILQEMLYGPAV----DWWAMGVLLYEMLCGHAPFEAEN 228

Query: 374 TDDMFK 379
            DD+F+
Sbjct: 229 EDDLFE 234

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 65.3 bits (160), Expect = 7e-12
 Identities = 71/263 (26%), Positives = 114/263 (43%), Gaps = 68/263 (25%)

Query: 157 DNFSEENLIGSGSFGSVY---KGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRH 212
             F    ++G GSFG V+   K + +D  +  A+KVLK       K+ +   + + +   
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRDRVRTKME 76

Query: 213 RNILK------IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           R+IL       IV    +   EG  +  L+ +F+R G+L             F +LS   
Sbjct: 77  RDILVEVNHPFIVKLHYAFQTEGKLY--LILDFLRGGDL-------------FTRLSKEV 121

Query: 267 RLNI------VIDVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLF 319
                     + ++A ALD+LH+     I + DLK  N+LLD EG I  + DFGL+K   
Sbjct: 122 MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIK-LTDFGLSK--- 174

Query: 320 EESNTPSKNQTMSNGLKGSVGYIPPEYINGH-----VSILGDIYSYGILLLEIFTGKRP- 373
           E  +   K  +      G+V Y+ PE +N            D +S+G+L+ E+ TG  P 
Sbjct: 175 ESIDHEKKAYSFC----GTVEYMAPEVVNRRGHTQSA----DWWSFGVLMFEMLTGTLPF 226

Query: 374 ----TDDMF----KDDLSIHKFV 388
                 +      K  L + +F+
Sbjct: 227 QGKDRKETMTMILKAKLGMPQFL 249

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 58/246 (23%), Positives = 98/246 (39%), Gaps = 57/246 (23%)

Query: 157 DNFSEENLIGSGSFGSV----YKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRH 212
            +F+   ++G GSFG V     KGT    E  A+K+LK       K  + + + +     
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKILK-------KDVVIQDDDVECTMV 69

Query: 213 -RNILKIVSSC-------SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSL 264
            + +L +           S        +   V E++  G+L   +           +   
Sbjct: 70  EKRVLALPGKPPFLTQLHSCFQTMDRLY--FVMEYVNGGDLMYHIQ-------QVGRFKE 120

Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESN 323
              +    ++A  L +L ++    I + DLK  NV+LD EG I  + DFG+ K    +  
Sbjct: 121 PHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIK-IADFGMCKENIWDGV 176

Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGH-----VSILGDIYSYGILLLEIFTGKRP----- 373
           T     T      G+  YI PE I        V    D +++G+LL E+  G+ P     
Sbjct: 177 TTK---TFC----GTPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAPFEGED 225

Query: 374 TDDMFK 379
            D++F+
Sbjct: 226 EDELFQ 231

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 52/250 (20%), Positives = 86/250 (34%), Gaps = 50/250 (20%)

Query: 132 SRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLK 190
                  P    +SGL   K +   D      ++G G  G V +       E  A+K+L+
Sbjct: 37  PPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ 96

Query: 191 LQQQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNL-DQW 248
                       E        +  +I++IV    +  Y G     +V E +  G L  + 
Sbjct: 97  -----DCPKARREVELHWRASQCPHIVRIVDVYEN-LYAGRKCLLIVMECLDGGELFSRI 150

Query: 249 LHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL---DEGM 305
                  +      +  +   I+  +  A+ YLH+     IAH D+K  N+L        
Sbjct: 151 QDRGDQAF------TEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNA 201

Query: 306 IAHVGDFGLAKFLFEESNTPSKNQTMSNGLK---GSVGYIPPEYINGHVSILG------- 355
           I  + DFG AK                N L     +  Y+ PE       +LG       
Sbjct: 202 ILKLTDFGFAKETTSH-----------NSLTTPCYTPYYVAPE-------VLGPEKYDKS 243

Query: 356 -DIYSYGILL 364
            D++S G+++
Sbjct: 244 CDMWSLGVIM 253

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 64.1 bits (157), Expect = 2e-11
 Identities = 57/263 (21%), Positives = 104/263 (39%), Gaps = 66/263 (25%)

Query: 157 DNFSEENLIGSGSFGSVY---KGTLAD-GETAAIKVLK----LQQQGALKSFIDECNALT 208
           + F    ++G G +G V+   K T A+ G+  A+KVLK    ++          E N L 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 209 SIRHRNILKIVSSCSSVD--YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
            ++H  I+ ++ +  +    Y       L+ E++  G L             F +L    
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLY-------LILEYLSGGEL-------------FMQLEREG 116

Query: 267 RLNI------VIDVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLF 319
                     + +++ AL +LH +    I + DLK  N++L+ +G +  + DFGL K   
Sbjct: 117 IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVK-LTDFGLCKESI 172

Query: 320 EESNTPSKNQTMSNGLKGSVGYIPPEYINGH-----VSILGDIYSYGILLLEIFTGKRP- 373
            +        T      G++ Y+ PE +        V    D +S G L+ ++ TG  P 
Sbjct: 173 HDGTVTH---TFC----GTIEYMAPEILMRSGHNRAV----DWWSLGALMYDMLTGAPPF 221

Query: 374 ----TDDMF----KDDLSIHKFV 388
                        K  L++  ++
Sbjct: 222 TGENRKKTIDKILKCKLNLPPYL 244

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 63.4 bits (155), Expect = 4e-11
 Identities = 70/278 (25%), Positives = 104/278 (37%), Gaps = 70/278 (25%)

Query: 132 SRRQSAPPSNEWQSGLSYLKISNAT-DNFSEENLIGSGSFGSVY----KGTLADGETAAI 186
           +   + PP+   Q  L      +A   +F    +IG GSFG V     K         A+
Sbjct: 12  NANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAE---EVFYAV 68

Query: 187 KVLKLQQQGALKSFIDECNALTSIRH-RNILK-------IVSSCSSVDYEGNDFKALVFE 238
           KVL+       K  I +      I   RN+L        +V    S       +   V +
Sbjct: 69  KVLQ-------KKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY--FVLD 119

Query: 239 FMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI------VIDVASALDYLHNQYDTPIAHC 292
           ++  G L             F  L   +            ++ASAL YLH+     I + 
Sbjct: 120 YINGGEL-------------FYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYR 163

Query: 293 DLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH- 350
           DLK  N+LLD +G I  + DFGL K   E ++T S   T      G+  Y+ PE ++   
Sbjct: 164 DLKPENILLDSQGHIV-LTDFGLCKENIEHNSTTS---TFC----GTPEYLAPEVLHKQP 215

Query: 351 ----VSILGDIYSYGILLLEIFTGKRP-----TDDMFK 379
               V    D +  G +L E+  G  P     T +M+ 
Sbjct: 216 YDRTV----DWWCLGAVLYEMLYGLPPFYSRNTAEMYD 249

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 63.5 bits (155), Expect = 7e-11
 Identities = 16/60 (26%), Positives = 24/60 (40%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L     +   P +  SL  L  L++S NN        +  L SL+ L+ S N +    
Sbjct: 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK 534

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 17/68 (25%), Positives = 23/68 (33%), Gaps = 2/68 (2%)

Query: 1  LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
          L L  N  +     S  S   L  LDLS   +       +  L  L  L L+ N +    
Sbjct: 33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLA 92

Query: 61 SREGIFAN 68
             G F+ 
Sbjct: 93 L--GAFSG 98

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 13/58 (22%), Positives = 23/58 (39%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDG 58
           L L  N  +     +   L  L +L     NL+         L +L+ LN+++N +  
Sbjct: 81  LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 60.4 bits (147), Expect = 6e-10
 Identities = 17/62 (27%), Positives = 24/62 (38%), Gaps = 1/62 (1%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLL-SLRHLNLSYNELDGE 59
           L + +N+F        K L  L  LD S N++     Q       SL  LNL+ N+    
Sbjct: 499 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 558

Query: 60  IS 61
             
Sbjct: 559 CE 560

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 60.0 bits (146), Expect = 7e-10
 Identities = 16/64 (25%), Positives = 25/64 (39%), Gaps = 1/64 (1%)

Query: 1   LYLGNNSFKGTIPVS-LKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGE 59
           L   +++ K     S   SLR L  LD+S  +        F+ L SL  L ++ N     
Sbjct: 401 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 460

Query: 60  ISRE 63
              +
Sbjct: 461 FLPD 464

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 22/76 (28%), Positives = 34/76 (44%), Gaps = 3/76 (3%)

Query: 1   LYLGNNSFKGTI-PVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGE 59
           L +  NSF+    P     LR L  LDLS   L    P  F+ L SL+ LN+S+N     
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL 509

Query: 60  ISREGIFANASAISIV 75
                 +   +++ ++
Sbjct: 510 D--TFPYKCLNSLQVL 523

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 57.7 bits (140), Expect = 4e-09
 Identities = 15/61 (24%), Positives = 23/61 (37%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L     +     + +SL  L+ L L+ N +       FS L SL+ L      L    
Sbjct: 57  LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE 116

Query: 61  S 61
           +
Sbjct: 117 N 117

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 21/72 (29%), Positives = 28/72 (38%), Gaps = 4/72 (5%)

Query: 1   LYLGNN--SFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDG 58
           L L  N  SFKG    S      L  LDLS N +   +   F  L  L HL+  ++ L  
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQ 410

Query: 59  EISREGIFANAS 70
                 +F +  
Sbjct: 411 MSE-FSVFLSLR 421

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 22/58 (37%), Positives = 27/58 (46%), Gaps = 2/58 (3%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLS--GKVPQFFSKLLSLRHLNLSYNEL 56
             L   S KG    S   L  L  LDLS N LS  G   Q      SL++L+LS+N +
Sbjct: 328 KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 385

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 47.3 bits (113), Expect = 8e-06
 Identities = 17/73 (23%), Positives = 27/73 (36%), Gaps = 7/73 (9%)

Query: 1   LYLGNNSFKGT-IPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLR----HLNLSYNE 55
           L + +N  +   +P    +L  L  LDLS N +          L  +      L+LS N 
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188

Query: 56  LDGEISREGIFAN 68
           ++      G F  
Sbjct: 189 MNFIQP--GAFKE 199

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 45.4 bits (108), Expect = 3e-05
 Identities = 16/57 (28%), Positives = 22/57 (38%), Gaps = 8/57 (14%)

Query: 12 IPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFAN 68
          +P S K       LDLS N L       F     L+ L+LS  E+       G + +
Sbjct: 26 LPFSTK------NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED--GAYQS 74

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 62.6 bits (153), Expect = 7e-11
 Identities = 59/236 (25%), Positives = 97/236 (41%), Gaps = 54/236 (22%)

Query: 157 DNFSEENLIGSGSFGSVY----KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRH 212
            +F    +IG GS+  V     K T       A+KV+K       K  +++   +  ++ 
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKT---DRIYAMKVVK-------KELVNDDEDIDWVQT 58

Query: 213 -RNILKIVSSC-------SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSL 264
            +++ +  S+        S    E   F   V E++  G+L   +          +KL  
Sbjct: 59  EKHVFEQASNHPFLVGLHSCFQTESRLF--FVIEYVNGGDLMFHMQ-------RQRKLPE 109

Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAK-FLFEES 322
                   +++ AL+YLH +    I + DLK  NVLLD EG I  + D+G+ K  L    
Sbjct: 110 EHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIK-LTDYGMCKEGLRPGD 165

Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYINGH-----VSILGDIYSYGILLLEIFTGKRP 373
            T     T      G+  YI PE + G      V    D ++ G+L+ E+  G+ P
Sbjct: 166 TT----STFC----GTPNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSP 209

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 62.6 bits (151), Expect = 7e-11
 Identities = 40/256 (15%), Positives = 67/256 (26%), Gaps = 61/256 (23%)

Query: 155 ATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKL--------QQQGALKSFIDECNA 206
            T+       IG G FG V++   AD    AIK++ +          Q   +  + E   
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 207 LTSI---------RHRNILKIV-------------------------SSCSSVDYEGNDF 232
              +         R    + +                          S+    D+  +D 
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHC 292
             +V EF   G           E    K  SL    +I+  + ++L            H 
Sbjct: 137 LFIVLEFEFGGID--------LEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHR 186

Query: 293 DLKSSNVLLDEGMIAHVGDFGLAK--------FLFEESNTPSKNQTMSNGLKGSVGYIPP 344
           DL   NVLL +  +  +      K              +           +      +  
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDE 246

Query: 345 EYINGHVSILGDIYSY 360
           +   G      DIY  
Sbjct: 247 DLFTGDGDYQFDIYRL 262

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 57/235 (24%), Positives = 96/235 (40%), Gaps = 52/235 (22%)

Query: 157 DNFSEENLIGSGSFGSVY----KGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRH 212
            +F    +IG GS+  V     K T       A++V+K       K  +++   +  ++ 
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKT---DRIYAMRVVK-------KELVNDDEDIDWVQT 101

Query: 213 -RNILKIVSSC-------SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSL 264
            +++ +  S+        S    E   F   V E++  G+L   +          +KL  
Sbjct: 102 EKHVFEQASNHPFLVGLHSCFQTESRLF--FVIEYVNGGDLMFHMQ-------RQRKLPE 152

Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESN 323
                   +++ AL+YLH +    I + DLK  NVLLD EG I  + D+G+ K   E   
Sbjct: 153 EHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIK-LTDYGMCK---EGLR 205

Query: 324 TPSKNQTMSNGLKGSVGYIPPEYINGH-----VSILGDIYSYGILLLEIFTGKRP 373
                 T      G+  YI PE + G      V    D ++ G+L+ E+  G+ P
Sbjct: 206 PGDTTSTFC----GTPNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSP 252

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 25/177 (14%), Positives = 56/177 (31%), Gaps = 36/177 (20%)

Query: 162 ENLIGSGSFGSVYKGT---------LADGETAAIKV----------LKLQQQGALKSFID 202
           ++     + G +Y+               +  ++K+              Q+ A    ++
Sbjct: 47  KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN 106

Query: 203 ECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNG-NLDQWLHPSTDEYCHFKK 261
           +   L S     I   +          + ++ LV   +  G +L   L     +      
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGV----HQDKYRFLVLPSL--GRSLQSAL-----DVSPKHV 155

Query: 262 LSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM--IAHVGDFGLAK 316
           LS    L +   +  AL++LH        H ++ + N+ +D        +  +G A 
Sbjct: 156 LSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 17/69 (24%), Positives = 24/69 (34%), Gaps = 1/69 (1%)

Query: 1   LYLGNNSFKGTIPVS-LKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGE 59
           L LG N     +     + L  + E+ LS N         F+ + SL+ L L    L   
Sbjct: 410 LDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNV 469

Query: 60  ISREGIFAN 68
            S    F  
Sbjct: 470 DSSPSPFQP 478

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 19/60 (31%), Positives = 26/60 (43%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L +N F        K L  L  +DL  NNL+      F+  +SL+ LNL  N +    
Sbjct: 541 LNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVE 600

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 61.6 bits (150), Expect = 3e-10
 Identities = 20/68 (29%), Positives = 29/68 (42%), Gaps = 2/68 (2%)

Query: 1  LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
          L L +N  +     +      L  LD+  N +S   P+   KL  L+ LNL +NEL    
Sbjct: 30 LNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLS 89

Query: 61 SREGIFAN 68
            +  FA 
Sbjct: 90 --DKTFAF 95

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 59.2 bits (144), Expect = 2e-09
 Identities = 16/65 (24%), Positives = 23/65 (35%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L  N+       S   L  L    L  NN+          L ++R+LNL  +     I
Sbjct: 253 LDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSI 312

Query: 61  SREGI 65
           S   +
Sbjct: 313 SLASL 317

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 58.5 bits (142), Expect = 3e-09
 Identities = 18/58 (31%), Positives = 27/58 (46%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDG 58
           L+L +NS +          + L  LDLS N LS        +L +L+ L LS N++  
Sbjct: 102 LHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 57.7 bits (140), Expect = 5e-09
 Identities = 17/68 (25%), Positives = 24/68 (35%), Gaps = 2/68 (2%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L +N        +      L EL L  N++       F K  +L  L+LS+N L    
Sbjct: 78  LNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTK 137

Query: 61  SREGIFAN 68
              G    
Sbjct: 138 --LGTQVQ 143

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 56.5 bits (137), Expect = 1e-08
 Identities = 16/71 (22%), Positives = 27/71 (38%), Gaps = 5/71 (7%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQ---FFSKLLSLRHLNLSYNELD 57
           L L +N  K   P    ++  L  L L+   L   + +         S+R+L+LS ++L 
Sbjct: 176 LELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLS 235

Query: 58  GEISREGIFAN 68
                   F  
Sbjct: 236 TTS--NTTFLG 244

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 20/76 (26%), Positives = 28/76 (36%), Gaps = 4/76 (5%)

Query: 1   LYLGNNSFKGTIPVSLKSLRG--LAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDG 58
           L L N+    T   +   L+   L  LDLS NNL+      F+ L  L +  L YN +  
Sbjct: 227 LSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQH 286

Query: 59  EISREGIFANASAISI 74
             S          +  
Sbjct: 287 LFS--HSLHGLFNVRY 300

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 55.4 bits (134), Expect = 3e-08
 Identities = 14/69 (20%), Positives = 25/69 (36%), Gaps = 1/69 (1%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLL-SLRHLNLSYNELDGE 59
           + LG N+          +   L  L+L  N ++    + F     +L  L++ +N  D  
Sbjct: 565 IDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT 624

Query: 60  ISREGIFAN 68
                 F N
Sbjct: 625 CESIAWFVN 633

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 55.0 bits (133), Expect = 3e-08
 Identities = 19/58 (32%), Positives = 26/58 (44%), Gaps = 2/58 (3%)

Query: 1   LYLGNNSFKG--TIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L   + K   + P   + LR L  LDLS NN++         L  L  L+L +N L
Sbjct: 459 LMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNL 516

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 55.0 bits (133), Expect = 3e-08
 Identities = 16/64 (25%), Positives = 22/64 (34%), Gaps = 2/64 (3%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSG--KVPQFFSKLLSLRHLNLSYNELDG 58
           +YL  N +      S   +  L  L L    L      P  F  L +L  L+LS N +  
Sbjct: 435 IYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN 494

Query: 59  EISR 62
               
Sbjct: 495 INDD 498

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 54.6 bits (132), Expect = 4e-08
 Identities = 17/74 (22%), Positives = 29/74 (39%), Gaps = 2/74 (2%)

Query: 2   YLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEIS 61
            L  ++  G     LK L  L  L+L  N       + F  L  L+ ++L  N L+    
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLP- 576

Query: 62  REGIFANASAISIV 75
              +F N  ++  +
Sbjct: 577 -ASVFNNQVSLKSL 589

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 54.6 bits (132), Expect = 5e-08
 Identities = 19/70 (27%), Positives = 26/70 (37%), Gaps = 4/70 (5%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFS--KLLSLRHLNLSYNELDG 58
           L L +N    T   +   L  L EL LS N +     +        SL+ L LS N++  
Sbjct: 126 LDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE 185

Query: 59  EISREGIFAN 68
                G F  
Sbjct: 186 FSP--GCFHA 193

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 54.2 bits (131), Expect = 6e-08
 Identities = 23/76 (30%), Positives = 28/76 (36%), Gaps = 10/76 (13%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLS--------GKVPQFFSKLLSLRHLNLS 52
           L L NN+        L+ L  L  LDL  NNL+        G    F   L  L  LNL 
Sbjct: 485 LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLE 544

Query: 53  YNELDGEISREGIFAN 68
            N  D       +F +
Sbjct: 545 SNGFDEIP--VEVFKD 558

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 53.9 bits (130), Expect = 7e-08
 Identities = 17/68 (25%), Positives = 26/68 (38%), Gaps = 2/68 (2%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L +G N+     P   + L  L  L+L  N LS    + F+   +L  L+L  N +    
Sbjct: 54  LDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIK 113

Query: 61  SREGIFAN 68
                F  
Sbjct: 114 --NNPFVK 119

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 53.9 bits (130), Expect = 8e-08
 Identities = 16/65 (24%), Positives = 26/65 (40%), Gaps = 2/65 (3%)

Query: 1   LYLGNNSFKGTIPVSLKSL--RGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDG 58
           L L NN  +      L       L +L+LS N +    P  F  +  L  L L+  +L  
Sbjct: 150 LLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGP 209

Query: 59  EISRE 63
            ++ +
Sbjct: 210 SLTEK 214

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 14/68 (20%), Positives = 29/68 (42%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
             +   S       S + L+ L  L++  N++ G     F+ L++L++L+LS +      
Sbjct: 310 QSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRT 369

Query: 61  SREGIFAN 68
                F +
Sbjct: 370 LTNETFVS 377

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 50.8 bits (122), Expect = 6e-07
 Identities = 19/77 (24%), Positives = 29/77 (37%), Gaps = 11/77 (14%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDL---------SCNNLSGKVPQFFSKLLSLRHLNL 51
            +L  N+ +     SL  L  +  L+L         S  +L       F  L  L HLN+
Sbjct: 277 FFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNM 336

Query: 52  SYNELDGEISREGIFAN 68
             N++ G  S   +F  
Sbjct: 337 EDNDIPGIKS--NMFTG 351

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 17/69 (24%), Positives = 28/69 (40%), Gaps = 4/69 (5%)

Query: 1   LYLGNNSFKGTIPVSLK----SLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L N+        +      +   L  L+L+ N +S      FS L  L  L+L  NE+
Sbjct: 358 LSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEI 417

Query: 57  DGEISREGI 65
             E++ +  
Sbjct: 418 GQELTGQEW 426

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 47.3 bits (113), Expect = 8e-06
 Identities = 10/68 (14%), Positives = 22/68 (32%), Gaps = 5/68 (7%)

Query: 1  LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
              +      +P  L     +  L+L+ N L       F++   L  L++ +N +    
Sbjct: 9  ADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLE 65

Query: 61 SREGIFAN 68
              +   
Sbjct: 66 --PELCQK 71

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 45.4 bits (108), Expect = 3e-05
 Identities = 18/68 (26%), Positives = 28/68 (41%), Gaps = 5/68 (7%)

Query: 1   LYLGNNSFKGTIPVSLK---SLRGLAELDLSCNNLSGKVPQFFS--KLLSLRHLNLSYNE 55
           L+L N     ++   L    +   +  L LS + LS      F   K  +L  L+LSYN 
Sbjct: 200 LFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNN 259

Query: 56  LDGEISRE 63
           L+   +  
Sbjct: 260 LNVVGNDS 267

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 60/260 (23%), Positives = 93/260 (35%), Gaps = 61/260 (23%)

Query: 156 TDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFID------ECNALT 208
            DN+  ++LIG GS+G VY        +  AIK  K+ +    +  ID      E   L 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK--KVNR--MFEDLIDCKRILREITILN 80

Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKA--LVFEFMRNGNLDQWLH-------PSTDEYCHF 259
            ++   I+++       D     F    +V E       D  L          T+E  H 
Sbjct: 81  RLKSDYIIRLYDLIIPDDLL--KFDELYIVLEIA-----DSDLKKLFKTPIFLTEE--HI 131

Query: 260 KKLSLMQRLNIVIDVASALDYLH--NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF 317
           K + L   L          +++H        I H DLK +N LL++     V DFGLA+ 
Sbjct: 132 KTI-LYNLLL-------GENFIHESG-----IIHRDLKPANCLLNQDCSVKVCDFGLART 178

Query: 318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVS---------ILG--------DIYSY 360
           +  E +T   N    N   G       + +  HV          IL         DI+S 
Sbjct: 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWST 238

Query: 361 GILLLEIFTGKRPTDDMFKD 380
           G +  E+    +   +   +
Sbjct: 239 GCIFAELLNMLQSHINDPTN 258

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 50/236 (21%), Positives = 83/236 (35%), Gaps = 45/236 (19%)

Query: 156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIK--VLKLQQQGALKSFIDECNA------- 206
              ++ +  I SGS+G+V  G  ++G   AIK     +     +    D           
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 207 --LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH----PSTDEYCHFK 260
             L    H NIL +       +        LV E MR  +L Q +H      + ++  + 
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQY- 138

Query: 261 KLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFE 320
                     +  +   L  LH      + H DL   N+LL +     + DF LA+    
Sbjct: 139 ---------FMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTA 186

Query: 321 ESNTPSKNQTMSNGLKGSVG---YIPPEYI--NGHVSILGDIYSYGILLLEIFTGK 371
           ++N               V    Y  PE +      + L D++S G ++ E+F  K
Sbjct: 187 DAN-----------KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 50/230 (21%), Positives = 85/230 (36%), Gaps = 44/230 (19%)

Query: 156 TDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFID------ECNALT 208
              +     IGSG+ G V            AIK  KL +    ++         E   + 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSR--PFQNQTHAKRAYRELVLMK 79

Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKA--LVFEFMRNGNLDQWLH-PSTDEYCHFKKLSLM 265
            + H+NI+ +++   +      +F+   +V E M + NL Q +      E   +      
Sbjct: 80  CVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY------ 131

Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
               ++  +   + +LH      I H DLK SN+++       + DFGLA+       T 
Sbjct: 132 ----LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-------TA 177

Query: 326 SKNQTMSNGLKGSVG---YIPPEYI-NGHVSILGDIYSYGILLLEIFTGK 371
             +  M+      V    Y  PE I         DI+S G ++ E+  G 
Sbjct: 178 GTSFMMT----PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 60.7 bits (148), Expect = 3e-10
 Identities = 58/236 (24%), Positives = 96/236 (40%), Gaps = 45/236 (19%)

Query: 156 TDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFID------ECNALT 208
           + +F  ++L+G G++G V   T    GE  AIK  K++        +       E   L 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK--KIE---PFDKPLFALRTLREIKILK 64

Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFM--------RNGNLDQWLHPSTDEYCHFK 260
             +H NI+ I +      +E  +   ++ E M            L      S D   +F 
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQML------SDDHIQYF- 117

Query: 261 KLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFE 320
              + Q L        A+  LH    + + H DLK SN+L++      V DFGLA+ + E
Sbjct: 118 ---IYQTLR-------AVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164

Query: 321 ESNTPSKNQTMSNGLKGSVG---YIPPEYI--NGHVSILGDIYSYGILLLEIFTGK 371
            +   S+     +G+   V    Y  PE +  +   S   D++S G +L E+F  +
Sbjct: 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 34/171 (19%), Positives = 60/171 (35%), Gaps = 31/171 (18%)

Query: 164 LIGSGSFGSVYKGT-LADGETAAIKVLKLQQQG--------------ALKSFIDECNALT 208
            IGSG FG +Y        E  A  V+K++ Q               A K  I +     
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEY-CHFKKLSLMQR 267
            + +  I          +++G  ++ +V E          L     +             
Sbjct: 104 QLDYLGIPLFY-GSGLTEFKGRSYRFMVMER---------LGIDLQKISGQNGTFKKSTV 153

Query: 268 LNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM--IAHVGDFGLAK 316
           L + I +   L+Y+H        H D+K++N+LL        ++ D+GL+ 
Sbjct: 154 LQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 61.0 bits (148), Expect = 4e-10
 Identities = 51/230 (22%), Positives = 85/230 (36%), Gaps = 44/230 (19%)

Query: 156 TDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFID------ECNALT 208
              +     IGSG+ G V            AIK  KL +    ++         E   + 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSR--PFQNQTHAKRAYRELVLMK 116

Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKA--LVFEFMRNGNLDQWLH-PSTDEYCHFKKLSLM 265
            + H+NI+ +++   +      +F+   LV E M + NL Q +      E   +      
Sbjct: 117 CVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY------ 168

Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
               ++  +   + +LH      I H DLK SN+++       + DFGLA+       T 
Sbjct: 169 ----LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-------TA 214

Query: 326 SKNQTMSNGLKGSVG---YIPPEYI-NGHVSILGDIYSYGILLLEIFTGK 371
             +  M+      V    Y  PE I         DI+S G ++ E+   K
Sbjct: 215 GTSFMMT----PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 60.2 bits (146), Expect = 6e-10
 Identities = 47/209 (22%), Positives = 75/209 (35%), Gaps = 46/209 (22%)

Query: 156 TDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIR--- 211
            D +   +LIG+GS+G V +     +    AIK  K+      + F D  +    +R   
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK--KIL-----RVFEDLIDCKRILREIA 104

Query: 212 ------HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH-------PSTDEYCH 258
                 H +++K++      D E  D   +V E       D             T+   H
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKKLFRTPVYLTEL--H 157

Query: 259 FKKLSLMQRLNIVIDVASALDYLH--NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK 316
            K L L   L         + Y+H        I H DLK +N L+++     V DFGLA+
Sbjct: 158 IKTL-LYNLLV-------GVKYVHSAG-----ILHRDLKPANCLVNQDCSVKVCDFGLAR 204

Query: 317 FLFEESNTPSKNQTMSNGLKGSVGYIPPE 345
            +    N  S+          ++   P  
Sbjct: 205 TVDYPENGNSQLPISPREDDMNLVTFPHT 233

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 59.8 bits (145), Expect = 6e-10
 Identities = 36/173 (20%), Positives = 65/173 (37%), Gaps = 32/173 (18%)

Query: 164 LIGSGSFGSVYKGT------LADGETAAIKV-----------LKLQQQGALKSFIDECNA 206
            IG G FG +Y         +       +KV           LK  Q+ A    I +   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNG-NLDQWLHPSTDEYCHFKKLSLM 265
              +++  + K        D  G  ++ ++ +    G +L +       E    K+ S  
Sbjct: 102 TRKLKYLGVPKYW-GSGLHDKNGKSYRFMIMDRF--GSDLQKIY-----EANA-KRFSRK 152

Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM--IAHVGDFGLAK 316
             L + + +   L+Y+H        H D+K+SN+LL+       ++ D+GLA 
Sbjct: 153 TVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 59.6 bits (145), Expect = 7e-10
 Identities = 56/231 (24%), Positives = 92/231 (39%), Gaps = 47/231 (20%)

Query: 156 TDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFID------ECNALT 208
              +     +GSG++GSV        GE  AIK  KL +    +S I       E   L 
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK--KLSR--PFQSEIFAKRAYRELLLLK 78

Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKA--LVFEFMRNGNLDQWLH-PSTDEYCHFKKLSLM 265
            ++H N++ ++    +      +F    LV  FM   +L + +    ++E   +      
Sbjct: 79  HMQHENVIGLLD-VFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKFSEEKIQY------ 130

Query: 266 QRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTP 325
               +V  +   L Y+H+     + H DLK  N+ ++E     + DFGLA+         
Sbjct: 131 ----LVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR--------- 174

Query: 326 SKNQTMSNGLKGSVG---YIPPEYI--NGHVSILGDIYSYGILLLEIFTGK 371
                    + G V    Y  PE I    H +   DI+S G ++ E+ TGK
Sbjct: 175 ----HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 59.7 bits (145), Expect = 7e-10
 Identities = 48/272 (17%), Positives = 92/272 (33%), Gaps = 90/272 (33%)

Query: 154 NATDNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRH 212
            ++  +S    +G+GSFG V +    + G+  A+K +    +   +    E + +  + H
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDH 59

Query: 213 RNILKI-------------------------------VSSCSSVDYEGNDFKA--LVFEF 239
            NI+K+                                +   SV    +  K   ++ E+
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 240 M---------RNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIA 290
           +               + +            + + Q          A+ ++H+     I 
Sbjct: 120 VPDTLHKVLKSFIRSGRSI---PMNLI---SIYIYQLFR-------AVGFIHSLG---IC 163

Query: 291 HCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYI------P 343
           H D+K  N+L++ +     + DFG AK L         ++         V YI       
Sbjct: 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKL-------IPSEPS-------VAYICSRFYRA 209

Query: 344 PEYING----HVSILGDIYSYGILLLEIFTGK 371
           PE + G      SI  D++S G +  E+  GK
Sbjct: 210 PELMLGATEYTPSI--DLWSIGCVFGELILGK 239

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 59.2 bits (144), Expect = 9e-10
 Identities = 59/242 (24%), Positives = 100/242 (41%), Gaps = 59/242 (24%)

Query: 157 DNFSEENLIGSGSFGSVY---KGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRH 212
           +NF    ++G+G++G V+   K +  D G+  A+KVLK       K+ I +        H
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLK-------KATIVQKAKT--TEH 104

Query: 213 ----RNILKIVSSC-------SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK 261
               R +L+ +           +   E      L+ +++  G L             F  
Sbjct: 105 TRTERQVLEHIRQSPFLVTLHYAFQTETKLH--LILDYINGGEL-------------FTH 149

Query: 262 LSLMQRLNI------VIDVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGL 314
           LS  +R         V ++  AL++LH      I + D+K  N+LLD  G +  + DFGL
Sbjct: 150 LSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVV-LTDFGL 205

Query: 315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILG---DIYSYGILLLEIFTGK 371
           +K    E       +       G++ Y+ P+ + G  S      D +S G+L+ E+ TG 
Sbjct: 206 SK----EFVADETERAYD--FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

Query: 372 RP 373
            P
Sbjct: 260 SP 261

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 15/75 (20%), Positives = 30/75 (40%), Gaps = 2/75 (2%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L     +        +L  L  L++S NNL       +++L SL  L+ S+N ++   
Sbjct: 478 LDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSK 537

Query: 61  SREGIFANASAISIV 75
               +     +++  
Sbjct: 538 --GILQHFPKSLAFF 550

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 16/68 (23%), Positives = 27/68 (39%), Gaps = 1/68 (1%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L  N  +   P S   L  L  L      L+        +L++L+ LN+++N +    
Sbjct: 85  LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS-C 143

Query: 61  SREGIFAN 68
                F+N
Sbjct: 144 KLPAYFSN 151

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 19/71 (26%), Positives = 27/71 (38%), Gaps = 2/71 (2%)

Query: 1   LYLGNNSFKGTIPVS-LKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGE 59
           L   +++ K     S   SL  L  LD+S  N        F  L SL  L ++ N     
Sbjct: 404 LDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDN 463

Query: 60  ISREGIFANAS 70
                +FAN +
Sbjct: 464 TL-SNVFANTT 473

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 55.0 bits (133), Expect = 3e-08
 Identities = 14/56 (25%), Positives = 22/56 (39%)

Query: 1  LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
          + L  N  K     S  +   L  LDLS   +     + +  L  L +L L+ N +
Sbjct: 37 IDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 55.0 bits (133), Expect = 3e-08
 Identities = 19/72 (26%), Positives = 27/72 (37%), Gaps = 3/72 (4%)

Query: 1   LYLGNNSFKGTIPVS-LKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGE 59
           L +  NSFK     +   +   L  LDLS   L       F  L  L+ LN+S+N L   
Sbjct: 453 LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFL 512

Query: 60  ISREGIFANASA 71
                 +    +
Sbjct: 513 D--SSHYNQLYS 522

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 53.5 bits (129), Expect = 8e-08
 Identities = 13/57 (22%), Positives = 20/57 (35%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELD 57
           L + +N+           L  L+ LD S N +            SL   NL+ N + 
Sbjct: 502 LNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 52.0 bits (125), Expect = 3e-07
 Identities = 15/68 (22%), Positives = 22/68 (32%), Gaps = 2/68 (2%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L     +     +   L  L+ L L+ N +    P  FS L SL +L     +L    
Sbjct: 61  LDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLE 120

Query: 61  SREGIFAN 68
                   
Sbjct: 121 --SFPIGQ 126

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 48.1 bits (115), Expect = 5e-06
 Identities = 18/70 (25%), Positives = 28/70 (40%), Gaps = 4/70 (5%)

Query: 1   LYLGNNSFKGTIPVSLKSLRG--LAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDG 58
           L L  N+   +   S   L    L  LDLS N     +   F  L  L+HL+  ++ L  
Sbjct: 355 LDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKR 413

Query: 59  EISREGIFAN 68
            ++    F +
Sbjct: 414 -VTEFSAFLS 422

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 26/74 (35%), Positives = 33/74 (44%), Gaps = 7/74 (9%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFS--KLLSLRHLNLSYNELDG 58
           L L  N  KG+I     +L  L+ LDLS N LS      +S     SLRHL+LS+N    
Sbjct: 333 LTLTMN--KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGA-- 388

Query: 59  EISREGIFANASAI 72
            I     F     +
Sbjct: 389 -IIMSANFMGLEEL 401

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 17/74 (22%), Positives = 26/74 (35%), Gaps = 5/74 (6%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLA----ELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           + L  N  +      L+ LR        LD+S N +     Q F + + L  L L  N  
Sbjct: 158 VDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAF-QGIKLHELTLRGNFN 216

Query: 57  DGEISREGIFANAS 70
              I +  +   A 
Sbjct: 217 SSNIMKTCLQNLAG 230

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 13/61 (21%), Positives = 22/61 (36%), Gaps = 5/61 (8%)

Query: 1   LYLGNNSFKG-TIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKL----LSLRHLNLSYNE 55
           L + +N      +P    +L  L  +DLS N +          L         L++S N 
Sbjct: 133 LNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNP 192

Query: 56  L 56
           +
Sbjct: 193 I 193

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 41.9 bits (99), Expect = 4e-04
 Identities = 13/68 (19%), Positives = 23/68 (33%), Gaps = 5/68 (7%)

Query: 1  LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
              +      +P  +        +DLS N L       FS    L+ L+LS  E++   
Sbjct: 16 YQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIE 72

Query: 61 SREGIFAN 68
            +  +  
Sbjct: 73 --DKAWHG 78

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 41/179 (22%), Positives = 67/179 (37%), Gaps = 21/179 (11%)

Query: 144 QSGLSYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFID 202
           +SGL   K +   D      ++G G  G V +       E  A+K+L+            
Sbjct: 5   KSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARR 59

Query: 203 ECNALTSI-RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNL-DQWLHPSTDEYCHFK 260
           E        +  +I++IV    +  Y G     +V E +  G L  +        +    
Sbjct: 60  EVELHWRASQCPHIVRIVDVYEN-LYAGRKCLLIVMECLDGGELFSRIQDRGDQAF---- 114

Query: 261 KLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVGDFGLAK 316
             +  +   I+  +  A+ YLH+     IAH D+K  N+L        I  + DFG AK
Sbjct: 115 --TEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 63/264 (23%), Positives = 103/264 (39%), Gaps = 43/264 (16%)

Query: 125 IYHIVKTSRRQSAPPSNE-WQSGLSYLKISNA---TDNFSEENLIGSGSFGSVYKGT-LA 179
           +Y    +S ++     N+ +        + N     D +  ++LIG GSFG V K     
Sbjct: 18  LYFQSMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRV 77

Query: 180 DGETAAIKVLK----LQQQGALKSFIDECNALTSIRHR---NILKIVSSCSSVDYEGNDF 232
           + E  AIK++K       Q        E   L  +          IV       +  +  
Sbjct: 78  EQEWVAIKIIKNKKAFLNQA-----QIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132

Query: 233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHC 292
             LVFE +   NL   L        +F+ +SL         + +AL +L    +  I HC
Sbjct: 133 --LVFEMLSY-NLYDLL-----RNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHC 183

Query: 293 DLKSSNVLLDEGMIAH--VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH 350
           DLK  N+LL     +   + DFG +             Q +   ++ S  Y  PE + G 
Sbjct: 184 DLKPENILLCNPKRSAIKIVDFGSSCQ---------LGQRIYQYIQ-SRFYRSPEVLLGM 233

Query: 351 ---VSILGDIYSYGILLLEIFTGK 371
              ++I  D++S G +L+E+ TG+
Sbjct: 234 PYDLAI--DMWSLGCILVEMHTGE 255

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 20/59 (33%), Positives = 33/59 (55%), Gaps = 2/59 (3%)

Query: 1   LYLGNNSFK-GTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDG 58
           +Y+G N+ K   +  SL+ ++ L  L+   N L GK+P  F   + L  LNL+YN++  
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITE 367

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 58.5 bits (142), Expect = 3e-09
 Identities = 9/77 (11%), Positives = 26/77 (33%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
                     T  +   +L+ L ++++       K+P F   L  ++ +N++ N      
Sbjct: 230 ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGE 289

Query: 61  SREGIFANASAISIVGN 77
             +  +   +   +   
Sbjct: 290 QLKDDWQALADAPVGEK 306

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 57.0 bits (138), Expect = 7e-09
 Identities = 13/64 (20%), Positives = 21/64 (32%), Gaps = 7/64 (10%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAEL------DLSCNNLSGKVPQFFSKLLSLRHLNLSYN 54
           + L  NSF    P    +   L         D   N    + P+  +   SL  L +  N
Sbjct: 518 IDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSN 576

Query: 55  ELDG 58
           ++  
Sbjct: 577 DIRK 580

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 12/65 (18%), Positives = 22/65 (33%), Gaps = 7/65 (10%)

Query: 1   LYLGNNSFKG-------TIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSY 53
           +    N            +  +      ++ ++LS N +S    + FS    L  +NL  
Sbjct: 407 IDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMG 466

Query: 54  NELDG 58
           N L  
Sbjct: 467 NMLTE 471

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 55.4 bits (134), Expect = 3e-08
 Identities = 14/56 (25%), Positives = 27/56 (48%), Gaps = 1/56 (1%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L    N  +G +P +  S   LA L+L+ N ++     F      + +L+ ++N+L
Sbjct: 335 LECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKL 389

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 54.3 bits (131), Expect = 6e-08
 Identities = 15/95 (15%), Positives = 26/95 (27%), Gaps = 6/95 (6%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSG----KVPQFFSKLLSLRHLNLSYNEL 56
           L L      G +P ++  L  L  L L  +          P+  S  +S           
Sbjct: 86  LSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHY 145

Query: 57  DGEISREGIFANASAIS--IVGNDKLCGGIQKLQL 89
                      + S +    + +D     I+K   
Sbjct: 146 QKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 10/65 (15%), Positives = 24/65 (36%), Gaps = 1/65 (1%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
             + ++  + +I  S +      ++    NN++  V +   +L  LR   +  +    E 
Sbjct: 164 DCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAEN 222

Query: 61  SREGI 65
             E  
Sbjct: 223 ICEAW 227

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 51.2 bits (123), Expect = 5e-07
 Identities = 12/69 (17%), Positives = 23/69 (33%), Gaps = 9/69 (13%)

Query: 1   LYLGNNSFK--------GTIPVSLKSLRGLAELDLSCNNL-SGKVPQFFSKLLSLRHLNL 51
           + +  N                       +  + +  NNL +  V     K+  L  L  
Sbjct: 278 INVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLEC 337

Query: 52  SYNELDGEI 60
            YN+L+G++
Sbjct: 338 LYNQLEGKL 346

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 50.8 bits (122), Expect = 7e-07
 Identities = 23/120 (19%), Positives = 39/120 (32%), Gaps = 1/120 (0%)

Query: 6   NSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGI 65
           + +     VSL S   +  L L     SG+VP    +L  L  L L  +         G 
Sbjct: 67  DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126

Query: 66  FANASAISIVGNDKLCGGIQKLQLPECSRKNPRKRLSLKIV-IPVTISVPIFILLLAALV 124
              ++ +S     K+    QK  +    R++    +   I   P   S+     +     
Sbjct: 127 KGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 50.4 bits (121), Expect = 8e-07
 Identities = 14/67 (20%), Positives = 23/67 (34%), Gaps = 10/67 (14%)

Query: 1   LYLGNNSFKG-------TIPVSLKSLRGLAELDLSCNNLSGKVPQ--FFSKLLSLRHLNL 51
           + L  N               + K+   L  +DL  N L+  +      + L  L  ++L
Sbjct: 462 INLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDL 520

Query: 52  SYNELDG 58
           SYN    
Sbjct: 521 SYNSFSK 527

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 17/79 (21%), Positives = 32/79 (40%), Gaps = 12/79 (15%)

Query: 1   LYLGNNSFKGTIP--VSLKSLRGLAELDLSCNNLSG-------KVPQFFSKLLSLRHLNL 51
           L   +N  K  IP     KS+  ++ +D S N +          +     K +++  +NL
Sbjct: 382 LSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINL 440

Query: 52  SYNELDGEISREGIFANAS 70
           S N++        +F+  S
Sbjct: 441 SNNQISKFPK--ELFSTGS 457

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 11/60 (18%), Positives = 19/60 (31%), Gaps = 3/60 (5%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQ--FFSKLLSLRHLNLSYNELDG 58
           L L  N               +  L  + N L   +P       +  +  ++ SYNE+  
Sbjct: 358 LNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGS 416

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 47.3 bits (113), Expect = 7e-06
 Identities = 8/56 (14%), Positives = 20/56 (35%), Gaps = 3/56 (5%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L +G+N  +  +   +     ++ LD+  N        +    +      L Y++ 
Sbjct: 571 LQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 42.0 bits (99), Expect = 4e-04
 Identities = 5/62 (8%), Positives = 19/62 (30%), Gaps = 2/62 (3%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           +   +N+    +  ++  L  L +  +  +    +      +  +  +    Y   D + 
Sbjct: 188 IGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQ-YKTEDLKW 245

Query: 61  SR 62
             
Sbjct: 246 DN 247

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 11/56 (19%), Positives = 16/56 (28%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L  N        +L   + L  L      +S           +L  L L  N +
Sbjct: 86  LVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHI 141

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 57.3 bits (139), Expect = 7e-09
 Identities = 15/69 (21%), Positives = 28/69 (40%), Gaps = 1/69 (1%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKV-PQFFSKLLSLRHLNLSYNELDGE 59
           L L  N F+    +S  +   L  L +  N    ++       L +LR L+LS+++++  
Sbjct: 306 LVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETS 365

Query: 60  ISREGIFAN 68
                   N
Sbjct: 366 DCCNLQLRN 374

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 10/56 (17%), Positives = 19/56 (33%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L+           + L + + L  L L  N++S            L+ L+   N +
Sbjct: 110 LFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAI 165

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 54.6 bits (132), Expect = 4e-08
 Identities = 16/70 (22%), Positives = 28/70 (40%), Gaps = 3/70 (4%)

Query: 1   LYLGNN--SFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDG 58
           L L ++         + L++L  L  L+LS N       + F +   L  L+L++  L  
Sbjct: 355 LDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV 414

Query: 59  EISREGIFAN 68
               +  F N
Sbjct: 415 -KDAQSPFQN 423

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 54.6 bits (132), Expect = 4e-08
 Identities = 17/58 (29%), Positives = 28/58 (48%), Gaps = 1/58 (1%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDG 58
           + L  + F      +     GL ELDL+  +LS ++P     L +L+ L LS N+ + 
Sbjct: 259 INLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFEN 315

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 53.9 bits (130), Expect = 8e-08
 Identities = 23/69 (33%), Positives = 29/69 (42%), Gaps = 3/69 (4%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQ-FFSKLLSLRHLNLSYNELDGE 59
           L L  N        + K    L  LDL+   L  K  Q  F  L  L+ LNLS++ LD  
Sbjct: 381 LNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI- 439

Query: 60  ISREGIFAN 68
            S E +F  
Sbjct: 440 -SSEQLFDG 447

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 53.9 bits (130), Expect = 8e-08
 Identities = 19/68 (27%), Positives = 24/68 (35%), Gaps = 2/68 (2%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L        +P  L  L  L +L LS N          S   SL HL++  N    E+
Sbjct: 283 LDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLEL 341

Query: 61  SREGIFAN 68
              G   N
Sbjct: 342 G-TGCLEN 348

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 20/59 (33%), Positives = 28/59 (47%), Gaps = 3/59 (5%)

Query: 1   LYLGNNSFKGTIPV---SLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L  N F         SL++L  L  L LS  +LS      F+ L  + H++LS+N L
Sbjct: 454 LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRL 512

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 14/68 (20%), Positives = 19/68 (27%), Gaps = 2/68 (2%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L    N        +   L  L  LDL+   +       F     L  L L+ N L    
Sbjct: 38  LEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMA 97

Query: 61  SREGIFAN 68
             E   + 
Sbjct: 98  --ETALSG 103

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 12/56 (21%), Positives = 18/56 (32%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L           + +S   L  L L+ N L        S   +L+HL      +
Sbjct: 62  LDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGI 117

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 19/72 (26%), Positives = 27/72 (37%), Gaps = 2/72 (2%)

Query: 1   LYLGNNSFKGTIPVS-LKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGE 59
           L L     K     S  ++L  L  L+LS + L     Q F  L +L+HLNL  N     
Sbjct: 405 LDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKG 464

Query: 60  ISRE-GIFANAS 70
             ++        
Sbjct: 465 NIQKTNSLQTLG 476

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 51.2 bits (123), Expect = 6e-07
 Identities = 16/75 (21%), Positives = 29/75 (38%), Gaps = 3/75 (4%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L           +  SL+ +  +DLS N L+    +  S L  + +LNL+ N +   +
Sbjct: 481 LVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIIL 539

Query: 61  SREGIFANASAISIV 75
               +    S    +
Sbjct: 540 --PSLLPILSQQRTI 552

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 50.4 bits (121), Expect = 8e-07
 Identities = 14/75 (18%), Positives = 25/75 (33%), Gaps = 5/75 (6%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSG---KVPQFFSKLLSLRHLNLSYNELD 57
           L L ++    +       L  L  L+L  N+      +       L  L  L LS+ +L 
Sbjct: 430 LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489

Query: 58  GEISREGIFANASAI 72
                +  F +   +
Sbjct: 490 SID--QHAFTSLKMM 502

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 17/58 (29%), Positives = 29/58 (50%), Gaps = 1/58 (1%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDG 58
           + L +N    +   +L  L+G+  L+L+ N++S  +P     L   R +NL  N LD 
Sbjct: 505 VDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 44.6 bits (106), Expect = 6e-05
 Identities = 8/58 (13%), Positives = 18/58 (31%), Gaps = 2/58 (3%)

Query: 1   LYLGNNSFKGTIPVSLKSLRG--LAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
               +   +   P   + L    +  ++L  +         F     L+ L+L+   L
Sbjct: 233 GTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL 290

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 16/68 (23%), Positives = 26/68 (38%), Gaps = 5/68 (7%)

Query: 1  LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
              N      IP +L        L+ S N L       FS+L++L  L+L+  ++    
Sbjct: 17 YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73

Query: 61 SREGIFAN 68
            E  F +
Sbjct: 74 --EDTFQS 79

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 15/58 (25%), Positives = 22/58 (37%), Gaps = 2/58 (3%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRH--LNLSYNEL 56
           LYLG+N               L  LD   N +     +  S L    +  LNL+ N++
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 12/70 (17%), Positives = 25/70 (35%), Gaps = 3/70 (4%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLA--ELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDG 58
           L   NN+        + SL+      L+L+ N+++G +          + LN    +   
Sbjct: 158 LDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLL 216

Query: 59  EISREGIFAN 68
            I +    + 
Sbjct: 217 VIFKGLKNST 226

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 57.2 bits (138), Expect = 8e-09
 Identities = 11/58 (18%), Positives = 22/58 (37%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDG 58
                        +S  +L+ L +++L       ++P F   L  L+ LN++ N    
Sbjct: 472 ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS 529

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 54.9 bits (132), Expect = 4e-08
 Identities = 10/75 (13%), Positives = 25/75 (33%), Gaps = 8/75 (10%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLS-------GKVPQFFSKLLSLRHLNLSY 53
           + L  N  +        +   ++ + LS N ++             +     L  ++L +
Sbjct: 678 VTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRF 737

Query: 54  NELDGEISREGIFAN 68
           N+L   +S +     
Sbjct: 738 NKL-TSLSDDFRATT 751

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 10/62 (16%), Positives = 21/62 (33%), Gaps = 7/62 (11%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDL------SCNNLSGKVPQFFSKLLSLRHLNLSYN 54
           + +  N F  + P    +   L    +        N +  + P   +   SL  L +  N
Sbjct: 758 MDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSN 816

Query: 55  EL 56
           ++
Sbjct: 817 DI 818

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 51.4 bits (123), Expect = 4e-07
 Identities = 10/51 (19%), Positives = 20/51 (39%)

Query: 6   NSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           + +     V L +   +  L L+     G+VP    +L  L+ L+   +  
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSE 359

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 51.4 bits (123), Expect = 4e-07
 Identities = 10/63 (15%), Positives = 21/63 (33%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L     KG +P ++  L  L  L    ++ +     F  + L+        + +    
Sbjct: 328 LSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHY 387

Query: 61  SRE 63
            + 
Sbjct: 388 KKM 390

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 50.6 bits (121), Expect = 8e-07
 Identities = 19/73 (26%), Positives = 31/73 (42%), Gaps = 5/73 (6%)

Query: 1   LYLGNNSFKG-TIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGE 59
            Y+G N+ +      SL+ +  L  LD   N +     + F   + L  L L YN+++ E
Sbjct: 553 FYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIE-E 609

Query: 60  ISREGIFANASAI 72
           I  E   A    +
Sbjct: 610 IP-EDFCAFTDQV 621

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 10/56 (17%), Positives = 20/56 (35%), Gaps = 3/56 (5%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
                N      P  + +   L +L +  N++  KV +       L  L+++ N  
Sbjct: 787 RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDE--KLTPQLYILDIADNPN 839

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 9/66 (13%), Positives = 20/66 (30%), Gaps = 10/66 (15%)

Query: 1   LYLGNNSFKG---------TIPVSLKSLRGLAELDLSCNNLSG-KVPQFFSKLLSLRHLN 50
           L +  N              +     +   +    +  NNL          K++ L  L+
Sbjct: 520 LNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLD 579

Query: 51  LSYNEL 56
             +N++
Sbjct: 580 CVHNKV 585

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 21/82 (25%), Positives = 35/82 (42%), Gaps = 10/82 (12%)

Query: 1   LYLGNNSFKGTIP--VSLKSLRGLAELDLSCNNLSGKVPQFFS-----KLLSLRHLNLSY 53
           L   +N  K  IP   + KS+  +  +D S N +  +           K ++   + LSY
Sbjct: 624 LGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSY 682

Query: 54  NELDGEISREGIFANASAISIV 75
           NE+    +   +FA  S IS +
Sbjct: 683 NEIQKFPT--ELFATGSPISTI 702

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 15/64 (23%), Positives = 25/64 (39%), Gaps = 8/64 (12%)

Query: 1   LYLGNNSFK-------GTIPVSLKSLRGLAELDLSCNNLSGKVPQF-FSKLLSLRHLNLS 52
           + L NN               + K+   L  +DL  N L+     F  + L  L ++++S
Sbjct: 702 IILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVS 761

Query: 53  YNEL 56
           YN  
Sbjct: 762 YNCF 765

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 49.1 bits (117), Expect = 3e-06
 Identities = 14/69 (20%), Positives = 23/69 (33%), Gaps = 5/69 (7%)

Query: 1   LYLGNNSFKGTIPVSL-KSLRGLAELDLSCNNLSGKVPQ--FFSKLLSLRHLNLSYNELD 57
           L L  N  +  IP         +  L  S N L   +P       +  +  ++ SYN++ 
Sbjct: 600 LKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIG 657

Query: 58  GEISREGIF 66
            E       
Sbjct: 658 SEGRNISCS 666

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 12/78 (15%), Positives = 24/78 (30%), Gaps = 6/78 (7%)

Query: 1   LYLGNNSFKG---TIPVSLKSLRG--LAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNE 55
           +    N        I  S+   +G   + + LS N +     + F+    +  + LS N 
Sbjct: 649 VDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNL 708

Query: 56  LDGEISREGIFANASAIS 73
           +   I    +        
Sbjct: 709 M-TSIPENSLKPKDGNYK 725

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 11/56 (19%), Positives = 22/56 (39%), Gaps = 2/56 (3%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L   +N  +  +  +  +   L +L L  N +      F +    +  L  S+N+L
Sbjct: 578 LDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKL 631

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 10/56 (17%), Positives = 21/56 (37%), Gaps = 4/56 (7%)

Query: 1   LYLGNNSFKGTIPVSLK--SLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYN 54
           + L  N    ++    +  +L  L+ +D+S N  S   P        L+   + + 
Sbjct: 733 IDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQ 786

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 7/63 (11%), Positives = 15/63 (23%), Gaps = 5/63 (7%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           +Y  N+ F               + +             +S L  L  + L       ++
Sbjct: 453 IYFANSPFTYDNIAVD-----WEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQL 507

Query: 61  SRE 63
              
Sbjct: 508 PDF 510

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 56.1 bits (136), Expect = 1e-08
 Identities = 48/230 (20%), Positives = 87/230 (37%), Gaps = 40/230 (17%)

Query: 156 TDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFID------ECNALT 208
              ++  + IG G++G V       +    AIK  K+      +          E   L 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK--KIS---PFEHQTYCQRTLREIKILL 80

Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQ 266
             RH NI+ I     +   E      +V + M   +L + L     ++++  +       
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY------- 132

Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
               +  +   L Y+H+     + H DLK SN+LL+      + DFGLA+    + +   
Sbjct: 133 ---FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH-- 184

Query: 327 KNQTMSNGLKGSVG---YIPPEYI--NGHVSILGDIYSYGILLLEIFTGK 371
                +  L   V    Y  PE +  +   +   DI+S G +L E+ + +
Sbjct: 185 -----TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 34/164 (20%)

Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           IG G+FG +  G  L   E  AIK+  ++ +        E             K + S  
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEY---------RFYKQLGSGD 65

Query: 224 ---SVDYEG--NDFKALVFEFMRNG-NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
               V Y G    + A+V E +  G +L+        + C  +  SL   L I I + S 
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELL--GPSLEDLF-----DLCD-RTFSLKTVLMIAIQLISR 117

Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGM-----IAHVGDFGLAK 316
           ++Y+H++    + + D+K  N L+         + H+ DF LAK
Sbjct: 118 MEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 46/234 (19%), Positives = 91/234 (38%), Gaps = 39/234 (16%)

Query: 156 TDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRN 214
              + +   +G G  G V+        +  AIK + L    ++K  + E   +  + H N
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69

Query: 215 ILKIV-------SSCSSVDYEGNDFKA--LVFEFMRNGNLDQWLH--PSTDEYCHFKKLS 263
           I+K+        S  +       +  +  +V E+M   +L   L   P  +E+       
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARL---- 124

Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEES 322
                  +  +   L Y+H+     + H DLK +N+ ++ E ++  +GDFGLA+ +    
Sbjct: 125 ------FMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175

Query: 323 NTPSKNQTMSNGLKGSVG---YIPPEYI--NGHVSILGDIYSYGILLLEIFTGK 371
           +           L   +    Y  P  +    + +   D+++ G +  E+ TGK
Sbjct: 176 SH-------KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 39/223 (17%)

Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           IGSGSFG +Y GT +A GE  AIK+  ++ +        E           I K++    
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIES---------KIYKMMQGGV 65

Query: 224 ---SVDYEG--NDFKALVFEFMRNG-NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASA 277
              ++ + G   D+  +V E +  G +L+         +C  +K SL   L +   + S 
Sbjct: 66  GIPTIRWCGAEGDYNVMVMELL--GPSLEDLF-----NFCS-RKFSLKTVLLLADQMISR 117

Query: 278 LDYLHNQYDTPIAHCDLKSSNVLLDEGM---IAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
           ++Y+H++      H D+K  N L+  G    + ++ DFGLAK   +           +  
Sbjct: 118 IEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 174

Query: 335 LKGSVGYIPPEYINGHVSILG----DIYSYGILLLEIFTGKRP 373
           L G+  Y     IN H+ I      D+ S G +L+    G  P
Sbjct: 175 LTGTARYAS---INTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 56/223 (25%), Positives = 90/223 (40%), Gaps = 48/223 (21%)

Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFID------ECNALTSIRHRNILK 217
           +GSG++G+V        G   AIK  KL +    +S +       E   L  +RH N++ 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIK--KLYR--PFQSELFAKRAYRELRLLKHMRHENVIG 88

Query: 218 IVSSCSSVDYEGNDFKA--LVFEFMRNGNLDQWLH--PSTDEYCHFKKLSLMQRLNIVID 273
           ++    + D   +DF    LV  FM   +L + +      ++   F          +V  
Sbjct: 89  LLD-VFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQF----------LVYQ 136

Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +   L Y+H      I H DLK  N+ ++E     + DFGLA+                +
Sbjct: 137 MLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-------------QADS 180

Query: 334 GLKGSVG---YIPPEYI--NGHVSILGDIYSYGILLLEIFTGK 371
            + G V    Y  PE I      +   DI+S G ++ E+ TGK
Sbjct: 181 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 52/232 (22%), Positives = 94/232 (40%), Gaps = 48/232 (20%)

Query: 156 TDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFID------ECNALT 208
            + +   + +GSG++GSV        G   A+K    +     +S I       E   L 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLK 83

Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKA--LVFEFMRNGNLDQWLH--PSTDEYCHFKKLSL 264
            ++H N++ ++    +      +F    LV   M   +L+  +     TD++  F     
Sbjct: 84  HMKHENVIGLLD-VFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF----- 136

Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNT 324
                ++  +   L Y+H+     I H DLK SN+ ++E     + DFGLA+        
Sbjct: 137 -----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------- 180

Query: 325 PSKNQTMSNGLKGSVG---YIPPEYI--NGHVSILGDIYSYGILLLEIFTGK 371
                  ++ + G V    Y  PE +    H +   DI+S G ++ E+ TG+
Sbjct: 181 -----HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 48/235 (20%), Positives = 92/235 (39%), Gaps = 47/235 (20%)

Query: 164 LIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFID----ECNALTSIRHRNILK- 217
            +G G+FG V     + + +  A+KV++      +K +      E + L  I++ +I   
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVR-----NIKKYTRSAKIEADILKKIQNDDINNN 96

Query: 218 -IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            IV       Y  +    L+FE +   +L + +        ++    +       I++  
Sbjct: 97  NIVKYHGKFMYYDHMC--LIFEPLGP-SLYEII-----TRNNYNGFHIEDIKLYCIEILK 148

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
           AL+YL       + H DLK  N+LLD+    +     +      +       +T S G+K
Sbjct: 149 ALNYLR---KMSLTHTDLKPENILLDDP---YFEKSLITVRRVTDGKKIQIYRTKSTGIK 202

Query: 337 ----GSVGYIPPEYINGHVS---------ILG-------DIYSYGILLLEIFTGK 371
               G   +   +Y    ++         IL        D++S+G +L E++TG 
Sbjct: 203 LIDFGCATFK-SDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 49/227 (21%), Positives = 86/227 (37%), Gaps = 45/227 (19%)

Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           IG GSFG +++GT L + +  AIK    +         DE             K+++ C+
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEY---------RTYKLLAGCT 66

Query: 224 ---SVDYEG--NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
              +V Y G       LV + +   +L+  L     + C  +K S+         + + +
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLLGP-SLEDLL-----DLCG-RKFSVKTVAMAAKQMLARV 119

Query: 279 DYLHNQYDTPIAHCDLKSSNVLLDEGM-----IAHVGDFGLAKFLFEESNTPSKNQTMSN 333
             +H +    + + D+K  N L+         + +V DFG+ KF  +             
Sbjct: 120 QSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 176

Query: 334 GLKGSVGYIPPEYINGHVSILG-------DIYSYGILLLEIFTGKRP 373
            L G+  Y+    IN H   LG       D+ + G + +    G  P
Sbjct: 177 NLSGTARYMS---INTH---LGREQSRRDDLEALGHVFMYFLRGSLP 217

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 54.0 bits (130), Expect = 7e-08
 Identities = 18/58 (31%), Positives = 32/58 (55%), Gaps = 1/58 (1%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNL-SGKVPQFFSKLLSLRHLNLSYNELD 57
           L     +        +  L+ L EL+++ N + S K+P++FS L +L HL+LS N++ 
Sbjct: 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 22/57 (38%), Positives = 29/57 (50%), Gaps = 1/57 (1%)

Query: 1   LYLGNNSFKGTI-PVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L +  NSF+    P     LR L  LDLS   L    P  F+ L SL+ LN++ N+L
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQL 506

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 52.0 bits (125), Expect = 3e-07
 Identities = 15/68 (22%), Positives = 26/68 (38%), Gaps = 1/68 (1%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L  N  +     +   L  L +L     NL+         L +L+ LN+++N +    
Sbjct: 81  LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SF 139

Query: 61  SREGIFAN 68
                F+N
Sbjct: 140 KLPEYFSN 147

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 52.0 bits (125), Expect = 3e-07
 Identities = 18/69 (26%), Positives = 26/69 (37%), Gaps = 2/69 (2%)

Query: 1   LYLGNNSFKGTIPVS-LKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGE 59
           L   +++ K     S   SLR L  LD+S  +        F+ L SL  L ++ N     
Sbjct: 401 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 460

Query: 60  ISREGIFAN 68
                IF  
Sbjct: 461 FLP-DIFTE 468

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 51.3 bits (123), Expect = 5e-07
 Identities = 15/56 (26%), Positives = 20/56 (35%)

Query: 1  LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
          L L  N  +     S  S   L  LDLS   +       +  L  L  L L+ N +
Sbjct: 33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 22/70 (31%), Positives = 31/70 (44%), Gaps = 4/70 (5%)

Query: 1   LYLGNN--SFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDG 58
           L L  N  SFKG    S      L  LDLS N +   +   F  L  L HL+  ++ L  
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK- 409

Query: 59  EISREGIFAN 68
           ++S   +F +
Sbjct: 410 QMSEFSVFLS 419

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 15/71 (21%), Positives = 30/71 (42%), Gaps = 3/71 (4%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQ-FFSKLLSLRHLNLSYNELDGE 59
           L + +   +         L  L  L ++ N+         F++L +L  L+LS  +L+ +
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-Q 484

Query: 60  ISREGIFANAS 70
           +S    F + S
Sbjct: 485 LS-PTAFNSLS 494

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 16/57 (28%), Positives = 24/57 (42%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELD 57
           L L     +   P +  SL  L  L+++ N L       F +L SL+ + L  N  D
Sbjct: 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 15/56 (26%), Positives = 22/56 (39%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L     +     + +SL  L+ L L+ N +       FS L SL+ L      L
Sbjct: 57  LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL 112

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 18/69 (26%), Positives = 27/69 (39%), Gaps = 5/69 (7%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGL----AELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L +N  +      L+ L  +      LDLS N ++   P  F K + L  L L  N  
Sbjct: 154 LDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFD 212

Query: 57  DGEISREGI 65
              + +  I
Sbjct: 213 SLNVMKTCI 221

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 18/72 (25%), Positives = 26/72 (36%), Gaps = 5/72 (6%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L N  F     + LKSL+    L  + N            L SL  L+LS N L  + 
Sbjct: 309 LELVNCKFGQFPTLKLKSLK---RLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKG 363

Query: 61  SREGIFANASAI 72
                    +++
Sbjct: 364 CCSQSDFGTTSL 375

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 53.3 bits (128), Expect = 9e-08
 Identities = 18/56 (32%), Positives = 25/56 (44%)

Query: 1  LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
            + ++S K  +    +S   + ELDLS N LS       +    L  LNLS N L
Sbjct: 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 15/57 (26%), Positives = 23/57 (40%), Gaps = 1/57 (1%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSG-KVPQFFSKLLSLRHLNLSYNEL 56
           +YL NN       +       +  LDL  N +      +  +   +L HLNL YN +
Sbjct: 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 16/56 (28%), Positives = 21/56 (37%), Gaps = 2/56 (3%)

Query: 1  LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
          L L  N         L     L  L+LS N L          L +LR L+L+ N +
Sbjct: 39 LDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV 92

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 47.5 bits (113), Expect = 7e-06
 Identities = 14/68 (20%), Positives = 30/68 (44%), Gaps = 4/68 (5%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L+  NN+      VS    +G   + L+ N ++            +++L+L  NE+D  +
Sbjct: 104 LHAANNNISR---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TV 159

Query: 61  SREGIFAN 68
           +   + A+
Sbjct: 160 NFAELAAS 167

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 16/93 (17%), Positives = 31/93 (33%), Gaps = 4/93 (4%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L +N     +    +S  G+  + L  N L   + +      +L H +L  N      
Sbjct: 196 LDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC-G 252

Query: 61  SREGIFANASAISIVGNDKLCGGIQKLQLPECS 93
           +    F+    +  V    +   +      EC+
Sbjct: 253 TLRDFFSKNQRVQTVAKQTVK-KLTGQNEEECT 284

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 14/56 (25%), Positives = 22/56 (39%), Gaps = 3/56 (5%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L  N     +   +     L  LDLS N L+  +   F     +  ++L  N+L
Sbjct: 174 LNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 53.5 bits (128), Expect = 9e-08
 Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 49/228 (21%)

Query: 165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCS 223
           IGSGSFG +Y GT +   E  AIK+  ++ +      + E           I +I+   +
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYES---------KIYRILQGGT 63

Query: 224 ---SVDYEG--NDFKALVFEFMRNGNLDQWLHPSTDEYCHF--KKLSLMQRLNIVIDVAS 276
              +V + G   D+  LV +          L PS ++  +F  +KLSL   L +   + +
Sbjct: 64  GIPNVRWFGVEGDYNVLVMDL---------LGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGM---IAHVGDFGLAKFLFEESNT----PSKNQ 329
            ++++H++      H D+K  N L+  G      ++ DFGLAK  + +++T    P +  
Sbjct: 115 RVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK-KYRDTSTHQHIPYREN 170

Query: 330 TMSNGLKGSVGYIPPEYINGHVSILG----DIYSYGILLLEIFTGKRP 373
                L G+  Y     +N H+ I      D+ S G +L+    G  P
Sbjct: 171 ---KNLTGTARYAS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 18/56 (32%), Positives = 25/56 (44%)

Query: 1  LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
            + ++S K  +    +S   + ELDLS N LS       +    L  LNLS N L
Sbjct: 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 15/57 (26%), Positives = 23/57 (40%), Gaps = 1/57 (1%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSG-KVPQFFSKLLSLRHLNLSYNEL 56
           +YL NN       +       +  LDL  N +      +  +   +L HLNL YN +
Sbjct: 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 16/56 (28%), Positives = 21/56 (37%), Gaps = 2/56 (3%)

Query: 1  LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
          L L  N         L     L  L+LS N L          L +LR L+L+ N +
Sbjct: 39 LDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV 92

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 47.7 bits (114), Expect = 4e-06
 Identities = 13/68 (19%), Positives = 30/68 (44%), Gaps = 4/68 (5%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L+  NN+    +  S    +G   + L+ N ++            +++L+L  NE+D  +
Sbjct: 104 LHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TV 159

Query: 61  SREGIFAN 68
           +   + A+
Sbjct: 160 NFAELAAS 167

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 46.5 bits (111), Expect = 8e-06
 Identities = 14/80 (17%), Positives = 27/80 (33%), Gaps = 3/80 (3%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L +N     +    +S  G+  + L  N L   + +      +L H +L  N      
Sbjct: 196 LDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CG 252

Query: 61  SREGIFANASAISIVGNDKL 80
           +    F+    +  V    +
Sbjct: 253 TLRDFFSKNQRVQTVAKQTV 272

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 43.8 bits (104), Expect = 7e-05
 Identities = 14/56 (25%), Positives = 21/56 (37%), Gaps = 3/56 (5%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L  N     +         L  LDLS N L+  +   F     +  ++L  N+L
Sbjct: 174 LNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 40.7 bits (96), Expect = 6e-04
 Identities = 7/45 (15%), Positives = 18/45 (40%), Gaps = 3/45 (6%)

Query: 12 IPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
          I  +    +      ++ ++L   +        +++ L+LS N L
Sbjct: 5  IKQNGNRYK---IEKVTDSSLKQALASLRQSAWNVKELDLSGNPL 46

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 42/236 (17%), Positives = 83/236 (35%), Gaps = 53/236 (22%)

Query: 164 LIGSGSFGSVYKG--TLADGETAAIKVLKLQQQGALKSFID----ECNALTSIRHR---N 214
            +G G+FG V +           A+K+++      +  + +    E N L  I+ +   N
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIR-----NVGKYREAARLEINVLKKIKEKDKEN 80

Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
               V      ++ G+    + FE +   N  ++L     +  +F+   L    ++   +
Sbjct: 81  KFLCVLMSDWFNFHGHMC--IAFELLGK-NTFEFL-----KENNFQPYPLPHVRHMAYQL 132

Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK------- 327
             AL +LH   +  + H DLK  N+L        + +   +       NT  +       
Sbjct: 133 CHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189

Query: 328 ---NQTMSNGLKGSVGYI------PPEYINGH---VSILGDIYSYGILLLEIFTGK 371
              ++  +         +      PPE I           D++S G +L E + G 
Sbjct: 190 TFDHEHHTT-------IVATRHYRPPEVILELGWAQPC--DVWSIGCILFEYYRGF 236

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 20/56 (35%), Positives = 26/56 (46%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L NN          K+L+ L  L L  N +S   P  F+ L+ L  L LS N+L
Sbjct: 57  LDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 112

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 17/56 (30%), Positives = 24/56 (42%), Gaps = 1/56 (1%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L  NS       SL +   L EL L+ N L  KVP   +    ++ + L  N +
Sbjct: 221 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 275

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 46.5 bits (111), Expect = 9e-06
 Identities = 19/69 (27%), Positives = 29/69 (42%), Gaps = 5/69 (7%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQF-FSKLLSLRHLNLSYNELDGE 59
           LYL  N  K  +P  +   + L EL +  N ++ KV +  F+ L  +  + L  N L   
Sbjct: 105 LYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSS 160

Query: 60  ISREGIFAN 68
               G F  
Sbjct: 161 GIENGAFQG 169

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 46.5 bits (111), Expect = 1e-05
 Identities = 20/56 (35%), Positives = 28/56 (50%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L+L  N        SLK L  LA+L LS N++S       +    LR L+L+ N+L
Sbjct: 197 LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 252

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 16/74 (21%), Positives = 28/74 (37%), Gaps = 7/74 (9%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSG------KVPQFFSKLLSLRHLNLSYN 54
           L+L NN     +P  L   + +  + L  NN+S         P + +K  S   ++L  N
Sbjct: 245 LHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 303

Query: 55  ELDGEISREGIFAN 68
            +     +   F  
Sbjct: 304 PVQYWEIQPSTFRC 317

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 18/71 (25%), Positives = 28/71 (39%), Gaps = 5/71 (7%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           + + + +   TIP  L     L EL L  N ++         L +L  L LS+N +   +
Sbjct: 176 IRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS-AV 231

Query: 61  SREGIFANASA 71
              G  AN   
Sbjct: 232 D-NGSLANTPH 241

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 50.0 bits (120), Expect = 3e-07
 Identities = 13/61 (21%), Positives = 23/61 (37%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L +           +L  L  L  LD+S +     +    + L  +  ++LSYN    +I
Sbjct: 93  LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI 152

Query: 61  S 61
            
Sbjct: 153 M 153

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 43.8 bits (104), Expect = 3e-05
 Identities = 14/60 (23%), Positives = 24/60 (40%), Gaps = 2/60 (3%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L + N       P  +  L  L  L +   +++       S L SL  L++S++  D  I
Sbjct: 71  LTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI 128

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 42.3 bits (100), Expect = 1e-04
 Identities = 11/57 (19%), Positives = 26/57 (45%), Gaps = 1/57 (1%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELD 57
           L + +++   +I   + +L  +  +DLS N     +      L  L+ LN+ ++ + 
Sbjct: 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVH 172

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 52.5 bits (125), Expect = 3e-07
 Identities = 75/534 (14%), Positives = 147/534 (27%), Gaps = 140/534 (26%)

Query: 25  LDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGN-DKLCGG 83
                +     V +F  ++L      ++Y  L   I  E    +      +   D+L   
Sbjct: 68  FWTLLSKQEEMVQKFVEEVL-----RINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYND 122

Query: 84  IQKLQLPECSRKNPRKRL--SLKIVIP---VTI--------SVPIFILLLAALVIYHIVK 130
            Q       SR  P  +L  +L  + P   V I        +       +A  V      
Sbjct: 123 NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTW------VALDV----CL 172

Query: 131 TSRRQSAPPSN-EW------QSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGET 183
           + + Q        W       S  + L++        + N        S  K  +   + 
Sbjct: 173 SYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQA 232

Query: 184 AAIKVLKLQQ-------------QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN 230
              ++LK +                A  +F   C  L + R + +   +S+ ++     +
Sbjct: 233 ELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLD 292

Query: 231 DFK-----------------------------------ALVFEFMRNGN--LDQWLHPST 253
                                                 +++ E +R+G    D W H + 
Sbjct: 293 HHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNC 352

Query: 254 DEYCHFKKLSL-------MQRL-----------NIVIDVASALDYLHNQYDTP--IAHCD 293
           D+     + SL        +++           +I   + S + +          + +  
Sbjct: 353 DKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLI-WFDVIKSDVMVVVNKL 411

Query: 294 LKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGY-IPPEYINGHVS 352
            K S  L+++          +     E          +   +     Y IP  + +  + 
Sbjct: 412 HKYS--LVEKQ--PKESTISIPSIYLELKVKLENEYALHRSIVDH--YNIPKTFDSDDLI 465

Query: 353 ILG-DIYSYGIL---LLEIFTGKRPTDDMFKD---DLS------IHKFVLMALPSHVMDV 399
               D Y Y  +   L  I   +R    +F+    D         H          +++ 
Sbjct: 466 PPYLDQYFYSHIGHHLKNIEHPER--MTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNT 523

Query: 400 L-DLSMLLEEENDHEKHEE------EDLFPDIESQVAQKKLEECLVSVMRIGVM 446
           L  L        D++   E       D  P IE  +   K    L+   RI +M
Sbjct: 524 LQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSK-YTDLL---RIALM 573

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.1 bits (103), Expect = 1e-04
 Identities = 50/332 (15%), Positives = 104/332 (31%), Gaps = 113/332 (34%)

Query: 175 KGTLADGETAAI--KVLKLQQQG----ALK-----------SFIDECNALTSIRHRNILK 217
             TL   E  ++  K L  + Q      L            S  D      + +H N  K
Sbjct: 295 SMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDK 354

Query: 218 IVSSC-SSVDY-EGNDFKALVFE----FMRNGNLDQ------WLHPSTDE----YCHFKK 261
           + +   SS++  E  +++ + F+    F  + ++        W      +         K
Sbjct: 355 LTTIIESSLNVLEPAEYRKM-FDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHK 413

Query: 262 LSLMQR---------LNIVIDVASALD---YLH----NQYDTPIAHCDLKSSNVLLDEGM 305
            SL+++          +I +++   L+    LH    + Y+ P            LD+  
Sbjct: 414 YSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYF 473

Query: 306 IAHVG--------------------DFGLAKFLFEESNTPSK--NQTMSNGLKGSVGYIP 343
            +H+G                    DF   +FL        K  + + +    GS+    
Sbjct: 474 YSHIGHHLKNIEHPERMTLFRMVFLDF---RFL------EQKIRHDSTAWNASGSI---- 520

Query: 344 PEYINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHV-----MD 398
                  ++ L  +  Y            P  +   + +    F L  +  ++      D
Sbjct: 521 -------LNTLQQLKFYK----PYICDNDPKYERLVNAIL--DF-LPKIEENLICSKYTD 566

Query: 399 VLDLSMLLEEENDHEKHEEEDLFPDIESQVAQ 430
           +L ++++          E+E +F +   QV +
Sbjct: 567 LLRIALM---------AEDEAIFEEAHKQVQR 589

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 16/69 (23%), Positives = 24/69 (34%), Gaps = 1/69 (1%)

Query: 1   LYLGNNSFKGTIPV-SLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGE 59
           L +   +    I   + + L  L  L L  N         F+ L +L  L L+   LDG 
Sbjct: 59  LKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGA 118

Query: 60  ISREGIFAN 68
           +     F  
Sbjct: 119 VLSGNFFKP 127

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 44.4 bits (105), Expect = 7e-05
 Identities = 15/57 (26%), Positives = 20/57 (35%), Gaps = 1/57 (1%)

Query: 1  LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQ-FFSKLLSLRHLNLSYNEL 56
          + L  NS       S   L+ L  L +        +    F  L SL  L L YN+ 
Sbjct: 35 VDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 44.0 bits (104), Expect = 7e-05
 Identities = 18/56 (32%), Positives = 25/56 (44%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L  N          ++L  L  LDLS N++     Q F  L +L+ L L  N+L
Sbjct: 328 LNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQL 383

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 18/71 (25%), Positives = 27/71 (38%), Gaps = 5/71 (7%)

Query: 1   LYLGNNSFKGT-IPV-SLKSLRGLAELDLSCNNLSGKVPQ-FFSKLLSLRHLNLSYNELD 57
           L L   +  G  +     K L  L  L L  NN+    P  FF  +     L+L++N++ 
Sbjct: 108 LTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK 167

Query: 58  GEISREGIFAN 68
                E    N
Sbjct: 168 --SICEEDLLN 176

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 40.5 bits (95), Expect = 9e-04
 Identities = 19/69 (27%), Positives = 27/69 (39%), Gaps = 4/69 (5%)

Query: 1   LYLGNNSFKGTIPVSL-KSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGE 59
             L  +     +  S+      L +L L+ N ++      F  L  L  LNLS N L G 
Sbjct: 280 CDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL-GS 337

Query: 60  ISREGIFAN 68
           I    +F N
Sbjct: 338 ID-SRMFEN 345

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 50.7 bits (122), Expect = 4e-07
 Identities = 39/236 (16%), Positives = 80/236 (33%), Gaps = 53/236 (22%)

Query: 164 LIGSGSFGSVYKG--TLADGETAAIKVLKLQQQGALKSFID----ECNALTSIRHR---N 214
            +G G+FG V +     A G   A+K++K      +  + +    E   L  +      +
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVK-----NVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
             + V      ++ G+    +VFE +   +   ++     +   F    L     +   +
Sbjct: 76  TFRCVQMLEWFEHHGHIC--IVFELLGL-STYDFI-----KENGFLPFRLDHIRKMAYQI 127

Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK------- 327
             ++++LH      + H DLK  N+L  +       +  + +      N   K       
Sbjct: 128 CKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184

Query: 328 ---NQTMSNGLKGSVGYI------PPEYINGH---VSILGDIYSYGILLLEIFTGK 371
              ++  S         +       PE I           D++S G +L+E + G 
Sbjct: 185 TYDDEHHST-------LVSTRHYRAPEVILALGWSQPC--DVWSIGCILIEYYLGF 231

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 51.3 bits (123), Expect = 5e-07
 Identities = 20/69 (28%), Positives = 30/69 (43%), Gaps = 1/69 (1%)

Query: 1   LYLGNNSFKGTI-PVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGE 59
           L LG+     TI   + ++L  L  LDL  + +    P  F  L  L  L L +  L   
Sbjct: 53  LELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDA 112

Query: 60  ISREGIFAN 68
           + ++G F N
Sbjct: 113 VLKDGYFRN 121

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 47.9 bits (114), Expect = 6e-06
 Identities = 16/56 (28%), Positives = 24/56 (42%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L  N        +   L  +A +DL  N+++    Q F  L  L+ L+L  N L
Sbjct: 319 LNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL 374

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 47.1 bits (112), Expect = 9e-06
 Identities = 14/57 (24%), Positives = 23/57 (40%), Gaps = 1/57 (1%)

Query: 1  LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKV-PQFFSKLLSLRHLNLSYNEL 56
          L L  N  +     S   L  L  L+L        +  + F  L +LR L+L  +++
Sbjct: 29 LLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKI 85

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 16/68 (23%), Positives = 25/68 (36%), Gaps = 2/68 (2%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L  N        +   L  L  L+LS N L       F  L  + +++L  N +   I
Sbjct: 295 LNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI--AI 352

Query: 61  SREGIFAN 68
            ++  F  
Sbjct: 353 IQDQTFKF 360

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 16/59 (27%), Positives = 27/59 (45%), Gaps = 3/59 (5%)

Query: 1   LYLGNNSFKGTI--PVSLKSLRGLAELDLSCNNLSG-KVPQFFSKLLSLRHLNLSYNEL 56
           L L        +      ++L+ L  LDLS N +    +   F KL SL+ ++ S N++
Sbjct: 102 LRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQI 160

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 21/61 (34%), Positives = 29/61 (47%), Gaps = 5/61 (8%)

Query: 1   LYLGNNSFKGTIPVSL-----KSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNE 55
           L+LG N  +      L     + L  L  L L+ N L+   P  FS L +LR L+L+ N 
Sbjct: 456 LFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNR 515

Query: 56  L 56
           L
Sbjct: 516 L 516

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 17/57 (29%), Positives = 28/57 (49%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELD 57
           L L +           ++L+ L  L+L+ N ++    + F  L +L+ LNLSYN L 
Sbjct: 271 LDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG 327

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 44.4 bits (105), Expect = 7e-05
 Identities = 17/65 (26%), Positives = 23/65 (35%), Gaps = 2/65 (3%)

Query: 1   LYLGNNSFKG-TIPVSLKSLRGLAELDLSCNNLSGKVPQ-FFSKLLSLRHLNLSYNELDG 58
           ++L  N  +   I   L  +  L  L L+ N  S        S+  SL  L L  N L  
Sbjct: 406 IHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQL 465

Query: 59  EISRE 63
               E
Sbjct: 466 AWETE 470

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 44.4 bits (105), Expect = 7e-05
 Identities = 28/164 (17%), Positives = 51/164 (31%), Gaps = 39/164 (23%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           LYL +N      P     L  L  L L+ N L+           +L  L++S N+L    
Sbjct: 485 LYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPA--NLEILDISRNQL--LA 540

Query: 61  SREGIFANASAISIVGNDKLCG-----------------------------------GIQ 85
               +F + S + I  N  +C                                     + 
Sbjct: 541 PNPDVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLF 600

Query: 86  KLQLPECSRKNPRKRLSLKIVIPVTISVPIFILLLAALVIYHIV 129
            L    C  +   K L   + I  T+++ +F++ +  +  +   
Sbjct: 601 SLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTKFRGF 644

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 41.7 bits (98), Expect = 5e-04
 Identities = 17/63 (26%), Positives = 22/63 (34%), Gaps = 6/63 (9%)

Query: 1   LYLGNNSFKGTIPVSLKS-LRGLAELDLSCNNLSGKV-----PQFFSKLLSLRHLNLSYN 54
           L L  N F         S    L +L L  N L            F  L  L+ L L++N
Sbjct: 431 LILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHN 490

Query: 55  ELD 57
            L+
Sbjct: 491 YLN 493

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 41.3 bits (97), Expect = 6e-04
 Identities = 22/97 (22%), Positives = 39/97 (40%), Gaps = 10/97 (10%)

Query: 1   LYLGNNSFKGTIPVSLKSLRG--LAELDLSCNNLSGKVPQFFSKL------LSLRHLNLS 52
           +   +N         L+ L+G  L+   L+ N+L  +V   + K       + L  L++S
Sbjct: 153 IDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVS 212

Query: 53  YNELDGEISREGIFANASAISIVGNDKLCGGIQKLQL 89
            N    +I+  G F+NA + S   +  L   I     
Sbjct: 213 GNGWTVDIT--GNFSNAISKSQAFSLILAHHIMGAGF 247

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 50.9 bits (122), Expect = 6e-07
 Identities = 25/71 (35%), Positives = 31/71 (43%), Gaps = 2/71 (2%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L LG N  K        S   L EL+L+ N +S   P  F+ L +LR L L  N L   I
Sbjct: 37  LDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LI 95

Query: 61  SREGIFANASA 71
              G+F   S 
Sbjct: 96  P-LGVFTGLSN 105

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 48.2 bits (115), Expect = 4e-06
 Identities = 12/68 (17%), Positives = 24/68 (35%), Gaps = 2/68 (2%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L + +       S K L  L  L++S       +       L+L  L++++  L   +
Sbjct: 181 LRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AV 239

Query: 61  SREGIFAN 68
                  +
Sbjct: 240 P-YLAVRH 246

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 21/69 (30%), Positives = 32/69 (46%), Gaps = 4/69 (5%)

Query: 1   LYLGNNSFKGTIPV-SLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGE 59
           L L +N  K  IP+     L  L +LD+S N +   +   F  L +L+ L +  N+L   
Sbjct: 85  LGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL-VY 142

Query: 60  ISREGIFAN 68
           IS    F+ 
Sbjct: 143 IS-HRAFSG 150

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 44.7 bits (106), Expect = 5e-05
 Identities = 15/56 (26%), Positives = 22/56 (39%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L +  N     +    + L  L  L++  N+L     + FS L SL  L L    L
Sbjct: 109 LDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNL 164

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 44.7 bits (106), Expect = 5e-05
 Identities = 13/56 (23%), Positives = 26/56 (46%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L + + +      ++++ L  L  L+LS N +S        +LL L+ + L   +L
Sbjct: 229 LSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQL 284

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 44.7 bits (106), Expect = 5e-05
 Identities = 15/57 (26%), Positives = 24/57 (42%), Gaps = 2/57 (3%)

Query: 1   LYLGNNSFKGTIPV-SLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L  N     +   +  +L  L  L L  N L       F+ L +L  L++S N++
Sbjct: 61  LELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKI 116

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 44.3 bits (105), Expect = 7e-05
 Identities = 15/57 (26%), Positives = 23/57 (40%), Gaps = 2/57 (3%)

Query: 1   LYLGNNSFKGTIPV-SLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L +G+N     I   +   L  L +L L   NL+    +  S L  L  L L +  +
Sbjct: 133 LEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNI 188

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 43.9 bits (104), Expect = 8e-05
 Identities = 16/62 (25%), Positives = 27/62 (43%), Gaps = 2/62 (3%)

Query: 1   LYLGNNSFKGTIPV-SLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGE 59
           L L   +   +IP  +L  L GL  L L   N++      F +L  L+ L +S+      
Sbjct: 157 LTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDT 215

Query: 60  IS 61
           ++
Sbjct: 216 MT 217

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 50.6 bits (121), Expect = 7e-07
 Identities = 43/278 (15%), Positives = 87/278 (31%), Gaps = 30/278 (10%)

Query: 1   LYLGNNSFKGTIPVSL-KSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGE 59
           L L +N  + ++   +    + L  LD+S N L   +      + SLRHL+LS+N+ D  
Sbjct: 81  LRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFD-V 135

Query: 60  ISREGIFANASAISI--VGNDKL----CGGIQKLQLPECSRKNPRKRLSLKIVIPVTISV 113
           +     F N + ++   +   K        +  L L           +            
Sbjct: 136 LPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIK---------GG 186

Query: 114 PIFILLLAALVIYHIVKTSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSV 173
               L +    + H+V       +   N   + L +L++SN   N      + +      
Sbjct: 187 ETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELT 246

Query: 174 YKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI-LKIVSSCSSVDYEGNDF 232
              TL +     I+          + F      +  +   N+ +          Y     
Sbjct: 247 RGPTLLNVTLQHIETTWKCSVKLFQFF--WPRPVEYLNIYNLTITERIDREEFTYSETAL 304

Query: 233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
           K+L+ E ++N            +   +   + M    +
Sbjct: 305 KSLMIEHVKNQVF------LFSKEALYSVFAEMNIKML 336

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 44.1 bits (104), Expect = 8e-05
 Identities = 16/56 (28%), Positives = 29/56 (51%), Gaps = 3/56 (5%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L +N   G++   L     +  LDL  N +   +P+  + L +L+ LN++ N+L
Sbjct: 433 LNLSSNMLTGSVFRCLPPK--VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQL 485

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 41.4 bits (97), Expect = 6e-04
 Identities = 16/56 (28%), Positives = 22/56 (39%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L  NS        +  L  L  L LS N +       F     L +L++S+N L
Sbjct: 57  LSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRL 112

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 49.9 bits (119), Expect = 7e-07
 Identities = 17/61 (27%), Positives = 21/61 (34%), Gaps = 4/61 (6%)

Query: 1   LYLGNNSFK---GTIPVSLKSLRGLAELDLSCNNLSGKVP-QFFSKLLSLRHLNLSYNEL 56
           L L N   +   G       +   L  LDLS N+L              L  LNLS+  L
Sbjct: 206 LALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL 265

Query: 57  D 57
            
Sbjct: 266 K 266

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 16/71 (22%), Positives = 26/71 (36%), Gaps = 7/71 (9%)

Query: 1   LYLGNNSFKGTI-------PVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSY 53
           L L +N   G         P+   +L+ LA  +      SG      +  + L+ L+LS+
Sbjct: 178 LDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSH 237

Query: 54  NELDGEISREG 64
           N L        
Sbjct: 238 NSLRDAAGAPS 248

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 17/56 (30%), Positives = 23/56 (41%), Gaps = 5/56 (8%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L     K  +P  L     L+ LDLS N L    P    +L  + +L+L  N  
Sbjct: 258 LNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDR-NP-SPDELPQVGNLSLKGNPF 308

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 49.6 bits (119), Expect = 8e-07
 Identities = 22/70 (31%), Positives = 32/70 (45%), Gaps = 4/70 (5%)

Query: 1   LYLGNN--SFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDG 58
           L L +N  SFKG    S      L  LDLS N +   +   F  L  L HL+  ++ L  
Sbjct: 57  LSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK- 114

Query: 59  EISREGIFAN 68
           ++S   +F +
Sbjct: 115 QMSEFSVFLS 124

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 16/56 (28%), Positives = 24/56 (42%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L     +   P +  SL  L  L++S NN        +  L SL+ L+ S N +
Sbjct: 180 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 235

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 19/58 (32%), Positives = 27/58 (46%), Gaps = 2/58 (3%)

Query: 1  LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGK--VPQFFSKLLSLRHLNLSYNEL 56
          L L +N  +         L  L +L LS N LS K    Q      SL++L+LS+N +
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 90

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 15/69 (21%), Positives = 31/69 (44%), Gaps = 3/69 (4%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNN-LSGKVPQFFSKLLSLRHLNLSYNELDGE 59
           L + +   +         L  L  L ++ N+     +P  F++L +L  L+LS  +L+ +
Sbjct: 131 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-Q 189

Query: 60  ISREGIFAN 68
           +S    F +
Sbjct: 190 LS-PTAFNS 197

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 18/69 (26%), Positives = 27/69 (39%), Gaps = 2/69 (2%)

Query: 1   LYLGNNSFKGTIPVSL-KSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGE 59
           L   +++ K     S+  SLR L  LD+S  +        F+ L SL  L ++ N     
Sbjct: 106 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 165

Query: 60  ISREGIFAN 68
                IF  
Sbjct: 166 FL-PDIFTE 173

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 50.0 bits (120), Expect = 8e-07
 Identities = 19/56 (33%), Positives = 24/56 (42%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L NN          K L+ L  L L  N +S    + FS L  L+ L +S N L
Sbjct: 59  LDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHL 114

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 17/68 (25%), Positives = 26/68 (38%), Gaps = 3/68 (4%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           LY+  N     IP +L     L EL +  N +       FS L ++  + +  N L+   
Sbjct: 107 LYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSG 163

Query: 61  SREGIFAN 68
              G F  
Sbjct: 164 FEPGAFDG 171

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 20/56 (35%), Positives = 26/56 (46%), Gaps = 1/56 (1%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L LG+N  +     SL  L  L EL L  N LS +VP     L  L+ + L  N +
Sbjct: 222 LGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNI 276

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 43.9 bits (104), Expect = 7e-05
 Identities = 18/75 (24%), Positives = 28/75 (37%), Gaps = 9/75 (12%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVP-------QFFSKLLSLRHLNLSY 53
           L+L NN     +P  L  L+ L  + L  NN++ KV         F  K      ++L  
Sbjct: 246 LHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFN 303

Query: 54  NELDGEISREGIFAN 68
           N +     +   F  
Sbjct: 304 NPVPYWEVQPATFRC 318

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 41.2 bits (97), Expect = 5e-04
 Identities = 15/69 (21%), Positives = 23/69 (33%), Gaps = 7/69 (10%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQF-FSKLLSLRHLNLSYNELDGE 59
           L +        IP  L     L EL L  N +   +      +   L  L L +N++   
Sbjct: 177 LRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-M 231

Query: 60  ISREGIFAN 68
           I   G  + 
Sbjct: 232 IE-NGSLSF 239

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 49.9 bits (120), Expect = 8e-07
 Identities = 12/56 (21%), Positives = 19/56 (33%), Gaps = 2/56 (3%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L +       P     L  L  + +    L  ++P    +   L  L L+ N L
Sbjct: 86  LELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPL 139

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 12/54 (22%), Positives = 23/54 (42%), Gaps = 2/54 (3%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYN 54
           + +        +P +++   GL  L L+ N L   +P   + L  LR L++   
Sbjct: 109 MTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRAC 160

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 46.5 bits (111), Expect = 1e-05
 Identities = 17/65 (26%), Positives = 26/65 (40%), Gaps = 10/65 (15%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLS-CNNL--------SGKVPQFFSKLLSLRHLNL 51
           L L  N  +  +P S+ SL  L EL +  C  L        S         L++L+ L L
Sbjct: 132 LTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRL 190

Query: 52  SYNEL 56
            +  +
Sbjct: 191 EWTGI 195

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 45.7 bits (109), Expect = 2e-05
 Identities = 14/57 (24%), Positives = 21/57 (36%), Gaps = 2/57 (3%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLS-YNEL 56
           L + N+     +  ++  L  L ELDL         P  F     L+ L L   + L
Sbjct: 211 LKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL 266

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 45.7 bits (109), Expect = 2e-05
 Identities = 13/54 (24%), Positives = 23/54 (42%), Gaps = 2/54 (3%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYN 54
           L L     + ++P S+ +L+ L  L +  + LS  +      L  L  L+L   
Sbjct: 188 LRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGC 239

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 44.2 bits (105), Expect = 5e-05
 Identities = 12/57 (21%), Positives = 25/57 (43%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELD 57
           L L + S   T+P+ +  L  L +LDL       ++P   ++L +   + +  +   
Sbjct: 258 LILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 43.8 bits (104), Expect = 7e-05
 Identities = 14/55 (25%), Positives = 19/55 (34%), Gaps = 2/55 (3%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLS-CNNLSGKVPQFFSKLLSLRHLNLSYN 54
           L L   +     P        L  L L  C+NL   +P    +L  L  L+L   
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGC 287

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 42.2 bits (100), Expect = 2e-04
 Identities = 9/46 (19%), Positives = 17/46 (36%), Gaps = 1/46 (2%)

Query: 11  TIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
                 + L  L  L L    +   +P   + L +L+ L +  + L
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL 218

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 41.5 bits (98), Expect = 4e-04
 Identities = 11/58 (18%), Positives = 19/58 (32%), Gaps = 4/58 (6%)

Query: 1   LYLGNNSFKGTIPVSLKSLR--GLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
                 + K      L+     G   L+L    L  + P    +L  L+H+ +    L
Sbjct: 61  ETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL 116

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 50.1 bits (120), Expect = 8e-07
 Identities = 52/248 (20%), Positives = 93/248 (37%), Gaps = 59/248 (23%)

Query: 156 TDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIR--- 211
              +     +G G++G V+K      GE  A+K  K+       +F +  +A  + R   
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK--KIF-----DAFQNSTDAQRTFREIM 60

Query: 212 -------HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH--PSTDEYCHFKKL 262
                  H NI+ +++   + +    D   LVF++M   +L   +          H + +
Sbjct: 61  ILTELSGHENIVNLLNVLRADND--RDV-YLVFDYM-ETDLHAVIRANILEPV--HKQYV 114

Query: 263 SLMQRLNIVIDVASALDYLH--NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFE 320
            + Q +         + YLH        + H D+K SN+LL+      V DFGL++    
Sbjct: 115 -VYQLIK-------VIKYLHSGG-----LLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161

Query: 321 ESNTPSKNQTMSNGLKGSVGYIPPEYINGHVS---------ILG--------DIYSYGIL 363
                +      N    +     P  +  +V+         +LG        D++S G +
Sbjct: 162 IRRVTNNIPLSINENTENFDDDQP-ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCI 220

Query: 364 LLEIFTGK 371
           L EI  GK
Sbjct: 221 LGEILCGK 228

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 16/56 (28%), Positives = 23/56 (41%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L  N+ +     + + L  L  L L  N++       F+ L SL  L L  N L
Sbjct: 80  LNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 18/56 (32%), Positives = 25/56 (44%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L +  N F    P S   L  L +L +  + +S      F  L SL  LNL++N L
Sbjct: 223 LEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNL 278

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 21/68 (30%), Positives = 32/68 (47%), Gaps = 4/68 (5%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L LG  + K  +P +L  L GL EL++S N+     P  F  L SL+ L +  +++   I
Sbjct: 201 LNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LI 257

Query: 61  SREGIFAN 68
                F  
Sbjct: 258 E-RNAFDG 264

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 44.7 bits (106), Expect = 4e-05
 Identities = 20/57 (35%), Positives = 25/57 (43%), Gaps = 2/57 (3%)

Query: 1   LYLGNNSFKGTIPV-SLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L LG NS +  I V +   L  L  L+L  N L+      F  L  LR L L  N +
Sbjct: 104 LQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPI 159

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 44.7 bits (106), Expect = 4e-05
 Identities = 17/58 (29%), Positives = 26/58 (44%), Gaps = 3/58 (5%)

Query: 1   LYLGNNSFKGTIPV-SLKSLRGLAELDLS-CNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L+L NN  + +IP  +   +  L  LDL     L       F  L +L++LNL    +
Sbjct: 152 LWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI 208

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 19/69 (27%), Positives = 27/69 (39%), Gaps = 5/69 (7%)

Query: 1   LYLGNNSFKGTIPV-SLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGE 59
           L LG       I   + + L  L  L+L   N+   +P   + L+ L  L +S N    E
Sbjct: 176 LDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFP-E 232

Query: 60  ISREGIFAN 68
           I   G F  
Sbjct: 233 IR-PGSFHG 240

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 40.5 bits (95), Expect = 8e-04
 Identities = 17/54 (31%), Positives = 26/54 (48%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYN 54
           L++ N+        +   L  L EL+L+ NNLS      F+ L  L  L+L +N
Sbjct: 247 LWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 25/69 (36%), Positives = 31/69 (44%), Gaps = 3/69 (4%)

Query: 1   LYLGNNSFKGTIPV-SLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGE 59
           L L +N    TI   S  SL  L  LDLS N LS     +F  L SL  LNL  N     
Sbjct: 81  LVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-T 138

Query: 60  ISREGIFAN 68
           +    +F++
Sbjct: 139 LGETSLFSH 147

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 47.8 bits (114), Expect = 4e-06
 Identities = 14/58 (24%), Positives = 24/58 (41%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDG 58
           L +  +  +   P SLKS++ ++ L L        +  F     S+  L L   +LD 
Sbjct: 179 LEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDT 236

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 47.4 bits (113), Expect = 6e-06
 Identities = 21/56 (37%), Positives = 26/56 (46%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L NN         L+    L  L L+ N ++      FS L SL HL+LSYN L
Sbjct: 57  LDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 13/57 (22%), Positives = 23/57 (40%), Gaps = 1/57 (1%)

Query: 1   LYLGNNSFKGTIPV-SLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L +GN      I       L  L EL++  ++L    P+    + ++ HL L   + 
Sbjct: 154 LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH 210

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 48.6 bits (115), Expect = 2e-06
 Identities = 17/57 (29%), Positives = 23/57 (40%), Gaps = 1/57 (1%)

Query: 1  LYLGNNSFKGTIP-VSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
          LY+ N      +    L+ L  L  L +  + L    P  F     L  LNLS+N L
Sbjct: 36 LYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNAL 92

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 42.4 bits (99), Expect = 2e-04
 Identities = 9/48 (18%), Positives = 14/48 (29%), Gaps = 1/48 (2%)

Query: 11 TIPVSLKSLRGLAELDLSCNNLSGKVPQF-FSKLLSLRHLNLSYNELD 57
               L     L EL +        +       L  LR+L +  + L 
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 22/68 (32%), Positives = 31/68 (45%), Gaps = 1/68 (1%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L ++        +  SL  L  LDLS N+LS     +F  L SL++LNL  N     +
Sbjct: 55  LILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TL 113

Query: 61  SREGIFAN 68
               +F N
Sbjct: 114 GVTSLFPN 121

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 47.4 bits (113), Expect = 7e-06
 Identities = 10/56 (17%), Positives = 20/56 (35%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L++        +      L  +  + +  + +      F   L SL  L+LS N +
Sbjct: 291 LHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLM 346

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 19/69 (27%), Positives = 24/69 (34%), Gaps = 2/69 (2%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSG-KVPQFFSKLLSLRHLNLSYNELDGE 59
           L L +N            L  L  L+L  N      V   F  L +L+ L +   E   E
Sbjct: 79  LDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSE 138

Query: 60  ISREGIFAN 68
           I R   FA 
Sbjct: 139 I-RRIDFAG 146

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 17/56 (30%), Positives = 23/56 (41%)

Query: 1  LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
          L L  N         L++   L  L L  + ++      F  L SL HL+LS N L
Sbjct: 31 LDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 16/71 (22%), Positives = 24/71 (33%), Gaps = 3/71 (4%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKV---PQFFSKLLSLRHLNLSYNELD 57
           + + N+          + L+ L  LDLS N +  +            SL+ L LS N L 
Sbjct: 315 ITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR 374

Query: 58  GEISREGIFAN 68
                  I   
Sbjct: 375 SMQKTGEILLT 385

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 16/58 (27%), Positives = 23/58 (39%), Gaps = 3/58 (5%)

Query: 1   LYLGNNSFK--GTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L  N  +        L +L+ L  LD+S N     +P        +R LNLS   +
Sbjct: 366 LVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGI 422

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 44.7 bits (106), Expect = 5e-05
 Identities = 16/56 (28%), Positives = 25/56 (44%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L +   S +     SLKS+R +  L L  +  +  +  F   L S+R+L L    L
Sbjct: 153 LEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNL 208

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 30/175 (17%), Positives = 55/175 (31%), Gaps = 10/175 (5%)

Query: 1   LYLGNNSFKGTIPV-SLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGE 59
           L +GN      I       L  L EL++   +L     Q    +  + HL L  +E    
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSES--A 185

Query: 60  ISREGIFANASAISIVG-NDKLCGGIQKLQLPECSRKNPRKRLSLKIVIPVTIS------ 112
              E      S++  +   D      Q   LP     +P K+L+ +  +    S      
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245

Query: 113 VPIFILLLAALVIYHIVKTSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGS 167
           +  +IL L+ +              P  ++  S L  ++          +  +  
Sbjct: 246 LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFY 300

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 15/61 (24%), Positives = 21/61 (34%), Gaps = 5/61 (8%)

Query: 1   LYLGNNSFKGTI---PVSLKSLRGLAELDLSCNNLS--GKVPQFFSKLLSLRHLNLSYNE 55
           L L  N              +   L  L LS N+L    K  +    L +L  L++S N 
Sbjct: 339 LDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNT 398

Query: 56  L 56
            
Sbjct: 399 F 399

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 41.2 bits (97), Expect = 6e-04
 Identities = 14/58 (24%), Positives = 26/58 (44%), Gaps = 6/58 (10%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLL-SLRHLNLSYNELD 57
           L +  N+F   +P S +    +  L+LS   +        + +  +L  L++S N LD
Sbjct: 392 LDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR----VVKTCIPQTLEVLDVSNNNLD 444

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 18/57 (31%), Positives = 24/57 (42%), Gaps = 2/57 (3%)

Query: 1   LYLGNNSFKGTIPV-SLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L +N     I   +   +  L  LDLS N+L       FS L +L  L L  N +
Sbjct: 69  LLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHI 124

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 15/74 (20%), Positives = 28/74 (37%), Gaps = 4/74 (5%)

Query: 1   LYLGNNSFKGTIPV-SLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGE 59
           L L +N    T+       L+ L  L L  N++       F  +  L+ L LS N++   
Sbjct: 93  LDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-R 150

Query: 60  ISREGIFANASAIS 73
                +  + + + 
Sbjct: 151 FP-VELIKDGNKLP 163

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 41.4 bits (97), Expect = 4e-04
 Identities = 18/57 (31%), Positives = 28/57 (49%), Gaps = 1/57 (1%)

Query: 1   LYLGNNSFKGTIP-VSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L +N+        +   L  L  L LS N+L+    + F  + +LR+L+LS N L
Sbjct: 44  LDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHL 100

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 18/78 (23%), Positives = 33/78 (42%), Gaps = 4/78 (5%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           LY+ NN     + +  + +  L  LDLS N+L   V +   +   L +L L +N +   +
Sbjct: 277 LYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI-VTL 333

Query: 61  SREGIFANASAISIVGND 78
                      +++  ND
Sbjct: 334 K-LSTHHTLKNLTLSHND 350

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 47.3 bits (113), Expect = 6e-06
 Identities = 13/56 (23%), Positives = 26/56 (46%), Gaps = 1/56 (1%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           + L  N  +  +      ++ L  L +S N L   +  +   + +L+ L+LS+N L
Sbjct: 253 VDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL 307

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 47.3 bits (113), Expect = 7e-06
 Identities = 19/81 (23%), Positives = 35/81 (43%), Gaps = 5/81 (6%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L +N     +  +      L  L L  N++   +    S   +L++L LS+N+ D   
Sbjct: 300 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD-CN 354

Query: 61  SREGIFANASAISIVGNDKLC 81
           S   +F N +  ++   D+ C
Sbjct: 355 SLRALFRNVARPAVDDADQHC 375

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 16/68 (23%), Positives = 26/68 (38%), Gaps = 2/68 (2%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L +   +     +      + +L +  N +    P  F  +  L  L L  N+L   +
Sbjct: 74  LNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SL 132

Query: 61  SREGIFAN 68
            R GIF N
Sbjct: 133 PR-GIFHN 139

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 44.3 bits (105), Expect = 6e-05
 Identities = 11/71 (15%), Positives = 28/71 (39%), Gaps = 2/71 (2%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           +   N++ +      L S R +  L+L+   +       F+   +++ L + +N +   +
Sbjct: 50  VTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YL 108

Query: 61  SREGIFANASA 71
               +F N   
Sbjct: 109 P-PHVFQNVPL 118

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 18/57 (31%), Positives = 25/57 (43%), Gaps = 2/57 (3%)

Query: 1   LYLGNNSFKGTIPVSL-KSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L  N    ++P  +  +   L  L +S NNL       F    SL++L LS N L
Sbjct: 122 LVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL 177

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 19/56 (33%), Positives = 26/56 (46%), Gaps = 2/56 (3%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L +N+        L +  GL E+DLS N L   +   F K+  L  L +S N L
Sbjct: 231 LKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL 284

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 9/70 (12%), Positives = 22/70 (31%), Gaps = 2/70 (2%)

Query: 1  LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
          +++   +          +L     +    + +             +  LNL+  +++ EI
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EI 84

Query: 61 SREGIFANAS 70
               FA A 
Sbjct: 85 D-TYAFAYAH 93

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 22/68 (32%), Positives = 27/68 (39%), Gaps = 2/68 (2%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L  N  +     S K LR L  L LS N++       F+ L +L  L L  N L   I
Sbjct: 69  LNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TI 127

Query: 61  SREGIFAN 68
              G F  
Sbjct: 128 P-NGAFVY 134

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 47.4 bits (113), Expect = 6e-06
 Identities = 16/56 (28%), Positives = 24/56 (42%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L  N      P S + L  L +L +  + +       F  L SL  +NL++N L
Sbjct: 212 LDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNL 267

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 47.1 bits (112), Expect = 8e-06
 Identities = 20/56 (35%), Positives = 30/56 (53%), Gaps = 2/56 (3%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L   + +  IP +L  L  L ELDLS N+LS   P  F  L+ L+ L +  +++
Sbjct: 190 LNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI 243

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 17/57 (29%), Positives = 24/57 (42%), Gaps = 2/57 (3%)

Query: 1   LYLGNNSFKGTIPV-SLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L  N  + TI + +   L  L  L+L  N L+      F  L  L+ L L  N +
Sbjct: 93  LQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPI 148

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 44.0 bits (104), Expect = 9e-05
 Identities = 20/58 (34%), Positives = 27/58 (46%), Gaps = 3/58 (5%)

Query: 1   LYLGNNSFKGTIPVSL-KSLRGLAELDLS-CNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L+L NN  + +IP      +  L  LDL     LS      F  L +LR+LNL+   L
Sbjct: 141 LWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL 197

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 21/69 (30%), Positives = 30/69 (43%), Gaps = 5/69 (7%)

Query: 1   LYLGNNSFKGTIPV-SLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGE 59
           L LG       I   + + L  L  L+L+  NL  ++P   + L+ L  L+LS N L   
Sbjct: 165 LDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS-A 221

Query: 60  ISREGIFAN 68
           I   G F  
Sbjct: 222 IR-PGSFQG 229

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 22/105 (20%), Positives = 45/105 (42%), Gaps = 5/105 (4%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L +N     +  +      L  L L  N++   +    S   +L++L LS+N+ D   
Sbjct: 306 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD-CN 360

Query: 61  SREGIFANASAISIVGNDKLCGGIQKLQLPECSRKNPRKRLSLKI 105
           S   +F N +  ++   D+ C    +L+   C +++ +  L   +
Sbjct: 361 SLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLL 405

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 48.0 bits (114), Expect = 5e-06
 Identities = 16/56 (28%), Positives = 27/56 (48%), Gaps = 2/56 (3%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           LY+ NN     + +  + +  L  LDLS N+L   V +   +   L +L L +N +
Sbjct: 283 LYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI 336

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 47.2 bits (112), Expect = 9e-06
 Identities = 13/56 (23%), Positives = 26/56 (46%), Gaps = 1/56 (1%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           + L  N  +  +      ++ L  L +S N L   +  +   + +L+ L+LS+N L
Sbjct: 259 VDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL 313

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 16/68 (23%), Positives = 26/68 (38%), Gaps = 2/68 (2%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L +   +     +      + +L +  N +    P  F  +  L  L L  N+L   +
Sbjct: 80  LNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SL 138

Query: 61  SREGIFAN 68
            R GIF N
Sbjct: 139 PR-GIFHN 145

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 44.1 bits (104), Expect = 7e-05
 Identities = 11/71 (15%), Positives = 28/71 (39%), Gaps = 2/71 (2%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           +   N++ +      L S R +  L+L+   +       F+   +++ L + +N +   +
Sbjct: 56  VTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YL 114

Query: 61  SREGIFANASA 71
               +F N   
Sbjct: 115 P-PHVFQNVPL 124

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 19/56 (33%), Positives = 26/56 (46%), Gaps = 2/56 (3%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L +N+        L +  GL E+DLS N L   +   F K+  L  L +S N L
Sbjct: 237 LKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL 290

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 18/57 (31%), Positives = 25/57 (43%), Gaps = 2/57 (3%)

Query: 1   LYLGNNSFKGTIPVSL-KSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L  N    ++P  +  +   L  L +S NNL       F    SL++L LS N L
Sbjct: 128 LVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL 183

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 41.1 bits (96), Expect = 7e-04
 Identities = 10/68 (14%), Positives = 24/68 (35%), Gaps = 5/68 (7%)

Query: 3  LGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISR 62
             + + G   ++L + +    +    + +             +  LNL+  +++ EI  
Sbjct: 37 QTQDVYFGFEDITLNNQK---IVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EID- 91

Query: 63 EGIFANAS 70
             FA A 
Sbjct: 92 TYAFAYAH 99

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 48.3 bits (115), Expect = 3e-06
 Identities = 20/68 (29%), Positives = 31/68 (45%), Gaps = 4/68 (5%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L + +N  +       K  + L  LDLS N L  K+       ++L+HL+LS+N  D  +
Sbjct: 50  LIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFD-AL 105

Query: 61  SREGIFAN 68
                F N
Sbjct: 106 PICKEFGN 113

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 44.1 bits (104), Expect = 7e-05
 Identities = 17/56 (30%), Positives = 28/56 (50%), Gaps = 3/56 (5%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L + +N    TI   L     +  LDL  N +   +P+   KL +L+ LN++ N+L
Sbjct: 404 LNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL 456

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 43.7 bits (103), Expect = 9e-05
 Identities = 15/56 (26%), Positives = 23/56 (41%)

Query: 1  LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
          L +  N         + SL  L  L +S N +       F     L +L+LS+N+L
Sbjct: 26 LNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 12/56 (21%), Positives = 19/56 (33%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
                +  +    +    +     LD S N L+  V +    L  L  L L  N+L
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL 360

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 18/60 (30%), Positives = 27/60 (45%), Gaps = 5/60 (8%)

Query: 1   LYLGNNSFKGTIPVS---LKSLRGLAELDLSCNNLSGKVPQ-FFSKLLSLRHLNLSYNEL 56
           L L  N  K  +         ++ L +LD+S N++S    +   S   SL  LN+S N L
Sbjct: 353 LILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL 411

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 41.8 bits (98), Expect = 4e-04
 Identities = 16/58 (27%), Positives = 27/58 (46%), Gaps = 2/58 (3%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLS--GKVPQFFSKLLSLRHLNLSYNEL 56
           L   NN    T+  +   L  L  L L  N L    K+ +  +++ SL+ L++S N +
Sbjct: 329 LDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSV 386

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 48.0 bits (114), Expect = 4e-06
 Identities = 41/194 (21%), Positives = 74/194 (38%), Gaps = 23/194 (11%)

Query: 165 IGSGSFGSVYKG-TLADGETAAIKVLKLQQQGALKSFIDECNALTSIR-----HRNILKI 218
           +G G F +V+    +   +  A+KV+K  +    ++ +DE   L S+R       N   +
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPNDPNREMV 103

Query: 219 VSSCSSVDYEGNDFK--ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           V         G +     +VFE + + +L +W+        +++ L L     I+  V  
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGH-HLLKWI-----IKSNYQGLPLPCVKKIIQQVLQ 157

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            LDYLH +    I H D+K  N+LL       V +  + +   E +          +G  
Sbjct: 158 GLDYLHTKCR--IIHTDIKPENILL------SVNEQYIRRLAAEATEWQRSGAPPPSGSA 209

Query: 337 GSVGYIPPEYINGH 350
            S           +
Sbjct: 210 VSTAPATAGNFLVN 223

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 18/57 (31%), Positives = 27/57 (47%), Gaps = 2/57 (3%)

Query: 1   LYLGNNSFKGTIPV-SLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           LYL +N+ +  +P  + + L  L  L L  N +S    + F  L SL  L L  N +
Sbjct: 134 LYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 17/68 (25%), Positives = 25/68 (36%), Gaps = 1/68 (1%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           ++L  N        S ++ R L  L L  N L+      F+ L  L  L+LS N     +
Sbjct: 37  IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSV 96

Query: 61  SREGIFAN 68
                F  
Sbjct: 97  D-PATFHG 103

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 17/69 (24%), Positives = 28/69 (40%), Gaps = 3/69 (4%)

Query: 1   LYLGNNSFKGTIPVS-LKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGE 59
           L L +N+   ++  +    L  L  L L    L    P  F  L +L++L L  N L   
Sbjct: 85  LDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-A 143

Query: 60  ISREGIFAN 68
           +  +  F +
Sbjct: 144 LP-DDTFRD 151

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 16/56 (28%), Positives = 21/56 (37%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L+L  N        + + L  L  L L  N ++   P  F  L  L  L L  N L
Sbjct: 158 LFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 40.7 bits (96), Expect = 6e-04
 Identities = 17/54 (31%), Positives = 25/54 (46%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYN 54
           L L  N      P + + L  L  L L  NNLS    +  + L +L++L L+ N
Sbjct: 182 LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 47.2 bits (112), Expect = 9e-06
 Identities = 15/61 (24%), Positives = 25/61 (40%), Gaps = 5/61 (8%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L + +N+   ++P     LR    L++S N L+  +P     LL L   +     L    
Sbjct: 66  LVIPDNNLT-SLPALPPELR---TLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALP 120

Query: 61  S 61
           S
Sbjct: 121 S 121

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 14/56 (25%), Positives = 24/56 (42%), Gaps = 5/56 (8%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L +  N    ++P+    L     L +  N L+ ++P+    L S   +NL  N L
Sbjct: 246 LMVSGNRLT-SLPMLPSGLL---SLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL 296

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 41.0 bits (96), Expect = 7e-04
 Identities = 12/56 (21%), Positives = 20/56 (35%), Gaps = 8/56 (14%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L +  N    ++PV    L  L+       +L   +P        L  L +  N+L
Sbjct: 86  LEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPS------GLCKLWIFGNQL 133

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 45.0 bits (107), Expect = 1e-05
 Identities = 23/56 (41%), Positives = 29/56 (51%), Gaps = 1/56 (1%)

Query: 1  LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
          LYL  N F   +P  L + + L  +DLS N +S    Q FS +  L  L LSYN L
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 39.6 bits (93), Expect = 9e-04
 Identities = 24/74 (32%), Positives = 35/74 (47%), Gaps = 4/74 (5%)

Query: 1   LYLGNNSFKGTIPVSL-KSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGE 59
           + L NN    T+      ++  L  L LS N L    P+ F  L SLR L+L  N++   
Sbjct: 59  IDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-V 116

Query: 60  ISREGIFANASAIS 73
           +   G F + SA+S
Sbjct: 117 VPE-GAFNDLSALS 129

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 46.0 bits (110), Expect = 1e-05
 Identities = 16/56 (28%), Positives = 24/56 (42%), Gaps = 2/56 (3%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L +G+N         L +L  L  L L+ N L  +  +    L +L  L LS N +
Sbjct: 270 LNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHI 323

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 46.0 bits (110), Expect = 1e-05
 Identities = 12/56 (21%), Positives = 22/56 (39%), Gaps = 2/56 (3%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L+L NN         +  L  L  L LS N+++   P   + L  +   + +   +
Sbjct: 292 LFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 44.1 bits (105), Expect = 5e-05
 Identities = 19/61 (31%), Positives = 30/61 (49%), Gaps = 4/61 (6%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           LY+G N    T   +L++L  L EL L+ +N+S       + L  +  LNL  N    ++
Sbjct: 93  LYIGTNKI--TDISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDL 148

Query: 61  S 61
           S
Sbjct: 149 S 149

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 43.3 bits (103), Expect = 1e-04
 Identities = 12/56 (21%), Positives = 25/56 (44%), Gaps = 3/56 (5%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           LYL  ++     P  L +L  +  L+L  N+         S +  L +L ++ +++
Sbjct: 115 LYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKV 167

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 42.9 bits (102), Expect = 1e-04
 Identities = 9/56 (16%), Positives = 19/56 (33%), Gaps = 4/56 (7%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
                N      P  + ++  L  L +  N ++       + L  L  L +  N++
Sbjct: 204 FTAYVNQITDITP--VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQI 255

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 42.9 bits (102), Expect = 1e-04
 Identities = 14/56 (25%), Positives = 22/56 (39%), Gaps = 4/56 (7%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L  N      P  L +L  L  L +  N ++         L +LR L L+ + +
Sbjct: 71  LNLNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNI 122

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 42.9 bits (102), Expect = 2e-04
 Identities = 16/56 (28%), Positives = 25/56 (44%), Gaps = 4/56 (7%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L +GNN      P  L +L  L  L++  N +S         L  L+ LN+  N++
Sbjct: 226 LKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQI 277

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 42.5 bits (101), Expect = 2e-04
 Identities = 17/63 (26%), Positives = 26/63 (41%), Gaps = 4/63 (6%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L +G N     I  ++K L  L  L++  N +S       + L  L  L L+ N+L  E 
Sbjct: 248 LEIGTNQIS-DIN-AVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNED 303

Query: 61  SRE 63
              
Sbjct: 304 MEV 306

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 42.1 bits (100), Expect = 2e-04
 Identities = 13/56 (23%), Positives = 21/56 (37%), Gaps = 4/56 (7%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L  N  +   P  L SL  L       N ++   P   + +  L  L +  N++
Sbjct: 182 LSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKI 233

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 41.0 bits (97), Expect = 6e-04
 Identities = 11/58 (18%), Positives = 24/58 (41%), Gaps = 4/58 (6%)

Query: 1  LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDG 58
            L   S    +    + L  + +L ++   ++    Q    L +L +LNL+ N++  
Sbjct: 27 AVLQKASVTDVVT--QEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITD 80

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 16/57 (28%), Positives = 26/57 (45%), Gaps = 2/57 (3%)

Query: 1   LYLGNNSFKGTIPV-SLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           + L NN     +   + + LR L  L L  N ++      F  L SL+ L L+ N++
Sbjct: 61  IDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKI 116

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 42.3 bits (100), Expect = 1e-04
 Identities = 18/57 (31%), Positives = 26/57 (45%), Gaps = 2/57 (3%)

Query: 1   LYLGNNSFKGTIPVSL-KSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L  N     +P SL + L  L  L L+ N ++      F  L +L  L+L  N+L
Sbjct: 85  LVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKL 140

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 18/56 (32%), Positives = 26/56 (46%)

Query: 1  LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
          + L  N+ K   P +    + L  +DLS N +S   P  F  L SL  L L  N++
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 44.6 bits (106), Expect = 5e-05
 Identities = 13/56 (23%), Positives = 23/56 (41%), Gaps = 4/56 (7%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L  N+     P  + SL  L  L    N +S       + L ++  L+  +N++
Sbjct: 314 LTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQI 365

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 43.4 bits (103), Expect = 1e-04
 Identities = 17/56 (30%), Positives = 25/56 (44%), Gaps = 4/56 (7%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L  N  +   P  + +L+ L  L L  NN+S   P   S L  L+ L    N++
Sbjct: 292 LELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV 343

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 42.6 bits (101), Expect = 2e-04
 Identities = 20/58 (34%), Positives = 26/58 (44%), Gaps = 4/58 (6%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDG 58
           L L  N  K     +L SL  L +LDL+ N +S   P   S L  L  L L  N++  
Sbjct: 226 LSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN 279

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 13/56 (23%), Positives = 25/56 (44%), Gaps = 4/56 (7%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           +   NN      P  LK+L  L ++ ++ N ++       + L +L  L L  N++
Sbjct: 73  INFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQI 124

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 15/56 (26%), Positives = 22/56 (39%), Gaps = 4/56 (7%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           + + NN      P  L +L  L  L L  N ++         L +L  L LS N +
Sbjct: 95  ILMNNNQIADITP--LANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTI 146

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 11/58 (18%), Positives = 18/58 (31%), Gaps = 4/58 (6%)

Query: 1  LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDG 58
            LG  +   T+      L  +  L      +          L +L  +N S N+L  
Sbjct: 29 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTD 82

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 41.5 bits (98), Expect = 4e-04
 Identities = 10/56 (17%), Positives = 21/56 (37%), Gaps = 4/56 (7%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L              ++ L  L +++ S N L+   P     L  L  + ++ N++
Sbjct: 51  LQADRL--GIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 102

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 41.5 bits (98), Expect = 5e-04
 Identities = 20/58 (34%), Positives = 27/58 (46%), Gaps = 4/58 (6%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDG 58
           L L NN      P  L  L  L EL L  N +S   P   + L +L +L L+ N+L+ 
Sbjct: 248 LDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED 301

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 41.1 bits (97), Expect = 7e-04
 Identities = 18/56 (32%), Positives = 24/56 (42%), Gaps = 4/56 (7%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L LG N      P  L  L  L  L+L+ N L        S L +L +L L +N +
Sbjct: 270 LKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNI 321

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 44.6 bits (106), Expect = 5e-05
 Identities = 16/56 (28%), Positives = 24/56 (42%), Gaps = 5/56 (8%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L N     ++P     L     L  SCN+L+ ++P+    L SL   N +   L
Sbjct: 76  LELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 126

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 14/56 (25%), Positives = 22/56 (39%), Gaps = 6/56 (10%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           + + NNS K  +P    SL     +    N L  ++P+    L  L  +    N L
Sbjct: 158 IDVDNNSLK-KLPDLPPSLE---FIAAGNNQLE-ELPEL-QNLPFLTAIYADNNSL 207

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 41.5 bits (98), Expect = 4e-04
 Identities = 14/56 (25%), Positives = 23/56 (41%), Gaps = 6/56 (10%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           +  GNN  +  +P  L++L  L  +    N+L     +     LSL  +    N L
Sbjct: 178 IAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK----KLPDLPLSLESIVAGNNIL 227

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 41.5 bits (98), Expect = 5e-04
 Identities = 13/56 (23%), Positives = 24/56 (42%), Gaps = 6/56 (10%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L + NN  +  +P  L++   L  +D+  N+L     +      SL  +    N+L
Sbjct: 136 LGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK----KLPDLPPSLEFIAAGNNQL 185

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 41.1 bits (97), Expect = 6e-04
 Identities = 15/56 (26%), Positives = 23/56 (41%), Gaps = 8/56 (14%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L    NS    +P   +SL+ L   + +   LS   P        L +L +S N+L
Sbjct: 96  LVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQL 143

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 40.7 bits (96), Expect = 8e-04
 Identities = 15/56 (26%), Positives = 22/56 (39%), Gaps = 6/56 (10%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           +Y  NNS K  +P    SL     +    N L  ++P+    L  L  +    N L
Sbjct: 200 IYADNNSLK-KLPDLPLSLE---SIVAGNNILE-ELPE-LQNLPFLTTIYADNNLL 249

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 44.4 bits (104), Expect = 7e-05
 Identities = 18/56 (32%), Positives = 25/56 (44%), Gaps = 3/56 (5%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L+L +     T+   L+ L  +  LDLS N L   +P   + L  L  L  S N L
Sbjct: 446 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNAL 498

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 44.0 bits (103), Expect = 1e-04
 Identities = 19/57 (33%), Positives = 26/57 (45%), Gaps = 3/57 (5%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELD 57
           L L +N  +  +P +L +LR L  L  S N L   V    + L  L+ L L  N L 
Sbjct: 468 LDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQ 521

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 43.6 bits (103), Expect = 7e-05
 Identities = 18/56 (32%), Positives = 28/56 (50%), Gaps = 1/56 (1%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L +N  + ++P+  ++L  L  LD+S N L+         L  L+ L L  NEL
Sbjct: 82  LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL 136

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 43.6 bits (103), Expect = 7e-05
 Identities = 22/71 (30%), Positives = 30/71 (42%), Gaps = 4/71 (5%)

Query: 1   LYLGNNSFKGTIPVSL-KSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGE 59
           LYL  N  K T+P  L      L +L L+ NNL+       + L +L  L L  N L   
Sbjct: 129 LYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL--Y 185

Query: 60  ISREGIFANAS 70
              +G F +  
Sbjct: 186 TIPKGFFGSHL 196

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 18/56 (32%), Positives = 25/56 (44%), Gaps = 3/56 (5%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L        + V   +L  L  LDLS N L   +P     L +L  L++S+N L
Sbjct: 60  LNLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRL 112

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 16/56 (28%), Positives = 24/56 (42%), Gaps = 2/56 (3%)

Query: 1  LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
          L+L  N        +L     L +L+L    L+    Q    L  L  L+LS+N+L
Sbjct: 36 LHLSENLLYTFSLATLMPYTRLTQLNLDRAELT--KLQVDGTLPVLGTLDLSHNQL 89

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 43.0 bits (102), Expect = 1e-04
 Identities = 15/56 (26%), Positives = 20/56 (35%)

Query: 1  LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
          L L  N  +     S  S   L  LDLS   +       +  L  L  L L+ N +
Sbjct: 33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 41.5 bits (98), Expect = 4e-04
 Identities = 18/57 (31%), Positives = 32/57 (56%), Gaps = 1/57 (1%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNL-SGKVPQFFSKLLSLRHLNLSYNEL 56
           L     +        +  L+ L EL+++ N + S K+P++FS L +L HL+LS N++
Sbjct: 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 40.7 bits (96), Expect = 6e-04
 Identities = 17/57 (29%), Positives = 23/57 (40%), Gaps = 2/57 (3%)

Query: 1   LYLGNNSFKGTIPVSL-KSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L L     + TI     +SL  L+ L L+ N +       FS L SL+ L      L
Sbjct: 57  LDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL 112

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 42.3 bits (100), Expect = 1e-04
 Identities = 15/57 (26%), Positives = 26/57 (45%), Gaps = 2/57 (3%)

Query: 1   LYLGNNSFKGTIPVSL-KSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           + L +N  +  +   + K L  L  L L  N ++      F  L S+R L+L  N++
Sbjct: 86  ILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI 141

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 15/57 (26%), Positives = 24/57 (42%), Gaps = 2/57 (3%)

Query: 1   LYLGNNSFKGTIPV-SLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           +   NN     I   + +   G+ E+ L+ N L     + F  L SL+ L L  N +
Sbjct: 62  INFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRI 117

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 15/56 (26%), Positives = 23/56 (41%), Gaps = 8/56 (14%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           +   NN     +P    SL     L +  N L+  +P+      SL  L++S N L
Sbjct: 145 INADNNQLT-MLPELPTSLE---VLSVRNNQLT-FLPELPE---SLEALDVSTNLL 192

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 41.1 bits (96), Expect = 7e-04
 Identities = 17/56 (30%), Positives = 28/56 (50%), Gaps = 8/56 (14%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L +  N+   ++P    SL     LD   N LS  +P+  +   SL+HL++  N+L
Sbjct: 85  LEITQNALI-SLPELPASLE---YLDACDNRLS-TLPELPA---SLKHLDVDNNQL 132

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 39.3 bits (92), Expect = 5e-04
 Identities = 20/57 (35%), Positives = 28/57 (49%), Gaps = 2/57 (3%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELD 57
           L   N     +I   L  L  L +L+LS N +SG +     K  +L HLNLS N++ 
Sbjct: 47  LSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 41.1 bits (95), Expect = 6e-04
 Identities = 13/66 (19%), Positives = 26/66 (39%), Gaps = 7/66 (10%)

Query: 1   LYLGNNSFKGTIPVSL---KSLRGLAELDLSCNNLSGK----VPQFFSKLLSLRHLNLSY 53
           L + +   +  +         L  L  +D+S   L+ +    +     K+  L+ +N+ Y
Sbjct: 257 LGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKY 316

Query: 54  NELDGE 59
           N L  E
Sbjct: 317 NYLSDE 322

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 40.6 bits (95), Expect = 7e-04
 Identities = 14/58 (24%), Positives = 25/58 (43%), Gaps = 2/58 (3%)

Query: 1   LYLGNNSFKGTIPVS-LKSLRGLAELDLS-CNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           + +  N     I      +L  L E+ +   NNL    P+ F  L +L++L +S   +
Sbjct: 59  IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI 116

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 39.7 bits (93), Expect = 7e-04
 Identities = 18/89 (20%), Positives = 35/89 (39%), Gaps = 18/89 (20%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L+      +  +  +L +L+    L LS NN+  K+    S + +LR L+L  N +    
Sbjct: 30  LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK--- 83

Query: 61  SREGIFANASAISIVGNDKLCGGIQKLQL 89
                        I   D +   +++L +
Sbjct: 84  ------------KIENLDAVADTLEELWI 100

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	477
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.81
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.71
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.49
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.34
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.24
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.22
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.22
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.16
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.15
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.15
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.09
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.07
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.05
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.04
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.04
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.0
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	98.97
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	98.95
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	98.92
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	98.92
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	98.91
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	98.91
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	98.91
3e6j_A	229	Variable lymphocyte receptor diversity region; var	98.89
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.86
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	98.85
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	98.85
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	98.85
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	98.84
3m19_A	251	Variable lymphocyte receptor A diversity region; a	98.82
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	98.81
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	98.81
3e6j_A	229	Variable lymphocyte receptor diversity region; var	98.8
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	98.8
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	98.79
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	98.78
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	98.78
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.77
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	98.77
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	98.76
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	98.76
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.75
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	98.74
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.73
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.73
3m19_A	251	Variable lymphocyte receptor A diversity region; a	98.72
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	98.71
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	98.71
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	98.71
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	98.69
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	98.69
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	98.69
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	98.68
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	98.67
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	98.67
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	98.67
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	98.67
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	98.65
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	98.64
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	98.64
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	98.63
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	98.63
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	98.62
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	98.61
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	98.61
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	98.61
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.59
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	98.59
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	98.58
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.57
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	98.57
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	98.56
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	98.56
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	98.54
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	98.54
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	98.54
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	98.53
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	98.53
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	98.53
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	98.53
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	98.53
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	98.53
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	98.52
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	98.52
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	98.5
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	98.5
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	98.5
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	98.49
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	98.48
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	98.48
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	98.47
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	98.47
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	98.47
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	98.47
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	98.46
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	98.45
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	98.45
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	98.45
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	98.44
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	98.44
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	98.43
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	98.42
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	98.41
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	98.4
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.4
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.39
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.38
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	98.38
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	98.38
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	98.37
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	98.37
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	98.37
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	98.36
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	98.36
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	98.34
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	98.34
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	98.33
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	98.32
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	98.31
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.31
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	98.27
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	98.27
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	98.25
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	98.25
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.24
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	98.2
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	98.2
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	98.19
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	98.18
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	98.14
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	98.12
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	98.09
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	98.06
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	98.05
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	98.05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	98.04
1o6v_A	466	Internalin A; bacterial infection, extracellular r	98.03
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	98.01
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	98.01
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	98.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	97.98
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.98
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	97.98
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	97.97
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	97.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	97.96
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	97.95
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.91
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.89
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	97.89
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	97.87
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.67
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.59
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	97.49
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.45
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.4
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.37
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	97.31
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.3
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.29
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	97.24
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.16
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.16
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	97.14
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.05
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.05
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	96.99
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.95
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.75
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	96.7
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.61
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.52
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	96.43
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	96.43
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	96.41
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	96.33
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	96.02
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	95.87
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.44
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	95.13
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	93.99
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.0
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	92.59
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	92.03
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	91.93
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	90.28
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	86.65
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	86.37
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	85.65
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	84.51
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	81.79
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	81.17

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.2e-58  Score=436.29  Aligned_cols=264  Identities=28%  Similarity=0.478  Sum_probs=209.5

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC------CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      ++|...+.||+|+||.||+|++.      ++..||||+++.......++|.+|+++|++++|||||+++|+|     .++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~-----~~~   87 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC-----VEG   87 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEE-----eeC
Confidence            46777889999999999999864      4778999999877666678899999999999999999999997     446


Q ss_pred             ceeeEEEeecCCCChhhhcccCCC------cccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTD------EYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG  304 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~  304 (477)
                      +..++|||||++|+|.++|+....      .......++|.+++.|+.|||+||.|||++   +|+||||||+|||++++
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN  164 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC
Confidence            678999999999999999975421      011235799999999999999999999999   99999999999999999


Q ss_pred             CcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCccccccc
Q 043902          305 MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL  382 (477)
Q Consensus       305 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~  382 (477)
                      +.+||+|||+|+......     .........||+.|+|||++ .+.++.++|||||||++|||+| |+.||....... 
T Consensus       165 ~~~Ki~DFGla~~~~~~~-----~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~-  238 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTD-----YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-  238 (299)
T ss_dssp             GCEEECCCSCHHHHTGGG-----CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-
T ss_pred             CcEEECCcccceecCCCC-----ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-
Confidence            999999999998763211     12223345689999999999 6789999999999999999999 899997642211 


Q ss_pred             ceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHH
Q 043902          383 SIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVV  462 (477)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl  462 (477)
                                   +...+.......                        .++.|+..+.+|+.+||+.||++||||+||+
T Consensus       239 -------------~~~~i~~~~~~~------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~  281 (299)
T 4asz_A          239 -------------VIECITQGRVLQ------------------------RPRTCPQEVYELMLGCWQREPHMRKNIKGIH  281 (299)
T ss_dssp             -------------HHHHHHHTCCCC------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             -------------HHHHHHcCCCCC------------------------CCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence                         111111100000                        0012344588999999999999999999999


Q ss_pred             HHHHHHHHh
Q 043902          463 NNLQAIRSK  471 (477)
Q Consensus       463 ~~L~~i~~~  471 (477)
                      +.|+++.+.
T Consensus       282 ~~L~~~~~~  290 (299)
T 4asz_A          282 TLLQNLAKA  290 (299)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHhc
Confidence            999998764

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=9.2e-58  Score=437.96  Aligned_cols=264  Identities=27%  Similarity=0.464  Sum_probs=203.8

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC------CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      ++|...+.||+|+||.||+|++.      +++.||||+++.......+.|.+|+++|++++|||||+++|+|     .+.
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~-----~~~  115 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVC-----TEG  115 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EEC
Confidence            45667789999999999999864      4788999999877666778999999999999999999999997     445


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCc--------ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDE--------YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD  302 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~--------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~  302 (477)
                      +..++|||||++|+|.++++.....        ......++|.+++.|+.|||+||.|||++   +|+||||||+||||+
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG  192 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEEC
Confidence            6789999999999999999764321        11225699999999999999999999999   999999999999999


Q ss_pred             CCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCccccc
Q 043902          303 EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKD  380 (477)
Q Consensus       303 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~  380 (477)
                      +++.+||+|||+|+......     .........||+.|||||++ .+.++.++|||||||++|||+| |+.||......
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~-----~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~  267 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTD-----YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT  267 (329)
T ss_dssp             TTTEEEECCCC---------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH
T ss_pred             CCCcEEEcccccceeccCCC-----cceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH
Confidence            99999999999998763211     12223446799999999999 5679999999999999999999 89999753221


Q ss_pred             ccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHH
Q 043902          381 DLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKF  460 (477)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e  460 (477)
                      .              +.+.+......             ..           ++.|+..+.+|+.+||+.||++||||+|
T Consensus       268 ~--------------~~~~i~~g~~~-------------~~-----------p~~~~~~~~~li~~cl~~dP~~RPs~~e  309 (329)
T 4aoj_A          268 E--------------AIDCITQGREL-------------ER-----------PRACPPEVYAIMRGCWQREPQQRHSIKD  309 (329)
T ss_dssp             H--------------HHHHHHHTCCC-------------CC-----------CTTCCHHHHHHHHHHCCSSTTTSCCHHH
T ss_pred             H--------------HHHHHHcCCCC-------------CC-----------cccccHHHHHHHHHHcCcChhHCcCHHH
Confidence            1              11111110000             00           0122445889999999999999999999


Q ss_pred             HHHHHHHHHHh
Q 043902          461 VVNNLQAIRSK  471 (477)
Q Consensus       461 vl~~L~~i~~~  471 (477)
                      |++.|+.+.+.
T Consensus       310 i~~~L~~l~~~  320 (329)
T 4aoj_A          310 VHARLQALAQA  320 (329)
T ss_dssp             HHHHHHHHHHS
T ss_pred             HHHHHHHHhhC
Confidence            99999998764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.6e-57  Score=428.88  Aligned_cols=262  Identities=29%  Similarity=0.488  Sum_probs=202.6

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .+++...+.||+|+||+||+|+++  ..||||+++...  ....+.|.+|++++++++|||||+++|+|.      .+..
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~------~~~~  106 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT------KDNL  106 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSC
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE------CCeE
Confidence            357778889999999999999975  369999997443  344578999999999999999999999873      2457


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++|||||++|+|.++|+...      ..+++.+++.|+.|||+||+|||++   +|+||||||+||||++++.+||+|||
T Consensus       107 ~iVmEy~~gGsL~~~l~~~~------~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFG  177 (307)
T 3omv_A          107 AIVTQWCEGSSLYKHLHVQE------TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFG  177 (307)
T ss_dssp             EEEEECCSSCBHHHHHHTSC------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCS
T ss_pred             EEEEEcCCCCCHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeecc
Confidence            99999999999999997543      4699999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCccccc----CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN----GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      +|+.....     ..........||+.|||||++.    +.++.++|||||||++|||+||+.||.......        
T Consensus       178 la~~~~~~-----~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~--------  244 (307)
T 3omv_A          178 LATVKSRW-----SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD--------  244 (307)
T ss_dssp             SCBC-----------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--------
T ss_pred             CceecccC-----CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH--------
Confidence            99865321     1122234567999999999983    358999999999999999999999997532111        


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIR  469 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  469 (477)
                           .+...+.......            ..+.        ....|+..+.+|+.+||+.||++||||.||++.|+.|+
T Consensus       245 -----~~~~~~~~~~~~p------------~~~~--------~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          245 -----QIIFMVGRGYASP------------DLSK--------LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             -----HHHHHHHTTCCCC------------CSTT--------SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             -----HHHHHHhcCCCCC------------Cccc--------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence                 0111111100000            0000        00123445889999999999999999999999999987


Q ss_pred             Hhh
Q 043902          470 SKI  472 (477)
Q Consensus       470 ~~~  472 (477)
                      ..+
T Consensus       300 ~~l  302 (307)
T 3omv_A          300 HSL  302 (307)
T ss_dssp             TTC
T ss_pred             ccC
Confidence            654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.8e-57  Score=431.84  Aligned_cols=260  Identities=23%  Similarity=0.399  Sum_probs=205.0

Q ss_pred             CCCCCCeeeeeccceEEEEEeC------CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      +++..+.||+|+||.||+|++.      +++.||||+++... ....+.|.+|+.++++++|||||+++|+|     ..+
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~-----~~~  101 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV-----TKD  101 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSS
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEE-----EEC
Confidence            4456788999999999999863      46789999997543 33457899999999999999999999997     345


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCc---------ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDE---------YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL  301 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll  301 (477)
                      +..++|||||++|+|.++|......         ......++|..++.|+.|||+||.|||++   +|+||||||+||||
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl  178 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV  178 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEE
Confidence            6789999999999999999654211         11235689999999999999999999999   99999999999999


Q ss_pred             cCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccc
Q 043902          302 DEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFK  379 (477)
Q Consensus       302 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~  379 (477)
                      ++++.+||+|||+|+.....+     .........||+.|+|||++ .+.++.++|||||||++|||+| |+.||.....
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~-----~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~  253 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAAD-----YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN  253 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGG-----CBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH
T ss_pred             CCCCCEEECCcccceeccCCC-----ceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999998764321     12233456799999999999 6789999999999999999999 8999976422


Q ss_pred             cccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChH
Q 043902          380 DDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMK  459 (477)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~  459 (477)
                      .              .+.+.+......                        +.++.|+..+.+|+.+||+.||++||||+
T Consensus       254 ~--------------~~~~~i~~~~~~------------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~  295 (308)
T 4gt4_A          254 Q--------------DVVEMIRNRQVL------------------------PCPDDCPAWVYALMIECWNEFPSRRPRFK  295 (308)
T ss_dssp             H--------------HHHHHHHTTCCC------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             H--------------HHHHHHHcCCCC------------------------CCcccchHHHHHHHHHHcCCChhHCcCHH
Confidence            1              111111111000                        00112345588999999999999999999


Q ss_pred             HHHHHHHHH
Q 043902          460 FVVNNLQAI  468 (477)
Q Consensus       460 evl~~L~~i  468 (477)
                      ||++.|+.+
T Consensus       296 ei~~~L~a~  304 (308)
T 4gt4_A          296 DIHSRLRAW  304 (308)
T ss_dssp             HHHHHHHTS
T ss_pred             HHHHHHHhc
Confidence            999999754

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.7e-55  Score=416.21  Aligned_cols=286  Identities=22%  Similarity=0.288  Sum_probs=201.9

Q ss_pred             cCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEE
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALV  236 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  236 (477)
                      ++|...+.||+|+||.||+|++ +|+.||||+++...... ..+..|+..+.+++|||||+++++|.... ......++|
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~-~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhh-HHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEE
Confidence            3566778999999999999998 58999999997543321 23345666677899999999999985321 122468999


Q ss_pred             EeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeeecCCCCCCeEecCCCcEEEec
Q 043902          237 FEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQY-----DTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       237 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ||||++|+|.++|+..        .++|..+++++.|+++||+|||+++     .++|+||||||+||||+.++.+||+|
T Consensus        80 ~Ey~~~gsL~~~l~~~--------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D  151 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRY--------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  151 (303)
T ss_dssp             EECCTTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             ecCCCCCcHHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence            9999999999999743        4899999999999999999999762     45899999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccccC-------CCCcccceeehHHHHHHHhhCCCCCCcccccccce
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-------HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSI  384 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~  384 (477)
                      ||+|+.......   ..........||+.|+|||++.+       .++.++|||||||++|||+||..||.........+
T Consensus       152 FGla~~~~~~~~---~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~  228 (303)
T 3hmm_A          152 LGLAVRHDSATD---TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             CTTCEEEETTTT---EESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             CCCCccccCCCC---ceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc
Confidence            999987632111   11112334579999999999844       36789999999999999999998876533222111


Q ss_pred             eeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          385 HKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       385 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                      ........  ...++......            +...|.+....   ...+++..+.+|+.+||+.||++||||.||++.
T Consensus       229 ~~~~~~~~--~~~~~~~~~~~------------~~~rp~~p~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          229 YDLVPSDP--SVEEMRKVVCE------------QKLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             TTTSCSSC--CHHHHHHHHTT------------SCCCCCCCGGG---GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             hhcccccc--hHHHHHHHHhc------------ccCCCCCCccc---cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            11110000  11111100000            00001111000   011235568899999999999999999999999


Q ss_pred             HHHHHHhhh
Q 043902          465 LQAIRSKIR  473 (477)
Q Consensus       465 L~~i~~~~~  473 (477)
                      |++|.++..
T Consensus       292 L~~l~~~~~  300 (303)
T 3hmm_A          292 LSQLSQQEG  300 (303)
T ss_dssp             HHHHHHC--
T ss_pred             HHHHHHHcC
Confidence            999987643

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.8e-55  Score=411.13  Aligned_cols=250  Identities=24%  Similarity=0.383  Sum_probs=195.1

Q ss_pred             CCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEE
Q 043902          160 SEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALV  236 (477)
Q Consensus       160 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  236 (477)
                      ...+.||+|+||.||+|... ++..||+|++....  ....+.|.+|++++++++|||||+++++|.... ..+...++|
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~lv  107 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEEE
Confidence            45567999999999999875 68999999997542  334578999999999999999999999864321 234568999


Q ss_pred             EeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC-CCcEEEeccccc
Q 043902          237 FEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE-GMIAHVGDFGLA  315 (477)
Q Consensus       237 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~DfG~a  315 (477)
                      ||||++|+|.+++...       ..+++..+..++.||+.||+|||++ .++|+||||||+|||++. ++.+||+|||+|
T Consensus       108 mEy~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla  179 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EeCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence            9999999999999753       5689999999999999999999998 123999999999999984 789999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccccCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCch
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSH  395 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  395 (477)
                      +...         ........||+.|||||++.++++.++|||||||++|||+||+.||.......             .
T Consensus       180 ~~~~---------~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-------------~  237 (290)
T 3fpq_A          180 TLKR---------ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAA-------------Q  237 (290)
T ss_dssp             GGCC---------TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-------------H
T ss_pred             EeCC---------CCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-------------H
Confidence            7541         12233467999999999998889999999999999999999999996532111             0


Q ss_pred             hHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          396 VMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       396 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      +...+.......            ..+           ..+...+.+|+.+||+.||++|||++|+++
T Consensus       238 ~~~~i~~~~~~~------------~~~-----------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          238 IYRRVTSGVKPA------------SFD-----------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHHHHTTTCCCG------------GGG-----------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHcCCCCC------------CCC-----------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111110000000            000           001223788999999999999999999975

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.2e-55  Score=423.66  Aligned_cols=271  Identities=23%  Similarity=0.411  Sum_probs=212.1

Q ss_pred             HHhhcCCCCCCeeeeeccceEEEEEeC------CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCC-CCcceeeeeccc
Q 043902          153 SNATDNFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRH-RNILKIVSSCSS  224 (477)
Q Consensus       153 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~  224 (477)
                      +...++|+..+.||+|+||.||+|++.      .++.||||.++... ....+.|.+|+++|.+++| ||||+++|+|. 
T Consensus        60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~-  138 (353)
T 4ase_A           60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT-  138 (353)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE-
Confidence            344578889999999999999999853      23689999997543 3345789999999999965 89999999984 


Q ss_pred             ccCCCCceeeEEEeecCCCChhhhcccCCCcc---------cccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCC
Q 043902          225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEY---------CHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLK  295 (477)
Q Consensus       225 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk  295 (477)
                         ..++..++|||||++|+|.++|+......         .....+++.+++.++.|||+||.|||++   +|+|||||
T Consensus       139 ---~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK  212 (353)
T 4ase_A          139 ---KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA  212 (353)
T ss_dssp             ---CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             ---ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccC
Confidence               44566899999999999999997543211         1124589999999999999999999999   99999999


Q ss_pred             CCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCC
Q 043902          296 SSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRP  373 (477)
Q Consensus       296 p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p  373 (477)
                      |+|||+++++.+||+|||+|+.....     ..........||+.|||||++ .+.++.++|||||||++|||+| |+.|
T Consensus       213 ~~NILl~~~~~vKi~DFGlar~~~~~-----~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~P  287 (353)
T 4ase_A          213 ARNILLSEKNVVKICDFGLARDIYKD-----PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP  287 (353)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTTC-----TTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             ccceeeCCCCCEEECcchhhhhcccC-----CCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCC
Confidence            99999999999999999999876321     122234456789999999999 6789999999999999999998 9999


Q ss_pred             CCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCC
Q 043902          374 TDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPR  453 (477)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~  453 (477)
                      |.......             .+...+.......             .|           +.++..+.+++.+||+.||+
T Consensus       288 f~~~~~~~-------------~~~~~i~~g~~~~-------------~p-----------~~~~~~~~~li~~c~~~dP~  330 (353)
T 4ase_A          288 YPGVKIDE-------------EFCRRLKEGTRMR-------------AP-----------DYTTPEMYQTMLDCWHGEPS  330 (353)
T ss_dssp             STTCCCSH-------------HHHHHHHHTCCCC-------------CC-----------TTCCHHHHHHHHHHTCSSGG
T ss_pred             CCCCCHHH-------------HHHHHHHcCCCCC-------------CC-----------ccCCHHHHHHHHHHcCcChh
Confidence            97532111             1111111110000             00           11234588999999999999


Q ss_pred             CCCChHHHHHHHHHHHHhh
Q 043902          454 DRVGMKFVVNNLQAIRSKI  472 (477)
Q Consensus       454 ~RPs~~evl~~L~~i~~~~  472 (477)
                      +|||+.||++.|+++.+.-
T Consensus       331 ~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          331 QRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             GSCCHHHHHHHHHHHHHHT
T ss_pred             HCcCHHHHHHHHHHHHHHh
Confidence            9999999999999987653

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.5e-54  Score=415.01  Aligned_cols=248  Identities=23%  Similarity=0.306  Sum_probs=202.1

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      ..|+..+.||+|+||.||+|+.. +|+.||||+++.......+.+.+|+++|++++|||||++++++     .+++..|+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEEE
Confidence            56888999999999999999975 7999999999876666667889999999999999999999995     56778999


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      |||||++|+|.+++..        ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|
T Consensus       149 vmEy~~gg~L~~~l~~--------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla  217 (346)
T 4fih_A          149 VMEFLEGGALTDIVTH--------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFC  217 (346)
T ss_dssp             EECCCTTEEHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEeCCCCCcHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCc
Confidence            9999999999999964        3489999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCc
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPS  394 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  394 (477)
                      +.+..       ........+||+.|+|||++ ...|+.++|||||||++|||+||+.||.......             
T Consensus       218 ~~~~~-------~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------------  277 (346)
T 4fih_A          218 AQVSK-------EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------------  277 (346)
T ss_dssp             EECCS-------SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------------
T ss_pred             eecCC-------CCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------------
Confidence            87632       12234456899999999999 4569999999999999999999999996532110             


Q ss_pred             hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          395 HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       395 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                       ....+.......             .+.         ...+...+.+|+.+||+.||++|||++|+++
T Consensus       278 -~~~~i~~~~~~~-------------~~~---------~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          278 -AMKMIRDNLPPR-------------LKN---------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             -HHHHHHHSSCCC-------------CSC---------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -HHHHHHcCCCCC-------------CCc---------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             111110000000             000         0011234789999999999999999999975

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.9e-54  Score=414.97  Aligned_cols=250  Identities=22%  Similarity=0.326  Sum_probs=196.2

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .++|+..+.||+|+||.||+|+.. +|+.||||+++...  ....+.+.+|+++|++++|||||++++++     .+++.
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~-----~~~~~   97 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-----EENGS   97 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE-----EECCE
Confidence            468999999999999999999865 79999999997543  34457899999999999999999999995     56778


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .|+||||+++|+|.+++.....     ..+++.+++.|+.||+.||.|||++   +|+||||||+||||+.++.+||+||
T Consensus        98 ~yiVmEy~~gg~L~~~i~~~~~-----~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DF  169 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINAQKG-----VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDF  169 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECST
T ss_pred             EEEEEeCCCCCcHHHHHHHcCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEccc
Confidence            9999999999999999975431     4578999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCccccc-CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      |+|+....       .........||+.|+|||++. ..++.++|||||||++|||+||+.||......           
T Consensus       170 Gla~~~~~-------~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-----------  231 (350)
T 4b9d_A          170 GIARVLNS-------TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK-----------  231 (350)
T ss_dssp             TEESCCCH-------HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----------
T ss_pred             ccceeecC-------CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-----------
Confidence            99987521       112233457999999999995 46999999999999999999999999753211           


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                            +++........             +.+.        ..+...+.+|+.+||+.||++|||++|+++
T Consensus       232 ------~~~~~i~~~~~-------------~~~~--------~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          232 ------NLVLKIISGSF-------------PPVS--------LHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ------HHHHHHHHTCC-------------CCCC--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------HHHHHHHcCCC-------------CCCC--------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  11111111000             0000        001234789999999999999999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.6e-54  Score=410.54  Aligned_cols=260  Identities=20%  Similarity=0.277  Sum_probs=202.3

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      .+.|...+.||+|+||.||+|+.. +|+.||||+++....     ..+|+.++++++|||||++++++     .+++..|
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~-----~~~~~~~  126 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAV-----REGPWVN  126 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEE-----EETTEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence            345777889999999999999975 799999999985432     24799999999999999999995     5677899


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC-cEEEeccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM-IAHVGDFG  313 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~DfG  313 (477)
                      +||||+++|+|.++++..       ..+++..+..++.||+.||.|||++   +|+||||||+||||+.++ .+||+|||
T Consensus       127 ivmEy~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFG  196 (336)
T 4g3f_A          127 IFMELLEGGSLGQLIKQM-------GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFG  196 (336)
T ss_dssp             EEECCCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCT
T ss_pred             EEEeccCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCC
Confidence            999999999999999754       4699999999999999999999999   999999999999999887 69999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCccccc-CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccC
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMAL  392 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  392 (477)
                      +|+.+......  ..........||+.|||||++. ..++.++|||||||++|||+||+.||........          
T Consensus       197 la~~~~~~~~~--~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----------  264 (336)
T 4g3f_A          197 HALCLQPDGLG--KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL----------  264 (336)
T ss_dssp             TCEEC--------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC----------
T ss_pred             CCeEccCCCcc--cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH----------
Confidence            99876332111  1111233457999999999994 5699999999999999999999999976432211          


Q ss_pred             CchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHhh
Q 043902          393 PSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSKI  472 (477)
Q Consensus       393 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  472 (477)
                         ...+......               ...+        ...+...+.+++.+||+.||.+|||+.|+++.|....+..
T Consensus       265 ---~~~i~~~~~~---------------~~~~--------~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~  318 (336)
T 4g3f_A          265 ---CLKIASEPPP---------------IREI--------PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV  318 (336)
T ss_dssp             ---HHHHHHSCCG---------------GGGS--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             ---HHHHHcCCCC---------------chhc--------CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence               0111110000               0000        0111334789999999999999999999999998877664


Q ss_pred             h
Q 043902          473 R  473 (477)
Q Consensus       473 ~  473 (477)
                      .
T Consensus       319 ~  319 (336)
T 4g3f_A          319 G  319 (336)
T ss_dssp             T
T ss_pred             h
Confidence            3

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.4e-53  Score=402.27  Aligned_cols=247  Identities=22%  Similarity=0.373  Sum_probs=201.5

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec---cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ---QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ++|+..+.||+|+||+||+|+.. +|+.||||+++..   .....+.+.+|+++|++++|||||++++++     ++++.
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~  106 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK  106 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence            57999999999999999999865 7999999999753   234457899999999999999999999994     67788


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .|+||||+++|+|.+++...       ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus       107 ~yivmEy~~gG~L~~~i~~~-------~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DF  176 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRKI-------GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDF  176 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEEecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEc
Confidence            99999999999999999754       5699999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      |+|+.+...     .........+||+.|+|||++ ...++.++||||+||++|||+||+.||......           
T Consensus       177 Gla~~~~~~-----~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-----------  240 (311)
T 4aw0_A          177 GTAKVLSPE-----SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG-----------  240 (311)
T ss_dssp             TTCEECCTT-----TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----------
T ss_pred             CCceecCCC-----CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----------
Confidence            999876321     122234456899999999999 556999999999999999999999999653211           


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVV  462 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl  462 (477)
                            +++..-.....           .+|.           .....+.+|+.+||+.||++|||++|++
T Consensus       241 ------~~~~~i~~~~~-----------~~p~-----------~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          241 ------LIFAKIIKLEY-----------DFPE-----------KFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             ------HHHHHHHHTCC-----------CCCT-----------TCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ------HHHHHHHcCCC-----------CCCc-----------ccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence                  11111111000           0010           0122378899999999999999999874

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.4e-53  Score=416.56  Aligned_cols=249  Identities=22%  Similarity=0.305  Sum_probs=202.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      .+.|+..+.||+|+||.||+|+.. +|+.||||+++.......+.+.+|+++|++++|||||++++++     ..++..|
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~~~  224 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELW  224 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EECCEEE
Confidence            357999999999999999999975 7999999999876666667899999999999999999999995     5567899


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +|||||++|+|.+++..        ..+++.++..++.||+.||.|||++   +|+||||||+||||+.++.+||+|||+
T Consensus       225 iVmEy~~gG~L~~~i~~--------~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGl  293 (423)
T 4fie_A          225 VVMEFLEGGALTDIVTH--------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGF  293 (423)
T ss_dssp             EEEECCTTEEHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTT
T ss_pred             EEEeCCCCCcHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCcc
Confidence            99999999999999864        3489999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCC
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      |+.+..       ........+||+.|||||++ ...|+.++|||||||++|||++|+.||.......            
T Consensus       294 a~~~~~-------~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------------  354 (423)
T 4fie_A          294 CAQVSK-------EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------------  354 (423)
T ss_dssp             CEECCS-------SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------------
T ss_pred             ceECCC-------CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------------
Confidence            987632       12234457899999999999 4569999999999999999999999996532110            


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                        +...+.......             .+.         ...+...+.+|+.+||+.||++|||+.|+++
T Consensus       355 --~~~~i~~~~~~~-------------~~~---------~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          355 --AMKMIRDNLPPR-------------LKN---------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             --HHHHHHHSCCCC-------------CSC---------TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --HHHHHHcCCCCC-------------Ccc---------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              111110000000             000         0001234789999999999999999999975

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.7e-52  Score=389.77  Aligned_cols=244  Identities=23%  Similarity=0.365  Sum_probs=185.3

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|+++...   ......+.+|++++++++|||||++++++     .+++.
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~   87 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSKDE   87 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECCE
Confidence            68999999999999999999864 79999999997442   33456799999999999999999999995     66788


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+ +|+|.+++...       ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        88 ~~ivmEy~-~g~L~~~l~~~-------~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DF  156 (275)
T 3hyh_A           88 IIMVIEYA-GNELFDYIVQR-------DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADF  156 (275)
T ss_dssp             EEEEEECC-CEEHHHHHHHS-------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCS
T ss_pred             EEEEEeCC-CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeec
Confidence            99999999 68999998754       4699999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccccCC--CCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH--VSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      |+|+....        ........||+.|+|||++.+.  ++.++||||+||++|||+||+.||.......         
T Consensus       157 Gla~~~~~--------~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~---------  219 (275)
T 3hyh_A          157 GLSNIMTD--------GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV---------  219 (275)
T ss_dssp             SCC-----------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------
T ss_pred             CCCeecCC--------CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH---------
Confidence            99986522        1223346799999999999543  4689999999999999999999996532110         


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                          -...+.....               .+|.           .....+.+|+.+||+.||++|||++|+++
T Consensus       220 ----~~~~i~~~~~---------------~~p~-----------~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          220 ----LFKNISNGVY---------------TLPK-----------FLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ----HHHHHHHTCC---------------CCCT-----------TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ----HHHHHHcCCC---------------CCCC-----------CCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                0011110000               0010           01233788999999999999999999986

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.3e-52  Score=393.26  Aligned_cols=260  Identities=23%  Similarity=0.397  Sum_probs=186.3

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeeccccc-------C
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVD-------Y  227 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------~  227 (477)
                      ++|+..+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++++++...+       .
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            45888999999999999999965 79999999997554 334567999999999999999999999874321       1


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcE
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIA  307 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~  307 (477)
                      ......|+||||+++|+|.+++.....    ....++..++.++.||+.||+|||++   +|+||||||+|||++.++.+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~v  157 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCT----IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVV  157 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCS----GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCC----CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcE
Confidence            123457999999999999999976532    23456778899999999999999999   99999999999999999999


Q ss_pred             EEecccccccccccCCCCC-----CCccccCCCcccccccCccccc-CCCCcccceeehHHHHHHHhhCCCCCCcccccc
Q 043902          308 HVGDFGLAKFLFEESNTPS-----KNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD  381 (477)
Q Consensus       308 kl~DfG~a~~~~~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~  381 (477)
                      ||+|||+|+.+........     ..........||+.|||||++. ..++.++|||||||++|||++   ||.......
T Consensus       158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~  234 (299)
T 4g31_A          158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV  234 (299)
T ss_dssp             EECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred             EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHH
Confidence            9999999987643221111     0112234567999999999994 569999999999999999996   775321100


Q ss_pred             cceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHH
Q 043902          382 LSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFV  461 (477)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev  461 (477)
                      .            .+..+.+.                 .+|.        ........+.+|+.+||+.||++|||+.|+
T Consensus       235 ~------------~~~~~~~~-----------------~~p~--------~~~~~~~~~~~li~~~L~~dP~~Rps~~ei  277 (299)
T 4g31_A          235 R------------TLTDVRNL-----------------KFPP--------LFTQKYPCEYVMVQDMLSPSPMERPEAINI  277 (299)
T ss_dssp             H------------HHHHHHTT-----------------CCCH--------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             H------------HHHHHhcC-----------------CCCC--------CCcccCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            0            00000000                 0011        111112336689999999999999999999


Q ss_pred             HH
Q 043902          462 VN  463 (477)
Q Consensus       462 l~  463 (477)
                      ++
T Consensus       278 l~  279 (299)
T 4g31_A          278 IE  279 (299)
T ss_dssp             HT
T ss_pred             hc
Confidence            86

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.4e-52  Score=393.99  Aligned_cols=198  Identities=28%  Similarity=0.398  Sum_probs=166.3

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC----CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA----DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      ++|++.+.||+|+||.||+|+..    +++.||+|+++...  ......+.+|+++|++++|||||++++++     .++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~   98 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-----QTE   98 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE-----EET
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EEC
Confidence            57999999999999999999852    47899999997432  22335788999999999999999999995     567


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +..|+||||+++|+|.+++...       ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~  168 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSKE-------VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLT  168 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEec
Confidence            7899999999999999999754       5699999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |||+|+....       .........||+.|+|||++ ...++.++|||||||++|||+||+.||..
T Consensus       169 DFGla~~~~~-------~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~  228 (304)
T 3ubd_A          169 DFGLSKESID-------HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG  228 (304)
T ss_dssp             SSEEEEC------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccccceeccC-------CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC
Confidence            9999986522       12233456799999999999 55699999999999999999999999975

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-49  Score=389.73  Aligned_cols=208  Identities=25%  Similarity=0.374  Sum_probs=174.5

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccc-cCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSV-DYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~~~  231 (477)
                      .++|++.+.||+|+||.||+|+.. +|+.||||+++...  ....+.+.+|+++|++++|||||++++++... .+.+.+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            367999999999999999999965 79999999997443  33446788999999999999999999987543 234567


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..|+|||||+ |+|.+++...       ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~-------~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~D  201 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSS-------QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGD  201 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSS-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECC
T ss_pred             EEEEEEeCCC-CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEee
Confidence            8999999995 6899999754       5699999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccccC--CCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      ||+|+.+....   ...........||+.|+|||++.+  .++.++||||+||++|||+||+.||...
T Consensus       202 FGla~~~~~~~---~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~  266 (398)
T 4b99_A          202 FGMARGLCTSP---AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK  266 (398)
T ss_dssp             CTTCBCC----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred             cceeeecccCc---cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC
Confidence            99998763211   112233455789999999999843  4799999999999999999999999753

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.7e-48  Score=377.66  Aligned_cols=204  Identities=24%  Similarity=0.349  Sum_probs=167.7

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEEeC----CCCEEEEEEeeeccchhhHHHHHHHHHHhcC-CCCCcceeeeecccccCC
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGTLA----DGETAAIKVLKLQQQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYE  228 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  228 (477)
                      ...+.|++.+.||+|+||.||+|+.+    +++.||+|.+.....  ...+.+|+++|.++ +||||+++++++     .
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~-----~   90 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCF-----R   90 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEE-----E
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEE-----E
Confidence            45678999999999999999999753    467899999865433  35688999999998 699999999985     5


Q ss_pred             CCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC-CcE
Q 043902          229 GNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG-MIA  307 (477)
Q Consensus       229 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~~  307 (477)
                      +.+..++||||+++|+|.+++.          .+++.++..++.|++.||+|||++   +|+||||||+|||++.+ +.+
T Consensus        91 ~~~~~~lvmE~~~g~~L~~~~~----------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~  157 (361)
T 4f9c_A           91 KNDHVVIAMPYLEHESFLDILN----------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKY  157 (361)
T ss_dssp             ETTEEEEEEECCCCCCHHHHHT----------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEE
T ss_pred             ECCEEEEEEeCCCcccHHHHHc----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeE
Confidence            6778999999999999999983          378999999999999999999999   99999999999999876 799


Q ss_pred             EEecccccccccccCCCC---------------------CCCccccCCCcccccccCcccccC--CCCcccceeehHHHH
Q 043902          308 HVGDFGLAKFLFEESNTP---------------------SKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILL  364 (477)
Q Consensus       308 kl~DfG~a~~~~~~~~~~---------------------~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl  364 (477)
                      ||+|||+|+...+.....                     ...........||+.|+|||++.+  .++.++||||+||++
T Consensus       158 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il  237 (361)
T 4f9c_A          158 ALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIF  237 (361)
T ss_dssp             EECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHH
T ss_pred             EECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHH
Confidence            999999998653221100                     000112234579999999999843  489999999999999


Q ss_pred             HHHhhCCCCCCcc
Q 043902          365 LEIFTGKRPTDDM  377 (477)
Q Consensus       365 ~elltg~~p~~~~  377 (477)
                      |||+||+.||...
T Consensus       238 ~ell~G~~Pf~~~  250 (361)
T 4f9c_A          238 LSLLSGRYPFYKA  250 (361)
T ss_dssp             HHHHHTCSSSSCC
T ss_pred             HHHHHCCCCCCCC
Confidence            9999999999653

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.7e-47  Score=366.65  Aligned_cols=284  Identities=31%  Similarity=0.531  Sum_probs=220.3

Q ss_pred             cHHHHHHhhcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccC
Q 043902          148 SYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDY  227 (477)
Q Consensus       148 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  227 (477)
                      ++.++...+++|+..+.||+|+||.||+|+..+|+.||+|++........+.+.+|++++++++||||++++++|     
T Consensus        30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----  104 (321)
T 2qkw_B           30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC-----  104 (321)
T ss_dssp             CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC-----
T ss_pred             cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----
Confidence            334556678999999999999999999999888999999998876666678899999999999999999999996     


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcE
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIA  307 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~  307 (477)
                      ...+..++||||+++|+|.+++.....   ....+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+
T Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~  178 (321)
T 2qkw_B          105 DERNEMILIYKYMENGNLKRHLYGSDL---PTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVP  178 (321)
T ss_dssp             CCTTCCEEEEECCTTCBTGGGSSSSCC---CSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCE
T ss_pred             cCCCeEEEEEEcCCCCcHHHHHhccCC---CccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCE
Confidence            456678999999999999999975432   224689999999999999999999999   99999999999999999999


Q ss_pred             EEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCccccccc-cee
Q 043902          308 HVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDL-SIH  385 (477)
Q Consensus       308 kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~-~~~  385 (477)
                      ||+|||+++......     .........||..|+|||.+ .+.++.++|||||||++|||+||+.||........ ...
T Consensus       179 kl~Dfg~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~  253 (321)
T 2qkw_B          179 KITDFGISKKGTELD-----QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA  253 (321)
T ss_dssp             EECCCTTCEECSSSS-----CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHH
T ss_pred             EEeeccccccccccc-----ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHH
Confidence            999999998652211     11223345689999999998 67799999999999999999999999975432211 000


Q ss_pred             eeeeccC-CchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          386 KFVLMAL-PSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       386 ~~~~~~~-~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                      .|..... ...+...+++                    ....    ....+++..+.+++.+||+.||++|||+.||++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~--------------------~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          254 EWAVESHNNGQLEQIVDP--------------------NLAD----KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             HHTHHHHTTTCCCSSSSS--------------------SCTT----CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhhhccccccHHHhcCh--------------------hhcc----ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            0000000 0000000000                    0000    0112335568999999999999999999999999


Q ss_pred             HHHHHHh
Q 043902          465 LQAIRSK  471 (477)
Q Consensus       465 L~~i~~~  471 (477)
                      |+.+.+.
T Consensus       310 L~~~l~~  316 (321)
T 2qkw_B          310 LEYALRL  316 (321)
T ss_dssp             HHHHHHS
T ss_pred             HHHHhhc
Confidence            9988753

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.1e-47  Score=366.53  Aligned_cols=286  Identities=34%  Similarity=0.582  Sum_probs=221.8

Q ss_pred             cCCccHHHHHHhhcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccc-hhhHHHHHHHHHHhcCCCCCcceeeeec
Q 043902          144 QSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQ-GALKSFIDECNALTSIRHRNILKIVSSC  222 (477)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~  222 (477)
                      ...++..++....++|+..+.||+|+||.||+|+..+|+.||||+++.... .....+.+|++++++++||||++++++|
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            346778899999999999999999999999999988899999999975432 2234789999999999999999999996


Q ss_pred             ccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec
Q 043902          223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD  302 (477)
Q Consensus       223 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~  302 (477)
                           ...+..++||||+++|+|.+++.....   ....+++..+..++.|++.||.|||+.+.++|+||||||+||+++
T Consensus        97 -----~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~  168 (326)
T 3uim_A           97 -----MTPTERLLVYPYMANGSVASCLRERPE---SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD  168 (326)
T ss_dssp             -----CCSSCCEEEEECCTTCBHHHHHHCCST---TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC
T ss_pred             -----ecCCceEEEEEeccCCCHHHHHHhccc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC
Confidence                 456678999999999999999986542   224599999999999999999999998777999999999999999


Q ss_pred             CCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccc--
Q 043902          303 EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFK--  379 (477)
Q Consensus       303 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~--  379 (477)
                      .++.+||+|||+++.....      .........||..|+|||.+ .+.++.++|||||||++|||+||+.||+....  
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  242 (326)
T 3uim_A          169 EEFEAVVGDFGLAKLMDYK------DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN  242 (326)
T ss_dssp             TTCCEEECCCSSCEECCSS------SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT
T ss_pred             CCCCEEeccCccccccCcc------cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccc
Confidence            9999999999999875221      12233445689999999999 66789999999999999999999999964211  


Q ss_pred             -cccceeeeeeccCCc-hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCC
Q 043902          380 -DDLSIHKFVLMALPS-HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVG  457 (477)
Q Consensus       380 -~~~~~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs  457 (477)
                       .......|+...... ....+.+....                        .....++...+.+++.+||+.||.+|||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps  298 (326)
T 3uim_A          243 DDDVMLLDWVKGLLKEKKLEALVDVDLQ------------------------GNYKDEEVEQLIQVALLCTQSSPMERPK  298 (326)
T ss_dssp             TSCSBHHHHHTTTTSSCCSTTSSCTTCT------------------------TSCCHHHHHHHHHHHHHHTCSCGGGSCC
T ss_pred             ccchhHHHHHHHHhhchhhhhhcChhhc------------------------cccCHHHHHHHHHHHHHHhCcCCccCCC
Confidence             111111111111111 11111111110                        0011223556999999999999999999


Q ss_pred             hHHHHHHHHH
Q 043902          458 MKFVVNNLQA  467 (477)
Q Consensus       458 ~~evl~~L~~  467 (477)
                      +.||++.|++
T Consensus       299 ~~ell~~L~~  308 (326)
T 3uim_A          299 MSEVVRMLEG  308 (326)
T ss_dssp             HHHHHHHHHT
T ss_pred             HHHHHHHhcC
Confidence            9999999975

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.6e-47  Score=390.30  Aligned_cols=197  Identities=24%  Similarity=0.368  Sum_probs=169.8

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHH---HHHHHHHhcCCCCCcceeeeecccccCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSF---IDECNALTSIRHRNILKIVSSCSSVDYE  228 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~e~~~l~~l~h~niv~l~~~~~~~~~~  228 (477)
                      .++|++.++||+|+||.||+|+.. +|+.||+|+++...   .......   ..++.+++.++|||||++++++     .
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f-----~  262 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H  262 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE-----E
Confidence            468999999999999999999975 79999999997432   1122233   3446777888999999999984     6


Q ss_pred             CCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEE
Q 043902          229 GNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH  308 (477)
Q Consensus       229 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k  308 (477)
                      +.+..|+||||++||+|.++|...       ..+++..+..++.||+.||.|||++   +|+||||||+||||+.+|++|
T Consensus       263 ~~~~lylVmEy~~GGdL~~~l~~~-------~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vK  332 (689)
T 3v5w_A          263 TPDKLSFILDLMNGGDLHYHLSQH-------GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVR  332 (689)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEE
T ss_pred             ECCEEEEEEecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEE
Confidence            778899999999999999999754       5699999999999999999999999   999999999999999999999


Q ss_pred             EecccccccccccCCCCCCCccccCCCcccccccCcccc-cC-CCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NG-HVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       309 l~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |+|||+|+.+..         ......+||+.|+|||++ .+ .++.++||||+||++|||++|+.||..
T Consensus       333 L~DFGlA~~~~~---------~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~  393 (689)
T 3v5w_A          333 ISDLGLACDFSK---------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ  393 (689)
T ss_dssp             ECCCTTCEECSS---------CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCG
T ss_pred             ecccceeeecCC---------CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999987622         123446899999999999 44 589999999999999999999999965

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=9.7e-47  Score=388.41  Aligned_cols=251  Identities=20%  Similarity=0.316  Sum_probs=202.1

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      .++|++.+.||+|+||.||+|+.+ +|+.||+|+++.......+.+.+|+++|++++|||||++++++     .+.+..+
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~  230 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV  230 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence            468999999999999999999875 7999999999876666667899999999999999999999995     6778899


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC--CcEEEecc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG--MIAHVGDF  312 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~--~~~kl~Df  312 (477)
                      +|||||++|+|.+++....      ..+++.++..++.||+.||.|||++   +|+||||||+|||++.+  +.+||+||
T Consensus       231 iv~E~~~gg~L~~~i~~~~------~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DF  301 (573)
T 3uto_A          231 MIYEFMSGGELFEKVADEH------NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDF  301 (573)
T ss_dssp             EEEECCCCCBHHHHHTCTT------SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred             EEEeecCCCcHHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeec
Confidence            9999999999999986543      4689999999999999999999999   99999999999999854  89999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCccccc-CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      |+|+.+..        ........||+.|+|||++. ..++.++||||+||++|||++|+.||........         
T Consensus       302 G~a~~~~~--------~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~---------  364 (573)
T 3uto_A          302 GLTAHLDP--------KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET---------  364 (573)
T ss_dssp             SSCEECCT--------TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---------
T ss_pred             cceeEccC--------CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---------
Confidence            99987622        12223457999999999994 4689999999999999999999999975322110         


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                          +..+........          ....+            .....+.+|+.+||+.||.+|||+.|+++
T Consensus       365 ----~~~i~~~~~~~~----------~~~~~------------~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          365 ----LRNVKSCDWNMD----------DSAFS------------GISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             ----HHHHHTTCCCCC----------SGGGT------------TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----HHHHHhCCCCCC----------ccccc------------CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                000100000000          00000            01233778999999999999999999986

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.7e-46  Score=358.84  Aligned_cols=269  Identities=25%  Similarity=0.420  Sum_probs=212.7

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      .++|...+.||+|+||.||+|... +++.||+|++........+.+.+|++++.+++||||+++++++     ..++..+
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL-----YKDKRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEE-----ecCCeeE
Confidence            467888999999999999999975 6899999998776666678899999999999999999999996     4567789


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +||||+++|+|.+++....      ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        84 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~  154 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMD------SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGL  154 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCC------TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTT
T ss_pred             EEEEecCCCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeeccc
Confidence            9999999999999997643      5689999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCC-------CccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceee
Q 043902          315 AKFLFEESNTPSK-------NQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHK  386 (477)
Q Consensus       315 a~~~~~~~~~~~~-------~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~  386 (477)
                      ++...........       .........||+.|+|||.+ ...++.++|||||||++|||++|..|+........... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~-  233 (310)
T 3s95_A          155 ARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG-  233 (310)
T ss_dssp             CEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS-
T ss_pred             ceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh-
Confidence            9876432211100       01111245799999999999 55689999999999999999999999865432221111 


Q ss_pred             eeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHH
Q 043902          387 FVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQ  466 (477)
Q Consensus       387 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  466 (477)
                             .......+....                            ..++..+.+++.+||+.||++|||+.|+++.|+
T Consensus       234 -------~~~~~~~~~~~~----------------------------~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~  278 (310)
T 3s95_A          234 -------LNVRGFLDRYCP----------------------------PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE  278 (310)
T ss_dssp             -------BCHHHHHHHTCC----------------------------TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -------hhhhccccccCC----------------------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence                   011111111100                            011234889999999999999999999999999


Q ss_pred             HHHHhhhh
Q 043902          467 AIRSKIRM  474 (477)
Q Consensus       467 ~i~~~~~~  474 (477)
                      +++..+..
T Consensus       279 ~l~~~~~~  286 (310)
T 3s95_A          279 TLRMHLAG  286 (310)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHhccC
Confidence            99987653

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.1e-45  Score=350.91  Aligned_cols=283  Identities=29%  Similarity=0.461  Sum_probs=220.1

Q ss_pred             cCCccHHHHHHhhcCCCCC------CeeeeeccceEEEEEeCCCCEEEEEEeeecc----chhhHHHHHHHHHHhcCCCC
Q 043902          144 QSGLSYLKISNATDNFSEE------NLIGSGSFGSVYKGTLADGETAAIKVLKLQQ----QGALKSFIDECNALTSIRHR  213 (477)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~  213 (477)
                      ...+++.++..++++|...      +.||+|+||.||+|.. +++.||+|++....    ....+.+.+|++++.+++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            4567888999999999887      8999999999999997 68899999987432    33457899999999999999


Q ss_pred             CcceeeeecccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecC
Q 043902          214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCD  293 (477)
Q Consensus       214 niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~d  293 (477)
                      ||+++++++     ...+..++||||+++|+|.+++....    ....+++..++.++.|++.||.|||+.   +|+|||
T Consensus        91 ~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~d  158 (307)
T 2nru_A           91 NLVELLGFS-----SDGDDLCLVYVYMPNGSLLDRLSCLD----GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRD  158 (307)
T ss_dssp             TBCCEEEEE-----CSSSSCEEEEECCTTCBHHHHHHTGG----GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             CeEEEEEEE-----ecCCceEEEEEecCCCcHHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCC
Confidence            999999996     45567899999999999999987532    125689999999999999999999999   999999


Q ss_pred             CCCCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccccCCCCcccceeehHHHHHHHhhCCCC
Q 043902          294 LKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRP  373 (477)
Q Consensus       294 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~S~Gvvl~elltg~~p  373 (477)
                      |||+||+++.++.+||+|||++......     ..........||..|+|||.+.+.++.++||||||+++|||+||+.|
T Consensus       159 lkp~Nili~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p  233 (307)
T 2nru_A          159 IKSANILLDEAFTAKISDFGLARASEKF-----AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPA  233 (307)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEECCSC-----SSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCS
T ss_pred             CCHHHEEEcCCCcEEEeecccccccccc-----cccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCC
Confidence            9999999999999999999999865221     11222334578999999999988899999999999999999999999


Q ss_pred             CCcccccccceeeeeec--cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCC
Q 043902          374 TDDMFKDDLSIHKFVLM--ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAAS  451 (477)
Q Consensus       374 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~d  451 (477)
                      |........ ...+...  .....+.+.++..+.                 .        ....+...+.+++.+||+.|
T Consensus       234 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-----------------~--------~~~~~~~~l~~li~~cl~~~  287 (307)
T 2nru_A          234 VDEHREPQL-LLDIKEEIEDEEKTIEDYIDKKMN-----------------D--------ADSTSVEAMYSVASQCLHEK  287 (307)
T ss_dssp             BCTTBSSSB-TTHHHHHHHTTSCCHHHHSCSSCS-----------------C--------CCHHHHHHHHHHHHHHTCSS
T ss_pred             cccCcchHH-HHHHHHHhhhhhhhhhhhcccccc-----------------c--------cchHHHHHHHHHHHHHcCCC
Confidence            976432211 0000000  000011111111110                 0        01123456889999999999


Q ss_pred             CCCCCChHHHHHHHHHHHH
Q 043902          452 PRDRVGMKFVVNNLQAIRS  470 (477)
Q Consensus       452 P~~RPs~~evl~~L~~i~~  470 (477)
                      |.+|||+.||++.|+++++
T Consensus       288 p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          288 KNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             TTTSCCHHHHHHHHHHHC-
T ss_pred             cccCcCHHHHHHHHHHHhc
Confidence            9999999999999999865

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=5.5e-46  Score=358.48  Aligned_cols=285  Identities=21%  Similarity=0.304  Sum_probs=208.7

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      .++|+..+.||+|+||.||+|+.. ++.||||+++..... ...+..|+.++.+++||||+++++++.... ......++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~~l   99 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDLWL   99 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceEEE
Confidence            468889999999999999999985 799999999755432 345667999999999999999999975321 12445799


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCC-------CCCeeecCCCCCCeEecCCCcEE
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQY-------DTPIAHCDLKSSNVLLDEGMIAH  308 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------~~~ivH~dlkp~NIll~~~~~~k  308 (477)
                      ||||+++|+|.+++...        .+++..++.++.|++.||.|||+.+       .++|+||||||+||+++.++.+|
T Consensus       100 v~e~~~~g~L~~~l~~~--------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k  171 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKAN--------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC  171 (322)
T ss_dssp             EEECCTTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred             EEecCCCCCHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence            99999999999999653        4899999999999999999999752       23899999999999999999999


Q ss_pred             EecccccccccccCCCCCCCccccCCCcccccccCcccccC------CCCcccceeehHHHHHHHhhCCCCCCccccccc
Q 043902          309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING------HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDL  382 (477)
Q Consensus       309 l~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~  382 (477)
                      |+|||+++......     .........||..|+|||++.+      .++.++|||||||++|||+||+.||........
T Consensus       172 L~DFg~a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~  246 (322)
T 3soc_A          172 IADFGLALKFEAGK-----SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM  246 (322)
T ss_dssp             ECCCTTCEEECTTS-----CCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCC
T ss_pred             EccCCccccccccc-----CccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhc
Confidence            99999998763221     1222334578999999999854      467789999999999999999999976433211


Q ss_pred             ceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHH
Q 043902          383 SIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVV  462 (477)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl  462 (477)
                      ..........+ ...++.+......            ..+.+.....   ...++..+.+++.+||+.||++|||+.||+
T Consensus       247 ~~~~~~~~~~~-~~~~~~~~~~~~~------------~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell  310 (322)
T 3soc_A          247 LPFEEEIGQHP-SLEDMQEVVVHKK------------KRPVLRDYWQ---KHAGMAMLCETIEECWDHDAEARLSAGCVG  310 (322)
T ss_dssp             CTTHHHHCSSC-CHHHHHHHHTTSC------------CCCCCCGGGG---SSHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             cchhhhhccCC-chhhhhhhhhccc------------CCCCcccccc---ccchHHHHHHHHHHHccCChhhCcCHHHHH
Confidence            10000000000 1111111100000            0000000000   012345589999999999999999999999


Q ss_pred             HHHHHHHHhh
Q 043902          463 NNLQAIRSKI  472 (477)
Q Consensus       463 ~~L~~i~~~~  472 (477)
                      +.|++|++..
T Consensus       311 ~~L~~l~~~~  320 (322)
T 3soc_A          311 ERITQMQRLT  320 (322)
T ss_dssp             HHHHHHHHHC
T ss_pred             HHHHHHHHHh
Confidence            9999998764

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=8.7e-46  Score=363.65  Aligned_cols=269  Identities=23%  Similarity=0.428  Sum_probs=208.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC--------CCCEEEEEEeeecc-chhhHHHHHHHHHHhcC-CCCCcceeeeecccc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA--------DGETAAIKVLKLQQ-QGALKSFIDECNALTSI-RHRNILKIVSSCSSV  225 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  225 (477)
                      .++|...+.||+|+||.||+|+..        ++..||||+++... ....+.+.+|+++++++ +||||++++++|   
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~---  156 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC---  156 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE---
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE---
Confidence            467888999999999999999852        35679999997553 33457899999999999 899999999996   


Q ss_pred             cCCCCceeeEEEeecCCCChhhhcccCCCc---------ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCC
Q 043902          226 DYEGNDFKALVFEFMRNGNLDQWLHPSTDE---------YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKS  296 (477)
Q Consensus       226 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp  296 (477)
                        ...+..++||||+++|+|.+++......         ......+++..++.++.||+.||.|||++   +|+||||||
T Consensus       157 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp  231 (370)
T 2psq_A          157 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA  231 (370)
T ss_dssp             --CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred             --ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccch
Confidence              4566789999999999999999764311         01124589999999999999999999999   999999999


Q ss_pred             CCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCC
Q 043902          297 SNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPT  374 (477)
Q Consensus       297 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~  374 (477)
                      +|||++.++.+||+|||+++......     .........+|+.|+|||++ ...++.++|||||||++|||+| |+.||
T Consensus       232 ~NIll~~~~~~kl~DFG~a~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~  306 (370)
T 2psq_A          232 RNVLVTENNVMKIADFGLARDINNID-----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY  306 (370)
T ss_dssp             GGEEECTTCCEEECCCSSCEETTCCC-----TTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             hhEEECCCCCEEEccccCCcccCccc-----ceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence            99999999999999999998653211     11223344578899999998 5679999999999999999999 99999


Q ss_pred             CcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCC
Q 043902          375 DDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRD  454 (477)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~  454 (477)
                      .......              +...+.......             .+           ..+...+.+++.+||+.||++
T Consensus       307 ~~~~~~~--------------~~~~~~~~~~~~-------------~~-----------~~~~~~l~~li~~~l~~dP~~  348 (370)
T 2psq_A          307 PGIPVEE--------------LFKLLKEGHRMD-------------KP-----------ANCTNELYMMMRDCWHAVPSQ  348 (370)
T ss_dssp             TTCCGGG--------------HHHHHHTTCCCC-------------CC-----------TTSCHHHHHHHHHHTCSSGGG
T ss_pred             CCCCHHH--------------HHHHHhcCCCCC-------------CC-----------CCCCHHHHHHHHHHcCCChhh
Confidence            7532111              111111100000             00           012334889999999999999


Q ss_pred             CCChHHHHHHHHHHHHhhhhc
Q 043902          455 RVGMKFVVNNLQAIRSKIRMR  475 (477)
Q Consensus       455 RPs~~evl~~L~~i~~~~~~~  475 (477)
                      |||+.|+++.|+++......+
T Consensus       349 Rpt~~ell~~L~~il~~~~~~  369 (370)
T 2psq_A          349 RPTFKQLVEDLDRILTLTTNE  369 (370)
T ss_dssp             SCCHHHHHHHHHHHHHHHC--
T ss_pred             CcCHHHHHHHHHHHHHHhccC
Confidence            999999999999998766543

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4.9e-46  Score=366.59  Aligned_cols=260  Identities=26%  Similarity=0.448  Sum_probs=207.3

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .++|...+.||+|+||.||+|+.. +++.||||+++... ......|.+|++++++++||||++++++|     ...+..
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~~  187 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQPI  187 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE-----CSSSSC
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----ecCCCc
Confidence            467888899999999999999986 78999999997543 23345788999999999999999999997     445678


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||+++|+|.+++....      ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus       188 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG  258 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRTEG------ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFG  258 (377)
T ss_dssp             EEEEECCTTCBHHHHHHHHG------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGG
T ss_pred             EEEEEcCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCC
Confidence            99999999999999997432      4589999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeecc
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      +++.....     ..........++..|+|||.+ .+.++.++|||||||++|||+| |..||......           
T Consensus       259 ~s~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-----------  322 (377)
T 3cbl_A          259 MSREEADG-----VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-----------  322 (377)
T ss_dssp             GCEECTTS-----EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-----------
T ss_pred             CceecCCC-----ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----------
Confidence            99864211     001111223467889999999 5679999999999999999999 99999753221           


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHh
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSK  471 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  471 (477)
                         .+.+.+.......             .|           +.++..+.+++.+||+.||++|||+.++++.|++++++
T Consensus       323 ---~~~~~~~~~~~~~-------------~~-----------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          323 ---QTREFVEKGGRLP-------------CP-----------ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             ---HHHHHHHTTCCCC-------------CC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---HHHHHHHcCCCCC-------------CC-----------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence               1111111110000             00           11234588999999999999999999999999999886


Q ss_pred             h
Q 043902          472 I  472 (477)
Q Consensus       472 ~  472 (477)
                      .
T Consensus       376 ~  376 (377)
T 3cbl_A          376 H  376 (377)
T ss_dssp             C
T ss_pred             c
Confidence            5

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.5e-45  Score=348.71  Aligned_cols=250  Identities=22%  Similarity=0.298  Sum_probs=201.9

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ..++|+..+.||+|+||.||+|.. .+|+.||+|++........+.+.+|+.++++++||||+++++++     ...+..
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~   92 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDEL   92 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEE-----EECCEE
Confidence            356899999999999999999986 47899999999877666667899999999999999999999986     446678


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||+++|+|.+++...        .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||
T Consensus        93 ~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg  161 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTET--------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG  161 (297)
T ss_dssp             EEEEECCTTCBHHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             EEEEECCCCCCHHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCC
Confidence            9999999999999999643        489999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccC
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMAL  392 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  392 (477)
                      ++.....       .........||+.|+|||.+ ...++.++|||||||++|||+||+.||........          
T Consensus       162 ~~~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----------  224 (297)
T 3fxz_A          162 FCAQITP-------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA----------  224 (297)
T ss_dssp             TCEECCS-------TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----------
T ss_pred             CceecCC-------cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----------
Confidence            9986532       12223445799999999999 56789999999999999999999999965321100          


Q ss_pred             CchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          393 PSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       393 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                         ...+...... .      ..     .           .+.+...+.+++.+||+.||++|||+.|+++
T Consensus       225 ---~~~~~~~~~~-~------~~-----~-----------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          225 ---LYLIATNGTP-E------LQ-----N-----------PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             ---HHHHHHHCSC-C------CS-----C-----------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---HHHHHhCCCC-C------CC-----C-----------ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence               0000000000 0      00     0           0011234789999999999999999999986

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.1e-46  Score=356.98  Aligned_cols=278  Identities=22%  Similarity=0.396  Sum_probs=207.2

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe-----CCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL-----ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      .++|+..+.||+|+||.||+|++     .+++.||||+++.......+.+.+|++++.+++||||++++++|..   .+.
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~   85 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGR   85 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH---HHH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCC
Confidence            46788899999999999999984     2688999999987766667889999999999999999999998742   223


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ...++||||+++|+|.+++....      ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~  156 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHK------ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIG  156 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCG------GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEEC
T ss_pred             CceEEEEEeCCCCCHHHHHHhcc------cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEc
Confidence            45799999999999999997653      4589999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      |||+++......    ..........++..|+|||.+ ...++.++||||||+++|||+||..|+.....+...   ...
T Consensus       157 Dfg~~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~---~~~  229 (295)
T 3ugc_A          157 DFGLTKVLPQDK----EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR---MIG  229 (295)
T ss_dssp             CCCSCC-----------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHH---HHC
T ss_pred             cCcccccccCCc----ceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHh---hhc
Confidence            999998763211    111223344578889999999 567899999999999999999999998653221100   000


Q ss_pred             cc-CCchh-HHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHH
Q 043902          390 MA-LPSHV-MDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQA  467 (477)
Q Consensus       390 ~~-~~~~~-~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  467 (477)
                      .. ..... ....+. ....     ...               .....++..+.+++.+||+.||++|||+.|+++.|++
T Consensus       230 ~~~~~~~~~~~~~~~-~~~~-----~~~---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~  288 (295)
T 3ugc_A          230 NDKQGQMIVFHLIEL-LKNN-----GRL---------------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ  288 (295)
T ss_dssp             TTCCTHHHHHHHHHH-HHTT-----CCC---------------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             CccccchhHHHHHHH-Hhcc-----CcC---------------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence            00 00000 000000 0000     000               0001123458899999999999999999999999999


Q ss_pred             HHHhhh
Q 043902          468 IRSKIR  473 (477)
Q Consensus       468 i~~~~~  473 (477)
                      +++.+.
T Consensus       289 l~~~l~  294 (295)
T 3ugc_A          289 IRDNMA  294 (295)
T ss_dssp             HHHC--
T ss_pred             HHHhcc
Confidence            998753

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=6.7e-46  Score=358.23  Aligned_cols=261  Identities=26%  Similarity=0.463  Sum_probs=205.0

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC----CCCEEEEEEeeec-cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA----DGETAAIKVLKLQ-QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      .++|.+.+.||+|+||.||+|...    .+..||||+++.. .....+.+.+|++++.+++||||+++++++     ...
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~  122 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----TRG  122 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CGG
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeC
Confidence            357788899999999999999974    3456999999854 334457899999999999999999999996     456


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +..++||||+++|+|.+++....      ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~  193 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTHD------GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVS  193 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTTT------TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred             CccEEEeeCCCCCcHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEEC
Confidence            67899999999999999997543      4689999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~  388 (477)
                      |||+++......    ..........+|..|+|||.+ .+.++.++|||||||++|||++ |+.||.......       
T Consensus       194 Dfg~a~~~~~~~----~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------  262 (325)
T 3kul_A          194 DFGLSRVLEDDP----DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-------  262 (325)
T ss_dssp             CCSSCEECC--------CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------
T ss_pred             CCCcccccccCc----cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-------
Confidence            999998763211    112223344567889999999 5678999999999999999999 999996532211       


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                             +...+.......             .+           ..+...+.+++.+||+.||.+|||+.||++.|+.+
T Consensus       263 -------~~~~~~~~~~~~-------------~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l  311 (325)
T 3kul_A          263 -------VISSVEEGYRLP-------------AP-----------MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL  311 (325)
T ss_dssp             -------HHHHHHTTCCCC-------------CC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------HHHHHHcCCCCC-------------CC-----------CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                   111111100000             00           01134488999999999999999999999999998


Q ss_pred             HHhh
Q 043902          469 RSKI  472 (477)
Q Consensus       469 ~~~~  472 (477)
                      .+..
T Consensus       312 ~~~~  315 (325)
T 3kul_A          312 IRSP  315 (325)
T ss_dssp             HHSC
T ss_pred             HhCc
Confidence            7653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.9e-45  Score=343.40  Aligned_cols=257  Identities=27%  Similarity=0.477  Sum_probs=207.6

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      .++|+..+.||+|+||.||+|...+++.||+|+++..... .+.+.+|++++.+++||||+++++++     ......++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   82 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPICL   82 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSEEE
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCceEE
Confidence            3578888999999999999999988899999999865433 36799999999999999999999996     45667899


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      ||||+++++|.+++....      ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        83 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~  153 (269)
T 4hcu_A           83 VFEFMEHGCLSDYLRTQR------GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT  153 (269)
T ss_dssp             EEECCTTCBHHHHHHTTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGG
T ss_pred             EEEeCCCCcHHHHHHhcC------cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccc
Confidence            999999999999997543      4689999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCC
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      +.....      .........+|..|+|||.+ ...++.++||||||+++|||+| |+.||.......            
T Consensus       154 ~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~------------  215 (269)
T 4hcu_A          154 RFVLDD------QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------------  215 (269)
T ss_dssp             GGBCCH------HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------------
T ss_pred             cccccc------ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH------------
Confidence            865221      12233445578889999999 5679999999999999999999 999996532211            


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHh
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSK  471 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  471 (477)
                        ....+......             ..+.           .+...+.+++.+||+.||++|||+.|+++.|+++.++
T Consensus       216 --~~~~~~~~~~~-------------~~~~-----------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          216 --VVEDISTGFRL-------------YKPR-----------LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             --HHHHHHTTCCC-------------CCCT-----------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --HHHHHhcCccC-------------CCCC-----------cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence              11111000000             0000           0123478999999999999999999999999999874

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3e-45  Score=349.86  Aligned_cols=268  Identities=26%  Similarity=0.412  Sum_probs=199.0

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhc--CCCCCcceeeeecccccCCCCce
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTS--IRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ..++|+..+.||+|+||.||+|+. +|+.||||++....   ...+..|.+++..  ++||||+++++++... ......
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~-~~~~~~   80 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTS-RHSSTQ   80 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE-ETTEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccc-cCCCce
Confidence            356899999999999999999998 68999999987543   2455666666665  7999999999986432 234566


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeeecCCCCCCeEecCC
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH--------NQYDTPIAHCDLKSSNVLLDEG  304 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~dlkp~NIll~~~  304 (477)
                      .++||||+++|+|.++++.        ..+++..++.++.|++.||.|||        +.   +|+||||||+|||++.+
T Consensus        81 ~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~  149 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQL--------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKN  149 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTT--------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTT
T ss_pred             eEEehhhccCCCHHHHHhh--------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCC
Confidence            8999999999999999954        35899999999999999999999        77   99999999999999999


Q ss_pred             CcEEEecccccccccccCCCCCCCccccCCCcccccccCcccccC-------CCCcccceeehHHHHHHHhhC-------
Q 043902          305 MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-------HVSILGDIYSYGILLLEIFTG-------  370 (477)
Q Consensus       305 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~Dv~S~Gvvl~elltg-------  370 (477)
                      +.+||+|||+++.......   ..........||+.|+|||.+.+       .++.++|||||||++|||+||       
T Consensus       150 ~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~  226 (301)
T 3q4u_A          150 GQCCIADLGLAVMHSQSTN---QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV  226 (301)
T ss_dssp             SCEEECCCTTCEEEETTTT---EEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCEEEeeCCCeeecccccc---cccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence            9999999999976532111   11112234579999999999843       355799999999999999999       


Q ss_pred             ---CCCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhc
Q 043902          371 ---KRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMC  447 (477)
Q Consensus       371 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C  447 (477)
                         +.||...........         ...........               .+.+...   .....+...+.+++.+|
T Consensus       227 ~~~~~pf~~~~~~~~~~~---------~~~~~~~~~~~---------------~~~~~~~---~~~~~~~~~l~~li~~c  279 (301)
T 3q4u_A          227 EDYKPPFYDVVPNDPSFE---------DMRKVVCVDQQ---------------RPNIPNR---WFSDPTLTSLAKLMKEC  279 (301)
T ss_dssp             CCCCCTTTTTSCSSCCHH---------HHHHHHTTSCC---------------CCCCCGG---GGGSHHHHHHHHHHHHH
T ss_pred             ccccccccccCCCCcchh---------hhhHHHhccCC---------------CCCCChh---hccCccHHHHHHHHHHH
Confidence               666654322211100         01110000000               0000000   00112355689999999


Q ss_pred             CCCCCCCCCChHHHHHHHHHH
Q 043902          448 SAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       448 l~~dP~~RPs~~evl~~L~~i  468 (477)
                      |+.||++|||+.||++.|++|
T Consensus       280 l~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          280 WYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhcChhhCCCHHHHHHHHhcc
Confidence            999999999999999999986

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.7e-45  Score=342.65  Aligned_cols=258  Identities=24%  Similarity=0.411  Sum_probs=207.0

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      .++|+..+.||+|+||.||+|+..++..||+|+++..... .+.+.+|++++.+++||||+++++++     ......++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   80 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPIYI   80 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC-HHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc-HHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCceEE
Confidence            4678889999999999999999988889999999865433 36789999999999999999999996     45667899


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      ||||+++++|.+++....      ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        81 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~  151 (268)
T 3sxs_A           81 VTEYISNGCLLNYLRSHG------KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMT  151 (268)
T ss_dssp             EEECCTTCBHHHHHHHHG------GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred             EEEccCCCcHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccc
Confidence            999999999999997542      4589999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCC
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      .....      ..........+|..|+|||.+ ...++.++||||||+++|||+| |+.||.......            
T Consensus       152 ~~~~~------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------------  213 (268)
T 3sxs_A          152 RYVLD------DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE------------  213 (268)
T ss_dssp             EECCT------TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH------------
T ss_pred             eecch------hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH------------
Confidence            86522      122233445577889999999 5578999999999999999999 999996532211            


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHhh
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSKI  472 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  472 (477)
                        ....+.....             ...+..           +...+.+++.+||+.||++|||+.|+++.|+.++++.
T Consensus       214 --~~~~~~~~~~-------------~~~~~~-----------~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          214 --VVLKVSQGHR-------------LYRPHL-----------ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             --HHHHHHTTCC-------------CCCCTT-----------SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             --HHHHHHcCCC-------------CCCCCc-----------ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence              0000000000             000000           0234789999999999999999999999999987764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.4e-45  Score=359.67  Aligned_cols=261  Identities=26%  Similarity=0.478  Sum_probs=196.5

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC----CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA----DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      .++|+..+.||+|+||.||+|+..    ++..||||+++... ....+.|.+|+.++++++||||++++++|     ...
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~  118 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-----TKS  118 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CSS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeC
Confidence            468999999999999999999864    57789999998543 34457899999999999999999999996     445


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +..++||||+++|+|.+++....      ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+
T Consensus       119 ~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~  189 (373)
T 2qol_A          119 KPVMIVTEYMENGSLDSFLRKHD------AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVS  189 (373)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTT------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEEC
T ss_pred             CceEEEEeCCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEEC
Confidence            67899999999999999997543      4689999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~  388 (477)
                      |||+++.......    .........++..|+|||++ .+.++.++|||||||++|||++ |+.||......        
T Consensus       190 Dfg~a~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--------  257 (373)
T 2qol_A          190 DFGLGRVLEDDPE----AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--------  257 (373)
T ss_dssp             CC--------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--------
T ss_pred             cCccccccccCCc----cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--------
Confidence            9999987632111    11112233457789999999 5679999999999999999998 99999653211        


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                            .+.+.++......             .           ...++..+.+++.+||+.||.+|||+.||++.|+++
T Consensus       258 ------~~~~~i~~~~~~~-------------~-----------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          258 ------DVIKAVDEGYRLP-------------P-----------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             ------HHHHHHHTTEECC-------------C-----------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------HHHHHHHcCCCCC-------------C-----------CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence                  1111111111000             0           001234588999999999999999999999999998


Q ss_pred             HHhh
Q 043902          469 RSKI  472 (477)
Q Consensus       469 ~~~~  472 (477)
                      ....
T Consensus       308 ~~~~  311 (373)
T 2qol_A          308 IRNP  311 (373)
T ss_dssp             HHCG
T ss_pred             HhCc
Confidence            7653

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.3e-45  Score=360.37  Aligned_cols=282  Identities=17%  Similarity=0.220  Sum_probs=209.4

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeCC------CCEEEEEEeeeccchh-----------hHHHHHHHHHHhcCCCCCcce
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLAD------GETAAIKVLKLQQQGA-----------LKSFIDECNALTSIRHRNILK  217 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~  217 (477)
                      ..++|.+.+.||+|+||.||+|.+.+      ++.||||++.......           ...+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            35689999999999999999998754      4789999987543211           123455666778889999999


Q ss_pred             eeeecccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCC
Q 043902          218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSS  297 (477)
Q Consensus       218 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~  297 (477)
                      +++++.... ......++||||+ +++|.+++....      ..+++..++.++.||+.||.|||++   +|+||||||+
T Consensus       113 ~~~~~~~~~-~~~~~~~lv~e~~-g~~L~~~~~~~~------~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~  181 (364)
T 3op5_A          113 YWGSGLHDK-NGKSYRFMIMDRF-GSDLQKIYEANA------KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKAS  181 (364)
T ss_dssp             EEEEEEEEE-TTEEEEEEEEECE-EEEHHHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGG
T ss_pred             EEeeeeecc-CCcceEEEEEeCC-CCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHH
Confidence            999975321 2345689999999 999999997643      5699999999999999999999999   9999999999


Q ss_pred             CeEec--CCCcEEEecccccccccccCCCCCCCccccCCCcccccccCccccc-CCCCcccceeehHHHHHHHhhCCCCC
Q 043902          298 NVLLD--EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFTGKRPT  374 (477)
Q Consensus       298 NIll~--~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~  374 (477)
                      |||++  .++.+||+|||+++.+..................||+.|+|||++. ..++.++|||||||++|||+||+.||
T Consensus       182 Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf  261 (364)
T 3op5_A          182 NLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW  261 (364)
T ss_dssp             GEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             HEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99999  8899999999999876443322222222334556999999999994 46899999999999999999999999


Q ss_pred             CcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCC
Q 043902          375 DDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRD  454 (477)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~  454 (477)
                      ........ ............+.++++..+..                           ..++..+.+++..|++.||.+
T Consensus       262 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~cl~~~p~~  313 (364)
T 3op5_A          262 EDNLKDPK-YVRDSKIRYRENIASLMDKCFPA---------------------------ANAPGEIAKYMETVKLLDYTE  313 (364)
T ss_dssp             GGGTTCHH-HHHHHHHHHHHCHHHHHHHHSCT---------------------------TCCCHHHHHHHHHHHTCCTTC
T ss_pred             cccccCHH-HHHHHHHHhhhhHHHHHHHhccc---------------------------ccCHHHHHHHHHHHhcCCCCC
Confidence            75322110 00000000011111111111100                           111455889999999999999


Q ss_pred             CCChHHHHHHHHHHHHhhhhc
Q 043902          455 RVGMKFVVNNLQAIRSKIRMR  475 (477)
Q Consensus       455 RPs~~evl~~L~~i~~~~~~~  475 (477)
                      ||++.+|++.|+++.++....
T Consensus       314 RP~~~~l~~~l~~~~~~~~~~  334 (364)
T 3op5_A          314 KPLYENLRDILLQGLKAIGSK  334 (364)
T ss_dssp             CCCHHHHHHHHHHHHHHTTCC
T ss_pred             CCCHHHHHHHHHHHHHHcCCC
Confidence            999999999999998876543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3e-45  Score=351.00  Aligned_cols=262  Identities=26%  Similarity=0.426  Sum_probs=198.9

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      ...++|++.+.||+|+||.||+|+. +|+.||||++....  ....+.+.+|++++++++||||+++++++     ....
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~  107 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-----TQPP  107 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSTT
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECC
Confidence            3457888999999999999999987 58899999997543  33456789999999999999999999996     4566


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeecCCCCCCeEecCCCcEEE
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTP--IAHCDLKSSNVLLDEGMIAHV  309 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~dlkp~NIll~~~~~~kl  309 (477)
                      ..++||||+++|+|.+++....    ....+++..++.++.|++.||+|||+.   +  |+||||||+||+++.++.+||
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL  180 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSG----AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKV  180 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTT----HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEE
T ss_pred             ceEEEEecCCCCcHHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEE
Confidence            7899999999999999997653    113489999999999999999999998   8  999999999999999999999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeee
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~  388 (477)
                      +|||+++....       .........||..|+|||.+ ...++.++|||||||++|||+||+.||.......       
T Consensus       181 ~Dfg~a~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~-------  246 (309)
T 3p86_A          181 CDFGLSRLKAS-------TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ-------  246 (309)
T ss_dssp             CCCC------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH-------
T ss_pred             CCCCCCccccc-------cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------
Confidence            99999975421       11223345789999999999 4568999999999999999999999997532211       


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                             ....+.....        ..    ..+           ..+...+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus       247 -------~~~~~~~~~~--------~~----~~~-----------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~  296 (309)
T 3p86_A          247 -------VVAAVGFKCK--------RL----EIP-----------RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL  296 (309)
T ss_dssp             -------HHHHHHHSCC--------CC----CCC-----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------HHHHHHhcCC--------CC----CCC-----------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                   0000000000        00    000           01123488999999999999999999999999998


Q ss_pred             HHhh
Q 043902          469 RSKI  472 (477)
Q Consensus       469 ~~~~  472 (477)
                      .+..
T Consensus       297 ~~~~  300 (309)
T 3p86_A          297 IKSA  300 (309)
T ss_dssp             HC--
T ss_pred             HHhC
Confidence            7654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.6e-44  Score=347.03  Aligned_cols=247  Identities=21%  Similarity=0.328  Sum_probs=199.3

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      ..++|+..+.||+|+||.||+|+. .+|+.||||++....  ....+.+.+|++++++++||||+++++++     ...+
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~~   87 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETEK   87 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECC
Confidence            356899999999999999999997 589999999997543  34456788999999999999999999996     5567


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+++|+|.+++...       ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~D  157 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVAH-------GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIAD  157 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECS
T ss_pred             EEEEEEECCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEee
Confidence            899999999999999999654       4589999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCccccc-CCC-CcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHV-SILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~-~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      ||++.....        ........||+.|+|||.+. ..+ +.++|||||||++|||+||+.||......         
T Consensus       158 FG~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---------  220 (328)
T 3fe3_A          158 FGFSNEFTV--------GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK---------  220 (328)
T ss_dssp             TTCCGGGSS--------SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH---------
T ss_pred             ccCceecCC--------CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH---------
Confidence            999976521        12234557999999999994 344 58999999999999999999999753211         


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                              ++.........           ..|..           ....+.+++.+||+.||.+|||++|+++
T Consensus       221 --------~~~~~i~~~~~-----------~~p~~-----------~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          221 --------ELRERVLRGKY-----------RIPFY-----------MSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             --------HHHHHHHHCCC-----------CCCTT-----------SCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             --------HHHHHHHhCCC-----------CCCCC-----------CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                    11111000000           00000           1233778999999999999999999975

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5.1e-45  Score=367.45  Aligned_cols=253  Identities=27%  Similarity=0.434  Sum_probs=203.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      .++|+..+.||+|+||.||+|.+. |+.||||+++...  ..+.|.+|++++++++||||++++++|.    ......++
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~~i  264 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYI  264 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEE----CTTSCEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEE----cCCCceEE
Confidence            467888899999999999999985 7899999998654  4478999999999999999999999974    34456899


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      ||||+++|+|.+++....     ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       265 v~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a  336 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSRG-----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT  336 (450)
T ss_dssp             EEECCTTCBHHHHHHHHC-----TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEecCCCcHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence            999999999999997542     13478999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCC
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      +....          ......++..|+|||.+ .+.++.++|||||||++|||+| |+.||.......            
T Consensus       337 ~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~------------  394 (450)
T 1k9a_A          337 KEASS----------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------------  394 (450)
T ss_dssp             EECC----------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT------------
T ss_pred             ccccc----------cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------------
Confidence            85411          11123568899999999 6679999999999999999999 999997542211            


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHh
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSK  471 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  471 (477)
                        +...+.......                        .+..++..+.+++.+||+.||++|||+.|+++.|+.++..
T Consensus       395 --~~~~i~~~~~~~------------------------~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          395 --VVPRVEKGYKMD------------------------APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             --HHHHHHTTCCCC------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             --HHHHHHcCCCCC------------------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence              111111100000                        0011234588999999999999999999999999999865

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.3e-44  Score=340.77  Aligned_cols=259  Identities=25%  Similarity=0.451  Sum_probs=205.9

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      ..++|+..+.||+|+||.||+|...++..||+|+++..... .+.+.+|++++.+++||||+++++++     ...+..+
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   95 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPIF   95 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSEE
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEE-----ecCCCeE
Confidence            35678889999999999999999988889999999865433 36789999999999999999999996     4566789


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +||||+++++|.+++....      ..+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        96 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~  166 (283)
T 3gen_A           96 IITEYMANGCLLNYLREMR------HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGL  166 (283)
T ss_dssp             EEECCCTTCBHHHHHHCGG------GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTG
T ss_pred             EEEeccCCCcHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccc
Confidence            9999999999999997532      4589999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccC
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMAL  392 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  392 (477)
                      ++.....      .........+|..|+|||.+ .+.++.++||||||+++|||+| |+.||.......           
T Consensus       167 ~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~-----------  229 (283)
T 3gen_A          167 SRYVLDD------EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-----------  229 (283)
T ss_dssp             GGGBCCH------HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----------
T ss_pred             ccccccc------ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH-----------
Confidence            9865221      12223345578889999999 5679999999999999999999 999997532211           


Q ss_pred             CchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHhh
Q 043902          393 PSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSKI  472 (477)
Q Consensus       393 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  472 (477)
                         ..+.+.......             .+.           .+...+.+++.+||+.||++|||++|+++.|+++.++.
T Consensus       230 ---~~~~~~~~~~~~-------------~~~-----------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e  282 (283)
T 3gen_A          230 ---TAEHIAQGLRLY-------------RPH-----------LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE  282 (283)
T ss_dssp             ---HHHHHHTTCCCC-------------CCT-----------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ---HHHHHhcccCCC-------------CCC-----------cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence               111111100000             000           00234889999999999999999999999999988653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5e-44  Score=344.54  Aligned_cols=259  Identities=21%  Similarity=0.276  Sum_probs=204.6

Q ss_pred             CccHHHHHHhhcC----------CCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCC
Q 043902          146 GLSYLKISNATDN----------FSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRN  214 (477)
Q Consensus       146 ~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n  214 (477)
                      .+++.++..+++.          |+..+.||+|+||.||+|+.. +|+.||||+++.......+.+.+|+.++.+++|||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence            3556666666543          566678999999999999976 79999999998766666678999999999999999


Q ss_pred             cceeeeecccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCC
Q 043902          215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDL  294 (477)
Q Consensus       215 iv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dl  294 (477)
                      |+++++++     ...+..++||||+++++|.+++..        ..+++..+..++.|++.||.|||+.   +|+||||
T Consensus       104 iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~--------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dl  167 (321)
T 2c30_A          104 VVEMYKSY-----LVGEELWVLMEFLQGGALTDIVSQ--------VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDI  167 (321)
T ss_dssp             BCCEEEEE-----EETTEEEEEECCCCSCBHHHHHTT--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred             cceEEEEE-----EECCEEEEEEecCCCCCHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCC
Confidence            99999996     345678999999999999999864        3489999999999999999999999   9999999


Q ss_pred             CCCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCC
Q 043902          295 KSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRP  373 (477)
Q Consensus       295 kp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p  373 (477)
                      ||+||+++.++.+||+|||++......       ........||..|+|||++ .+.++.++|||||||++|||++|+.|
T Consensus       168 kp~NIll~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p  240 (321)
T 2c30_A          168 KSDSILLTLDGRVKLSDFGFCAQISKD-------VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP  240 (321)
T ss_dssp             SGGGEEECTTCCEEECCCTTCEECCSS-------SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             CHHHEEECCCCcEEEeeeeeeeecccC-------ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999865321       1123345789999999999 55689999999999999999999999


Q ss_pred             CCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCC
Q 043902          374 TDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPR  453 (477)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~  453 (477)
                      |.......             ....+.+.... .       .      ..         .......+.+++.+||+.||+
T Consensus       241 f~~~~~~~-------------~~~~~~~~~~~-~-------~------~~---------~~~~~~~l~~li~~~l~~dp~  284 (321)
T 2c30_A          241 YFSDSPVQ-------------AMKRLRDSPPP-K-------L------KN---------SHKVSPVLRDFLERMLVRDPQ  284 (321)
T ss_dssp             TTTSCHHH-------------HHHHHHHSSCC-C-------C------TT---------GGGSCHHHHHHHHHHSCSSTT
T ss_pred             CCCCCHHH-------------HHHHHhcCCCC-C-------c------Cc---------cccCCHHHHHHHHHHccCChh
Confidence            96532110             00000000000 0       0      00         000123478899999999999


Q ss_pred             CCCChHHHHH
Q 043902          454 DRVGMKFVVN  463 (477)
Q Consensus       454 ~RPs~~evl~  463 (477)
                      +|||+.|+++
T Consensus       285 ~Rps~~ell~  294 (321)
T 2c30_A          285 ERATAQELLD  294 (321)
T ss_dssp             TSCCHHHHHT
T ss_pred             hCcCHHHHhc
Confidence            9999999986

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1e-44  Score=355.18  Aligned_cols=276  Identities=24%  Similarity=0.415  Sum_probs=212.4

Q ss_pred             ccHHHHHHhhcCCCCCCeeeeeccceEEEEEe------CCCCEEEEEEeeecc-chhhHHHHHHHHHHhcC-CCCCccee
Q 043902          147 LSYLKISNATDNFSEENLIGSGSFGSVYKGTL------ADGETAAIKVLKLQQ-QGALKSFIDECNALTSI-RHRNILKI  218 (477)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l  218 (477)
                      +.........++|...+.||+|+||.||+|++      .+++.||||+++... ....+.+.+|++++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            33445556678999999999999999999973      256899999998543 33456799999999999 78999999


Q ss_pred             eeecccccCCCCceeeEEEeecCCCChhhhcccCCCccc-----------------------------------------
Q 043902          219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYC-----------------------------------------  257 (477)
Q Consensus       219 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-----------------------------------------  257 (477)
                      +++|.    ..+...++||||+++|+|.+++........                                         
T Consensus        92 ~~~~~----~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (359)
T 3vhe_A           92 LGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF  167 (359)
T ss_dssp             EEEEC----STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred             eeeee----cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence            99974    344568999999999999999976532100                                         


Q ss_pred             ------------------ccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccccc
Q 043902          258 ------------------HFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLF  319 (477)
Q Consensus       258 ------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  319 (477)
                                        ....+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  244 (359)
T 3vhe_A          168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY  244 (359)
T ss_dssp             ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred             ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence                              012289999999999999999999999   99999999999999999999999999998653


Q ss_pred             ccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCCchhH
Q 043902          320 EESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALPSHVM  397 (477)
Q Consensus       320 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  397 (477)
                      ..     ..........||..|+|||++ ...++.++|||||||++|||+| |+.||.......             .+.
T Consensus       245 ~~-----~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------------~~~  306 (359)
T 3vhe_A          245 KD-----PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------------EFC  306 (359)
T ss_dssp             SC-----TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-------------HHH
T ss_pred             cc-----ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-------------HHH
Confidence            21     112233455688999999998 6678999999999999999999 999996532111             111


Q ss_pred             HHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHh
Q 043902          398 DVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSK  471 (477)
Q Consensus       398 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  471 (477)
                      ..+.......             .+.           .+...+.+++.+||+.||.+|||+.||++.|+++.+.
T Consensus       307 ~~~~~~~~~~-------------~~~-----------~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          307 RRLKEGTRMR-------------APD-----------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             HHHHHTCCCC-------------CCT-----------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHcCCCCC-------------CCC-----------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            1111110000             000           0123478999999999999999999999999998865

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.4e-45  Score=372.17  Aligned_cols=260  Identities=24%  Similarity=0.487  Sum_probs=208.9

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ...++|...+.||+|+||.||+|.+.++..||||+++.... ..+.|.+|++++++++||||+++++++.      .+..
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~~  257 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT------KEPI  257 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSC
T ss_pred             echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc-cHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCcc
Confidence            34567888999999999999999998889999999986543 3578999999999999999999999863      4458


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||+++|+|.+++....     ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG  329 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDE-----GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFG  329 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHH-----HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTT
T ss_pred             EEEEeecCCCcHHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCC
Confidence            99999999999999997532     13588999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeecc
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      +++.....      .........+|..|+|||.+ .+.++.++|||||||++|||+| |+.||.......          
T Consensus       330 ~a~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~----------  393 (454)
T 1qcf_A          330 LARVIEDN------EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE----------  393 (454)
T ss_dssp             GGGGBCCH------HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----------
T ss_pred             CceEcCCC------ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH----------
Confidence            99875221      11223344568899999999 5779999999999999999999 999997532211          


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHh
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSK  471 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  471 (477)
                          +...+.......                        .+..++..+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus       394 ----~~~~i~~~~~~~------------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          394 ----VIRALERGYRMP------------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             ----HHHHHHHTCCCC------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             ----HHHHHHcCCCCC------------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence                111111100000                        0011234588999999999999999999999999988654


Q ss_pred             h
Q 043902          472 I  472 (477)
Q Consensus       472 ~  472 (477)
                      .
T Consensus       446 ~  446 (454)
T 1qcf_A          446 T  446 (454)
T ss_dssp             S
T ss_pred             c
Confidence            3

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.6e-44  Score=341.18  Aligned_cols=272  Identities=14%  Similarity=0.190  Sum_probs=211.1

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeeccchhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .++|+..+.||+|+||.||+|.. .+|+.||+|++.....  .+.+.+|++.+.++ +|+|++++++++     ......
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~   81 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHN   81 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeec-----CCCcee
Confidence            46799999999999999999996 5789999999875432  25688899999999 799999999985     456778


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCc-----EE
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI-----AH  308 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~-----~k  308 (477)
                      ++||||+ +++|.+++....      ..+++..++.++.|++.||.|||++   +|+||||||+||+++.++.     +|
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~k  151 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCG------RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIY  151 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEE
T ss_pred             EEEEEec-CCCHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEE
Confidence            9999999 999999997543      4589999999999999999999999   9999999999999987776     99


Q ss_pred             EecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeee
Q 043902          309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       309 l~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~  387 (477)
                      |+|||+++....................||..|+|||.+ ...++.++|||||||++|||++|+.||.........    
T Consensus       152 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~----  227 (298)
T 1csn_A          152 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK----  227 (298)
T ss_dssp             ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH----
T ss_pred             EEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH----
Confidence            999999987644322221122234556799999999999 456899999999999999999999999763211100    


Q ss_pred             eeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHH
Q 043902          388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQA  467 (477)
Q Consensus       388 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  467 (477)
                            .....+........                     .......++..+.+++.+||+.||++|||+++|++.|++
T Consensus       228 ------~~~~~~~~~~~~~~---------------------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~  280 (298)
T 1csn_A          228 ------QKYERIGEKKQSTP---------------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK  280 (298)
T ss_dssp             ------HHHHHHHHHHHHSC---------------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             ------HHHHHHHhhccCcc---------------------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHH
Confidence                  00111111000000                     000011224458899999999999999999999999999


Q ss_pred             HHHhhhhc
Q 043902          468 IRSKIRMR  475 (477)
Q Consensus       468 i~~~~~~~  475 (477)
                      +.++....
T Consensus       281 ~~~~~~~~  288 (298)
T 1csn_A          281 VLERLNTT  288 (298)
T ss_dssp             HHHHTTCC
T ss_pred             HHHhcCCC
Confidence            99886643

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.5e-44  Score=348.26  Aligned_cols=269  Identities=18%  Similarity=0.232  Sum_probs=208.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeeccchhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .++|+..+.||+|+||.||+|+. .+|+.||||++.....  .+.+.+|+++++++ +||||+++++++     ...+..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~-----~~~~~~   80 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFG-----PCGKYN   80 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEE-----EETTEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEE-----ecCCcc
Confidence            46789999999999999999996 4789999999875433  24688999999999 999999999985     446778


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCc-----EE
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI-----AH  308 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~-----~k  308 (477)
                      ++||||+ +++|.+++....      ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.     +|
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~k  150 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLCD------RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIH  150 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEE
T ss_pred             EEEEEeC-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEE
Confidence            9999999 999999997542      4689999999999999999999999   9999999999999998887     99


Q ss_pred             EecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeee
Q 043902          309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       309 l~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~  387 (477)
                      |+|||+++....................||..|+|||.+ ...++.++|||||||++|||++|+.||........     
T Consensus       151 l~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~-----  225 (330)
T 2izr_A          151 IIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL-----  225 (330)
T ss_dssp             ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH-----
T ss_pred             EEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH-----
Confidence            999999987643222211112223456799999999999 45689999999999999999999999976422110     


Q ss_pred             eeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHH
Q 043902          388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQA  467 (477)
Q Consensus       388 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  467 (477)
                           .+....+.+......                     .....+.++ .+.+++..|++.||.+||++.+|.+.|++
T Consensus       226 -----~~~~~~i~~~~~~~~---------------------~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~  278 (330)
T 2izr_A          226 -----KERYQKIGDTKRATP---------------------IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD  278 (330)
T ss_dssp             -----HHHHHHHHHHHHHSC---------------------HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             -----HHHHHHHHhhhccCC---------------------HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence                 000111111100000                     000001123 58999999999999999999999999999


Q ss_pred             HHHhhh
Q 043902          468 IRSKIR  473 (477)
Q Consensus       468 i~~~~~  473 (477)
                      +.++..
T Consensus       279 ~~~~~~  284 (330)
T 2izr_A          279 LFDRKG  284 (330)
T ss_dssp             HHHHTT
T ss_pred             HHHHcC
Confidence            887754

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.4e-44  Score=346.98  Aligned_cols=252  Identities=20%  Similarity=0.328  Sum_probs=197.5

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc-hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ-GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++     ...+..
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~   80 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ   80 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCCeE
Confidence            468899999999999999999876 789999999975432 2346788999999999999999999996     556788


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||+++|+|.+++...       ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        81 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg  150 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIEPD-------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFG  150 (323)
T ss_dssp             EEEEECCTTEEGGGGSBTT-------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEee
Confidence            9999999999999999754       4589999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc-cCC-CCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGH-VSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~-~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      +++.+....     .........||+.|+|||++ ... .+.++|||||||++|||+||+.||..........       
T Consensus       151 ~a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-------  218 (323)
T 3tki_A          151 LATVFRYNN-----RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-------  218 (323)
T ss_dssp             TCEECEETT-----EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH-------
T ss_pred             ccceeccCC-----cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH-------
Confidence            998653211     12223456799999999999 334 4789999999999999999999997543221111       


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                           ...........               .         .......+.+++.+||+.||++|||+.|+++
T Consensus       219 -----~~~~~~~~~~~---------------~---------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          219 -----SDWKEKKTYLN---------------P---------WKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             -----HHHHTTCTTST---------------T---------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----HHHhcccccCC---------------c---------cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence                 11111000000               0         0001234778999999999999999999975

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.8e-44  Score=342.05  Aligned_cols=263  Identities=23%  Similarity=0.390  Sum_probs=202.8

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.++.+++||||+++++++     ...+
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~   84 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EEDD   84 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECSS
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeCC
Confidence            467899999999999999999865 78999999986432   33457889999999999999999999995     5667


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+++++|.+++...       ..+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~D  154 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIESH-------GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFD  154 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred             eEEEEEeCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEe
Confidence            899999999999999999743       4689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      ||+++.....      .........||+.|+|||.+ ...++.++|||||||++|||+||+.||.........       
T Consensus       155 fg~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-------  221 (294)
T 4eqm_A          155 FGIAKALSET------SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA-------  221 (294)
T ss_dssp             CSSSTTC-------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH-------
T ss_pred             CCCccccccc------cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-------
Confidence            9999865221      11223345689999999999 556899999999999999999999999753221100       


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC-ChHHHHHHHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRV-GMKFVVNNLQAIR  469 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~i~  469 (477)
                            ...+....                 +...    ......++..+.+++.+|++.||.+|| +++++.+.|+.+.
T Consensus       222 ------~~~~~~~~-----------------~~~~----~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          222 ------IKHIQDSV-----------------PNVT----TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             ------HHHHSSCC-----------------CCHH----HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             ------HHHhhccC-----------------CCcc----hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence                  00000000                 0000    000011234588999999999999999 8999999998876


Q ss_pred             Hhhh
Q 043902          470 SKIR  473 (477)
Q Consensus       470 ~~~~  473 (477)
                      ...+
T Consensus       275 ~~~~  278 (294)
T 4eqm_A          275 HENR  278 (294)
T ss_dssp             SSSS
T ss_pred             hhcc
Confidence            5543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=9.2e-44  Score=347.23  Aligned_cols=251  Identities=21%  Similarity=0.312  Sum_probs=200.4

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccch------hhHHHHHHHHHHhcCCCCCcceeeeecccccC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQG------ALKSFIDECNALTSIRHRNILKIVSSCSSVDY  227 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  227 (477)
                      ..+.|.+.+.||+|+||.||+|+.. +|+.||+|+++.....      ..+.+.+|+.++.+++||||+++++++     
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----   84 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY-----   84 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE-----
Confidence            4568999999999999999999975 6899999999854322      246789999999999999999999995     


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC--
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM--  305 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~--  305 (477)
                      .+....++||||+++|+|.+++...       ..+++..+..++.||+.||.|||+.   +|+||||||+||+++.++  
T Consensus        85 ~~~~~~~lv~e~~~gg~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~  154 (361)
T 2yab_A           85 ENRTDVVLILELVSGGELFDFLAQK-------ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIP  154 (361)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHTTC-------SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSS
T ss_pred             EeCCEEEEEEEcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCC
Confidence            5677899999999999999999754       4689999999999999999999999   999999999999998777  


Q ss_pred             --cEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCccccccc
Q 043902          306 --IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDL  382 (477)
Q Consensus       306 --~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~  382 (477)
                        .+||+|||++.....        ........||+.|+|||++ ...++.++|||||||++|+|++|..||....... 
T Consensus       155 ~~~vkl~DFG~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-  225 (361)
T 2yab_A          155 IPHIKLIDFGLAHEIED--------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-  225 (361)
T ss_dssp             SCCEEECCCSSCEECCT--------TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-
T ss_pred             ccCEEEEecCCceEcCC--------CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence              799999999987532        1123345699999999999 4578999999999999999999999996532111 


Q ss_pred             ceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHH
Q 043902          383 SIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVV  462 (477)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl  462 (477)
                                  ....+......                      ...+........+.+++.+||..||.+|||+.|++
T Consensus       226 ------------~~~~i~~~~~~----------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l  271 (361)
T 2yab_A          226 ------------TLANITAVSYD----------------------FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEAL  271 (361)
T ss_dssp             ------------HHHHHHTTCCC----------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             ------------HHHHHHhcCCC----------------------CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence                        00011000000                      00001111233478999999999999999999998


Q ss_pred             H
Q 043902          463 N  463 (477)
Q Consensus       463 ~  463 (477)
                      +
T Consensus       272 ~  272 (361)
T 2yab_A          272 R  272 (361)
T ss_dssp             T
T ss_pred             c
Confidence            4

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1e-43  Score=338.41  Aligned_cols=273  Identities=20%  Similarity=0.283  Sum_probs=207.9

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ..++|+..+.||+|+||.||+|+. .+++.||+|++......  ..+.+|++++.+++|++++..+..|.    ...+..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~~   80 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYN   80 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEE----EETTEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeec----CCCCce
Confidence            457899999999999999999996 57899999987654332  46788999999999999888887763    456778


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEe---cCCCcEEEe
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVG  310 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~  310 (477)
                      ++||||+ +++|.+++....      ..+++..++.++.|++.||.|||++   +|+||||||+||++   +.++.+||+
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~  150 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNFCS------RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYII  150 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEEC
T ss_pred             EEEEEcc-CCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEe
Confidence            9999999 999999997543      4589999999999999999999999   99999999999999   788999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      |||+++....................||..|+|||.+ ...++.++|||||||++|||++|+.||........       
T Consensus       151 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------  223 (296)
T 4hgt_A          151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-------  223 (296)
T ss_dssp             CCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS-------
T ss_pred             cCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhh-------
Confidence            9999987644322221122234456799999999999 45689999999999999999999999976432211       


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIR  469 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  469 (477)
                         ......+........                     .......++..+.+++.+|++.||++|||++||++.|+++.
T Consensus       224 ---~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~  279 (296)
T 4hgt_A          224 ---RQKYERISEKKMSTP---------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  279 (296)
T ss_dssp             ---SSHHHHHHHHHHHSC---------------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred             ---hhhhhhhhcccccch---------------------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence               011111111111100                     00000111345889999999999999999999999999999


Q ss_pred             Hhhhh
Q 043902          470 SKIRM  474 (477)
Q Consensus       470 ~~~~~  474 (477)
                      ++...
T Consensus       280 ~~~~~  284 (296)
T 4hgt_A          280 HRQGF  284 (296)
T ss_dssp             HHHTC
T ss_pred             HHhCC
Confidence            87654

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.4e-44  Score=348.09  Aligned_cols=275  Identities=24%  Similarity=0.363  Sum_probs=208.0

Q ss_pred             CCCCCeeeeeccceEEEEEeC-----CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          159 FSEENLIGSGSFGSVYKGTLA-----DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       159 ~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      |+..+.||+|+||.||++.+.     +++.||||+++... ....+.+.+|++++++++||||+++++++..   .....
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~  109 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED---AGAAS  109 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---TTTTE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEec---CCCce
Confidence            488899999999999998753     68899999998653 3345778999999999999999999999742   33567


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++|+|.+++...        .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+||
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Df  178 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRH--------SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDF  178 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGS--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCG
T ss_pred             EEEEEecccCCcHHHHHhhC--------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCc
Confidence            89999999999999999653        389999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      |++......    ...........+|..|+|||.+ ...++.++|||||||++|||+||+.||............+....
T Consensus       179 g~a~~~~~~----~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~  254 (318)
T 3lxp_A          179 GLAKAVPEG----HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQ  254 (318)
T ss_dssp             GGCEECCTT----CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHH
T ss_pred             ccccccccc----ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccc
Confidence            999876321    1111223445678889999999 55789999999999999999999999865322211111110000


Q ss_pred             CCc-hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHH
Q 043902          392 LPS-HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRS  470 (477)
Q Consensus       392 ~~~-~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  470 (477)
                      ... .+.+.++......             .           ...+...+.+++.+||+.||.+|||+.|+++.|+++.+
T Consensus       255 ~~~~~~~~~~~~~~~~~-------------~-----------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  310 (318)
T 3lxp_A          255 MTVLRLTELLERGERLP-------------R-----------PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE  310 (318)
T ss_dssp             HHHHHHHHHHHTTCCCC-------------C-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHhcccCCC-------------C-----------CccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            000 1111111110000             0           01123458899999999999999999999999999999


Q ss_pred             hhhhc
Q 043902          471 KIRMR  475 (477)
Q Consensus       471 ~~~~~  475 (477)
                      ++..+
T Consensus       311 ~~~~~  315 (318)
T 3lxp_A          311 KYQGQ  315 (318)
T ss_dssp             HHHC-
T ss_pred             hhccC
Confidence            88654

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.3e-43  Score=337.61  Aligned_cols=274  Identities=20%  Similarity=0.281  Sum_probs=211.7

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ..++|+..+.||+|+||.||+|+. .+|+.||+|++......  +.+.+|++++.+++|++++..+.++.    ......
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~~   80 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYN   80 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEE----EETTEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCcccccc----CCCCce
Confidence            357899999999999999999996 57899999998755432  56889999999999998888777763    456678


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEe---cCCCcEEEe
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVG  310 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~  310 (477)
                      ++||||+ +++|.+++....      ..+++..++.++.|++.||.|||++   +|+||||||+||++   +.++.+||+
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~  150 (296)
T 3uzp_A           81 VMVMELL-GPSLEDLFNFCS------RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYII  150 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEEC
T ss_pred             EEEEEec-CCCHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEe
Confidence            9999999 999999997443      4689999999999999999999999   99999999999999   488899999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      |||++.....................||..|+|||.+ ...++.++|||||||++|||+||+.||........       
T Consensus       151 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------  223 (296)
T 3uzp_A          151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-------  223 (296)
T ss_dssp             CCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS-------
T ss_pred             eCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhh-------
Confidence            9999987644322211112233456799999999999 45689999999999999999999999975322110       


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIR  469 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  469 (477)
                         ......+........                     .......++..+.+++.+||+.||++|||+.||++.|+++.
T Consensus       224 ---~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~  279 (296)
T 3uzp_A          224 ---RQKYERISEKKMSTP---------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  279 (296)
T ss_dssp             ---SSHHHHHHHHHHHSC---------------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred             ---hhhhhhhcccccCCc---------------------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence               001111111111000                     00000112345889999999999999999999999999998


Q ss_pred             Hhhhhc
Q 043902          470 SKIRMR  475 (477)
Q Consensus       470 ~~~~~~  475 (477)
                      .+....
T Consensus       280 ~~~~~~  285 (296)
T 3uzp_A          280 HRQGFS  285 (296)
T ss_dssp             HHTTCC
T ss_pred             HhcCCc
Confidence            886543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8.6e-45  Score=351.03  Aligned_cols=279  Identities=22%  Similarity=0.321  Sum_probs=209.8

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe-----CCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL-----ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      .++|+..+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++..   ...
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   98 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PGR   98 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---SSS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---CCC
Confidence            36788899999999999999984     3688999999987766666789999999999999999999998642   456


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ...++||||+++++|.+++....      ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~  169 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHR------ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIA  169 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHG------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEEC
T ss_pred             ceEEEEEeecCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEc
Confidence            67899999999999999997532      4589999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      |||++......    ...........||..|+|||.+ ...++.++|||||||++|||++|+.||.............. 
T Consensus       170 Dfg~~~~~~~~----~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~-  244 (327)
T 3lxl_A          170 DFGLAKLLPLD----KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE-  244 (327)
T ss_dssp             CGGGCEECCTT----CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC---
T ss_pred             ccccceecccC----CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccc-
Confidence            99999876321    1112233445688899999999 55689999999999999999999999865322211100000 


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIR  469 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  469 (477)
                       ........+.+......      ...               ....+...+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus       245 -~~~~~~~~~~~~~~~~~------~~~---------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  302 (327)
T 3lxl_A          245 -RDVPALSRLLELLEEGQ------RLP---------------APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW  302 (327)
T ss_dssp             ---CCHHHHHHHHHHTTC------CCC---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred             -cccccHHHHHHHhhccc------CCC---------------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence             00001111111000000      000               00112345889999999999999999999999999987


Q ss_pred             Hhhh
Q 043902          470 SKIR  473 (477)
Q Consensus       470 ~~~~  473 (477)
                      ....
T Consensus       303 ~~~~  306 (327)
T 3lxl_A          303 SGSR  306 (327)
T ss_dssp             ----
T ss_pred             hhhc
Confidence            6544

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-44  Score=353.12  Aligned_cols=266  Identities=23%  Similarity=0.411  Sum_probs=207.4

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC------CCCEEEEEEeeec-cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQ-QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYE  228 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  228 (477)
                      .++|...+.||+|+||.||+|++.      +++.||||+++.. .......+.+|+.++++++||||+++++++     .
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~  144 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS-----L  144 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----e
Confidence            467888999999999999999853      4678999999744 334446789999999999999999999996     4


Q ss_pred             CCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC---
Q 043902          229 GNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM---  305 (477)
Q Consensus       229 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~---  305 (477)
                      .....++||||+++|+|.+++............+++..++.++.|++.||.|||++   +|+||||||+|||++.++   
T Consensus       145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~  221 (367)
T 3l9p_A          145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR  221 (367)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred             cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCc
Confidence            55667999999999999999976543223335689999999999999999999999   999999999999999554   


Q ss_pred             cEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccc
Q 043902          306 IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLS  383 (477)
Q Consensus       306 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~  383 (477)
                      .+||+|||+++.......     ........||+.|+|||.+ .+.++.++|||||||++|||+| |..||......   
T Consensus       222 ~~kL~DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---  293 (367)
T 3l9p_A          222 VAKIGDFGMARDIYRAGY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---  293 (367)
T ss_dssp             CEEECCCHHHHHHHHHSS-----CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred             eEEECCCccccccccccc-----cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence            599999999986533211     1222334578899999998 6779999999999999999998 99999653211   


Q ss_pred             eeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          384 IHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       384 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                                 .+.+.+.......             .           ...+...+.+++.+||+.||.+|||+.||++
T Consensus       294 -----------~~~~~i~~~~~~~-------------~-----------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~  338 (367)
T 3l9p_A          294 -----------EVLEFVTSGGRMD-------------P-----------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE  338 (367)
T ss_dssp             -----------HHHHHHHTTCCCC-------------C-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------HHHHHHHcCCCCC-------------C-----------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                       1111111100000             0           0011334889999999999999999999999


Q ss_pred             HHHHHHHhh
Q 043902          464 NLQAIRSKI  472 (477)
Q Consensus       464 ~L~~i~~~~  472 (477)
                      .|+.+.+..
T Consensus       339 ~l~~~~~~~  347 (367)
T 3l9p_A          339 RIEYCTQDP  347 (367)
T ss_dssp             HHHHHHHCH
T ss_pred             HHHHHhhCh
Confidence            999988754

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=6.3e-44  Score=337.41  Aligned_cols=260  Identities=22%  Similarity=0.384  Sum_probs=195.7

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCC----CCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLAD----GETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      .++|+..+.||+|+||.||+|....    +..||+|+++... ....+.+.+|+.++++++||||+++++++.      .
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~   87 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------E   87 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------S
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc------c
Confidence            4678889999999999999998642    4579999987543 334567899999999999999999999852      3


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +..++||||+++|+|.+++....      ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~  158 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVRK------YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLG  158 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTT------TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEEC
T ss_pred             CccEEEEecCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEEC
Confidence            45789999999999999997543      4689999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~  388 (477)
                      |||+++.....      .........+|+.|+|||.+ ...++.++|||||||++|||++ |..||......+       
T Consensus       159 Dfg~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-------  225 (281)
T 1mp8_A          159 DFGLSRYMEDS------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------  225 (281)
T ss_dssp             C-------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------
T ss_pred             ccccccccCcc------cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-------
Confidence            99999875321      11122334567889999999 5678999999999999999997 999997532211       


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                             ....+.....         .    ..+           ..++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       226 -------~~~~i~~~~~---------~----~~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          226 -------VIGRIENGER---------L----PMP-----------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             -------HHHHHHTTCC---------C----CCC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------HHHHHHcCCC---------C----CCC-----------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                   0010100000         0    000           01133488999999999999999999999999999


Q ss_pred             HHhhhh
Q 043902          469 RSKIRM  474 (477)
Q Consensus       469 ~~~~~~  474 (477)
                      .++...
T Consensus       275 ~~~~~~  280 (281)
T 1mp8_A          275 LEEEKA  280 (281)
T ss_dssp             HHHHHH
T ss_pred             HHHhcc
Confidence            887543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=9.7e-44  Score=341.03  Aligned_cols=202  Identities=25%  Similarity=0.378  Sum_probs=170.9

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ..++|+..+.||+|+||.||+|+..+|+.||+|+++...  ......+.+|++++++++||||+++++++     .....
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~   93 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSERC   93 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCSSC
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----ccCCE
Confidence            457899999999999999999999889999999997543  23346788999999999999999999996     55677


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++ +|.+++....      ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+||
T Consensus        94 ~~lv~e~~~~-~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Df  163 (311)
T 3niz_A           94 LTLVFEFMEK-DLKKVLDENK------TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADF  163 (311)
T ss_dssp             EEEEEECCSE-EHHHHHHTCT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEcCCCC-CHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccC
Confidence            8999999974 8888876543      4589999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCccc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDMF  378 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~  378 (477)
                      |+++....       .........||..|+|||.+.  ..++.++|||||||++|||++|+.||....
T Consensus       164 g~a~~~~~-------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  224 (311)
T 3niz_A          164 GLARAFGI-------PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT  224 (311)
T ss_dssp             TTCEETTS-------CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cCceecCC-------CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC
Confidence            99986521       112233456899999999984  358999999999999999999999997643

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-44  Score=344.60  Aligned_cols=250  Identities=21%  Similarity=0.296  Sum_probs=199.6

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      .++|...+.||+|+||.||+|... +++.||+|.++.... ....+.+|++++.+++||||+++++++     .+.+..+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~   77 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESF-----ESMEELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc-cHHHHHHHHHHHHhCCCCCCCeEeEEE-----ecCCEEE
Confidence            468899999999999999999975 688999999975433 346788999999999999999999996     4567899


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC--CCcEEEecc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE--GMIAHVGDF  312 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~--~~~~kl~Df  312 (477)
                      +||||+++|+|.+++....      ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.  ++.+||+||
T Consensus        78 lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Df  148 (321)
T 1tki_A           78 MIFEFISGLDIFERINTSA------FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEF  148 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSS------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred             EEEEeCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEEC
Confidence            9999999999999997543      4689999999999999999999999   9999999999999987  789999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccccC-CCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      |+++....        ........||+.|+|||++.+ .++.++|||||||++|||++|..||.......          
T Consensus       149 g~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----------  210 (321)
T 1tki_A          149 GQARQLKP--------GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ----------  210 (321)
T ss_dssp             TTCEECCT--------TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH----------
T ss_pred             CCCeECCC--------CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH----------
Confidence            99987622        112234568999999999944 57999999999999999999999996532111          


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                         ....+.......                      ...........+.+++.+||+.||.+|||+.|+++
T Consensus       211 ---~~~~i~~~~~~~----------------------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          211 ---IIENIMNAEYTF----------------------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ---HHHHHHHTCCCC----------------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---HHHHHHcCCCCC----------------------ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               011111110000                      00011112345889999999999999999999987

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-43  Score=348.42  Aligned_cols=269  Identities=25%  Similarity=0.415  Sum_probs=210.0

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC--------CCCEEEEEEeeecc-chhhHHHHHHHHHHhcC-CCCCcceeeeecccc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA--------DGETAAIKVLKLQQ-QGALKSFIDECNALTSI-RHRNILKIVSSCSSV  225 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  225 (477)
                      .++|...+.||+|+||.||+|+..        ++..||||+++... ......+.+|+++++++ +||||++++++|   
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~---  144 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC---  144 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee---
Confidence            468888999999999999999852        34579999997553 33457889999999999 899999999996   


Q ss_pred             cCCCCceeeEEEeecCCCChhhhcccCCCc---------ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCC
Q 043902          226 DYEGNDFKALVFEFMRNGNLDQWLHPSTDE---------YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKS  296 (477)
Q Consensus       226 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp  296 (477)
                        ...+..++||||+++|+|.+++......         ......+++..++.++.|++.||.|||+.   +|+||||||
T Consensus       145 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp  219 (382)
T 3tt0_A          145 --TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA  219 (382)
T ss_dssp             --CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred             --ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCc
Confidence              4566789999999999999999764311         01124689999999999999999999999   999999999


Q ss_pred             CCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCC
Q 043902          297 SNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPT  374 (477)
Q Consensus       297 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~  374 (477)
                      +||+++.++.+||+|||+++......     .........+|..|+|||++ ...++.++|||||||++|||+| |..||
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~  294 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHID-----YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY  294 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCC-----TTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             ceEEEcCCCcEEEcccCccccccccc-----ccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999998653211     11223345678899999999 5678999999999999999999 99999


Q ss_pred             CcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCC
Q 043902          375 DDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRD  454 (477)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~  454 (477)
                      ......              .+.+.+.......             .+           ..+...+.+++.+||+.||++
T Consensus       295 ~~~~~~--------------~~~~~~~~~~~~~-------------~~-----------~~~~~~l~~li~~~l~~dP~~  336 (382)
T 3tt0_A          295 PGVPVE--------------ELFKLLKEGHRMD-------------KP-----------SNCTNELYMMMRDCWHAVPSQ  336 (382)
T ss_dssp             TTCCHH--------------HHHHHHHTTCCCC-------------CC-----------SSCCHHHHHHHHHHTCSSGGG
T ss_pred             CCCCHH--------------HHHHHHHcCCCCC-------------CC-----------ccCCHHHHHHHHHHcCCChhh
Confidence            653211              1111111110000             00           011334889999999999999


Q ss_pred             CCChHHHHHHHHHHHHhhhhc
Q 043902          455 RVGMKFVVNNLQAIRSKIRMR  475 (477)
Q Consensus       455 RPs~~evl~~L~~i~~~~~~~  475 (477)
                      |||+.||++.|+++.+....+
T Consensus       337 Rps~~ell~~L~~~~~~~~~~  357 (382)
T 3tt0_A          337 RPTFKQLVEDLDRIVALTSNQ  357 (382)
T ss_dssp             SCCHHHHHHHHHHHHHHSCSC
T ss_pred             CcCHHHHHHHHHHHHHHHhcC
Confidence            999999999999998765443

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.4e-43  Score=341.20  Aligned_cols=247  Identities=21%  Similarity=0.331  Sum_probs=198.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec---cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ---QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .++|+..+.||+|+||.||+|+.. +|+.||+|+++..   .......+.+|++++++++||||+++++++     ...+
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~   78 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCC
Confidence            467889999999999999999975 6999999999754   233456789999999999999999999985     5667


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+++|+|.+++...       ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~D  148 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSRE-------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITD  148 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred             EEEEEEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEee
Confidence            899999999999999998743       4589999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      ||+++....       .........||+.|+|||++ ...++.++|||||||++|||++|+.||.......         
T Consensus       149 FG~a~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---------  212 (337)
T 1o6l_A          149 FGLCKEGIS-------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---------  212 (337)
T ss_dssp             CTTCBCSCC-------TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---------
T ss_pred             ccchhhccc-------CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH---------
Confidence            999975421       11223456799999999999 5568999999999999999999999996532110         


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC-----ChHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRV-----GMKFVVN  463 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  463 (477)
                          ....+.....               .+|.           .....+.+++.+||+.||.+||     +++|+++
T Consensus       213 ----~~~~i~~~~~---------------~~p~-----------~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          213 ----LFELILMEEI---------------RFPR-----------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ----HHHHHHHCCC---------------CCCT-----------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ----HHHHHHcCCC---------------CCCC-----------CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence                0000110000               0000           0123478999999999999999     8998875

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.8e-44  Score=333.67  Aligned_cols=257  Identities=26%  Similarity=0.465  Sum_probs=206.6

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      .++|+..+.||+|+||.||+|...+++.||+|+++..... .+.+.+|++++.+++||||+++++++     ...+..++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   80 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPICL   80 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSCEE
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCCeEE
Confidence            3578888999999999999999988899999999865433 36789999999999999999999996     44567899


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      ||||+++++|.+++....      ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        81 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~  151 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQR------GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT  151 (267)
T ss_dssp             EECCCTTCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGG
T ss_pred             EEeCCCCCcHHHHHhhCc------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccc
Confidence            999999999999997543      4589999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCC
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      ......      .........++..|+|||.+ ...++.++||||||+++|||++ |+.||.......            
T Consensus       152 ~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------------  213 (267)
T 3t9t_A          152 RFVLDD------QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------------  213 (267)
T ss_dssp             GGBCCH------HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------------
T ss_pred             cccccc------cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH------------
Confidence            865221      12223345678899999999 5678999999999999999999 899986532111            


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHh
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSK  471 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  471 (477)
                        ..+.+......             ..+.           .+...+.+++.+|++.||++|||+.|+++.|+++.++
T Consensus       214 --~~~~i~~~~~~-------------~~~~-----------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          214 --VVEDISTGFRL-------------YKPR-----------LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             --HHHHHHTTCCC-------------CCCT-----------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --HHHHHhcCCcC-------------CCCc-----------cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence              00100000000             0000           0123478999999999999999999999999999864

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=344.24  Aligned_cols=294  Identities=23%  Similarity=0.343  Sum_probs=203.7

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHH--HhcCCCCCcceeeeecccccCCCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNA--LTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .++|+..+.||+|+||.||+|+. +++.||||+++....   ..+..|.++  +..++||||+++++.+...........
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            56888999999999999999987 689999999975432   344444444  556899999999987655445666678


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCC------CCCeeecCCCCCCeEecCCCcE
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQY------DTPIAHCDLKSSNVLLDEGMIA  307 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~~ivH~dlkp~NIll~~~~~~  307 (477)
                      ++||||+++|+|.+++...        ..++..++.++.|++.||.|||+.+      .++|+||||||+|||++.++.+
T Consensus        88 ~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  159 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLH--------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC  159 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred             EEEEecCCCCcHHHHHhhc--------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence            9999999999999999654        3588999999999999999999863      3389999999999999999999


Q ss_pred             EEecccccccccccCCCCC-CCccccCCCcccccccCcccccC--------CCCcccceeehHHHHHHHhhCCCCCCccc
Q 043902          308 HVGDFGLAKFLFEESNTPS-KNQTMSNGLKGSVGYIPPEYING--------HVSILGDIYSYGILLLEIFTGKRPTDDMF  378 (477)
Q Consensus       308 kl~DfG~a~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~Dv~S~Gvvl~elltg~~p~~~~~  378 (477)
                      ||+|||+++.+........ ..........||..|+|||++.+        .++.++|||||||++|||+||..||....
T Consensus       160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  239 (336)
T 3g2f_A          160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE  239 (336)
T ss_dssp             EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred             EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence            9999999987643211110 11222334569999999999854        46789999999999999999987764322


Q ss_pred             ccccceeeeeeccC-CchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCC
Q 043902          379 KDDLSIHKFVLMAL-PSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVG  457 (477)
Q Consensus       379 ~~~~~~~~~~~~~~-~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs  457 (477)
                      ........+..... .....++ .......  .  .+    ..++....     ....+...+.+++.+||+.||++|||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~--~~----~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps  305 (336)
T 3g2f_A          240 SVPEYQMAFQTEVGNHPTFEDM-QVLVSRE--K--QR----PKFPEAWK-----ENSLAVRSLKETIEDCWDQDAEARLT  305 (336)
T ss_dssp             CCCCCCCTTHHHHCSSCCHHHH-HHHHTTS--C--CC----CCCCTTCC-----CCSHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred             chhHHHHhhhcccCCCchHHHH-Hhhhccc--c--cC----CCCCcccc-----cccchHHHHHHHHHHHhcCChhhCcc
Confidence            11110000000000 0000000 0000000  0  00    00000000     00112445899999999999999999


Q ss_pred             hHHHHHHHHHHHHhhhhc
Q 043902          458 MKFVVNNLQAIRSKIRMR  475 (477)
Q Consensus       458 ~~evl~~L~~i~~~~~~~  475 (477)
                      ++|+++.|+++...+...
T Consensus       306 ~~e~l~~L~~ll~~~~~~  323 (336)
T 3g2f_A          306 AQXAEERMAELMMIWERN  323 (336)
T ss_dssp             HHHHHHHHHHHHHCCCC-
T ss_pred             hHHHHHHHHHHHHHHHhc
Confidence            999999999999876543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.5e-44  Score=345.67  Aligned_cols=266  Identities=24%  Similarity=0.441  Sum_probs=208.2

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe------CCCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL------ADGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYE  228 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  228 (477)
                      .++|...+.||+|+||.||+|..      .+++.||+|+++... ....+.+.+|++++++++||||+++++++     .
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~   96 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC-----S   96 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE-----e
Confidence            56788899999999999999985      245789999997543 34457889999999999999999999996     4


Q ss_pred             CCceeeEEEeecCCCChhhhcccCCCcc-----------------cccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeee
Q 043902          229 GNDFKALVFEFMRNGNLDQWLHPSTDEY-----------------CHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAH  291 (477)
Q Consensus       229 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~-----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH  291 (477)
                      ..+..++||||+++|+|.+++.......                 .....+++..++.++.|++.||.|||++   +|+|
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH  173 (314)
T 2ivs_A           97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVH  173 (314)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcc
Confidence            5667899999999999999997643200                 0123489999999999999999999999   9999


Q ss_pred             cCCCCCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-
Q 043902          292 CDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-  369 (477)
Q Consensus       292 ~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-  369 (477)
                      |||||+||+++.++.+||+|||+++.....     ..........+|..|+|||.+ ...++.++|||||||++|||+| 
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~  248 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEE-----DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL  248 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTT-----SCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred             cccchheEEEcCCCCEEEcccccccccccc-----ccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhC
Confidence            999999999999999999999999865321     112223345578899999998 5668999999999999999999 


Q ss_pred             CCCCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCC
Q 043902          370 GKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSA  449 (477)
Q Consensus       370 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~  449 (477)
                      |+.||......              .+...+.......             .+           ..+...+.+++.+||+
T Consensus       249 g~~p~~~~~~~--------------~~~~~~~~~~~~~-------------~~-----------~~~~~~~~~li~~~l~  290 (314)
T 2ivs_A          249 GGNPYPGIPPE--------------RLFNLLKTGHRME-------------RP-----------DNCSEEMYRLMLQCWK  290 (314)
T ss_dssp             SCCSSTTCCGG--------------GHHHHHHTTCCCC-------------CC-----------TTCCHHHHHHHHHHTC
T ss_pred             CCCCCCCCCHH--------------HHHHHhhcCCcCC-------------CC-----------ccCCHHHHHHHHHHcc
Confidence            99999653221              1111111110000             00           0113348899999999


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhh
Q 043902          450 ASPRDRVGMKFVVNNLQAIRSKI  472 (477)
Q Consensus       450 ~dP~~RPs~~evl~~L~~i~~~~  472 (477)
                      .||++|||+.|+++.|+++..+.
T Consensus       291 ~dp~~Rps~~~l~~~l~~~~~~~  313 (314)
T 2ivs_A          291 QEPDKRPVFADISKDLEKMMVKR  313 (314)
T ss_dssp             SSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             CChhhCcCHHHHHHHHHHHHhhc
Confidence            99999999999999999998764

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.1e-44  Score=369.09  Aligned_cols=258  Identities=26%  Similarity=0.475  Sum_probs=207.4

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ..++|...+.||+|+||.||+|.+. ++..||||+++.... ..+.|.+|++++++++||||++++++|     ......
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~-----~~~~~~  291 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPF  291 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSC
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEE-----ecCCcE
Confidence            3456788899999999999999976 488999999986543 357899999999999999999999997     445678


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||+++|+|.+++.....     ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG  363 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNR-----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFG  363 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTT
T ss_pred             EEEEEccCCCCHHHHHHhcCc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecc
Confidence            999999999999999975421     4589999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeecc
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      +++....      ..........++..|+|||.+ .+.++.++|||||||++|||+| |+.||......           
T Consensus       364 ~a~~~~~------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-----------  426 (495)
T 1opk_A          364 LSRLMTG------DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----------  426 (495)
T ss_dssp             CEECCTT------CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----------
T ss_pred             cceeccC------CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-----------
Confidence            9987522      112223345567899999999 5679999999999999999999 99999753221           


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRS  470 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  470 (477)
                         .+.+.+.......                        .+..++..+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus       427 ---~~~~~~~~~~~~~------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          427 ---QVYELLEKDYRME------------------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             ---GHHHHHHTTCCCC------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             ---HHHHHHHcCCCCC------------------------CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence               1111121111000                        001123458899999999999999999999999987644

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.5e-44  Score=347.72  Aligned_cols=258  Identities=26%  Similarity=0.463  Sum_probs=197.1

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCE----EEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGET----AAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEG  229 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  229 (477)
                      .++|+..+.||+|+||.||+|++. +++.    ||+|.++... ....+.+.+|+.++++++||||++++++|..     
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----   88 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----   88 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES-----
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----
Confidence            467889999999999999999864 4443    5788775432 3445789999999999999999999999742     


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEE
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV  309 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl  309 (477)
                       ...++|+||+++|+|.+++....      ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||
T Consensus        89 -~~~~~v~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl  158 (327)
T 3poz_A           89 -STVQLITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKI  158 (327)
T ss_dssp             -SSEEEEEECCTTCBHHHHHHHST------TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEE
T ss_pred             -CCeEEEEEecCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEE
Confidence             23789999999999999997643      5689999999999999999999999   9999999999999999999999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeee
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~  387 (477)
                      +|||+++......     .........+|..|+|||.+ .+.++.++|||||||++|||+| |+.||.......      
T Consensus       159 ~Dfg~a~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------  227 (327)
T 3poz_A          159 TDFGLAKLLGAEE-----KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------  227 (327)
T ss_dssp             CCTTHHHHHTTTC-----C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------
T ss_pred             ccCcceeEccCCc-----ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH------
Confidence            9999998763211     12223344578899999999 6679999999999999999999 999997532211      


Q ss_pred             eeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHH
Q 043902          388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQA  467 (477)
Q Consensus       388 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  467 (477)
                              +...+.......             .+           ..+...+.+++.+||+.||.+|||+.|+++.|+.
T Consensus       228 --------~~~~~~~~~~~~-------------~~-----------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~  275 (327)
T 3poz_A          228 --------ISSILEKGERLP-------------QP-----------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK  275 (327)
T ss_dssp             --------HHHHHHTTCCCC-------------CC-----------TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHH
T ss_pred             --------HHHHHHcCCCCC-------------CC-----------ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence                    112221111000             00           0013348899999999999999999999999999


Q ss_pred             HHHh
Q 043902          468 IRSK  471 (477)
Q Consensus       468 i~~~  471 (477)
                      +...
T Consensus       276 ~~~~  279 (327)
T 3poz_A          276 MARD  279 (327)
T ss_dssp             HHTS
T ss_pred             HHhh
Confidence            8754

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.5e-44  Score=341.61  Aligned_cols=261  Identities=28%  Similarity=0.491  Sum_probs=194.5

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ..++|+..+.||+|+||.||+|+..  ..||+|+++...  ....+.+.+|++++++++||||+++++++      ....
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~------~~~~   93 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS------TAPQ   93 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE------CSSS
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec------cCCc
Confidence            3578999999999999999999864  469999997543  34457899999999999999999999974      3445


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++++|.+++....      ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+||
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Df  164 (289)
T 3og7_A           94 LAIVTQWCEGSSLYHHLHASE------TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDF  164 (289)
T ss_dssp             CEEEEECCCEEEHHHHHTTC---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCC
T ss_pred             cEEEEEecCCCcHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccc
Confidence            799999999999999997543      5689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCccccc----CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeee
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN----GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~  388 (477)
                      |++......     ..........||..|+|||.+.    ..++.++||||||+++|||++|+.||.......       
T Consensus       165 g~~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------  232 (289)
T 3og7_A          165 GLATEKSRW-----SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-------  232 (289)
T ss_dssp             C-----------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-------
T ss_pred             eeccccccc-----cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-------
Confidence            999765221     1122233456899999999983    357889999999999999999999997532211       


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                            .+.+.+.......   .         .+..        ...++..+.+++.+||+.||.+|||+.|+++.|+++
T Consensus       233 ------~~~~~~~~~~~~~---~---------~~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l  286 (289)
T 3og7_A          233 ------QIIEMVGRGSLSP---D---------LSKV--------RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL  286 (289)
T ss_dssp             ------HHHHHHHHTSCCC---C---------TTSS--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             ------HHHHHhcccccCc---c---------hhhc--------cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence                  1111111110000   0         0000        001234588999999999999999999999999987


Q ss_pred             HH
Q 043902          469 RS  470 (477)
Q Consensus       469 ~~  470 (477)
                      .+
T Consensus       287 ~~  288 (289)
T 3og7_A          287 AR  288 (289)
T ss_dssp             TC
T ss_pred             hh
Confidence            64

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.6e-44  Score=342.71  Aligned_cols=258  Identities=25%  Similarity=0.406  Sum_probs=196.4

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      .++|+..+.||+|+||.||+|+.. ++.||+|+++...  ..+.+.+|++++++++||||+++++++.       +..++
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~~~~l   76 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACL-------NPVCL   76 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCT-------TTTEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEc-------CCcEE
Confidence            357888899999999999999984 7889999987443  3478999999999999999999999863       23789


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCc-EEEecccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI-AHVGDFGL  314 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~-~kl~DfG~  314 (477)
                      ||||+++|+|.+++.....    ...+++..++.++.|+++||.|||+....+|+||||||+||+++.++. +||+|||+
T Consensus        77 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~  152 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAEP----LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT  152 (307)
T ss_dssp             EEECCTTCBHHHHHHCSSS----EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred             EEEcCCCCCHHHHHhccCC----CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence            9999999999999976531    245789999999999999999999932229999999999999988876 79999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCC
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      +.....          ......||..|+|||.+ ...++.++|||||||++|||+||+.||.........          
T Consensus       153 ~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----------  212 (307)
T 2eva_A          153 ACDIQT----------HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR----------  212 (307)
T ss_dssp             ----------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH----------
T ss_pred             cccccc----------ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH----------
Confidence            975421          12234589999999999 457899999999999999999999999753221100          


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHhhh
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSKIR  473 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~  473 (477)
                        ..........            ....            ..++..+.+++.+||+.||++|||+.|+++.|+.+.+.+.
T Consensus       213 --~~~~~~~~~~------------~~~~------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  266 (307)
T 2eva_A          213 --IMWAVHNGTR------------PPLI------------KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP  266 (307)
T ss_dssp             --HHHHHHTTCC------------CCCB------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred             --HHHHHhcCCC------------CCcc------------cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence              0000000000            0000            0112347899999999999999999999999999987653

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6e-44  Score=335.63  Aligned_cols=253  Identities=28%  Similarity=0.483  Sum_probs=189.4

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccc----hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQ----GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .++|+..+.||+|+||.||+|... |+.||||+++....    ...+.+.+|++++++++||||++++++|     ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   79 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC-----LKEP   79 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCC-
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ecCC
Confidence            467888999999999999999984 88999999875432    2346789999999999999999999996     4566


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC--------
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE--------  303 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~--------  303 (477)
                      ..++||||+++++|.+++..        ..+++..++.++.|++.||.|||++...+|+||||||+||+++.        
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~  151 (271)
T 3dtc_A           80 NLCLVMEFARGGPLNRVLSG--------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLS  151 (271)
T ss_dssp             -CEEEEECCTTEEHHHHHTS--------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCS
T ss_pred             ceEEEEEcCCCCCHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccccc
Confidence            78999999999999999863        35899999999999999999999981112999999999999986        


Q ss_pred             CCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCccccccc
Q 043902          304 GMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDL  382 (477)
Q Consensus       304 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~  382 (477)
                      ++.+||+|||++.....         .......||..|+|||.+ ...++.++||||||+++|||+||+.||........
T Consensus       152 ~~~~kl~Dfg~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  222 (271)
T 3dtc_A          152 NKILKITDFGLAREWHR---------TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV  222 (271)
T ss_dssp             SCCEEECCCCC----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH
T ss_pred             CcceEEccCCccccccc---------ccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            77899999999976522         112234689999999999 55689999999999999999999999975321110


Q ss_pred             ceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHH
Q 043902          383 SIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVV  462 (477)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl  462 (477)
                                   ............             .+           ..+...+.+++.+|++.||++|||+.|++
T Consensus       223 -------------~~~~~~~~~~~~-------------~~-----------~~~~~~~~~li~~~l~~~p~~Rps~~e~l  265 (271)
T 3dtc_A          223 -------------AYGVAMNKLALP-------------IP-----------STCPEPFAKLMEDCWNPDPHSRPSFTNIL  265 (271)
T ss_dssp             -------------HHHHHTSCCCCC-------------CC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             -------------HHhhhcCCCCCC-------------CC-----------cccCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence                         000000000000             00           01133488999999999999999999999


Q ss_pred             HHHHHH
Q 043902          463 NNLQAI  468 (477)
Q Consensus       463 ~~L~~i  468 (477)
                      +.|++|
T Consensus       266 ~~L~~l  271 (271)
T 3dtc_A          266 DQLTTI  271 (271)
T ss_dssp             HHHHC-
T ss_pred             HHHhcC
Confidence            999864

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=7.9e-44  Score=334.61  Aligned_cols=255  Identities=23%  Similarity=0.381  Sum_probs=201.1

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .++|...+.||+|+||.||+|+.. ++.||+|+++...  ....+.+.+|+.++.+++||||++++++|..   ......
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~~   84 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS---PPAPHP   84 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECT---TTSSSC
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEcc---CCCCCe
Confidence            467889999999999999999985 8899999998653  3345679999999999999999999999742   223678


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeecCCCCCCeEecCCCcEEEec
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTP--IAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ++||||+++|+|.+++.....     ..+++..++.++.|++.||.|||+.   +  ++||||||+||+++.++.++|+|
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~  156 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGTN-----FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISM  156 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCSS-----CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred             EeeecccCCCcHHHHHhhccc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEe
Confidence            999999999999999986532     3589999999999999999999998   7  99999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccccC-C---CCcccceeehHHHHHHHhhCCCCCCcccccccceeee
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-H---VSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~---~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~  387 (477)
                      ||++...            ......||+.|+|||.+.+ .   ++.++|||||||++|||+||+.||........     
T Consensus       157 ~~~~~~~------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----  219 (271)
T 3kmu_A          157 ADVKFSF------------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-----  219 (271)
T ss_dssp             GGSCCTT------------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-----
T ss_pred             ccceeee------------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-----
Confidence            9987542            1123467899999999943 2   34489999999999999999999975322110     


Q ss_pred             eeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHH
Q 043902          388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQA  467 (477)
Q Consensus       388 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  467 (477)
                              ...........             ..+           ..+...+.+++..||+.||++|||++|+++.|++
T Consensus       220 --------~~~~~~~~~~~-------------~~~-----------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~  267 (271)
T 3kmu_A          220 --------GMKVALEGLRP-------------TIP-----------PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEK  267 (271)
T ss_dssp             --------HHHHHHSCCCC-------------CCC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --------HHHHHhcCCCC-------------CCC-----------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                    00000000000             000           0113348899999999999999999999999999


Q ss_pred             HHHh
Q 043902          468 IRSK  471 (477)
Q Consensus       468 i~~~  471 (477)
                      ++++
T Consensus       268 l~~~  271 (271)
T 3kmu_A          268 MQDK  271 (271)
T ss_dssp             HCC-
T ss_pred             hhcC
Confidence            8653

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-43  Score=341.25  Aligned_cols=250  Identities=20%  Similarity=0.312  Sum_probs=199.2

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccch------hhHHHHHHHHHHhcCCCCCcceeeeecccccCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQG------ALKSFIDECNALTSIRHRNILKIVSSCSSVDYE  228 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  228 (477)
                      .+.|...+.||+|+||.||+|... +|+.||+|+++.....      ..+.+.+|+.++.+++||||+++++++     .
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~   84 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E   84 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence            457888999999999999999975 6899999999754321      356789999999999999999999996     5


Q ss_pred             CCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC---
Q 043902          229 GNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM---  305 (477)
Q Consensus       229 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~---  305 (477)
                      .....++||||+++|+|.+++...       ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++   
T Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~  154 (326)
T 2y0a_A           85 NKTDVILILELVAGGELFDFLAEK-------ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPK  154 (326)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHTTS-------SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSS
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhc-------CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCC
Confidence            567899999999999999999754       4689999999999999999999999   999999999999999887   


Q ss_pred             -cEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccc
Q 043902          306 -IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLS  383 (477)
Q Consensus       306 -~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~  383 (477)
                       .+||+|||+++.....        .......||+.|+|||++ ...++.++|||||||++|||++|+.||.......  
T Consensus       155 ~~~kl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--  224 (326)
T 2y0a_A          155 PRIKIIDFGLAHKIDFG--------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--  224 (326)
T ss_dssp             CCEEECCCTTCEECCTT--------SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--
T ss_pred             CCEEEEECCCCeECCCC--------CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--
Confidence             8999999999875221        122345689999999999 4578999999999999999999999996532111  


Q ss_pred             eeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          384 IHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       384 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                                 .+..+......                      ........+...+.+++.+||+.||++|||+.|+++
T Consensus       225 -----------~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          225 -----------TLANVSAVNYE----------------------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             -----------HHHHHHHTCCC----------------------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -----------HHHHHHhcCCC----------------------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                       00000000000                      000011112344789999999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-43  Score=348.23  Aligned_cols=263  Identities=26%  Similarity=0.444  Sum_probs=194.7

Q ss_pred             CCCCCCeeeeeccceEEEEEeC--CC--CEEEEEEeeec-cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA--DG--ETAAIKVLKLQ-QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .|...+.||+|+||.||+|+..  ++  ..||+|.++.. .....+.+.+|+.++++++||||++++++|.    ..++.
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~----~~~~~  165 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGS  165 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEEC----CCSSC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE----cCCCC
Confidence            3556689999999999999863  22  36899998743 3345678999999999999999999999873    44567


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++|+|.+++....      ..+++..++.++.|+++||.|||++   +|+||||||+||+++.++.+||+||
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DF  236 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNET------HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADF  236 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTT------CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEECCCCCCHHHHHhhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeec
Confidence            899999999999999997543      4578999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeec
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  390 (477)
                      |+++........   .........+|..|+|||.+ .+.++.++|||||||++|||+| |.+||.......         
T Consensus       237 G~a~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---------  304 (373)
T 3c1x_A          237 GLARDMYDKEFD---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---------  304 (373)
T ss_dssp             ------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---------
T ss_pred             cccccccccccc---cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---------
Confidence            999865321111   11122345678899999999 6678999999999999999999 677776532211         


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRS  470 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  470 (477)
                           ....+.....         .    ..|           +.++..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus       305 -----~~~~~~~~~~---------~----~~p-----------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~  355 (373)
T 3c1x_A          305 -----ITVYLLQGRR---------L----LQP-----------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  355 (373)
T ss_dssp             -----HHHHHHTTCC---------C----CCC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----HHHHHHcCCC---------C----CCC-----------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                 0000000000         0    000           0113348899999999999999999999999999988


Q ss_pred             hhhh
Q 043902          471 KIRM  474 (477)
Q Consensus       471 ~~~~  474 (477)
                      .+..
T Consensus       356 ~~~~  359 (373)
T 3c1x_A          356 TFIG  359 (373)
T ss_dssp             TCCS
T ss_pred             hccc
Confidence            7653

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.9e-44  Score=343.26  Aligned_cols=273  Identities=23%  Similarity=0.399  Sum_probs=202.8

Q ss_pred             cCCCCCCeeeeeccceEEEEEe-----CCCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTL-----ADGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      +.|+..+.||+|+||.||+|++     .+++.||+|+++... ....+.+.+|++++.+++||||+++++++..   ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   97 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGG   97 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCC
Confidence            4578889999999999999984     368899999998543 3345788999999999999999999999742   333


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ...++||||+++|+|.+++....      ..+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~  168 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKNK------NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIG  168 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHHT------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEEC
T ss_pred             ceEEEEEEeCCCCcHHHHHHhcc------ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEEC
Confidence            56899999999999999996433      4589999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      |||++......    ...........||..|+|||.+ ...++.++||||||+++|||+||..|+..........   ..
T Consensus       169 Dfg~~~~~~~~----~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~  241 (302)
T 4e5w_A          169 DFGLTKAIETD----KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKM---IG  241 (302)
T ss_dssp             CCTTCEECCTT----CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH---HC
T ss_pred             cccccccccCC----CcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhc---cC
Confidence            99999876321    1112233455688899999999 5678999999999999999999999865421110000   00


Q ss_pred             ccCCc-hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          390 MALPS-HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       390 ~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                      ..... ....+... ....     ...    ..           ...+...+.+++.+||+.||.+|||+.|+++.|+++
T Consensus       242 ~~~~~~~~~~~~~~-~~~~-----~~~----~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          242 PTHGQMTVTRLVNT-LKEG-----KRL----PC-----------PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             SCCGGGHHHHHHHH-HHTT-----CCC----CC-----------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CcccccCHHHHHHH-Hhcc-----CCC----CC-----------CCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            00000 00111100 0000     000    00           001134588999999999999999999999999987


Q ss_pred             H
Q 043902          469 R  469 (477)
Q Consensus       469 ~  469 (477)
                      .
T Consensus       301 l  301 (302)
T 4e5w_A          301 L  301 (302)
T ss_dssp             H
T ss_pred             h
Confidence            5

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=7.6e-44  Score=346.70  Aligned_cols=271  Identities=25%  Similarity=0.457  Sum_probs=208.2

Q ss_pred             HHHhhcCCCCCCeeeeeccceEEEEEeC------CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeeccc
Q 043902          152 ISNATDNFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSS  224 (477)
Q Consensus       152 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  224 (477)
                      +....++|...+.||+|+||.||+|+..      +++.||+|+++... ....+.+.+|++++++++||||++++++|  
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--  119 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC--  119 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE--
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE--
Confidence            3445688999999999999999999874      34789999998543 33457899999999999999999999996  


Q ss_pred             ccCCCCceeeEEEeecCCCChhhhcccCCCcc-----------------cccccCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 043902          225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEY-----------------CHFKKLSLMQRLNIVIDVASALDYLHNQYDT  287 (477)
Q Consensus       225 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~  287 (477)
                         ...+..++||||+++|+|.+++.......                 .....+++..++.++.||+.||.|||++   
T Consensus       120 ---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---  193 (343)
T 1luf_A          120 ---AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---  193 (343)
T ss_dssp             ---CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             ---ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence               44667899999999999999997642110                 0125689999999999999999999999   


Q ss_pred             CeeecCCCCCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHH
Q 043902          288 PIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLE  366 (477)
Q Consensus       288 ~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~e  366 (477)
                      +|+||||||+||+++.++.+||+|||+++......     .........+|..|+|||.+ .+.++.++|||||||++||
T Consensus       194 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~e  268 (343)
T 1luf_A          194 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD-----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE  268 (343)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG-----CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             CeecCCCCcceEEECCCCeEEEeecCCCcccccCc-----cccccCCCcccceecChhhhccCCcCcccccHHHHHHHHH
Confidence            99999999999999999999999999998653211     11222345678999999998 5679999999999999999


Q ss_pred             Hhh-CCCCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhh
Q 043902          367 IFT-GKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGV  445 (477)
Q Consensus       367 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  445 (477)
                      |+| |..||........             ...+.+....              ..+           +.++..+.+++.
T Consensus       269 l~t~g~~p~~~~~~~~~-------------~~~~~~~~~~--------------~~~-----------~~~~~~l~~li~  310 (343)
T 1luf_A          269 IFSYGLQPYYGMAHEEV-------------IYYVRDGNIL--------------ACP-----------ENCPLELYNLMR  310 (343)
T ss_dssp             HHTTTCCTTTTSCHHHH-------------HHHHHTTCCC--------------CCC-----------TTCCHHHHHHHH
T ss_pred             HHhcCCCcCCCCChHHH-------------HHHHhCCCcC--------------CCC-----------CCCCHHHHHHHH
Confidence            999 9999965321110             0000000000              000           011334889999


Q ss_pred             hcCCCCCCCCCChHHHHHHHHHHHHhhh
Q 043902          446 MCSAASPRDRVGMKFVVNNLQAIRSKIR  473 (477)
Q Consensus       446 ~Cl~~dP~~RPs~~evl~~L~~i~~~~~  473 (477)
                      +||+.||++|||+.|+++.|+++.++..
T Consensus       311 ~~l~~~p~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          311 LCWSKLPADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred             HHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence            9999999999999999999999887654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.3e-43  Score=349.30  Aligned_cols=209  Identities=19%  Similarity=0.256  Sum_probs=176.8

Q ss_pred             hcCCCCCCeeeee--ccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          156 TDNFSEENLIGSG--SFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       156 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      .++|++.+.||+|  +||.||+|+.. +|+.||||+++...  ....+.+.+|++++++++||||+++++++     ...
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~   98 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF-----IAD   98 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EET
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEE-----EEC
Confidence            5689999999999  99999999976 79999999998553  33456788899999999999999999996     456


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +..++||||+++|+|.+++.....     ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~  170 (389)
T 3gni_B           99 NELWVVTSFMAYGSAKDLICTHFM-----DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLS  170 (389)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHTCT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred             CEEEEEEEccCCCCHHHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEc
Confidence            789999999999999999975422     4589999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccccC---CCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      |||.+.....................||..|+|||++.+   .++.++|||||||++|||++|+.||...
T Consensus       171 dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  240 (389)
T 3gni_B          171 GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  240 (389)
T ss_dssp             CGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             ccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence            999987653322111111222334578999999999943   6899999999999999999999999764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.2e-43  Score=336.58  Aligned_cols=266  Identities=26%  Similarity=0.429  Sum_probs=203.6

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCC----CCEEEEEEeeec-cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLAD----GETAAIKVLKLQ-QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      ..+|...+.||+|+||.||+|+..+    ...+|+|.++.. .....+.+.+|+.++++++||||++++++|.    ..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~   99 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSE   99 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC----CSS
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE----cCC
Confidence            4567888999999999999998642    235899988753 3344578999999999999999999999863    455


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +..++||||+++|+|.+++....      ..+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~  170 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRNET------HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVA  170 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTT------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEEC
T ss_pred             CceEEEEeCCCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEEC
Confidence            67899999999999999997543      5589999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~  388 (477)
                      |||+++........   .........+|..|+|||.+ ...++.++||||||+++|||++ |.+||.......       
T Consensus       171 Dfg~a~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-------  240 (298)
T 3f66_A          171 DFGLARDMYDKEYY---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------  240 (298)
T ss_dssp             SCGGGCCCSCGGGC---BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-------
T ss_pred             cccccccccccchh---ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-------
Confidence            99999865322111   12223445678899999999 5678999999999999999999 555554422111       


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                             ....+.....         .    ..+.           .++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       241 -------~~~~~~~~~~---------~----~~~~-----------~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  289 (298)
T 3f66_A          241 -------ITVYLLQGRR---------L----LQPE-----------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  289 (298)
T ss_dssp             -------HHHHHHTTCC---------C----CCCT-----------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------HHHHHhcCCC---------C----CCCc-----------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                   0000000000         0    0000           0123488999999999999999999999999999


Q ss_pred             HHhhhhc
Q 043902          469 RSKIRMR  475 (477)
Q Consensus       469 ~~~~~~~  475 (477)
                      ...+..+
T Consensus       290 ~~~~~~~  296 (298)
T 3f66_A          290 FSTFIGE  296 (298)
T ss_dssp             HHTSCCS
T ss_pred             HHhhccC
Confidence            9876543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.9e-43  Score=332.40  Aligned_cols=260  Identities=24%  Similarity=0.486  Sum_probs=206.5

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      .++|+..+.||+|+||.||+|...++..||+|+++.... ..+.+.+|++++++++||||+++++++.      .+..++
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~   84 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYI   84 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCEE
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc------CCCcEE
Confidence            467888999999999999999998888999999975433 3478999999999999999999999853      345799


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      ||||+++++|.+++....     ...+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        85 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~  156 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTPS-----GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLA  156 (279)
T ss_dssp             EEECCTTCBHHHHTTSHH-----HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEecCCCCCHHHHHhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccc
Confidence            999999999999997431     13689999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCC
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      ......      .........++..|+|||.+ .+.++.++||||||+++|||+| |+.||.......            
T Consensus       157 ~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------------  218 (279)
T 1qpc_A          157 RLIEDN------EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------------  218 (279)
T ss_dssp             EECSSS------CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------------
T ss_pred             ccccCc------ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH------------
Confidence            875321      12223345578899999999 5678999999999999999999 999986532111            


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHhhh
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSKIR  473 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~  473 (477)
                        ....+.......             .+           ..+...+.+++.+|++.||++|||+.++++.|+++.....
T Consensus       219 --~~~~~~~~~~~~-------------~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  272 (279)
T 1qpc_A          219 --VIQNLERGYRMV-------------RP-----------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE  272 (279)
T ss_dssp             --HHHHHHTTCCCC-------------CC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             --HHHHHhcccCCC-------------Cc-----------ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence              111110000000             00           0112348899999999999999999999999999987754


Q ss_pred             h
Q 043902          474 M  474 (477)
Q Consensus       474 ~  474 (477)
                      .
T Consensus       273 ~  273 (279)
T 1qpc_A          273 G  273 (279)
T ss_dssp             -
T ss_pred             C
Confidence            4

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=8.2e-45  Score=366.12  Aligned_cols=259  Identities=27%  Similarity=0.485  Sum_probs=202.1

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      ..++|...+.||+|+||.||+|.+.++..||||+++.... ..+.|.+|++++++++||||++++++|.      .+..+
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~------~~~~~  254 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIY  254 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEc------CCceE
Confidence            4567888899999999999999998888899999986543 3478999999999999999999999963      24579


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +||||+++|+|.+++....     ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       255 iv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~  326 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGET-----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGL  326 (452)
T ss_dssp             EEECCCTTCBHHHHHSHHH-----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred             EEehhhcCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCcc
Confidence            9999999999999997431     14589999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccC
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMAL  392 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  392 (477)
                      ++.....      .........++..|+|||.+ .+.++.++|||||||++|||+| |+.||.......           
T Consensus       327 a~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-----------  389 (452)
T 1fmk_A          327 ARLIEDN------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----------  389 (452)
T ss_dssp             TC--------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----------
T ss_pred             ceecCCC------ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-----------
Confidence            9865321      11222344578899999998 6789999999999999999999 999996532111           


Q ss_pred             CchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHhh
Q 043902          393 PSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSKI  472 (477)
Q Consensus       393 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  472 (477)
                         +.+.+.......             .           ...++..+.+++.+||+.||++|||++++++.|+.+....
T Consensus       390 ---~~~~i~~~~~~~-------------~-----------~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          390 ---VLDQVERGYRMP-------------C-----------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             ---HHHHHHTTCCCC-------------C-----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             ---HHHHHHcCCCCC-------------C-----------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence               111111100000             0           0112345889999999999999999999999999886544

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.7e-43  Score=335.54  Aligned_cols=252  Identities=28%  Similarity=0.495  Sum_probs=197.6

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccch-------hhHHHHHHHHHHhcCCCCCcceeeeecccccC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQG-------ALKSFIDECNALTSIRHRNILKIVSSCSSVDY  227 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  227 (477)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++......       ..+.+.+|++++++++||||+++++++.    
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----   93 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH----   93 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET----
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec----
Confidence            468889999999999999999974 7899999998654321       1267899999999999999999999863    


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeecCCCCCCeEecCCC
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTP--IAHCDLKSSNVLLDEGM  305 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~dlkp~NIll~~~~  305 (477)
                       +.  .++||||+++|+|.+++....      ..+++..++.++.|++.||.|||++   +  |+||||||+||+++.++
T Consensus        94 -~~--~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~  161 (287)
T 4f0f_A           94 -NP--PRMVMEFVPCGDLYHRLLDKA------HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLD  161 (287)
T ss_dssp             -TT--TEEEEECCTTCBHHHHHHCTT------SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCC
T ss_pred             -CC--CeEEEEecCCCCHHHHHhccc------CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccC
Confidence             22  269999999999999886543      5689999999999999999999998   8  99999999999998877


Q ss_pred             c-----EEEecccccccccccCCCCCCCccccCCCcccccccCccccc---CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          306 I-----AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN---GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       306 ~-----~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      .     +||+|||+++...          .......||..|+|||.+.   ..++.++|||||||++|||++|+.||...
T Consensus       162 ~~~~~~~kl~Dfg~~~~~~----------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  231 (287)
T 4f0f_A          162 ENAPVCAKVADFGLSQQSV----------HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY  231 (287)
T ss_dssp             TTCSCCEEECCCTTCBCCS----------SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CCCceeEEeCCCCcccccc----------ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccc
Confidence            6     9999999997541          1233456899999999982   34789999999999999999999999753


Q ss_pred             cccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCC
Q 043902          378 FKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVG  457 (477)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs  457 (477)
                      .......           ............             .+           ..+...+.+++.+||+.||.+|||
T Consensus       232 ~~~~~~~-----------~~~~~~~~~~~~-------------~~-----------~~~~~~l~~li~~~l~~dp~~Rps  276 (287)
T 4f0f_A          232 SYGKIKF-----------INMIREEGLRPT-------------IP-----------EDCPPRLRNVIELCWSGDPKKRPH  276 (287)
T ss_dssp             CCCHHHH-----------HHHHHHSCCCCC-------------CC-----------TTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred             cccHHHH-----------HHHHhccCCCCC-------------CC-----------cccCHHHHHHHHHHhcCChhhCcC
Confidence            2211100           000000000000             00           011334889999999999999999


Q ss_pred             hHHHHHHHHHH
Q 043902          458 MKFVVNNLQAI  468 (477)
Q Consensus       458 ~~evl~~L~~i  468 (477)
                      +.|+++.|+++
T Consensus       277 ~~~ll~~L~~l  287 (287)
T 4f0f_A          277 FSYIVKELSEL  287 (287)
T ss_dssp             HHHHHHHHHTC
T ss_pred             HHHHHHHHHhC
Confidence            99999999864

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-43  Score=338.61  Aligned_cols=281  Identities=19%  Similarity=0.245  Sum_probs=205.5

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .++|...+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++..   ......
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~~   84 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHK   84 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec---CCCceE
Confidence            467889999999999999999976 58999999998543 3345778899999999999999999998642   334478


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEe----cCCCcEEE
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL----DEGMIAHV  309 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl  309 (477)
                      ++||||+++|+|.+++.....    ...+++..++.++.|++.||.|||+.   +|+||||||+||++    +.++.+||
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL  157 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSN----AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKL  157 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGG----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEE
T ss_pred             EEEEeCCCCCCHHHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEE
Confidence            999999999999999976431    13489999999999999999999999   99999999999999    78889999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCccccc---------CCCCcccceeehHHHHHHHhhCCCCCCccccc
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN---------GHVSILGDIYSYGILLLEIFTGKRPTDDMFKD  380 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~  380 (477)
                      +|||+++....        ........||..|+|||++.         ..++.++|||||||++|||+||+.||......
T Consensus       158 ~Dfg~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  229 (319)
T 4euu_A          158 TDFGAARELED--------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP  229 (319)
T ss_dssp             CCCTTCEECCT--------TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG
T ss_pred             ccCCCceecCC--------CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc
Confidence            99999987632        11223456899999999873         56899999999999999999999999643221


Q ss_pred             ccceeeeeeccCCchhHHHhhhhhhhhh----cccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC
Q 043902          381 DLSIHKFVLMALPSHVMDVLDLSMLLEE----ENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRV  456 (477)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  456 (477)
                      ... .        +.+..++........    .............+.     ...........+.+++.+||+.||++||
T Consensus       230 ~~~-~--------~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~ll~~~L~~dP~~R~  295 (319)
T 4euu_A          230 RRN-K--------EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPV-----SCSLSRGLQVLLTPVLANILEADQEKCW  295 (319)
T ss_dssp             GGC-H--------HHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCT-----TCSSCHHHHHHHHHHHHHHSCCCTTTSC
T ss_pred             chh-H--------HHHHHHhcCCCcccchhhhcccCCccccCccCCc-----ccccchhHHHHhHHHHHHhccCChhhhc
Confidence            100 0        001111110000000    000000000000000     0011122345588999999999999999


Q ss_pred             ChHHHHHHHHHH
Q 043902          457 GMKFVVNNLQAI  468 (477)
Q Consensus       457 s~~evl~~L~~i  468 (477)
                      |++|+++...+.
T Consensus       296 s~~ell~h~~d~  307 (319)
T 4euu_A          296 GFDQFFAETSDI  307 (319)
T ss_dssp             CHHHHHHHHHHH
T ss_pred             cHHHhhhccHHH
Confidence            999999887653

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.1e-43  Score=338.92  Aligned_cols=291  Identities=24%  Similarity=0.378  Sum_probs=202.7

Q ss_pred             HHHHHHhhcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcC--CCCCcceeeeeccccc
Q 043902          149 YLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSI--RHRNILKIVSSCSSVD  226 (477)
Q Consensus       149 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~~  226 (477)
                      ........++|+..+.||+|+||.||+|+.. ++.||||++.....   ..+..|.+++...  +||||+++++++....
T Consensus        29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            3344455678999999999999999999985 89999999974432   4455566666554  8999999999874321


Q ss_pred             CCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeeecCCCCCCeEe
Q 043902          227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQY-----DTPIAHCDLKSSNVLL  301 (477)
Q Consensus       227 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~dlkp~NIll  301 (477)
                       ......++||||+++|+|.+++...        .+++..++.++.|++.||.|||+.+     .++|+||||||+||++
T Consensus       105 -~~~~~~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill  175 (337)
T 3mdy_A          105 -GSWTQLYLITDYHENGSLYDYLKST--------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV  175 (337)
T ss_dssp             -GGGCEEEEEECCCTTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE
T ss_pred             -CCCCceEEEEeccCCCcHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE
Confidence             1126789999999999999999643        4899999999999999999999752     3389999999999999


Q ss_pred             cCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccccC-CCCc------ccceeehHHHHHHHhhCCCCC
Q 043902          302 DEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-HVSI------LGDIYSYGILLLEIFTGKRPT  374 (477)
Q Consensus       302 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~------~~Dv~S~Gvvl~elltg~~p~  374 (477)
                      +.++.+||+|||+++........   .........||..|+|||++.+ ..+.      ++|||||||++|||+||..|+
T Consensus       176 ~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~  252 (337)
T 3mdy_A          176 KKNGTCCIADLGLAVKFISDTNE---VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG  252 (337)
T ss_dssp             CTTSCEEECCCTTCEECC------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred             CCCCCEEEEeCCCceeecccccc---ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcc
Confidence            99999999999999765321111   1112234579999999999844 3333      489999999999999995554


Q ss_pred             CcccccccceeeeeeccCC-chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCC
Q 043902          375 DDMFKDDLSIHKFVLMALP-SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPR  453 (477)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~-~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~  453 (477)
                      .........+......... ......+.....               .+......   ..+++...+.+++.+||+.||+
T Consensus       253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~  314 (337)
T 3mdy_A          253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKL---------------RPSFPNRW---SSDECLRQMGKLMTECWAHNPA  314 (337)
T ss_dssp             TBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC---------------CCCCCGGG---GGSHHHHHHHHHHHHHSCSSGG
T ss_pred             cccccccccHhhhcCCCCchhhhHHHHhhhcc---------------Cccccccc---hhhHHHHHHHHHHHHhhhhChh
Confidence            3221111111100000000 011111110000               00000000   0123466699999999999999


Q ss_pred             CCCChHHHHHHHHHHHHhhh
Q 043902          454 DRVGMKFVVNNLQAIRSKIR  473 (477)
Q Consensus       454 ~RPs~~evl~~L~~i~~~~~  473 (477)
                      +|||+.||++.|+++.+...
T Consensus       315 ~Rps~~ell~~L~~l~~~~~  334 (337)
T 3mdy_A          315 SRLTALRVKKTLAKMSESQD  334 (337)
T ss_dssp             GSCCHHHHHHHHHHHHHTTT
T ss_pred             hCCCHHHHHHHHHHHHhhcc
Confidence            99999999999999988754

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.5e-43  Score=340.11  Aligned_cols=268  Identities=26%  Similarity=0.421  Sum_probs=209.3

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEe------CCCCEEEEEEeeeccc-hhhHHHHHHHHHHhcC-CCCCcceeeeeccccc
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTL------ADGETAAIKVLKLQQQ-GALKSFIDECNALTSI-RHRNILKIVSSCSSVD  226 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  226 (477)
                      ..++|...+.||+|+||.||+|+.      .+++.||+|+++.... ...+.+.+|++++.++ +||||++++++|    
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~----   96 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC----   96 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE----
Confidence            346888999999999999999984      3568999999985432 3457899999999999 999999999996    


Q ss_pred             CCCCceeeEEEeecCCCChhhhcccCCCcc-----------cccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCC
Q 043902          227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEY-----------CHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLK  295 (477)
Q Consensus       227 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk  295 (477)
                       ...+..++||||+++|+|.+++.......           .....+++..++.++.|++.||.|||++   +|+|||||
T Consensus        97 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlk  172 (313)
T 1t46_A           97 -TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA  172 (313)
T ss_dssp             -CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             -ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCc
Confidence             45567899999999999999997653210           0113589999999999999999999999   99999999


Q ss_pred             CCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCC
Q 043902          296 SSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRP  373 (477)
Q Consensus       296 p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p  373 (477)
                      |+||+++.++.+||+|||++......     ..........+|..|+|||.+ .+.++.++|||||||++|||+| |+.|
T Consensus       173 p~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p  247 (313)
T 1t46_A          173 ARNILLTHGRITKICDFGLARDIKND-----SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP  247 (313)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSC-----TTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             cceEEEcCCCCEEEcccccccccccc-----ccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999865321     112223345678899999998 6678999999999999999999 9999


Q ss_pred             CCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCC
Q 043902          374 TDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPR  453 (477)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~  453 (477)
                      |.......             .....+.......             .+           ..+...+.+++.+||+.||.
T Consensus       248 ~~~~~~~~-------------~~~~~~~~~~~~~-------------~~-----------~~~~~~l~~li~~~l~~dp~  290 (313)
T 1t46_A          248 YPGMPVDS-------------KFYKMIKEGFRML-------------SP-----------EHAPAEMYDIMKTCWDADPL  290 (313)
T ss_dssp             STTCCSSH-------------HHHHHHHHTCCCC-------------CC-----------TTSCHHHHHHHHHHTCSSGG
T ss_pred             CCcccchh-------------HHHHHhccCCCCC-------------Cc-----------ccCCHHHHHHHHHHcCCCch
Confidence            86532111             1111111111000             00           00123488999999999999


Q ss_pred             CCCChHHHHHHHHHHHHhh
Q 043902          454 DRVGMKFVVNNLQAIRSKI  472 (477)
Q Consensus       454 ~RPs~~evl~~L~~i~~~~  472 (477)
                      +|||+.|+++.|+++.++.
T Consensus       291 ~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          291 KRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             GSCCHHHHHHHHHHHHHHT
T ss_pred             hCcCHHHHHHHHHHHHHHh
Confidence            9999999999999988764

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=7.5e-44  Score=338.03  Aligned_cols=262  Identities=26%  Similarity=0.478  Sum_probs=210.8

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ..++|+..+.||+|+||.||+|... ++..||+|+++.... ..+.+.+|++++++++||||+++++++     ......
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   84 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPF   84 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST-HHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCCE
Confidence            4567888999999999999999976 588999999975433 457899999999999999999999996     456678


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||+++++|.+++.....     ..+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg  156 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNR-----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFG  156 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCT-----TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             EEEEEcCCCCcHHHHHHhccc-----CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCc
Confidence            999999999999999976432     5689999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeecc
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      ++.....      ..........+|..|+|||.+ .+.++.++||||||+++|+|++ |..||......           
T Consensus       157 ~~~~~~~------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-----------  219 (288)
T 3kfa_A          157 LSRLMTG------DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----------  219 (288)
T ss_dssp             GGGTSCS------SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----------
T ss_pred             cceeccC------CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----------
Confidence            9986522      122233445678899999999 5678999999999999999999 99998653211           


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHh
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSK  471 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  471 (477)
                         .+.+.+.......             .+           ..++..+.+++.+|++.||.+|||+.|+++.|+.+..+
T Consensus       220 ---~~~~~~~~~~~~~-------------~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          220 ---QVYELLEKDYRME-------------RP-----------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             ---GHHHHHHTTCCCC-------------CC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---HHHHHHhccCCCC-------------CC-----------CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence               1111111110000             00           01133488999999999999999999999999998877


Q ss_pred             hhh
Q 043902          472 IRM  474 (477)
Q Consensus       472 ~~~  474 (477)
                      ...
T Consensus       273 ~~~  275 (288)
T 3kfa_A          273 SSI  275 (288)
T ss_dssp             HHH
T ss_pred             ccc
Confidence            544

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.7e-43  Score=335.94  Aligned_cols=250  Identities=23%  Similarity=0.326  Sum_probs=192.1

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc--------------------------hhhHHHHHHHHHHh
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ--------------------------GALKSFIDECNALT  208 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~  208 (477)
                      .++|+..+.||+|+||.||+|+.. +++.||||+++....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            468999999999999999999864 689999999975421                          12356899999999


Q ss_pred             cCCCCCcceeeeecccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 043902          209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTP  288 (477)
Q Consensus       209 ~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~  288 (477)
                      +++||||+++++++..   ......++||||+++++|.+++..        ..+++..++.++.|++.||.|||++   +
T Consensus        92 ~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~---~  157 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEVPTL--------KPLSEDQARFYFQDLIKGIEYLHYQ---K  157 (298)
T ss_dssp             TCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCSSCS--------SCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             hCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence            9999999999999742   235678999999999999887542        4589999999999999999999999   9


Q ss_pred             eeecCCCCCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccccCC----CCcccceeehHHHH
Q 043902          289 IAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH----VSILGDIYSYGILL  364 (477)
Q Consensus       289 ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~Dv~S~Gvvl  364 (477)
                      |+||||||+||+++.++.+||+|||+++.....       ........||..|+|||.+.+.    ++.++|||||||++
T Consensus       158 ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l  230 (298)
T 2zv2_A          158 IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS-------DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL  230 (298)
T ss_dssp             EECCCCCGGGEEECTTSCEEECCCTTCEECSSS-------SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHH
T ss_pred             eeccCCCHHHEEECCCCCEEEecCCCccccccc-------cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHH
Confidence            999999999999999999999999999865321       1223345789999999999442    47889999999999


Q ss_pred             HHHhhCCCCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHh
Q 043902          365 LEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIG  444 (477)
Q Consensus       365 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  444 (477)
                      |||++|+.||......              .+...+..... .       ...   .+            .+...+.+++
T Consensus       231 ~~l~~g~~pf~~~~~~--------------~~~~~~~~~~~-~-------~~~---~~------------~~~~~l~~li  273 (298)
T 2zv2_A          231 YCFVFGQCPFMDERIM--------------CLHSKIKSQAL-E-------FPD---QP------------DIAEDLKDLI  273 (298)
T ss_dssp             HHHHHSSCSSCCSSHH--------------HHHHHHHHCCC-C-------CCS---SS------------CCCHHHHHHH
T ss_pred             HHHHHCCCCCCCccHH--------------HHHHHHhcccC-C-------CCC---cc------------ccCHHHHHHH
Confidence            9999999999653111              00000000000 0       000   00            0123478999


Q ss_pred             hhcCCCCCCCCCChHHHHH
Q 043902          445 VMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       445 ~~Cl~~dP~~RPs~~evl~  463 (477)
                      .+||+.||++|||+.|+++
T Consensus       274 ~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          274 TRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHTCSCTTTSCCHHHHTT
T ss_pred             HHHhhcChhhCCCHHHHhc
Confidence            9999999999999999875

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.6e-43  Score=339.98  Aligned_cols=272  Identities=23%  Similarity=0.429  Sum_probs=192.9

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEEeCC-C---CEEEEEEeeec--cchhhHHHHHHHHHHhcCCCCCcceeeeecccccC
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGTLAD-G---ETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDY  227 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  227 (477)
                      ...++|+..+.||+|+||.||+|+... +   ..||||+++..  .....+.+.+|++++++++||||+++++++.....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            345789999999999999999998653 3   27999999754  34456789999999999999999999999743211


Q ss_pred             C-CCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCc
Q 043902          228 E-GNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI  306 (477)
Q Consensus       228 ~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~  306 (477)
                      . .....++||||+++|+|.+++...... .....+++..++.++.|++.||.|||++   +|+||||||+||+++.++.
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIG-ENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSC
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhcc-ccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCC
Confidence            1 111248999999999999998643211 0113589999999999999999999999   9999999999999999999


Q ss_pred             EEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccce
Q 043902          307 AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSI  384 (477)
Q Consensus       307 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~  384 (477)
                      +||+|||+++......     .........++..|+|||.+ ...++.++|||||||++|||+| |+.||........  
T Consensus       176 ~kl~Dfg~a~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--  248 (323)
T 3qup_A          176 VCVADFGLSRKIYSGD-----YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI--  248 (323)
T ss_dssp             EEECCCCC----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--
T ss_pred             EEEeeccccccccccc-----cccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH--
Confidence            9999999998653211     11222344567899999999 5678999999999999999999 9999975322110  


Q ss_pred             eeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          385 HKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       385 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                                 ...+...... .             .+           ..+...+.+++.+||+.||++|||+.|+++.
T Consensus       249 -----------~~~~~~~~~~-~-------------~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  292 (323)
T 3qup_A          249 -----------YNYLIGGNRL-K-------------QP-----------PECMEEVYDLMYQCWSADPKQRPSFTCLRME  292 (323)
T ss_dssp             -----------HHHHHTTCCC-C-------------CC-----------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -----------HHHHhcCCCC-C-------------CC-----------CccCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                       0011100000 0             00           0112348899999999999999999999999


Q ss_pred             HHHHHHhh
Q 043902          465 LQAIRSKI  472 (477)
Q Consensus       465 L~~i~~~~  472 (477)
                      |+++....
T Consensus       293 l~~~l~~~  300 (323)
T 3qup_A          293 LENILGHL  300 (323)
T ss_dssp             HHHHHHC-
T ss_pred             HHHHHHHh
Confidence            99988754

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.8e-44  Score=345.63  Aligned_cols=275  Identities=22%  Similarity=0.395  Sum_probs=209.3

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe-----CCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL-----ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      .++|+..+.||+|+||.||+|++     .+|+.||+|+++.......+.+.+|++++++++||||+++++++..   ...
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~  116 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGR  116 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe---cCC
Confidence            45688899999999999999984     3688999999987666667889999999999999999999998742   234


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ...++||||+++++|.+++....      ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~  187 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKHK------ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIG  187 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHST------TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEEC
T ss_pred             CceEEEEECCCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEe
Confidence            46899999999999999997653      4589999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      |||++.......    ..........++..|+|||.+ ...++.++|||||||++|||+||..|+........   ....
T Consensus       188 Dfg~~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~---~~~~  260 (326)
T 2w1i_A          188 DFGLTKVLPQDK----EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM---RMIG  260 (326)
T ss_dssp             CCTTCEECCSSC----SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHH---HHHC
T ss_pred             cCcchhhccccc----cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHH---Hhhc
Confidence            999998763211    111122334577889999999 55689999999999999999999999864211100   0000


Q ss_pred             ccCC-c----hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          390 MALP-S----HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       390 ~~~~-~----~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                      .... .    .+.+.+.....         .    ..           ...++..+.+++.+||+.||++|||+.||++.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~---------~----~~-----------~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~  316 (326)
T 2w1i_A          261 NDKQGQMIVFHLIELLKNNGR---------L----PR-----------PDGCPDEIYMIMTECWNNNVNQRPSFRDLALR  316 (326)
T ss_dssp             TTCCTHHHHHHHHHHHHTTCC---------C----CC-----------CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cccchhhhHHHHHHHhhcCCC---------C----CC-----------CCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            0000 0    00111110000         0    00           01123458899999999999999999999999


Q ss_pred             HHHHHHhhh
Q 043902          465 LQAIRSKIR  473 (477)
Q Consensus       465 L~~i~~~~~  473 (477)
                      |+++++++.
T Consensus       317 L~~l~~~l~  325 (326)
T 2w1i_A          317 VDQIRDQMA  325 (326)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHhc
Confidence            999998764

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=8e-43  Score=343.60  Aligned_cols=251  Identities=19%  Similarity=0.297  Sum_probs=199.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      .++|++.+.||+|+||.||+|... +|+.||+|++..........+.+|++++.+++||||+++++++     ......+
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~~  124 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV  124 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEE-----EeCCEEE
Confidence            468999999999999999999875 7899999999876555557889999999999999999999996     5567899


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC--CCcEEEecc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE--GMIAHVGDF  312 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~--~~~~kl~Df  312 (477)
                      +||||+++|+|.+++....      ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.  ++.+||+||
T Consensus       125 lv~E~~~gg~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DF  195 (387)
T 1kob_A          125 LILEFLSGGELFDRIAAED------YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDF  195 (387)
T ss_dssp             EEEECCCCCBHHHHTTCTT------CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCC
T ss_pred             EEEEcCCCCcHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEec
Confidence            9999999999999997543      4689999999999999999999999   9999999999999974  568999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      |+++....        ........||+.|+|||++ ...++.++|||||||++|||+||+.||.......          
T Consensus       196 G~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~----------  257 (387)
T 1kob_A          196 GLATKLNP--------DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE----------  257 (387)
T ss_dssp             TTCEECCT--------TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH----------
T ss_pred             ccceecCC--------CcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH----------
Confidence            99987522        1112234689999999999 4568999999999999999999999996532110          


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                         .+..+........          ....+            .....+.+++.+||+.||++|||+.|+++
T Consensus       258 ---~~~~i~~~~~~~~----------~~~~~------------~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          258 ---TLQNVKRCDWEFD----------EDAFS------------SVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             ---HHHHHHHCCCCCC----------SSTTT------------TSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ---HHHHHHhCCCCCC----------ccccc------------cCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence               0001100000000          00000            01234789999999999999999999986

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.5e-43  Score=334.52  Aligned_cols=199  Identities=25%  Similarity=0.400  Sum_probs=168.0

Q ss_pred             cCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      ++|+..+.||+|+||.||+|+..+|+.||+|+++...  ......+.+|++++++++||||+++++++     ...+..+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   76 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRLV   76 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEE-----ccCCeEE
Confidence            5788899999999999999999889999999997543  22346788999999999999999999996     4566799


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +||||+++ +|.+++....      ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        77 lv~e~~~~-~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~  146 (288)
T 1ob3_A           77 LVFEHLDQ-DLKKLLDVCE------GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL  146 (288)
T ss_dssp             EEEECCSE-EHHHHHHTST------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             EEEEecCC-CHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECcc
Confidence            99999975 9999887543      4589999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      ++....       .........||..|+|||.+.  ..++.++|||||||++|||+||+.||...
T Consensus       147 ~~~~~~-------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  204 (288)
T 1ob3_A          147 ARAFGI-------PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV  204 (288)
T ss_dssp             HHHHCC----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccCc-------cccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            986521       111223446899999999984  35899999999999999999999999753

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4e-43  Score=339.33  Aligned_cols=245  Identities=26%  Similarity=0.397  Sum_probs=195.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|++....   ......+.+|+++++.++||||+++++++     ...+
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~~   82 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI-----TTPT   82 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence            46889999999999999999996 478999999997532   22346789999999999999999999996     4567


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+ +|+|.+++...       ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|
T Consensus        83 ~~~lv~E~~-~g~l~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~D  151 (336)
T 3h4j_B           83 DIVMVIEYA-GGELFDYIVEK-------KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIAD  151 (336)
T ss_dssp             EEEEEECCC-CEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECC
T ss_pred             EEEEEEECC-CCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEE
Confidence            799999999 78999888643       4589999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccccCC--CCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH--VSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      ||++.....        ........||+.|+|||.+.+.  .+.++|||||||++|||++|+.||........  ...+.
T Consensus       152 FG~s~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--~~~i~  221 (336)
T 3h4j_B          152 FGLSNIMTD--------GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL--FKKVN  221 (336)
T ss_dssp             SSCTBTTTT--------SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC--BCCCC
T ss_pred             eccceeccC--------CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH--HHHHH
Confidence            999986522        1223345689999999999543  37899999999999999999999975322211  00000


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      ...                          ...|..           ....+.+++.+||+.||.+|||++|+++
T Consensus       222 ~~~--------------------------~~~p~~-----------~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          222 SCV--------------------------YVMPDF-----------LSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             SSC--------------------------CCCCTT-----------SCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             cCC--------------------------CCCccc-----------CCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            000                          000000           0223788999999999999999999975

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.4e-43  Score=343.47  Aligned_cols=247  Identities=26%  Similarity=0.380  Sum_probs=194.3

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec---cchhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ---QQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~  230 (477)
                      .++|+..+.||+|+||.||+|+.. +|+.||+|+++..   .......+.+|.+++..+ +||||+++++++     ...
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~~   96 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----QTP   96 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----EeC
Confidence            578999999999999999999975 6899999999854   233456788999999988 799999999985     567


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +..++||||+++|+|.+++...       ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+
T Consensus        97 ~~~~lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~  166 (353)
T 3txo_A           97 DRLFFVMEFVNGGDLMFHIQKS-------RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLA  166 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEc
Confidence            7899999999999999999754       4589999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      |||+++....       .........||+.|+|||++ ...++.++|||||||++|||++|+.||.......        
T Consensus       167 DFG~a~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--------  231 (353)
T 3txo_A          167 DFGMCKEGIC-------NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD--------  231 (353)
T ss_dssp             CCTTCBCSCC----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------
T ss_pred             cccceeeccc-------CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH--------
Confidence            9999975321       12223445799999999999 4568999999999999999999999997532211        


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCCh------HHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGM------KFVVN  463 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~  463 (477)
                           ....+.....               .+|..           ....+.+++.+||+.||.+||++      +|+++
T Consensus       232 -----~~~~i~~~~~---------------~~p~~-----------~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          232 -----LFEAILNDEV---------------VYPTW-----------LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             -----HHHHHHHCCC---------------CCCTT-----------SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             -----HHHHHHcCCC---------------CCCCC-----------CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                 0011111000               00100           12337889999999999999998      66664

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-43  Score=345.44  Aligned_cols=269  Identities=25%  Similarity=0.439  Sum_probs=204.5

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEe------CCCCEEEEEEeeecc-chhhHHHHHHHHHHhcC-CCCCcceeeeeccccc
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTL------ADGETAAIKVLKLQQ-QGALKSFIDECNALTSI-RHRNILKIVSSCSSVD  226 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  226 (477)
                      ..++|...+.||+|+||.||+|+.      .++..||+|+++... ....+.+.+|+.++.++ +||||+++++++    
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~----  118 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC----  118 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence            457888999999999999999985      245689999997542 33457899999999999 899999999996    


Q ss_pred             CCCCceeeEEEeecCCCChhhhcccCCCcc----------------cccccCCHHHHHHHHHHHHHHHHHHHcCCCCCee
Q 043902          227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEY----------------CHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIA  290 (477)
Q Consensus       227 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv  290 (477)
                       ...+..++||||+++|+|.+++.......                .....+++..++.++.|++.||.|||++   +|+
T Consensus       119 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv  194 (344)
T 1rjb_A          119 -TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV  194 (344)
T ss_dssp             -CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             -eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence             44567899999999999999997653210                0113489999999999999999999999   999


Q ss_pred             ecCCCCCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh
Q 043902          291 HCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT  369 (477)
Q Consensus       291 H~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt  369 (477)
                      ||||||+||+++.++.+||+|||++.......     .........||+.|+|||.+ .+.++.++|||||||++|||+|
T Consensus       195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t  269 (344)
T 1rjb_A          195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDS-----NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS  269 (344)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCT-----TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred             cCCCChhhEEEcCCCcEEeCCCccCcccccCc-----cceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHc
Confidence            99999999999999999999999998663211     12223445678899999998 6679999999999999999998


Q ss_pred             -CCCCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcC
Q 043902          370 -GKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCS  448 (477)
Q Consensus       370 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl  448 (477)
                       |..||.......             .+...+.......             .+           ..+...+.+++.+||
T Consensus       270 ~g~~p~~~~~~~~-------------~~~~~~~~~~~~~-------------~~-----------~~~~~~l~~li~~~l  312 (344)
T 1rjb_A          270 LGVNPYPGIPVDA-------------NFYKLIQNGFKMD-------------QP-----------FYATEEIYIIMQSCW  312 (344)
T ss_dssp             TSCCSSTTCCCSH-------------HHHHHHHTTCCCC-------------CC-----------TTCCHHHHHHHHHHT
T ss_pred             CCCCCcccCCcHH-------------HHHHHHhcCCCCC-------------CC-----------CCCCHHHHHHHHHHc
Confidence             999997532111             1111111111000             00           001234889999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhh
Q 043902          449 AASPRDRVGMKFVVNNLQAIRSKIR  473 (477)
Q Consensus       449 ~~dP~~RPs~~evl~~L~~i~~~~~  473 (477)
                      +.||.+|||+.|+++.|+.+.+...
T Consensus       313 ~~dp~~Rps~~~l~~~l~~~~~~~~  337 (344)
T 1rjb_A          313 AFDSRKRPSFPNLTSFLGCQLADAE  337 (344)
T ss_dssp             CSSGGGSCCHHHHHHHHHHHC----
T ss_pred             CCCchhCcCHHHHHHHHHHHHHHHH
Confidence            9999999999999999999877644

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.6e-43  Score=340.29  Aligned_cols=258  Identities=26%  Similarity=0.429  Sum_probs=199.4

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCE----EEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGET----AAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEG  229 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  229 (477)
                      .++|+..+.||+|+||.||+|+.. +++.    ||+|.+.... ......+.+|+.++.+++||||++++++|.      
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------   85 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP------   85 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC------
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc------
Confidence            357888999999999999999864 4554    7777775432 333456788999999999999999999862      


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEE
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV  309 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl  309 (477)
                      .+..++||||+++|+|.+++....      ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||
T Consensus        86 ~~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl  156 (325)
T 3kex_A           86 GSSLQLVTQYLPLGSLLDHVRQHR------GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQV  156 (325)
T ss_dssp             BSSEEEEEECCTTCBSHHHHHSSG------GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEE
T ss_pred             CCccEEEEEeCCCCCHHHHHHHcc------ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEE
Confidence            345889999999999999997543      4688999999999999999999999   9999999999999999999999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeee
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~  387 (477)
                      +|||+++......     .........+|..|+|||.+ .+.++.++|||||||++|||+| |+.||......       
T Consensus       157 ~Dfg~a~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------  224 (325)
T 3kex_A          157 ADFGVADLLPPDD-----KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-------  224 (325)
T ss_dssp             CSCSGGGGSCCCT-----TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT-------
T ss_pred             CCCCcccccCccc-----ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH-------
Confidence            9999998763221     12223445678899999999 5779999999999999999999 99999753211       


Q ss_pred             eeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHH
Q 043902          388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQA  467 (477)
Q Consensus       388 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  467 (477)
                             .+.+.+.......             .+.           .+...+.+++.+||+.||.+|||+.|+++.|++
T Consensus       225 -------~~~~~~~~~~~~~-------------~~~-----------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~  273 (325)
T 3kex_A          225 -------EVPDLLEKGERLA-------------QPQ-----------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTR  273 (325)
T ss_dssp             -------HHHHHHHTTCBCC-------------CCT-----------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHH
T ss_pred             -------HHHHHHHcCCCCC-------------CCC-----------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                   1111111110000             000           012237789999999999999999999999998


Q ss_pred             HHHh
Q 043902          468 IRSK  471 (477)
Q Consensus       468 i~~~  471 (477)
                      +...
T Consensus       274 ~~~~  277 (325)
T 3kex_A          274 MARD  277 (325)
T ss_dssp             HTTS
T ss_pred             HHhc
Confidence            8654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.6e-43  Score=340.12  Aligned_cols=261  Identities=23%  Similarity=0.364  Sum_probs=196.8

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccC------
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDY------  227 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------  227 (477)
                      .++|+..+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|++++++++||||++++++|.....      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            467889999999999999999976 79999999998543 3345789999999999999999999998743210      


Q ss_pred             ----------------------------------------------CCCceeeEEEeecCCCChhhhcccCCCccccccc
Q 043902          228 ----------------------------------------------EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKK  261 (477)
Q Consensus       228 ----------------------------------------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~  261 (477)
                                                                    ......++||||+++|+|.+++.....    ...
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----~~~  160 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS----LED  160 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS----GGG
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC----ccc
Confidence                                                          122348999999999999999986542    245


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccccccCCCCCC-----CccccCCCc
Q 043902          262 LSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSK-----NQTMSNGLK  336 (477)
Q Consensus       262 l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~-----~~~~~~~~~  336 (477)
                      .++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++...........     .........
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV  237 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence            67788999999999999999999   9999999999999999999999999999876432111000     012234567


Q ss_pred             ccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhccccccc
Q 043902          337 GSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKH  415 (477)
Q Consensus       337 gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  415 (477)
                      ||+.|+|||.+ ...++.++|||||||++|||++|..|+....                   .........         
T Consensus       238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-------------------~~~~~~~~~---------  289 (332)
T 3qd2_B          238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-------------------RIITDVRNL---------  289 (332)
T ss_dssp             -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-------------------HHHHHHHTT---------
T ss_pred             CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-------------------HHHHHhhcc---------
Confidence            99999999999 5578999999999999999999877653210                   000000000         


Q ss_pred             ccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          416 EEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       416 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                          ..+.        ........+.+++.+||+.||++|||+.|+++
T Consensus       290 ----~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          290 ----KFPL--------LFTQKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             ----CCCH--------HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             ----CCCc--------ccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence                0000        11122344688999999999999999999986

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.4e-43  Score=333.18  Aligned_cols=251  Identities=24%  Similarity=0.369  Sum_probs=197.2

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ..|...+.||+|+||.||+|... ++..||+|++....  ....+.+.+|+.++++++||||+++++++... .......
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc-cCCCceE
Confidence            45677789999999999999875 68899999997543  34457789999999999999999999986432 2345678


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeecCCCCCCeEec-CCCcEEEe
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTP--IAHCDLKSSNVLLD-EGMIAHVG  310 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~dlkp~NIll~-~~~~~kl~  310 (477)
                      ++||||+++|+|.+++...       ..+++..++.++.|++.||.|||+.   +  |+||||||+||+++ .++.+||+
T Consensus       105 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~  174 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIG  174 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred             EEEEEecCCCCHHHHHHHc-------cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEe
Confidence            9999999999999999743       4589999999999999999999998   7  99999999999997 78899999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccccCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      |||++....         ........||..|+|||.+.+.++.++|||||||++|+|+||+.||........        
T Consensus       175 Dfg~~~~~~---------~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------  237 (290)
T 1t4h_A          175 DLGLATLKR---------ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--------  237 (290)
T ss_dssp             CTTGGGGCC---------TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--------
T ss_pred             eCCCccccc---------ccccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH--------
Confidence            999997541         112233468999999999988899999999999999999999999965321110        


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                           ....+.......            ..+           ......+.+++.+||+.||.+|||+.|+++
T Consensus       238 -----~~~~~~~~~~~~------------~~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          238 -----IYRRVTSGVKPA------------SFD-----------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -----HHHHHTTTCCCG------------GGG-----------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----HHHHHhccCCcc------------ccC-----------CCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                 000000000000            000           000234889999999999999999999985

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=345.43  Aligned_cols=274  Identities=18%  Similarity=0.228  Sum_probs=199.8

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC----CCCEEEEEEeeeccch-----------hhHHHHHHHHHHhcCCCCCcceeee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA----DGETAAIKVLKLQQQG-----------ALKSFIDECNALTSIRHRNILKIVS  220 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~  220 (477)
                      .++|...+.||+|+||.||+|...    ++..+|+|++......           ....+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            467899999999999999999975    5788999998754321           1234678889999999999999999


Q ss_pred             ecccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeE
Q 043902          221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVL  300 (477)
Q Consensus       221 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIl  300 (477)
                      ++... +......++||||+ +++|.+++...       ..+++..++.++.|++.||.|||++   +|+||||||+||+
T Consensus       116 ~~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl  183 (345)
T 2v62_A          116 SGLTE-FKGRSYRFMVMERL-GIDLQKISGQN-------GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLL  183 (345)
T ss_dssp             EEEEE-SSSCEEEEEEEECE-EEEHHHHCBGG-------GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred             ccccc-cCCCcEEEEEEecc-CCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEE
Confidence            97532 23467899999999 99999999754       3689999999999999999999999   9999999999999


Q ss_pred             ecCCC--cEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          301 LDEGM--IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       301 l~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      ++.++  .+||+|||+++.+..................||..|+|||++ ...++.++|||||||++|||+||+.||...
T Consensus       184 l~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~  263 (345)
T 2v62_A          184 LGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN  263 (345)
T ss_dssp             EESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred             EccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            99887  999999999987644322222222223456799999999999 556899999999999999999999999642


Q ss_pred             cccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHH-HHHHHHHHHHHHhhhcCCCCCCCCC
Q 043902          378 FKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQK-KLEECLVSVMRIGVMCSAASPRDRV  456 (477)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~Cl~~dP~~RP  456 (477)
                      .........         ..........                    ...... ....++..+.+++.+||+.||++||
T Consensus       264 ~~~~~~~~~---------~~~~~~~~~~--------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp  314 (345)
T 2v62_A          264 LKDPVAVQT---------AKTNLLDELP--------------------QSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKP  314 (345)
T ss_dssp             TTCHHHHHH---------HHHHHHHTTT--------------------HHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCC
T ss_pred             ccccHHHHH---------HHHhhccccc--------------------HHHHhhccccccHHHHHHHHHHHhhcCcccCC
Confidence            211110000         0000000000                    000000 0001234589999999999999999


Q ss_pred             ChHHHHHHHHHHHH
Q 043902          457 GMKFVVNNLQAIRS  470 (477)
Q Consensus       457 s~~evl~~L~~i~~  470 (477)
                      |+++|++.|+++..
T Consensus       315 s~~~l~~~L~~~~~  328 (345)
T 2v62_A          315 NYQALKKILNPHGI  328 (345)
T ss_dssp             CHHHHHHHHCTTCC
T ss_pred             CHHHHHHHHhccCC
Confidence            99999999987543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-43  Score=335.21  Aligned_cols=244  Identities=26%  Similarity=0.362  Sum_probs=197.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .++|+..+.||+|+||.||+|+.. +|+.||+|+++...   ....+.+.+|..+++.++||||+++++++     .+..
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~   79 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ   79 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCC
Confidence            467889999999999999999975 79999999998542   23456788999999999999999999985     5667


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+++|+|.+++...       ..+++..+..++.||+.||.|||++   +|+||||||+||+++.++.+||+|
T Consensus        80 ~~~lv~e~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~D  149 (318)
T 1fot_A           80 QIFMIMDYIEGGELFSLLRKS-------QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITD  149 (318)
T ss_dssp             EEEEEECCCCSCBHHHHHHHT-------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred             EEEEEEeCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEee
Confidence            899999999999999999754       4589999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      ||+++....          ......||+.|+|||++ ...++.++|||||||++|||++|+.||.......         
T Consensus       150 fg~a~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---------  210 (318)
T 1fot_A          150 FGFAKYVPD----------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---------  210 (318)
T ss_dssp             CSSCEECSS----------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---------
T ss_pred             cCcceecCC----------ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---------
Confidence            999986521          12345789999999999 4568999999999999999999999996532110         


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC-----ChHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRV-----GMKFVVN  463 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  463 (477)
                          ....+......               +|.           .....+.+++.+||+.||++||     +++|+++
T Consensus       211 ----~~~~i~~~~~~---------------~p~-----------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          211 ----TYEKILNAELR---------------FPP-----------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             ----HHHHHHHCCCC---------------CCT-----------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----HHHHHHhCCCC---------------CCC-----------CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                01111111000               000           0123378999999999999999     8888874

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.8e-43  Score=330.60  Aligned_cols=251  Identities=23%  Similarity=0.312  Sum_probs=202.6

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ..++|+..+.||+|+||.||+|... ++..||+|++........+.+.+|++++.+++||||+++++++     ......
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   81 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF-----EDNTDI   81 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCeE
Confidence            4567889999999999999999975 5789999999876666668899999999999999999999996     456779


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEe---cCCCcEEEe
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVG  310 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~  310 (477)
                      ++||||+++++|.+++...       ..+++..++.++.|++.||.|||++   +|+||||||+||++   +.++.+||+
T Consensus        82 ~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~  151 (277)
T 3f3z_A           82 YLVMELCTGGELFERVVHK-------RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLI  151 (277)
T ss_dssp             EEEEECCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred             EEEEeccCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEE
Confidence            9999999999999988654       4589999999999999999999999   99999999999999   788999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccccCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      |||++.....        ........||..|+|||.+.+.++.++||||||+++|||+||+.||........        
T Consensus       152 Dfg~~~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--------  215 (277)
T 3f3z_A          152 DFGLAARFKP--------GKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV--------  215 (277)
T ss_dssp             CCTTCEECCT--------TSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------
T ss_pred             ecccceeccC--------ccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH--------
Confidence            9999986522        122234568999999999988899999999999999999999999965322110        


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                           ...+......               .+       ......+...+.+++.+||+.||++|||+.|+++
T Consensus       216 -----~~~~~~~~~~---------------~~-------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          216 -----MLKIREGTFT---------------FP-------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             -----HHHHHHCCCC---------------CC-------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -----HHHHHhCCCC---------------CC-------chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 0000000000               00       0000112344889999999999999999999985

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.8e-43  Score=336.97  Aligned_cols=244  Identities=21%  Similarity=0.248  Sum_probs=190.5

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++....  ......+..|+..+.++ +||||++++++|     ..++.
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~-----~~~~~  131 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW-----EEGGI  131 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE-----EeCCE
Confidence            57889999999999999999976 79999999986432  23334556666666555 899999999996     45678


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+ +++|.+++....      ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DF  201 (311)
T 3p1a_A          132 LYLQTELC-GPSLQQHCEAWG------ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDF  201 (311)
T ss_dssp             EEEEEECC-CCBHHHHHHHHC------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCC
T ss_pred             EEEEEecc-CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccc
Confidence            99999999 779998886543      4699999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccccCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccC
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMAL  392 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  392 (477)
                      |++.....        ........||+.|+|||++.+.++.++|||||||++|||++|..|+.....             
T Consensus       202 G~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-------------  260 (311)
T 3p1a_A          202 GLLVELGT--------AGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEG-------------  260 (311)
T ss_dssp             TTCEECC--------------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-------------
T ss_pred             eeeeeccc--------CCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------------
Confidence            99976522        112234568999999999988899999999999999999999776643110             


Q ss_pred             CchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          393 PSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       393 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                         ...+......                        .+....+...+.+++.+||+.||++|||+.|+++
T Consensus       261 ---~~~~~~~~~~------------------------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          261 ---WQQLRQGYLP------------------------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             ---HHHHTTTCCC------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---HHHHhccCCC------------------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence               0000000000                        0001112344889999999999999999999985

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=6e-43  Score=340.19  Aligned_cols=282  Identities=24%  Similarity=0.382  Sum_probs=208.6

Q ss_pred             CccHHHHHHhhcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhc--CCCCCcceeeeecc
Q 043902          146 GLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTS--IRHRNILKIVSSCS  223 (477)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~  223 (477)
                      ..+........++|...+.||+|+||.||+|+. +|+.||||+++...   ...+.+|.+++..  ++||||+++++++.
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~  106 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADN  106 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence            334444455678999999999999999999998 58999999997443   3567888888887  78999999999974


Q ss_pred             cccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeeecCCC
Q 043902          224 SVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH--------NQYDTPIAHCDLK  295 (477)
Q Consensus       224 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~dlk  295 (477)
                      ... ......++||||+++|+|.+++...        .+++..++.++.|++.||.|||        +.   +|+|||||
T Consensus       107 ~~~-~~~~~~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlk  174 (342)
T 1b6c_B          107 KDN-GTWTQLWLVSDYHEHGSLFDYLNRY--------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLK  174 (342)
T ss_dssp             CCC-SSCCCEEEEECCCTTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCS
T ss_pred             ccC-CccceeEEEEeecCCCcHHHHHhcc--------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCC
Confidence            311 1113789999999999999999643        4899999999999999999999        77   99999999


Q ss_pred             CCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccccCC-------CCcccceeehHHHHHHHh
Q 043902          296 SSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH-------VSILGDIYSYGILLLEIF  368 (477)
Q Consensus       296 p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~Dv~S~Gvvl~ell  368 (477)
                      |+||+++.++.+||+|||++........   ..........||..|+|||.+.+.       ++.++|||||||++|||+
T Consensus       175 p~NIll~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~  251 (342)
T 1b6c_B          175 SKNILVKKNGTCCIADLGLAVRHDSATD---TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA  251 (342)
T ss_dssp             GGGEEECTTSCEEECCCTTCEEEETTTT---EEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHEEECCCCCEEEEECCCceecccccc---ccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHH
Confidence            9999999999999999999987632110   001123445789999999998542       347899999999999999


Q ss_pred             hC----------CCCCCcccccccceeeeeeccCCchhHHHh-hhhhhhhhcccccccccccccchhhhHHHHHHHHHHH
Q 043902          369 TG----------KRPTDDMFKDDLSIHKFVLMALPSHVMDVL-DLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECL  437 (477)
Q Consensus       369 tg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (477)
                      ||          +.||...........         .+...+ .....                +.+....   ...++.
T Consensus       252 tg~~~~~~~~~~~~p~~~~~~~~~~~~---------~~~~~~~~~~~~----------------~~~~~~~---~~~~~~  303 (342)
T 1b6c_B          252 RRCSIGGIHEDYQLPYYDLVPSDPSVE---------EMRKVVCEQKLR----------------PNIPNRW---QSCEAL  303 (342)
T ss_dssp             TTBCBTTBCCCCCCTTTTTSCSSCCHH---------HHHHHHTTSCCC----------------CCCCGGG---GTSHHH
T ss_pred             hccCcCCcccccccCccccCcCcccHH---------HHHHHHHHHHhC----------------CCCcccc---cchhHH
Confidence            99          566644322111100         011111 00000                0000000   011235


Q ss_pred             HHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHhhhh
Q 043902          438 VSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSKIRM  474 (477)
Q Consensus       438 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~  474 (477)
                      ..+.+++.+||+.||++|||+.||++.|+++.++...
T Consensus       304 ~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~~  340 (342)
T 1b6c_B          304 RVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI  340 (342)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC-
T ss_pred             HHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhcC
Confidence            5689999999999999999999999999999987654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=348.14  Aligned_cols=253  Identities=18%  Similarity=0.282  Sum_probs=198.4

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      ...++|+..+.||+|+||.||+|... +|+.+|+|++....  ....+.+.+|++++++++||||+++++++     ...
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~   82 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEE   82 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECS
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EEC
Confidence            34678999999999999999999864 78999999997543  23446789999999999999999999995     567


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec---CCCcE
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIA  307 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~---~~~~~  307 (477)
                      +..++||||+++|+|.+.+...       ..+++..+..++.||+.||.|||++   +|+||||||+|||++   .++.+
T Consensus        83 ~~~~lv~E~~~gg~L~~~i~~~-------~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~v  152 (444)
T 3soa_A           83 GHHYLIFDLVTGGELFEDIVAR-------EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAV  152 (444)
T ss_dssp             SEEEEEECCCBCCBHHHHHHHC-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCE
T ss_pred             CEEEEEEEeCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcE
Confidence            7899999999999999998754       4589999999999999999999999   999999999999998   56789


Q ss_pred             EEecccccccccccCCCCCCCccccCCCcccccccCccccc-CCCCcccceeehHHHHHHHhhCCCCCCcccccccceee
Q 043902          308 HVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHK  386 (477)
Q Consensus       308 kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~  386 (477)
                      ||+|||++.....       .........||+.|+|||++. ..++.++|||||||++|+|++|..||.......     
T Consensus       153 kL~DFG~a~~~~~-------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-----  220 (444)
T 3soa_A          153 KLADFGLAIEVEG-------EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-----  220 (444)
T ss_dssp             EECCCSSCBCCCT-------TCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----
T ss_pred             EEccCceeEEecC-------CCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-----
Confidence            9999999976522       122234467999999999994 469999999999999999999999996532111     


Q ss_pred             eeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          387 FVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       387 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                               +...+.....   ...      ....            ..+...+.+++.+||+.||++|||+.|+++
T Consensus       221 ---------~~~~i~~~~~---~~~------~~~~------------~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          221 ---------LYQQIKAGAY---DFP------SPEW------------DTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             ---------HHHHHHHTCC---CCC------TTTT------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ---------HHHHHHhCCC---CCC------cccc------------ccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                     1111100000   000      0000            011234789999999999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=7.5e-43  Score=335.81  Aligned_cols=205  Identities=27%  Similarity=0.416  Sum_probs=158.8

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .++|+..+.||+|+||.||+|... +|+.||+|+++... ......+.+|++++++++||||+++++++     ..++..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~   78 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKL   78 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeE
Confidence            468999999999999999999865 68999999998543 23346788999999999999999999995     556789


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||++ |+|.+++...... .....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        79 ~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  153 (317)
T 2pmi_A           79 TLVFEFMD-NDLKKYMDSRTVG-NTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFG  153 (317)
T ss_dssp             EEEEECCC-CBHHHHHHHHHSS-SCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCS
T ss_pred             EEEEEecC-CCHHHHHHhcccc-ccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCc
Confidence            99999997 5999988643210 1124589999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccccC--CCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      +++....       .........||..|+|||.+.+  .++.++|||||||++|||+||+.||...
T Consensus       154 ~~~~~~~-------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  212 (317)
T 2pmi_A          154 LARAFGI-------PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT  212 (317)
T ss_dssp             SCEETTS-------CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cceecCC-------CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9986522       1112234568999999999843  5899999999999999999999999754

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.1e-42  Score=337.12  Aligned_cols=268  Identities=24%  Similarity=0.427  Sum_probs=207.0

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC--------CCCEEEEEEeeecc-chhhHHHHHHHHHHhcC-CCCCcceeeeecccc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA--------DGETAAIKVLKLQQ-QGALKSFIDECNALTSI-RHRNILKIVSSCSSV  225 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  225 (477)
                      .++|...+.||+|+||.||+|+..        ++..||+|+++... ......+.+|++++.++ +||||++++++|   
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~---  110 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC---  110 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE---
Confidence            478889999999999999999863        46789999998543 34457789999999999 899999999996   


Q ss_pred             cCCCCceeeEEEeecCCCChhhhcccCCCcc---------cccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCC
Q 043902          226 DYEGNDFKALVFEFMRNGNLDQWLHPSTDEY---------CHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKS  296 (477)
Q Consensus       226 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp  296 (477)
                        ...+..++||||+++|+|.+++.......         .....+++..++.++.|++.||.|||+.   +|+||||||
T Consensus       111 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp  185 (334)
T 2pvf_A          111 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA  185 (334)
T ss_dssp             --CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred             --ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCcc
Confidence              45667899999999999999997653210         0123589999999999999999999999   999999999


Q ss_pred             CCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCC
Q 043902          297 SNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPT  374 (477)
Q Consensus       297 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~  374 (477)
                      +||+++.++.+||+|||+++.....     ..........+|..|+|||.+ .+.++.++|||||||++|||+| |+.||
T Consensus       186 ~NIll~~~~~~kL~Dfg~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~  260 (334)
T 2pvf_A          186 RNVLVTENNVMKIADFGLARDINNI-----DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY  260 (334)
T ss_dssp             GGEEECTTCCEEECCCTTCEECTTT-----SSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             ceEEEcCCCCEEEcccccccccccc-----ccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCc
Confidence            9999999999999999999865321     111223344578899999998 5678999999999999999999 99999


Q ss_pred             CcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCC
Q 043902          375 DDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRD  454 (477)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~  454 (477)
                      .......              +...+.......             .+           ..+...+.+++.+||+.||.+
T Consensus       261 ~~~~~~~--------------~~~~~~~~~~~~-------------~~-----------~~~~~~l~~li~~~l~~dp~~  302 (334)
T 2pvf_A          261 PGIPVEE--------------LFKLLKEGHRMD-------------KP-----------ANCTNELYMMMRDCWHAVPSQ  302 (334)
T ss_dssp             TTCCHHH--------------HHHHHHHTCCCC-------------CC-----------TTCCHHHHHHHHHHTCSSGGG
T ss_pred             CcCCHHH--------------HHHHHhcCCCCC-------------CC-----------ccCCHHHHHHHHHHccCChhh
Confidence            6532111              111111100000             00           011334889999999999999


Q ss_pred             CCChHHHHHHHHHHHHhhhh
Q 043902          455 RVGMKFVVNNLQAIRSKIRM  474 (477)
Q Consensus       455 RPs~~evl~~L~~i~~~~~~  474 (477)
                      |||+.|+++.|+++......
T Consensus       303 Rps~~ell~~L~~l~~~~~~  322 (334)
T 2pvf_A          303 RPTFKQLVEDLDRILTLTTN  322 (334)
T ss_dssp             SCCHHHHHHHHHHHHHHHC-
T ss_pred             CcCHHHHHHHHHHHHhcccc
Confidence            99999999999999876543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1e-42  Score=340.64  Aligned_cols=251  Identities=21%  Similarity=0.346  Sum_probs=198.2

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      ..++|+..+.||+|+||.||+|... +|+.||+|+++...  ....+.+.+|++++++++||||+++++++     ...+
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~  101 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES  101 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence            3567999999999999999999875 68999999997543  33456789999999999999999999995     5667


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC---CcEE
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG---MIAH  308 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~---~~~k  308 (477)
                      ..++||||+++|+|.+++...       ..+++..+..++.||+.||.|||++   +|+||||||+||+++.+   +.+|
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~k  171 (362)
T 2bdw_A          102 FHYLVFDLVTGGELFEDIVAR-------EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVK  171 (362)
T ss_dssp             EEEEEECCCCSCBHHHHHTTC-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEE
T ss_pred             EEEEEEecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEE
Confidence            889999999999999998754       4589999999999999999999999   99999999999999865   4599


Q ss_pred             EecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeee
Q 043902          309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       309 l~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~  387 (477)
                      |+|||++.....        ........||+.|+|||++ ...++.++|||||||++|||++|+.||........     
T Consensus       172 l~DfG~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-----  238 (362)
T 2bdw_A          172 LADFGLAIEVND--------SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-----  238 (362)
T ss_dssp             ECCCTTCBCCTT--------CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----
T ss_pred             EeecCcceEecC--------CcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-----
Confidence            999999986522        1122345789999999999 44689999999999999999999999965321100     


Q ss_pred             eeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       388 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                              ...+........          .   +         ....+...+.+++.+||+.||++|||+.|+++
T Consensus       239 --------~~~i~~~~~~~~----------~---~---------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          239 --------YAQIKAGAYDYP----------S---P---------EWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             --------HHHHHHTCCCCC----------T---T---------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             --------HHHHHhCCCCCC----------c---c---------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                    000000000000          0   0         00011234789999999999999999999875

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=341.66  Aligned_cols=249  Identities=23%  Similarity=0.372  Sum_probs=197.8

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .++|.+.+.||+|+||.||+|+.. +++.||+|+++...   ......+.+|++++++++||||+++++++     ...+
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~   88 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QDEE   88 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCC
Confidence            467889999999999999999865 68899999997542   33457889999999999999999999985     5667


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+.+|+|.+++...       ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~D  158 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQN-------VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITD  158 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             EEEEEEecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEec
Confidence            899999999999999999754       4589999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccccC----CCCcccceeehHHHHHHHhhCCCCCCcccccccceeee
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING----HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~  387 (477)
                      ||+++....        ........||+.|+|||++.+    .++.++|||||||++|||+||+.||........     
T Consensus       159 FG~a~~~~~--------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-----  225 (384)
T 4fr4_A          159 FNIAAMLPR--------ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-----  225 (384)
T ss_dssp             CTTCEECCT--------TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH-----
T ss_pred             cceeeeccC--------CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH-----
Confidence            999986522        122345679999999999832    489999999999999999999999964321110     


Q ss_pred             eeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCC-hHHHHH
Q 043902          388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVG-MKFVVN  463 (477)
Q Consensus       388 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~  463 (477)
                            ..+...+.....              .+|.           .+...+.+++.+||+.||.+||+ ++++.+
T Consensus       226 ------~~~~~~~~~~~~--------------~~p~-----------~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          226 ------KEIVHTFETTVV--------------TYPS-----------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ------HHHHHHHHHCCC--------------CCCT-----------TSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ------HHHHHHHhhccc--------------CCCC-----------cCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                  000111100000              0000           01234889999999999999998 666653

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.1e-43  Score=342.99  Aligned_cols=246  Identities=19%  Similarity=0.303  Sum_probs=191.4

Q ss_pred             CCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEee
Q 043902          161 EENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEF  239 (477)
Q Consensus       161 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~  239 (477)
                      ..+.||+|+||.||+|... +|+.||+|+++.......+.+.+|++++.+++||||++++++|     ...+..++||||
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~lv~E~  167 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF-----ESKNDIVLVMEY  167 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEEEEEEEC
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEEEEeC
Confidence            3568999999999999864 7899999999876656667899999999999999999999996     456789999999


Q ss_pred             cCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEe--cCCCcEEEeccccccc
Q 043902          240 MRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL--DEGMIAHVGDFGLAKF  317 (477)
Q Consensus       240 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll--~~~~~~kl~DfG~a~~  317 (477)
                      +++|+|.+++....      ..+++..++.++.||+.||.|||+.   +|+||||||+|||+  +.++.+||+|||+++.
T Consensus       168 ~~~~~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~  238 (373)
T 2x4f_A          168 VDGGELFDRIIDES------YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARR  238 (373)
T ss_dssp             CTTCEEHHHHHHTG------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEE
T ss_pred             CCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCcee
Confidence            99999999886542      4689999999999999999999999   99999999999999  5678999999999987


Q ss_pred             ccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCchh
Q 043902          318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHV  396 (477)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  396 (477)
                      ...        ........||+.|+|||++ .+.++.++|||||||++|||+||+.||.......             .+
T Consensus       239 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------------~~  297 (373)
T 2x4f_A          239 YKP--------REKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-------------TL  297 (373)
T ss_dssp             CCT--------TCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------------HH
T ss_pred             cCC--------ccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-------------HH
Confidence            632        1122334689999999999 5568999999999999999999999996532111             11


Q ss_pred             HHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          397 MDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       397 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      ..+........          ..            ........+.+++.+||+.||.+|||+.|+++
T Consensus       298 ~~i~~~~~~~~----------~~------------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          298 NNILACRWDLE----------DE------------EFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             HHHHHTCCCSC----------SG------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHhccCCCC----------hh------------hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            11111110000          00            00011234889999999999999999999997

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2e-43  Score=339.64  Aligned_cols=279  Identities=24%  Similarity=0.408  Sum_probs=212.9

Q ss_pred             cHHHHHHhhcCCCCCCeeeeeccceEEEEEe------CCCCEEEEEEeeecc-chhhHHHHHHHHHHhcC-CCCCcceee
Q 043902          148 SYLKISNATDNFSEENLIGSGSFGSVYKGTL------ADGETAAIKVLKLQQ-QGALKSFIDECNALTSI-RHRNILKIV  219 (477)
Q Consensus       148 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~  219 (477)
                      ...+.....++|...+.||+|+||.||+|+.      .+++.||||+++... ....+.+.+|++++.++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3344455568899999999999999999974      356899999998543 33446789999999999 799999999


Q ss_pred             eecccccCCCCceeeEEEeecCCCChhhhcccCCCccc---------ccccCCHHHHHHHHHHHHHHHHHHHcCCCCCee
Q 043902          220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYC---------HFKKLSLMQRLNIVIDVASALDYLHNQYDTPIA  290 (477)
Q Consensus       220 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~---------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv  290 (477)
                      ++|.    ..+...++||||+++|+|.+++........         ....+++..++.++.|++.||.|||+.   +|+
T Consensus        98 ~~~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~  170 (316)
T 2xir_A           98 GACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCI  170 (316)
T ss_dssp             EEEC----CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             EEEe----cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence            9973    344568999999999999999986542110         012388999999999999999999999   999


Q ss_pred             ecCCCCCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh
Q 043902          291 HCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT  369 (477)
Q Consensus       291 H~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt  369 (477)
                      ||||||+||+++.++.+||+|||+++.....     ..........||..|+|||.+ .+.++.++|||||||++|||+|
T Consensus       171 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t  245 (316)
T 2xir_A          171 HRDLAARNILLSEKNVVKICDFGLARDIYKD-----PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS  245 (316)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCGGGSCTTTC-----TTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             cccCccceEEECCCCCEEECCCccccccccC-----ccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHh
Confidence            9999999999999999999999999865321     112223445678899999998 6678999999999999999998


Q ss_pred             -CCCCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcC
Q 043902          370 -GKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCS  448 (477)
Q Consensus       370 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl  448 (477)
                       |+.||.......             .+...+.......             .+.           .+...+.+++.+||
T Consensus       246 ~g~~p~~~~~~~~-------------~~~~~~~~~~~~~-------------~~~-----------~~~~~l~~li~~~l  288 (316)
T 2xir_A          246 LGASPYPGVKIDE-------------EFCRRLKEGTRMR-------------APD-----------YTTPEMYQTMLDCW  288 (316)
T ss_dssp             TSCCSSTTCCCSH-------------HHHHHHHHTCCCC-------------CCT-----------TCCHHHHHHHHHHT
T ss_pred             CCCCCCcccchhH-------------HHHHHhccCccCC-------------CCC-----------CCCHHHHHHHHHHc
Confidence             999996532111             1111111100000             000           01234889999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhhhc
Q 043902          449 AASPRDRVGMKFVVNNLQAIRSKIRMR  475 (477)
Q Consensus       449 ~~dP~~RPs~~evl~~L~~i~~~~~~~  475 (477)
                      +.||.+|||+.|+++.|+.+.+....+
T Consensus       289 ~~dp~~Rps~~ell~~L~~~~~~~~~~  315 (316)
T 2xir_A          289 HGEPSQRPTFSELVEHLGNLLQANAQQ  315 (316)
T ss_dssp             CSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred             CCChhhCcCHHHHHHHHHHHHhhhccC
Confidence            999999999999999999998775543

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5e-44  Score=337.55  Aligned_cols=254  Identities=27%  Similarity=0.436  Sum_probs=196.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      .++|+..+.||+|+||.||+|+.. |+.||+|+++...  ..+.+.+|++++.+++||||+++++++.    ...+..++
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~~~l   92 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYI   92 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--CCEE
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEE----cCCCceEE
Confidence            467889999999999999999884 8899999997543  3478999999999999999999999863    34457899


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      ||||+++++|.+++....     ...+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++
T Consensus        93 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~  164 (278)
T 1byg_A           93 VTEYMAKGSLVDYLRSRG-----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT  164 (278)
T ss_dssp             EECCCTTEEHHHHHHHHH-----HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred             EEecCCCCCHHHHHHhcc-----cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccc
Confidence            999999999999997432     13478999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCC
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      .....          ......++..|+|||.+ ...++.++||||||+++|||+| |+.||.......            
T Consensus       165 ~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------------  222 (278)
T 1byg_A          165 KEASS----------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------------  222 (278)
T ss_dssp             ---------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG------------
T ss_pred             ccccc----------cccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH------------
Confidence            75421          11223568889999999 5678999999999999999998 999996532111            


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHhh
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSKI  472 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  472 (477)
                        +...+.......             .+           ..++..+.+++.+||+.||++|||+.|+++.|++++...
T Consensus       223 --~~~~~~~~~~~~-------------~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~  275 (278)
T 1byg_A          223 --VVPRVEKGYKMD-------------AP-----------DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE  275 (278)
T ss_dssp             --HHHHHTTTCCCC-------------CC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             --HHHHHhcCCCCC-------------Cc-----------ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence              111110000000             00           011334889999999999999999999999999998753

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.1e-43  Score=344.34  Aligned_cols=254  Identities=20%  Similarity=0.284  Sum_probs=197.7

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-----chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-----QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEG  229 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  229 (477)
                      .+.|++.+.||+|+||.||+|... +|+.||||+++...     ....+.+.+|+.++++++||||+++++++     ..
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~   97 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY-----SS   97 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence            457889999999999999999865 78999999997432     11357789999999999999999999986     45


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCc---
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI---  306 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~---  306 (477)
                      .+..++||||+++|+|.+++.....   ....+++..+..++.||+.||.|||++   +|+||||||+||+++.++.   
T Consensus        98 ~~~~~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~  171 (351)
T 3c0i_A           98 DGMLYMVFEFMDGADLCFEIVKRAD---AGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAP  171 (351)
T ss_dssp             TTEEEEEEECCSSCBHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCC
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHhcc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCc
Confidence            6789999999999999888754321   113589999999999999999999999   9999999999999986654   


Q ss_pred             EEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCccccccccee
Q 043902          307 AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIH  385 (477)
Q Consensus       307 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~  385 (477)
                      +||+|||++......       ........||+.|+|||++ ...++.++|||||||++|||++|+.||......     
T Consensus       172 vkl~Dfg~a~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----  239 (351)
T 3c0i_A          172 VKLGGFGVAIQLGES-------GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-----  239 (351)
T ss_dssp             EEECCCTTCEECCTT-------SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH-----
T ss_pred             EEEecCcceeEecCC-------CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH-----
Confidence            999999999876321       1223345799999999999 456899999999999999999999999652110     


Q ss_pred             eeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          386 KFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       386 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                               ....+.......                      ...........+.+++.+||+.||++|||+.|+++
T Consensus       240 ---------~~~~i~~~~~~~----------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          240 ---------LFEGIIKGKYKM----------------------NPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             ---------HHHHHHHTCCCC----------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---------HHHHHHcCCCCC----------------------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                     001111100000                      00001112344889999999999999999999985

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.1e-43  Score=337.53  Aligned_cols=272  Identities=23%  Similarity=0.291  Sum_probs=196.0

Q ss_pred             hcCCCCC-CeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCCce
Q 043902          156 TDNFSEE-NLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       156 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .+.|.+. +.||+|+||.||+|... +++.||||+++.........+.+|++++.++ +||||+++++++     ...+.
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~-----~~~~~   85 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF-----EEEDR   85 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EETTE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeCCE
Confidence            3567764 78999999999999854 7899999999876655667899999999985 799999999996     45678


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCc---EEE
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI---AHV  309 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl  309 (477)
                      .++||||+++|+|.+++...       ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++.   +||
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl  155 (316)
T 2ac3_A           86 FYLVFEKMRGGSILSHIHKR-------RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKI  155 (316)
T ss_dssp             EEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEE
T ss_pred             EEEEEEcCCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEE
Confidence            99999999999999999753       4589999999999999999999999   9999999999999998776   999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCccccc------CCCCcccceeehHHHHHHHhhCCCCCCcccccccc
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN------GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLS  383 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~  383 (477)
                      +|||++.....................||..|+|||.+.      +.++.++|||||||++|||+||+.||......+..
T Consensus       156 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  235 (316)
T 2ac3_A          156 CDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG  235 (316)
T ss_dssp             CCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC
T ss_pred             EEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc
Confidence            999999765321111111111223446899999999984      35899999999999999999999999765433221


Q ss_pred             eeeeeeccCCc-hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHH
Q 043902          384 IHKFVLMALPS-HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVV  462 (477)
Q Consensus       384 ~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl  462 (477)
                      +.   ...... ....+........           ..++       ..........+.+++.+||+.||++|||+.|++
T Consensus       236 ~~---~~~~~~~~~~~~~~~i~~~~-----------~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l  294 (316)
T 2ac3_A          236 WD---RGEACPACQNMLFESIQEGK-----------YEFP-------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL  294 (316)
T ss_dssp             C-------CCHHHHHHHHHHHHHCC-----------CCCC-------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             cc---ccccchhHHHHHHHHHhccC-----------cccC-------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHh
Confidence            11   000000 0011111000000           0000       000111234588999999999999999999998


Q ss_pred             H
Q 043902          463 N  463 (477)
Q Consensus       463 ~  463 (477)
                      +
T Consensus       295 ~  295 (316)
T 2ac3_A          295 Q  295 (316)
T ss_dssp             H
T ss_pred             c
Confidence            6

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=9.6e-43  Score=334.54  Aligned_cols=272  Identities=26%  Similarity=0.452  Sum_probs=197.6

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEEeC----CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccC
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGTLA----DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDY  227 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  227 (477)
                      ...++|...+.||+|+||.||+|...    ++..||+|+++...  ....+.+.+|+.++.+++||||+++++++.....
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            34578888999999999999999753    34589999997543  3345778999999999999999999999754332


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcE
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIA  307 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~  307 (477)
                      ......++||||+++|+|.+++...... .....+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLE-TGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBT-TSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhh-cCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcE
Confidence            2233569999999999999998533211 1225689999999999999999999999   99999999999999999999


Q ss_pred             EEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCccccccccee
Q 043902          308 HVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIH  385 (477)
Q Consensus       308 kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~  385 (477)
                      ||+|||+++......     .........++..|+|||.+ ...++.++||||||+++|||+| |..||.......    
T Consensus       187 kl~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----  257 (313)
T 3brb_A          187 CVADFGLSKKIYSGD-----YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE----  257 (313)
T ss_dssp             EECSCSCC---------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----
T ss_pred             EEeecCcceeccccc-----ccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH----
Confidence            999999998653211     11222334578899999999 5678999999999999999999 888986532211    


Q ss_pred             eeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHH
Q 043902          386 KFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNL  465 (477)
Q Consensus       386 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  465 (477)
                                ..+.+.......             .+           ..+...+.+++.+||+.||.+|||+.++++.|
T Consensus       258 ----------~~~~~~~~~~~~-------------~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L  303 (313)
T 3brb_A          258 ----------MYDYLLHGHRLK-------------QP-----------EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQL  303 (313)
T ss_dssp             ----------HHHHHHTTCCCC-------------CB-----------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             ----------HHHHHHcCCCCC-------------CC-----------ccccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence                      011000000000             00           01133488999999999999999999999999


Q ss_pred             HHHHHhh
Q 043902          466 QAIRSKI  472 (477)
Q Consensus       466 ~~i~~~~  472 (477)
                      +++.+.+
T Consensus       304 ~~l~~~l  310 (313)
T 3brb_A          304 EKLLESL  310 (313)
T ss_dssp             HHHHHHC
T ss_pred             HHHHHhc
Confidence            9998765

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.5e-43  Score=342.49  Aligned_cols=250  Identities=24%  Similarity=0.326  Sum_probs=183.9

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ..++|+..+.||+|+||.||+|+.. +++.||||+++...  ..+.+.+|++++.+++||||++++++|     ...+..
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~  123 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIF-----ETPTEI  123 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeE-----ecCCeE
Confidence            4578999999999999999999976 58899999998553  236788999999999999999999996     456789


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC---CCcEEEe
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE---GMIAHVG  310 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~  310 (477)
                      ++||||+++|+|.+++...       ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.   ++.+||+
T Consensus       124 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~  193 (349)
T 2w4o_A          124 SLVLELVTGGELFDRIVEK-------GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIA  193 (349)
T ss_dssp             EEEECCCCSCBHHHHHTTC-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEc
Confidence            9999999999999999754       4589999999999999999999999   9999999999999975   8899999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      |||+++....        ........||+.|+|||++ ...++.++|||||||++|||++|+.||.........      
T Consensus       194 Dfg~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------  259 (349)
T 2w4o_A          194 DFGLSKIVEH--------QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM------  259 (349)
T ss_dssp             CCC------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH------
T ss_pred             cCccccccCc--------ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH------
Confidence            9999986521        1122345689999999999 456899999999999999999999999653221100      


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                            ...+........          ....            ......+.+++.+||+.||++|||+.|+++
T Consensus       260 ------~~~i~~~~~~~~----------~~~~------------~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          260 ------FRRILNCEYYFI----------SPWW------------DEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             ------HHHHHTTCCCCC----------TTTT------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ------HHHHHhCCCccC----------Cchh------------hhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  011111000000          0000            011234789999999999999999999986

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-43  Score=334.64  Aligned_cols=261  Identities=25%  Similarity=0.408  Sum_probs=205.4

Q ss_pred             cCCCCCC-eeeeeccceEEEEEeC---CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          157 DNFSEEN-LIGSGSFGSVYKGTLA---DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       157 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      ++|.+.+ .||+|+||.||+|...   ++..||+|+++... ....+.+.+|++++.+++||||+++++++.      .+
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~   82 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------AE   82 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------SS
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec------CC
Confidence            4555555 8999999999999853   57889999998643 344578999999999999999999999962      34


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+++++|.+++....      ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~D  153 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISD  153 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCT------TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECC
T ss_pred             CcEEEEEeCCCCCHHHHHHhCC------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECc
Confidence            5899999999999999997543      5689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeee
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~  389 (477)
                      ||++.......    ..........+|..|+|||.+ ...++.++||||||+++|||+| |+.||.......        
T Consensus       154 fg~~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------  221 (287)
T 1u59_A          154 FGLSKALGADD----SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------  221 (287)
T ss_dssp             CTTCEECTTCS----CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--------
T ss_pred             ccceeeeccCc----ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--------
Confidence            99998763211    111223344568899999999 5678999999999999999999 999996532211        


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIR  469 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  469 (477)
                            +...+.......             .+           ..++..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       222 ------~~~~i~~~~~~~-------------~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  271 (287)
T 1u59_A          222 ------VMAFIEQGKRME-------------CP-----------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  271 (287)
T ss_dssp             ------HHHHHHTTCCCC-------------CC-----------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------HHHHHhcCCcCC-------------CC-----------CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                  111111100000             00           011334889999999999999999999999999998


Q ss_pred             Hhhhh
Q 043902          470 SKIRM  474 (477)
Q Consensus       470 ~~~~~  474 (477)
                      .+...
T Consensus       272 ~~~~~  276 (287)
T 1u59_A          272 YSLAS  276 (287)
T ss_dssp             HHHHT
T ss_pred             HhcCC
Confidence            77554

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=332.31  Aligned_cols=206  Identities=26%  Similarity=0.407  Sum_probs=168.9

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeeccc-----hhhHHHHHHHHHHhcC---CCCCcceeeeecccc
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQ-----GALKSFIDECNALTSI---RHRNILKIVSSCSSV  225 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~  225 (477)
                      ..++|+..+.||+|+||.||+|+. .+++.||+|+++....     .....+.+|++++.++   +||||++++++|...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            467899999999999999999996 4789999999975431     1234667777777766   499999999998543


Q ss_pred             cCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC
Q 043902          226 DYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM  305 (477)
Q Consensus       226 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~  305 (477)
                      ........++||||+. |+|.+++.....     ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~  157 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-----PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGG  157 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTS
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCC
Confidence            3223336899999996 699999976532     3489999999999999999999999   999999999999999999


Q ss_pred             cEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          306 IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       306 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      .+||+|||+++....        ........||..|+|||.+ .+.++.++|||||||++|||++|+.||...
T Consensus       158 ~~kl~Dfg~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  222 (308)
T 3g33_A          158 TVKLADFGLARIYSY--------QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN  222 (308)
T ss_dssp             CEEECSCSCTTTSTT--------CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS
T ss_pred             CEEEeeCccccccCC--------CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999976521        1222345689999999999 667999999999999999999999999753

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6.6e-43  Score=332.30  Aligned_cols=197  Identities=23%  Similarity=0.402  Sum_probs=166.7

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ++|+..+.||+|+||.||+|+.. +++.||+|+++...  ......+.+|++++++++||||+++++++     ..++..
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEE-----EeCCEE
Confidence            57888999999999999999975 68999999997543  33347788999999999999999999996     456789


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||+++ ++.+++....      ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||
T Consensus        77 ~lv~e~~~~-~l~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg  146 (292)
T 3o0g_A           77 TLVFEFCDQ-DLKKYFDSCN------GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFG  146 (292)
T ss_dssp             EEEEECCSE-EHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEecCCC-CHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence            999999976 5555554332      4689999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCccccc-CC-CCcccceeehHHHHHHHhhCCCCCC
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GH-VSILGDIYSYGILLLEIFTGKRPTD  375 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~-~~~~~Dv~S~Gvvl~elltg~~p~~  375 (477)
                      +++....       .........||..|+|||.+. .. ++.++|||||||++|||+||..||.
T Consensus       147 ~~~~~~~-------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~  203 (292)
T 3o0g_A          147 LARAFGI-------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  203 (292)
T ss_dssp             TCEECCS-------CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred             cceecCC-------ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc
Confidence            9986521       122234456899999999983 33 7999999999999999999888864

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=6.9e-43  Score=330.23  Aligned_cols=259  Identities=22%  Similarity=0.409  Sum_probs=201.5

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeCC----CCEEEEEEeeec-cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLAD----GETAAIKVLKLQ-QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEG  229 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  229 (477)
                      ..++|...+.||+|+||.||+|+..+    +..||+|+++.. .....+.+.+|++++++++||||+++++++.      
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------   83 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE------   83 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC------
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc------
Confidence            35678899999999999999998542    346999998754 3344578999999999999999999999853      


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEE
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV  309 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl  309 (477)
                      .+..++||||+++++|.+++....      ..+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||
T Consensus        84 ~~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl  154 (281)
T 3cc6_A           84 EEPTWIIMELYPYGELGHYLERNK------NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKL  154 (281)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHT------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEE
T ss_pred             CCCCEEEEecCCCCCHHHHHHhcc------ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEe
Confidence            234689999999999999997532      4589999999999999999999999   9999999999999999999999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeee
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~  387 (477)
                      +|||++......      .........+|..|+|||.+ .+.++.++||||||+++|||+| |+.||.......      
T Consensus       155 ~Dfg~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~------  222 (281)
T 3cc6_A          155 GDFGLSRYIEDE------DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD------  222 (281)
T ss_dssp             CCCCGGGCC---------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG------
T ss_pred             CccCCCcccccc------cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH------
Confidence            999999865321      11122344578899999999 5678999999999999999998 999996432211      


Q ss_pred             eeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHH
Q 043902          388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQA  467 (477)
Q Consensus       388 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  467 (477)
                              ....+.......             .+.           .+...+.+++.+||+.||++|||+.|+++.|++
T Consensus       223 --------~~~~~~~~~~~~-------------~~~-----------~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~  270 (281)
T 3cc6_A          223 --------VIGVLEKGDRLP-------------KPD-----------LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD  270 (281)
T ss_dssp             --------HHHHHHHTCCCC-------------CCT-----------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --------HHHHHhcCCCCC-------------CCC-----------CCCHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence                    111111000000             000           012348899999999999999999999999999


Q ss_pred             HHHhh
Q 043902          468 IRSKI  472 (477)
Q Consensus       468 i~~~~  472 (477)
                      +.+..
T Consensus       271 ~~~~~  275 (281)
T 3cc6_A          271 VYQME  275 (281)
T ss_dssp             HHHHH
T ss_pred             HHHhh
Confidence            87653

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=7.2e-43  Score=344.04  Aligned_cols=199  Identities=24%  Similarity=0.371  Sum_probs=171.7

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~  230 (477)
                      .++|+..+.||+|+||.||+|+.. +++.||+|+++...   ......+..|..++.++ +||||+++++++     ...
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~~  125 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTE  125 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----ECS
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----EEC
Confidence            468899999999999999999976 68899999998542   23345688899999887 899999999985     567


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +..++||||+++|+|..++...       ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+
T Consensus       126 ~~~~lV~E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~  195 (396)
T 4dc2_A          126 SRLFFVIEYVNGGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLT  195 (396)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred             CEEEEEEEcCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEe
Confidence            7899999999999999998754       4689999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |||+++....       .........||+.|+|||++ ...++.++|||||||++|||++|+.||..
T Consensus       196 DFGla~~~~~-------~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~  255 (396)
T 4dc2_A          196 DYGMCKEGLR-------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  255 (396)
T ss_dssp             CCTTCBCCCC-------TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred             ecceeeeccc-------CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence            9999975321       12233456799999999999 45689999999999999999999999964

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-42  Score=335.99  Aligned_cols=261  Identities=26%  Similarity=0.479  Sum_probs=198.3

Q ss_pred             cCCCCCCeeeeeccceEEEEEeCC-----CCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLAD-----GETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      ++|+..+.||+|+||.||+|....     +..||+|+++... ......+.+|++++.+++||||+++++++     ...
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~  118 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----SKY  118 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSS
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----ecC
Confidence            466678899999999999998642     2369999998543 33446789999999999999999999996     456


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +..++||||+++|+|.+++....      ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~  189 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKD------GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVS  189 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTT------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEEC
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEEC
Confidence            67899999999999999997543      4689999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~  388 (477)
                      |||+++.......    .........+|..|+|||.+ .+.++.++|||||||++|||+| |+.||.......       
T Consensus       190 Dfg~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------  258 (333)
T 1mqb_A          190 DFGLSRVLEDDPE----ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------  258 (333)
T ss_dssp             CCCC---------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------
T ss_pred             CCCcchhhccccc----cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH-------
Confidence            9999987632111    11122234467889999999 5678999999999999999999 999996532111       


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                             +...+.......             .+           ..+...+.+++.+||+.||++||++.|+++.|+++
T Consensus       259 -------~~~~~~~~~~~~-------------~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  307 (333)
T 1mqb_A          259 -------VMKAINDGFRLP-------------TP-----------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  307 (333)
T ss_dssp             -------HHHHHHTTCCCC-------------CC-----------TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -------HHHHHHCCCcCC-------------Cc-----------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                   111111000000             00           01133488999999999999999999999999998


Q ss_pred             HHhhh
Q 043902          469 RSKIR  473 (477)
Q Consensus       469 ~~~~~  473 (477)
                      .....
T Consensus       308 ~~~~~  312 (333)
T 1mqb_A          308 IRAPD  312 (333)
T ss_dssp             HHSGG
T ss_pred             Hhcch
Confidence            77644

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=368.65  Aligned_cols=255  Identities=24%  Similarity=0.393  Sum_probs=198.9

Q ss_pred             eeeeeccceEEEEEeC---CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEEee
Q 043902          164 LIGSGSFGSVYKGTLA---DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEF  239 (477)
Q Consensus       164 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~  239 (477)
                      .||+|+||.||+|.+.   ++..||||+++... ....+.+.+|++++++++||||++++++|.     . +..++||||
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~-----~-~~~~lv~E~  416 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-----A-EALMLVMEM  416 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----S-SSEEEEEEC
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEec-----c-CCeEEEEEe
Confidence            7999999999999864   46679999998643 335678999999999999999999999973     2 458999999


Q ss_pred             cCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccccc
Q 043902          240 MRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLF  319 (477)
Q Consensus       240 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  319 (477)
                      +++|+|.+++....      ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       417 ~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~  487 (613)
T 2ozo_A          417 AGGGPLHKFLVGKR------EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALG  487 (613)
T ss_dssp             CTTCBHHHHHTTCT------TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred             CCCCcHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence            99999999997543      5689999999999999999999999   99999999999999999999999999998753


Q ss_pred             ccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCCchhH
Q 043902          320 EESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALPSHVM  397 (477)
Q Consensus       320 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  397 (477)
                      ...    ..........+|+.|+|||++ .+.++.++|||||||++|||+| |+.||.......              +.
T Consensus       488 ~~~----~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--------------~~  549 (613)
T 2ozo_A          488 ADD----SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------------VM  549 (613)
T ss_dssp             ------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--------------HH
T ss_pred             CCC----ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--------------HH
Confidence            211    111112233457899999999 5789999999999999999998 999997532211              11


Q ss_pred             HHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHhhhhc
Q 043902          398 DVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSKIRMR  475 (477)
Q Consensus       398 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~  475 (477)
                      +.+.......                        .+..++..+.+++.+||+.||++|||+.+|++.|+.+......+
T Consensus       550 ~~i~~~~~~~------------------------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~  603 (613)
T 2ozo_A          550 AFIEQGKRME------------------------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  603 (613)
T ss_dssp             HHHHTTCCCC------------------------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCS
T ss_pred             HHHHcCCCCC------------------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccc
Confidence            1111110000                        00112445889999999999999999999999999988776543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=7.1e-43  Score=348.53  Aligned_cols=260  Identities=20%  Similarity=0.274  Sum_probs=202.2

Q ss_pred             HHHHHhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccc
Q 043902          150 LKISNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSV  225 (477)
Q Consensus       150 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  225 (477)
                      .++....++|+..++||+|+||.||+|+.. +++.||+|+++...   ......+.+|..++.+++||||++++++|   
T Consensus        67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~---  143 (437)
T 4aw2_A           67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF---  143 (437)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE---
T ss_pred             hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE---
Confidence            344456789999999999999999999976 57899999997532   22234588999999999999999999986   


Q ss_pred             cCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC
Q 043902          226 DYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM  305 (477)
Q Consensus       226 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~  305 (477)
                        .+.+..++||||+++|+|.+++....      ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++
T Consensus       144 --~~~~~~~lV~Ey~~gg~L~~~l~~~~------~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g  212 (437)
T 4aw2_A          144 --QDDNNLYLVMDYYVGGDLLTLLSKFE------DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNG  212 (437)
T ss_dssp             --ECSSEEEEEECCCTTCBHHHHHHTTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTS
T ss_pred             --eeCCEEEEEEecCCCCcHHHHHHHcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCC
Confidence              56778999999999999999997643      4689999999999999999999999   999999999999999999


Q ss_pred             cEEEecccccccccccCCCCCCCccccCCCcccccccCccccc------CCCCcccceeehHHHHHHHhhCCCCCCcccc
Q 043902          306 IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN------GHVSILGDIYSYGILLLEIFTGKRPTDDMFK  379 (477)
Q Consensus       306 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~  379 (477)
                      .+||+|||+++.....      .........||+.|+|||++.      +.++.++|||||||++|||+||+.||.....
T Consensus       213 ~vkL~DFGla~~~~~~------~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~  286 (437)
T 4aw2_A          213 HIRLADFGSCLKLMED------GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL  286 (437)
T ss_dssp             CEEECCCTTCEECCTT------SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred             CEEEcchhhhhhcccC------CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh
Confidence            9999999999765321      122234467999999999983      3589999999999999999999999965321


Q ss_pred             cccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCC--CCC
Q 043902          380 DDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRD--RVG  457 (477)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs  457 (477)
                      ..             ....++.......             +|...        ......+.+|+.+||..+|++  ||+
T Consensus       287 ~~-------------~~~~i~~~~~~~~-------------~p~~~--------~~~s~~~~dLi~~lL~~~~~r~~r~~  332 (437)
T 4aw2_A          287 VE-------------TYGKIMNHKERFQ-------------FPTQV--------TDVSENAKDLIRRLICSREHRLGQNG  332 (437)
T ss_dssp             HH-------------HHHHHHTHHHHCC-------------CCSSC--------CCSCHHHHHHHHTTSSCGGGCTTTTT
T ss_pred             hH-------------HHHhhhhcccccc-------------CCccc--------ccCCHHHHHHHHHHhcccccccCCCC
Confidence            11             1111111100000             00000        001233788999999888888  999


Q ss_pred             hHHHHH
Q 043902          458 MKFVVN  463 (477)
Q Consensus       458 ~~evl~  463 (477)
                      ++|+++
T Consensus       333 ~~eil~  338 (437)
T 4aw2_A          333 IEDFKK  338 (437)
T ss_dssp             THHHHT
T ss_pred             HHHHhC
Confidence            999875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.8e-43  Score=341.28  Aligned_cols=273  Identities=25%  Similarity=0.405  Sum_probs=210.3

Q ss_pred             HHhhcCCCCCCeeeeeccceEEEEEeC-CC-----CEEEEEEeeecc-chhhHHHHHHHHHHhcC-CCCCcceeeeeccc
Q 043902          153 SNATDNFSEENLIGSGSFGSVYKGTLA-DG-----ETAAIKVLKLQQ-QGALKSFIDECNALTSI-RHRNILKIVSSCSS  224 (477)
Q Consensus       153 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  224 (477)
                      ....++|...+.||+|+||.||+|... ++     ..||+|.++... ....+.+.+|++++.++ +||||++++++|  
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--  119 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC--  119 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE--
Confidence            334578889999999999999999864 22     479999997553 33457789999999999 899999999996  


Q ss_pred             ccCCCCceeeEEEeecCCCChhhhcccCCCc-------ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCC
Q 043902          225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDE-------YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSS  297 (477)
Q Consensus       225 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~  297 (477)
                         ...+..++||||+++|+|.+++......       ......+++..++.++.|++.||.|||++   +|+||||||+
T Consensus       120 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~  193 (333)
T 2i1m_A          120 ---THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAAR  193 (333)
T ss_dssp             ---CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred             ---ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccc
Confidence               4556789999999999999998643110       00124579999999999999999999999   9999999999


Q ss_pred             CeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCC
Q 043902          298 NVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTD  375 (477)
Q Consensus       298 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~  375 (477)
                      ||+++.++.+||+|||+++......     .........+|..|+|||.+ .+.++.++|||||||++|||+| |..||.
T Consensus       194 NIl~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  268 (333)
T 2i1m_A          194 NVLLTNGHVAKIGDFGLARDIMNDS-----NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP  268 (333)
T ss_dssp             GCEEEGGGEEEBCCCGGGCCGGGCT-----TSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             eEEECCCCeEEECcccccccccccc-----ceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCc
Confidence            9999999999999999998653211     12223345678899999998 6678999999999999999999 999986


Q ss_pred             cccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCC
Q 043902          376 DMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDR  455 (477)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R  455 (477)
                      ......             .....+.......             .+.           .++..+.+++.+||+.||.+|
T Consensus       269 ~~~~~~-------------~~~~~~~~~~~~~-------------~~~-----------~~~~~l~~li~~~l~~~p~~R  311 (333)
T 2i1m_A          269 GILVNS-------------KFYKLVKDGYQMA-------------QPA-----------FAPKNIYSIMQACWALEPTHR  311 (333)
T ss_dssp             TCCSSH-------------HHHHHHHHTCCCC-------------CCT-----------TCCHHHHHHHHHHTCSSGGGS
T ss_pred             ccchhH-------------HHHHHHhcCCCCC-------------CCC-----------CCCHHHHHHHHHHhccChhhC
Confidence            532111             1111111111000             000           012347899999999999999


Q ss_pred             CChHHHHHHHHHHHHhhhhc
Q 043902          456 VGMKFVVNNLQAIRSKIRMR  475 (477)
Q Consensus       456 Ps~~evl~~L~~i~~~~~~~  475 (477)
                      ||+.||++.|+++..+.+..
T Consensus       312 ps~~~l~~~L~~~~~~~~~~  331 (333)
T 2i1m_A          312 PTFQQICSFLQEQAQEDRRE  331 (333)
T ss_dssp             CCHHHHHHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHHHHhhhcc
Confidence            99999999999998876554

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-42  Score=331.72  Aligned_cols=264  Identities=23%  Similarity=0.396  Sum_probs=201.8

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CC---CEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DG---ETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .|...+.||+|+||.||+|.+. ++   ..||+|+++... ....+.+.+|+.++++++||||+++++++.    ..+..
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~   97 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIML----PPEGL   97 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC----CSSSC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe----cCCCC
Confidence            4555689999999999999853 22   379999987543 344578899999999999999999999973    33444


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+.+|+|.+++....      ..+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+||
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Df  168 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSPQ------RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADF  168 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCTT------CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCT
T ss_pred             cEEEEecccCCCHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcC
Confidence            589999999999999997643      5689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      |+++........   .........+|..|+|||.+ ...++.++|||||||++|||+||..|+.......          
T Consensus       169 g~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~----------  235 (298)
T 3pls_A          169 GLARDILDREYY---SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF----------  235 (298)
T ss_dssp             TSSCTTTTGGGG---CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG----------
T ss_pred             CCcccccCCccc---ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH----------
Confidence            999865321110   11223345678999999999 4568999999999999999999665543211110          


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHh
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSK  471 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  471 (477)
                         .+...+.......             .+           ..+...+.+++.+||+.||.+|||+.|+++.|+++.+.
T Consensus       236 ---~~~~~~~~~~~~~-------------~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  288 (298)
T 3pls_A          236 ---DLTHFLAQGRRLP-------------QP-----------EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA  288 (298)
T ss_dssp             ---GHHHHHHTTCCCC-------------CC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---HHHHHhhcCCCCC-------------CC-----------ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence               1111111100000             00           00123488999999999999999999999999999987


Q ss_pred             hhh
Q 043902          472 IRM  474 (477)
Q Consensus       472 ~~~  474 (477)
                      +..
T Consensus       289 l~~  291 (298)
T 3pls_A          289 LLG  291 (298)
T ss_dssp             CCS
T ss_pred             Hhc
Confidence            654

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.2e-43  Score=341.04  Aligned_cols=273  Identities=14%  Similarity=0.162  Sum_probs=205.0

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCC---------CCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCccee--------
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLAD---------GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKI--------  218 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l--------  218 (477)
                      .++|...+.||+|+||.||+|+...         ++.||+|++...     +.+.+|++++.+++||||+++        
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            4689999999999999999999763         789999998754     467899999999999999984        


Q ss_pred             -------eeecccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeee
Q 043902          219 -------VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAH  291 (477)
Q Consensus       219 -------~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH  291 (477)
                             ++++.    ..+...++||||+ +++|.+++....     ...+++..++.++.|++.||.|||++   +|+|
T Consensus       116 ~~~i~~~~~~~~----~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH  182 (352)
T 2jii_A          116 LLAIPTCMGFGV----HQDKYRFLVLPSL-GRSLQSALDVSP-----KHVLSERSVLQVACRLLDALEFLHEN---EYVH  182 (352)
T ss_dssp             TCSCCCCCEEEE----ETTTEEEEEEECC-CEEHHHHHHHSG-----GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBC
T ss_pred             ccCccchhhccc----cCCcEEEEEecCC-CcCHHHHHHhCC-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccC
Confidence                   44431    3467889999999 999999997542     25699999999999999999999999   9999


Q ss_pred             cCCCCCCeEecCCC--cEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHh
Q 043902          292 CDLKSSNVLLDEGM--IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIF  368 (477)
Q Consensus       292 ~dlkp~NIll~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ell  368 (477)
                      |||||+||+++.++  .+||+|||+++.+..................||..|+|||.+ ...++.++|||||||++|||+
T Consensus       183 ~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~  262 (352)
T 2jii_A          183 GNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWL  262 (352)
T ss_dssp             SCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence            99999999999998  999999999987644322222122233445799999999999 447899999999999999999


Q ss_pred             hCCCCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcC
Q 043902          369 TGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCS  448 (477)
Q Consensus       369 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl  448 (477)
                      ||+.||........            .+......... .   ............            .....+.+++.+||
T Consensus       263 ~g~~pf~~~~~~~~------------~~~~~~~~~~~-~---~~~~~~~~~~~~------------~~~~~l~~li~~~l  314 (352)
T 2jii_A          263 YGFLPWTNCLPNTE------------DIMKQKQKFVD-K---PGPFVGPCGHWI------------RPSETLQKYLKVVM  314 (352)
T ss_dssp             HSCCTTGGGTTCHH------------HHHHHHHHHHH-S---CCCEECTTSCEE------------CCCHHHHHHHHHHH
T ss_pred             hCCCCcccCCcCHH------------HHHHHHHhccC-C---hhhhhhhccccC------------CCcHHHHHHHHHHH
Confidence            99999976421111            01110000000 0   000000000000            00234889999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhhh
Q 043902          449 AASPRDRVGMKFVVNNLQAIRSKIRM  474 (477)
Q Consensus       449 ~~dP~~RPs~~evl~~L~~i~~~~~~  474 (477)
                      +.||++|||++||++.|+++.++...
T Consensus       315 ~~dp~~Rps~~~l~~~L~~~~~~~~~  340 (352)
T 2jii_A          315 ALTYEEKPPYAMLRNNLEALLQDLRV  340 (352)
T ss_dssp             TCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             hCChhhCCCHHHHHHHHHHHHHhcCC
Confidence            99999999999999999999988654

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.8e-42  Score=348.83  Aligned_cols=206  Identities=23%  Similarity=0.341  Sum_probs=158.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec--cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .++|++.+.||+|+||.||+|+.. +++.||||++...  .....+.+.+|++++.+++||||+++++++..........
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            468999999999999999999865 7899999998753  2334578899999999999999999999986554455677


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+ +|+|.+++...       ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DF  200 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTP-------VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDF  200 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSS-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEecc-ccchhhhcccC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeeccc
Confidence            99999998 57999998754       4689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCC--------------------CccccCCCcccccccCcccc--cCCCCcccceeehHHHHHHHhhC
Q 043902          313 GLAKFLFEESNTPSK--------------------NQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTG  370 (477)
Q Consensus       313 G~a~~~~~~~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~--~~~~~~~~Dv~S~Gvvl~elltg  370 (477)
                      |+++...........                    .........||+.|+|||++  ...++.++|||||||++|||+||
T Consensus       201 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             ccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            999876322111000                    01123456789999999976  45699999999999999999994


Q ss_pred             CC
Q 043902          371 KR  372 (477)
Q Consensus       371 ~~  372 (477)
                      ..
T Consensus       281 ~~  282 (458)
T 3rp9_A          281 IK  282 (458)
T ss_dssp             ST
T ss_pred             cc
Confidence            33

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3e-44  Score=369.16  Aligned_cols=259  Identities=27%  Similarity=0.483  Sum_probs=206.8

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      ..++|+..+.||+|+||.||+|.+.++..||||+++.... ..+.|.+|+++|++++||||++++++|.      .+..+
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~------~~~~~  337 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIY  337 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCE
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEe------eccce
Confidence            4567888899999999999999998888899999986543 3478999999999999999999999963      24589


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +||||+++|+|.+++....     ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       338 lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~  409 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGET-----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGL  409 (535)
T ss_dssp             EEECCCTTEEHHHHHSHHH-----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred             EeeehhcCCcHHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccccc
Confidence            9999999999999997431     14589999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccC
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMAL  392 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  392 (477)
                      ++.....      .........++..|+|||.+ .+.++.++|||||||++|||+| |+.||.......           
T Consensus       410 a~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-----------  472 (535)
T 2h8h_A          410 ARLIEDN------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----------  472 (535)
T ss_dssp             TTTCCCH------HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-----------
T ss_pred             ceecCCC------ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----------
Confidence            9865211      11223344578899999998 6779999999999999999999 999997532211           


Q ss_pred             CchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHhh
Q 043902          393 PSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSKI  472 (477)
Q Consensus       393 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  472 (477)
                         +.+.+.......                        ....+...+.+|+.+||+.||++|||+.+|++.|+.+....
T Consensus       473 ---~~~~i~~~~~~~------------------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          473 ---VLDQVERGYRMP------------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             ---HHHHHHTTCCCC------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             ---HHHHHHcCCCCC------------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence               111111100000                        00112345889999999999999999999999999876543

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.9e-43  Score=339.21  Aligned_cols=258  Identities=26%  Similarity=0.457  Sum_probs=196.6

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCE----EEEEEeeec-cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGET----AAIKVLKLQ-QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEG  229 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  229 (477)
                      .++|+..+.||+|+||.||+|+.. +++.    ||+|.++.. .....+.+.+|+.++++++||||++++++|..     
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----   88 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----   88 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-----
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-----
Confidence            467899999999999999999864 4554    566766533 33445789999999999999999999999742     


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEE
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV  309 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl  309 (477)
                       ...++|+||+.+|+|.+++....      ..+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||
T Consensus        89 -~~~~~v~~~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL  158 (327)
T 3lzb_A           89 -STVQLITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKI  158 (327)
T ss_dssp             -SSEEEEECCCSSCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEE
T ss_pred             -CCceEEEEecCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEE
Confidence             23789999999999999997643      4689999999999999999999999   9999999999999999999999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeee
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~  387 (477)
                      +|||+++......     .........+|..|+|||.+ ...++.++|||||||++|||++ |+.||.......      
T Consensus       159 ~DfG~a~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------  227 (327)
T 3lzb_A          159 TDFGLAKLLGAEE-----KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------  227 (327)
T ss_dssp             CCTTC---------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------
T ss_pred             ccCcceeEccCcc-----ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH------
Confidence            9999998753211     12223344568899999999 6678999999999999999999 999997532221      


Q ss_pred             eeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHH
Q 043902          388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQA  467 (477)
Q Consensus       388 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  467 (477)
                              +...+.......             .+           ..+...+.+++.+||+.||.+|||+.|+++.|++
T Consensus       228 --------~~~~~~~~~~~~-------------~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  275 (327)
T 3lzb_A          228 --------ISSILEKGERLP-------------QP-----------PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSK  275 (327)
T ss_dssp             --------HHHHHHTTCCCC-------------CC-----------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --------HHHHHHcCCCCC-------------CC-----------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                    111111111000             00           0012348899999999999999999999999999


Q ss_pred             HHHh
Q 043902          468 IRSK  471 (477)
Q Consensus       468 i~~~  471 (477)
                      +...
T Consensus       276 ~~~~  279 (327)
T 3lzb_A          276 MARD  279 (327)
T ss_dssp             HHTS
T ss_pred             HHhC
Confidence            8754

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.7e-43  Score=332.16  Aligned_cols=251  Identities=20%  Similarity=0.395  Sum_probs=197.8

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CC-------CEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DG-------ETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDY  227 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  227 (477)
                      .++|...+.||+|+||.||+|+.. ++       ..||+|+++.......+.+.+|++++.+++||||+++++++     
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----   81 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVC-----   81 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEE-----
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----
Confidence            457888999999999999999864 23       47999999876666678899999999999999999999996     


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCc-
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI-  306 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~-  306 (477)
                      ...+..++||||+++|+|.+++....      ..+++..++.++.|++.||.|||++   +|+||||||+||+++.++. 
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~  152 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNK------NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDR  152 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTG------GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBG
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcc
Confidence            44667899999999999999997643      4489999999999999999999999   9999999999999998887 


Q ss_pred             -------EEEecccccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          307 -------AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       307 -------~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                             +||+|||++.....           .....||..|+|||.+.  ..++.++|||||||++|||+||..|+...
T Consensus       153 ~~~~~~~~kl~Dfg~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~  221 (289)
T 4fvq_A          153 KTGNPPFIKLSDPGISITVLP-----------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA  221 (289)
T ss_dssp             GGTBCCEEEECCCCSCTTTSC-----------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             cccccceeeeccCcccccccC-----------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc
Confidence                   99999999875411           12235788999999994  56899999999999999999965544321


Q ss_pred             cccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCC
Q 043902          378 FKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVG  457 (477)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs  457 (477)
                      ....             .............     ..                     ....+.+++.+||+.||++|||
T Consensus       222 ~~~~-------------~~~~~~~~~~~~~-----~~---------------------~~~~l~~li~~~l~~dp~~Rps  262 (289)
T 4fvq_A          222 LDSQ-------------RKLQFYEDRHQLP-----AP---------------------KAAELANLINNCMDYEPDHRPS  262 (289)
T ss_dssp             SCHH-------------HHHHHHHTTCCCC-----CC---------------------SSCTTHHHHHHHSCSSGGGSCC
T ss_pred             cchH-------------HHHHHhhccCCCC-----CC---------------------CCHHHHHHHHHHcCCChhHCcC
Confidence            1110             0001110000000     00                     0122778999999999999999


Q ss_pred             hHHHHHHHHHHHH
Q 043902          458 MKFVVNNLQAIRS  470 (477)
Q Consensus       458 ~~evl~~L~~i~~  470 (477)
                      +.|+++.|+++..
T Consensus       263 ~~~ll~~l~~l~~  275 (289)
T 4fvq_A          263 FRAIIRDLNSLFT  275 (289)
T ss_dssp             HHHHHHHHHTCC-
T ss_pred             HHHHHHHHHHhcC
Confidence            9999999988754

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2e-42  Score=336.67  Aligned_cols=244  Identities=22%  Similarity=0.287  Sum_probs=198.0

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .++|+..+.||+|+||.||+|+.. +|+.||+|+++...   ....+.+.+|++++++++||||+++++++     .+..
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~  114 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNS  114 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcCC
Confidence            467889999999999999999975 78999999997542   23456788999999999999999999985     5667


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+++|+|.+++...       ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus       115 ~~~lv~e~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~D  184 (350)
T 1rdq_E          115 NLYMVMEYVAGGEMFSHLRRI-------GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTD  184 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             EEEEEEcCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcc
Confidence            899999999999999999753       4589999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      ||+++....          ......||+.|+|||++ ...++.++|||||||++|||++|+.||.......         
T Consensus       185 Fg~a~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---------  245 (350)
T 1rdq_E          185 FGFAKRVKG----------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---------  245 (350)
T ss_dssp             CTTCEECSS----------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------
T ss_pred             cccceeccC----------CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH---------
Confidence            999986521          12345799999999999 5568999999999999999999999996532110         


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCC-----hHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVG-----MKFVVN  463 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  463 (477)
                          ....+......               +|.           .+...+.+++.+||+.||.+||+     ++|+++
T Consensus       246 ----~~~~i~~~~~~---------------~p~-----------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          246 ----IYEKIVSGKVR---------------FPS-----------HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ----HHHHHHHCCCC---------------CCT-----------TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----HHHHHHcCCCC---------------CCC-----------CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                00111110000               000           01234789999999999999998     788764

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.5e-43  Score=339.75  Aligned_cols=265  Identities=20%  Similarity=0.347  Sum_probs=194.1

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      ..++|+..+.||+|+||.||+|+. .+++.||||+++...   ......+.+|++++.+++||||+++++++.... ...
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   88 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAG   88 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCC
Confidence            357899999999999999999996 478999999997543   233467889999999999999999999864321 122


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ...++||||+++++|.+++...       ..+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+
T Consensus        89 ~~~~lv~e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~  158 (311)
T 3ork_A           89 PLPYIVMEYVDGVTLRDIVHTE-------GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVM  158 (311)
T ss_dssp             EEEEEEEECCCEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEEC
T ss_pred             cccEEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEe
Confidence            3459999999999999999743       4589999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      |||+++......    ..........||..|+|||.+ ...++.++|||||||++|||+||+.||........       
T Consensus       159 Dfg~a~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-------  227 (311)
T 3ork_A          159 DFGIARAIADSG----NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-------  227 (311)
T ss_dssp             CCSCC----------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------
T ss_pred             eccCcccccccc----cccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-------
Confidence            999998653211    111223345689999999999 55789999999999999999999999965322110       


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHH-HHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVV-NNLQAI  468 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl-~~L~~i  468 (477)
                            ..........                +      .....+.+...+.+++.+||+.||++||++.+++ ..+.++
T Consensus       228 ------~~~~~~~~~~----------------~------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          228 ------AYQHVREDPI----------------P------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             ------HHHHHHCCCC----------------C------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ------HHHHhcCCCC----------------C------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence                  0000000000                0      0000011234488999999999999999766554 555554


Q ss_pred             H
Q 043902          469 R  469 (477)
Q Consensus       469 ~  469 (477)
                      .
T Consensus       280 ~  280 (311)
T 3ork_A          280 H  280 (311)
T ss_dssp             H
T ss_pred             h
Confidence            3

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6.3e-43  Score=339.17  Aligned_cols=248  Identities=22%  Similarity=0.373  Sum_probs=197.2

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcC-CCCCcceeeeecccccCC
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYE  228 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  228 (477)
                      ...++|...+.||+|+||.||+|+.. +|+.||+|+++...   ......+..|..++.++ +||||+++++++     .
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-----~   88 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----Q   88 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----E
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----E
Confidence            45678999999999999999999975 68999999998542   33446788899999876 899999999985     5


Q ss_pred             CCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEE
Q 043902          229 GNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH  308 (477)
Q Consensus       229 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k  308 (477)
                      +.+..++||||+++|+|.+++...       ..+++..+..++.||+.||.|||++   +|+||||||+||+++.++.+|
T Consensus        89 ~~~~~~lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vk  158 (345)
T 1xjd_A           89 TKENLFFVMEYLNGGDLMYHIQSC-------HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIK  158 (345)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEE
Confidence            677899999999999999999753       4589999999999999999999999   999999999999999999999


Q ss_pred             EecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeee
Q 043902          309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       309 l~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~  387 (477)
                      |+|||+++....       .........||+.|+|||++ ...++.++|||||||++|||++|+.||.......      
T Consensus       159 L~DFG~a~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------  225 (345)
T 1xjd_A          159 IADFGMCKENML-------GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------  225 (345)
T ss_dssp             ECCCTTCBCCCC-------TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------
T ss_pred             EeEChhhhhccc-------CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH------
Confidence            999999975421       11223456799999999999 4568999999999999999999999996532111      


Q ss_pred             eeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChH-HHH
Q 043902          388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMK-FVV  462 (477)
Q Consensus       388 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl  462 (477)
                                 +........           ..+|..           ....+.+++.+||+.||++||++. |++
T Consensus       226 -----------~~~~i~~~~-----------~~~p~~-----------~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          226 -----------LFHSIRMDN-----------PFYPRW-----------LEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             -----------HHHHHHHCC-----------CCCCTT-----------SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             -----------HHHHHHhCC-----------CCCCcc-----------cCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                       110000000           000000           123478999999999999999997 664

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.9e-42  Score=348.20  Aligned_cols=272  Identities=19%  Similarity=0.264  Sum_probs=207.8

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      .++|.+.+.||+|+||.||+|+. .+++.||||+++.....  ..+..|++++..++|++.+..+.++.    ...+..+
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~----~~~~~~~   79 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG----VEGDYNV   79 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEE----EETTEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEE----eeCCEEE
Confidence            46899999999999999999996 47999999998755432  46889999999998755555444432    4566789


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEe---cCCCcEEEec
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVGD  311 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~D  311 (477)
                      +||||+ +++|.+++....      ..+++..++.|+.||+.||.|||++   +|+||||||+|||+   +.++.+||+|
T Consensus        80 lvme~~-g~sL~~ll~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~D  149 (483)
T 3sv0_A           80 LVMDLL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIID  149 (483)
T ss_dssp             EEEECC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECC
T ss_pred             EEEECC-CCCHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEe
Confidence            999999 999999997533      4689999999999999999999999   99999999999999   6889999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      ||+++.+..................||..|+|||.+ ...++.++|||||||++|||++|+.||.........       
T Consensus       150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~-------  222 (483)
T 3sv0_A          150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-------  222 (483)
T ss_dssp             CTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHH-------
T ss_pred             CCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHH-------
Confidence            999987644322221122233466799999999999 557899999999999999999999999764221100       


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRS  470 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  470 (477)
                         ..+..+........                     .......++..+.+++..||+.||++||++.+|++.|+++..
T Consensus       223 ---~~~~~i~~~~~~~~---------------------~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~  278 (483)
T 3sv0_A          223 ---QKYEKISEKKVATS---------------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI  278 (483)
T ss_dssp             ---HHHHHHHHHHHHSC---------------------HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             ---HHHHHHhhcccccc---------------------HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence               01111111111000                     011112234568999999999999999999999999999987


Q ss_pred             hhhh
Q 043902          471 KIRM  474 (477)
Q Consensus       471 ~~~~  474 (477)
                      ....
T Consensus       279 ~~~~  282 (483)
T 3sv0_A          279 REGF  282 (483)
T ss_dssp             HTTC
T ss_pred             HcCC
Confidence            6543

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=8.3e-43  Score=345.45  Aligned_cols=256  Identities=19%  Similarity=0.277  Sum_probs=200.3

Q ss_pred             HHHHhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeeccccc
Q 043902          151 KISNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVD  226 (477)
Q Consensus       151 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  226 (477)
                      ++....++|+..+.||+|+||.||+|+.. +++.||+|+++...   ......+.+|..++..++||||+++++++    
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~----  138 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF----  138 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE----
Confidence            34445689999999999999999999976 68999999997532   22335688999999999999999999996    


Q ss_pred             CCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCc
Q 043902          227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI  306 (477)
Q Consensus       227 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~  306 (477)
                       .+....++||||+++|+|.+++...        .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.
T Consensus       139 -~~~~~~~lV~E~~~gg~L~~~l~~~--------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~  206 (410)
T 3v8s_A          139 -QDDRYLYMVMEYMPGGDLVNLMSNY--------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGH  206 (410)
T ss_dssp             -ECSSEEEEEECCCTTEEHHHHHHHC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred             -EECCEEEEEEeCCCCCcHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCC
Confidence             5677899999999999999998643        488999999999999999999999   9999999999999999999


Q ss_pred             EEEecccccccccccCCCCCCCccccCCCcccccccCcccccC-C----CCcccceeehHHHHHHHhhCCCCCCcccccc
Q 043902          307 AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-H----VSILGDIYSYGILLLEIFTGKRPTDDMFKDD  381 (477)
Q Consensus       307 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~----~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~  381 (477)
                      +||+|||+++....      ..........||+.|+|||++.+ .    ++.++|||||||++|||+||+.||.......
T Consensus       207 ikL~DFG~a~~~~~------~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~  280 (410)
T 3v8s_A          207 LKLADFGTCMKMNK------EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG  280 (410)
T ss_dssp             EEECCCTTCEECCT------TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             EEEeccceeEeecc------CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh
Confidence            99999999986522      11223345679999999999832 2    7899999999999999999999996532111


Q ss_pred             cceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCC--CCChH
Q 043902          382 LSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRD--RVGMK  459 (477)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~  459 (477)
                                   ....++.......             +|..         ......+.+|+.+||..+|.+  ||+++
T Consensus       281 -------------~~~~i~~~~~~~~-------------~p~~---------~~~s~~~~~li~~lL~~~~~rlgR~~~~  325 (410)
T 3v8s_A          281 -------------TYSKIMNHKNSLT-------------FPDD---------NDISKEAKNLICAFLTDREVRLGRNGVE  325 (410)
T ss_dssp             -------------HHHHHHTHHHHCC-------------CCTT---------CCCCHHHHHHHHHHSSCGGGCTTSSCHH
T ss_pred             -------------HHHHHHhcccccc-------------CCCc---------ccccHHHHHHHHHHccChhhhCCCCCHH
Confidence                         1111111100000             0000         001234789999999999988  99999


Q ss_pred             HHHH
Q 043902          460 FVVN  463 (477)
Q Consensus       460 evl~  463 (477)
                      ||++
T Consensus       326 ei~~  329 (410)
T 3v8s_A          326 EIKR  329 (410)
T ss_dssp             HHHT
T ss_pred             HHhc
Confidence            9975

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.5e-43  Score=341.94  Aligned_cols=251  Identities=24%  Similarity=0.415  Sum_probs=192.8

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCC--CCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRH--RNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~~~  231 (477)
                      .++|++.+.||+|+||.||++...+++.||||+++...  ....+.+.+|++++.+++|  |||+++++++     ....
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-----~~~~   82 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITDQ   82 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE-----eeCC
Confidence            46788999999999999999998889999999997543  3344778999999999976  9999999996     4567


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||| +.+++|.+++...       ..+++..+..++.|++.||.|||+.   +|+||||||+|||++ ++.+||+|
T Consensus        83 ~~~lv~e-~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~D  150 (343)
T 3dbq_A           83 YIYMVME-CGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLID  150 (343)
T ss_dssp             EEEEEEC-CCSEEHHHHHHHS-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECC
T ss_pred             EEEEEEe-CCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEee
Confidence            8999999 5588999999754       4689999999999999999999999   999999999999997 57899999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCccccc------------CCCCcccceeehHHHHHHHhhCCCCCCcccc
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN------------GHVSILGDIYSYGILLLEIFTGKRPTDDMFK  379 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~  379 (477)
                      ||+++.....     ..........||+.|+|||++.            +.++.++|||||||++|||++|+.||.....
T Consensus       151 FG~a~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  225 (343)
T 3dbq_A          151 FGIANQMQPD-----TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN  225 (343)
T ss_dssp             CSSSCCC-----------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred             cccccccCcc-----cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh
Confidence            9999865321     1112233457999999999983            4688999999999999999999999965321


Q ss_pred             cccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChH
Q 043902          380 DDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMK  459 (477)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~  459 (477)
                      ...            .+...+++.....             ++...           ...+.+++.+||+.||.+|||+.
T Consensus       226 ~~~------------~~~~~~~~~~~~~-------------~~~~~-----------~~~l~~li~~~L~~dp~~Rpt~~  269 (343)
T 3dbq_A          226 QIS------------KLHAIIDPNHEIE-------------FPDIP-----------EKDLQDVLKCCLKRDPKQRISIP  269 (343)
T ss_dssp             HHH------------HHHHHHCTTSCCC-------------CCCCS-----------CHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHH------------HHHHHhcCCcccC-------------CcccC-----------CHHHHHHHHHHcCCChhHCCCHH
Confidence            100            1112222111100             00000           12378999999999999999999


Q ss_pred             HHHHH
Q 043902          460 FVVNN  464 (477)
Q Consensus       460 evl~~  464 (477)
                      |+++.
T Consensus       270 e~l~h  274 (343)
T 3dbq_A          270 ELLAH  274 (343)
T ss_dssp             HHHTS
T ss_pred             HHHhC
Confidence            99853

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.3e-43  Score=345.48  Aligned_cols=284  Identities=18%  Similarity=0.238  Sum_probs=208.3

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .++|...+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++..   ......
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---~~~~~~   84 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHK   84 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc---CCCCee
Confidence            467889999999999999999976 58999999998543 3345778899999999999999999998642   334468


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEe----cCCCcEEE
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL----DEGMIAHV  309 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl  309 (477)
                      ++||||+++|+|.+++.....    ...+++..++.++.|++.||.|||+.   +|+||||||+||++    +.++.+||
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL  157 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSN----AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKL  157 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGG----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEE
T ss_pred             EEEEecCCCCCHHHHHHhhhc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEE
Confidence            999999999999999976431    13489999999999999999999999   99999999999999    78888999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCccccc---------CCCCcccceeehHHHHHHHhhCCCCCCccccc
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN---------GHVSILGDIYSYGILLLEIFTGKRPTDDMFKD  380 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~  380 (477)
                      +|||+++....        ........||..|+|||++.         +.++.++|||||||++|||+||+.||......
T Consensus       158 ~DFG~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~  229 (396)
T 4eut_A          158 TDFGAARELED--------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP  229 (396)
T ss_dssp             CCGGGCEECCC--------GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT
T ss_pred             ecCCCceEccC--------CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc
Confidence            99999987522        12233456899999999983         45788999999999999999999999643221


Q ss_pred             ccceeeeeeccCCchhHHHhhhhhhhhh----cccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC
Q 043902          381 DLSIHKFVLMALPSHVMDVLDLSMLLEE----ENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRV  456 (477)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  456 (477)
                      .... .        .+..++........    .............+..     ....+.....+.+++.+||+.||++||
T Consensus       230 ~~~~-~--------~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~l~~~~~~~l~~ll~~~L~~dP~~R~  295 (396)
T 4eut_A          230 RRNK-E--------VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVS-----CSLSRGLQVLLTPVLANILEADQEKCW  295 (396)
T ss_dssp             TTCH-H--------HHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTT-----CSSCHHHHHHHHHHHHHHSCCCTTTSC
T ss_pred             cchH-H--------HHHHHhcCCCcccchhheeccCCCcccCccCCcc-----cccchHHHhhchHHHHHhhccChhhhc
Confidence            1100 0        00111100000000    0000000000000000     001122345588999999999999999


Q ss_pred             ChHHHHHHHHHHHHh
Q 043902          457 GMKFVVNNLQAIRSK  471 (477)
Q Consensus       457 s~~evl~~L~~i~~~  471 (477)
                      |+.|+++.++.+..+
T Consensus       296 s~~e~l~~l~~il~~  310 (396)
T 4eut_A          296 GFDQFFAETSDILHR  310 (396)
T ss_dssp             CHHHHHHHHHHHHTC
T ss_pred             cHHHHHHHHHHHhhc
Confidence            999999999988765

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.2e-42  Score=325.84  Aligned_cols=252  Identities=20%  Similarity=0.327  Sum_probs=199.3

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .++|+..+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+.++++++||||+++++++     ...+..
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   80 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ   80 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EETTEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEE-----EcCCEE
Confidence            467889999999999999999975 78999999997543 33457889999999999999999999986     456778


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||+++++|.+++...       ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||
T Consensus        81 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  150 (276)
T 2yex_A           81 YLFLEYCSGGELFDRIEPD-------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFG  150 (276)
T ss_dssp             EEEEECCTTEEGGGGSBTT-------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EEEEEecCCCcHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCC
Confidence            9999999999999999754       4589999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccccC-C-CCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-H-VSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      .+.......     .........|+..|+|||.+.+ . .+.++||||||+++|||+||+.||.........+       
T Consensus       151 ~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------  218 (276)
T 2yex_A          151 LATVFRYNN-----RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-------  218 (276)
T ss_dssp             TCEECEETT-----EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH-------
T ss_pred             CccccCCCc-----chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH-------
Confidence            998653211     1122344568999999999943 4 4789999999999999999999997643221111       


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                           ..+........               .         .......+.+++.+||+.||++|||+.|+++
T Consensus       219 -----~~~~~~~~~~~---------------~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          219 -----SDWKEKKTYLN---------------P---------WKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             -----HHHHTTCTTST---------------T---------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----HHhhhcccccC---------------c---------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                 11110000000               0         0001234788999999999999999999975

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.4e-42  Score=335.66  Aligned_cols=199  Identities=25%  Similarity=0.372  Sum_probs=172.5

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~  230 (477)
                      .++|+..+.||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|..++.++ +||||+++++++     ...
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~   82 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTE   82 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----EeC
Confidence            457889999999999999999975 68999999998542   33446688999999988 899999999985     556


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +..++||||+++|+|.+++...       ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+
T Consensus        83 ~~~~lv~e~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~  152 (345)
T 3a8x_A           83 SRLFFVIEYVNGGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLT  152 (345)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEE
Confidence            7899999999999999999743       4589999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |||+++....       .........||+.|+|||++ ...++.++|||||||++|||++|+.||..
T Consensus       153 DFG~a~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  212 (345)
T 3a8x_A          153 DYGMCKEGLR-------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  212 (345)
T ss_dssp             CGGGCBCSCC-------TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             eccccccccC-------CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence            9999975421       11223456799999999999 45689999999999999999999999964

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=6.1e-43  Score=342.24  Aligned_cols=252  Identities=21%  Similarity=0.281  Sum_probs=188.1

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ..++|...+.||+|+||.||+++.. +++.||+|++...... .+.+.+|+.++++++||||+++++++     ...+..
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~~   91 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVI-----LTPTHL   91 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEE-----eeCCEE
Confidence            3578999999999999999999976 7899999999754332 36788999999999999999999996     456789


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCc--EEEec
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI--AHVGD  311 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~--~kl~D  311 (477)
                      ++||||+++|+|.+++...       ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++.  +||+|
T Consensus        92 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~D  161 (361)
T 3uc3_A           92 AIIMEYASGGELYERICNA-------GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICD  161 (361)
T ss_dssp             EEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECC
T ss_pred             EEEEEeCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEee
Confidence            9999999999999998643       4589999999999999999999999   9999999999999987765  99999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCC-cccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVS-ILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~-~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      ||+++....        ........||+.|+|||++ ...++ .++|||||||++|||++|+.||.......        
T Consensus       162 fg~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--------  225 (361)
T 3uc3_A          162 FGYSKSSVL--------HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--------  225 (361)
T ss_dssp             CCCC-----------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--------
T ss_pred             cCccccccc--------cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--------
Confidence            999974321        1222345689999999998 44554 45899999999999999999997532211        


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                           .....+.........           .+..         ......+.+|+.+||+.||++|||+.|+++
T Consensus       226 -----~~~~~~~~~~~~~~~-----------~~~~---------~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          226 -----DYRKTIQRILSVKYS-----------IPDD---------IRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             -----CHHHHHHHHHTTCCC-----------CCTT---------SCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             -----HHHHHHHHHhcCCCC-----------CCCc---------CCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence                 011111110000000           0000         001234789999999999999999999986

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=5.8e-43  Score=345.85  Aligned_cols=249  Identities=24%  Similarity=0.423  Sum_probs=193.0

Q ss_pred             cCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeecc--chhhHHHHHHHHHHhcCC--CCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIR--HRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .+|++.+.||+|+||.||+|...+++.||||++....  ....+.+.+|++++.+++  ||||+++++++     ...+.
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~-----~~~~~  130 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITDQY  130 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE-----ecCCE
Confidence            4689999999999999999998889999999997543  334578899999999996  59999999986     44567


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||| +.+++|.+++...       ..+++..+..++.||+.||.|||+.   +|+||||||+|||++ ++.+||+||
T Consensus       131 ~~lv~E-~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DF  198 (390)
T 2zmd_A          131 IYMVME-CGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDF  198 (390)
T ss_dssp             EEEEEE-CCSEEHHHHHHHC-------SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCC
T ss_pred             EEEEEe-cCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEec
Confidence            999999 5688999999754       4588999999999999999999999   999999999999996 578999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccccC------------CCCcccceeehHHHHHHHhhCCCCCCccccc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING------------HVSILGDIYSYGILLLEIFTGKRPTDDMFKD  380 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------------~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~  380 (477)
                      |+++.+....     .........||+.|+|||++.+            .++.++|||||||++|||++|+.||......
T Consensus       199 G~a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~  273 (390)
T 2zmd_A          199 GIANQMQPDT-----TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ  273 (390)
T ss_dssp             SSSCCC--------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH
T ss_pred             CccccccCCC-----ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH
Confidence            9998753211     1112344579999999999843            5899999999999999999999999653211


Q ss_pred             ccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHH
Q 043902          381 DLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKF  460 (477)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e  460 (477)
                      .            ..+..+++......             ++...           ...+.+++.+||+.||.+|||+.|
T Consensus       274 ~------------~~~~~~~~~~~~~~-------------~~~~~-----------~~~~~~li~~~L~~dP~~Rps~~e  317 (390)
T 2zmd_A          274 I------------SKLHAIIDPNHEIE-------------FPDIP-----------EKDLQDVLKCCLKRDPKQRISIPE  317 (390)
T ss_dssp             H------------HHHHHHHCTTSCCC-------------CCCCS-----------CHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             H------------HHHHHHhCccccCC-------------CCccc-----------hHHHHHHHHHHcccChhhCCCHHH
Confidence            0            01122222111100             00000           123789999999999999999999


Q ss_pred             HHH
Q 043902          461 VVN  463 (477)
Q Consensus       461 vl~  463 (477)
                      +++
T Consensus       318 ll~  320 (390)
T 2zmd_A          318 LLA  320 (390)
T ss_dssp             HHT
T ss_pred             Hhh
Confidence            985

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.7e-42  Score=349.63  Aligned_cols=201  Identities=25%  Similarity=0.257  Sum_probs=165.6

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec--cchhhHHHHHHHHHHhcCCCCCcceeeeeccccc-CCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSSCSSVD-YEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~~~  231 (477)
                      .++|+..+.||+|+||.||+|... +|+.||||++...  .....+.+.+|+.++++++||||+++++++.... .+...
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            578999999999999999999865 6899999999754  3344577889999999999999999999975422 13345


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+++ +|.+.+.         ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus       141 ~~~lv~E~~~~-~l~~~~~---------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~D  207 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  207 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHT---------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred             eEEEEEeCCCC-CHHHHHh---------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEE
Confidence            68999999976 5666664         3488999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      ||+++....        ........||+.|+|||++ ...++.++|||||||++|||++|+.||...
T Consensus       208 FG~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~  266 (464)
T 3ttj_A          208 FGLARTAGT--------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  266 (464)
T ss_dssp             CCCC-------------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEeeeecCC--------CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999986521        1223446789999999999 557999999999999999999999999763

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=6.9e-43  Score=330.93  Aligned_cols=253  Identities=25%  Similarity=0.315  Sum_probs=195.6

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .++|...+.||+|+||.||+|... ++..+|+|++.... ....+.+.+|++++++++||||+++++++     ......
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~   95 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNM   95 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe-----ecCCeE
Confidence            467889999999999999999875 68999999998654 33457889999999999999999999996     456778


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEe---cCCCcEEEe
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVG  310 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~  310 (477)
                      ++||||+++|+|.+++.....   ....+++..++.++.|++.||.|||+.   +|+||||||+||++   +.++.+||+
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~  169 (285)
T 3is5_A           96 YIVMETCEGGELLERIVSAQA---RGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKII  169 (285)
T ss_dssp             EEEECCCSCCBHHHHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEEC
T ss_pred             EEEEEeCCCCcHHHHHHhhhh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEE
Confidence            999999999999998854311   125689999999999999999999999   99999999999999   456789999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccccCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      |||++.....        ........||..|+|||.+.+.++.++|||||||++|||++|+.||.......         
T Consensus       170 Dfg~a~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~---------  232 (285)
T 3is5_A          170 DFGLAELFKS--------DEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE---------  232 (285)
T ss_dssp             CCCCCCC------------------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------
T ss_pred             eeecceecCC--------cccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH---------
Confidence            9999976522        11223456899999999998889999999999999999999999997532111         


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                              .............   ....                .....+.+++.+||+.||++|||+.|+++
T Consensus       233 --------~~~~~~~~~~~~~---~~~~----------------~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          233 --------VQQKATYKEPNYA---VECR----------------PLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             --------HHHHHHHCCCCCC---C--C----------------CCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             --------HHhhhccCCcccc---cccC----------------cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    0000000000000   0000                00234788999999999999999999985

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.5e-42  Score=332.82  Aligned_cols=250  Identities=21%  Similarity=0.314  Sum_probs=199.2

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccch------hhHHHHHHHHHHhcCCCCCcceeeeecccccCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQG------ALKSFIDECNALTSIRHRNILKIVSSCSSVDYE  228 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  228 (477)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|+++.....      ..+.+.+|+.++.+++||||+++++++     .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~   85 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY-----E   85 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE-----e
Confidence            467889999999999999999975 6899999999754321      356799999999999999999999996     4


Q ss_pred             CCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC---
Q 043902          229 GNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM---  305 (477)
Q Consensus       229 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~---  305 (477)
                      .....++||||+++++|.+++...       ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++   
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~  155 (321)
T 2a2a_A           86 NRTDVVLILELVSGGELFDFLAQK-------ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPI  155 (321)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHTC-------SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSS
T ss_pred             cCCEEEEEEEcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCc
Confidence            567899999999999999999754       4589999999999999999999999   999999999999999888   


Q ss_pred             -cEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccc
Q 043902          306 -IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLS  383 (477)
Q Consensus       306 -~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~  383 (477)
                       .+||+|||++.....        ........||..|+|||.+ .+.++.++|||||||++|||+||+.||.......  
T Consensus       156 ~~~kl~Dfg~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--  225 (321)
T 2a2a_A          156 PHIKLIDFGLAHEIED--------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--  225 (321)
T ss_dssp             CCEEECCCTTCEECCT--------TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--
T ss_pred             CCEEEccCccceecCc--------cccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH--
Confidence             799999999986532        1122345689999999999 4568999999999999999999999996532111  


Q ss_pred             eeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          384 IHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       384 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                                 .+..+......                      ............+.+++.+||+.||++|||+.|+++
T Consensus       226 -----------~~~~i~~~~~~----------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          226 -----------TLANITSVSYD----------------------FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             -----------HHHHHHTTCCC----------------------CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             -----------HHHHHHhcccc----------------------cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                       00000000000                      000001111334889999999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=8.2e-43  Score=335.62  Aligned_cols=274  Identities=19%  Similarity=0.254  Sum_probs=205.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      .++|+..+.||+|+||.||+++. .+|+.||+|++........+.+.+|++++++++||||+++++++.... ......+
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~  106 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAW  106 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeE
Confidence            46899999999999999999997 579999999998766666788999999999999999999999974211 2445789


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +||||+++|+|.+++.....   ....+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       107 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~  180 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKD---KGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGS  180 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             EEEEeCCCCcHHHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCc
Confidence            99999999999999875211   125689999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCC--CccccCCCcccccccCcccccC----CCCcccceeehHHHHHHHhhCCCCCCcccccccceeeee
Q 043902          315 AKFLFEESNTPSK--NQTMSNGLKGSVGYIPPEYING----HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       315 a~~~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~----~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~  388 (477)
                      +............  .........||..|+|||.+.+    .++.++|||||||++|||++|+.||.........     
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-----  255 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-----  255 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-----
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-----
Confidence            8764211000000  0000122346899999999843    2689999999999999999999999643221111     


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                             ....+.......         .   .            ..+...+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus       256 -------~~~~~~~~~~~~---------~---~------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  304 (317)
T 2buj_A          256 -------VALAVQNQLSIP---------Q---S------------PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL  304 (317)
T ss_dssp             -------HHHHHHCC--CC---------C---C------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             -------hhHHhhccCCCC---------c---c------------ccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence                   000000000000         0   0            00123488999999999999999999999999988


Q ss_pred             HHhh
Q 043902          469 RSKI  472 (477)
Q Consensus       469 ~~~~  472 (477)
                      ....
T Consensus       305 ~~~~  308 (317)
T 2buj_A          305 QPPA  308 (317)
T ss_dssp             CCCC
T ss_pred             CCCC
Confidence            6543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2e-42  Score=334.17  Aligned_cols=247  Identities=21%  Similarity=0.301  Sum_probs=188.1

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe----CCCCEEEEEEeeecc----chhhHHHHHHHHHHhcCCCCCcceeeeecccccC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL----ADGETAAIKVLKLQQ----QGALKSFIDECNALTSIRHRNILKIVSSCSSVDY  227 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  227 (477)
                      .++|+..+.||+|+||.||+|+.    .+|+.||+|+++...    ......+.+|++++.+++||||+++++++     
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----   90 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF-----   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE-----
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE-----
Confidence            46789999999999999999986    478999999997542    23345678899999999999999999996     


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcE
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIA  307 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~  307 (477)
                      ...+..++||||+++|+|.+++...       ..+++..+..++.||+.||.|||++   +|+||||||+||+++.++.+
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~  160 (327)
T 3a62_A           91 QTGGKLYLILEYLSGGELFMQLERE-------GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHV  160 (327)
T ss_dssp             ECSSCEEEEEECCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCE
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcE
Confidence            4567899999999999999999743       4588999999999999999999999   99999999999999999999


Q ss_pred             EEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceee
Q 043902          308 HVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHK  386 (477)
Q Consensus       308 kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~  386 (477)
                      ||+|||+++....       .........||+.|+|||.+ ...++.++|||||||++|||++|+.||.......     
T Consensus       161 kl~Dfg~~~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----  228 (327)
T 3a62_A          161 KLTDFGLCKESIH-------DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-----  228 (327)
T ss_dssp             EECCCSCC-----------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----
T ss_pred             EEEeCCccccccc-------CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-----
Confidence            9999999975421       11223345789999999999 5568999999999999999999999997532111     


Q ss_pred             eeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC-----ChHHH
Q 043902          387 FVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRV-----GMKFV  461 (477)
Q Consensus       387 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev  461 (477)
                              ....+......               +|.           .....+.+++.+||+.||.+||     ++.|+
T Consensus       229 --------~~~~i~~~~~~---------------~p~-----------~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~  274 (327)
T 3a62_A          229 --------TIDKILKCKLN---------------LPP-----------YLTQEARDLLKKLLKRNAASRLGAGPGDAGEV  274 (327)
T ss_dssp             --------HHHHHHHTCCC---------------CCT-----------TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHH
T ss_pred             --------HHHHHHhCCCC---------------CCC-----------CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHH
Confidence                    01111111000               000           0123478999999999999999     66777


Q ss_pred             HH
Q 043902          462 VN  463 (477)
Q Consensus       462 l~  463 (477)
                      ++
T Consensus       275 l~  276 (327)
T 3a62_A          275 QA  276 (327)
T ss_dssp             HH
T ss_pred             Hc
Confidence            64

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.8e-43  Score=337.35  Aligned_cols=242  Identities=22%  Similarity=0.340  Sum_probs=196.5

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc--------hhhHHHHHHHHHHhcCCCCCcceeeeecccc
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ--------GALKSFIDECNALTSIRHRNILKIVSSCSSV  225 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  225 (477)
                      ..++|+..+.||+|+||.||+|+.. +++.||||+++....        .....+.+|++++++++||||+++++++   
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~---   98 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF---   98 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE---
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE---
Confidence            4578999999999999999999864 789999999985431        1334678899999999999999999996   


Q ss_pred             cCCCCceeeEEEeecCCC-ChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC
Q 043902          226 DYEGNDFKALVFEFMRNG-NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG  304 (477)
Q Consensus       226 ~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~  304 (477)
                        ...+..++||||+.+| +|.+++...       ..+++..++.++.|++.||.|||++   +|+||||||+||+++.+
T Consensus        99 --~~~~~~~lv~e~~~~g~~l~~~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~  166 (335)
T 3dls_A           99 --ENQGFFQLVMEKHGSGLDLFAFIDRH-------PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAED  166 (335)
T ss_dssp             --ECSSEEEEEEECCTTSCBHHHHHHTC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred             --eeCCEEEEEEEeCCCCccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCC
Confidence              5677899999999777 999999754       4589999999999999999999999   99999999999999999


Q ss_pred             CcEEEecccccccccccCCCCCCCccccCCCcccccccCcccccC-CC-CcccceeehHHHHHHHhhCCCCCCccccccc
Q 043902          305 MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-HV-SILGDIYSYGILLLEIFTGKRPTDDMFKDDL  382 (477)
Q Consensus       305 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~  382 (477)
                      +.+||+|||+++....        ........||+.|+|||.+.+ .+ +.++|||||||++|||++|+.||........
T Consensus       167 ~~~kL~Dfg~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  238 (335)
T 3dls_A          167 FTIKLIDFGSAAYLER--------GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE  238 (335)
T ss_dssp             SCEEECCCTTCEECCT--------TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT
T ss_pred             CcEEEeecccceECCC--------CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh
Confidence            9999999999987522        112233568999999999843 44 8899999999999999999999965221100


Q ss_pred             ceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHH
Q 043902          383 SIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVV  462 (477)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl  462 (477)
                                         .....               +..           +...+.+++.+||+.||++|||+.|++
T Consensus       239 -------------------~~~~~---------------~~~-----------~~~~l~~li~~~L~~dP~~Rps~~ell  273 (335)
T 3dls_A          239 -------------------AAIHP---------------PYL-----------VSKELMSLVSGLLQPVPERRTTLEKLV  273 (335)
T ss_dssp             -------------------TCCCC---------------SSC-----------CCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             -------------------hccCC---------------Ccc-----------cCHHHHHHHHHHccCChhhCcCHHHHh
Confidence                               00000               000           023378999999999999999999998


Q ss_pred             HH
Q 043902          463 NN  464 (477)
Q Consensus       463 ~~  464 (477)
                      +.
T Consensus       274 ~h  275 (335)
T 3dls_A          274 TD  275 (335)
T ss_dssp             HC
T ss_pred             cC
Confidence            73

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.2e-42  Score=335.34  Aligned_cols=200  Identities=24%  Similarity=0.349  Sum_probs=173.3

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEG  229 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  229 (477)
                      ..++|+..+.||+|+||.||+|+.. +|+.||+|+++...   ....+.+..|..++..+ +||+|+++++++     ..
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~   92 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT   92 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----EC
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----Ec
Confidence            3578999999999999999999976 58899999998542   33456788999999988 799999999985     56


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEE
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV  309 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl  309 (477)
                      .+..++||||+++|+|.+++...       ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||
T Consensus        93 ~~~~~lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL  162 (353)
T 2i0e_A           93 MDRLYFVMEYVNGGDLMYHIQQV-------GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKI  162 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEE
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEE
Confidence            77899999999999999999753       4589999999999999999999999   9999999999999999999999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      +|||+++....       .........||+.|+|||++ ...++.++|||||||++|||++|+.||..
T Consensus       163 ~DFG~a~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~  223 (353)
T 2i0e_A          163 ADFGMCKENIW-------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG  223 (353)
T ss_dssp             CCCTTCBCCCC-------TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EeCCccccccc-------CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC
Confidence            99999975321       11223456799999999999 55689999999999999999999999965

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.5e-42  Score=335.23  Aligned_cols=266  Identities=23%  Similarity=0.294  Sum_probs=198.5

Q ss_pred             HHHhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec-----cchhhHHHHHHHHHHhcCCCCCcceeeeecccc
Q 043902          152 ISNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ-----QQGALKSFIDECNALTSIRHRNILKIVSSCSSV  225 (477)
Q Consensus       152 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  225 (477)
                      +....++|...+.||+|+||.||+|... +++.||+|++...     .....+.+.+|++++++++||||+++++++   
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~---   97 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY---   97 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh---
Confidence            4556788999999999999999999874 7889999999744     234457899999999999999999999996   


Q ss_pred             cCCCCceeeEEEeecCCCChhhhcccCCCc---------------------------------ccccccCCHHHHHHHHH
Q 043902          226 DYEGNDFKALVFEFMRNGNLDQWLHPSTDE---------------------------------YCHFKKLSLMQRLNIVI  272 (477)
Q Consensus       226 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---------------------------------~~~~~~l~~~~~~~i~~  272 (477)
                        ...+..++||||+++|+|.+++......                                 ......+++..++.++.
T Consensus        98 --~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  175 (345)
T 3hko_A           98 --EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR  175 (345)
T ss_dssp             --ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred             --ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence              5567899999999999999998521100                                 00012346778889999


Q ss_pred             HHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC--cEEEecccccccccccCCCCCCCccccCCCcccccccCccccc--
Q 043902          273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM--IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--  348 (477)
Q Consensus       273 ~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--  348 (477)
                      |++.||.|||+.   +|+||||||+||+++.++  .+||+|||+++.+......   .........||+.|+|||.+.  
T Consensus       176 qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~  249 (345)
T 3hko_A          176 QIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG---EYYGMTTKAGTPYFVAPEVLNTT  249 (345)
T ss_dssp             HHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC-----------CCCGGGCCHHHHTCS
T ss_pred             HHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCcc---ccccccccCCCccccCchhhccC
Confidence            999999999999   999999999999998776  8999999999865332111   112234556899999999983  


Q ss_pred             -CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhH
Q 043902          349 -GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQ  427 (477)
Q Consensus       349 -~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~  427 (477)
                       +.++.++|||||||++|||++|+.||.......             ....+.........             +.    
T Consensus       250 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------------~~~~~~~~~~~~~~-------------~~----  299 (345)
T 3hko_A          250 NESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD-------------TISQVLNKKLCFEN-------------PN----  299 (345)
T ss_dssp             SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------------HHHHHHHCCCCTTS-------------GG----
T ss_pred             CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHH-------------HHHHHHhcccccCC-------------cc----
Confidence             468999999999999999999999996532211             11111111110000             00    


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          428 VAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       428 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                           .......+.+++.+||+.||.+|||+.|+++
T Consensus       300 -----~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          300 -----YNVLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             -----GGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             -----cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                 0001234789999999999999999999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=344.27  Aligned_cols=206  Identities=23%  Similarity=0.370  Sum_probs=176.3

Q ss_pred             HHHHhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeeccccc
Q 043902          151 KISNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVD  226 (477)
Q Consensus       151 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  226 (477)
                      +.....++|+..+.||+|+||.||+|+.. +|+.||+|+++...   ......+.+|..++.+++||||+++++++    
T Consensus        55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~----  130 (412)
T 2vd5_A           55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF----  130 (412)
T ss_dssp             HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE----
T ss_pred             hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE----
Confidence            34445689999999999999999999975 79999999997532   23345688999999999999999999985    


Q ss_pred             CCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCc
Q 043902          227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI  306 (477)
Q Consensus       227 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~  306 (477)
                       .+.+..++||||+++|+|.+++....      ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.+++
T Consensus       131 -~~~~~~~lVmE~~~gg~L~~~l~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~  200 (412)
T 2vd5_A          131 -QDENYLYLVMEYYVGGDLLTLLSKFG------ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGH  200 (412)
T ss_dssp             -ECSSEEEEEECCCCSCBHHHHHHHHS------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred             -eeCCEEEEEEcCCCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCC
Confidence             56778999999999999999997532      3689999999999999999999999   9999999999999999999


Q ss_pred             EEEecccccccccccCCCCCCCccccCCCcccccccCccccc--------CCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          307 AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--------GHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       307 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      +||+|||+++.....      .........||+.|+|||++.        +.++.++|||||||++|||++|+.||..
T Consensus       201 vkL~DFGla~~~~~~------~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~  272 (412)
T 2vd5_A          201 IRLADFGSCLKLRAD------GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA  272 (412)
T ss_dssp             EEECCCTTCEECCTT------SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             EEEeechhheeccCC------CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC
Confidence            999999999875221      112233457999999999984        3589999999999999999999999965

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.6e-42  Score=343.45  Aligned_cols=252  Identities=22%  Similarity=0.291  Sum_probs=190.0

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--------chhhHHHHHHHHHHhcCCCCCcceeeeeccc
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--------QGALKSFIDECNALTSIRHRNILKIVSSCSS  224 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  224 (477)
                      ...++|...+.||+|+||.||+|... +++.||+|++....        ......+.+|++++++++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            34678999999999999999999865 68999999997542        112235789999999999999999999852 


Q ss_pred             ccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC
Q 043902          225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG  304 (477)
Q Consensus       225 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~  304 (477)
                           .+..++||||+++|+|.+++...       ..+++..+..++.|++.||.|||++   +|+||||||+|||++.+
T Consensus       211 -----~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~  275 (419)
T 3i6u_A          211 -----AEDYYIVLELMEGGELFDKVVGN-------KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQ  275 (419)
T ss_dssp             -----SSEEEEEEECCTTCBGGGGTSSS-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSS
T ss_pred             -----cCceEEEEEcCCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecC
Confidence                 34478999999999999998754       4689999999999999999999999   99999999999999754


Q ss_pred             ---CcEEEecccccccccccCCCCCCCccccCCCcccccccCccccc----CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          305 ---MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN----GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       305 ---~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                         +.+||+|||+++....        ........||+.|+|||++.    +.++.++|||||||++|||+||+.||...
T Consensus       276 ~~~~~~kl~DFG~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~  347 (419)
T 3i6u_A          276 EEDCLIKITDFGHSKILGE--------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH  347 (419)
T ss_dssp             SSSCCEEECCSSTTTSCC-------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred             CCcceEEEeecccceecCC--------CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence               4599999999986522        12233457899999999983    45789999999999999999999999653


Q ss_pred             cccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCC
Q 043902          378 FKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVG  457 (477)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs  457 (477)
                      ....             .+.+.+......                     ...+........+.+++.+||+.||++|||
T Consensus       348 ~~~~-------------~~~~~i~~~~~~---------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps  393 (419)
T 3i6u_A          348 RTQV-------------SLKDQITSGKYN---------------------FIPEVWAEVSEKALDLVKKLLVVDPKARFT  393 (419)
T ss_dssp             SSSC-------------CHHHHHHTTCCC---------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred             cchH-------------HHHHHHhcCCCC---------------------CCchhhcccCHHHHHHHHHHccCChhHCcC
Confidence            2111             011111100000                     000011112345889999999999999999


Q ss_pred             hHHHHH
Q 043902          458 MKFVVN  463 (477)
Q Consensus       458 ~~evl~  463 (477)
                      +.|+++
T Consensus       394 ~~e~l~  399 (419)
T 3i6u_A          394 TEEALR  399 (419)
T ss_dssp             HHHHHH
T ss_pred             HHHHhC
Confidence            999986

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.4e-42  Score=340.12  Aligned_cols=207  Identities=26%  Similarity=0.346  Sum_probs=174.9

Q ss_pred             CccHHHHHHhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCC-----CCCcceee
Q 043902          146 GLSYLKISNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIR-----HRNILKIV  219 (477)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~  219 (477)
                      .+++.+.....++|.+.+.||+|+||.||+|+.. +++.||||+++... .....+..|++++.+++     ||||++++
T Consensus        24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~  102 (360)
T 3llt_A           24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKYH  102 (360)
T ss_dssp             SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred             eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence            3444444556789999999999999999999974 78999999997432 23366788999999886     99999999


Q ss_pred             eecccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCe
Q 043902          220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNV  299 (477)
Q Consensus       220 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NI  299 (477)
                      +++     ...+..++||||+ +++|.+++.....     ..+++..+..++.||+.||.|||+.   +|+||||||+||
T Consensus       103 ~~~-----~~~~~~~lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NI  168 (360)
T 3llt_A          103 GKF-----MYYDHMCLIFEPL-GPSLYEIITRNNY-----NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENI  168 (360)
T ss_dssp             EEE-----EETTEEEEEECCC-CCBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             cee-----eECCeeEEEEcCC-CCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccE
Confidence            986     4456799999999 9999999976532     4589999999999999999999999   999999999999


Q ss_pred             EecC-------------------------CCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCc
Q 043902          300 LLDE-------------------------GMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSI  353 (477)
Q Consensus       300 ll~~-------------------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~  353 (477)
                      |++.                         ++.+||+|||+++....          ......||+.|+|||++ ...++.
T Consensus       169 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~  238 (360)
T 3llt_A          169 LLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD----------YHGSIINTRQYRAPEVILNLGWDV  238 (360)
T ss_dssp             EESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS----------CCCSCCSCGGGCCHHHHTTCCCCT
T ss_pred             EEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC----------CCcCccCcccccCcHHHcCCCCCC
Confidence            9975                         78999999999986421          12345689999999999 557999


Q ss_pred             ccceeehHHHHHHHhhCCCCCCcc
Q 043902          354 LGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       354 ~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      ++|||||||++|||+||+.||...
T Consensus       239 ~~DiwslG~il~ell~g~~pf~~~  262 (360)
T 3llt_A          239 SSDMWSFGCVLAELYTGSLLFRTH  262 (360)
T ss_dssp             THHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccchHHHHHHHHHHHHCCCCCCCC
Confidence            999999999999999999999753

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.1e-43  Score=365.93  Aligned_cols=252  Identities=26%  Similarity=0.417  Sum_probs=196.6

Q ss_pred             CeeeeeccceEEEEEeC---CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEE
Q 043902          163 NLIGSGSFGSVYKGTLA---DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVF  237 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  237 (477)
                      +.||+|+||.||+|.+.   .++.||||+++...  ....+.+.+|++++.+++||||++++++|.      .+..++||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~------~~~~~lv~  448 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE------AESWMLVM  448 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE------SSSEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------cCCEEEEE
Confidence            47999999999999653   46789999998543  233578999999999999999999999973      23478999


Q ss_pred             eecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          238 EFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       238 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      ||+++|+|.+++...       ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       449 E~~~~g~L~~~l~~~-------~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~  518 (635)
T 4fl3_A          449 EMAELGPLNKYLQQN-------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA  518 (635)
T ss_dssp             ECCTTEEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHH
T ss_pred             EccCCCCHHHHHhhC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccc
Confidence            999999999999754       4689999999999999999999999   999999999999999999999999999987


Q ss_pred             ccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCCch
Q 043902          318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALPSH  395 (477)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  395 (477)
                      +.....    .........+|..|+|||++ .+.++.++|||||||++|||+| |+.||.......              
T Consensus       519 ~~~~~~----~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--------------  580 (635)
T 4fl3_A          519 LRADEN----YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------------  580 (635)
T ss_dssp             TTC-----------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------------
T ss_pred             cccCcc----ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------------
Confidence            632111    11222334567899999999 5679999999999999999999 999997642211              


Q ss_pred             hHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHhh
Q 043902          396 VMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSKI  472 (477)
Q Consensus       396 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  472 (477)
                      +.+.+.......             .           ...++..+.+++..||+.||++|||+.+|++.|+++..++
T Consensus       581 ~~~~i~~~~~~~-------------~-----------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          581 VTAMLEKGERMG-------------C-----------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             HHHHHHTTCCCC-------------C-----------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCCC-------------C-----------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            111111110000             0           0112345889999999999999999999999999987764

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.6e-42  Score=324.93  Aligned_cols=247  Identities=24%  Similarity=0.364  Sum_probs=195.3

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      +.++|++.+.||+|+||.||+|... ++..||+|++....   ......+.+|+.++++++||||+++++++     ...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   81 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDA   81 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE-----ecC
Confidence            3568889999999999999999865 67899999997532   22346788999999999999999999996     456


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +..++||||+++|+|.+++...       ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~  151 (279)
T 3fdn_A           82 TRVYLILEYAPLGTVYRELQKL-------SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA  151 (279)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEEC
T ss_pred             CEEEEEEecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEE
Confidence            7799999999999999998754       4589999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      |||++....         ........|+..|+|||.+ ...++.++||||||+++|||++|+.||.......        
T Consensus       152 Dfg~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------  214 (279)
T 3fdn_A          152 DFGWSVHAP---------SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--------  214 (279)
T ss_dssp             SCCEESCC-----------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------
T ss_pred             eccccccCC---------cccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH--------
Confidence            999986542         1122345689999999999 4568999999999999999999999996532110        


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                           ....+......               .+.           .....+.+++.+||+.||.+|||+.|+++.
T Consensus       215 -----~~~~~~~~~~~---------------~~~-----------~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          215 -----TYKRISRVEFT---------------FPD-----------FVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             -----HHHHHHHTCCC---------------CCT-----------TSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             -----HHHHHHhCCCC---------------CCC-----------cCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                 00000000000               000           012347899999999999999999999963

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1e-42  Score=329.40  Aligned_cols=257  Identities=26%  Similarity=0.402  Sum_probs=202.4

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccC------
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDY------  227 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------  227 (477)
                      ...+|+..+.||+|+||.||+|... +|+.||+|+++...    ..+.+|++++.+++||||+++++++....+      
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            3467889999999999999999976 79999999998654    356789999999999999999998643211      


Q ss_pred             -----CCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec
Q 043902          228 -----EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD  302 (477)
Q Consensus       228 -----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~  302 (477)
                           ......++||||+++|+|.+++....     ...+++..++.++.|++.||.|||+.   +|+||||||+||+++
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~  156 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-----GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLV  156 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGG-----GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEc
Confidence                 22455799999999999999997542     24689999999999999999999999   999999999999999


Q ss_pred             CCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccc
Q 043902          303 EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD  381 (477)
Q Consensus       303 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~  381 (477)
                      .++.+||+|||++......        .......||..|+|||.+ ...++.++||||||+++|||++|..|+.....  
T Consensus       157 ~~~~~kl~Dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--  226 (284)
T 2a19_B          157 DTKQVKIGDFGLVTSLKND--------GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK--  226 (284)
T ss_dssp             ETTEEEECCCTTCEESSCC--------SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH--
T ss_pred             CCCCEEECcchhheecccc--------ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH--
Confidence            9999999999999875321        122334689999999999 55689999999999999999999988743110  


Q ss_pred             cceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHH
Q 043902          382 LSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFV  461 (477)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev  461 (477)
                                   ....+.+...                 +.           .....+.+++.+||+.||.+|||+.|+
T Consensus       227 -------------~~~~~~~~~~-----------------~~-----------~~~~~~~~li~~~l~~dp~~Rps~~e~  265 (284)
T 2a19_B          227 -------------FFTDLRDGII-----------------SD-----------IFDKKEKTLLQKLLSKKPEDRPNTSEI  265 (284)
T ss_dssp             -------------HHHHHHTTCC-----------------CT-----------TSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             -------------HHHHhhcccc-----------------cc-----------cCCHHHHHHHHHHccCChhhCcCHHHH
Confidence                         0000000000                 00           012237789999999999999999999


Q ss_pred             HHHHHHHHHhhhh
Q 043902          462 VNNLQAIRSKIRM  474 (477)
Q Consensus       462 l~~L~~i~~~~~~  474 (477)
                      ++.|+.++.....
T Consensus       266 l~~l~~~~~~~~~  278 (284)
T 2a19_B          266 LRTLTVWKKSPEK  278 (284)
T ss_dssp             HHHHHHHTC----
T ss_pred             HHHHHHHhhCCCc
Confidence            9999998876554

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.1e-43  Score=347.92  Aligned_cols=260  Identities=15%  Similarity=0.146  Sum_probs=191.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeec---cchhhHHHHHHH---HHHhcCCCCCcceeeeeccccc--
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQ---QQGALKSFIDEC---NALTSIRHRNILKIVSSCSSVD--  226 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~l~~~~~~~~--  226 (477)
                      .++|...+.||+|+||.||+|+. .+|+.||||+++..   .....+.+.+|+   +.+++++||||+++++.+....  
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788899999999999999996 47999999999843   334557889999   5566668999999985432100  


Q ss_pred             CCCC------------c-----eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 043902          227 YEGN------------D-----FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPI  289 (477)
Q Consensus       227 ~~~~------------~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i  289 (477)
                      +...            +     ..++||||+ +|+|.+++............+++..++.++.||+.||+|||++   +|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            0111            1     378999999 6899999975321101113345688899999999999999999   99


Q ss_pred             eecCCCCCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cC-----------CCCcccce
Q 043902          290 AHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NG-----------HVSILGDI  357 (477)
Q Consensus       290 vH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~-----------~~~~~~Dv  357 (477)
                      +||||||+|||++.++.+||+|||+++...          .......| ..|+|||++ ..           .++.++||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~----------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv  296 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA  296 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETT----------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecC----------CcccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence            999999999999999999999999998531          12234456 899999999 44           68999999


Q ss_pred             eehHHHHHHHhhCCCCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHH
Q 043902          358 YSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECL  437 (477)
Q Consensus       358 ~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (477)
                      |||||++|||+||+.||........  .           ..+.. ..                 +            .+.
T Consensus       297 wSlG~il~elltg~~Pf~~~~~~~~--~-----------~~~~~-~~-----------------~------------~~~  333 (377)
T 3byv_A          297 WALGLVIYWIWCADLPITKDAALGG--S-----------EWIFR-SC-----------------K------------NIP  333 (377)
T ss_dssp             HHHHHHHHHHHHSSCCC------CC--S-----------GGGGS-SC-----------------C------------CCC
T ss_pred             HHHHHHHHHHHHCCCCCcccccccc--h-----------hhhhh-hc-----------------c------------CCC
Confidence            9999999999999999965322110  0           00000 00                 0            012


Q ss_pred             HHHHHHhhhcCCCCCCCCCChHHHHH--HHHHHHHhhh
Q 043902          438 VSVMRIGVMCSAASPRDRVGMKFVVN--NLQAIRSKIR  473 (477)
Q Consensus       438 ~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~i~~~~~  473 (477)
                      ..+.+++.+||+.||++|||+.|+++  .++++++...
T Consensus       334 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~  371 (377)
T 3byv_A          334 QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELS  371 (377)
T ss_dssp             HHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHHHH
Confidence            34789999999999999999999996  6666665543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.9e-42  Score=348.70  Aligned_cols=247  Identities=23%  Similarity=0.351  Sum_probs=188.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec---cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ---QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .++|+..+.||+|+||.||+|+.. +|+.||||+++..   .......+.+|++++++++||||++++++|     ...+
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~-----~~~~  221 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHD  221 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE-----EETT
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE-----eeCC
Confidence            467899999999999999999865 7899999999854   233446778899999999999999999996     4566


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN-QYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ..++||||+++|+|.+++...       ..+++..+..++.|++.||.|||+ .   +|+||||||+|||++.++.+||+
T Consensus       222 ~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~  291 (446)
T 4ejn_A          222 RLCFVMEYANGGELFFHLSRE-------RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKIT  291 (446)
T ss_dssp             EEEEEECCCSSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEEC
T ss_pred             EEEEEEeeCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEc
Confidence            799999999999999998643       468999999999999999999998 7   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      |||+++....       .........||+.|+|||++ .+.++.++|||||||++|||++|+.||.......        
T Consensus       292 DFG~a~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--------  356 (446)
T 4ejn_A          292 DFGLCKEGIK-------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--------  356 (446)
T ss_dssp             CCCCCCTTCC------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------
T ss_pred             cCCCceeccC-------CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--------
Confidence            9999975421       12223446799999999999 6679999999999999999999999996532111        


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC-----ChHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRV-----GMKFVVN  463 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  463 (477)
                            +.+.+   ....           ..+|.           .....+.+++.+||+.||.+||     |++|+++
T Consensus       357 ------~~~~i---~~~~-----------~~~p~-----------~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          357 ------LFELI---LMEE-----------IRFPR-----------TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ------HHHHH---HHCC-----------CCCCT-----------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ------HHHHH---HhCC-----------CCCCc-----------cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                  11100   0000           00000           0123478999999999999999     9999985

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=7.6e-42  Score=344.50  Aligned_cols=246  Identities=26%  Similarity=0.391  Sum_probs=198.6

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .++|...+.||+|+||.||+|+.. +|+.||||+++...   ......+.+|+++++.++||||+++++++     ...+
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~-----~~~~   89 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI-----STPS   89 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECC
Confidence            467889999999999999999975 79999999997542   23346789999999999999999999996     4567


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+++|+|.+++...       ..+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|
T Consensus        90 ~~~lv~E~~~gg~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~D  159 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYICKN-------GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIAD  159 (476)
T ss_dssp             EEEEEEECCSSEEHHHHTTSS-------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             EEEEEEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEe
Confidence            899999999999999999754       4589999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccccCC--CCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH--VSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      ||++.....        ........||+.|+|||.+.+.  .+.++|||||||++|||++|+.||.......        
T Consensus       160 FG~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~--------  223 (476)
T 2y94_A          160 FGLSNMMSD--------GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT--------  223 (476)
T ss_dssp             CSSCEECCT--------TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH--------
T ss_pred             ccchhhccc--------cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH--------
Confidence            999987522        1122345689999999999543  4789999999999999999999997532110        


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                           ....+.+....               .|.           .....+.+++.+||+.||.+|||+.|+++
T Consensus       224 -----~~~~i~~~~~~---------------~p~-----------~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          224 -----LFKKICDGIFY---------------TPQ-----------YLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             -----HHHHHHTTCCC---------------CCT-----------TCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -----HHHHHhcCCcC---------------CCc-----------cCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                 01111111000               000           01223788999999999999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.6e-42  Score=332.25  Aligned_cols=262  Identities=20%  Similarity=0.236  Sum_probs=195.2

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      ..++|...+.||+|+||.||+|... +++.||+|+++...   ....+.+.+|+.++.+++||||+++++++     ...
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~  106 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG-----EID  106 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EET
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE-----eeC
Confidence            3578999999999999999999975 78899999997543   22346789999999999999999999996     446


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +..++||||+++++|.+++...       ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~  176 (309)
T 2h34_A          107 GQLYVDMRLINGVDLAAMLRRQ-------GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLV  176 (309)
T ss_dssp             TEEEEEEECCCCEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred             CeEEEEEEecCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEe
Confidence            6789999999999999999753       4589999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      |||++......      .........|+..|+|||.+ .+.++.++||||||+++|||+||+.||.......        
T Consensus       177 Dfg~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------  242 (309)
T 2h34_A          177 DFGIASATTDE------KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV--------  242 (309)
T ss_dssp             SCCC----------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH--------
T ss_pred             cCccCcccccc------ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH--------
Confidence            99999765221      11222345689999999999 5568999999999999999999999996532110        


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC-ChHHHHHHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRV-GMKFVVNNLQAI  468 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~i  468 (477)
                            +...+.......          ...            ...++..+.+++.+||+.||++|| |++++++.|+++
T Consensus       243 ------~~~~~~~~~~~~----------~~~------------~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~  294 (309)
T 2h34_A          243 ------MGAHINQAIPRP----------STV------------RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAA  294 (309)
T ss_dssp             ------HHHHHHSCCCCG----------GGT------------STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred             ------HHHHhccCCCCc----------ccc------------CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence                  001110000000          000            001123478899999999999999 999999999987


Q ss_pred             HHhhh
Q 043902          469 RSKIR  473 (477)
Q Consensus       469 ~~~~~  473 (477)
                      .+...
T Consensus       295 l~~~~  299 (309)
T 2h34_A          295 LATAD  299 (309)
T ss_dssp             CC---
T ss_pred             HHhhc
Confidence            65543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.8e-42  Score=329.05  Aligned_cols=260  Identities=25%  Similarity=0.413  Sum_probs=201.3

Q ss_pred             hcCCCCCC-eeeeeccceEEEEEe---CCCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCC
Q 043902          156 TDNFSEEN-LIGSGSFGSVYKGTL---ADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEG  229 (477)
Q Consensus       156 ~~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  229 (477)
                      .++|...+ .||+|+||.||+|.+   .+++.||||+++...  ....+.+.+|++++++++||||+++++++      .
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~------~   88 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC------E   88 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE------E
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE------C
Confidence            45677777 999999999999964   246889999997543  23357899999999999999999999986      2


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEE
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV  309 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl  309 (477)
                      .+..++||||+++++|.+++...       ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||
T Consensus        89 ~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl  158 (291)
T 1xbb_A           89 AESWMLVMEMAELGPLNKYLQQN-------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKI  158 (291)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEE
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhC-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEE
Confidence            34578999999999999999754       4589999999999999999999999   9999999999999999999999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeee
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~  387 (477)
                      +|||++.......    ..........++..|+|||.+ ...++.++||||||+++|||+| |+.||.......      
T Consensus       159 ~Dfg~~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------  228 (291)
T 1xbb_A          159 SDFGLSKALRADE----NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------  228 (291)
T ss_dssp             CCCTTCEECCTTC----SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------
T ss_pred             ccCCcceeeccCC----CcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------
Confidence            9999998653211    111122334467889999999 5568999999999999999999 999997532211      


Q ss_pred             eeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHH
Q 043902          388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQA  467 (477)
Q Consensus       388 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  467 (477)
                              +...+.......             .+           ..+...+.+++.+||+.||++|||+.|+++.|++
T Consensus       229 --------~~~~~~~~~~~~-------------~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  276 (291)
T 1xbb_A          229 --------VTAMLEKGERMG-------------CP-----------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  276 (291)
T ss_dssp             --------HHHHHHTTCCCC-------------CC-----------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             --------HHHHHHcCCCCC-------------CC-----------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                    111111100000             00           0113348899999999999999999999999999


Q ss_pred             HHHhhh
Q 043902          468 IRSKIR  473 (477)
Q Consensus       468 i~~~~~  473 (477)
                      +.....
T Consensus       277 ~~~~~~  282 (291)
T 1xbb_A          277 YYYDVV  282 (291)
T ss_dssp             HHHHHH
T ss_pred             HHHHHh
Confidence            877643

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.6e-42  Score=333.80  Aligned_cols=270  Identities=22%  Similarity=0.254  Sum_probs=191.3

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCC-CCCcceeeeeccccc---CCC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIR-HRNILKIVSSCSSVD---YEG  229 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~---~~~  229 (477)
                      ...+|+..+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.++.++. ||||+++++++....   ...
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            3468889999999999999999965 78999999998776666678999999999996 999999999874221   144


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeecCCCCCCeEecCCCcE
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTP--IAHCDLKSSNVLLDEGMIA  307 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~dlkp~NIll~~~~~~  307 (477)
                      ....++||||+. |+|.+++....    ....+++..++.++.|++.||.|||+.   +  |+||||||+||+++.++.+
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKME----SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHH----TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCE
T ss_pred             CceEEEEEEecC-CCHHHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCE
Confidence            556899999995 79999886421    124689999999999999999999998   7  9999999999999999999


Q ss_pred             EEecccccccccccCCCCCC-----CccccCCCcccccccCcccc----cCCCCcccceeehHHHHHHHhhCCCCCCccc
Q 043902          308 HVGDFGLAKFLFEESNTPSK-----NQTMSNGLKGSVGYIPPEYI----NGHVSILGDIYSYGILLLEIFTGKRPTDDMF  378 (477)
Q Consensus       308 kl~DfG~a~~~~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~----~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~  378 (477)
                      ||+|||+++...........     .........||..|+|||.+    ...++.++|||||||++|||+||+.||....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            99999999876332111000     00111244589999999997    2357899999999999999999999996532


Q ss_pred             ccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCCh
Q 043902          379 KDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGM  458 (477)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  458 (477)
                      ....                 .........        ..                .+...+.+++.+||+.||.+|||+
T Consensus       258 ~~~~-----------------~~~~~~~~~--------~~----------------~~~~~~~~li~~~l~~~p~~Rps~  296 (337)
T 3ll6_A          258 KLRI-----------------VNGKYSIPP--------HD----------------TQYTVFHSLIRAMLQVNPEERLSI  296 (337)
T ss_dssp             -------------------------CCCCT--------TC----------------CSSGGGHHHHHHHSCSSGGGSCCH
T ss_pred             HHHh-----------------hcCcccCCc--------cc----------------ccchHHHHHHHHHccCChhhCcCH
Confidence            1110                 000000000        00                001126789999999999999999


Q ss_pred             HHHHHHHHHHHHhhh
Q 043902          459 KFVVNNLQAIRSKIR  473 (477)
Q Consensus       459 ~evl~~L~~i~~~~~  473 (477)
                      .|+++.|+.+.+...
T Consensus       297 ~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          297 AEVVHQLQEIAAARN  311 (337)
T ss_dssp             HHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHhccC
Confidence            999999999987643

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.7e-42  Score=323.95  Aligned_cols=249  Identities=26%  Similarity=0.443  Sum_probs=181.0

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      ..++|.+.+.||+|+||.||+|+. .+|+.||+|++....   ....+.+.+|++++.+++||||+++++++     ...
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   83 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDS   83 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-----ECS
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-----ccC
Confidence            346788999999999999999986 479999999997542   22346789999999999999999999996     456


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +..++||||+++++|.+++....      ..+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~  154 (278)
T 3cok_A           84 NYVYLVLEMCHNGEMNRYLKNRV------KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIA  154 (278)
T ss_dssp             SEEEEEEECCTTEEHHHHHHTCS------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEEC
T ss_pred             CeEEEEEecCCCCcHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEE
Confidence            78999999999999999997543      5689999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      |||++......       ........||..|+|||.+ ...++.++||||||+++|||++|+.||........ +.....
T Consensus       155 dfg~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~  226 (278)
T 3cok_A          155 DFGLATQLKMP-------HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-LNKVVL  226 (278)
T ss_dssp             CCTTCEECC-----------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CCS
T ss_pred             eecceeeccCC-------CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-HHHHhh
Confidence            99999865221       1112235689999999999 55689999999999999999999999975321110 000000


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      .            ..               ..+.           .....+.+++.+||+.||++|||+.|+++
T Consensus       227 ~------------~~---------------~~~~-----------~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          227 A------------DY---------------EMPS-----------FLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             S------------CC---------------CCCT-----------TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             c------------cc---------------CCcc-----------ccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            0            00               0000           00223789999999999999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4e-42  Score=337.44  Aligned_cols=257  Identities=14%  Similarity=0.122  Sum_probs=199.8

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEE------eCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCC---CCCcceeeeeccc
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGT------LADGETAAIKVLKLQQQGALKSFIDECNALTSIR---HRNILKIVSSCSS  224 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~  224 (477)
                      ...++|.+.+.||+|+||.||+|.      ..+++.||+|+++...   ...+..|++++.+++   |+||+++++++  
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~--  136 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAH--  136 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEE--
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheee--
Confidence            345788899999999999999994      4478999999997543   356777888877776   99999999996  


Q ss_pred             ccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC-
Q 043902          225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE-  303 (477)
Q Consensus       225 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-  303 (477)
                         ...+..++||||+++|+|.+++.....  .....+++..++.++.||+.||.|||+.   +|+||||||+|||++. 
T Consensus       137 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~  208 (365)
T 3e7e_A          137 ---LFQNGSVLVGELYSYGTLLNAINLYKN--TPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNG  208 (365)
T ss_dssp             ---ECSSCEEEEECCCCSCBHHHHHHHHHT--STTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGG
T ss_pred             ---ecCCCcEEEEeccCCCcHHHHHHHhhc--ccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEeccc
Confidence               456678999999999999999974211  0125699999999999999999999999   9999999999999998 


Q ss_pred             ----------CCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCC
Q 043902          304 ----------GMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKR  372 (477)
Q Consensus       304 ----------~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~  372 (477)
                                ++.+||+|||+++.+...     ..........||..|+|||++ ...++.++|||||||++|||+||+.
T Consensus       209 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~  283 (365)
T 3e7e_A          209 FLEQDDEDDLSAGLALIDLGQSIDMKLF-----PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY  283 (365)
T ss_dssp             GTCC------CTTEEECCCTTCEEGGGS-----CTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSC
T ss_pred             ccCccccccccCCEEEeeCchhhhhhcc-----CCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence                      899999999999765221     112334556799999999999 4468999999999999999999999


Q ss_pred             CCCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCC
Q 043902          373 PTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASP  452 (477)
Q Consensus       373 p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP  452 (477)
                      ||............    .++.                          .+             ....+.+++..|++.+|
T Consensus       284 pf~~~~~~~~~~~~----~~~~--------------------------~~-------------~~~~~~~~~~~~l~~~p  320 (365)
T 3e7e_A          284 MKVKNEGGECKPEG----LFRR--------------------------LP-------------HLDMWNEFFHVMLNIPD  320 (365)
T ss_dssp             CCEEEETTEEEECS----CCTT--------------------------CS-------------SHHHHHHHHHHHHCCCC
T ss_pred             ccccCCCCceeech----hccc--------------------------cC-------------cHHHHHHHHHHHcCCCC
Confidence            98643221110000    0000                          00             02236678889999999


Q ss_pred             CCC-CChHHHHHHHHHHHHh
Q 043902          453 RDR-VGMKFVVNNLQAIRSK  471 (477)
Q Consensus       453 ~~R-Ps~~evl~~L~~i~~~  471 (477)
                      .+| |+++++.+.|+++.++
T Consensus       321 ~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          321 CHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             TTCCCCHHHHHHHHHHHHHH
T ss_pred             CCcchHHHHHHHHHHHHHHH
Confidence            999 6788888888887665

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.1e-42  Score=340.80  Aligned_cols=255  Identities=21%  Similarity=0.295  Sum_probs=187.9

Q ss_pred             hcCCCCC-CeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhc-CCCCCcceeeeecccccCCCCce
Q 043902          156 TDNFSEE-NLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTS-IRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       156 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .++|... +.||+|+||.||+|... +|+.||||+++..     ..+.+|++++.+ .+||||+++++++... +.+...
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~  133 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC  133 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcE
Confidence            3566665 68999999999999875 6899999999742     456788888754 5899999999986421 134567


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC---CCcEEE
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE---GMIAHV  309 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl  309 (477)
                      .++||||+++|+|.+++.....     ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.   ++.+||
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl  205 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRGD-----QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKL  205 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC--------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEE
T ss_pred             EEEEEEeCCCCcHHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEE
Confidence            8999999999999999976431     4589999999999999999999999   9999999999999997   789999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeee
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~  388 (477)
                      +|||+++....        ........||..|+|||++ .+.++.++|||||||++|||++|+.||........      
T Consensus       206 ~DFG~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------  271 (400)
T 1nxk_A          206 TDFGFAKETTS--------HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------  271 (400)
T ss_dssp             CCCTTCEECC-------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSS------
T ss_pred             EecccccccCC--------CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccc------
Confidence            99999986521        1122345689999999999 56799999999999999999999999975322111      


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                          .......+..... .             ++.       .....+...+.+|+.+||+.||++|||+.|+++
T Consensus       272 ----~~~~~~~i~~~~~-~-------------~~~-------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          272 ----SPGMKTRIRMGQY-E-------------FPN-------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             ----CCSHHHHHHHTCC-C-------------CCT-------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----cHHHHHHHHcCcc-c-------------CCC-------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                0001111100000 0             000       000011334789999999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.3e-42  Score=331.37  Aligned_cols=265  Identities=23%  Similarity=0.382  Sum_probs=195.6

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeec---cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQ---QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      ..++|.+.+.||+|+||.||+|.. .+|+.||+|+++..   .......+.+|+.++++++||||+++++++     ...
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~  104 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF-----IED  104 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EET
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcC
Confidence            346789999999999999999986 47899999999743   234457789999999999999999999996     345


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +..++||||+++++|.+++.....   ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~  178 (310)
T 2wqm_A          105 NELNIVLELADAGDLSRMIKHFKK---QKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLG  178 (310)
T ss_dssp             TEEEEEEECCCSCBHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEEC
T ss_pred             CcEEEEEecCCCCCHHHHHHHhcc---cccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEE
Confidence            678999999999999999864211   124589999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      |||++......       ........|+..|+|||.+ .+.++.++||||||+++|||++|+.||........       
T Consensus       179 Dfg~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------  244 (310)
T 2wqm_A          179 DLGLGRFFSSK-------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-------  244 (310)
T ss_dssp             CC-------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-------
T ss_pred             eccceeeecCC-------CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-------
Confidence            99999765221       1122345689999999998 55689999999999999999999999864211100       


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIR  469 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  469 (477)
                           .+...+.....                +...       ...+...+.+++.+||+.||++|||+.||++.|++++
T Consensus       245 -----~~~~~~~~~~~----------------~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~  296 (310)
T 2wqm_A          245 -----SLCKKIEQCDY----------------PPLP-------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH  296 (310)
T ss_dssp             -----HHHHHHHTTCS----------------CCCC-------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----HHHHHhhcccC----------------CCCc-------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence                 00000000000                0000       0001234889999999999999999999999999998


Q ss_pred             Hhh
Q 043902          470 SKI  472 (477)
Q Consensus       470 ~~~  472 (477)
                      +..
T Consensus       297 ~~~  299 (310)
T 2wqm_A          297 ACT  299 (310)
T ss_dssp             HHH
T ss_pred             Hhh
Confidence            764

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5.1e-42  Score=336.39  Aligned_cols=211  Identities=24%  Similarity=0.281  Sum_probs=172.3

Q ss_pred             HHHHHHhhcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccc-----------hhhHHHHHHHHHHhcCCCCCcce
Q 043902          149 YLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQ-----------GALKSFIDECNALTSIRHRNILK  217 (477)
Q Consensus       149 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~niv~  217 (477)
                      ..++....++|...+.||+|+||.||+|...+|+.||||++.....           ...+.+.+|++++++++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            4567778899999999999999999999988899999999864322           12367899999999999999999


Q ss_pred             eeeecccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCC
Q 043902          218 IVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSS  297 (477)
Q Consensus       218 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~  297 (477)
                      +++++...........++||||++ |+|.+++....      ..+++..+..++.|++.||.|||++   +|+||||||+
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~  163 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR------IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPG  163 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGG
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChH
Confidence            999975543345567899999997 68888887543      4689999999999999999999999   9999999999


Q ss_pred             CeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCC
Q 043902          298 NVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTD  375 (477)
Q Consensus       298 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~  375 (477)
                      ||+++.++.+||+|||+++....        ........||..|+|||.+.  ..++.++|||||||++|||++|+.||.
T Consensus       164 NIl~~~~~~~kl~Dfg~~~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~  235 (362)
T 3pg1_A          164 NILLADNNDITICDFNLAREDTA--------DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR  235 (362)
T ss_dssp             GEEECTTCCEEECCTTC-----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             HEEEcCCCCEEEEecCccccccc--------ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCC
Confidence            99999999999999999975421        12233456899999999983  468999999999999999999999997


Q ss_pred             cc
Q 043902          376 DM  377 (477)
Q Consensus       376 ~~  377 (477)
                      ..
T Consensus       236 ~~  237 (362)
T 3pg1_A          236 GS  237 (362)
T ss_dssp             CS
T ss_pred             CC
Confidence            53

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.7e-42  Score=332.56  Aligned_cols=266  Identities=24%  Similarity=0.439  Sum_probs=203.0

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe------CCCCEEEEEEeeec-cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL------ADGETAAIKVLKLQ-QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYE  228 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  228 (477)
                      .++|...+.||+|+||.||+|+.      .+++.||||++... .......+.+|+.++.+++||||+++++++     .
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~  103 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS-----L  103 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEE-----c
Confidence            57899999999999999999984      25778999999744 334456789999999999999999999996     4


Q ss_pred             CCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC---CC
Q 043902          229 GNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE---GM  305 (477)
Q Consensus       229 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~  305 (477)
                      .....++||||+++|+|.+++............+++..++.++.|++.||.|||+.   +|+||||||+||+++.   +.
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~  180 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR  180 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcc
Confidence            45668999999999999999986543322335689999999999999999999999   9999999999999984   45


Q ss_pred             cEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccc
Q 043902          306 IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLS  383 (477)
Q Consensus       306 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~  383 (477)
                      .+||+|||++.......     .........||..|+|||.+ .+.++.++|||||||++|||+| |+.||.......  
T Consensus       181 ~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--  253 (327)
T 2yfx_A          181 VAKIGDFGMARDIYRAS-----YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--  253 (327)
T ss_dssp             CEEECCCHHHHHHHC-----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred             eEEECcccccccccccc-----ccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH--
Confidence            69999999997653211     11122334578899999998 6678999999999999999998 999986532111  


Q ss_pred             eeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          384 IHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       384 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                                  +.+.+.......             .+           ..+...+.+++.+||+.||.+|||+.|+++
T Consensus       254 ------------~~~~~~~~~~~~-------------~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  297 (327)
T 2yfx_A          254 ------------VLEFVTSGGRMD-------------PP-----------KNCPGPVYRIMTQCWQHQPEDRPNFAIILE  297 (327)
T ss_dssp             ------------HHHHHHTTCCCC-------------CC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------HHHHHhcCCCCC-------------CC-----------CCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                        111111000000             00           011234889999999999999999999999


Q ss_pred             HHHHHHHhh
Q 043902          464 NLQAIRSKI  472 (477)
Q Consensus       464 ~L~~i~~~~  472 (477)
                      .|+.+....
T Consensus       298 ~l~~~~~~~  306 (327)
T 2yfx_A          298 RIEYCTQDP  306 (327)
T ss_dssp             HHHHHHHCH
T ss_pred             HHHHHhcCH
Confidence            999887653

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.2e-41  Score=341.19  Aligned_cols=211  Identities=24%  Similarity=0.302  Sum_probs=170.7

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec--cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      ..++|...+.||+|+||.||+|+.. +++.||||+++..  .....+.+.+|++++++++||||+++++++.........
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            3578999999999999999999865 6889999999753  233457889999999999999999999997654434446


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+. |+|.+++...       ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~~-------~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~D  172 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKTP-------IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCD  172 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHSS-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred             eEEEEEecCC-cCHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEcc
Confidence            7999999985 6999999754       4589999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCC---------------CCccccCCCcccccccCcccc--cCCCCcccceeehHHHHHHHhhCCCCC
Q 043902          312 FGLAKFLFEESNTPS---------------KNQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPT  374 (477)
Q Consensus       312 fG~a~~~~~~~~~~~---------------~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~Dv~S~Gvvl~elltg~~p~  374 (477)
                      ||+++..........               ..........||..|+|||++  ...++.++|||||||++|||++|..||
T Consensus       173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            999987643211100               000123566799999999986  456999999999999999999977776


Q ss_pred             Cc
Q 043902          375 DD  376 (477)
Q Consensus       375 ~~  376 (477)
                      ..
T Consensus       253 ~~  254 (432)
T 3n9x_A          253 IN  254 (432)
T ss_dssp             CS
T ss_pred             cc
Confidence            54

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.4e-41  Score=321.76  Aligned_cols=250  Identities=21%  Similarity=0.344  Sum_probs=197.6

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .++|++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|++++.+++||||+++++++     .....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   79 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF   79 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCCE
Confidence            578999999999999999999875 68999999997543  33456788999999999999999999996     45677


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCc---EEE
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI---AHV  309 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl  309 (477)
                      .++||||+++++|.+++...       ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.   +||
T Consensus        80 ~~~v~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl  149 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVAR-------EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKL  149 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEE
T ss_pred             EEEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEE
Confidence            89999999999999888644       4589999999999999999999999   9999999999999986655   999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeee
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~  388 (477)
                      +|||++.....        ........||..|+|||.+ ...++.++||||||+++|+|++|+.||.......       
T Consensus       150 ~Dfg~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------  214 (284)
T 3kk8_A          150 ADFGLAIEVND--------SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------  214 (284)
T ss_dssp             CCCTTCEECCS--------SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------
T ss_pred             eeceeeEEccc--------CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-------
Confidence            99999976522        1222345689999999999 5568999999999999999999999996532111       


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                             ....+.......   .         .+.         ...+...+.+++.+||+.||++|||+.|+++
T Consensus       215 -------~~~~~~~~~~~~---~---------~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          215 -------LYAQIKAGAYDY---P---------SPE---------WDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             -------HHHHHHHTCCCC---C---------TTT---------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -------HHHHHHhccccC---C---------chh---------hcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                   000000000000   0         000         0011234789999999999999999999986

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=5.4e-42  Score=330.82  Aligned_cols=249  Identities=19%  Similarity=0.249  Sum_probs=175.7

Q ss_pred             CCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCC-CCCcceeeeecccccCCCCceeeEEEee
Q 043902          162 ENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIR-HRNILKIVSSCSSVDYEGNDFKALVFEF  239 (477)
Q Consensus       162 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~  239 (477)
                      .+.||+|+||.||+|... +++.||||++...   ....+.+|+.++.++. ||||+++++++     .+....++||||
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~~~~~~lv~e~   87 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVF-----HDQLHTFLVMEL   87 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSEEEEEECC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEE-----EcCCEEEEEEEc
Confidence            478999999999999975 6899999999754   2356788999999997 99999999996     566789999999


Q ss_pred             cCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC---cEEEecccccc
Q 043902          240 MRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM---IAHVGDFGLAK  316 (477)
Q Consensus       240 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~DfG~a~  316 (477)
                      +++|+|.+++...       ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++   .+||+|||+++
T Consensus        88 ~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           88 LNGGELFERIKKK-------KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             CCSCBHHHHHHHC-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             cCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            9999999999754       4689999999999999999999999   999999999999997665   89999999998


Q ss_pred             cccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCch
Q 043902          317 FLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSH  395 (477)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  395 (477)
                      ....       .........||..|+|||.+ ...++.++|||||||++|||++|+.||........          ...
T Consensus       158 ~~~~-------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------~~~  220 (325)
T 3kn6_A          158 LKPP-------DNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT----------CTS  220 (325)
T ss_dssp             ECCC-----------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-----------------CCC
T ss_pred             ecCC-------CCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc----------ccc
Confidence            6522       11223345689999999999 55689999999999999999999999975322110          001


Q ss_pred             hHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          396 VMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       396 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      ..+++.........                  ...+....+...+.+++.+||+.||.+|||+.|+++
T Consensus       221 ~~~~~~~i~~~~~~------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          221 AVEIMKKIKKGDFS------------------FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHHHHHHHTTTCCC------------------CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             HHHHHHHHHcCCCC------------------CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            11111111100000                  000011122345889999999999999999999873

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.4e-42  Score=324.41  Aligned_cols=258  Identities=21%  Similarity=0.330  Sum_probs=201.2

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc------hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ------GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEG  229 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  229 (477)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|+++....      ...+.+.+|++++.+++||||+++++++     ..
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~   79 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF-----EN   79 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhee-----cC
Confidence            56888999999999999999976 689999999975432      1357899999999999999999999996     45


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC----
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM----  305 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~----  305 (477)
                      ....++||||+++++|.+++...       ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++    
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~  149 (283)
T 3bhy_A           80 KTDVVLILELVSGGELFDFLAEK-------ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNP  149 (283)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSC
T ss_pred             CCeEEEEEeecCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCC
Confidence            67789999999999999999643       4589999999999999999999999   999999999999998877    


Q ss_pred             cEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccce
Q 043902          306 IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSI  384 (477)
Q Consensus       306 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~  384 (477)
                      .+||+|||++.....        ........|+..|+|||.+ .+.++.++||||||+++|||++|+.||........  
T Consensus       150 ~~kl~dfg~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--  219 (283)
T 3bhy_A          150 RIKLIDFGIAHKIEA--------GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET--  219 (283)
T ss_dssp             CEEECCCTTCEECC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--
T ss_pred             ceEEEecccceeccC--------CCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH--
Confidence            899999999986522        1122344689999999999 45789999999999999999999999965321110  


Q ss_pred             eeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH-
Q 043902          385 HKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN-  463 (477)
Q Consensus       385 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~-  463 (477)
                                 ...+......                      ...+........+.+++.+||+.||++|||+.|+++ 
T Consensus       220 -----------~~~~~~~~~~----------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          220 -----------LTNISAVNYD----------------------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             -----------HHHHHTTCCC----------------------CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             -----------HHHhHhcccC----------------------CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence                       0000000000                      000011112344889999999999999999999997 


Q ss_pred             -HHHHHHHhh
Q 043902          464 -NLQAIRSKI  472 (477)
Q Consensus       464 -~L~~i~~~~  472 (477)
                       .++.++.+.
T Consensus       267 ~~~~~~~~~~  276 (283)
T 3bhy_A          267 SWIKAIRRRN  276 (283)
T ss_dssp             HHHHHHHHCC
T ss_pred             HHHHHHHHHh
Confidence             566666553

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.3e-42  Score=329.68  Aligned_cols=275  Identities=19%  Similarity=0.267  Sum_probs=195.7

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc--hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ--GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|++.....  ...+.+.+|++++++++||||+++++++     ...+..
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   77 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVF-----RRKRRL   77 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhhee-----ecCCeE
Confidence            57889999999999999999975 589999999865432  3346788999999999999999999996     456778


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||+++++|.+++...       ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        78 ~lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  147 (311)
T 4agu_A           78 HLVFEYCDHTVLHELDRYQ-------RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFG  147 (311)
T ss_dssp             EEEEECCSEEHHHHHHHTS-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEeCCCchHHHHHhhh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCC
Confidence            9999999999999988654       4589999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCcccccccc--eeeeee
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLS--IHKFVL  389 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~--~~~~~~  389 (477)
                      ++.....       .........||..|+|||.+.  ..++.++|||||||++|||+||+.||......+..  ......
T Consensus       148 ~~~~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  220 (311)
T 4agu_A          148 FARLLTG-------PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLG  220 (311)
T ss_dssp             TCEECC-------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             CchhccC-------cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhc
Confidence            9987532       112223456899999999983  46899999999999999999999999764322110  000000


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      . ................    ..............     .........+.+++.+||+.||++|||++|+++
T Consensus       221 ~-~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          221 D-LIPRHQQVFSTNQYFS----GVKIPDPEDMEPLE-----LKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             S-CCHHHHHHHHTCGGGT----TCCCCCCSSCCCHH-----HHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             c-cccccccccccccccc----cCcCCCccccchhh-----hhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0 0001111111000000    00000000000000     000112344889999999999999999999985

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2e-42  Score=333.66  Aligned_cols=268  Identities=21%  Similarity=0.406  Sum_probs=206.2

Q ss_pred             HHHhhcCCCCCCeeeeeccceEEEEEeC------CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeeccc
Q 043902          152 ISNATDNFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSS  224 (477)
Q Consensus       152 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  224 (477)
                      .....++|+..+.||+|+||.||+|...      +++.||+|+++... ......+.+|++++++++||||+++++++  
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--   97 (322)
T 1p4o_A           20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV--   97 (322)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE--
T ss_pred             hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE--
Confidence            3445678999999999999999999754      36789999997543 23446789999999999999999999996  


Q ss_pred             ccCCCCceeeEEEeecCCCChhhhcccCCCc---ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEe
Q 043902          225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDE---YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL  301 (477)
Q Consensus       225 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll  301 (477)
                         ...+..++||||+++|+|.+++......   ......+++..++.++.|++.||.|||++   +|+||||||+||++
T Consensus        98 ---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli  171 (322)
T 1p4o_A           98 ---SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV  171 (322)
T ss_dssp             ---CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred             ---ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence               4566789999999999999999753210   00114578999999999999999999999   99999999999999


Q ss_pred             cCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccc
Q 043902          302 DEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFK  379 (477)
Q Consensus       302 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~  379 (477)
                      +.++.+||+|||+++......     .........+|..|+|||.+ .+.++.++|||||||++|||+| |+.||.....
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  246 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETD-----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN  246 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGG-----CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred             cCCCeEEECcCcccccccccc-----ccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH
Confidence            999999999999998653211     11223344578899999999 5678999999999999999999 8999865321


Q ss_pred             cccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChH
Q 043902          380 DDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMK  459 (477)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~  459 (477)
                      ..              ....+.......             .+           ..+...+.+++.+||+.||.+|||+.
T Consensus       247 ~~--------------~~~~~~~~~~~~-------------~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~  288 (322)
T 1p4o_A          247 EQ--------------VLRFVMEGGLLD-------------KP-----------DNCPDMLFELMRMCWQYNPKMRPSFL  288 (322)
T ss_dssp             HH--------------HHHHHHTTCCCC-------------CC-----------TTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HH--------------HHHHHHcCCcCC-------------CC-----------CCCCHHHHHHHHHHcCCCcccCcCHH
Confidence            11              111110000000             00           01133488999999999999999999


Q ss_pred             HHHHHHHHHHH
Q 043902          460 FVVNNLQAIRS  470 (477)
Q Consensus       460 evl~~L~~i~~  470 (477)
                      |+++.|+++.+
T Consensus       289 e~l~~L~~~~~  299 (322)
T 1p4o_A          289 EIISSIKEEME  299 (322)
T ss_dssp             HHHHHHGGGSC
T ss_pred             HHHHHHHHhhc
Confidence            99999987644

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.2e-42  Score=338.41  Aligned_cols=245  Identities=25%  Similarity=0.357  Sum_probs=193.7

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .+.|+..+.||+|+||.||+|+. .+|+.||||++....   ....+.+.+|++++++++||||+++++++     ...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~  127 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-----LREH  127 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETT
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECC
Confidence            35588889999999999999986 478999999997542   23346789999999999999999999996     4466


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+. |+|.+++....      ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|
T Consensus       128 ~~~lv~e~~~-g~l~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D  197 (348)
T 1u5q_A          128 TAWLVMEYCL-GSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGD  197 (348)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECC
T ss_pred             eEEEEEecCC-CCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEee
Confidence            8899999996 68888875432      5689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc----cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeee
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI----NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~  387 (477)
                      ||++.....           .....||+.|+|||++    .+.++.++|||||||++|||+||+.||.......      
T Consensus       198 fG~a~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------  260 (348)
T 1u5q_A          198 FGSASIMAP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------  260 (348)
T ss_dssp             CTTCBSSSS-----------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------
T ss_pred             ccCceecCC-----------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------
Confidence            999976521           1235689999999997    3468999999999999999999999986532110      


Q ss_pred             eeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       388 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                             .+..+......             ...+           ..+...+.+++.+||+.||++|||+.|+++
T Consensus       261 -------~~~~~~~~~~~-------------~~~~-----------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          261 -------ALYHIAQNESP-------------ALQS-----------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             -------HHHHHHHSCCC-------------CCCC-----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -------HHHHHHhcCCC-------------CCCC-----------CCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                   00011000000             0000           001233788999999999999999999985

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.6e-42  Score=339.80  Aligned_cols=208  Identities=24%  Similarity=0.372  Sum_probs=162.9

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec--cchhhHHHHHHHHHHhcCC-CCCcceeeeecccccCCCC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ--QQGALKSFIDECNALTSIR-HRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~  230 (477)
                      ..++|+..+.||+|+||.||+|... +|+.||||++...  .......+.+|+.++.++. ||||+++++++..   .+.
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~~   83 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---DND   83 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---TTS
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec---CCC
Confidence            4578999999999999999999864 7899999998643  3344567889999999997 9999999999742   344


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ...++||||++ |+|.+++..        ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        84 ~~~~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~  151 (388)
T 3oz6_A           84 RDVYLVFDYME-TDLHAVIRA--------NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVA  151 (388)
T ss_dssp             SCEEEEEECCS-EEHHHHHHH--------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred             CEEEEEecccC-cCHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEec
Confidence            57899999997 689998864        3488999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCC--------------CCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCC
Q 043902          311 DFGLAKFLFEESNTP--------------SKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPT  374 (477)
Q Consensus       311 DfG~a~~~~~~~~~~--------------~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~  374 (477)
                      |||+++.........              ...........||+.|+|||++.  ..++.++|||||||++|||++|+.||
T Consensus       152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf  231 (388)
T 3oz6_A          152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF  231 (388)
T ss_dssp             CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence            999998753211100              01122234467999999999984  46899999999999999999999999


Q ss_pred             Ccc
Q 043902          375 DDM  377 (477)
Q Consensus       375 ~~~  377 (477)
                      ...
T Consensus       232 ~~~  234 (388)
T 3oz6_A          232 PGS  234 (388)
T ss_dssp             CCS
T ss_pred             CCC
Confidence            763

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=8.4e-42  Score=325.02  Aligned_cols=252  Identities=24%  Similarity=0.382  Sum_probs=194.0

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      ++|.....||+|+||.||+|... +++.||+|.++.......+.+.+|+.++.+++||||+++++++     ...+..++
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~l   96 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF-----SENGFIKI   96 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEE-----EETTEEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEE-----EeCCcEEE
Confidence            45556679999999999999964 6889999999876666668899999999999999999999996     45667899


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC-CCcEEEecccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE-GMIAHVGDFGL  314 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~DfG~  314 (477)
                      ||||+++++|.+++.....    ...+++..+..++.|++.||.|||+.   +++||||||+||+++. ++.+||+|||+
T Consensus        97 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~  169 (295)
T 2clq_A           97 FMEQVPGGSLSALLRSKWG----PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGT  169 (295)
T ss_dssp             EEECCSEEEHHHHHHHTTC----CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTT
T ss_pred             EEEeCCCCCHHHHHHhhcc----CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeeccc
Confidence            9999999999999975431    13567899999999999999999999   9999999999999987 89999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCccccc-C--CCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-G--HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~--~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      +......       ........|+..|+|||.+. +  .++.++||||||+++|||+||+.||........         
T Consensus       170 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------  233 (295)
T 2clq_A          170 SKRLAGI-------NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---------  233 (295)
T ss_dssp             CEESCC------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH---------
T ss_pred             ccccCCC-------CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH---------
Confidence            9865221       11223456899999999983 3  378999999999999999999999964321110         


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                            ..........   .          +.+.        ..+...+.+++.+||+.||++|||+.|+++
T Consensus       234 ------~~~~~~~~~~---~----------~~~~--------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          234 ------AMFKVGMFKV---H----------PEIP--------ESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             ------HHHHHHHHCC---C----------CCCC--------TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ------HHHhhccccc---c----------cccc--------ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                  0000000000   0          0000        011234789999999999999999999985

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=9e-42  Score=329.86  Aligned_cols=263  Identities=28%  Similarity=0.424  Sum_probs=200.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCE--EEEEEeeec-cchhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGET--AAIKVLKLQ-QQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~  230 (477)
                      .++|...+.||+|+||.||+|+.. ++..  +|+|.++.. .....+.+.+|++++.++ +||||+++++++     ...
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~   98 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHR   98 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE-----EET
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee-----eeC
Confidence            367889999999999999999864 5654  499988743 233456789999999999 899999999996     456


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCc---------ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDE---------YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL  301 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll  301 (477)
                      +..++||||+++|+|.+++......         ......+++..++.++.|++.||.|||++   +|+||||||+||++
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~  175 (327)
T 1fvr_A           99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILV  175 (327)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEE
Confidence            7899999999999999999764300         00124689999999999999999999999   99999999999999


Q ss_pred             cCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccc
Q 043902          302 DEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFK  379 (477)
Q Consensus       302 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~  379 (477)
                      +.++.+||+|||+++....        ........++..|+|||.+ ...++.++|||||||++|||+| |+.||.....
T Consensus       176 ~~~~~~kL~Dfg~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~  247 (327)
T 1fvr_A          176 GENYVAKIADFGLSRGQEV--------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC  247 (327)
T ss_dssp             CGGGCEEECCTTCEESSCE--------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             cCCCeEEEcccCcCccccc--------cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH
Confidence            9999999999999974321        1122234567889999999 5568999999999999999998 9999965321


Q ss_pred             cccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChH
Q 043902          380 DDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMK  459 (477)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~  459 (477)
                      ..              +.+.+.......             .+           ..+...+.+++.+||+.||.+|||+.
T Consensus       248 ~~--------------~~~~~~~~~~~~-------------~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~  289 (327)
T 1fvr_A          248 AE--------------LYEKLPQGYRLE-------------KP-----------LNCDDEVYDLMRQCWREKPYERPSFA  289 (327)
T ss_dssp             HH--------------HHHHGGGTCCCC-------------CC-----------TTBCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HH--------------HHHHhhcCCCCC-------------CC-----------CCCCHHHHHHHHHHccCChhhCcCHH
Confidence            11              111110000000             00           00123488999999999999999999


Q ss_pred             HHHHHHHHHHHhh
Q 043902          460 FVVNNLQAIRSKI  472 (477)
Q Consensus       460 evl~~L~~i~~~~  472 (477)
                      |+++.|+++.++.
T Consensus       290 ell~~L~~~~~~~  302 (327)
T 1fvr_A          290 QILVSLNRMLEER  302 (327)
T ss_dssp             HHHHHHHHHHHSS
T ss_pred             HHHHHHHHHHHhh
Confidence            9999999988764

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.7e-42  Score=336.46  Aligned_cols=247  Identities=24%  Similarity=0.300  Sum_probs=187.5

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHH-HhcCCCCCcceeeeecccccCCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNA-LTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      .++|+..+.||+|+||.||+|+.. +++.||+|+++...   ......+..|..+ ++.++||||+++++++     ...
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~~~  111 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTA  111 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----ECS
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EeC
Confidence            467899999999999999999976 68899999997543   2233456677776 5678999999999985     567


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +..++||||+++|+|.+++...       ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+
T Consensus       112 ~~~~lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~  181 (373)
T 2r5t_A          112 DKLYFVLDYINGGELFYHLQRE-------RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLT  181 (373)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEEC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEe
Confidence            7899999999999999999753       4588999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      |||+++....       .........||+.|+|||++ ...++.++|||||||++|||++|+.||.......        
T Consensus       182 DFG~a~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--------  246 (373)
T 2r5t_A          182 DFGLCKENIE-------HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--------  246 (373)
T ss_dssp             CCCBCGGGBC-------CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH--------
T ss_pred             eCcccccccc-------CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH--------
Confidence            9999986422       11223456799999999999 4568999999999999999999999996532111        


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                           ....++.....               ++.           .....+.+++.+||+.||.+||++.+.++
T Consensus       247 -----~~~~i~~~~~~---------------~~~-----------~~~~~~~~li~~lL~~dp~~R~~~~~~~~  289 (373)
T 2r5t_A          247 -----MYDNILNKPLQ---------------LKP-----------NITNSARHLLEGLLQKDRTKRLGAKDDFM  289 (373)
T ss_dssp             -----HHHHHHHSCCC---------------CCS-----------SSCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred             -----HHHHHHhcccC---------------CCC-----------CCCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence                 01111111000               000           01233788999999999999999864433

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.9e-42  Score=332.61  Aligned_cols=202  Identities=27%  Similarity=0.430  Sum_probs=162.2

Q ss_pred             HHhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc--hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCC
Q 043902          153 SNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ--GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEG  229 (477)
Q Consensus       153 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  229 (477)
                      ....++|+..+.||+|+||.||+|+.. +++.||+|+++....  .....+.+|++++++++||||+++++++     ..
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~  104 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVI-----HH  104 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEE-----EE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEE-----ec
Confidence            345678999999999999999999864 789999999975432  2345678999999999999999999996     45


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEe-----cCC
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL-----DEG  304 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll-----~~~  304 (477)
                      .+..++||||++ |+|.+++...       ..+++..+..++.|++.||.|||++   +|+||||||+||++     +.+
T Consensus       105 ~~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~  173 (329)
T 3gbz_A          105 NHRLHLIFEYAE-NDLKKYMDKN-------PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASET  173 (329)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----C
T ss_pred             CCEEEEEEecCC-CCHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCcc
Confidence            678999999997 5999999754       4589999999999999999999999   99999999999999     455


Q ss_pred             CcEEEecccccccccccCCCCCCCccccCCCcccccccCcccccC--CCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          305 MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       305 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      +.+||+|||+++....       .........||..|+|||++.+  .++.++|||||||++|||++|+.||...
T Consensus       174 ~~~kl~Dfg~a~~~~~-------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  241 (329)
T 3gbz_A          174 PVLKIGDFGLARAFGI-------PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD  241 (329)
T ss_dssp             CEEEECCTTHHHHHC------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ceEEECcCCCccccCC-------cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence            5699999999986521       1122334567999999999843  4899999999999999999999999753

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.5e-41  Score=331.56  Aligned_cols=207  Identities=24%  Similarity=0.308  Sum_probs=174.5

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ..++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++.+++||||+++++++..........
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            4568999999999999999999865 78899999997543 334477899999999999999999999986544455567


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+. |+|.+++..        ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+||
T Consensus       105 ~~iv~e~~~-~~L~~~l~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Df  172 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKT--------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDF  172 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEcccC-cCHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeC
Confidence            899999996 599998864        3489999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-c-CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-N-GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      |+++.......    .........||+.|+|||++ . ..++.++|||||||++|||+||+.||...
T Consensus       173 g~a~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  235 (364)
T 3qyz_A          173 GLARVADPDHD----HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK  235 (364)
T ss_dssp             TTCEECCGGGC----BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cceEecCCCCC----ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCC
Confidence            99987632111    11123445789999999987 3 34899999999999999999999999754

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.1e-41  Score=348.29  Aligned_cols=251  Identities=23%  Similarity=0.330  Sum_probs=198.0

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc-------------hhhHHHHHHHHHHhcCCCCCcceeee
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ-------------GALKSFIDECNALTSIRHRNILKIVS  220 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l~~  220 (477)
                      ..++|.+.+.||+|+||.||+|+.. +++.||+|+++....             ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4678999999999999999999975 688999999975421             23467899999999999999999999


Q ss_pred             ecccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeE
Q 043902          221 SCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVL  300 (477)
Q Consensus       221 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIl  300 (477)
                      ++     ......++||||+++|+|.+++...       ..+++..+..++.||+.||.|||+.   +|+||||||+||+
T Consensus       114 ~~-----~~~~~~~lv~e~~~gg~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil  178 (504)
T 3q5i_A          114 VF-----EDKKYFYLVTEFYEGGELFEQIINR-------HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENIL  178 (504)
T ss_dssp             EE-----ECSSEEEEEEECCTTCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred             EE-----EcCCEEEEEEecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEE
Confidence            96     5677899999999999999988643       4589999999999999999999999   9999999999999


Q ss_pred             ecCCC---cEEEecccccccccccCCCCCCCccccCCCcccccccCcccccCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          301 LDEGM---IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       301 l~~~~---~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      ++.++   .+||+|||++.....        ........||+.|+|||++.+.++.++||||+||++|+|++|..||...
T Consensus       179 ~~~~~~~~~~kl~Dfg~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  250 (504)
T 3q5i_A          179 LENKNSLLNIKIVDFGLSSFFSK--------DYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQ  250 (504)
T ss_dssp             ESSTTCCSSEEECCCTTCEECCT--------TSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EecCCCCccEEEEECCCCEEcCC--------CCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            98775   699999999987522        1223345689999999999888999999999999999999999999753


Q ss_pred             cccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCC
Q 043902          378 FKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVG  457 (477)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs  457 (477)
                      .....             +..+.......                      ...........+.+++.+||+.||.+|||
T Consensus       251 ~~~~~-------------~~~i~~~~~~~----------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t  295 (504)
T 3q5i_A          251 NDQDI-------------IKKVEKGKYYF----------------------DFNDWKNISDEAKELIKLMLTYDYNKRCT  295 (504)
T ss_dssp             SHHHH-------------HHHHHHCCCCC----------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCC
T ss_pred             CHHHH-------------HHHHHcCCCCC----------------------CccccCCCCHHHHHHHHHHcCCChhHCCC
Confidence            22110             00010000000                      00001112344889999999999999999


Q ss_pred             hHHHHH
Q 043902          458 MKFVVN  463 (477)
Q Consensus       458 ~~evl~  463 (477)
                      +.|+++
T Consensus       296 ~~e~l~  301 (504)
T 3q5i_A          296 AEEALN  301 (504)
T ss_dssp             HHHHHT
T ss_pred             HHHHhc
Confidence            999985

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.8e-41  Score=345.83  Aligned_cols=250  Identities=22%  Similarity=0.339  Sum_probs=194.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .++|+..+.||+|+||.||+|+.. ++..||+|+++...  ......+.+|+.++++++||||++++++|     .....
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~  110 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRN  110 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence            457889999999999999999975 78999999997543  33357889999999999999999999996     55678


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC---CCcEEE
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE---GMIAHV  309 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl  309 (477)
                      .++||||+++|+|.+++...       ..+++..+..++.||+.||.|||++   +|+||||||+||+++.   ++.+||
T Consensus       111 ~~lv~e~~~~g~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl  180 (494)
T 3lij_A          111 YYLVMECYKGGELFDEIIHR-------MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKI  180 (494)
T ss_dssp             EEEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEE
T ss_pred             EEEEEecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEE
Confidence            99999999999999988643       4589999999999999999999999   9999999999999976   445999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCcccccCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      +|||++.....        ........||+.|+|||++.+.++.++|||||||++|+|++|+.||........       
T Consensus       181 ~DfG~a~~~~~--------~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------  245 (494)
T 3lij_A          181 VDFGLSAVFEN--------QKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI-------  245 (494)
T ss_dssp             CCCTTCEECBT--------TBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------
T ss_pred             EECCCCeECCC--------CccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH-------
Confidence            99999987532        122334569999999999988899999999999999999999999975322110       


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                            +..+........          .   +         ........+.+++.+||+.||.+|||+.|+++
T Consensus       246 ------~~~i~~~~~~~~----------~---~---------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          246 ------LRKVEKGKYTFD----------S---P---------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             ------HHHHHHTCCCCC----------S---G---------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ------HHHHHhCCCCCC----------c---h---------hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence                  001100000000          0   0         00011234789999999999999999999985

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.3e-41  Score=344.54  Aligned_cols=251  Identities=23%  Similarity=0.331  Sum_probs=198.7

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      ..++|.+.+.||+|+||.||+|+.. +++.||||+++...  ......+.+|++++++++||||+++++++     ....
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~   94 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSS   94 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----EcCC
Confidence            4568999999999999999999975 78999999997432  33457889999999999999999999996     5577


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec---CCCcEE
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAH  308 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~---~~~~~k  308 (477)
                      ..++||||+++|+|.+++...       ..+++..+..++.|++.||.|||++   +|+||||||+||+++   .++.+|
T Consensus        95 ~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~k  164 (486)
T 3mwu_A           95 SFYIVGELYTGGELFDEIIKR-------KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIK  164 (486)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEE
T ss_pred             EEEEEEEcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEE
Confidence            899999999999999988643       4689999999999999999999999   999999999999995   556899


Q ss_pred             EecccccccccccCCCCCCCccccCCCcccccccCcccccCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeee
Q 043902          309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       309 l~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~  388 (477)
                      |+|||+++....        ........||+.|+|||++.+.++.++|||||||++|+|++|+.||........      
T Consensus       165 l~Dfg~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------  230 (486)
T 3mwu_A          165 IIDFGLSTCFQQ--------NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI------  230 (486)
T ss_dssp             ECSCSCTTTBCC--------C----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------
T ss_pred             EEECCcCeECCC--------CCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------
Confidence            999999986522        122334568999999999988899999999999999999999999965321110      


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                             +..+........             .+.         .......+.+++.+||+.||.+|||+.|+++
T Consensus       231 -------~~~i~~~~~~~~-------------~~~---------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          231 -------LKRVETGKYAFD-------------LPQ---------WRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             -------HHHHHHTCCCSC-------------SGG---------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -------HHHHHhCCCCCC-------------Ccc---------cCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                   001100000000             000         0011234789999999999999999999986

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.1e-41  Score=347.97  Aligned_cols=252  Identities=23%  Similarity=0.342  Sum_probs=199.3

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .++|...+.||+|+||.||+|+.. +|+.||+|+++...   ......+.+|++++.+++||||+++++++     .+.+
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~~  257 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKD  257 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----eeCC
Confidence            467889999999999999999975 79999999997542   23346788999999999999999999985     5667


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+++|+|.+++.....     ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus       258 ~l~lVmEy~~gg~L~~~l~~~~~-----~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~D  329 (576)
T 2acx_A          258 ALCLVLTLMNGGDLKFHIYHMGQ-----AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISD  329 (576)
T ss_dssp             EEEEEECCCCSCBHHHHHHSSSS-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEe
Confidence            89999999999999999975431     4589999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      ||+++....        ........||+.|+|||++ .+.++.++|||||||++|||++|+.||........        
T Consensus       330 FGla~~~~~--------~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~--------  393 (576)
T 2acx_A          330 LGLAVHVPE--------GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--------  393 (576)
T ss_dssp             CTTCEECCT--------TCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC--------
T ss_pred             cccceeccc--------CccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh--------
Confidence            999987522        1122345799999999999 45689999999999999999999999975321110        


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC-----ChHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRV-----GMKFVVN  463 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  463 (477)
                        ...+...+.....              .++           ......+.+|+.+||+.||.+||     +++||++
T Consensus       394 --~~~i~~~i~~~~~--------------~~p-----------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          394 --REEVERLVKEVPE--------------EYS-----------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             --HHHHHHHHHHCCC--------------CCC-----------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             --HHHHHHHhhcccc--------------cCC-----------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence              0011111110000              000           00123478999999999999999     6788874

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=333.98  Aligned_cols=199  Identities=24%  Similarity=0.400  Sum_probs=162.8

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccch-hhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQG-ALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      ++|...+.||+|+||.||+|+.. +++.||+|+++..... ....+.+|++++++++||||+++++++     ...+..+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEE-----ECSSCEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEE-----eeCCEEE
Confidence            57888999999999999999975 7899999999754322 223456799999999999999999996     4567789


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +||||++ |+|.+++....      ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        77 lv~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~  146 (324)
T 3mtl_A           77 LVFEYLD-KDLKQYLDDCG------NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGL  146 (324)
T ss_dssp             EEEECCS-EEHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSE
T ss_pred             EEecccc-cCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcc
Confidence            9999997 58998887543      4589999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      ++....       .........||..|+|||.+.  ..++.++|||||||++|||+||+.||...
T Consensus       147 a~~~~~-------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  204 (324)
T 3mtl_A          147 ARAKSI-------PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS  204 (324)
T ss_dssp             EECC-------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccC-------CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            976421       122233456899999999984  45899999999999999999999999764

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.3e-41  Score=329.19  Aligned_cols=194  Identities=25%  Similarity=0.356  Sum_probs=167.3

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeeccchhhHHHHHHHHHHhcCC-CCCcceeeeecccccCCCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIR-HRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .++|+..+.||+|+||.||+|+. .+++.||+|+++...   .+.+.+|++++.+++ ||||+++++++..   ......
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~~~~  108 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKD---PVSRTP  108 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCCE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeecc---CCCCce
Confidence            46788999999999999999986 478999999997443   367899999999997 9999999999742   235678


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC-cEEEecc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM-IAHVGDF  312 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Df  312 (477)
                      ++||||+++++|.+++.          .+++..+..++.|++.||.|||++   +|+||||||+||+++.++ .+||+||
T Consensus       109 ~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Df  175 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQ----------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDW  175 (330)
T ss_dssp             EEEEECCCCCCHHHHGG----------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             EEEEeccCchhHHHHHH----------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeC
Confidence            99999999999999884          378899999999999999999999   999999999999999776 8999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      |+++....        ........|+..|+|||.+.  ..++.++|||||||++|||++|+.||..
T Consensus       176 g~a~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~  233 (330)
T 3nsz_A          176 GLAEFYHP--------GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH  233 (330)
T ss_dssp             TTCEECCT--------TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             CCceEcCC--------CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            99986532        11223456899999999983  4689999999999999999999999954

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.9e-42  Score=328.78  Aligned_cols=262  Identities=26%  Similarity=0.401  Sum_probs=192.4

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC--CCC--EEEEEEeeec---cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA--DGE--TAAIKVLKLQ---QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYE  228 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  228 (477)
                      .++|+..+.||+|+||.||+|++.  +++  .||+|+++..   .....+.+.+|++++.+++||||+++++++.     
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----   91 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-----   91 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc-----
Confidence            467889999999999999999853  333  6899998754   2344578999999999999999999999963     


Q ss_pred             CCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEE
Q 043902          229 GNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH  308 (477)
Q Consensus       229 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k  308 (477)
                      . ...++|+||+++++|.+++....      ..+++..++.++.|++.||.|||++   +++||||||+||+++.++.+|
T Consensus        92 ~-~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~k  161 (291)
T 1u46_A           92 T-PPMKMVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVK  161 (291)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHHG------GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEE
T ss_pred             c-CCceeeEecccCCCHHHHHHhcc------CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEE
Confidence            2 23789999999999999997532      4589999999999999999999999   999999999999999999999


Q ss_pred             EecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceee
Q 043902          309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHK  386 (477)
Q Consensus       309 l~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~  386 (477)
                      |+|||++.......    ..........+|..|+|||.+ ...++.++||||||+++|||++ |+.||........    
T Consensus       162 l~Dfg~~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----  233 (291)
T 1u46_A          162 IGDFGLMRALPQND----DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI----  233 (291)
T ss_dssp             ECCCTTCEECCC-C----CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----
T ss_pred             Eccccccccccccc----cchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH----
Confidence            99999998763211    111223345578889999999 5568999999999999999999 9999965321110    


Q ss_pred             eeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHH
Q 043902          387 FVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQ  466 (477)
Q Consensus       387 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  466 (477)
                               ...+......         ..    .+           ..+...+.+++.+||+.||++|||+.++++.|+
T Consensus       234 ---------~~~~~~~~~~---------~~----~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  280 (291)
T 1u46_A          234 ---------LHKIDKEGER---------LP----RP-----------EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL  280 (291)
T ss_dssp             ---------HHHHHTSCCC---------CC----CC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---------HHHHHccCCC---------CC----CC-----------cCcCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence                     0000000000         00    00           011334889999999999999999999999999


Q ss_pred             HHHHhhh
Q 043902          467 AIRSKIR  473 (477)
Q Consensus       467 ~i~~~~~  473 (477)
                      ++...-.
T Consensus       281 ~~~~~~~  287 (291)
T 1u46_A          281 EAQPTDM  287 (291)
T ss_dssp             HHC----
T ss_pred             HhCccch
Confidence            8876543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.1e-41  Score=333.82  Aligned_cols=254  Identities=22%  Similarity=0.363  Sum_probs=199.6

Q ss_pred             HHHhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc--------hhhHHHHHHHHHHhcC-CCCCcceeeee
Q 043902          152 ISNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ--------GALKSFIDECNALTSI-RHRNILKIVSS  221 (477)
Q Consensus       152 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~l~~~  221 (477)
                      .....++|.+.+.||+|+||.||+|+.. +|+.||||+++....        ...+.+.+|+.++.++ +||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            3445678999999999999999999975 799999999975431        1245678999999999 79999999998


Q ss_pred             cccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEe
Q 043902          222 CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL  301 (477)
Q Consensus       222 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll  301 (477)
                      +     ......++||||+++++|.+++...       ..+++..+..++.|++.||.|||+.   +|+||||||+||++
T Consensus       169 ~-----~~~~~~~lv~e~~~g~~L~~~l~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~  233 (365)
T 2y7j_A          169 Y-----ESSSFMFLVFDLMRKGELFDYLTEK-------VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILL  233 (365)
T ss_dssp             E-----EBSSEEEEEECCCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             E-----eeCCEEEEEEEeCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            6     4567899999999999999999743       4689999999999999999999999   99999999999999


Q ss_pred             cCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccccC-------CCCcccceeehHHHHHHHhhCCCCC
Q 043902          302 DEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-------HVSILGDIYSYGILLLEIFTGKRPT  374 (477)
Q Consensus       302 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~Dv~S~Gvvl~elltg~~p~  374 (477)
                      +.++.+||+|||++.....        ........||+.|+|||++.+       .++.++|||||||++|||+||+.||
T Consensus       234 ~~~~~ikl~DfG~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf  305 (365)
T 2y7j_A          234 DDNMQIRLSDFGFSCHLEP--------GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF  305 (365)
T ss_dssp             CTTCCEEECCCTTCEECCT--------TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCCCCEEEEecCcccccCC--------CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCC
Confidence            9999999999999987532        112234578999999999832       4788999999999999999999999


Q ss_pred             CcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCC
Q 043902          375 DDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRD  454 (477)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~  454 (477)
                      .......             ....+.......                      .......+...+.+++.+||+.||++
T Consensus       306 ~~~~~~~-------------~~~~i~~~~~~~----------------------~~~~~~~~~~~~~~li~~~L~~dP~~  350 (365)
T 2y7j_A          306 WHRRQIL-------------MLRMIMEGQYQF----------------------SSPEWDDRSSTVKDLISRLLQVDPEA  350 (365)
T ss_dssp             CCSSHHH-------------HHHHHHHTCCCC----------------------CHHHHSSSCHHHHHHHHHHSCSSTTT
T ss_pred             CCCCHHH-------------HHHHHHhCCCCC----------------------CCcccccCCHHHHHHHHHHcCCChhH
Confidence            6521110             000000000000                      00000111334889999999999999


Q ss_pred             CCChHHHHH
Q 043902          455 RVGMKFVVN  463 (477)
Q Consensus       455 RPs~~evl~  463 (477)
                      |||+.|+++
T Consensus       351 Rps~~ell~  359 (365)
T 2y7j_A          351 RLTAEQALQ  359 (365)
T ss_dssp             SCCHHHHHH
T ss_pred             CcCHHHHhc
Confidence            999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-41  Score=330.50  Aligned_cols=203  Identities=26%  Similarity=0.392  Sum_probs=164.7

Q ss_pred             HHhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc-----hhhHHHHHHHHHHhcCCCCCcceeeeeccccc
Q 043902          153 SNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ-----GALKSFIDECNALTSIRHRNILKIVSSCSSVD  226 (477)
Q Consensus       153 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  226 (477)
                      ....++|...+.||+|+||.||+|+.. +|+.||+|+++....     .....+.+|++++++++||||+++++++    
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----   81 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF----   81 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE----
Confidence            445678999999999999999999975 689999999974322     1235788999999999999999999996    


Q ss_pred             CCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCc
Q 043902          227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI  306 (477)
Q Consensus       227 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~  306 (477)
                       ...+..++||||+++ +|.+++....      ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.
T Consensus        82 -~~~~~~~lv~e~~~~-~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~  150 (346)
T 1ua2_A           82 -GHKSNISLVFDFMET-DLEVIIKDNS------LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGV  150 (346)
T ss_dssp             -CCTTCCEEEEECCSE-EHHHHHTTCC------SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCC
T ss_pred             -eeCCceEEEEEcCCC-CHHHHHHhcC------cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCC
Confidence             456678999999975 8988887543      4588899999999999999999999   9999999999999999999


Q ss_pred             EEEecccccccccccCCCCCCCccccCCCcccccccCcccccC--CCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          307 AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       307 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      +||+|||+++....       .........||..|+|||.+.+  .++.++|||||||++|||++|..||...
T Consensus       151 ~kl~Dfg~a~~~~~-------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~  216 (346)
T 1ua2_A          151 LKLADFGLAKSFGS-------PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD  216 (346)
T ss_dssp             EEECCCGGGSTTTS-------CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEEEecccceeccC-------CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence            99999999986522       1122334568999999999843  4899999999999999999999998653

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.7e-41  Score=321.25  Aligned_cols=245  Identities=24%  Similarity=0.354  Sum_probs=197.2

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .++|...+.||+|+||.||+|+.. +++.||+|++....   ......+.+|++++.+++||||+++++++     ...+
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   87 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF-----HDRK   87 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE-----EcCC
Confidence            467889999999999999999975 67899999997542   22346789999999999999999999996     4567


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+++|+|.+++...       ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~D  157 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQKH-------GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIAD  157 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECC
T ss_pred             EEEEEEEeCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEec
Confidence            889999999999999999753       4589999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      ||++.....         .......|+..|+|||.+ ...++.++||||||+++|||++|+.||.......         
T Consensus       158 fg~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------  219 (284)
T 2vgo_A          158 FGWSVHAPS---------LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE---------  219 (284)
T ss_dssp             CTTCEECSS---------SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---------
T ss_pred             ccccccCcc---------cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH---------
Confidence            999875421         122345689999999999 4568999999999999999999999996532111         


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                          ....+......               ++.           .....+.+++.+|++.||.+|||+.|+++
T Consensus       220 ----~~~~~~~~~~~---------------~~~-----------~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          220 ----THRRIVNVDLK---------------FPP-----------FLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             ----HHHHHHTTCCC---------------CCT-----------TSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----HHHHHhccccC---------------CCC-----------cCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                00011100000               000           01233789999999999999999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-41  Score=330.99  Aligned_cols=200  Identities=27%  Similarity=0.345  Sum_probs=164.5

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec--cchhhHHHHHHHHHHhcCCCCCcceeeeeccccc-CCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSSCSSVD-YEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~~~  231 (477)
                      .++|...+.||+|+||.||+|... +|+.||||++...  .....+.+.+|++++++++||||+++++++.... .....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            568899999999999999999974 7999999998643  2334567899999999999999999999975321 11224


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+ +++|.+++..        ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~--------~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D  171 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH--------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILD  171 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred             eEEEEEecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEe
Confidence            569999999 8899999864        3488999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-c-CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-N-GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      ||+++....          ......+|..|+|||++ . ..++.++||||+||++|||++|+.||...
T Consensus       172 fg~a~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  229 (367)
T 1cm8_A          172 FGLARQADS----------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS  229 (367)
T ss_dssp             CTTCEECCS----------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eeccccccc----------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999986521          12345789999999998 3 46899999999999999999999999753

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.5e-41  Score=324.90  Aligned_cols=250  Identities=23%  Similarity=0.316  Sum_probs=195.4

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ..++|...+.||+|+||.||+|+.. +|+.||+|+++.........+.+|++++.+++||||+++++++     ...+..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   81 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY-----ESTTHY   81 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhc-----ccCCEE
Confidence            3567889999999999999999975 7899999999866544456789999999999999999999985     456788


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEe---cCCCcEEEe
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAHVG  310 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~  310 (477)
                      ++||||+++++|.+++...       ..+++..++.++.|++.||.|||+.   +|+||||||+||++   +.++.+||+
T Consensus        82 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~  151 (304)
T 2jam_A           82 YLVMQLVSGGELFDRILER-------GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMIT  151 (304)
T ss_dssp             EEEECCCCSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBC
T ss_pred             EEEEEcCCCccHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEc
Confidence            9999999999999998643       4589999999999999999999999   99999999999999   788999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      |||++.....         .......||..|+|||.+ .+.++.++|||||||++|||++|+.||........       
T Consensus       152 Dfg~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------  215 (304)
T 2jam_A          152 DFGLSKMEQN---------GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL-------  215 (304)
T ss_dssp             SCSTTCCCCC---------BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------
T ss_pred             cCCcceecCC---------CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-------
Confidence            9999875411         112234589999999999 55689999999999999999999999965321110       


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                            ...+........          ....            ......+.+++.+||+.||++|||+.|+++
T Consensus       216 ------~~~i~~~~~~~~----------~~~~------------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          216 ------FEKIKEGYYEFE----------SPFW------------DDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             ------HHHHHHCCCCCC----------TTTT------------TTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ------HHHHHcCCCCCC----------cccc------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                  000000000000          0000            001234889999999999999999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=5.3e-42  Score=332.76  Aligned_cols=251  Identities=22%  Similarity=0.303  Sum_probs=193.0

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCCce
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ..++|+..+.||+|+||.||+|... +|+.||+|+++....    ...+|++++.++ +||||+++++++     .+.+.
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~   90 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVY-----DDGKY   90 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCE
Confidence            3567899999999999999999975 689999999975542    235688888887 799999999995     56778


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC----CcEE
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG----MIAH  308 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~----~~~k  308 (477)
                      .++||||+++|+|.+++...       ..+++..+..++.||+.||.|||++   +|+||||||+||++.++    +.+|
T Consensus        91 ~~lv~E~~~gg~L~~~i~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~k  160 (342)
T 2qr7_A           91 VYVVTELMKGGELLDKILRQ-------KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIR  160 (342)
T ss_dssp             EEEEECCCCSCBHHHHHHTC-------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEE
T ss_pred             EEEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEE
Confidence            99999999999999998754       4589999999999999999999999   99999999999998533    3599


Q ss_pred             EecccccccccccCCCCCCCccccCCCcccccccCccccc-CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeee
Q 043902          309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       309 l~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~  387 (477)
                      |+|||+++.....       ........||+.|+|||++. ..++.++|||||||++|||++|+.||.......      
T Consensus       161 l~Dfg~a~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------  227 (342)
T 2qr7_A          161 ICDFGFAKQLRAE-------NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT------  227 (342)
T ss_dssp             ECCCTTCEECBCT-------TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC------
T ss_pred             EEECCCcccCcCC-------CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC------
Confidence            9999999865321       11233456899999999994 458999999999999999999999996532111      


Q ss_pred             eeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       388 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                              ..+++...........      ....            ......+.+++.+||+.||++|||+.|+++
T Consensus       228 --------~~~~~~~i~~~~~~~~------~~~~------------~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          228 --------PEEILARIGSGKFSLS------GGYW------------NSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             --------HHHHHHHHHHCCCCCC------STTT------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --------HHHHHHHHccCCcccC------cccc------------ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                    1111111000000000      0000            001234789999999999999999999985

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.8e-41  Score=333.43  Aligned_cols=201  Identities=25%  Similarity=0.264  Sum_probs=161.8

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec--cchhhHHHHHHHHHHhcCCCCCcceeeeeccccc-CCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSSCSSVD-YEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~~~  231 (477)
                      .++|...+.||+|+||.||+|... +++.||||++...  .....+.+.+|+.++++++||||+++++++.... .....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            468999999999999999999865 6899999999753  2334567889999999999999999999975322 12334


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||++ |+|.+++.         ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|
T Consensus       104 ~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~D  170 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  170 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHH---------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred             ceEEEEEcCC-CCHHHHHh---------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEE
Confidence            7899999996 47888875         3478999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      ||+++....        ........||..|+|||++ ...++.++|||||||++|||++|+.||...
T Consensus       171 fg~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  229 (371)
T 2xrw_A          171 FGLARTAGT--------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT  229 (371)
T ss_dssp             CCC------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eeccccccc--------ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            999986521        1123345789999999999 556899999999999999999999999764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=7.6e-42  Score=334.87  Aligned_cols=198  Identities=27%  Similarity=0.434  Sum_probs=171.3

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .++|+..+.||+|+||.||+|... +++.||+|+++... ....+.+.+|+.++.+++||||+++++++     ..++..
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~  106 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI  106 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEE-----EETTEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEE-----EECCEE
Confidence            467889999999999999999976 78999999998653 34457889999999999999999999986     456779


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN-QYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      ++||||+++++|.+++...       ..+++..+..++.|++.||.|||+ .   +|+||||||+||+++.++.+||+||
T Consensus       107 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Df  176 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDF  176 (360)
T ss_dssp             EEEECCCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCC
T ss_pred             EEEEECCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEEC
Confidence            9999999999999999753       458999999999999999999998 4   7999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      |++.....         .......||..|+|||++ ...++.++|||||||++|||+||+.||...
T Consensus       177 g~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  233 (360)
T 3eqc_A          177 GVSGQLID---------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  233 (360)
T ss_dssp             CCCHHHHH---------HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred             CCCccccc---------ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99976522         122345689999999999 556899999999999999999999999764

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.3e-41  Score=321.98  Aligned_cols=248  Identities=21%  Similarity=0.312  Sum_probs=198.7

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .++|...+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+.++++++||||+++++++     ...+
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~   88 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDND   88 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee-----ccCC
Confidence            467889999999999999999976 58899999987542   33456788999999999999999999996     4567


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+++++|.+++...       ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|
T Consensus        89 ~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d  158 (294)
T 2rku_A           89 FVFVVLELCRRRSLLELHKRR-------KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGD  158 (294)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred             EEEEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEe
Confidence            899999999999999988643       4689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      ||++......       ........||..|+|||.+ ...++.++||||||+++|||+||+.||.......         
T Consensus       159 fg~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------  222 (294)
T 2rku_A          159 FGLATKVEYD-------GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---------  222 (294)
T ss_dssp             CTTCEECCST-------TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---------
T ss_pred             ccCceecccC-------ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---------
Confidence            9999865221       1122345689999999999 4568999999999999999999999996532111         


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                          ....+.....               ..+.           .....+.+++.+||+.||++|||+.|+++.
T Consensus       223 ----~~~~~~~~~~---------------~~~~-----------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          223 ----TYLRIKKNEY---------------SIPK-----------HINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             ----HHHHHHTTCC---------------CCCT-----------TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ----HHHHHhhccC---------------CCcc-----------ccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                0000000000               0000           012237889999999999999999999863

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.1e-42  Score=328.36  Aligned_cols=252  Identities=22%  Similarity=0.339  Sum_probs=194.5

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++.+++||||+++++++     ...+..
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   91 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY-----YHDGKL   91 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECC-CE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeee-----eeCCeE
Confidence            4578999999999999999999976 6899999999876666678899999999999999999999996     345678


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||+++++|.+++....      ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||
T Consensus        92 ~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  162 (302)
T 2j7t_A           92 WIMIEFCPGGAVDAIMLELD------RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFG  162 (302)
T ss_dssp             EEEEECCTTEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCH
T ss_pred             EEEEEeCCCCcHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECC
Confidence            99999999999999886532      4589999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc------cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeee
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI------NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~------~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~  387 (477)
                      ++......       ........||..|+|||.+      ...++.++||||||+++|||++|+.||........     
T Consensus       163 ~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----  230 (302)
T 2j7t_A          163 VSAKNLKT-------LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-----  230 (302)
T ss_dssp             HHHHHHHH-------HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----
T ss_pred             CCcccccc-------ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-----
Confidence            98643211       1122335689999999987      34588999999999999999999999975321110     


Q ss_pred             eeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       388 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                              ...+......       ..     ..+           ..+...+.+++.+||+.||++|||+.|+++
T Consensus       231 --------~~~~~~~~~~-------~~-----~~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          231 --------LLKIAKSDPP-------TL-----LTP-----------SKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             --------HHHHHHSCCC-------CC-----SSG-----------GGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             --------HHHHhccCCc-------cc-----CCc-----------cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                    0000000000       00     000           001234789999999999999999999985

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.6e-42  Score=332.48  Aligned_cols=276  Identities=20%  Similarity=0.300  Sum_probs=196.6

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc--hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ--GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .++|+..+.||+|+||.||+|+.. +|+.||+|++.....  ...+.+.+|++++++++||||++++++|     ...+.
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~   98 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC-----KKKKR   98 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEe-----ecCCE
Confidence            467889999999999999999975 589999999865432  2345688999999999999999999996     45677


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++++|.+++...       ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+||
T Consensus        99 ~~lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Df  168 (331)
T 4aaa_A           99 WYLVFEFVDHTILDDLELFP-------NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDF  168 (331)
T ss_dssp             EEEEEECCSEEHHHHHHHST-------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEecCCcchHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeC
Confidence            89999999999999887644       4589999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccccC--CCCcccceeehHHHHHHHhhCCCCCCcccccccceeeee--
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV--  388 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~--  388 (477)
                      |+++.....       ........||..|+|||.+.+  .++.++|||||||++|||++|+.||......... ....  
T Consensus       169 g~~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~  240 (331)
T 4aaa_A          169 GFARTLAAP-------GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQL-YHIMMC  240 (331)
T ss_dssp             TTC-------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHH
T ss_pred             CCceeecCC-------ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHHH
Confidence            999765221       122334568999999999844  5899999999999999999999999764322110 0000  


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      ....+..............    ............     .......+...+.+++.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          241 LGNLIPRHQELFNKNPVFA----GVRLPEIKEREP-----LERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HCSCCHHHHHHHHHCGGGT----TCCCCCCSSCCC-----HHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hCCCChhhhhHhhhccccc----cccCccccccch-----hhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000111111111100000    000000000000     00011122445889999999999999999999985

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.4e-41  Score=346.16  Aligned_cols=250  Identities=25%  Similarity=0.386  Sum_probs=199.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .++|...+.||+|+||.||+|+.. +|+.||||++....   ......+.+|++++++++||||+++++++     ...+
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~   99 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----EDKG   99 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCC
Confidence            467889999999999999999975 78999999997442   33457899999999999999999999996     5677


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEe---cCCCcEE
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL---DEGMIAH  308 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll---~~~~~~k  308 (477)
                      ..++||||+.+|+|.+++...       ..+++..+..++.|++.||.|||++   +|+||||||+||++   +.++.+|
T Consensus       100 ~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~k  169 (484)
T 3nyv_A          100 YFYLVGEVYTGGELFDEIISR-------KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIR  169 (484)
T ss_dssp             EEEEEECCCCSCBHHHHHHTC-------SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEE
T ss_pred             EEEEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEE
Confidence            899999999999999998754       4589999999999999999999999   99999999999999   5678999


Q ss_pred             EecccccccccccCCCCCCCccccCCCcccccccCcccccCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeee
Q 043902          309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       309 l~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~  388 (477)
                      |+|||+++....        ........||+.|+|||++.+.++.++|||||||++|+|++|+.||........      
T Consensus       170 l~Dfg~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------  235 (484)
T 3nyv_A          170 IIDFGLSTHFEA--------SKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDI------  235 (484)
T ss_dssp             ECCTTHHHHBCC--------CCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------
T ss_pred             EEeeeeeEEccc--------ccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH------
Confidence            999999986522        112233468999999999988899999999999999999999999975321110      


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                             +..+........             .+.         .......+.+++.+||+.||.+|||+.|+++
T Consensus       236 -------~~~i~~~~~~~~-------------~~~---------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          236 -------LKKVEKGKYTFE-------------LPQ---------WKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             -------HHHHHHCCCCCC-------------SGG---------GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------HHHHHcCCCCCC-------------Ccc---------cccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence                   001100000000             000         0011234789999999999999999999985

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.3e-41  Score=326.88  Aligned_cols=247  Identities=21%  Similarity=0.310  Sum_probs=198.6

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .++|...+.||+|+||.||+++.. +++.||+|++....   ....+.+.+|+.++++++||||+++++++     ...+
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~  114 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDND  114 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCC
Confidence            467889999999999999999975 58899999997542   33456789999999999999999999996     4567


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+++++|.+++...       ..+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|
T Consensus       115 ~~~lv~e~~~~~~L~~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~D  184 (335)
T 2owb_A          115 FVFVVLELCRRRSLLELHKRR-------KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGD  184 (335)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECC
T ss_pred             eEEEEEecCCCCCHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEee
Confidence            899999999999999988643       4589999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      ||++......       ........||..|+|||.+ ...++.++|||||||++|||++|+.||.......         
T Consensus       185 fg~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------  248 (335)
T 2owb_A          185 FGLATKVEYD-------GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---------  248 (335)
T ss_dssp             CTTCEECCST-------TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---------
T ss_pred             ccCceecccC-------cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH---------
Confidence            9999865221       1122345689999999999 5568999999999999999999999996532111         


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                          ....+......               .+.           .+...+.+++.+||+.||++|||+.|+++
T Consensus       249 ----~~~~~~~~~~~---------------~~~-----------~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          249 ----TYLRIKKNEYS---------------IPK-----------HINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             ----HHHHHHHTCCC---------------CCT-----------TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ----HHHHHhcCCCC---------------CCc-----------cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                00000000000               000           01223788999999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=5e-41  Score=342.38  Aligned_cols=204  Identities=25%  Similarity=0.387  Sum_probs=175.1

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .++|...+.||+|+||.||+|+.. +|+.||+|+++...   ......+.+|++++.+++||||+++++++     ....
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~~  258 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ETKT  258 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----eeCC
Confidence            367888899999999999999975 69999999997543   23346788999999999999999999985     5667


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+++|+|.+++.....   ....+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus       259 ~l~lVmE~~~gg~L~~~l~~~~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~D  332 (543)
T 3c4z_A          259 DLCLVMTIMNGGDIRYHIYNVDE---DNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISD  332 (543)
T ss_dssp             EEEEEECCCTTCBHHHHHHTSST---TSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred             EEEEEEEeccCCCHHHHHHHhhc---ccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEee
Confidence            89999999999999999875431   124689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      ||+++.....       ........||+.|+|||++ ...++.++|||||||++|||+||+.||...
T Consensus       333 FGla~~~~~~-------~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~  392 (543)
T 3c4z_A          333 LGLAVELKAG-------QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR  392 (543)
T ss_dssp             CTTCEECCTT-------CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred             cceeeeccCC-------CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence            9999875321       1123345799999999999 456899999999999999999999999753

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.5e-41  Score=321.39  Aligned_cols=249  Identities=25%  Similarity=0.376  Sum_probs=199.6

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ..+.|...+.||+|+||.||+|... +++.||+|+++... ....+.+.+|+.++.+++||||+++++++     .....
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   94 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTK   94 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----ecCCe
Confidence            3467889999999999999999864 78999999997553 34457899999999999999999999986     34567


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++++|.+++..        ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+||
T Consensus        95 ~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Df  163 (303)
T 3a7i_A           95 LWIIMEYLGGGSALDLLEP--------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADF  163 (303)
T ss_dssp             EEEEEECCTTEEHHHHHTT--------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEEEeCCCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeec
Confidence            8999999999999999864        3589999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      |++......       ........||..|+|||.+ ...++.++||||||+++|||++|+.||.......          
T Consensus       164 g~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----------  226 (303)
T 3a7i_A          164 GVAGQLTDT-------QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK----------  226 (303)
T ss_dssp             TTCEECBTT-------BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----------
T ss_pred             ccceecCcc-------ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH----------
Confidence            999865321       1223345689999999999 5568999999999999999999999996532110          


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                          ....+.......             .+           ..+...+.+++.+||+.||.+|||+.|+++.
T Consensus       227 ----~~~~~~~~~~~~-------------~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          227 ----VLFLIPKNNPPT-------------LE-----------GNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             ----HHHHHHHSCCCC-------------CC-----------SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             ----HHHHhhcCCCCC-------------Cc-----------cccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                001110000000             00           0012347899999999999999999999864

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7.2e-42  Score=322.85  Aligned_cols=256  Identities=23%  Similarity=0.323  Sum_probs=198.6

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .++|+..+.||+|+||.||+|+.. +|+.||+|++....  ....+.+.+|++++++++||||+++++++..   .....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~   81 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT   81 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---GGGTE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec---CCCce
Confidence            468889999999999999999975 78999999998543  3345678999999999999999999998642   34567


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCC-----eeecCCCCCCeEecCCCcE
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTP-----IAHCDLKSSNVLLDEGMIA  307 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-----ivH~dlkp~NIll~~~~~~  307 (477)
                      .++||||+++++|.+++.....   ....+++..++.++.|++.||.|||+.   +     |+||||||+||+++.++.+
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~  155 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTK---ERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNV  155 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCE
T ss_pred             EEEEEeCCCCCCHHHHHHhhcc---cCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCE
Confidence            8999999999999999975321   124589999999999999999999998   7     9999999999999999999


Q ss_pred             EEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceee
Q 043902          308 HVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHK  386 (477)
Q Consensus       308 kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~  386 (477)
                      ||+|||+++....       .........|+..|+|||.+ ...++.++||||||+++|||+||+.||.......     
T Consensus       156 kl~dfg~~~~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----  223 (279)
T 2w5a_A          156 KLGDFGLARILNH-------DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-----  223 (279)
T ss_dssp             EECCCCHHHHC----------CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----
T ss_pred             EEecCchheeecc-------ccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH-----
Confidence            9999999986521       11112234688999999999 5578999999999999999999999997532110     


Q ss_pred             eeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHH
Q 043902          387 FVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNL  465 (477)
Q Consensus       387 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  465 (477)
                               +.+.+......             ..+           ..+...+.+++.+||+.||++|||+.|+++.+
T Consensus       224 ---------~~~~i~~~~~~-------------~~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          224 ---------LAGKIREGKFR-------------RIP-----------YRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             ---------HHHHHHHTCCC-------------CCC-----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             ---------HHHHHhhcccc-------------cCC-----------cccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence                     11101000000             000           00123488999999999999999999998754

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=6.5e-41  Score=327.09  Aligned_cols=209  Identities=23%  Similarity=0.391  Sum_probs=171.2

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccC---CC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDY---EG  229 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---~~  229 (477)
                      .++|+..+.||+|+||.||+|+. .+|+.||+|++....  ......+.+|++++++++||||+++++++.....   ..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            46889999999999999999997 478999999986443  2234678899999999999999999999754211   11


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEE
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV  309 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl  309 (477)
                      .+..++||||+++ +|.+.+....      ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl  165 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVL------VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKL  165 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred             CceEEEEEeccCC-CHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEE
Confidence            4578999999975 7777776543      4589999999999999999999999   9999999999999999999999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      +|||+++.......   ..........||+.|+|||.+.  ..++.++|||||||++|||+||+.||...
T Consensus       166 ~Dfg~a~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  232 (351)
T 3mi9_A          166 ADFGLARAFSLAKN---SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN  232 (351)
T ss_dssp             CCCTTCEECCCCSS---SSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccchhccccccccc---ccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999987632111   1122334567899999999884  35799999999999999999999999764

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.4e-41  Score=316.96  Aligned_cols=246  Identities=26%  Similarity=0.410  Sum_probs=190.1

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .++|.+.+.||+|+||.||+|... +|+.||+|+++...   ....+.+.+|+..+++++||||+++++++     ...+
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   84 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI-----STPT   84 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE-----ecCC
Confidence            468889999999999999999976 79999999997542   23346789999999999999999999996     4567


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+++++|.+++...       ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d  154 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICKH-------GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIAD  154 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECC
T ss_pred             eEEEEEeccCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEee
Confidence            899999999999999999753       4589999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccccCC--CCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH--VSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      ||++.....        ........|+..|+|||.+.+.  .+.++||||||+++|||++|+.||......         
T Consensus       155 fg~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------  217 (276)
T 2h6d_A          155 FGLSNMMSD--------GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---------  217 (276)
T ss_dssp             CCGGGCCCC---------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---------
T ss_pred             cccccccCC--------CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---------
Confidence            999976522        1112334689999999999543  378999999999999999999999653111         


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                           ...+.+.....              ..+.           .+...+.+++.+||+.||++|||+.|+++
T Consensus       218 -----~~~~~~~~~~~--------------~~~~-----------~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          218 -----TLFKKIRGGVF--------------YIPE-----------YLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             -----HHHHHHHHCCC--------------CCCT-----------TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----HHHHHhhcCcc--------------cCch-----------hcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                 01111100000              0000           01234788999999999999999999987

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=6e-41  Score=324.00  Aligned_cols=260  Identities=17%  Similarity=0.280  Sum_probs=199.1

Q ss_pred             cHHHHHHhhcCCCCC-CeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCC-CCCcceeeeec
Q 043902          148 SYLKISNATDNFSEE-NLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIR-HRNILKIVSSC  222 (477)
Q Consensus       148 ~~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~  222 (477)
                      .+.......+.|... +.||+|+||.||+|... +++.||+|+++...  ......+.+|+.++.+++ ||||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            334445556677776 88999999999999875 68999999997543  333578899999999995 69999999995


Q ss_pred             ccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec
Q 043902          223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD  302 (477)
Q Consensus       223 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~  302 (477)
                           ...+..++||||+++|+|.+++.....     ..+++..++.++.|++.||.|||++   +|+||||||+||+++
T Consensus        99 -----~~~~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~  165 (327)
T 3lm5_A           99 -----ENTSEIILILEYAAGGEIFSLCLPELA-----EMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLS  165 (327)
T ss_dssp             -----ECSSEEEEEEECCTTEEGGGGGSSCC------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEES
T ss_pred             -----EeCCeEEEEEEecCCCcHHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEe
Confidence                 566789999999999999999865422     5689999999999999999999999   999999999999999


Q ss_pred             C---CCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCccc
Q 043902          303 E---GMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMF  378 (477)
Q Consensus       303 ~---~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~  378 (477)
                      .   ++.+||+|||+++....        ........||+.|+|||++ .+.++.++|||||||++|||+||+.||....
T Consensus       166 ~~~~~~~~kL~Dfg~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  237 (327)
T 3lm5_A          166 SIYPLGDIKIVDFGMSRKIGH--------ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED  237 (327)
T ss_dssp             CBTTBCCEEECCGGGCEEC-----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCCCCCcEEEeeCccccccCC--------ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            7   78999999999987522        1122345689999999999 5578999999999999999999999996532


Q ss_pred             ccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCCh
Q 043902          379 KDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGM  458 (477)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  458 (477)
                      ....             ...+........          ..            ....+...+.+++.+||+.||++|||+
T Consensus       238 ~~~~-------------~~~i~~~~~~~~----------~~------------~~~~~~~~~~~li~~~L~~dP~~Rpt~  282 (327)
T 3lm5_A          238 NQET-------------YLNISQVNVDYS----------EE------------TFSSVSQLATDFIQSLLVKNPEKRPTA  282 (327)
T ss_dssp             HHHH-------------HHHHHHTCCCCC----------TT------------TTTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             chHH-------------HHHHHhcccccC----------ch------------hhcccCHHHHHHHHHHcCCChhhCcCH
Confidence            2110             000000000000          00            000113347899999999999999999


Q ss_pred             HHHHH
Q 043902          459 KFVVN  463 (477)
Q Consensus       459 ~evl~  463 (477)
                      +|+++
T Consensus       283 ~~ll~  287 (327)
T 3lm5_A          283 EICLS  287 (327)
T ss_dssp             HHHTT
T ss_pred             HHHhC
Confidence            99975

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.8e-41  Score=324.42  Aligned_cols=251  Identities=25%  Similarity=0.350  Sum_probs=193.1

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ...++|+..+.||+|+||.||+|... +|+.||+|++....  ..+.+.+|+.++.+++||||+++++++     ...+.
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   98 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSY-----FKNTD   98 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEE-----EETTE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEE-----EeCCE
Confidence            34578999999999999999999875 68999999998643  346789999999999999999999986     34667


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++++|.+++....      ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+||
T Consensus        99 ~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  169 (314)
T 3com_A           99 LWIVMEYCGAGSVSDIIRLRN------KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADF  169 (314)
T ss_dssp             EEEEEECCTTEEHHHHHHHHT------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred             EEEEeecCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeec
Confidence            899999999999999986322      5689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      |++.....       .........|+..|+|||.+ ...++.++||||||+++|||++|+.||........         
T Consensus       170 g~~~~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------  233 (314)
T 3com_A          170 GVAGQLTD-------TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA---------  233 (314)
T ss_dssp             TTCEECBT-------TBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH---------
T ss_pred             ccchhhhh-------hccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH---------
Confidence            99976532       11223345689999999999 55689999999999999999999999965321100         


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                           ...+.....       ....    .+           ......+.+++.+||+.||.+|||+.|+++
T Consensus       234 -----~~~~~~~~~-------~~~~----~~-----------~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          234 -----IFMIPTNPP-------PTFR----KP-----------ELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             -----HHHHHHSCC-------CCCS----SG-----------GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -----HHHHhcCCC-------cccC----Cc-----------ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                 000000000       0000    00           001234789999999999999999999985

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-41  Score=332.86  Aligned_cols=253  Identities=21%  Similarity=0.319  Sum_probs=196.2

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe----CCCCEEEEEEeeecc----chhhHHHHHHHHHHhcC-CCCCcceeeeeccccc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL----ADGETAAIKVLKLQQ----QGALKSFIDECNALTSI-RHRNILKIVSSCSSVD  226 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  226 (477)
                      .++|...+.||+|+||.||+|+.    .+|+.||||+++...    ....+.+.+|++++.++ +||||+++++++    
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~----  128 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF----  128 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE----
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE----
Confidence            46889999999999999999987    378999999987432    23346677899999999 699999999986    


Q ss_pred             CCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCc
Q 043902          227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI  306 (477)
Q Consensus       227 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~  306 (477)
                       ......++||||+++|+|.+++...       ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.
T Consensus       129 -~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~  197 (355)
T 1vzo_A          129 -QTETKLHLILDYINGGELFTHLSQR-------ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGH  197 (355)
T ss_dssp             -EETTEEEEEECCCCSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSC
T ss_pred             -eeCceEEEEeecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCc
Confidence             4566789999999999999999753       4589999999999999999999999   9999999999999999999


Q ss_pred             EEEecccccccccccCCCCCCCccccCCCcccccccCcccccC---CCCcccceeehHHHHHHHhhCCCCCCcccccccc
Q 043902          307 AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLS  383 (477)
Q Consensus       307 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~  383 (477)
                      +||+|||+++.....      .........||..|+|||++.+   .++.++|||||||++|||+||+.||.......  
T Consensus       198 ~kl~DfG~a~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--  269 (355)
T 1vzo_A          198 VVLTDFGLSKEFVAD------ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--  269 (355)
T ss_dssp             EEESCSSEEEECCGG------GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--
T ss_pred             EEEeeCCCCeecccC------CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc--
Confidence            999999999865221      1222334568999999999953   37899999999999999999999996432111  


Q ss_pred             eeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC-----Ch
Q 043902          384 IHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRV-----GM  458 (477)
Q Consensus       384 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~  458 (477)
                                 ....+.........           ..+           .++...+.+++.+||+.||.+||     |+
T Consensus       270 -----------~~~~~~~~~~~~~~-----------~~~-----------~~~~~~~~~li~~~L~~dP~~R~~~~~~s~  316 (355)
T 1vzo_A          270 -----------SQAEISRRILKSEP-----------PYP-----------QEMSALAKDLIQRLLMKDPKKRLGCGPRDA  316 (355)
T ss_dssp             -----------CHHHHHHHHHHCCC-----------CCC-----------TTSCHHHHHHHHHHTCSSGGGSTTSSTTTH
T ss_pred             -----------hHHHHHHHHhccCC-----------CCC-----------cccCHHHHHHHHHHhhhCHHHhcCCCCCCH
Confidence                       01111111000000           000           00123478899999999999999     89


Q ss_pred             HHHHHH
Q 043902          459 KFVVNN  464 (477)
Q Consensus       459 ~evl~~  464 (477)
                      +|+++.
T Consensus       317 ~ell~h  322 (355)
T 1vzo_A          317 DEIKEH  322 (355)
T ss_dssp             HHHHTS
T ss_pred             HHHHcC
Confidence            998863

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.2e-40  Score=316.81  Aligned_cols=253  Identities=23%  Similarity=0.358  Sum_probs=194.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc----chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ----QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      .++|.+.+.||+|+||.||+|... +++.||+|+++...    ......+.+|++++.+++||||+++++++..   ...
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   80 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEK   80 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C--
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCC
Confidence            478999999999999999999975 68999999997542    2345789999999999999999999998632   345


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ...++||||++++ |.+++....     ...+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+
T Consensus        81 ~~~~lv~e~~~~~-l~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~  151 (305)
T 2wtk_C           81 QKMYMVMEYCVCG-MQEMLDSVP-----EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKIS  151 (305)
T ss_dssp             -CEEEEEECCSEE-HHHHHHHST-----TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred             CeEEEEehhccCC-HHHHHHhCc-----ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEee
Confidence            6789999999876 777765432     15689999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccccC---CCCcccceeehHHHHHHHhhCCCCCCcccccccceeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~  387 (477)
                      |||++......     ..........||..|+|||.+.+   ..+.++||||||+++|||++|+.||......       
T Consensus       152 dfg~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------  219 (305)
T 2wtk_C          152 ALGVAEALHPF-----AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-------  219 (305)
T ss_dssp             CCTTCEECCTT-----CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------
T ss_pred             ccccccccCcc-----ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-------
Confidence            99999865321     11222334568999999999854   2478999999999999999999999653111       


Q ss_pred             eeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       388 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                             ...+.+.....              ..+           ..+...+.+++.+||+.||.+|||+.|+++.
T Consensus       220 -------~~~~~i~~~~~--------------~~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          220 -------KLFENIGKGSY--------------AIP-----------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             -------HHHHHHHHCCC--------------CCC-----------SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -------HHHHHHhcCCC--------------CCC-----------CccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                   00111100000              000           0012347899999999999999999999863

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.3e-41  Score=327.91  Aligned_cols=264  Identities=18%  Similarity=0.271  Sum_probs=198.1

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchh-----------------hHHHHHHHHHHhcCCCCCccee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGA-----------------LKSFIDECNALTSIRHRNILKI  218 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~l  218 (477)
                      .++|.+.+.||+|+||.||+|.. +|+.||+|++.......                 .+.+.+|++++.+++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 89999999997543211                 1789999999999999999999


Q ss_pred             eeecccccCCCCceeeEEEeecCCCChhhh------cccCCCcccccccCCHHHHHHHHHHHHHHHHHHHc-CCCCCeee
Q 043902          219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQW------LHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN-QYDTPIAH  291 (477)
Q Consensus       219 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH  291 (477)
                      ++++     ...+..++||||+++|+|.++      +....     ...+++..++.++.|++.||.|||+ .   +|+|
T Consensus       109 ~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H  175 (348)
T 2pml_X          109 EGII-----TNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-----TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICH  175 (348)
T ss_dssp             SEEE-----ESSSEEEEEEECCTTCBSSEESSSEESSCSSS-----CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred             EEEE-----eeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-----ccCCCHHHHHHHHHHHHHHHHHHhccC---CEee
Confidence            9996     456789999999999999999      54321     2578999999999999999999998 8   9999


Q ss_pred             cCCCCCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccccC--CCCc-ccceeehHHHHHHHh
Q 043902          292 CDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSI-LGDIYSYGILLLEIF  368 (477)
Q Consensus       292 ~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~-~~Dv~S~Gvvl~ell  368 (477)
                      |||||+||+++.++.+||+|||.+.....         .......|+..|+|||.+.+  .++. ++|||||||++|||+
T Consensus       176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~  246 (348)
T 2pml_X          176 RDVKPSNILMDKNGRVKLSDFGESEYMVD---------KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF  246 (348)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCEECBT---------TEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHH
T ss_pred             cCCChHhEEEcCCCcEEEecccccccccc---------ccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHH
Confidence            99999999999999999999999986522         12344568999999999943  4555 999999999999999


Q ss_pred             hCCCCCCcccccccceeeeeec--cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhh
Q 043902          369 TGKRPTDDMFKDDLSIHKFVLM--ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVM  446 (477)
Q Consensus       369 tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  446 (477)
                      +|+.||................  .++........+                     ............+...+.+++.+
T Consensus       247 ~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~l~~li~~  305 (348)
T 2pml_X          247 YNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYP---------------------LTNKKSTCSNNFLSNEDIDFLKL  305 (348)
T ss_dssp             HSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTT---------------------TCC--------CCCHHHHHHHHH
T ss_pred             hCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhcc---------------------ccccccccchhhcCHHHHHHHHH
Confidence            9999997533211000000000  000000000000                     00000000001123458899999


Q ss_pred             cCCCCCCCCCChHHHHH
Q 043902          447 CSAASPRDRVGMKFVVN  463 (477)
Q Consensus       447 Cl~~dP~~RPs~~evl~  463 (477)
                      ||+.||.+|||+.|+++
T Consensus       306 ~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          306 FLRKNPAERITSEDALK  322 (348)
T ss_dssp             HCCSSGGGSCCHHHHHT
T ss_pred             HccCChhhCCCHHHHhc
Confidence            99999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.5e-41  Score=331.40  Aligned_cols=286  Identities=19%  Similarity=0.234  Sum_probs=196.6

Q ss_pred             HHhhcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccC----
Q 043902          153 SNATDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDY----  227 (477)
Q Consensus       153 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----  227 (477)
                      ....++|+..+.||+|+||.||+|+. .+|+.||+|++.....    ...+|++++++++||||+++++++.....    
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            34567899999999999999999986 4799999999875432    23479999999999999999998743221    


Q ss_pred             -----------------------------CCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHH
Q 043902          228 -----------------------------EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL  278 (477)
Q Consensus       228 -----------------------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L  278 (477)
                                                   ......++||||++ |+|.+.+.....   ....+++..+..++.|+++||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~aL  154 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR---SGRSIPMNLISIYIYQLFRAV  154 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh---cCCCCCHHHHHHHHHHHHHHH
Confidence                                         33455889999997 588777753110   125689999999999999999


Q ss_pred             HHHHcCCCCCeeecCCCCCCeEec-CCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccccC--CCCccc
Q 043902          279 DYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILG  355 (477)
Q Consensus       279 ~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~  355 (477)
                      .|||+.   +|+||||||+||+++ .++.+||+|||+++....        ........||..|+|||.+.+  .++.++
T Consensus       155 ~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~  223 (383)
T 3eb0_A          155 GFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP--------SEPSVAYICSRFYRAPELMLGATEYTPSI  223 (383)
T ss_dssp             HHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCT--------TSCCCCCCCCSSCCCHHHHTTCSSCCTHH
T ss_pred             HHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCC--------CCCCcCcccCCCccCHHHhcCCCCCCcch
Confidence            999999   999999999999998 688999999999986522        112234567999999999843  589999


Q ss_pred             ceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCchhHHHh--hhhhhhhhcccccccccccccchhhh-HHHHHH
Q 043902          356 DIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVL--DLSMLLEEENDHEKHEEEDLFPDIES-QVAQKK  432 (477)
Q Consensus       356 Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--d~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  432 (477)
                      |||||||++|||++|+.||......+. +...+...-......+.  ++...            +..++.... ......
T Consensus       224 DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~g~p~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~  290 (383)
T 3eb0_A          224 DLWSIGCVFGELILGKPLFSGETSIDQ-LVRIIQIMGTPTKEQMIRMNPHYT------------EVRFPTLKAKDWRKIL  290 (383)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHHHCTTC--------------CCCCCCCCCCHHHHS
T ss_pred             hhhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHHhCcccc------------cccCCccCcccHHhhC
Confidence            999999999999999999976422211 00000000000000000  00000            000000000 000111


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCCCChHHHHH--HHHHHHH
Q 043902          433 LEECLVSVMRIGVMCSAASPRDRVGMKFVVN--NLQAIRS  470 (477)
Q Consensus       433 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~i~~  470 (477)
                      .+.+...+.+|+.+||+.||.+|||+.|+++  .++.++.
T Consensus       291 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             CTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred             CCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence            1112344889999999999999999999984  4555544

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4.7e-41  Score=336.24  Aligned_cols=198  Identities=24%  Similarity=0.330  Sum_probs=167.2

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcC------CCCCcceeeeecccccC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSI------RHRNILKIVSSCSSVDY  227 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~  227 (477)
                      ...+|++.+.||+|+||.||+|... +++.||||+++... .....+.+|++++..+      +|+||+++++++     
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~-----  168 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF-----  168 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE-----
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeec-----
Confidence            3567999999999999999999865 68999999997543 2335677788877776      577999999986     


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCc-
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI-  306 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~-  306 (477)
                      ......++||||+. ++|.+++.....     ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++. 
T Consensus       169 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~  239 (429)
T 3kvw_A          169 TFRNHICMTFELLS-MNLYELIKKNKF-----QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRS  239 (429)
T ss_dssp             EETTEEEEEECCCC-CBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSC
T ss_pred             ccCCeEEEEEeccC-CCHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCc
Confidence            44678999999995 699998876532     4589999999999999999999999   9999999999999999887 


Q ss_pred             -EEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          307 -AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       307 -~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                       +||+|||+++...          .......||+.|+|||++ ...++.++|||||||++|||+||+.||...
T Consensus       240 ~vkL~DFG~a~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          240 GIKVIDFGSSCYEH----------QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             CEEECCCTTCEETT----------CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ceEEeecccceecC----------CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence             9999999997541          112345789999999999 557999999999999999999999999764

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=8.4e-41  Score=326.56  Aligned_cols=211  Identities=25%  Similarity=0.342  Sum_probs=173.2

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ..++|...+.||+|+||.||+|+.. +|+.||||+++... ......+.+|++++++++||||+++++++....+.....
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            3578899999999999999999975 68999999997443 334467889999999999999999999976544555678


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+. |+|.+++..        ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+||
T Consensus        89 ~~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Df  156 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST--------QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDF  156 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEeccC-ccHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEec
Confidence            999999996 699998864        3489999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCC---CccccCCCcccccccCcccc-c-CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          313 GLAKFLFEESNTPSK---NQTMSNGLKGSVGYIPPEYI-N-GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       313 G~a~~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~-~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      |+++...........   .........||..|+|||.+ . +.++.++|||||||++|||++|+.||...
T Consensus       157 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  226 (353)
T 2b9h_A          157 GLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR  226 (353)
T ss_dssp             TTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999876332111100   01122345789999999987 3 56899999999999999999999999764

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.1e-41  Score=352.78  Aligned_cols=259  Identities=22%  Similarity=0.392  Sum_probs=200.6

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC----CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA----DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      .++|...+.||+|+||.||+|.+.    .+..||+|.++... ....+.+.+|+.++.+++||||+++++++.      .
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------~  462 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------E  462 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC------S
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe------c
Confidence            355677788999999999999864    24579999987543 334578999999999999999999999862      3


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +..++||||+++|+|.+++....      ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~  533 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVRK------FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLG  533 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTT------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEEC
T ss_pred             CceEEEEEcCCCCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEE
Confidence            45799999999999999997543      4589999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~  388 (477)
                      |||+++.....      .........+|+.|+|||.+ .+.++.++|||||||++|||++ |..||......+       
T Consensus       534 DFG~a~~~~~~------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-------  600 (656)
T 2j0j_A          534 DFGLSRYMEDS------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------  600 (656)
T ss_dssp             CCCCCCSCCC----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------
T ss_pred             ecCCCeecCCC------cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH-------
Confidence            99999875221      11122334567899999999 5679999999999999999997 999997532211       


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                             +...+......             ..+           ..++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       601 -------~~~~i~~~~~~-------------~~~-----------~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          601 -------VIGRIENGERL-------------PMP-----------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             -------HHHHHHHTCCC-------------CCC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------HHHHHHcCCCC-------------CCC-----------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                   00101000000             000           01134488999999999999999999999999999


Q ss_pred             HHhhh
Q 043902          469 RSKIR  473 (477)
Q Consensus       469 ~~~~~  473 (477)
                      .++..
T Consensus       650 l~~~k  654 (656)
T 2j0j_A          650 LEEEK  654 (656)
T ss_dssp             HHHHH
T ss_pred             HHHhc
Confidence            87644

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.1e-41  Score=334.89  Aligned_cols=265  Identities=11%  Similarity=0.019  Sum_probs=180.3

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc---hhhHHHHHHH---HHHhcCCCCCcceeeeec------
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ---GALKSFIDEC---NALTSIRHRNILKIVSSC------  222 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~h~niv~l~~~~------  222 (477)
                      ..+|...+.||+|+||.||+|+.. +|+.||||+++....   ...+.+.+|+   +.|.. +||||++++..+      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence            445888999999999999999965 789999999986542   3345677774   55555 799988855322      


Q ss_pred             -ccccC------------CCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHH------HHHHHHHHHHHHHHHc
Q 043902          223 -SSVDY------------EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQR------LNIVIDVASALDYLHN  283 (477)
Q Consensus       223 -~~~~~------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~------~~i~~~ia~~L~~LH~  283 (477)
                       .....            ......++||||++ |+|.+++....      ..+.+..+      +.++.||+.||+|||+
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~------~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~  212 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD------FVYVFRGDEGILALHILTAQLIRLAANLQS  212 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH------HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc------cccchhhhhhhhhHHHHHHHHHHHHHHHHH
Confidence             11000            00145899999998 89999997542      23445555      7888999999999999


Q ss_pred             CCCCCeeecCCCCCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCccccc---CCCCcccceeeh
Q 043902          284 QYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN---GHVSILGDIYSY  360 (477)
Q Consensus       284 ~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~Dv~S~  360 (477)
                      +   +|+||||||+|||++.++.+||+|||+++....          ......+|..|+|||++.   ..++.++|||||
T Consensus       213 ~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSl  279 (371)
T 3q60_A          213 K---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----------RGPASSVPVTYAPREFLNASTATFTHALNAWQL  279 (371)
T ss_dssp             T---TEEETTCSGGGEEECTTSCEEECCGGGEEETTC----------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHH
T ss_pred             C---CCccCcCCHHHEEECCCCCEEEEecceeeecCC----------CccCccCCcCCcChhhccCCCCCcCccccHHHH
Confidence            9   999999999999999999999999999986521          111345679999999994   368999999999


Q ss_pred             HHHHHHHhhCCCCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHH
Q 043902          361 GILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSV  440 (477)
Q Consensus       361 Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  440 (477)
                      ||++|||+||+.||..............  ....    ....               ...++..         ..+...+
T Consensus       280 G~il~elltg~~Pf~~~~~~~~~~~~~~--~~~~----~~~~---------------~~~~~~~---------~~~~~~~  329 (371)
T 3q60_A          280 GLSIYRVWCLFLPFGLVTPGIKGSWKRP--SLRV----PGTD---------------SLAFGSC---------TPLPDFV  329 (371)
T ss_dssp             HHHHHHHHHSSCSTTBCCTTCTTCCCBC--CTTS----CCCC---------------SCCCTTS---------SCCCHHH
T ss_pred             HHHHHHHHhCCCCCCCcCcccccchhhh--hhhh----cccc---------------ccchhhc---------cCCCHHH
Confidence            9999999999999976532211100000  0000    0000               0000000         0012348


Q ss_pred             HHHhhhcCCCCCCCCCChHHHHH--HHHHHHHh
Q 043902          441 MRIGVMCSAASPRDRVGMKFVVN--NLQAIRSK  471 (477)
Q Consensus       441 ~~l~~~Cl~~dP~~RPs~~evl~--~L~~i~~~  471 (477)
                      .+++.+||+.||++|||+.|+++  .++++...
T Consensus       330 ~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  362 (371)
T 3q60_A          330 KTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNE  362 (371)
T ss_dssp             HHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHH
T ss_pred             HHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHH
Confidence            89999999999999999999985  45555444

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.2e-41  Score=321.49  Aligned_cols=206  Identities=21%  Similarity=0.332  Sum_probs=166.4

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeeccccc--------
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVD--------  226 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------  226 (477)
                      .++|...+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++....        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            468889999999999999999976 58999999998776666788999999999999999999999864221        


Q ss_pred             -CCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec-CC
Q 043902          227 -YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD-EG  304 (477)
Q Consensus       227 -~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~-~~  304 (477)
                       .......++||||++ |+|.+++..        ..+++..++.++.|++.||.|||++   +|+||||||+||+++ ++
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~  157 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ--------GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTED  157 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTT
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc--------CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCC
Confidence             234567899999997 699999864        3488999999999999999999999   999999999999997 56


Q ss_pred             CcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-c-CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          305 MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-N-GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       305 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      +.+||+|||+++.......    .........+|..|+|||.+ . +.++.++|||||||++|||+||+.||...
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  228 (320)
T 2i6l_A          158 LVLKIGDFGLARIMDPHYS----HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA  228 (320)
T ss_dssp             TEEEECCCTTCBCC------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CeEEEccCccccccCCCcc----cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCC
Confidence            7999999999986532110    11122334578899999988 3 56899999999999999999999999754

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.9e-41  Score=318.43  Aligned_cols=246  Identities=19%  Similarity=0.274  Sum_probs=193.3

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~  230 (477)
                      ..++|+..+.||+|+||.||+|... +++.||+|+++...  ......+.+|+..+.++ +||||+++++++     ...
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~-----~~~   83 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW-----AED   83 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEE-----EET
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeee-----ecC
Confidence            3567889999999999999999976 79999999998542  33456788999999999 999999999996     456


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC-------
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE-------  303 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-------  303 (477)
                      +..++||||+++++|.+++.....   ....+++..++.++.|++.||.|||++   +|+||||||+||+++.       
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~  157 (289)
T 1x8b_A           84 DHMLIQNEYCNGGSLADAISENYR---IMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAA  157 (289)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------
T ss_pred             CeEEEEEEecCCCcHHHHHHhhcc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccc
Confidence            689999999999999999975321   114589999999999999999999999   9999999999999984       


Q ss_pred             ------------CCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccccC--CCCcccceeehHHHHHHHhh
Q 043902          304 ------------GMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFT  369 (477)
Q Consensus       304 ------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~ellt  369 (477)
                                  ...+||+|||.+.....           .....||..|+|||.+.+  .++.++|||||||++|||++
T Consensus       158 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  226 (289)
T 1x8b_A          158 SEEGDEDDWASNKVMFKIGDLGHVTRISS-----------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAG  226 (289)
T ss_dssp             ------------CCCEEECCCTTCEETTC-----------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTT
T ss_pred             ccccccccccCCceEEEEcccccccccCC-----------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhc
Confidence                        44799999999986521           112358999999999944  46789999999999999999


Q ss_pred             CCCCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCC
Q 043902          370 GKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSA  449 (477)
Q Consensus       370 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~  449 (477)
                      |.+|+.....                ...+...... .             .+.           .+...+.+++.+||+
T Consensus       227 ~~~~~~~~~~----------------~~~~~~~~~~-~-------------~~~-----------~~~~~~~~li~~~l~  265 (289)
T 1x8b_A          227 AEPLPRNGDQ----------------WHEIRQGRLP-R-------------IPQ-----------VLSQEFTELLKVMIH  265 (289)
T ss_dssp             CCCCCSSSHH----------------HHHHHTTCCC-C-------------CSS-----------CCCHHHHHHHHHHTC
T ss_pred             CCCCCcchhH----------------HHHHHcCCCC-C-------------CCc-----------ccCHHHHHHHHHHhC
Confidence            9987643210                0111100000 0             000           012347899999999


Q ss_pred             CCCCCCCChHHHHH
Q 043902          450 ASPRDRVGMKFVVN  463 (477)
Q Consensus       450 ~dP~~RPs~~evl~  463 (477)
                      .||++|||+.|+++
T Consensus       266 ~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          266 PDPERRPSAMALVK  279 (289)
T ss_dssp             SSGGGSCCHHHHHT
T ss_pred             CCcccCCCHHHHhh
Confidence            99999999999985

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.7e-41  Score=325.73  Aligned_cols=251  Identities=22%  Similarity=0.298  Sum_probs=191.6

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--------chhhHHHHHHHHHHhcCCCCCcceeeeecccc
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--------QGALKSFIDECNALTSIRHRNILKIVSSCSSV  225 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  225 (477)
                      ..++|.+.+.||+|+||.||+|... +++.||||++....        ......+.+|++++++++||||+++++++.  
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--   85 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD--   85 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc--
Confidence            3467889999999999999999875 68899999986432        122345889999999999999999999863  


Q ss_pred             cCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC
Q 043902          226 DYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM  305 (477)
Q Consensus       226 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~  305 (477)
                         .. ..++||||+++++|.+++...       ..+++..++.++.|++.||.|||++   +|+||||||+||+++.++
T Consensus        86 ---~~-~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~  151 (322)
T 2ycf_A           86 ---AE-DYYIVLELMEGGELFDKVVGN-------KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQE  151 (322)
T ss_dssp             ---SS-SEEEEEECCTTEETHHHHSTT-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSS
T ss_pred             ---CC-ceEEEEecCCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCC
Confidence               22 379999999999999998754       4689999999999999999999999   999999999999998765


Q ss_pred             c---EEEecccccccccccCCCCCCCccccCCCcccccccCcccc----cCCCCcccceeehHHHHHHHhhCCCCCCccc
Q 043902          306 I---AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI----NGHVSILGDIYSYGILLLEIFTGKRPTDDMF  378 (477)
Q Consensus       306 ~---~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~  378 (477)
                      .   +||+|||+++....        ........||..|+|||++    ...++.++|||||||++|||++|+.||....
T Consensus       152 ~~~~~kl~Dfg~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  223 (322)
T 2ycf_A          152 EDCLIKITDFGHSKILGE--------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR  223 (322)
T ss_dssp             SSCCEEECCCTTCEECCC--------CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred             CCCeEEEccCccceeccc--------ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            4   99999999986521        1112234689999999997    3468999999999999999999999996532


Q ss_pred             ccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCCh
Q 043902          379 KDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGM  458 (477)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  458 (477)
                      ...             .+.+.+.....             ...        .+....+...+.+++.+||+.||++|||+
T Consensus       224 ~~~-------------~~~~~~~~~~~-------------~~~--------~~~~~~~~~~~~~li~~~l~~dP~~Rps~  269 (322)
T 2ycf_A          224 TQV-------------SLKDQITSGKY-------------NFI--------PEVWAEVSEKALDLVKKLLVVDPKARFTT  269 (322)
T ss_dssp             CSS-------------CHHHHHHHTCC-------------CCC--------HHHHTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             hHH-------------HHHHHHHhCcc-------------ccC--------chhhhhcCHHHHHHHHHHcccCHhhCCCH
Confidence            211             01111100000             000        00011123458899999999999999999


Q ss_pred             HHHHH
Q 043902          459 KFVVN  463 (477)
Q Consensus       459 ~evl~  463 (477)
                      .|+++
T Consensus       270 ~~~l~  274 (322)
T 2ycf_A          270 EEALR  274 (322)
T ss_dssp             HHHHT
T ss_pred             HHHhh
Confidence            99984

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.8e-41  Score=329.17  Aligned_cols=289  Identities=20%  Similarity=0.219  Sum_probs=188.2

Q ss_pred             HHHHHhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccC-
Q 043902          150 LKISNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDY-  227 (477)
Q Consensus       150 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-  227 (477)
                      .......++|.+.+.||+|+||.||+|+.. +|+.||||++..... ....+.++++.+..++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            345567789999999999999999999975 689999999865432 23567788888999999999999999754321 


Q ss_pred             -CCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHH--cCCCCCeeecCCCCCCeEecC-
Q 043902          228 -EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH--NQYDTPIAHCDLKSSNVLLDE-  303 (477)
Q Consensus       228 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--~~~~~~ivH~dlkp~NIll~~-  303 (477)
                       ......++||||+++ +|...+....   .....+++..+..++.|++.||.|||  +.   +|+||||||+||+++. 
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~  167 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYY---RRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEA  167 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETT
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHh---hcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCC
Confidence             223347899999976 5444333210   01256889999999999999999999  77   9999999999999996 


Q ss_pred             CCcEEEecccccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCcccccc
Q 043902          304 GMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD  381 (477)
Q Consensus       304 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~  381 (477)
                      ++.+||+|||+++....        ........||..|+|||++.  ..++.++|||||||++|||+||+.||.......
T Consensus       168 ~~~~kl~Dfg~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  239 (360)
T 3e3p_A          168 DGTLKLCDFGSAKKLSP--------SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG  239 (360)
T ss_dssp             TTEEEECCCTTCBCCCT--------TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             CCcEEEeeCCCceecCC--------CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH
Confidence            89999999999986532        11223456899999999983  348999999999999999999999997632211


Q ss_pred             cceeeeeecc--CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChH
Q 043902          382 LSIHKFVLMA--LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMK  459 (477)
Q Consensus       382 ~~~~~~~~~~--~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~  459 (477)
                      . +.......  .+......+++..................++.        ........+.+|+.+||+.||.+|||+.
T Consensus       240 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~L~~dP~~Rpt~~  310 (360)
T 3e3p_A          240 Q-LHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSD--------HSLKDAKEAYDLLSALLQYLPEERMKPY  310 (360)
T ss_dssp             H-HHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTT--------CCCTTHHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             H-HHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccch--------hhccccHHHHHHHHHHhccCccccCCHH
Confidence            1 10000000  00011111111100000000000000000000        0001234588999999999999999999


Q ss_pred             HHHH
Q 043902          460 FVVN  463 (477)
Q Consensus       460 evl~  463 (477)
                      |+++
T Consensus       311 e~l~  314 (360)
T 3e3p_A          311 EALC  314 (360)
T ss_dssp             HHTT
T ss_pred             HHhc
Confidence            9985

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=6.2e-41  Score=323.74  Aligned_cols=207  Identities=24%  Similarity=0.406  Sum_probs=171.7

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEEe--CCCCEEEEEEeeeccc--hhhHHHHHHHHHHhcC---CCCCcceeeeeccccc
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGTL--ADGETAAIKVLKLQQQ--GALKSFIDECNALTSI---RHRNILKIVSSCSSVD  226 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~  226 (477)
                      ...++|+..+.||+|+||.||+|+.  .+|+.||+|+++....  .....+.+|+.+++++   +||||++++++|....
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            3567899999999999999999997  3688999999975432  2234566777776665   8999999999975333


Q ss_pred             CCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCc
Q 043902          227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI  306 (477)
Q Consensus       227 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~  306 (477)
                      .......++||||+. |+|.+++.....     ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~  158 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPE-----PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQ  158 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCC
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhccc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCC
Confidence            335677899999997 699999875432     4589999999999999999999999   9999999999999999999


Q ss_pred             EEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          307 AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       307 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      +||+|||+++....        ........||..|+|||.+ .+.++.++|||||||++|||+||+.||...
T Consensus       159 ~kl~Dfg~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  222 (326)
T 1blx_A          159 IKLADFGLARIYSF--------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS  222 (326)
T ss_dssp             EEECSCCSCCCCCG--------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             EEEecCcccccccC--------CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence            99999999976521        1223445789999999999 567899999999999999999999999753

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.2e-40  Score=350.29  Aligned_cols=201  Identities=24%  Similarity=0.351  Sum_probs=174.2

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec---cchhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ---QQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEG  229 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  229 (477)
                      ..++|+..+.||+|+||.||+|+.. +++.||||+++..   .....+.+..|..++..+ +||+|+++++++     .+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~  413 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT  413 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BC
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----Ee
Confidence            3468899999999999999999975 6889999999853   234457788999999988 799999999984     66


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEE
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV  309 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl  309 (477)
                      .+..++||||+++|+|.+++...       ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||
T Consensus       414 ~~~~~lV~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL  483 (674)
T 3pfq_A          414 MDRLYFVMEYVNGGDLMYHIQQV-------GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKI  483 (674)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEE
T ss_pred             CCEEEEEEeCcCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEE
Confidence            77899999999999999999754       4589999999999999999999999   9999999999999999999999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      +|||+++....       .........||+.|+|||++ ...++.++|||||||++|||++|+.||...
T Consensus       484 ~DFGla~~~~~-------~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~  545 (674)
T 3pfq_A          484 ADFGMCKENIW-------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE  545 (674)
T ss_dssp             CCCTTCEECCC-------TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eecceeecccc-------CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC
Confidence            99999986421       12223456799999999999 567999999999999999999999999753

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4e-41  Score=329.84  Aligned_cols=201  Identities=25%  Similarity=0.354  Sum_probs=154.3

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec--cchhhHHHHHHHHHHhcCCCCCcceeeeeccccc-CCCC
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSSCSSVD-YEGN  230 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~~  230 (477)
                      ..++|...+.||+|+||.||+|... +|+.||||++...  .....+.+.+|++++++++||||+++++++.... ....
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            3478999999999999999999864 7899999999753  2334567889999999999999999999974321 1233


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ...++|+||+ +++|.+++..        ..+++..+..++.||++||.|||+.   +|+||||||+||+++.++.+||+
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~  174 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKC--------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL  174 (367)
T ss_dssp             CCCEEEEECC-CEECC-------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CeEEEEeccc-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEe
Confidence            5679999999 7899988864        3489999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      |||+++....          ......||..|+|||.+.  ..++.++|||||||++|||++|+.||...
T Consensus       175 DFG~a~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  233 (367)
T 2fst_X          175 DFGLARHTAD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT  233 (367)
T ss_dssp             C-------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             eccccccccc----------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999986421          123457899999999984  46899999999999999999999999753

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=328.02  Aligned_cols=261  Identities=23%  Similarity=0.316  Sum_probs=196.8

Q ss_pred             HHHHHhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcC-CCCCcceeeeecccccC
Q 043902          150 LKISNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDY  227 (477)
Q Consensus       150 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  227 (477)
                      .++....++|+..+.||+|+||.||+|+.. +|+.||+|++..... ....+.+|+.++.++ +||||+++++++.....
T Consensus        17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   95 (326)
T 2x7f_A           17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP   95 (326)
T ss_dssp             CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred             hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence            344556789999999999999999999974 789999999975543 347889999999999 79999999999753211


Q ss_pred             -CCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCc
Q 043902          228 -EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI  306 (477)
Q Consensus       228 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~  306 (477)
                       ...+..++||||+++|+|.+++....     ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~  167 (326)
T 2x7f_A           96 PGMDDQLWLVMEFCGAGSVTDLIKNTK-----GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAE  167 (326)
T ss_dssp             -CCCCEEEEEEECCTTEEHHHHHHHSG-----GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCC
T ss_pred             ccccceEEEEEEcCCCCcHHHHHHhcc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCC
Confidence             11567899999999999999997542     24689999999999999999999999   9999999999999999999


Q ss_pred             EEEecccccccccccCCCCCCCccccCCCcccccccCccccc------CCCCcccceeehHHHHHHHhhCCCCCCccccc
Q 043902          307 AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN------GHVSILGDIYSYGILLLEIFTGKRPTDDMFKD  380 (477)
Q Consensus       307 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~  380 (477)
                      +||+|||++.....       .........||..|+|||.+.      +.++.++|||||||++|||+||+.||......
T Consensus       168 ~kl~Dfg~~~~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~  240 (326)
T 2x7f_A          168 VKLVDFGVSAQLDR-------TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM  240 (326)
T ss_dssp             EEECCCTTTC--------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred             EEEeeCcCceecCc-------CccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH
Confidence            99999999976522       111223456899999999984      35889999999999999999999999653211


Q ss_pred             ccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHH
Q 043902          381 DLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKF  460 (477)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e  460 (477)
                      ..             ...+......        ...    .+            .+...+.+++.+||+.||.+|||+.|
T Consensus       241 ~~-------------~~~~~~~~~~--------~~~----~~------------~~~~~l~~li~~~l~~dp~~Rps~~~  283 (326)
T 2x7f_A          241 RA-------------LFLIPRNPAP--------RLK----SK------------KWSKKFQSFIESCLVKNHSQRPATEQ  283 (326)
T ss_dssp             HH-------------HHHHHHSCCC--------CCS----CS------------CSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             HH-------------HHHhhcCccc--------cCC----cc------------ccCHHHHHHHHHHhccChhhCCCHHH
Confidence            00             0000000000        000    00            01234789999999999999999999


Q ss_pred             HHH
Q 043902          461 VVN  463 (477)
Q Consensus       461 vl~  463 (477)
                      +++
T Consensus       284 ll~  286 (326)
T 2x7f_A          284 LMK  286 (326)
T ss_dssp             HHT
T ss_pred             Hhh
Confidence            986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=9.6e-42  Score=325.83  Aligned_cols=271  Identities=22%  Similarity=0.335  Sum_probs=181.5

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      ...++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++.+++||||+++++++     ...+
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   86 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF-----VVKD   86 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEE-----ESSS
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEE-----eecC
Confidence            34578999999999999999999864 78999999987543 33456788999999999999999999996     3456


Q ss_pred             eeeEEEeecCCCChhhhcccCCCc-ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDE-YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      ..++||||+++++|.+++...... ......+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~  163 (303)
T 2vwi_A           87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIA  163 (303)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred             CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEE
Confidence            789999999999999998641100 00125689999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~  388 (477)
                      |||++.........  ..........||..|+|||.+.  ..++.++|||||||++|||+||+.||.........     
T Consensus       164 dfg~~~~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----  236 (303)
T 2vwi_A          164 DFGVSAFLATGGDI--TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL-----  236 (303)
T ss_dssp             CCHHHHHCC-----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH-----
T ss_pred             eccchheeccCCCc--cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH-----
Confidence            99999765321110  0111223456899999999983  46899999999999999999999999753221100     


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                              .........    ............            ..+...+.+++.+||+.||.+|||+.|+++
T Consensus       237 --------~~~~~~~~~----~~~~~~~~~~~~------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          237 --------MLTLQNDPP----SLETGVQDKEML------------KKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             --------HHHHTSSCC----CTTC-----CCC------------CCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             --------HHHhccCCC----ccccccccchhh------------hhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence                    000000000    000000000000            001234789999999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6.8e-42  Score=329.45  Aligned_cols=263  Identities=21%  Similarity=0.332  Sum_probs=195.6

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ..++|+..+.||+|+||.||+|+..+  .+|+|+++...  ....+.+.+|+.++.+++||||+++++++     ...+.
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~  103 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC-----MSPPH  103 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEE-----ECSSC
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEE-----ecCCc
Confidence            45789999999999999999999753  59999987542  23345678899999999999999999996     34567


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++++|.+++....      ..+++..++.++.|++.||.|||++   +++||||||+||+++ ++.+||+||
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Df  173 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAK------IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDF  173 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSC------CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCC
T ss_pred             eEEEeecccCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeec
Confidence            899999999999999997643      4689999999999999999999999   999999999999998 679999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccccC----------CCCcccceeehHHHHHHHhhCCCCCCccccccc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING----------HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDL  382 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~  382 (477)
                      |++.........  ..........|+..|+|||.+.+          .++.++|||||||++|||+||+.||....... 
T Consensus       174 g~~~~~~~~~~~--~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-  250 (319)
T 2y4i_B          174 GLFSISGVLQAG--RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-  250 (319)
T ss_dssp             SCCC------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-
T ss_pred             CCcccccccccc--ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence            998764221111  11222334568999999999842          36889999999999999999999997532211 


Q ss_pred             ceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHH
Q 043902          383 SIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVV  462 (477)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl  462 (477)
                                   ....+.......      ..  .   .            .+...+.+++.+||+.||++|||+.|++
T Consensus       251 -------------~~~~~~~~~~~~------~~--~---~------------~~~~~l~~li~~~l~~~p~~Rpt~~~l~  294 (319)
T 2y4i_B          251 -------------IIWQMGTGMKPN------LS--Q---I------------GMGKEISDILLFCWAFEQEERPTFTKLM  294 (319)
T ss_dssp             -------------HHHHHHTTCCCC------CC--C---S------------SCCTTHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred             -------------HHHHhccCCCCC------CC--c---C------------CCCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence                         000000000000      00  0   0            0012378999999999999999999999


Q ss_pred             HHHHHHHHhhh
Q 043902          463 NNLQAIRSKIR  473 (477)
Q Consensus       463 ~~L~~i~~~~~  473 (477)
                      +.|+++.++..
T Consensus       295 ~~l~~l~~~~~  305 (319)
T 2y4i_B          295 DMLEKLPKRNR  305 (319)
T ss_dssp             HHHTTC-----
T ss_pred             HHHHHHHHhhc
Confidence            99999887754

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.9e-40  Score=316.10  Aligned_cols=252  Identities=22%  Similarity=0.325  Sum_probs=197.9

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---------chhhHHHHHHHHHHhcCC-CCCcceeeeec
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---------QGALKSFIDECNALTSIR-HRNILKIVSSC  222 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~  222 (477)
                      ...++|...+.||+|+||.||+|... +|+.||+|+++...         ....+.+.+|++++.++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            34578999999999999999999975 68999999997543         123467889999999995 99999999996


Q ss_pred             ccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec
Q 043902          223 SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD  302 (477)
Q Consensus       223 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~  302 (477)
                           ......++||||+++++|.+++...       ..+++..++.++.|++.||.|||+.   +++||||||+||+++
T Consensus        94 -----~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~  158 (298)
T 1phk_A           94 -----ETNTFFFLVFDLMKKGELFDYLTEK-------VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLD  158 (298)
T ss_dssp             -----ECSSEEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred             -----ccCCeEEEEEeccCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEc
Confidence                 5567899999999999999999743       4689999999999999999999999   999999999999999


Q ss_pred             CCCcEEEecccccccccccCCCCCCCccccCCCcccccccCccccc-------CCCCcccceeehHHHHHHHhhCCCCCC
Q 043902          303 EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-------GHVSILGDIYSYGILLLEIFTGKRPTD  375 (477)
Q Consensus       303 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~Dv~S~Gvvl~elltg~~p~~  375 (477)
                      .++.+||+|||++.....        ........|+..|+|||.+.       ..++.++||||||+++|||++|+.||.
T Consensus       159 ~~~~~kl~dfg~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  230 (298)
T 1phk_A          159 DDMNIKLTDFGFSCQLDP--------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW  230 (298)
T ss_dssp             TTCCEEECCCTTCEECCT--------TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCCcEEEecccchhhcCC--------CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCc
Confidence            999999999999986522        11223456899999999873       347899999999999999999999996


Q ss_pred             cccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCC
Q 043902          376 DMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDR  455 (477)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R  455 (477)
                      ......             ....+........             .+.         ...+...+.+++.+||+.||++|
T Consensus       231 ~~~~~~-------------~~~~~~~~~~~~~-------------~~~---------~~~~~~~l~~li~~~l~~dp~~R  275 (298)
T 1phk_A          231 HRKQML-------------MLRMIMSGNYQFG-------------SPE---------WDDYSDTVKDLVSRFLVVQPQKR  275 (298)
T ss_dssp             CSSHHH-------------HHHHHHHTCCCCC-------------TTT---------GGGSCHHHHHHHHHHCCSSGGGS
T ss_pred             CccHHH-------------HHHHHhcCCcccC-------------ccc---------ccccCHHHHHHHHHHccCCcccC
Confidence            532110             0000110000000             000         00113348899999999999999


Q ss_pred             CChHHHHH
Q 043902          456 VGMKFVVN  463 (477)
Q Consensus       456 Ps~~evl~  463 (477)
                      ||+.|+++
T Consensus       276 ps~~~ll~  283 (298)
T 1phk_A          276 YTAEEALA  283 (298)
T ss_dssp             CCHHHHTT
T ss_pred             CCHHHHHh
Confidence            99999985

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.2e-41  Score=326.81  Aligned_cols=256  Identities=24%  Similarity=0.406  Sum_probs=194.9

Q ss_pred             HHHHHhhcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeecc--chhhHHHHHHHHHHhcCC--CCCcceeeeecccc
Q 043902          150 LKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIR--HRNILKIVSSCSSV  225 (477)
Q Consensus       150 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~  225 (477)
                      ..+....++|++.+.||+|+||.||++...+++.||+|++....  ....+.+.+|++++.+++  |+||+++++++   
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~---   97 (313)
T 3cek_A           21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE---   97 (313)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE---
T ss_pred             eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe---
Confidence            33445567899999999999999999998889999999997543  334578899999999997  59999999986   


Q ss_pred             cCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC
Q 043902          226 DYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM  305 (477)
Q Consensus       226 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~  305 (477)
                        ...+..++||| +.+++|.+++...       ..+++..++.++.|++.||.|||+.   +|+||||||+||++++ +
T Consensus        98 --~~~~~~~lv~e-~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~  163 (313)
T 3cek_A           98 --ITDQYIYMVME-CGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-G  163 (313)
T ss_dssp             --ECSSEEEEEEC-CCSEEHHHHHHHC-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-T
T ss_pred             --ecCCEEEEEEe-cCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-C
Confidence              45667999999 5688999999754       4689999999999999999999999   9999999999999975 7


Q ss_pred             cEEEecccccccccccCCCCCCCccccCCCcccccccCcccccC------------CCCcccceeehHHHHHHHhhCCCC
Q 043902          306 IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING------------HVSILGDIYSYGILLLEIFTGKRP  373 (477)
Q Consensus       306 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------------~~~~~~Dv~S~Gvvl~elltg~~p  373 (477)
                      .+||+|||++.......     .........||..|+|||.+.+            .++.++|||||||++|||++|+.|
T Consensus       164 ~~kL~Dfg~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p  238 (313)
T 3cek_A          164 MLKLIDFGIANQMQPDT-----TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP  238 (313)
T ss_dssp             EEEECCCSSSCC-------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             eEEEeeccccccccCcc-----ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCc
Confidence            99999999998653211     1112234568999999999843            688899999999999999999999


Q ss_pred             CCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCC
Q 043902          374 TDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPR  453 (477)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~  453 (477)
                      |........            .+...+++.....             ++..           +...+.+++.+||+.||.
T Consensus       239 f~~~~~~~~------------~~~~~~~~~~~~~-------------~~~~-----------~~~~l~~li~~~l~~dp~  282 (313)
T 3cek_A          239 FQQIINQIS------------KLHAIIDPNHEIE-------------FPDI-----------PEKDLQDVLKCCLKRDPK  282 (313)
T ss_dssp             TTTCCSHHH------------HHHHHHCTTSCCC-------------CCCC-----------SCHHHHHHHHHHTCSSTT
T ss_pred             hhhHHHHHH------------HHHHHHhcccccC-------------Cccc-----------chHHHHHHHHHHccCCcc
Confidence            965321110            1111221111100             0000           022378899999999999


Q ss_pred             CCCChHHHHH
Q 043902          454 DRVGMKFVVN  463 (477)
Q Consensus       454 ~RPs~~evl~  463 (477)
                      +|||+.|+++
T Consensus       283 ~Rps~~ell~  292 (313)
T 3cek_A          283 QRISIPELLA  292 (313)
T ss_dssp             TSCCHHHHHT
T ss_pred             cCcCHHHHhc
Confidence            9999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=9.7e-41  Score=330.52  Aligned_cols=203  Identities=24%  Similarity=0.340  Sum_probs=163.2

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccC-CCCceee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDY-EGNDFKA  234 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~~~~  234 (477)
                      ..+|+..+.||+|+||.||+|+...+..+|+|++.....    ...+|++++++++||||+++++++..... ......+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            457889999999999999999987777799988864332    22369999999999999999999754322 3344578


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec-CCCcEEEeccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFG  313 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~DfG  313 (477)
                      +||||++++.+........    ....+++..+..++.|+++||.|||+.   +|+||||||+|||++ .++.+||+|||
T Consensus       115 lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAK----LKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEeeccCccHHHHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence            9999998754443332110    125689999999999999999999999   999999999999999 79999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccccC--CCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      +++....        ........||..|+|||.+.+  .++.++|||||||++|||++|+.||...
T Consensus       188 ~a~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  245 (394)
T 4e7w_A          188 SAKILIA--------GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE  245 (394)
T ss_dssp             TCEECCT--------TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CcccccC--------CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9987522        112234568999999999833  5899999999999999999999999764

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.8e-40  Score=329.42  Aligned_cols=202  Identities=23%  Similarity=0.337  Sum_probs=166.4

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCC--------CCCcceeeeeccccc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIR--------HRNILKIVSSCSSVD  226 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~~~~  226 (477)
                      .++|.+.+.||+|+||.||+|+.. +++.||||+++... ...+.+.+|++++++++        |+||+++++++....
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            468999999999999999999864 68899999997543 33467889999999885        788999999864211


Q ss_pred             CCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC-
Q 043902          227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM-  305 (477)
Q Consensus       227 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-  305 (477)
                       ......++||||+ +++|.+++....     ...+++..++.++.||+.||.|||+++  +|+||||||+|||++.++ 
T Consensus       115 -~~~~~~~lv~e~~-~~~l~~~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~  185 (397)
T 1wak_A          115 -VNGTHICMVFEVL-GHHLLKWIIKSN-----YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQ  185 (397)
T ss_dssp             -TTEEEEEEEECCC-CCBHHHHHHHTT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHH
T ss_pred             -CCCceEEEEEecc-CccHHHHHHhcc-----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccch
Confidence             2456789999999 556666554332     145899999999999999999999853  899999999999999775 


Q ss_pred             ------------------------------------------------cEEEecccccccccccCCCCCCCccccCCCcc
Q 043902          306 ------------------------------------------------IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG  337 (477)
Q Consensus       306 ------------------------------------------------~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~g  337 (477)
                                                                      .+||+|||+++....          ......|
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~----------~~~~~~g  255 (397)
T 1wak_A          186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK----------HFTEDIQ  255 (397)
T ss_dssp             HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB----------CSCSCCS
T ss_pred             hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc----------cCccCCC
Confidence                                                            799999999986521          1234568


Q ss_pred             cccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          338 SVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       338 t~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      |..|+|||++ ...++.++|||||||++|||+||+.||...
T Consensus       256 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  296 (397)
T 1wak_A          256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPH  296 (397)
T ss_dssp             CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             CCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCC
Confidence            9999999999 556899999999999999999999999754

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=6.1e-41  Score=329.58  Aligned_cols=199  Identities=26%  Similarity=0.338  Sum_probs=164.7

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccC-CCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDY-EGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~  231 (477)
                      .++|...+.||+|+||.||+|... +|+.||+|+++...  ....+.+.+|+.++++++||||+++++++..... ....
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            478889999999999999999865 68999999997542  3335778899999999999999999999743221 1112


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+. ++|.+++.         ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|
T Consensus       121 ~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~D  187 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG---------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILD  187 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT---------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECS
T ss_pred             eEEEEEcccc-ccHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEe
Confidence            3499999996 68888874         3489999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      ||+++....          ......||..|+|||.+.  ..++.++|||||||++|||+||+.||...
T Consensus       188 fg~a~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  245 (371)
T 4exu_A          188 FGLARHADA----------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK  245 (371)
T ss_dssp             TTCC------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cCccccccc----------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence            999976421          223456899999999984  46899999999999999999999999753

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3e-40  Score=313.11  Aligned_cols=253  Identities=23%  Similarity=0.327  Sum_probs=199.3

Q ss_pred             HHhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCC
Q 043902          153 SNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEG  229 (477)
Q Consensus       153 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  229 (477)
                      ....++|++.+.||+|+||.||+|+.. +++.||+|++....  ......+.+|++++++++||||+++++++     ..
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~   92 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----ED   92 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE-----eC
Confidence            344578999999999999999999975 78999999997543  23457889999999999999999999996     45


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC---Cc
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG---MI  306 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~---~~  306 (477)
                      .+..++||||+++++|.+++...       ..+++..++.++.|++.||.|||+.   +++||||||+||+++.+   +.
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~  162 (287)
T 2wei_A           93 SSSFYIVGELYTGGELFDEIIKR-------KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCD  162 (287)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCC
T ss_pred             CCeEEEEEEccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCccc
Confidence            67789999999999999988643       4589999999999999999999999   99999999999999754   47


Q ss_pred             EEEecccccccccccCCCCCCCccccCCCcccccccCcccccCCCCcccceeehHHHHHHHhhCCCCCCcccccccceee
Q 043902          307 AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHK  386 (477)
Q Consensus       307 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~  386 (477)
                      +||+|||++.....        ........||..|+|||.+.+.++.++||||||+++|+|++|+.||........    
T Consensus       163 ~kL~Dfg~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----  230 (287)
T 2wei_A          163 IKIIDFGLSTCFQQ--------NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI----  230 (287)
T ss_dssp             EEECSTTGGGTBCC--------CSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----
T ss_pred             EEEeccCcceeecC--------CCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH----
Confidence            99999999986522        111223458999999999988899999999999999999999999965321110    


Q ss_pred             eeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          387 FVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       387 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                               ...+........             .+.         ...+...+.+++.+||+.||++|||+.|+++
T Consensus       231 ---------~~~~~~~~~~~~-------------~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          231 ---------LKRVETGKYAFD-------------LPQ---------WRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             ---------HHHHHHCCCCCC-------------SGG---------GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------HHHHHcCCCCCC-------------chh---------hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence                     000000000000             000         0011234789999999999999999999987

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.3e-40  Score=322.83  Aligned_cols=256  Identities=21%  Similarity=0.312  Sum_probs=171.8

Q ss_pred             hhcCCCCCC-eeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          155 ATDNFSEEN-LIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       155 ~~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ..++|.+.+ .||+|+||.||+|... +|+.||+|++....    .........+..++||||+++++++.... .....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~  100 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMH-HGKRC  100 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCce
Confidence            457788854 6999999999999976 79999999997532    12222233456679999999999874321 23556


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC---CCcEEE
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE---GMIAHV  309 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl  309 (477)
                      .++||||+++|+|.+++.....     ..+++..++.++.|++.||.|||++   +|+||||||+||+++.   ++.+||
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~~-----~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl  172 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERGD-----QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKL  172 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC-C-----CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEE
T ss_pred             EEEEEeccCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEE
Confidence            8999999999999999986532     4689999999999999999999999   9999999999999976   456999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeee
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~  388 (477)
                      +|||+++...         ........||+.|+|||.+ .+.++.++|||||||++|||++|+.||...........   
T Consensus       173 ~Dfg~~~~~~---------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---  240 (336)
T 3fhr_A          173 TDFGFAKETT---------QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---  240 (336)
T ss_dssp             CCCTTCEEC-------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------
T ss_pred             eccccceecc---------ccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---
Confidence            9999998652         1122345679999999999 56689999999999999999999999965432211000   


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                             ....+......              .+.       .....+...+.+++.+||+.||.+|||+.|+++
T Consensus       241 -------~~~~~~~~~~~--------------~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          241 -------MKRRIRLGQYG--------------FPN-------PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             -----------------C--------------CCT-------TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -------HHHhhhccccc--------------cCc-------hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                   00000000000              000       000011334789999999999999999999997

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=5.1e-41  Score=318.81  Aligned_cols=253  Identities=19%  Similarity=0.281  Sum_probs=181.3

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc--hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ--GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .++|+..+.||+|+||.||+|+.. +|+.||+|+++....  .....+.++...++.++||||+++++++     ...+.
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----~~~~~   80 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGAL-----FREGD   80 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSS
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeee-----eccCC
Confidence            568889999999999999999974 789999999975432  2223344555568888999999999996     45667


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||++ |+|.+++.....   ....+++..++.++.|++.||.|||+++  +|+||||||+||+++.++.+||+||
T Consensus        81 ~~lv~e~~~-~~l~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Df  154 (290)
T 3fme_A           81 VWICMELMD-TSLDKFYKQVID---KGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDF  154 (290)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC
T ss_pred             EEEEEehhc-cchHHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeec
Confidence            899999997 588887754210   1256899999999999999999999842  8999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-----cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeee
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-----NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~  387 (477)
                      |++.....        ........||..|+|||.+     ...++.++|||||||++|||+||+.||........     
T Consensus       155 g~~~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----  221 (290)
T 3fme_A          155 GISGYLVD--------DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-----  221 (290)
T ss_dssp             -----------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-----
T ss_pred             CCcccccc--------cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-----
Confidence            99976522        1122334689999999995     34589999999999999999999999964211110     


Q ss_pred             eeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       388 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                             .+...+.......              +.          ..+...+.+++.+||+.||++|||+.|+++
T Consensus       222 -------~~~~~~~~~~~~~--------------~~----------~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          222 -------QLKQVVEEPSPQL--------------PA----------DKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             -------HHHHHHHSCCCCC--------------CT----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -------HHHHHhccCCCCc--------------cc----------ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                   1111111100000              00          001234789999999999999999999987

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=8.4e-41  Score=333.65  Aligned_cols=203  Identities=25%  Similarity=0.352  Sum_probs=162.7

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccC-CCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDY-EGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~~~  233 (477)
                      ..+|+..+.||+|+||.||+|+.. +|+.||||++....    ....+|++++++++||||+++++++..... .+....
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            346888999999999999999975 68999999987543    223479999999999999999998743221 223346


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC-CcEEEecc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG-MIAHVGDF  312 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Df  312 (477)
                      ++||||+++ +|.+.+....   .....+++..+..++.||++||.|||++   +|+||||||+|||++.+ +.+||+||
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~---~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DF  201 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYS---RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDF  201 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHH---HTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             Eeehhcccc-cHHHHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccc
Confidence            799999976 6666554211   0125689999999999999999999999   99999999999999955 67899999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccccC--CCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      |+++.....        .......||..|+|||++.+  .++.++|||||||++|||++|+.||...
T Consensus       202 G~a~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~  260 (420)
T 1j1b_A          202 GSAKQLVRG--------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD  260 (420)
T ss_dssp             TTCEECCTT--------CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hhhhhcccC--------CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            999875321        11234568999999999833  6899999999999999999999999763

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.4e-41  Score=332.60  Aligned_cols=208  Identities=22%  Similarity=0.294  Sum_probs=154.5

Q ss_pred             cCCCC-CCeeeeeccceEEEEEeC---CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSE-ENLIGSGSFGSVYKGTLA---DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      +.|.. .++||+|+||.||+|+..   +++.||+|+++....  ...+.+|++++.+++||||+++++++..   .....
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~~   94 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLS---HADRK   94 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTTTE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEec---CCCCe
Confidence            34554 458999999999999965   578999999975432  2578899999999999999999999642   45677


Q ss_pred             eeEEEeecCCCChhhhcccCCC--cccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEe----cCCCc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTD--EYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL----DEGMI  306 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll----~~~~~  306 (477)
                      .++||||+. |+|.+++.....  .......+++..++.++.||+.||.|||+.   +|+||||||+|||+    +.++.
T Consensus        95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~  170 (405)
T 3rgf_A           95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGR  170 (405)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTC
T ss_pred             EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCc
Confidence            999999996 588877753210  001123589999999999999999999999   99999999999999    77889


Q ss_pred             EEEecccccccccccCCCCCCCccccCCCcccccccCcccccC--CCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          307 AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       307 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      +||+|||+++.....    ...........||+.|+|||++.+  .++.++|||||||++|||+||+.||...
T Consensus       171 ~kl~Dfg~a~~~~~~----~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          171 VKIADMGFARLFNSP----LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             EEECCTTCCC--------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             EEEEECCCceecCCC----CcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            999999999876321    111122344678999999999843  5899999999999999999999999754

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=6e-40  Score=313.21  Aligned_cols=261  Identities=25%  Similarity=0.395  Sum_probs=189.3

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeeccccc--------
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVD--------  226 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------  226 (477)
                      .++|+..+.||+|+||.||+|+.. +|+.||+|+++... ...+.+.+|+.++++++||||+++++++....        
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            467889999999999999999964 78999999997543 34478899999999999999999999864311        


Q ss_pred             CCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCc
Q 043902          227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI  306 (477)
Q Consensus       227 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~  306 (477)
                      .......++||||+++|+|.+++....      ..+++..++.++.|++.||.|||++   +|+||||||+||+++.++.
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~  154 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSEN------LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRN  154 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSC------GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccc------cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCC
Confidence            123567899999999999999997543      4578899999999999999999999   9999999999999999999


Q ss_pred             EEEecccccccccccCCCC-------CCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          307 AHVGDFGLAKFLFEESNTP-------SKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       307 ~kl~DfG~a~~~~~~~~~~-------~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      +||+|||++..........       ...........||..|+|||.+.  +.++.++|||||||++|||++   ||...
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~  231 (303)
T 1zy4_A          155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG  231 (303)
T ss_dssp             EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence            9999999998653211000       00012233456899999999984  368999999999999999998   55321


Q ss_pred             cccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCC
Q 043902          378 FKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVG  457 (477)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs  457 (477)
                      ....             .....+..... .  ..          +..        ...+...+.+++.+||+.||.+|||
T Consensus       232 ~~~~-------------~~~~~~~~~~~-~--~~----------~~~--------~~~~~~~~~~li~~~l~~dp~~Rps  277 (303)
T 1zy4_A          232 MERV-------------NILKKLRSVSI-E--FP----------PDF--------DDNKMKVEKKIIRLLIDHDPNKRPG  277 (303)
T ss_dssp             HHHH-------------HHHHHHHSTTC-C--CC----------TTC--------CTTTSHHHHHHHHHHTCSSGGGSCC
T ss_pred             hhHH-------------HHHHhcccccc-c--cC----------ccc--------cccchHHHHHHHHHHHhcCcccCcC
Confidence            1100             00000000000 0  00          000        0011234789999999999999999


Q ss_pred             hHHHHH
Q 043902          458 MKFVVN  463 (477)
Q Consensus       458 ~~evl~  463 (477)
                      +.|+++
T Consensus       278 ~~~ll~  283 (303)
T 1zy4_A          278 ARTLLN  283 (303)
T ss_dssp             HHHHHH
T ss_pred             HHHHhC
Confidence            999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=6.4e-40  Score=318.13  Aligned_cols=197  Identities=22%  Similarity=0.320  Sum_probs=167.1

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe--CCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCC------CcceeeeecccccC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL--ADGETAAIKVLKLQQQGALKSFIDECNALTSIRHR------NILKIVSSCSSVDY  227 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~l~~~~~~~~~  227 (477)
                      .++|++.+.||+|+||.||+|..  .+++.||+|+++... ...+.+.+|++++.+++|+      +++++++++     
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~-----   86 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF-----   86 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE-----
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc-----
Confidence            46899999999999999999986  368899999997543 3346788899999888655      489999985     


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC----
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE----  303 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~----  303 (477)
                      ...+..++||||+ +++|.+++.....     ..+++..+..++.|++.||.|||++   +|+||||||+||+++.    
T Consensus        87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~  157 (339)
T 1z57_A           87 EHHGHICIVFELL-GLSTYDFIKENGF-----LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYT  157 (339)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEE
T ss_pred             ccCCcEEEEEcCC-CCCHHHHHHhcCC-----CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccc
Confidence            4567899999999 8899999975531     4688999999999999999999999   9999999999999987    


Q ss_pred             ---------------CCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHH
Q 043902          304 ---------------GMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEI  367 (477)
Q Consensus       304 ---------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~el  367 (477)
                                     ++.+||+|||+++....          ......||..|+|||.+ ...++.++|||||||++|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el  227 (339)
T 1z57_A          158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDE----------HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEY  227 (339)
T ss_dssp             EEEC----CEEEEESCCCEEECCCSSCEETTS----------CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHH
T ss_pred             cccCCccccccccccCCCceEeeCcccccCcc----------ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHH
Confidence                           66899999999976421          12345689999999999 55789999999999999999


Q ss_pred             hhCCCCCCcc
Q 043902          368 FTGKRPTDDM  377 (477)
Q Consensus       368 ltg~~p~~~~  377 (477)
                      +||+.||...
T Consensus       228 ~~g~~pf~~~  237 (339)
T 1z57_A          228 YLGFTVFPTH  237 (339)
T ss_dssp             HHSSCSCCCS
T ss_pred             HhCCCCCCCC
Confidence            9999999753

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=319.45  Aligned_cols=243  Identities=22%  Similarity=0.351  Sum_probs=186.3

Q ss_pred             HHHhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc------hhhHHHHHHHHHHhcC----CCCCcceeee
Q 043902          152 ISNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ------GALKSFIDECNALTSI----RHRNILKIVS  220 (477)
Q Consensus       152 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~h~niv~l~~  220 (477)
                      .....++|...+.||+|+||.||+|+.. +++.||+|+++....      .....+.+|+.++.++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            3445678999999999999999999864 789999999975432      1223456788888888    8999999999


Q ss_pred             ecccccCCCCceeeEEEee-cCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCe
Q 043902          221 SCSSVDYEGNDFKALVFEF-MRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNV  299 (477)
Q Consensus       221 ~~~~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NI  299 (477)
                      ++     ...+..++|+|| +.+++|.+++...       ..+++..++.++.|++.||.|||+.   +|+||||||+||
T Consensus       106 ~~-----~~~~~~~~v~e~~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni  170 (312)
T 2iwi_A          106 WF-----ETQEGFMLVLERPLPAQDLFDYITEK-------GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENI  170 (312)
T ss_dssp             EC----------CEEEEECCSSEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGE
T ss_pred             EE-----ecCCeEEEEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhE
Confidence            95     456678999999 7899999999753       4589999999999999999999999   999999999999


Q ss_pred             Eec-CCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCC-CcccceeehHHHHHHHhhCCCCCCc
Q 043902          300 LLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHV-SILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       300 ll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~-~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      +++ .++.+||+|||++.....         .......|+..|+|||++ ...+ +.++|||||||++|||++|+.||..
T Consensus       171 l~~~~~~~~kl~dfg~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  241 (312)
T 2iwi_A          171 LIDLRRGCAKLIDFGSGALLHD---------EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER  241 (312)
T ss_dssp             EEETTTTEEEECCCSSCEECCS---------SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             EEeCCCCeEEEEEcchhhhccc---------CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence            999 889999999999987622         122345689999999998 3444 5689999999999999999999964


Q ss_pred             ccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC
Q 043902          377 MFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRV  456 (477)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  456 (477)
                      ...                   ..+.....               +           ..+...+.+++.+||+.||++||
T Consensus       242 ~~~-------------------~~~~~~~~---------------~-----------~~~~~~~~~li~~~l~~~p~~Rp  276 (312)
T 2iwi_A          242 DQE-------------------ILEAELHF---------------P-----------AHVSPDCCALIRRCLAPKPSSRP  276 (312)
T ss_dssp             HHH-------------------HHHTCCCC---------------C-----------TTSCHHHHHHHHHHTCSSTTTSC
T ss_pred             hHH-------------------HhhhccCC---------------c-----------ccCCHHHHHHHHHHccCChhhCc
Confidence            210                   11100000               0           00123378899999999999999


Q ss_pred             ChHHHHH
Q 043902          457 GMKFVVN  463 (477)
Q Consensus       457 s~~evl~  463 (477)
                      |+.|+++
T Consensus       277 s~~e~l~  283 (312)
T 2iwi_A          277 SLEEILL  283 (312)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHhc
Confidence            9999986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=318.59  Aligned_cols=199  Identities=27%  Similarity=0.340  Sum_probs=164.4

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccC-CCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDY-EGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~  231 (477)
                      .++|...+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+.++++++||||+++++++..... ....
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            467889999999999999999875 68999999997542  3335678899999999999999999999743210 0112


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+. ++|.+++.         ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|
T Consensus       103 ~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~D  169 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG---------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILD  169 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT---------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECS
T ss_pred             eEEEEecccc-CCHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEee
Confidence            3599999996 68888774         3489999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      ||+++....          ......||..|+|||.+.  ..++.++|||||||++|||++|+.||...
T Consensus       170 fg~~~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  227 (353)
T 3coi_A          170 FGLARHADA----------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK  227 (353)
T ss_dssp             TTCTTC------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS
T ss_pred             cccccCCCC----------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999976421          123456899999999984  46899999999999999999999999753

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.9e-40  Score=332.50  Aligned_cols=258  Identities=22%  Similarity=0.305  Sum_probs=180.9

Q ss_pred             cCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCCceeeE
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      +.|...+.||+|+||+||.+...+|+.||||++....   .+.+.+|++++.++ +||||+++++++     ...+..++
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~l   86 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYI   86 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEE
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEE
Confidence            3445568899999999987776789999999987543   35678899999876 899999999985     56678999


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCC-----------
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEG-----------  304 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-----------  304 (477)
                      ||||+. |+|.+++.............++..++.++.||+.||.|||++   +|+||||||+|||++.+           
T Consensus        87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~  162 (434)
T 2rio_A           87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGA  162 (434)
T ss_dssp             EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred             EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCC
Confidence            999995 699999976532111111123445678999999999999999   99999999999999754           


Q ss_pred             --CcEEEecccccccccccCCCCCCCccccCCCcccccccCccccc--------CCCCcccceeehHHHHHHHhh-CCCC
Q 043902          305 --MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--------GHVSILGDIYSYGILLLEIFT-GKRP  373 (477)
Q Consensus       305 --~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~Dv~S~Gvvl~ellt-g~~p  373 (477)
                        +.+||+|||+++........   .........||+.|+|||++.        +.++.++|||||||++|||+| |+.|
T Consensus       163 ~~~~~kL~DFG~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~P  239 (434)
T 2rio_A          163 ENLRILISDFGLCKKLDSGQSS---FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP  239 (434)
T ss_dssp             CSCEEEECCCTTCEECCC-----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred             CceEEEEcccccceecCCCCcc---ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCC
Confidence              48999999999876321110   111223457999999999983        358999999999999999999 9999


Q ss_pred             CCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCC
Q 043902          374 TDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPR  453 (477)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~  453 (477)
                      |........               .++.......         .   .+...       ...+...+.+++.+||+.||.
T Consensus       240 f~~~~~~~~---------------~i~~~~~~~~---------~---~~~~~-------~~~~~~~~~~li~~~L~~dP~  285 (434)
T 2rio_A          240 FGDKYSRES---------------NIIRGIFSLD---------E---MKCLH-------DRSLIAEATDLISQMIDHDPL  285 (434)
T ss_dssp             TCSTTTHHH---------------HHHHTCCCCC---------C---CTTCC-------CHHHHHHHHHHHHHHTCSSGG
T ss_pred             CCCchhhHH---------------HHhcCCCCcc---------c---ccccc-------cccchHHHHHHHHHHhhCChh
Confidence            965321110               0110000000         0   00000       011234588999999999999


Q ss_pred             CCCChHHHHH
Q 043902          454 DRVGMKFVVN  463 (477)
Q Consensus       454 ~RPs~~evl~  463 (477)
                      +|||+.||++
T Consensus       286 ~Rps~~eil~  295 (434)
T 2rio_A          286 KRPTAMKVLR  295 (434)
T ss_dssp             GSCCHHHHHT
T ss_pred             hCCCHHHHHh
Confidence            9999999985

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=9.2e-40  Score=321.60  Aligned_cols=202  Identities=22%  Similarity=0.313  Sum_probs=165.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeeccchhhHHHHHHHHHHhcCC-----------CCCcceeeeecc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSIR-----------HRNILKIVSSCS  223 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~  223 (477)
                      .++|...+.||+|+||.||+|+. .+++.||||+++... .....+.+|++++.+++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            46899999999999999999996 478999999997543 23467888999998886           899999999874


Q ss_pred             cccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec-
Q 043902          224 SVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD-  302 (477)
Q Consensus       224 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~-  302 (477)
                      ... ......++||||+ +++|.+++.....     ..+++..++.++.||+.||.|||+++  +|+||||||+|||++ 
T Consensus        97 ~~~-~~~~~~~lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~  167 (373)
T 1q8y_A           97 HKG-PNGVHVVMVFEVL-GENLLALIKKYEH-----RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEI  167 (373)
T ss_dssp             EEE-TTEEEEEEEECCC-CEEHHHHHHHTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEE
T ss_pred             ccC-CCCceEEEEEecC-CCCHHHHHHHhhc-----cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEec
Confidence            321 2334789999999 8999999976432     45899999999999999999999842  899999999999994 


Q ss_pred             -----CCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          303 -----EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       303 -----~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                           ..+.+||+|||++.....          ......||..|+|||++ ...++.++|||||||++|||+||+.||..
T Consensus       168 ~~~~~~~~~~kl~Dfg~a~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  237 (373)
T 1q8y_A          168 VDSPENLIQIKIADLGNACWYDE----------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP  237 (373)
T ss_dssp             EETTTTEEEEEECCCTTCEETTB----------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             cCCCcCcceEEEcccccccccCC----------CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence                 445899999999986521          12334689999999999 55689999999999999999999999975


Q ss_pred             c
Q 043902          377 M  377 (477)
Q Consensus       377 ~  377 (477)
                      .
T Consensus       238 ~  238 (373)
T 1q8y_A          238 D  238 (373)
T ss_dssp             -
T ss_pred             C
Confidence            3

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.5e-39  Score=320.92  Aligned_cols=201  Identities=28%  Similarity=0.345  Sum_probs=166.1

Q ss_pred             HhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCC-CC-----Ccceeeeeccccc
Q 043902          154 NATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIR-HR-----NILKIVSSCSSVD  226 (477)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~  226 (477)
                      ...++|.+.+.||+|+||.||+|... +++.||||+++... .....+..|++++..++ |+     +++++++++    
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~----  125 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF----  125 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE----
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeee----
Confidence            34678999999999999999999865 68899999997543 23466778888888875 45     488988885    


Q ss_pred             CCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec--CC
Q 043902          227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD--EG  304 (477)
Q Consensus       227 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~--~~  304 (477)
                       ...+..++||||++ |+|.+++.....     ..+++..+..++.|++.||.|||++ ..+|+||||||+|||++  .+
T Consensus       126 -~~~~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~  197 (382)
T 2vx3_A          126 -MFRNHLCLVFEMLS-YNLYDLLRNTNF-----RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKR  197 (382)
T ss_dssp             -EETTEEEEEEECCC-CBHHHHHHHTTT-----SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTS
T ss_pred             -ccCCceEEEEecCC-CCHHHHHhhcCc-----CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCC
Confidence             44578999999995 599999876531     4589999999999999999999952 23899999999999994  57


Q ss_pred             CcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          305 MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       305 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      +.+||+|||+++....          ......||+.|+|||++ ...++.++|||||||++|||+||+.||...
T Consensus       198 ~~~kL~DFG~a~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          198 SAIKIVDFGSSCQLGQ----------RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             CCEEECCCTTCEETTC----------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CcEEEEeccCceeccc----------ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            7899999999986521          12345689999999999 456899999999999999999999999764

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.3e-40  Score=320.60  Aligned_cols=242  Identities=23%  Similarity=0.331  Sum_probs=193.4

Q ss_pred             HHhhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccch------hhHHHHHHHHHHhcCC--CCCcceeeeecc
Q 043902          153 SNATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQG------ALKSFIDECNALTSIR--HRNILKIVSSCS  223 (477)
Q Consensus       153 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~~~~~  223 (477)
                      ....++|++.+.||+|+||.||+|+.. +++.||||+++.....      ....+.+|+.++.+++  |+||+++++++ 
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~-  117 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF-  117 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE-
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE-
Confidence            344678999999999999999999864 7899999999754321      2245678999999996  59999999996 


Q ss_pred             cccCCCCceeeEEEeecCC-CChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec
Q 043902          224 SVDYEGNDFKALVFEFMRN-GNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD  302 (477)
Q Consensus       224 ~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~  302 (477)
                          ...+..++|+|++.+ ++|.+++...       ..+++..++.++.|++.||.|||+.   +|+||||||+||+++
T Consensus       118 ----~~~~~~~lv~e~~~~~~~L~~~l~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~  183 (320)
T 3a99_A          118 ----ERPDSFVLILERPEPVQDLFDFITER-------GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILID  183 (320)
T ss_dssp             ----ECSSEEEEEEECCSSEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEE
T ss_pred             ----ecCCcEEEEEEcCCCCccHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEe
Confidence                456778999999976 8999998753       4689999999999999999999999   999999999999999


Q ss_pred             -CCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCC-CCcccceeehHHHHHHHhhCCCCCCcccc
Q 043902          303 -EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGH-VSILGDIYSYGILLLEIFTGKRPTDDMFK  379 (477)
Q Consensus       303 -~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~-~~~~~Dv~S~Gvvl~elltg~~p~~~~~~  379 (477)
                       +++.+||+|||+++....         .......||..|+|||++ ... .+.++|||||||++|||+||+.||.....
T Consensus       184 ~~~~~~kL~Dfg~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  254 (320)
T 3a99_A          184 LNRGELKLIDFGSGALLKD---------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE  254 (320)
T ss_dssp             TTTTEEEECCCTTCEECCS---------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH
T ss_pred             CCCCCEEEeeCcccccccc---------ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh
Confidence             788999999999987521         122345689999999998 344 47899999999999999999999964210


Q ss_pred             cccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChH
Q 043902          380 DDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMK  459 (477)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~  459 (477)
                                         .........              +            .+...+.+++.+||+.||++|||+.
T Consensus       255 -------------------~~~~~~~~~--------------~------------~~~~~~~~li~~~l~~dp~~Rps~~  289 (320)
T 3a99_A          255 -------------------IIRGQVFFR--------------Q------------RVSSECQHLIRWCLALRPSDRPTFE  289 (320)
T ss_dssp             -------------------HHHCCCCCS--------------S------------CCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             -------------------hhccccccc--------------c------------cCCHHHHHHHHHHccCChhhCcCHH
Confidence                               000000000              0            0123378999999999999999999


Q ss_pred             HHHH
Q 043902          460 FVVN  463 (477)
Q Consensus       460 evl~  463 (477)
                      |+++
T Consensus       290 ~ll~  293 (320)
T 3a99_A          290 EIQN  293 (320)
T ss_dssp             HHHT
T ss_pred             HHhc
Confidence            9986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.6e-39  Score=314.16  Aligned_cols=257  Identities=21%  Similarity=0.262  Sum_probs=174.8

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHH-HHhcCCCCCcceeeeecccccCCCCce
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECN-ALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .++|...+.||+|+||.||+|... +|+.||||+++... ......+..|+. +++.++||||+++++++     ...+.
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~-----~~~~~   95 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGAL-----FREGD   95 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEE-----ECSSE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEE-----EeCCc
Confidence            468889999999999999999975 78999999998653 233355666666 67788999999999996     45667


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++ +|.+++.....  .....+++..+..++.|++.||.|||+.  .+|+||||||+||+++.++.+||+||
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Df  170 (327)
T 3aln_A           96 CWICMELMST-SFDKFYKYVYS--VLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDF  170 (327)
T ss_dssp             EEEEECCCSE-EHHHHHHHHHH--TTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCC
T ss_pred             eEEEEeecCC-ChHHHHHHHHh--hhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccC
Confidence            8999999975 88777753100  0115689999999999999999999984  28999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCccccc-----CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeee
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-----GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~  387 (477)
                      |+++....        ........||..|+|||.+.     ..++.++|||||||++|||++|+.||.........+...
T Consensus       171 g~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  242 (327)
T 3aln_A          171 GISGQLVD--------SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV  242 (327)
T ss_dssp             SSSCC--------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC
T ss_pred             CCceeccc--------ccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH
Confidence            99976522        11122346899999999982     358999999999999999999999997532211111111


Q ss_pred             eeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       388 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      .....+.         +...            ..+            .+...+.+++.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~---------~~~~------------~~~------------~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          243 VKGDPPQ---------LSNS------------EER------------EFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCSCCCC---------CCCC------------SSC------------CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             hcCCCCC---------CCCc------------ccc------------cCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            1000000         0000            000            01234889999999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.6e-39  Score=316.06  Aligned_cols=197  Identities=23%  Similarity=0.368  Sum_probs=164.2

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CC-CEEEEEEeeeccchhhHHHHHHHHHHhcCCCCC------cceeeeecccccC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DG-ETAAIKVLKLQQQGALKSFIDECNALTSIRHRN------ILKIVSSCSSVDY  227 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~  227 (477)
                      .++|.+.+.||+|+||.||+|... ++ +.||+|+++... ...+.+.+|++++++++|++      ++.+.+++     
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~-----   91 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWF-----   91 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE-----
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee-----
Confidence            468999999999999999999864 44 689999997543 33467888999999987665      88888874     


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEe------
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL------  301 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll------  301 (477)
                      ...+..++||||+ +++|.+++....     ...+++..++.++.||+.||.|||++   +|+||||||+|||+      
T Consensus        92 ~~~~~~~lv~e~~-~~~l~~~l~~~~-----~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~  162 (355)
T 2eu9_A           92 NFHGHMCIAFELL-GKNTFEFLKENN-----FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFE  162 (355)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEE
T ss_pred             eeCCeEEEEEecc-CCChHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccc
Confidence            4566899999999 667777665442     14689999999999999999999999   99999999999999      


Q ss_pred             -------------cCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHH
Q 043902          302 -------------DEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEI  367 (477)
Q Consensus       302 -------------~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~el  367 (477)
                                   +.++.+||+|||+++....          ......||..|+|||++ ...++.++|||||||++|||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el  232 (355)
T 2eu9_A          163 TLYNEHKSCEEKSVKNTSIRVADFGSATFDHE----------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEY  232 (355)
T ss_dssp             EEECCC-CCCEEEESCCCEEECCCTTCEETTS----------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCCCcEEEeecCccccccc----------cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHH
Confidence                         5678999999999976421          12345689999999999 55789999999999999999


Q ss_pred             hhCCCCCCcc
Q 043902          368 FTGKRPTDDM  377 (477)
Q Consensus       368 ltg~~p~~~~  377 (477)
                      +||+.||...
T Consensus       233 ~~g~~pf~~~  242 (355)
T 2eu9_A          233 YRGFTLFQTH  242 (355)
T ss_dssp             HHSSCSCCCS
T ss_pred             HhCCCCCCCC
Confidence            9999999754

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3e-39  Score=333.18  Aligned_cols=206  Identities=26%  Similarity=0.423  Sum_probs=171.7

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec-cchhhHHHHHHHHHHhcCCCCCcceeeeeccccc-CCCCce
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ-QQGALKSFIDECNALTSIRHRNILKIVSSCSSVD-YEGNDF  232 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~~~~  232 (477)
                      .++|.+.+.||+|+||.||+|... +|+.||||+++.. .....+.+.+|++++.+++||||+++++++.... +...+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            478999999999999999999874 6899999998754 3344577999999999999999999999875422 233677


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCc---EEE
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI---AHV  309 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl  309 (477)
                      .++||||+++|+|.+++.....    ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.   +||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~----~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL  165 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFEN----CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKI  165 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSC----TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred             EEEEEEeCCCCCHHHHHHhccc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEE
Confidence            8999999999999999986431    24588899999999999999999999   9999999999999997664   999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      +|||++.....        ........||..|+|||.+ .+.++.++|||||||++|||+||+.||..
T Consensus       166 ~DFG~a~~~~~--------~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~  225 (676)
T 3qa8_A          166 IDLGYAKELDQ--------GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP  225 (676)
T ss_dssp             CSCCCCCBTTS--------CCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccccccccc--------ccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence            99999986522        1122345789999999999 56799999999999999999999999965

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.6e-39  Score=342.23  Aligned_cols=247  Identities=21%  Similarity=0.311  Sum_probs=194.4

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC--CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA--DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .++|++.+.||+|+||.||+|...  +|+.||||++.... ......+.+|++++.+++||||++++++|..........
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            478999999999999999999975  68999999987443 344567899999999999999999999975433222233


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++++|.+++..         .+++..++.++.||+.||.|||++   +|+||||||+||+++.+ .+||+||
T Consensus       159 ~~lv~E~~~g~~L~~~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DF  225 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ---------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDL  225 (681)
T ss_dssp             EEEEEECCCCEECC----C---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCC
T ss_pred             eEEEEEeCCCCcHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEec
Confidence            6999999999999987752         489999999999999999999999   99999999999999986 8999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccccCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccC
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMAL  392 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  392 (477)
                      |+++....           .....||+.|+|||++.+..+.++|||||||++|||++|..||.......          +
T Consensus       226 G~a~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------~  284 (681)
T 2pzi_A          226 GAVSRINS-----------FGYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------L  284 (681)
T ss_dssp             TTCEETTC-----------CSCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECSS----------C
T ss_pred             ccchhccc-----------CCccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccccc----------c
Confidence            99986521           13456899999999996666999999999999999999998876422111          0


Q ss_pred             CchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC-ChHHHHHHHHHHHHh
Q 043902          393 PSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRV-GMKFVVNNLQAIRSK  471 (477)
Q Consensus       393 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~i~~~  471 (477)
                      +...                                   ........+.+++.+||+.||++|| +++++...|..+...
T Consensus       285 ~~~~-----------------------------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  329 (681)
T 2pzi_A          285 PEDD-----------------------------------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE  329 (681)
T ss_dssp             CTTC-----------------------------------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred             cccc-----------------------------------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence            0000                                   0000123478899999999999999 567777777766543

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.2e-40  Score=326.68  Aligned_cols=251  Identities=22%  Similarity=0.337  Sum_probs=182.2

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCCcee
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ...+|...+.||+|+||+||.....+|+.||||++.....   ..+.+|++++.++ +||||+++++++     ......
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~   93 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQ   93 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEE
Confidence            3456888899999999997665566899999999975432   2356899999999 799999999985     456778


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC-----CCcEE
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE-----GMIAH  308 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-----~~~~k  308 (477)
                      ++||||+. |+|.+++....      ....+..++.++.||+.||.|||+.   +|+||||||+||+++.     ...+|
T Consensus        94 ~lv~E~~~-g~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~k  163 (432)
T 3p23_A           94 YIAIELCA-ATLQEYVEQKD------FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAM  163 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSS------CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEE
T ss_pred             EEEEECCC-CCHHHHHHhcC------CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEE
Confidence            99999995 69999997653      2344455678999999999999999   9999999999999943     34688


Q ss_pred             EecccccccccccCCCCCCCccccCCCcccccccCccccc----CCCCcccceeehHHHHHHHhh-CCCCCCcccccccc
Q 043902          309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN----GHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLS  383 (477)
Q Consensus       309 l~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~  383 (477)
                      |+|||+++......    ..........||+.|+|||++.    ..++.++|||||||++|||+| |..||........ 
T Consensus       164 L~DFG~a~~~~~~~----~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-  238 (432)
T 3p23_A          164 ISDFGLCKKLAVGR----HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-  238 (432)
T ss_dssp             ECCTTEEECC----------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-
T ss_pred             EecccceeeccCCC----cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-
Confidence            99999998763211    1112234467999999999984    357889999999999999999 9999854221110 


Q ss_pred             eeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          384 IHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       384 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                                   ......... .           ...+.          ......+.+|+.+||+.||.+|||+.||++
T Consensus       239 -------------~~~~~~~~~-~-----------~~~~~----------~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          239 -------------NILLGACSL-D-----------CLHPE----------KHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             -------------HHHTTCCCC-T-----------TSCTT----------CHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -------------HHHhccCCc-c-----------ccCcc----------ccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence                         000000000 0           00000          001233678999999999999999999983

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.2e-38  Score=301.54  Aligned_cols=234  Identities=12%  Similarity=0.086  Sum_probs=181.7

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .++|++.+.||+|+||.||+|+.. +|+.||||+++...   ....+.+.+|+..+.+++||||+++++++     ...+
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~  104 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV-----HTRA  104 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EETT
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE-----EECC
Confidence            367999999999999999999975 58999999998543   23347889999999999999999999996     4567


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+++++|.+++...         ....++..++.|++.||.|||++   +|+||||||+||+++.++.+||++
T Consensus       105 ~~~lv~e~~~g~~L~~~l~~~---------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~  172 (286)
T 3uqc_A          105 GGLVVAEWIRGGSLQEVADTS---------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAY  172 (286)
T ss_dssp             EEEEEEECCCEEEHHHHHTTC---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECS
T ss_pred             cEEEEEEecCCCCHHHHHhcC---------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEe
Confidence            799999999999999999532         35567889999999999999999   999999999999999999999975


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccccCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      +|.                           ++      .++.++|||||||++|||+||+.||............  ...
T Consensus       173 ~~~---------------------------~~------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~--~~~  217 (286)
T 3uqc_A          173 PAT---------------------------MP------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA--ERD  217 (286)
T ss_dssp             CCC---------------------------CT------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC--CBC
T ss_pred             ccc---------------------------cC------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH--HHH
Confidence            432                           22      2588999999999999999999999764332211000  000


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHh
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSK  471 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  471 (477)
                      ......   .+                           ......++..+.+++.+||+.||++| |+.|+++.|+++...
T Consensus       218 ~~~~~~---~~---------------------------~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          218 TAGQPI---EP---------------------------ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             TTSCBC---CH---------------------------HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             hccCCC---Ch---------------------------hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence            000000   00                           00000113348899999999999999 999999999998765


Q ss_pred             h
Q 043902          472 I  472 (477)
Q Consensus       472 ~  472 (477)
                      .
T Consensus       267 ~  267 (286)
T 3uqc_A          267 A  267 (286)
T ss_dssp             -
T ss_pred             C
Confidence            3

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=312.29  Aligned_cols=250  Identities=22%  Similarity=0.298  Sum_probs=175.4

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc--hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ--GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .++|+..+.||+|+||.||+|... +|+.||||+++....  ...+.+.++..++..++||||+++++++     ...+.
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~-----~~~~~   98 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTF-----ITNTD   98 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEE-----ecCCc
Confidence            467888899999999999999975 789999999985432  2223344555678888999999999996     45668


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN-QYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      .++||||+ ++.+..+.....      ..+++..++.++.|++.||.|||+ .   +++||||||+||+++.++.+||+|
T Consensus        99 ~~lv~e~~-~~~~~~l~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~d  168 (318)
T 2dyl_A           99 VFIAMELM-GTCAEKLKKRMQ------GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCD  168 (318)
T ss_dssp             EEEEECCC-SEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECC
T ss_pred             EEEEEecc-CCcHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEE
Confidence            99999999 556666554322      468999999999999999999998 5   899999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCccccc------CCCCcccceeehHHHHHHHhhCCCCCCccccccccee
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN------GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIH  385 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~  385 (477)
                      ||++.....        ........||..|+|||.+.      ..++.++|||||||++|||++|+.||........   
T Consensus       169 fg~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---  237 (318)
T 2dyl_A          169 FGISGRLVD--------DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE---  237 (318)
T ss_dssp             CTTC----------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---
T ss_pred             CCCchhccC--------CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH---
Confidence            999976522        11223346899999999983      3578899999999999999999999965221100   


Q ss_pred             eeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          386 KFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       386 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                               .+..+......              ..+..         ..+...+.+++.+||+.||.+|||+.|+++
T Consensus       238 ---------~~~~~~~~~~~--------------~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          238 ---------VLTKVLQEEPP--------------LLPGH---------MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             ---------HHHHHHHSCCC--------------CCCSS---------SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ---------HHHHHhccCCC--------------CCCcc---------CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                     00111100000              00000         001234789999999999999999999986

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1e-37  Score=297.46  Aligned_cols=235  Identities=22%  Similarity=0.288  Sum_probs=177.7

Q ss_pred             hcCCCCC-CeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHH-hcCCCCCcceeeeecccccCCCCce
Q 043902          156 TDNFSEE-NLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNAL-TSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       156 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .++|... +.||+|+||.||+|... +++.||+|+++..     ..+.+|+.++ ...+||||+++++++... ......
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~   89 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC   89 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCce
Confidence            4567776 78999999999999874 7899999999743     4667888887 556899999999986431 133667


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC---CCcEEE
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE---GMIAHV  309 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl  309 (477)
                      .++||||+++|+|.+++.....     ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.   ++.+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl  161 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGD-----QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKL  161 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEE
T ss_pred             EEEEEeecCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEE
Confidence            8999999999999999976532     4689999999999999999999999   9999999999999998   789999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCcccccCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      +|||++....                            ...++.++|||||||++|||+||+.||..........  ...
T Consensus       162 ~Dfg~a~~~~----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~--~~~  211 (299)
T 3m2w_A          162 TDFGFAKETT----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--GMK  211 (299)
T ss_dssp             CCCTTCEECT----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C--CSC
T ss_pred             eccccccccc----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH--HHH
Confidence            9999987541                            1346789999999999999999999996532211100  000


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      ..+...                      ....+       ......+...+.+++.+||+.||.+|||+.|+++
T Consensus       212 ~~~~~~----------------------~~~~~-------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          212 TRIRMG----------------------QYEFP-------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CSSCTT----------------------CCSSC-------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhhc----------------------cccCC-------chhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            000000                      00000       0001112345889999999999999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-38  Score=316.34  Aligned_cols=258  Identities=16%  Similarity=0.136  Sum_probs=181.5

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCC-CCcceeeee---------
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQ---QGALKSFIDECNALTSIRH-RNILKIVSS---------  221 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~niv~l~~~---------  221 (477)
                      +..|...+.||+|+||.||+|+. .+|+.||||+++...   ....+.+.+|+.++..++| +|......+         
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            44577788999999999999995 479999999988433   2235789999999999987 332211111         


Q ss_pred             c------------ccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 043902          222 C------------SSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPI  289 (477)
Q Consensus       222 ~------------~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i  289 (477)
                      +            ...........+++|+++ +++|.+++............+++..++.++.|+++||.|||++   +|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence            0            000000022356677765 7899998842100000125688899999999999999999999   99


Q ss_pred             eecCCCCCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc----------cC-CCCccccee
Q 043902          290 AHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI----------NG-HVSILGDIY  358 (477)
Q Consensus       290 vH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~-~~~~~~Dv~  358 (477)
                      +||||||+|||++.++.+||+|||+++....          ......| ..|+|||++          .+ .++.++|||
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~----------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw  301 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW  301 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTE----------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCC----------ccccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence            9999999999999999999999999986521          1334466 999999998          22 378899999


Q ss_pred             ehHHHHHHHhhCCCCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHH
Q 043902          359 SYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLV  438 (477)
Q Consensus       359 S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  438 (477)
                      ||||++|||+||+.||........     .        ..++..    .              +            .++.
T Consensus       302 SlGvil~elltg~~Pf~~~~~~~~-----~--------~~~~~~----~--------------~------------~~~~  338 (413)
T 3dzo_A          302 TLGLAIYWIWCADLPNTDDAALGG-----S--------EWIFRS----C--------------K------------NIPQ  338 (413)
T ss_dssp             HHHHHHHHHHHSSCCCCTTGGGSC-----S--------GGGGSS----C--------------C------------CCCH
T ss_pred             HHHHHHHHHHHCCCCCCCcchhhh-----H--------HHHHhh----c--------------c------------cCCH
Confidence            999999999999999975322110     0        000000    0              0            0023


Q ss_pred             HHHHHhhhcCCCCCCCCCChHHHHHH--HHHHHHh
Q 043902          439 SVMRIGVMCSAASPRDRVGMKFVVNN--LQAIRSK  471 (477)
Q Consensus       439 ~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~~~  471 (477)
                      .+.+|+.+||+.||++|||+.|+++.  ++++++.
T Consensus       339 ~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~~  373 (413)
T 3dzo_A          339 PVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE  373 (413)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHHH
Confidence            48899999999999999999888653  4444433

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.9e-37  Score=300.62  Aligned_cols=197  Identities=20%  Similarity=0.229  Sum_probs=160.6

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeecc--------chhhHHHHHHHHHHhcCC---------CCCccee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQ--------QGALKSFIDECNALTSIR---------HRNILKI  218 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv~l  218 (477)
                      .++|+..+.||+|+||.||+|+. +|+.||||+++...        ....+.+.+|+.++++++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46788999999999999999998 68999999998653        223477889999888885         6676666


Q ss_pred             eeecccc-------------------------cCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHH
Q 043902          219 VSSCSSV-------------------------DYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID  273 (477)
Q Consensus       219 ~~~~~~~-------------------------~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~  273 (477)
                      .+.+...                         ++...+..++||||+++|++.+.+..        ..+++..+..++.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--------~~~~~~~~~~i~~q  169 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--------KLSSLATAKSILHQ  169 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--------TCCCHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--------cCCCHHHHHHHHHH
Confidence            6653210                         01136789999999999976666632        34799999999999


Q ss_pred             HHHHHHHHH-cCCCCCeeecCCCCCCeEecCCC--------------------cEEEecccccccccccCCCCCCCcccc
Q 043902          274 VASALDYLH-NQYDTPIAHCDLKSSNVLLDEGM--------------------IAHVGDFGLAKFLFEESNTPSKNQTMS  332 (477)
Q Consensus       274 ia~~L~~LH-~~~~~~ivH~dlkp~NIll~~~~--------------------~~kl~DfG~a~~~~~~~~~~~~~~~~~  332 (477)
                      |+.||.||| +.   +|+||||||+|||++.++                    .+||+|||+|+....            
T Consensus       170 i~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------------  234 (336)
T 2vuw_A          170 LTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------------  234 (336)
T ss_dssp             HHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------------
T ss_pred             HHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------------
Confidence            999999999 88   999999999999999887                    999999999987521            


Q ss_pred             CCCcccccccCcccccCCCCcccceeehHHH-HHHHhhCCCCCCc
Q 043902          333 NGLKGSVGYIPPEYINGHVSILGDIYSYGIL-LLEIFTGKRPTDD  376 (477)
Q Consensus       333 ~~~~gt~~y~aPE~~~~~~~~~~Dv~S~Gvv-l~elltg~~p~~~  376 (477)
                      ....||..|+|||++.+..+.++||||+|++ .+++++|..||..
T Consensus       235 ~~~~gt~~y~aPE~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~  279 (336)
T 2vuw_A          235 GIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSN  279 (336)
T ss_dssp             TEEECCCCTTCSGGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred             CcEEEeecccChhhhcCCCccceehhhhhCCCCcccccccCCCcc
Confidence            1236899999999997767999999998777 7788889999853

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=1.6e-31  Score=275.07  Aligned_cols=185  Identities=18%  Similarity=0.069  Sum_probs=129.4

Q ss_pred             eeeeccceEEEEE-eCCCCEEEEEEeeecc----------chhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCCce
Q 043902          165 IGSGSFGSVYKGT-LADGETAAIKVLKLQQ----------QGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       165 lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .+.|+.|.+..++ ...|+.+++|++....          ....++|.+|+++|+++ .|+||+++++++     ++++.
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~~  316 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQS  316 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSSE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECCE
Confidence            4556666665554 3358899999997431          22346799999999999 699999999994     77889


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .||||||++|++|.++|...       ..++..   +|+.||+.||+|+|++   |||||||||+|||+++++.+||+||
T Consensus       317 ~yLVMEyv~G~~L~d~i~~~-------~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DF  383 (569)
T 4azs_A          317 GWLVMEKLPGRLLSDMLAAG-------EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDF  383 (569)
T ss_dssp             EEEEEECCCSEEHHHHHHTT-------CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEecCCCCcHHHHHHhC-------CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeec
Confidence            99999999999999999765       345554   4889999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccccCCCCcccceeehHHHHHHHhhCCCCC
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPT  374 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~S~Gvvl~elltg~~p~  374 (477)
                      |+|+....       .........||+.|+|||++.+++..++|+||+|++++++.++..++
T Consensus       384 GlAr~~~~-------~~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          384 GSIVTTPQ-------DCSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             TTEESCC----------CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHHH
T ss_pred             ccCeeCCC-------CCccccCceechhhccHHHhCCCCCCcccccccccchhhhccccchh
Confidence            99986532       11223346799999999999888899999999999998887765543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=1.7e-27  Score=243.86  Aligned_cols=190  Identities=16%  Similarity=0.126  Sum_probs=141.2

Q ss_pred             CCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccc--------hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          160 SEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQ--------GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       160 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      ...+.||+|+||.||+|.. .++.+++|.......        ...+.+.+|++++++++||||+++..++.     ..+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-----~~~  412 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV-----DLD  412 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE-----ETT
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE-----eCC
Confidence            3467899999999999955 578899998653221        12356899999999999999995555432     234


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+++++|.+++..               +..++.|+++||.|||++   +|+||||||+|||++.  .+||+|
T Consensus       413 ~~~lVmE~~~ggsL~~~l~~---------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~D  472 (540)
T 3en9_A          413 NKRIMMSYINGKLAKDVIED---------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIID  472 (540)
T ss_dssp             TTEEEEECCCSEEHHHHSTT---------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECC
T ss_pred             ccEEEEECCCCCCHHHHHHH---------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEE
Confidence            46999999999999999863               457999999999999999   9999999999999998  999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCccccc---CCCCcccceeehHHHHHHHhhCCCCCC
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN---GHVSILGDIYSYGILLLEIFTGKRPTD  375 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~Dv~S~Gvvl~elltg~~p~~  375 (477)
                      ||+++....................||+.|+|||++.   ..|+..+|+||..+-..+-+.++.+|.
T Consensus       473 FGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          473 FGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            9999876221000000000123567999999999994   357888999999999999888877763

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=2e-24  Score=202.93  Aligned_cols=139  Identities=17%  Similarity=0.181  Sum_probs=112.0

Q ss_pred             HHHhhcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccc------------------hhhHHHHHHHHHHhcCCCC
Q 043902          152 ISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQ------------------GALKSFIDECNALTSIRHR  213 (477)
Q Consensus       152 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~  213 (477)
                      +......|...+.||+|+||.||+|...+|+.||+|+++....                  .....+.+|++++++++  
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--  162 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--  162 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence            3344556677799999999999999997799999999964321                  13467899999999998  


Q ss_pred             CcceeeeecccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecC
Q 043902          214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCD  293 (477)
Q Consensus       214 niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~d  293 (477)
                      | +++.+++.      .+..++||||+++|+|.+ +...             ....++.|++.||.|||+.   +|+|||
T Consensus       163 ~-~~v~~~~~------~~~~~lvmE~~~g~~L~~-l~~~-------------~~~~i~~qi~~~l~~lH~~---giiHrD  218 (282)
T 1zar_A          163 G-LAVPKVYA------WEGNAVLMELIDAKELYR-VRVE-------------NPDEVLDMILEEVAKFYHR---GIVHGD  218 (282)
T ss_dssp             T-SSSCCEEE------EETTEEEEECCCCEEGGG-CCCS-------------CHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             C-CCcCeEEe------ccceEEEEEecCCCcHHH-cchh-------------hHHHHHHHHHHHHHHHHHC---CCEeCC
Confidence            4 55555431      244699999999999998 4321             2346999999999999999   999999


Q ss_pred             CCCCCeEecCCCcEEEeccccccc
Q 043902          294 LKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       294 lkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      |||+|||++ ++.+||+|||+++.
T Consensus       219 lkp~NILl~-~~~vkl~DFG~a~~  241 (282)
T 1zar_A          219 LSQYNVLVS-EEGIWIIDFPQSVE  241 (282)
T ss_dssp             CSTTSEEEE-TTEEEECCCTTCEE
T ss_pred             CCHHHEEEE-CCcEEEEECCCCeE
Confidence            999999999 99999999999964

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.81  E-value=2.9e-20  Score=172.43  Aligned_cols=137  Identities=19%  Similarity=0.222  Sum_probs=105.7

Q ss_pred             CCCCCCeeeeeccceEEEEEe-CCCCE--EEEEEeeeccch------------------------hhHHHHHHHHHHhcC
Q 043902          158 NFSEENLIGSGSFGSVYKGTL-ADGET--AAIKVLKLQQQG------------------------ALKSFIDECNALTSI  210 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l  210 (477)
                      -|...+.||+|+||.||+|.. .+|+.  ||||+++.....                        ....+.+|+..+.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            356778999999999999997 68888  999997643111                        113678999999999


Q ss_pred             CCCCc--ceeeeecccccCCCCceeeEEEeecCC-C----ChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHH-
Q 043902          211 RHRNI--LKIVSSCSSVDYEGNDFKALVFEFMRN-G----NLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLH-  282 (477)
Q Consensus       211 ~h~ni--v~l~~~~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-  282 (477)
                      .|+++  ..++++         ...++||||+.+ |    +|.++...          .++..+..++.|++.||.||| 
T Consensus       128 ~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~----------~~~~~~~~i~~qi~~~l~~lH~  188 (258)
T 1zth_A          128 KEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE----------LKELDVEGIFNDVVENVKRLYQ  188 (258)
T ss_dssp             HHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG----------GGGSCHHHHHHHHHHHHHHHHH
T ss_pred             HhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc----------cChHHHHHHHHHHHHHHHHHHH
Confidence            88764  334432         246899999942 4    66665431          223456789999999999999 


Q ss_pred             cCCCCCeeecCCCCCCeEecCCCcEEEecccccccc
Q 043902          283 NQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFL  318 (477)
Q Consensus       283 ~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  318 (477)
                      +.   +|+||||||+|||++.  .++|+|||+|...
T Consensus       189 ~~---givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          189 EA---ELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TS---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             HC---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            88   9999999999999998  8999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.71  E-value=1e-17  Score=161.41  Aligned_cols=136  Identities=15%  Similarity=0.199  Sum_probs=98.2

Q ss_pred             cCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccc--------------hhhHHH--------HHHHHHHhcCCCCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQ--------------GALKSF--------IDECNALTSIRHRN  214 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~~--------~~e~~~l~~l~h~n  214 (477)
                      .-|++...||+|++|.||+|...+|+.||||+++....              ......        .+|...|.++.+.+
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            34888999999999999999998999999999863211              001122        23455555553333


Q ss_pred             c--ceeeeecccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeec
Q 043902          215 I--LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHC  292 (477)
Q Consensus       215 i--v~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~  292 (477)
                      +  ...+++         ...++||||+++++|..+....             ....++.|++.+|.|||+.   +||||
T Consensus       175 v~vp~p~~~---------~~~~LVME~i~G~~L~~l~~~~-------------~~~~l~~qll~~l~~lH~~---gIVHr  229 (397)
T 4gyi_A          175 FPVPEPIAQ---------SRHTIVMSLVDALPMRQVSSVP-------------DPASLYADLIALILRLAKH---GLIHG  229 (397)
T ss_dssp             CSCCCEEEE---------ETTEEEEECCSCEEGGGCCCCS-------------CHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred             CCCCeeeec---------cCceEEEEecCCccHhhhcccH-------------HHHHHHHHHHHHHHHHHHC---CCcCC
Confidence            2  122221         1237999999999887664321             2346789999999999998   99999


Q ss_pred             CCCCCCeEecCCC----------cEEEeccccccc
Q 043902          293 DLKSSNVLLDEGM----------IAHVGDFGLAKF  317 (477)
Q Consensus       293 dlkp~NIll~~~~----------~~kl~DfG~a~~  317 (477)
                      ||||.|||+++++          .+.|+||+-+..
T Consensus       230 DLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          230 DFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             CCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            9999999998776          389999997754

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.49  E-value=1.5e-14  Score=154.85  Aligned_cols=92  Identities=42%  Similarity=0.700  Sum_probs=81.2

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcCCcc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGNDKL   80 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~~l   80 (477)
                      |+|++|+|+|.||.+|++|++|+.||||+|+|+|.||..+++|++|++||||+|+|+|.||....+.++....+.+|+.+
T Consensus       661 L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~L  740 (768)
T 3rgz_A          661 LNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGL  740 (768)
T ss_dssp             EECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEE
T ss_pred             EeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchh
Confidence            57899999999999999999999999999999999999999999999999999999999998887888888999999999


Q ss_pred             ccccccccCCcccCCC
Q 043902           81 CGGIQKLQLPECSRKN   96 (477)
Q Consensus        81 ~g~~~~~~~~~~~~~~   96 (477)
                      ||.+    ++.|...+
T Consensus       741 cg~~----l~~C~~~~  752 (768)
T 3rgz_A          741 CGYP----LPRCDPSN  752 (768)
T ss_dssp             ESTT----SCCCCSCC
T ss_pred             cCCC----CcCCCCCc
Confidence            9976    34675443

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.34  E-value=2.4e-12  Score=119.29  Aligned_cols=147  Identities=14%  Similarity=0.131  Sum_probs=112.3

Q ss_pred             HHhhcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCC-CCCcceeeeecccccCCCCc
Q 043902          153 SNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIR-HRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       153 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~  231 (477)
                      ......|+....++.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..+.++++++     ...+
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~-----~~~~   83 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDG   83 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETT
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEE-----ecCC
Confidence            344567877788888889999999864 6899999987533233356888999998884 67788888875     3456


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCC--------------------------
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQY--------------------------  285 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------  285 (477)
                      ..++||||++|.+|.+.+...            .....++.+++++|..||+..                          
T Consensus        84 ~~~lv~e~i~G~~l~~~~~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (263)
T 3tm0_A           84 WSNLLMSEADGVLCSEEYEDE------------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA  151 (263)
T ss_dssp             EEEEEEECCSSEEHHHHCCTT------------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred             ceEEEEEecCCeehhhccCCc------------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccc
Confidence            789999999999998764211            123467889999999999810                          


Q ss_pred             ------------------------------CCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          286 ------------------------------DTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       286 ------------------------------~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                                                    ...++|+|++|.||+++++..+.|+||+.+..
T Consensus       152 ~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                          13589999999999998766677999998754

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.24  E-value=3.8e-12  Score=136.30  Aligned_cols=85  Identities=32%  Similarity=0.469  Sum_probs=74.2

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccccc-ccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGI-FANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-~~~~~~~~~~~n~~   79 (477)
                      |+|++|+|+|.||.+|++|++|+.|+|++|+|+|.||.+|++|++|+.||||+|+|+|.+|.... +..+..+.+.+ |.
T Consensus       637 LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~-N~  715 (768)
T 3rgz_A          637 LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSN-NN  715 (768)
T ss_dssp             EECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCS-SE
T ss_pred             EECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcC-Cc
Confidence            58999999999999999999999999999999999999999999999999999999999998744 44555555555 46


Q ss_pred             ccccccc
Q 043902           80 LCGGIQK   86 (477)
Q Consensus        80 l~g~~~~   86 (477)
                      ++|.+|.
T Consensus       716 l~g~iP~  722 (768)
T 3rgz_A          716 LSGPIPE  722 (768)
T ss_dssp             EEEECCS
T ss_pred             ccccCCC
Confidence            7887654

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.22  E-value=6.5e-12  Score=119.59  Aligned_cols=83  Identities=31%  Similarity=0.445  Sum_probs=73.0

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcCCcc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGNDKL   80 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~~l   80 (477)
                      |+|++|++++.+|. ++.+++|++|+|++|+|+|.+|..|..+++|+.|+|++|+|+|.+|....+.++..+.+.+|+.+
T Consensus       226 L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~l  304 (313)
T 1ogq_A          226 IHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL  304 (313)
T ss_dssp             EECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEE
T ss_pred             EECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCc
Confidence            46777888766655 78888999999999999999999999999999999999999999998877888899999999999


Q ss_pred             cccc
Q 043902           81 CGGI   84 (477)
Q Consensus        81 ~g~~   84 (477)
                      ||.+
T Consensus       305 c~~p  308 (313)
T 1ogq_A          305 CGSP  308 (313)
T ss_dssp             ESTT
T ss_pred             cCCC
Confidence            9975

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.22  E-value=1.7e-11  Score=113.39  Aligned_cols=138  Identities=17%  Similarity=0.118  Sum_probs=98.2

Q ss_pred             cCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCC--cceeeeecccccCCCCceee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRN--ILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~~~~~~  234 (477)
                      .++....+.+.|..+.||++...+|+.+++|+....   ....+..|+++++.+.+.+  +.++++++     ..++..+
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~-----~~~~~~~   91 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDW   91 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEE
T ss_pred             CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEec-----cCCCCCE
Confidence            344433333455568999998877888999997643   2245778999988885444  45577764     3345689


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQY-----------------------------  285 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----------------------------  285 (477)
                      +||||++|.+|.  ...          .+   ...++.++++.|..||+..                             
T Consensus        92 ~v~e~i~G~~l~--~~~----------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (264)
T 1nd4_A           92 LLLGEVPGQDLL--SSH----------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQD  156 (264)
T ss_dssp             EEEECCSSEETT--TSC----------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTT
T ss_pred             EEEEecCCcccC--cCc----------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccch
Confidence            999999998884  211          11   1256778888888888742                             


Q ss_pred             --------------------------CCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          286 --------------------------DTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       286 --------------------------~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                                                ...++|+|++|.||+++++..+.|+|||.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          157 DLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             SCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                      11299999999999998876677999999764

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.16  E-value=3.4e-11  Score=103.68  Aligned_cols=82  Identities=28%  Similarity=0.339  Sum_probs=60.9

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~~   79 (477)
                      |+|++|+|++..|..|+++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|.. ..+.++..+.+.+|+.
T Consensus        35 L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~  114 (170)
T 3g39_A           35 LYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPW  114 (170)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCB
T ss_pred             EEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCC
Confidence            578888888766777888888888888888888655566788888888888888888655543 3456667777777765


Q ss_pred             ccc
Q 043902           80 LCG   82 (477)
Q Consensus        80 l~g   82 (477)
                      .|.
T Consensus       115 ~c~  117 (170)
T 3g39_A          115 DCA  117 (170)
T ss_dssp             CTT
T ss_pred             CCC
Confidence            554

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.15  E-value=3.5e-11  Score=103.97  Aligned_cols=81  Identities=26%  Similarity=0.331  Sum_probs=53.2

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~~   79 (477)
                      |+|++|+|++..|..|+++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+.. ..+.++..+.+.+|+.
T Consensus        38 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~  117 (174)
T 2r9u_A           38 LWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPW  117 (174)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCB
T ss_pred             EEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCc
Confidence            467777777666677777777777777777777544445677777777777777777544432 2355566666666654


Q ss_pred             cc
Q 043902           80 LC   81 (477)
Q Consensus        80 l~   81 (477)
                      -|
T Consensus       118 ~c  119 (174)
T 2r9u_A          118 DC  119 (174)
T ss_dssp             CT
T ss_pred             cc
Confidence            44

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.15  E-value=2.8e-11  Score=106.47  Aligned_cols=81  Identities=20%  Similarity=0.265  Sum_probs=55.4

Q ss_pred             CeecCCcccccCch-hccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccc-cccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPV-SLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREG-IFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~-~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~~~~~~~~~~~n~   78 (477)
                      |+|++|+|++..|. .++++++|++|+|++|+|++..|..|+.+++|+.|+|++|+|++..|... .+.++..+.+.+| 
T Consensus        34 L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-  112 (192)
T 1w8a_A           34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDN-  112 (192)
T ss_dssp             EECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSS-
T ss_pred             EECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCC-
Confidence            46778888744443 37788888888888888887777778888888888888888887666542 3455555555555 


Q ss_pred             cccc
Q 043902           79 KLCG   82 (477)
Q Consensus        79 ~l~g   82 (477)
                      .+.+
T Consensus       113 ~l~~  116 (192)
T 1w8a_A          113 QISC  116 (192)
T ss_dssp             CCCE
T ss_pred             cCCe
Confidence            3443

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.09  E-value=7.1e-11  Score=114.11  Aligned_cols=79  Identities=24%  Similarity=0.262  Sum_probs=44.5

Q ss_pred             CeecC-CcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcCCc
Q 043902            1 LYLGN-NSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~-n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~~   79 (477)
                      |+|++ |+|++..|..|++|++|+.|+|++|+|+|..|..|++|++|+.|+|++|+|++..|..+....+..+.+.+|+.
T Consensus        36 L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~L~~l~l~~N~~  115 (347)
T 2ifg_A           36 LYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL  115 (347)
T ss_dssp             EECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEECCSSCC
T ss_pred             EEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCCceEEEeeCCCc
Confidence            45554 66665444556666666666666666666555566666666666666666664443333333344444445543

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.07  E-value=4e-10  Score=109.36  Aligned_cols=146  Identities=15%  Similarity=0.160  Sum_probs=106.2

Q ss_pred             CCCeeeeeccceEEEEEeCCCCEEEEEEee--ecc-chhhHHHHHHHHHHhcCC--CCCcceeeeecccccCCCCceeeE
Q 043902          161 EENLIGSGSFGSVYKGTLADGETAAIKVLK--LQQ-QGALKSFIDECNALTSIR--HRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       161 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      ..+.|+.|.++.||+.... +..+++|+..  ... ......+.+|.++++.+.  +..+.+++++|...  ...+..++
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g~~~~  118 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIGRAFY  118 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTSSCEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccCCeEE
Confidence            3567899999999999875 4678888776  322 122356788999999886  45678888886432  11245789


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCC------------------------------
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQY------------------------------  285 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------  285 (477)
                      ||||++|.++.+...         ..++..++..++.++++.|+.||+..                              
T Consensus       119 vme~v~G~~l~~~~~---------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (359)
T 3dxp_A          119 IMEFVSGRVLWDQSL---------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS  189 (359)
T ss_dssp             EEECCCCBCCCCTTC---------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred             EEEecCCeecCCCcc---------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence            999999988754211         34678888999999999999999731                              


Q ss_pred             -------------------------CCCeeecCCCCCCeEecCCCc--EEEecccccccc
Q 043902          286 -------------------------DTPIAHCDLKSSNVLLDEGMI--AHVGDFGLAKFL  318 (477)
Q Consensus       286 -------------------------~~~ivH~dlkp~NIll~~~~~--~kl~DfG~a~~~  318 (477)
                                               ...++|||+++.||+++.++.  +.|.||+.+...
T Consensus       190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                     247999999999999997653  689999988653

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.05  E-value=3.6e-12  Score=128.94  Aligned_cols=79  Identities=27%  Similarity=0.130  Sum_probs=64.0

Q ss_pred             CeecCCcccccCchhcc-CCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLK-SLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~-~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~~   79 (477)
                      |+|++|+|+|.+|..+. ++++|++|+|++|.|++. |. +..+++|+.|+|++|+|++.+|....+.++..+.+.+| .
T Consensus       149 L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N-~  225 (487)
T 3oja_A          149 LDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNN-K  225 (487)
T ss_dssp             EECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTS-C
T ss_pred             EECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCC-c
Confidence            68999999998999886 899999999999999966 43 44699999999999999987666555667777777666 4


Q ss_pred             ccc
Q 043902           80 LCG   82 (477)
Q Consensus        80 l~g   82 (477)
                      +++
T Consensus       226 l~~  228 (487)
T 3oja_A          226 LVL  228 (487)
T ss_dssp             CCE
T ss_pred             Ccc
Confidence            554

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.04  E-value=1.8e-10  Score=103.52  Aligned_cols=82  Identities=20%  Similarity=0.223  Sum_probs=62.3

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccc-cccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREG-IFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~~~~~~~~~~~n~~   79 (477)
                      |+|++|+|++..|..|+++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|... .+.++..+.+.+| .
T Consensus        62 L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-~  140 (220)
T 2v70_A           62 INFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDN-Q  140 (220)
T ss_dssp             EECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTS-C
T ss_pred             EECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCC-c
Confidence            5788889987666688889999999999999987777778888899999999999887766653 3455555655555 4


Q ss_pred             cccc
Q 043902           80 LCGG   83 (477)
Q Consensus        80 l~g~   83 (477)
                      +.+.
T Consensus       141 l~~~  144 (220)
T 2v70_A          141 ITTV  144 (220)
T ss_dssp             CCCB
T ss_pred             CCEE
Confidence            4443

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.04  E-value=1.9e-10  Score=101.15  Aligned_cols=77  Identities=36%  Similarity=0.452  Sum_probs=62.0

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccc-cccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREG-IFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~~~~~~~~~~~n~   78 (477)
                      |+|++|+|+ .+|..|+++++|++|+|++|+|++..|..|..|++|+.|+|++|+|++..|..+ .+.++..+.+.+|.
T Consensus        36 L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~  113 (193)
T 2wfh_A           36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGND  113 (193)
T ss_dssp             EECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSC
T ss_pred             EECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCC
Confidence            578899998 889889999999999999999997777789999999999999999997666543 35566666666653

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.00  E-value=2.8e-10  Score=107.78  Aligned_cols=191  Identities=18%  Similarity=0.153  Sum_probs=122.3

Q ss_pred             CCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCC-CCC--cceeeeecccccCCCCceeeEEEe
Q 043902          162 ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIR-HRN--ILKIVSSCSSVDYEGNDFKALVFE  238 (477)
Q Consensus       162 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~~~~~~~~~lv~e  238 (477)
                      .+.++.|.+..||+..    ..+++|+....  .....+.+|.+.+..+. +..  +.+++..+..  ...-...++||+
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~--~~~~~~~~~vm~   96 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP--SETYQMSFAGFT   96 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC--CSSCSCSCEEEE
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCC--CCCCCcceEEEc
Confidence            4678999999999863    56888886533  23467889999998873 332  4455544321  011124589999


Q ss_pred             ecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------
Q 043902          239 FMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQY---------------------------------  285 (477)
Q Consensus       239 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---------------------------------  285 (477)
                      +++|.++.....         ..++..++..++.++++.|+.||+..                                 
T Consensus        97 ~i~G~~l~~~~~---------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (304)
T 3sg8_A           97 KIKGVPLTPLLL---------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG  167 (304)
T ss_dssp             CCCCEECCHHHH---------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred             ccCCeECCcccc---------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence            999988865322         33677778888888888888888611                                 


Q ss_pred             ----------------------CCCeeecCCCCCCeEecC--CCcEEEecccccccccccCCCCCCCccccCCC---cc-
Q 043902          286 ----------------------DTPIAHCDLKSSNVLLDE--GMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL---KG-  337 (477)
Q Consensus       286 ----------------------~~~ivH~dlkp~NIll~~--~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~---~g-  337 (477)
                                            .+.++|+|++|.||++++  +..+.|+||+.+......     .+.......   .+ 
T Consensus       168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-----~Dl~~~~~~~~~~~~  242 (304)
T 3sg8_A          168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-----NDFISLMEDDEEYGM  242 (304)
T ss_dssp             HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-----HHHHTTCCTTTSCCH
T ss_pred             ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-----HHHHHHHhhccccCH
Confidence                                  135899999999999998  566889999998654110     000000000   00 


Q ss_pred             --------cccccC-cccccCCCCcccceeehHHHHHHHhhCCCCCC
Q 043902          338 --------SVGYIP-PEYINGHVSILGDIYSYGILLLEIFTGKRPTD  375 (477)
Q Consensus       338 --------t~~y~a-PE~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~  375 (477)
                              ..+... |+.. .......+.|++|.++|.+.+|..+|.
T Consensus       243 ~~~~~~l~~Y~~~~~~~~~-~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          243 EFVSKILNHYKHKDIPTVL-EKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHHHHHHHTCSCHHHHH-HHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHHHHHHHHcCCCCcHHHH-HHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence                    001111 1211 011223589999999999999998863

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=98.97  E-value=3.3e-10  Score=99.51  Aligned_cols=82  Identities=22%  Similarity=0.320  Sum_probs=72.4

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccc-cccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREG-IFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~~~~~~~~~~~n~~   79 (477)
                      |+|++|+|++.+|..|+++++|++|+|++|+|++..|..|..+++|++|+|++|+|++.+|... .+.++..+.+.+|+.
T Consensus        59 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  138 (192)
T 1w8a_A           59 LELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF  138 (192)
T ss_dssp             EECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCB
T ss_pred             EECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCc
Confidence            6899999998889999999999999999999998888889999999999999999999888763 366777788888876


Q ss_pred             ccc
Q 043902           80 LCG   82 (477)
Q Consensus        80 l~g   82 (477)
                      -|.
T Consensus       139 ~c~  141 (192)
T 1w8a_A          139 NCN  141 (192)
T ss_dssp             CCS
T ss_pred             cCc
Confidence            554

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=98.95  E-value=8.4e-10  Score=96.97  Aligned_cols=81  Identities=28%  Similarity=0.294  Sum_probs=53.0

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~~   79 (477)
                      |+|++|+|++..|..|++|++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+.. ..+.++..+.+.+|+.
T Consensus        59 L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~  138 (193)
T 2wfh_A           59 IDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPL  138 (193)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCE
T ss_pred             EECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCe
Confidence            467777777555566777777777777777777666666777777777777777777433332 2245556666666655


Q ss_pred             cc
Q 043902           80 LC   81 (477)
Q Consensus        80 l~   81 (477)
                      .|
T Consensus       139 ~C  140 (193)
T 2wfh_A          139 YC  140 (193)
T ss_dssp             EC
T ss_pred             ec
Confidence            44

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=98.92  E-value=4.1e-10  Score=107.10  Aligned_cols=81  Identities=35%  Similarity=0.632  Sum_probs=66.4

Q ss_pred             Ceec-CCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccc-cccccchhhhhcCC
Q 043902            1 LYLG-NNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREG-IFANASAISIVGND   78 (477)
Q Consensus         1 l~l~-~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~~~~~~~~~~~n~   78 (477)
                      |+|+ +|+++|.+|.+|+++++|++|+|++|+++|.+|..|+.+++|++|+|++|+|+|.+|... .+.++..+.+.+| 
T Consensus        81 L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-  159 (313)
T 1ogq_A           81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN-  159 (313)
T ss_dssp             EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS-
T ss_pred             eeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC-
Confidence            5778 499999999999999999999999999999999999999999999999999998888763 3556666666655 


Q ss_pred             cccc
Q 043902           79 KLCG   82 (477)
Q Consensus        79 ~l~g   82 (477)
                      .+.|
T Consensus       160 ~l~~  163 (313)
T 1ogq_A          160 RISG  163 (313)
T ss_dssp             CCEE
T ss_pred             cccC
Confidence            4443

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=98.92  E-value=1.2e-09  Score=94.62  Aligned_cols=82  Identities=23%  Similarity=0.221  Sum_probs=63.3

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~~   79 (477)
                      |+|++|+|++..|..++++++|++|+|++|+|++..|..|+.+++|+.|+|++|+|++..+.. ..+.++..+.+.+| .
T Consensus        33 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N-~  111 (177)
T 2o6r_A           33 LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTN-Q  111 (177)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS-C
T ss_pred             EEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCC-c
Confidence            578999999655566899999999999999999666667899999999999999999766654 33566666666666 4


Q ss_pred             cccc
Q 043902           80 LCGG   83 (477)
Q Consensus        80 l~g~   83 (477)
                      +.+-
T Consensus       112 l~~~  115 (177)
T 2o6r_A          112 LKSV  115 (177)
T ss_dssp             CSCC
T ss_pred             ceEe
Confidence            5443

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=98.91  E-value=1.1e-09  Score=98.37  Aligned_cols=81  Identities=27%  Similarity=0.298  Sum_probs=63.4

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccc-cccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREG-IFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~~~~~~~~~~~n~~   79 (477)
                      |+|++|+|++..|..|+++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..|..+ .+.++..+.+.+| .
T Consensus        61 L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~  139 (220)
T 2v9t_B           61 IDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDN-K  139 (220)
T ss_dssp             EECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS-C
T ss_pred             EECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCC-c
Confidence            5789999998888999999999999999999994444557889999999999999998777653 3556666666655 3


Q ss_pred             ccc
Q 043902           80 LCG   82 (477)
Q Consensus        80 l~g   82 (477)
                      +.+
T Consensus       140 l~~  142 (220)
T 2v9t_B          140 LQT  142 (220)
T ss_dssp             CSC
T ss_pred             CCE
Confidence            443

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=98.91  E-value=1.3e-09  Score=97.86  Aligned_cols=81  Identities=19%  Similarity=0.206  Sum_probs=65.1

Q ss_pred             CeecCCcccccCch-hccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccc-cccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPV-SLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREG-IFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~-~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~~~~~~~~~~~n~   78 (477)
                      |+|++|+|++..|. .|+++++|++|+|++|+|++..|..|+.+++|+.|+|++|+|++..|..+ .+.++..+.+.+|.
T Consensus        37 L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  116 (220)
T 2v70_A           37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNR  116 (220)
T ss_dssp             EECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSC
T ss_pred             EEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCc
Confidence            57899999976564 48999999999999999997777789999999999999999997776543 35666666666664


Q ss_pred             cccc
Q 043902           79 KLCG   82 (477)
Q Consensus        79 ~l~g   82 (477)
                       +.+
T Consensus       117 -l~~  119 (220)
T 2v70_A          117 -ITC  119 (220)
T ss_dssp             -CCC
T ss_pred             -CCe
Confidence             444

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=98.91  E-value=9.3e-10  Score=114.97  Aligned_cols=81  Identities=26%  Similarity=0.308  Sum_probs=56.7

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccccc-c-cccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGI-F-ANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-~-~~~~~~~~~~n~   78 (477)
                      |+|++|+|++.+|..|++|++|++|+|++|+|++..|..|+.|++|+.|||++|+|++.+|.... + .++..+.+.+|+
T Consensus       499 L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np  578 (635)
T 4g8a_A          499 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND  578 (635)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCC
T ss_pred             EECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCC
Confidence            46777777776677777777777777777777766666777777777777777777776666532 2 355666677776


Q ss_pred             ccc
Q 043902           79 KLC   81 (477)
Q Consensus        79 ~l~   81 (477)
                      ..|
T Consensus       579 ~~C  581 (635)
T 4g8a_A          579 FAC  581 (635)
T ss_dssp             BCC
T ss_pred             Ccc
Confidence            655

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=98.89  E-value=1.5e-09  Score=98.24  Aligned_cols=80  Identities=29%  Similarity=0.419  Sum_probs=59.1

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~~   79 (477)
                      |+|++|+|++..|..|+.+++|++|+|++|+|++..|..|..+++|+.|+|++|+|+ .+|.. ..+.++..+.+.+| .
T Consensus        69 L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N-~  146 (229)
T 3e6j_A           69 LYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN-Q  146 (229)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSS-C
T ss_pred             EECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCC-c
Confidence            578889997433345788999999999999999666667888999999999999998 66654 34556666666655 4


Q ss_pred             ccc
Q 043902           80 LCG   82 (477)
Q Consensus        80 l~g   82 (477)
                      +.+
T Consensus       147 l~~  149 (229)
T 3e6j_A          147 LKS  149 (229)
T ss_dssp             CCC
T ss_pred             CCc
Confidence            443

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=98.86  E-value=1.6e-09  Score=90.87  Aligned_cols=79  Identities=23%  Similarity=0.265  Sum_probs=68.1

Q ss_pred             CeecCCccc-ccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccccc-ccccchhhhhcCC
Q 043902            1 LYLGNNSFK-GTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGI-FANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~-g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-~~~~~~~~~~~n~   78 (477)
                      |+|++|+++ |.+|..++.+++|++|+|++|++++.  ..++.+++|++|+|++|++++.+|.... +.++..+.+.+|.
T Consensus        22 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~   99 (149)
T 2je0_A           22 LVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNK   99 (149)
T ss_dssp             EECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSC
T ss_pred             EEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCc
Confidence            579999999 89999999999999999999999965  7899999999999999999987887644 6777777777764


Q ss_pred             cccc
Q 043902           79 KLCG   82 (477)
Q Consensus        79 ~l~g   82 (477)
                       +.+
T Consensus       100 -i~~  102 (149)
T 2je0_A          100 -IKD  102 (149)
T ss_dssp             -CCS
T ss_pred             -CCC
Confidence             444

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=98.85  E-value=2.9e-09  Score=101.88  Aligned_cols=76  Identities=17%  Similarity=0.184  Sum_probs=39.6

Q ss_pred             eecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCC
Q 043902            2 YLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGND   78 (477)
Q Consensus         2 ~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~   78 (477)
                      +|++|+|+ .+|.+++++++|++|+|++|++.|.+|..|+.+++|+.|+|++|++.+.+|.. ..+.++..+.+.+|+
T Consensus       212 ~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~  288 (328)
T 4fcg_A          212 KIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCV  288 (328)
T ss_dssp             EEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCT
T ss_pred             EccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCC
Confidence            45555555 34445555555555555555555555555555555555555555555555543 223344444444443

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=98.85  E-value=2.2e-09  Score=110.18  Aligned_cols=77  Identities=25%  Similarity=0.322  Sum_probs=48.9

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcCCcc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGNDKL   80 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~~l   80 (477)
                      |+|++|+|+ .+|. +++|++|+.|+|++|+|+ .+|..|+.|++|+.|+|++|+|++ +|....+.++..+.+.+| .+
T Consensus       446 L~Ls~n~l~-~lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp~l~~l~~L~~L~Ls~N-~l  520 (567)
T 1dce_A          446 LHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNN-RL  520 (567)
T ss_dssp             EECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSS-CC
T ss_pred             EEecCCCCC-CCcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-CcccCCCCCCcEEECCCC-CC
Confidence            466777777 3665 777777777777777777 667777777777777777777775 554344555555555444 34


Q ss_pred             cc
Q 043902           81 CG   82 (477)
Q Consensus        81 ~g   82 (477)
                      .+
T Consensus       521 ~~  522 (567)
T 1dce_A          521 QQ  522 (567)
T ss_dssp             CS
T ss_pred             CC
Confidence            44

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=98.85  E-value=3e-09  Score=95.51  Aligned_cols=81  Identities=23%  Similarity=0.236  Sum_probs=66.3

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~~   79 (477)
                      |+|++|+|++..|..|+.+++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+.. ..+.++..+.+.+|. 
T Consensus        37 L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~-  115 (220)
T 2v9t_B           37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANK-  115 (220)
T ss_dssp             EECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC-
T ss_pred             EECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCC-
Confidence            589999999666668999999999999999999888999999999999999999999544433 235666667666664 


Q ss_pred             ccc
Q 043902           80 LCG   82 (477)
Q Consensus        80 l~g   82 (477)
                      +.+
T Consensus       116 l~~  118 (220)
T 2v9t_B          116 INC  118 (220)
T ss_dssp             CCC
T ss_pred             CCE
Confidence            444

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=98.84  E-value=2.5e-09  Score=92.19  Aligned_cols=78  Identities=18%  Similarity=0.279  Sum_probs=65.2

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~~   79 (477)
                      +++++|+|+ .||..+.  ++|++|+|++|+|++..|..|+.+++|+.|+|++|+|++..+.. ..+.++..+.+.+| .
T Consensus        17 l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N-~   92 (174)
T 2r9u_A           17 VNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN-H   92 (174)
T ss_dssp             EECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS-C
T ss_pred             EEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC-c
Confidence            578999998 9999875  89999999999999888999999999999999999999755544 34667777777666 4


Q ss_pred             ccc
Q 043902           80 LCG   82 (477)
Q Consensus        80 l~g   82 (477)
                      +.+
T Consensus        93 l~~   95 (174)
T 2r9u_A           93 LKS   95 (174)
T ss_dssp             CCC
T ss_pred             cce
Confidence            444

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=98.82  E-value=3.5e-09  Score=97.14  Aligned_cols=77  Identities=26%  Similarity=0.298  Sum_probs=57.4

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n   77 (477)
                      |+|++|+|++..|..|+.+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|.. ..+.++..+.+.+|
T Consensus        88 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  165 (251)
T 3m19_A           88 LGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTN  165 (251)
T ss_dssp             EECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             EECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCC
Confidence            578888888655566888888888888888888655566788888888888888888655543 33556666666655

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=98.81  E-value=5.3e-09  Score=90.43  Aligned_cols=77  Identities=23%  Similarity=0.205  Sum_probs=36.1

Q ss_pred             eecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCC
Q 043902            2 YLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGND   78 (477)
Q Consensus         2 ~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~   78 (477)
                      +|++|+|++..|..++++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+.. ..+.++..+.+.+|+
T Consensus        58 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~  135 (177)
T 2o6r_A           58 SLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP  135 (177)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             ECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCC
Confidence            45555555333333455555555555555555444444455555555555555555332222 123344444444443

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=98.81  E-value=4.4e-09  Score=90.32  Aligned_cols=80  Identities=20%  Similarity=0.236  Sum_probs=66.0

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~~   79 (477)
                      |++++|+|+ .+|..+.  ++|++|+|++|+|++..|..|+.+++|++|+|++|+|++..|.. ..+.++..+.+.+| .
T Consensus        14 l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N-~   89 (170)
T 3g39_A           14 VDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN-Q   89 (170)
T ss_dssp             EECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS-C
T ss_pred             EEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC-c
Confidence            578999999 7998874  89999999999999888999999999999999999999766654 34666777777666 4


Q ss_pred             ccccc
Q 043902           80 LCGGI   84 (477)
Q Consensus        80 l~g~~   84 (477)
                      +.+.+
T Consensus        90 l~~~~   94 (170)
T 3g39_A           90 LKSIP   94 (170)
T ss_dssp             CCCCC
T ss_pred             cCEeC
Confidence            55433

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=98.80  E-value=4.4e-09  Score=95.09  Aligned_cols=78  Identities=28%  Similarity=0.294  Sum_probs=60.0

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~   78 (477)
                      |+|++|+|++..|..|+++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+.. ..+.++..+.+.+|.
T Consensus        45 L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~  123 (229)
T 3e6j_A           45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNK  123 (229)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCc
Confidence            578899999877888899999999999999998444456788999999999999998655544 335666666666553

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=98.80  E-value=5e-09  Score=93.13  Aligned_cols=77  Identities=27%  Similarity=0.361  Sum_probs=58.0

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n   77 (477)
                      |+|++|+|++..|..|+++++|++|+|++|+|++..|..|+.+++|++|+|++|+|++..+.. ..+.++..+.+.+|
T Consensus        57 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  134 (208)
T 2o6s_A           57 LYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQN  134 (208)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             EECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCC
Confidence            578889998544455788999999999999998665666788899999999999988665543 33556666666665

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=98.79  E-value=3.7e-09  Score=101.13  Aligned_cols=64  Identities=17%  Similarity=0.007  Sum_probs=61.5

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREG   64 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~   64 (477)
                      |+|++|++.|.+|..++++++|++|+|++|++.+.+|..++++++|+.|+|++|++.|.+|...
T Consensus       234 L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l  297 (328)
T 4fcg_A          234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLI  297 (328)
T ss_dssp             EECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGG
T ss_pred             EECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHH
Confidence            6899999999999999999999999999999999999999999999999999999999999873

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=98.78  E-value=2.1e-09  Score=116.30  Aligned_cols=77  Identities=27%  Similarity=0.362  Sum_probs=57.0

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcCCcc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGNDKL   80 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~~l   80 (477)
                      |+|++|+|++.+|..|+++++|+.|+|++|+|++..|..+.  ++|+.|||++|+|+|.+|..  +.++..+.+.+|+..
T Consensus       485 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~  560 (844)
T 3j0a_A          485 LYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFI  560 (844)
T ss_dssp             CCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCC
T ss_pred             EECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCcc
Confidence            56777777766666777888888888888888765555555  67888888888888777765  346677788888887


Q ss_pred             c
Q 043902           81 C   81 (477)
Q Consensus        81 ~   81 (477)
                      |
T Consensus       561 C  561 (844)
T 3j0a_A          561 C  561 (844)
T ss_dssp             C
T ss_pred             c
Confidence            7

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=98.78  E-value=5.2e-09  Score=100.91  Aligned_cols=80  Identities=16%  Similarity=0.086  Sum_probs=66.7

Q ss_pred             eecCC-cccccCchhccCCCCCCeEECCC-CccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCC
Q 043902            2 YLGNN-SFKGTIPVSLKSLRGLAELDLSC-NNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGND   78 (477)
Q Consensus         2 ~l~~n-~~~g~~p~~~~~l~~L~~l~l~~-N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~   78 (477)
                      ++++| +|+ .||. |+.+++|++|+|++ |+|++..|..|+.|++|+.|+|++|+|+|.+|.. ..+.++..+.+.+| 
T Consensus        14 ~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N-   90 (347)
T 2ifg_A           14 RCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN-   90 (347)
T ss_dssp             ECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS-
T ss_pred             EcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC-
Confidence            56777 899 7999 99999999999996 9999777789999999999999999999988876 34666666666665 


Q ss_pred             cccccc
Q 043902           79 KLCGGI   84 (477)
Q Consensus        79 ~l~g~~   84 (477)
                      .|.+-+
T Consensus        91 ~l~~~~   96 (347)
T 2ifg_A           91 ALESLS   96 (347)
T ss_dssp             CCSCCC
T ss_pred             ccceeC
Confidence            555543

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=98.77  E-value=2.5e-09  Score=91.67  Aligned_cols=79  Identities=28%  Similarity=0.280  Sum_probs=67.4

Q ss_pred             CeecCCccc-ccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccccc-ccccchhhhhcCC
Q 043902            1 LYLGNNSFK-GTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGI-FANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~-g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-~~~~~~~~~~~n~   78 (477)
                      |+|++|+++ |.+|..++.+++|++|+|++|.|++.  ..++.+++|+.|+|++|++++.+|.... +.++..+.+.+| 
T Consensus        29 L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N-  105 (168)
T 2ell_A           29 LVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGN-  105 (168)
T ss_dssp             EECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSS-
T ss_pred             EECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCC-
Confidence            578999998 89999999999999999999999965  7899999999999999999987887654 677777777776 


Q ss_pred             cccc
Q 043902           79 KLCG   82 (477)
Q Consensus        79 ~l~g   82 (477)
                      .+.+
T Consensus       106 ~l~~  109 (168)
T 2ell_A          106 KLKD  109 (168)
T ss_dssp             SCCS
T ss_pred             ccCc
Confidence            4444

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=98.77  E-value=7e-09  Score=96.38  Aligned_cols=82  Identities=26%  Similarity=0.303  Sum_probs=60.8

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~~   79 (477)
                      |+|++|++++..|..++++++|++|+|++|+|++..|..|+.+++|+.|+|++|+|++..|.. ..+.++..+.+.+| .
T Consensus       114 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N-~  192 (272)
T 3rfs_A          114 LVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQN-Q  192 (272)
T ss_dssp             EECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS-C
T ss_pred             EECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCC-c
Confidence            578888888666666888888888888888888666667788888888888888888666554 33556666666555 3


Q ss_pred             cccc
Q 043902           80 LCGG   83 (477)
Q Consensus        80 l~g~   83 (477)
                      +.+.
T Consensus       193 l~~~  196 (272)
T 3rfs_A          193 LKSV  196 (272)
T ss_dssp             CSCC
T ss_pred             CCcc
Confidence            4443

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=98.76  E-value=4.8e-09  Score=92.41  Aligned_cols=74  Identities=19%  Similarity=0.224  Sum_probs=34.9

Q ss_pred             eecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcC
Q 043902            2 YLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGN   77 (477)
Q Consensus         2 ~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n   77 (477)
                      +|++|.++ .+ ..++.+++|++|+|++|++++..|..|+.|++|++|+|++|++++..|.. ..+.++..+.+.+|
T Consensus        72 ~l~~n~~~-~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n  146 (197)
T 4ezg_A           72 TINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYN  146 (197)
T ss_dssp             EEESCCCS-CC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSC
T ss_pred             EccCCCCC-cc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCC
Confidence            44555443 22 24555555555555555555545555555555555555555555433332 22333444444444

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=98.76  E-value=2.3e-09  Score=113.51  Aligned_cols=74  Identities=31%  Similarity=0.503  Sum_probs=53.8

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n   77 (477)
                      |+|++|+|+ .||.+|++|++|++|+|++|+|+ .||..|++|++|++|+|++|.|+ .+|.. ..+.++..+.+.+|
T Consensus       252 L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N  326 (727)
T 4b8c_D          252 LYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGN  326 (727)
T ss_dssp             CBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTS
T ss_pred             EEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCC
Confidence            577888888 78877888888888888888888 77877888888888888888776 66654 33445555555544

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=98.75  E-value=5.8e-09  Score=89.31  Aligned_cols=75  Identities=28%  Similarity=0.280  Sum_probs=54.5

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcC--cccccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI--SREGIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~--p~~~~~~~~~~~~~~~n   77 (477)
                      |+|++|.|++.  ..++.+++|++|+|++|++++.+|..+..+++|++|+|++|+|++..  +....+.++..+.+.+|
T Consensus        54 L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N  130 (168)
T 2ell_A           54 LSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC  130 (168)
T ss_dssp             EEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSS
T ss_pred             EeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCC
Confidence            57788888844  67888888888888888888778877777888888888888888632  22233555666666555

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=98.74  E-value=5.9e-09  Score=110.41  Aligned_cols=61  Identities=25%  Similarity=0.312  Sum_probs=31.7

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE   63 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~   63 (477)
                      |+|++|+|+ .||.+|++|++|++|+|++|.|+ .||..|++|++|+.|+|++|.|+|.+|..
T Consensus       275 L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~  335 (727)
T 4b8c_D          275 LDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKI  335 (727)
T ss_dssp             EECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHH
T ss_pred             EeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHH
Confidence            345555555 45555555555555555555554 45555555555555555555555554443

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=98.73  E-value=3.7e-09  Score=88.57  Aligned_cols=79  Identities=25%  Similarity=0.294  Sum_probs=64.1

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCc-Cccc-ccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGE-ISRE-GIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~-~p~~-~~~~~~~~~~~~~n~   78 (477)
                      |+|++|++++.  ..++++++|++|+|++|.+++.+|..++.+++|++|+|++|++++. .|.. ..+.++..+.+.+| 
T Consensus        47 L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N-  123 (149)
T 2je0_A           47 LSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC-  123 (149)
T ss_dssp             EECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTC-
T ss_pred             EECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCC-
Confidence            57899999954  7899999999999999999988999999999999999999999973 2233 44566677777666 


Q ss_pred             cccc
Q 043902           79 KLCG   82 (477)
Q Consensus        79 ~l~g   82 (477)
                      .+++
T Consensus       124 ~l~~  127 (149)
T 2je0_A          124 EVTN  127 (149)
T ss_dssp             GGGG
T ss_pred             cccc
Confidence            4444

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=98.72  E-value=1.4e-08  Score=93.10  Aligned_cols=81  Identities=22%  Similarity=0.254  Sum_probs=62.3

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~~   79 (477)
                      |+|++|++++..|..|+++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|.. ..+.++..+.+.+| .
T Consensus        40 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N-~  118 (251)
T 3m19_A           40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGN-Q  118 (251)
T ss_dssp             EECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSS-C
T ss_pred             EEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCC-c
Confidence            578888998777778889999999999999999877778888999999999999998655544 23556666666555 4


Q ss_pred             ccc
Q 043902           80 LCG   82 (477)
Q Consensus        80 l~g   82 (477)
                      +.+
T Consensus       119 l~~  121 (251)
T 3m19_A          119 LKS  121 (251)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            443

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=98.71  E-value=5.5e-09  Score=109.27  Aligned_cols=77  Identities=10%  Similarity=0.130  Sum_probs=65.4

Q ss_pred             CCcccccCchhccCCCCCCeEECCCCccCcc-----------------cCcccC--CCCCCCeEEcccccccCcCccc-c
Q 043902            5 NNSFKGTIPVSLKSLRGLAELDLSCNNLSGK-----------------VPQFFS--KLLSLRHLNLSYNELDGEISRE-G   64 (477)
Q Consensus         5 ~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~-----------------~p~~~~--~l~~L~~l~l~~N~l~g~~p~~-~   64 (477)
                      +|+|+| ||.+|++|++|++|+|++|+|+|.                 +|..++  +|++|++|+|++|+++|.+|.. .
T Consensus       192 ~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~  270 (636)
T 4eco_A          192 SNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK  270 (636)
T ss_dssp             SCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTT
T ss_pred             cCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHh
Confidence            789998 999999999999999999999986                 999988  9999999999999999999976 3


Q ss_pred             cccccchhhhhcCCcccc
Q 043902           65 IFANASAISIVGNDKLCG   82 (477)
Q Consensus        65 ~~~~~~~~~~~~n~~l~g   82 (477)
                      .+.++..+.+.+|..+.|
T Consensus       271 ~l~~L~~L~Ls~n~~l~~  288 (636)
T 4eco_A          271 ALPEMQLINVACNRGISG  288 (636)
T ss_dssp             TCSSCCEEECTTCTTSCH
T ss_pred             cCCCCCEEECcCCCCCcc
Confidence            366777777777765665

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=98.71  E-value=7.5e-09  Score=106.27  Aligned_cols=80  Identities=29%  Similarity=0.355  Sum_probs=68.9

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcC-ccc-ccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI-SRE-GIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~-p~~-~~~~~~~~~~~~~n~   78 (477)
                      |+|++|+|+ .||..|++|++|+.|+|++|+|++ || .|+.|++|+.|+|++|+|++.+ |.. ..+.++..+.+.+| 
T Consensus       468 L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N-  543 (567)
T 1dce_A          468 LDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN-  543 (567)
T ss_dssp             EECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTS-
T ss_pred             eecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCC-
Confidence            689999999 999999999999999999999996 88 8999999999999999999886 665 44667777777766 


Q ss_pred             cccccc
Q 043902           79 KLCGGI   84 (477)
Q Consensus        79 ~l~g~~   84 (477)
                      .+++.+
T Consensus       544 ~l~~~~  549 (567)
T 1dce_A          544 SLCQEE  549 (567)
T ss_dssp             GGGGSS
T ss_pred             cCCCCc
Confidence            455544

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=98.71  E-value=1.4e-08  Score=95.26  Aligned_cols=78  Identities=23%  Similarity=0.196  Sum_probs=62.3

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccc-cccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREG-IFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~~~~~~~~~~~n~   78 (477)
                      |+|++|+|++..|..|+++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+ .+.++..+.+.+|.
T Consensus       105 L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~  183 (290)
T 1p9a_G          105 LDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS  183 (290)
T ss_dssp             EECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCc
Confidence            5789999996666789999999999999999997666778999999999999999995444332 35666666666664

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=98.69  E-value=5.9e-09  Score=111.81  Aligned_cols=35  Identities=23%  Similarity=0.312  Sum_probs=27.6

Q ss_pred             CeecCCcccccCchhccCCCCCCeEEC-CCCccCcc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDL-SCNNLSGK   35 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l-~~N~l~g~   35 (477)
                      |+|++|+|+|.||++|++|++|++||| ++|.|+|.
T Consensus       328 L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~  363 (876)
T 4ecn_A          328 LSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG  363 (876)
T ss_dssp             EECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHT
T ss_pred             EECccCCCCCcCchHHhccccceEeeeccccccccc
Confidence            577888888888888888888888888 77766555

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=98.69  E-value=1.5e-08  Score=95.74  Aligned_cols=81  Identities=28%  Similarity=0.304  Sum_probs=62.8

Q ss_pred             CeecCCcccc-cCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCC
Q 043902            1 LYLGNNSFKG-TIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g-~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~   78 (477)
                      |+|++|.+++ .+|..++.+++|++|+|++|++++..|..|..+++|+.|+|++|++++..+.. ..+.++..+.+.+| 
T Consensus       155 L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-  233 (306)
T 2z66_A          155 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN-  233 (306)
T ss_dssp             EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTS-
T ss_pred             EECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCC-
Confidence            5788899987 57888999999999999999999877888889999999999999998655533 23556666666666 


Q ss_pred             cccc
Q 043902           79 KLCG   82 (477)
Q Consensus        79 ~l~g   82 (477)
                      .+.+
T Consensus       234 ~l~~  237 (306)
T 2z66_A          234 HIMT  237 (306)
T ss_dssp             CCCB
T ss_pred             CCcc
Confidence            3443

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=98.69  E-value=1.3e-08  Score=101.94  Aligned_cols=81  Identities=25%  Similarity=0.213  Sum_probs=43.6

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~~   79 (477)
                      |+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+.. ..+.++..+.+.+|+.
T Consensus       223 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~  302 (452)
T 3zyi_A          223 LEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW  302 (452)
T ss_dssp             EECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCE
T ss_pred             EECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCc
Confidence            345555555555555666666666666666666555555566666666666666665433332 1234444455555544


Q ss_pred             cc
Q 043902           80 LC   81 (477)
Q Consensus        80 l~   81 (477)
                      -|
T Consensus       303 ~C  304 (452)
T 3zyi_A          303 NC  304 (452)
T ss_dssp             EC
T ss_pred             CC
Confidence            33

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=98.68  E-value=1.2e-08  Score=101.66  Aligned_cols=81  Identities=23%  Similarity=0.193  Sum_probs=43.5

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~~   79 (477)
                      |+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+.. ..+.++..+.+.+|+.
T Consensus       212 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~  291 (440)
T 3zyj_A          212 LDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW  291 (440)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCE
T ss_pred             EECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCc
Confidence            345555555555555555666666666666665555555555666666666666665433332 1234444555555554


Q ss_pred             cc
Q 043902           80 LC   81 (477)
Q Consensus        80 l~   81 (477)
                      .|
T Consensus       292 ~C  293 (440)
T 3zyj_A          292 NC  293 (440)
T ss_dssp             EC
T ss_pred             cC
Confidence            43

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=98.67  E-value=1.8e-08  Score=100.88  Aligned_cols=77  Identities=26%  Similarity=0.264  Sum_probs=53.6

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n   77 (477)
                      |+|++|++++..|..|+++++|++|+|++|.+++..|..|+.+++|+.|+|++|++++..|.. ..+.++..+.+.+|
T Consensus       304 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  381 (455)
T 3v47_A          304 LTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTN  381 (455)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCC
Confidence            467777777666777777777777777777777666777777777777777777777666654 23455555555554

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=98.67  E-value=2.5e-08  Score=88.59  Aligned_cols=81  Identities=30%  Similarity=0.297  Sum_probs=64.4

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~~   79 (477)
                      |+|++|+|++..|..++++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+.. ..+.++..+.+.+| .
T Consensus        33 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N-~  111 (208)
T 2o6s_A           33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTN-Q  111 (208)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS-C
T ss_pred             EEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCC-c
Confidence            589999999655566899999999999999999666667899999999999999999665544 34666777766666 4


Q ss_pred             ccc
Q 043902           80 LCG   82 (477)
Q Consensus        80 l~g   82 (477)
                      +.+
T Consensus       112 l~~  114 (208)
T 2o6s_A          112 LQS  114 (208)
T ss_dssp             CCC
T ss_pred             Ccc
Confidence            443

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=98.67  E-value=5.2e-09  Score=109.44  Aligned_cols=78  Identities=23%  Similarity=0.422  Sum_probs=67.4

Q ss_pred             CeecCCccccc-----------------Cchhcc--CCCCCCeEECCCCccCcccCcccCCCCCCCeEEccccc-ccC-c
Q 043902            1 LYLGNNSFKGT-----------------IPVSLK--SLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNE-LDG-E   59 (477)
Q Consensus         1 l~l~~n~~~g~-----------------~p~~~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~-l~g-~   59 (477)
                      |+|++|+|+|.                 +|.+++  +|++|++|+|++|+++|.+|..|++|++|++|+|++|+ |+| .
T Consensus       211 L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~  290 (636)
T 4eco_A          211 FYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQ  290 (636)
T ss_dssp             EEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHH
T ss_pred             EECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCcccc
Confidence            68999999986                 999999  99999999999999999999999999999999999998 999 8


Q ss_pred             Cccccc-c------cccchhhhhcCC
Q 043902           60 ISREGI-F------ANASAISIVGND   78 (477)
Q Consensus        60 ~p~~~~-~------~~~~~~~~~~n~   78 (477)
                      +|.... +      .++..+.+.+|.
T Consensus       291 lp~~~~~L~~~~~l~~L~~L~L~~n~  316 (636)
T 4eco_A          291 LKDDWQALADAPVGEKIQIIYIGYNN  316 (636)
T ss_dssp             HHHHHHHHHHSGGGGTCCEEECCSSC
T ss_pred             chHHHHhhhccccCCCCCEEECCCCc
Confidence            887633 2      566666666654

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=98.67  E-value=1.3e-08  Score=95.10  Aligned_cols=77  Identities=23%  Similarity=0.253  Sum_probs=55.1

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccc-cccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREG-IFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~~~~~~~~~~~n   77 (477)
                      |+|++|++++..|..++++++|++|+|++|+|++..+..|..+++|+.|+|++|++++..|... .+.++..+.+.+|
T Consensus       134 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  211 (285)
T 1ozn_A          134 LYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN  211 (285)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCC
Confidence            5678888885555558888888888888888885555568888888888888888887766553 2455555555555

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=98.65  E-value=2.7e-08  Score=92.34  Aligned_cols=82  Identities=27%  Similarity=0.254  Sum_probs=67.0

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~~   79 (477)
                      |+|++|+|++..|..++++++|++|+|++|++++..|..|+.+++|++|+|++|+|++..|.. ..+.++..+.+.+| .
T Consensus        90 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n-~  168 (272)
T 3rfs_A           90 LILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYN-Q  168 (272)
T ss_dssp             EECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS-C
T ss_pred             EECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCC-C
Confidence            578999999766677899999999999999999777778999999999999999999766654 34667777777766 4


Q ss_pred             cccc
Q 043902           80 LCGG   83 (477)
Q Consensus        80 l~g~   83 (477)
                      +.+.
T Consensus       169 l~~~  172 (272)
T 3rfs_A          169 LQSL  172 (272)
T ss_dssp             CCCC
T ss_pred             cCcc
Confidence            4443

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=98.64  E-value=1.9e-08  Score=105.01  Aligned_cols=78  Identities=21%  Similarity=0.144  Sum_probs=59.5

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~   78 (477)
                      |||++|+|++..|.+|++|++|++|||++|+|++..|.+|.+|++|++|+|++|+|++..|.. ..+.++..+.+.+|+
T Consensus        57 LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~  135 (635)
T 4g8a_A           57 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN  135 (635)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSC
T ss_pred             EEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCc
Confidence            688899999555567899999999999999998666678888999999999999888654444 235566666666553

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=98.64  E-value=3.1e-08  Score=91.87  Aligned_cols=81  Identities=28%  Similarity=0.329  Sum_probs=61.4

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~~   79 (477)
                      |+|++|+|++..|..|+++++|++|+|++|+|++..+..|+.+++|+.|+|++|++++..+.. ..+.++..+.+.+| .
T Consensus       114 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N-~  192 (270)
T 2o6q_A          114 LRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNN-Q  192 (270)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS-C
T ss_pred             EECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCC-c
Confidence            578899999766677899999999999999999655566888999999999999998655543 23556666666666 3


Q ss_pred             ccc
Q 043902           80 LCG   82 (477)
Q Consensus        80 l~g   82 (477)
                      +.+
T Consensus       193 l~~  195 (270)
T 2o6q_A          193 LKR  195 (270)
T ss_dssp             CSC
T ss_pred             CCc
Confidence            443

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=98.63  E-value=1.3e-08  Score=109.27  Aligned_cols=78  Identities=13%  Similarity=0.064  Sum_probs=63.2

Q ss_pred             cCCcccccCchhccCCCCCCeEECCCCccCc-----------------ccCcccC--CCCCCCeEEcccccccCcCccc-
Q 043902            4 GNNSFKGTIPVSLKSLRGLAELDLSCNNLSG-----------------KVPQFFS--KLLSLRHLNLSYNELDGEISRE-   63 (477)
Q Consensus         4 ~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g-----------------~~p~~~~--~l~~L~~l~l~~N~l~g~~p~~-   63 (477)
                      .+|+|+| ||.+|++|++|++|+|++|+|+|                 .||..++  +|++|++|+|++|+++|.+|.. 
T Consensus       433 ~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l  511 (876)
T 4ecn_A          433 LTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFL  511 (876)
T ss_dssp             CSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGG
T ss_pred             ccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHH
Confidence            3588887 89889999999999999999998                 4888887  8999999999999998888875 


Q ss_pred             ccccccchhhhhcCCcccc
Q 043902           64 GIFANASAISIVGNDKLCG   82 (477)
Q Consensus        64 ~~~~~~~~~~~~~n~~l~g   82 (477)
                      ..+.++..+.+.+|..+.|
T Consensus       512 ~~L~~L~~L~Ls~N~~lsg  530 (876)
T 4ecn_A          512 YDLPELQSLNIACNRGISA  530 (876)
T ss_dssp             GGCSSCCEEECTTCTTSCH
T ss_pred             hCCCCCCEEECcCCCCccc
Confidence            3356677777777765665

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=98.63  E-value=3.4e-08  Score=92.61  Aligned_cols=58  Identities=31%  Similarity=0.348  Sum_probs=32.7

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGE   59 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~   59 (477)
                      |+|++|+|+ .+|..+..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++.
T Consensus        82 L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~  139 (290)
T 1p9a_G           82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTL  139 (290)
T ss_dssp             EECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCC
T ss_pred             EECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCcc
Confidence            345555555 5555555555666666666666544445555556666666666665543

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=98.62  E-value=3e-08  Score=96.14  Aligned_cols=78  Identities=24%  Similarity=0.164  Sum_probs=53.4

Q ss_pred             CeecCCcccccCchhcc-CCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLK-SLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~-~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~   78 (477)
                      |+|++|+|++..+..+. ++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+.. ..+.++..+.+.+|.
T Consensus        44 L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  123 (361)
T 2xot_A           44 LDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNH  123 (361)
T ss_dssp             EECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             EECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCc
Confidence            57788888865555566 7888888888888888666667888888888888888887554433 234555555555553

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=98.61  E-value=1.6e-08  Score=87.27  Aligned_cols=74  Identities=18%  Similarity=0.153  Sum_probs=50.9

Q ss_pred             CeecCCcccccCchhccCCC-CCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLR-GLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~-~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~   78 (477)
                      |+|++|+|+ .+|. +..+. +|++|+|++|+|++.  ..|+.+++|++|+|++|+|++..|.. ..+.++..+.+.+|.
T Consensus        24 L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~   99 (176)
T 1a9n_A           24 LDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS   99 (176)
T ss_dssp             EECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCC
T ss_pred             EEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCc
Confidence            567888888 5665 44444 888888888888853  56788888888888888888543333 345566666666553

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=98.61  E-value=2.5e-08  Score=103.77  Aligned_cols=78  Identities=29%  Similarity=0.197  Sum_probs=56.3

Q ss_pred             CeecCCcccc-cCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccccc-ccccchhhhhcCC
Q 043902            1 LYLGNNSFKG-TIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGI-FANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g-~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-~~~~~~~~~~~n~   78 (477)
                      |+|++|++++ .+|..++.+++|++|+|++|++++.+|..|+.+++|+.|+|++|++++.+|.... +.++..+.+.+|.
T Consensus       453 L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~  532 (606)
T 3vq2_A          453 LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNR  532 (606)
T ss_dssp             EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSC
T ss_pred             EECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCc
Confidence            4677788876 3677778888888888888888877777777888888888888888777666532 4555666666554

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=98.61  E-value=2.9e-08  Score=87.41  Aligned_cols=78  Identities=18%  Similarity=0.198  Sum_probs=68.2

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~   78 (477)
                      |+|++|++++..|..++.+++|++|+|++|++++..|..++.+++|+.|+|++|.+.+.+|....+.++..+.+.+|.
T Consensus        93 L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~~n~  170 (197)
T 4ezg_A           93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDG  170 (197)
T ss_dssp             EEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECTTBC
T ss_pred             EEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccHhhcCCCCCCEEECCCCC
Confidence            589999999889999999999999999999999989999999999999999999944577765567777777777664

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=98.59  E-value=2.7e-08  Score=103.45  Aligned_cols=63  Identities=32%  Similarity=0.325  Sum_probs=40.0

Q ss_pred             CeecCCccccc---CchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc
Q 043902            1 LYLGNNSFKGT---IPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE   63 (477)
Q Consensus         1 l~l~~n~~~g~---~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~   63 (477)
                      |+|++|++++.   .+..++.+++|++|+|++|++++..|..|+.+++|+.|+|++|++++.+|..
T Consensus       454 L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  519 (606)
T 3t6q_A          454 LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEA  519 (606)
T ss_dssp             EECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGG
T ss_pred             EECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhH
Confidence            45666666652   2245666666666666666666666666666666666666666666665554

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=98.58  E-value=4.1e-08  Score=95.20  Aligned_cols=81  Identities=23%  Similarity=0.179  Sum_probs=63.1

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccc-cccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREG-IFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~~~~~~~~~~~n~~   79 (477)
                      |+|++|+|++..|..|+++++|++|+|++|+|++..|..|..|++|+.|+|++|+|++..|..+ .+.++..+.+.+| .
T Consensus        69 L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N-~  147 (361)
T 2xot_A           69 LLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQN-Q  147 (361)
T ss_dssp             EECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS-C
T ss_pred             EECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCC-c
Confidence            5789999996666779999999999999999997666788999999999999999997666543 3555666655555 4


Q ss_pred             ccc
Q 043902           80 LCG   82 (477)
Q Consensus        80 l~g   82 (477)
                      +.+
T Consensus       148 l~~  150 (361)
T 2xot_A          148 ISR  150 (361)
T ss_dssp             CCS
T ss_pred             CCe
Confidence            443

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.57  E-value=4.5e-07  Score=85.58  Aligned_cols=137  Identities=16%  Similarity=0.101  Sum_probs=94.1

Q ss_pred             CCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCC---CcceeeeecccccCCCCceeeEEEe
Q 043902          162 ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHR---NILKIVSSCSSVDYEGNDFKALVFE  238 (477)
Q Consensus       162 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~~~~~~~~~~lv~e  238 (477)
                      .+.++.|....||+.    |..+++|+...  ......+..|.++|..+.+.   .+.+++.++.    ...+..++|||
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEEEEe
Confidence            456888888899988    57788888532  23346788999999998642   3556666642    23456789999


Q ss_pred             ecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcC----------------------------------
Q 043902          239 FMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQ----------------------------------  284 (477)
Q Consensus       239 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----------------------------------  284 (477)
                      |++|.++.+..-         ..++..+...++.++++.|..||+.                                  
T Consensus        94 ~i~G~~l~~~~~---------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l  164 (306)
T 3tdw_A           94 KVQGQILGEDGM---------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLL  164 (306)
T ss_dssp             CCCSEECHHHHH---------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGS
T ss_pred             ccCCeECchhhh---------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccccc
Confidence            999988866321         1234445555555555555555542                                  


Q ss_pred             -----------------------CCCCeeecCCCCCCeEecC---CCc-EEEeccccccc
Q 043902          285 -----------------------YDTPIAHCDLKSSNVLLDE---GMI-AHVGDFGLAKF  317 (477)
Q Consensus       285 -----------------------~~~~ivH~dlkp~NIll~~---~~~-~kl~DfG~a~~  317 (477)
                                             ..+.++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       165 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          165 DESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             CHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             chhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                   2235799999999999987   344 58999998764

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=98.57  E-value=1.4e-08  Score=96.42  Aligned_cols=76  Identities=22%  Similarity=0.236  Sum_probs=52.4

Q ss_pred             CeecCCcc-cccCchhcc-------CCCCCCeEECCCCccCcccCccc--CCCCCCCeEEcccccccCcCcccc-cc---
Q 043902            1 LYLGNNSF-KGTIPVSLK-------SLRGLAELDLSCNNLSGKVPQFF--SKLLSLRHLNLSYNELDGEISREG-IF---   66 (477)
Q Consensus         1 l~l~~n~~-~g~~p~~~~-------~l~~L~~l~l~~N~l~g~~p~~~--~~l~~L~~l~l~~N~l~g~~p~~~-~~---   66 (477)
                      |+|++|++ ++.+|..+.       ++++|++|+|++|+++|.+|..+  +.+++|++|+|++|+|++. |... .+   
T Consensus        68 L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~  146 (312)
T 1wwl_A           68 LSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQW  146 (312)
T ss_dssp             CCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTT
T ss_pred             cccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHh
Confidence            56777777 556777766       77788888888888887777765  7777888888888888766 5432 22   


Q ss_pred             --cccchhhhhcC
Q 043902           67 --ANASAISIVGN   77 (477)
Q Consensus        67 --~~~~~~~~~~n   77 (477)
                        .++..+.+.+|
T Consensus       147 ~~~~L~~L~L~~N  159 (312)
T 1wwl_A          147 LKPGLKVLSIAQA  159 (312)
T ss_dssp             CCTTCCEEEEESC
T ss_pred             hcCCCcEEEeeCC
Confidence              45555555554

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=98.56  E-value=8.2e-08  Score=91.87  Aligned_cols=77  Identities=22%  Similarity=0.194  Sum_probs=54.4

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~   78 (477)
                      |+|++|++++..|..++++++|++|+|++|++++..|..|+.+++|+.|+|++|+|+ .+|.. ..+.++..+.+.+|+
T Consensus       198 L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~  275 (332)
T 2ft3_A          198 LHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNN  275 (332)
T ss_dssp             CBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSC
T ss_pred             EECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCC
Confidence            567778888666677778888888888888887666667777788888888888877 56654 334555555555553

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=98.56  E-value=4e-08  Score=101.25  Aligned_cols=77  Identities=18%  Similarity=0.281  Sum_probs=52.2

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccC-cccCcccCCCCCCCeEEcccccccCcCcccc-cccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLS-GKVPQFFSKLLSLRHLNLSYNELDGEISREG-IFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~-g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~~~~~~~~~~~n   77 (477)
                      |+|++|.+++.+|..++++++|++|+|++|.++ |.+|..++.+++|+.|+|++|++++.+|... .+.++..+.+.+|
T Consensus       426 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  504 (570)
T 2z63_A          426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN  504 (570)
T ss_dssp             EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCC
Confidence            466777777777777777777777777777776 5677777777777777777777776656542 2445555555554

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=98.54  E-value=3.4e-08  Score=100.74  Aligned_cols=76  Identities=25%  Similarity=0.157  Sum_probs=61.9

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~   78 (477)
                      |+|++|++++..|..|+++++|++|+|++|++++..|..|+.+++|++|+|++|+|+ .+|.. .+.++..+.+.+|.
T Consensus        26 L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~-~l~~L~~L~L~~N~  101 (520)
T 2z7x_B           26 LNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH-PTVNLKHLDLSFNA  101 (520)
T ss_dssp             EECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC-CCCCCSEEECCSSC
T ss_pred             EECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc-ccCCccEEeccCCc
Confidence            578888888777778888999999999999998877888888999999999999888 57766 56667777666664

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=98.54  E-value=5.7e-08  Score=97.21  Aligned_cols=78  Identities=23%  Similarity=0.146  Sum_probs=65.8

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccc-cccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREG-IFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~~~~~~~~~~~n~   78 (477)
                      |+|++|+|++..|..|+++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+... .+.++..+.+.+|.
T Consensus        80 L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  158 (452)
T 3zyi_A           80 LNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNP  158 (452)
T ss_dssp             EECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCC
T ss_pred             EECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCC
Confidence            6899999998888899999999999999999998888999999999999999999996555433 35666777666664

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=98.54  E-value=4.9e-08  Score=100.59  Aligned_cols=76  Identities=28%  Similarity=0.204  Sum_probs=63.7

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~   78 (477)
                      |+|++|+|++..|.+|+++++|++|+|++|+|++..|..|+.+++|++|||++|+|+ .+|.. .+.++..+.+.+|.
T Consensus        57 L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~-~l~~L~~L~Ls~N~  132 (562)
T 3a79_B           57 LSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC-PMASLRHLDLSFND  132 (562)
T ss_dssp             EECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC-CCTTCSEEECCSSC
T ss_pred             EECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc-ccccCCEEECCCCC
Confidence            578899999766778999999999999999999877888999999999999999998 67766 66777777777764

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.53  E-value=2.3e-08  Score=100.99  Aligned_cols=83  Identities=24%  Similarity=0.231  Sum_probs=65.5

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccC-CCCCCCeEEcccccccCcCcccccccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFS-KLLSLRHLNLSYNELDGEISREGIFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~~   79 (477)
                      |+|++|+|++..|..++++++|++|+|++|.|+|.+|..+. .+++|+.|+|++|.|++. |....+.++..+.+.+| .
T Consensus       125 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L~Ls~N-~  202 (487)
T 3oja_A          125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSN-K  202 (487)
T ss_dssp             EECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSS-C
T ss_pred             EECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cccccCCCCCEEECCCC-C
Confidence            57888999988888899999999999999999988888886 789999999999999965 44444666666666665 4


Q ss_pred             cccccc
Q 043902           80 LCGGIQ   85 (477)
Q Consensus        80 l~g~~~   85 (477)
                      +.+.++
T Consensus       203 l~~~~~  208 (487)
T 3oja_A          203 LAFMGP  208 (487)
T ss_dssp             CCEECG
T ss_pred             CCCCCH
Confidence            555443

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=98.53  E-value=4.6e-08  Score=100.41  Aligned_cols=78  Identities=27%  Similarity=0.238  Sum_probs=60.4

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~   78 (477)
                      |+|++|++++..|.+|+++++|++|+|++|++++..|..|+.+++|++|+|++|+|++.+|.. ..+.++..+.+.+|.
T Consensus        31 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~  109 (549)
T 2z81_A           31 LDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNP  109 (549)
T ss_dssp             EECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCC
T ss_pred             EECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCc
Confidence            578888888777788888888888888888888777788888888888888888888766653 345566666666664

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=98.53  E-value=6.3e-08  Score=96.87  Aligned_cols=78  Identities=22%  Similarity=0.178  Sum_probs=63.4

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~   78 (477)
                      |+|++|++++.+|..++++++|++|+|++|++++..|..|+.+++|+.|+|++|++++..|.. ..+.++..+.+.+|.
T Consensus       280 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  358 (455)
T 3v47_A          280 CDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNH  358 (455)
T ss_dssp             EECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSC
T ss_pred             EEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCc
Confidence            578889999888888999999999999999999888888999999999999999998766655 335666666666663

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=98.53  E-value=4e-08  Score=84.78  Aligned_cols=75  Identities=20%  Similarity=0.234  Sum_probs=60.1

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcc--c-ccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISR--E-GIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~-~~~~~~~~~~~~~n   77 (477)
                      |+|++|+|++ + ..++.+++|++|+|++|+|++..|..++.+++|++|+|++|+|+ .+|.  . ..+.++..+.+.+|
T Consensus        47 L~Ls~N~l~~-~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N  123 (176)
T 1a9n_A           47 IDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRN  123 (176)
T ss_dssp             EECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSS
T ss_pred             EECCCCCCCc-c-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCC
Confidence            6899999995 4 68999999999999999999544455599999999999999996 5665  2 34556667777777


Q ss_pred             C
Q 043902           78 D   78 (477)
Q Consensus        78 ~   78 (477)
                      +
T Consensus       124 ~  124 (176)
T 1a9n_A          124 P  124 (176)
T ss_dssp             G
T ss_pred             C
Confidence            5

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=98.53  E-value=7.1e-08  Score=91.11  Aligned_cols=78  Identities=18%  Similarity=0.269  Sum_probs=66.6

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCc-ccCcccCCCCCCCeEEcccccccCcCcccc-cccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSG-KVPQFFSKLLSLRHLNLSYNELDGEISREG-IFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g-~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~~~~~~~~~~~n~   78 (477)
                      |+|++|.+++.+|..++++++|++|+|++|.+++ .+|..+..+++|+.|+|++|++++..|... .+.++..+.+.+|.
T Consensus       131 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~  210 (306)
T 2z66_A          131 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN  210 (306)
T ss_dssp             EECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred             EECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCc
Confidence            5789999998888999999999999999999997 689999999999999999999998767653 35666677776664

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=98.53  E-value=1.1e-07  Score=90.86  Aligned_cols=77  Identities=27%  Similarity=0.300  Sum_probs=61.3

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~   78 (477)
                      |+|++|++++..|..++.+++|++|+|++|.+++..|..|..+++|+.|+|++|+|+ .+|.. ..+.++..+.+.+|+
T Consensus       197 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~  274 (330)
T 1xku_A          197 LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNN  274 (330)
T ss_dssp             EECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSC
T ss_pred             EECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCc
Confidence            578889999877888999999999999999999777778888999999999999988 66654 335556666666553

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=98.52  E-value=6.7e-08  Score=97.37  Aligned_cols=76  Identities=21%  Similarity=0.257  Sum_probs=41.5

Q ss_pred             CeecCCcccccCc-hhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccc-cccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIP-VSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREG-IFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p-~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~~~~~~~~~~~n   77 (477)
                      |+|++|+|+ .+| ..++++++|+.|+|++|.|++..|..|..+++|+.|+|++|++++..|... .+.++..+.+.+|
T Consensus       229 L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  306 (477)
T 2id5_A          229 LSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGN  306 (477)
T ss_dssp             EEEESSCCC-SCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSS
T ss_pred             EECcCCccc-ccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCC
Confidence            355666666 344 346666666666666666665555556666666666666666665544432 2334444444444

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=98.52  E-value=6.1e-08  Score=91.80  Aligned_cols=78  Identities=26%  Similarity=0.261  Sum_probs=60.4

Q ss_pred             CeecCCcccccCch----hccCCCCCCeEECCCCccCcccCcccCCC---CCCCeEEcccccccCcCcccccccccchhh
Q 043902            1 LYLGNNSFKGTIPV----SLKSLRGLAELDLSCNNLSGKVPQFFSKL---LSLRHLNLSYNELDGEISREGIFANASAIS   73 (477)
Q Consensus         1 l~l~~n~~~g~~p~----~~~~l~~L~~l~l~~N~l~g~~p~~~~~l---~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~   73 (477)
                      |+|++|+|+ .+|.    -++++++|++|||++|+|++.+|..++.+   ++|++|+|++|+|+ .+|.... .++..+.
T Consensus       202 L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~-~~L~~L~  278 (310)
T 4glp_A          202 LALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP-AKLRVLD  278 (310)
T ss_dssp             CBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC-SCCSCEE
T ss_pred             EECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc-CCCCEEE
Confidence            688999998 4554    25788999999999999998888888877   59999999999999 6776542 5666666


Q ss_pred             hhcCCcccc
Q 043902           74 IVGNDKLCG   82 (477)
Q Consensus        74 ~~~n~~l~g   82 (477)
                      +.+| .+.+
T Consensus       279 Ls~N-~l~~  286 (310)
T 4glp_A          279 LSSN-RLNR  286 (310)
T ss_dssp             CCSC-CCCS
T ss_pred             CCCC-cCCC
Confidence            6665 4444

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=98.50  E-value=5.8e-08  Score=92.07  Aligned_cols=80  Identities=25%  Similarity=0.233  Sum_probs=61.0

Q ss_pred             CeecCCcccc--cCchh-ccCCCCCCeEECCCCccCcccC-cccCCCCCCCeEEcccccccCcCcccccccccchhhhhc
Q 043902            1 LYLGNNSFKG--TIPVS-LKSLRGLAELDLSCNNLSGKVP-QFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVG   76 (477)
Q Consensus         1 l~l~~n~~~g--~~p~~-~~~l~~L~~l~l~~N~l~g~~p-~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~   76 (477)
                      |+|++|+|++  .+|.. +.++++|++|+|++|+|++.+| ..+..+++|+.|+|++|+|+ .+|.... .++..+.+.+
T Consensus       206 L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~-~~L~~L~Ls~  283 (312)
T 1wwl_A          206 LALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP-AKLSVLDLSY  283 (312)
T ss_dssp             EECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC-SEEEEEECCS
T ss_pred             EECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc-CCceEEECCC
Confidence            5789999983  44433 5788999999999999998876 45677899999999999999 7777644 5666666666


Q ss_pred             CCccccc
Q 043902           77 NDKLCGG   83 (477)
Q Consensus        77 n~~l~g~   83 (477)
                      | .+.+.
T Consensus       284 N-~l~~~  289 (312)
T 1wwl_A          284 N-RLDRN  289 (312)
T ss_dssp             S-CCCSC
T ss_pred             C-CCCCC
Confidence            6 45544

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=98.50  E-value=7.9e-08  Score=89.37  Aligned_cols=78  Identities=21%  Similarity=0.144  Sum_probs=62.0

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~   78 (477)
                      |+|++|++++..|..|+++++|++|+|++|++++..|..|..+++|++|+|++|++++..|.. ..+.++..+.+.+|.
T Consensus        33 L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~  111 (276)
T 2z62_A           33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN  111 (276)
T ss_dssp             EECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred             EECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCC
Confidence            578999999666668999999999999999999777778999999999999999999766554 335566666665553

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=98.50  E-value=9.1e-08  Score=91.53  Aligned_cols=75  Identities=31%  Similarity=0.266  Sum_probs=60.7

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n   77 (477)
                      |+|++|++++..|..|+++++|++|+|++|++++..|..|+.+++|++|+|++|+++ .+|.... .++..+.+.+|
T Consensus        59 L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~-~~L~~L~l~~n  133 (332)
T 2ft3_A           59 LDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP-SSLVELRIHDN  133 (332)
T ss_dssp             EECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC-TTCCEEECCSS
T ss_pred             EECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc-ccCCEEECCCC
Confidence            578899999766778999999999999999999888889999999999999999998 5665532 55666666555

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=98.49  E-value=6.8e-08  Score=100.41  Aligned_cols=77  Identities=17%  Similarity=0.021  Sum_probs=59.5

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccc-cccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREG-IFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~~~~~~~~~~~n   77 (477)
                      |+|++|+|++..|.+|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..|... .+.++..+.+.+|
T Consensus        38 L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n  115 (606)
T 3t6q_A           38 LEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQT  115 (606)
T ss_dssp             EECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTS
T ss_pred             EEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeecccc
Confidence            5788888887777888888888888888888887778888888888888888888887766552 3455555555555

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=98.48  E-value=9.4e-08  Score=89.28  Aligned_cols=78  Identities=23%  Similarity=0.192  Sum_probs=65.0

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~   78 (477)
                      |+|++|++++..|..++++++|++|+|++|++++..|..|+.+++|+.|+|++|+|++..+.. ..+.++..+.+.+|.
T Consensus       110 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~  188 (285)
T 1ozn_A          110 LHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNR  188 (285)
T ss_dssp             EECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             EECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCc
Confidence            579999999877888999999999999999999766677999999999999999999655543 335666667666664

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=98.48  E-value=1.1e-07  Score=90.75  Aligned_cols=75  Identities=21%  Similarity=0.307  Sum_probs=53.6

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~   78 (477)
                      |+|++|+++ .+|..+.  ++|++|+|++|++++..|..|..+++|+.|+|++|++++..|.. ..+.++..+.+.+|.
T Consensus       176 L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~  251 (330)
T 1xku_A          176 IRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK  251 (330)
T ss_dssp             EECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSC
T ss_pred             EECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCc
Confidence            467788887 6776654  77888888888888777778888888888888888888665543 334556666666553

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=98.47  E-value=1.7e-07  Score=86.77  Aligned_cols=78  Identities=27%  Similarity=0.373  Sum_probs=63.6

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~   78 (477)
                      |+|++|++++..|..++++++|++|+|++|+|++..|..|+.+++|++|+|++|+|++..+.. ..+.++..+.+.+|.
T Consensus        90 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~  168 (270)
T 2o6q_A           90 LWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQ  168 (270)
T ss_dssp             EECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCc
Confidence            578999999655566899999999999999999877788999999999999999999655543 335666666666663

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.47  E-value=1.1e-07  Score=98.53  Aligned_cols=77  Identities=17%  Similarity=0.157  Sum_probs=50.3

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n   77 (477)
                      |+|++|.|++..|..|+++++|++|+|++|.|++..|..|+.+++|++|+|++|.|++..|.. ..+.++..+.+.+|
T Consensus        80 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N  157 (597)
T 3oja_B           80 LNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNN  157 (597)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             EECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCC
Confidence            466777777666667777777777777777777666666777777777777777777443333 23455555555554

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=98.47  E-value=1.3e-07  Score=87.96  Aligned_cols=78  Identities=22%  Similarity=0.156  Sum_probs=64.9

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~   78 (477)
                      |+|++|++++..|..++++++|++|+|++|.+++..|..|..+++|+.|++++|++++..+.. ..+.++..+.+.+|.
T Consensus        57 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~  135 (276)
T 2z62_A           57 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL  135 (276)
T ss_dssp             EECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSC
T ss_pred             EECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCc
Confidence            589999999766678999999999999999999888889999999999999999999765533 345666666666664

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=98.47  E-value=9.6e-08  Score=92.22  Aligned_cols=78  Identities=31%  Similarity=0.328  Sum_probs=61.2

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~   78 (477)
                      |+|++|++++..+..++++++|++|+|++|++++..|..|+++++|++|+|++|++++..+.. ..+.++..+.+.+|.
T Consensus        57 L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~  135 (353)
T 2z80_A           57 LDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNP  135 (353)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCC
T ss_pred             EECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCC
Confidence            578899999655557999999999999999999877888999999999999999998644432 335666667666663

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=98.46  E-value=1.1e-07  Score=98.80  Aligned_cols=77  Identities=19%  Similarity=0.138  Sum_probs=44.8

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n   77 (477)
                      |+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..|.. ..+.++..+.+.+|
T Consensus        37 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n  114 (606)
T 3vq2_A           37 IDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVET  114 (606)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTS
T ss_pred             EECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCC
Confidence            456666666555556666666666666666666555666666666666666666666555543 22444444444444

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.45  E-value=1.4e-07  Score=97.97  Aligned_cols=78  Identities=23%  Similarity=0.275  Sum_probs=64.8

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~   78 (477)
                      |+|++|.|++..|..|+++++|++|+|++|.|++..|..|+++++|++|+|++|.|++.+|.. ..+.++..+.+.+|.
T Consensus       104 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  182 (597)
T 3oja_B          104 LYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR  182 (597)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSC
T ss_pred             EECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCC
Confidence            689999999877788999999999999999999544455799999999999999999887765 345667777766663

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=98.45  E-value=1.1e-07  Score=91.85  Aligned_cols=81  Identities=28%  Similarity=0.301  Sum_probs=66.3

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcc--c-ccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISR--E-GIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~-~~~~~~~~~~~~~n   77 (477)
                      |+|++|++++..|..|+++++|++|+|++|+|++..+..|+.+++|++|+|++|++++ +|.  . ..+.++..+.+.+|
T Consensus        81 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~~l~~L~~L~l~~n  159 (353)
T 2z80_A           81 LVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQILRVGNM  159 (353)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSS-SCSSCSCTTCTTCCEEEEEES
T ss_pred             EECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcc-cCchhhhccCCCCcEEECCCC
Confidence            5899999998778889999999999999999995444459999999999999999994 554  2 34677777777777


Q ss_pred             Ccccc
Q 043902           78 DKLCG   82 (477)
Q Consensus        78 ~~l~g   82 (477)
                      +.+..
T Consensus       160 ~~~~~  164 (353)
T 2z80_A          160 DTFTK  164 (353)
T ss_dssp             SSCCE
T ss_pred             ccccc
Confidence            55444

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=98.45  E-value=1.4e-07  Score=94.98  Aligned_cols=78  Identities=31%  Similarity=0.316  Sum_probs=62.9

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~   78 (477)
                      |+|++|+|++..|..|+++++|++|+|++|++++..|..|++|++|++|+|++|+|++..+.. ..+.++..+.+.+|.
T Consensus        37 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~  115 (477)
T 2id5_A           37 LDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENK  115 (477)
T ss_dssp             EECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSC
T ss_pred             EECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCc
Confidence            578999999777888999999999999999999888889999999999999999998544433 335666666666664

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=98.44  E-value=8e-08  Score=87.28  Aligned_cols=78  Identities=13%  Similarity=0.115  Sum_probs=59.0

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCc-cCcccCcccCCCCCCCeEEccc-ccccCcCcccc-cccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNN-LSGKVPQFFSKLLSLRHLNLSY-NELDGEISREG-IFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~-l~g~~p~~~~~l~~L~~l~l~~-N~l~g~~p~~~-~~~~~~~~~~~~n   77 (477)
                      |+|++|+|++..|..|+++++|++|+|++|+ +++..|..|..+++|+.|+|++ |+|++..|..+ .+.++..+.+.+|
T Consensus        36 L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n  115 (239)
T 2xwt_C           36 LKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNT  115 (239)
T ss_dssp             EEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEE
T ss_pred             EEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCC
Confidence            5788999996555579999999999999997 8855555888999999999998 99985544442 3556666666666


Q ss_pred             C
Q 043902           78 D   78 (477)
Q Consensus        78 ~   78 (477)
                      .
T Consensus       116 ~  116 (239)
T 2xwt_C          116 G  116 (239)
T ss_dssp             C
T ss_pred             C
Confidence            3

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=98.44  E-value=9e-08  Score=97.56  Aligned_cols=77  Identities=22%  Similarity=0.286  Sum_probs=57.1

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCc--ccCcccCCCCCCCeEEcccccccCcCccc--ccccccchhhhhc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSG--KVPQFFSKLLSLRHLNLSYNELDGEISRE--GIFANASAISIVG   76 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g--~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~~~~~~~~~~   76 (477)
                      |+|++|++++.+|..++++++|++|+|++|++++  .+|..++.+++|+.|+|++|++++.+|..  ..+.++..+.+.+
T Consensus       329 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~  408 (520)
T 2z7x_B          329 LDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSS  408 (520)
T ss_dssp             EECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCS
T ss_pred             EEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcC
Confidence            5678888887788888888888888888888886  66777888888888888888888766654  2244555555555


Q ss_pred             C
Q 043902           77 N   77 (477)
Q Consensus        77 n   77 (477)
                      |
T Consensus       409 N  409 (520)
T 2z7x_B          409 N  409 (520)
T ss_dssp             S
T ss_pred             C
Confidence            5

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=98.43  E-value=1.7e-07  Score=93.40  Aligned_cols=78  Identities=26%  Similarity=0.193  Sum_probs=62.9

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~   78 (477)
                      |+|++|+|++..|..|+++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+.. ..+.++..+.+.+|.
T Consensus        69 L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  147 (440)
T 3zyj_A           69 LNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNP  147 (440)
T ss_dssp             EECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCC
T ss_pred             EEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCc
Confidence            578999999777788999999999999999999777788999999999999999999554433 335666666666664

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=98.42  E-value=1.3e-07  Score=97.08  Aligned_cols=80  Identities=28%  Similarity=0.292  Sum_probs=66.0

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccC-cCccc-ccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDG-EISRE-GIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g-~~p~~-~~~~~~~~~~~~~n~   78 (477)
                      |+|++|++++..|..|+++++|++|+|++|++++..|..|+.+++|++|+|++|++++ .+|.. ..+.++..+.+.+|.
T Consensus        55 L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~  134 (549)
T 2z81_A           55 LILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVE  134 (549)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESS
T ss_pred             EECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCc
Confidence            6899999998888899999999999999999998777789999999999999999996 34443 446667777777765


Q ss_pred             cc
Q 043902           79 KL   80 (477)
Q Consensus        79 ~l   80 (477)
                      .+
T Consensus       135 ~~  136 (549)
T 2z81_A          135 TF  136 (549)
T ss_dssp             SC
T ss_pred             cc
Confidence            33

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=98.41  E-value=4.9e-08  Score=92.80  Aligned_cols=78  Identities=26%  Similarity=0.282  Sum_probs=46.3

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~~   79 (477)
                      |+|++|+|+ .+|. ...+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++ +|.. ..+.++..+.+.+|+.
T Consensus       174 L~L~~N~l~-~~~~-~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~  249 (317)
T 3o53_A          174 LNLQYNFIY-DVKG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGF  249 (317)
T ss_dssp             EECTTSCCC-EEEC-CCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCC
T ss_pred             EECCCCcCc-cccc-ccccccCCEEECCCCcCC-cchhhhcccCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCc
Confidence            456667776 3333 234666777777777776 445556666777777777777763 4443 2344555566666665


Q ss_pred             ccc
Q 043902           80 LCG   82 (477)
Q Consensus        80 l~g   82 (477)
                      .|+
T Consensus       250 ~~~  252 (317)
T 3o53_A          250 HCG  252 (317)
T ss_dssp             BHH
T ss_pred             cCc
Confidence            544

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=98.40  E-value=1.4e-07  Score=92.27  Aligned_cols=75  Identities=28%  Similarity=0.286  Sum_probs=38.0

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n   77 (477)
                      |+|++|++++.  ..++++++|++|+|++|.+++..|..|..+++|+.|+|++|++++..+....+.++..+.+.+|
T Consensus       231 L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~n  305 (390)
T 3o6n_A          231 LKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHN  305 (390)
T ss_dssp             EECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEECSSSCCTTCCEEECCSS
T ss_pred             EECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcccCcccCCCCCCCEEECCCC
Confidence            34555555532  3455555555555555555555555555555555555555555532211122344444444444

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.40  E-value=1.4e-06  Score=80.59  Aligned_cols=135  Identities=21%  Similarity=0.141  Sum_probs=94.8

Q ss_pred             eeeeeccc-eEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCC-CCCcceeeeecccccCCCCceeeEEEeec
Q 043902          164 LIGSGSFG-SVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIR-HRNILKIVSSCSSVDYEGNDFKALVFEFM  240 (477)
Q Consensus       164 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~  240 (477)
                      .+..|..+ .||+.... ++..+++|+-...   ....+..|...|..+. +-.+.++++++     ...+..++|||++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~-----~~~~~~~lvme~l  102 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFI-----RTPDDAWLLTTAI  102 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEEEEECC
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEE-----EECCeEEEEEEee
Confidence            45556665 68998765 5678999986643   3356778988888774 33467777775     3446789999999


Q ss_pred             CCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------------
Q 043902          241 RNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQY-----------------------------------  285 (477)
Q Consensus       241 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----------------------------------  285 (477)
                      ++.++.+.....           ......++.+++..|..||+..                                   
T Consensus       103 ~G~~~~~~~~~~-----------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (272)
T 4gkh_A          103 PGKTAFQVLEEY-----------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDER  171 (272)
T ss_dssp             CSEEHHHHHHHC-----------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGG
T ss_pred             CCccccccccCC-----------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccc
Confidence            998887654321           1123345666677777777421                                   


Q ss_pred             --------------------CCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          286 --------------------DTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       286 --------------------~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                                          .+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus       172 ~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          172 NGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             TTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                                12379999999999999887778999998864

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.38  E-value=1.6e-07  Score=85.93  Aligned_cols=81  Identities=27%  Similarity=0.318  Sum_probs=56.8

Q ss_pred             CeecCCccc---ccCchhccCCCCCCeEECCCCccCc--ccCcccCCCCCCCeEEcccccccCcCccccccc--ccchhh
Q 043902            1 LYLGNNSFK---GTIPVSLKSLRGLAELDLSCNNLSG--KVPQFFSKLLSLRHLNLSYNELDGEISREGIFA--NASAIS   73 (477)
Q Consensus         1 l~l~~n~~~---g~~p~~~~~l~~L~~l~l~~N~l~g--~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~--~~~~~~   73 (477)
                      ++++.|+..   +.++....++++|+.|+||+|+|++  .+|..+..+++|+.|+|++|+|++. .....+.  ++..+.
T Consensus       148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~-~~l~~l~~l~L~~L~  226 (267)
T 3rw6_A          148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE-RELDKIKGLKLEELW  226 (267)
T ss_dssp             CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG-GGGGGGTTSCCSEEE
T ss_pred             ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc-hhhhhcccCCcceEE
Confidence            356677433   3333333678899999999999998  6778888999999999999999964 2222222  666666


Q ss_pred             hhcCCccccc
Q 043902           74 IVGNDKLCGG   83 (477)
Q Consensus        74 ~~~n~~l~g~   83 (477)
                      +.+|+ +|+.
T Consensus       227 L~~Np-l~~~  235 (267)
T 3rw6_A          227 LDGNS-LCDT  235 (267)
T ss_dssp             CTTST-TGGG
T ss_pred             ccCCc-Cccc
Confidence            77765 6654

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=98.38  E-value=1.9e-07  Score=100.94  Aligned_cols=43  Identities=28%  Similarity=0.382  Sum_probs=18.3

Q ss_pred             ccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccC
Q 043902           16 LKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDG   58 (477)
Q Consensus        16 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g   58 (477)
                      |++|++|++|+|++|+|++..|..|++|++|++|+|++|.+++
T Consensus        69 f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~  111 (844)
T 3j0a_A           69 FRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSD  111 (844)
T ss_dssp             TSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSS
T ss_pred             hcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCc
Confidence            4444444444444444443334444444444444444444443

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=98.38  E-value=2e-07  Score=98.26  Aligned_cols=80  Identities=31%  Similarity=0.379  Sum_probs=41.2

Q ss_pred             eecCCcccccCch-hccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccc--cccccchhhhhcCC
Q 043902            2 YLGNNSFKGTIPV-SLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREG--IFANASAISIVGND   78 (477)
Q Consensus         2 ~l~~n~~~g~~p~-~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~--~~~~~~~~~~~~n~   78 (477)
                      +|++|+|+ .||. .|+++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|...  .+.++..+.+.+|+
T Consensus       542 ~L~~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~  620 (680)
T 1ziw_A          542 NLESNGFD-EIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNP  620 (680)
T ss_dssp             ECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCC
T ss_pred             ECCCCCCC-CCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCC
Confidence            45555555 4443 35555555555555555553333344555555555555555555444332  24445555555555


Q ss_pred             cccc
Q 043902           79 KLCG   82 (477)
Q Consensus        79 ~l~g   82 (477)
                      ..|.
T Consensus       621 ~~c~  624 (680)
T 1ziw_A          621 FDCT  624 (680)
T ss_dssp             CCBC
T ss_pred             cccC
Confidence            5543

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=98.37  E-value=2.7e-07  Score=95.01  Aligned_cols=74  Identities=20%  Similarity=0.257  Sum_probs=54.9

Q ss_pred             CeecCCcccccCchh-ccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVS-LKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~-~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n   77 (477)
                      |+|++|++++.+|.. +..+++|++|+|++|+|+|.+|..+.  ++|+.|+|++|+|+ .+|.. ..+.++..+.+.+|
T Consensus       408 L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N  483 (562)
T 3a79_B          408 LDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASN  483 (562)
T ss_dssp             EECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSS
T ss_pred             EECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCC
Confidence            578889998767765 78888888888888888888777665  67888888888888 56654 33455555655555

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=98.37  E-value=3.1e-07  Score=89.88  Aligned_cols=57  Identities=19%  Similarity=0.226  Sum_probs=32.6

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEccccccc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELD   57 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~   57 (477)
                      |+|++|++++..|..|+++++|++|+|++|++++..|..|+.+++|++|+|++|+++
T Consensus        74 L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  130 (390)
T 3o6n_A           74 LNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS  130 (390)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             EECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC
Confidence            345555555444445556666666666666665555555555666666666666655

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=98.37  E-value=1.4e-07  Score=89.30  Aligned_cols=78  Identities=15%  Similarity=0.098  Sum_probs=64.7

Q ss_pred             CeecCCcccccCchhc--cCCCCCCeEECCCCccCcccC----cccCCCCCCCeEEcccccccCcCcccc-cccccchhh
Q 043902            1 LYLGNNSFKGTIPVSL--KSLRGLAELDLSCNNLSGKVP----QFFSKLLSLRHLNLSYNELDGEISREG-IFANASAIS   73 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~--~~l~~L~~l~l~~N~l~g~~p----~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~~~~~~~~   73 (477)
                      |+|++|.++|.+|..+  +++++|++|+|++|.+++.+|    ..+..+++|++|+|++|++++.+|... .+.++..+.
T Consensus        96 L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  175 (310)
T 4glp_A           96 LTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLD  175 (310)
T ss_dssp             EEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEE
T ss_pred             EEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEE
Confidence            5789999999999998  999999999999999998766    456689999999999999987776653 466677777


Q ss_pred             hhcCC
Q 043902           74 IVGND   78 (477)
Q Consensus        74 ~~~n~   78 (477)
                      +.+|.
T Consensus       176 Ls~N~  180 (310)
T 4glp_A          176 LSDNP  180 (310)
T ss_dssp             CCSCT
T ss_pred             CCCCC
Confidence            77775

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=98.36  E-value=7.5e-09  Score=91.25  Aligned_cols=78  Identities=24%  Similarity=0.311  Sum_probs=63.3

Q ss_pred             CeecCCcccccCch------hccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccccc-ccccchhh
Q 043902            1 LYLGNNSFKGTIPV------SLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGI-FANASAIS   73 (477)
Q Consensus         1 l~l~~n~~~g~~p~------~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-~~~~~~~~   73 (477)
                      ++|+.|.|+|.+|.      .++++++|++|+|++|+|++ +| .+..+++|+.|+|++|+|+ .+|.... +.++..+.
T Consensus        23 l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~   99 (198)
T 1ds9_A           23 TEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELW   99 (198)
T ss_dssp             TTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEE
T ss_pred             cchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEE
Confidence            46888999999887      89999999999999999995 88 8999999999999999999 6776533 35666666


Q ss_pred             hhcCCcccc
Q 043902           74 IVGNDKLCG   82 (477)
Q Consensus        74 ~~~n~~l~g   82 (477)
                      +.+| .+.+
T Consensus       100 L~~N-~l~~  107 (198)
T 1ds9_A          100 ISYN-QIAS  107 (198)
T ss_dssp             EEEE-ECCC
T ss_pred             CcCC-cCCc
Confidence            6666 4444

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=98.36  E-value=3.1e-08  Score=87.28  Aligned_cols=74  Identities=26%  Similarity=0.337  Sum_probs=60.8

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~   78 (477)
                      |+|++|+|++ +| .++++++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++ +|....+.++..+.+.+|.
T Consensus        53 L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~~~~~l~~L~~L~l~~N~  126 (198)
T 1ds9_A           53 LALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LSGIEKLVNLRVLYMSNNK  126 (198)
T ss_dssp             EECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HHHHHHHHHSSEEEESEEE
T ss_pred             EECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CCccccCCCCCEEECCCCc
Confidence            5789999995 88 8999999999999999999 889888888999999999999996 5654445666666666663

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=98.34  E-value=2.8e-07  Score=84.96  Aligned_cols=71  Identities=24%  Similarity=0.302  Sum_probs=33.1

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n   77 (477)
                      |+|++|+|+ .+|....  ++|++|+|++|+|++ +| .++.+++|+.|+|++|+|++ +|....+.++..+.+.+|
T Consensus        90 L~L~~N~l~-~l~~~~~--~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~-~~~l~~l~~L~~L~L~~N  160 (263)
T 1xeu_A           90 LSVNRNRLK-NLNGIPS--ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKS-IVMLGFLSKLEVLDLHGN  160 (263)
T ss_dssp             EECCSSCCS-CCTTCCC--SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCB-CGGGGGCTTCCEEECTTS
T ss_pred             EECCCCccC-CcCcccc--CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCC-ChHHccCCCCCEEECCCC
Confidence            345555555 3443222  555555555555553 33 35555555555555555553 232223334444444333

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=98.34  E-value=1.7e-07  Score=85.09  Aligned_cols=35  Identities=20%  Similarity=0.222  Sum_probs=16.9

Q ss_pred             CCCeEECCCCccCcccCcccCCCCCCCeEEccccc
Q 043902           21 GLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNE   55 (477)
Q Consensus        21 ~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~   55 (477)
                      +|++|+|++|++++..|..|+.+++|+.|+|++|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~   66 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDV   66 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCS
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCC
Confidence            45555555555553333344455555555555553

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=98.33  E-value=3.1e-07  Score=94.61  Aligned_cols=77  Identities=21%  Similarity=0.208  Sum_probs=43.1

Q ss_pred             CeecCCcccccCc-hhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEccccccc-CcCccc-ccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIP-VSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELD-GEISRE-GIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p-~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~-g~~p~~-~~~~~~~~~~~~~n   77 (477)
                      |+|++|++++..| ..++++++|++|+|++|.+++.+|..|..+++|+.|+|++|.++ +.+|.. ..+.++..+.+.+|
T Consensus       401 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n  480 (570)
T 2z63_A          401 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC  480 (570)
T ss_dssp             EECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTS
T ss_pred             EEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCC
Confidence            3556666665444 34566666666666666666666666666666666666666665 445543 22344444444444

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=98.32  E-value=2.2e-07  Score=88.21  Aligned_cols=79  Identities=28%  Similarity=0.151  Sum_probs=63.0

Q ss_pred             CeecCCcccccCchhc-cCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSL-KSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~-~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~~   79 (477)
                      |+|++|++++..|..+ ..+++|++|+|++|+|++ +|. ...+++|+.|+|++|+|++..|....+.++..+.+.+| .
T Consensus       149 L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N-~  225 (317)
T 3o53_A          149 LDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNN-K  225 (317)
T ss_dssp             EECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE-EEC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTS-C
T ss_pred             EECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc-ccc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCC-c
Confidence            6899999998878877 489999999999999994 454 34599999999999999976555455677777777776 4


Q ss_pred             ccc
Q 043902           80 LCG   82 (477)
Q Consensus        80 l~g   82 (477)
                      +..
T Consensus       226 l~~  228 (317)
T 3o53_A          226 LVL  228 (317)
T ss_dssp             CCE
T ss_pred             ccc
Confidence            443

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=98.31  E-value=4.9e-07  Score=83.36  Aligned_cols=71  Identities=23%  Similarity=0.321  Sum_probs=50.5

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n   77 (477)
                      |+|++|+++ .+| .++.+++|++|+|++|+|++ +|. ++.+++|+.|+|++|+|++ +|.... .++..+.+.+|
T Consensus        46 L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~-l~~~~~-~~L~~L~L~~N  116 (263)
T 1xeu_A           46 FNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKN-LNGIPS-ACLSRLFLDNN  116 (263)
T ss_dssp             EECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSC-CTTCCC-SSCCEEECCSS
T ss_pred             EECcCCCcc-cch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCC-cCcccc-CcccEEEccCC
Confidence            467888888 677 68888888888888888884 444 8888888888888888885 444322 55555555555

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.31  E-value=1.6e-07  Score=85.94  Aligned_cols=60  Identities=27%  Similarity=0.290  Sum_probs=52.4

Q ss_pred             CeecCCcccc--cCchhccCCCCCCeEECCCCccCcccCcccCCCC--CCCeEEcccccccCcCcc
Q 043902            1 LYLGNNSFKG--TIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLL--SLRHLNLSYNELDGEISR   62 (477)
Q Consensus         1 l~l~~n~~~g--~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~--~L~~l~l~~N~l~g~~p~   62 (477)
                      |+|++|+|++  .+|..++.+++|+.|+|++|+|++.  ..+..+.  +|+.|+|++|.+++.+|.
T Consensus       175 L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~  238 (267)
T 3rw6_A          175 LNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRD  238 (267)
T ss_dssp             EECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSS
T ss_pred             EECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCc
Confidence            6899999998  7778899999999999999999965  3455555  999999999999998874

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=98.27  E-value=5e-07  Score=84.64  Aligned_cols=72  Identities=24%  Similarity=0.294  Sum_probs=53.0

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n   77 (477)
                      |+|++|++++ + +.++.+++|+.|+|++|++++.  ..++.+++|+.|+|++|++++..| ...+.++..+.+.+|
T Consensus       117 L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N  188 (291)
T 1h6t_A          117 LSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKN  188 (291)
T ss_dssp             EECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSS
T ss_pred             EECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCC
Confidence            5788888884 4 4688888888888888888853  567888888888888888886554 444556666666555

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=98.27  E-value=4.2e-07  Score=87.38  Aligned_cols=77  Identities=26%  Similarity=0.386  Sum_probs=53.2

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~~   79 (477)
                      |+|++|.+++ + +.+..+++|++|+|++|++++ +| .+..+++|+.|+|++|++++..|.. ..+.++..+.+.+|+ 
T Consensus       248 L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~-  322 (347)
T 4fmz_A          248 LEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-IS-VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH-  322 (347)
T ss_dssp             EECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSS-
T ss_pred             EECCCCccCC-C-hhHhcCCCcCEEEccCCccCC-Ch-hhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCc-
Confidence            4677888874 4 457788888888888888884 44 4777888888888888887766654 335566666666664 


Q ss_pred             ccc
Q 043902           80 LCG   82 (477)
Q Consensus        80 l~g   82 (477)
                      +.+
T Consensus       323 l~~  325 (347)
T 4fmz_A          323 ITD  325 (347)
T ss_dssp             CCC
T ss_pred             ccc
Confidence            444

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=98.25  E-value=7.8e-07  Score=93.75  Aligned_cols=57  Identities=26%  Similarity=0.253  Sum_probs=27.2

Q ss_pred             eecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccC
Q 043902            2 YLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDG   58 (477)
Q Consensus         2 ~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g   58 (477)
                      +|++|++++..|..++++++|++|+|++|+|++..|..|+.+++|++|+|++|++++
T Consensus        55 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~  111 (680)
T 1ziw_A           55 DVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQK  111 (680)
T ss_dssp             ECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC
T ss_pred             ECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCc
Confidence            445555554444445555555555555555552222234445555555555555443

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=98.25  E-value=8.9e-07  Score=82.91  Aligned_cols=72  Identities=21%  Similarity=0.269  Sum_probs=47.7

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n   77 (477)
                      |++++|.++ .+|. ++.+++|++|+|++|++++. |. ++.+++|+.|+|++|++++ +|....+.++..+.+.+|
T Consensus        51 L~l~~~~i~-~~~~-~~~l~~L~~L~L~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~L~~n  122 (291)
T 1h6t_A           51 IIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTDI-KP-LANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHN  122 (291)
T ss_dssp             EECTTSCCC-CCTT-GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTS
T ss_pred             EEccCCCcc-cChh-HhcCCCCCEEEccCCccCCC-cc-cccCCCCCEEECCCCcCCC-ChhhccCCCCCEEECCCC
Confidence            466777777 5543 77777777777777777743 33 7777777777777777774 444444555555655555

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.24  E-value=1.1e-06  Score=84.77  Aligned_cols=84  Identities=6%  Similarity=-0.048  Sum_probs=55.3

Q ss_pred             CCee-eeeccceEEEEEeC-------CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCC-C--CCcceeeeecccccC
Q 043902          162 ENLI-GSGSFGSVYKGTLA-------DGETAAIKVLKLQQ---QGALKSFIDECNALTSIR-H--RNILKIVSSCSSVDY  227 (477)
Q Consensus       162 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~  227 (477)
                      .+.| +.|....+|+....       +++.+++|+.....   ......+..|+.++..+. +  -.+.++++++.... 
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~-  103 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD-  103 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST-
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC-
Confidence            3567 78888999998764       26788898865432   101245678888888774 2  35677777753211 


Q ss_pred             CCCceeeEEEeecCCCChhh
Q 043902          228 EGNDFKALVFEFMRNGNLDQ  247 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~  247 (477)
                       ..+..++||||++|.++.+
T Consensus       104 -~~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          104 -VLGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             -TTSSCEEEEECCCCBCCCB
T ss_pred             -ccCCceEEEEecCCCChhh
Confidence             1134689999999877654

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=98.20  E-value=9e-07  Score=90.52  Aligned_cols=66  Identities=29%  Similarity=0.391  Sum_probs=37.3

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n   77 (477)
                      |+|++|+|+ .||   +.+++|++|+|++|+|++ ||. |.+  +|+.|+|++|+|++ +|.  .+.++..+.+.+|
T Consensus        85 L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~--~l~~L~~L~Ls~N  150 (571)
T 3cvr_A           85 LEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE--LPALLEYINADNN  150 (571)
T ss_dssp             EECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC--CCTTCCEEECCSS
T ss_pred             EECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC--cCccccEEeCCCC
Confidence            456666666 566   445666666666666664 665 544  66666666666665 444  2334444444333

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=98.20  E-value=8.7e-07  Score=91.53  Aligned_cols=72  Identities=24%  Similarity=0.294  Sum_probs=46.8

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n   77 (477)
                      |+|++|+|++ + +.++.|++|+.|+|++|+|++.  ..|+.|++|+.|+|++|+|++.+| ...+.++..+.+.+|
T Consensus       114 L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N  185 (605)
T 1m9s_A          114 LSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKN  185 (605)
T ss_dssp             EECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSS
T ss_pred             EEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCC
Confidence            4677777774 3 3477777777777777777743  456777777777777777776555 334555555555554

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=98.19  E-value=1.1e-06  Score=89.80  Aligned_cols=71  Identities=23%  Similarity=0.272  Sum_probs=51.6

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcCCcc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGNDKL   80 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~~l   80 (477)
                      |+|++|+|++ ||..+.  ++|++|+|++|+|+ .||   +.+++|+.|+|++|+|++ +|. . ..++..+.+.+| .+
T Consensus        64 L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l-~~~L~~L~Ls~N-~l  132 (571)
T 3cvr_A           64 LQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-L-PASLKHLDVDNN-QL  132 (571)
T ss_dssp             EECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-C-CTTCCEEECCSS-CC
T ss_pred             EEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-h-hcCCCEEECCCC-cC
Confidence            5788888885 887763  78888888888888 788   457888888888888887 666 2 225555555555 45


Q ss_pred             cc
Q 043902           81 CG   82 (477)
Q Consensus        81 ~g   82 (477)
                      .+
T Consensus       133 ~~  134 (571)
T 3cvr_A          133 TM  134 (571)
T ss_dssp             SC
T ss_pred             CC
Confidence            44

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=98.18  E-value=1.4e-06  Score=82.20  Aligned_cols=73  Identities=21%  Similarity=0.289  Sum_probs=52.5

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~   78 (477)
                      |++++|.++ .+| .+..+++|++|+|++|++++ +|. +..+++|++|+|++|++++ +|....+.++..+.+.+|.
T Consensus        46 L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~-~~~~~~l~~L~~L~l~~n~  118 (308)
T 1h6u_A           46 LSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQ  118 (308)
T ss_dssp             EECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSC-CGGGTTCTTCCEEECTTSC
T ss_pred             EEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCC-chhhcCCCCCCEEECCCCC
Confidence            467788887 566 57888888888888888884 444 8888888888888888875 4544445666666666553

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=98.14  E-value=2.1e-06  Score=81.11  Aligned_cols=72  Identities=17%  Similarity=0.229  Sum_probs=47.8

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n   77 (477)
                      |+|++|++++ +|. ++.+++|++|+|++|++++. |. ++.+++|+.|+|++|++++..+ ...+.++..+.+.+|
T Consensus       112 L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n  183 (308)
T 1h6u_A          112 LDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNI-SP-LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDN  183 (308)
T ss_dssp             EECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSS
T ss_pred             EECCCCCCCC-chh-hcCCCCCCEEECCCCccCcC-cc-ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCC
Confidence            5677888874 554 77788888888888888743 33 7777778888888887775333 333455555555544

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=98.12  E-value=1.9e-06  Score=86.03  Aligned_cols=53  Identities=21%  Similarity=0.182  Sum_probs=30.8

Q ss_pred             CCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcC
Q 043902           20 RGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGN   77 (477)
Q Consensus        20 ~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n   77 (477)
                      ++|++|+|++|++++ +| +|+++++|++|++++|++++ +|..  ..++..+.+.+|
T Consensus       131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~--~~~L~~L~L~~n  183 (454)
T 1jl5_A          131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDL--PPSLEFIAAGNN  183 (454)
T ss_dssp             TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCC--CTTCCEEECCSS
T ss_pred             CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCC--cccccEEECcCC
Confidence            466667777676664 66 46666666667666666664 4443  124444444443

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=98.09  E-value=2.3e-06  Score=88.33  Aligned_cols=54  Identities=28%  Similarity=0.410  Sum_probs=27.6

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDG   58 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g   58 (477)
                      |+|++|+|++ +|. +++|++|+.|+|++|+|++ +| .+..|++|+.|+|++|+|++
T Consensus        70 L~Ls~N~l~~-~~~-l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~  123 (605)
T 1m9s_A           70 LFLNGNKLTD-IKP-LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD  123 (605)
T ss_dssp             EECTTSCCCC-CGG-GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC
T ss_pred             EEeeCCCCCC-Chh-hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC
Confidence            3455555553 222 5555555555555555552 33 45555555555555555553

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=98.06  E-value=4.6e-07  Score=86.60  Aligned_cols=81  Identities=15%  Similarity=0.120  Sum_probs=62.4

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcc-cCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGK-VPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~-~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~   78 (477)
                      |++++|.+++.+|. +.++++|++|+|++|.+++. +|..+..+++|+.|+|++|.+++.+|.. ..+.++..+.+.+|.
T Consensus        75 L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~  153 (336)
T 2ast_B           75 FRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS  153 (336)
T ss_dssp             EECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCB
T ss_pred             EEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCC
Confidence            46788888866555 66788999999999998876 8888888999999999999888766654 335667777777775


Q ss_pred             cccc
Q 043902           79 KLCG   82 (477)
Q Consensus        79 ~l~g   82 (477)
                      .+.+
T Consensus       154 ~l~~  157 (336)
T 2ast_B          154 GFSE  157 (336)
T ss_dssp             SCCH
T ss_pred             CCCH
Confidence            5554

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=98.05  E-value=2.3e-06  Score=85.52  Aligned_cols=56  Identities=25%  Similarity=0.229  Sum_probs=49.2

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISR   62 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~   62 (477)
                      |+|++|+|++ +  .++.+++|++|+|++|+|+| +|  ++.+++|+.|+|++|+|+|..+.
T Consensus       196 L~l~~N~l~~-~--~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~  251 (457)
T 3bz5_A          196 LNCDTNNITK-L--DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVS  251 (457)
T ss_dssp             EECCSSCCSC-C--CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCT
T ss_pred             EECcCCcCCe-e--ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHH
Confidence            5789999995 4  49999999999999999997 78  89999999999999999986543

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=98.05  E-value=2e-06  Score=82.74  Aligned_cols=77  Identities=21%  Similarity=0.241  Sum_probs=52.7

Q ss_pred             eecCCcccccCchhccCCCCCCeEECCCCccCcccCc-ccCCCCCCCeEEcccccccCcCcccc--cccccchhhhhcCC
Q 043902            2 YLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQ-FFSKLLSLRHLNLSYNELDGEISREG--IFANASAISIVGND   78 (477)
Q Consensus         2 ~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~L~~l~l~~N~l~g~~p~~~--~~~~~~~~~~~~n~   78 (477)
                      +-++|+|+ .||..+  .++|++|+|++|+|+ .||. +|.+|++|++|+|++|++.+.+|...  .+.++..+...+++
T Consensus        15 ~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N   90 (350)
T 4ay9_X           15 LCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN   90 (350)
T ss_dssp             EEESTTCC-SCCTTC--CTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEET
T ss_pred             EecCCCCC-ccCcCc--CCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCC
Confidence            45678888 888776  367888888888888 5654 68888888888888888877777542  23344444444444


Q ss_pred             cccc
Q 043902           79 KLCG   82 (477)
Q Consensus        79 ~l~g   82 (477)
                      .+..
T Consensus        91 ~l~~   94 (350)
T 4ay9_X           91 NLLY   94 (350)
T ss_dssp             TCCE
T ss_pred             cccc
Confidence            4443

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=98.04  E-value=6.2e-07  Score=87.64  Aligned_cols=78  Identities=18%  Similarity=0.186  Sum_probs=57.1

Q ss_pred             CeecCCccc--c---cCchhccCCCCCCeEECCCCccC----cccCcccCCCCCCCeEEcccccccCc----Ccccc---
Q 043902            1 LYLGNNSFK--G---TIPVSLKSLRGLAELDLSCNNLS----GKVPQFFSKLLSLRHLNLSYNELDGE----ISREG---   64 (477)
Q Consensus         1 l~l~~n~~~--g---~~p~~~~~l~~L~~l~l~~N~l~----g~~p~~~~~l~~L~~l~l~~N~l~g~----~p~~~---   64 (477)
                      |+|++|+|+  |   .+|..+..+++|++|+|++|.|+    +.+|..+..+++|+.|+|++|.|++.    +|...   
T Consensus       192 L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~  271 (386)
T 2ca6_A          192 VKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKL  271 (386)
T ss_dssp             EECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTC
T ss_pred             EECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhc
Confidence            578888888  3   45557888888888888888886    67888888888888888888888765    44432   


Q ss_pred             cccccchhhhhcCC
Q 043902           65 IFANASAISIVGND   78 (477)
Q Consensus        65 ~~~~~~~~~~~~n~   78 (477)
                      .+.++..+.+.+|.
T Consensus       272 ~~~~L~~L~L~~n~  285 (386)
T 2ca6_A          272 ENIGLQTLRLQYNE  285 (386)
T ss_dssp             SSCCCCEEECCSSC
T ss_pred             cCCCeEEEECcCCc
Confidence            14556666665553

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=98.03  E-value=2.8e-06  Score=85.18  Aligned_cols=77  Identities=27%  Similarity=0.322  Sum_probs=51.2

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcCCcc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGNDKL   80 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~~l   80 (477)
                      |+|++|++++..|  ++.+++|+.|+|++|++++..|  ++.+++|+.|++++|.+++. +....+.++..+.+.+| .+
T Consensus       292 L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n-~l  365 (466)
T 1o6v_A          292 LELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHN-QI  365 (466)
T ss_dssp             EECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSS-CC
T ss_pred             EEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc-hhhccCCCCCEEeCCCC-cc
Confidence            4677888885433  7778888888888888886655  67777777778877777754 44444555555555544 34


Q ss_pred             ccc
Q 043902           81 CGG   83 (477)
Q Consensus        81 ~g~   83 (477)
                      .+.
T Consensus       366 ~~~  368 (466)
T 1o6v_A          366 SDL  368 (466)
T ss_dssp             CBC
T ss_pred             Ccc
Confidence            443

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=98.01  E-value=7e-06  Score=78.74  Aligned_cols=71  Identities=20%  Similarity=0.322  Sum_probs=34.7

Q ss_pred             eecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcC
Q 043902            2 YLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGN   77 (477)
Q Consensus         2 ~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n   77 (477)
                      ++++|.++ .+|. ++.+++|++|+|++|+++ .+|. +..+++|++|+|++|.+++ +|....+.++..+.+.+|
T Consensus        50 ~l~~~~i~-~~~~-~~~~~~L~~L~l~~n~i~-~~~~-~~~l~~L~~L~L~~n~i~~-~~~~~~l~~L~~L~l~~n  120 (347)
T 4fmz_A           50 VVAGEKVA-SIQG-IEYLTNLEYLNLNGNQIT-DISP-LSNLVKLTNLYIGTNKITD-ISALQNLTNLRELYLNED  120 (347)
T ss_dssp             ECCSSCCC-CCTT-GGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCC-CGGGTTCTTCSEEECTTS
T ss_pred             EEeCCccc-cchh-hhhcCCccEEEccCCccc-cchh-hhcCCcCCEEEccCCcccC-chHHcCCCcCCEEECcCC
Confidence            44555555 4443 555555555555555555 3333 5555555555555555553 333333344444444333

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=98.01  E-value=9.7e-07  Score=84.34  Aligned_cols=72  Identities=13%  Similarity=0.208  Sum_probs=41.1

Q ss_pred             eecCCcccccCchhccCC--CCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCc-Cccc-ccccccchhhhhcC
Q 043902            2 YLGNNSFKGTIPVSLKSL--RGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGE-ISRE-GIFANASAISIVGN   77 (477)
Q Consensus         2 ~l~~n~~~g~~p~~~~~l--~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~-~p~~-~~~~~~~~~~~~~n   77 (477)
                      +|++|.++   |..+..+  ++|+.|++++|.+++.+|. +..+++|+.|+|++|.+++. +|.. ..+.++..+.+.+|
T Consensus        53 ~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~  128 (336)
T 2ast_B           53 DLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL  128 (336)
T ss_dssp             ECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred             ccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCc
Confidence            55566655   4555555  6666666666666655444 44566666666666666654 4433 22445555555544

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=98.00  E-value=4.7e-06  Score=83.22  Aligned_cols=70  Identities=21%  Similarity=0.249  Sum_probs=48.4

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n   77 (477)
                      |+|++|+|+| +| +++.+++|++|+|++|+|++ +|  ++.+++|++|+|++|+|++. | ...+.++..+.+.+|
T Consensus        47 L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~-~~~l~~L~~L~L~~N  116 (457)
T 3bz5_A           47 LDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D-VTPLTKLTYLNCDTN  116 (457)
T ss_dssp             EECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C-CTTCTTCCEEECCSS
T ss_pred             EEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e-cCCCCcCCEEECCCC
Confidence            5677888884 56 67888888888888888885 45  77777888888888887763 3 333455555555555

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=97.98  E-value=4.7e-06  Score=83.57  Aligned_cols=72  Identities=31%  Similarity=0.412  Sum_probs=51.3

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n   77 (477)
                      |+|++|++++..|  ++.+++|++|+|++|++++..|  +..+++|+.|+|++|++++..| ...+.++..+.+.+|
T Consensus       248 L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~L~~n  319 (466)
T 1o6v_A          248 LDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP-ISNLKNLTYLTLYFN  319 (466)
T ss_dssp             EECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG-GGGCTTCSEEECCSS
T ss_pred             EECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh-hcCCCCCCEEECcCC
Confidence            5678888885544  7888888888888888885443  7778888888888888886544 444556666666655

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.98  E-value=2.7e-05  Score=74.40  Aligned_cols=150  Identities=17%  Similarity=0.184  Sum_probs=79.6

Q ss_pred             CeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCC--CCCcceeeeeccccc-CCCCceeeEEEee
Q 043902          163 NLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIR--HRNILKIVSSCSSVD-YEGNDFKALVFEF  239 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~-~~~~~~~~lv~e~  239 (477)
                      +.|+.|..+.||+....+| .+++|+.....    .....|..++..+.  .-.+.+++....... ....+..+++|+|
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566677889999987655 58899887521    23334455444442  113344443210000 0124567899999


Q ss_pred             cCCCChh--------------hhcccCCCcc--c-----ccccCCHHHH-------------------------------
Q 043902          240 MRNGNLD--------------QWLHPSTDEY--C-----HFKKLSLMQR-------------------------------  267 (477)
Q Consensus       240 ~~~g~L~--------------~~l~~~~~~~--~-----~~~~l~~~~~-------------------------------  267 (477)
                      ++|.++.              .-++......  .     ....-.|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542              0111100000  0     0001122211                               


Q ss_pred             HHHHHHHHHHHHHHHc----------CCCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          268 LNIVIDVASALDYLHN----------QYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       268 ~~i~~~ia~~L~~LH~----------~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      ..+...+..++.+|+.          .....++|+|+++.||+++.++.+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            1111224446666653          0234899999999999998788899999998753

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=97.98  E-value=2.3e-06  Score=85.45  Aligned_cols=55  Identities=31%  Similarity=0.463  Sum_probs=45.8

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccC--cCccc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDG--EISRE   63 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g--~~p~~   63 (477)
                      |+|++|+|++ +|..   +++|++|+|++|+++ .+|.   .+++|+.|+|++|+++|  .+|..
T Consensus       322 L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~  378 (454)
T 1jl5_A          322 LNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPES  378 (454)
T ss_dssp             EECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTT
T ss_pred             EECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHH
Confidence            5788888884 7765   588999999999999 6887   47899999999999998  67765

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=97.97  E-value=3.3e-06  Score=81.22  Aligned_cols=76  Identities=17%  Similarity=0.144  Sum_probs=60.0

Q ss_pred             CeecCCcccccCch-hccCCCCCCeEECCCCccCcccCc-ccCCCCCCCe-EEcccccccCcCccccc-ccccchhhhhc
Q 043902            1 LYLGNNSFKGTIPV-SLKSLRGLAELDLSCNNLSGKVPQ-FFSKLLSLRH-LNLSYNELDGEISREGI-FANASAISIVG   76 (477)
Q Consensus         1 l~l~~n~~~g~~p~-~~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~L~~-l~l~~N~l~g~~p~~~~-~~~~~~~~~~~   76 (477)
                      |+|++|+|+ .||. .|++|++|++|+|++|++.+.+|. .|.+|++|.. +++++|+|++..|..+. +.++..+.+.+
T Consensus        35 L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~  113 (350)
T 4ay9_X           35 LRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN  113 (350)
T ss_dssp             EEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEE
T ss_pred             EEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccc
Confidence            689999999 6775 699999999999999999888885 6889998775 67778999966665533 55566666655


Q ss_pred             C
Q 043902           77 N   77 (477)
Q Consensus        77 n   77 (477)
                      |
T Consensus       114 n  114 (350)
T 4ay9_X          114 T  114 (350)
T ss_dssp             E
T ss_pred             c
Confidence            5

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=97.96  E-value=1.7e-06  Score=83.65  Aligned_cols=78  Identities=31%  Similarity=0.259  Sum_probs=61.4

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccC----cccCCCC-CCCeEEcccccccCcCcccccc------ccc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVP----QFFSKLL-SLRHLNLSYNELDGEISREGIF------ANA   69 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p----~~~~~l~-~L~~l~l~~N~l~g~~p~~~~~------~~~   69 (477)
                      +.|++|+++|.+|..+...++|++|||++|+|++..+    ..|..++ +|+.|+|++|+|++..+.....      .++
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L   82 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV   82 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence            3688999999999988888889999999999996666    7788888 8999999999999776654221      455


Q ss_pred             chhhhhcCC
Q 043902           70 SAISIVGND   78 (477)
Q Consensus        70 ~~~~~~~n~   78 (477)
                      ..+.+.+|.
T Consensus        83 ~~L~Ls~n~   91 (362)
T 3goz_A           83 TSLNLSGNF   91 (362)
T ss_dssp             CEEECCSSC
T ss_pred             cEEECcCCc
Confidence            556665553

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=97.96  E-value=3.1e-06  Score=87.58  Aligned_cols=69  Identities=23%  Similarity=0.344  Sum_probs=45.0

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~   78 (477)
                      |+|++|+|+ .+|   ..+++|+.|+|++|+|+ .||.   .+++|+.|+|++|+|+ .+|.. ..+.++..+.+.+|+
T Consensus       226 L~Ls~N~L~-~lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~  295 (622)
T 3g06_A          226 LIVSGNRLT-SLP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNP  295 (622)
T ss_dssp             EECCSSCCS-CCC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCC
T ss_pred             EEccCCccC-cCC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCC
Confidence            467777777 466   45567777777777777 5666   5567777777777777 55654 334455555555554

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=97.95  E-value=1.1e-06  Score=85.72  Aligned_cols=78  Identities=17%  Similarity=0.257  Sum_probs=62.8

Q ss_pred             CeecCCccc-ccCc---hhccCCCCCCeEECCCCccC--c---ccCcccCCCCCCCeEEccccccc----CcCccc-ccc
Q 043902            1 LYLGNNSFK-GTIP---VSLKSLRGLAELDLSCNNLS--G---KVPQFFSKLLSLRHLNLSYNELD----GEISRE-GIF   66 (477)
Q Consensus         1 l~l~~n~~~-g~~p---~~~~~l~~L~~l~l~~N~l~--g---~~p~~~~~l~~L~~l~l~~N~l~----g~~p~~-~~~   66 (477)
                      |+|++|+|+ +.+|   ..+..+++|++|+|++|+|+  |   .+|..+..+++|+.|+|++|.|+    +.+|.. ..+
T Consensus       164 L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~  243 (386)
T 2ca6_A          164 IICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW  243 (386)
T ss_dssp             EECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGC
T ss_pred             EECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccC
Confidence            579999998 6677   57889999999999999999  4   56668999999999999999996    566654 335


Q ss_pred             cccchhhhhcCC
Q 043902           67 ANASAISIVGND   78 (477)
Q Consensus        67 ~~~~~~~~~~n~   78 (477)
                      .++..+.+.+|.
T Consensus       244 ~~L~~L~L~~n~  255 (386)
T 2ca6_A          244 PNLRELGLNDCL  255 (386)
T ss_dssp             TTCCEEECTTCC
T ss_pred             CCcCEEECCCCC
Confidence            566666666664

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.91  E-value=2.5e-05  Score=72.76  Aligned_cols=79  Identities=16%  Similarity=0.139  Sum_probs=57.8

Q ss_pred             CCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCC---CCcceeeeecccccCCCCceee
Q 043902          158 NFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRH---RNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      .....+.+|.|..+.||+.+..||+.|++|+...........|..|.+.|+.+.-   -.+.+++++.         ..+
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---------~~~   86 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---------DRT   86 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------TTE
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---------Cce
Confidence            4455678999999999999999999999998765444334567889988887742   2355666552         137


Q ss_pred             EEEeecCCCCh
Q 043902          235 LVFEFMRNGNL  245 (477)
Q Consensus       235 lv~e~~~~g~L  245 (477)
                      +||||++++..
T Consensus        87 lv~e~l~~~~~   97 (288)
T 3f7w_A           87 LAMEWVDERPP   97 (288)
T ss_dssp             EEEECCCCCCC
T ss_pred             EEEEeecccCC
Confidence            89999987643

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.89  E-value=2.3e-05  Score=76.65  Aligned_cols=75  Identities=16%  Similarity=0.079  Sum_probs=48.4

Q ss_pred             CCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc-------hhhHHHHHHHHHHhcCCC--C-CcceeeeecccccCCCC
Q 043902          162 ENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ-------GALKSFIDECNALTSIRH--R-NILKIVSSCSSVDYEGN  230 (477)
Q Consensus       162 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-niv~l~~~~~~~~~~~~  230 (477)
                      .+.||.|.++.||+++.. +++.++||.......       .....+..|.+++..+..  + .+.+++.+.       .
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d-------~  107 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T  107 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc-------C
Confidence            457899999999999754 568899998653211       123456778888887632  3 344555442       2


Q ss_pred             ceeeEEEeecCCC
Q 043902          231 DFKALVFEFMRNG  243 (477)
Q Consensus       231 ~~~~lv~e~~~~g  243 (477)
                      +..++||||+++.
T Consensus       108 ~~~~lvmE~l~g~  120 (397)
T 2olc_A          108 EMAVTVMEDLSHL  120 (397)
T ss_dssp             TTTEEEECCCTTS
T ss_pred             CccEEEEEeCCCc
Confidence            2357999999763

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=97.89  E-value=1e-05  Score=83.73  Aligned_cols=54  Identities=30%  Similarity=0.369  Sum_probs=39.9

Q ss_pred             CCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcCCccc
Q 043902           20 RGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGNDKLC   81 (477)
Q Consensus        20 ~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~~l~   81 (477)
                      ++|+.|+|++|+|+ .+|   ..+++|+.|+|++|+|+ .+|.  .+.++..+.+.+| .+.
T Consensus       221 ~~L~~L~Ls~N~L~-~lp---~~l~~L~~L~Ls~N~L~-~lp~--~~~~L~~L~Ls~N-~L~  274 (622)
T 3g06_A          221 SGLKELIVSGNRLT-SLP---VLPSELKELMVSGNRLT-SLPM--LPSGLLSLSVYRN-QLT  274 (622)
T ss_dssp             TTCCEEECCSSCCS-CCC---CCCTTCCEEECCSSCCS-CCCC--CCTTCCEEECCSS-CCC
T ss_pred             CCCCEEEccCCccC-cCC---CCCCcCcEEECCCCCCC-cCCc--ccccCcEEeCCCC-CCC
Confidence            67888888888888 477   45678999999999998 5665  3556666666665 444

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=97.87  E-value=2.8e-06  Score=82.20  Aligned_cols=78  Identities=24%  Similarity=0.209  Sum_probs=62.0

Q ss_pred             CeecCCcccccCc----hhccCCC-CCCeEECCCCccCcccCcccCCC-----CCCCeEEcccccccCcCccccc-----
Q 043902            1 LYLGNNSFKGTIP----VSLKSLR-GLAELDLSCNNLSGKVPQFFSKL-----LSLRHLNLSYNELDGEISREGI-----   65 (477)
Q Consensus         1 l~l~~n~~~g~~p----~~~~~l~-~L~~l~l~~N~l~g~~p~~~~~l-----~~L~~l~l~~N~l~g~~p~~~~-----   65 (477)
                      |+|++|+|++..+    ..+.+++ +|++|+|++|+|++..|..|..+     ++|+.|+|++|+|++..+....     
T Consensus        27 L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~  106 (362)
T 3goz_A           27 LDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAA  106 (362)
T ss_dssp             EECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHT
T ss_pred             EEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHh
Confidence            6899999996666    6788998 89999999999998888888776     9999999999999977665321     


Q ss_pred             c-cccchhhhhcCC
Q 043902           66 F-ANASAISIVGND   78 (477)
Q Consensus        66 ~-~~~~~~~~~~n~   78 (477)
                      + .++..+.+.+|.
T Consensus       107 ~~~~L~~L~Ls~N~  120 (362)
T 3goz_A          107 IPFTITVLDLGWND  120 (362)
T ss_dssp             SCTTCCEEECCSSC
T ss_pred             CCCCccEEECcCCc
Confidence            1 455666666654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.67  E-value=0.00035  Score=65.58  Aligned_cols=143  Identities=16%  Similarity=0.137  Sum_probs=90.4

Q ss_pred             CCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCC---CCCcceeeeecccccCCCCceeeEEE
Q 043902          161 EENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIR---HRNILKIVSSCSSVDYEGNDFKALVF  237 (477)
Q Consensus       161 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~~~~~~lv~  237 (477)
                      ..+.|+.|....+|+... ++..+++|+....   ....+..|.+.|+.+.   ...+.++++++.     ..+..++||
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-----~~g~~~lvm  110 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGN-----SQGHSFLLL  110 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-----CSSEEEEEE
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEee-----cCCceEEEE
Confidence            346789999999999986 4678889987643   2467888988888773   356778887753     346789999


Q ss_pred             eecCCCChhh-----------hcccCCC--ccc-------------ccccCCHHHHH---HHH----------------H
Q 043902          238 EFMRNGNLDQ-----------WLHPSTD--EYC-------------HFKKLSLMQRL---NIV----------------I  272 (477)
Q Consensus       238 e~~~~g~L~~-----------~l~~~~~--~~~-------------~~~~l~~~~~~---~i~----------------~  272 (477)
                      ||+++.++..           -|+....  .+.             ....-+|....   ++.                .
T Consensus       111 e~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~  190 (312)
T 3jr1_A          111 EALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNID  190 (312)
T ss_dssp             ECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHH
T ss_pred             EeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHH
Confidence            9999876521           1222111  000             00112454322   111                1


Q ss_pred             HHHHHH-HHHHc-CCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          273 DVASAL-DYLHN-QYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       273 ~ia~~L-~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      .+...+ ..|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       191 ~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          191 LIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            111111 23321 2356899999999999999887 8899974

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.59  E-value=0.00021  Score=66.96  Aligned_cols=74  Identities=7%  Similarity=0.069  Sum_probs=45.0

Q ss_pred             CCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCc-ceeeeecccccCCCCceeeEEE
Q 043902          159 FSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI-LKIVSSCSSVDYEGNDFKALVF  237 (477)
Q Consensus       159 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~~~~~~lv~  237 (477)
                      +...+.|+.|....+|+.     ..+++|+........ ....+|...+..+...++ .++++++       .+..++++
T Consensus        20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~-------~~~~~~v~   86 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD-------PATGVMVT   86 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC-------TTTCCEEE
T ss_pred             ccceeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE-------CCCCEEEE
Confidence            334678999999999998     568888876432211 223457777766632222 4556542       22347899


Q ss_pred             eec-CCCCh
Q 043902          238 EFM-RNGNL  245 (477)
Q Consensus       238 e~~-~~g~L  245 (477)
                      ||+ ++.++
T Consensus        87 e~i~~g~~l   95 (301)
T 3dxq_A           87 RYIAGAQTM   95 (301)
T ss_dssp             ECCTTCEEC
T ss_pred             eecCCCccC
Confidence            999 65444

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=97.49  E-value=9.5e-06  Score=81.03  Aligned_cols=77  Identities=17%  Similarity=0.078  Sum_probs=49.0

Q ss_pred             CeecCCcccccCchhccCC-----CCCCeEECCCCccCcc----cCcccCCCCCCCeEEcccccccCcCccccc------
Q 043902            1 LYLGNNSFKGTIPVSLKSL-----RGLAELDLSCNNLSGK----VPQFFSKLLSLRHLNLSYNELDGEISREGI------   65 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l-----~~L~~l~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~------   65 (477)
                      |+|++|.+++..+..+...     ++|++|+|++|.+++.    +|..+..+++|+.|+|++|.+++..+....      
T Consensus       289 L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~  368 (461)
T 1z7x_W          289 LSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQP  368 (461)
T ss_dssp             EECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTST
T ss_pred             EECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCC
Confidence            5677888776555444432     6788888888887765    566677777888888888877754333211      


Q ss_pred             ccccchhhhhcC
Q 043902           66 FANASAISIVGN   77 (477)
Q Consensus        66 ~~~~~~~~~~~n   77 (477)
                      ..++..+.+.+|
T Consensus       369 ~~~L~~L~L~~n  380 (461)
T 1z7x_W          369 GSVLRVLWLADC  380 (461)
T ss_dssp             TCCCCEEECTTS
T ss_pred             CCceEEEECCCC
Confidence            234555555555

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.45  E-value=0.00012  Score=59.11  Aligned_cols=53  Identities=26%  Similarity=0.421  Sum_probs=40.9

Q ss_pred             eecCCccc-ccCchhccCCCCCCeEECCCCccCcccC-cccCCCCCCCeEEccccccc
Q 043902            2 YLGNNSFK-GTIPVSLKSLRGLAELDLSCNNLSGKVP-QFFSKLLSLRHLNLSYNELD   57 (477)
Q Consensus         2 ~l~~n~~~-g~~p~~~~~l~~L~~l~l~~N~l~g~~p-~~~~~l~~L~~l~l~~N~l~   57 (477)
                      +.++++|+ ..+|..+.  ++|+.|+|++|+|+ .|| ..|..+++|+.|+|++|.+.
T Consensus        14 ~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           14 DCGRRGLTWASLPTAFP--VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             ECCSSCCCTTTSCSCCC--TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EeCCCCCccccCCCCCC--cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence            55777776 46776542  46899999999999 555 46788999999999999775

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.40  E-value=0.00032  Score=69.04  Aligned_cols=78  Identities=10%  Similarity=-0.005  Sum_probs=47.0

Q ss_pred             CCeeecCCCCCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccccC----CCCcccceeehHH
Q 043902          287 TPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING----HVSILGDIYSYGI  362 (477)
Q Consensus       287 ~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~Dv~S~Gv  362 (477)
                      ..++|||++|.||+++.++ ++++||+.+......     .+.... ...-...|.+|+....    ......++.+...
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-----~Dla~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-----FDIGAY-LGNLILAFFAQDGHATQENDRKEYKQWILRTIE  304 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-----HHHHHH-HHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-----HHHHHH-HHHHHHHHHhcccccccccchHHHHHHHHHHHH
Confidence            4899999999999998876 999999988754110     000000 0000134566655421    1122345567888


Q ss_pred             HHHHHhhCC
Q 043902          363 LLLEIFTGK  371 (477)
Q Consensus       363 vl~elltg~  371 (477)
                      .+|+.++++
T Consensus       305 ~~~~~y~~~  313 (420)
T 2pyw_A          305 QTWNLFNKR  313 (420)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            888887753

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.37  E-value=0.0025  Score=59.99  Aligned_cols=166  Identities=12%  Similarity=0.060  Sum_probs=85.9

Q ss_pred             HHHHHHhhcCCCC-----CCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCC--cceeeee
Q 043902          149 YLKISNATDNFSE-----ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRN--ILKIVSS  221 (477)
Q Consensus       149 ~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~  221 (477)
                      ..++......|..     .+.|+.|....+|+....+| .+++|+.....  ....+..|+.++..+...+  +.+++..
T Consensus         9 ~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~   85 (322)
T 2ppq_A            9 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPR   85 (322)
T ss_dssp             HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred             HHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCC
Confidence            3444444444543     23466788889999987655 68889887521  1234556777766663212  3344332


Q ss_pred             ccccc-CCCCceeeEEEeecCCCChhhh--------------cccCCCccccc-----ccCCHHHHHH------------
Q 043902          222 CSSVD-YEGNDFKALVFEFMRNGNLDQW--------------LHPSTDEYCHF-----KKLSLMQRLN------------  269 (477)
Q Consensus       222 ~~~~~-~~~~~~~~lv~e~~~~g~L~~~--------------l~~~~~~~~~~-----~~l~~~~~~~------------  269 (477)
                      ..... ....+..+++++|++|..+...              ++.........     ....|...+.            
T Consensus        86 ~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~  165 (322)
T 2ppq_A           86 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG  165 (322)
T ss_dssp             TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred             CCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhh
Confidence            10000 0112456899999988654210              11110000000     0011222110            


Q ss_pred             HHHHHHHHHHHHHcC----CCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          270 IVIDVASALDYLHNQ----YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       270 i~~~ia~~L~~LH~~----~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      +...+...+.+++..    ....++|+|+.+.||+++++..+.|+||+.+..
T Consensus       166 l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          166 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            011244455555532    134799999999999999876668999988753

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=97.31  E-value=2.6e-05  Score=75.49  Aligned_cols=57  Identities=26%  Similarity=0.182  Sum_probs=32.2

Q ss_pred             CeecCCcccccCchhc-----cCCCCCCeEECCCCccCc----ccCcccCCCCCCCeEEccccccc
Q 043902            1 LYLGNNSFKGTIPVSL-----KSLRGLAELDLSCNNLSG----KVPQFFSKLLSLRHLNLSYNELD   57 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~-----~~l~~L~~l~l~~N~l~g----~~p~~~~~l~~L~~l~l~~N~l~   57 (477)
                      |+|++|+|+..-...+     ...++|++|+|++|.|+.    .++..+..+++|++|||++|.|+
T Consensus       131 L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~  196 (372)
T 3un9_A          131 LGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLG  196 (372)
T ss_dssp             EECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCH
T ss_pred             hhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCC
Confidence            4566666664333333     234566666666666653    24444455666666666666665

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.30  E-value=0.0014  Score=62.05  Aligned_cols=150  Identities=12%  Similarity=0.141  Sum_probs=81.4

Q ss_pred             CeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCC--Ccceeeeeccccc-CCCCceeeEEEee
Q 043902          163 NLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHR--NILKIVSSCSSVD-YEGNDFKALVFEF  239 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~-~~~~~~~~lv~e~  239 (477)
                      ..++ |....||+....+|+.+++|+...... ....+..|..++..+...  .+++++.. .... ....+..+++|++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEEEEC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEEEEe
Confidence            4566 788899998877788899999874321 224566677777776422  23444432 1100 0124456889999


Q ss_pred             cCCCChhh-----h---------cccC--CCcccccccCCHHHH----HH---------------HHHHHHHHHHHHHcC
Q 043902          240 MRNGNLDQ-----W---------LHPS--TDEYCHFKKLSLMQR----LN---------------IVIDVASALDYLHNQ  284 (477)
Q Consensus       240 ~~~g~L~~-----~---------l~~~--~~~~~~~~~l~~~~~----~~---------------i~~~ia~~L~~LH~~  284 (477)
                      ++|.++..     +         ++..  ..........++...    ..               +...+...+..+...
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            98754321     0         1100  000000111222111    00               011111223333221


Q ss_pred             ----CCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          285 ----YDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       285 ----~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                          ....++|||+++.||+++ + .+.|+||+.+..
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                234689999999999999 4 899999988754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.29  E-value=0.0018  Score=61.48  Aligned_cols=32  Identities=31%  Similarity=0.295  Sum_probs=27.6

Q ss_pred             CCCeeecCCCCCCeEecCC----CcEEEeccccccc
Q 043902          286 DTPIAHCDLKSSNVLLDEG----MIAHVGDFGLAKF  317 (477)
Q Consensus       286 ~~~ivH~dlkp~NIll~~~----~~~kl~DfG~a~~  317 (477)
                      ...++|||+.+.||+++.+    ..+.|+||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            3479999999999999874    6899999998865

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=97.24  E-value=4.1e-05  Score=76.33  Aligned_cols=78  Identities=21%  Similarity=0.180  Sum_probs=62.5

Q ss_pred             CeecCCccccc----CchhccCCCCCCeEECCCCccCcccCcccCC-----CCCCCeEEcccccccC----cCccc-ccc
Q 043902            1 LYLGNNSFKGT----IPVSLKSLRGLAELDLSCNNLSGKVPQFFSK-----LLSLRHLNLSYNELDG----EISRE-GIF   66 (477)
Q Consensus         1 l~l~~n~~~g~----~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~-----l~~L~~l~l~~N~l~g----~~p~~-~~~   66 (477)
                      |+|++|.+++.    +|..+..+++|++|+|++|.+++..+..+..     +++|+.|+|++|.+++    .+|.. ..+
T Consensus       318 L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~  397 (461)
T 1z7x_W          318 LWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLAN  397 (461)
T ss_dssp             EECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHC
T ss_pred             eEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhC
Confidence            57899999975    7888889999999999999999776665543     7799999999999996    66654 335


Q ss_pred             cccchhhhhcCC
Q 043902           67 ANASAISIVGND   78 (477)
Q Consensus        67 ~~~~~~~~~~n~   78 (477)
                      .++..+.+.+|+
T Consensus       398 ~~L~~L~l~~N~  409 (461)
T 1z7x_W          398 HSLRELDLSNNC  409 (461)
T ss_dssp             CCCCEEECCSSS
T ss_pred             CCccEEECCCCC
Confidence            667777777774

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.16  E-value=0.00072  Score=66.64  Aligned_cols=73  Identities=15%  Similarity=0.216  Sum_probs=49.0

Q ss_pred             CCeeeeeccceEEEEEeCC--------CCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCc-ceeeeecccccCCCCce
Q 043902          162 ENLIGSGSFGSVYKGTLAD--------GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI-LKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       162 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~~~~  232 (477)
                      .+.|+.|....+|++...+        ++.+++|+......  ...+..|..++..+...++ .++++.+     .+   
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~---  147 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIF-----SG---  147 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT---
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC---
Confidence            3567888889999998753        57899998853211  1455678888887743333 5666653     21   


Q ss_pred             eeEEEeecCCCCh
Q 043902          233 KALVFEFMRNGNL  245 (477)
Q Consensus       233 ~~lv~e~~~~g~L  245 (477)
                       .+|+||++|.++
T Consensus       148 -g~v~e~l~G~~l  159 (429)
T 1nw1_A          148 -GRLEEYIPSRPL  159 (429)
T ss_dssp             -EEEECCCCEEEC
T ss_pred             -CEEEEEeCCccc
Confidence             389999986444

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.16  E-value=0.0017  Score=56.43  Aligned_cols=103  Identities=10%  Similarity=0.023  Sum_probs=68.0

Q ss_pred             CChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccccccC
Q 043902          243 GNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES  322 (477)
Q Consensus       243 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  322 (477)
                      -+|.+.|....      .++++.++|.++.|.+.+|.-+-...  .-..+=+.|..|++..+|.+...+ +.+.      
T Consensus        33 vSL~eIL~~~~------~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------   97 (229)
T 2yle_A           33 LSLEEILRLYN------QPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD------   97 (229)
T ss_dssp             EEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C---------
T ss_pred             ccHHHHHHHcC------CCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc------
Confidence            37889987654      78999999999999999988773210  111233456899999999888754 1110      


Q ss_pred             CCCCCCccccCCCcccccccCcccccCCCCcccceeehHHHHHHHhhCCCC
Q 043902          323 NTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRP  373 (477)
Q Consensus       323 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~S~Gvvl~elltg~~p  373 (477)
                                   .....+.|||......+.+.=|||+|+++|.-+--..|
T Consensus        98 -------------~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 -------------AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ----------------------CCSSSSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             -------------ccccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCC
Confidence                         11234678888755667888999999999999874333

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=97.14  E-value=9.2e-05  Score=71.61  Aligned_cols=78  Identities=19%  Similarity=0.274  Sum_probs=59.3

Q ss_pred             CeecCCcccc----cCchhccCCCCCCeEECCCCccCc----ccCcccCCCCCCCeEEcccccccCc----Cccc-cccc
Q 043902            1 LYLGNNSFKG----TIPVSLKSLRGLAELDLSCNNLSG----KVPQFFSKLLSLRHLNLSYNELDGE----ISRE-GIFA   67 (477)
Q Consensus         1 l~l~~n~~~g----~~p~~~~~l~~L~~l~l~~N~l~g----~~p~~~~~l~~L~~l~l~~N~l~g~----~p~~-~~~~   67 (477)
                      |+|++|.|+.    .++..+..+++|++|||++|.|++    .++..+..+++|+.|+|++|.|++.    ++.. ....
T Consensus       160 L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~  239 (372)
T 3un9_A          160 LRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHP  239 (372)
T ss_dssp             EECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCS
T ss_pred             eeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCC
Confidence            6899999985    466677899999999999999985    3567788889999999999999853    2111 1235


Q ss_pred             ccchhhhhcCC
Q 043902           68 NASAISIVGND   78 (477)
Q Consensus        68 ~~~~~~~~~n~   78 (477)
                      ++..+.+.+|+
T Consensus       240 ~L~~L~Ls~N~  250 (372)
T 3un9_A          240 SLELLHLYFNE  250 (372)
T ss_dssp             SCCEEECTTSS
T ss_pred             CCCEEeccCCC
Confidence            56667776664

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.05  E-value=0.0015  Score=63.03  Aligned_cols=144  Identities=10%  Similarity=0.139  Sum_probs=82.6

Q ss_pred             CCeeeeeccceEEEEEeC--------CCCEEEEEEeeeccchhhHHHHHHHHHHhcCC-CCCcceeeeecccccCCCCce
Q 043902          162 ENLIGSGSFGSVYKGTLA--------DGETAAIKVLKLQQQGALKSFIDECNALTSIR-HRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       162 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .+.|..|-...+|++...        +++.+++|+..... .......+|.++++.+. +.-..++++++     .+   
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~---  125 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVF-----PE---  125 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT---
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC---
Confidence            356777888899999874        25789999864322 23456678988888774 32235666664     22   


Q ss_pred             eeEEEeecCCCChhhh-----------------cccCCCcccccccCC--HHHHHHHHHHHHH-----------------
Q 043902          233 KALVFEFMRNGNLDQW-----------------LHPSTDEYCHFKKLS--LMQRLNIVIDVAS-----------------  276 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~-----------------l~~~~~~~~~~~~l~--~~~~~~i~~~ia~-----------------  276 (477)
                       .+||||++|.+|..-                 |+......  .....  +.++.++..++..                 
T Consensus       126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~--~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l  202 (379)
T 3feg_A          126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPF--TKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL  202 (379)
T ss_dssp             -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSS--CCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred             -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCC--CCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence             289999988655321                 11111000  11122  3444444433321                 


Q ss_pred             --HHHHHH----cC-CCCCeeecCCCCCCeEecCC----CcEEEeccccccc
Q 043902          277 --ALDYLH----NQ-YDTPIAHCDLKSSNVLLDEG----MIAHVGDFGLAKF  317 (477)
Q Consensus       277 --~L~~LH----~~-~~~~ivH~dlkp~NIll~~~----~~~kl~DfG~a~~  317 (477)
                        .+..|.    .. ....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence              223332    21 23468999999999999876    6899999988754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.05  E-value=0.0027  Score=62.95  Aligned_cols=74  Identities=19%  Similarity=0.113  Sum_probs=47.3

Q ss_pred             CCeeeeeccceEEEEEeCC-CCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCc-ceeeeecccccCCCCceeeEEEee
Q 043902          162 ENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI-LKIVSSCSSVDYEGNDFKALVFEF  239 (477)
Q Consensus       162 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~~~~~~lv~e~  239 (477)
                      .+.|+.|-...+|++...+ +..+++|+....... .-....|..++..+...++ .++++.+     . +   .+|+||
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~-----~-~---G~v~e~  182 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF-----T-N---GRIEEF  182 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE-----T-T---EEEEEC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe-----C-C---eEEEEe
Confidence            4578888889999999865 478889987543221 1122578888888864444 5666653     1 1   259999


Q ss_pred             cCCCCh
Q 043902          240 MRNGNL  245 (477)
Q Consensus       240 ~~~g~L  245 (477)
                      ++|.+|
T Consensus       183 I~G~~l  188 (458)
T 2qg7_A          183 MDGYAL  188 (458)
T ss_dssp             CCSEEC
T ss_pred             eCCccC
Confidence            987554

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=96.99  E-value=0.00013  Score=75.21  Aligned_cols=78  Identities=9%  Similarity=0.006  Sum_probs=55.0

Q ss_pred             Ceec--CCcccccCchhccC-CCCCCeEECCCCccCc-ccCcccCCCCCCCeEEcccccccCc-Cccc-ccccccchhhh
Q 043902            1 LYLG--NNSFKGTIPVSLKS-LRGLAELDLSCNNLSG-KVPQFFSKLLSLRHLNLSYNELDGE-ISRE-GIFANASAISI   74 (477)
Q Consensus         1 l~l~--~n~~~g~~p~~~~~-l~~L~~l~l~~N~l~g-~~p~~~~~l~~L~~l~l~~N~l~g~-~p~~-~~~~~~~~~~~   74 (477)
                      |+|+  +|.+++..+..++. +++|++|+|++|++++ .+|..+..+++|+.|+|++|.|++. ++.. ..+.++..+.+
T Consensus       441 L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l  520 (592)
T 3ogk_B          441 FAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWV  520 (592)
T ss_dssp             EEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEE
T ss_pred             EEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeEC
Confidence            3454  33577777776654 8889999999998887 5666678888899999999988754 3322 23566667777


Q ss_pred             hcCC
Q 043902           75 VGND   78 (477)
Q Consensus        75 ~~n~   78 (477)
                      .+|+
T Consensus       521 s~n~  524 (592)
T 3ogk_B          521 QGYR  524 (592)
T ss_dssp             ESCB
T ss_pred             cCCc
Confidence            7775

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.95  E-value=0.0068  Score=57.60  Aligned_cols=31  Identities=19%  Similarity=0.290  Sum_probs=27.6

Q ss_pred             CCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          287 TPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       287 ~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      ..++|+|+.+.||++++++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4799999999999999888899999988764

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.75  E-value=0.0018  Score=62.40  Aligned_cols=73  Identities=12%  Similarity=0.189  Sum_probs=43.5

Q ss_pred             CeeeeeccceEEEEEeCC---------CCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCC-cceeeeecccccCCCCce
Q 043902          163 NLIGSGSFGSVYKGTLAD---------GETAAIKVLKLQQQGALKSFIDECNALTSIRHRN-ILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~~~~  232 (477)
                      +.++.|....+|+....+         ++.+++|+....... ......|.+++..+...+ ..++++..     .    
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~----  108 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF-----N----  108 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec-----C----
Confidence            467788888999998754         268888987643221 122356777777774333 44666542     1    


Q ss_pred             eeEEEeecCCCCh
Q 043902          233 KALVFEFMRNGNL  245 (477)
Q Consensus       233 ~~lv~e~~~~g~L  245 (477)
                      .++||||++|.++
T Consensus       109 ~~~v~e~i~G~~l  121 (369)
T 3c5i_A          109 GGRIEEWLYGDPL  121 (369)
T ss_dssp             TEEEEECCCSEEC
T ss_pred             CcEEEEEecCCcC
Confidence            2689999987544

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=96.70  E-value=0.00048  Score=59.41  Aligned_cols=58  Identities=16%  Similarity=0.197  Sum_probs=45.0

Q ss_pred             CeecCC-cccc----cCchhccCCCCCCeEECCCCccCc----ccCcccCCCCCCCeEEcccccccC
Q 043902            1 LYLGNN-SFKG----TIPVSLKSLRGLAELDLSCNNLSG----KVPQFFSKLLSLRHLNLSYNELDG   58 (477)
Q Consensus         1 l~l~~n-~~~g----~~p~~~~~l~~L~~l~l~~N~l~g----~~p~~~~~l~~L~~l~l~~N~l~g   58 (477)
                      |+|++| .|+.    .+...+...++|++|+|++|+|+.    .+...+...++|++|+|++|.|+.
T Consensus        41 L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~  107 (185)
T 1io0_A           41 VNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG  107 (185)
T ss_dssp             EECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred             EEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence            578888 8764    355667778899999999999974    245556667889999999999875

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.52  E-value=0.0026  Score=51.15  Aligned_cols=57  Identities=18%  Similarity=0.242  Sum_probs=44.0

Q ss_pred             CeEECCCCccC-cccCcccCCCCCCCeEEcccccccCcCccc-c-cccccchhhhhcCCcccc
Q 043902           23 AELDLSCNNLS-GKVPQFFSKLLSLRHLNLSYNELDGEISRE-G-IFANASAISIVGNDKLCG   82 (477)
Q Consensus        23 ~~l~l~~N~l~-g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~-~~~~~~~~~~~~n~~l~g   82 (477)
                      ..++.++|+|+ ..+|..+.  ++|+.|+|++|+|+ .+|.. + .+.++..+.+.+|+..|.
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~Cd   70 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWRCD   70 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCBCS
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCeecc
Confidence            48999999997 67887654  37999999999999 55554 2 255677788888987764

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=96.43  E-value=0.00064  Score=58.59  Aligned_cols=58  Identities=19%  Similarity=0.217  Sum_probs=48.7

Q ss_pred             CeecCCcccc----cCchhccCCCCCCeEECCCCccCcc----cCcccCCCCCCCeEEc--ccccccC
Q 043902            1 LYLGNNSFKG----TIPVSLKSLRGLAELDLSCNNLSGK----VPQFFSKLLSLRHLNL--SYNELDG   58 (477)
Q Consensus         1 l~l~~n~~~g----~~p~~~~~l~~L~~l~l~~N~l~g~----~p~~~~~l~~L~~l~l--~~N~l~g   58 (477)
                      |+|++|+|+.    .|...+...++|++|+|++|.|+..    +...+...++|+.|+|  ++|.|+.
T Consensus        70 L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~  137 (185)
T 1io0_A           70 FSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGN  137 (185)
T ss_dssp             EECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred             EECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCH
Confidence            6899999975    3556677789999999999999964    6777888899999999  8899874

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=96.43  E-value=0.002  Score=61.01  Aligned_cols=53  Identities=25%  Similarity=0.335  Sum_probs=33.2

Q ss_pred             CeecCCcccccCch-hccCCCCCCeEECCCCccCcccC-cccCCCCCCC-eEEccccccc
Q 043902            1 LYLGNNSFKGTIPV-SLKSLRGLAELDLSCNNLSGKVP-QFFSKLLSLR-HLNLSYNELD   57 (477)
Q Consensus         1 l~l~~n~~~g~~p~-~~~~l~~L~~l~l~~N~l~g~~p-~~~~~l~~L~-~l~l~~N~l~   57 (477)
                      |+|++|+++ .||. .|.++++|+.|+|++| ++ .|| .+|..+.+|+ .|++++ +++
T Consensus       231 l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~  286 (329)
T 3sb4_A          231 LDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVT  286 (329)
T ss_dssp             EECTTBCCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCC
T ss_pred             EECCCCCcc-eecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cce
Confidence            356666666 5554 3677777777777766 65 343 4566777776 777766 454

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=96.41  E-value=0.00045  Score=66.34  Aligned_cols=60  Identities=18%  Similarity=0.171  Sum_probs=43.2

Q ss_pred             CCCCCCeEECCCCccCcccCcccC---CCCCCCeEEcccccccCc----Cccc-ccccccchhhhhcC
Q 043902           18 SLRGLAELDLSCNNLSGKVPQFFS---KLLSLRHLNLSYNELDGE----ISRE-GIFANASAISIVGN   77 (477)
Q Consensus        18 ~l~~L~~l~l~~N~l~g~~p~~~~---~l~~L~~l~l~~N~l~g~----~p~~-~~~~~~~~~~~~~n   77 (477)
                      .+++|++|+|++|.+++..+..+.   .+++|+.|+||.|.|++.    ++.. ..+.++..+.+..|
T Consensus       250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n  317 (362)
T 2ra8_A          250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYN  317 (362)
T ss_dssp             TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSB
T ss_pred             CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCC
Confidence            588999999999999876654443   688999999999999863    3322 23455566655544

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=96.33  E-value=0.00048  Score=70.93  Aligned_cols=58  Identities=14%  Similarity=0.141  Sum_probs=34.3

Q ss_pred             CeecCCccccc----CchhccCCCCCCeEECCCCccC----cccCcccCCCCCCCeEEcccccccC
Q 043902            1 LYLGNNSFKGT----IPVSLKSLRGLAELDLSCNNLS----GKVPQFFSKLLSLRHLNLSYNELDG   58 (477)
Q Consensus         1 l~l~~n~~~g~----~p~~~~~l~~L~~l~l~~N~l~----g~~p~~~~~l~~L~~l~l~~N~l~g   58 (477)
                      |+|++|.+++.    ++..+.++++|++|+|++|.++    +.++..+.++++|+.|+|++|.+++
T Consensus       169 L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~  234 (592)
T 3ogk_B          169 LLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE  234 (592)
T ss_dssp             EECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG
T ss_pred             EECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH
Confidence            35566666544    4444555666666666666665    3445555566666666666666664

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=96.02  E-value=0.00055  Score=70.52  Aligned_cols=65  Identities=14%  Similarity=0.111  Sum_probs=42.9

Q ss_pred             hhccCCCCCCeEECCCCccCcccCcccCC-CCCCCeEEcccccccCcCccc--ccccccchhhhhcCCc
Q 043902           14 VSLKSLRGLAELDLSCNNLSGKVPQFFSK-LLSLRHLNLSYNELDGEISRE--GIFANASAISIVGNDK   79 (477)
Q Consensus        14 ~~~~~l~~L~~l~l~~N~l~g~~p~~~~~-l~~L~~l~l~~N~l~g~~p~~--~~~~~~~~~~~~~n~~   79 (477)
                      .-+.++++|+.|+|++ ++++..+..++. +++|+.|+|++|.+++..+..  ..+.++..+.+.+|+.
T Consensus       426 ~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~  493 (594)
T 2p1m_B          426 AIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF  493 (594)
T ss_dssp             HHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSC
T ss_pred             HHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCC
Confidence            3367778888888876 677666666665 778888888888876543322  2245666666666653

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=95.87  E-value=0.0015  Score=67.28  Aligned_cols=78  Identities=12%  Similarity=0.056  Sum_probs=55.7

Q ss_pred             CeecCCcccccCchhccC-CCCCCeEECCCCccCcccCccc-CCCCCCCeEEcccccccCcCccc--ccccccchhhhhc
Q 043902            1 LYLGNNSFKGTIPVSLKS-LRGLAELDLSCNNLSGKVPQFF-SKLLSLRHLNLSYNELDGEISRE--GIFANASAISIVG   76 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~-l~~L~~l~l~~N~l~g~~p~~~-~~l~~L~~l~l~~N~l~g~~p~~--~~~~~~~~~~~~~   76 (477)
                      |+|++ ++++..+..++. +++|++|+|++|.+++..+..+ ..+++|+.|+|++|.+++..+..  ..+.++..+.+.+
T Consensus       437 L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~  515 (594)
T 2p1m_B          437 LSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSS  515 (594)
T ss_dssp             EECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEES
T ss_pred             EeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeC
Confidence            45655 677666777766 8899999999999987766655 67899999999999986543321  2245666666666


Q ss_pred             CCc
Q 043902           77 NDK   79 (477)
Q Consensus        77 n~~   79 (477)
                      |+.
T Consensus       516 ~~~  518 (594)
T 2p1m_B          516 CSV  518 (594)
T ss_dssp             SCC
T ss_pred             CCC
Confidence            643

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.44  E-value=0.026  Score=55.14  Aligned_cols=74  Identities=11%  Similarity=0.096  Sum_probs=47.9

Q ss_pred             CCeeeeeccceEEEEEeCC--------CCEEEEEEeeeccchhhHHHHHHHHHHhcCC-CCCcceeeeecccccCCCCce
Q 043902          162 ENLIGSGSFGSVYKGTLAD--------GETAAIKVLKLQQQGALKSFIDECNALTSIR-HRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       162 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .+.+..|-...+|+....+        ++.+++|+....... .....+|..+++.+. +.-..++++.+     .    
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~-----~----  144 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF-----P----  144 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc-----C----
Confidence            3567778888999998753        578999987543221 123356777777774 22245555542     1    


Q ss_pred             eeEEEeecCCCCh
Q 043902          233 KALVFEFMRNGNL  245 (477)
Q Consensus       233 ~~lv~e~~~~g~L  245 (477)
                      -++|+||++|.+|
T Consensus       145 ~~~I~efI~G~~l  157 (424)
T 3mes_A          145 EGRIEEFIDGEPL  157 (424)
T ss_dssp             TEEEEECCCSEEC
T ss_pred             CCEEEEEeCCccC
Confidence            2689999998654

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=95.13  E-value=0.0089  Score=56.43  Aligned_cols=42  Identities=14%  Similarity=0.145  Sum_probs=35.5

Q ss_pred             CCCCCeEECCCCccCcccC-cccCCCCCCCeEEcccccccCcCccc
Q 043902           19 LRGLAELDLSCNNLSGKVP-QFFSKLLSLRHLNLSYNELDGEISRE   63 (477)
Q Consensus        19 l~~L~~l~l~~N~l~g~~p-~~~~~l~~L~~l~l~~N~l~g~~p~~   63 (477)
                      |++|+.|+|++ +++ .|+ .+|..|++|+.|+|++|.++ .|+..
T Consensus       100 ~~~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~-~i~~~  142 (329)
T 3sb4_A          100 KQTLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAP-NLLPE  142 (329)
T ss_dssp             CTTCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCC-EECTT
T ss_pred             cCCCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCcc-ccchh
Confidence            99999999999 899 565 57999999999999999998 55544

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=93.99  E-value=0.016  Score=49.94  Aligned_cols=58  Identities=17%  Similarity=0.204  Sum_probs=38.8

Q ss_pred             CeecCC-cccc----cCchhccCCCCCCeEECCCCccCcc----cCcccCCCCCCCeEEcccccccC
Q 043902            1 LYLGNN-SFKG----TIPVSLKSLRGLAELDLSCNNLSGK----VPQFFSKLLSLRHLNLSYNELDG   58 (477)
Q Consensus         1 l~l~~n-~~~g----~~p~~~~~l~~L~~l~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~g   58 (477)
                      |+|++| +|..    .|-..+..-+.|+.|+|++|+|+..    |-..+..-+.|+.|+|++|+|+.
T Consensus        46 L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~  112 (197)
T 1pgv_A           46 VNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP  112 (197)
T ss_dssp             EECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred             EECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence            466664 6542    2445566777888888888888732    33444455778888888888863

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.00  E-value=0.033  Score=54.15  Aligned_cols=30  Identities=27%  Similarity=0.401  Sum_probs=25.0

Q ss_pred             CeeecCCCCCCeEe------cCCCcEEEeccccccc
Q 043902          288 PIAHCDLKSSNVLL------DEGMIAHVGDFGLAKF  317 (477)
Q Consensus       288 ~ivH~dlkp~NIll------~~~~~~kl~DfG~a~~  317 (477)
                      .++|+|+.+.||++      +++..++++||-.|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4566799999988754

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=92.59  E-value=0.016  Score=55.54  Aligned_cols=76  Identities=13%  Similarity=0.209  Sum_probs=46.0

Q ss_pred             eecCCcccccCchhcc--CCCCCCeEECCC--CccCcc-----cCccc--CCCCCCCeEEcccccccCcCccc----ccc
Q 043902            2 YLGNNSFKGTIPVSLK--SLRGLAELDLSC--NNLSGK-----VPQFF--SKLLSLRHLNLSYNELDGEISRE----GIF   66 (477)
Q Consensus         2 ~l~~n~~~g~~p~~~~--~l~~L~~l~l~~--N~l~g~-----~p~~~--~~l~~L~~l~l~~N~l~g~~p~~----~~~   66 (477)
                      +|..|.++...-..++  .+++|+.|+|+.  |+..|.     +-..+  ..+++|++|+|++|.+++..+..    ..+
T Consensus       199 ~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~  278 (362)
T 2ra8_A          199 EIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL  278 (362)
T ss_dssp             EEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSG
T ss_pred             EEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccC
Confidence            4455555543333444  799999999863  332222     11223  35789999999999998543322    235


Q ss_pred             cccchhhhhcC
Q 043902           67 ANASAISIVGN   77 (477)
Q Consensus        67 ~~~~~~~~~~n   77 (477)
                      .++..+.+..|
T Consensus       279 ~~L~~LdLs~n  289 (362)
T 2ra8_A          279 PQLETMDISAG  289 (362)
T ss_dssp             GGCSEEECCSS
T ss_pred             CCCCEEECCCC
Confidence            56666666555

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=92.03  E-value=0.045  Score=46.18  Aligned_cols=47  Identities=9%  Similarity=0.105  Sum_probs=32.5

Q ss_pred             cCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEccccc-cc
Q 043902           11 TIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNE-LD   57 (477)
Q Consensus        11 ~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~-l~   57 (477)
                      .+|...-.--+|+.||||++.++..==..+..+++|+.|+|+++. ++
T Consensus        52 ~LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~It   99 (176)
T 3e4g_A           52 HLPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIE   99 (176)
T ss_dssp             GSCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCC
T ss_pred             cCCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccC
Confidence            345543223468888888888875444556788888888888874 55

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=91.93  E-value=0.058  Score=46.40  Aligned_cols=55  Identities=13%  Similarity=0.119  Sum_probs=42.8

Q ss_pred             CeecCCcccc----cCchhccCCCCCCeEECCCCccCcc----cCcccCCCCCCCeEEccccc
Q 043902            1 LYLGNNSFKG----TIPVSLKSLRGLAELDLSCNNLSGK----VPQFFSKLLSLRHLNLSYNE   55 (477)
Q Consensus         1 l~l~~n~~~g----~~p~~~~~l~~L~~l~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~   55 (477)
                      |+|++|+|+.    .|-..+..-+.|++|+|+.|.|+..    |-..+..-+.|+.|+|++|.
T Consensus        75 L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~  137 (197)
T 1pgv_A           75 FSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQR  137 (197)
T ss_dssp             EECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCS
T ss_pred             EEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCc
Confidence            6789999984    3444566779999999999999953    44456666789999999764

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=90.28  E-value=0.24  Score=30.72  Aligned_cols=26  Identities=4%  Similarity=0.139  Sum_probs=11.3

Q ss_pred             eeeeeeechhHHHHHHHHHHHHhhhh
Q 043902          104 KIVIPVTISVPIFILLLAALVIYHIV  129 (477)
Q Consensus       104 ~~~~~~~~~~~~~~~~~~~~~~~~~~  129 (477)
                      .++.+|+.+++++++++.++++++++
T Consensus        12 ~IA~gVVgGv~~~~ii~~~~~~~~RR   37 (44)
T 2ks1_B           12 SIATGMVGALLLLLVVALGIGLFMRR   37 (44)
T ss_dssp             SSTHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             eEEeehhHHHHHHHHHHHHHHHHhhh
Confidence            34445554444444444333344333

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=86.65  E-value=0.59  Score=45.20  Aligned_cols=52  Identities=15%  Similarity=0.232  Sum_probs=34.8

Q ss_pred             ccccCch-hccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc
Q 043902            8 FKGTIPV-SLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE   63 (477)
Q Consensus         8 ~~g~~p~-~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~   63 (477)
                      ++ .|+. .|.++ +|+.++|.+ +++-.-+.+|..+.+|+.++|++|+++ .||..
T Consensus       146 i~-~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~  198 (401)
T 4fdw_A          146 LK-SIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPAS  198 (401)
T ss_dssp             CC-EECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTT
T ss_pred             cc-EECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-Eechh
Confidence            55 4443 46663 688888875 677333457888888888888888887 55543

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=86.37  E-value=0.37  Score=29.82  Aligned_cols=26  Identities=19%  Similarity=0.218  Sum_probs=11.2

Q ss_pred             eeeeeechhHHHHHHHHHHHHhhhhh
Q 043902          105 IVIPVTISVPIFILLLAALVIYHIVK  130 (477)
Q Consensus       105 ~~~~~~~~~~~~~~~~~~~~~~~~~~  130 (477)
                      ++.+|+.+++++++++...+++++++
T Consensus        12 IA~gVVgGv~~v~ii~~~~~~~~RRR   37 (44)
T 2l2t_A           12 IAAGVIGGLFILVIVGLTFAVYVRRK   37 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEeehHHHHHHHHHHHHHHHHhhhh
Confidence            44445544444444443333443333

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=85.65  E-value=0.48  Score=39.81  Aligned_cols=57  Identities=9%  Similarity=0.072  Sum_probs=42.5

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCc-cCcccCcccCCC----CCCCeEEccccc-cc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNN-LSGKVPQFFSKL----LSLRHLNLSYNE-LD   57 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~-l~g~~p~~~~~l----~~L~~l~l~~N~-l~   57 (477)
                      |||+++.++..==..++.+++|+.|+|+++. +|..-=..++.+    ++|+.|+|+++. +|
T Consensus        66 LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~IT  128 (176)
T 3e4g_A           66 IDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVT  128 (176)
T ss_dssp             EEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCC
T ss_pred             EeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCC
Confidence            5788888875434557899999999999984 775433445554    479999999974 65

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=84.51  E-value=0.8  Score=44.26  Aligned_cols=50  Identities=14%  Similarity=0.194  Sum_probs=30.1

Q ss_pred             CcccccC-chhccCCCCCCeEECCCCccC----ccc-CcccCCCCCCCeEEccccccc
Q 043902            6 NSFKGTI-PVSLKSLRGLAELDLSCNNLS----GKV-PQFFSKLLSLRHLNLSYNELD   57 (477)
Q Consensus         6 n~~~g~~-p~~~~~l~~L~~l~l~~N~l~----g~~-p~~~~~l~~L~~l~l~~N~l~   57 (477)
                      |+++ .| +..|.++++|+.|++.+|.++    ..| +..|..+++|+.++|.+ +++
T Consensus       257 ~~i~-~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~  312 (401)
T 4fdw_A          257 NGVT-NIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIR  312 (401)
T ss_dssp             TTCC-EECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCC
T ss_pred             CCcc-EEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceE
Confidence            4455 34 345777777777777776654    123 34567777777777763 354

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=81.79  E-value=2.7  Score=36.36  Aligned_cols=88  Identities=15%  Similarity=0.217  Sum_probs=64.3

Q ss_pred             ccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccc
Q 043902          260 KKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSV  339 (477)
Q Consensus       260 ~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~  339 (477)
                      ..++...+++++.+|+....++++.     +|--|+|+|++++.++.+++.-.|+-..+                     
T Consensus        76 k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~f~~~~~p~i~~RGik~~l---------------------  129 (215)
T 4ann_A           76 KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELFFTRDGLPIAKTRGLQNVV---------------------  129 (215)
T ss_dssp             GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEEECTTSCEEESCCEETTTB---------------------
T ss_pred             HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEEEcCCCCEEEEEccCccCC---------------------
Confidence            4578899999999999988666644     78899999999999999999888875433                     


Q ss_pred             cccCcccccCCCCcccceeehHHHHHHHhhCCCCCCccccc
Q 043902          340 GYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKD  380 (477)
Q Consensus       340 ~y~aPE~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~  380 (477)
                         +|.-    .+...=.-.+=+++..+++++..|+.....
T Consensus       130 ---~P~~----~~ee~fL~qyKAliiall~~K~~Fe~l~~G  163 (215)
T 4ann_A          130 ---DPLP----VSEAEFLTRYKALVICAFNEKQSFDALVEG  163 (215)
T ss_dssp             ---SCCC----CCHHHHHHHHHHHHHHHHCTTCCHHHHHHS
T ss_pred             ---CCCC----CCHHHHHHHHHHHHHHHHcCCCCHHHHHcC
Confidence               1211    111112235678888999999998764443

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=81.17  E-value=1.8  Score=37.61  Aligned_cols=85  Identities=15%  Similarity=0.197  Sum_probs=60.5

Q ss_pred             ccCCHHHHHHHHHHHHHHHH-HHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCccc
Q 043902          260 KKLSLMQRLNIVIDVASALD-YLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGS  338 (477)
Q Consensus       260 ~~l~~~~~~~i~~~ia~~L~-~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt  338 (477)
                      ..++...+++++.+|+.... +++     .-+|--|+|+||++|.++.++|.-.|+-..+                    
T Consensus        80 ~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~f~~~~~p~i~hRGi~~~l--------------------  134 (219)
T 4ano_A           80 RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLMFNRALEPFFLHVGVKESL--------------------  134 (219)
T ss_dssp             HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEEECTTCCEEESCCEETTTB--------------------
T ss_pred             HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEEEeCCCcEEEEEcCCcccC--------------------
Confidence            34788899999999887766 555     4578899999999999999999888875433                    


Q ss_pred             ccccCcccccCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          339 VGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       339 ~~y~aPE~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                          +|.-+    +..-=.-++=+++..++.++..|+..
T Consensus       135 ----pP~e~----~ee~fl~qyKali~all~~K~~Fe~l  165 (219)
T 4ano_A          135 ----PPDEW----DDERLLREVKATVLALTEGEYRFDEY  165 (219)
T ss_dssp             ----SSCSC----CHHHHHHHHHHHHHHHTTCSSCHHHH
T ss_pred             ----CCCCC----CHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence                22211    11111225667888888898888653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	477
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-55
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-50
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-48
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-47
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	8e-47
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	8e-47
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-46
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-46
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-46
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-45
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-44
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-44
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-44
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-44
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-44
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-43
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-43
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-42
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-42
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-42
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	9e-42
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-41
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-41
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-40
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-40
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-40
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	9e-40
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-39
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-38
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-38
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-38
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-37
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-37
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	7e-37
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-36
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-36
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-36
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-35
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-35
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-35
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-34
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-34
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-34
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-34
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-33
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-33
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-32
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-32
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-32
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-31
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-30
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-30
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-30
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-29
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-29
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-29
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-28
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-28
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-27
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-26
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-23
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-23
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-17
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-14
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-08
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-07
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	9e-04
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.001
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.002
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.004
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	8e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.001
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.002
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.001
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.002

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 1e-55
 Identities = 76/319 (23%), Positives = 124/319 (38%), Gaps = 61/319 (19%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGA--LKSFIDECNALTSIRHRN 214
              +    IGSGSFG+VYKG        A+K+L +       L++F +E   L   RH N
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
           IL        + Y      A+V ++    +L   LH          K  +++ ++I    
Sbjct: 66  ILLF------MGYSTAPQLAIVTQWCEGSSLYHHLH------IIETKFEMIKLIDIARQT 113

Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
           A  +DYLH +    I H DLKS+N+ L E +   +GDFGLA      S +          
Sbjct: 114 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS-----HQFEQ 165

Query: 335 LKGSVGYIPPEYI----NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM 390
           L GS+ ++ PE I        S   D+Y++GI+L E+ TG+ P  ++             
Sbjct: 166 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN------------ 213

Query: 391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAA 450
                             +          L PD+      K    C  ++ R+   C   
Sbjct: 214 ----------------NRDQIIFMVGRGYLSPDLS-----KVRSNCPKAMKRLMAECLKK 252

Query: 451 SPRDRVGMKFVVNNLQAIR 469
              +R     ++ +++ + 
Sbjct: 253 KRDERPLFPQILASIELLA 271

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (438), Expect = 1e-50
 Identities = 66/303 (21%), Positives = 118/303 (38%), Gaps = 42/303 (13%)

Query: 155 ATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQ-QQGALKSFIDECNALTSIRH 212
             D+F + + +G+G+ G V+K +    G   A K++ L+ +       I E   L     
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             I+    +        +   ++  E M  G+LDQ L           ++       + I
Sbjct: 64  PYIVGFYGAF-----YSDGEISICMEHMDGGSLDQVLK-------KAGRIPEQILGKVSI 111

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            V   L YL  ++   I H D+K SN+L++      + DFG++  L +         +M+
Sbjct: 112 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---------SMA 160

Query: 333 NGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSI------- 384
           N   G+  Y+ PE + G H S+  DI+S G+ L+E+  G+ P       +L +       
Sbjct: 161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVE 220

Query: 385 ---------HKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEE 435
                     +     L S+ MD      + E  +         L   + S   Q  + +
Sbjct: 221 GDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK 280

Query: 436 CLV 438
           CL+
Sbjct: 281 CLI 283

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 7e-48
 Identities = 60/315 (19%), Positives = 124/315 (39%), Gaps = 59/315 (18%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
           +       +G+G FG V+ G        A+K LK        +F+ E N +  ++H+ ++
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLV 71

Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           ++ +  +       +   ++ E+M NG+L  +L           KL++ + L++   +A 
Sbjct: 72  RLYAVVT------QEPIYIITEYMENGSLVDFLK-----TPSGIKLTINKLLDMAAQIAE 120

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            + ++  +      H DL+++N+L+ + +   + DFGLA+ +           T   G K
Sbjct: 121 GMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI------EDNEYTAREGAK 171

Query: 337 GSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSH 395
             + +  PE IN G  +I  D++S+GILL EI T  R                       
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG------------------ 213

Query: 396 VMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDR 455
                                  ++  ++E      + + C   + ++  +C    P DR
Sbjct: 214 -------------------MTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDR 254

Query: 456 VGMKFVVNNLQAIRS 470
               ++ + L+   +
Sbjct: 255 PTFDYLRSVLEDFFT 269

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 1e-47
 Identities = 62/252 (24%), Positives = 103/252 (40%), Gaps = 21/252 (8%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHR 213
           +++     IG+GS+G   K    +DG+    K L      +   +  + E N L  ++H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
           NI++            N    +V E+   G+L   +   T E  +   L     L ++  
Sbjct: 64  NIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQY---LDEEFVLRVMTQ 117

Query: 274 VASALDYLHNQYDT--PIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
           +  AL   H + D    + H DLK +NV LD      +GDFGLA+ L       + + + 
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-------NHDTSF 170

Query: 332 SNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDL--SIHKFV 388
           +    G+  Y+ PE +N    +   DI+S G LL E+     P     + +L   I +  
Sbjct: 171 AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 230

Query: 389 LMALPSHVMDVL 400
              +P    D L
Sbjct: 231 FRRIPYRYSDEL 242

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 8e-47
 Identities = 57/244 (23%), Positives = 98/244 (40%), Gaps = 22/244 (9%)

Query: 162 ENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKI 218
           +  IG GSF +VYKG   +     A   L+ ++  +   + F +E   L  ++H NI++ 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 219 VSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASAL 278
             S  S   +G     LV E M +G L  +L         FK + +    +    +   L
Sbjct: 74  YDSWESTV-KGKKCIVLVTELMTSGTLKTYLK-------RFKVMKIKVLRSWCRQILKGL 125

Query: 279 DYLHNQYDTPIAHCDLKSSNVLL-DEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKG 337
            +LH +   PI H DLK  N+ +        +GD GLA           K  + +  + G
Sbjct: 126 QFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---------KRASFAKAVIG 175

Query: 338 SVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVM 397
           +  ++ PE          D+Y++G+ +LE+ T + P  +         +      P+   
Sbjct: 176 TPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 235

Query: 398 DVLD 401
            V  
Sbjct: 236 KVAI 239

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 8e-47
 Identities = 65/320 (20%), Positives = 123/320 (38%), Gaps = 43/320 (13%)

Query: 162 ENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSS 221
           +  IG G FG V++G    GE  A+K+   +++ +      E      +RH NIL  +++
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAA 65

Query: 222 CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYL 281
            +  +        LV ++  +G+L  +L+           +++   + + +  AS L +L
Sbjct: 66  DNKDNGTWTQL-WLVSDYHEHGSLFDYLNR--------YTVTVEGMIKLALSTASGLAHL 116

Query: 282 HNQY-----DTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
           H +         IAH DLKS N+L+ +     + D GLA      ++T        N   
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT---IDIAPNHRV 173

Query: 337 GSVGYIPPEYINGHVSILG-------DIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL 389
           G+  Y+ PE ++  +++         DIY+ G++  EI              L  +  V 
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233

Query: 390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSA 449
                  M               +   E+ L P+I ++    +    +  +MR    C  
Sbjct: 234 SDPSVEEM--------------RKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWY 276

Query: 450 ASPRDRVGMKFVVNNLQAIR 469
           A+   R+    +   L  + 
Sbjct: 277 ANGAARLTALRIKKTLSQLS 296

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  161 bits (408), Expect = 2e-46
 Identities = 71/337 (21%), Positives = 138/337 (40%), Gaps = 70/337 (20%)

Query: 148 SYLKISNATDNFSEE---------NLIGSGSFGSVYKGTLA----DGETAAIKVLKLQQ- 193
           ++   + A   F++E          +IG+G FG V  G L          AIK LK    
Sbjct: 8   TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 194 QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPST 253
           +   + F+ E + +    H N++ +    +      +    ++ EFM NG+LD +L    
Sbjct: 68  EKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-----STPVMIITEFMENGSLDSFLR--- 119

Query: 254 DEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG 313
               +  + +++Q + ++  +A+ + YL +       H DL + N+L++  ++  V DFG
Sbjct: 120 ---QNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFG 173

Query: 314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GK 371
           L++FL ++++ P+   T + G K  + +  PE I     +   D++SYGI++ E+ + G+
Sbjct: 174 LSRFLEDDTSDPT--YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231

Query: 372 RPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQK 431
           RP  DM                                        +D+   IE      
Sbjct: 232 RPYWDM--------------------------------------TNQDVINAIEQDYRLP 253

Query: 432 KLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI 468
              +C  ++ ++ + C       R     +VN L  +
Sbjct: 254 PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 2e-46
 Identities = 68/324 (20%), Positives = 122/324 (37%), Gaps = 59/324 (18%)

Query: 144 QSGLSYLKISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDE 203
             GL+        ++   E  +G G FG V+ GT       AIK LK       ++F+ E
Sbjct: 4   TQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQE 62

Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              +  +RH  ++++ +  S       +   +V E+M  G+L  +L   T +Y       
Sbjct: 63  AQVMKKLRHEKLVQLYAVVS------EEPIYIVTEYMSKGSLLDFLKGETGKYLRLP--- 113

Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
             Q +++   +AS + Y+         H DL+++N+L+ E ++  V DFGLA+ +     
Sbjct: 114 --QLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI----- 163

Query: 324 TPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDL 382
                 T   G K  + +  PE    G  +I  D++S+GILL E+ T  R          
Sbjct: 164 -EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP-------- 214

Query: 383 SIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMR 442
                                        +      ++   +E         EC  S+  
Sbjct: 215 -----------------------------YPGMVNREVLDQVERGYRMPCPPECPESLHD 245

Query: 443 IGVMCSAASPRDRVGMKFVVNNLQ 466
           +   C    P +R   +++   L+
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAFLE 269

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 5e-46
 Identities = 69/315 (21%), Positives = 112/315 (35%), Gaps = 63/315 (20%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
                   IG G FG V  G    G   A+K +K       ++F+ E + +T +RH N++
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLV 63

Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           +++        E      +V E+M  G+L  +L            L     L   +DV  
Sbjct: 64  QLLGVI----VEEKGGLYIVTEYMAKGSLVDYLRSR-----GRSVLGGDCLLKFSLDVCE 114

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
           A++YL         H DL + NVL+ E  +A V DFGL K      +T           K
Sbjct: 115 AMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----------GK 161

Query: 337 GSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSH 395
             V +  PE +     S   D++S+GILL EI++  R                       
Sbjct: 162 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP--------------------- 200

Query: 396 VMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDR 455
                           + +   +D+ P +E        + C  +V  +   C       R
Sbjct: 201 ----------------YPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMR 244

Query: 456 VGMKFVVNNLQAIRS 470
                +   L+ I++
Sbjct: 245 PSFLQLREQLEHIKT 259

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 4e-45
 Identities = 67/314 (21%), Positives = 111/314 (35%), Gaps = 59/314 (18%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
              +    IGSG FG V+ G   + +  AIK ++       + FI+E   +  + H  ++
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLV 63

Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           ++   C            LVFEFM +G L  +L             +    L + +DV  
Sbjct: 64  QLYGVC-----LEQAPICLVFEFMEHGCLSDYLR------TQRGLFAAETLLGMCLDVCE 112

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            + YL       + H DL + N L+ E  +  V DFG+ +F+           T S G K
Sbjct: 113 GMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFV------LDDQYTSSTGTK 163

Query: 337 GSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSH 395
             V +  PE  +    S   D++S+G+L+ E+F+  +                       
Sbjct: 164 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP--------------------- 202

Query: 396 VMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDR 455
                           +E     ++  DI +     K       V +I   C    P DR
Sbjct: 203 ----------------YENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDR 246

Query: 456 VGMKFVVNNLQAIR 469
                ++  L  I 
Sbjct: 247 PAFSRLLRQLAEIA 260

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  155 bits (394), Expect = 2e-44
 Identities = 58/235 (24%), Positives = 88/235 (37%), Gaps = 34/235 (14%)

Query: 156 TDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKL---QQQGALKSFIDECNALTSIR 211
              FS+   IG GSFG+VY    + + E  AIK +     Q     +  I E   L  +R
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H N ++                 LV E+      D           H K L  ++   + 
Sbjct: 74  HPNTIQYRGCY-----LREHTAWLVMEYCLGSASDLLEV-------HKKPLQEVEIAAVT 121

Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
                 L YLH+     + H D+K+ N+LL E  +  +GDFG A  +             
Sbjct: 122 HGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----------AP 167

Query: 332 SNGLKGSVGYIPPEYI----NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDL 382
           +N   G+  ++ PE I     G      D++S GI  +E+   K P  +M     
Sbjct: 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 3e-44
 Identities = 65/330 (19%), Positives = 118/330 (35%), Gaps = 64/330 (19%)

Query: 155 ATDNFSEENL-IGSGSFGSVYKGTLA---DGETAAIKVLKLQ-QQGALKSFIDECNALTS 209
             DN    ++ +G G+FGSV +G           AIKVLK   ++   +  + E   +  
Sbjct: 6   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65

Query: 210 IRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN 269
           + +  I++++  C +          LV E    G L ++L          +++ +     
Sbjct: 66  LDNPYIVRLIGVCQAEAL------MLVMEMAGGGPLHKFLV------GKREEIPVSNVAE 113

Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
           ++  V+  + YL  +      H DL + NVLL     A + DFGL+K L  + +  +   
Sbjct: 114 LLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 170

Query: 330 TMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKF 387
                 K  + +  PE IN    S   D++SYG+ + E  + G++P   M          
Sbjct: 171 AG----KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM---------- 216

Query: 388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMC 447
                                       +  ++   IE     +   EC   +  +   C
Sbjct: 217 ----------------------------KGPEVMAFIEQGKRMECPPECPPELYALMSDC 248

Query: 448 SAASPRDRVGMKFVVNNLQAIRSKIRMREE 477
                 DR     V   ++A    +  + E
Sbjct: 249 WIYKWEDRPDFLTVEQRMRACYYSLASKVE 278

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 4e-44
 Identities = 58/248 (23%), Positives = 110/248 (44%), Gaps = 25/248 (10%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNIL 216
            + +    +G+G FG V  G        AIK++K         FI+E   + ++ H  ++
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLV 62

Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
           ++   C+           ++ E+M NG L  +L           +    Q L +  DV  
Sbjct: 63  QLYGVCTK-----QRPIFIITEYMANGCLLNYLR------EMRHRFQTQQLLEMCKDVCE 111

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
           A++YL ++      H DL + N L+++  +  V DFGL++++ ++        T S G K
Sbjct: 112 AMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD------EYTSSVGSK 162

Query: 337 GSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL--SIHKFVLMAL 392
             V + PPE +     S   DI+++G+L+ EI++ GK P +     +    I + + +  
Sbjct: 163 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 222

Query: 393 PSHVMDVL 400
           P    + +
Sbjct: 223 PHLASEKV 230

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 4e-44
 Identities = 53/231 (22%), Positives = 96/231 (41%), Gaps = 28/231 (12%)

Query: 154 NATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRH 212
           N  D +     +G G+FG VYK         AA KV+  + +  L+ ++ E + L S  H
Sbjct: 9   NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68

Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            NI+K++ +         +   ++ EF   G +D  +          + L+  Q   +  
Sbjct: 69  PNIVKLLDAF-----YYENNLWILIEFCAGGAVDAVMLE------LERPLTESQIQVVCK 117

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
               AL+YLH+     I H DLK+ N+L        + DFG++          ++     
Sbjct: 118 QTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN-------TRTIQRR 167

Query: 333 NGLKGSVGYIPPEYINGHVSILG------DIYSYGILLLEIFTGKRPTDDM 377
           +   G+  ++ PE +    S         D++S GI L+E+   + P  ++
Sbjct: 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 5e-44
 Identities = 61/245 (24%), Positives = 104/245 (42%), Gaps = 29/245 (11%)

Query: 161 EENLIGSGSFGSVYKGTLAD---GETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNI 215
           E+  +GSG+FG+V KG        +T A+K+LK +          + E N +  + +  I
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           ++++  C        +   LV E    G L+++L          + +     + +V  V+
Sbjct: 71  VRMIGICE------AESWMLVMEMAELGPLNKYL-------QQNRHVKDKNIIELVHQVS 117

Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
             + YL         H DL + NVLL     A + DFGL+K L  + N            
Sbjct: 118 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY----YKAQTHG 170

Query: 336 KGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL--SIHKFVLMA 391
           K  V +  PE I     S   D++S+G+L+ E F+ G++P   M   ++   + K   M 
Sbjct: 171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG 230

Query: 392 LPSHV 396
            P+  
Sbjct: 231 CPAGC 235

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 1e-43
 Identities = 57/246 (23%), Positives = 95/246 (38%), Gaps = 30/246 (12%)

Query: 157 DNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLK---LQQQGALKSFIDECNALTSIRH 212
           ++F     +G G FG+VY           A+KVL    L++ G       E    + +RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            NIL++                L+ E+   G + + L           K    +    + 
Sbjct: 66  PNILRLYGYF-----HDATRVYLILEYAPLGTVYRELQ-------KLSKFDEQRTATYIT 113

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           ++A+AL Y H++    + H D+K  N+LL       + DFG +              +  
Sbjct: 114 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA---------PSSRR 161

Query: 333 NGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP-TDDMFKDDLSIHKFVLM 390
             L G++ Y+PPE I G       D++S G+L  E   GK P   + +++       V  
Sbjct: 162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 221

Query: 391 ALPSHV 396
             P  V
Sbjct: 222 TFPDFV 227

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 2e-43
 Identities = 69/328 (21%), Positives = 127/328 (38%), Gaps = 61/328 (18%)

Query: 150 LKISNATDNFSEENLIGSGSFGSVYKGTLAD----GETAAIKVL-KLQQQGALKSFIDEC 204
           +  S+   +F+E  +IG G FG VY GTL D        A+K L ++   G +  F+ E 
Sbjct: 22  IGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEG 79

Query: 205 NALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSL 264
             +    H N+L ++  C            +V  +M++G+L  ++             ++
Sbjct: 80  IIMKDFSHPNVLSLLGIC----LRSEGSPLVVLPYMKHGDLRNFIR------NETHNPTV 129

Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNT 324
              +   + VA  + +L ++      H DL + N +LDE     V DFGLA+ ++++   
Sbjct: 130 KDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE-- 184

Query: 325 PSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLS 383
              +     G K  V ++  E +     +   D++S+G+LL E+ T   P          
Sbjct: 185 -FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP---------- 233

Query: 384 IHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRI 443
                    P   ++  D+++ L +           L P           E C   +  +
Sbjct: 234 ---------PYPDVNTFDITVYLLQ-------GRRLLQP-----------EYCPDPLYEV 266

Query: 444 GVMCSAASPRDRVGMKFVVNNLQAIRSK 471
            + C       R     +V+ + AI S 
Sbjct: 267 MLKCWHPKAEMRPSFSELVSRISAIFST 294

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 1e-42
 Identities = 46/236 (19%), Positives = 89/236 (37%), Gaps = 24/236 (10%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRN 214
           +++     +G G++G V         E  A+K++ +++     ++   E      + H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
           ++K             + + L  E+   G L   + P          +           +
Sbjct: 65  VVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPD-------IGMPEPDAQRFFHQL 112

Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
            + + YLH      I H D+K  N+LLDE     + DFGLA          +  + + N 
Sbjct: 113 MAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLLNK 164

Query: 335 LKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV 388
           + G++ Y+ PE +      +   D++S GI+L  +  G+ P D           + 
Sbjct: 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 220

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 2e-42
 Identities = 50/222 (22%), Positives = 95/222 (42%), Gaps = 25/222 (11%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLK---LQQQGALKSFIDECNALTSIRH 212
           ++F    ++G GSF +V     LA     AIK+L+   + ++  +     E + ++ + H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
              +K+  +      + ++       + +NG L +++                       
Sbjct: 68  PFFVKLYFTF-----QDDEKLYFGLSYAKNGELLKYI-------RKIGSFDETCTRFYTA 115

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           ++ SAL+YLH +    I H DLK  N+LL+E M   + DFG AK       +P   Q  +
Sbjct: 116 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV-----LSPESKQARA 167

Query: 333 NGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRP 373
           N   G+  Y+ PE +         D+++ G ++ ++  G  P
Sbjct: 168 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 3e-42
 Identities = 52/232 (22%), Positives = 100/232 (43%), Gaps = 25/232 (10%)

Query: 148 SYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNA 206
           S + + +    ++    IG G+ G+VY    +A G+  AI+ + LQQQ   +  I+E   
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70

Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           +   ++ NI+  + S         D   +V E++  G+L   +            +   Q
Sbjct: 71  MRENKNPNIVNYLDSY-----LVGDELWVVMEYLAGGSLTDVVTE--------TCMDEGQ 117

Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
              +  +   AL++LH+     + H D+KS N+LL       + DFG    +       +
Sbjct: 118 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-------T 167

Query: 327 KNQTMSNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDM 377
             Q+  + + G+  ++ PE +         DI+S GI+ +E+  G+ P  + 
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  148 bits (374), Expect = 9e-42
 Identities = 65/323 (20%), Positives = 126/323 (39%), Gaps = 59/323 (18%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
            + + ++ +G G +G VY+G       T A+K LK      ++ F+ E   +  I+H N+
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNL 75

Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           ++++  C            ++ EFM  GNL  +L       C+ +++S +  L +   ++
Sbjct: 76  VQLLGVC-----TREPPFYIITEFMTYGNLLDYLR-----ECNRQEVSAVVLLYMATQIS 125

Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGL 335
           SA++YL  +      H DL + N L+ E  +  V DFGL++ +           T   G 
Sbjct: 126 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM------TGDTYTAHAGA 176

Query: 336 KGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPS 394
           K  + +  PE +     SI  D++++G+LL EI T                         
Sbjct: 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP-------------------- 216

Query: 395 HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRD 454
                            +   +   ++  +E     ++ E C   V  +   C   +P D
Sbjct: 217 -----------------YPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 259

Query: 455 RVGMKFVVNNLQAIRSKIRMREE 477
           R     +    + +  +  + +E
Sbjct: 260 RPSFAEIHQAFETMFQESSISDE 282

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 2e-41
 Identities = 62/319 (19%), Positives = 119/319 (37%), Gaps = 62/319 (19%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLADGETA-----AIKVLKLQQ-QGALKSFIDECNALTSI 210
              + + +IG+G FG VYKG L           AIK LK    +     F+ E   +   
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 211 RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
            H NI+++    S           ++ E+M NG LD++L           + S++Q + +
Sbjct: 67  SHHNIIRLEGVISK-----YKPMMIITEYMENGALDKFLR------EKDGEFSVLQLVGM 115

Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
           +  +A+ + YL N       H DL + N+L++  ++  V DFGL++ L ++     +   
Sbjct: 116 LRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD----PEATY 168

Query: 331 MSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL 389
            ++G K  + +  PE I     +   D++S+GI++ E+ T                    
Sbjct: 169 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE------------ 216

Query: 390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSA 449
                                        ++   I          +C  ++ ++ + C  
Sbjct: 217 -------------------------LSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQ 251

Query: 450 ASPRDRVGMKFVVNNLQAI 468
                R     +V+ L  +
Sbjct: 252 QERARRPKFADIVSILDKL 270

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  147 bits (371), Expect = 3e-41
 Identities = 64/346 (18%), Positives = 119/346 (34%), Gaps = 75/346 (21%)

Query: 148 SYLKISNATDNFSEENLIGSGSFGSVYKGTL------ADGETAAIKVLKLQ-QQGALKSF 200
             L +    +N      IG G+FG V++               A+K+LK +        F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 201 IDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---------- 250
             E   +    + NI+K++  C            L+FE+M  G+L+++L           
Sbjct: 64  QREAALMAEFDNPNIVKLLGVC-----AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 118

Query: 251 -------PSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE 303
                   +         LS  ++L I   VA+ + YL  +      H DL + N L+ E
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGE 175

Query: 304 GMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH-VSILGDIYSYGI 362
            M+  + DFGL++ ++                   + ++PPE I  +  +   D+++YG+
Sbjct: 176 NMVVKIADFGLSRNIYSADYY-----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 230

Query: 363 LLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFP 422
           +L EIF+                                          +     E++  
Sbjct: 231 VLWEIFSYGLQP-------------------------------------YYGMAHEEVIY 253

Query: 423 DIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI 468
            +         E C + +  +  +C +  P DR     +   LQ +
Sbjct: 254 YVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 1e-40
 Identities = 61/257 (23%), Positives = 107/257 (41%), Gaps = 38/257 (14%)

Query: 157 DNFSEENLIGSGSFGSVYKGTL------ADGETAAIKVLKLQ-QQGALKSFIDECNALTS 209
           +N     ++GSG+FG V   T             A+K+LK +      ++ + E   +T 
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 210 I-RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH----------------PS 252
           +  H NI+ ++ +C       +    L+FE+   G+L  +L                   
Sbjct: 97  LGSHENIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151

Query: 253 TDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF 312
            +E      L+    L     VA  +++L  +      H DL + NVL+  G +  + DF
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDF 208

Query: 313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGK 371
           GLA+ +  +SN       +    +  V ++ PE +  G  +I  D++SYGILL EIF+  
Sbjct: 209 GLARDIMSDSNY-----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263

Query: 372 RPTDDMFKDDLSIHKFV 388
                    D + +K +
Sbjct: 264 VNPYPGIPVDANFYKLI 280

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  144 bits (365), Expect = 1e-40
 Identities = 50/230 (21%), Positives = 95/230 (41%), Gaps = 20/230 (8%)

Query: 153 SNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLK---LQQQGALKSFIDECNALT 208
           S+ +D +    ++G G    V+    L      A+KVL+    +       F  E     
Sbjct: 3   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62

Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
           ++ H  I+ +  +  +    G     +V E++    L   +H           ++  + +
Sbjct: 63  ALNHPAIVAVYDTGEAETPAGPLP-YIVMEYVDGVTLRDIVH-------TEGPMTPKRAI 114

Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
            ++ D   AL++ H      I H D+K +N+++       V DFG+A+ + +  N+    
Sbjct: 115 EVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS---- 167

Query: 329 QTMSNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDM 377
            T +  + G+  Y+ PE   G  V    D+YS G +L E+ TG+ P    
Sbjct: 168 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 217

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 4e-40
 Identities = 70/335 (20%), Positives = 122/335 (36%), Gaps = 69/335 (20%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQQ-QGALKSFIDECNALTS 209
           +  S    +G+G+FG V + T           T A+K+LK        ++ + E   L+ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 210 I-RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFK-------- 260
           +  H NI+ ++ +C+           ++ E+   G+L  +L    D +   K        
Sbjct: 83  LGNHMNIVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137

Query: 261 ---KLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF 317
               L L   L+    VA  + +L ++      H DL + N+LL  G I  + DFGLA+ 
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARD 194

Query: 318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD 376
           +  +SN       +    +  V ++ PE I N   +   D++SYGI L E+F+       
Sbjct: 195 IKNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249

Query: 377 MFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEEC 436
               D   +K +                         K     L P+         ++ C
Sbjct: 250 GMPVDSKFYKMI-------------------------KEGFRMLSPEHAPAEMYDIMKTC 284

Query: 437 LVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSK 471
                        A P  R   K +V  ++   S+
Sbjct: 285 W-----------DADPLKRPTFKQIVQLIEKQISE 308

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 9e-40
 Identities = 62/261 (23%), Positives = 118/261 (45%), Gaps = 31/261 (11%)

Query: 150 LKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVL-----KLQQQGALKSFIDE 203
           L+I   T+ F +  ++GSG+FG+VYKG  + +GE   I V      +     A K  +DE
Sbjct: 3   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61

Query: 204 CNALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLS 263
              + S+ + ++ +++  C +   +      L+ + M  G L  ++        H   + 
Sbjct: 62  AYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVR------EHKDNIG 109

Query: 264 LMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESN 323
               LN  + +A  ++YL ++    + H DL + NVL+       + DFGLAK L     
Sbjct: 110 SQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL----- 161

Query: 324 TPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDD 381
              + +  + G K  + ++  E I +   +   D++SYG+ + E+ T G +P D +   +
Sbjct: 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221

Query: 382 LS--IHKFVLMALPSHVMDVL 400
           +S  + K   +  P      +
Sbjct: 222 ISSILEKGERLPQPPICTIDV 242

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  143 bits (362), Expect = 2e-39
 Identities = 47/230 (20%), Positives = 91/230 (39%), Gaps = 26/230 (11%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           D++     +G+G+FG V++ T  A G   A K +    +   ++   E   ++ +RH  +
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           + +  +      E ++   +++EFM  G L + +           K+S  + +  +  V 
Sbjct: 86  VNLHDAF-----EDDNEMVMIYEFMSGGELFEKVA------DEHNKMSEDEAVEYMRQVC 134

Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLL--DEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
             L ++H        H DLK  N++          + DFGL   L  + +          
Sbjct: 135 KGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT------ 185

Query: 334 GLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDL 382
              G+  +  PE   G  V    D++S G+L   + +G  P      D+ 
Sbjct: 186 --TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET 233

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 1e-38
 Identities = 71/322 (22%), Positives = 116/322 (36%), Gaps = 65/322 (20%)

Query: 157 DNFSEENLIGSGSFGSVYKGTL----ADGETAAIKVLK---LQQQGALKSFIDECNALTS 209
            +      +G GSFG V +G          + A+K LK   L Q  A+  FI E NA+ S
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 210 IRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN 269
           + HRN++++     +   +      +V E    G+L   L        H     L     
Sbjct: 68  LDHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLR------KHQGHFLLGTLSR 115

Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
             + VA  + YL ++      H DL + N+LL    +  +GDFGL + L +  +      
Sbjct: 116 YAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH----Y 168

Query: 330 TMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKF 387
            M    K    +  PE +     S   D + +G+ L E+FT G+ P   +          
Sbjct: 169 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---------- 218

Query: 388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMC 447
                  +   +L             K ++E               E+C   +  + V C
Sbjct: 219 -------NGSQIL------------HKIDKEGERLPRP--------EDCPQDIYNVMVQC 251

Query: 448 SAASPRDRVGMKFVVNNLQAIR 469
            A  P DR     + + L   +
Sbjct: 252 WAHKPEDRPTFVALRDFLLEAQ 273

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 2e-38
 Identities = 67/332 (20%), Positives = 119/332 (35%), Gaps = 68/332 (20%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLADGET---AAIKVLK-LQQQGALKSFIDECNALTSI-R 211
           ++   +++IG G+FG V K  +        AAIK +K    +   + F  E   L  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPST---------DEYCHFKKL 262
           H NI+ ++ +C     E   +  L  E+  +GNL  +L  S                  L
Sbjct: 70  HPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124

Query: 263 SLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEES 322
           S  Q L+   DVA  +DYL  +      H DL + N+L+ E  +A + DFGL++      
Sbjct: 125 SSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG----- 176

Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDD 381
               +        +  V ++  E +N    +   D++SYG+LL EI +            
Sbjct: 177 ---QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-------- 225

Query: 382 LSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVM 441
                                         +      +L+  +      +K   C   V 
Sbjct: 226 -----------------------------PYCGMTCAELYEKLPQGYRLEKPLNCDDEVY 256

Query: 442 RIGVMCSAASPRDRVGMKFVVNNLQAIRSKIR 473
            +   C    P +R     ++ +L  +  + +
Sbjct: 257 DLMRQCWREKPYERPSFAQILVSLNRMLEERK 288

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  140 bits (355), Expect = 2e-38
 Identities = 44/237 (18%), Positives = 87/237 (36%), Gaps = 26/237 (10%)

Query: 150 LKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALT 208
           +K  +  D +     +GSG+FG V++    A G     K +         +  +E + + 
Sbjct: 22  VKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMN 81

Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
            + H  ++ +  +      E      L+ EF+  G L   +           K+S  + +
Sbjct: 82  QLHHPKLINLHDAF-----EDKYEMVLILEFLSGGELFDRIA------AEDYKMSEAEVI 130

Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV--GDFGLAKFLFEESNTPS 326
           N +      L ++H      I H D+K  N++ +    + V   DFGLA  L        
Sbjct: 131 NYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL-------- 179

Query: 327 KNQTMSNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDL 382
               +      +  +  PE ++   V    D+++ G+L   + +G  P       + 
Sbjct: 180 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET 236

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 3e-37
 Identities = 51/253 (20%), Positives = 98/253 (38%), Gaps = 30/253 (11%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLAD----GETAAIKVLK-LQQQGALKSFIDECNALTSIR 211
           +       IG G FG V++G            AIK  K        + F+ E   +    
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H +I+K++   +       +   ++ E    G L  +L            L L   +   
Sbjct: 67  HPHIVKLIGVIT------ENPVWIIMELCTLGELRSFLQ------VRKYSLDLASLILYA 114

Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
             +++AL YL ++      H D+ + NVL+       +GDFGL++++             
Sbjct: 115 YQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM------EDSTYYK 165

Query: 332 SNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDL--SIHKF 387
           ++  K  + ++ PE IN    +   D++ +G+ + EI   G +P   +  +D+   I   
Sbjct: 166 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG 225

Query: 388 VLMALPSHVMDVL 400
             + +P +    L
Sbjct: 226 ERLPMPPNCPPTL 238

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 6e-37
 Identities = 52/321 (16%), Positives = 112/321 (34%), Gaps = 61/321 (19%)

Query: 157 DNFSEENLIGSGSFGSVYKGTL------ADGETAAIKVLKLQQ-QGALKSFIDECNALTS 209
           +  +    +G GSFG VY+G              AIK +           F++E + +  
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 210 IRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---PSTDEYCHFKKLSLMQ 266
               ++++++               ++ E M  G+L  +L    P+          SL +
Sbjct: 80  FNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134

Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
            + +  ++A  + YL+        H DL + N ++ E     +GDFG+ + ++E      
Sbjct: 135 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-- 189

Query: 327 KNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIH 385
                       V ++ PE + +G  +   D++S+G++L EI T                
Sbjct: 190 ---RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP----------- 235

Query: 386 KFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGV 445
                                     ++    E +   +       K + C   +  +  
Sbjct: 236 --------------------------YQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMR 269

Query: 446 MCSAASPRDRVGMKFVVNNLQ 466
           MC   +P+ R     ++++++
Sbjct: 270 MCWQYNPKMRPSFLEIISSIK 290

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 7e-37
 Identities = 60/293 (20%), Positives = 99/293 (33%), Gaps = 25/293 (8%)

Query: 154 NATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVL-KLQQQGALKSFIDECNALTSIR 211
           +    ++  + IG G++G V       +    AIK +   + Q   +  + E   L   R
Sbjct: 5   DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64

Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H NI+ I     +   E      LV   M                   + LS       +
Sbjct: 65  HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYK---------LLKTQHLSNDHICYFL 115

Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
             +   L Y+H+     + H DLK SN+LL+      + DFGLA+    + +        
Sbjct: 116 YQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 172

Query: 332 SNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL 389
                 +  Y  PE +      +   DI+S G +L E+ + +         D   H   +
Sbjct: 173 ----VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 228

Query: 390 MALPSH----VMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLV 438
           +  PS      +  L     L       K     LFP+     A   L++ L 
Sbjct: 229 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNA-DSKALDLLDKMLT 280

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 2e-36
 Identities = 54/295 (18%), Positives = 105/295 (35%), Gaps = 26/295 (8%)

Query: 152 ISNATDNFSEENLIGSGSFGSVYKGT--LADGETAAIKVLKLQ-----QQGALKSFIDEC 204
           +  A   +     IG G++G V+K       G   A+K +++Q        +    +   
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61

Query: 205 NALTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSL 264
             L +  H N++++   C+    +      LVFE +                     +  
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK------VPEPGVPT 115

Query: 265 MQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNT 324
               +++  +   LD+LH+     + H DLK  N+L+       + DFGLA+        
Sbjct: 116 ETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY------ 166

Query: 325 PSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLS 383
               Q     +  ++ Y  PE +     +   D++S G +  E+F  K         D  
Sbjct: 167 --SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 224

Query: 384 IHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLV 438
                ++ LP       D+++  +  +       E    DI  ++ +  L +CL 
Sbjct: 225 GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDI-DELGKDLLLKCLT 278

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  134 bits (337), Expect = 2e-36
 Identities = 46/237 (19%), Positives = 84/237 (35%), Gaps = 23/237 (9%)

Query: 149 YLKISNATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQ-QGALKSFIDECNA 206
           + +  +  D +   +++G+G+F  V         +  AIK +  +  +G   S  +E   
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           L  I+H NI+ +         E      L+ + +  G L   +             +   
Sbjct: 61  LHKIKHPNIVALDDIY-----ESGGHLYLIMQLVSGGELFDRIV-------EKGFYTERD 108

Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPS 326
              ++  V  A+ YLH+                 LDE     + DFGL+K          
Sbjct: 109 ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME-------- 160

Query: 327 KNQTMSNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDL 382
              ++ +   G+ GY+ PE +     S   D +S G++   +  G  P  D     L
Sbjct: 161 DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL 217

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 6e-36
 Identities = 63/288 (21%), Positives = 113/288 (39%), Gaps = 25/288 (8%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
            ++++  +IG+GSFG VY+  L D GE  AIK +   +    +    E   +  + H NI
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNI 75

Query: 216 LKIVSSCSSVDYEGND-FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
           +++     S   + ++ +  LV +++         H S  +    + L ++     +  +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK----QTLPVIYVKLYMYQL 131

Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
             +L Y+H+     I H D+K  N+LLD +  +  + DFG AK L       S   +   
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-- 186

Query: 334 GLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRP-TDDMFKDDLSIHKFVLM 390
                  Y  PE I G    +   D++S G +L E+  G+     D   D L     VL 
Sbjct: 187 ------YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 240

Query: 391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLV 438
                 +  ++ +    +    + H    +F       A       L 
Sbjct: 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLE 288

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 1e-35
 Identities = 63/329 (19%), Positives = 115/329 (34%), Gaps = 64/329 (19%)

Query: 157 DNFSEENLIGSGSFGSVYKGT------LADGETAAIKVLKLQQ-QGALKSFIDECNALTS 209
           D       +G G+FG V +         A   T A+K+LK        ++ + E   L  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 210 IRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---------PSTDEYCHFK 260
           I H      V +      +      ++ EF + GNL  +L              E  +  
Sbjct: 73  IGHHLN---VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129

Query: 261 KLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFE 320
            L+L   +     VA  +++L ++      H DL + N+LL E  +  + DFGLA+ +++
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186

Query: 321 ESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFK 379
           +      +       +  + ++ PE I +   +I  D++S+G+LL EIF+         K
Sbjct: 187 DP-----DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241

Query: 380 DDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVS 439
            D    + +                         K       PD  +    + + +C   
Sbjct: 242 IDEEFCRRL-------------------------KEGTRMRAPDYTTPEMYQTMLDCW-- 274

Query: 440 VMRIGVMCSAASPRDRVGMKFVVNNLQAI 468
                       P  R     +V +L  +
Sbjct: 275 ---------HGEPSQRPTFSELVEHLGNL 294

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 1e-35
 Identities = 59/294 (20%), Positives = 123/294 (41%), Gaps = 25/294 (8%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHR 213
             + +   IG G+FG V+K      G+  A+K + ++  ++G   + + E   L  ++H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 214 NILKIVSSCSSVDYEGNDFKA---LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
           N++ ++  C +     N  K    LVF+F  +       +          K +L +   +
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-------VLVKFTLSEIKRV 122

Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
           +  + + L Y+H      I H D+K++NVL+    +  + DFGLA+      N+      
Sbjct: 123 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS---QPN 176

Query: 331 MSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRP-TDDMFKDDLSIHKF 387
                  ++ Y PPE + G        D++  G ++ E++T       +  +  L++   
Sbjct: 177 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236

Query: 388 VLMALPSHV---MDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLV 438
           +  ++   V   +D  +L   LE     ++  ++ L   +    A   +++ LV
Sbjct: 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLV 290

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  130 bits (327), Expect = 4e-35
 Identities = 51/230 (22%), Positives = 94/230 (40%), Gaps = 31/230 (13%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           +N+  + ++G G    V +       +  A+K++ +   G+  +   +     +++  +I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 216 LKIVSSCSSV-----DYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNI 270
           L+ VS   ++      YE N F  LVF+ M+ G L  +L            LS  +   I
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-------EKVTLSEKETRKI 115

Query: 271 VIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQT 330
           +  +   +  LH      I H DLK  N+LLD+ M   + DFG +  L            
Sbjct: 116 MRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL--------DPGE 164

Query: 331 MSNGLKGSVGYIPPEYINGHVSILG-------DIYSYGILLLEIFTGKRP 373
               + G+  Y+ PE I   ++          D++S G+++  +  G  P
Sbjct: 165 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  129 bits (325), Expect = 2e-34
 Identities = 55/226 (24%), Positives = 99/226 (43%), Gaps = 30/226 (13%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLK---LQQQGALKSFIDECNALTSIRH 212
            +F     +G+GSFG V+      +G   A+KVLK   + +   ++   DE   L+ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             I+++  +      +      ++ +++  G L              ++           
Sbjct: 64  PFIIRMWGTF-----QDAQQIFMIMDYIEGGELFSL-------LRKSQRFPNPVAKFYAA 111

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           +V  AL+YLH++    I + DLK  N+LLD+     + DFG AK++ + + T        
Sbjct: 112 EVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-------- 160

Query: 333 NGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDM 377
             L G+  YI PE ++    +   D +S+GIL+ E+  G  P  D 
Sbjct: 161 --LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS 204

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 4e-34
 Identities = 47/229 (20%), Positives = 91/229 (39%), Gaps = 25/229 (10%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           + +     +G G FG V++    +  +T   K +K++          E + L   RHRNI
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNI 63

Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           L +  S      E  +   ++FEF+   ++ + ++          +L+  + ++ V  V 
Sbjct: 64  LHLHESF-----ESMEELVMIFEFISGLDIFERIN------TSAFELNEREIVSYVHQVC 112

Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV--GDFGLAKFLFEESNTPSKNQTMSN 333
            AL +LH+     I H D++  N++      + +   +FG A+ L    N          
Sbjct: 113 EALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEY 169

Query: 334 GLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDL 382
                  Y P  + +  VS   D++S G L+  + +G  P        +
Sbjct: 170 -------YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI 211

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  127 bits (319), Expect = 6e-34
 Identities = 53/231 (22%), Positives = 89/231 (38%), Gaps = 21/231 (9%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
           + +     IGSGSFG +Y GT +A GE  AIK+  ++ +        E      ++    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVG 64

Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           +  +  C        D+  +V E +     D +   S       +K SL   L +   + 
Sbjct: 65  IPTIRWC----GAEGDYNVMVMELLGPSLEDLFNFCS-------RKFSLKTVLLLADQMI 113

Query: 276 SALDYLHNQYDTPIAHCDLKSSNVL---LDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           S ++Y+H++      H D+K  N L     +G + ++ DFGLAK   +           +
Sbjct: 114 SRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 170

Query: 333 NGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDL 382
             L G+  Y       G   S   D+ S G +L+    G  P   +     
Sbjct: 171 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  128 bits (323), Expect = 7e-34
 Identities = 50/235 (21%), Positives = 89/235 (37%), Gaps = 33/235 (14%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLAD-GETAAIKVLKL------QQQGALKSFIDECNALTS 209
           ++FS   +IG G FG VY    AD G+  A+K L        Q +    +     + +++
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 210 IRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLN 269
                I+ +  +         D  + + + M  G+L   L             S      
Sbjct: 64  GDCPFIVCMSYAF-----HTPDKLSFILDLMNGGDLHYHLS-------QHGVFSEADMRF 111

Query: 270 IVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQ 329
              ++   L+++HN+    + + DLK +N+LLDE     + D GLA            ++
Sbjct: 112 YAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF---------SK 159

Query: 330 TMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDL 382
              +   G+ GY+ PE +          D +S G +L ++  G  P       D 
Sbjct: 160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 214

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 1e-33
 Identities = 52/232 (22%), Positives = 96/232 (41%), Gaps = 28/232 (12%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLK---LQQQGALKSFIDECNALT-SIR 211
           ++F    ++G GSFG V+        +  AIK LK   +     ++  + E   L+ +  
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 212 HRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIV 271
           H  +  +  +      +  +    V E++  G+L   +           K  L +     
Sbjct: 62  HPFLTHMFCTF-----QTKENLFFVMEYLNGGDLMYHIQ-------SCHKFDLSRATFYA 109

Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTM 331
            ++   L +LH++    I + DLK  N+LLD+     + DFG+ K               
Sbjct: 110 AEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN-------MLGDAK 159

Query: 332 SNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDL 382
           +N   G+  YI PE + G   +   D +S+G+LL E+  G+ P     +++L
Sbjct: 160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 211

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 1e-33
 Identities = 66/332 (19%), Positives = 119/332 (35%), Gaps = 70/332 (21%)

Query: 157 DNFSEENLIGSGSFGSVYKGTL--------ADGETAAIKVLKLQQ-QGALKSFIDECNAL 207
           D       +G G+FG V                   A+K+LK    +  L   I E   +
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 208 TSI-RHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLH---------PSTDEYC 257
             I +H+NI+ ++ +C+      +    ++ E+   GNL ++L               + 
Sbjct: 73  KMIGKHKNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127

Query: 258 HFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF 317
             ++LS    ++    VA  ++YL ++      H DL + NVL+ E  +  + DFGLA+ 
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARD 184

Query: 318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD 376
           +             +   +  V ++ PE + +   +   D++S+G+LL EIFT       
Sbjct: 185 I-----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--- 236

Query: 377 MFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEEC 436
                                              +     E+LF  ++      K   C
Sbjct: 237 ----------------------------------PYPGVPVEELFKLLKEGHRMDKPSNC 262

Query: 437 LVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI 468
              +  +   C  A P  R   K +V +L  I
Sbjct: 263 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 1e-32
 Identities = 55/284 (19%), Positives = 97/284 (34%), Gaps = 30/284 (10%)

Query: 163 NLIGSGSFGSVYKGT-LADGETAAIKVLKLQ-----QQGALKSFIDECNALTSIRHRNIL 216
           + +G G F +VYK       +  AIK +KL      + G  ++ + E   L  + H NI+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 217 KIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVAS 276
            ++ +            +LVF+FM                 +   L+       ++    
Sbjct: 64  GLLDAF-----GHKSNISLVFDFMETDLEVIIKD-------NSLVLTPSHIKAYMLMTLQ 111

Query: 277 ALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
            L+YLH  +   I H DLK +N+LLDE  +  + DFGLAK     +   +          
Sbjct: 112 GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV------- 161

Query: 337 GSVGYIPPEYINGH--VSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPS 394
            +  Y  PE + G     +  D+++ G +L E+             D     F  +  P+
Sbjct: 162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT 221

Query: 395 HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLV 438
                   S+                            ++   +
Sbjct: 222 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFL 265

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  123 bits (309), Expect = 2e-32
 Identities = 39/233 (16%), Positives = 73/233 (31%), Gaps = 23/233 (9%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNI 215
            ++     IG GSFG +++GT L + +  AIK    +         DE      +     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62

Query: 216 LKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVA 275
           +  V        +      LV + +     D             +K S+         + 
Sbjct: 63  IPNVYYF----GQEGLHNVLVIDLLGPSLEDLLDL-------CGRKFSVKTVAMAAKQML 111

Query: 276 SALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG-----DFGLAKFLFEESNTPSKNQT 330
           + +  +H +    + + D+K  N L+      +       DFG+ KF  +          
Sbjct: 112 ARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 168

Query: 331 MSNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDL 382
               L G+  Y+      G   S   D+ + G + +    G  P   +     
Sbjct: 169 EKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN 221

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  123 bits (308), Expect = 2e-32
 Identities = 57/288 (19%), Positives = 108/288 (37%), Gaps = 29/288 (10%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRN 214
           + +     IG G++G VYK     GET A+K ++L++  +G   + I E + L  ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
           I+K+     +          LVFE +                     L  +   + ++ +
Sbjct: 62  IVKLYDVIHT-----KKRLVLVFEHLDQDLKKLLDV-------CEGGLESVTAKSFLLQL 109

Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNG 334
            + + Y H++    + H DLK  N+L++      + DFGLA+         +        
Sbjct: 110 LNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT--- 163

Query: 335 LKGSVGYIPPEYINGH--VSILGDIYSYGILLLEIFTGKRPTDDMFKDDL--SIHKFVLM 390
               + Y  P+ + G    S   DI+S G +  E+  G      + + D    I + +  
Sbjct: 164 ----LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT 219

Query: 391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLV 438
               +  +V +L         +E    E     +  +     L + L 
Sbjct: 220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGL-DESGIDLLSKMLK 266

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 1e-31
 Identities = 60/289 (20%), Positives = 109/289 (37%), Gaps = 29/289 (10%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKL--QQQGALKSFIDECNALTSIRHR 213
           +NF +   IG G++G VYK      GE  A+K ++L  + +G   + I E + L  + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
           NI+K++           +   LVFEF+                     + L    + +  
Sbjct: 62  NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDA------SALTGIPLPLIKSYLFQ 110

Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +   L + H+     + H DLK  N+L++      + DFGLA+                 
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF-------GVPVRTYT 160

Query: 334 GLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA 391
               ++ Y  PE +    + S   DI+S G +  E+ T +       + D     F  + 
Sbjct: 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 220

Query: 392 LPSHVMDVLDLSMLLEEEN--DHEKHEEEDLFPDIESQVAQKKLEECLV 438
            P  V+     SM   + +     + +   + P +  +  +  L + L 
Sbjct: 221 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPL-DEDGRSLLSQMLH 268

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 1e-30
 Identities = 50/256 (19%), Positives = 93/256 (36%), Gaps = 28/256 (10%)

Query: 162 ENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSI-RHRNILKIV 219
             ++G G  G V +       E  A+K+L+   +        E        +  +I++IV
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIV 71

Query: 220 SSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALD 279
               ++ Y G     +V E +  G L   +    D     +  +  +   I+  +  A+ 
Sbjct: 72  DVYENL-YAGRKCLLIVMECLDGGELFSRIQDRGD-----QAFTEREASEIMKSIGEAIQ 125

Query: 280 YLHNQYDTPIAHCDLKSSNVLLDEGM---IAHVGDFGLAKFLFEESNTPSKNQTMSNGLK 336
           YLH+     IAH D+K  N+L        I  + DFG AK     ++  +   T      
Sbjct: 126 YLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP----- 177

Query: 337 GSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSH 395
               Y+ PE +         D++S G+++  +  G  P        +S      + +  +
Sbjct: 178 ---YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 234

Query: 396 VMDVLDLSMLLEEEND 411
                + S + EE   
Sbjct: 235 EFPNPEWSEVSEEVKM 250

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 1e-30
 Identities = 49/241 (20%), Positives = 92/241 (38%), Gaps = 35/241 (14%)

Query: 154 NATDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKL------QQQGALKSFIDECNA 206
           N  D +     +GSG F  V K    + G   A K +K       ++  + +    E + 
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66

Query: 207 LTSIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQ 266
           L  I+H N++ +         E      L+ E +  G L  +           + L+  +
Sbjct: 67  LKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDF-------LAEKESLTEEE 114

Query: 267 RLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE----GMIAHVGDFGLAKFLFEES 322
               +  + + + YLH+     IAH DLK  N++L +         + DFGLA  +    
Sbjct: 115 ATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---- 167

Query: 323 NTPSKNQTMSNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDD 381
                       + G+  ++ PE +N   + +  D++S G++   + +G  P     K +
Sbjct: 168 ----DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 223

Query: 382 L 382
            
Sbjct: 224 T 224

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 4e-30
 Identities = 52/290 (17%), Positives = 104/290 (35%), Gaps = 31/290 (10%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHR 213
             + +   IG G++G+V+K       E  A+K ++L    +G   S + E   L  ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 214 NILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVID 273
           NI+++           +    LVFEF        +             L      + +  
Sbjct: 62  NIVRLHDVL-----HSDKKLTLVFEFCDQDLKKYF-------DSCNGDLDPEIVKSFLFQ 109

Query: 274 VASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
           +   L + H++    + H DLK  N+L++      + +FGLA+                +
Sbjct: 110 LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-------GIPVRCYS 159

Query: 334 GLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRP---TDDMFKDDLSIHKFV 388
               ++ Y PP+ + G    S   D++S G +  E+    RP    +D+      I + +
Sbjct: 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219

Query: 389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLV 438
                     +  L                ++ P + +   +  L+  L 
Sbjct: 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKL-NATGRDLLQNLLK 268

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 2e-29
 Identities = 50/240 (20%), Positives = 84/240 (35%), Gaps = 38/240 (15%)

Query: 164 LIGSGSFGSVYKGT-LADGETAAIKVLKLQ------QQGALKSFIDECNALTSIR--HRN 214
           L+GSG FGSVY G  ++D    AIK ++        +         E   L  +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 215 ILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDV 274
           +++++           D   L+ E                       L      +    V
Sbjct: 71  VIRLLDWFER-----PDSFVLILERPEPVQDLFDFI------TERGALQEELARSFFWQV 119

Query: 275 ASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQTMSN 333
             A+ + HN     + H D+K  N+L+D       + DFG    L           T+  
Sbjct: 120 LEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---------KDTVYT 167

Query: 334 GLKGSVGYIPPEYINGH--VSILGDIYSYGILLLEIFTGKRP---TDDMFKDDLSIHKFV 388
              G+  Y PPE+I  H        ++S GILL ++  G  P    +++ +  +   + V
Sbjct: 168 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 227

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 5e-29
 Identities = 62/292 (21%), Positives = 105/292 (35%), Gaps = 33/292 (11%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLK--LQQQGALKSFIDECNALTSIRHR 213
             + +   +GSG++G+V        G   AIK L    Q +   K    E   L  +RH 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 214 NILKIVSSCSSVDYEGNDFK-ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
           N++ ++   +  +   +     LV  FM              +    +KL   +   +V 
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDL---------GKLMKHEKLGEDRIQFLVY 128

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            +   L Y+H      I H DLK  N+ ++E     + DFGLA+    E           
Sbjct: 129 QMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY------- 178

Query: 333 NGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM 390
                +  Y  PE I      +   DI+S G ++ E+ TGK         D       + 
Sbjct: 179 ---VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235

Query: 391 ALPS----HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLV 438
             P       +   +    ++   + EK +   +  +  S +A   LE+ LV
Sbjct: 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNA-SPLAVNLLEKMLV 286

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 5e-29
 Identities = 47/222 (21%), Positives = 90/222 (40%), Gaps = 27/222 (12%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLK---LQQQGALKSFIDECNALTSIRH 212
           ++F    L+G G+FG V      A G   A+K+L+   +  +  +   + E   L + RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             +  +  +      + +D    V E+   G L   L          +  +  +      
Sbjct: 65  PFLTALKYAF-----QTHDRLCFVMEYANGGELFFHLS-------RERVFTEERARFYGA 112

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
           ++ SAL+YLH++    + + D+K  N++LD+     + DFGL K    +           
Sbjct: 113 EIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-------GATM 162

Query: 333 NGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRP 373
               G+  Y+ PE +         D +  G+++ E+  G+ P
Sbjct: 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  112 bits (281), Expect = 2e-28
 Identities = 57/254 (22%), Positives = 98/254 (38%), Gaps = 38/254 (14%)

Query: 125 IYHIVKTSRRQSAPPSNEWQSGLSYLKISNATDNFSEENLIGSGSFGSVYKGT-LADGET 183
           +Y  V T R     P   W      ++  N  D++     +G G +  V++   + + E 
Sbjct: 9   VYTDVNTHR-----PREYWDYESHVVEWGNQ-DDYQLVRKLGRGKYSEVFEAINITNNEK 62

Query: 184 AAIKVLKLQQQGALKSFIDECNALTSIR-HRNILKIVSSCSSVDYEGNDFKALVFEFMRN 242
             +K+LK  ++   K    E   L ++R   NI+ +           +   ALVFE + N
Sbjct: 63  VVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIVKD---PVSRTPALVFEHVNN 116

Query: 243 GNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD 302
            +  Q           ++ L+       + ++  ALDY H+     I H D+K  NV++D
Sbjct: 117 TDFKQ----------LYQTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMID 163

Query: 303 -EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYS 359
            E     + D+GLA+F               N    S  +  PE +          D++S
Sbjct: 164 HEHRKLRLIDWGLAEFY--------HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWS 215

Query: 360 YGILLLEIFTGKRP 373
            G +L  +   K P
Sbjct: 216 LGCMLASMIFRKEP 229

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 7e-28
 Identities = 56/292 (19%), Positives = 103/292 (35%), Gaps = 31/292 (10%)

Query: 156 TDNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLK--LQQQGALKSFIDECNALTSIRH 212
            + +   + +GSG++GSV        G   A+K L    Q     K    E   L  ++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
            N++ ++   +            +   +             +     +KL+      ++ 
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHVQFLIY 128

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            +   L Y+H+     I H DLK SN+ ++E     + DFGLA+   +E           
Sbjct: 129 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----- 180

Query: 333 NGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM 390
                +  Y  PE +    H +   DI+S G ++ E+ TG+         D       L+
Sbjct: 181 -----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235

Query: 391 ALPSH----VMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLV 438
             P       +        ++      K    ++F    + +A   LE+ LV
Sbjct: 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLV 286

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  111 bits (277), Expect = 1e-27
 Identities = 53/246 (21%), Positives = 91/246 (36%), Gaps = 31/246 (12%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVL---KLQQQGALKSFIDECNALTSIRH 212
           D F     +G+GSFG V        G   A+K+L   K+ +   ++  ++E   L ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
             ++K+  S              V E++  G +   L           + S         
Sbjct: 101 PFLVKLEFSFKDNSNLYM-----VMEYVAGGEMFSHL-------RRIGRFSEPHARFYAA 148

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            +    +YLH+     + + DLK  N+L+D+     V DFG AK +   + T        
Sbjct: 149 QIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-------- 197

Query: 333 NGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRP-TDDMFKDDLSIHKFVLM 390
             L G+   + PE I     +   D ++ G+L+ E+  G  P   D             +
Sbjct: 198 --LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

Query: 391 ALPSHV 396
             PSH 
Sbjct: 256 RFPSHF 261

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 1e-26
 Identities = 52/228 (22%), Positives = 95/228 (41%), Gaps = 31/228 (13%)

Query: 157 DNFSEENLIGSGSFGSVYKGTLA----DGETAAIKVLK----LQQQGALKSFIDECNALT 208
           +NF    ++G+G++G V+          G+  A+KVLK    +Q+    +    E   L 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 209 SIRHRNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRL 268
            IR    L  +       ++      L+ +++  G L   L          ++ +  +  
Sbjct: 84  HIRQSPFLVTLHYA----FQTETKLHLILDYINGGELFTHLS-------QRERFTEHEVQ 132

Query: 269 NIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKN 328
             V ++  AL++LH      I + D+K  N+LLD      + DFGL+K         +  
Sbjct: 133 IYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF------VADE 183

Query: 329 QTMSNGLKGSVGYIPPEYINGHVSILG---DIYSYGILLLEIFTGKRP 373
              +    G++ Y+ P+ + G  S      D +S G+L+ E+ TG  P
Sbjct: 184 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.6 bits (247), Expect = 1e-23
 Identities = 58/275 (21%), Positives = 91/275 (33%), Gaps = 29/275 (10%)

Query: 157 DNFSEENLIGSGSFGSVYKGT-LADGETAAIKVLK--LQQQGALKSFIDECNALTSIRHR 213
             +     IGSG+ G V            AIK L    Q Q   K    E   +  + H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 214 NILKIVSSCSSVD-YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
           NI+ +++  +     E      LV E M              E          +   ++ 
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE----------RMSYLLY 126

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMS 332
            +   + +LH+     I H DLK SN+++       + DFGLA+         +    M 
Sbjct: 127 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--------AGTSFMM 175

Query: 333 NGLKGSVGYIPPEYINGH-VSILGDIYSYGILLLEIFTGKRP-TDDMFKDDLSIHKFVLM 390
                +  Y  PE I G       DI+S G ++ E+   K       + D  +     L 
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235

Query: 391 ALPSHVMDVLD--LSMLLEEENDHEKHEEEDLFPD 423
                 M  L   +   +E    +       LFPD
Sbjct: 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 270

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 97.8 bits (242), Expect = 5e-23
 Identities = 47/289 (16%), Positives = 98/289 (33%), Gaps = 32/289 (11%)

Query: 162 ENLIGSGSFGSVYKGT-LADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVS 220
              +G G F +V+    + +    A+K+++  +    ++  DE   L  +   +  K  S
Sbjct: 18  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDS 76

Query: 221 SCSSVDYEGNDFKAL-VFEFMRNGNLDQWLHPSTDEYCHFKKL--------SLMQRLNIV 271
             ++     +  K L  F       +   +            +         L+    I 
Sbjct: 77  MGAN-----HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131

Query: 272 IDVASALDYLHNQYDTPIAHCDLKSSNVLLD-EGMIAHVGDFGLAKFLFEESNTPSKNQT 330
             +   LDY+H +    I H D+K  NVL++      ++    +A              +
Sbjct: 132 KQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189

Query: 331 MSNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRP-------TDDMFKDDL 382
           +      +  Y  PE + G       DI+S   L+ E+ TG          +     D +
Sbjct: 190 I-----QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244

Query: 383 SIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQK 431
           +    +L  LPS+++     +          ++  +  F  +E  + +K
Sbjct: 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEK 293

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 76.7 bits (188), Expect = 6e-17
 Identities = 23/166 (13%), Positives = 49/166 (29%), Gaps = 29/166 (17%)

Query: 163 NLIGSGSFGSVYKGTLADGETAAIKVLKL----------QQQGALKSFIDECNALTSIRH 212
            L+G G   +V+           +K  K+          ++      F            
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 213 RNILKIVSSCSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVI 272
           R + K+        Y      A++ E +                    ++ +     ++ 
Sbjct: 66  RALQKLQGLAVPKVYAWEGN-AVLMELID--------------AKELYRVRVENPDEVLD 110

Query: 273 DVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFL 318
            +   +   +++    I H DL   NVL+ E  I  + DF  +  +
Sbjct: 111 MILEEVAKFYHRG---IVHGDLSQYNVLVSEEGI-WIIDFPQSVEV 152

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 70.6 bits (171), Expect = 5e-14
 Identities = 24/68 (35%), Positives = 33/68 (48%), Gaps = 4/68 (5%)

Query: 26  DLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGNDKLCGGIQ 85
           DL  N + G +PQ  ++L  L  LN+S+N L GEI + G        +   N  LCG   
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS-- 307

Query: 86  KLQLPECS 93
              LP C+
Sbjct: 308 --PLPACT 313

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 52.7 bits (125), Expect = 5e-08
 Identities = 15/60 (25%), Positives = 25/60 (41%), Gaps = 4/60 (6%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L  N+     PVS  SL  L  L  + N +S       + L ++  L+  +N++    
Sbjct: 312 LTLYFNNISDISPVS--SLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLT 367

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 50.8 bits (120), Expect = 2e-07
 Identities = 13/54 (24%), Positives = 20/54 (37%), Gaps = 4/54 (7%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYN 54
           L+  NN        SL +L  +  L    N +S   P   + L  +  L L+  
Sbjct: 334 LFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.2 bits (90), Expect = 9e-04
 Identities = 21/65 (32%), Positives = 28/65 (43%), Gaps = 4/65 (6%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
           L L  N  K     +L SL  L +LDL+ N +S   P   S L  L  L L  N++    
Sbjct: 224 LSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS 279

Query: 61  SREGI 65
              G+
Sbjct: 280 PLAGL 284

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.8 bits (89), Expect = 0.001
 Identities = 13/61 (21%), Positives = 20/61 (32%), Gaps = 4/61 (6%)

Query: 1  LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEI 60
            LG  +   T+  S   L  +  L      +  K       L +L  +N S N+L    
Sbjct: 27 TVLGKTNVTDTV--SQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDIT 82

Query: 61 S 61
           
Sbjct: 83 P 83

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.002
 Identities = 13/40 (32%), Positives = 19/40 (47%), Gaps = 2/40 (5%)

Query: 19  LRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDG 58
           L+ L  L L  NN+S   P   S L  L+ L  + N++  
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD 343

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 50.4 bits (119), Expect = 2e-07
 Identities = 20/56 (35%), Positives = 26/56 (46%)

Query: 1  LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
          L L NN          K+L+ L  L L  N +S   P  F+ L+ L  L LS N+L
Sbjct: 36 LDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.5 bits (108), Expect = 5e-06
 Identities = 15/72 (20%), Positives = 24/72 (33%), Gaps = 9/72 (12%)

Query: 1   LYLGNNSFKGT----IPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLL-----SLRHLNL 51
           L+L +     +    +  +L +   L ELDLS N L         + +      L  L L
Sbjct: 374 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVL 433

Query: 52  SYNELDGEISRE 63
                  E+   
Sbjct: 434 YDIYWSEEMEDR 445

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 4e-05
 Identities = 14/64 (21%), Positives = 20/64 (31%), Gaps = 5/64 (7%)

Query: 1  LYLGNNSFKGTIPVSL-KSLRGLAELDLSCNNLSGKVPQFFSKLL----SLRHLNLSYNE 55
          L +            L   L+    + L    L+    +  S  L    +L  LNL  NE
Sbjct: 7  LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66

Query: 56 LDGE 59
          L   
Sbjct: 67 LGDV 70

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 4e-04
 Identities = 8/39 (20%), Positives = 13/39 (33%), Gaps = 1/39 (2%)

Query: 22 LAELDLSCNNLSGK-VPQFFSKLLSLRHLNLSYNELDGE 59
          +  LD+ C  LS     +    L   + + L    L   
Sbjct: 4  IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEA 42

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (91), Expect = 6e-04
 Identities = 13/63 (20%), Positives = 22/63 (34%), Gaps = 9/63 (14%)

Query: 1  LYLGNNSFKG----TIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLL-----SLRHLNL 51
          + L +          I  +L+    LAEL+L  N L         + L      ++ L+L
Sbjct: 32 VRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSL 91

Query: 52 SYN 54
             
Sbjct: 92 QNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (89), Expect = 0.001
 Identities = 19/93 (20%), Positives = 33/93 (35%), Gaps = 12/93 (12%)

Query: 22  LAELDLSCNNLSGKVPQFFSKLL----SLRHLNLSYNELDGEISR---EGIFANASAISI 74
           L  L L+  ++S       +  L    SLR L+LS N L         E +      +  
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430

Query: 75  VG-NDKLCGGIQKLQLPECSRKNPRKRLSLKIV 106
           +   D       + +L    +  P    SL+++
Sbjct: 431 LVLYDIYWSEEMEDRLQALEKDKP----SLRVI 459

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 45.2 bits (105), Expect = 1e-05
 Identities = 16/56 (28%), Positives = 26/56 (46%), Gaps = 8/56 (14%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
           L + NN     +P     L     L  S N+L+ +VP+      +L+ L++ YN L
Sbjct: 289 LNVSNNKLI-ELPALPPRLE---RLIASFNHLA-EVPELPQ---NLKQLHVEYNPL 336

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 37.1 bits (84), Expect = 0.004
 Identities = 10/47 (21%), Positives = 18/47 (38%), Gaps = 5/47 (10%)

Query: 1   LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLR 47
           L    N     +P   ++L+   +L +  N L  + P     +  LR
Sbjct: 309 LIASFNHLA-EVPELPQNLK---QLHVEYNPLR-EFPDIPESVEDLR 350

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.9 bits (89), Expect = 6e-04
 Identities = 13/48 (27%), Positives = 20/48 (41%), Gaps = 4/48 (8%)

Query: 5   NNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLS 52
           +N      P  L SL  L E+ L  N +S   P   +   +L  + L+
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.1 bits (89), Expect = 8e-04
 Identities = 12/69 (17%), Positives = 19/69 (27%), Gaps = 11/69 (15%)

Query: 2   YLGNNSFKGTIPVSL------KSLRGLAELDLSCNNLSGKVPQ-----FFSKLLSLRHLN 50
            L +         ++          GL  L L  N +     +        K+  L  L 
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308

Query: 51  LSYNELDGE 59
           L+ N    E
Sbjct: 309 LNGNRFSEE 317

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.5 bits (88), Expect = 0.001
 Identities = 14/53 (26%), Positives = 18/53 (33%), Gaps = 1/53 (1%)

Query: 5   NNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELD 57
           NN+        L  L  L  L L  N+L   +P+ F     L    L  N   
Sbjct: 157 NNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.8 bits (86), Expect = 0.002
 Identities = 12/45 (26%), Positives = 14/45 (31%), Gaps = 2/45 (4%)

Query: 11 TIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNE 55
           +P  L   +    L LS N L             L  LNL   E
Sbjct: 24 ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.2 bits (85), Expect = 0.001
 Identities = 8/42 (19%), Positives = 15/42 (35%), Gaps = 1/42 (2%)

Query: 15 SLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNEL 56
             +     ELDL    +   +    + L     ++ S NE+
Sbjct: 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 53

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.2 bits (87), Expect = 0.001
 Identities = 10/61 (16%), Positives = 21/61 (34%), Gaps = 2/61 (3%)

Query: 1  LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGK-VPQFFSKLLSLRHLNLSYNELDGE 59
               +     +       R +  +DLS + +    +    S+   L++L+L    L   
Sbjct: 28 FRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDP 86

Query: 60 I 60
          I
Sbjct: 87 I 87

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (85), Expect = 0.002
 Identities = 7/38 (18%), Positives = 10/38 (26%)

Query: 15  SLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLS 52
                 G   LD+S   +          L  LR  +  
Sbjct: 196 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	477
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.42
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.08
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.01
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	98.98
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	98.96
d2ifga3	156	High affinity nerve growth factor receptor, N-term	98.9
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	98.83
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	98.71
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	98.66
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	98.64
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	98.57
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	98.55
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	98.52
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.5
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	98.33
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.32
d2ifga3	156	High affinity nerve growth factor receptor, N-term	98.27
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	98.17
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	98.15
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	98.15
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.13
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.09
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.0
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.0
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	97.98
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	97.96
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	97.85
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	97.81
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	97.8
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	97.69
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	97.67
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	97.63
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	97.6
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.59
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	97.48
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.4
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.59
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	96.56
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.52
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	96.47
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	96.2
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	95.67
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	95.62
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	95.37
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	94.5
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	93.98
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	87.84
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	80.62

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-55  Score=410.19  Aligned_cols=262  Identities=27%  Similarity=0.475  Sum_probs=202.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeec--cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .++|+..+.||+|+||.||+|+++  ..||||+++..  .....+.|.+|++++++++||||++++++|.      .+..
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~------~~~~   78 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------APQL   78 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSC
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe------ccEE
Confidence            467899999999999999999874  36999999744  3445678999999999999999999999863      3457


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||+++|+|.+++....      ..+++..++.++.||++||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus        79 ~lv~Ey~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFG  149 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHIIE------TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFG  149 (276)
T ss_dssp             EEEEECCCEEEHHHHHHTSC------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCC
T ss_pred             EEEEecCCCCCHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEcccc
Confidence            99999999999999997543      4589999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCccccc----CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN----GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      +|+.....     ..........||+.|+|||++.    +.++.++|||||||++|||+||+.||.......        
T Consensus       150 la~~~~~~-----~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--------  216 (276)
T d1uwha_         150 LATVKSRW-----SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--------  216 (276)
T ss_dssp             CSCC-----------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--------
T ss_pred             ceeecccc-----CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--------
Confidence            99875321     1122334567999999999983    247999999999999999999999997532111        


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIR  469 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  469 (477)
                           .+...+.......            ..+.        ....++..+.+|+.+||+.||++||||+||++.|+.|+
T Consensus       217 -----~~~~~~~~~~~~p------------~~~~--------~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~  271 (276)
T d1uwha_         217 -----QIIFMVGRGYLSP------------DLSK--------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA  271 (276)
T ss_dssp             -----HHHHHHHHTSCCC------------CGGG--------SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----HHHHHHhcCCCCC------------cchh--------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                 1111111110000            0000        00112345889999999999999999999999999998


Q ss_pred             Hhh
Q 043902          470 SKI  472 (477)
Q Consensus       470 ~~~  472 (477)
                      +.+
T Consensus       272 ~~~  274 (276)
T d1uwha_         272 RSL  274 (276)
T ss_dssp             HTC
T ss_pred             HcC
Confidence            753

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=409.78  Aligned_cols=256  Identities=27%  Similarity=0.468  Sum_probs=196.8

Q ss_pred             cCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEE
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALV  236 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  236 (477)
                      ++|+..+.||+|+||.||+|++.+++.||||+++.... ..++|.+|++++++++||||++++|+|     ..++..++|
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~-----~~~~~~~lv   78 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPICLV   78 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSCEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCccccccee-----ccCCceEEE
Confidence            56788899999999999999998889999999975443 347899999999999999999999997     345678999


Q ss_pred             EeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccc
Q 043902          237 FEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK  316 (477)
Q Consensus       237 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  316 (477)
                      |||+++|+|.+++....      ..+++..++.++.|+|.||.|||++   +|+||||||+|||+++++.+||+|||+++
T Consensus        79 ~E~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~  149 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQR------GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTR  149 (263)
T ss_dssp             EECCTTCBHHHHHHTTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---
T ss_pred             EEecCCCcHHHHhhccc------cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchhe
Confidence            99999999999987553      5689999999999999999999999   99999999999999999999999999998


Q ss_pred             cccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhC-CCCCCcccccccceeeeeeccCCc
Q 043902          317 FLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTG-KRPTDDMFKDDLSIHKFVLMALPS  394 (477)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~  394 (477)
                      .....      .........||..|+|||++ .+.++.++|||||||++|||+|+ ++||......              
T Consensus       150 ~~~~~------~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~--------------  209 (263)
T d1sm2a_         150 FVLDD------QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--------------  209 (263)
T ss_dssp             ---------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH--------------
T ss_pred             eccCC------CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH--------------
Confidence            76321      12223345789999999999 56799999999999999999995 5555432110              


Q ss_pred             hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHh
Q 043902          395 HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSK  471 (477)
Q Consensus       395 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  471 (477)
                      .+.+.+......             ..|           +.+...+.+++.+||+.||++||||+||++.|++|++.
T Consensus       210 ~~~~~i~~~~~~-------------~~p-----------~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         210 EVVEDISTGFRL-------------YKP-----------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             HHHHHHHHTCCC-------------CCC-----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCC-------------CCc-----------cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            111111111000             001           01134488999999999999999999999999999864

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-54  Score=400.74  Aligned_cols=257  Identities=24%  Similarity=0.475  Sum_probs=204.0

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      .++|+..+.||+|+||.||+|++++++.||||+++.... ..+.|.+|++++++++|||||+++|+|.      .+..++
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~------~~~~~i   84 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYI   84 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeec------cCCeEE
Confidence            457888899999999999999998889999999975443 3478999999999999999999999863      234689


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      ||||+++|+|.+++....     ...+++..++.|+.||++||.|||++   +|+||||||+||||++++.+||+|||+|
T Consensus        85 v~Ey~~~g~L~~~~~~~~-----~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla  156 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPS-----GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLA  156 (272)
T ss_dssp             EEECCTTCBHHHHTTSHH-----HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEeCCCCcHHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccce
Confidence            999999999999876542     24589999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCc
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPS  394 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  394 (477)
                      +....      ..........||+.|+|||++ .+.++.++|||||||++|||+||..|+.......             
T Consensus       157 ~~~~~------~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-------------  217 (272)
T d1qpca_         157 RLIED------NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-------------  217 (272)
T ss_dssp             EECSS------SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------------
T ss_pred             EEccC------CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-------------
Confidence            87632      122334456789999999999 5779999999999999999999666543321110             


Q ss_pred             hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHH
Q 043902          395 HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRS  470 (477)
Q Consensus       395 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  470 (477)
                      .+...+......             ..|           +.++..+.+|+.+||+.||++||||+||++.|+.+-.
T Consensus       218 ~~~~~i~~~~~~-------------~~p-----------~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         218 EVIQNLERGYRM-------------VRP-----------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHHHHHHTTCCC-------------CCC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCC-------------CCc-----------ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            011111110000             000           0123348899999999999999999999999998754

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-54  Score=398.21  Aligned_cols=252  Identities=20%  Similarity=0.328  Sum_probs=197.8

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .++|++.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++     .+++..
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~-----~~~~~~   78 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ   78 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEE-----EETTEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeee-----ccCcee
Confidence            357889999999999999999975 79999999997543 23346789999999999999999999995     556789


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||+++|+|.+++...       ..+++..+..++.||+.||.|||++   +|+||||||+|||+++++.+||+|||
T Consensus        79 ~ivmEy~~gg~L~~~l~~~-------~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG  148 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEPD-------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFG  148 (271)
T ss_dssp             EEEEECCTTEEGGGGSBTT-------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEeccCCCcHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccch
Confidence            9999999999999999754       4699999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCccccc-CC-CCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GH-VSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~-~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      +|+......     .........||+.|+|||++. .. ++.++|||||||++|||+||+.||.........+       
T Consensus       149 ~a~~~~~~~-----~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-------  216 (271)
T d1nvra_         149 LATVFRYNN-----RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-------  216 (271)
T ss_dssp             TCEECEETT-----EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-------
T ss_pred             hheeeccCC-----ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-------
Confidence            998763211     122344567999999999994 44 4688999999999999999999997533221110       


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                           ...........            ..+            .....+.+|+.+||+.||++|||++|+++
T Consensus       217 -----~~~~~~~~~~~------------~~~------------~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         217 -----SDWKEKKTYLN------------PWK------------KIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             -----HHHHTTCTTST------------TGG------------GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----HHHhcCCCCCC------------ccc------------cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                 01110000000            000            01233778999999999999999999875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.7e-54  Score=406.96  Aligned_cols=261  Identities=26%  Similarity=0.496  Sum_probs=193.9

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCC---EEEEEEeeec-cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGE---TAAIKVLKLQ-QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      ++|+..+.||+|+||.||+|++. +++   .||||.+... .....+.|.+|+++|++++|||||+++|+|     ..++
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~-----~~~~  100 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVV-----TKST  100 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CSSS
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEE-----eeCC
Confidence            45566789999999999999875 332   5888888654 334457899999999999999999999997     4456


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+++|+|.+++....      ..+++.+++.++.||++||.|||++   +|+||||||+||||+.++.+||+|
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~------~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~D  171 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQND------GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSD  171 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTT------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred             EEEEEEEecCCCcceeeecccc------CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECC
Confidence            7899999999999999887643      4689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeee
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~  389 (477)
                      ||+++........  ..........||+.|+|||.+ .+.++.++|||||||++|||+| |+.||.+.....        
T Consensus       172 FGla~~~~~~~~~--~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~--------  241 (299)
T d1jpaa_         172 FGLSRFLEDDTSD--PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD--------  241 (299)
T ss_dssp             C-------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------
T ss_pred             cccceEccCCCCc--ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH--------
Confidence            9999876432111  111223345689999999999 6789999999999999999998 899997532211        


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIR  469 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  469 (477)
                            +...+.......                        .+.+++..+.+|+.+||+.||++||||.||++.|+++.
T Consensus       242 ------~~~~i~~~~~~~------------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l  291 (299)
T d1jpaa_         242 ------VINAIEQDYRLP------------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI  291 (299)
T ss_dssp             ------HHHHHHTTCCCC------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ------HHHHHHcCCCCC------------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence                  111111110000                        00112445889999999999999999999999999886


Q ss_pred             Hh
Q 043902          470 SK  471 (477)
Q Consensus       470 ~~  471 (477)
                      +.
T Consensus       292 ~~  293 (299)
T d1jpaa_         292 RN  293 (299)
T ss_dssp             HS
T ss_pred             cC
Confidence            53

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-53  Score=394.89  Aligned_cols=253  Identities=25%  Similarity=0.469  Sum_probs=206.6

Q ss_pred             cCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEE
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALV  236 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  236 (477)
                      ++|+..+.||+|+||.||+|++++++.||||+++..... .++|.+|++++++++||||++++|+|     .+++..++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~-~~~~~~Ev~~~~~l~HpnIv~~~g~~-----~~~~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC-HHHHHHHHHHHHTCCCTTBCCEEEEE-----CCSSSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC-HHHHHHHHHHHHhcCCCceeeEEEEE-----eeCCceEEE
Confidence            688999999999999999999988889999999865443 37899999999999999999999997     456679999


Q ss_pred             EeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccc
Q 043902          237 FEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK  316 (477)
Q Consensus       237 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  316 (477)
                      |||+++|+|..++....      ..+++..+++++.|+++||.|||+.   +|+||||||+||++++++.+||+|||+++
T Consensus        78 ~Ey~~~g~l~~~~~~~~------~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~  148 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMR------HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR  148 (258)
T ss_dssp             EECCTTEEHHHHHHSGG------GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred             EEccCCCcHHHhhhccc------cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhhe
Confidence            99999999999976543      5689999999999999999999999   99999999999999999999999999998


Q ss_pred             cccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCCc
Q 043902          317 FLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALPS  394 (477)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  394 (477)
                      .....      .........||..|+|||.+ .+.++.++|||||||++|||+| |+.||.......             
T Consensus       149 ~~~~~------~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-------------  209 (258)
T d1k2pa_         149 YVLDD------EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------------  209 (258)
T ss_dssp             BCSSS------SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------------
T ss_pred             eccCC------CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-------------
Confidence            66321      12233346789999999999 6779999999999999999998 899997643221             


Q ss_pred             hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          395 HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       395 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                       +...+......             ..|.           .++..+.+++.+||+.||++|||++|+++.|.+|
T Consensus       210 -~~~~i~~~~~~-------------~~p~-----------~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         210 -TAEHIAQGLRL-------------YRPH-----------LASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             -HHHHHHTTCCC-------------CCCT-----------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             -HHHHHHhCCCC-------------CCcc-----------cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence             11111110000             0010           1133488999999999999999999999998643

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.5e-54  Score=405.69  Aligned_cols=259  Identities=25%  Similarity=0.455  Sum_probs=207.5

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      .++|+..+.||+|+||.||+|++. +|+.||||+++.... ..++|.+|+++|++++|||||+++++|     .+++..+
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~   89 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFY   89 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSCE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccE-----eeCCeeE
Confidence            457888899999999999999975 688999999875433 347899999999999999999999996     4566789


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +||||+++|+|.+++.....     ..+++..++.++.||++||.|||++   +|+||||||+|||+++++.+||+|||+
T Consensus        90 iv~E~~~~g~l~~~l~~~~~-----~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~  161 (287)
T d1opja_          90 IITEFMTYGNLLDYLRECNR-----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGL  161 (287)
T ss_dssp             EEEECCTTCBHHHHHHHSCT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred             EEeecccCcchHHHhhhccc-----cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccc
Confidence            99999999999999975432     5689999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCC
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      |+....      ..........|++.|+|||++ .+.++.++|||||||++|||+||..|+.......            
T Consensus       162 a~~~~~------~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~------------  223 (287)
T d1opja_         162 SRLMTG------DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------------  223 (287)
T ss_dssp             TTTCCS------SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------------
T ss_pred             eeecCC------CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH------------
Confidence            987522      122334455689999999998 6789999999999999999999777654321110            


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHh
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSK  471 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  471 (477)
                       .+.+.+.......             .|           +.++..+.+|+.+||+.||++||||+||++.|+.+.++
T Consensus       224 -~~~~~i~~~~~~~-------------~~-----------~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         224 -QVYELLEKDYRME-------------RP-----------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             -HHHHHHHTTCCCC-------------CC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             -HHHHHHhcCCCCC-------------CC-----------ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence             1122222111100             00           01234488999999999999999999999999987654

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-54  Score=401.66  Aligned_cols=261  Identities=25%  Similarity=0.403  Sum_probs=205.5

Q ss_pred             cCCCCCCe-eeeeccceEEEEEeC---CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          157 DNFSEENL-IGSGSFGSVYKGTLA---DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       157 ~~~~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      ++|...+. ||+|+||.||+|.++   ++..||||+++... ....+.|.+|+++|++++|||||+++|+|.      .+
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~------~~   81 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------AE   81 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------SS
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec------cC
Confidence            34555564 999999999999864   35579999997543 344678999999999999999999999973      23


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+++|+|.+++....      ..+++..++.++.||++||.|||++   +|+||||||+||+++.++.+||+|
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~D  152 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISD  152 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCT------TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECC
T ss_pred             eEEEEEEeCCCCcHHHHhhccc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeecc
Confidence            4799999999999999986543      5689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeee
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~  389 (477)
                      ||+++......    ..........||+.|+|||++ .+.++.++|||||||++|||+| |+.||.......        
T Consensus       153 FGla~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--------  220 (285)
T d1u59a_         153 FGLSKALGADD----SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------  220 (285)
T ss_dssp             CTTCEECTTCS----CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--------
T ss_pred             chhhhcccccc----cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH--------
Confidence            99998763211    112223345689999999999 6789999999999999999998 999997532211        


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIR  469 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  469 (477)
                            +...+.......             .           ++.++..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus       221 ------~~~~i~~~~~~~-------------~-----------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         221 ------VMAFIEQGKRME-------------C-----------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             ------HHHHHHTTCCCC-------------C-----------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------HHHHHHcCCCCC-------------C-----------CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                  111111100000             0           0112345889999999999999999999999999887


Q ss_pred             Hhhhh
Q 043902          470 SKIRM  474 (477)
Q Consensus       470 ~~~~~  474 (477)
                      ..+..
T Consensus       271 ~~~~~  275 (285)
T d1u59a_         271 YSLAS  275 (285)
T ss_dssp             HHHHT
T ss_pred             HHhhh
Confidence            65543

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-53  Score=393.18  Aligned_cols=248  Identities=23%  Similarity=0.375  Sum_probs=195.2

Q ss_pred             CCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEE
Q 043902          160 SEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALV  236 (477)
Q Consensus       160 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  236 (477)
                      +..+.||+|+||+||+|+.. +++.||+|.++...  ....+.+.+|+++|++++|||||++++++... .......++|
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~~~~~iv   90 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec-cccCCEEEEE
Confidence            45568999999999999975 68899999997543  34456799999999999999999999987432 1345678999


Q ss_pred             EeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeecCCCCCCeEec-CCCcEEEeccc
Q 043902          237 FEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTP--IAHCDLKSSNVLLD-EGMIAHVGDFG  313 (477)
Q Consensus       237 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~dlkp~NIll~-~~~~~kl~DfG  313 (477)
                      |||+++|+|.+++...       ..+++..+..++.||++||.|||++   +  |+||||||+|||++ +++.+||+|||
T Consensus        91 mE~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFG  160 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLG  160 (270)
T ss_dssp             EECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             EeCCCCCcHHHHHhcc-------ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecC
Confidence            9999999999999753       4689999999999999999999998   6  99999999999996 57899999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccccCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCC
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      +|+...         ........||+.|+|||++.++++.++|||||||++|||+||+.||........           
T Consensus       161 la~~~~---------~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~-----------  220 (270)
T d1t4ha_         161 LATLKR---------ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----------  220 (270)
T ss_dssp             GGGGCC---------TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----------
T ss_pred             cceecc---------CCccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH-----------
Confidence            997641         122334579999999999988899999999999999999999999965321110           


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                        +...+.......               ...        ..+...+.+|+.+||+.||++|||++|+++
T Consensus       221 --~~~~i~~~~~~~---------------~~~--------~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         221 --IYRRVTSGVKPA---------------SFD--------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             --HHHHHTTTCCCG---------------GGG--------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --HHHHHHcCCCCc---------------ccC--------ccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence              011110000000               000        001233788999999999999999999975

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-53  Score=395.77  Aligned_cols=249  Identities=22%  Similarity=0.304  Sum_probs=201.7

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      .++|+..+.||+|+||.||+|+.. +|+.||||+++.......+.+.+|++++++++||||+++++++     ...+..+
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~   93 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELW   93 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEE-----EECCEEE
Confidence            357999999999999999999864 7999999999876666668899999999999999999999995     4567899


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +||||+++|+|.+++..        ..+++.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        94 ivmEy~~gg~L~~~~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~  162 (293)
T d1yhwa1          94 VVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF  162 (293)
T ss_dssp             EEEECCTTCBHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEecCCCcHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchh
Confidence            99999999999998764        3489999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCC
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      |+.+..       .........||+.|+|||++ .+.++.++|||||||++|||+||+.||.......            
T Consensus       163 a~~~~~-------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------------  223 (293)
T d1yhwa1         163 CAQITP-------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------------  223 (293)
T ss_dssp             CEECCS-------TTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------------
T ss_pred             heeecc-------ccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH------------
Confidence            987632       12233456799999999999 5568999999999999999999999996532111            


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                       .+..+...... .       .    ..+           +.+...+.+++.+||+.||.+|||++|+++
T Consensus       224 -~~~~~~~~~~~-~-------~----~~~-----------~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         224 -ALYLIATNGTP-E-------L----QNP-----------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             -HHHHHHHHCSC-C-------C----SSG-----------GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -HHHHHHhCCCC-C-------C----CCc-----------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             00001000000 0       0    000           011234789999999999999999999975

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=388.51  Aligned_cols=244  Identities=24%  Similarity=0.353  Sum_probs=199.1

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec---cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ---QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++...   .....+.+.+|++++++++||||+++++++     .+++.
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~   80 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDATR   80 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EECCE
Confidence            57889999999999999999975 6899999999743   233457789999999999999999999995     56778


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++|+|.+++...       ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        81 ~~ivmEy~~~g~L~~~l~~~-------~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DF  150 (263)
T d2j4za1          81 VYLILEYAPLGTVYRELQKL-------SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADF  150 (263)
T ss_dssp             EEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEeecCCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeeccc
Confidence            99999999999999999753       4689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCccccc-CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      |+|+....         .......||+.|+|||++. ..++.++|||||||++|||+||+.||.......          
T Consensus       151 G~a~~~~~---------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----------  211 (263)
T d2j4za1         151 GWSVHAPS---------SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE----------  211 (263)
T ss_dssp             CSCSCCCC---------CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----------
T ss_pred             ceeeecCC---------CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH----------
Confidence            99976521         1223457999999999995 458999999999999999999999996532111          


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                             .+.......           ..+|.           .+...+.+++.+||+.||++|||++|+++
T Consensus       212 -------~~~~i~~~~-----------~~~p~-----------~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         212 -------TYKRISRVE-----------FTFPD-----------FVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             -------HHHHHHTTC-----------CCCCT-----------TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------HHHHHHcCC-----------CCCCc-----------cCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                   111000000           00111           01234788999999999999999999986

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=393.19  Aligned_cols=260  Identities=24%  Similarity=0.435  Sum_probs=197.0

Q ss_pred             cCCCCCCeeeeeccceEEEEEeCCC-----CEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLADG-----ETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      +.|+..++||+|+||.||+|.+++.     ..||||+++... ......|.+|++++++++|||||+++|+|     ...
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~-----~~~   81 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----SKY   81 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEE-----ecC
Confidence            4677889999999999999986532     379999997543 33446799999999999999999999997     445


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +..++||||+.+|++.+++....      ..+++.+++.++.|++.||.|||+.   +|+||||||+||||+.++.+||+
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~  152 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKD------GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVS  152 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTT------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEEC
T ss_pred             CceEEEEEecccCcchhhhhccc------ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEc
Confidence            67899999999999999886543      5699999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      |||+++......    ..........||+.|+|||++ .+.++.++|||||||++|||+||..|+.......        
T Consensus       153 DFGla~~~~~~~----~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~--------  220 (283)
T d1mqba_         153 DFGLSRVLEDDP----EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--------  220 (283)
T ss_dssp             CCCC---------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------
T ss_pred             ccchhhcccCCC----ccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH--------
Confidence            999998763311    112223445689999999998 6689999999999999999999766653321110        


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIR  469 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  469 (477)
                           .+.+.+.......             .           +..++..+.+|+.+||+.||++||||.||++.|+++.
T Consensus       221 -----~~~~~i~~~~~~~-------------~-----------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~  271 (283)
T d1mqba_         221 -----EVMKAINDGFRLP-------------T-----------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  271 (283)
T ss_dssp             -----HHHHHHHTTCCCC-------------C-----------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             -----HHHHHHhccCCCC-------------C-----------chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence                 1111121111100             0           0112345889999999999999999999999999886


Q ss_pred             Hh
Q 043902          470 SK  471 (477)
Q Consensus       470 ~~  471 (477)
                      +.
T Consensus       272 ~~  273 (283)
T d1mqba_         272 RA  273 (283)
T ss_dssp             HS
T ss_pred             hC
Confidence            54

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-53  Score=391.42  Aligned_cols=257  Identities=23%  Similarity=0.321  Sum_probs=189.5

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|+++...  ....+.+.+|++++++++||||+++++++..   ..++.
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~   79 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT   79 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCCE
Confidence            367999999999999999999865 78999999997543  3345678999999999999999999998642   34556


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCC--CCCeeecCCCCCCeEecCCCcEEEe
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQY--DTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      .++||||+++|+|.+++.....   ....+++..++.++.|++.||.|||++.  ..+|+||||||+|||++.++.+||+
T Consensus        80 ~~ivmEy~~~g~L~~~i~~~~~---~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~  156 (269)
T d2java1          80 LYIVMEYCEGGDLASVITKGTK---ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG  156 (269)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEEC
T ss_pred             EEEEEecCCCCcHHHHHHhccc---cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEe
Confidence            8999999999999999864321   1256999999999999999999999861  1249999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVL  389 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  389 (477)
                      |||+|+....       .........||+.|+|||++ ...++.++|||||||++|||+||+.||........       
T Consensus       157 DFG~a~~~~~-------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~-------  222 (269)
T d2java1         157 DFGLARILNH-------DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-------  222 (269)
T ss_dssp             CHHHHHHC------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------
T ss_pred             eccceeeccc-------CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH-------
Confidence            9999987632       12223456789999999999 55799999999999999999999999965322110       


Q ss_pred             ccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          390 MALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       390 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                            ...+......              ..|.           .+...+.+|+.+||+.||.+|||++|+++
T Consensus       223 ------~~~i~~~~~~--------------~~~~-----------~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         223 ------AGKIREGKFR--------------RIPY-----------RYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ------HHHHHHTCCC--------------CCCT-----------TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------HHHHHcCCCC--------------CCCc-----------ccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                  0011110000              0000           01234789999999999999999999975

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-53  Score=394.10  Aligned_cols=252  Identities=26%  Similarity=0.424  Sum_probs=196.9

Q ss_pred             CeeeeeccceEEEEEeC---CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEEE
Q 043902          163 NLIGSGSFGSVYKGTLA---DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALVF  237 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  237 (477)
                      +.||+|+||.||+|.++   .++.||||+++...  ....+.|.+|++++++++|||||+++++|.     . +..++||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-----~-~~~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----A-ESWMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----S-SSEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-----c-CCEEEEE
Confidence            47999999999999864   35689999997432  334578999999999999999999999973     2 3468999


Q ss_pred             eecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          238 EFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       238 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      ||+++|+|.+++...       ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        87 E~~~~g~L~~~l~~~-------~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~  156 (277)
T d1xbba_          87 EMAELGPLNKYLQQN-------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA  156 (277)
T ss_dssp             ECCTTEEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EcCCCCcHHHHHhhc-------cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhh
Confidence            999999999999754       4699999999999999999999999   999999999999999999999999999987


Q ss_pred             ccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCCch
Q 043902          318 LFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALPSH  395 (477)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  395 (477)
                      ....    ...........||+.|+|||.+ .+.++.++|||||||++|||+| |+.||.+....              .
T Consensus       157 ~~~~----~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--------------~  218 (277)
T d1xbba_         157 LRAD----ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------------E  218 (277)
T ss_dssp             CCTT----CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------------H
T ss_pred             cccc----ccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--------------H
Confidence            6321    1112233445789999999999 6779999999999999999998 89999753211              1


Q ss_pred             hHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHhh
Q 043902          396 VMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSKI  472 (477)
Q Consensus       396 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  472 (477)
                      +...+.......             .|           ..++..+.+|+.+||+.||++|||++||.+.|+.+..+.
T Consensus       219 ~~~~i~~~~~~~-------------~p-----------~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  271 (277)
T d1xbba_         219 VTAMLEKGERMG-------------CP-----------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  271 (277)
T ss_dssp             HHHHHHTTCCCC-------------CC-----------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCCC-------------CC-----------cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence            111111110000             00           112345889999999999999999999999998875543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-52  Score=394.34  Aligned_cols=251  Identities=21%  Similarity=0.300  Sum_probs=202.0

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      .+.|++.+.||+|+||.||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++     .+.+..+
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~~~   85 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF-----YYENNLW   85 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEE-----EETTEEE
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCeEE
Confidence            356888999999999999999975 7899999999877666778899999999999999999999996     4567899


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +||||+++|+|.+++....      ..+++.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        86 lvmEy~~~g~L~~~~~~~~------~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~  156 (288)
T d2jfla1          86 ILIEFCAGGAVDAVMLELE------RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGV  156 (288)
T ss_dssp             EEEECCTTEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEecCCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechh
Confidence            9999999999999976432      4699999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCccccc------CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeee
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN------GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~  388 (477)
                      |+....       .........||+.|+|||++.      ..++.++|||||||++|||+||+.||........      
T Consensus       157 a~~~~~-------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~------  223 (288)
T d2jfla1         157 SAKNTR-------TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------  223 (288)
T ss_dssp             CEECHH-------HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------
T ss_pred             hhccCC-------CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH------
Confidence            976522       112234567999999999872      2478999999999999999999999975322110      


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                             +..+......        .      .+ .        ...+...+.+|+.+||+.||++|||++|+++
T Consensus       224 -------~~~i~~~~~~--------~------~~-~--------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         224 -------LLKIAKSEPP--------T------LA-Q--------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             -------HHHHHHSCCC--------C------CS-S--------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -------HHHHHcCCCC--------C------CC-c--------cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   1111100000        0      00 0        0011234789999999999999999999976

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-53  Score=388.97  Aligned_cols=253  Identities=27%  Similarity=0.441  Sum_probs=196.4

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      .++|+..+.||+|+||.||+|+++ |..||||+++...  ..+.|.+|++++++++||||++++|+|.    +..+..++
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~----~~~~~~~l   78 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYI   78 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--CCEE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEE----ecCCcEEE
Confidence            356778899999999999999984 7899999997543  3478999999999999999999999873    44556799


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      ||||+++|+|.+++....     ...+++..+++++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        79 v~ey~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s  150 (262)
T d1byga_          79 VTEYMAKGSLVDYLRSRG-----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT  150 (262)
T ss_dssp             EECCCTTEEHHHHHHHHH-----HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred             EEeccCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccc
Confidence            999999999999997532     14589999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeeeeccCC
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFVLMALP  393 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  393 (477)
                      +....          ......+|..|+|||++ .+.++.++|||||||++|||+| |+.||......+            
T Consensus       151 ~~~~~----------~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~------------  208 (262)
T d1byga_         151 KEASS----------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------------  208 (262)
T ss_dssp             ---------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG------------
T ss_pred             eecCC----------CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH------------
Confidence            86521          12234578899999999 6789999999999999999999 687776532221            


Q ss_pred             chhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHh
Q 043902          394 SHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSK  471 (477)
Q Consensus       394 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  471 (477)
                        +...+.......             .+           +.+...+.+|+.+||+.||.+||||.|+++.|++|+..
T Consensus       209 --~~~~i~~~~~~~-------------~~-----------~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         209 --VVPRVEKGYKMD-------------AP-----------DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             --HHHHHTTTCCCC-------------CC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --HHHHHHcCCCCC-------------CC-----------ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence              111111000000             00           01123478999999999999999999999999999764

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-52  Score=395.51  Aligned_cols=198  Identities=27%  Similarity=0.434  Sum_probs=173.8

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .++|++.+.||+|+||+||+|+.. +|+.||+|+++... ......+.+|+.+|++++|||||+++++|     .+.+..
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~   79 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI   79 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEE-----ECSSEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence            578999999999999999999965 78999999998543 34456889999999999999999999996     566789


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN-QYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      ++||||+++|+|.+++...       ..+++..+..++.|++.||.|||+ +   +|+||||||+|||++.++.+||+||
T Consensus        80 ~iVmEy~~gg~L~~~l~~~-------~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DF  149 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDF  149 (322)
T ss_dssp             EEEEECCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeC
Confidence            9999999999999999754       468999999999999999999996 5   8999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      |+|+...+         .......||+.|+|||++ ...++.++||||+||++|||+||+.||...
T Consensus       150 Gla~~~~~---------~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~  206 (322)
T d1s9ja_         150 GVSGQLID---------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  206 (322)
T ss_dssp             CCCHHHHH---------HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred             CCccccCC---------CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            99987632         223346799999999999 567999999999999999999999999753

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-52  Score=396.18  Aligned_cols=261  Identities=26%  Similarity=0.457  Sum_probs=200.7

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCC-C-----CEEEEEEeeec-cchhhHHHHHHHHHHhcC-CCCCcceeeeecccccC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLAD-G-----ETAAIKVLKLQ-QQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDY  227 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  227 (477)
                      .++|+..+.||+|+||.||+|+... +     ..||+|.+... .......+.+|+.++.++ +|||||+++++|     
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----  110 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC-----  110 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE-----
Confidence            3578889999999999999998642 2     36899988643 334457899999999998 899999999996     


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCcc----------------cccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeee
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDEY----------------CHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAH  291 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH  291 (477)
                      ...+..++||||+++|+|.++++......                .....+++..++.++.||++||+|||++   +|+|
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiH  187 (325)
T d1rjba_         111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH  187 (325)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence            45667899999999999999997653211                1124589999999999999999999999   9999


Q ss_pred             cCCCCCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-
Q 043902          292 CDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-  369 (477)
Q Consensus       292 ~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-  369 (477)
                      |||||+||+++.++.+||+|||+|+......     .........||+.|+|||++ .+.++.++|||||||++|||+| 
T Consensus       188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~  262 (325)
T d1rjba_         188 RDLAARNVLVTHGKVVKICDFGLARDIMSDS-----NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL  262 (325)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCT-----TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred             ccCchhccccccCCeEEEeeccccccccCCC-----ceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhC
Confidence            9999999999999999999999998763311     12233455689999999998 6789999999999999999998 


Q ss_pred             CCCCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCC
Q 043902          370 GKRPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSA  449 (477)
Q Consensus       370 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~  449 (477)
                      |+.||.......             .+..++.......             .|           ..++..+.+|+.+||+
T Consensus       263 g~~Pf~~~~~~~-------------~~~~~~~~~~~~~-------------~p-----------~~~~~~l~~li~~cl~  305 (325)
T d1rjba_         263 GVNPYPGIPVDA-------------NFYKLIQNGFKMD-------------QP-----------FYATEEIYIIMQSCWA  305 (325)
T ss_dssp             SCCSSTTCCCSH-------------HHHHHHHTTCCCC-------------CC-----------TTCCHHHHHHHHHHTC
T ss_pred             CCCCCCCCCHHH-------------HHHHHHhcCCCCC-------------CC-----------CcCCHHHHHHHHHHcC
Confidence            899997532211             1122221111100             00           0123448899999999


Q ss_pred             CCCCCCCChHHHHHHHH
Q 043902          450 ASPRDRVGMKFVVNNLQ  466 (477)
Q Consensus       450 ~dP~~RPs~~evl~~L~  466 (477)
                      .||++|||++||++.|.
T Consensus       306 ~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         306 FDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SSGGGSCCHHHHHHHHH
T ss_pred             CChhHCcCHHHHHHHHh
Confidence            99999999999999985

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-52  Score=389.45  Aligned_cols=257  Identities=27%  Similarity=0.456  Sum_probs=198.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      .++|++.+.||+|+||.||+|++++++.||||+++.... ..+.|.+|+.++++++|||||+++++|.      .+..++
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~------~~~~~l   88 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIYI   88 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEe------cCCeEE
Confidence            357889999999999999999998888999999975543 3478999999999999999999999963      234789


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLA  315 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  315 (477)
                      ||||+++|+|..++....     ...++|.+++.++.||+.||+|||++   +|+||||||+||||+.++.+||+|||++
T Consensus        89 v~Ey~~~g~l~~~~~~~~-----~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla  160 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGET-----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA  160 (285)
T ss_dssp             EECCCTTCBHHHHHSHHH-----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             EEEecCCCchhhhhhhcc-----cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchh
Confidence            999999999999887542     24689999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCc
Q 043902          316 KFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPS  394 (477)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  394 (477)
                      +.....      .........||+.|+|||++ .+.++.++|||||||++|||+||..|+.......             
T Consensus       161 ~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-------------  221 (285)
T d1fmka3         161 RLIEDN------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------------  221 (285)
T ss_dssp             C--------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------------
T ss_pred             hhccCC------CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-------------
Confidence            865321      12223345689999999999 7789999999999999999999766654321110             


Q ss_pred             hhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHH
Q 043902          395 HVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRS  470 (477)
Q Consensus       395 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  470 (477)
                      .+.+.+.......                        ..+.+..++.+++.+||+.||++||||++|+++|+.+..
T Consensus       222 ~~~~~i~~~~~~~------------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         222 EVLDQVERGYRMP------------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             HHHHHHHTTCCCC------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             HHHHHHHhcCCCC------------------------CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence            1111111110000                        001123458899999999999999999999999887543

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-51  Score=384.91  Aligned_cols=248  Identities=22%  Similarity=0.370  Sum_probs=197.6

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ++|++.+.||+|+||.||+|+.. +|+.||||+++...   ....+.+.+|++++++++||||+++++++     .+++.
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~   82 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK   82 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSSE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECCE
Confidence            57999999999999999999974 79999999997432   33457899999999999999999999995     56778


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++|+|.+++...       ..+++..+..++.|++.||.|||++   +|+||||||+|||+++++.+||+||
T Consensus        83 ~~ivmEy~~gg~L~~~~~~~-------~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DF  152 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRKI-------GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDF  152 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEEEccCCCCHHHhhhcc-------CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEeccc
Confidence            99999999999999998754       5699999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      |+|+.+...     ..........||+.|+|||++ ...++.++|||||||++|||+||+.||.......          
T Consensus       153 G~a~~~~~~-----~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----------  217 (288)
T d1uu3a_         153 GTAKVLSPE-----SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL----------  217 (288)
T ss_dssp             TTCEECC---------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------
T ss_pred             ccceecccC-----CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH----------
Confidence            999876321     112223446799999999999 5578999999999999999999999997532111          


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                             +...-....           ..+|.           .....+.+|+.+||+.||++|||++|+++
T Consensus       218 -------~~~~i~~~~-----------~~~p~-----------~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         218 -------IFQKIIKLE-----------YDFPE-----------KFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             -------HHHHHHTTC-----------CCCCT-----------TCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             -------HHHHHHcCC-----------CCCCc-----------cCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence                   111000000           00010           01233789999999999999999999754

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-52  Score=386.38  Aligned_cols=260  Identities=22%  Similarity=0.384  Sum_probs=196.3

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeCC----CCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLAD----GETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      .++|+..+.||+|+||.||+|++..    +..||||.++... ....+.|.+|++++++++||||++++++|.      .
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------~   79 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------E   79 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------S
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------c
Confidence            3578888999999999999998642    3468888886433 344577999999999999999999999862      3


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +..++||||+++|+|.+++....      ..+++..++.++.||++||.|||++   +|+||||||+||+++.++.+||+
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~~~------~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~  150 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQVRK------YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLG  150 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTT------TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEEC
T ss_pred             CeEEEEEEeccCCcHHhhhhccC------CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEc
Confidence            46799999999999999876543      5689999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~  388 (477)
                      |||+|+.....      .........||+.|+|||.+ .+.++.++|||||||++|||+| |.+||.......       
T Consensus       151 DfG~a~~~~~~------~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-------  217 (273)
T d1mp8a_         151 DFGLSRYMEDS------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------  217 (273)
T ss_dssp             C-------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------
T ss_pred             cchhheeccCC------cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-------
Confidence            99999875321      12223345689999999999 6789999999999999999998 899987543221       


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                             +...+.....         .    ..|           ..++..+.+|+.+||+.||++|||+.||++.|+.+
T Consensus       218 -------~~~~i~~~~~---------~----~~~-----------~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         218 -------VIGRIENGER---------L----PMP-----------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             -------HHHHHHTTCC---------C----CCC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------HHHHHHcCCC---------C----CCC-----------CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                   1111100000         0    000           11234588999999999999999999999999999


Q ss_pred             HHhhhh
Q 043902          469 RSKIRM  474 (477)
Q Consensus       469 ~~~~~~  474 (477)
                      .++...
T Consensus       267 ~~~~k~  272 (273)
T d1mp8a_         267 LEEEKA  272 (273)
T ss_dssp             HHHHHH
T ss_pred             HHHhhC
Confidence            877543

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=384.53  Aligned_cols=260  Identities=25%  Similarity=0.436  Sum_probs=203.0

Q ss_pred             CCeeeeeccceEEEEEeCCC----CEEEEEEeeec-cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEE
Q 043902          162 ENLIGSGSFGSVYKGTLADG----ETAAIKVLKLQ-QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALV  236 (477)
Q Consensus       162 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  236 (477)
                      .++||+|+||+||+|++.++    ..||||+++.. .....++|.+|++++++++||||++++|+|.    ..+...++|
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~----~~~~~~~lv  107 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPLVV  107 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE----ETTTEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEE----ecCCceEEE
Confidence            36899999999999997532    25899999743 4455688999999999999999999999974    345678999


Q ss_pred             EeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccccc
Q 043902          237 FEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAK  316 (477)
Q Consensus       237 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  316 (477)
                      |||+++|+|.+++....      ..+++..++.++.|++.||.|||+.   +|+||||||+|||+++++.+||+|||+++
T Consensus       108 ~E~~~~g~l~~~~~~~~------~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~  178 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNET------HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR  178 (311)
T ss_dssp             EECCTTCBHHHHHHCTT------CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGC
T ss_pred             EEEeecCchhhhhcccc------ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchh
Confidence            99999999999987654      5678899999999999999999999   99999999999999999999999999998


Q ss_pred             cccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeeccCCch
Q 043902          317 FLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMALPSH  395 (477)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  395 (477)
                      ........   .........||..|+|||.+ .+.++.++||||||+++|||+||..||....... .+.          
T Consensus       179 ~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~----------  244 (311)
T d1r0pa_         179 DMYDKEFD---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DIT----------  244 (311)
T ss_dssp             CTTTTTCC---CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CH----------
T ss_pred             hccccccc---cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHH----------
Confidence            76432211   12223345789999999998 6789999999999999999999888875422111 000          


Q ss_pred             hHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHhhhh
Q 043902          396 VMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSKIRM  474 (477)
Q Consensus       396 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~  474 (477)
                       ..+... ..         .    ..|           +.++..+.+|+.+||+.||++||||.||++.|+++++.+..
T Consensus       245 -~~i~~g-~~---------~----~~p-----------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~  297 (311)
T d1r0pa_         245 -VYLLQG-RR---------L----LQP-----------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  297 (311)
T ss_dssp             -HHHHTT-CC---------C----CCC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             -HHHHcC-CC---------C----CCc-----------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence             000000 00         0    000           01133488999999999999999999999999999987544

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-51  Score=389.35  Aligned_cols=269  Identities=24%  Similarity=0.419  Sum_probs=207.2

Q ss_pred             HHHHhhcCCCCCCeeeeeccceEEEEEeC------CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecc
Q 043902          151 KISNATDNFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCS  223 (477)
Q Consensus       151 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  223 (477)
                      +++...++|+..+.||+|+||.||+|++.      +++.||||+++... ....+.|.+|++++++++||||++++++| 
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-   85 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC-   85 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee-
Confidence            44445678999999999999999999863      45789999997543 33456799999999999999999999997 


Q ss_pred             cccCCCCceeeEEEeecCCCChhhhcccCCCc-----------------ccccccCCHHHHHHHHHHHHHHHHHHHcCCC
Q 043902          224 SVDYEGNDFKALVFEFMRNGNLDQWLHPSTDE-----------------YCHFKKLSLMQRLNIVIDVASALDYLHNQYD  286 (477)
Q Consensus       224 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~  286 (477)
                          ...+..++||||+++|+|.+++......                 ......+++..++.++.|++.||+|||++  
T Consensus        86 ----~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~--  159 (301)
T d1lufa_          86 ----AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--  159 (301)
T ss_dssp             ----CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             ----ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC--
Confidence                4456789999999999999999643210                 11224589999999999999999999999  


Q ss_pred             CCeeecCCCCCCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHH
Q 043902          287 TPIAHCDLKSSNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLL  365 (477)
Q Consensus       287 ~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~  365 (477)
                       +|+||||||+|||++.++.+||+|||+|+......     .........||+.|+|||.+ ...++.++|||||||++|
T Consensus       160 -~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~  233 (301)
T d1lufa_         160 -KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD-----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW  233 (301)
T ss_dssp             -TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG-----CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred             -CeEeeEEcccceEECCCCcEEEccchhheeccCCc-----cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHH
Confidence             99999999999999999999999999998763321     12233445688999999999 667999999999999999


Q ss_pred             HHhhCC-CCCCcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHh
Q 043902          366 EIFTGK-RPTDDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIG  444 (477)
Q Consensus       366 elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  444 (477)
                      ||++|. +||.......              +...+.....                +..        ++.++..+.+|+
T Consensus       234 ell~~~~~p~~~~~~~e--------------~~~~v~~~~~----------------~~~--------p~~~~~~~~~li  275 (301)
T d1lufa_         234 EIFSYGLQPYYGMAHEE--------------VIYYVRDGNI----------------LAC--------PENCPLELYNLM  275 (301)
T ss_dssp             HHHTTTCCTTTTSCHHH--------------HHHHHHTTCC----------------CCC--------CTTCCHHHHHHH
T ss_pred             HHHccCCCCCCCCCHHH--------------HHHHHHcCCC----------------CCC--------CccchHHHHHHH
Confidence            999985 5675432211              1111100000                000        011233488999


Q ss_pred             hhcCCCCCCCCCChHHHHHHHHHHHH
Q 043902          445 VMCSAASPRDRVGMKFVVNNLQAIRS  470 (477)
Q Consensus       445 ~~Cl~~dP~~RPs~~evl~~L~~i~~  470 (477)
                      .+||+.||++||||.||+++|++|.+
T Consensus       276 ~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         276 RLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             HHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            99999999999999999999999863

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=383.80  Aligned_cols=286  Identities=22%  Similarity=0.281  Sum_probs=202.2

Q ss_pred             cCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeEE
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKALV  236 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  236 (477)
                      ++|...+.||+|+||.||+|++ +|+.||||+++..... ...+..|+..+.+++||||++++++|.... ......++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEE
Confidence            4566778999999999999997 6899999999754321 122334555566789999999999986422 233468999


Q ss_pred             EeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeeecCCCCCCeEecCCCcEEEec
Q 043902          237 FEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQY-----DTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       237 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      |||+++|+|.++++..        .++|..+++++.|+|.||.|||+..     .++|+||||||+||||+.++.+||+|
T Consensus        80 ~Ey~~~g~L~~~l~~~--------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D  151 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRY--------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  151 (303)
T ss_dssp             EECCTTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred             EecccCCCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence            9999999999999753        4899999999999999999999731     24999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccccCC-------CCcccceeehHHHHHHHhhCCCCCCcccccccce
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYINGH-------VSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSI  384 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~  384 (477)
                      ||+++.......   ..........||+.|+|||++.+.       ++.++|||||||++|||+||..||..........
T Consensus       152 FGl~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~  228 (303)
T d1vjya_         152 LGLAVRHDSATD---TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             CTTCEEEETTTT---EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             cCccccccCCCc---ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence            999987643211   112223456799999999998442       6789999999999999999998876533222111


Q ss_pred             eeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHH
Q 043902          385 HKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNN  464 (477)
Q Consensus       385 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  464 (477)
                      ........  ....+.+....            +...|.+.....   ..+++..+.+|+.+||+.||++|||+.||++.
T Consensus       229 ~~~~~~~~--~~~~~~~~~~~------------~~~~p~~~~~~~---~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         229 YDLVPSDP--SVEEMRKVVCE------------QKLRPNIPNRWQ---SCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             TTTSCSSC--CHHHHHHHHTT------------SCCCCCCCGGGG---GCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             hhcccccc--hHHHHHHHHhc------------cccCCCCCcccC---ChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            11111000  11111110000            000011111100   11234558899999999999999999999999


Q ss_pred             HHHHHHhhh
Q 043902          465 LQAIRSKIR  473 (477)
Q Consensus       465 L~~i~~~~~  473 (477)
                      |++|.++..
T Consensus       292 L~~i~~~~~  300 (303)
T d1vjya_         292 LSQLSQQEG  300 (303)
T ss_dssp             HHHHHHHHC
T ss_pred             HHHHHHhcC
Confidence            999987653

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-50  Score=384.09  Aligned_cols=251  Identities=22%  Similarity=0.312  Sum_probs=184.8

Q ss_pred             hhcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          155 ATDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ..+.|+..+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+++|++++||||+++++++     .+++.
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~   81 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGH   81 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCE
Confidence            3467899999999999999999975 78999999997543 23346788999999999999999999995     56778


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec---CCCcEEE
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHV  309 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl  309 (477)
                      .++||||+++|+|.+++...       ..+++..+..++.||+.||.|||++   +|+||||||+||++.   +++.+||
T Consensus        82 ~~lvmE~~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl  151 (307)
T d1a06a_          82 LYLIMQLVSGGELFDRIVEK-------GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMI  151 (307)
T ss_dssp             EEEEECCCCSCBHHHHHHTC-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred             EEEEEeccCCCcHHHhhhcc-------cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEE
Confidence            99999999999999999754       4699999999999999999999999   999999999999994   5789999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeee
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~  388 (477)
                      +|||+|+....        ........||+.|+|||++ .+.++.++|||||||++|||+||+.||.+......      
T Consensus       152 ~DFG~a~~~~~--------~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------  217 (307)
T d1a06a_         152 SDFGLSKMEDP--------GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL------  217 (307)
T ss_dssp             CCC--------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------
T ss_pred             eccceeEEccC--------CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH------
Confidence            99999986522        1223345799999999999 45689999999999999999999999965321110      


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                             ...+........          ....+            .....+.+|+.+||+.||++|||++|+++
T Consensus       218 -------~~~i~~~~~~~~----------~~~~~------------~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         218 -------FEQILKAEYEFD----------SPYWD------------DISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             -------HHHHHTTCCCCC----------TTTTT------------TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -------HHHHhccCCCCC----------Ccccc------------CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                   001110000000          00000            11234789999999999999999999986

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.2e-51  Score=387.76  Aligned_cols=244  Identities=25%  Similarity=0.335  Sum_probs=195.6

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      +.|+..+.||+|+||.||+|+.. +|+.||||+++...   ....+.+.+|++++++++|||||++++++     .+++.
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~   89 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-----LREHT   89 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEE-----EECCE
Confidence            45888999999999999999864 78999999997543   33446789999999999999999999996     45678


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++|+|..++...       ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus        90 ~~iv~E~~~~g~l~~~~~~~-------~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DF  159 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLEVHK-------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDF  159 (309)
T ss_dssp             EEEEEECCSEEHHHHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCC
T ss_pred             EEEEEEecCCCchHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeec
Confidence            99999999999998776543       5689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCccccc----CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeee
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN----GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~  388 (477)
                      |+|+....           .....||+.|+|||++.    +.++.++|||||||++|||++|+.||.......       
T Consensus       160 G~a~~~~~-----------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-------  221 (309)
T d1u5ra_         160 GSASIMAP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------  221 (309)
T ss_dssp             TTCBSSSS-----------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------
T ss_pred             ccccccCC-----------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-------
Confidence            99986421           23457999999999983    358999999999999999999999996532111       


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                            .+..+......             ...+           ..+...+.+|+.+||+.||++|||++|+++
T Consensus       222 ------~~~~i~~~~~~-------------~~~~-----------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         222 ------ALYHIAQNESP-------------ALQS-----------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             ------HHHHHHHSCCC-------------CCSC-----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ------HHHHHHhCCCC-------------CCCC-----------CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                  00111100000             0000           001234789999999999999999999975

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.5e-50  Score=388.11  Aligned_cols=251  Identities=20%  Similarity=0.319  Sum_probs=201.7

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++     .+.+..+
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~   99 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV   99 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----EETTEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence            468999999999999999999964 7999999999876666667899999999999999999999995     5577899


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec--CCCcEEEecc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD--EGMIAHVGDF  312 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~--~~~~~kl~Df  312 (477)
                      +||||+++|+|.+++....      ..+++..+..++.||+.||.|||++   +|+||||||+|||++  .++.+||+||
T Consensus       100 ivmE~~~gg~L~~~l~~~~------~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DF  170 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADEH------NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDF  170 (350)
T ss_dssp             EEECCCCSCBHHHHHTCTT------SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCC
T ss_pred             EEEEcCCCCCHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeec
Confidence            9999999999999986543      4699999999999999999999999   999999999999996  4678999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      |+|+.+..        ........||+.|+|||++ ...++.++|||||||++|||+||+.||.......          
T Consensus       171 G~a~~~~~--------~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----------  232 (350)
T d1koaa2         171 GLTAHLDP--------KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE----------  232 (350)
T ss_dssp             TTCEECCT--------TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------
T ss_pred             chheeccc--------ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH----------
Confidence            99987622        1223345789999999999 5568999999999999999999999996532111          


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                         .+..+........          ....            ..+...+.+|+.+||+.||++|||++|+++
T Consensus       233 ---~~~~i~~~~~~~~----------~~~~------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         233 ---TLRNVKSCDWNMD----------DSAF------------SGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             ---HHHHHHHTCCCSC----------CGGG------------GGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ---HHHHHHhCCCCCC----------cccc------------cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               0111110000000          0000            001234789999999999999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-51  Score=390.35  Aligned_cols=257  Identities=26%  Similarity=0.463  Sum_probs=199.0

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCC----EEEEEEeeec-cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGE----TAAIKVLKLQ-QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGN  230 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  230 (477)
                      ++|+..++||+|+||+||+|.+. +|+    .||+|.++.. .....+.|.+|++++++++|||||+++|+|..      
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------   82 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------   82 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence            46899999999999999999864 444    5888888643 33456789999999999999999999999742      


Q ss_pred             ceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEe
Q 043902          231 DFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVG  310 (477)
Q Consensus       231 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  310 (477)
                      +..++++||+.+|+|.+++....      ..+++..++.++.|||.||.|||++   +|+||||||+|||++.++.+||+
T Consensus        83 ~~~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~  153 (317)
T d1xkka_          83 STVQLITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT  153 (317)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTS------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEEC
T ss_pred             CCeeEEEEeccCCcccccccccc------cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEee
Confidence            34678999999999999887553      5689999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeeee
Q 043902          311 DFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       311 DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~  388 (477)
                      |||+|+......     .........||+.|+|||++ .+.++.++|||||||++|||+| |+.||......        
T Consensus       154 DFGla~~~~~~~-----~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--------  220 (317)
T d1xkka_         154 DFGLAKLLGAEE-----KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------  220 (317)
T ss_dssp             CCSHHHHTTTTC-----C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--------
T ss_pred             ccccceeccccc-----ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--------
Confidence            999998763211     12223345689999999998 6789999999999999999999 78888653221        


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAI  468 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  468 (477)
                            .+...+.......             .|           +.++..+.+|+.+||+.||.+|||+.||++.|+.+
T Consensus       221 ------~~~~~i~~~~~~~-------------~p-----------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         221 ------EISSILEKGERLP-------------QP-----------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             ------GHHHHHHHTCCCC-------------CC-----------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------HHHHHHHcCCCCC-------------CC-----------cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence                  1122221111000             00           11234588999999999999999999999999988


Q ss_pred             HHh
Q 043902          469 RSK  471 (477)
Q Consensus       469 ~~~  471 (477)
                      ...
T Consensus       271 ~~~  273 (317)
T d1xkka_         271 ARD  273 (317)
T ss_dssp             HHS
T ss_pred             HhC
Confidence            653

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5e-50  Score=386.24  Aligned_cols=251  Identities=20%  Similarity=0.290  Sum_probs=201.6

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      .++|++.+.||+|+||.||+|+.. +|+.||||+++.........+.+|+++|++++||||+++++++     .+++..+
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~  102 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV  102 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence            467999999999999999999964 7999999999876655567889999999999999999999995     5678899


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec--CCCcEEEecc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD--EGMIAHVGDF  312 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~--~~~~~kl~Df  312 (477)
                      +||||+++|+|.+++....      ..+++.+++.++.||+.||.|||++   +|+||||||+|||++  .++.+||+||
T Consensus       103 ivmE~~~gg~L~~~~~~~~------~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DF  173 (352)
T d1koba_         103 LILEFLSGGELFDRIAAED------YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDF  173 (352)
T ss_dssp             EEEECCCCCBHHHHTTCTT------CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCC
T ss_pred             EEEEcCCCChHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeec
Confidence            9999999999998876543      4699999999999999999999999   999999999999998  6789999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      |+|+....        ........||+.|+|||++ ...++.++|||||||++|||+||+.||.+.....          
T Consensus       174 Gla~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----------  235 (352)
T d1koba_         174 GLATKLNP--------DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE----------  235 (352)
T ss_dssp             TTCEECCT--------TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH----------
T ss_pred             ccceecCC--------CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH----------
Confidence            99987622        1223345689999999999 4569999999999999999999999997532211          


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                             .+..........      .....+            .....+.+|+.+||+.||.+|||++|+++
T Consensus       236 -------~~~~i~~~~~~~------~~~~~~------------~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         236 -------TLQNVKRCDWEF------DEDAFS------------SVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             -------HHHHHHHCCCCC------CSSTTT------------TSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             -------HHHHHHhCCCCC------Cccccc------------CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   111000000000      000000            01234789999999999999999999986

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-50  Score=378.59  Aligned_cols=250  Identities=21%  Similarity=0.313  Sum_probs=199.8

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc------chhhHHHHHHHHHHhcCCCCCcceeeeecccccCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ------QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYE  228 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  228 (477)
                      .++|++.+.||+|+||.||+|+.. +|+.||||+++...      ....+.+.+|+++|++++|||||++++++     .
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~   83 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E   83 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence            467999999999999999999974 79999999997432      12357899999999999999999999995     5


Q ss_pred             CCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC---
Q 043902          229 GNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM---  305 (477)
Q Consensus       229 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~---  305 (477)
                      +.+..++||||+++|+|.+++...       ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++   
T Consensus        84 ~~~~~~iv~E~~~gg~L~~~i~~~-------~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~  153 (293)
T d1jksa_          84 NKTDVILILELVAGGELFDFLAEK-------ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPK  153 (293)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSS
T ss_pred             ECCEEEEEEEcCCCccccchhccc-------cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcc
Confidence            678899999999999999999754       4699999999999999999999999   999999999999998776   


Q ss_pred             -cEEEecccccccccccCCCCCCCccccCCCcccccccCccccc-CCCCcccceeehHHHHHHHhhCCCCCCcccccccc
Q 043902          306 -IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLS  383 (477)
Q Consensus       306 -~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~  383 (477)
                       .+||+|||+|.....        ........||+.|+|||++. ..++.++|||||||++|||+||+.||........ 
T Consensus       154 ~~vkl~DfG~a~~~~~--------~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-  224 (293)
T d1jksa_         154 PRIKIIDFGLAHKIDF--------GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-  224 (293)
T ss_dssp             CCEEECCCTTCEECTT--------SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-
T ss_pred             cceEecchhhhhhcCC--------CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH-
Confidence             599999999987622        12233457899999999994 5699999999999999999999999975322110 


Q ss_pred             eeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          384 IHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       384 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                                  +..+......                      ........+...+.+|+.+||+.||++|||++|+++
T Consensus       225 ------------~~~i~~~~~~----------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         225 ------------LANVSAVNYE----------------------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             ------------HHHHHTTCCC----------------------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ------------HHHHHhcCCC----------------------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                        0000000000                      000011112344789999999999999999999985

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-50  Score=382.33  Aligned_cols=267  Identities=23%  Similarity=0.412  Sum_probs=196.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC------CCCEEEEEEeeecc-chhhHHHHHHHHHHhcC-CCCCcceeeeecccccC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQQ-QGALKSFIDECNALTSI-RHRNILKIVSSCSSVDY  227 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  227 (477)
                      .++|+..+.||+|+||.||+|++.      +++.||||+++... ....+.+.+|...+.++ +|+||+.+++++.    
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~----   87 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT----   87 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec----
Confidence            467889999999999999999853      34689999997543 34456788888888877 6899999999873    


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCcc---------cccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCC
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDEY---------CHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSN  298 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~N  298 (477)
                      ..+...++||||+++|+|.+++.......         .....+++.+++.++.||++||.|||++   +|+||||||+|
T Consensus        88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~N  164 (299)
T d1ywna1          88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN  164 (299)
T ss_dssp             STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred             cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccc
Confidence            45567899999999999999997543211         1124589999999999999999999999   99999999999


Q ss_pred             eEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCC-CCCCc
Q 043902          299 VLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGK-RPTDD  376 (477)
Q Consensus       299 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~-~p~~~  376 (477)
                      ||+++++.+||+|||+|+......     .........||+.|+|||.+ .+.++.++|||||||++|||+||. .||..
T Consensus       165 ILl~~~~~~Kl~DFGla~~~~~~~-----~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~  239 (299)
T d1ywna1         165 ILLSEKNVVKICDFGLARDIYKDP-----DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  239 (299)
T ss_dssp             EEECGGGCEEECC------CCSCT-----TSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             eeECCCCcEEEccCcchhhccccc-----cccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence            999999999999999998653211     12233456799999999999 667999999999999999999974 56754


Q ss_pred             ccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC
Q 043902          377 MFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRV  456 (477)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  456 (477)
                      .....             .+...+.......             .|           +.++..+.+++.+||+.||++||
T Consensus       240 ~~~~~-------------~~~~~~~~~~~~~-------------~~-----------~~~~~~l~~li~~cl~~dP~~Rp  282 (299)
T d1ywna1         240 VKIDE-------------EFCRRLKEGTRMR-------------AP-----------DYTTPEMYQTMLDCWHGEPSQRP  282 (299)
T ss_dssp             CCCSH-------------HHHHHHHHTCCCC-------------CC-----------TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCHHH-------------HHHHHHhcCCCCC-------------CC-----------ccCCHHHHHHHHHHcCCChhHCc
Confidence            22111             1111111110000             00           01133488999999999999999


Q ss_pred             ChHHHHHHHHHHHHh
Q 043902          457 GMKFVVNNLQAIRSK  471 (477)
Q Consensus       457 s~~evl~~L~~i~~~  471 (477)
                      |++||++.|++|.+.
T Consensus       283 t~~eil~~L~~ilq~  297 (299)
T d1ywna1         283 TFSELVEHLGNLLQA  297 (299)
T ss_dssp             CHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHhC
Confidence            999999999998653

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.3e-49  Score=372.74  Aligned_cols=264  Identities=19%  Similarity=0.312  Sum_probs=199.2

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeecc---chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQ---QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .++|++.+.||+|+||.||+|+. .+|+.||||+++...   ......+.+|++++++++||||+++++++...+ ....
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~   84 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP   84 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence            46799999999999999999986 479999999997543   334567999999999999999999999875321 2334


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+++|+|.+++...       ..+++.+++.++.||+.||.|||++   +|+||||||+|||++.++..+|+|
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~-------~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d  154 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTE-------GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMD  154 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECC
T ss_pred             eEEEEEECCCCCEehhhhccc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeeh
Confidence            588999999999999988644       4689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      ||.+......    ...........||+.|+|||++ .+.++.++|||||||++|||+||+.||.......         
T Consensus       155 ~~~~~~~~~~----~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---------  221 (277)
T d1o6ya_         155 FGIARAIADS----GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS---------  221 (277)
T ss_dssp             CTTCEECC--------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---------
T ss_pred             hhhhhhhccc----cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH---------
Confidence            9998765321    1122234456799999999999 4568999999999999999999999997532111         


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC-ChHHHHHHHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRV-GMKFVVNNLQAIR  469 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~i~  469 (477)
                              .............      ....            ..++..+.+++.+||+.||++|| |++++++.|.+++
T Consensus       222 --------~~~~~~~~~~~~~------~~~~------------~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         222 --------VAYQHVREDPIPP------SARH------------EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             --------HHHHHHHCCCCCG------GGTS------------SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             --------HHHHHHhcCCCCC------chhc------------cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence                    1111010000000      0000            01123488999999999999999 8999999998876

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=377.58  Aligned_cols=256  Identities=26%  Similarity=0.399  Sum_probs=191.4

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC--CC--CEEEEEEeeec---cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCC
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA--DG--ETAAIKVLKLQ---QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEG  229 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  229 (477)
                      ++|+..+.||+|+||.||+|++.  ++  ..||||+++..   .....+.|.+|++++++++||||++++|+|.     +
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~-----~   82 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-----T   82 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----e
Confidence            56888999999999999999853  23  36899998743   2344578999999999999999999999973     2


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEE
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV  309 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl  309 (477)
                       ...++||||+++|++.+++....      ..+++..++.++.|+|.||.|||++   +|+||||||+||+++.++.+||
T Consensus        83 -~~~~lv~e~~~~~~l~~~~~~~~------~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl  152 (273)
T d1u46a_          83 -PPMKMVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKI  152 (273)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHG------GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEE
T ss_pred             -cchheeeeeecCcchhhhhhccc------CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceee
Confidence             34689999999999999876543      5699999999999999999999999   9999999999999999999999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCCCcccccccceeee
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~  387 (477)
                      +|||+++......    ..........||..|+|||.+ ...++.++|||||||++|||+| |+.||........     
T Consensus       153 ~DfGl~~~~~~~~----~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~-----  223 (273)
T d1u46a_         153 GDFGLMRALPQND----DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-----  223 (273)
T ss_dssp             CCCTTCEECCC-C----CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----
T ss_pred             ccchhhhhcccCC----CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH-----
Confidence            9999998763211    122233445678899999999 6679999999999999999998 8999965322110     


Q ss_pred             eeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHH
Q 043902          388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQA  467 (477)
Q Consensus       388 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  467 (477)
                              ...+......         ..       .        .+.++..+.+|+.+||+.||++||||.||.+.|++
T Consensus       224 --------~~~i~~~~~~---------~~-------~--------~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         224 --------LHKIDKEGER---------LP-------R--------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             --------HHHHHTSCCC---------CC-------C--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --------HHHHHhCCCC---------CC-------C--------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence                    0011000000         00       0        00112348899999999999999999999998887


Q ss_pred             H
Q 043902          468 I  468 (477)
Q Consensus       468 i  468 (477)
                      .
T Consensus       272 ~  272 (273)
T d1u46a_         272 A  272 (273)
T ss_dssp             H
T ss_pred             c
Confidence            5

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-49  Score=375.85  Aligned_cols=247  Identities=22%  Similarity=0.360  Sum_probs=200.4

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec---cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ---QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|+++..   .....+.+.+|+.+|++++||||+++++++     .+.+
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~   78 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----cccc
Confidence            467999999999999999999964 7999999999754   233457789999999999999999999995     6778


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+++|+|.+++...       ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus        79 ~~~iv~ey~~gg~L~~~~~~~-------~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~D  148 (337)
T d1o6la_          79 RLCFVMEYANGGELFFHLSRE-------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITD  148 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred             ccccceeccCCCchhhhhhcc-------cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEee
Confidence            899999999999999998754       5689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      ||+|+....       .........||+.|+|||++ ...++.++||||+||++|||+||+.||.......         
T Consensus       149 FG~a~~~~~-------~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---------  212 (337)
T d1o6la_         149 FGLCKEGIS-------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---------  212 (337)
T ss_dssp             CTTCBCSCC-------TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---------
T ss_pred             ccccccccc-------CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---------
Confidence            999986522       12233456799999999999 5569999999999999999999999997532211         


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCC-----hHHHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVG-----MKFVVN  463 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  463 (477)
                              +........           ..+|.           .+...+.+|+.+||+.||.+||+     ++|+++
T Consensus       213 --------~~~~i~~~~-----------~~~p~-----------~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         213 --------LFELILMEE-----------IRFPR-----------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             --------HHHHHHHCC-----------CCCCT-----------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --------HHHHHhcCC-----------CCCCc-----------cCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence                    111100000           00010           01233788999999999999995     777765

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.7e-49  Score=373.26  Aligned_cols=243  Identities=26%  Similarity=0.355  Sum_probs=198.3

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec---cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ---QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ++|++.+.||+|+||.||+|+.. +|+.||||+++..   .....+.+.+|+.++++++||||+++++++     .+.+.
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCCe
Confidence            57889999999999999999974 7999999999743   233457899999999999999999999995     56788


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+++|+|..++...       ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus        79 ~~ivmE~~~gg~l~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DF  148 (316)
T d1fota_          79 IFMIMDYIEGGELFSLLRKS-------QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDF  148 (316)
T ss_dssp             EEEEECCCCSCBHHHHHHHT-------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             eeeEeeecCCcccccccccc-------ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecC
Confidence            99999999999999998765       4578899999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccccC-CCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      |+|+....          ......||+.|+|||++.+ .++.++|||||||++|||+||+.||......           
T Consensus       149 G~a~~~~~----------~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-----------  207 (316)
T d1fota_         149 GFAKYVPD----------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-----------  207 (316)
T ss_dssp             SSCEECSS----------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----------
T ss_pred             ccceEecc----------ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH-----------
Confidence            99987621          2234679999999999954 5899999999999999999999999753211           


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC-----ChHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRV-----GMKFVVN  463 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  463 (477)
                            ++........           ..+|.           .....+.+++.+||..||.+||     |++|+++
T Consensus       208 ------~~~~~i~~~~-----------~~~p~-----------~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         208 ------KTYEKILNAE-----------LRFPP-----------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ------HHHHHHHHCC-----------CCCCT-----------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ------HHHHHHHcCC-----------CCCCC-----------CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                  1111100000           00000           0123378899999999999996     8999875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-49  Score=376.21  Aligned_cols=266  Identities=26%  Similarity=0.401  Sum_probs=206.7

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe------CCCCEEEEEEeeecc-chhhHHHHHHHHHHhcC-CCCCcceeeeecccccC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL------ADGETAAIKVLKLQQ-QGALKSFIDECNALTSI-RHRNILKIVSSCSSVDY  227 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  227 (477)
                      .++|+..+.||+|+||.||+|++      .+++.||||+++... ......|.+|+.++.++ +|||||+++++|     
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~-----   96 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC-----   96 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----
Confidence            46788889999999999999985      246789999998543 34456789999999999 699999999997     


Q ss_pred             CCCceeeEEEeecCCCChhhhcccCCCc-----------ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCC
Q 043902          228 EGNDFKALVFEFMRNGNLDQWLHPSTDE-----------YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKS  296 (477)
Q Consensus       228 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp  296 (477)
                      ......++||||+++|+|.+++......           ......+++..+..++.||++||+|||++   +++||||||
T Consensus        97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp  173 (311)
T d1t46a_          97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA  173 (311)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence            4556789999999999999999754321           11224689999999999999999999999   999999999


Q ss_pred             CCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhC-CCCC
Q 043902          297 SNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTG-KRPT  374 (477)
Q Consensus       297 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg-~~p~  374 (477)
                      +||+++.++.+||+|||.++.....     ..........||+.|+|||.+ .+.++.++|||||||++|||+|+ .+||
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~  248 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKND-----SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY  248 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSC-----TTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             ccccccccCcccccccchheeccCC-----CcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCC
Confidence            9999999999999999999876321     123344567899999999999 67899999999999999999995 5555


Q ss_pred             CcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCC
Q 043902          375 DDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRD  454 (477)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~  454 (477)
                      ......             +.+..+++......             .+           +.++..+.+|+.+||+.||.+
T Consensus       249 ~~~~~~-------------~~~~~~i~~~~~~~-------------~~-----------~~~~~~l~~Li~~cl~~dP~~  291 (311)
T d1t46a_         249 PGMPVD-------------SKFYKMIKEGFRML-------------SP-----------EHAPAEMYDIMKTCWDADPLK  291 (311)
T ss_dssp             TTCCSS-------------HHHHHHHHHTCCCC-------------CC-----------TTSCHHHHHHHHHHTCSSGGG
T ss_pred             CCCCHH-------------HHHHHHHhcCCCCC-------------Cc-----------ccccHHHHHHHHHHcCCChhH
Confidence            432111             11222222211100             00           011344889999999999999


Q ss_pred             CCChHHHHHHHHHHHHh
Q 043902          455 RVGMKFVVNNLQAIRSK  471 (477)
Q Consensus       455 RPs~~evl~~L~~i~~~  471 (477)
                      ||||.||+++|+++.++
T Consensus       292 RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         292 RPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             SCCHHHHHHHHHHHHHH
T ss_pred             CcCHHHHHHHHHHhhcc
Confidence            99999999999876544

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-49  Score=373.07  Aligned_cols=264  Identities=25%  Similarity=0.425  Sum_probs=202.1

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC--------CCCEEEEEEeeeccc-hhhHHHHHHHHHHhcC-CCCCcceeeeecccc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA--------DGETAAIKVLKLQQQ-GALKSFIDECNALTSI-RHRNILKIVSSCSSV  225 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  225 (477)
                      .++|...+.||+|+||.||+|+..        ++..||||+++.... .....+.+|...+.++ +||||++++++|   
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~---   88 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC---   88 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc---
Confidence            457888899999999999999853        234799999975543 3457888999999888 899999999997   


Q ss_pred             cCCCCceeeEEEeecCCCChhhhcccCCCc---------ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCC
Q 043902          226 DYEGNDFKALVFEFMRNGNLDQWLHPSTDE---------YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKS  296 (477)
Q Consensus       226 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp  296 (477)
                        .+++..++||||+++|+|.+++......         ......+++..++.++.||+.||+|||+.   +|+||||||
T Consensus        89 --~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp  163 (299)
T d1fgka_          89 --TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA  163 (299)
T ss_dssp             --CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             --ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecc
Confidence              4456789999999999999999755321         11235689999999999999999999999   999999999


Q ss_pred             CCeEecCCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhh-CCCCC
Q 043902          297 SNVLLDEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFT-GKRPT  374 (477)
Q Consensus       297 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-g~~p~  374 (477)
                      +|||++.++.+||+|||+++......     .........||+.|+|||.+ .+.++.++|||||||++|||+| |..||
T Consensus       164 ~NiLl~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~  238 (299)
T d1fgka_         164 RNVLVTEDNVMKIADFGLARDIHHID-----YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY  238 (299)
T ss_dssp             GGEEECTTCCEEECSTTCCCCGGGCC-----TTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             cceeecCCCCeEeccchhhccccccc-----cccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCC
Confidence            99999999999999999998764321     12233456789999999999 7789999999999999999998 78888


Q ss_pred             CcccccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCC
Q 043902          375 DDMFKDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRD  454 (477)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~  454 (477)
                      ......              .+.+.+.......             .|           ..++..+.+|+.+||+.||++
T Consensus       239 ~~~~~~--------------~~~~~i~~~~~~~-------------~p-----------~~~~~~l~~li~~cl~~dP~~  280 (299)
T d1fgka_         239 PGVPVE--------------ELFKLLKEGHRMD-------------KP-----------SNCTNELYMMMRDCWHAVPSQ  280 (299)
T ss_dssp             TTCCHH--------------HHHHHHHTTCCCC-------------CC-----------SSCCHHHHHHHHHHTCSSGGG
T ss_pred             CCCCHH--------------HHHHHHHcCCCCC-------------CC-----------ccchHHHHHHHHHHccCCHhH
Confidence            653221              1111221111100             00           011334889999999999999


Q ss_pred             CCChHHHHHHHHHHHH
Q 043902          455 RVGMKFVVNNLQAIRS  470 (477)
Q Consensus       455 RPs~~evl~~L~~i~~  470 (477)
                      |||+.||++.|++|.+
T Consensus       281 Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         281 RPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             SCCHHHHHHHHHHHHH
T ss_pred             CcCHHHHHHHHHHHhh
Confidence            9999999999999865

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=376.59  Aligned_cols=261  Identities=28%  Similarity=0.423  Sum_probs=199.7

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCC--EEEEEEeeec-cchhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCCc
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGE--TAAIKVLKLQ-QQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~  231 (477)
                      ++|+..+.||+|+||.||+|++. +|.  .||||.++.. .....+.|.+|+++|.++ +||||++++++|     ..++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~   84 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRG   84 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE-----EETT
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEE-----ecCC
Confidence            67888899999999999999875 444  4777877643 334457899999999999 799999999997     4567


Q ss_pred             eeeEEEeecCCCChhhhcccCCC---------cccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTD---------EYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD  302 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~  302 (477)
                      ..++||||+++|+|.++++....         .......+++..++.++.|||.||.|||+.   +|+||||||+|||++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~  161 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG  161 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEc
Confidence            89999999999999999975421         011236799999999999999999999999   999999999999999


Q ss_pred             CCCcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCC-CCCccccc
Q 043902          303 EGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKR-PTDDMFKD  380 (477)
Q Consensus       303 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~-p~~~~~~~  380 (477)
                      .++.+||+|||+++....        ........||..|+|||.+ .+.++.++|||||||++|||++|.. ||......
T Consensus       162 ~~~~~kl~DfG~a~~~~~--------~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~  233 (309)
T d1fvra_         162 ENYVAKIADFGLSRGQEV--------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA  233 (309)
T ss_dssp             GGGCEEECCTTCEESSCE--------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred             CCCceEEccccccccccc--------cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH
Confidence            999999999999986522        1122344689999999999 6789999999999999999999764 56543211


Q ss_pred             ccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHH
Q 043902          381 DLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKF  460 (477)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e  460 (477)
                      .              +.+.+.......             .|           ..++..+.+|+.+||+.||++||||+|
T Consensus       234 ~--------------~~~~i~~~~~~~-------------~~-----------~~~~~~~~~li~~cl~~dP~~RPs~~e  275 (309)
T d1fvra_         234 E--------------LYEKLPQGYRLE-------------KP-----------LNCDDEVYDLMRQCWREKPYERPSFAQ  275 (309)
T ss_dssp             H--------------HHHHGGGTCCCC-------------CC-----------TTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             H--------------HHHHHHhcCCCC-------------CC-----------ccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            1              111111100000             00           011334889999999999999999999


Q ss_pred             HHHHHHHHHHh
Q 043902          461 VVNNLQAIRSK  471 (477)
Q Consensus       461 vl~~L~~i~~~  471 (477)
                      |++.|+++.++
T Consensus       276 il~~L~~i~~~  286 (309)
T d1fvra_         276 ILVSLNRMLEE  286 (309)
T ss_dssp             HHHHHHHHHHS
T ss_pred             HHHHHHHHHhc
Confidence            99999998765

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=7e-49  Score=380.26  Aligned_cols=248  Identities=22%  Similarity=0.315  Sum_probs=193.6

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc---chhhHHHH---HHHHHHhcCCCCCcceeeeecccccCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ---QGALKSFI---DECNALTSIRHRNILKIVSSCSSVDYE  228 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~  228 (477)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++....   ......+.   +++++++.++||||+++++++     .
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~   77 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H   77 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----E
Confidence            367999999999999999999975 79999999997432   11223333   457788888999999999995     5


Q ss_pred             CCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEE
Q 043902          229 GNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH  308 (477)
Q Consensus       229 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k  308 (477)
                      ..+..++||||+++|+|.+++...       ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+|
T Consensus        78 ~~~~~~ivmE~~~gg~L~~~l~~~-------~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iK  147 (364)
T d1omwa3          78 TPDKLSFILDLMNGGDLHYHLSQH-------GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVR  147 (364)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEE
T ss_pred             ECCEEEEEEEecCCCcHHHHHHhc-------ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEE
Confidence            677899999999999999999754       4688999999999999999999999   999999999999999999999


Q ss_pred             EecccccccccccCCCCCCCccccCCCcccccccCcccc-cC-CCCcccceeehHHHHHHHhhCCCCCCcccccccceee
Q 043902          309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NG-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHK  386 (477)
Q Consensus       309 l~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~  386 (477)
                      |+|||+|+....         .......||+.|+|||++ .+ .++.++|||||||++|||+||+.||........    
T Consensus       148 l~DFGla~~~~~---------~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----  214 (364)
T d1omwa3         148 ISDLGLACDFSK---------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----  214 (364)
T ss_dssp             ECCCTTCEECSS---------SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH----
T ss_pred             EeeeceeeecCC---------CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH----
Confidence            999999987522         123345799999999998 44 489999999999999999999999975322111    


Q ss_pred             eeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCC-----hHHH
Q 043902          387 FVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVG-----MKFV  461 (477)
Q Consensus       387 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev  461 (477)
                                ..+........           ...|.           .+...+.+|+.+||+.||++|||     ++|+
T Consensus       215 ----------~~~~~~~~~~~-----------~~~~~-----------~~s~~~~~li~~~L~~dP~~R~t~~~~~a~ei  262 (364)
T d1omwa3         215 ----------HEIDRMTLTMA-----------VELPD-----------SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV  262 (364)
T ss_dssp             ----------HHHHHHSSSCC-----------CCCCS-----------SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHH
T ss_pred             ----------HHHHHhcccCC-----------CCCCC-----------CCCHHHHHHHHHHcccCHHHhCCCcccCHHHH
Confidence                      01110000000           00000           01234789999999999999999     5777


Q ss_pred             HH
Q 043902          462 VN  463 (477)
Q Consensus       462 l~  463 (477)
                      ++
T Consensus       263 l~  264 (364)
T d1omwa3         263 KE  264 (364)
T ss_dssp             HT
T ss_pred             Hc
Confidence            64

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.7e-48  Score=363.41  Aligned_cols=249  Identities=22%  Similarity=0.327  Sum_probs=198.2

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc---------hhhHHHHHHHHHHhcCC-CCCcceeeeecccc
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ---------GALKSFIDECNALTSIR-HRNILKIVSSCSSV  225 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~  225 (477)
                      ++|+..+.||+|+||+||+|+.. +|+.||||+++....         ...+.+.+|+.++++++ ||||+++++++   
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~---   79 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY---   79 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec---
Confidence            67889999999999999999964 789999999975421         12346889999999997 99999999995   


Q ss_pred             cCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC
Q 043902          226 DYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM  305 (477)
Q Consensus       226 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~  305 (477)
                        .+++..++||||+++|+|.+++...       ..+++.++..++.||+.||+|||++   +|+||||||+||+++.++
T Consensus        80 --~~~~~~~ivmE~~~~g~L~~~l~~~-------~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~  147 (277)
T d1phka_          80 --ETNTFFFLVFDLMKKGELFDYLTEK-------VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDM  147 (277)
T ss_dssp             --ECSSEEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred             --ccCcceEEEEEcCCCchHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCC
Confidence              5678899999999999999999754       5699999999999999999999999   999999999999999999


Q ss_pred             cEEEecccccccccccCCCCCCCccccCCCcccccccCccccc-------CCCCcccceeehHHHHHHHhhCCCCCCccc
Q 043902          306 IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-------GHVSILGDIYSYGILLLEIFTGKRPTDDMF  378 (477)
Q Consensus       306 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~  378 (477)
                      .+||+|||+++....        ........||..|+|||++.       ..++.++||||+||++|||+||+.||....
T Consensus       148 ~~kl~DFG~a~~~~~--------~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~  219 (277)
T d1phka_         148 NIKLTDFGFSCQLDP--------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK  219 (277)
T ss_dssp             CEEECCCTTCEECCT--------TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CeEEccchheeEccC--------CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence            999999999987622        12234467999999999983       236889999999999999999999997532


Q ss_pred             ccccceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCCh
Q 043902          379 KDDLSIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGM  458 (477)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  458 (477)
                      ....             ...+......         .    ..+.         ...+...+.+++.+||+.||++|||+
T Consensus       220 ~~~~-------------~~~i~~~~~~---------~----~~~~---------~~~~s~~~~~li~~~L~~~p~~R~s~  264 (277)
T d1phka_         220 QMLM-------------LRMIMSGNYQ---------F----GSPE---------WDDYSDTVKDLVSRFLVVQPQKRYTA  264 (277)
T ss_dssp             HHHH-------------HHHHHHTCCC---------C----CTTT---------GGGSCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             HHHH-------------HHHHHhCCCC---------C----CCcc---------cccCCHHHHHHHHHHccCChhHCcCH
Confidence            1110             0001110000         0    0000         00112348899999999999999999


Q ss_pred             HHHHH
Q 043902          459 KFVVN  463 (477)
Q Consensus       459 ~evl~  463 (477)
                      +||++
T Consensus       265 ~eil~  269 (277)
T d1phka_         265 EEALA  269 (277)
T ss_dssp             HHHTT
T ss_pred             HHHHc
Confidence            99875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-48  Score=373.31  Aligned_cols=255  Identities=21%  Similarity=0.275  Sum_probs=194.2

Q ss_pred             hcCCCCCC-eeeeeccceEEEEEe-CCCCEEEEEEeeeccchhhHHHHHHHHHHhcC-CCCCcceeeeecccccCCCCce
Q 043902          156 TDNFSEEN-LIGSGSFGSVYKGTL-ADGETAAIKVLKLQQQGALKSFIDECNALTSI-RHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       156 ~~~~~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .++|.+.. .||+|+||.||+|+. .+|+.||||+++..     ..+.+|++++.++ +||||+++++++... +..+..
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~   83 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC   83 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeec-ccCCCE
Confidence            46788764 699999999999986 47999999999743     5677899987655 899999999986421 134567


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC---CCcEEE
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE---GMIAHV  309 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl  309 (477)
                      .|+|||||++|+|.+++.....     ..+++.++..++.||+.||+|||++   +|+||||||+|||++.   ++.+||
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~-----~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl  155 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGD-----QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKL  155 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSC-----CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEE
T ss_pred             EEEEEECCCCCcHHHHHHhcCC-----CCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccc
Confidence            8999999999999999975421     4699999999999999999999999   9999999999999985   567999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCccccc-CCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeee
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-GHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFV  388 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~  388 (477)
                      +|||+|+....        ........||+.|+|||++. ..++.++|||||||++|||+||+.||........  ....
T Consensus       156 ~DFG~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--~~~~  225 (335)
T d2ozaa1         156 TDFGFAKETTS--------HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGM  225 (335)
T ss_dssp             CCCTTCEECCC--------CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------
T ss_pred             cccceeeeccC--------CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH--HHHH
Confidence            99999987532        12234457999999999994 4699999999999999999999999965322110  0000


Q ss_pred             eccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          389 LMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       389 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                      ...+..                      ....+|.       .....+...+.+|+.+||+.||++|||+.|+++
T Consensus       226 ~~~i~~----------------------~~~~~~~-------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         226 KTRIRM----------------------GQYEFPN-------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             --CCCS----------------------CSSSCCT-------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHhc----------------------CCCCCCC-------cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            000000                      0000000       011122344889999999999999999999986

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-49  Score=373.68  Aligned_cols=250  Identities=21%  Similarity=0.300  Sum_probs=199.2

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      .++|++.+.||+|+||.||+|... +|+.||||+++..... ...+.+|+++|++++||||+++++++     ++++..|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~   77 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF-----ESMEELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence            467899999999999999999975 7889999999865433 35688999999999999999999985     5677899


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC--CCcEEEecc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE--GMIAHVGDF  312 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~--~~~~kl~Df  312 (477)
                      +||||+++|+|.+++....      ..+++.++..++.||+.||.|||++   +|+||||||+|||++.  ...+||+||
T Consensus        78 lvmE~~~gg~L~~~i~~~~------~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DF  148 (321)
T d1tkia_          78 MIFEFISGLDIFERINTSA------FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEF  148 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSS------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred             EEEecCCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEccc
Confidence            9999999999999997543      4689999999999999999999999   9999999999999984  458999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      |+++....        ........+|+.|+|||.. ...++.++||||+||++|||++|+.||.......          
T Consensus       149 G~~~~~~~--------~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~----------  210 (321)
T d1tkia_         149 GQARQLKP--------GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ----------  210 (321)
T ss_dssp             TTCEECCT--------TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH----------
T ss_pred             chhhcccc--------CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH----------
Confidence            99986521        1122335689999999999 5568999999999999999999999997532211          


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                         -+..+.......                      .......+...+.+|+.+||..||.+|||++|+++
T Consensus       211 ---~~~~i~~~~~~~----------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         211 ---IIENIMNAEYTF----------------------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ---HHHHHHHTCCCC----------------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---HHHHHHhCCCCC----------------------ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               011111110000                      00011112334789999999999999999999986

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.4e-48  Score=373.44  Aligned_cols=243  Identities=22%  Similarity=0.290  Sum_probs=198.0

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec---cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ---QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      ++|++.+.||+|+||.||+|+.. +|+.||||+++..   .....+.+.+|+++|++++||||+++++++     .....
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~  115 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----ccccc
Confidence            57999999999999999999975 7999999999743   233456789999999999999999999985     56778


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .++||||+.+|+|..++...       ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus       116 ~~~v~e~~~~g~l~~~l~~~-------~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DF  185 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLRRI-------GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDF  185 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             cccccccccccchhhhHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeec
Confidence            99999999999999998754       4689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      |+|+....          ......||+.|+|||++ ...++.++|||||||++|||+||+.||.......          
T Consensus       186 G~a~~~~~----------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~----------  245 (350)
T d1rdqe_         186 GFAKRVKG----------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ----------  245 (350)
T ss_dssp             TTCEECSS----------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------
T ss_pred             eeeeeccc----------ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH----------
Confidence            99987621          22346799999999999 4468999999999999999999999996531110          


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC-----ChHHHHH
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRV-----GMKFVVN  463 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  463 (477)
                         ....+......               .|.           .+...+.+++.+||+.||.+|+     |++|+++
T Consensus       246 ---~~~~i~~~~~~---------------~p~-----------~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         246 ---IYEKIVSGKVR---------------FPS-----------HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---HHHHHHHCCCC---------------CCT-----------TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---HHHHHhcCCCC---------------CCc-----------cCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence               00111100000               000           0123478999999999999994     8999875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-48  Score=366.60  Aligned_cols=195  Identities=26%  Similarity=0.352  Sum_probs=163.0

Q ss_pred             CCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc-----hhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          161 EENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ-----GALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       161 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      .+++||+|+||+||+|+.. +|+.||||+++....     ...+.+.+|++++++++||||+++++++     ..++..+
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCcee
Confidence            3578999999999999965 699999999874432     1235788999999999999999999995     5667799


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +||||+.++++..+....       ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        77 ivmE~~~~~~~~~~~~~~-------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~  146 (299)
T d1ua2a_          77 LVFDFMETDLEVIIKDNS-------LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGL  146 (299)
T ss_dssp             EEEECCSEEHHHHHTTCC-------SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred             ehhhhhcchHHhhhhhcc-------cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCcc
Confidence            999999988877766533       5688899999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCcccc-cC-CCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NG-HVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      |+....       .........||+.|+|||++ .+ .++.++|||||||++|||+||+.||...
T Consensus       147 a~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~  204 (299)
T d1ua2a_         147 AKSFGS-------PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD  204 (299)
T ss_dssp             GSTTTS-------CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccCC-------CcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence            986532       12223345789999999998 33 4799999999999999999999999653

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-49  Score=372.62  Aligned_cols=264  Identities=20%  Similarity=0.392  Sum_probs=204.8

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC------CCCEEEEEEeeec-cchhhHHHHHHHHHHhcCCCCCcceeeeecccccCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA------DGETAAIKVLKLQ-QQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYE  228 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  228 (477)
                      .++|...+.||+|+||.||+|.++      ++..||||+++.. .......|.+|++++++++||||++++++|     .
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~-----~   93 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S   93 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE-----C
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE-----e
Confidence            467788899999999999999863      3578999999744 334446789999999999999999999997     4


Q ss_pred             CCceeeEEEeecCCCChhhhcccCCCc---ccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC
Q 043902          229 GNDFKALVFEFMRNGNLDQWLHPSTDE---YCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM  305 (477)
Q Consensus       229 ~~~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~  305 (477)
                      ..+..++||||+++|+|.+++......   ......+++..+..++.|+|+||.|||++   +|+||||||+|||+++++
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred             cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCc
Confidence            456789999999999999998643210   01224579999999999999999999999   999999999999999999


Q ss_pred             cEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCC-CCCCcccccccc
Q 043902          306 IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGK-RPTDDMFKDDLS  383 (477)
Q Consensus       306 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~-~p~~~~~~~~~~  383 (477)
                      ++||+|||+++......     .........||+.|+|||.+ .+.++.++|||||||++|||+||. .||.......  
T Consensus       171 ~~Kl~DFGla~~~~~~~-----~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~--  243 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETD-----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--  243 (308)
T ss_dssp             CEEECCTTCCCGGGGGG-----CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--
T ss_pred             eEEEeecccceeccCCc-----ceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH--
Confidence            99999999998764321     12233445689999999999 677999999999999999999985 6665432111  


Q ss_pred             eeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHH
Q 043902          384 IHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVN  463 (477)
Q Consensus       384 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  463 (477)
                                 .+..+.+.... .             .           +..++..+.+++.+||+.||++||||.||++
T Consensus       244 -----------~~~~i~~~~~~-~-------------~-----------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         244 -----------VLRFVMEGGLL-D-------------K-----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             -----------HHHHHHTTCCC-C-------------C-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------HHHHHHhCCCC-C-------------C-----------cccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                       11111111000 0             0           0012345899999999999999999999999


Q ss_pred             HHHHHHH
Q 043902          464 NLQAIRS  470 (477)
Q Consensus       464 ~L~~i~~  470 (477)
                      .|++..+
T Consensus       288 ~L~~~~~  294 (308)
T d1p4oa_         288 SIKEEME  294 (308)
T ss_dssp             HHGGGSC
T ss_pred             HHHHhcC
Confidence            9987644

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=368.17  Aligned_cols=200  Identities=27%  Similarity=0.416  Sum_probs=167.3

Q ss_pred             cCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++...  ....+.+.+|++++++++||||+++++++     .+++..
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~-----~~~~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccc-----ccccce
Confidence            5889999999999999999996 479999999997543  23357899999999999999999999995     567789


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++||||+.++ +.+++....     ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        77 ~iv~e~~~~~-~~~~~~~~~-----~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG  147 (298)
T d1gz8a_          77 YLVFEFLHQD-LKKFMDASA-----LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFG  147 (298)
T ss_dssp             EEEEECCSEE-HHHHHHHTT-----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTT
T ss_pred             eEEEeecCCc-hhhhhhhhc-----ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCC
Confidence            9999999764 444443221     15699999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc--cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI--NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      .|+....       .........||+.|+|||.+  ...++.++|||||||++|||++|+.||...
T Consensus       148 ~a~~~~~-------~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~  206 (298)
T d1gz8a_         148 LARAFGV-------PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD  206 (298)
T ss_dssp             HHHHHCC-------CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cceeccC-------CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence            9987522       12334455799999999987  334689999999999999999999999753

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-48  Score=368.62  Aligned_cols=246  Identities=22%  Similarity=0.383  Sum_probs=196.7

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec---cchhhHHHHHHHHHHh-cCCCCCcceeeeecccccCCCCc
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ---QQGALKSFIDECNALT-SIRHRNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~~~  231 (477)
                      ++|.+.+.||+|+||+||+|+.. +|+.||||+++..   .....+.+..|..++. .++||||+++++++     .+++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence            57889999999999999999975 7899999999743   2334466777877765 68999999999995     5677


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..|+||||+++|+|.+++...       ..+++.++..++.||+.||.|||++   +|+||||||+|||+++++.+||+|
T Consensus        77 ~~yivmEy~~~g~L~~~i~~~-------~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~D  146 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQSC-------HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIAD  146 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred             ceeEEEeecCCCcHHHHhhcc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccc
Confidence            899999999999999999754       4589999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeec
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLM  390 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  390 (477)
                      ||+++....       .........||+.|+|||++ .+.++.++|||||||++|||+||+.||.+.....         
T Consensus       147 FG~a~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---------  210 (320)
T d1xjda_         147 FGMCKENML-------GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---------  210 (320)
T ss_dssp             CTTCBCCCC-------TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------
T ss_pred             cchhhhccc-------ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---------
Confidence            999986522       12233446799999999999 5579999999999999999999999997532211         


Q ss_pred             cCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChH-HHHH
Q 043902          391 ALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMK-FVVN  463 (477)
Q Consensus       391 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~  463 (477)
                              +........           ..+|.           .+...+.+|+.+||+.||++|||+. |+++
T Consensus       211 --------~~~~i~~~~-----------~~~p~-----------~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         211 --------LFHSIRMDN-----------PFYPR-----------WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             --------HHHHHHHCC-----------CCCCT-----------TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             --------HHHHHHcCC-----------CCCCc-----------cCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence                    111000000           00110           0123478999999999999999995 6753

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.8e-48  Score=363.36  Aligned_cols=199  Identities=24%  Similarity=0.357  Sum_probs=169.3

Q ss_pred             cCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      ++|+..+.||+|+||+||+|+.++|+.||||+++...  ....+.+.+|+.+|++++||||+++++++     ...+..+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~~   76 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRLV   76 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeec-----ccCCcee
Confidence            5788999999999999999999999999999997543  33357899999999999999999999995     5667799


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFGL  314 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  314 (477)
                      +++||+.++.+..+....       ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||.
T Consensus        77 i~~e~~~~~~~~~~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~  146 (286)
T d1ob3a_          77 LVFEHLDQDLKKLLDVCE-------GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL  146 (286)
T ss_dssp             EEEECCSEEHHHHHHTST-------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             EEEEeehhhhHHHHHhhc-------CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEeccccc
Confidence            999999887777766543       5699999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      +.....       .........+++.|+|||.+.  ..++.++|||||||++|||++|+.||...
T Consensus       147 a~~~~~-------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~  204 (286)
T d1ob3a_         147 ARAFGI-------PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV  204 (286)
T ss_dssp             HHHHCC----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ceeccc-------CccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence            987532       122233446889999999983  35799999999999999999999999764

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-48  Score=365.58  Aligned_cols=205  Identities=23%  Similarity=0.372  Sum_probs=170.5

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-C-CCEEEEEEeeecc--chhhHHHHHHHHHHhcC---CCCCcceeeeecccccCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-D-GETAAIKVLKLQQ--QGALKSFIDECNALTSI---RHRNILKIVSSCSSVDYE  228 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~  228 (477)
                      .++|++.+.||+|+||+||+|+.. + ++.||||+++...  ......+.+|+.+++.+   +||||++++++|......
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            478999999999999999999863 4 6679999997543  22234566777776655   899999999998654445


Q ss_pred             CCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEE
Q 043902          229 GNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAH  308 (477)
Q Consensus       229 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k  308 (477)
                      .....+++|||+.++++........      ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~------~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~k  156 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPE------PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK  156 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCT------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred             cCceEEEEEEeccCCchhhhhhccC------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCee
Confidence            6678899999998887765544332      5689999999999999999999999   999999999999999999999


Q ss_pred             EecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       309 l~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      |+|||+++...        .........||+.|+|||++ ...++.++||||+||++|||+||+.||...
T Consensus       157 l~dfg~~~~~~--------~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~  218 (305)
T d1blxa_         157 LADFGLARIYS--------FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS  218 (305)
T ss_dssp             ECSCCSCCCCC--------GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ecchhhhhhhc--------ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC
Confidence            99999987642        22334556799999999998 667999999999999999999999999754

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-48  Score=360.46  Aligned_cols=239  Identities=24%  Similarity=0.334  Sum_probs=190.8

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccc------hhhHHHHHHHHHHhcCC--CCCcceeeeeccccc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQ------GALKSFIDECNALTSIR--HRNILKIVSSCSSVD  226 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~  226 (477)
                      .++|++.+.||+|+||.||+|+.. +|+.||||+++....      .....+.+|+.++++++  ||||+++++++    
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~----   78 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF----   78 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE----
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE----
Confidence            357899999999999999999964 799999999974321      12244678999999986  89999999995    


Q ss_pred             CCCCceeeEEEeecCC-CChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC-C
Q 043902          227 YEGNDFKALVFEFMRN-GNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE-G  304 (477)
Q Consensus       227 ~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~  304 (477)
                       .+.+..++||||+.+ +++.+++...       ..+++..+..++.||+.||.|||++   +|+||||||+|||++. +
T Consensus        79 -~~~~~~~lv~e~~~~~~~l~~~~~~~-------~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~  147 (273)
T d1xwsa_          79 -ERPDSFVLILERPEPVQDLFDFITER-------GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNR  147 (273)
T ss_dssp             -ECSSEEEEEEECCSSEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTT
T ss_pred             -eeCCeEEEEEEeccCcchHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCC
Confidence             567789999999976 6788887643       5689999999999999999999999   9999999999999985 4


Q ss_pred             CcEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCC-CCcccceeehHHHHHHHhhCCCCCCccccccc
Q 043902          305 MIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGH-VSILGDIYSYGILLLEIFTGKRPTDDMFKDDL  382 (477)
Q Consensus       305 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~-~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~  382 (477)
                      +.+||+|||+|+...         ........||+.|+|||++ ... ++.++|||||||++|||+||+.||.....   
T Consensus       148 ~~vkl~DFG~a~~~~---------~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---  215 (273)
T d1xwsa_         148 GELKLIDFGSGALLK---------DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---  215 (273)
T ss_dssp             TEEEECCCTTCEECC---------SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---
T ss_pred             CeEEECccccceecc---------cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH---
Confidence            799999999998652         2223456799999999998 334 57789999999999999999999964210   


Q ss_pred             ceeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHH
Q 043902          383 SIHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVV  462 (477)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl  462 (477)
                                      +......               ++.           .+...+.+++.+||+.||++|||++|++
T Consensus       216 ----------------i~~~~~~---------------~~~-----------~~s~~~~~li~~~L~~dp~~R~s~~eil  253 (273)
T d1xwsa_         216 ----------------IIRGQVF---------------FRQ-----------RVSSECQHLIRWCLALRPSDRPTFEEIQ  253 (273)
T ss_dssp             ----------------HHHCCCC---------------CSS-----------CCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             ----------------HhhcccC---------------CCC-----------CCCHHHHHHHHHHccCCHhHCcCHHHHh
Confidence                            0000000               000           0022378899999999999999999998


Q ss_pred             H
Q 043902          463 N  463 (477)
Q Consensus       463 ~  463 (477)
                      +
T Consensus       254 ~  254 (273)
T d1xwsa_         254 N  254 (273)
T ss_dssp             T
T ss_pred             c
Confidence            6

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-46  Score=356.84  Aligned_cols=269  Identities=20%  Similarity=0.291  Sum_probs=202.6

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCceeeE
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFKAL  235 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  235 (477)
                      ++|++.+.||+|+||.||+|+.. +|+.||||++......  +.+..|++++++++|+|++..+..|.    ...+..++
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~----~~~~~~~i   80 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNVM   80 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEE----EETTEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEE----ecCCEEEE
Confidence            57999999999999999999864 7899999998765432  46789999999999888777766653    45677899


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEec---CCCcEEEecc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLD---EGMIAHVGDF  312 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~Df  312 (477)
                      ||||+ ++++.+.+....      ..+++..+..++.|++.||+|||++   +|+||||||+|||++   .+..+||+||
T Consensus        81 vme~~-~~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DF  150 (299)
T d1ckia_          81 VMELL-GPSLEDLFNFCS------RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDF  150 (299)
T ss_dssp             EEECC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred             EEEEc-CCchhhhhhhcc------CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeecc
Confidence            99999 556666655432      5689999999999999999999999   999999999999985   4557999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccccC-CCCcccceeehHHHHHHHhhCCCCCCcccccccceeeeeecc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING-HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKFVLMA  391 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  391 (477)
                      |+|+.+..................||+.|+|||.+.+ .++.++|||||||++|||+||+.||..........       
T Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~-------  223 (299)
T d1ckia_         151 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-------  223 (299)
T ss_dssp             SSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------------
T ss_pred             CcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH-------
Confidence            9999875433333223334456789999999999944 68999999999999999999999997643221100       


Q ss_pred             CCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHHHHHh
Q 043902          392 LPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQAIRSK  471 (477)
Q Consensus       392 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  471 (477)
                         .............                     .......++..+.+++..|++.||++||+++++.+.|+.+..+
T Consensus       224 ---~~~~~~~~~~~~~---------------------~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         224 ---KYERISEKKMSTP---------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             ----HHHHHHHHHHSC---------------------HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ---HHHHhhcccCCCC---------------------hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence               0001100000000                     0001112245588999999999999999999999999987654


Q ss_pred             h
Q 043902          472 I  472 (477)
Q Consensus       472 ~  472 (477)
                      .
T Consensus       280 ~  280 (299)
T d1ckia_         280 Q  280 (299)
T ss_dssp             H
T ss_pred             c
Confidence            3

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-46  Score=362.23  Aligned_cols=206  Identities=24%  Similarity=0.306  Sum_probs=169.1

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeecc-chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQ-QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      +.+|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++||||+++++++....+......
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            46799999999999999999986 489999999997543 3445788999999999999999999999865444444445


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      +++ +|+.+|+|.+++..        ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus        87 ~l~-~~~~~g~L~~~l~~--------~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG  154 (345)
T d1pmea_          87 YLV-THLMGADLYKLLKT--------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFG  154 (345)
T ss_dssp             EEE-EECCCEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEE-EeecCCchhhhhhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccC
Confidence            555 56679999999964        3489999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccc-c-CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-N-GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      +++.......    .........||+.|+|||.+ . ..++.++||||+||++|||++|+.||...
T Consensus       155 ~a~~~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~  216 (345)
T d1pmea_         155 LARVADPDHD----HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK  216 (345)
T ss_dssp             TCEECCGGGC----BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ceeeccCCCc----cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCC
Confidence            9987633211    12223456799999999998 3 35789999999999999999999999764

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.1e-45  Score=348.24  Aligned_cols=271  Identities=14%  Similarity=0.199  Sum_probs=207.9

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCC-CCcceeeeecccccCCCCcee
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRH-RNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~~~~~  233 (477)
                      .++|++.+.||+|+||.||+|+.. +|+.||||+++....  ...+.+|++.++.++| +|++.+++++     ..+...
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~   76 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHN   76 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCCcc
Confidence            467999999999999999999965 789999999865432  2457789999999965 8999999885     556778


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecC-----CCcEE
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDE-----GMIAH  308 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-----~~~~k  308 (477)
                      ++||||+ +++|.+++....      ..+++..+..++.|++.||.|||++   +|+||||||+||+++.     ++.+|
T Consensus        77 ~~vme~~-~~~l~~~~~~~~------~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vk  146 (293)
T d1csna_          77 VLVIDLL-GPSLEDLLDLCG------RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIY  146 (293)
T ss_dssp             EEEEECC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEE
T ss_pred             EEEEEec-CCCHHHHHHhhc------cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceE
Confidence            9999999 789999887543      4689999999999999999999999   9999999999999974     56899


Q ss_pred             EecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcccccccceeee
Q 043902          309 VGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLSIHKF  387 (477)
Q Consensus       309 l~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~  387 (477)
                      |+|||+|+.+..................||+.|+|||.+ ...++.++|||||||++|||+||+.||.........    
T Consensus       147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~----  222 (293)
T d1csna_         147 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK----  222 (293)
T ss_dssp             ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH----
T ss_pred             EcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH----
Confidence            999999998754333222233344566899999999999 446999999999999999999999999753221100    


Q ss_pred             eeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCChHHHHHHHHH
Q 043902          388 VLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVGMKFVVNNLQA  467 (477)
Q Consensus       388 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  467 (477)
                            .....+.+......                     ..+....++.++.+++..|++.+|++||+++.+.+.|++
T Consensus       223 ------~~~~~i~~~~~~~~---------------------~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~  275 (293)
T d1csna_         223 ------QKYERIGEKKQSTP---------------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK  275 (293)
T ss_dssp             ------HHHHHHHHHHHHSC---------------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             ------HHHHHHHhccCCCC---------------------hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence                  00111111100000                     001111234458899999999999999999999999998


Q ss_pred             HHHhhhh
Q 043902          468 IRSKIRM  474 (477)
Q Consensus       468 i~~~~~~  474 (477)
                      +.++...
T Consensus       276 ~~~~~~~  282 (293)
T d1csna_         276 VLERLNT  282 (293)
T ss_dssp             HHHHTTC
T ss_pred             HHHHcCC
Confidence            8776543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-45  Score=349.53  Aligned_cols=209  Identities=22%  Similarity=0.370  Sum_probs=168.0

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec--cchhhHHHHHHHHHHhcCCCCCcceeeeeccccc---CCC
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSSCSSVD---YEG  229 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---~~~  229 (477)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++...  .......+.+|+++|++++|||++++++++....   ...
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            478999999999999999999974 7999999998644  2334577899999999999999999999875422   123


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEE
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHV  309 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl  309 (477)
                      ....++||||+.++.+..+....       ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~-------~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl  158 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVL-------VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKL  158 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTT-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEE
T ss_pred             CceEEEEEeccCCCccchhhhcc-------cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEe
Confidence            45689999999887776655433       5688999999999999999999999   9999999999999999999999


Q ss_pred             ecccccccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          310 GDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       310 ~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      +|||+++........   .........||+.|+|||.+.  ..++.++|||||||++|||++|+.||...
T Consensus       159 ~dfg~~~~~~~~~~~---~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~  225 (318)
T d3blha1         159 ADFGLARAFSLAKNS---QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN  225 (318)
T ss_dssp             CCCTTCEECCC--------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             eecceeeeccccccc---ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC
Confidence            999999865322111   122334457999999999983  35899999999999999999999999753

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-46  Score=359.41  Aligned_cols=201  Identities=26%  Similarity=0.346  Sum_probs=163.3

Q ss_pred             CCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCCcceeeeeccccc-CCCCceeeE
Q 043902          158 NFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIRHRNILKIVSSCSSVD-YEGNDFKAL  235 (477)
Q Consensus       158 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~~~~~~l  235 (477)
                      +|+..++||+|+||+||+|+.. +|+.||||+++....    ...+|+++|++++||||+++++++.... ..+..+.++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5788899999999999999975 799999999975432    2347999999999999999999975432 134456789


Q ss_pred             EEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC-cEEEecccc
Q 043902          236 VFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM-IAHVGDFGL  314 (477)
Q Consensus       236 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~DfG~  314 (477)
                      ||||++++.+..+.....    ....+++..+..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+
T Consensus        97 v~Ey~~~~~~~~l~~~~~----~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~  169 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSR----AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS  169 (350)
T ss_dssp             EEECCSEEHHHHHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred             EEeccCCccHHHHHhhhh----ccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccc
Confidence            999998764444332111    125699999999999999999999999   999999999999999765 899999999


Q ss_pred             cccccccCCCCCCCccccCCCcccccccCccccc--CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          315 AKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN--GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       315 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      ++....        ........||..|+|||.+.  ..++.++||||+||++|||++|+.||...
T Consensus       170 a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~  226 (350)
T d1q5ka_         170 AKQLVR--------GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD  226 (350)
T ss_dssp             CEECCT--------TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred             hhhccC--------CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC
Confidence            987632        12233457899999999873  46899999999999999999999999753

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-45  Score=355.72  Aligned_cols=200  Identities=27%  Similarity=0.348  Sum_probs=164.6

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeec--cchhhHHHHHHHHHHhcCCCCCcceeeeeccccc-CCCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ--QQGALKSFIDECNALTSIRHRNILKIVSSCSSVD-YEGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~~~  231 (477)
                      .++|++.+.||+|+||+||+|... +|+.||||+++..  .....+.+.+|+++|++++|||||+++++|.... .....
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            468999999999999999999964 7999999999753  2334568899999999999999999999975432 12344


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..++||||+ +.+|..+.+.        ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+|++|
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~D  164 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH--------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILD  164 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred             eEEEEEecc-cccHHHHHHh--------ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccc
Confidence            679999999 6678877653        3599999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-c-CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-N-GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      ||+|+...          .......||+.|+|||.+ . ..++.++||||+||++|||++|+.||...
T Consensus       165 fg~a~~~~----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~  222 (346)
T d1cm8a_         165 FGLARQAD----------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS  222 (346)
T ss_dssp             CTTCEECC----------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccceeccC----------CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence            99998652          123456789999999998 3 35799999999999999999999999764

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-45  Score=345.50  Aligned_cols=198  Identities=23%  Similarity=0.353  Sum_probs=170.9

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCcee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDFK  233 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  233 (477)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++...  ......+.+|+.++++++||||++++++|     ......
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-----ccccce
Confidence            57899999999999999999964 78999999997543  34457899999999999999999999996     567788


Q ss_pred             eEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEeccc
Q 043902          234 ALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDFG  313 (477)
Q Consensus       234 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  313 (477)
                      ++|++++.+++|..++...       ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus        77 ~iv~~~~~~~~l~~~~~~~-------~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG  146 (292)
T d1unla_          77 TLVFEFCDQDLKKYFDSCN-------GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFG  146 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTT-------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             eEEeeeccccccccccccc-------cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecc
Confidence            9999999999998887654       5688999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCccccc-C-CCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYIN-G-HVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      .++.....       ........++..|+|||.+. . .++.++|||||||++|||++|+.||..
T Consensus       147 ~a~~~~~~-------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~  204 (292)
T d1unla_         147 LARAFGIP-------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_dssp             TCEECCSC-------CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred             hhhcccCC-------CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence            99876321       22233445788899999983 3 379999999999999999999999744

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.6e-45  Score=352.09  Aligned_cols=194  Identities=25%  Similarity=0.350  Sum_probs=166.0

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCC-CCCcceeeeecccccCCCCceee
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIR-HRNILKIVSSCSSVDYEGNDFKA  234 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~  234 (477)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++...   .+.+.+|+++|.+++ ||||+++++++..   ......+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~~  108 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPA  108 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCcee
Confidence            57999999999999999999974 78999999997543   367889999999995 9999999998642   3456789


Q ss_pred             EEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCC-cEEEeccc
Q 043902          235 LVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGM-IAHVGDFG  313 (477)
Q Consensus       235 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~DfG  313 (477)
                      +||||+.+++|..+.          ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++ .+||+|||
T Consensus       109 ~v~e~~~~~~L~~~~----------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG  175 (328)
T d3bqca1         109 LVFEHVNNTDFKQLY----------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWG  175 (328)
T ss_dssp             EEEECCCSCBGGGTT----------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGG
T ss_pred             EEEeecCCCcHHHHh----------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccc
Confidence            999999999997764          3589999999999999999999999   999999999999998654 69999999


Q ss_pred             ccccccccCCCCCCCccccCCCcccccccCcccccC--CCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          314 LAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING--HVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       314 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      +|+....        ........+|..|+|||.+.+  .++.++||||+||++|||++|+.||...
T Consensus       176 ~a~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~  233 (328)
T d3bqca1         176 LAEFYHP--------GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG  233 (328)
T ss_dssp             GCEECCT--------TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             cceeccC--------CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence            9987532        122344578999999999833  4799999999999999999999999653

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-44  Score=348.84  Aligned_cols=201  Identities=24%  Similarity=0.231  Sum_probs=160.3

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccC-CCCc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDY-EGND  231 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~  231 (477)
                      .++|++.++||+|+||+||+|+.. +|+.||||+++...  ......+.+|+.++++++||||+++++++..... +...
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            367999999999999999999975 79999999997543  3344678999999999999999999999754322 3567


Q ss_pred             eeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEec
Q 043902          232 FKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGD  311 (477)
Q Consensus       232 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  311 (477)
                      ..|+||||+.++.+. .+.         ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+|++|
T Consensus        96 ~~~iv~Ey~~~~l~~-~~~---------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~d  162 (355)
T d2b1pa1          96 DVYLVMELMDANLCQ-VIQ---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  162 (355)
T ss_dssp             EEEEEEECCSEEHHH-HHT---------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred             eeEEEEeccchHHHH-hhh---------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeec
Confidence            899999999765554 443         3478999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          312 FGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       312 fG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      ||+++....        ........+|+.|+|||++ ...++.++||||+||++|||++|+.||...
T Consensus       163 f~~~~~~~~--------~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~  221 (355)
T d2b1pa1         163 FGLARTAGT--------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  221 (355)
T ss_dssp             CCC-----------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hhhhhcccc--------ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence            999876522        2233455689999999999 556899999999999999999999999653

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=350.34  Aligned_cols=201  Identities=23%  Similarity=0.336  Sum_probs=167.3

Q ss_pred             hcCCCCCCeeeeeccceEEEEEe-CCCCEEEEEEeeecc--chhhHHHHHHHHHHhcCCCCCcceeeeecccccCCCCce
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTL-ADGETAAIKVLKLQQ--QGALKSFIDECNALTSIRHRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .++|++.+.||+|+||+||+|+. .+|+.||||+++...  ....+.+.+|+++|++++|||++++++++..........
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            57899999999999999999986 479999999997543  334467889999999999999999999875433223444


Q ss_pred             eeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCcEEEecc
Q 043902          233 KALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMIAHVGDF  312 (477)
Q Consensus       233 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  312 (477)
                      .+++++|+.+|+|.+++..        ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+|++||
T Consensus        97 ~~~i~~~~~gg~L~~~~~~--------~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~df  165 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC--------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF  165 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEEeecCCchhhhccc--------ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCcccccccccccccccc
Confidence            5667788889999999854        3589999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCCCCCCCccccCCCcccccccCcccc-c-CCCCcccceeehHHHHHHHhhCCCCCCcc
Q 043902          313 GLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-N-GHVSILGDIYSYGILLLEIFTGKRPTDDM  377 (477)
Q Consensus       313 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~  377 (477)
                      |.+...          ........|+..|+|||.. . ..++.++|||||||++|+|++|+.||...
T Consensus       166 g~a~~~----------~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~  222 (348)
T d2gfsa1         166 GLARHT----------DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT  222 (348)
T ss_dssp             ----CC----------TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             chhccc----------CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence            999754          2233456799999999987 3 34789999999999999999999999753

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-44  Score=344.54  Aligned_cols=252  Identities=22%  Similarity=0.332  Sum_probs=195.6

Q ss_pred             hcCCCCCCeeeeeccceEEEEEeC----CCCEEEEEEeeec----cchhhHHHHHHHHHHhcCCC-CCcceeeeeccccc
Q 043902          156 TDNFSEENLIGSGSFGSVYKGTLA----DGETAAIKVLKLQ----QQGALKSFIDECNALTSIRH-RNILKIVSSCSSVD  226 (477)
Q Consensus       156 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~  226 (477)
                      .++|++.+.||+|+||+||+|+..    +|+.||||+++..    .....+.+.+|++++++++| |||+++++++    
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~----   98 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF----   98 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE----
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee----
Confidence            367999999999999999999852    5889999998643    22345678899999999976 8999999985    


Q ss_pred             CCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEecCCCc
Q 043902          227 YEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLLDEGMI  306 (477)
Q Consensus       227 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~  306 (477)
                       +.....++||||+.+|+|.+++...       ..+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.
T Consensus        99 -~~~~~~~~v~e~~~~~~L~~~i~~~-------~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~  167 (322)
T d1vzoa_          99 -QTETKLHLILDYINGGELFTHLSQR-------ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGH  167 (322)
T ss_dssp             -EETTEEEEEECCCCSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSC
T ss_pred             -ccCCceeeeeecccccHHHHHHHhc-------ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCC
Confidence             5667899999999999999998754       4578899999999999999999999   9999999999999999999


Q ss_pred             EEEecccccccccccCCCCCCCccccCCCcccccccCcccccC---CCCcccceeehHHHHHHHhhCCCCCCcccccccc
Q 043902          307 AHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYING---HVSILGDIYSYGILLLEIFTGKRPTDDMFKDDLS  383 (477)
Q Consensus       307 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~  383 (477)
                      +||+|||+++.+...      .........|++.|+|||.+.+   .++.++|||||||++|||+||+.||........ 
T Consensus       168 vkL~DFG~a~~~~~~------~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-  240 (322)
T d1vzoa_         168 VVLTDFGLSKEFVAD------ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-  240 (322)
T ss_dssp             EEESCSSEEEECCGG------GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-
T ss_pred             EEEeeccchhhhccc------ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence            999999999875321      2223345678999999999832   478899999999999999999999976432211 


Q ss_pred             eeeeeeccCCchhHHHhhhhhhhhhcccccccccccccchhhhHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCC-----h
Q 043902          384 IHKFVLMALPSHVMDVLDLSMLLEEENDHEKHEEEDLFPDIESQVAQKKLEECLVSVMRIGVMCSAASPRDRVG-----M  458 (477)
Q Consensus       384 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~  458 (477)
                                  ...+........           ...|           ..+...+.+++.+||++||++|||     +
T Consensus       241 ------------~~~i~~~~~~~~-----------~~~~-----------~~~s~~~~~li~~~l~~dP~~R~s~~~~t~  286 (322)
T d1vzoa_         241 ------------QAEISRRILKSE-----------PPYP-----------QEMSALAKDLIQRLLMKDPKKRLGCGPRDA  286 (322)
T ss_dssp             ------------HHHHHHHHHHCC-----------CCCC-----------TTSCHHHHHHHHHHTCSSGGGSTTSSTTTH
T ss_pred             ------------HHHHHHhcccCC-----------CCCc-----------ccCCHHHHHHHHHHcccCHHHcCCCCcccH
Confidence                        011111000000           0000           011334889999999999999995     7


Q ss_pred             HHHHH
Q 043902          459 KFVVN  463 (477)
Q Consensus       459 ~evl~  463 (477)
                      +|+++
T Consensus       287 ~eil~  291 (322)
T d1vzoa_         287 DEIKE  291 (322)
T ss_dssp             HHHHT
T ss_pred             HHHHc
Confidence            88875

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3e-39  Score=314.24  Aligned_cols=199  Identities=22%  Similarity=0.272  Sum_probs=156.0

Q ss_pred             cCCCCCCeeeeeccceEEEEEeC-CCCEEEEEEeeeccchhhHHHHHHHHHHhcCC-----------CCCcceeeeeccc
Q 043902          157 DNFSEENLIGSGSFGSVYKGTLA-DGETAAIKVLKLQQQGALKSFIDECNALTSIR-----------HRNILKIVSSCSS  224 (477)
Q Consensus       157 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~  224 (477)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++.... ..+.+.+|++++++++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            35999999999999999999964 799999999985532 2367788998888775           5789999888642


Q ss_pred             ccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeEecC
Q 043902          225 VDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN-QYDTPIAHCDLKSSNVLLDE  303 (477)
Q Consensus       225 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~  303 (477)
                         ......+++++++..+..........    ....+++..+..++.||+.||.|||+ .   +|+||||||+|||++.
T Consensus        92 ---~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~  161 (362)
T d1q8ya_          92 ---KGPNGVHVVMVFEVLGENLLALIKKY----EHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEI  161 (362)
T ss_dssp             ---EETTEEEEEEEECCCCEEHHHHHHHT----TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEE
T ss_pred             ---ccccceeeeeeecccccccccccccc----cccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeec
Confidence               33455666777665544322222111    22568899999999999999999998 6   9999999999999986


Q ss_pred             CC------cEEEecccccccccccCCCCCCCccccCCCcccccccCcccc-cCCCCcccceeehHHHHHHHhhCCCCCCc
Q 043902          304 GM------IAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIPPEYI-NGHVSILGDIYSYGILLLEIFTGKRPTDD  376 (477)
Q Consensus       304 ~~------~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~  376 (477)
                      ++      .++++|||.+....          .......||+.|+|||.+ ...++.++||||+||+++||++|+.||..
T Consensus       162 ~~~~~~~~~~kl~dfg~s~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~  231 (362)
T d1q8ya_         162 VDSPENLIQIKIADLGNACWYD----------EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP  231 (362)
T ss_dssp             EETTTTEEEEEECCCTTCEETT----------BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             cCcccccceeeEeecccccccc----------cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCC
Confidence            54      49999999997642          122345799999999998 66789999999999999999999999965

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=3e-25  Score=194.29  Aligned_cols=164  Identities=19%  Similarity=0.158  Sum_probs=120.8

Q ss_pred             CCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccc------------------hhhHHHHHHHHHHhcCCCCCcceeeee
Q 043902          160 SEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQ------------------GALKSFIDECNALTSIRHRNILKIVSS  221 (477)
Q Consensus       160 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~l~~~  221 (477)
                      .+.+.||+|+||.||+|+..+|+.||||+++....                  ........|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            35679999999999999988999999998763211                  012345568889999999999988876


Q ss_pred             cccccCCCCceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeEe
Q 043902          222 CSSVDYEGNDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQYDTPIAHCDLKSSNVLL  301 (477)
Q Consensus       222 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll  301 (477)
                      .         ..+++|||+++..+..              ++......++.|+++|+.|||++   +|+||||||+|||+
T Consensus        83 ~---------~~~lvme~~~~~~~~~--------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv  136 (191)
T d1zara2          83 E---------GNAVLMELIDAKELYR--------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV  136 (191)
T ss_dssp             E---------TTEEEEECCCCEEGGG--------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred             c---------CCEEEEEeeccccccc--------------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheee
Confidence            2         1379999998865543              23334567899999999999999   99999999999999


Q ss_pred             cCCCcEEEecccccccccccCCCCCCCccccCCCcccccccC------cccccCCCCcccceeehHHHHH
Q 043902          302 DEGMIAHVGDFGLAKFLFEESNTPSKNQTMSNGLKGSVGYIP------PEYINGHVSILGDIYSYGILLL  365 (477)
Q Consensus       302 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~Dv~S~Gvvl~  365 (477)
                      +++ .++|+|||.|.....    +  .         ...|..      .+.+...++.++|+||..--+.
T Consensus       137 ~~~-~~~liDFG~a~~~~~----~--~---------~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         137 SEE-GIWIIDFPQSVEVGE----E--G---------WREILERDVRNIITYFSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             ETT-EEEECCCTTCEETTS----T--T---------HHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred             eCC-CEEEEECCCcccCCC----C--C---------cHHHHHHHHHHHHHHHcCCCCCcccHHHHHHHHh
Confidence            976 589999999975411    0  0         001111      1233456889999999865443

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.42  E-value=4.2e-14  Score=132.55  Aligned_cols=87  Identities=33%  Similarity=0.519  Sum_probs=78.9

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcCCcc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGNDKL   80 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~~l   80 (477)
                      |++++|+++|.+| +++.+++|+.|+|++|+|+|.+|.+|++|++|++|||++|+|+|.+|....+.++..+.+.+|+.+
T Consensus       226 l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l  304 (313)
T d1ogqa_         226 IHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL  304 (313)
T ss_dssp             EECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEE
T ss_pred             ccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccc
Confidence            4688999997765 699999999999999999999999999999999999999999999998777888888999999999


Q ss_pred             ccccccccCCcc
Q 043902           81 CGGIQKLQLPEC   92 (477)
Q Consensus        81 ~g~~~~~~~~~~   92 (477)
                      ||.|    +|+|
T Consensus       305 ~g~p----lp~c  312 (313)
T d1ogqa_         305 CGSP----LPAC  312 (313)
T ss_dssp             ESTT----SSCC
T ss_pred             cCCC----CCCC
Confidence            9975    4666

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.08  E-value=4e-11  Score=95.16  Aligned_cols=74  Identities=24%  Similarity=0.321  Sum_probs=61.5

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~   78 (477)
                      |+|++|+|+ .+|. ++++++|++|||++|.|+ .+|..|+.+++|+.|++++|+|+ .+|....+.++..+.+.+|.
T Consensus         3 L~Ls~n~l~-~l~~-l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~~~~~l~~L~~L~l~~N~   76 (124)
T d1dcea3           3 LHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQELLLCNNR   76 (124)
T ss_dssp             EECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCGGGTTCSSCCEEECCSSC
T ss_pred             EEcCCCCCC-CCcc-cccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccCccccccccCeEECCCCc
Confidence            689999999 7774 899999999999999998 78888999999999999999998 46665556677777766664

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.01  E-value=4.8e-11  Score=111.28  Aligned_cols=79  Identities=27%  Similarity=0.286  Sum_probs=66.9

Q ss_pred             CeecCCcccc--cCchhccCCCCCCeEECCC-CccCcccCcccCCCCCCCeEEcccccccCcCccccc-ccccchhhhhc
Q 043902            1 LYLGNNSFKG--TIPVSLKSLRGLAELDLSC-NNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGI-FANASAISIVG   76 (477)
Q Consensus         1 l~l~~n~~~g--~~p~~~~~l~~L~~l~l~~-N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-~~~~~~~~~~~   76 (477)
                      |+|++|+++|  .||.++++|++|++|+|++ |+|+|.||.+|++|++|++|+|++|+|+|.+|.... ...+..+....
T Consensus        55 L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~  134 (313)
T d1ogqa_          55 LDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSY  134 (313)
T ss_dssp             EEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCS
T ss_pred             EECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccccccc
Confidence            6899999998  6899999999999999996 899999999999999999999999999998876533 44455555555


Q ss_pred             CCc
Q 043902           77 NDK   79 (477)
Q Consensus        77 n~~   79 (477)
                      |..
T Consensus       135 N~~  137 (313)
T d1ogqa_         135 NAL  137 (313)
T ss_dssp             SEE
T ss_pred             ccc
Confidence            543

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.98  E-value=2.7e-10  Score=90.22  Aligned_cols=74  Identities=28%  Similarity=0.344  Sum_probs=62.3

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcc---cccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISR---EGIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~---~~~~~~~~~~~~~~n   77 (477)
                      |+|++|+|+ .+|.+++.+++|+.|++++|.|+ .+|. ++.+++|+.|++++|+|+. +|.   ...+.++..+.+.+|
T Consensus        25 L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~~-~~~l~~L~~L~l~~N~i~~-~~~~~~l~~~~~L~~L~l~~N  100 (124)
T d1dcea3          25 LDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQ-SAAIQPLVSCPRLVLLNLQGN  100 (124)
T ss_dssp             EECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCGG-GTTCSSCCEEECCSSCCCS-SSTTGGGGGCTTCCEEECTTS
T ss_pred             EECCCCccC-cchhhhhhhhccccccccccccc-ccCc-cccccccCeEECCCCccCC-CCCchhhcCCCCCCEEECCCC
Confidence            689999999 89999999999999999999999 6774 9999999999999999994 333   233556667777777


Q ss_pred             C
Q 043902           78 D   78 (477)
Q Consensus        78 ~   78 (477)
                      +
T Consensus       101 ~  101 (124)
T d1dcea3         101 S  101 (124)
T ss_dssp             G
T ss_pred             c
Confidence            4

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=98.96  E-value=2.5e-10  Score=98.22  Aligned_cols=82  Identities=20%  Similarity=0.277  Sum_probs=61.8

Q ss_pred             CeecCCcccccCc-hhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccccc-ccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIP-VSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGI-FANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p-~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-~~~~~~~~~~~n~   78 (477)
                      |+|++|+|++.++ ..|+++++|++|+|++|++++..|..|..+++|+.|+|++|+|++..|..+. +.++..+.+.+| 
T Consensus        34 L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N-  112 (192)
T d1w8aa_          34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDN-  112 (192)
T ss_dssp             EECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSS-
T ss_pred             EEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCc-
Confidence            5788999986564 4578899999999999999988888888889999999999999865555433 556666666655 


Q ss_pred             ccccc
Q 043902           79 KLCGG   83 (477)
Q Consensus        79 ~l~g~   83 (477)
                      .+.+-
T Consensus       113 ~l~~i  117 (192)
T d1w8aa_         113 QISCV  117 (192)
T ss_dssp             CCCEE
T ss_pred             ccccc
Confidence            44443

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.90  E-value=7.3e-10  Score=91.57  Aligned_cols=80  Identities=26%  Similarity=0.339  Sum_probs=61.1

Q ss_pred             CeecCC-cccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCC
Q 043902            1 LYLGNN-SFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n-~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~   78 (477)
                      |+|++| .|+..-+.+|.+|++|+.|+|++|+|++.-|..|..+++|++|+|++|+|+ .+|.. +...++..+.+.+|+
T Consensus        36 L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np  114 (156)
T d2ifga3          36 LYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNP  114 (156)
T ss_dssp             EECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSC
T ss_pred             eecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhccccccccccCCCc
Confidence            456555 588433456999999999999999999666778999999999999999999 45543 445567778888887


Q ss_pred             ccc
Q 043902           79 KLC   81 (477)
Q Consensus        79 ~l~   81 (477)
                      .-|
T Consensus       115 ~~C  117 (156)
T d2ifga3         115 LHC  117 (156)
T ss_dssp             CCC
T ss_pred             ccC
Confidence            654

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=98.83  E-value=1.4e-09  Score=93.33  Aligned_cols=80  Identities=21%  Similarity=0.279  Sum_probs=46.9

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccc-cccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREG-IFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~~~~~~~~~~~n~~   79 (477)
                      |+|++|++++.+|..+..+++|++|+|++|+|++..|..|.+|++|++|+|++|+|++..|..+ .+.++..+.+.+|+.
T Consensus        59 L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~  138 (192)
T d1w8aa_          59 LELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF  138 (192)
T ss_dssp             EECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCB
T ss_pred             eeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccc
Confidence            4566666665555666666666666666666664445556666666666666666664444332 244455555555544


Q ss_pred             c
Q 043902           80 L   80 (477)
Q Consensus        80 l   80 (477)
                      .
T Consensus       139 ~  139 (192)
T d1w8aa_         139 N  139 (192)
T ss_dssp             C
T ss_pred             c
Confidence            3

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.71  E-value=3.7e-09  Score=87.77  Aligned_cols=75  Identities=19%  Similarity=0.171  Sum_probs=62.2

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~   78 (477)
                      |+|++|+|+ .||..+..+++|+.||||+|+|+ .++ .|..+++|+.|+|++|+++...+.. ..+.++..+.+.+|.
T Consensus        23 L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~   98 (162)
T d1a9na_          23 LDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS   98 (162)
T ss_dssp             EECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCC
T ss_pred             EECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceecccc
Confidence            689999999 88987889999999999999999 775 5899999999999999999544433 236677777777774

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.66  E-value=1.1e-08  Score=92.53  Aligned_cols=81  Identities=30%  Similarity=0.275  Sum_probs=67.6

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGNDK   79 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~~   79 (477)
                      |++++|.+++..|..+..+++|+.|++++|+|++..|..|..+++|++|+|++|+|+ .+|.. ..+.++..+.+.+|+.
T Consensus       129 L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~  207 (266)
T d1p9ag_         129 LYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW  207 (266)
T ss_dssp             EECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred             ccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCC
Confidence            467889999555556888999999999999999777788999999999999999999 77765 4466777888888987


Q ss_pred             ccc
Q 043902           80 LCG   82 (477)
Q Consensus        80 l~g   82 (477)
                      .|.
T Consensus       208 ~Cd  210 (266)
T d1p9ag_         208 LCN  210 (266)
T ss_dssp             CCS
T ss_pred             CCC
Confidence            764

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.64  E-value=8.4e-09  Score=94.23  Aligned_cols=76  Identities=22%  Similarity=0.245  Sum_probs=46.7

Q ss_pred             eecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccccc-ccccchhhhhcC
Q 043902            2 YLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGI-FANASAISIVGN   77 (477)
Q Consensus         2 ~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-~~~~~~~~~~~n   77 (477)
                      ++++|+|++..|..|+.+++|+.|+|++|+|++..|..|..+++|+.|++++|++++..|..+. +.++..+.+.+|
T Consensus       135 ~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N  211 (284)
T d1ozna_         135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN  211 (284)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             hhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccccc
Confidence            5667777744445566777777777777777755566667777777777777777765555432 334444444433

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.57  E-value=3e-08  Score=91.43  Aligned_cols=59  Identities=31%  Similarity=0.280  Sum_probs=42.1

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEIS   61 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p   61 (477)
                      |++++|.+++..|..+.++++|++|+|++|+|+ .||.+|.++++|++|+|++|+|+ .|+
T Consensus       200 L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~-~i~  258 (305)
T d1xkua_         200 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIG  258 (305)
T ss_dssp             EECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC-CCC
T ss_pred             cccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccC-ccC
Confidence            356677777666666777777777777777777 66777777777777777777777 444

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.55  E-value=2.2e-08  Score=90.39  Aligned_cols=71  Identities=21%  Similarity=0.261  Sum_probs=39.4

Q ss_pred             ecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcC
Q 043902            3 LGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGN   77 (477)
Q Consensus         3 l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n   77 (477)
                      .++|+|+ .||.++.  ++|++|||++|+|++..|.+|.++++|+.|+|++|+|+ .+|....+.++..+.+.+|
T Consensus        17 C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~~~~l~~L~~L~Ls~N   87 (266)
T d1p9ag_          17 CDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPVLGTLDLSHN   87 (266)
T ss_dssp             CTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEECCSCCTTCCEEECCSS
T ss_pred             ccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccccccccccccccccccc
Confidence            4555666 5665553  35666666666666433345666666666666666665 4444434445555554444

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.52  E-value=1.8e-08  Score=83.48  Aligned_cols=75  Identities=19%  Similarity=0.219  Sum_probs=59.2

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc---ccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE---GIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~~~~~~~~~~~n   77 (477)
                      |+|++|+|+ .++ .++.+++|++|+|++|+++...|..+..+++|+.|+|++|+|+. ++..   ..+.++..+.+.+|
T Consensus        46 L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N  122 (162)
T d1a9na_          46 IDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE-LGDLDPLASLKSLTYLCILRN  122 (162)
T ss_dssp             EECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSS
T ss_pred             EECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceeccccccc-cccccccccccccchhhcCCC
Confidence            689999999 775 59999999999999999994444456789999999999999984 4432   33556666666666


Q ss_pred             C
Q 043902           78 D   78 (477)
Q Consensus        78 ~   78 (477)
                      +
T Consensus       123 ~  123 (162)
T d1a9na_         123 P  123 (162)
T ss_dssp             G
T ss_pred             c
Confidence            4

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.50  E-value=2.1e-07  Score=83.49  Aligned_cols=149  Identities=14%  Similarity=0.146  Sum_probs=98.6

Q ss_pred             HHHHhhcCCCCCCeeeeeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCC-CCCcceeeeecccccCCC
Q 043902          151 KISNATDNFSEENLIGSGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIR-HRNILKIVSSCSSVDYEG  229 (477)
Q Consensus       151 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~  229 (477)
                      ++......|+..+..+.++.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++.++     ..
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~   81 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RH   81 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----ec
Confidence            3444455665555444444568999875 56678888887655444456778888877663 33356666663     34


Q ss_pred             CceeeEEEeecCCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHcCC------------------------
Q 043902          230 NDFKALVFEFMRNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHNQY------------------------  285 (477)
Q Consensus       230 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------  285 (477)
                      ++..++||+++++.++.+......            ....++.++++.+..||+..                        
T Consensus        82 ~~~~~lv~~~l~G~~~~~~~~~~~------------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (263)
T d1j7la_          82 DGWSNLLMSEADGVLCSEEYEDEQ------------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNND  149 (263)
T ss_dssp             TTEEEEEEECCSSEEHHHHTTTCS------------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTT
T ss_pred             CCceEEEEEecccccccccccccc------------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHH
Confidence            567899999999988866543211            12234555666666666421                        


Q ss_pred             --------------------------------CCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          286 --------------------------------DTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       286 --------------------------------~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                                                      ...++|+|+.|.||+++++..+-|.||+.+..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         150 LADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                            12379999999999999877777999998864

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.33  E-value=2e-07  Score=84.78  Aligned_cols=77  Identities=21%  Similarity=0.205  Sum_probs=36.6

Q ss_pred             eecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccc-cccccchhhhhcCC
Q 043902            2 YLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREG-IFANASAISIVGND   78 (477)
Q Consensus         2 ~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~~~~~~~~~~~n~   78 (477)
                      +|++|+|++..|..|.++++|+.|++++|++++..|..|..+++|+.||+++|++++..|... ...++..+.+.+|+
T Consensus       159 ~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~  236 (284)
T d1ozna_         159 FLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNP  236 (284)
T ss_dssp             ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSC
T ss_pred             ccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCC
Confidence            445555554444445555555555555555554445555555555555555555554333321 23334444444443

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.32  E-value=1.4e-07  Score=89.63  Aligned_cols=71  Identities=20%  Similarity=0.243  Sum_probs=39.5

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhc
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVG   76 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~   76 (477)
                      |+|++|+|++ ++ .+..+++|++|+|++|+|+ .+| .|+.|++|++|+|++|+|++.+| ...+.++..+.+.+
T Consensus       312 L~ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~  382 (384)
T d2omza2         312 LTLYFNNISD-IS-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLND  382 (384)
T ss_dssp             EECCSSCCSC-CG-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCC
T ss_pred             EECCCCCCCC-Cc-ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCC
Confidence            3566666664 33 2666666666666666666 344 46666666666666666665433 22233444443333

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.27  E-value=4.6e-07  Score=74.21  Aligned_cols=76  Identities=16%  Similarity=0.030  Sum_probs=60.3

Q ss_pred             eecCCcccccCchhccCCCCCCeEECCCC-ccCcccCcccCCCCCCCeEEcccccccCcCcccc-cccccchhhhhcCC
Q 043902            2 YLGNNSFKGTIPVSLKSLRGLAELDLSCN-NLSGKVPQFFSKLLSLRHLNLSYNELDGEISREG-IFANASAISIVGND   78 (477)
Q Consensus         2 ~l~~n~~~g~~p~~~~~l~~L~~l~l~~N-~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~~~~~~~~~~~n~   78 (477)
                      +.++|+++ .+|..+..+++|++|+|++| .|+..-+..|..|++|+.|+|++|+|+...|..+ .+.++..+.+.+|.
T Consensus        14 ~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~   91 (156)
T d2ifga3          14 RCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA   91 (156)
T ss_dssp             ECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred             EecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence            56788888 88999999999999999766 5884444679999999999999999996555543 35566666666664

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.17  E-value=7.8e-07  Score=81.60  Aligned_cols=77  Identities=27%  Similarity=0.300  Sum_probs=65.4

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccc-ccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISRE-GIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~   78 (477)
                      |++++|.+++.+|..+.+++.+++|++++|.+++..|..+..+++|+.|+|++|.|+ .+|.. ..+.++..+.+.+|.
T Consensus       176 L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~  253 (305)
T d1xkua_         176 LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNN  253 (305)
T ss_dssp             EECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSC
T ss_pred             EECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCc
Confidence            578899999999999999999999999999999877888999999999999999998 56665 336677777777663

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=98.15  E-value=2.8e-08  Score=85.35  Aligned_cols=64  Identities=27%  Similarity=0.326  Sum_probs=46.9

Q ss_pred             cCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCccccc-ccccchhhhhcC
Q 043902           11 TIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGI-FANASAISIVGN   77 (477)
Q Consensus        11 ~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-~~~~~~~~~~~n   77 (477)
                      .+|.+++.|++|++|+|++|+|+ .|| .|..|++|+.|+|++|+|+ .+|.... ..++..+.+.+|
T Consensus        39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N  103 (198)
T d1m9la_          39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYN  103 (198)
T ss_dssp             CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEE
T ss_pred             hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccc
Confidence            45567888999999999999988 676 4888889999999999888 5664432 334555555555

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.15  E-value=6.5e-07  Score=78.36  Aligned_cols=59  Identities=24%  Similarity=0.322  Sum_probs=27.5

Q ss_pred             ccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcC
Q 043902           16 LKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGN   77 (477)
Q Consensus        16 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n   77 (477)
                      +.++++|+.|++++|.+++..+  ++++++|+.|+|++|++++ +|....+.++..+.+.+|
T Consensus       147 ~~~~~~L~~L~l~~n~~~~~~~--l~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls~N  205 (227)
T d1h6ua2         147 LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNN  205 (227)
T ss_dssp             GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECTTS
T ss_pred             hccccccccccccccccccchh--hcccccceecccCCCccCC-ChhhcCCCCCCEEECcCC
Confidence            4445555555555555542221  4555555555555555553 333333344444444443

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.13  E-value=1e-06  Score=76.05  Aligned_cols=73  Identities=21%  Similarity=0.290  Sum_probs=53.7

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~   78 (477)
                      |++++|.++ .++ .+..+++|++|+|++|+|++ +| .++.|++|+.|++++|+|++ +|....+.++..+.+.+|.
T Consensus        51 L~l~~~~i~-~l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~~l~~l~~L~~L~l~~~~  123 (210)
T d1h6ta2          51 IIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNG  123 (210)
T ss_dssp             EECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTSC
T ss_pred             EECcCCCCC-Cch-hHhhCCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-ccccccccccccccccccc
Confidence            467888888 455 37888999999999999985 55 36888899999999999884 5654445566666555553

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.09  E-value=1.5e-06  Score=74.28  Aligned_cols=72  Identities=19%  Similarity=0.347  Sum_probs=44.4

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n   77 (477)
                      |++++|+++ .++ .+..|++|++|+|++|+|++. |. ++++++|+.|++++|.+. .+|....+..+..+.+.+|
T Consensus        45 L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~~-~~~~l~~l~~L~~L~l~~~  116 (199)
T d2omxa2          45 LQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIA-DITPLANLTNLTGLTLFNN  116 (199)
T ss_dssp             EECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCC-CCGGGTTCTTCSEEECCSS
T ss_pred             EECCCCCCC-Ccc-ccccCCCcCcCccccccccCc-cc-ccCCcccccccccccccc-ccccccccccccccccccc
Confidence            456677776 554 367777777777777777743 32 777777777777777776 3443333444444444433

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.00  E-value=2.2e-06  Score=80.92  Aligned_cols=72  Identities=18%  Similarity=0.320  Sum_probs=56.4

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n   77 (477)
                      |++++|+++ .+ +.+..|++|++|||++|+|+ .+|. |++|++|++|+|++|++++. +....+.++..+...+|
T Consensus        49 L~l~~~~I~-~l-~gl~~L~nL~~L~Ls~N~l~-~l~~-l~~L~~L~~L~L~~n~i~~i-~~l~~l~~L~~L~~~~~  120 (384)
T d2omza2          49 LQADRLGIK-SI-DGVEYLNNLTQINFSNNQLT-DITP-LKNLTKLVDILMNNNQIADI-TPLANLTNLTGLTLFNN  120 (384)
T ss_dssp             EECCSSCCC-CC-TTGGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSS
T ss_pred             EECCCCCCC-Cc-cccccCCCCCEEeCcCCcCC-CCcc-ccCCcccccccccccccccc-ccccccccccccccccc
Confidence            578899998 56 46899999999999999999 5554 99999999999999999964 44444566666555444

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.00  E-value=1.3e-05  Score=71.00  Aligned_cols=131  Identities=15%  Similarity=0.111  Sum_probs=83.1

Q ss_pred             eeeeecc-ceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCC--CCCcceeeeecccccCCCCceeeEEEeec
Q 043902          164 LIGSGSF-GSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIR--HRNILKIVSSCSSVDYEGNDFKALVFEFM  240 (477)
Q Consensus       164 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~~~~~~lv~e~~  240 (477)
                      .+..|.. +.||+....++..+++|.......   ..+..|...+..+.  .-.+.++++++     .+++..++||+++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~-----~~~~~~~~v~~~i   88 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLLLGEV   88 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEEEECC
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeec-----ccccceEEEEEee
Confidence            3445554 578999988888899998765433   34566777766653  23356667664     3456689999999


Q ss_pred             CCCChhhhcccCCCcccccccCCHHHHHHHHHHHHHHHHHHHc-------------------------------------
Q 043902          241 RNGNLDQWLHPSTDEYCHFKKLSLMQRLNIVIDVASALDYLHN-------------------------------------  283 (477)
Q Consensus       241 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-------------------------------------  283 (477)
                      +|.++.+...            ..   ...+.++++.|.-||+                                     
T Consensus        89 ~G~~~~~~~~------------~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (255)
T d1nd4a_          89 PGQDLLSSHL------------AP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  153 (255)
T ss_dssp             SSEETTTSCC------------CH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             eccccccccc------------cH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchh
Confidence            8866543210            10   1112223333333332                                     


Q ss_pred             --------------CC----CCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          284 --------------QY----DTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       284 --------------~~----~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                                    ..    .+.++|+|+.|.||+++++..+-|+||+.+..
T Consensus       154 ~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         154 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                          11    12489999999999999887778999988754

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.98  E-value=3.3e-06  Score=72.77  Aligned_cols=72  Identities=24%  Similarity=0.341  Sum_probs=56.2

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n   77 (477)
                      |+|++|+|++ +| .+++|++|++|++++|+|+ .+| .+..+++|+.|++++|.++ .++....+..+..+...+|
T Consensus        73 L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~-~~~~l~~l~~l~~l~~~~n  144 (210)
T d1h6ta2          73 LFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLGNN  144 (210)
T ss_dssp             EECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCC-CCGGGGGCTTCCEEECCSS
T ss_pred             EeCCCccccC-cc-ccccCcccccccccccccc-ccc-ccccccccccccccccccc-ccccccccccccccccccc
Confidence            6899999995 66 4799999999999999999 577 5899999999999999987 4554434444444444444

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.96  E-value=4e-06  Score=71.54  Aligned_cols=73  Identities=21%  Similarity=0.337  Sum_probs=58.3

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~   78 (477)
                      |+|++|+|++ +|+ ++++++|++|++++|.++ .+|. ++.+++|+.|++++|.+... +....+.++..+.+.+|.
T Consensus        67 L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~l~~~~~~~~-~~~~~l~~L~~L~l~~n~  139 (199)
T d2omxa2          67 INFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLTLFNNQITDI-DPLKNLTNLNRLELSSNT  139 (199)
T ss_dssp             EECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCGG-GTTCTTCSEEECCSSCCCCC-GGGTTCTTCSEEECCSSC
T ss_pred             CccccccccC-ccc-ccCCcccccccccccccc-cccc-cccccccccccccccccccc-cccchhhhhHHhhhhhhh
Confidence            6899999995 554 999999999999999998 6664 89999999999999999853 434445666666666553

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.85  E-value=4.3e-07  Score=74.98  Aligned_cols=67  Identities=27%  Similarity=0.227  Sum_probs=48.9

Q ss_pred             cCchhccCCCCCCeEECCCCccCcc--cCcccCCCCCCCeEEcccccccCcCccc--ccccccchhhhhcCC
Q 043902           11 TIPVSLKSLRGLAELDLSCNNLSGK--VPQFFSKLLSLRHLNLSYNELDGEISRE--GIFANASAISIVGND   78 (477)
Q Consensus        11 ~~p~~~~~l~~L~~l~l~~N~l~g~--~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~~~~~~~~~~n~   78 (477)
                      .++.....+++|++|+||+|+|+..  ++..+..+++|+.||||+|.++ .++..  .....+..+.+.+|+
T Consensus        56 ~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Np  126 (162)
T d1koha1          56 TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNS  126 (162)
T ss_dssp             HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTST
T ss_pred             hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCC
Confidence            4454556789999999999999942  3456788999999999999999 45543  223455666666664

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=97.81  E-value=8.8e-07  Score=75.66  Aligned_cols=74  Identities=26%  Similarity=0.342  Sum_probs=61.1

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcCC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGND   78 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~   78 (477)
                      |+|++|+|+ .|| .++.|++|+.|+|++|.|+ .+|..+..+++|+.|++++|+++. ++....+.++..+.+.+|.
T Consensus        53 L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~~~~~l~~L~~L~L~~N~  126 (198)
T d1m9la_          53 LALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LSGIEKLVNLRVLYMSNNK  126 (198)
T ss_dssp             EECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HHHHHHHHHSSEEEESEEE
T ss_pred             eECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-cccccccccccccccccch
Confidence            689999999 786 5999999999999999999 888777777899999999999994 5554456666666666663

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=97.80  E-value=8.7e-06  Score=75.55  Aligned_cols=66  Identities=27%  Similarity=0.378  Sum_probs=48.1

Q ss_pred             CeecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcC
Q 043902            1 LYLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGN   77 (477)
Q Consensus         1 l~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n   77 (477)
                      |+|++|.++ .+|+.   +++|++|+|++|+|+ .+|..++   +|+.|++++|+++ .++...  ..+..+.+.+|
T Consensus        43 LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~~---~L~~L~l~~n~l~-~l~~lp--~~L~~L~L~~n  108 (353)
T d1jl5a_          43 LELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELPQ---SLKSLLVDNNNLK-ALSDLP--PLLEYLGVSNN  108 (353)
T ss_dssp             EECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCCT---TCCEEECCSSCCS-CCCSCC--TTCCEEECCSS
T ss_pred             EEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccchh---hhhhhhhhhcccc-hhhhhc--ccccccccccc
Confidence            689999999 89964   578999999999999 8997654   6788888888887 454321  22344444444

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.69  E-value=1.1e-05  Score=70.97  Aligned_cols=75  Identities=21%  Similarity=0.280  Sum_probs=56.0

Q ss_pred             eecCCcccccCchhccCCCCCCeEECCCCccCcccCc-ccCCCCCCCeEEcccccccCcCcccc--cccccchhhhhcCC
Q 043902            2 YLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQ-FFSKLLSLRHLNLSYNELDGEISREG--IFANASAISIVGND   78 (477)
Q Consensus         2 ~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~L~~l~l~~N~l~g~~p~~~--~~~~~~~~~~~~n~   78 (477)
                      +.++++++ .+|.++-  +++++|||++|+|+ .+|. .|.++++|++|+|++|.+...+|...  .+..+..+.+..++
T Consensus        14 ~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n   89 (242)
T d1xwdc1          14 LCQESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN   89 (242)
T ss_dssp             EEESCSCS-SCCSCSC--SCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCT
T ss_pred             EEeCCCCC-CcCCCCC--CCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeeccccccccccccccccccc
Confidence            45678888 8998763  68999999999999 5654 78999999999999999987776542  24445555555444


Q ss_pred             cc
Q 043902           79 KL   80 (477)
Q Consensus        79 ~l   80 (477)
                      .+
T Consensus        90 ~l   91 (242)
T d1xwdc1          90 NL   91 (242)
T ss_dssp             TC
T ss_pred             cc
Confidence            43

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.67  E-value=1.9e-05  Score=68.57  Aligned_cols=52  Identities=27%  Similarity=0.346  Sum_probs=28.0

Q ss_pred             eecCCcccccCchhccCCCCCCeEECCCCccCcccCcccCCCCCCCeEEccccccc
Q 043902            2 YLGNNSFKGTIPVSLKSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELD   57 (477)
Q Consensus         2 ~l~~n~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~   57 (477)
                      ++++|+++ .++ .+++|++|++|+|++|++++..|  +..+++|+.|++++|.++
T Consensus        47 ~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~   98 (227)
T d1h6ua2          47 SAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK   98 (227)
T ss_dssp             ECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS
T ss_pred             ECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--cccccccccccccccccc
Confidence            44555555 443 35555555555555555553322  555555555555555555

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.63  E-value=6.5e-06  Score=67.58  Aligned_cols=61  Identities=28%  Similarity=0.225  Sum_probs=49.2

Q ss_pred             CeecCCccccc--CchhccCCCCCCeEECCCCccCcccCc-ccCCCCCCCeEEcccccccCcCcc
Q 043902            1 LYLGNNSFKGT--IPVSLKSLRGLAELDLSCNNLSGKVPQ-FFSKLLSLRHLNLSYNELDGEISR   62 (477)
Q Consensus         1 l~l~~n~~~g~--~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~L~~l~l~~N~l~g~~p~   62 (477)
                      |+|++|+|+..  ++..+..+++|+.|||++|.++ .++. .+....+|+.|+|++|.+++....
T Consensus        70 L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~  133 (162)
T d1koha1          70 LNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRD  133 (162)
T ss_dssp             CCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSS
T ss_pred             eeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCccc
Confidence            78999999942  3456889999999999999999 6655 444556899999999999876553

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=97.60  E-value=2.5e-05  Score=72.34  Aligned_cols=55  Identities=27%  Similarity=0.318  Sum_probs=41.0

Q ss_pred             cCCCCCCeEECCCCccCcccCcccCCCCCCCeEEcccccccCcCcccccccccchhhhhcCC
Q 043902           17 KSLRGLAELDLSCNNLSGKVPQFFSKLLSLRHLNLSYNELDGEISREGIFANASAISIVGND   78 (477)
Q Consensus        17 ~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~   78 (477)
                      ..+++|++|+|++|+|+ .+|..   +++|+.|+|++|+|+ .+|..  ..++..+.+.+|+
T Consensus       281 ~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~--~~~L~~L~L~~N~  335 (353)
T d1jl5a_         281 DLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL--PQNLKQLHVEYNP  335 (353)
T ss_dssp             CCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC--CTTCCEEECCSSC
T ss_pred             ccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc--cCCCCEEECcCCc
Confidence            34678889999999988 78864   467888899999888 67754  3456667766665

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.59  E-value=5.3e-05  Score=69.65  Aligned_cols=72  Identities=13%  Similarity=0.116  Sum_probs=46.8

Q ss_pred             ceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCC--cceeeeecccccCCCCceeeEEEeecCCC
Q 043902          171 GSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRN--ILKIVSSCSSVDYEGNDFKALVFEFMRNG  243 (477)
Q Consensus       171 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~~~~~~lv~e~~~~g  243 (477)
                      -.||+++..+|+.+++|+.+.... ..+++..|.+.+..|....  ++..+...........+..+.++++++|.
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            489999999999999999875532 2366778888887774222  22222221111223456678899998764

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.48  E-value=2.5e-05  Score=68.40  Aligned_cols=76  Identities=17%  Similarity=0.201  Sum_probs=59.2

Q ss_pred             CeecCCcccccCch-hccCCCCCCeEECCCCccCcccCc-ccCCCCCCCeEEccc-ccccCcCcccc-cccccchhhhhc
Q 043902            1 LYLGNNSFKGTIPV-SLKSLRGLAELDLSCNNLSGKVPQ-FFSKLLSLRHLNLSY-NELDGEISREG-IFANASAISIVG   76 (477)
Q Consensus         1 l~l~~n~~~g~~p~-~~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~L~~l~l~~-N~l~g~~p~~~-~~~~~~~~~~~~   76 (477)
                      |+|++|+|+ .||. .|.++++|++|+|++|.++..+|. .|..+++++.|+++. |+++...+..+ .+.++..+.+.+
T Consensus        34 L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~  112 (242)
T d1xwdc1          34 LRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN  112 (242)
T ss_dssp             EEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEES
T ss_pred             EECcCCcCC-ccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccccch
Confidence            689999999 6665 699999999999999999877765 688999999999864 67775555542 345666666655


Q ss_pred             C
Q 043902           77 N   77 (477)
Q Consensus        77 n   77 (477)
                      |
T Consensus       113 ~  113 (242)
T d1xwdc1         113 T  113 (242)
T ss_dssp             C
T ss_pred             h
Confidence            5

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.40  E-value=0.00014  Score=68.62  Aligned_cols=75  Identities=17%  Similarity=0.108  Sum_probs=47.4

Q ss_pred             CeeeeeccceEEEEEeC-CCCEEEEEEeeec-------cchhhHHHHHHHHHHhcCC-C--CCcceeeeecccccCCCCc
Q 043902          163 NLIGSGSFGSVYKGTLA-DGETAAIKVLKLQ-------QQGALKSFIDECNALTSIR-H--RNILKIVSSCSSVDYEGND  231 (477)
Q Consensus       163 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~~~  231 (477)
                      +.||.|....||+++.. +++.++||.-...       ......+...|.+.|..+. +  ..+.+++.++       .+
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-------~~  104 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------TE  104 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------TT
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-------CC
Confidence            46899999999999865 4678999975421       1112344556777776652 2  3466666653       23


Q ss_pred             eeeEEEeecCCCC
Q 043902          232 FKALVFEFMRNGN  244 (477)
Q Consensus       232 ~~~lv~e~~~~g~  244 (477)
                      ..++|||++++..
T Consensus       105 ~~~lvmE~L~~~~  117 (392)
T d2pula1         105 MAVTVMEDLSHLK  117 (392)
T ss_dssp             TTEEEECCCTTSE
T ss_pred             CCEEEEeccCCcc
Confidence            4578999997643

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.59  E-value=0.019  Score=51.51  Aligned_cols=168  Identities=11%  Similarity=-0.013  Sum_probs=82.1

Q ss_pred             ccHHHHHHhhcCCCCCCeee-----eeccceEEEEEeCCCCEEEEEEeeeccchhhHHHHHHHHHHhcCCCCC--cceee
Q 043902          147 LSYLKISNATDNFSEENLIG-----SGSFGSVYKGTLADGETAAIKVLKLQQQGALKSFIDECNALTSIRHRN--ILKIV  219 (477)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~lg-----~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~  219 (477)
                      .+..++.....+|...+...     .|---+.|+.+..+| .+++|++.....  ......|++++..+...+  +...+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence            45567777778887755443     455567899988665 489999865322  134444566666553222  22211


Q ss_pred             eecccc-cCCCCceeeEEEeecCCCChhhh--------------cc----cCCCcccccc----------------cCCH
Q 043902          220 SSCSSV-DYEGNDFKALVFEFMRNGNLDQW--------------LH----PSTDEYCHFK----------------KLSL  264 (477)
Q Consensus       220 ~~~~~~-~~~~~~~~~lv~e~~~~g~L~~~--------------l~----~~~~~~~~~~----------------~l~~  264 (477)
                      ...... ..........++.+..+......              ++    ..........                ....
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            111000 01113345566666655432110              00    0000000000                0000


Q ss_pred             HHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeEecCCCcEEEeccccccc
Q 043902          265 MQRLNIVIDVASALDYLHN-QYDTPIAHCDLKSSNVLLDEGMIAHVGDFGLAKF  317 (477)
Q Consensus       265 ~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  317 (477)
                      ......+......+.-.+. ....+++|+|+.++||+++.+...-|.||+.+..
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            1111122222222222222 1234799999999999999988778999998854

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.56  E-value=0.00024  Score=67.92  Aligned_cols=57  Identities=26%  Similarity=0.222  Sum_probs=32.8

Q ss_pred             eecCCcccccC----chhccCCCCCCeEECCCCccCcc----cCcccC-CCCCCCeEEcccccccC
Q 043902            2 YLGNNSFKGTI----PVSLKSLRGLAELDLSCNNLSGK----VPQFFS-KLLSLRHLNLSYNELDG   58 (477)
Q Consensus         2 ~l~~n~~~g~~----p~~~~~l~~L~~l~l~~N~l~g~----~p~~~~-~l~~L~~l~l~~N~l~g   58 (477)
                      ++++|.++..-    ...+...++|++|+|++|+|++.    ++..+. ..+.|++|+|++|+|+.
T Consensus       318 ~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~  383 (460)
T d1z7xw1         318 WVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD  383 (460)
T ss_dssp             ECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred             cccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCCh
Confidence            45566665432    22334455677777777777642    344443 34567777777777763

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.52  E-value=0.0042  Score=58.08  Aligned_cols=73  Identities=14%  Similarity=0.115  Sum_probs=48.6

Q ss_pred             CCeeeeeccceEEEEEeCC--------CCEEEEEEeeeccchhhHHHHHHHHHHhcCC-CCCcceeeeecccccCCCCce
Q 043902          162 ENLIGSGSFGSVYKGTLAD--------GETAAIKVLKLQQQGALKSFIDECNALTSIR-HRNILKIVSSCSSVDYEGNDF  232 (477)
Q Consensus       162 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~  232 (477)
                      .+.|+.|-.-.+|++...+        .+.|.+++... ... .....+|..+++.+. +.-..++++++.         
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~---------  115 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET-ESHLVAESVIFTLLSERHLGPKLYGIFS---------  115 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC-HHHHHHHHHHHHHHHHTTSSSCEEEEET---------
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch-hhHHHHHHHHHHHHHhCCCCCeEEEEcC---------
Confidence            3568888888999998753        35677777652 222 245567888888774 433457777752         


Q ss_pred             eeEEEeecCCCCh
Q 043902          233 KALVFEFMRNGNL  245 (477)
Q Consensus       233 ~~lv~e~~~~g~L  245 (477)
                      -.+|+||+++.++
T Consensus       116 ~g~I~efi~g~~l  128 (395)
T d1nw1a_         116 GGRLEEYIPSRPL  128 (395)
T ss_dssp             TEEEECCCCEEEC
T ss_pred             CceEEEEeccccC
Confidence            1689999987544

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.47  E-value=0.00037  Score=62.38  Aligned_cols=40  Identities=20%  Similarity=0.190  Sum_probs=19.0

Q ss_pred             CCCCCeEECCCCccCcc-cCcccCCCCCCCeEEcccccccC
Q 043902           19 LRGLAELDLSCNNLSGK-VPQFFSKLLSLRHLNLSYNELDG   58 (477)
Q Consensus        19 l~~L~~l~l~~N~l~g~-~p~~~~~l~~L~~l~l~~N~l~g   58 (477)
                      ..+|++|||++|.+++. ++..+..+++|++|+|+++.+++
T Consensus        45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~   85 (284)
T d2astb2          45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSD   85 (284)
T ss_dssp             CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCH
T ss_pred             CCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCc
Confidence            34455555555554432 23334455555555555555443

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.20  E-value=0.0019  Score=57.57  Aligned_cols=43  Identities=33%  Similarity=0.323  Sum_probs=29.7

Q ss_pred             ccCCCCCCeEECCCC-ccCcccCcccCCCCCCCeEEccc-ccccC
Q 043902           16 LKSLRGLAELDLSCN-NLSGKVPQFFSKLLSLRHLNLSY-NELDG   58 (477)
Q Consensus        16 ~~~l~~L~~l~l~~N-~l~g~~p~~~~~l~~L~~l~l~~-N~l~g   58 (477)
                      +.++++|++|+|++| .+++..+..++++++|++|+|++ +.+++
T Consensus       171 ~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~  215 (284)
T d2astb2         171 VRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIP  215 (284)
T ss_dssp             HHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCG
T ss_pred             ccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCCh
Confidence            456777777777764 56766777777777777777777 45554

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=95.67  E-value=0.0013  Score=60.28  Aligned_cols=57  Identities=18%  Similarity=0.213  Sum_probs=38.8

Q ss_pred             eecCCcccc----cCchhccCCCCCCeEECCCCccCcc-----cCcccCCCCCCCeEEcccccccC
Q 043902            2 YLGNNSFKG----TIPVSLKSLRGLAELDLSCNNLSGK-----VPQFFSKLLSLRHLNLSYNELDG   58 (477)
Q Consensus         2 ~l~~n~~~g----~~p~~~~~l~~L~~l~l~~N~l~g~-----~p~~~~~l~~L~~l~l~~N~l~g   58 (477)
                      ++++|+++.    .+...+..++.|+.|+|++|+++..     +...+..+++|+.|+|++|.|+.
T Consensus       164 ~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~  229 (344)
T d2ca6a1         164 ICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTH  229 (344)
T ss_dssp             ECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHH
T ss_pred             ecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccc
Confidence            456666652    3444566778888888888887632     34456777888888888888753

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.62  E-value=0.0017  Score=61.69  Aligned_cols=77  Identities=23%  Similarity=0.297  Sum_probs=50.5

Q ss_pred             CeecCCccc----ccCchhccCCCCCCeEECCCCccCc----ccCcccCC-CCCCCeEEcccccccCc----Cccc-ccc
Q 043902            1 LYLGNNSFK----GTIPVSLKSLRGLAELDLSCNNLSG----KVPQFFSK-LLSLRHLNLSYNELDGE----ISRE-GIF   66 (477)
Q Consensus         1 l~l~~n~~~----g~~p~~~~~l~~L~~l~l~~N~l~g----~~p~~~~~-l~~L~~l~l~~N~l~g~----~p~~-~~~   66 (477)
                      |+|++|.|+    ..|+..+..+++|++|||++|.|+.    .+...+.. ..+|+.|+|++|++++.    ++.. ...
T Consensus        32 L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~  111 (460)
T d1z7xw1          32 VRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTL  111 (460)
T ss_dssp             EEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSC
T ss_pred             EEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccchhhcc
Confidence            578888887    2556677889999999999998863    23333332 34799999999998753    2221 123


Q ss_pred             cccchhhhhcC
Q 043902           67 ANASAISIVGN   77 (477)
Q Consensus        67 ~~~~~~~~~~n   77 (477)
                      .++..+.+.+|
T Consensus       112 ~~L~~L~L~~N  122 (460)
T d1z7xw1         112 PTLQELHLSDN  122 (460)
T ss_dssp             TTCCEEECCSS
T ss_pred             ccccccccccc
Confidence            44555555554

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=95.37  E-value=0.0026  Score=58.30  Aligned_cols=58  Identities=21%  Similarity=0.207  Sum_probs=46.5

Q ss_pred             CeecCCccccc-----CchhccCCCCCCeEECCCCccCcc----cCcccCCCCCCCeEEcccccccC
Q 043902            1 LYLGNNSFKGT-----IPVSLKSLRGLAELDLSCNNLSGK----VPQFFSKLLSLRHLNLSYNELDG   58 (477)
Q Consensus         1 l~l~~n~~~g~-----~p~~~~~l~~L~~l~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~g   58 (477)
                      |+|++|+++..     +...+..+++|+.|+|++|.++..    +...+..+++|+.|+|++|.|++
T Consensus       191 L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~  257 (344)
T d2ca6a1         191 VKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA  257 (344)
T ss_dssp             EECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCH
T ss_pred             cccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCc
Confidence            57888988732     445578889999999999998743    55677889999999999999875

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=94.50  E-value=0.0068  Score=48.99  Aligned_cols=58  Identities=17%  Similarity=0.212  Sum_probs=41.8

Q ss_pred             CeecC-Cccccc----CchhccCCCCCCeEECCCCccCcc----cCcccCCCCCCCeEEcccccccC
Q 043902            1 LYLGN-NSFKGT----IPVSLKSLRGLAELDLSCNNLSGK----VPQFFSKLLSLRHLNLSYNELDG   58 (477)
Q Consensus         1 l~l~~-n~~~g~----~p~~~~~l~~L~~l~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~g   58 (477)
                      |+|++ |.++..    +-..+...++|++|+|++|.++..    +...+...++|+.|+|++|.++.
T Consensus        20 L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~   86 (167)
T d1pgva_          20 VNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP   86 (167)
T ss_dssp             EECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred             EEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcch
Confidence            46776 346532    334577888999999999999843    23345567889999999999874

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=93.98  E-value=0.0084  Score=48.43  Aligned_cols=42  Identities=10%  Similarity=0.161  Sum_probs=30.5

Q ss_pred             cCCCCCCeEECCCC-ccCcc----cCcccCCCCCCCeEEcccccccC
Q 043902           17 KSLRGLAELDLSCN-NLSGK----VPQFFSKLLSLRHLNLSYNELDG   58 (477)
Q Consensus        17 ~~l~~L~~l~l~~N-~l~g~----~p~~~~~l~~L~~l~l~~N~l~g   58 (477)
                      .+.++|++|+|+++ .++..    +-..+...++|+.|+|++|.+..
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~   58 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISD   58 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBH
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccch
Confidence            45688999999874 56532    33456777889999999998863

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=87.84  E-value=0.072  Score=42.45  Aligned_cols=45  Identities=9%  Similarity=0.074  Sum_probs=28.4

Q ss_pred             hhccCCCCCCeEECCC-CccCcc----cCcccCCCCCCCeEEcccccccC
Q 043902           14 VSLKSLRGLAELDLSC-NNLSGK----VPQFFSKLLSLRHLNLSYNELDG   58 (477)
Q Consensus        14 ~~~~~l~~L~~l~l~~-N~l~g~----~p~~~~~l~~L~~l~l~~N~l~g   58 (477)
                      .-..+.++|++|+|++ |.++..    +-..+...++|+.|+|++|.++.
T Consensus        11 ~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~   60 (166)
T d1io0a_          11 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSND   60 (166)
T ss_dssp             HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCH
T ss_pred             HHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccH
Confidence            3345667788888876 456522    23345567777888888877753

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=80.62  E-value=0.31  Score=38.45  Aligned_cols=58  Identities=16%  Similarity=0.200  Sum_probs=41.7

Q ss_pred             CeecC-Ccccc----cCchhccCCCCCCeEECCCCccCcc----cCcccCCCCCCCeEEcccccccC
Q 043902            1 LYLGN-NSFKG----TIPVSLKSLRGLAELDLSCNNLSGK----VPQFFSKLLSLRHLNLSYNELDG   58 (477)
Q Consensus         1 l~l~~-n~~~g----~~p~~~~~l~~L~~l~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~g   58 (477)
                      |+|++ |.++.    .+-..+...++|++|+|++|.++..    |-..+...++|+.|++++|.++.
T Consensus        22 L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~   88 (166)
T d1io0a_          22 VNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG   88 (166)
T ss_dssp             EECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred             EEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccc
Confidence            35665 45542    1333456889999999999999854    33345667899999999998873